<SEC-DOCUMENT>0001156039-22-000084.txt : 20221019
<SEC-HEADER>0001156039-22-000084.hdr.sgml : 20221019
<ACCEPTANCE-DATETIME>20221019123821
ACCESSION NUMBER:		0001156039-22-000084
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		97
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20221019
DATE AS OF CHANGE:		20221019

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Elevance Health, Inc.
		CENTRAL INDEX KEY:			0001156039
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				352145715
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16751
		FILM NUMBER:		221317913

	BUSINESS ADDRESS:	
		STREET 1:		220 VIRGINIA AVENUE
		CITY:			INDIANAPOLIS
		STATE:			IN
		ZIP:			46204
		BUSINESS PHONE:		8003311476

	MAIL ADDRESS:	
		STREET 1:		220 VIRGINIA AVENUE
		CITY:			INDIANAPOLIS
		STATE:			IN
		ZIP:			46204

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Anthem, Inc.
		DATE OF NAME CHANGE:	20141202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WELLPOINT, INC
		DATE OF NAME CHANGE:	20100105

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WELLPOINT INC
		DATE OF NAME CHANGE:	20041130
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>elv-20220930.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:975646a6-f010-4ab0-98cc-185c6d29d7c2,g:966d453b-5cd7-4ddd-af0c-9c9c0ae080e9,d:186e051878fe4219970efc72a9fcdad4--><html xmlns:srt="http://fasb.org/srt/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:elv="http://www.elevancehealth.com/20220930" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>elv-20220930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80L2ZyYWc6YTE5MjRjYzczNGQyNGRhOWJjN2NhZTg1NTM1MzBlZWYvdGFibGU6MDljZjgzM2VhYjg4NGMwODg3MzZkZGEyYzYwYTJjM2EvdGFibGVyYW5nZTowOWNmODMzZWFiODg0YzA4ODczNmRkYTJjNjBhMmMzYV8zLTEtMS0xLTcwMzYz_3f8346b1-9706-4d10-bc72-ae8493c78d8b">false</ix:nonNumeric><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80L2ZyYWc6YTE5MjRjYzczNGQyNGRhOWJjN2NhZTg1NTM1MzBlZWYvdGFibGU6MDljZjgzM2VhYjg4NGMwODg3MzZkZGEyYzYwYTJjM2EvdGFibGVyYW5nZTowOWNmODMzZWFiODg0YzA4ODczNmRkYTJjNjBhMmMzYV80LTEtMS0xLTcwMzYz_92a529a6-71e3-4875-a9d2-ced96143ee52">2022</ix:nonNumeric><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80L2ZyYWc6YTE5MjRjYzczNGQyNGRhOWJjN2NhZTg1NTM1MzBlZWYvdGFibGU6MDljZjgzM2VhYjg4NGMwODg3MzZkZGEyYzYwYTJjM2EvdGFibGVyYW5nZTowOWNmODMzZWFiODg0YzA4ODczNmRkYTJjNjBhMmMzYV81LTEtMS0xLTcwMzYz_b69997cd-9ab0-449e-8b64-c53c813ac050">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80L2ZyYWc6YTE5MjRjYzczNGQyNGRhOWJjN2NhZTg1NTM1MzBlZWYvdGFibGU6MDljZjgzM2VhYjg4NGMwODg3MzZkZGEyYzYwYTJjM2EvdGFibGVyYW5nZTowOWNmODMzZWFiODg0YzA4ODczNmRkYTJjNjBhMmMzYV82LTEtMS0xLTcwMzYz_590de4c7-e705-4453-928d-3642df5d7875">0001156039</ix:nonNumeric><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80L2ZyYWc6YTE5MjRjYzczNGQyNGRhOWJjN2NhZTg1NTM1MzBlZWYvdGFibGU6MDljZjgzM2VhYjg4NGMwODg3MzZkZGEyYzYwYTJjM2EvdGFibGVyYW5nZTowOWNmODMzZWFiODg0YzA4ODczNmRkYTJjNjBhMmMzYV83LTEtMS0xLTcwMzYz_7ba497b3-e12f-49b5-9d82-0b1fa73c3019">12/31</ix:nonNumeric><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMS0xLTEtMS03MDM2Mw_0a867403-6163-4051-82f3-50402c642766">28,306</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMS0zLTEtMS03MDM2Mw_5f118897-1645-4ee1-a748-afc09cd8b8b3">25,641</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMi0xLTEtMS03MDM2Mw_9039c42d-2375-449c-8741-c1606109e8f6">10</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMi0zLTEtMS03MDM2Mw_7053144a-90e4-4cba-b0f9-d28ece74226f">6</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfNC0xLTEtMS03MDM2Mw_d48685df-74ba-41a6-ad4b-d31b0eba4ca9">671</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfNC0zLTEtMS03MDM2Mw_5a952f47-aa31-4ce2-8b3a-f860344e37eb">616</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfNS0xLTEtMS03MDM2Mw_fa82274b-0538-4f43-90c2-e9fffad1fc7b">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfNS0zLTEtMS03MDM2Mw_04efe429-4e0b-486a-a2fc-7b5fa1605a84">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfOC0xLTEtMS03MDM2Mw_ca0fb707-1d71-4af4-bbd5-e5106da977e0">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfOC0zLTEtMS03MDM2Mw_7427c26d-ff6f-4863-844d-cad5a9777f37">&#8212;</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfOS0xLTEtMS03MDM2Mw_5db77eb5-5906-4d08-a9e9-16dfa246239b">100,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfOS0zLTEtMS03MDM2Mw_7d4abdea-b813-454f-950e-cfc1f6298d3a">100,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTAtMS0xLTEtNzAzNjM_079347cf-0b40-46d9-ad98-d6b066acbc6d">&#8212;</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTAtMy0xLTEtNzAzNjM_fc00af15-fdb5-404f-9a32-6d14e144665a">&#8212;</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTEtMS0xLTEtNzAzNjM_c7cf99a6-f5da-4a47-a33f-f42a16e1a840">&#8212;</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTEtMy0xLTEtNzAzNjM_f6f8f886-6f8b-4c52-bbf0-64e4dfb0c823">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTMtMS0xLTEtNzAzNjM_3d241e5d-5c29-46d2-be94-0b8fe7946f48">0.01</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTMtMy0xLTEtNzAzNjM_2461a54c-7a42-464d-93a8-56cf16280947">0.01</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTQtMS0xLTEtNzAzNjM_e773574d-9f44-4b45-bf90-86861bfe6b53">900,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTQtMy0xLTEtNzAzNjM_36b8cd6a-a991-4ac0-9222-121b3d2e210b">900,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTUtMS0xLTEtNzAzNjM_8bcc349e-4f7f-4ef1-bde7-d7564b3eb503">238,974,624</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTUtMy0xLTEtNzAzNjM_298a62d1-dc69-4888-aab8-30c42d33b1f3">241,770,746</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTYtMS0xLTEtNzAzNjM_fca7bf09-372d-45c3-9b2a-5c42dce69b68">238,974,624</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTYtMy0xLTEtNzAzNjM_f3edb303-4811-4fb2-9262-5887ac63358e">241,770,746</ix:nonFraction><ix:nonNumeric contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMi0xLTEtMS03NzQ3Mg_35223446-da43-4885-b1af-792d126f0d02">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMi0xLTEtMS03NzQ3Mg_9be99ce3-7827-4188-b28e-80ce38a6cc7e">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMy0xLTEtMS03NzQ4MQ_3f09f4af-f1d9-4a52-8c2e-e79a525ccc59">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMy0xLTEtMS03NzQ4MQ_ce213197-b1dc-4b00-96f5-82a38cd1810f">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfNC0xLTEtMS03NzQ5OQ_3538eea0-82a4-4a60-af7e-b84b7a69ca57">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfNC0xLTEtMS03NzQ5OQ_3bcb0bf3-e902-449c-94d0-fd8995ada510">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="elv-20220930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ffea20b96c2462c92744a6e44bb6555_I20221012"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9aceaf2b19bf4d5d916eb0f2039e41de_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7580839926f4e24b08f10312dd69479_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76e906fcfdeb4832b77b338196e38474_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0197b6d912c4e2c944e0737a73738ae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if80200fe052042f58072c2a346401da5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe28dcb0adc145abbec6cb9c3accca38_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3dffb789514e442d91844bfa2454ef52_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8291afc45194b679cb982efb46d0686_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0227e2707e394244aed3f2fd57a0e03a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c5ee8ddad2f413fa5b819e04a12bc1e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d548577ea164af88a7545c8710fbb5d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a7c1fc826a441d7bce0a7af3b9d916c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f1b74a9d46a4c919ed5a0017b50fe3c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab76c5a7b7904191b99afa7db58ad7f2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedbdb762566945d88726ef37a57f9349_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2eb86bcfdff541038fc2cecb77088e6d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18c7f78957fb4eb298325eb813673f5d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3f5943c567e426a969bf7881111eeb8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i621d34b256184efca4a6e336041bad02_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88a00773c76441adab343709fb0e30d1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc88fa2fe41a476fa802a9582efda818_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cbead8991b44f1e8a37f09fb333172d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa8050991ea141e9b2f0cc25ecfbe2d6_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i235ece1dc7f94255b99200f736f634e0_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bd5ffed39c44ee5bf9209ae6a1336e6_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic32281f0fb4a46c1bd7c7cf96160ceac_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93a6de0ab799413e882ff2eac44ac62c_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25fd263bfa4b408cb320d07c5b039a60_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c004427a7414fc8897f44bcaea19bf9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i754312c63f4847bda9a7fff60f065564_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cdce901c495496b82564eaa2135b662_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86841404e36945a0a2b5a2801b6585e3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0a535c1ffe84e6da717792a25f25e09_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65acda5bd384478ba43ea184238b1adb_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b8abccde0624b77a8a1712e55378767_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i205ff9c272f244b9a2a2473a5d2d0aa2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15035aec9b66494a932fa4d9f722665b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f7b2e2c4f76452991af9030ab9b7ec1_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a417cc9e3284886a04a57fe479fce58_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae11bd779d7e4ef58f1fb3d8564575a0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38ec61ed676c4597b3ce8d3bb80f93a4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2cbc4d0d7964a2681d5c5fa0021cf8b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8e22949ca024e19a7be910f7fb72de0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bcdceadaae34b568b184717c1feb64d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40273135b4c443249ac1e3576b1f8880_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34ca5d23dd9d4c319c952057c4c553af_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1636ce35b3f44cc59d3c0058be2140e7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43c107c4cc114c2994db1a2d71a9a4a9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2cd31b0b2f047d489ecdade092e7658_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fe61236f9a84e4fb0548f191cf989dd_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22199380ce254d5e8f1a20db003d38e1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46b2d401ea4a43a8b53425d8ac39c3cc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90fc51345bd34cceaa9d7388a64ab064_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32778a5cba784b46a29f834b6b7d8ffd_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3596a4a5edf4aca9700a1210c5e82cb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb48a1922b7e435cb7c30da74d59221f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62d7a38b20f74260a57c7b27f73b7906_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2573eaa31b44cd6abfa3facbdb6292a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cfb30e0735e44c5aa78cf9d1eb3d3a8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23a4bf41cfe343828c4306abe17a0154_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68316ab96a734ae2b0f2dd2591bf303f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fb01790dc8947cc9fa28938b654f73f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1c5b423fd0049679c05d61c789fee90_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d28810bc7644f938e65b4df5ea870b9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib068c2f2d2f9451e85b8ebefd20a58b9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12e2179304f94f76a1f8fa22e0c596d7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if71d617a922b4549a876a2aeb86d0fb3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58e67abfbcd74df68e8cc1c6309c6fa7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa6a2ab38f55454590fbcb0d8bf0cb81_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ad7dc64de9f4333a507db7171be2b9f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd7bbc6ac8054bf59b507514156a792b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89e5268adb4e41acac42b6e71ed6a956_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ce5dd3a2a6441349bc5e6572d8958ca_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec47e227732d4b219990442f8321eb49_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72cc3c90ae37402bb1a3406ca8ec8281_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50902a61a4dd4c3abe12641611a989d0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07b85a9cf8364984ad848fb7ac29fcc6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e1170d9414d4932b37104a99abbfcd7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad1b58d99a92454aaecc9a643c16c0c1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id08298fdd1324292a7e56ccb4754a37f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d2e1c82b14b435aa3b898cd3e04de1b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="medical_member"><xbrli:measure>elv:medical_member</xbrli:measure></xbrli:unit><xbrli:unit id="county"><xbrli:measure>elv:county</xbrli:measure></xbrli:unit><xbrli:unit id="states"><xbrli:measure>elv:states</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i2bc73b260c78413bbf502ba5c1050cce_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">elv:IntegraManagedCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67668f78684042f3ae9dc8e1ad62b947_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">elv:IntegraManagedCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26a408574c2c4c619b3f6a7fb2eb52ef_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d84cf76f3a74a17bfd21c61cad87a45_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib724e06caec84704b13a828ba8b9b8fc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ab5335cb1b5494eba34054f0ef63dc2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ce8730226514909b48e611420368522_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dd22b7bb98e4e4f844ecae3c390bdd0_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idba3a272e1b8405eaeead18d34613b77_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i266f1d31e2b94bbcba7b6d2f8441491f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie72e88979b5548e48539cc5d886e25fd_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4f6b49781dc450db479bd159632e422_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51b351f32e2a4a91830c15bcaca2d1a7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67eb9d5cdedf417fa6217167e453f99b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i708db0a3275f4fd58d30b7138cf68571_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08ff1fe2d3cf4ba1a7a645773295ee0d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ea9c5ffa135471d84290457cc62b377_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if46ba3a6ed924704ab80b46d4892ce9c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i582c7462a2a24ee19ae7c3e8b13e6258_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e3fb6e7405848e39ed7671d9a9683da_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie05876f14e3546779aaacef9d285ee2c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5a6260b0cc245e3ad18420b5dda8138_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id54f0058c591469baef2d1557dcb55a8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2340f4d1ac2b47dfbe6521a9386a70f4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9b964677bcb4f018f7b0e35a345ad57_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc53677b69024b148f62349f82fe723c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bd8e4d367e5434c93d5ed2fb93b9c90_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcad3b58ad0a402e9c5f36c2257b46ad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b05039f1d944a39a5f7c4a08ecd9386_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fe0fa1cefe04a9ab9bd771236eb24fd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1998952a2fec4ef987e45747bc6a365e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf59770742dd4e0c909bf664464f6f51_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i962a4141a6934bd0b79803a5e587f115_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b33199b5e8040e88c3779bab1338a41_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="securities"><xbrli:measure>elv:securities</xbrli:measure></xbrli:unit><xbrli:context id="ifcf9e5652a88433fa305f979016b813a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6df5bdfdef2f4265b69076190eb614fd_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icff2cdd7573a4a7cb6c9db9fbe416a43_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib856546a61004b9daf43ccbcaf623bae_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i082f7dec90e34caa9e126e175c14b069_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d1cb440b1e64fc3a441588000782d1b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97d6a8ee2de34d46b8a9b30fcdfac191_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic06c4cd0bfbf4349bb38d37c2a08f1d5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03fb8a2f17234cf88446cfa6c92be531_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i306fe04bc56d46bda85faed45e988b22_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bae2ef9bb1f4ef789325dd8bddd7037_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d30de3c97a84918b22998e42c90804e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25961790b2e241c39e1d9b6ee2a7abf8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e76ffeb19be42d4a1e2d44c3205ecab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47e63f11825d402e9000e5995d8b173f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85e2285118fb48818a1361310a8c779d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a60715792a94db5a003dde44cc00d7d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i808391c8a062488da8dfcc76e14f106b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieaad01ac86274516a2427e2324cbdace_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6ef12a8ed884a10a5de9971fb0a2ef8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i341b56b7c33d48c6ad350fd7fbaf27d5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fddf0df137b450988ab2a4425925e2c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb05027535a4458e88a535ee3031f6ae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67d0a155fc6f462db3e652e6e997c5a6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33efd1a573514923804d15df68fbc169_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7efa70157d8f49d1932d09a94dfe1529_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d4cd6b13d62409ea6135442dfd3c169_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd1d2d7db12846a4a3ec11dffaaa857a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib08d03a09c464eb5bc34b1ee5faf7ea2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i525deba77845499db8929bee8586f509_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if83fa79c889143edbd4e4ba481c5106e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76d0d6767c2146a4aa94f20b9f15ea40_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbe9a6627d614becb080363c4cc79132_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e6a553b24d9430485f058f6dabd9ef0_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i623def1f7d994412a99937dd097a9306_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf2a7ef2990b49d18dfaee52d861df7a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis">us-gaap:MaturityOvernightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d66732359c54c7ba0fed0dc86c8903a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis">us-gaap:MaturityOvernightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55aa272b38d249cf8f65430d3ab7ec89_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis">us-gaap:MaturityOvernightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6575af0d7a33465d80ae8b7e123eb574_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis">us-gaap:MaturityOvernightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82413feb72304cfd9028728f729361cc_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis">us-gaap:MaturityOvernightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee555febc7b1489c841bed85cfdde1c7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis">us-gaap:MaturityOvernightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdb7c3f4f8e543b8a2df60e3edae8983_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0ee2e1f5c8c43419e04e58cfb917f9c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98e1be64addb482ea782f65135d60a05_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fc2e84bcad34027932d35097b9f9bdb_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bebbc6255564194a65092412ac06f67_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ed17b4bb7f34660b7206d12cd763384_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a3b331afc414af99ac6c1599df2287a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79076969c3024e269accd9bc7038ee4d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83c6fbea402043d5841f091c58e82693_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5832f9a26ea3435bbd561c28893f542e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54b54a3342e648a4af00533f1570f055_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80f80d23604d47ea9d6d5d3db271166b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0630c845d0544c8fb78216ec9ee4246a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ea6ffa026ed49ad880282333c15e05b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09ec78a8f2934ad988a5a84ed45afe95_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9963152709494c7192e65f8d93db6abd_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3bd3a5e8f4e46668a696ae3513051dc_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i879983c43359419d9305755bc21b11e8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bae3ca7f392419cb36507af34fd85e1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if54e2a09642243b0af22bd387b96cc86_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i319c0932f552442f91e807fadf6869b2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id72f5fdb790d488389e012081716a861_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd52d310cc6249de9d64e53d7b7f960d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7954908cb6bc4a09af7d436befca47cf_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6d1fbf1b64a48d993287eda3253e59e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c77fcbcf9014952b22ac069325f92a6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8679b29bd646468da600ed87da53d36b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ffe957d5ff14ba187fff4116dcf8991_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0fe98e383084014b1bc9ab32ce423dd_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30a0f87e5ab9493cbf1db457f967922d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id225b53b5eb14421a1c1ea44abf2ab1f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i572ccbdc7947481c8deddaa8e2068caa_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67e47d6156fe4e30a2db3dbc795c804e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie17e65ae944d47f1b80529dd1e22cea8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2b35a0942fa4be398836e787b4033fe_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i194d8de15f8b4abe9a293c428ef86751_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd6037d7dd8543e2a047fa4c031268df_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c4b8b65febc483694f935949190933a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i359143f746854b4a9c1ab808c68d5640_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if36f830bb3c64269a716998cc4d3631d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60026054e5d341ac957c97a96698628d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97d580beda144d4491df94dbd14b5e63_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa2c59dfa7804e66a650f900b9d23c9e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3a7f443bdad4168b5798971706c5f40_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iece93ac436104fd6a1cd99c3cd0e562a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i484f5fd44cb84fbc9b4c45aae397c186_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4609d385fde4f5e8ed90e175cff6320_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2998bb1d7c3e43cb9610ba10dc2f2d9c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0b480fb15b94cdcb1a697f67988e588_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8518fee768764a0f95c228de9e1ea364_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0add331b12f44d51b7ece36e400dc1f5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DerivativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c5802f494354611a73f807c38dce059_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DerivativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e550fd94b994ce49630d8444c71806b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DerivativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icad4a668efc449218c1bacb86f5187e1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DerivativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id12430cdfde949268546e42fae69aacb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f7e82e807e34b52b194ae404cbff7c8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39708ec10b1d42fc910b98395c8b0d03_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52d00975607245648c820ae081dffc76_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52e0633755af4f07991cc898c84730a5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec5d8d8c36b445f181d4b0e14e790e50_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dc525e82e4f4b78b55e13f877d9d212_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i059ab6a34c854d4590c340b2aa206fc2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i017bb4e3633b454f85f310109f119763_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c4f3be4159040cca4c6330bada73b9f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd0cddd1e2704317822ec1aa4b6a8d50_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa1f82c236bf4e9fa6b63e8a1dd059b3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i480713ec0004444aae07ba823a2a3710_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac7e634bfc3043a3b61901be4796c354_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if77a6a1ea8a845e1b8f8f10a6494dd9d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52ea3e0c81e449c4aabaeaba693601b4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d9263de42c24bbeb3029c5c835d1b7e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d73240dd06c484fb3d57ea0c58ca9f6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a51c1b83ca44cebb3cb541c6c1ffd23_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ebb31481dbc46e3a7f18240069b415d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0107aa86d0304c8c820c9d1f402f3a58_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43e3349630db458383c85c2d30827d66_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide59a28c7a594301ab29f18f850bbebb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c0368bfa4554cd2952ff8415fba1e2d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cd0cba106b646758a3d426fe4185e71_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide71a36d93e440ac9bbd26d0f1185292_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3f130bdbeda4a229139760fe1a5256c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b17717cfed84a8695f0ebee25d6d1b0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5595401992294f4db26af9c67d94813c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i247198472ac444b4a705c2d6d3870893_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id70934c0fdca477cbb28d1fa3a921841_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16e26cf91f824b138d31ee3ccbbc2486_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if08d21b298724dbe87a66843d0d5ec37_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcc2f3cd485c43e0a5b93811cbad0040_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id97d07a393824fba8c5a533ddc17248b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d9daa1bf9aa49618c67c4fe0feca8a1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia67cf78d5c9e49c386e4366d79e071f5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e39bd703c7c487eb5d185ba13bfcc36_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66059c1693064085997c288e33979c72_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4693331b053e467aa44d2753305e57c5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55dbd61667064a73939c76e993f892e4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1ea0fca2f2f4b16904060514710f24b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id73c6074257a4797b02f0bb8c9813727_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cda0b9d394240d5bed36877535df125_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia570c61ac2774f2c9b61f2b04614af6f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f9ec3d81af44e958f1beabb66a20af5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77434cd540454880bbde697445471783_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae3f929a16f5495498ceb553e33f710f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab52a629947044ddb6c7a30c64d60ec1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DerivativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18aaf10638ba48758ecf2c6f063e2eef_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DerivativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49bbc62b7c9a4dbfaa94dc46b4ed4750_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DerivativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc70625496934ce88087fd178a0df18b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DerivativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b40fde7beb04a09997961c706c7c577_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93e6bc23bb5d43ee9937560149125ce1_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4cd3d9e543549eaa00430a7132f99eb_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8152f64e6f1140eeb2ee778012282130_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87cc99f09b354f98929e5403fc89254a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a4e9a98582e440e8a5c609a87e70538_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c398eb1a12b438d8cf5d7ed7a27c98d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if55f75de2be747fb9680406ea945d82f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18f0ad9f943549f6888eff0dae5c5a2e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie02e43daa33841138e86f2e8ac128f8a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id659cd826a1649d69ea5d4c304dc4002_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59df98c5cae2479d82b25b79673a28bc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05e4435be64e4eadacb9d5b77a7762b8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e5801b0241a4a7596c82b85f6595b87_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4eb613993924401da535c4ab70affa54_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b050ebc022448918209b90933f84fd1_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59c52d2dd9a244878f20d09c30559d47_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c3c0ca17622496e8271489dbd81a554_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd53ebecdb7c4377a7e274fef86d5b98_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51a6e283ad82499983038a1294335516_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id012155f0536487e80c5f21ecb0cff93_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i956f35bd2d5e479b8fc6a91a40089b3d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f0ecc541cf74ed2a635167eb7164491_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafd89c3d325847c59f8b3bc903c4c035_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i964bac3f30f64868a6e633166235cda5_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37e5af918e28462f98ca407c5455389f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i553640a02dc34c459280bd0390c2547a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i221dfdac7a494b34b788cabffbef260c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65f9f1ca30204478a443b52bedc3c6a1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i991cee8de28a4252a7c5e88856804403_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43ab9adfffbb4e97a0584ba6cb437018_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a83a959df4a4ea893a96ae9001a4dac_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c5c7d954c4c45a3b0db4aa4accc3482_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfaad08561af4facb21116cd28f9c4d5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id13f4c069f824d9e8ada49274ed13fc6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9ee845b2ef44f35b34e439f2a98463e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib31555a5dc6d48e9a6d0c3e812552916_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47db3e3b640944bd98e5bc0d5641a14f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id23aa1cee27e4b5ba329c79f052b0f8d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63d36abe1cfe4cdeab60b3c14cb6960b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf4ef63bd2e548af937bde8217b31fd0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabe0feb61e774f4db61e3b30a3a23479_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i207053455c4d4c45b53e5fa230ebb0ae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a7e8295eb174731af155b02715f0698_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaeb1d12977ce4b2aa244d83f0a51489a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia381401dee2b49a69141fac81ccda064_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1c0c8330af1412c8daa5f4cc313c34b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie12564db4311425aa96c7f9f9b74dc88_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id36628eb07534a42afaaae7affc76a88_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3c6abfca5ec440eb693997af5ab6d46_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib25ede8a88f9477dbd274859e7a2b1b1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bbc82c5b8774ddc80a06a94578b2a62_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7c1d9dfb7814c5da0eb0bcb78535511_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2eef42da7d1c4cd495f66b68093f8dc3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17f3cb9f8c1d492197e639b5a0369fef_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8e9a443d6054bb489dd821a7385bab4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i518bf560bf5b42db9717fa1237d56fc5_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32803f4645204fb0b79a26f39fe31411_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5866a8bbba704cf588b8904b077bac81_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic61874748541445bb5346014604b1e2f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cf718e43d2d431aab9e48ee4460c848_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c42a359a2a345cd9ba70d1ac59c63f2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i013231985bd7411185b88460522d8b36_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3995587e895e4e8e900e6e6a4ad92b08_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i979bf304459b469a85f5dbd972a86ebf_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0595bb2db424b7bac7ac1ec8646dd16_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6f5962645aa44dd9e99d61abdd0873a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice322a96213244e6b5ed9fa8b2fd063c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2c9a53d41b6411c8a7299de747052ee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea0cd3e6f73d4c37a185721b7213f0fe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1007523085804985812acc850dc8d6fe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4182a920dc6d4e8cb42614e778766e1c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibacb5db0efb1418d913cc8583b863da5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icaff25a1e31245299f7a5ef30e5e99d3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id192e31548bb42f29d1bf3d4dbb6cda2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b0ea34f1f294d20a310a2ef4c41c0f4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5424e3c2015944248e4c1ead87f81144_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e857bc4e13a4ae5a65583609fa0ba9a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64ce2ea324434d348d29360ed18b52c5_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9adaeacf598a42c3b72b8540b126e10b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2a144458c3940758b57b3397f45a257_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice7c432e6884478fb38f1d9ca1399f9d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice7f613275f549788763308d4be93610_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id81fb73bd9e640338bfa72bb4f5aeb76_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bc19a6512f743a0a8a79c92a23c64a9_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee58b3e2710246daa6dbe09d63e5064d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35884d0201ae464ebc6e5b8946fa1612_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie653179541d1493c93be7e3886e9fb52_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7c823f42d7a4c78b75c5623fcf615d7_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieef52ac747e64c7391e7c7a1120b53d2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8ff1fa5d8714816a640a8280fcee30a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i757b9a9c9e7e4558a1cd9992f88382fc_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b17535592154a3fb04e22ab93e36684_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e4c924470664c728da0afbb46130f3e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ed55d475fdc4a698c26523269fb993b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a16a462df304b1fbf48724140afd63c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">elv:SeniorUnsecuredNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94bbf9e2e436430ea18a870d630e7782_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">elv:SeniorUnsecuredNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b0d34ecb74d4c1499f643aa80821af3_I20220516"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">elv:ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">elv:SeniorUnsecuredNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i593ecd4bf79e46d2af49bec65e9db2cc_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">elv:FourPointOneZeroPercentDueTwoThousandThirtyTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">elv:SeniorUnsecuredNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e26d0baf7484549aaadded8ad6a1ef1_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">elv:FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">elv:SeniorUnsecuredNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i447dee49344c463eb1ad142f17bbb55b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">elv:SurplusNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ddfea0816d8449f8a18879a56b75aa3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">elv:SurplusNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cfc7f22d3c342fc85354d517d3e8f44_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">elv:A5YearFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e231fbcfa194a74b537f2bd7332d1ce_I20220418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">elv:A5YearFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e6137b64fca4e85985b05a00cc0980e_D20220418-20220418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">elv:A2021364DayFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-18</xbrli:startDate><xbrli:endDate>2022-04-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id48e07a7766647e2a8bc809c7668f9aa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">elv:A2021364DayFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8956e0659bb44abdac0434240d851087_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1994da759a8049c09f0ece33102e8d07_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d538ffdcb394ef6b8ca39b9232da03f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab9bfa7369d94d23b70eb52ac9d5c353_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3177560ea74b47d094f58090cff05a3a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98f60619d5db44bdbcef4568c650ac97_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c996ccf5375467690ef0a371d48e033_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id074490de8a844b3947b679412d173b1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3ce2a7827404c4b95ca73a4c71f739d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:FederalHomeLoanBankAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idadc7d2ec88044dcaa0a3de4ed833cec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:FederalHomeLoanBankAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec40b9c51c114cbc9d3101bef95add9d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a1b6fdf93194651bf7efdc8011a5b9c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief81cd0e712a4475b910c6e1044349aa_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">elv:BCBSAntitrustLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie706cb4d8ca64cb3aeb950d443b981ec_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GainContingenciesByNatureAxis">elv:PharmacypricingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">elv:AnthemInc.v.ExpressScriptsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib999e2b9904743fc9d242837ba067eb4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GainContingenciesByNatureAxis">elv:OperationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">elv:AnthemInc.v.ExpressScriptsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if86d9fcaf90e4c74a4febd7d2876346b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">elv:AnthemInc.v.ExpressScriptsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i593ccc71545a463aa762ea6a7a1efafc_I20221018"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9e73fa43f474637904386532065813b_D20221018-20221018"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-18</xbrli:startDate><xbrli:endDate>2022-10-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90083e53041c4397abce83d13efa37ae_I20210126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59f143f05a8b4cdf99dd35b50717b3d8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="elv:PerformancemeasurementperiodAxis">elv:A2022To2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0032fd5f2e3430db780393923fe52c6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1666c9555de74b4dbc65fef3b1b917cd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1506e71de0d34c81941b49a8af7876e9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1a95b18f4a549a9916b28653b0280e7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cf014dd12e9477788ecb92ec4a95f02_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i488068315a5d438e968d54c5b20cc063_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d87ef5b685049cc85f3a91696bb60cb_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a64d441bc804e49bc8a45a553ba2057_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38542daa11574b0aad0519ecfa5263ef_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93b560992cd743cb8ceceaf0b0b2e931_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibeb89cf81873481eb8b9811ea6dfe3bc_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">elv:NonCreditComponentsOfImpairmentsOnInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic35e765820354c2cafb66117c9ea4c7a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">elv:NonCreditComponentsOfImpairmentsOnInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96e9251b744b4f7e9ecbb677bd8634fa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">elv:NonCreditComponentsOfImpairmentsOnInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56a76ec5b38f428db6242e45a2f30037_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">elv:NonCreditComponentsOfImpairmentsOnInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i117df451326545f9986059648cfd22dc_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">elv:NonCreditComponentsOfImpairmentsOnInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i365146e911f1424ea5fe059db32e3d7d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">elv:NonCreditComponentsOfImpairmentsOnInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a0fc272f1aa4de39b8e80fa4ef950f7_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">elv:NonCreditComponentsOfImpairmentsOnInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic726783a65004c40a48a29cda9bf3769_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">elv:NonCreditComponentsOfImpairmentsOnInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e43378757a544d788aed5dc1dd1ce21_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">elv:NonCreditComponentsOfImpairmentsOnInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3854b434ec0e41f19c683b643a2b65b0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">elv:NonCreditComponentsOfImpairmentsOnInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cae8c9b8e124d8f9c6a483e1f50d63a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6333d6f4a7f542d0a6c873c6d721b20f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f296ec510ae4b489100cc4e4401f16d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7d0a14cf7b04d2689e8c00fe9ee50bc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibce0012780de42b39687b8dc2c2d2645_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9291c2ff4b2f443a9a229d05ba749f08_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35dbebbdfb3b4ab58592b593d907d827_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if60627e1e84e4b339448c6d14a9087be_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadc106beeb124c7ba342f63d01a137d2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b066b6520a04587be918ef721ac7343_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bc72b35cf17467ea46cbd502a8f690f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib948503264de432899d049dd0575663c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice4c66b286684bc78853a3bcc0e579a8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9538c473eb54495b6cdee761ef557a7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff4c8270a3144c10bdf362046062d8a5_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideb63a96f5c749ca9094200a8ba2b7e9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a9aee5d11bb47bd9cb89fcdd8efe039_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafaf34467ec1493eb045796ec8e537ed_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7d788695b784dbea530ea0825b12aac_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95f866b9b2ea4f848e8122f80341b0c2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4c04580eba94b4d90b41a5d0c88cc4a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i834e9db2373b4b68b3452b49ef4aa755_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8642636cf706437d9a3a0aba479b0966_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56f8a70ced554e39b672ce48d8b75303_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3ad1d3b885146b998e9a975d801f76b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf3fd69d4d55450c8e871275758301b5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i967583dc4bba46948e14836718b94da9_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54c1ad6c70e943cbb0219aed34cfe0fe_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iada0e8e50ae7426592cf04d9556323d4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i472f221347be479aa71a0a08747b91a3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3126da39a5443229f14991bb4782574_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="elv:PerformancemeasurementperiodAxis">elv:A2022To2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d4742d632984f94b7fd17314cc4c078_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="elv:PerformancemeasurementperiodAxis">elv:A2022To2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6a892d97bb04fbca567d9781dcbbfb9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="elv:PerformancemeasurementperiodAxis">elv:A2021To2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i973466ad3bf64618843bf4007e0b486f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="elv:PerformancemeasurementperiodAxis">elv:A2021To2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>elv:segment</xbrli:measure></xbrli:unit><xbrli:context id="i613f3949b7024615a0b0e144265e921b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:CommercialSpecialtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f9be59a634a40b88e6dbcaae7d7deac_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78f61d39fc7a4472a65a1d69f1fa77e6_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fe4f30315e9486cab1e53788aa7d851_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idec57493ab1e4934bf922237f912f0b6_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cfa8e1a475a4cdbbb5a9828060b71b3_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32ced2539b8f4d329078b81a982fc92c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:OtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bd87a9fe9284c9382b2f66c6c0889e0_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7fc6c71c6004a74ba6b839f6bb3ff09_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8f86bdb8cf2469aa0b7d726398ab429_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:CommercialSpecialtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if830019dcb7d41e7b0f6d3696e6ff1bb_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id770a0ff048944b9ba5c4f267af241c1_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40ca534e715147f98238ecf1aaea0e0d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42cb539441714260b2dac721cc7b7385_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:CommercialSpecialtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4396f9c7ead4882afe910b3265d1ae6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2b72584a9a44b80a8f513401ff64d97_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43f1507e8bcc4d748dfbaec841ee2693_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4cf254d155841919857d544d09721ab_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia289890cc9a84272b385fe830e5a181c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:CommercialSpecialtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice278b94888d4092b77546bceeb6bea5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic31a5ad6faf248238ec05a2850499106_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i535f1617c8544db396ede0c7f1da6d87_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:OtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6493eedb9ee14f9abe78a63b29dc2a76_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3412b5e435444238a5abd7fdd03b86f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea48a3ae14cb42c597f9265f719b100c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:CommercialSpecialtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa92746fb4df4c01b8d7210e2ae19cf9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i699414c0bc4847948f60c7721dfe388f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49e4f34abd44464ba18d17589d4817f5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib642ee435246417986a7c59ac081ac68_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:CommercialSpecialtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife47ac82fe0345dc920d78c9e6c54bff_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b6a789eb76947a58a5f3eb47c31e312_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0e62d9102304c3abf2cad1b68e9c3f4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i489b1390122443e2bb59851e5a3062fd_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f47d7a5179d4dfc97384ed285da7911_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:CommercialSpecialtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f08825ff0ad45c9a9bd4fcfbee83337_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i460716678d6242c19377280954cd4752_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie284f26c8937426abf5fb54b5296c8e3_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:OtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67ab17589f884d1fbeb85f1ff8c7347b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia37eef0dbc8c45e3a79a0e793d82369b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48ef62bcfeb448e584ac8677641f5a48_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:CommercialSpecialtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iade9083183e24a63a024e8c92ebde4f4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84ba57a42d554362bd86af8887714be2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5a10db4f5de43ae9ca27fb423936d50_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib035444b5f354e3599e287f69135039a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:CommercialSpecialtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i250482f83321476e96b00f0a8172c63f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb6d5e1babc8461ba8510bfa1a69afaf_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib01b6477a138483b87a1c6749d60194d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i070cb4af0e734e3b97f862746b92ef65_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie38e2cab8d46445aa0e1d1b6c282a05a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:CommercialSpecialtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09dc82dcd92645758117fe7914de65ad_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42a32ee4b8c040ed9b7f3e8951e03bb9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f17939a81c848e68bf70536f100b8f8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:OtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc176686245540f388bb95d4741dab61_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95dfc1da6af04fd08d490195296eb3ed_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e811d8b6a8a405db8cfa3af19e8d5e0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:CommercialSpecialtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2afef55df394f80a6083eef46447e0c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d3be1d743ba40d2804be36571b03d27_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49ec233198524d05b69059ae1a04c04f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie50df0b7e812404f8ac6506d19378156_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief5f8447f8f6441dab988369cb18391b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e22b3359b804b6096c6db064b631db3_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98a4fbec4a714f71b3cd75ec9f0deb96_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b41a0ca0abe41f19104d40411fe8b3c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a10c1e4505b4d6aa5128ba88498d53d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bc040a46a814b49b1241f6aaa87b4e7_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dfb62cf41374a68bb7efc705ab95d1f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2be8cfab42284be8ad0db60f8e9c7251_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:DentalVisionProductsAndServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic19125c669154425a6176b41f3b63e4a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:DentalVisionProductsAndServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic71d76f1bed042819c52df0907d93ee5_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:DentalVisionProductsAndServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf64a53a0693483598a35f9ecae91e19_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:DentalVisionProductsAndServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c235873956f485f8766fe1f4a6dfd52_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47937f7e9daf42b98dfabfafd8f29aec_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5b0fcd0d81b45e1972a3219cc11a422_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf7752a749a54daf8ecef7f516fccbbf_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdc016ae937c445185ef3dac290c94cb_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad555599326849b4986b0f696e0bc3b6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d9d03d05fa0487499d5eeb2019e07de_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2b81e7a6c124962bb984bd28230e269_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f22558ff60c480a8751522ee586cca6_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18518353f665475a9bb0d0e357886227_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c5f026845034ad7bf3ab1ee5be68a4b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea0bebe050d8402fac705ade0fc21e7a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1c6d6e169f84a139863b8469ab9d241_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:PharmacyproductsandservicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bdd175f0fdb4015821b828ea0c2e286_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:PharmacyproductsandservicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94aa51feb4bf48bf9c5bba05c04ac8d2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:PharmacyproductsandservicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f53ea737c1440078ec9ff5e42581227_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:PharmacyproductsandservicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e39237895504dfea4708a360ce4fd9f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IntegratedHealthServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54804e82cd9d4171953e5f7a0443759d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IntegratedHealthServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaee2f1ec149648168e2cb6bec6fee839_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IntegratedHealthServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf128bf301b34428b46cea6538e515e6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IntegratedHealthServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf78127a63ae4e2d9451e2182c5330af_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfb2059876d84fbfa46eeb173a42357c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4583bb7be664541bff123dc3d369c76_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i667448e355dd40e0bd386f14f3dfe774_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i401e0447e56649b8bf0e2ea99deca4b9_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:SegmentEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a4d250516594092a504c84e2ce84ea7_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:SegmentEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i888bd500cb4e464fa25e8b7832db7c26_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:SegmentEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7421e7130f5a434fbc857ff8e1006b5b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:SegmentEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0372d0f0be2a4fa7ae88750cdaac34d5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie530874bee08404db56ee4857d5efd5d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6bbcf70f0bb4a6bbd6551b90da88d89_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c94be5ee16a47e7a9596ba6add05232_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id593e5d6da124d95ab48675ffd8977c9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14164de3b9fa4fbda3f76ea2a11abc8b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52e3da93e21e46f280c3dae71bf5cb8c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4de2ea0a2eff4ca086ad80177a4451f3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13859b3a61354d53ab9916db584893cd_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bc3de5499444f1ba422babbbc5f65b9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbcb7d1337e04045a0fcd99dc012728f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3195b764ef2343888e4fdd71a0e4a7cc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4354544bc10d440fa1ec78849d381792_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e8f393fc0344308ba714b6a9bbd73cb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic90c1cc5ab9f4b6093ae613918639e5e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab7acc5aba584173aa7d2d55cc110fc3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic300e08f31844af79ab58566cb788e9a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb088b3cd90a4e8a854fa32b4d4e5601_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i186e051878fe4219970efc72a9fcdad4_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTgw_29320d33-fdd0-4a28-b6af-b59569c4707a">10-Q</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Mark One)</span></div><div style="margin-bottom:3pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGFibGU6NzAwMjcxMGUxZmE1NDEzNjlmZWVlZmRiM2U4NzkyZTQvdGFibGVyYW5nZTo3MDAyNzEwZTFmYTU0MTM2OWZlZWVmZGIzZTg3OTJlNF8wLTAtMS0xLTcwMzYz_370e520d-bcd1-4698-b125-31c6505d2d98">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Quarterly Period Ended <ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8xMzQ_37e78253-d4f5-4094-bfec-07b65a667e26">September 30, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGFibGU6YzMwZDhlNmE4ZDk2NDQ2YmJlZjY2ZTM1MTQxNzg2ODgvdGFibGVyYW5nZTpjMzBkOGU2YThkOTY0NDZiYmVmNjZlMzUxNDE3ODY4OF8wLTAtMS0xLTcwMzYz_26d34172-2223-407c-9b93-ca5153eac286">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number: <ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTc1_c6b4c897-be16-41d2-ac45-ed61385dc34e">001-16751</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><img src="elv-20220930_g1.jpg" alt="elv-20220930_g1.jpg" style="height:40px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"/></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTc2_c5574828-f98a-498c-8a61-9fc022e335d9">ELEVANCE HEALTH, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.805%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.222%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGFibGU6MWNlYWMyNGRlMWMwNDJkOTkyODFlMWJmYjliYjM3YzYvdGFibGVyYW5nZToxY2VhYzI0ZGUxYzA0MmQ5OTI4MWUxYmZiOWJiMzdjNl8wLTAtMS0xLTcwMzYz_ac2d1310-9fdf-447a-bdb2-a86748b7d38d">Indiana</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGFibGU6MWNlYWMyNGRlMWMwNDJkOTkyODFlMWJmYjliYjM3YzYvdGFibGVyYW5nZToxY2VhYzI0ZGUxYzA0MmQ5OTI4MWUxYmZiOWJiMzdjNl8wLTItMS0xLTcwMzYz_754b336a-3ae1-4d5e-bd3c-38551ac77bba">35-2145715</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification Number)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTgx_f57745f9-bcbe-4fc6-8eab-256f13d951e2">220 Virginia Avenue</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTc3_4160fabb-2ce0-4817-98f7-d79a7433c657">Indianapolis</ix:nonNumeric>, <ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTgy_d8d29d9c-1188-4fc7-b4f4-e89d81b9ec7f">Indiana</ix:nonNumeric> <ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTgz_d850084e-a753-4a69-9412-3d7967c63d84">46204</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTg0_20f379c6-171e-4505-ba14-d695d847d56d">833</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTg1_9004e950-9e81-4975-80e4-2cd83e7f254c">401-1577</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name, former address and former fiscal year, if changed since last report)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:33.014%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.207%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.015%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGFibGU6NDA5ZWFkNThhZWQ4NGM1MDk5MmEyMjM3ODIwZDgzYjMvdGFibGVyYW5nZTo0MDllYWQ1OGFlZDg0YzUwOTkyYTIyMzc4MjBkODNiM18xLTAtMS0xLTcwMzYz_3efafcbd-54e8-4f56-8ffd-1091db13c068">Common Stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGFibGU6NDA5ZWFkNThhZWQ4NGM1MDk5MmEyMjM3ODIwZDgzYjMvdGFibGVyYW5nZTo0MDllYWQ1OGFlZDg0YzUwOTkyYTIyMzc4MjBkODNiM18xLTItMS0xLTcwMzYz_39fb8d15-a5a5-4844-bf14-27a8ea6eced5">ELV</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGFibGU6NDA5ZWFkNThhZWQ4NGM1MDk5MmEyMjM3ODIwZDgzYjMvdGFibGVyYW5nZTo0MDllYWQ1OGFlZDg0YzUwOTkyYTIyMzc4MjBkODNiM18xLTQtMS0xLTcwMzYz_cafb3729-3397-41ec-8b0b-d050c78c687e">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past&#160;90&#160;days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTg2_cfc9ac97-0b30-4436-883f-470041321a05">Yes</ix:nonNumeric>&#160;&#9746;    No&#160;&#160;&#9744;</span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTc5_b584b0f7-c274-4669-9f7b-1d5ce2d83756">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.425%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGFibGU6ODZjNTkwZjIzNDYwNDM1OWI5NWMxYmFhZTRiOGZjMzgvdGFibGVyYW5nZTo4NmM1OTBmMjM0NjA0MzU5Yjk1YzFiYWFlNGI4ZmMzOF8wLTAtMS0xLTcwMzYz_1690b136-a930-466a-b7fd-334a87d58f0e">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGFibGU6ODZjNTkwZjIzNDYwNDM1OWI5NWMxYmFhZTRiOGZjMzgvdGFibGVyYW5nZTo4NmM1OTBmMjM0NjA0MzU5Yjk1YzFiYWFlNGI4ZmMzOF8xLTUtMS0xLTcwMzYz_65e25eb1-0639-4894-ab52-a16ba4e59021">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGFibGU6ODZjNTkwZjIzNDYwNDM1OWI5NWMxYmFhZTRiOGZjMzgvdGFibGVyYW5nZTo4NmM1OTBmMjM0NjA0MzU5Yjk1YzFiYWFlNGI4ZmMzOF8yLTEtMS0xLTcwMzYz_b30ba526-fbde-478f-bae7-0a0d9451dfc2">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange    Act. &#9744;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;<ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTc4_99ba8c13-e81e-4705-b767-c887e4f26865">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;No&#160;&#160;&#9746; </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 12, 2022, <ix:nonFraction unitRef="shares" contextRef="i5ffea20b96c2462c92744a6e44bb6555_I20221012" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTE2_a8f4f962-e5d4-426b-b845-cbbde3b4ef3d">238,827,582</ix:nonFraction> shares of the Registrant&#8217;s Common Stock were outstanding.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i186e051878fe4219970efc72a9fcdad4_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Elevance Health, Inc.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quarterly Report on Form 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Period Ended September&#160;30, 2022 </span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.019%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.423%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.258%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I. FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_13">FINANCIAL STATEMENTS</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_16">Consolidated Balance Sheets as of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_16">Sep</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_16">tember </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_16">30, 2022 (Unaudited) and December&#160;31, 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:right;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_16">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_22">Consolidated Statements of Income (Unaudited) for the Three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_22">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_22"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_22">Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_22">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_22"> 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:right;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_22">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_25">Consolidated Statements of Comprehensive Income (Unaudited) for the Three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_25">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_25"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_25">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_25">&#160;30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:right;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_25">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_28">Consolidated Statements of Cash Flows (Unaudited) for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_28">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_28"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_28">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_28">&#160;30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:right;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_28">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_31">Consolidated Statements of Changes in Equity (Unaudited) for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_31">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_31"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_31">Se</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_31">ptember</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_31">&#160;30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:right;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_31">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_34">Notes to Consolidated Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:right;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_34">8</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_103">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:right;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_103">42</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_142">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:right;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_142">60</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_145">CONTROLS AND PROCEDURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:right;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_145">60</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II. OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_151">LEGAL PROCEEDINGS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:right;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_151">60</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_154">RISK FACTORS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:right;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_154">60</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_157">UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:right;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_157">61</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_160">DEFAULTS UPON SENIOR SECURITIES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:right;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_157">61</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_163">MINE SAFETY DISCLOSURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:right;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_157">61</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_166">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:right;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_157">61</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_169">EXHIBITS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:right;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_169">62</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_172">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:right;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i186e051878fe4219970efc72a9fcdad4_172">63</a></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-1-</span></div></div></div><div id="i186e051878fe4219970efc72a9fcdad4_10"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I. FINANCIAL INFORMATION</span></div><div id="i186e051878fe4219970efc72a9fcdad4_13"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS</span></div><div id="i186e051878fe4219970efc72a9fcdad4_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Elevance Health, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.806%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNC0xLTEtMS03MDM2Mw_b25c02b7-9cf4-4775-96eb-c9ab7ea32557">8,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNC0zLTEtMS03MDM2Mw_ff7b57da-afb1-4405-b2d8-cc15d71183bc">4,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fixed maturity securities (amortized cost of $<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNS0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjYwYWZiNmM0NWJjODQ0YWViMmU1ZDQ3ZjYxNmY0NWI1XzQ5_0a867403-6163-4051-82f3-50402c642766">28,306</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNS0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjYwYWZiNmM0NWJjODQ0YWViMmU1ZDQ3ZjYxNmY0NWI1XzU2_5f118897-1645-4ee1-a748-afc09cd8b8b3">25,641</ix:nonFraction>; allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNS0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjYwYWZiNmM0NWJjODQ0YWViMmU1ZDQ3ZjYxNmY0NWI1Xzkx_9039c42d-2375-449c-8741-c1606109e8f6">10</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNS0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjYwYWZiNmM0NWJjODQ0YWViMmU1ZDQ3ZjYxNmY0NWI1Xzk4_7053144a-90e4-4cba-b0f9-d28ece74226f">6</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNS0xLTEtMS03MDM2Mw_4cfb29ea-c82e-4bfa-b12c-62f5bfb75e04">25,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNS0zLTEtMS03MDM2Mw_bcea3af4-ebef-4de8-b4ae-e90c02f2273a">26,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNi0xLTEtMS03MDM2Mw_48751797-4c9e-4a51-a8cc-77b70b6d97d3">1,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNi0zLTEtMS03MDM2Mw_8c90f301-cadd-4efd-bc35-2a8dce6b57af">1,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:PremiumsReceivableAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfOS0xLTEtMS03MDM2Mw_166a9215-217c-4e15-967f-29d3a0fd77f3">6,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:PremiumsReceivableAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfOS0zLTEtMS03MDM2Mw_edac5729-41ea-4c26-8909-a7fdfe6d55a3">5,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Self-funded receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="elv:SelfFundedReceivablesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTAtMS0xLTEtNzAzNjM_bd08ae4d-a26f-46bd-b8a1-08479d2b63c0">3,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="elv:SelfFundedReceivablesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTAtMy0xLTEtNzAzNjM_96a6b8bd-5dae-4e0d-b69f-703152538d7e">4,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:OtherReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTEtMS0xLTEtNzAzNjM_76331aad-de26-420b-8b58-27232a072789">3,651</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:OtherReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTEtMy0xLTEtNzAzNjM_842cc9a2-0196-43c0-b0e2-c30033adfe79">3,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTQtMS0xLTEtNzAzNjM_3caaae89-67e3-40a5-84d6-502ce172f8d8">5,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTQtMy0xLTEtNzAzNjM_7a234402-edb8-4ff0-82d2-f625fbcbd5df">4,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTUtMS0xLTEtNzAzNjM_84938057-6d23-4cc0-b262-00d18c4adc7c">55,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTUtMy0xLTEtNzAzNjM_cab522dc-69cd-4066-af3c-048df9886fda">51,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fixed maturity securities (amortized cost of $<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpmZmIzNzU5ZDUyMTQ0ZmU5YjA1ZmZkNzIwZTBhZDBhZV80OQ_d48685df-74ba-41a6-ad4b-d31b0eba4ca9">671</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpmZmIzNzU5ZDUyMTQ0ZmU5YjA1ZmZkNzIwZTBhZDBhZV81Ng_5a952f47-aa31-4ce2-8b3a-f860344e37eb">616</ix:nonFraction>; allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpmZmIzNzU5ZDUyMTQ0ZmU5YjA1ZmZkNzIwZTBhZDBhZV85MQ_fa82274b-0538-4f43-90c2-e9fffad1fc7b">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpmZmIzNzU5ZDUyMTQ0ZmU5YjA1ZmZkNzIwZTBhZDBhZV85OA_04efe429-4e0b-486a-a2fc-7b5fa1605a84">0</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTctMS0xLTEtNzAzNjM_2327fa46-16dd-41d0-aa96-0416d61db1fc">622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTctMy0xLTEtNzAzNjM_d9a9aec6-404d-4ef8-ad58-b1e04e0a9bb4">632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other invested assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTktMS0xLTEtNzAzNjM_c69a1481-7ae0-4516-88eb-0bd8e049893a">5,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTktMy0xLTEtNzAzNjM_ea6a34e0-412d-43bc-92a9-e468c5c1f7cd">5,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMjAtMS0xLTEtNzAzNjM_b8836ef9-e790-4f6d-8438-754e9ff3a567">4,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMjAtMy0xLTEtNzAzNjM_114141a2-5afe-459b-85d5-b5111ee632bd">3,919</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMjEtMS0xLTEtNzAzNjM_2b75a546-a681-4508-a4e1-6153cb8ffc16">24,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMjEtMy0xLTEtNzAzNjM_f5287ea6-e791-4eea-a46b-e3d0d74281fa">24,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMjItMS0xLTEtNzAzNjM_e9fa2db0-1a3a-42dc-9ff6-f6891b38df82">10,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMjItMy0xLTEtNzAzNjM_b25bf039-365c-49d0-8c68-e478eed4e3bc">10,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMjMtMS0xLTEtNzAzNjM_a460baed-4f38-4cc5-a5e5-1e1fdac19243">2,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMjMtMy0xLTEtNzAzNjM_b552b1d9-17c8-4adb-a621-e91f7b764d6a">1,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMjQtMS0xLTEtNzAzNjM_7418ad33-6fb5-46b8-90cb-7ea5961bf618">103,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMjQtMy0xLTEtNzAzNjM_2f0c9fc9-c3db-43cf-bbb0-82d52afb016d">97,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities and equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical claims payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMzAtMS0xLTEtNzAzNjM_61307a7e-54e5-4584-8b8a-1b2e11b3dc34">15,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMzAtMy0xLTEtNzAzNjM_f9e0feca-50da-418b-b2e2-1235b972022e">13,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other policyholder liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:OtherPolicyholderFunds" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMzItMS0xLTEtNzAzNjM_235935d8-178b-4c72-90c5-3f883e36310c">5,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:OtherPolicyholderFunds" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMzItMy0xLTEtNzAzNjM_e2bc35a3-5c50-457e-9bd3-7376352ccc73">5,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unearned income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:UnearnedPremiums" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMzQtMS0xLTEtNzAzNjM_ae309075-65f3-4837-8355-3853af55da30">3,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:UnearnedPremiums" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMzQtMy0xLTEtNzAzNjM_1af84325-46bb-48a8-b946-cd7e15ef18be">1,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMzUtMS0xLTEtNzAzNjM_7846ae37-98b8-40ef-b7a0-795fc5dcf108">4,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMzUtMy0xLTEtNzAzNjM_ce320689-9058-4d1c-aa13-cb7cc3674e8c">4,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMzktMS0xLTEtNzAzNjM_266984c2-6046-4797-822f-82a5e3ea605f">265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMzktMy0xLTEtNzAzNjM_af9a11d5-753f-4a5f-85aa-c3dad025ea61">275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDAtMS0xLTEtNzAzNjM_919f29e3-1ecb-48e6-bac8-d56799c0e4c0">2,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDAtMy0xLTEtNzAzNjM_3eea9d83-2d8a-4dd2-9f9f-074415b73865">1,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDEtMS0xLTEtNzAzNjM_aac8e14c-350b-4c9a-91aa-e50e39a4d9f7">9,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDEtMy0xLTEtNzAzNjM_be0130ba-d2fc-45e1-8952-c916d457844a">7,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDItMS0xLTEtNzAzNjM_8e8c798d-ab8a-477e-a0a2-91f61af71215">41,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDItMy0xLTEtNzAzNjM_27344730-47bc-4591-b8a7-316cac7a9fd1">34,885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt, less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDMtMS0xLTEtNzAzNjM_df9c9711-a4ac-4d38-90ae-0417b0cc7730">21,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDMtMy0xLTEtNzAzNjM_1e04c5f9-0a0f-49f2-84d8-61e604180c74">21,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reserves for future policy benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDQtMS0xLTEtNzAzNjM_cc1255b8-edc6-4ba5-b802-8b4a5b79191e">825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDQtMy0xLTEtNzAzNjM_1915fb7a-3102-4098-9e7d-e733c07b42fb">802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDUtMS0xLTEtNzAzNjM_9ecaf131-6a7c-404d-ae4d-074646f3f0ab">1,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDUtMy0xLTEtNzAzNjM_0a0c99a1-0a96-4b73-b83c-f0c60d716733">2,805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDYtMS0xLTEtNzAzNjM_9e9b5437-4052-4638-87c5-51509e92d062">1,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDYtMy0xLTEtNzAzNjM_8ca96023-e1d8-4df1-bdc6-c81400693a9d">1,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDctMS0xLTEtNzAzNjM_127aa7bc-c9de-4936-8177-5cdefe48d4d2">66,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDctMy0xLTEtNzAzNjM_73fa3eab-e34b-46ce-9379-f640dc5293b4">61,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commitments and contingencies &#8211; Note 11</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDktMS0xLTEtNzAzNjM_0d4c64e5-6e1b-409d-9e60-8a4d1a5d6336"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDktMy0xLTEtNzAzNjM_403a9fef-9320-43a1-bd54-9a1fd03708ee"></ix:nonFraction></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preferred stock, without par value, shares authorized &#8211; <ix:nonFraction unitRef="shares" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo1NjU1MjhhNWU2Njg0NmVjYjNjYTYwOWQ0NWZjYzczOV82MA_5db77eb5-5906-4d08-a9e9-16dfa246239b">100,000,000</ix:nonFraction>; shares issued and outstanding &#8211; <ix:nonFraction unitRef="shares" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo1NjU1MjhhNWU2Njg0NmVjYjNjYTYwOWQ0NWZjYzczOV85Ng_079347cf-0b40-46d9-ad98-d6b066acbc6d">none</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTItMS0xLTEtNzAzNjM_e9fe6978-82cc-4bd2-b66f-6a771622b827">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTItMy0xLTEtNzAzNjM_35a00a2e-18d0-4569-8ac8-2b141719eca6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTMtMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpjMTI4ZjdjMzNkM2Q0ZWUwOTc0ZjQyNmVmMTQ3YWIzZF8yOA_3d241e5d-5c29-46d2-be94-0b8fe7946f48">0.01</ix:nonFraction>, shares authorized &#8211; <ix:nonFraction unitRef="shares" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTMtMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpjMTI4ZjdjMzNkM2Q0ZWUwOTc0ZjQyNmVmMTQ3YWIzZF81Mg_e773574d-9f44-4b45-bf90-86861bfe6b53">900,000,000</ix:nonFraction>; shares issued and outstanding &#8211; </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTMtMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpjMTI4ZjdjMzNkM2Q0ZWUwOTc0ZjQyNmVmMTQ3YWIzZF84OQ_8bcc349e-4f7f-4ef1-bde7-d7564b3eb503">238,974,624</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTMtMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpjMTI4ZjdjMzNkM2Q0ZWUwOTc0ZjQyNmVmMTQ3YWIzZF85Ng_298a62d1-dc69-4888-aab8-30c42d33b1f3">241,770,746</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTMtMS0xLTEtNzAzNjM_36eaecf3-b0aa-47b3-bd1d-f629b4e8ce6a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTMtMy0xLTEtNzAzNjM_d3e445ba-dd2e-4531-b163-6e4912e630a7">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTQtMS0xLTEtNzAzNjM_70a22655-55b4-4dda-8231-89035d764d5e">9,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTQtMy0xLTEtNzAzNjM_759a49fc-b4fd-4915-bc43-05e96bd469c2">9,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTUtMS0xLTEtNzAzNjM_b506d1d7-5f47-41a3-b6a5-58a94c4be61c">29,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTUtMy0xLTEtNzAzNjM_f2f01902-784a-4e68-bef4-56232bac1c6c">27,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTYtMS0xLTEtNzAzNjM_3770ab9b-53f4-4f53-9d6f-6669dee9271c">2,784</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTYtMy0xLTEtNzAzNjM_3daec55a-2abe-4ad0-8559-d0cd20a1c003">178</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTctMS0xLTEtNzAzNjM_82e14b1b-e7b4-49d4-9746-e8c5586ddfda">35,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTctMy0xLTEtNzAzNjM_c84f4e15-614c-44b3-9268-3818a2a00327">36,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTgtMS0xLTEtNzAzNjM_59859c1d-e318-46f9-9c09-b1781b08dba6">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTgtMy0xLTEtNzAzNjM_f9808274-0dce-48cc-beaa-cb5fae0c8948">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTktMS0xLTEtNzAzNjM_e7ac78f1-05ca-47ea-8d27-6fcca280da93">36,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTktMy0xLTEtNzAzNjM_73e0e7f7-4405-4757-96f4-0075a6c64a6a">36,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities and equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNjAtMS0xLTEtNzAzNjM_f062241a-f017-4960-a597-3001d3b35f0f">103,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNjAtMy0xLTEtNzAzNjM_d9d8f038-f934-49df-a317-b85bdcaa1ae0">97,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-2-</span></div></div></div><div id="i186e051878fe4219970efc72a9fcdad4_22"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Elevance Health, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Income</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.809%"><tr><td style="width:1.0%"></td><td style="width:48.448%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.949%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMy0xLTEtMS03MDM2Mw_a1aebfb1-c223-4fcd-a559-798fa30ea5ba">33,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMy0zLTEtMS03MDM2Mw_ce15d6a7-354e-4a6c-bb34-cf345e2379c8">30,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMy01LTEtMS03MDM2Mw_8b8e041c-c6e3-4c95-94bd-b1cb11336f29">99,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMy03LTEtMS03MDM2Mw_bbeb9578-abd7-45d7-9bc7-04e04bc8444d">86,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="elv:ProductRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNC0xLTEtMS03MDM2Mw_29b16c6d-7b55-4572-b009-c211e862a175">3,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="elv:ProductRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNC0zLTEtMS03MDM2Mw_10c24259-1d66-4621-a62e-0d0f5acb74ec">3,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="elv:ProductRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNC01LTEtMS03MDM2Mw_a1a6050d-f8ae-4bc1-a20a-6174e4cc5680">10,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="elv:ProductRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNC03LTEtMS03MDM2Mw_060dbcb3-5e19-43b4-8344-17c1662467c3">9,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Administrative fees and other revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNS0xLTEtMS03MDM2Mw_02e46e60-a3c7-45c2-9398-b367d72e2bfa">1,931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNS0zLTEtMS03MDM2Mw_a472ffaa-c7e1-4560-9c3d-fe3e024cb318">1,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNS01LTEtMS03MDM2Mw_659b7395-4bb3-4ed2-a7c1-f279e529e70f">5,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNS03LTEtMS03MDM2Mw_6cb10f95-c09a-4923-9f0a-2c1318b9f0c3">5,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="elv:OperatingRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNi0xLTEtMS03MDM2Mw_84299c95-1878-4428-96d0-7a7de1a5dd94">39,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="elv:OperatingRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNi0zLTEtMS03MDM2Mw_cb752263-9ccd-429b-9e06-7c48a50345cd">35,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="elv:OperatingRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNi01LTEtMS03MDM2Mw_04bd5b5d-620a-4da2-8359-d2f5ec5b2ccf">115,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="elv:OperatingRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNi03LTEtMS03MDM2Mw_07bdaa2d-9b5f-45c5-9bad-997d456ea07b">100,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNy0xLTEtMS03MDM2Mw_86dc72f5-f6f3-477e-9c8f-f57bc18990b3">371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNy0zLTEtMS03MDM2Mw_584495f3-5588-4a71-b2b3-bf62efdd25af">335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNy01LTEtMS03MDM2Mw_0b907670-793f-4e91-9912-b7eddfae997d">1,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNy03LTEtMS03MDM2Mw_82dcbb47-948b-4252-81b6-9bf9c2d9a76b">1,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (losses) gains on financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" sign="-" name="elv:NetLossesGainsOnFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfOC0xLTEtMS03MDM2Mw_35366142-9fb5-4f8e-a191-41aac40ffe84">57</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" sign="-" name="elv:NetLossesGainsOnFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfOC0zLTEtMS03MDM2Mw_c4c32e90-c26f-43a2-957a-67849f02131f">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" sign="-" name="elv:NetLossesGainsOnFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfOC01LTEtMS03MDM2Mw_4fc52e99-bef7-4acf-ab17-40f3090564df">439</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="elv:NetLossesGainsOnFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfOC03LTEtMS03MDM2Mw_ec82f094-0dc7-4431-879a-78c45563deb3">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfOS0xLTEtMS03MDM2Mw_05be369e-c6e1-4fab-8bc6-5ea021f94bfa">39,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfOS0zLTEtMS03MDM2Mw_5d75a6ec-5c1e-467c-a1dc-7d0d37d125eb">35,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfOS01LTEtMS03MDM2Mw_0a692752-b460-4a0d-9501-fd9d8fcf5ce0">116,666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfOS03LTEtMS03MDM2Mw_40b13063-fbb7-4d2f-bb50-3934d6fafa00">102,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTEtMS0xLTEtNzAzNjM_a2cadb98-011d-47c1-9b94-1e058418c1f7">29,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTEtMy0xLTEtNzAzNjM_8d796097-8d97-41b5-b7b6-495ff634fa12">26,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTEtNS0xLTEtNzAzNjM_f06033a6-790c-447b-844f-9b5d59587ea2">86,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTEtNy0xLTEtNzAzNjM_6a6fe7a9-94de-4a74-8499-cbc563e4610a">75,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTItMS0xLTEtNzAzNjM_31ee173b-9fe8-45da-ba51-bde4bf9af270">3,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTItMy0xLTEtNzAzNjM_c8f5bed4-69f4-4266-aba2-17dc6a1c14e3">2,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTItNS0xLTEtNzAzNjM_c8b47490-32c8-44a0-b5ae-3ef6402e57ec">9,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTItNy0xLTEtNzAzNjM_5498ca33-fcb6-4fb8-a533-6bcc0d26ffc7">7,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTMtMS0xLTEtNzAzNjM_17189a79-647c-4d92-82c1-d0867fc20b9b">4,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTMtMy0xLTEtNzAzNjM_629576e5-f984-4af8-8932-b942d31da47f">3,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTMtNS0xLTEtNzAzNjM_6884e06d-156c-4999-8b26-81d0dda7cd18">13,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTMtNy0xLTEtNzAzNjM_8c0a45d5-b50c-4e66-9619-d1ee0fc04a0a">11,692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTQtMS0xLTEtNzAzNjM_6093ba63-3840-48a5-bcc3-75ee5ca1b3c0">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTQtMy0xLTEtNzAzNjM_783be160-648b-486b-aa35-65e7b4fdfda0">201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTQtNS0xLTEtNzAzNjM_121552a3-432c-4337-b07b-7239ff042dfd">622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTQtNy0xLTEtNzAzNjM_afc6fecd-5a3d-41c0-b911-3bec2b36e72c">598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTUtMS0xLTEtNzAzNjM_7da01f2c-4239-4c93-820e-5c62976801c0">225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTUtMy0xLTEtNzAzNjM_07b4e7e2-44ce-4685-8acf-058b2c8ea3c0">136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTUtNS0xLTEtNzAzNjM_bd4d37e1-4fd2-4075-8c38-2a498c738f08">520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTUtNy0xLTEtNzAzNjM_2068a02f-1a10-43a2-af9c-8cadbaf57e69">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTYtMS0xLTEtNzAzNjM_36f086f4-a769-47d6-8e80-e21708e83cd8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTYtMy0xLTEtNzAzNjM_eb1ab1f3-0abc-4962-933d-04637bce2921">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTYtNS0xLTEtNzAzNjM_cb13feea-11c1-4a6f-8460-3d3557729844">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTYtNy0xLTEtNzAzNjM_40539981-f293-4291-b951-e4e3b965a2cf">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTgtMS0xLTEtNzAzNjM_5dc0b4b9-46bf-4ca8-b1b2-e1bffdab9b10">37,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTgtMy0xLTEtNzAzNjM_114b7fa0-fbf3-4773-9ba6-e0b50347dcfa">33,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTgtNS0xLTEtNzAzNjM_f8f91b85-f1e4-4a75-8370-b6d98831c987">110,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTgtNy0xLTEtNzAzNjM_f150a5cf-e4e5-429d-b087-6ee2d1f0dc8d">95,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income tax expense</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTktMS0xLTEtNzAzNjM_216d058d-2029-4527-a52f-cdb44c7c94a3">2,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTktMy0xLTEtNzAzNjM_2f18b6ef-4e2a-4c8a-a3e9-606094ee58c9">1,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTktNS0xLTEtNzAzNjM_21736ce5-d8b9-4684-b3f8-f07b2247ed2b">6,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTktNy0xLTEtNzAzNjM_c57c3953-d3ba-4d13-86c6-c14827570981">6,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjAtMS0xLTEtNzAzNjM_9209cfd3-cdef-47f6-9568-c6c0192b84ea">533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjAtMy0xLTEtNzAzNjM_cc73fd27-e2f7-4390-a4ca-b2b9f8fc66d5">494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjAtNS0xLTEtNzAzNjM_f2d9e4a8-0fe5-41d0-936c-c75e4db5efd5">1,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjAtNy0xLTEtNzAzNjM_21abaddb-3db3-40f7-8cfe-1ae1c08998ff">1,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjMtMS0xLTEtNzAzNjM_07fc90db-2d29-4159-a4ee-93ce25660af3">1,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjMtMy0xLTEtNzAzNjM_4f3b2149-58e6-438f-832e-a132c438432b">1,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjMtNS0xLTEtNzAzNjM_b4a76474-3410-4ce2-9226-46439cfea8ba">5,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjMtNy0xLTEtNzAzNjM_68536a74-caa5-488b-8e76-e1d309418b4d">4,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss (income) attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjQtMS0xLTEtNzAzNjM_dd665f31-fe84-4f74-8871-a6420b34cb2e">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjQtMy0xLTEtNzAzNjM_4ed56cef-8695-44ad-9aa9-c1de4127c0d9">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjQtNS0xLTEtNzAzNjM_b7a8e27e-ea5e-497e-970a-4dda854a0d23">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjQtNy0xLTEtNzAzNjM_d1fc3417-da39-44d6-b3ed-a1be23000733">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shareholders&#8217; net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjUtMS0xLTEtNzAzNjM_b77e2de2-f4ed-4d01-a644-68f4c1671426">1,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjUtMy0xLTEtNzAzNjM_55f0c62f-09f0-44d5-9867-92249b0cd77d">1,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjUtNS0xLTEtNzAzNjM_4fcff109-d39b-4594-8d64-2b440e89b2c0">5,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjUtNy0xLTEtNzAzNjM_5e8dd00f-28ad-49d1-8699-bd08ae10cae4">4,967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shareholders&#8217; net income per share</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjktMS0xLTEtNzAzNjM_f5c2603d-ddf7-4e51-a73b-ec7d9d43a6e0">6.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjktMy0xLTEtNzAzNjM_46b83318-de0b-403f-81c0-d817681d9f86">6.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjktNS0xLTEtNzAzNjM_0d93ca97-c5d5-4076-8af3-a7de2d7788d5">21.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjktNy0xLTEtNzAzNjM_79369056-3879-4525-9c6d-7645e3d4ab3b">20.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMzMtMS0xLTEtNzAzNjM_950d68e3-cf7f-4b09-9fa5-79dbdc6b76d8">6.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMzMtMy0xLTEtNzAzNjM_86edfc47-c721-4c62-9e8d-c7add9ebe251">6.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMzMtNS0xLTEtNzAzNjM_3d7c0952-d830-4965-af9e-1bde9c4cd365">20.86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMzMtNy0xLTEtNzAzNjM_bf4f3948-53af-40ef-b513-0383aa6b4df8">20.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dividends per share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMzQtMS0xLTEtNzAzNjM_e9613c2a-c7cb-4b92-b30d-f7276104381e">1.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMzQtMy0xLTEtNzAzNjM_13fb18da-fa13-403e-8319-29af654d6acd">1.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMzQtNS0xLTEtNzAzNjM_69709bd3-e194-44f5-8b4a-8d5e0f0d7e98">3.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMzQtNy0xLTEtNzAzNjM_dbad93e3-5368-4ba6-a3f4-728fccc7c16d">3.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-3-</span></div></div></div><div id="i186e051878fe4219970efc72a9fcdad4_25"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Elevance Health, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive Income</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMi0yLTEtMS03MDM2Mw_07fc90db-2d29-4159-a4ee-93ce25660af3">1,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMi00LTEtMS03MDM2Mw_4f3b2149-58e6-438f-832e-a132c438432b">1,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMi02LTEtMS03MDM2Mw_b4a76474-3410-4ce2-9226-46439cfea8ba">5,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMi04LTEtMS03MDM2Mw_68536a74-caa5-488b-8e76-e1d309418b4d">4,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive (loss) income, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in net unrealized losses/gains on investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNC0yLTEtMS03MDM2Mw_6c4d61bc-943f-43bc-8ead-71ea9934723e">639</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNC00LTEtMS03MDM2Mw_587ff9c5-2252-4304-b884-352130fc421c">97</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNC02LTEtMS03MDM2Mw_a3d835e8-b66b-4844-baf9-368ef26c8bbd">2,630</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNC04LTEtMS03MDM2Mw_ad7e3326-5b61-4d5d-837f-8882018f926d">284</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in non-credit component of impairment losses on investments</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" sign="-" name="elv:Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNS0yLTEtMS03MDM2Mw_9e75a41f-656b-4be5-aa04-7316152c193d">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" sign="-" name="elv:Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNS00LTEtMS03MDM2Mw_a9704881-1342-4fa5-adca-b5a622265553">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" sign="-" name="elv:Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNS02LTEtMS03MDM2Mw_530e4ab5-5377-42ff-ad69-a3def2303e5f">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="elv:Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNS04LTEtMS03MDM2Mw_6e593c25-cfd6-4cbf-9ec3-5b6bef60e23e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in net unrealized gains/losses on cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNi0yLTEtMS03MDM2Mw_6f8829dc-3aca-4fee-b193-df80c4d86cc8">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNi00LTEtMS03MDM2Mw_056c4500-adcc-44a0-a744-dc99ff0147b8">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNi02LTEtMS03MDM2Mw_d2dd1f1f-a362-4d65-bedc-aa52f948607c">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNi04LTEtMS03MDM2Mw_bd7206ba-1b0c-4249-8076-25dd4e8d2d72">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in net periodic pension and postretirement costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNy0yLTEtMS03MDM2Mw_bfc93804-9305-42de-93aa-32369406e196">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNy00LTEtMS03MDM2Mw_8a9fda7f-57d8-48dc-9cbd-6ec8d6de6c2f">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNy02LTEtMS03MDM2Mw_329b046b-189e-4d99-9e42-bda75b23296f">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNy04LTEtMS03MDM2Mw_9df14152-70f7-4b47-8293-786a98d70edb">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfOC0yLTEtMS03MDM2Mw_3b19b880-cee3-45ea-8344-a07b09cb7401">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfOC00LTEtMS03MDM2Mw_e9b5875f-8e95-4b90-9971-fd17c75eb296">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfOC02LTEtMS03MDM2Mw_5b94f8e6-8f07-40c7-8329-715e0121ca77">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfOC04LTEtMS03MDM2Mw_1685b84e-b1b6-4730-b297-fefbf8d83798">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfOS0yLTEtMS03MDM2Mw_f1de3961-bd4b-47ad-871d-8c8b0f874929">638</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfOS00LTEtMS03MDM2Mw_c4860713-0ede-495a-9b15-f593c82be1ed">87</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfOS02LTEtMS03MDM2Mw_9cf3dc15-fb61-4057-a86b-e45cc2171289">2,617</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfOS04LTEtMS03MDM2Mw_6a8ad056-ada3-4b6f-bb50-36db80698fec">254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss (income) attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTAtMi0xLTEtNzAzNjM_15a68b92-17e9-4ced-96a7-b24848e968a2">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTAtNC0xLTEtNzAzNjM_9f87d48f-aa6f-4e7f-9b18-8dedae7c65b5">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTAtNi0xLTEtNzAzNjM_ef97573a-5821-4ee8-9731-068521e0b950">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTAtOC0xLTEtNzAzNjM_470adeb7-cf77-4d22-bcac-8903cb74dedb">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive loss attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTEtMi0xLTEtNzAzNjM_d6f461b2-8412-45ec-99dd-114ad2cf6391">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTEtNC0xLTEtNzAzNjM_2fe0250a-be68-41c9-8922-9102045dc136">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTEtNi0xLTEtNzAzNjM_c783fcdb-6049-47f7-a296-e75a038f3642">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTEtOC0xLTEtNzAzNjM_ecf478f4-9857-4e7b-9896-e06c023da622">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total shareholders&#8217; comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTItMi0xLTEtNzAzNjM_c94bc44d-74d5-4f65-848f-2b73d5cbda66">983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTItNC0xLTEtNzAzNjM_de8f3409-1424-484b-9e29-245267c88831">1,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTItNi0xLTEtNzAzNjM_345bf6cf-8e24-4977-92de-3769521b083c">2,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTItOC0xLTEtNzAzNjM_ad03ec6a-14d1-4fbc-a4e6-8100e049c92a">4,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-4-</span></div></div></div><div id="i186e051878fe4219970efc72a9fcdad4_28"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Elevance Health, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.553%"><tr><td style="width:1.0%"></td><td style="width:74.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.858%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.859%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMy0xLTEtMS03MDM2Mw_b4a76474-3410-4ce2-9226-46439cfea8ba">5,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMy0zLTEtMS03MDM2Mw_2849565b-81f5-4193-857f-f9686c17b1dd">4,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net losses (gains) on financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" sign="-" name="elv:NetLossesGainsOnFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNS0xLTEtMS03MDM2Mw_fe702a20-403c-4f86-8401-ef850577f0d9">439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="elv:NetLossesGainsOnFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNS0zLTEtMS03MDM2Mw_d2327fc5-a47a-4f35-910e-2150236b77b3">107</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity in net earnings of other invested assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNi0xLTEtMS03MDM2Mw_d3ef4e5e-e344-45c4-9949-f2ba1803c9a4">304</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNi0zLTEtMS03MDM2Mw_54592a6b-120a-4116-ac94-d0abcaa22aee">437</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:DepreciationAmortizationAndAccretionNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNy0xLTEtMS03MDM2Mw_d02f3b22-f481-4250-a7f6-82e9fc87df10">1,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNy0zLTEtMS03MDM2Mw_8bc8bae8-fe0b-43ab-97ec-0db7df6e12f1">942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMTItMS0xLTEtNzAzNjM_6a20793c-1b92-4471-bac7-6f7076d0a122">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMTItMy0xLTEtNzAzNjM_af49a705-b525-4a67-bdb0-9d73f814bd3b">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMTYtMS0xLTEtNzAzNjM_db83d731-6d51-4539-87bc-b3030d8c4d84">191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMTYtMy0xLTEtNzAzNjM_348b45a3-b21c-458b-b932-ed58b8d9e645">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMTktMS0xLTEtNzAzNjM_0577167c-be54-4d96-b526-2f31d03ba117">678</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMTktMy0xLTEtNzAzNjM_731453c0-e035-40af-a390-8d2f983f5b34">1,751</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other invested assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInTradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjAtMS0xLTEtNzAzNjM_a8e60d7c-1810-464c-9bd8-26624f86eec2">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInTradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjAtMy0xLTEtNzAzNjM_aabc0132-87bf-47f9-98ad-3a94aaa7aa8a">56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjEtMS0xLTEtNzAzNjM_a37f2316-1a8d-4ae7-b31f-fda8bb64fa1c">474</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjEtMy0xLTEtNzAzNjM_9f3a8ac8-d964-44fd-bf7e-de8ada129bbd">470</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Policy liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjItMS0xLTEtNzAzNjM_f8da7829-514a-4a60-8e5e-aa9d71894faa">1,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjItMy0xLTEtNzAzNjM_1a4f4790-bf57-4b5b-bca7-aea994cdae42">2,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unearned income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjMtMS0xLTEtNzAzNjM_900178db-9643-48a4-b778-1f40956f322a">2,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjMtMy0xLTEtNzAzNjM_502d199f-2d89-49a1-907e-2867c7ed7b9c">308</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjQtMS0xLTEtNzAzNjM_013f6c62-1259-4f80-ba69-88035e6be37e">598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjQtMy0xLTEtNzAzNjM_65f10258-020d-474c-90c5-453c7e1cd35d">1,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjctMS0xLTEtNzAzNjM_d2db5723-b2ef-4818-ad6b-c4ea45f233ed">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjctMy0xLTEtNzAzNjM_1a526070-a4e5-4392-9941-cdb55954a16b">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjgtMS0xLTEtNzAzNjM_46811483-5b64-4be4-a6c8-127f45865bdf">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjgtMy0xLTEtNzAzNjM_bc5ba57b-b1f0-4c02-b736-50da2a3b520f">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjktMS0xLTEtNzAzNjM_3164f8bb-ec1a-48e6-8bac-96d5f8d8472c">9,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjktMy0xLTEtNzAzNjM_e10aeefc-8094-4e31-93f2-1f548f48cbb8">6,692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMzQtMS0xLTEtNzAzNjM_60dd2acb-e21c-434c-9236-0fc5cf9f327f">19,612</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMzQtMy0xLTEtNzAzNjM_1dc5eb7f-7c8d-4a56-b082-2d433c436a4a">15,130</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="elv:Proceedsfromsaleofequityandfixedmaturitysecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMzUtMS0xLTEtNzAzNjM_7a2adc67-4d73-4a19-8c33-d305eb642c0a">9,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="elv:Proceedsfromsaleofequityandfixedmaturitysecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMzUtMy0xLTEtNzAzNjM_24823eef-4bfd-483b-9434-1813a1b19248">8,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maturities, calls and redemptions from investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMzYtMS0xLTEtNzAzNjM_10a0ee6f-28ec-45d3-b0c7-438a209dc53a">7,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMzYtMy0xLTEtNzAzNjM_237d1501-4892-4a15-a003-806fb9f8d5ed">3,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in securities lending collateral</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInCollateralHeldUnderSecuritiesLending" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNDItMS0xLTEtNzAzNjM_73454faa-6c37-4a5d-b3b1-c6ccb4decca8">677</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInCollateralHeldUnderSecuritiesLending" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNDItMy0xLTEtNzAzNjM_6b648c05-e565-4d0a-96fd-14af89bd577b">1,030</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of subsidiaries, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNDMtMS0xLTEtNzAzNjM_dfbdca23-0e9d-41b1-b62e-14c331c05251">623</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNDMtMy0xLTEtNzAzNjM_500092af-76a4-451b-bae5-b5df8ed01c55">3,442</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNDUtMS0xLTEtNzAzNjM_9fb06078-07e2-4ae0-a120-7e2543a3e517">854</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNDUtMy0xLTEtNzAzNjM_898a48ff-ba4f-44ad-bba2-0d7a8567e133">747</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNDctMS0xLTEtNzAzNjM_8bb31ddb-d70d-4c7d-9e70-b2adbf0d58e8">91</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNDctMy0xLTEtNzAzNjM_19c96dd9-6192-49d2-b668-371aeb6d9d4d">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNDgtMS0xLTEtNzAzNjM_3e212242-fad7-4caa-8974-161e7a770fd8">4,849</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNDgtMy0xLTEtNzAzNjM_fe13c711-afcc-4d1e-89a5-9fd678b7e6a6">8,672</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net proceeds from (repayments of) commercial paper borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTAtMS0xLTEtNzAzNjM_83d64320-e67f-4cfb-94e0-fccbac56f9ca">375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTAtMy0xLTEtNzAzNjM_c97fc879-d04c-455c-927d-54f2dc618cb8">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from long-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTEtMS0xLTEtNzAzNjM_dee294b7-ef7e-4b86-b05f-26ee9dcc5509">1,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTEtMy0xLTEtNzAzNjM_af7ac265-8cc7-400a-b57a-03aa3135d624">3,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayments of long-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTItMS0xLTEtNzAzNjM_1a6258b4-f4eb-4657-be1c-f9508e0c2a17">982</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTItMy0xLTEtNzAzNjM_eecad325-569a-4865-806b-a074238ed0e6">954</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTMtMS0xLTEtNzAzNjM_32716d5c-8e78-43e3-a986-20a18e15abf3">1,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTMtMy0xLTEtNzAzNjM_fae2a976-20e9-4121-a11f-cc41c6019a06">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayments of short-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTQtMS0xLTEtNzAzNjM_6063834f-922b-46ba-9b8a-1f37a88a83eb">1,375</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTQtMy0xLTEtNzAzNjM_9c2ee4d0-abac-4570-b0e7-b32f47a9776b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in securities lending payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInSecuritiesLendingPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTUtMS0xLTEtNzAzNjM_222a21e9-cfff-4062-97b7-e614f6d83091">685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInSecuritiesLendingPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTUtMy0xLTEtNzAzNjM_d27fee32-e00e-4085-a456-b93ade0d119a">1,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in bank overdrafts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:IncreaseDecreaseInOutstandingChecksFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTYtMS0xLTEtNzAzNjM_ba6f1f3a-947f-4682-81db-6a735dddf84d">181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInOutstandingChecksFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTYtMy0xLTEtNzAzNjM_da58dffd-52cf-47a2-bf3d-7032c7054c7b">316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase and retirement of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjAtMS0xLTEtNzAzNjM_2d03039a-0744-4195-9f9d-b3bc327a6c2f">1,748</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjAtMy0xLTEtNzAzNjM_5d37c5f1-5cb8-4231-8430-d359ce06b67f">1,378</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjItMS0xLTEtNzAzNjM_89126e3a-b11e-4ed4-94ad-eb90eca68e3c">924</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjItMy0xLTEtNzAzNjM_61cde3d8-50bf-40d0-b463-4d53d1c3c72a">831</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock under employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjMtMS0xLTEtNzAzNjM_ebd16222-e643-4503-9f44-b8c167dc73da">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjMtMy0xLTEtNzAzNjM_95691029-b4c7-4a4c-a927-02f06d063f65">161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Taxes paid through withholding of common stock under employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjQtMS0xLTEtNzAzNjM_60ee13ca-53a3-42ec-a10e-22be4397365a">91</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjQtMy0xLTEtNzAzNjM_bcf3cf2a-cf48-4138-a915-618671a2f218">101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjYtMS0xLTEtNzAzNjM_ae6bc819-bc4f-44b2-ad89-ed5bbf9a210c">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjYtMy0xLTEtNzAzNjM_f333991a-10cd-4014-b4da-cd1b857fb406">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjctMS0xLTEtNzAzNjM_cb26265c-798c-4892-8ee3-68af064bbcdd">1,060</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjctMy0xLTEtNzAzNjM_a40fdee5-5747-40d5-b7dc-61666df6952e">1,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of foreign exchange rates on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjgtMS0xLTEtNzAzNjM_08c3f605-b395-452d-8391-83d961c53eca">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjgtMy0xLTEtNzAzNjM_e2e105a8-88ee-493d-948a-7b4e644c0fc9">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjktMS0xLTEtNzAzNjM_c3cffddf-0a33-4a32-a150-700e94375417">3,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjktMy0xLTEtNzAzNjM_8ef25136-a3cb-4892-93ab-12b4be184b2b">251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNzAtMS0xLTEtNzAzNjM_cdf60764-8046-4458-9bb5-6c3d0f0f8d58">4,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aceaf2b19bf4d5d916eb0f2039e41de_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNzAtMy0xLTEtNzAzNjM_17eb493c-168f-4d8c-8dc5-6a0428934895">5,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNzEtMS0xLTEtNzAzNjM_fe14d069-d869-4979-99ce-107441f3c574">8,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7580839926f4e24b08f10312dd69479_I20210930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNzEtMy0xLTEtNzAzNjM_8f2be329-bb53-4d37-ad3e-b310d97f8f5f">5,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-5-</span></div></div></div><div id="i186e051878fe4219970efc72a9fcdad4_31"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Elevance Health, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Changes in Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:26.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.838%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.838%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.231%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.231%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.181%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.352%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shareholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling <br/>Interests</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021 (audited)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76e906fcfdeb4832b77b338196e38474_I20211231" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNS0xLTEtMS03MDM2Mw_ab738709-64c2-4e7d-b74c-135b57d207b7">241.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76e906fcfdeb4832b77b338196e38474_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNS0zLTEtMS03MDM2Mw_9fb66a90-865e-4c70-a397-29028d328f4f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0197b6d912c4e2c944e0737a73738ae_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNS01LTEtMS03MDM2Mw_600c1654-c9b2-49a1-b675-2da02bbf3bee">9,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if80200fe052042f58072c2a346401da5_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNS03LTEtMS03MDM2Mw_068b84cc-0498-47cc-9413-36464faead5f">27,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe28dcb0adc145abbec6cb9c3accca38_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNS05LTEtMS03MDM2Mw_a9b4a507-b26f-4277-b286-a90fcbb706fd">178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dffb789514e442d91844bfa2454ef52_I20211231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNS0xMS0xLTEtNzAzNjM_b103163c-8abb-4ac1-87dd-d0e4b51237b2">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNS0xMy0xLTEtNzAzNjM_bc3081aa-7b94-4a16-a2e2-94e356ca9231">36,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of Accounting Standards Update 2020-06 (Note 2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8291afc45194b679cb982efb46d0686_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNi03LTEtMS03MDM2Mw_42244242-50f6-414d-9213-650198b362c2">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0227e2707e394244aed3f2fd57a0e03a_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNi0xMy0xLTEtNzAzNjM_e22e21ef-a643-41c0-a438-0d6b6f6784d2">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76e906fcfdeb4832b77b338196e38474_I20211231" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNy0xLTEtMS03MDM2Mw_7a99a140-4a86-4c84-a737-5cd19d13349f">241.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76e906fcfdeb4832b77b338196e38474_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNy0zLTEtMS03MDM2Mw_0ede5f9b-c733-458c-a506-194c49042e48">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0197b6d912c4e2c944e0737a73738ae_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNy01LTEtMS03MDM2Mw_46ff1f05-36c3-4678-999e-f1ea8c83d799">9,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c5ee8ddad2f413fa5b819e04a12bc1e_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNy03LTEtMS03MDM2Mw_9b781994-4d89-403f-8670-a5190818cd03">27,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe28dcb0adc145abbec6cb9c3accca38_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNy05LTEtMS03MDM2Mw_4cfb1796-fd6b-4e70-808d-81bc66904da0">178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dffb789514e442d91844bfa2454ef52_I20211231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNy0xMS0xLTEtNzAzNjM_b103163c-8abb-4ac1-87dd-d0e4b51237b2">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d548577ea164af88a7545c8710fbb5d_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNy0xMy0xLTEtNzAzNjM_a33d66a5-d2c4-49cc-b8f9-b90dfa120a03">36,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a7c1fc826a441d7bce0a7af3b9d916c_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfOC03LTEtMS03MDM2Mw_1a2c367e-3d9f-4b70-b067-caa3fdde87f1">1,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f1b74a9d46a4c919ed5a0017b50fe3c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfOC0xMS0xLTEtNzAzNjM_4017e767-2047-47ae-ab40-c0523170a369">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfOC0xMy0xLTEtNzAzNjM_8e6247f5-92d1-4cff-a6ab-8eaa80a0a6a6">1,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab76c5a7b7904191b99afa7db58ad7f2_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfOS05LTEtMS03MDM2Mw_323493b9-0a47-4d69-9258-7e6649406fec">1,058</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f1b74a9d46a4c919ed5a0017b50fe3c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfOS0xMS0xLTEtNzAzNjM_5000b216-eb99-40a3-98ec-8ba935aeba3f">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfOS0xMy0xLTEtNzAzNjM_ed0be1d6-720b-4d20-8b4c-4231f1396c4a">1,063</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f1b74a9d46a4c919ed5a0017b50fe3c_D20220101-20220331" decimals="-6" name="elv:NoncontrollingInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTItMTEtMS0xLTcwMzYz_cd164c10-9620-4676-bf57-4cd9a7293b1a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331" decimals="-6" name="elv:NoncontrollingInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTItMTMtMS0xLTcwMzYz_50ff4ae6-5a79-42f5-84a7-22949edbe188">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase and retirement of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iedbdb762566945d88726ef37a57f9349_D20220101-20220331" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTMtMS0xLTEtNzAzNjM_b68a1b4d-b5ab-495b-97e4-d2001a0ef0d5">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2eb86bcfdff541038fc2cecb77088e6d_D20220101-20220331" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTMtNS0xLTEtNzAzNjM_d441d75d-ed66-430c-b005-d0e9d8c7cc06">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a7c1fc826a441d7bce0a7af3b9d916c_D20220101-20220331" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTMtNy0xLTEtNzAzNjM_6dc6a853-cc87-4d3c-b29e-1c35d0dfc2e9">500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTMtMTMtMS0xLTcwMzYz_5d8a0e00-01ae-45c2-b721-15904c2e0074">545</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends and dividend equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a7c1fc826a441d7bce0a7af3b9d916c_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTQtNy0xLTEtNzAzNjM_9c536f59-10d0-4369-84d2-22ff31425b46">312</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTQtMTMtMS0xLTcwMzYz_c0a68609-d4c1-4a64-8858-ff31655bd9ac">312</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock plans, net of related tax benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iedbdb762566945d88726ef37a57f9349_D20220101-20220331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTUtMS0xLTEtNzAzNjM_8b4ed2c7-1284-4809-9fbd-20fb96ed77f0">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eb86bcfdff541038fc2cecb77088e6d_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTUtNS0xLTEtNzAzNjM_1a978fcb-7552-4760-b531-ced4408bba26">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTUtMTMtMS0xLTcwMzYz_610b8cb1-538b-490e-a772-e7f5fe99886f">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debenture repurchases, conversions and tax adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eb86bcfdff541038fc2cecb77088e6d_D20220101-20220331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTYtNS0xLTEtNzAzNjM_1e3e737e-9836-4d10-a577-6ea89544ce0f">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTYtMTMtMS0xLTcwMzYz_496a4436-af2a-4eba-8251-3175fb7281a0">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i18c7f78957fb4eb298325eb813673f5d_I20220331" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTctMS0xLTEtNzAzNjM_deb37648-8501-428c-8e92-329fc9028866">241.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c7f78957fb4eb298325eb813673f5d_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTctMy0xLTEtNzAzNjM_0719c607-73dc-4f5c-af47-f6931036f001">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3f5943c567e426a969bf7881111eeb8_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTctNS0xLTEtNzAzNjM_48b4329a-d422-4c80-b053-1dcdd5c7449f">9,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i621d34b256184efca4a6e336041bad02_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTctNy0xLTEtNzAzNjM_129db2c3-88c2-4f0c-9211-bb18001f860c">28,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88a00773c76441adab343709fb0e30d1_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTctOS0xLTEtNzAzNjM_3ad5c1f5-82f1-4e39-b2f5-03229df70a9e">1,236</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc88fa2fe41a476fa802a9582efda818_I20220331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTctMTEtMS0xLTcwMzYz_60879d39-daac-4e98-adce-4bf541d4f69f">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cbead8991b44f1e8a37f09fb333172d_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTctMTMtMS0xLTcwMzYz_f957414e-cb88-4b0f-aea6-6cf919e298c9">36,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa8050991ea141e9b2f0cc25ecfbe2d6_D20220401-20220630" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTgtNy0xLTEtNzAzNjM_81cb30d4-d9d1-4146-8abf-4b4a82b7daf5">1,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i235ece1dc7f94255b99200f736f634e0_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTgtMTEtMS0xLTcwMzYz_3d5da46c-a549-4ca6-84bc-23861ad9277b">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTgtMTMtMS0xLTcwMzYz_7a54279e-be15-4966-9152-0cc633b3c488">1,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8bd5ffed39c44ee5bf9209ae6a1336e6_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTktOS0xLTEtNzAzNjM_a12ed51d-883d-434a-8e69-4f71a88a1b64">913</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i235ece1dc7f94255b99200f736f634e0_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTktMTEtMS0xLTcwMzYz_6140d397-193c-4841-b8a7-60ee37309ae1">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTktMTMtMS0xLTcwMzYz_59172a88-84c6-4361-ab68-09b4da00088e">916</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i235ece1dc7f94255b99200f736f634e0_D20220401-20220630" decimals="-6" name="elv:NoncontrollingInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjAtMTEtMS0xLTcwMzYz_bf47a5ac-a1c3-467c-9410-1fb6f097ddd2">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630" decimals="-6" name="elv:NoncontrollingInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjAtMTMtMS0xLTcwMzYz_f99433d6-bec8-47d7-856c-36994aa77900">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase and retirement of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ic32281f0fb4a46c1bd7c7cf96160ceac_D20220401-20220630" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjMtMS0xLTEtNzAzNjM_6240aea2-f360-4ba9-9c43-f91a0923f219">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93a6de0ab799413e882ff2eac44ac62c_D20220401-20220630" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjMtNS0xLTEtNzAzNjM_19b9b0d2-3660-4ede-ad27-08b8a469788f">48</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa8050991ea141e9b2f0cc25ecfbe2d6_D20220401-20220630" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjMtNy0xLTEtNzAzNjM_d229d4d4-5b6b-449d-a9a6-989ceaa46401">576</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjMtMTMtMS0xLTcwMzYz_9a950e4c-30c4-46b7-8967-c4a4e1ffd8dc">624</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends and dividend equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa8050991ea141e9b2f0cc25ecfbe2d6_D20220401-20220630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjQtNy0xLTEtNzAzNjM_0929d02c-e36d-41cd-bc24-a423a6348831">310</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjQtMTMtMS0xLTcwMzYz_bf757cd2-3fa0-4acd-8ac9-d9401ca46838">310</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock plans, net of related tax benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic32281f0fb4a46c1bd7c7cf96160ceac_D20220401-20220630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjUtMS0xLTEtNzAzNjM_999fa1d2-895d-4b4b-a7b5-2813803f4702">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93a6de0ab799413e882ff2eac44ac62c_D20220401-20220630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjUtNS0xLTEtNzAzNjM_7a831dab-ed84-4ead-9375-0a5fa9baf85a">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjUtMTMtMS0xLTcwMzYz_65b0d53c-3efb-40a6-9a1e-8a5574b47ab9">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debenture repurchases and conversions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93a6de0ab799413e882ff2eac44ac62c_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjYtNS0xLTEtNzAzNjM_edb7bb40-fb36-4561-abac-cb4b8202571b">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjYtMTMtMS0xLTcwMzYz_a891d44c-60f1-4831-a44a-109948909bb0">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i25fd263bfa4b408cb320d07c5b039a60_I20220630" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjgtMS0xLTEtNzAzNjM_1d7e959c-251c-43ef-977f-fdf53b2fadb1">240.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25fd263bfa4b408cb320d07c5b039a60_I20220630" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjgtMy0xLTEtNzAzNjM_76739f4a-65a2-4133-a444-1a212d580d9b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c004427a7414fc8897f44bcaea19bf9_I20220630" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjgtNS0xLTEtNzAzNjM_6fabf038-732a-4001-8f39-b552be66b733">9,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i754312c63f4847bda9a7fff60f065564_I20220630" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjgtNy0xLTEtNzAzNjM_02e3a019-d3bd-4587-a05e-74689d323c72">28,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3cdce901c495496b82564eaa2135b662_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjgtOS0xLTEtNzAzNjM_69f95a52-635f-4fac-a0b6-17a445befbbc">2,149</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86841404e36945a0a2b5a2801b6585e3_I20220630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjgtMTEtMS0xLTcwMzYz_a6cdb6ad-34cd-4e6f-a617-f07e45a29742">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0a535c1ffe84e6da717792a25f25e09_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjgtMTMtMS0xLTcwMzYz_0312384b-659c-4274-bc0c-c021351c37c6">35,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65acda5bd384478ba43ea184238b1adb_D20220701-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjktNy0xLTEtNzAzNjM_c4bf6fea-58a9-4584-a180-00e7ba183633">1,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b8abccde0624b77a8a1712e55378767_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjktMTEtMS0xLTcwMzYz_13b91e72-6128-4dd1-bc6e-ef989fe3f38c">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjktMTMtMS0xLTcwMzYz_0444eedb-1e6c-4eb5-a550-130b59c2e63c">1,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i205ff9c272f244b9a2a2473a5d2d0aa2_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzAtOS0xLTEtNzAzNjM_b27cb043-c772-40ab-bf0c-e3c8d1897d4e">635</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b8abccde0624b77a8a1712e55378767_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzAtMTEtMS0xLTcwMzYz_50411e5d-5a62-490f-b26f-ee42503bfa30">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzAtMTMtMS0xLTcwMzYz_ab0e6914-b965-4d95-a720-63093282973a">638</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b8abccde0624b77a8a1712e55378767_D20220701-20220930" decimals="-6" name="elv:NoncontrollingInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzEtMTEtMS0xLTcwMzYz_0f68a1d0-21b3-43eb-89c4-df9d941572e1">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzEtMTMtMS0xLTcwMzYz_d83626ad-2735-44a5-99d8-ab8bf1e18f5b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase and retirement of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i15035aec9b66494a932fa4d9f722665b_D20220701-20220930" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzQtMS0xLTEtNzAzNjM_0582aa9a-ebd0-4b91-8e10-65db34d209be">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f7b2e2c4f76452991af9030ab9b7ec1_D20220701-20220930" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzQtNS0xLTEtNzAzNjM_04901c20-0cca-42ec-a55f-984add25e920">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65acda5bd384478ba43ea184238b1adb_D20220701-20220930" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzQtNy0xLTEtNzAzNjM_a9d06089-c5f5-44f5-b4c5-27cd365ded61">532</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzQtMTMtMS0xLTcwMzYz_727ffcc4-7d36-4975-82be-127a8d78de3f">579</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends and dividend equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65acda5bd384478ba43ea184238b1adb_D20220701-20220930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzUtNy0xLTEtNzAzNjM_2c10b7e5-0aa1-4712-bba1-299b81663b0a">307</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzUtMTMtMS0xLTcwMzYz_8a97dcdd-f41a-4119-98bd-376ed242e486">307</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock plans, net of related tax benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i15035aec9b66494a932fa4d9f722665b_D20220701-20220930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzYtMS0xLTEtNzAzNjM_c0b6a367-0298-4956-94af-fde24c6cfde3">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f7b2e2c4f76452991af9030ab9b7ec1_D20220701-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzYtNS0xLTEtNzAzNjM_64e0eba1-71a7-451a-8733-bd699429d6e5">103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzYtMTMtMS0xLTcwMzYz_b501ec45-f515-4a97-8d83-6aab02c6ff50">103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debenture repurchases and conversions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f7b2e2c4f76452991af9030ab9b7ec1_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzctNS0xLTEtNzAzNjM_c420276e-aba1-413a-b4c3-0e0ff175ba0f">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzctMTMtMS0xLTcwMzYz_ace6ec2c-680b-4cff-811b-bf077a23f0e5">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8a417cc9e3284886a04a57fe479fce58_I20220930" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzktMS0xLTEtNzAzNjM_e2aff9a2-6ba4-4096-90a3-e1cbdc5272cc">239.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a417cc9e3284886a04a57fe479fce58_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzktMy0xLTEtNzAzNjM_afa3cb50-fe5f-4f30-a2f0-6ea4d9851f3f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae11bd779d7e4ef58f1fb3d8564575a0_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzktNS0xLTEtNzAzNjM_932c3596-f692-4231-a894-ce182e4a0560">9,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38ec61ed676c4597b3ce8d3bb80f93a4_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzktNy0xLTEtNzAzNjM_aeef03a8-af05-4f27-a576-48e80b4316b0">29,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2cbc4d0d7964a2681d5c5fa0021cf8b_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzktOS0xLTEtNzAzNjM_7666c8dd-7bca-492d-8c0e-90342081e9e2">2,784</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8e22949ca024e19a7be910f7fb72de0_I20220930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzktMTEtMS0xLTcwMzYz_a56728f8-6dd3-4e5b-b67e-da3696173540">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzktMTMtMS0xLTcwMzYz_65fa22bc-438c-460c-b13c-2ca53fe33847">36,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-6-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:26.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.268%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.268%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.057%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.365%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="42" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Elevance Health, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statements of Changes in Equity (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shareholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss) </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling <br/>Interests</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par<br/>Value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bcdceadaae34b568b184717c1feb64d_I20201231" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfNi0xLTEtMS03MDM2Mw_57bda2ac-cf5e-417c-90ca-9b989b3e20eb">245.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bcdceadaae34b568b184717c1feb64d_I20201231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfNi0zLTEtMS03MDM2Mw_c119b623-d4ef-42d5-ad80-5b131622bd22">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40273135b4c443249ac1e3576b1f8880_I20201231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfNi01LTEtMS03MDM2Mw_c74af2a4-8fad-419b-a2d1-1a71add186e8">9,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34ca5d23dd9d4c319c952057c4c553af_I20201231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfNi03LTEtMS03MDM2Mw_9fabf912-d43a-4d38-819a-b24646ea306a">23,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1636ce35b3f44cc59d3c0058be2140e7_I20201231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfNi05LTEtMS03MDM2Mw_bbeac06d-4246-432c-a0c5-b214a1a15833">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43c107c4cc114c2994db1a2d71a9a4a9_I20201231" decimals="-6" name="us-gaap:MinorityInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfNi0xMS0xLTEtNzAzNjM_957c8cdc-6226-4621-8176-5b9dde63e5b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2cd31b0b2f047d489ecdade092e7658_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfNi0xMy0xLTEtNzAzNjM_3e51eecb-b818-413d-b14e-825cbdabc3c2">33,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe61236f9a84e4fb0548f191cf989dd_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfNy03LTEtMS03MDM2Mw_05dda133-d1e3-4335-ab0e-af131c7a9a1d">1,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22199380ce254d5e8f1a20db003d38e1_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfNy0xMS0xLTEtNzAzNjM_a954a059-73e7-4a2c-8e02-f7c1741bc1e9">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfNy0xMy0xLTEtNzAzNjM_45b8a857-268a-4a20-a256-4f712cc878b5">1,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46b2d401ea4a43a8b53425d8ac39c3cc_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfOC05LTEtMS03MDM2Mw_0406c18e-b3bc-41b7-a84b-44f335940626">345</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22199380ce254d5e8f1a20db003d38e1_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfOC0xMS0xLTEtNzAzNjM_98c72e14-4da0-4ee3-b905-86d4f49159d3">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfOC0xMy0xLTEtNzAzNjM_9e4b5319-c6a1-4556-91f5-0bf4852782e5">347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22199380ce254d5e8f1a20db003d38e1_D20210101-20210331" decimals="-6" name="elv:NoncontrollingInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfOS0xMS0xLTEtNzAzNjM_b18d8fb8-1a3e-4acd-9628-09e37e126a90">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331" decimals="-6" name="elv:NoncontrollingInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfOS0xMy0xLTEtNzAzNjM_03f71477-7f2b-4dc6-a0fc-52ef13892d55">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase and retirement of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i90fc51345bd34cceaa9d7388a64ab064_D20210101-20210331" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTAtMS0xLTEtNzAzNjM_a3d52942-9e2a-417e-9544-2abb3dc65a3a">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90fc51345bd34cceaa9d7388a64ab064_D20210101-20210331" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTAtMy0xLTEtNzAzNjM_21142a5c-957b-4e5f-be44-101d0e8fa190">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32778a5cba784b46a29f834b6b7d8ffd_D20210101-20210331" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTAtNS0xLTEtNzAzNjM_f742a97a-697c-410e-926f-2849ca650cb1">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fe61236f9a84e4fb0548f191cf989dd_D20210101-20210331" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTAtNy0xLTEtNzAzNjM_5f182f22-6ee1-4e8d-850c-715a04c02877">393</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTAtMTMtMS0xLTcwMzYz_72676e0c-2bbd-4183-929c-1a8f76b2a08f">447</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends and dividend equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fe61236f9a84e4fb0548f191cf989dd_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTEtNy0xLTEtNzAzNjM_9869e9f2-6967-4f30-978c-fae717871f29">281</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTEtMTMtMS0xLTcwMzYz_6a361749-a73b-48f1-bc9e-058c3e7a1af3">281</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock plans, net of related tax benefits</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i90fc51345bd34cceaa9d7388a64ab064_D20210101-20210331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTItMS0xLTEtNzAzNjM_70c399c1-652e-45de-8b7e-72cbc568dfe6">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32778a5cba784b46a29f834b6b7d8ffd_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTItNS0xLTEtNzAzNjM_54df4f0c-4351-41fc-b71c-f39eae230c48">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTItMTMtMS0xLTcwMzYz_0042bc7f-01ed-4a34-9fcf-3f62131a66ff">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia3596a4a5edf4aca9700a1210c5e82cb_I20210331" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTQtMS0xLTEtNzAzNjM_99ebf2d8-03e3-4ae1-97f8-e85e8b8b092b">244.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3596a4a5edf4aca9700a1210c5e82cb_I20210331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTQtMy0xLTEtNzAzNjM_24ba610d-e9af-4977-9e78-b3a306a04e1c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb48a1922b7e435cb7c30da74d59221f_I20210331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTQtNS0xLTEtNzAzNjM_fb11b625-ad35-4bc6-ac28-8ba0e50d648a">9,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62d7a38b20f74260a57c7b27f73b7906_I20210331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTQtNy0xLTEtNzAzNjM_682bb275-b665-46fa-928b-34f9ea34ae18">24,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2573eaa31b44cd6abfa3facbdb6292a_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTQtOS0xLTEtNzAzNjM_54bff426-4af7-4f22-8762-fbfc6af9e50a">195</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cfb30e0735e44c5aa78cf9d1eb3d3a8_I20210331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTQtMTEtMS0xLTcwMzYz_ebb0b6e6-5c7b-4131-81fa-c2b75c876460">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23a4bf41cfe343828c4306abe17a0154_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTQtMTMtMS0xLTcwMzYz_3d813677-b3af-415e-9694-55e5d1a4b2c7">33,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68316ab96a734ae2b0f2dd2591bf303f_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTUtNy0xLTEtNzAzNjM_8eb895ef-7c1e-4033-be08-20c344e67c59">1,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb01790dc8947cc9fa28938b654f73f_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTUtMTEtMS0xLTcwMzYz_20d598f0-f73b-4fb9-b9cd-f2da8971d6a7">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTUtMTMtMS0xLTcwMzYz_d905d9d3-e48a-4801-aeea-d5e12cfdeaaa">1,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1c5b423fd0049679c05d61c789fee90_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTYtOS0xLTEtNzAzNjM_37c6b770-e6b8-4942-b44b-938b553dfcf4">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb01790dc8947cc9fa28938b654f73f_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTYtMTEtMS0xLTcwMzYz_3a760008-402e-4373-9f54-b5e59a0d304c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTYtMTMtMS0xLTcwMzYz_ad13d601-011a-45ad-a0a4-53a88e7e7b76">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb01790dc8947cc9fa28938b654f73f_D20210401-20210630" decimals="-6" name="elv:NoncontrollingInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTctMTEtMS0xLTcwMzYz_ff87d7bf-3aea-4bf3-a0da-11df20465996">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630" decimals="-6" name="elv:NoncontrollingInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTctMTMtMS0xLTcwMzYz_ac593ad3-95a4-45aa-b974-4f45ffad62ba">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase and retirement of common stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0d28810bc7644f938e65b4df5ea870b9_D20210401-20210630" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTktMS0xLTEtNzAzNjM_4c00df5d-4e71-4481-8ce0-6fbdabae3f7d">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d28810bc7644f938e65b4df5ea870b9_D20210401-20210630" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTktMy0xLTEtNzAzNjM_9cd5d10d-5e19-461a-8030-c38529814f0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib068c2f2d2f9451e85b8ebefd20a58b9_D20210401-20210630" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTktNS0xLTEtNzAzNjM_9b94ca12-c936-47a5-9b43-b5942e2dafe3">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68316ab96a734ae2b0f2dd2591bf303f_D20210401-20210630" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTktNy0xLTEtNzAzNjM_df6ca11f-40df-412c-b918-cb97c3308d06">433</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTktMTMtMS0xLTcwMzYz_63078fba-9ae8-4714-a034-14741cf680d0">480</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends and dividend equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68316ab96a734ae2b0f2dd2591bf303f_D20210401-20210630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjAtNy0xLTEtNzAzNjM_00ae1046-90d0-4d5d-bfbe-8bca027848a1">279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjAtMTMtMS0xLTcwMzYz_9aeb0b76-4e25-4666-a7bc-9d4f7c57bbab">279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock plans, net of related tax benefits</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0d28810bc7644f938e65b4df5ea870b9_D20210401-20210630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjEtMS0xLTEtNzAzNjM_bc705f74-cf6c-41e1-ba89-9c73f2bb571e">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib068c2f2d2f9451e85b8ebefd20a58b9_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjEtNS0xLTEtNzAzNjM_20387bf5-079d-433c-866e-6e9125b26689">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjEtMTMtMS0xLTcwMzYz_9bf72abb-7271-47d5-b8bd-7d9e3fb17426">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debenture repurchases and conversions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib068c2f2d2f9451e85b8ebefd20a58b9_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjItNS0xLTEtNzAzNjM_169b2736-c988-4864-a11a-4841ccfaf5b0">216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjItMTMtMS0xLTcwMzYz_59b13b48-b586-40c0-8971-9d3637c90495">216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i12e2179304f94f76a1f8fa22e0c596d7_I20210630" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjQtMS0xLTEtNzAzNjM_cc1c8033-4a80-488e-9cc1-603eb1e1e9ab">243.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12e2179304f94f76a1f8fa22e0c596d7_I20210630" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjQtMy0xLTEtNzAzNjM_7162ddd0-5524-4f23-9c89-ebaa100d7c7f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if71d617a922b4549a876a2aeb86d0fb3_I20210630" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjQtNS0xLTEtNzAzNjM_6ac4b7e0-f1e5-4350-b6df-0bcc3b109612">9,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58e67abfbcd74df68e8cc1c6309c6fa7_I20210630" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjQtNy0xLTEtNzAzNjM_88d6c83e-c96a-4760-8523-580e45910529">25,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa6a2ab38f55454590fbcb0d8bf0cb81_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjQtOS0xLTEtNzAzNjM_aecbfa1e-1b52-4ad7-8077-29339277688f">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad7dc64de9f4333a507db7171be2b9f_I20210630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjQtMTEtMS0xLTcwMzYz_5c8fe8cf-fbbd-446c-ad74-77614c22ebce">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd7bbc6ac8054bf59b507514156a792b_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjQtMTMtMS0xLTcwMzYz_7be85060-8bc8-4194-acba-03c73c9aa32c">35,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e5268adb4e41acac42b6e71ed6a956_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjUtNy0xLTEtNzAzNjM_03860f59-ef44-43ac-bb63-f7e0d782eace">1,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ce5dd3a2a6441349bc5e6572d8958ca_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjUtMTEtMS0xLTc3NDQ4_df8379d8-13f1-4e3c-b34e-03a3d6ebc074">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjUtMTMtMS0xLTcwMzYz_8f72eafd-0459-4735-a6ac-65c090b9bb41">1,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec47e227732d4b219990442f8321eb49_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjYtOS0xLTEtNzAzNjM_202753fe-632c-4d2c-831e-0cfb8160e903">86</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ce5dd3a2a6441349bc5e6572d8958ca_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjYtMTEtMS0xLTc3NDUx_388de8e5-40a2-4a4f-9d8c-752aa0a0df57">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjYtMTMtMS0xLTcwMzYz_b01c395d-28df-444f-a0ef-7861a32b37d1">87</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ce5dd3a2a6441349bc5e6572d8958ca_D20210701-20210930" decimals="-6" name="elv:NoncontrollingInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjctMTEtMS0xLTc3NDUz_041b3169-cc85-487d-8474-f36c5763b524">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="elv:NoncontrollingInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjctMTMtMS0xLTcwMzYz_c0577fda-1a66-4f24-a2b9-1a597e37b9ef">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase and retirement of common stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i72cc3c90ae37402bb1a3406ca8ec8281_D20210701-20210930" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjktMS0xLTEtNzAzNjM_0efa336f-5725-49d8-b45d-a192af5af372">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72cc3c90ae37402bb1a3406ca8ec8281_D20210701-20210930" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjktMy0xLTEtNzAzNjM_6ba1b529-a0d1-4686-8d28-b60b67aa6a20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50902a61a4dd4c3abe12641611a989d0_D20210701-20210930" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjktNS0xLTEtNzAzNjM_6685c2a1-e994-4bb5-83a2-fb420a29d541">44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89e5268adb4e41acac42b6e71ed6a956_D20210701-20210930" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjktNy0xLTEtNzAzNjM_02582152-8762-45fb-a747-369018ebc9ef">407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjktMTMtMS0xLTcwMzYz_1fee2d42-0250-4f63-9da1-72c916426bf8">451</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends and dividend equivalents</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89e5268adb4e41acac42b6e71ed6a956_D20210701-20210930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzAtNy0xLTEtNzAzNjM_1176915b-5733-4228-af06-671a286bcc09">276</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzAtMTMtMS0xLTcwMzYz_b8ca8d02-8faf-4a24-9cc1-b701bb905453">276</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock plans, net of related tax benefits</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i72cc3c90ae37402bb1a3406ca8ec8281_D20210701-20210930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzEtMS0xLTEtNzAzNjM_095a524a-72fd-41b0-99f5-0e17b2c12a2a">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50902a61a4dd4c3abe12641611a989d0_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzEtNS0xLTEtNzAzNjM_a78445c5-936b-4ae2-86c5-f08a77da847d">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzEtMTMtMS0xLTcwMzYz_e9345665-a525-4144-9a3c-b3fa51a1f474">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debenture repurchases and conversions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50902a61a4dd4c3abe12641611a989d0_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzItNS0xLTEtNzAzNjM_9384abe5-119e-43aa-9f55-f1a99cb4c33f">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzItMTMtMS0xLTcwMzYz_e189f4d2-d5f9-482c-a1e0-36c4a435ce04">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i07b85a9cf8364984ad848fb7ac29fcc6_I20210930" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzMtMS0xLTEtNzAzNjM_fd87de62-8849-4145-9b07-a332ac725b88">242.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07b85a9cf8364984ad848fb7ac29fcc6_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzMtMy0xLTEtNzAzNjM_cedfa0ec-d9fb-43f8-a4ab-f3d9a3a5969b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e1170d9414d4932b37104a99abbfcd7_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzMtNS0xLTEtNzAzNjM_365a1dbb-8543-4b7c-b3c6-d4249a8cf02e">9,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad1b58d99a92454aaecc9a643c16c0c1_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzMtNy0xLTEtNzAzNjM_3b15b03f-8184-49af-a697-bba421423491">26,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id08298fdd1324292a7e56ccb4754a37f_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzMtOS0xLTEtNzAzNjM_5a55c149-4463-42ab-9ad3-e6dce514930b">103</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d2e1c82b14b435aa3b898cd3e04de1b_I20210930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzItMTEtMS0xLTc3NTI3_59d0a261-79fd-4dd0-8065-a16c3097cd83">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7580839926f4e24b08f10312dd69479_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzMtMTMtMS0xLTcwMzYz_7777d776-e1bd-45a1-8b28-dff5a05e344d">35,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-7-</span></div></div></div><div id="i186e051878fe4219970efc72a9fcdad4_34"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Elevance Health, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September&#160;30, 2022 </span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In Millions, Except Per Share Data or As Otherwise Stated Herein)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i186e051878fe4219970efc72a9fcdad4_37"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zNy9mcmFnOjc4NWU5Zjk1ZTZhZDQyMDdhYTk4OTdjZmM5ZDZmNWJiL3RleHRyZWdpb246Nzg1ZTlmOTVlNmFkNDIwN2FhOTg5N2NmYzlkNmY1YmJfNDA1NA_a9694de4-7d63-453d-bd9a-8cf909decafa" continuedAt="ib3d9ad4e0b274cf49aa5c154dc184dc1" escape="true">Organization</ix:nonNumeric></span></div><ix:continuation id="ib3d9ad4e0b274cf49aa5c154dc184dc1"><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 18, 2022, our shareholders approved a proposal to amend our amended and restated articles of incorporation to change our name from Anthem, Inc. to Elevance Health, Inc. This amendment and name change went into effect on June 27, 2022. We began operating as Elevance Health, Inc. and trading under our new ticker symbol &#8220;ELV&#8221; on June 28, 2022. References to the terms &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221; or &#8220;Elevance Health&#8221; used throughout these Notes to Consolidated Financial Statements refer to Elevance Health, Inc., an Indiana corporation, and unless the context otherwise requires, its direct and indirect subsidiaries. References to the &#8220;states&#8221; include the District of Columbia and Puerto Rico, unless the context otherwise requires.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Elevance Health is a health company with the purpose of improving the health of humanity. We are the largest health insurer in the United States in terms of medical membership, serving over <ix:nonFraction unitRef="medical_member" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="elv:NumberOfMedicalMembersServed" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zNy9mcmFnOjc4NWU5Zjk1ZTZhZDQyMDdhYTk4OTdjZmM5ZDZmNWJiL3RleHRyZWdpb246Nzg1ZTlmOTVlNmFkNDIwN2FhOTg5N2NmYzlkNmY1YmJfOTQ1_c5b46c45-97b6-4b93-b7fb-d28512566499">47</ix:nonFraction> million medical members through our affiliated health plans as of September&#160;30, 2022. We offer a broad spectrum of network-based managed care risk-based plans to Individual, Group, Medicaid and Medicare markets. In addition, we provide a broad array of managed care services to fee-based customers, including claims processing, stop loss insurance, provider network access, medical management, care management and wellness programs, actuarial services and other administrative services. We also provide services to the federal government in connection with our Federal Health Products &amp; Services business, which administers the Federal Employees Health Benefits (&#8220;FEHB&#8221;) Program. We provide an array of specialty services both to our subsidiary health plans and also unaffiliated health plans, including pharmacy benefits management (&#8220;PBM&#8221;) services and dental, vision, life, disability and supplemental health insurance benefits, as well as integrated health services. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an independent licensee of the Blue Cross and Blue Shield Association (&#8220;BCBSA&#8221;), an association of independent health benefit plans. We serve our members as the Blue Cross licensee for California and as the Blue Cross and Blue Shield (&#8220;BCBS&#8221;) licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding <ix:nonFraction unitRef="county" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="INF" name="elv:NumberOfCountiesInStateOfKansasCompanyDoesNotServe" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zNy9mcmFnOjc4NWU5Zjk1ZTZhZDQyMDdhYTk4OTdjZmM5ZDZmNWJiL3RleHRyZWdpb246Nzg1ZTlmOTVlNmFkNDIwN2FhOTg5N2NmYzlkNmY1YmJfMjI0NA_e6897a2e-f099-4741-b744-ef214194ecda">30</ix:nonFraction> counties in the Kansas City area), Nevada, New Hampshire, New York (in the New York City metropolitan area and upstate New York), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.) and Wisconsin. In a majority of these service areas, we do business as Anthem Blue Cross, Anthem Blue Cross and Blue Shield, and Empire Blue Cross Blue Shield or Empire Blue Cross. In addition, we conduct business through arrangements with other BCBS licensees as well as other strategic partners. Through our subsidiaries, we also serve customers in numerous states as AIM Specialty Health, Amerigroup, Aspire Health, Beacon, CareMore, Freedom Health, HealthLink, HealthSun, Integra Managed Care, MMM, Optimum HealthCare, Simply Healthcare, and/or UniCare. We offer PBM services through our IngenioRx, Inc. (&#8220;IngenioRx&#8221;) subsidiary. We are licensed to conduct insurance operations in all <ix:nonFraction unitRef="states" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="INF" name="us-gaap:NumberOfStatesInWhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zNy9mcmFnOjc4NWU5Zjk1ZTZhZDQyMDdhYTk4OTdjZmM5ZDZmNWJiL3RleHRyZWdpb246Nzg1ZTlmOTVlNmFkNDIwN2FhOTg5N2NmYzlkNmY1YmJfMzE0Mw_61c2cb15-0aa5-4ec4-9c0d-8f0cf853f34e">50</ix:nonFraction> states, the District of Columbia and Puerto Rico through our subsidiaries.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our name change to Elevance Health, on June 15, 2022 we announced that over the next several years we will organize our brand portfolio into the following core go-to-market brands:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Anthem Blue Cross/Anthem Blue Cross and Blue Shield &#8212; represents our existing Anthem-branded and affiliated Blue Cross and/or Blue Shield licensed plans;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Wellpoint &#8212; we intend to unite select non-BCBSA licensed Medicare, Medicaid and Commercial plans under the Wellpoint name; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Carelon &#8212; this brand will bring together our healthcare brands and capabilities, including our Diversified Business Group and IngenioRx business under a single brand name. We now refer to our Diversified Business Group as Carelon. In January 2023, IngenioRx will become CarelonRx.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are currently no segment changes associated with this branding strategy. Our branding strategy reflects the evolution of our business from a traditional health insurance company to a lifetime, trusted health partner, and given this evolution we are in the process of reviewing and modifying how we will manage our businesses in the future.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-8-</span></div></div></div><div id="i186e051878fe4219970efc72a9fcdad4_40"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTYyNDA_8013aa47-179b-46a6-990e-3311cf3afcdc" continuedAt="ia513f259b6634f41af0a6517b191b0a0" escape="true">Basis of Presentation and Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="ia513f259b6634f41af0a6517b191b0a0" continuedAt="ifb1457723ef24b00ba1c03e28f2a0a9d"><div style="margin-bottom:9pt;text-indent:18pt"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTYyMjU_b89989e9-de19-4407-9eaa-be30c2a883a4" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for annual financial statements. We have omitted certain footnote disclosures that would substantially duplicate the disclosures in our 2021 Annual Report on Form 10-K, unless the information contained in those disclosures materially changed or is required by GAAP. In the opinion of management, all adjustments, including normal recurring adjustments, necessary for a fair statement of the consolidated financial statements as of and for the three and nine months ended September&#160;30, 2022 and 2021 have been recorded. The results of operations for the three and nine months ended September&#160;30, 2022 are not necessarily indicative of the results that may be expected for the full year ending December&#160;31, 2022, or any other period. The seasonal nature of portions of our health care and related benefits business, competitive and other market conditions, as well as COVID-19 related impacts, may cause full-year results to differ from estimates based upon our interim results of operations. These unaudited consolidated financial statements should be read in conjunction with our audited consolidated financial statements as of and for the year ended December&#160;31, 2021 included in our 2021 Annual Report on Form 10-K.</span></ix:nonNumeric></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTYyNDc_0abb0ab3-7914-479d-8f1f-1d8b337a81af" escape="true">Certain of our subsidiaries operate outside of the United States and have functional currencies other than the U.S. dollar (&#8220;USD&#8221;). We translate the assets and liabilities of those subsidiaries to USD using the exchange rate in effect at the end of the period. We translate the revenues and expenses of those subsidiaries to USD using the average exchange rates in effect during the period. The net effect of these translation adjustments is included in &#8220;Foreign currency translation adjustments&#8221; in our consolidated statements of comprehensive income.</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-indent:18pt"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTYyNDE_274f5144-0240-44a3-a0d8-b9f616ec3692" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We control a number of bank accounts that are used exclusively to hold customer funds for the administration of customer benefits and we have cash and cash equivalents on deposit to meet certain regulatory requirements. These amounts totaled $<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMjA1Mw_47b5ca11-78ab-4f2f-b1de-e03fcfa0ff0b">291</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMjA2MA_dbc73ce1-725d-4d7c-b6da-429679d0a7da">173</ix:nonFraction> at September&#160;30, 2022 and December&#160;31, 2021, respectively, and are included in the cash and cash equivalents line on our consolidated balance sheets.</span></ix:nonNumeric></div><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTYyMDk_01d69204-a2fb-403c-ae02-8295cac355eb" continuedAt="i6e540652b2494af5afb677599cb7ceee" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classify fixed maturity securities in our investment portfolio as &#8220;available-for-sale&#8221; and report those securities at fair value. Certain fixed maturity securities are available to support current operations and, accordingly, we classify such investments as current assets without regard to their contractual maturity. Investments used to satisfy contractual, regulatory or other requirements are classified as long-term, without regard to contractual maturity.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a fixed maturity security is in an unrealized loss position and we have the intent to sell the fixed maturity security, or it is more likely than not that we will have to sell the fixed maturity security before recovery of its amortized cost basis, we write down the fixed maturity security&#8217;s cost basis to fair value and record an impairment loss in our consolidated statements of income. For impaired fixed maturity securities that we do not intend to sell or if it is more likely than not that we will not have to sell such securities, but we expect that we will not fully recover the amortized cost basis, we recognize the credit component of the impairment as an allowance for credit loss in our consolidated balance sheets and record an impairment loss in our consolidated statements of income. The non-credit component of the impairment is recognized in accumulated other comprehensive loss. Furthermore, unrealized losses entirely caused by non-credit-related factors related to fixed maturity securities for which we expect to fully recover the amortized cost basis continue to be recognized in accumulated other comprehensive loss. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit component of an impairment is determined primarily by comparing the net present value of projected future cash flows with the amortized cost basis of the fixed maturity security. The net present value is calculated by discounting our best estimate of projected future cash flows at the effective interest rate implicit in the fixed maturity security at the date of purchase. For mortgage-backed and asset-backed securities, cash flow estimates are based on assumptions regarding the underlying collateral, including prepayment speeds, vintage, type of underlying asset, geographic concentrations, default rates, recoveries and changes in value. For all other securities, cash flow estimates are driven by assumptions regarding probability of default, including changes in credit ratings and estimates regarding timing and amount of recoveries associated with a default.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For asset-backed securities included in fixed maturity securities, we recognize income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The net investment in the </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-9-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ifb1457723ef24b00ba1c03e28f2a0a9d" continuedAt="id7db99573a0d4eeaab6533fe35a2baf2"><ix:continuation id="i6e540652b2494af5afb677599cb7ceee"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">securities is adjusted to the amount that would have existed had the new effective yield been applied since the purchase date of the securities. Such adjustments are reported within net investment income.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The changes in fair value of our marketable equity securities are recognized in our results of operations within net gains and losses on financial instruments. Certain marketable equity securities are held to satisfy contractual obligations, and are reported under the caption &#8220;Other invested assets&#8221; in our consolidated balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have corporate-owned life insurance policies on certain participants in our deferred compensation plans and other members of management. The cash surrender value of the corporate-owned life insurance policies is reported under the caption &#8220;Other invested assets&#8221; in our consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the equity method of accounting for investments in companies in which our ownership interest may enable us to influence the operating or financial decisions of the investee company. Our proportionate share of equity in net income of these unconsolidated affiliates is reported within net investment income. The equity method investments are reported under the caption &#8220;Other invested assets&#8221; in our consolidated balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment income is recorded when earned. All securities sold resulting in investment gains and losses are recorded on the trade date. Realized gains and losses are determined on the basis of the cost or amortized cost of the specific securities sold.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in securities lending programs whereby marketable securities in our investment portfolio are transferred to independent brokers or dealers in exchange for cash and securities collateral. We recognize the collateral as an asset, which is reported under the caption &#8220;Other current assets&#8221; in our consolidated balance sheets, and we record a corresponding liability for the obligation to return the collateral to the borrower, which is reported under the caption &#8220;Other current liabilities&#8221; in our consolidated balance sheets. The securities on loan are reported in the applicable investment category on our consolidated balance sheets. Unrealized gains or losses on securities lending collateral are included in accumulated other comprehensive loss as a separate component of shareholders&#8217; equity. The market value of loaned securities and that of the collateral pledged can fluctuate in non-synchronized fashions.&#160;To the extent the loaned securities&#8217; value appreciates faster or depreciates slower than the value of the collateral pledged, we are exposed to the risk of the shortfall.&#160;As a primary mitigating mechanism, the loaned securities and collateral pledged are marked to market on a daily basis and the shortfall, if any, is collected accordingly.&#160;Secondarily, the collateral level is set at <ix:nonFraction unitRef="number" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="2" name="elv:SecuritiesLendingTransactionsInitialCollateralPercentageValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfNzg5OQ_b7985803-2bbf-4e96-97e5-ce0d347f2cf7">102</ix:nonFraction>% of the value of the loaned securities, which provides a cushion before any shortfall arises. The investment of the cash collateral is subject to market risk, which is managed by limiting the investments to higher quality and shorter duration instruments.</span></div></ix:continuation><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTYyMDY_95d4b6f9-b037-40ab-8632-2a7f2f6a2634" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Receivables are reported net of amounts for expected credit losses. The allowance for doubtful accounts is based on historical collection trends, future forecasts and our judgment regarding the ability to collect specific accounts.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Premium receivables include the uncollected amounts from risk-based groups, individuals and government programs for insurance services. Premium receivables are reported net of an allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfODYxNg_7c92a3cf-d8ed-4f03-94d3-bf8bd500cce5">140</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfODYyMw_4537415f-1299-489a-b1a7-5263d1698bc1">142</ix:nonFraction> at September&#160;30, 2022 and December&#160;31, 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Self-funded receivables include administrative fees, claims and other amounts due from fee-based customers for administrative services. Self-funded receivables are reported net of an allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="elv:SelffundedReceivablesAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfODg3Mw_4ca7dbd4-2641-46bf-b3f3-bbe47e3f2962">82</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="elv:SelffundedReceivablesAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfODg4MA_b6198c18-14da-46c0-9b69-817b30452a82">50</ix:nonFraction> at September&#160;30, 2022 and December&#160;31, 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other receivables include pharmacy rebates, provider advances, claims recoveries, reinsurance receivables, proceeds due from brokers on investment trades, accrued investment income, and other miscellaneous amounts due to us. These receivables are reported net of an allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfOTIxMw_14e67373-f988-48ea-a6fa-59f5dacb82f8">709</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfOTIyMA_503ca952-c826-4797-9e49-4a992b9f850c">648</ix:nonFraction> at September&#160;30, 2022 and December&#160;31, 2021, respectively.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTYyMDc_e19f9c31-f1e8-4539-b478-f94937431404" escape="true"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTYyNDM_6463b266-c16c-41eb-89d9-273e1f8115fa" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For our non-risk-based contracts, we had no material contract assets, contract liabilities or deferred contract costs&#160;recorded on our consolidated balance sheet at September&#160;30, 2022. For the three and nine months ended September&#160;30, 2022 and 2021, revenue recognized from performance obligations related to prior periods, such as due to changes in transaction price, was not material. For contracts that have an original expected duration of greater than one year, revenue expected to be recognized in future periods related to unfulfilled contractual performance obligations and contracts with variable consideration related to undelivered performance obligations is not material.</span></ix:nonNumeric></ix:nonNumeric></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-10-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id7db99573a0d4eeaab6533fe35a2baf2" continuedAt="ia00e94f5e29c47abb70c3bf946c57b58"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTYyMzg_2c374fa9-70b1-499a-8006-738ee041c3bd" continuedAt="i8ad9c4df279b426fa0b1bd53e858d3e6" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Guidance: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update No. 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2021-01&#8221;). The amendments in ASU 2021-01 provide optional expedients and exceptions for applying GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference the London Interbank Offered Rate (&#8220;LIBOR&#8221;) or another reference rate expected to be discontinued because of the reference rate reform. The provisions must be applied at a Topic, Subtopic, or Industry Subtopic level for all transactions other than derivatives, which may be applied at a hedging relationship level. We adopted ASU 2021-01 on January 7, 2021, and the adoption did not have an impact on our consolidated financial position, results of operations or cash flows.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued Accounting Standards Update No. 2020-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements to Subtopic 310-20, Receivables&#8212;Nonrefundable Fees and Other Costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-08&#8221;). The amendments in ASU 2020-08 clarify when an entity should assess whether a callable debt security is within the scope of accounting guidance, which impacts the amortization period for nonrefundable fees and other costs. ASU 2020-08 became effective for interim and annual reporting periods beginning after December 15, 2020. The amendments were to be applied on a prospective basis as of the beginning of the period of adoption for existing or newly purchased callable debt securities. We adopted ASU 2020-08 on January 1, 2021, and the adoption did not have an impact on our consolidated financial position, results of operations or cash flows.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued Accounting Standards Update No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-06&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments eliminate two of the three accounting models that require separate accounting for convertible features of debt securities, simplify the contract settlement assessment for equity classification, require the use of the if-converted method for all convertible instruments in the diluted earnings per share calculation and expand disclosure requirements. The amendments became effective for our annual and interim reporting periods beginning after December 15, 2021. We adopted ASU 2020-06 on January 1, 2022 using the modified retrospective transition method, which resulted in an increase to our reported debt outstanding of $<ix:nonFraction unitRef="usd" contextRef="ic8291afc45194b679cb982efb46d0686_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTI1Njc_c5342a1d-cb82-47b3-888d-52515fd89795">31</ix:nonFraction>, a decrease to our deferred tax liabilities of $<ix:nonFraction unitRef="usd" contextRef="ic8291afc45194b679cb982efb46d0686_I20211231" decimals="-6" sign="-" name="us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTI2MTc_b209a8ff-17c4-4885-bf87-f793dde00411">8</ix:nonFraction>, and a corresponding cumulative-effect reduction to our opening retained earnings of $<ix:nonFraction unitRef="usd" contextRef="ic8291afc45194b679cb982efb46d0686_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTI3MDU_e9a116c8-e970-4c9d-ae9f-d8ed062b1b8a">23</ix:nonFraction>; these amounts are not material to our overall consolidated financial position. The adoption of ASU 2020-06 did not have an impact on our results of operations or our consolidated cash flows. Use of the if-converted method did not have an impact on our overall earnings per share calculation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued Accounting Standards Update No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2019-12&#8221;). The amendments in ASU 2019-12 remove certain exceptions to the general principles in Accounting Standards Codification Topic 740. The amendments also clarify and amend existing guidance to improve consistent application. The amendments became effective for our annual reporting periods beginning after December 15, 2020. The transition method (retrospective, modified retrospective, or prospective basis) related to the amendments depends on the applicable guidance, and all amendments for which there is no transition guidance specified are to be applied on a prospective basis. We adopted ASU 2019-12 on January 1, 2021, and the adoption did not have an impact on our consolidated financial position, results of operations or cash flows.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Guidance Not Yet Adopted: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, the FASB issued Accounting Standards Update No. 2020-11,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Financial Services&#8212;Insurance (Topic 944): Effective Date and Early Application </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-11&#8221;). The amendments in ASU 2020-11 make changes to the effective date and early application of Accounting Standards Update No. 2018-12,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Financial Services&#8212;Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2018-12&#8221;), which was issued in November 2018. The amendments in ASU 2020-11 have extended the original effective date by one year, and now the amendments are required for our interim and annual reporting periods beginning after December 15, 2022. The amendments in ASU 2018-12 make changes to a variety of areas to simplify or improve the existing recognition, measurement, presentation and disclosure requirements for long-duration contracts issued by an insurance entity. The amendments require insurers to annually review the assumptions they make about their policyholders and update the liabilities for future policy benefits if the assumptions change. The amendments also simplify the amortization of deferred contract acquisition costs and add new disclosure requirements about the assumptions insurers use to measure their liabilities and how they may affect future cash flows. The amendments related to the liability for future policy benefits for traditional and limited-payment contracts and deferred acquisition costs are to be applied to contracts in force as of the beginning of the earliest period presented, with an option to apply such amendments retrospectively with a cumulative-effect adjustment to the opening balance of retained earnings as of the earliest period presented. The amendments </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-11-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia00e94f5e29c47abb70c3bf946c57b58"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8ad9c4df279b426fa0b1bd53e858d3e6">for market risk benefits are to be applied retrospectively. We do not believe the adoption of ASU 2020-11 and ASU 2018-12 will have a material impact on our consolidated financial position, results of operations, cash flows, and related disclosures.</ix:continuation></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other new accounting pronouncements that were issued or became effective since the issuance of our 2021 Annual Report on Form 10-K that had, or are expected to have, a material impact on our consolidated financial position, results of operations or cash flows.</span></div></ix:continuation><div id="i186e051878fe4219970efc72a9fcdad4_43"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80My9mcmFnOjliOWMxNzAxMmU0ZTQ0ODY4ZTBhZjFmOTdkY2E5MWQ3L3RleHRyZWdpb246OWI5YzE3MDEyZTRlNDQ4NjhlMGFmMWY5N2RjYTkxZDdfMTYxMw_59033067-7666-45eb-b5b6-882b010d6de7" continuedAt="i9ef8213127af4d059793788bdeab7d75" escape="true">Business Acquisitions</ix:nonNumeric></span></div><ix:continuation id="i9ef8213127af4d059793788bdeab7d75" continuedAt="i3e080c1f7b724729b150ce241e25791b"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Completed Acquisitions </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 5, 2022, we completed our acquisition of Integra Managed Care (&#8220;Integra&#8221;) from Personal Touch Holding Corporation. Integra is a managed long-term care plan that serves New York state Medicaid members, enabling adults with long-term care needs and disabilities to live safely and independently in their own homes. The purchase price was allocated to the tangible and intangible net assets acquired based on management&#8217;s initial estimates of their fair values, of which $<ix:nonFraction unitRef="usd" contextRef="i2bc73b260c78413bbf502ba5c1050cce_D20220101-20220930" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80My9mcmFnOjliOWMxNzAxMmU0ZTQ0ODY4ZTBhZjFmOTdkY2E5MWQ3L3RleHRyZWdpb246OWI5YzE3MDEyZTRlNDQ4NjhlMGFmMWY5N2RjYTkxZDdfNTI5_f02807d7-fd46-46dc-8d50-233242c4f20b">89</ix:nonFraction> has been allocated to finite-lived intangible assets, $<ix:nonFraction unitRef="usd" contextRef="i2bc73b260c78413bbf502ba5c1050cce_D20220101-20220930" decimals="-6" name="us-gaap:IndefinitelivedIntangibleAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80My9mcmFnOjliOWMxNzAxMmU0ZTQ0ODY4ZTBhZjFmOTdkY2E5MWQ3L3RleHRyZWdpb246OWI5YzE3MDEyZTRlNDQ4NjhlMGFmMWY5N2RjYTkxZDdfNTg2_f26d7a92-eb28-4b7e-90db-f272d58a2a28">250</ix:nonFraction> to indefinite-lived intangible assets, and $<ix:nonFraction unitRef="usd" contextRef="i67668f78684042f3ae9dc8e1ad62b947_I20220930" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80My9mcmFnOjliOWMxNzAxMmU0ZTQ0ODY4ZTBhZjFmOTdkY2E5MWQ3L3RleHRyZWdpb246OWI5YzE3MDEyZTRlNDQ4NjhlMGFmMWY5N2RjYTkxZDdfNjMy_52287ba0-13e4-4e5e-8221-eece199cc4c9">123</ix:nonFraction> to goodwill, including measurement period adjustments to goodwill of $<ix:nonFraction unitRef="usd" contextRef="i2bc73b260c78413bbf502ba5c1050cce_D20220101-20220930" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80My9mcmFnOjliOWMxNzAxMmU0ZTQ0ODY4ZTBhZjFmOTdkY2E5MWQ3L3RleHRyZWdpb246OWI5YzE3MDEyZTRlNDQ4NjhlMGFmMWY5N2RjYTkxZDdfMTA5OTUxMTYzMTYwMg_4b551f7e-0128-4f02-9cd2-a3ad665c10a4">13</ix:nonFraction> during the quarter ended September 30, 2022. The majority of goodwill is deductible for income tax purposes. As of September&#160;30, 2022, the initial accounting for the acquisition had not been finalized. Any subsequent adjustments made to the assets acquired or liabilities assumed during the measurement period will be recorded as an adjustment to goodwill. The proforma effects of this acquisition for prior periods were not material to our consolidated results of operations.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3e080c1f7b724729b150ce241e25791b">Acquisitions completed during the year ended December 31, 2021, for which the initial accounting was finalized during the three months ended June 30, 2022 included myNEXUS, Inc. (&#8220;myNEXUS&#8221;), a comprehensive home-based nursing management company for payors, and MMM Holdings, LLC (&#8220;MMM&#8221;), including its Medicare Advantage plan, Medicaid plan and other affiliated companies. As of September&#160;30, 2022, the purchase price of each transaction was allocated to the tangible and intangible net assets acquired based on management&#8217;s final estimates of their fair values, of which $<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80My9mcmFnOjliOWMxNzAxMmU0ZTQ0ODY4ZTBhZjFmOTdkY2E5MWQ3L3RleHRyZWdpb246OWI5YzE3MDEyZTRlNDQ4NjhlMGFmMWY5N2RjYTkxZDdfMTIzNg_0c7fe715-3b97-4fe2-aed6-abf51553b000">1,577</ix:nonFraction> has been allocated to finite-lived intangible assets, $<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:IndefinitelivedIntangibleAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80My9mcmFnOjliOWMxNzAxMmU0ZTQ0ODY4ZTBhZjFmOTdkY2E5MWQ3L3RleHRyZWdpb246OWI5YzE3MDEyZTRlNDQ4NjhlMGFmMWY5N2RjYTkxZDdfMTI5Mw_fc01178b-7572-4beb-a374-c3efe4b87605">20</ix:nonFraction> to indefinite-lived intangible assets, and $<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80My9mcmFnOjliOWMxNzAxMmU0ZTQ0ODY4ZTBhZjFmOTdkY2E5MWQ3L3RleHRyZWdpb246OWI5YzE3MDEyZTRlNDQ4NjhlMGFmMWY5N2RjYTkxZDdfMTMzOQ_a17f3546-f225-429c-b11b-62f189441805">2,531</ix:nonFraction> to goodwill. The majority of goodwill is not deductible for income tax purposes.</ix:continuation> </span></div><div id="i186e051878fe4219970efc72a9fcdad4_46"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RleHRyZWdpb246OTUyNTkzMWNkYzk1NGYyMjk1NTk0OTI4ZjE0ZDQ3ZDJfMjgw_d525050f-b52f-4ea5-9554-8516349fa58d" continuedAt="i56870966017045889a1ea5f264e5caa6" escape="true">Business Optimization Initiatives</ix:nonNumeric></span></div><ix:continuation id="i56870966017045889a1ea5f264e5caa6"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RleHRyZWdpb246OTUyNTkzMWNkYzk1NGYyMjk1NTk0OTI4ZjE0ZDQ3ZDJfMjgy_b9da77fe-5b71-450f-aa56-49dd5aa1e72a" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provided below is a summary of the activity, by reportable segment, related to the liability for employee termination costs previously incurred in connection with our enterprise-wide business optimization initiatives introduced in 2020.</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial &amp; Specialty Business</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Government Business</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">IngenioRx</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020 Business Optimization Initiatives</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for employee termination costs at            January 1, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a408574c2c4c619b3f6a7fb2eb52ef_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfMy0xLTEtMS03MDM2Mw_9d7c91f9-2e3f-4132-b4e3-addf25ae1d93">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d84cf76f3a74a17bfd21c61cad87a45_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfMy0zLTEtMS03MDM2Mw_f3974a7b-a6c0-4b86-a82c-b5692f50aa1e">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib724e06caec84704b13a828ba8b9b8fc_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfMy01LTEtMS03MDM2Mw_8b038cef-110e-4f0c-a5f4-f99607f7ad8a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ab5335cb1b5494eba34054f0ef63dc2_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfMy03LTEtMS03MDM2Mw_a61e3d7b-5dce-4160-96a4-c5ac00e982bf">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ce8730226514909b48e611420368522_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfMy05LTEtMS03MDM2Mw_7ac20fce-c301-495d-b511-39da99136eaa">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dd22b7bb98e4e4f844ecae3c390bdd0_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfNS0xLTEtMS03MDM2Mw_487800de-3a9f-4420-97cc-feb6cd63894d">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idba3a272e1b8405eaeead18d34613b77_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfNS0zLTEtMS03MDM2Mw_d74b1471-33eb-4ffb-b765-0585a4d335b8">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i266f1d31e2b94bbcba7b6d2f8441491f_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfNS01LTEtMS03MDM2Mw_18063b04-f063-490d-870e-dda3ac444ba8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie72e88979b5548e48539cc5d886e25fd_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfNS03LTEtMS03MDM2Mw_d5e6bbfe-366d-4539-8526-a3415bbf858b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f6b49781dc450db479bd159632e422_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfNS05LTEtMS03MDM2Mw_1ce645be-e541-40bb-96da-ee4c23f7832d">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for employee termination costs at September&#160;30, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51b351f32e2a4a91830c15bcaca2d1a7_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfNi0xLTEtMS03MDM2Mw_894ff9bd-b96a-47d1-a401-1453481b9b79">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67eb9d5cdedf417fa6217167e453f99b_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfNi0zLTEtMS03MDM2Mw_b025c8c2-0799-4cd7-8da0-473b19774450">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i708db0a3275f4fd58d30b7138cf68571_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfNi01LTEtMS03MDM2Mw_14082ab3-df3f-4641-9e71-3852fa9e71d3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08ff1fe2d3cf4ba1a7a645773295ee0d_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfNi03LTEtMS03MDM2Mw_71949408-c0f5-46cb-8ef8-9ba862a98d67">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ea9c5ffa135471d84290457cc62b377_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfNi05LTEtMS03MDM2Mw_e047241f-ceac-4529-b7b6-6668b4107485">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i186e051878fe4219970efc72a9fcdad4_49"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzY3Ng_2b2c299c-e698-4162-be3a-51e8f1e4c39c" continuedAt="icdfa5d37498b4beba883db9f0df953bb" escape="true">Investments </ix:nonNumeric></span></div><ix:continuation id="icdfa5d37498b4beba883db9f0df953bb" continuedAt="i8a197d8203fb46e59cff037789ab4de4"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed Maturity Securities</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our available-for-sale fixed maturity securities for declines based on qualitative and quantitative factors. We have established an allowance for credit loss and recorded credit loss expense as a reflection of our expected impairment losses. We continue to review our investment portfolios under our impairment review policy. Given the inherent uncertainty of changes in market conditions and the significant judgments involved, there is a continuing risk that declines in fair value may occur and additional material impairment losses for credit losses on investments may be recorded in future periods.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-12-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8a197d8203fb46e59cff037789ab4de4" continuedAt="ibc3ae33f3fea426da5506d70d09afdca"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzY3Mg_dc899ee7-ba42-423d-893c-8b1abdae93cc" escape="true"><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of current and long-term fixed maturity securities, available-for-sale, at September&#160;30, 2022 and December&#160;31, 2021 is as follows:</span></div><div style="margin-bottom:4pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.872%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost or Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance <br/>For Credit <br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair&#160;Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States Government securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if46ba3a6ed924704ab80b46d4892ce9c_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNC0xLTEtMS03MDM2Mw_026334ea-9ad8-41bb-9175-bc42f0dfcdbd">1,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if46ba3a6ed924704ab80b46d4892ce9c_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNC0zLTEtMS03MDM2Mw_6d396840-abbf-4e0a-92a0-f4fbb73f766f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if46ba3a6ed924704ab80b46d4892ce9c_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNC01LTEtMS03MDM2Mw_22867b7a-6a6f-445c-9b9b-d96fb752fe7d">125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if46ba3a6ed924704ab80b46d4892ce9c_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNC03LTEtMS03MDM2Mw_caae6ccf-5657-40c5-9044-10d8ce7c2025">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if46ba3a6ed924704ab80b46d4892ce9c_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNC05LTEtMS03MDM2Mw_a1d6f041-9061-4fe0-b359-c80464f3eb30">1,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government sponsored securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i582c7462a2a24ee19ae7c3e8b13e6258_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNS0xLTEtMS03MDM2Mw_a184c2e4-3c42-4a81-9509-dc395fe84326">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i582c7462a2a24ee19ae7c3e8b13e6258_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNS0zLTEtMS03MDM2Mw_00332aeb-1d9c-4d6d-a787-1af10da1308a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i582c7462a2a24ee19ae7c3e8b13e6258_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNS01LTEtMS03MDM2Mw_195fdcd5-9f6f-447d-a14d-2b83ed436d1d">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i582c7462a2a24ee19ae7c3e8b13e6258_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNS03LTEtMS03MDM2Mw_a0b4dd91-2cb0-4eee-80da-955abb73085c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i582c7462a2a24ee19ae7c3e8b13e6258_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNS05LTEtMS03MDM2Mw_798b89db-6fa1-4313-aa7a-d985cbbea49e">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3fb6e7405848e39ed7671d9a9683da_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNi0xLTEtMS03MDM2Mw_ec5ea18a-e31c-4a54-b77e-96b3f75ec852">322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3fb6e7405848e39ed7671d9a9683da_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNi0zLTEtMS03MDM2Mw_b5e920f3-67d7-4a07-aeab-aeb631e9f1c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e3fb6e7405848e39ed7671d9a9683da_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNi01LTEtMS03MDM2Mw_7b2607c9-992d-40c2-8e1f-b91eee8a5489">70</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e3fb6e7405848e39ed7671d9a9683da_I20220930" decimals="-6" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNi03LTEtMS03MDM2Mw_072e8007-dbb9-4298-a25a-56e7779f8a2b">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3fb6e7405848e39ed7671d9a9683da_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNi05LTEtMS03MDM2Mw_0e573c60-5302-4b85-982a-9422c2464034">251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie05876f14e3546779aaacef9d285ee2c_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNy0xLTEtMS03MDM2Mw_abb0cd43-36c8-4b61-ac94-50f920462115">4,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie05876f14e3546779aaacef9d285ee2c_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNy0zLTEtMS03MDM2Mw_c4250aba-50fd-41d4-bb79-582fb319158a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie05876f14e3546779aaacef9d285ee2c_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNy01LTEtMS03MDM2Mw_7514025e-1705-4827-8f0d-b4ab21939fe8">355</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie05876f14e3546779aaacef9d285ee2c_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNy03LTEtMS03MDM2Mw_fdea8827-1132-47d6-a958-43f68808a498">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie05876f14e3546779aaacef9d285ee2c_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNy05LTEtMS03MDM2Mw_fe61a0cb-3338-4322-b0bd-ce5d5615b10b">4,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5a6260b0cc245e3ad18420b5dda8138_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfOC0xLTEtMS03MDM2Mw_a534938d-c367-40b8-ac08-3ab7838330dd">13,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5a6260b0cc245e3ad18420b5dda8138_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfOC0zLTEtMS03MDM2Mw_aa756af8-3c3f-47b8-b3c3-430fe1c60e40">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5a6260b0cc245e3ad18420b5dda8138_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfOC01LTEtMS03MDM2Mw_036a2451-39ff-469b-8682-5b4cdb9a1809">1,560</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5a6260b0cc245e3ad18420b5dda8138_I20220930" decimals="-6" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfOC03LTEtMS03MDM2Mw_03bae6c4-5e80-496f-90f2-2c87ace43a2e">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5a6260b0cc245e3ad18420b5dda8138_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfOC05LTEtMS03MDM2Mw_08dc1d79-16c7-465d-9f87-99c42f828a87">12,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id54f0058c591469baef2d1557dcb55a8_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfOS0xLTEtMS03MDM2Mw_4bdce773-db95-494c-b16f-9e9070789859">4,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id54f0058c591469baef2d1557dcb55a8_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfOS0zLTEtMS03MDM2Mw_5c76ce44-88e6-4328-aee5-24cc919d3dee">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id54f0058c591469baef2d1557dcb55a8_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfOS01LTEtMS03MDM2Mw_a7bed922-4116-4b21-a5d6-3780bbe575a2">506</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id54f0058c591469baef2d1557dcb55a8_I20220930" decimals="-6" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfOS03LTEtMS03MDM2Mw_bd76b123-1060-461e-9c6b-0c37b3b7ff5b">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id54f0058c591469baef2d1557dcb55a8_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfOS05LTEtMS03MDM2Mw_0b7711d0-46d8-43af-86c5-048ee309d62d">4,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2340f4d1ac2b47dfbe6521a9386a70f4_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTAtMS0xLTEtNzAzNjM_e0bb3588-ab16-457f-ba4a-a8194892a0a9">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2340f4d1ac2b47dfbe6521a9386a70f4_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTAtMy0xLTEtNzAzNjM_1563c570-d8b4-43ef-9713-8c2ea03f412c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2340f4d1ac2b47dfbe6521a9386a70f4_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTAtNS0xLTEtNzAzNjM_18c22b18-e147-4389-aa91-2f0ff22c9dfb">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2340f4d1ac2b47dfbe6521a9386a70f4_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTAtNy0xLTEtNzAzNjM_099bf890-cb1e-4b0d-ba20-21fcd8e42c0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2340f4d1ac2b47dfbe6521a9386a70f4_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTAtOS0xLTEtNzAzNjM_4e327c39-29a0-491a-a5fe-a647f7a900ea">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9b964677bcb4f018f7b0e35a345ad57_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTEtMS0xLTEtNzAzNjM_8733edeb-d533-4e14-b44f-cf2a94fd4b3d">3,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9b964677bcb4f018f7b0e35a345ad57_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTEtMy0xLTEtNzAzNjM_578cc442-f73b-4ce5-b6a8-eb18576036f7">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9b964677bcb4f018f7b0e35a345ad57_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTEtNS0xLTEtNzAzNjM_53eced14-8edf-4021-9403-90848dc6f7c4">250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9b964677bcb4f018f7b0e35a345ad57_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTEtNy0xLTEtNzAzNjM_799a8687-d509-4b6d-880a-af7cb52ea35a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9b964677bcb4f018f7b0e35a345ad57_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTEtOS0xLTEtNzAzNjM_d2d2eb1c-002f-4bc3-980d-60dedc174f74">3,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTItMS0xLTEtNzAzNjM_6e021212-d0ef-4aee-b682-bf2a5670795f">28,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTItMy0xLTEtNzAzNjM_38543df2-e8f0-485f-8135-dcbf8e5091a8">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTItNS0xLTEtNzAzNjM_bc921858-6bc8-4222-8f38-31f4f757d852">2,877</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTItNy0xLTEtNzAzNjM_741ab323-2b85-4fe8-ad1b-4aaa90846409">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTItOS0xLTEtNzAzNjM_6dba7d2a-0f1c-436c-8a12-b109885d38ca">26,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States Government securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc53677b69024b148f62349f82fe723c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTUtMS0xLTEtNzAzNjM_4d0f322a-4613-4299-a93f-597fd6c2f78a">1,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc53677b69024b148f62349f82fe723c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTUtMy0xLTEtNzAzNjM_ed60c78d-fc6e-4a9f-9b08-d73f732a3908">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc53677b69024b148f62349f82fe723c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTUtNS0xLTEtNzAzNjM_fc887cf7-7530-42e7-9a9e-312af4dbfe9a">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc53677b69024b148f62349f82fe723c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTUtNy0xLTEtNzAzNjM_bf1087f5-76af-466a-90cb-ab4d749fce3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc53677b69024b148f62349f82fe723c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTUtOS0xLTEtNzAzNjM_abacf052-a7b4-453a-a469-826c2fa06ef6">1,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government sponsored securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bd8e4d367e5434c93d5ed2fb93b9c90_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTYtMS0xLTEtNzAzNjM_f1e51f66-fa16-4118-917f-17eeb0f6ae71">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bd8e4d367e5434c93d5ed2fb93b9c90_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTYtMy0xLTEtNzAzNjM_70ed0dd8-b31b-4d35-9db2-bbbc6259058d">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6bd8e4d367e5434c93d5ed2fb93b9c90_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTYtNS0xLTEtNzAzNjM_382d91c4-db25-4cd9-8d4f-b29ac2b28231">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bd8e4d367e5434c93d5ed2fb93b9c90_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTYtNy0xLTEtNzAzNjM_eb48433e-a959-4bf9-9164-01d90d740d80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bd8e4d367e5434c93d5ed2fb93b9c90_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTYtOS0xLTEtNzAzNjM_4ad044d2-7f4e-497b-9b55-f3ff41f7d9f9">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcad3b58ad0a402e9c5f36c2257b46ad_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTctMS0xLTEtNzAzNjM_503d15d3-5a41-4a9f-b0e9-d23ede2df0b6">353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcad3b58ad0a402e9c5f36c2257b46ad_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTctMy0xLTEtNzAzNjM_cf715e06-64d0-486b-a3b2-84630b77d433">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifcad3b58ad0a402e9c5f36c2257b46ad_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTctNS0xLTEtNzAzNjM_ca58aa2b-fc15-4a43-9b55-7e3f6c3e0460">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcad3b58ad0a402e9c5f36c2257b46ad_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTctNy0xLTEtNzAzNjM_338ddd1c-0d16-4a7b-8a98-a09ea7952f80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcad3b58ad0a402e9c5f36c2257b46ad_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTctOS0xLTEtNzAzNjM_da80239d-071b-421b-83ca-1451942a419b">347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b05039f1d944a39a5f7c4a08ecd9386_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTgtMS0xLTEtNzAzNjM_24f32d87-bb69-4b03-8ace-f5e837171e3b">5,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b05039f1d944a39a5f7c4a08ecd9386_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTgtMy0xLTEtNzAzNjM_4be1f899-bf05-4b00-bfdc-0eb266beeeab">310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b05039f1d944a39a5f7c4a08ecd9386_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTgtNS0xLTEtNzAzNjM_68fe4d16-dfe4-453b-9f14-a8ad16a35a9d">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b05039f1d944a39a5f7c4a08ecd9386_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTgtNy0xLTEtNzAzNjM_1053c63b-a0a8-42b5-9cf7-6798603e7023">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b05039f1d944a39a5f7c4a08ecd9386_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTgtOS0xLTEtNzAzNjM_79931052-1994-4d6d-adc4-7e83dee96985">5,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe0fa1cefe04a9ab9bd771236eb24fd_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTktMS0xLTEtNzAzNjM_8c0029b4-c3e4-4bd1-883d-f16bd676d4b3">12,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe0fa1cefe04a9ab9bd771236eb24fd_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTktMy0xLTEtNzAzNjM_4105e612-b1cb-47f5-91f9-f19a0fa829c9">401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fe0fa1cefe04a9ab9bd771236eb24fd_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTktNS0xLTEtNzAzNjM_cea127dc-f27f-496b-9831-c8b1883e9795">78</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fe0fa1cefe04a9ab9bd771236eb24fd_I20211231" decimals="-6" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTktNy0xLTEtNzAzNjM_2caa5f19-bf82-4347-bb85-863501f277d8">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe0fa1cefe04a9ab9bd771236eb24fd_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTktOS0xLTEtNzAzNjM_5b8dd115-4aab-4e16-8f23-c1205c319b88">12,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1998952a2fec4ef987e45747bc6a365e_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjAtMS0xLTEtNzAzNjM_fb7385f2-1d1b-43ee-ba1b-2633c3eade15">4,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1998952a2fec4ef987e45747bc6a365e_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjAtMy0xLTEtNzAzNjM_671c251d-73ae-49ce-99b4-f85162c85908">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1998952a2fec4ef987e45747bc6a365e_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjAtNS0xLTEtNzAzNjM_dbd4d693-5bb7-4e27-8d27-10d8d985494f">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1998952a2fec4ef987e45747bc6a365e_I20211231" decimals="-6" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjAtNy0xLTEtNzAzNjM_ff90f1fe-bf6d-436a-8399-73b847b5eb6f">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1998952a2fec4ef987e45747bc6a365e_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjAtOS0xLTEtNzAzNjM_77f9937c-b6db-416e-b1ae-58e1325887d2">4,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf59770742dd4e0c909bf664464f6f51_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjEtMS0xLTEtNzAzNjM_9da86dc4-c101-4c06-b04a-a30e766bbbde">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf59770742dd4e0c909bf664464f6f51_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjEtMy0xLTEtNzAzNjM_17a45140-9350-4f62-9f98-72b12837d07b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf59770742dd4e0c909bf664464f6f51_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjEtNS0xLTEtNzAzNjM_c4d0a0b6-a27b-4240-a0b4-cc86838999a7">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf59770742dd4e0c909bf664464f6f51_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjEtNy0xLTEtNzAzNjM_690f5aca-1bd1-496c-b4a2-dd244d2e44c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf59770742dd4e0c909bf664464f6f51_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjEtOS0xLTEtNzAzNjM_8954cb4b-999b-4272-b38c-52b3dd2ba9b5">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i962a4141a6934bd0b79803a5e587f115_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjItMS0xLTEtNzAzNjM_a9ae5fc2-a7ce-41d9-b4d0-134acc4827bb">2,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i962a4141a6934bd0b79803a5e587f115_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjItMy0xLTEtNzAzNjM_daa14a7c-b2e6-4c58-a043-882232ba8c1d">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i962a4141a6934bd0b79803a5e587f115_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjItNS0xLTEtNzAzNjM_493481c3-4309-46bb-9f4a-263f7ff5a082">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i962a4141a6934bd0b79803a5e587f115_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjItNy0xLTEtNzAzNjM_b68d04c0-8cb6-4618-bee6-13ed1c27f6c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i962a4141a6934bd0b79803a5e587f115_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjItOS0xLTEtNzAzNjM_ae734963-4f51-46b1-8152-87d66ec2c943">2,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjMtMS0xLTEtNzAzNjM_0eb94afb-f19f-4e5e-9f68-0ba8797b2d61">26,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjMtMy0xLTEtNzAzNjM_73806c59-3471-4b3e-a224-157128bbe1eb">830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjMtNS0xLTEtNzAzNjM_656a1f0d-9552-4a51-8bdb-3d7ecaeb6208">182</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjMtNy0xLTEtNzAzNjM_991fbb57-b17a-4d80-ac36-38dc2cf0de8b">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjMtOS0xLTEtNzAzNjM_ae2a8f4e-94ca-418c-84e6-bfa1b6562404">26,899</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-13-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ibc3ae33f3fea426da5506d70d09afdca" continuedAt="i4d3701725a7c4060a6342824f9c39673"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzY1Mw_60a738ec-30c6-4921-90af-4423859fb5c8" escape="true"><div style="margin-bottom:3pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For fixed maturity securities in an unrealized loss position at September&#160;30, 2022 and December&#160;31, 2021, the following table summarizes the aggregate fair values and gross unrealized losses by length of time those securities have continuously been in an unrealized loss position:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.358%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Securities are whole amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States Government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i9b33199b5e8040e88c3779bab1338a41_I20220930" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNC0xLTEtMS03MDM2Mw_0126608e-a088-4114-9eb4-534a1c01db02">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b33199b5e8040e88c3779bab1338a41_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNC0zLTEtMS03MDM2Mw_b3049ee5-07d4-473d-800c-5735a58d7302">911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b33199b5e8040e88c3779bab1338a41_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNC01LTEtMS03MDM2Mw_879c20bf-a747-47e8-b074-7412fb1ee5b9">77</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i9b33199b5e8040e88c3779bab1338a41_I20220930" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNC03LTEtMS03MDM2Mw_866d20a1-131c-49b8-a3b1-c407191f7c5a">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b33199b5e8040e88c3779bab1338a41_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNC05LTEtMS03MDM2Mw_80664865-37b4-449c-b5c7-ba6ed2774c2e">303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b33199b5e8040e88c3779bab1338a41_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNC0xMS0xLTEtNzAzNjM_09dd5c10-1eed-481d-828b-83184b7e4510">48</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government sponsored securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="ifcf9e5652a88433fa305f979016b813a_I20220930" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNS0xLTEtMS03MDM2Mw_c34a808b-71f2-4a18-a815-a3a1d224b951">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcf9e5652a88433fa305f979016b813a_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNS0zLTEtMS03MDM2Mw_6638b439-071d-411f-8aa7-59882b5fe4ed">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifcf9e5652a88433fa305f979016b813a_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNS01LTEtMS03MDM2Mw_98832ccc-a061-4ead-8976-7eaf642cc231">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="ifcf9e5652a88433fa305f979016b813a_I20220930" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNS03LTEtMS03MDM2Mw_8cd04ed9-8f19-4880-8147-5dc7d91d25c5">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcf9e5652a88433fa305f979016b813a_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNS05LTEtMS03MDM2Mw_f7d19899-f7f4-4e8f-8ea4-a659b7f53ace">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcf9e5652a88433fa305f979016b813a_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNS0xMS0xLTEtNzAzNjM_6d6da5bf-1e92-48ea-9d4c-216a85a888e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i6df5bdfdef2f4265b69076190eb614fd_I20220930" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNi0xLTEtMS03MDM2Mw_93431c62-74b2-49f3-931e-4b880df7019b">225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6df5bdfdef2f4265b69076190eb614fd_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNi0zLTEtMS03MDM2Mw_efc93508-f7a4-48e1-b25f-08137cfabf5e">169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6df5bdfdef2f4265b69076190eb614fd_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNi01LTEtMS03MDM2Mw_99862734-a01b-436d-aff4-d84d5a292c80">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i6df5bdfdef2f4265b69076190eb614fd_I20220930" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNi03LTEtMS03MDM2Mw_b3a9c034-c295-4f14-b2d4-560aca8be890">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6df5bdfdef2f4265b69076190eb614fd_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNi05LTEtMS03MDM2Mw_de68b15d-5d8c-415b-8b11-5b05df0c9307">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6df5bdfdef2f4265b69076190eb614fd_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNi0xMS0xLTEtNzAzNjM_78f98260-a0bd-44c4-b91f-5e898d09c9d7">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="icff2cdd7573a4a7cb6c9db9fbe416a43_I20220930" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNy0xLTEtMS03MDM2Mw_e2d6bba7-39c4-461a-801d-5eb4420b355d">1,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff2cdd7573a4a7cb6c9db9fbe416a43_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNy0zLTEtMS03MDM2Mw_1eba52c4-9dcd-42a1-b82b-b52ead920a7a">3,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icff2cdd7573a4a7cb6c9db9fbe416a43_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNy01LTEtMS03MDM2Mw_20fd906e-a73f-4a02-a790-2cd05a8ed200">314</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="icff2cdd7573a4a7cb6c9db9fbe416a43_I20220930" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNy03LTEtMS03MDM2Mw_05afab4c-1c32-4487-9053-12690bf901d0">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff2cdd7573a4a7cb6c9db9fbe416a43_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNy05LTEtMS03MDM2Mw_75e080e2-9d0a-4fab-a69b-e939b93d138e">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icff2cdd7573a4a7cb6c9db9fbe416a43_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNy0xMS0xLTEtNzAzNjM_3d2fb1e0-36b9-49e7-b6c5-e021fe499f3f">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="ib856546a61004b9daf43ccbcaf623bae_I20220930" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOC0xLTEtMS03MDM2Mw_7947c617-1de6-4d97-af50-982611187610">4,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib856546a61004b9daf43ccbcaf623bae_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOC0zLTEtMS03MDM2Mw_31029c8d-4ae8-4039-b61e-110138c13c45">10,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib856546a61004b9daf43ccbcaf623bae_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOC01LTEtMS03MDM2Mw_d71e67e6-23a9-4e21-a355-f58ef2e5b5a7">1,165</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="ib856546a61004b9daf43ccbcaf623bae_I20220930" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOC03LTEtMS03MDM2Mw_88dfb6a9-2e0f-42bb-a706-c59e18499528">1,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib856546a61004b9daf43ccbcaf623bae_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOC05LTEtMS03MDM2Mw_a8c066c6-a44b-4a31-b04c-2cb7df858d04">1,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib856546a61004b9daf43ccbcaf623bae_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOC0xMS0xLTEtNzAzNjM_fd79b5fb-d32b-41fa-a693-e0607b939e89">395</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i082f7dec90e34caa9e126e175c14b069_I20220930" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOS0xLTEtMS03MDM2Mw_aa6a4bee-c19b-426d-8f4c-b5d339ead060">2,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i082f7dec90e34caa9e126e175c14b069_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOS0zLTEtMS03MDM2Mw_b34a2575-f0a2-40e9-bffd-277d51d155c6">2,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i082f7dec90e34caa9e126e175c14b069_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOS01LTEtMS03MDM2Mw_62b511f5-c732-423e-bf1c-b6d188d6b5f1">294</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i082f7dec90e34caa9e126e175c14b069_I20220930" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOS03LTEtMS03MDM2Mw_3119b9bb-f369-454f-bb92-39c29a978d2b">530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i082f7dec90e34caa9e126e175c14b069_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOS05LTEtMS03MDM2Mw_b68992ee-79f3-4536-92e9-8ed3aef3d5aa">1,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i082f7dec90e34caa9e126e175c14b069_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOS0xMS0xLTEtNzAzNjM_e7e34acc-b9c6-4922-96fb-d1a4dd39c754">212</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i2d1cb440b1e64fc3a441588000782d1b_I20220930" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTAtMS0xLTEtNzAzNjM_2047dd3b-3126-4e29-99e1-4dd8fa64aa45">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1cb440b1e64fc3a441588000782d1b_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTAtMy0xLTEtNzAzNjM_2458b3d7-893b-4fd4-91f2-162f5c9979c9">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d1cb440b1e64fc3a441588000782d1b_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTAtNS0xLTEtNzAzNjM_d08068bc-1d0e-48eb-bb54-857c2354faf7">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i2d1cb440b1e64fc3a441588000782d1b_I20220930" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTAtNy0xLTEtNzAzNjM_ec13ef90-6445-47c0-ba7c-06b440932bee">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1cb440b1e64fc3a441588000782d1b_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTAtOS0xLTEtNzAzNjM_cc96c445-b69e-44cf-af83-aae2ebe0a977">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d1cb440b1e64fc3a441588000782d1b_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTAtMTEtMS0xLTcwMzYz_d46599ea-c432-46eb-8c1d-b44b6e6c11aa">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i97d6a8ee2de34d46b8a9b30fcdfac191_I20220930" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTEtMS0xLTEtNzAzNjM_4f8e6404-acfe-4793-a832-524dbea184db">921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97d6a8ee2de34d46b8a9b30fcdfac191_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTEtMy0xLTEtNzAzNjM_caad35a8-cf03-4154-9be4-71a943737a04">2,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97d6a8ee2de34d46b8a9b30fcdfac191_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTEtNS0xLTEtNzAzNjM_42f9d362-072f-4337-9fbb-75cbe9cc44a6">165</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i97d6a8ee2de34d46b8a9b30fcdfac191_I20220930" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTEtNy0xLTEtNzAzNjM_f84a6692-25b8-40cc-b073-9b122e9e7234">269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97d6a8ee2de34d46b8a9b30fcdfac191_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTEtOS0xLTEtNzAzNjM_9f308256-c654-4e9d-bee4-457fac133620">670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97d6a8ee2de34d46b8a9b30fcdfac191_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTEtMTEtMS0xLTcwMzYz_702cd87f-03cd-41a1-b8de-8442a64c60e8">85</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="ic06c4cd0bfbf4349bb38d37c2a08f1d5_I20220930" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTItMS0xLTEtNzAzNjM_6c136bbd-0620-41ea-9366-3005a1ea4d80">9,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic06c4cd0bfbf4349bb38d37c2a08f1d5_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTItMy0xLTEtNzAzNjM_57789a0c-b6ae-4fbd-8b16-54c0ceed8a85">20,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic06c4cd0bfbf4349bb38d37c2a08f1d5_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTItNS0xLTEtNzAzNjM_eee6e49d-7c6c-44ef-aadd-9be5d8541d15">2,056</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="ic06c4cd0bfbf4349bb38d37c2a08f1d5_I20220930" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTItNy0xLTEtNzAzNjM_3e62b70e-ec8e-49e5-abb6-dc2219e9d8f4">2,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic06c4cd0bfbf4349bb38d37c2a08f1d5_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTItOS0xLTEtNzAzNjM_b62ecdd3-7472-4d79-a93d-d07f97fabdcf">4,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic06c4cd0bfbf4349bb38d37c2a08f1d5_I20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTItMTEtMS0xLTcwMzYz_3dab8ffb-0e75-4143-9fac-0fbcafbfc9ed">821</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States Government securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i03fb8a2f17234cf88446cfa6c92be531_I20211231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTctMS0xLTEtNzAzNjM_e8a50a90-a5ef-45c9-bbd7-c4c8ce7606c2">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fb8a2f17234cf88446cfa6c92be531_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTctMy0xLTEtNzAzNjM_91fdf948-26f8-43eb-aeb3-32b27279507b">990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03fb8a2f17234cf88446cfa6c92be531_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTctNS0xLTEtNzAzNjM_d192eaa5-0fa5-4932-a0a2-fcc466141577">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i03fb8a2f17234cf88446cfa6c92be531_I20211231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTctNy0xLTEtNzAzNjM_f4403e52-d07b-4387-b67a-dfa7d5e413a1">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fb8a2f17234cf88446cfa6c92be531_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTctOS0xLTEtNzAzNjM_4f9e86b9-a837-4c46-9c8b-a97cf8173894">176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03fb8a2f17234cf88446cfa6c92be531_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTctMTEtMS0xLTcwMzYz_9c28987c-d1e7-45e1-a2e5-12cc9e9127db">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government sponsored securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i306fe04bc56d46bda85faed45e988b22_I20211231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTgtMS0xLTEtNzAzNjM_25afa4ee-f0be-43d0-8a27-6e5f1f2a6a30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i306fe04bc56d46bda85faed45e988b22_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTgtMy0xLTEtNzAzNjM_53a17fce-3560-4647-ae15-98d756f29996">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i306fe04bc56d46bda85faed45e988b22_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTgtNS0xLTEtNzAzNjM_2d4a5b97-9a15-43aa-92fd-220b5440501c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i306fe04bc56d46bda85faed45e988b22_I20211231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTgtNy0xLTEtNzAzNjM_8cbba628-5854-49db-bea9-51df82a029cd">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i306fe04bc56d46bda85faed45e988b22_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTgtOS0xLTEtNzAzNjM_acd21f24-9cec-42b7-a125-e334bba3be54">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i306fe04bc56d46bda85faed45e988b22_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTgtMTEtMS0xLTcwMzYz_83a8f576-99c4-4be2-a33c-55f88f09480e">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i0bae2ef9bb1f4ef789325dd8bddd7037_I20211231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTktMS0xLTEtNzAzNjM_2d600e76-a27c-4078-99e0-c58170cab356">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bae2ef9bb1f4ef789325dd8bddd7037_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTktMy0xLTEtNzAzNjM_d1e78571-a0dd-4467-a060-687669d14dfc">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bae2ef9bb1f4ef789325dd8bddd7037_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTktNS0xLTEtNzAzNjM_4ab4fbbb-61f8-4eb7-9671-fb8b17869256">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i0bae2ef9bb1f4ef789325dd8bddd7037_I20211231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTktNy0xLTEtNzAzNjM_13fd5c96-faa8-496d-b673-28ed953af0d0">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bae2ef9bb1f4ef789325dd8bddd7037_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTktOS0xLTEtNzAzNjM_2d71f527-3952-45de-be18-c942110ecba8">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bae2ef9bb1f4ef789325dd8bddd7037_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTktMTEtMS0xLTcwMzYz_f4ae4121-e715-4e34-a7e5-0122e6413cea">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i4d30de3c97a84918b22998e42c90804e_I20211231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjAtMS0xLTEtNzAzNjM_1e54fb0d-ebed-4285-8ab3-8892441e9fe3">281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d30de3c97a84918b22998e42c90804e_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjAtMy0xLTEtNzAzNjM_2ffdbce4-321c-46bb-9e92-c8c349b6c48f">634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d30de3c97a84918b22998e42c90804e_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjAtNS0xLTEtNzAzNjM_9a110d74-0e53-493d-ae56-1e04d09117b7">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i4d30de3c97a84918b22998e42c90804e_I20211231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjAtNy0xLTEtNzAzNjM_883b4245-04fa-4cb0-9b91-730b2deb78db">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d30de3c97a84918b22998e42c90804e_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjAtOS0xLTEtNzAzNjM_ba456091-3da5-4536-aea6-e958668c4462">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d30de3c97a84918b22998e42c90804e_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjAtMTEtMS0xLTcwMzYz_13a5be22-6e2f-4ffd-a91e-e34d32573789">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i25961790b2e241c39e1d9b6ee2a7abf8_I20211231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjEtMS0xLTEtNzAzNjM_426c662a-f39d-4e55-902b-1298dbb819c6">1,846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25961790b2e241c39e1d9b6ee2a7abf8_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjEtMy0xLTEtNzAzNjM_198af97d-b09e-4deb-af35-80bfcc4ac278">3,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25961790b2e241c39e1d9b6ee2a7abf8_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjEtNS0xLTEtNzAzNjM_652a1b5f-78f9-4cf4-bd11-91c32753cd73">57</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i25961790b2e241c39e1d9b6ee2a7abf8_I20211231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjEtNy0xLTEtNzAzNjM_a068183f-4c03-4902-b2a0-2f50df567029">403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25961790b2e241c39e1d9b6ee2a7abf8_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjEtOS0xLTEtNzAzNjM_b6f823ad-554e-45a1-b147-f25f1e06fab9">485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25961790b2e241c39e1d9b6ee2a7abf8_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjEtMTEtMS0xLTcwMzYz_472663ca-ed00-44bf-9665-9a95d0131103">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i6e76ffeb19be42d4a1e2d44c3205ecab_I20211231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjItMS0xLTEtNzAzNjM_a344848c-c4f7-48d3-81c8-6c37969965a1">692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e76ffeb19be42d4a1e2d44c3205ecab_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjItMy0xLTEtNzAzNjM_2e6d2aa0-e31d-42a2-816b-1edd78bf1ed8">1,967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e76ffeb19be42d4a1e2d44c3205ecab_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjItNS0xLTEtNzAzNjM_a9098e15-711f-4eba-b9d5-03bdbe7574b2">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i6e76ffeb19be42d4a1e2d44c3205ecab_I20211231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjItNy0xLTEtNzAzNjM_fc863673-310a-4c96-a24c-25ff3d6ac3d1">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e76ffeb19be42d4a1e2d44c3205ecab_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjItOS0xLTEtNzAzNjM_cf89194f-3778-49e5-8310-42e427d1dafc">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e76ffeb19be42d4a1e2d44c3205ecab_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjItMTEtMS0xLTcwMzYz_e867467d-bdff-40de-bc25-93bf7c90e8b2">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i47e63f11825d402e9000e5995d8b173f_I20211231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjMtMS0xLTEtNzAzNjM_24cc7eed-e6f8-4b7d-8778-8feca83377c9">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47e63f11825d402e9000e5995d8b173f_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjMtMy0xLTEtNzAzNjM_3ba28983-2310-4d22-a6c2-2cf20f53b8b0">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47e63f11825d402e9000e5995d8b173f_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjMtNS0xLTEtNzAzNjM_84f783e8-2b71-4a9d-b151-f90148484f2e">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i47e63f11825d402e9000e5995d8b173f_I20211231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjMtNy0xLTEtNzAzNjM_5f101ce9-6f97-4423-8a82-53d4a513652e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47e63f11825d402e9000e5995d8b173f_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjMtOS0xLTEtNzAzNjM_0baa9fea-e6b3-403c-8e3f-e4603bf23c83">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47e63f11825d402e9000e5995d8b173f_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjMtMTEtMS0xLTcwMzYz_6bfdcfae-df5b-4277-9049-479ce26ecdc5">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i85e2285118fb48818a1361310a8c779d_I20211231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjQtMS0xLTEtNzAzNjM_dac4b9eb-5dcb-4996-8834-d53996d8ed7c">511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85e2285118fb48818a1361310a8c779d_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjQtMy0xLTEtNzAzNjM_08af4fb2-be0c-4a3b-a3b7-7a896ece8f3f">1,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85e2285118fb48818a1361310a8c779d_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjQtNS0xLTEtNzAzNjM_2333ffc0-27f9-4bf0-8a9d-14e031acdd29">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i85e2285118fb48818a1361310a8c779d_I20211231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjQtNy0xLTEtNzAzNjM_2c4373da-0c7b-4333-b9e7-5dca2c24fae8">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85e2285118fb48818a1361310a8c779d_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjQtOS0xLTEtNzAzNjM_96949e66-9e6f-4e94-bcf9-98805008db4f">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85e2285118fb48818a1361310a8c779d_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjQtMTEtMS0xLTcwMzYz_a1aa1a6d-3718-4473-b0ec-a85bd2f8df77">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i7a60715792a94db5a003dde44cc00d7d_I20211231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjUtMS0xLTEtNzAzNjM_5f03bcde-8213-4216-b37d-fe6a04f52f9e">3,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a60715792a94db5a003dde44cc00d7d_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjUtMy0xLTEtNzAzNjM_1db9578a-2b62-4b2d-a66d-53c880aec595">8,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a60715792a94db5a003dde44cc00d7d_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjUtNS0xLTEtNzAzNjM_fd31bd81-8e3a-4e05-b6a5-53153683f363">131</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="securities" contextRef="i7a60715792a94db5a003dde44cc00d7d_I20211231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjUtNy0xLTEtNzAzNjM_b84e2961-27ee-44b0-acce-c69514592669">686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a60715792a94db5a003dde44cc00d7d_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjUtOS0xLTEtNzAzNjM_714fe19c-5b04-4e0e-b11d-a16779cb03ab">985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a60715792a94db5a003dde44cc00d7d_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjUtMTEtMS0xLTcwMzYz_4a65cfb7-f835-4665-9913-dd0b8c427f72">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although not material to our consolidated results of operations, during the nine months ended September&#160;30, 2022, we recorded a combination of credit losses, losses on sales of fixed maturity securities and impairments related to our exposure resulting from investments in Russia and Ukraine. At September&#160;30, 2022, our remaining holdings of Russia and Ukraine fixed maturity securities were not material.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized losses on our securities shown in the table above have not been recognized into income because, as of September 30, 2022, we do not intend to sell these investments and it is likely that we will not be required to sell these investments prior to their maturity or anticipated recovery. The declines in fair values are largely due to increasing interest rates driven by the high rate of inflation and other market conditions and not by unfavorable changes in the credit quality characteristics that impact our assessment on collectability of principal and interest. We have evaluated qualitative and quantitative factors for indications of credit losses on our securities, including factors such as credit rating, foreign political conflicts, uncertainties around future ability to collect payment, significant declines in fair value and industry conditions, market data, and notifications of maturity and coupon default, and have recorded an allowance for credit losses in the amount of $<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfMzI5ODUzNDg5NTA5MQ_2547dffe-e454-4812-b566-b2fa90258334">10</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfMzI5ODUzNDg5NTA5Ng_5b724c86-1c56-47ce-8408-b499b44076ab">6</ix:nonFraction> at September 30, 2022 and December 31, 2021, respectively. </span></div></ix:continuation><div style="text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-14-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:18pt"><span><br/></span></div><ix:continuation id="i4d3701725a7c4060a6342824f9c39673" continuedAt="ia36072faafe949358246e57afd41f5b6"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzY1MQ_7accf119-cb36-4ae7-8dfa-20ccd074be2d" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of fixed maturity securities at September&#160;30, 2022, by contractual maturity, are shown below. Expected maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations.</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.782%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfMS0xLTEtMS03MDM2Mw_db7a7578-2114-4ea4-9446-1065d6261e2e">911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfMS0zLTEtMS03MDM2Mw_6542d94b-5e13-4dec-8ff8-ff984a510525">901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfMi0xLTEtMS03MDM2Mw_928db848-3296-4256-8149-d7b91ca2bc12">7,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfMi0zLTEtMS03MDM2Mw_baf063a8-1795-4053-ab8c-6cece977eab9">6,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfMy0xLTEtMS03MDM2Mw_acf0da85-89c1-485f-8404-3307d7d1d52e">9,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfMy0zLTEtMS03MDM2Mw_5c9d4e82-14c0-4209-9b6a-93b8ae736fa5">8,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfNC0xLTEtMS03MDM2Mw_03fe26e4-badd-4755-b359-75f77db9be36">6,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfNC0zLTEtMS03MDM2Mw_af3812c9-4ac3-4ac4-ac86-7404ac105226">5,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfNS0xLTEtMS03MDM2Mw_e50fe243-7256-4a1d-8a2e-7142f401fe2d">4,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfNS0zLTEtMS03MDM2Mw_60d923d0-0e8b-4b77-bf0d-5c6b80a9e2ea">4,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfNi0xLTEtMS03MDM2Mw_4193d61b-85ff-4e7b-a530-4e536973a2d0">28,977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfNi0zLTEtMS03MDM2Mw_8869f2a3-05e7-431b-8703-c280aa752f70">26,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:1pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2022, we received total proceeds from sales, maturities, calls or redemptions of fixed maturity securities of $<ix:nonFraction unitRef="usd" contextRef="i808391c8a062488da8dfcc76e14f106b_D20220701-20220930" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNDcyMw_e402ba77-f7b6-4a49-a952-92c60c173733">5,281</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ieaad01ac86274516a2427e2324cbdace_D20220101-20220930" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNDczMA_2cfcaa63-ef20-4508-a44d-f6a61d07185a">15,953</ix:nonFraction>, respectively. During the three and nine months ended September&#160;30, 2021, we received total proceeds from sales, maturities, calls or redemptions of fixed maturity securities of $<ix:nonFraction unitRef="usd" contextRef="ic6ef12a8ed884a10a5de9971fb0a2ef8_D20210701-20210930" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNDg4Mw_d43fd478-69dc-4f90-bc39-1491078bbde6">2,620</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i341b56b7c33d48c6ad350fd7fbaf27d5_D20210101-20210930" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNDg5MA_fd695cd3-aa38-4767-a0c9-5dcc6e65fa10">8,570</ix:nonFraction>, respectively.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we may sell securities at a loss for a number of reasons, including, but not limited to: (i)&#160;changes in the investment environment; (ii)&#160;expectation that the fair value could deteriorate further; (iii)&#160;desire to reduce exposure to an issuer or an industry; (iv)&#160;changes in credit quality; or (v)&#160;changes in expected cash flow.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All securities sold resulting in investment gains and losses are recorded on the trade date. Realized gains and losses are determined on the basis of the cost or amortized cost of the specific securities sold.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Securities </span></div><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="elv:InvestmentsinequitysecuritiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzYzOQ_ffa8e40f-e1da-4047-b304-72d2426a7172" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of marketable equity securities at September&#160;30, 2022 and December&#160;31, 2021 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"></td><td style="width:68.211%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange traded funds</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fddf0df137b450988ab2a4425925e2c_I20220930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjI1OWFhNDJkZWQ4ODRkNTZiNGNkZDMzZDEyMGVlM2ZlL3RhYmxlcmFuZ2U6MjU5YWE0MmRlZDg4NGQ1NmI0Y2RkMzNkMTIwZWUzZmVfMi01LTEtMS03MDM2Mw_cfb5d5f1-5f5e-4572-8d3b-a6df476a6df1">1,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb05027535a4458e88a535ee3031f6ae_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjI1OWFhNDJkZWQ4ODRkNTZiNGNkZDMzZDEyMGVlM2ZlL3RhYmxlcmFuZ2U6MjU5YWE0MmRlZDg4NGQ1NmI0Y2RkMzNkMTIwZWUzZmVfMi03LTEtMS03MDM2Mw_36572866-c664-4df6-b99e-a2cbc3dda1bb">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common equity securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67d0a155fc6f462db3e652e6e997c5a6_I20220930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjI1OWFhNDJkZWQ4ODRkNTZiNGNkZDMzZDEyMGVlM2ZlL3RhYmxlcmFuZ2U6MjU5YWE0MmRlZDg4NGQ1NmI0Y2RkMzNkMTIwZWUzZmVfNC01LTEtMS03MDM2Mw_e706112a-ded6-4083-88de-0ebb7a288410">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33efd1a573514923804d15df68fbc169_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjI1OWFhNDJkZWQ4ODRkNTZiNGNkZDMzZDEyMGVlM2ZlL3RhYmxlcmFuZ2U6MjU5YWE0MmRlZDg4NGQ1NmI0Y2RkMzNkMTIwZWUzZmVfNC03LTEtMS03MDM2Mw_d6c60308-ede0-4811-9c81-5dc14abcffee">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7efa70157d8f49d1932d09a94dfe1529_I20220930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjI1OWFhNDJkZWQ4ODRkNTZiNGNkZDMzZDEyMGVlM2ZlL3RhYmxlcmFuZ2U6MjU5YWE0MmRlZDg4NGQ1NmI0Y2RkMzNkMTIwZWUzZmVfNS01LTEtMS03MDM2Mw_2bb79fd1-fee7-4f8f-bde1-a91f245533ba">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d4cd6b13d62409ea6135442dfd3c169_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjI1OWFhNDJkZWQ4ODRkNTZiNGNkZDMzZDEyMGVlM2ZlL3RhYmxlcmFuZ2U6MjU5YWE0MmRlZDg4NGQ1NmI0Y2RkMzNkMTIwZWUzZmVfNS03LTEtMS03MDM2Mw_47a6d5f4-5dfd-4ee7-9993-746e67b70f39">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjI1OWFhNDJkZWQ4ODRkNTZiNGNkZDMzZDEyMGVlM2ZlL3RhYmxlcmFuZ2U6MjU5YWE0MmRlZDg4NGQ1NmI0Y2RkMzNkMTIwZWUzZmVfNi01LTEtMS03MDM2Mw_95753e35-3d66-4be9-873d-cb8043b2910b">1,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjI1OWFhNDJkZWQ4ODRkNTZiNGNkZDMzZDEyMGVlM2ZlL3RhYmxlcmFuZ2U6MjU5YWE0MmRlZDg4NGQ1NmI0Y2RkMzNkMTIwZWUzZmVfNi03LTEtMS03MDM2Mw_c07b63ca-e5b0-4f81-9bec-72974174528e">1,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Invested Assets</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other invested assets include primarily our investments in limited partnerships, joint ventures and other non-controlled corporations, mortgage loans and the cash surrender value of corporate-owned life insurance policies. Investments in limited partnerships, joint ventures and other non-controlled corporations are carried at our share in the entities&#8217; undistributed earnings, which approximates fair value. Financial information for certain of these investments are reported on a one or three month lag due to the timing of when we receive financial information from the companies.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-15-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia36072faafe949358246e57afd41f5b6"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Gains and Losses</span></div><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:GainLossOnInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzY3NQ_908a62ff-fb3b-432f-8dad-c6d2c4253419" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net investment (losses) gains for the three and nine months ended September&#160;30, 2022 and 2021 are as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended <br/>September 30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (losses) gains:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized gains from sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808391c8a062488da8dfcc76e14f106b_D20220701-20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNC0xLTEtMS03MDM2Mw_73832c28-97a1-406b-8a91-239c65675ac3">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6ef12a8ed884a10a5de9971fb0a2ef8_D20210701-20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNC0zLTEtMS03MDM2Mw_9746b5b7-a4fb-43e0-86fe-0d512c20c7ec">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaad01ac86274516a2427e2324cbdace_D20220101-20220930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNC01LTEtMS03MDM2Mw_e884ea6b-7ea0-4dca-afe5-4242330ddbb0">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i341b56b7c33d48c6ad350fd7fbaf27d5_D20210101-20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNC03LTEtMS03MDM2Mw_30b3e25a-f2cb-4553-83aa-ab4419ae4a9f">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized losses from sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i808391c8a062488da8dfcc76e14f106b_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNS0xLTEtMS03MDM2Mw_62894cb1-1e10-45d1-b449-10e5ce978388">99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6ef12a8ed884a10a5de9971fb0a2ef8_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNS0zLTEtMS03MDM2Mw_34740849-091e-4bb4-b5e9-0821a2006ad2">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieaad01ac86274516a2427e2324cbdace_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNS01LTEtMS03MDM2Mw_9f2f0723-bca6-474c-b464-ba0f17bb9fd2">353</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i341b56b7c33d48c6ad350fd7fbaf27d5_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNS03LTEtMS03MDM2Mw_deeac256-7cfd-4052-9f1b-b6c36e57c65e">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment (losses) recoveries recognized in income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i808391c8a062488da8dfcc76e14f106b_D20220701-20220930" decimals="-6" name="elv:Impairmentlossesreversalsoninvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNi0xLTEtMS03MDM2Mw_dad0275b-7957-49bc-866f-77de749bac76">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6ef12a8ed884a10a5de9971fb0a2ef8_D20210701-20210930" decimals="-6" name="elv:Impairmentlossesreversalsoninvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNi0zLTEtMS03MDM2Mw_c9a085bf-4df0-4000-bc7a-b473e440de34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieaad01ac86274516a2427e2324cbdace_D20220101-20220930" decimals="-6" name="elv:Impairmentlossesreversalsoninvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNi01LTEtMS03MDM2Mw_8f13b5ba-de29-4244-a66b-4ba470c627cc">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i341b56b7c33d48c6ad350fd7fbaf27d5_D20210101-20210930" decimals="-6" sign="-" name="elv:Impairmentlossesreversalsoninvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNi03LTEtMS03MDM2Mw_25afab26-db64-4ade-9a30-62369f1cabd1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized (losses) gains from sales of fixed maturity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i808391c8a062488da8dfcc76e14f106b_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNy0xLTEtMS03MDM2Mw_a8ce7513-ecb4-4407-a493-03decc532b9a">96</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6ef12a8ed884a10a5de9971fb0a2ef8_D20210701-20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNy0zLTEtMS03MDM2Mw_a1ef21b2-cd97-46c7-b0dd-a0a3b6c575f8">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieaad01ac86274516a2427e2324cbdace_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNy01LTEtMS03MDM2Mw_13a95b5e-3c7b-46b9-983f-e10d583bf036">334</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i341b56b7c33d48c6ad350fd7fbaf27d5_D20210101-20210930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNy03LTEtMS03MDM2Mw_26dfa4d5-c2f9-417a-a3cd-06dbc8e430b1">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses) gains recognized on equity securities still held at the end of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd1d2d7db12846a4a3ec11dffaaa857a_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfOS0xLTEtMS03MDM2Mw_496bfe16-e75b-44ff-9553-999c14e15029">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib08d03a09c464eb5bc34b1ee5faf7ea2_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfOS0zLTEtMS03MDM2Mw_84a92956-dfab-4430-aaba-6de30b7ea9ba">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i525deba77845499db8929bee8586f509_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfOS01LTEtMS03MDM2Mw_b49377b3-67a9-40e8-873e-1fcc89a980fc">192</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if83fa79c889143edbd4e4ba481c5106e_D20210101-20210930" decimals="-6" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfOS03LTEtMS03MDM2Mw_05ced053-5c81-460a-9493-6a0cd749063b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gains (losses) recognized on equity securities sold during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd1d2d7db12846a4a3ec11dffaaa857a_D20220701-20220930" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTAtMS0xLTEtNzAzNjM_66375a3c-2253-4e5d-8768-3dde7b791418">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib08d03a09c464eb5bc34b1ee5faf7ea2_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTAtMy0xLTEtNzAzNjM_16035d55-d445-443c-8b8c-3db30ec3c1cf">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i525deba77845499db8929bee8586f509_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTAtNS0xLTEtNzAzNjM_24cec831-be1f-4813-894a-909a52f36d4d">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if83fa79c889143edbd4e4ba481c5106e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTAtNy0xLTEtNzAzNjM_894ab211-3869-441f-825c-26a6cfb889fa">57</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net losses on equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd1d2d7db12846a4a3ec11dffaaa857a_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTEtMS0xLTEtNzAzNjM_a788e90e-5240-45c4-b298-d66538210b32">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib08d03a09c464eb5bc34b1ee5faf7ea2_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTEtMy0xLTEtNzAzNjM_bfe809bb-6635-492f-92eb-210bea003103">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i525deba77845499db8929bee8586f509_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTEtNS0xLTEtNzAzNjM_712a8774-9636-47fd-b9ee-4f19e0e994a4">212</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if83fa79c889143edbd4e4ba481c5106e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTEtNy0xLTEtNzAzNjM_551865b7-6b8b-445f-a60a-53cef965f9ae">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76d0d6767c2146a4aa94f20b9f15ea40_D20220701-20220930" decimals="-6" name="elv:GainsFromOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTMtMS0xLTEtNzAzNjM_137a3c15-d6a4-445d-8337-e2de2149a768">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbe9a6627d614becb080363c4cc79132_D20210701-20210930" decimals="-6" name="elv:GainsFromOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTMtMy0xLTEtNzAzNjM_0bd06864-733c-40da-bb28-7416ead6d8e9">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e6a553b24d9430485f058f6dabd9ef0_D20220101-20220930" decimals="-6" name="elv:GainsFromOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTMtNS0xLTEtNzAzNjM_c09bb098-37af-4a43-ac85-f4e391163dd0">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i623def1f7d994412a99937dd097a9306_D20210101-20210930" decimals="-6" name="elv:GainsFromOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTMtNy0xLTEtNzAzNjM_8cbc1d9b-8948-42f5-a7a3-1d31287e4206">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76d0d6767c2146a4aa94f20b9f15ea40_D20220701-20220930" decimals="-6" name="elv:GrossLossesFromOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTQtMS0xLTEtNzAzNjM_659fa136-0a14-44d2-a8f5-1a1ba937a53a">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbe9a6627d614becb080363c4cc79132_D20210701-20210930" decimals="-6" name="elv:GrossLossesFromOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTQtMy0xLTEtNzAzNjM_d1ef209c-ab6e-4356-a123-7267fe4c9eee">93</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e6a553b24d9430485f058f6dabd9ef0_D20220101-20220930" decimals="-6" name="elv:GrossLossesFromOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTQtNS0xLTEtNzAzNjM_52bbf305-8539-4e49-9d5c-0f38f11e6e21">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i623def1f7d994412a99937dd097a9306_D20210101-20210930" decimals="-6" name="elv:GrossLossesFromOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTQtNy0xLTEtNzAzNjM_ceb2a4ff-2c7b-4740-81d2-0c40a0f5cc3b">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment (losses) recoveries recognized in income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76d0d6767c2146a4aa94f20b9f15ea40_D20220701-20220930" decimals="-6" name="elv:Impairmentlossesreversalsoninvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTUtMS0xLTEtNzAzNjM_bbe2669c-1c53-4228-8255-ea072ae7a404">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbe9a6627d614becb080363c4cc79132_D20210701-20210930" decimals="-6" sign="-" name="elv:Impairmentlossesreversalsoninvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTUtMy0xLTEtNzAzNjM_c8afd86f-c7f3-4c8b-a9d2-cd5a50c7e20b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e6a553b24d9430485f058f6dabd9ef0_D20220101-20220930" decimals="-6" name="elv:Impairmentlossesreversalsoninvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTUtNS0xLTEtNzAzNjM_50237d38-74be-4c6b-902f-8d5221f13b2d">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i623def1f7d994412a99937dd097a9306_D20210101-20210930" decimals="-6" name="elv:Impairmentlossesreversalsoninvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTUtNy0xLTEtNzAzNjM_2dfb51dd-d8f3-4f2a-b9ea-88accad4cdc4">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net losses (gains) on other investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76d0d6767c2146a4aa94f20b9f15ea40_D20220701-20220930" decimals="-6" name="us-gaap:GainLossOnSaleOfOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTYtMS0xLTEtNzAzNjM_44c1f90a-a1f8-4a6e-a3e6-46694451d1f8">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbe9a6627d614becb080363c4cc79132_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTYtMy0xLTEtNzAzNjM_20434646-9eb6-4613-a5e2-825661869d61">90</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e6a553b24d9430485f058f6dabd9ef0_D20220101-20220930" decimals="-6" name="us-gaap:GainLossOnSaleOfOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTYtNS0xLTEtNzAzNjM_29e92fd9-ac10-466c-93e6-a3bce63a6865">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i623def1f7d994412a99937dd097a9306_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTYtNy0xLTEtNzAzNjM_73b749cf-c7a7-45ca-9222-69bf6f31f3d3">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (losses) gains on investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" sign="-" name="elv:InvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTctMS0xLTEtNzAzNjM_bfc1a45d-104f-46cb-9d68-12ef6286af50">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" sign="-" name="elv:InvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTctMy0xLTEtNzAzNjM_c391f4e2-c708-4737-b3b3-e96fda1c7c47">73</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" sign="-" name="elv:InvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTctNS0xLTEtNzAzNjM_f9177582-192b-4295-bc79-a34c3ac77aa2">482</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="elv:InvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTctNy0xLTEtNzAzNjM_22a82c3f-ec79-438f-bc49-c5934cab34e6">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Investment Income</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022 and December&#160;31, 2021, accrued investment income totaled $<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AccruedInvestmentIncomeReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNjM2NQ_9f12b5dc-880a-4ed8-9d14-517fa55b8b65">228</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:AccruedInvestmentIncomeReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNjM3Mg_a2033e7f-5f68-48eb-83ae-b7000c074074">205</ix:nonFraction>, respectively. We recognize accrued investment income under the caption &#8220;Other receivables&#8221; on our consolidated balance sheets.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securities Lending Programs</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in securities lending programs whereby marketable securities in our investment portfolio are transferred to independent brokers or dealers in exchange for cash and securities collateral. The fair value of the collateral received at the time of the transactions amounted to $<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:SecuritiesLoanedFairValueOfCollateral" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNjgxOQ_4a74aab8-b527-40dc-9e01-cc263654dab5">2,841</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:SecuritiesLoanedFairValueOfCollateral" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNjgyNg_7e784a7d-15f3-4731-8810-4a274a3c8434">2,155</ix:nonFraction> at September&#160;30, 2022 and December&#160;31, 2021, respectively. The value of the collateral represented <ix:nonFraction unitRef="number" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="INF" name="elv:SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNjg5Nw_c57bee45-ac34-4278-82d4-676401419e75"><ix:nonFraction unitRef="number" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="INF" name="elv:SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNjg5Nw_d0ad560a-46d2-47f8-82f8-187d4b43e43e">102</ix:nonFraction></ix:nonFraction>% of the market value of the securities on loan at each of September&#160;30, 2022 and December&#160;31, 2021. We recognize the collateral as an asset under the caption &#8220;Other current assets&#8221; in our consolidated balance sheets, and we recognize a corresponding liability for the obligation to return the collateral to the borrower under the caption &#8220;Other current liabilities.&#8221; The securities on loan are reported in the applicable investment category on our consolidated balance sheets. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022 and December&#160;31, 2021, the remaining contractual maturity of our securities lending agreements included overnight and continuous transactions of cash for $<ix:nonFraction unitRef="usd" contextRef="ibf2a7ef2990b49d18dfaee52d861df7a_I20220930" decimals="-6" name="us-gaap:DepositsReceivedForSecuritiesLoanedAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzQ5MQ_d3da1895-8a58-4667-9f1b-345ee6c57ed0">2,636</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i6d66732359c54c7ba0fed0dc86c8903a_I20211231" decimals="-6" name="us-gaap:DepositsReceivedForSecuritiesLoanedAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzQ5OA_be0cc82a-6b32-4006-b500-d44038d4df96">1,874</ix:nonFraction>, respectively, of United States Government securities for $<ix:nonFraction unitRef="usd" contextRef="i55aa272b38d249cf8f65430d3ab7ec89_I20220930" decimals="-6" name="us-gaap:DepositsReceivedForSecuritiesLoanedAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzU1OQ_0edd9b9d-b14f-4aca-901a-647b3af9ed3b">180</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i6575af0d7a33465d80ae8b7e123eb574_I20211231" decimals="-6" name="us-gaap:DepositsReceivedForSecuritiesLoanedAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzU2Ng_effe326c-f218-4967-a2b4-3946167df572">281</ix:nonFraction>, respectively, and of Other securities for $<ix:nonFraction unitRef="usd" contextRef="i82413feb72304cfd9028728f729361cc_I20220930" decimals="-6" name="us-gaap:DepositsReceivedForSecuritiesLoanedAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzYxMg_533aac7e-2d05-4c55-9c2e-3ea6b08d7aa7">25</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="iee555febc7b1489c841bed85cfdde1c7_I20211231" decimals="-6" name="us-gaap:DepositsReceivedForSecuritiesLoanedAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzYxOQ_fe894076-19a6-433b-bb78-e31deaa8157d">0</ix:nonFraction>, respectively.</span></div></ix:continuation><div id="i186e051878fe4219970efc72a9fcdad4_55"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81NS9mcmFnOmFlMmM4ZTM0YmY2YjRkOWFhNDA4ZmYzNWI1NDBkY2EyL3RleHRyZWdpb246YWUyYzhlMzRiZjZiNGQ5YWE0MDhmZjM1YjU0MGRjYTJfMTQzMw_241f54a1-966b-4ba4-9b94-46f303010e43" continuedAt="i87e135f55a2b45c783bdb9f49de104b2" escape="true">Derivative Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="i87e135f55a2b45c783bdb9f49de104b2" continuedAt="ib10490ce1ae6434181dc5c98aabc8f55"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We primarily invest in the following types of derivative financial instruments: interest rate swaps, futures, forward contracts, put and call options, swaptions, embedded derivatives and warrants. We also enter into master netting agreements, which reduce credit risk by permitting net settlement of transactions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into various interest rate swap contracts to convert a portion of our interest rate exposure on our long-term debt from fixed rates to floating rates. The floating rates payable on all of our fair value hedges are benchmarked to </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-16-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib10490ce1ae6434181dc5c98aabc8f55"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIBOR or the Secured Overnight Financing Rate (&#8220;SOFR&#8221;). Any amounts recognized for changes in fair value of these derivatives are included in the captions &#8220;Other current assets,&#8221; &#8220;Other noncurrent assets,&#8221; &#8220;Other current liabilities&#8221; or &#8220;Other noncurrent liabilities&#8221; in our consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unrecognized loss for all expired and terminated cash flow hedges included in accumulated other comprehensive loss, net of tax, was $<ix:nonFraction unitRef="usd" contextRef="ifdb7c3f4f8e543b8a2df60e3edae8983_I20220930" decimals="-6" sign="-" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81NS9mcmFnOmFlMmM4ZTM0YmY2YjRkOWFhNDA4ZmYzNWI1NDBkY2EyL3RleHRyZWdpb246YWUyYzhlMzRiZjZiNGQ5YWE0MDhmZjM1YjU0MGRjYTJfMTA0Nw_b36833e1-6316-41ba-a75d-3150327cd984">231</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia0ee2e1f5c8c43419e04e58cfb917f9c_I20211231" decimals="-6" sign="-" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81NS9mcmFnOmFlMmM4ZTM0YmY2YjRkOWFhNDA4ZmYzNWI1NDBkY2EyL3RleHRyZWdpb246YWUyYzhlMzRiZjZiNGQ5YWE0MDhmZjM1YjU0MGRjYTJfMTA1NQ_483bd706-0c2e-4214-9456-4e9efebbe735">239</ix:nonFraction> at September&#160;30, 2022 and December&#160;31, 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">three and nine months ended September&#160;30, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, we recognized net (losses) gains on non-hedging derivatives of $(<ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81NS9mcmFnOmFlMmM4ZTM0YmY2YjRkOWFhNDA4ZmYzNWI1NDBkY2EyL3RleHRyZWdpb246YWUyYzhlMzRiZjZiNGQ5YWE0MDhmZjM1YjU0MGRjYTJfMTE1OQ_7f8068d1-840d-42b8-9ad7-c0d6d6457c41">3</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81NS9mcmFnOmFlMmM4ZTM0YmY2YjRkOWFhNDA4ZmYzNWI1NDBkY2EyL3RleHRyZWdpb246YWUyYzhlMzRiZjZiNGQ5YWE0MDhmZjM1YjU0MGRjYTJfMTE2Ng_c933dc0a-3976-4cec-908c-07c4527586b2">43</ix:nonFraction>, respectively. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">three and nine months ended September&#160;30, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, we recognized net gains on non-hedging derivatives of $<ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81NS9mcmFnOmFlMmM4ZTM0YmY2YjRkOWFhNDA4ZmYzNWI1NDBkY2EyL3RleHRyZWdpb246YWUyYzhlMzRiZjZiNGQ5YWE0MDhmZjM1YjU0MGRjYTJfMTI1Ng_d530a5d6-09cf-4c5e-989b-83cdd220ca43">12</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81NS9mcmFnOmFlMmM4ZTM0YmY2YjRkOWFhNDA4ZmYzNWI1NDBkY2EyL3RleHRyZWdpb246YWUyYzhlMzRiZjZiNGQ5YWE0MDhmZjM1YjU0MGRjYTJfMTI2Mw_c41e5fce-48fe-46b9-bbf9-179be647e460">59</ix:nonFraction>, respectively.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information relating to the fair value of our derivative assets and liabilities, see Note 7, &#8220;Fair Value,&#8221; of this Form 10-Q.</span></div></ix:continuation><div id="i186e051878fe4219970efc72a9fcdad4_58"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RleHRyZWdpb246ZTIyYTVkZjliODYyNDAwOWJhY2RlNjY5ZmIxMGEzYTNfMTE1OTg_f1668bd1-3fc9-4e3e-9b9d-1f0bf76e537a" continuedAt="i5318d0faeddf47628e74a349859d4d7d" escape="true">Fair Value</ix:nonNumeric></span></div><ix:continuation id="i5318d0faeddf47628e74a349859d4d7d" continuedAt="i4e866bc8079540ae8fd3d4c17a56c865"><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities recorded at fair value in our consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Level inputs, as defined by FASB guidance for fair value measurements and disclosures, are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.553%"><tr><td style="width:1.0%"></td><td style="width:8.317%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.736%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Level&#160;Input</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Input Definition</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs that reflect management&#8217;s best estimate of what market participants would use in pricing the asset or liability at the measurement date.</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:4pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following methods, assumptions and inputs were used to determine the fair value of each class of the following assets and liabilities recorded at fair value in our consolidated balance sheets:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash equivalents:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cash equivalents primarily consist of highly rated money market funds with maturities of three months or less and are purchased daily at par value with specified yield rates. Due to the high ratings and short-term nature of the funds, we designate all cash equivalents as Level I.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fixed maturity securities, available-for-sale:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair values of available-for-sale fixed maturity securities are based on quoted market prices, where available. These fair values are obtained primarily from third-party pricing services, which generally use Level I or Level II inputs for the determination of fair value to facilitate fair value measurements and disclosures. Level II securities primarily include corporate securities, securities from states, municipalities and political subdivisions, mortgage-backed securities, United States government securities, foreign government securities, and certain other asset-backed securities. For securities not actively traded, the pricing services may use quoted market prices of comparable instruments or discounted cash flow analyses, incorporating inputs that are currently observable in the markets for similar securities. We have controls in place to review the pricing services&#8217; qualifications and procedures used to determine fair values. In addition, we periodically review the pricing services&#8217; pricing methodologies, data sources and pricing inputs to ensure the fair values obtained are reasonable. Inputs that are often used in the valuation methodologies include, but are not limited to, broker quotes, benchmark yields, credit spreads, default rates and prepayment speeds. We also have certain fixed maturity securities, primarily corporate debt securities, which are designated Level III securities. For these securities, the valuation methodologies may incorporate broker quotes or discounted cash flow analyses using assumptions for inputs such as expected cash flows, benchmark yields, credit spreads, default rates and prepayment speeds that are not observable in the markets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity securities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair values of equity securities are generally designated as Level I and are based on quoted market prices. For certain equity securities, quoted market prices for the identical security are not always available, and the fair value is estimated by reference to similar securities for which quoted prices are available. These securities are designated Level II. We also have certain equity securities, including private equity securities, for which the fair value is estimated based on each security&#8217;s current condition and future cash flow projections. Such securities are designated Level III. The fair values of these private equity securities are generally based on either broker quotes or discounted cash flow projections using assumptions </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-17-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4e866bc8079540ae8fd3d4c17a56c865" continuedAt="i8664eadbd75449c8b6887d119f2280d0"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for inputs such as the weighted-average cost of capital, long-term revenue growth rates and earnings before interest, taxes, depreciation and amortization, and/or revenue multiples that are not observable in the markets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Securities lending collateral:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair values of securities lending collateral are based on quoted market prices, where available. These fair values are obtained primarily from third-party pricing services, which generally use Level I or Level II inputs for the determination of fair value, to facilitate fair value measurements and disclosures.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair values are based on the quoted market prices by the financial institution that is the counterparty to the derivative transaction. We independently verify prices provided by the counterparties using valuation models that incorporate observable market inputs for similar derivative transactions. Derivatives are designated as Level II securities. Derivatives presented within the fair value hierarchy table below are presented on a gross basis and not on a master netting basis by counterparty.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-18-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;text-indent:18pt"><ix:continuation id="i8664eadbd75449c8b6887d119f2280d0" continuedAt="i08daf08975294f028fbc76253456f797"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RleHRyZWdpb246ZTIyYTVkZjliODYyNDAwOWJhY2RlNjY5ZmIxMGEzYTNfMTE2MTM_de3fcc4d-3bef-436a-beae-3d0a85a86c81" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of fair value measurements by level for assets and liabilities measured at fair value on a recurring basis at September&#160;30, 2022 and December&#160;31, 2021 is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.786%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e1be64addb482ea782f65135d60a05_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMy0xLTEtMS03MDM2Mw_e8f75415-c416-4615-ad61-bebc6ddcdac0">5,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fc2e84bcad34027932d35097b9f9bdb_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMy0zLTEtMS03MDM2Mw_57725ab8-86a2-4969-a4cc-bd916012d6a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bebbc6255564194a65092412ac06f67_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMy01LTEtMS03MDM2Mw_7c25e956-c065-42aa-9813-dbc20b8ec6ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMy03LTEtMS03MDM2Mw_ada658ee-10c4-4292-9154-e20bc5a9fe42">5,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities, available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States Government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ed17b4bb7f34660b7206d12cd763384_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNS0xLTEtMS03MDM2Mw_0d2344b4-457e-4716-8042-a196ca9b157f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a3b331afc414af99ac6c1599df2287a_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNS0zLTEtMS03MDM2Mw_dcb5e57b-6d0a-4b77-90f4-f6eb573cdfd2">1,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79076969c3024e269accd9bc7038ee4d_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNS01LTEtMS03MDM2Mw_9a0bf0f6-26d5-4bb8-b1b4-e8a96e5b12af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if46ba3a6ed924704ab80b46d4892ce9c_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNS03LTEtMS03MDM2Mw_cd0e535d-4620-4d0b-a8ae-09d239be385f">1,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government sponsored securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83c6fbea402043d5841f091c58e82693_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNi0xLTEtMS03MDM2Mw_63722c19-2b1f-4ba6-8fd6-38c35114b4fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5832f9a26ea3435bbd561c28893f542e_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNi0zLTEtMS03MDM2Mw_22ecc788-bb3f-4c19-977d-3e341dd75fcb">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54b54a3342e648a4af00533f1570f055_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNi01LTEtMS03MDM2Mw_41685c28-2d15-4485-bd69-843121cd8852">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i582c7462a2a24ee19ae7c3e8b13e6258_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNi03LTEtMS03MDM2Mw_9b30aa15-9b55-46ec-8275-c29aa723d457">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80f80d23604d47ea9d6d5d3db271166b_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNy0xLTEtMS03MDM2Mw_f2d25d6d-443c-4662-925f-fde6ac19cd30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0630c845d0544c8fb78216ec9ee4246a_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNy0zLTEtMS03MDM2Mw_15d632f4-d4e8-4e9c-9152-7a8c55b39786">251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea6ffa026ed49ad880282333c15e05b_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNy01LTEtMS03MDM2Mw_59871fd0-f8a7-44f3-9ff3-945dfec26092">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3fb6e7405848e39ed7671d9a9683da_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNy03LTEtMS03MDM2Mw_f1176f1c-e0ab-4ef2-bcd5-509269f32902">251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions, tax-exempt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09ec78a8f2934ad988a5a84ed45afe95_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfOC0xLTEtMS03MDM2Mw_919b5517-4ac0-40d2-8c67-33c1721a13a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9963152709494c7192e65f8d93db6abd_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfOC0zLTEtMS03MDM2Mw_953ac71e-efa8-4361-95e3-a92fb3b25dd3">4,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3bd3a5e8f4e46668a696ae3513051dc_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfOC01LTEtMS03MDM2Mw_97b9482e-c108-4043-b890-580895d4fa43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie05876f14e3546779aaacef9d285ee2c_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfOC03LTEtMS03MDM2Mw_0639ccc2-9254-44ec-b5c4-e3f222c00022">4,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i879983c43359419d9305755bc21b11e8_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfOS0xLTEtMS03MDM2Mw_d6e72fce-89e6-437c-808a-803761c8436c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bae3ca7f392419cb36507af34fd85e1_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfOS0zLTEtMS03MDM2Mw_d9d3958c-6a5a-4c1b-9c45-0e3d33e5f755">12,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if54e2a09642243b0af22bd387b96cc86_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfOS01LTEtMS03MDM2Mw_d99ac5ce-5bf3-4123-9210-15f96c560d2a">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5a6260b0cc245e3ad18420b5dda8138_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfOS03LTEtMS03MDM2Mw_b38fdc5d-8698-4f36-a661-e33977ae8a92">12,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i319c0932f552442f91e807fadf6869b2_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTAtMS0xLTEtNzAzNjM_1f39649d-fa96-44d6-a08e-7cd110f253dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id72f5fdb790d488389e012081716a861_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTAtMy0xLTEtNzAzNjM_66cd1156-4551-47fb-8cc5-9e13957cb55a">4,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd52d310cc6249de9d64e53d7b7f960d_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTAtNS0xLTEtNzAzNjM_ed592c5d-b0bf-4598-b3cd-1cc295e10fed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id54f0058c591469baef2d1557dcb55a8_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTAtNy0xLTEtNzAzNjM_2a6adbb2-f5ed-4780-b2ce-e8ae82da8643">4,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7954908cb6bc4a09af7d436befca47cf_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTEtMS0xLTEtNzAzNjM_a4e9b76d-f136-44b5-b7b2-4e328a458aa9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d1fbf1b64a48d993287eda3253e59e_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTEtMy0xLTEtNzAzNjM_e8660a88-185d-4143-9225-aa4c19f4ca95">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c77fcbcf9014952b22ac069325f92a6_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTEtNS0xLTEtNzAzNjM_45fbfec9-b995-4456-b235-e8b237de859d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2340f4d1ac2b47dfbe6521a9386a70f4_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTEtNy0xLTEtNzAzNjM_5ef5b0bc-b6de-4ea5-8cf5-2a7ce36c55bc">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8679b29bd646468da600ed87da53d36b_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTItMS0xLTEtNzAzNjM_a82af760-23d6-4f00-8282-868e11c19767">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ffe957d5ff14ba187fff4116dcf8991_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTItMy0xLTEtNzAzNjM_eba66374-0664-43e7-bb7c-8fca9180ba1e">3,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0fe98e383084014b1bc9ab32ce423dd_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTItNS0xLTEtNzAzNjM_52edb3b9-b505-491b-9f98-57b0376e6b32">311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30a0f87e5ab9493cbf1db457f967922d_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTItNy0xLTEtNzAzNjM_5b190e4a-00ba-441a-ae0e-3ec060bf972f">3,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities, available-for-sale</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e1be64addb482ea782f65135d60a05_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTMtMS0xLTEtNzAzNjM_abc28bab-9997-487c-a132-75b371fa33d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fc2e84bcad34027932d35097b9f9bdb_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTMtMy0xLTEtNzAzNjM_6a3338a3-aaaa-474b-af19-b03674a2f043">25,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bebbc6255564194a65092412ac06f67_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTMtNS0xLTEtNzAzNjM_7231c176-86f9-45ac-9838-7329f402cb48">440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTMtNy0xLTEtNzAzNjM_e34f3e57-0c90-49cf-abdf-860c5b5ce2cc">26,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange traded funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id225b53b5eb14421a1c1ea44abf2ab1f_I20220930" decimals="-6" name="elv:EquitySecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTUtMS0xLTEtNzAzNjM_30acd456-2169-4bbe-a34f-781d1e4f536b">1,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i572ccbdc7947481c8deddaa8e2068caa_I20220930" decimals="-6" name="elv:EquitySecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTUtMy0xLTEtNzAzNjM_d5e2c05f-ee07-4c3c-bdd2-a1f8d98ae8f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67e47d6156fe4e30a2db3dbc795c804e_I20220930" decimals="-6" name="elv:EquitySecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTUtNS0xLTEtNzAzNjM_259d3df3-98cf-4d43-9be3-daae4a22e862">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie17e65ae944d47f1b80529dd1e22cea8_I20220930" decimals="-6" name="elv:EquitySecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTUtNy0xLTEtNzAzNjM_7ae7c4d8-da32-40e9-841c-f9c7edd0748e">1,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2b35a0942fa4be398836e787b4033fe_I20220930" decimals="-6" name="elv:EquitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTctMS0xLTEtNzAzNjM_0b8a4890-faa5-4184-a73c-2c03b282f377">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i194d8de15f8b4abe9a293c428ef86751_I20220930" decimals="-6" sign="-" name="elv:EquitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTctMy0xLTEtNzAzNjM_8f8e3e09-43d0-47de-aa3e-e9e494e916d1">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6037d7dd8543e2a047fa4c031268df_I20220930" decimals="-6" name="elv:EquitySecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTctNS0xLTEtNzAzNjM_51ac7a6d-db4f-4148-8ea0-504d578107fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c4b8b65febc483694f935949190933a_I20220930" decimals="-6" name="elv:EquitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTctNy0xLTEtNzAzNjM_c9ffaaa2-eecb-4490-a360-dbd8e5e5710c">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i359143f746854b4a9c1ab808c68d5640_I20220930" decimals="-6" name="elv:EquitySecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTgtMS0xLTEtNzAzNjM_85c1bc51-189f-4f47-8df5-20b1f97a7ce1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if36f830bb3c64269a716998cc4d3631d_I20220930" decimals="-6" name="elv:EquitySecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTgtMy0xLTEtNzAzNjM_eebf1f0c-b031-49f0-9448-45070462c1af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60026054e5d341ac957c97a96698628d_I20220930" decimals="-6" name="elv:EquitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTgtNS0xLTEtNzAzNjM_11adc892-fbdf-463b-bebc-4cc7c374aa85">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97d580beda144d4491df94dbd14b5e63_I20220930" decimals="-6" name="elv:EquitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTgtNy0xLTEtNzAzNjM_7c1fd6fc-45f5-4072-8f6f-77a2367aeb9c">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2c59dfa7804e66a650f900b9d23c9e_I20220930" decimals="-6" name="elv:EquitySecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTktMS0xLTEtNzAzNjM_89627344-7447-4c1f-84a4-0c76dabc905e">1,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3a7f443bdad4168b5798971706c5f40_I20220930" decimals="-6" sign="-" name="elv:EquitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTktMy0xLTEtNzAzNjM_30c8b927-f640-41e0-8768-f166c9dfc631">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iece93ac436104fd6a1cd99c3cd0e562a_I20220930" decimals="-6" name="elv:EquitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTktNS0xLTEtNzAzNjM_3f0b969a-c822-4c25-ac8f-85474401800c">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f5fd44cb84fbc9b4c45aae397c186_I20220930" decimals="-6" name="elv:EquitySecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTktNy0xLTEtNzAzNjM_80fd7dae-a019-4d97-9068-1881c7c28cca">1,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other invested assets - common equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4609d385fde4f5e8ed90e175cff6320_I20220930" decimals="-6" name="us-gaap:OtherLongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjAtMS0xLTEtNzAzNjM_e529cd0b-fbdd-40ea-93c3-16a0882f894a">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2998bb1d7c3e43cb9610ba10dc2f2d9c_I20220930" decimals="-6" name="us-gaap:OtherLongTermInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjAtMy0xLTEtNzAzNjM_e7fb9c5d-cd68-4740-bf25-56534610d4bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b480fb15b94cdcb1a697f67988e588_I20220930" decimals="-6" name="us-gaap:OtherLongTermInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjAtNS0xLTEtNzAzNjM_2b0f87a0-9cc1-478e-ba16-17340f031934">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8518fee768764a0f95c228de9e1ea364_I20220930" decimals="-6" name="us-gaap:OtherLongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjAtNy0xLTEtNzAzNjM_3d725e6a-9414-4bd3-a7fe-86daec1639df">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities lending collateral</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e1be64addb482ea782f65135d60a05_I20220930" decimals="-6" name="us-gaap:SecuritiesHeldAsCollateralAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjEtMS0xLTEtNzAzNjM_117d375e-c3f4-40a6-9ee5-27b82763ffb8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fc2e84bcad34027932d35097b9f9bdb_I20220930" decimals="-6" name="us-gaap:SecuritiesHeldAsCollateralAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjEtMy0xLTEtNzAzNjM_8178f26b-7c84-4359-95ca-086b17b6d4cb">2,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bebbc6255564194a65092412ac06f67_I20220930" decimals="-6" name="us-gaap:SecuritiesHeldAsCollateralAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjEtNS0xLTEtNzAzNjM_20570912-dee2-4c12-ba0a-ed0a96941927">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:SecuritiesHeldAsCollateralAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjEtNy0xLTEtNzAzNjM_27b5c617-cf6c-4d97-a9bd-24387299c8b4">2,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives - other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0add331b12f44d51b7ece36e400dc1f5_I20220930" decimals="-6" name="us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjItMS0xLTEtNzAzNjM_08e5de7c-1953-4696-a4a0-5b5b0394c240">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5802f494354611a73f807c38dce059_I20220930" decimals="-6" name="us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjItMy0xLTEtNzAzNjM_6d334b03-93bd-4b2d-afe6-624b733c9403">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e550fd94b994ce49630d8444c71806b_I20220930" decimals="-6" name="us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjItNS0xLTEtNzAzNjM_642648fe-67e2-4a4e-804e-d9553270922c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad4a668efc449218c1bacb86f5187e1_I20220930" decimals="-6" name="us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjItNy0xLTEtNzAzNjM_dc52b2dd-fc1e-4e2e-a0a9-bad0a3a6ba60">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e1be64addb482ea782f65135d60a05_I20220930" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjMtMS0xLTEtNzAzNjM_738d0a99-1407-4820-9b28-bc7649af26df">7,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fc2e84bcad34027932d35097b9f9bdb_I20220930" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjMtMy0xLTEtNzAzNjM_0b745de8-f7fc-4ebf-90b2-6f16e00aecbb">28,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bebbc6255564194a65092412ac06f67_I20220930" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjMtNS0xLTEtNzAzNjM_3a27232a-f871-43db-9b0f-05a17765dce2">535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjMtNy0xLTEtNzAzNjM_d99aa05c-ea01-4f70-bc45-add28cbd9add">36,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives - other liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0add331b12f44d51b7ece36e400dc1f5_I20220930" decimals="-6" name="us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjUtMS0xLTEtNzAzNjM_c7313a9c-9d23-4836-9d64-f8108ade30d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c5802f494354611a73f807c38dce059_I20220930" decimals="-6" name="us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjUtMy0xLTEtNzAzNjM_ac52aba1-d784-49d7-bcba-8836f4bca3cc">70</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e550fd94b994ce49630d8444c71806b_I20220930" decimals="-6" name="us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjUtNS0xLTEtNzAzNjM_5e53d56b-1bbe-44f0-b4f5-82673813ef0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icad4a668efc449218c1bacb86f5187e1_I20220930" decimals="-6" name="us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjUtNy0xLTEtNzAzNjM_03fcf62e-fab8-438b-a78b-d9374894d2df">70</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e1be64addb482ea782f65135d60a05_I20220930" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjYtMS0xLTEtNzAzNjM_a4c3fa82-4647-4f30-8dad-559a4317c0b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fc2e84bcad34027932d35097b9f9bdb_I20220930" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjYtMy0xLTEtNzAzNjM_da921449-22da-49a9-9b17-757e4b5275f8">70</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bebbc6255564194a65092412ac06f67_I20220930" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjYtNS0xLTEtNzAzNjM_36c715a5-51b2-490a-8370-230fb52e1c18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjYtNy0xLTEtNzAzNjM_ffbbc5a7-8db9-4183-aec0-9f5bb1e4ec75">70</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id12430cdfde949268546e42fae69aacb_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzAtMS0xLTEtNzAzNjM_10176f25-5520-44e1-bb1d-9c48d4f8375b">2,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f7e82e807e34b52b194ae404cbff7c8_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzAtMy0xLTEtNzAzNjM_f632b4d6-93ce-4fd9-b50f-302b807e2227">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39708ec10b1d42fc910b98395c8b0d03_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzAtNS0xLTEtNzAzNjM_8a775841-7457-4fe2-a18e-e8819a7477f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzAtNy0xLTEtNzAzNjM_d13f1444-8090-46fb-8d62-51a3b85d71e1">2,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities, available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States Government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d00975607245648c820ae081dffc76_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzItMS0xLTEtNzAzNjM_7dfe5551-bbfc-4805-b338-e20d97d98e12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52e0633755af4f07991cc898c84730a5_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzItMy0xLTEtNzAzNjM_8e3f57c1-3fc0-4f08-9d64-c67046757d1a">1,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec5d8d8c36b445f181d4b0e14e790e50_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzItNS0xLTEtNzAzNjM_a2f24423-5ada-40d4-b52c-d75788c2fa48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc53677b69024b148f62349f82fe723c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzItNy0xLTEtNzAzNjM_3badeec4-3d7b-4505-af73-7dfddaba17d5">1,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government sponsored securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dc525e82e4f4b78b55e13f877d9d212_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzMtMS0xLTEtNzAzNjM_8f9dedb2-7a27-47bc-8a64-c8cc53888af1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059ab6a34c854d4590c340b2aa206fc2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzMtMy0xLTEtNzAzNjM_ee8114a8-a23a-4cbe-b462-1e3956b5975b">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i017bb4e3633b454f85f310109f119763_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzMtNS0xLTEtNzAzNjM_1e36db3d-fc0b-4e53-94e9-ae9598b92b9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bd8e4d367e5434c93d5ed2fb93b9c90_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzMtNy0xLTEtNzAzNjM_c8f3acbc-d938-4343-9da7-c677aa693faa">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f3be4159040cca4c6330bada73b9f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzQtMS0xLTEtNzAzNjM_188aeb2a-e960-48aa-b9fa-22d88e467d85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd0cddd1e2704317822ec1aa4b6a8d50_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzQtMy0xLTEtNzAzNjM_532f984f-37ee-46e1-a8a3-05dfb9ea61e1">347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa1f82c236bf4e9fa6b63e8a1dd059b3_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzQtNS0xLTEtNzAzNjM_f3e6d398-1c57-4861-93b0-8bc0b12fe741">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcad3b58ad0a402e9c5f36c2257b46ad_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzQtNy0xLTEtNzAzNjM_cd1cc902-42eb-4ef7-b541-91c045631ad5">347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions, tax-exempt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i480713ec0004444aae07ba823a2a3710_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzUtMS0xLTEtNzAzNjM_f884bfb2-7afa-42ee-8a70-11817a046a25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac7e634bfc3043a3b61901be4796c354_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzUtMy0xLTEtNzAzNjM_5f561fe4-3240-4efd-91cd-2c18786ba289">5,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if77a6a1ea8a845e1b8f8f10a6494dd9d_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzUtNS0xLTEtNzAzNjM_c540c42c-b265-4021-82c6-9de3ba434f2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b05039f1d944a39a5f7c4a08ecd9386_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzUtNy0xLTEtNzAzNjM_b9355276-2da0-489d-b45c-9d95bac4b40c">5,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ea3e0c81e449c4aabaeaba693601b4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzYtMS0xLTEtNzAzNjM_ca3684e4-5897-4287-a822-d49982364272">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d9263de42c24bbeb3029c5c835d1b7e_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzYtMy0xLTEtNzAzNjM_09d72d30-3dcd-42fe-b994-6291901c74ee">12,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d73240dd06c484fb3d57ea0c58ca9f6_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzYtNS0xLTEtNzAzNjM_ea800974-f808-4a43-a4f9-d8722f68d405">336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe0fa1cefe04a9ab9bd771236eb24fd_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzYtNy0xLTEtNzAzNjM_562a9a6e-219c-4550-95b2-50217239095d">12,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a51c1b83ca44cebb3cb541c6c1ffd23_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzctMS0xLTEtNzAzNjM_ebdd724f-0e34-4d88-8ae2-0ac5a7615602">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ebb31481dbc46e3a7f18240069b415d_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzctMy0xLTEtNzAzNjM_8d872492-b261-42c2-ab0b-ffb219d09bdf">4,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0107aa86d0304c8c820c9d1f402f3a58_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzctNS0xLTEtNzAzNjM_25688419-6b38-4c11-b4e8-e051f5743bc3">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1998952a2fec4ef987e45747bc6a365e_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzctNy0xLTEtNzAzNjM_328c8d15-3327-4c82-bebd-a43a9e3d93ae">4,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43e3349630db458383c85c2d30827d66_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzgtMS0xLTEtNzAzNjM_ba2a9232-6e3c-4a56-9d65-37ae122da462">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide59a28c7a594301ab29f18f850bbebb_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzgtMy0xLTEtNzAzNjM_707bf8c3-6f22-4b5c-b095-e22fb9ef1d2a">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0368bfa4554cd2952ff8415fba1e2d_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzgtNS0xLTEtNzAzNjM_d1df3636-317e-4da5-abfd-2361b9b51ee1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf59770742dd4e0c909bf664464f6f51_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzgtNy0xLTEtNzAzNjM_c5ce6c61-37e5-42a3-922e-1d6c13a8f6e0">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd0cba106b646758a3d426fe4185e71_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzktMS0xLTEtNzAzNjM_ed68c9e0-ff39-44ee-8627-4ba65273b3f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide71a36d93e440ac9bbd26d0f1185292_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzktMy0xLTEtNzAzNjM_cf36bbcb-280c-4718-a92d-329752ebc32d">2,888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3f130bdbeda4a229139760fe1a5256c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzktNS0xLTEtNzAzNjM_6daa8140-b529-40be-b591-d040cbe3ed11">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b17717cfed84a8695f0ebee25d6d1b0_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzktNy0xLTEtNzAzNjM_fd94c03f-1792-4a05-a121-c478ce915010">2,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities, available-for-sale</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id12430cdfde949268546e42fae69aacb_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDAtMS0xLTEtNzAzNjM_55b721a5-de1e-4ad3-b902-552be252e343">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f7e82e807e34b52b194ae404cbff7c8_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDAtMy0xLTEtNzAzNjM_891ef9dc-adb0-4983-9ed3-93ad8151a32c">26,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39708ec10b1d42fc910b98395c8b0d03_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDAtNS0xLTEtNzAzNjM_23d6c0ce-7a59-4ad7-8e4d-c66e7a92aefe">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDAtNy0xLTEtNzAzNjM_c872339b-2bb6-419f-95c1-0ea4278c7b82">26,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange traded funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5595401992294f4db26af9c67d94813c_I20211231" decimals="-6" name="elv:EquitySecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDItMS0xLTEtNzAzNjM_11245b0d-bc5d-4c74-8db3-a062e276fe35">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i247198472ac444b4a705c2d6d3870893_I20211231" decimals="-6" name="elv:EquitySecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDItMy0xLTEtNzAzNjM_13b45ae0-8583-43a7-aba8-914547674d2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id70934c0fdca477cbb28d1fa3a921841_I20211231" decimals="-6" name="elv:EquitySecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDItNS0xLTEtNzAzNjM_7b998c5c-eeae-41c6-902c-e8925e859ca3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16e26cf91f824b138d31ee3ccbbc2486_I20211231" decimals="-6" name="elv:EquitySecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDItNy0xLTEtNzAzNjM_b53debef-67b4-4224-96de-528a66713e72">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if08d21b298724dbe87a66843d0d5ec37_I20211231" decimals="-6" name="elv:EquitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDQtMS0xLTEtNzAzNjM_c1b326a9-57fc-4798-996f-5a05106e2cab">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcc2f3cd485c43e0a5b93811cbad0040_I20211231" decimals="-6" name="elv:EquitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDQtMy0xLTEtNzAzNjM_6b30489c-9812-472c-a117-6b852698923a">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97d07a393824fba8c5a533ddc17248b_I20211231" decimals="-6" name="elv:EquitySecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDQtNS0xLTEtNzAzNjM_c6a900f0-915b-46a6-b088-606a9374de5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d9daa1bf9aa49618c67c4fe0feca8a1_I20211231" decimals="-6" name="elv:EquitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDQtNy0xLTEtNzAzNjM_8156e1a0-18fa-4f5c-bdb7-89b33496285d">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia67cf78d5c9e49c386e4366d79e071f5_I20211231" decimals="-6" name="elv:EquitySecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDUtMS0xLTEtNzAzNjM_ea8968f9-e5e6-4034-a336-71368226cf6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e39bd703c7c487eb5d185ba13bfcc36_I20211231" decimals="-6" name="elv:EquitySecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDUtMy0xLTEtNzAzNjM_89c027df-7fd5-414b-99d4-0d92b1a1af6a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66059c1693064085997c288e33979c72_I20211231" decimals="-6" name="elv:EquitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDUtNS0xLTEtNzAzNjM_a77ba8ad-a751-44f7-94b2-7dc397931c12">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4693331b053e467aa44d2753305e57c5_I20211231" decimals="-6" name="elv:EquitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDUtNy0xLTEtNzAzNjM_a0b7617b-f7a4-457f-9912-a32d32d2a521">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55dbd61667064a73939c76e993f892e4_I20211231" decimals="-6" name="elv:EquitySecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDYtMS0xLTEtNzAzNjM_f9c0c8aa-7ec3-4e26-b998-f47945923bcb">1,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1ea0fca2f2f4b16904060514710f24b_I20211231" decimals="-6" name="elv:EquitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDYtMy0xLTEtNzAzNjM_20748f0b-473e-49b3-a751-33d313d69f75">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id73c6074257a4797b02f0bb8c9813727_I20211231" decimals="-6" name="elv:EquitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDYtNS0xLTEtNzAzNjM_7587f3be-74ba-4ce9-958a-7827513057d4">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cda0b9d394240d5bed36877535df125_I20211231" decimals="-6" name="elv:EquitySecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDYtNy0xLTEtNzAzNjM_63f4fea7-4add-4355-ac32-a038d08403e6">1,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other invested assets - common equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia570c61ac2774f2c9b61f2b04614af6f_I20211231" decimals="-6" name="us-gaap:OtherLongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDctMS0xLTEtNzAzNjM_456c8659-d822-4545-a534-53348e8ad1f7">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f9ec3d81af44e958f1beabb66a20af5_I20211231" decimals="-6" name="us-gaap:OtherLongTermInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDctMy0xLTEtNzAzNjM_e4c4aa6b-891e-47c7-aadb-cf8c234a95c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77434cd540454880bbde697445471783_I20211231" decimals="-6" name="us-gaap:OtherLongTermInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDctNS0xLTEtNzAzNjM_029b1073-832b-483d-9db8-53ca8a58a47b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae3f929a16f5495498ceb553e33f710f_I20211231" decimals="-6" name="us-gaap:OtherLongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDctNy0xLTEtNzAzNjM_089ee275-fcbd-4992-bd26-dac7b7c09633">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities lending collateral</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id12430cdfde949268546e42fae69aacb_I20211231" decimals="-6" name="us-gaap:SecuritiesHeldAsCollateralAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDgtMS0xLTEtNzAzNjM_912d01b0-e9cf-455e-968e-37d839ce4e3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f7e82e807e34b52b194ae404cbff7c8_I20211231" decimals="-6" name="us-gaap:SecuritiesHeldAsCollateralAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDgtMy0xLTEtNzAzNjM_418fd121-5d6e-419d-80c7-9f9c3dd9baa6">2,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39708ec10b1d42fc910b98395c8b0d03_I20211231" decimals="-6" name="us-gaap:SecuritiesHeldAsCollateralAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDgtNS0xLTEtNzAzNjM_bb391564-b1f5-4b87-a508-a65b60cdc514">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:SecuritiesHeldAsCollateralAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDgtNy0xLTEtNzAzNjM_21e9cc90-2e35-4c9b-be8b-e14391b9b377">2,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives - other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab52a629947044ddb6c7a30c64d60ec1_I20211231" decimals="-6" name="us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDktMS0xLTEtNzAzNjM_a8fecc93-fd37-4380-ad37-ce2e766d26f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18aaf10638ba48758ecf2c6f063e2eef_I20211231" decimals="-6" name="us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDktMy0xLTEtNzAzNjM_e8e4620b-9187-43de-8f4b-de2ddfd5a528">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49bbc62b7c9a4dbfaa94dc46b4ed4750_I20211231" decimals="-6" name="us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDktNS0xLTEtNzAzNjM_9e1df719-3cd8-47df-a77d-f77449a7863d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc70625496934ce88087fd178a0df18b_I20211231" decimals="-6" name="us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDktNy0xLTEtNzAzNjM_74a35a43-28e4-4e04-af18-08b0d68dba57">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id12430cdfde949268546e42fae69aacb_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTAtMS0xLTEtNzAzNjM_b66e165c-8c55-4092-b88a-141f6b38a86e">4,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f7e82e807e34b52b194ae404cbff7c8_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTAtMy0xLTEtNzAzNjM_8b35cfca-64f5-4e09-a16c-943ecef2c107">28,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39708ec10b1d42fc910b98395c8b0d03_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTAtNS0xLTEtNzAzNjM_16d42da2-454b-481c-83de-d7de254068ba">449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTAtNy0xLTEtNzAzNjM_c1d36586-1df6-4de9-843b-bf468a97871e">33,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives - other liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab52a629947044ddb6c7a30c64d60ec1_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTItMS0xLTEtNzAzNjM_1c39d883-e70b-4219-91d5-264c24b2e347">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18aaf10638ba48758ecf2c6f063e2eef_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTItMy0xLTEtNzAzNjM_1a25abf3-be59-45e9-a284-cae0765569f7">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49bbc62b7c9a4dbfaa94dc46b4ed4750_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTItNS0xLTEtNzAzNjM_d5158e1a-88a9-4b40-b1e3-169203c709ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc70625496934ce88087fd178a0df18b_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTItNy0xLTEtNzAzNjM_33f81231-e408-47d4-903b-e8197e9014f6">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id12430cdfde949268546e42fae69aacb_I20211231" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTMtMS0xLTEtNzAzNjM_b86e2bc3-b076-470c-afc8-207b00a51c89">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f7e82e807e34b52b194ae404cbff7c8_I20211231" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTMtMy0xLTEtNzAzNjM_6262ae5e-2b13-437b-beb6-527ca10571dc">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39708ec10b1d42fc910b98395c8b0d03_I20211231" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTMtNS0xLTEtNzAzNjM_5a33793e-38c5-40a1-8471-f56f96f45765">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTMtNy0xLTEtNzAzNjM_6f65e0b9-9dac-42cb-94c4-283f9fb98b5d">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-19-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i08daf08975294f028fbc76253456f797" continuedAt="ide2a50ef1f9246f3932e61b1e8314d0b"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RleHRyZWdpb246ZTIyYTVkZjliODYyNDAwOWJhY2RlNjY5ZmIxMGEzYTNfMTE1ODc_2b42225b-ddfd-494c-b595-aa47f4534baf" continuedAt="i15ea8b2923a3458dab805d911b1ab065" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balances of assets measured at fair value on a recurring basis using Level III inputs for the three months ended September 30, 2022 and 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Residential<br/>Mortgage-<br/>backed<br/>Securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance at July 1, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b40fde7beb04a09997961c706c7c577_I20220630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfNS0xLTEtMS03MDM2Mw_7a8d0cae-fbb5-492f-a192-0a88b082ad69">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93e6bc23bb5d43ee9937560149125ce1_I20220630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfNS0zLTEtMS03MDM2Mw_a01cba5c-0194-4980-b6e8-3ae04be0efea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4cd3d9e543549eaa00430a7132f99eb_I20220630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfNS03LTEtMS03MDM2Mw_5cf11884-efaf-4fc3-9eee-f8d6f8f2dd6b">218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8152f64e6f1140eeb2ee778012282130_I20220630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfNS05LTEtMS03MDM2Mw_9ae975b0-d174-4c70-ab62-e39d8deb6afd">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0a535c1ffe84e6da717792a25f25e09_I20220630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfNS0xMy0xLTEtNzAzNjM_228433e7-7f26-47ec-8717-8cb4cbdcd5a5">467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total losses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87cc99f09b354f98929e5403fc89254a_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfNy0xLTEtMS03MDM2Mw_751073b5-19a4-41f8-8757-7af4912a5c58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a4e9a98582e440e8a5c609a87e70538_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfNy0zLTEtMS03MDM2Mw_18179a95-db23-4316-8fff-60c8b0c24e9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c398eb1a12b438d8cf5d7ed7a27c98d_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfNy03LTEtMS03MDM2Mw_6c8e7ca6-459f-4bba-995a-76eec8bbce79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55f75de2be747fb9680406ea945d82f_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfNy05LTEtMS03MDM2Mw_2bb4c48c-0a02-4860-a6db-701301162d1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfNy0xMy0xLTEtNzAzNjM_a25d2682-0cf0-426c-89e6-09dcbc5b6398">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87cc99f09b354f98929e5403fc89254a_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfOC0xLTEtMS03MDM2Mw_dee61587-a968-42b4-9814-7202aaa732ab">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a4e9a98582e440e8a5c609a87e70538_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfOC0zLTEtMS03MDM2Mw_0f26cf63-ab48-4b40-8239-f609b1b6d002">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c398eb1a12b438d8cf5d7ed7a27c98d_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfOC03LTEtMS03MDM2Mw_4431abe0-109d-4e56-bf89-21b80e5ea9e3">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55f75de2be747fb9680406ea945d82f_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfOC05LTEtMS03MDM2Mw_70ef5b82-3ffd-4108-8c56-58068eff1579">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfOC0xMy0xLTEtNzAzNjM_56840250-cbc1-48f2-ba73-74c1c4ba2e5f">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87cc99f09b354f98929e5403fc89254a_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfOS0xLTEtMS03MDM2Mw_22a138fc-6288-4772-8426-81d62b509949">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a4e9a98582e440e8a5c609a87e70538_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfOS0zLTEtMS03MDM2Mw_2a64cf3b-100b-4c76-bf86-aaa0960d352f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c398eb1a12b438d8cf5d7ed7a27c98d_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfOS03LTEtMS03MDM2Mw_855aebf1-7d5f-4a69-9cf3-2c15a49e1c55">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55f75de2be747fb9680406ea945d82f_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfOS05LTEtMS03MDM2Mw_22c16bf7-dfc5-41ac-aa06-08a409e290c0">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfOS0xMy0xLTEtNzAzNjM_bc4d67c1-78f6-4e3a-ad64-c88533415bd6">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87cc99f09b354f98929e5403fc89254a_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTAtMS0xLTEtNzAzNjM_e53931dd-f7dc-491a-a252-82da47b9b827">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a4e9a98582e440e8a5c609a87e70538_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTAtMy0xLTEtNzAzNjM_da6a6fb9-3be8-4d81-9ef9-e69c95e59181">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c398eb1a12b438d8cf5d7ed7a27c98d_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTAtNy0xLTEtNzAzNjM_38b1350c-96cb-4830-9ebd-a8218d3f96ac">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if55f75de2be747fb9680406ea945d82f_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTAtOS0xLTEtNzAzNjM_042ae16f-9850-4261-95b1-4dea8cddcc43">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTAtMTMtMS0xLTcwMzYz_e7e38fdd-a2dc-48b5-8b6f-4f77ff0dc209">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87cc99f09b354f98929e5403fc89254a_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTEtMS0xLTEtNzAzNjM_1b6359b6-24f5-4951-8d25-ade30fd97bab">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a4e9a98582e440e8a5c609a87e70538_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTEtMy0xLTEtNzAzNjM_dafebbc3-bc6e-4aee-9c13-381fe8963a7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c398eb1a12b438d8cf5d7ed7a27c98d_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTEtNy0xLTEtNzAzNjM_91d375f6-0232-4181-af3b-fb35fddc68bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55f75de2be747fb9680406ea945d82f_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTEtOS0xLTEtNzAzNjM_05a95f01-21ae-4b79-9ffa-c690dbd21d1a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTEtMTMtMS0xLTcwMzYz_ca2e05a4-a459-4a97-8d49-a916a83cb270">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers out of Level III</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87cc99f09b354f98929e5403fc89254a_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTMtMS0xLTEtNzAzNjM_b6bf3aab-9d80-4b4a-9d91-a5453b908b9e">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a4e9a98582e440e8a5c609a87e70538_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTMtMy0xLTEtNzAzNjM_0a514483-c640-4d58-9900-1929ecd8595d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c398eb1a12b438d8cf5d7ed7a27c98d_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTMtNy0xLTEtNzAzNjM_3894ffa4-962c-4a32-a5ef-07e1204f45ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55f75de2be747fb9680406ea945d82f_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTMtOS0xLTEtNzAzNjM_3d04c32e-a086-445b-a9dc-5afa1b60a972">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTMtMTMtMS0xLTcwMzYz_f8ef0c6e-f885-41c9-8ab5-252944a21cc3">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance at September 30, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5a6260b0cc245e3ad18420b5dda8138_I20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTQtMS0xLTEtNzAzNjM_e9ce3cce-4348-422e-aa0d-4b5460d67c0b">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id54f0058c591469baef2d1557dcb55a8_I20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTQtMy0xLTEtNzAzNjM_502fce7e-fd0e-4244-a30b-8ddfcad6f266">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30a0f87e5ab9493cbf1db457f967922d_I20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTQtNy0xLTEtNzAzNjM_65dbbcdb-b631-491f-b36b-0999b59eda41">311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18f0ad9f943549f6888eff0dae5c5a2e_I20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTQtOS0xLTEtNzAzNjM_39964bcd-d939-46d5-aef7-ccbfb1c780ca">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTQtMTMtMS0xLTcwMzYz_0dffb59c-9507-4c66-b287-47e7040e2903">535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-5.4pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrealized losses included in net income related to assets still held at September 30, 2022</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87cc99f09b354f98929e5403fc89254a_D20220701-20220930" decimals="-6" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTUtMS0xLTEtNzAzNjM_47a4f498-e727-47e6-ac3b-63261b198f83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a4e9a98582e440e8a5c609a87e70538_D20220701-20220930" decimals="-6" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTUtMy0xLTEtNzAzNjM_6bfa1764-73ae-44d6-a385-2a6182fc438f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c398eb1a12b438d8cf5d7ed7a27c98d_D20220701-20220930" decimals="-6" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTUtNy0xLTEtNzAzNjM_bca5bb58-e447-4563-b2b8-83cf2ee5c415">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55f75de2be747fb9680406ea945d82f_D20220701-20220930" decimals="-6" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTUtOS0xLTEtNzAzNjM_67d5ae43-8725-4adb-945c-0b6103b7c930">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTUtMTMtMS0xLTcwMzYz_62ec1e34-0849-4826-9f9b-3d25110402ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance at July 1, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02e43daa33841138e86f2e8ac128f8a_I20210630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTgtMS0xLTEtNzAzNjM_4e9e0b6d-51a5-4f84-ac7c-b32af307426f">351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id659cd826a1649d69ea5d4c304dc4002_I20210630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTgtMy0xLTEtNzAzNjM_99b2b79b-f8b2-4fb6-8bf8-48728b6acfb1">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59df98c5cae2479d82b25b79673a28bc_I20210630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTgtNy0xLTEtNzAzNjM_84860620-ae97-4424-97a8-aa40ba6dc20d">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05e4435be64e4eadacb9d5b77a7762b8_I20210630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTgtOS0xLTEtNzAzNjM_c02a421f-5cab-48af-a9ee-d46570468589">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd7bbc6ac8054bf59b507514156a792b_I20210630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTgtMTMtMS0xLTcwMzYz_cd2c78ce-1079-4d76-abda-e85750b138f8">437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total gains:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5801b0241a4a7596c82b85f6595b87_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjAtMS0xLTEtNzAzNjM_b1998775-5dba-472e-be27-90676dd93cf2">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb613993924401da535c4ab70affa54_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjAtMy0xLTEtNzAzNjM_d1810d28-c192-4c96-b3c3-2bde8fdbfd05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b050ebc022448918209b90933f84fd1_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjAtNy0xLTEtNzAzNjM_d5a758bc-59e2-4588-972d-19afc9d0359d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59c52d2dd9a244878f20d09c30559d47_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjAtOS0xLTEtNzAzNjM_ac8226c0-50fe-42b8-99db-740ff70998c8">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjAtMTMtMS0xLTcwMzYz_acd38e00-89b0-47c7-b999-3f46391eba50">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e5801b0241a4a7596c82b85f6595b87_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjEtMS0xLTEtNzAzNjM_ef0b95fd-60eb-4bff-a4c5-03a0a4946944">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb613993924401da535c4ab70affa54_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjEtMy0xLTEtNzAzNjM_0044eaec-0e05-45a0-b163-c6ae7326a4c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b050ebc022448918209b90933f84fd1_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjEtNy0xLTEtNzAzNjM_ef849248-b6a8-44b2-9ecd-af8137627deb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59c52d2dd9a244878f20d09c30559d47_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjEtOS0xLTEtNzAzNjM_d92b1269-cf21-4ce7-adcf-8252b8f99276">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjEtMTMtMS0xLTcwMzYz_69fda2e3-5051-4d0b-8dcc-01f9e6833d6f">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5801b0241a4a7596c82b85f6595b87_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjItMS0xLTEtNzAzNjM_f88a2248-ed32-4380-a6f3-ec36b03c4e6c">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb613993924401da535c4ab70affa54_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjItMy0xLTEtNzAzNjM_3d2c4f7a-addd-4932-a7f5-cc8809b34713">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b050ebc022448918209b90933f84fd1_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjItNy0xLTEtNzAzNjM_c26050fa-24e1-4e52-b6a3-fd61efa85d6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59c52d2dd9a244878f20d09c30559d47_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjItOS0xLTEtNzAzNjM_7c3b93a1-6bb9-49a8-8db9-ec38b4f0fbff">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjItMTMtMS0xLTcwMzYz_03e6e7e9-4c17-4699-9c3d-ed3a894bc7db">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5801b0241a4a7596c82b85f6595b87_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjMtMS0xLTEtNzAzNjM_9f0f9803-67c0-4caf-99a2-60307e8c9a08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb613993924401da535c4ab70affa54_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjMtMy0xLTEtNzAzNjM_5a7d91e1-ab4d-4398-af55-6bbb41b92ead">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b050ebc022448918209b90933f84fd1_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjMtNy0xLTEtNzAzNjM_f0eb1ab2-e320-4cff-8207-fd6d8a5e8f75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59c52d2dd9a244878f20d09c30559d47_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjMtOS0xLTEtNzAzNjM_012fb98f-29e9-4ec4-b40c-db1e1574e1cc">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjMtMTMtMS0xLTcwMzYz_768bd0e7-3887-497f-b10a-29c6c5c7d963">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e5801b0241a4a7596c82b85f6595b87_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjQtMS0xLTEtNzAzNjM_ee5104f2-6a87-4b69-87c1-627b5fc28546">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb613993924401da535c4ab70affa54_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjQtMy0xLTEtNzAzNjM_d4a34427-8bd4-4e02-8f36-1e6f86c42db7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b050ebc022448918209b90933f84fd1_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjQtNy0xLTEtNzAzNjM_b69fdb0a-0a06-4f4a-887d-2c469ada0145">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59c52d2dd9a244878f20d09c30559d47_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjQtOS0xLTEtNzAzNjM_a79321c9-ee34-4f2e-8a20-19ee69249ca8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjQtMTMtMS0xLTcwMzYz_9ac53965-3662-434f-a517-af9dd9ae3390">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers out of Level III</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e5801b0241a4a7596c82b85f6595b87_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjYtMS0xLTEtNzAzNjM_37150e05-f685-40e5-9545-308ef585f2f9">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4eb613993924401da535c4ab70affa54_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjYtMy0xLTEtNzAzNjM_4f181901-a309-4c74-8de6-c2e01616ba71">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b050ebc022448918209b90933f84fd1_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjYtNy0xLTEtNzAzNjM_111830aa-0e03-42d9-86f5-f65300e400e4">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59c52d2dd9a244878f20d09c30559d47_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjYtOS0xLTEtNzAzNjM_dfde69f6-edc5-411d-8a04-ac566815b93b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjYtMTMtMS0xLTcwMzYz_41befb67-01b6-4f90-8142-97c767306f09">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance at September 30, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c3c0ca17622496e8271489dbd81a554_I20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjctMS0xLTEtNzAzNjM_a909d93e-eb3a-4502-87c0-c7bbbd4cce3a">334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd53ebecdb7c4377a7e274fef86d5b98_I20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjctMy0xLTEtNzAzNjM_beca998d-c89a-400c-96d7-c47e24a69f04">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a6e283ad82499983038a1294335516_I20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjctNy0xLTEtNzAzNjM_1f82a721-c3d9-4662-9db4-ce2a8da9b3e9">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id012155f0536487e80c5f21ecb0cff93_I20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjctOS0xLTEtNzAzNjM_d0d2af18-9ae5-42b6-bd40-f53bf3a44e29">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7580839926f4e24b08f10312dd69479_I20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjctMTMtMS0xLTcwMzYz_a0b2c713-b181-4a2d-ad54-1c43addc2a52">421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-5.4pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrealized gains included in net income related to assets still held at September 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5801b0241a4a7596c82b85f6595b87_D20210701-20210930" decimals="-6" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjgtMS0xLTEtNzAzNjM_349c8410-6c40-443f-8efd-332a70941098">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb613993924401da535c4ab70affa54_D20210701-20210930" decimals="-6" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjgtMy0xLTEtNzAzNjM_a370660e-a3c8-4e37-9ac4-562ebfc116d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b050ebc022448918209b90933f84fd1_D20210701-20210930" decimals="-6" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjgtNy0xLTEtNzAzNjM_cad52866-59f1-4844-be02-8a2395697228">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59c52d2dd9a244878f20d09c30559d47_D20210701-20210930" decimals="-6" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjgtOS0xLTEtNzAzNjM_f7e5c80f-7d8e-4fa1-ba6b-b50b464bb60c">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjgtMTMtMS0xLTcwMzYz_d015323a-ac49-4e6c-b505-a3949435c406">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-20-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ide2a50ef1f9246f3932e61b1e8314d0b" continuedAt="i83382ed0200b473bb20dc3b501bd5774"><ix:continuation id="i15ea8b2923a3458dab805d911b1ab065"><div style="margin-top:5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balances of assets measured at fair value on a recurring basis using Level III inputs for the nine months ended September 30, 2022 and 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.872%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Residential<br/>Mortgage-<br/>backed<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance at January 1, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe0fa1cefe04a9ab9bd771236eb24fd_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMy0xLTEtMS03MDM2Mw_eac75d08-15c8-4421-885b-8085325604bc">336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1998952a2fec4ef987e45747bc6a365e_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMy0zLTEtMS03MDM2Mw_859ba166-7577-43f9-9980-130f1ee054bd">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b17717cfed84a8695f0ebee25d6d1b0_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMy03LTEtMS03MDM2Mw_78c171d0-fd3a-46b8-8246-3107e978f27f">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i956f35bd2d5e479b8fc6a91a40089b3d_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMy05LTEtMS03MDM2Mw_d12dfd27-9580-4242-83c5-4be2aeb9a3e7">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMy0xMy0xLTEtNzAzNjM_ba900181-9976-46da-959d-ff072653c634">449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total losses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f0ecc541cf74ed2a635167eb7164491_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNS0xLTEtMS03MDM2Mw_726bc08d-22dc-4c5c-ac2d-5a6391afd8ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafd89c3d325847c59f8b3bc903c4c035_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNS0zLTEtMS03MDM2Mw_f69c37c9-33c7-4715-b9d6-81d2644032fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964bac3f30f64868a6e633166235cda5_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNS03LTEtMS03MDM2Mw_1fa60ab1-9ab6-4d8f-b2e0-cc65612dc2ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37e5af918e28462f98ca407c5455389f_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNS05LTEtMS03MDM2Mw_2a1f0763-8b5d-4948-94bc-194c3d1e9330">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNS0xMy0xLTEtNzAzNjM_2fc9a7a0-56d4-407d-b65e-4e28120f6315">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f0ecc541cf74ed2a635167eb7164491_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNi0xLTEtMS03MDM2Mw_929f32f7-7920-4b20-b21c-e941c7c0bf21">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafd89c3d325847c59f8b3bc903c4c035_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNi0zLTEtMS03MDM2Mw_8b4c64e7-d9ad-4a42-9cb0-2f0686521787">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964bac3f30f64868a6e633166235cda5_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNi03LTEtMS03MDM2Mw_29a81e42-c17e-4bc2-86c0-7ab6e95f9a17">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37e5af918e28462f98ca407c5455389f_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNi05LTEtMS03MDM2Mw_8504244f-ce7f-4870-87d6-b63383cac575">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNi0xMy0xLTEtNzAzNjM_2b65eb7e-9789-4e09-a4e7-6ff7ad0c179c">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f0ecc541cf74ed2a635167eb7164491_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNy0xLTEtMS03MDM2Mw_80885c27-8837-495e-af71-de91c8a6c27b">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafd89c3d325847c59f8b3bc903c4c035_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNy0zLTEtMS03MDM2Mw_c1a8ba3a-5241-4f04-984b-32293bd88e67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964bac3f30f64868a6e633166235cda5_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNy03LTEtMS03MDM2Mw_c7d9d3c6-7f2c-4ee2-b781-9c92fd7fce55">281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37e5af918e28462f98ca407c5455389f_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNy05LTEtMS03MDM2Mw_8e2853db-f8ae-4129-ad9c-46b663a52b4f">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNy0xMy0xLTEtNzAzNjM_6674ac73-bc74-485c-b92a-c0246fc622f9">345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f0ecc541cf74ed2a635167eb7164491_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfOC0xLTEtMS03MDM2Mw_31700694-301f-41a1-b506-07190bb857a0">201</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafd89c3d325847c59f8b3bc903c4c035_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfOC0zLTEtMS03MDM2Mw_bda0c03d-a3ee-4538-9b72-13f9688add86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i964bac3f30f64868a6e633166235cda5_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfOC03LTEtMS03MDM2Mw_953911ca-3c27-4528-86be-ff0ae1823190">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37e5af918e28462f98ca407c5455389f_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfOC05LTEtMS03MDM2Mw_f8fad6f6-3ea4-45b4-acd6-7e3fe07286c9">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfOC0xMy0xLTEtNzAzNjM_18af83e8-49d6-4762-8954-bbac7eefec7d">221</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f0ecc541cf74ed2a635167eb7164491_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfOS0xLTEtMS03MDM2Mw_64f1328e-0501-4c66-844b-7fa2cd2bcc64">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafd89c3d325847c59f8b3bc903c4c035_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfOS0zLTEtMS03MDM2Mw_5c6f9a4b-ec77-4596-bb87-1db4f0d7004d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964bac3f30f64868a6e633166235cda5_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfOS03LTEtMS03MDM2Mw_a6ebf810-4849-4150-8c65-d58825c86faa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37e5af918e28462f98ca407c5455389f_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfOS05LTEtMS03MDM2Mw_38b58f0a-162f-46e0-bc22-24725c3ac5b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfOS0xMy0xLTEtNzAzNjM_41035f99-85d7-4a9c-b77c-09e865cef513">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers into Level III</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f0ecc541cf74ed2a635167eb7164491_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTAtMS0xLTEtNzAzNjM_988543e2-3308-4587-86e9-7910d68dc5eb">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafd89c3d325847c59f8b3bc903c4c035_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTAtMy0xLTEtNzAzNjM_888a7c2d-8516-4a78-91c8-0a44c88f741a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964bac3f30f64868a6e633166235cda5_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTAtNy0xLTEtNzAzNjM_17833122-40cc-45c9-9dbe-b3599a48437a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37e5af918e28462f98ca407c5455389f_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTAtOS0xLTEtNzAzNjM_e0917061-ee49-4cc1-8d17-72883e5dea19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTAtMTMtMS0xLTcwMzYz_bd336d56-dec1-48b0-9c52-0d998687b9b4">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers out of Level III</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f0ecc541cf74ed2a635167eb7164491_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTEtMS0xLTEtNzAzNjM_184f97b9-ff82-4214-bdff-88b0254d36af">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafd89c3d325847c59f8b3bc903c4c035_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTEtMy0xLTEtNzAzNjM_9617dbd4-8ed4-412a-a3f8-de873fe90497">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i964bac3f30f64868a6e633166235cda5_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTEtNy0xLTEtNzAzNjM_d3457771-82a4-4d84-9273-cd5e36ac548e">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37e5af918e28462f98ca407c5455389f_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTEtOS0xLTEtNzAzNjM_2b6be980-3f84-4481-a8d8-65e94b7ceae5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTEtMTMtMS0xLTcwMzYz_b34324dd-ec1d-4940-8466-6713b50f69aa">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance at September 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5a6260b0cc245e3ad18420b5dda8138_I20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTItMS0xLTEtNzAzNjM_8420cc06-29ff-4ee7-9048-16ff2f7b0966">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id54f0058c591469baef2d1557dcb55a8_I20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTItMy0xLTEtNzAzNjM_b857c06d-4d78-40c5-9b97-52330df5fbfb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30a0f87e5ab9493cbf1db457f967922d_I20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTItNy0xLTEtNzAzNjM_cc3e3e59-2a26-4b38-9392-f4f94867d8bd">311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18f0ad9f943549f6888eff0dae5c5a2e_I20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTItOS0xLTEtNzAzNjM_fa948c5a-b416-496b-91aa-fa7d443554bc">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTItMTMtMS0xLTcwMzYz_6339e84d-4712-44bb-9e3b-a5259971783e">535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrealized gains included in net income related to assets still held at September 30, 2022</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f0ecc541cf74ed2a635167eb7164491_D20220101-20220930" decimals="-6" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTMtMS0xLTEtNzAzNjM_4a907513-4d2b-4956-acd6-2a8830ec5c0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafd89c3d325847c59f8b3bc903c4c035_D20220101-20220930" decimals="-6" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTMtMy0xLTEtNzAzNjM_15e32249-a88e-496f-b62a-b4ed880a5404">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964bac3f30f64868a6e633166235cda5_D20220101-20220930" decimals="-6" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTMtNy0xLTEtNzAzNjM_a40b3421-b81d-43ca-8906-5de7ff398255">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37e5af918e28462f98ca407c5455389f_D20220101-20220930" decimals="-6" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTMtOS0xLTEtNzAzNjM_f1b6a323-bd9d-4af0-8ff4-ed1aad3ceb4f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTMtMTMtMS0xLTcwMzYz_ce802bb7-5d1f-490b-a97d-a7d331d01971">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance at January 1, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i553640a02dc34c459280bd0390c2547a_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTYtMS0xLTEtNzAzNjM_5eadac17-ec0c-455d-a5e9-95dc2cfe2311">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i221dfdac7a494b34b788cabffbef260c_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTYtMy0xLTEtNzAzNjM_33168d87-c524-4811-a3ac-775191dce143">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65f9f1ca30204478a443b52bedc3c6a1_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTYtNy0xLTEtNzAzNjM_e666fff9-89d5-4951-8211-7701223d5cf9">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i991cee8de28a4252a7c5e88856804403_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTYtOS0xLTEtNzAzNjM_84356ca4-3895-4cba-ace2-79bd87235202">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aceaf2b19bf4d5d916eb0f2039e41de_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTYtMTMtMS0xLTcwMzYz_a73e4c81-0b8b-4e21-a3c2-456d29bf4b77">392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total gains:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43ab9adfffbb4e97a0584ba6cb437018_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTgtMS0xLTEtNzAzNjM_683cdac6-5875-4a95-979c-dc64ed06d7f0">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a83a959df4a4ea893a96ae9001a4dac_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTgtMy0xLTEtNzAzNjM_bad25342-8400-47ad-8dc4-9ccdb64bc234">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c5c7d954c4c45a3b0db4aa4accc3482_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTgtNy0xLTEtNzAzNjM_f564110a-d21b-48cb-8e4d-1be984ec9826">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfaad08561af4facb21116cd28f9c4d5_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTgtOS0xLTEtNzAzNjM_b9f30bff-773e-4405-8d30-98fcb4e76479">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTgtMTMtMS0xLTcwMzYz_7759aa2f-315c-48ed-beb3-174c7e165570">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43ab9adfffbb4e97a0584ba6cb437018_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTktMS0xLTEtNzAzNjM_c95c56ef-71c6-4020-b6c5-2d9b0f527cda">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a83a959df4a4ea893a96ae9001a4dac_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTktMy0xLTEtNzAzNjM_73147fe4-1e8e-4f80-8a41-7f10e7e1a92c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c5c7d954c4c45a3b0db4aa4accc3482_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTktNy0xLTEtNzAzNjM_3cd7229b-c615-477f-bf45-06be5a949704">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfaad08561af4facb21116cd28f9c4d5_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTktOS0xLTEtNzAzNjM_e749a566-4564-441a-bab1-08b4e5f876db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTktMTMtMS0xLTcwMzYz_76a34470-4193-4898-85f0-4cf5bd0d35f8">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43ab9adfffbb4e97a0584ba6cb437018_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjAtMS0xLTEtNzAzNjM_ab93d82b-9541-445a-bfce-9c6f56592c90">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a83a959df4a4ea893a96ae9001a4dac_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjAtMy0xLTEtNzAzNjM_ca8ca65b-2c7a-4faa-a1cf-d5d19e04af58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c5c7d954c4c45a3b0db4aa4accc3482_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjAtNy0xLTEtNzAzNjM_fe2e9fd0-9d64-4b8a-926d-5db5bba019d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfaad08561af4facb21116cd28f9c4d5_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjAtOS0xLTEtNzAzNjM_3d1cbbe2-0f30-45d0-8f61-693ecb1507e0">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjAtMTMtMS0xLTcwMzYz_6ff87408-18ac-408c-9b98-083f2269f85e">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43ab9adfffbb4e97a0584ba6cb437018_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjEtMS0xLTEtNzAzNjM_baa58536-aaef-4a72-9400-1881aec561df">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a83a959df4a4ea893a96ae9001a4dac_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjEtMy0xLTEtNzAzNjM_868a5670-225a-4539-9f70-b65ada7bb463">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c5c7d954c4c45a3b0db4aa4accc3482_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjEtNy0xLTEtNzAzNjM_3521269d-66b0-44a4-abab-01c16d2bc8d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idfaad08561af4facb21116cd28f9c4d5_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjEtOS0xLTEtNzAzNjM_3424b830-d77a-4701-aa39-9855f391b388">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjEtMTMtMS0xLTcwMzYz_02647908-f052-4581-8e71-65e05c9e1bf1">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43ab9adfffbb4e97a0584ba6cb437018_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjItMS0xLTEtNzAzNjM_77337826-8127-4f06-bcb7-6c404b788819">118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a83a959df4a4ea893a96ae9001a4dac_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjItMy0xLTEtNzAzNjM_1e7859bf-d6d9-4390-981e-1367d8341e19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c5c7d954c4c45a3b0db4aa4accc3482_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjItNy0xLTEtNzAzNjM_7f4ce19f-5f0b-4827-b122-a01e5b0d03ec">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfaad08561af4facb21116cd28f9c4d5_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjItOS0xLTEtNzAzNjM_811d9cd8-1285-4600-91ac-9b61545a18ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjItMTMtMS0xLTcwMzYz_d7e37dbc-8fbe-4971-88ea-48346ce6ad48">119</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers out of Level III</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43ab9adfffbb4e97a0584ba6cb437018_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjQtMS0xLTEtNzAzNjM_c14363d4-7ede-4ebe-ba17-304cfc0b5232">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a83a959df4a4ea893a96ae9001a4dac_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjQtMy0xLTEtNzAzNjM_6fa330c0-2738-4921-b498-79a0e40219d2">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c5c7d954c4c45a3b0db4aa4accc3482_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjQtNy0xLTEtNzAzNjM_2087294e-16ab-4a70-b081-1862482ce2f6">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfaad08561af4facb21116cd28f9c4d5_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjQtOS0xLTEtNzAzNjM_65377797-6fea-4823-b7f6-eeea2ac94a57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjQtMTMtMS0xLTcwMzYz_410f82f5-7534-4248-bcb9-71fa2ad7fe5b">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance at September 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c3c0ca17622496e8271489dbd81a554_I20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjUtMS0xLTEtNzAzNjM_c843bd8e-0c8e-4402-91e8-93663be493dc">334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd53ebecdb7c4377a7e274fef86d5b98_I20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjUtMy0xLTEtNzAzNjM_39141372-970a-4555-ba02-831693700c69">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a6e283ad82499983038a1294335516_I20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjUtNy0xLTEtNzAzNjM_2ae13b52-27e2-4412-b589-3d71906aae36">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id012155f0536487e80c5f21ecb0cff93_I20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjUtOS0xLTEtNzAzNjM_9eb408aa-5e2d-4771-9e47-5b5c9589ff08">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7580839926f4e24b08f10312dd69479_I20210930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjUtMTMtMS0xLTcwMzYz_29e50067-5184-4884-ac02-125f504f28cf">421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrealized gains included in net income related to assets still held at September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43ab9adfffbb4e97a0584ba6cb437018_D20210101-20210930" decimals="-6" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjYtMS0xLTEtNzAzNjM_2e331202-6d5b-4475-a360-f25aa102dca1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a83a959df4a4ea893a96ae9001a4dac_D20210101-20210930" decimals="-6" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjYtMy0xLTEtNzAzNjM_4c08fd03-2fdb-4795-b21c-55fce8664ffd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c5c7d954c4c45a3b0db4aa4accc3482_D20210101-20210930" decimals="-6" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjYtNy0xLTEtNzAzNjM_0e6dc493-4ac2-403a-854d-3f719ec0995a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfaad08561af4facb21116cd28f9c4d5_D20210101-20210930" decimals="-6" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjYtOS0xLTEtNzAzNjM_414e565c-5c21-4163-86eb-8bae931e3846">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjYtMTMtMS0xLTcwMzYz_5f1fb610-600c-44ab-8495-9f1e1c45735e">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no individually material transfers into or out of Level III during the three and nine months ended September&#160;30, 2022 or 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain assets and liabilities are measured at fair value on a nonrecurring basis; that is, the instruments are not measured at fair value on an ongoing basis but are subject to fair value adjustments only in certain circumstances. As disclosed in Note&#160;3, &#8220;Business Acquisitions,&#8221; we completed our acquisition of Integra in the second quarter of 2022 and the acquisitions&#160;of&#160;myNEXUS and MMM during the second quarter of 2021. The net assets acquired in our acquisitions of Integra, myNEXUS and MMM and resulting goodwill and other intangible assets were recorded at fair value&#160;primarily&#160;using Level III inputs. The majority of&#160;assets acquired and liabilities assumed were recorded at their carrying values as of the respective date of acquisition, as their carrying values approximated their fair values due to their short-term nature. The fair values of goodwill and other intangible assets acquired in our acquisitions of Integra, myNEXUS and MMM were internally estimated based on the income approach. The income approach estimates fair value based on the present value of the cash flows that the assets could be expected to generate in the future. We developed internal estimates for the expected cash flows and discount rate in the present value calculation.&#160;Other than the assets acquired and liabilities assumed in our acquisitions of Integra, myNEXUS and MMM described above, there were no material assets or liabilities measured at fair value on a nonrecurring basis during the three and nine months ended September&#160;30, 2022 or 2021.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-21-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i83382ed0200b473bb20dc3b501bd5774" continuedAt="i861d70e61ebf43c7ae4e6a1020c735d5"><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our valuation policy is determined by members of our treasury and accounting departments. Whenever possible, our policy is to obtain quoted market prices in active markets to estimate fair values for recognition and disclosure purposes. Where quoted market prices in active markets are not available, fair values are estimated using discounted cash flow analyses, broker quotes, unobservable inputs or other valuation techniques. These techniques are significantly affected by our assumptions, including discount rates and estimates of future cash flows. The use of assumptions for unobservable inputs for the determination of fair value involves a level of judgment and uncertainty. Changes in assumptions that reasonably could have been different at the reporting date may result in a higher or lower determination of fair value. Changes in fair value measurements, if significant, may affect performance of cash flows.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Potential taxes and other transaction costs are not considered in estimating fair values. Our valuation policy is generally to obtain quoted prices for each security from third-party pricing services, which are derived through recently reported trades for identical or similar securities making adjustments through the reporting date based upon available market observable information. As we are responsible for the determination of fair value, we perform analysis on the prices received from the pricing services to determine whether the prices are reasonable estimates of fair value. This analysis is performed by our internal treasury personnel who are familiar with our investment portfolios, the pricing services engaged and the valuation techniques and inputs used. Our analysis includes procedures such as a review of month-to-month price fluctuations and price comparisons to secondary pricing services. There were no adjustments to quoted market prices obtained from the pricing services during the three and nine months ended September&#160;30, 2022 or 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the preceding disclosures on assets recorded at fair value in the consolidated balance sheets, FASB guidance also requires the disclosure of fair values for certain other financial instruments for which it is practicable to estimate fair value, whether or not such values are recognized in our consolidated balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-financial instruments such as real estate, property and equipment, other current assets, deferred income taxes, intangible assets and certain financial instruments, such as policy liabilities, are excluded from the fair value disclosures. Therefore, the fair value amounts cannot be aggregated to determine our underlying economic value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts reported in the consolidated balance sheets for cash, premium receivables, self-funded receivables, other receivables, unearned income, accounts payable and accrued expenses, and certain other current liabilities approximate fair value because of the short-term nature of these items. These assets and liabilities are not listed in the table below.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following methods and assumptions were used to estimate the fair value of each class of financial instrument that is recorded at its carrying value in our consolidated balance sheets:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other invested assets:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other invested assets include primarily our investments in limited partnerships, joint ventures and other non-controlled corporations and mortgage loans, as well as the cash surrender value of corporate-owned life insurance policies. Investments in limited partnerships, joint ventures and other non-controlled corporations are carried at our share in the entities&#8217; undistributed earnings, which approximates fair value. Mortgage loans are carried at amortized cost, which approximates fair value. The carrying value of corporate-owned life insurance policies represents the cash surrender value as reported by the respective insurer, which approximates fair value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short-term borrowings:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The fair value of our short-term borrowings is based on quoted market prices for the same or similar debt, or, if no quoted market prices were available, on the current market interest rates estimated to be available to us for debt of similar terms and remaining maturities. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term debt&#8212;commercial paper:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The carrying amount for commercial paper approximates fair value, as the underlying instruments have variable interest rates at market value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term debt&#8212;senior unsecured notes and surplus notes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The fair values of our notes are based on quoted market prices in active markets for the same or similar debt, or, if no quoted market prices are available, on the current market observable rates estimated to be available to us for debt of similar terms and remaining maturities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term debt&#8212;convertible debentures:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The fair value of our convertible debentures is based on the quoted market price in the active private market in which the convertible debentures trade.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-22-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i861d70e61ebf43c7ae4e6a1020c735d5"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="elv:CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RleHRyZWdpb246ZTIyYTVkZjliODYyNDAwOWJhY2RlNjY5ZmIxMGEzYTNfMTE1OTI_78e2ef85-ae35-48d2-9b25-199d357c8682" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the estimated fair values by level of each class of financial instrument that is recorded at its carrying value on our consolidated balance sheets at September&#160;30, 2022 and December&#160;31, 2021 is as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.872%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;I</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other invested assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id13f4c069f824d9e8ada49274ed13fc6_I20220930" decimals="-6" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfNC0xLTEtMS03MDM2Mw_01751f70-4ea6-43fe-8128-93853ef7c6e1">5,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9ee845b2ef44f35b34e439f2a98463e_I20220930" decimals="-6" name="us-gaap:OtherLongTermInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfNC0zLTEtMS03MDM2Mw_d3438c53-aa4c-434e-9111-f47d100f2cc4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib31555a5dc6d48e9a6d0c3e812552916_I20220930" decimals="-6" name="us-gaap:OtherLongTermInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfNC01LTEtMS03MDM2Mw_8b760c26-edb0-467a-a0ce-cad90831bbf7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db3e3b640944bd98e5bc0d5641a14f_I20220930" decimals="-6" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfNC03LTEtMS03MDM2Mw_ddd9fc01-d7eb-49ec-b81e-369eccf1e078">5,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id23aa1cee27e4b5ba329c79f052b0f8d_I20220930" decimals="-6" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfNC05LTEtMS03MDM2Mw_f7b0832e-2f29-4c79-a07e-73fc53c73a7b">5,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id13f4c069f824d9e8ada49274ed13fc6_I20220930" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfNy0xLTEtMS03MDM2Mw_f1a79f15-d672-440a-8031-fb400c2bf3a0">265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63d36abe1cfe4cdeab60b3c14cb6960b_I20220930" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfNy0zLTEtMS03MDM2Mw_31edfcd8-b81f-4587-a076-73f41dd60dd4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf4ef63bd2e548af937bde8217b31fd0_I20220930" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfNy01LTEtMS03MDM2Mw_9113b55d-e2fe-4d30-8720-ccb6ef284302">265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabe0feb61e774f4db61e3b30a3a23479_I20220930" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfNy03LTEtMS03MDM2Mw_fdb8b065-b5b2-4e61-97f0-bb7439b88633">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfNy05LTEtMS03MDM2Mw_b0fed781-6995-4e92-99a0-c8175e5b23bc">265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id13f4c069f824d9e8ada49274ed13fc6_I20220930" decimals="-6" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfOS0xLTEtMS03MDM2Mw_5eae4cad-9b9c-4ede-8347-6ba23719298a">675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63d36abe1cfe4cdeab60b3c14cb6960b_I20220930" decimals="-6" name="us-gaap:CommercialPaper" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfOS0zLTEtMS03MDM2Mw_d032d70a-4eee-4c3d-856e-46b0569e03ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf4ef63bd2e548af937bde8217b31fd0_I20220930" decimals="-6" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfOS01LTEtMS03MDM2Mw_55508bd7-d142-4f1e-a3eb-867e77aacabc">675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabe0feb61e774f4db61e3b30a3a23479_I20220930" decimals="-6" name="us-gaap:CommercialPaper" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfOS03LTEtMS03MDM2Mw_1ee94a35-164d-4146-ad0d-7f3814f339a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfOS05LTEtMS03MDM2Mw_7e6675eb-3c46-473b-b512-b6d6fcd03a0b">675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id13f4c069f824d9e8ada49274ed13fc6_I20220930" decimals="-6" name="us-gaap:NotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTAtMS0xLTEtNzAzNjM_31386dfd-a108-4399-ab00-7faa43726743">22,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63d36abe1cfe4cdeab60b3c14cb6960b_I20220930" decimals="-6" name="us-gaap:NotesPayable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTAtMy0xLTEtNzAzNjM_55dac73c-83b2-419a-ad9e-976e4af63e7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf4ef63bd2e548af937bde8217b31fd0_I20220930" decimals="-6" name="us-gaap:NotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTAtNS0xLTEtNzAzNjM_50974f44-b561-42a5-95a1-0a4ffcfe4c59">20,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabe0feb61e774f4db61e3b30a3a23479_I20220930" decimals="-6" name="us-gaap:NotesPayable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTAtNy0xLTEtNzAzNjM_1cdab1b7-89ee-435c-942c-59c6b6a6d828">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:NotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTAtOS0xLTEtNzAzNjM_1f957cac-6370-4be6-b1e1-86282d4120b1">20,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debentures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id13f4c069f824d9e8ada49274ed13fc6_I20220930" decimals="-6" name="us-gaap:ConvertibleDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTEtMS0xLTEtNzAzNjM_5ac13f50-b990-4888-a681-45aed7ae1a54">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63d36abe1cfe4cdeab60b3c14cb6960b_I20220930" decimals="-6" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTEtMy0xLTEtNzAzNjM_18bdfafa-652e-4522-9782-a25a9e405507">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf4ef63bd2e548af937bde8217b31fd0_I20220930" decimals="-6" name="us-gaap:ConvertibleDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTEtNS0xLTEtNzAzNjM_b65dde94-bbff-4aa6-a744-4408bad3ab96">554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabe0feb61e774f4db61e3b30a3a23479_I20220930" decimals="-6" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTEtNy0xLTEtNzAzNjM_cf44e703-e8af-43cc-8e18-1d1ffa3faca3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:ConvertibleDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTEtOS0xLTEtNzAzNjM_ce314576-2363-48f3-80fc-db1bf56d5d23">554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other invested assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207053455c4d4c45b53e5fa230ebb0ae_I20211231" decimals="-6" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTUtMS0xLTEtNzAzNjM_de4d2764-2fea-4b10-847e-f183eb58667b">5,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7e8295eb174731af155b02715f0698_I20211231" decimals="-6" name="us-gaap:OtherLongTermInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTUtMy0xLTEtNzAzNjM_d587944a-d915-4139-8fc8-e3753a72c051">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeb1d12977ce4b2aa244d83f0a51489a_I20211231" decimals="-6" name="us-gaap:OtherLongTermInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTUtNS0xLTEtNzAzNjM_c7d341fb-41ea-4675-9775-a73a73098732">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia381401dee2b49a69141fac81ccda064_I20211231" decimals="-6" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTUtNy0xLTEtNzAzNjM_eb2be4b0-a1bf-4abd-b1ab-2a8ebf7cd985">5,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1c0c8330af1412c8daa5f4cc313c34b_I20211231" decimals="-6" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTUtOS0xLTEtNzAzNjM_7f99b006-994d-4a89-928f-634206163288">5,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207053455c4d4c45b53e5fa230ebb0ae_I20211231" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTgtMS0xLTEtNzAzNjM_efc347a0-6443-47da-a8cf-58ef8f51db4f">275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie12564db4311425aa96c7f9f9b74dc88_I20211231" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTgtMy0xLTEtNzAzNjM_e9f764cc-717c-46f2-a81f-d84a5c43a503">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id36628eb07534a42afaaae7affc76a88_I20211231" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTgtNS0xLTEtNzAzNjM_3459864a-41ae-491d-913f-ebcd9ba8f10b">275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c6abfca5ec440eb693997af5ab6d46_I20211231" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTgtNy0xLTEtNzAzNjM_9a383c71-0167-441f-abf2-9654873eebd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTgtOS0xLTEtNzAzNjM_59ec2371-afae-4da5-8ded-86b31fe8572e">275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207053455c4d4c45b53e5fa230ebb0ae_I20211231" decimals="-6" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTktMS0xLTEtNzAzNjM_0cf7a4a3-0b36-43f5-bedf-5cea45773f77">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie12564db4311425aa96c7f9f9b74dc88_I20211231" decimals="-6" name="us-gaap:CommercialPaper" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTktMy0xLTEtNzAzNjM_9aab3739-461e-4289-9348-47973b719c73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id36628eb07534a42afaaae7affc76a88_I20211231" decimals="-6" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTktNS0xLTEtNzAzNjM_8830aac7-86ae-40b8-9e54-670b71a01b00">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c6abfca5ec440eb693997af5ab6d46_I20211231" decimals="-6" name="us-gaap:CommercialPaper" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTktNy0xLTEtNzAzNjM_3379a02e-ce94-45d2-ab5e-0abe220fbb1a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTktOS0xLTEtNzAzNjM_69dbb90d-7b0d-44cf-8c10-ff7d14370e88">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207053455c4d4c45b53e5fa230ebb0ae_I20211231" decimals="-6" name="us-gaap:NotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMjAtMS0xLTEtNzAzNjM_d8271ff5-df32-4caa-b8f2-da1c5b1d6dc8">22,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie12564db4311425aa96c7f9f9b74dc88_I20211231" decimals="-6" name="us-gaap:NotesPayable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMjAtMy0xLTEtNzAzNjM_77308575-0cae-41c3-a1c9-549a8c3e87fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id36628eb07534a42afaaae7affc76a88_I20211231" decimals="-6" name="us-gaap:NotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMjAtNS0xLTEtNzAzNjM_d9da5258-ad42-43ef-937c-be382a10f96e">25,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c6abfca5ec440eb693997af5ab6d46_I20211231" decimals="-6" name="us-gaap:NotesPayable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMjAtNy0xLTEtNzAzNjM_9aff5827-408e-49a8-a83a-9d56fa6ef6b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:NotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMjAtOS0xLTEtNzAzNjM_0dd77bfc-fb94-4c1b-b8c0-5cddff5f1c22">25,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debentures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207053455c4d4c45b53e5fa230ebb0ae_I20211231" decimals="-6" name="us-gaap:ConvertibleDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMjEtMS0xLTEtNzAzNjM_78e0b2e8-98c7-4096-81a3-be4517cebb38">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie12564db4311425aa96c7f9f9b74dc88_I20211231" decimals="-6" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMjEtMy0xLTEtNzAzNjM_3c4a26b9-79e7-41c9-add4-ba0794dd1f4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id36628eb07534a42afaaae7affc76a88_I20211231" decimals="-6" name="us-gaap:ConvertibleDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMjEtNS0xLTEtNzAzNjM_efa9aa26-beb6-4a6b-9646-a92f9d230d3f">687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c6abfca5ec440eb693997af5ab6d46_I20211231" decimals="-6" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMjEtNy0xLTEtNzAzNjM_31d0f6b5-84dd-43e4-941d-aeda1c7d6ce6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:ConvertibleDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMjEtOS0xLTEtNzAzNjM_1ddfddb5-d188-4ac1-8b73-f3485e1005f8">687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i186e051878fe4219970efc72a9fcdad4_61"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82MS9mcmFnOjljZjk2YmNmZjFkZTQ3Zjk5OWU2ZGZlMGYyYjc2NTAwL3RleHRyZWdpb246OWNmOTZiY2ZmMWRlNDdmOTk5ZTZkZmUwZjJiNzY1MDBfODMx_c7e35546-eb2d-4f5a-94be-b28419af9708" continuedAt="i01be070cc07a4a0490de1417e00a9a38" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="i01be070cc07a4a0490de1417e00a9a38"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended September 30, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021, we recognized income tax expense of $<ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82MS9mcmFnOjljZjk2YmNmZjFkZTQ3Zjk5OWU2ZGZlMGYyYjc2NTAwL3RleHRyZWdpb246OWNmOTZiY2ZmMWRlNDdmOTk5ZTZkZmUwZjJiNzY1MDBfODA_9209cfd3-cdef-47f6-9568-c6c0192b84ea">533</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82MS9mcmFnOjljZjk2YmNmZjFkZTQ3Zjk5OWU2ZGZlMGYyYjc2NTAwL3RleHRyZWdpb246OWNmOTZiY2ZmMWRlNDdmOTk5ZTZkZmUwZjJiNzY1MDBfODc_cc73fd27-e2f7-4390-a4ca-b2b9f8fc66d5">494</ix:nonFraction>, respectively, which represent effective income tax rates of <ix:nonFraction unitRef="number" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82MS9mcmFnOjljZjk2YmNmZjFkZTQ3Zjk5OWU2ZGZlMGYyYjc2NTAwL3RleHRyZWdpb246OWNmOTZiY2ZmMWRlNDdmOTk5ZTZkZmUwZjJiNzY1MDBfMTUx_c8e42b56-a3a7-43f1-98b9-ed65b332e6c0">24.8</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82MS9mcmFnOjljZjk2YmNmZjFkZTQ3Zjk5OWU2ZGZlMGYyYjc2NTAwL3RleHRyZWdpb246OWNmOTZiY2ZmMWRlNDdmOTk5ZTZkZmUwZjJiNzY1MDBfMTU4_a38bf58e-d798-45ce-83f7-8fccdf4387d8">24.7</ix:nonFraction>%, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021, we recognized income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82MS9mcmFnOjljZjk2YmNmZjFkZTQ3Zjk5OWU2ZGZlMGYyYjc2NTAwL3RleHRyZWdpb246OWNmOTZiY2ZmMWRlNDdmOTk5ZTZkZmUwZjJiNzY1MDBfMzg0_f2d9e4a8-0fe5-41d0-936c-c75e4db5efd5">1,557</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82MS9mcmFnOjljZjk2YmNmZjFkZTQ3Zjk5OWU2ZGZlMGYyYjc2NTAwL3RleHRyZWdpb246OWNmOTZiY2ZmMWRlNDdmOTk5ZTZkZmUwZjJiNzY1MDBfMzkx_21abaddb-3db3-40f7-8cfe-1ae1c08998ff">1,555</ix:nonFraction>, respectively, which represent effective income tax rates of <ix:nonFraction unitRef="number" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82MS9mcmFnOjljZjk2YmNmZjFkZTQ3Zjk5OWU2ZGZlMGYyYjc2NTAwL3RleHRyZWdpb246OWNmOTZiY2ZmMWRlNDdmOTk5ZTZkZmUwZjJiNzY1MDBfNDU1_68117518-0086-4255-8bcf-1ea373df2770">23.5</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82MS9mcmFnOjljZjk2YmNmZjFkZTQ3Zjk5OWU2ZGZlMGYyYjc2NTAwL3RleHRyZWdpb246OWNmOTZiY2ZmMWRlNDdmOTk5ZTZkZmUwZjJiNzY1MDBfNDYy_f68acc29-eea6-4523-91ef-ec2777c7847b">23.8</ix:nonFraction>%, respectively. The decrease in our effective tax rate from the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was primarily related to the tax impact of expected geographic changes in our mix of 2022 earnings.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes receivable totaled $<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:IncomeTaxesReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82MS9mcmFnOjljZjk2YmNmZjFkZTQ3Zjk5OWU2ZGZlMGYyYjc2NTAwL3RleHRyZWdpb246OWNmOTZiY2ZmMWRlNDdmOTk5ZTZkZmUwZjJiNzY1MDBfNjYy_3ce9f430-d8a1-4ea1-be92-2ae83a70fd94">214</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:IncomeTaxesReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82MS9mcmFnOjljZjk2YmNmZjFkZTQ3Zjk5OWU2ZGZlMGYyYjc2NTAwL3RleHRyZWdpb246OWNmOTZiY2ZmMWRlNDdmOTk5ZTZkZmUwZjJiNzY1MDBfNjY5_7a3c69e6-6375-430a-be22-68172bd371a9">173</ix:nonFraction> at September&#160;30, 2022 and December&#160;31, 2021, respectively. We recognized the income taxes receivable as an asset under the caption &#8220;Other current assets&#8221; in our consolidated balance sheets.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-23-</span></div></div></div><div id="i186e051878fe4219970efc72a9fcdad4_64"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfMjA1Nw_1c3aab61-0ddf-4627-8f3b-8e0d5fa38077" continuedAt="i8ad4b63e00804a49b66e1336b18dd17e" escape="true">Medical Claims Payable</ix:nonNumeric></span></div><ix:continuation id="i8ad4b63e00804a49b66e1336b18dd17e" continuedAt="icd73bea9f72245f1ae7b56a48541c7d5"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfMjA1MQ_cee36f9d-2bfd-4820-bbbb-362fb4fc4bee" continuedAt="i222f20e9424a4ecb8a40f57cc9578508" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balances for medical claims payable, by segment (see Note 15, &#8220;Segment Information&#8221;), for the nine months ended September 30, 2022 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.764%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial<br/>&amp; Specialty<br/>Business</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Government<br/>Business</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross medical claims payable, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib25ede8a88f9477dbd274859e7a2b1b1_I20211231" decimals="-6" name="elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMS0xLTEtMS03MDM2Mw_bd300db1-40fe-4828-a67d-63768786041c">3,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bbc82c5b8774ddc80a06a94578b2a62_I20211231" decimals="-6" name="elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMS0zLTEtMS03MDM2Mw_0becc51d-d6a8-43a6-9942-6e880ffd3867">9,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7c1d9dfb7814c5da0eb0bcb78535511_I20211231" decimals="-6" name="elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMS01LTEtMS03MDM2Mw_d9ef7952-2903-4fdb-a495-f958ede2ae55">278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMS03LTEtMS03MDM2Mw_9a744ecc-9905-40b3-9458-b76f15001ba1">13,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded medical claims payable, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib25ede8a88f9477dbd274859e7a2b1b1_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMi0xLTEtMS03MDM2Mw_f4a8601e-e01b-45c0-a8f0-e812029e3b4f">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bbc82c5b8774ddc80a06a94578b2a62_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMi0zLTEtMS03MDM2Mw_d08f854e-1c72-42a8-81b9-b774d45af7b6">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7c1d9dfb7814c5da0eb0bcb78535511_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMi01LTEtMS03MDM2Mw_4e35f806-1434-40e8-9c3b-227a7ec2d1d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMi03LTEtMS03MDM2Mw_2a82e90a-d6e1-4f1c-9504-d0c95684ee11">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net medical claims payable, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib25ede8a88f9477dbd274859e7a2b1b1_I20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMy0xLTEtMS03MDM2Mw_f25d069d-fbae-47c8-b065-6d245c1147d6">3,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bbc82c5b8774ddc80a06a94578b2a62_I20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMy0zLTEtMS03MDM2Mw_cab477ad-80e1-4578-9a41-77afa1e76c96">9,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7c1d9dfb7814c5da0eb0bcb78535511_I20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMy01LTEtMS03MDM2Mw_80dd3741-f617-4a27-94ee-e517da7a1ee9">278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMy03LTEtMS03MDM2Mw_6e5e31a5-3a01-42a7-97c0-7ff2fa4f31ef">13,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business combinations and purchase adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eef42da7d1c4cd495f66b68093f8dc3_I20220930" decimals="-6" name="elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNC0xLTEtMS03MDM2Mw_10a8dff2-2296-4ab9-b38f-d01120c43d5e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17f3cb9f8c1d492197e639b5a0369fef_I20220930" decimals="-6" name="elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNC0zLTEtMS03MDM2Mw_eca2860d-9488-44d2-b539-bae9b5a24f12">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8e9a443d6054bb489dd821a7385bab4_I20220930" decimals="-6" name="elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNC01LTEtMS03MDM2Mw_009cc6f2-a9a1-4674-b022-b8ae189ab6f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNC03LTEtMS03MDM2Mw_bfa53440-c95b-41fc-9d5f-e7f8583aefae">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net incurred medical claims:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i518bf560bf5b42db9717fa1237d56fc5_D20220101-20220930" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNi0xLTEtMS03MDM2Mw_b709f846-30fa-4ce0-acb1-eafc2e233251">22,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32803f4645204fb0b79a26f39fe31411_D20220101-20220930" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNi0zLTEtMS03MDM2Mw_01150bc0-20c8-4f48-b83e-53bb320c5b80">60,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5866a8bbba704cf588b8904b077bac81_D20220101-20220930" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNi01LTEtMS03MDM2Mw_c44b0242-c903-4834-970c-af80d85867ed">1,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNi03LTEtMS03MDM2Mw_091c7d49-4e5a-48d3-8b5c-532afed01d19">84,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods redundancies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i518bf560bf5b42db9717fa1237d56fc5_D20220101-20220930" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNy0xLTEtMS03MDM2Mw_bc9545f4-0771-466d-ba95-01b7f9237719">183</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32803f4645204fb0b79a26f39fe31411_D20220101-20220930" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNy0zLTEtMS03MDM2Mw_21b764ac-6a7f-482b-82c3-051f18e7720a">639</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5866a8bbba704cf588b8904b077bac81_D20220101-20220930" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNy01LTEtMS03MDM2Mw_e20d78ae-f914-4761-b236-f595741d5bbe">79</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNy03LTEtMS03MDM2Mw_2d366951-80ea-466c-870f-5a4c0600b821">901</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net incurred medical claims</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i518bf560bf5b42db9717fa1237d56fc5_D20220101-20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfOC0xLTEtMS03MDM2Mw_9e294d34-fc3d-4acb-abb2-342f1bc9af93">21,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32803f4645204fb0b79a26f39fe31411_D20220101-20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfOC0zLTEtMS03MDM2Mw_8530e2d4-f13c-4384-a3f8-6f2023d9fda3">60,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5866a8bbba704cf588b8904b077bac81_D20220101-20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfOC01LTEtMS03MDM2Mw_1851838a-4567-4cce-beb3-f9392656dcb5">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfOC03LTEtMS03MDM2Mw_419a3057-1de6-4288-afb2-a3edf3696456">83,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net payments attributable to:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period medical claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i518bf560bf5b42db9717fa1237d56fc5_D20220101-20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTAtMS0xLTEtNzAzNjM_280f1b07-8906-47b2-a599-a9dd32dfefcf">18,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32803f4645204fb0b79a26f39fe31411_D20220101-20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTAtMy0xLTEtNzAzNjM_13e027bf-f22d-4609-96e7-e1e40377a07c">50,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5866a8bbba704cf588b8904b077bac81_D20220101-20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTAtNS0xLTEtNzAzNjM_18dd131c-a2fb-4a40-8251-47e6f9f49fcf">899</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTAtNy0xLTEtNzAzNjM_95c6af18-39ec-4dd7-9b4a-e4a83b9a2319">70,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods medical claims</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i518bf560bf5b42db9717fa1237d56fc5_D20220101-20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTEtMS0xLTEtNzAzNjM_5e9aa492-5942-48fe-b53a-4f83bbdebf09">3,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32803f4645204fb0b79a26f39fe31411_D20220101-20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTEtMy0xLTEtNzAzNjM_de8a0e44-0111-4fa8-a657-4b1862098010">7,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5866a8bbba704cf588b8904b077bac81_D20220101-20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTEtNS0xLTEtNzAzNjM_803cd570-dcae-4050-9c1a-903fb77b1136">184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTEtNy0xLTEtNzAzNjM_0088f39a-e9b7-4c9f-a8e4-9f8e7b99fd6b">11,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i518bf560bf5b42db9717fa1237d56fc5_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTItMS0xLTEtNzAzNjM_29ce81fc-95a9-422d-8a74-02c40b5a9043">21,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32803f4645204fb0b79a26f39fe31411_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTItMy0xLTEtNzAzNjM_df1f0fcd-7b1b-46d9-8e62-c6073cfcc647">58,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5866a8bbba704cf588b8904b077bac81_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTItNS0xLTEtNzAzNjM_46d59599-e4f7-4ebb-a62f-5228a4588fd7">1,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTItNy0xLTEtNzAzNjM_6b350583-6bdf-4722-a2bd-187270eaa55f">81,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net medical claims payable, end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eef42da7d1c4cd495f66b68093f8dc3_I20220930" decimals="-6" name="elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTMtMS0xLTEtNzAzNjM_943508c7-58ab-42e3-aec8-c3953abea237">3,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17f3cb9f8c1d492197e639b5a0369fef_I20220930" decimals="-6" name="elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTMtMy0xLTEtNzAzNjM_f25ded52-64ad-40e7-85c8-051b338410d8">10,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8e9a443d6054bb489dd821a7385bab4_I20220930" decimals="-6" name="elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTMtNS0xLTEtNzAzNjM_9d424c4a-240d-471d-b9a0-3f31c783cda2">273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTMtNy0xLTEtNzAzNjM_40324b84-da3f-4275-8888-02c7bedf20cd">14,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded medical claims payable, end of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eef42da7d1c4cd495f66b68093f8dc3_I20220930" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTQtMS0xLTEtNzAzNjM_123913f9-2df4-4f68-b89a-d8cc1d39cd60">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17f3cb9f8c1d492197e639b5a0369fef_I20220930" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTQtMy0xLTEtNzAzNjM_9f2fe880-1b59-4831-bef2-3fbf741924a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8e9a443d6054bb489dd821a7385bab4_I20220930" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTQtNS0xLTEtNzAzNjM_08742301-02f5-4e0b-9310-2e8e3daae123">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTQtNy0xLTEtNzAzNjM_11006ac0-44e6-4bf1-80aa-42e746269a59">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross medical claims payable, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eef42da7d1c4cd495f66b68093f8dc3_I20220930" decimals="-6" name="elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTUtMS0xLTEtNzAzNjM_f41be0dd-b641-4d65-9280-d78f10250f80">3,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17f3cb9f8c1d492197e639b5a0369fef_I20220930" decimals="-6" name="elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTUtMy0xLTEtNzAzNjM_91c62e0e-4434-4827-9054-73aee01c2b2d">10,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8e9a443d6054bb489dd821a7385bab4_I20220930" decimals="-6" name="elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTUtNS0xLTEtNzAzNjM_484cff98-568d-41c7-aad0-f20610847c75">273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTUtNy0xLTEtNzAzNjM_752b6751-7f8f-4b8a-9b08-ec58c5379720">15,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, the total of net incurred but not reported liabilities plus expected development on reported claims for the Commercial &amp; Specialty Business was $<ix:nonFraction unitRef="usd" contextRef="ic61874748541445bb5346014604b1e2f_I20220930" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfMzQx_263504ad-b8cd-4d12-817a-987923a208c3">81</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i9cf718e43d2d431aab9e48ee4460c848_I20220930" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfMzQ1_4284365f-a30c-4b3b-899e-ec98986569eb">388</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i0c42a359a2a345cd9ba70d1ac59c63f2_I20220930" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfMzUy_5386877b-653f-4a5c-8485-34fcd9346a60">3,449</ix:nonFraction> for the claim years 2020 and prior, 2021 and 2022, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, the total of net incurred but not reported liabilities plus expected development on reported claims for the Government Business was $<ix:nonFraction unitRef="usd" contextRef="i013231985bd7411185b88460522d8b36_I20220930" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfNTUz_f6c0e07a-73f3-47ac-978c-c1ce51c92054">148</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i3995587e895e4e8e900e6e6a4ad92b08_I20220930" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfNTU3_f28ccc36-f369-4711-bd7a-3e2f973d5fe8">508</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i979bf304459b469a85f5dbd972a86ebf_I20220930" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfNTY0_ce801818-16be-4e82-9e47-490fea42cf8a">10,151</ix:nonFraction> for the claim years 2020 and prior, 2021 and 2022, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, the total of net incurred but not reported liabilities plus expected development on reported claims for Other was $<ix:nonFraction unitRef="usd" contextRef="id0595bb2db424b7bac7ac1ec8646dd16_I20220930" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfNzQ3_e8ee377d-14ba-4618-9ad8-24824ceae6ce">2</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ie6f5962645aa44dd9e99d61abdd0873a_I20220930" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfNzUx_7ce1e190-b7a4-4c75-81f4-6a6d8bde473f">14</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ice322a96213244e6b5ed9fa8b2fd063c_I20220930" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfNzU4_cf81ede2-83e3-4cf2-819b-0b7fe124930a">257</ix:nonFraction> for the claim years 2020 and prior, 2021 and 2022, respectively.</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-24-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="icd73bea9f72245f1ae7b56a48541c7d5" continuedAt="iabc0868708724b53b8274db78ff864bd"><ix:continuation id="i222f20e9424a4ecb8a40f57cc9578508"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balances for medical claims payable, by segment (see Note 15, &#8220;Segment Information&#8221;), for the nine months ended September 30, 2021 is as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.764%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial<br/>&amp; Specialty<br/>Business</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Government<br/>Business</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross medical claims payable, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c9a53d41b6411c8a7299de747052ee_I20201231" decimals="-6" name="elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMS0xLTEtMS03MDM2Mw_01ae6b44-de73-4f3a-9be4-54abcdae55e6">3,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea0cd3e6f73d4c37a185721b7213f0fe_I20201231" decimals="-6" name="elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMS0zLTEtMS03MDM2Mw_460961d7-d5f2-4bf5-94d5-efd2701bbd6f">7,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1007523085804985812acc850dc8d6fe_I20201231" decimals="-6" name="elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMS01LTEtMS03MDM2Mw_cfa6deb3-08d9-4100-b9de-cce121351637">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aceaf2b19bf4d5d916eb0f2039e41de_I20201231" decimals="-6" name="elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMS03LTEtMS03MDM2Mw_b5b6d2c3-3c9d-4e13-8bca-5509d4aa7499">11,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded medical claims payable, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2c9a53d41b6411c8a7299de747052ee_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMi0xLTEtMS03MDM2Mw_d17ee7bd-6ca2-4e79-be8f-f6df2ac68f5a">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea0cd3e6f73d4c37a185721b7213f0fe_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMi0zLTEtMS03MDM2Mw_11dcb89b-6c37-4905-bd00-76707716ae66">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1007523085804985812acc850dc8d6fe_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMi01LTEtMS03MDM2Mw_79e8ba00-4596-4c90-90d9-16921beec95d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9aceaf2b19bf4d5d916eb0f2039e41de_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMi03LTEtMS03MDM2Mw_291963af-4874-4566-8fe4-fc693a2ecb8b">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net medical claims payable, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c9a53d41b6411c8a7299de747052ee_I20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMy0xLTEtMS03MDM2Mw_4792a5a7-3d40-400a-b77b-31359aceede3">3,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea0cd3e6f73d4c37a185721b7213f0fe_I20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMy0zLTEtMS03MDM2Mw_7ac15117-aa6f-4cc9-83e8-cd6aa3f3955d">7,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1007523085804985812acc850dc8d6fe_I20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMy01LTEtMS03MDM2Mw_465feb59-250c-41ee-8bdc-aa3056f1a4ff">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aceaf2b19bf4d5d916eb0f2039e41de_I20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMy03LTEtMS03MDM2Mw_1f49da38-adbb-4bc9-a873-c022050c314e">11,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business combinations and purchase adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4182a920dc6d4e8cb42614e778766e1c_I20210930" decimals="-6" name="elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNC0xLTEtMS03MDM2Mw_dfccb110-5265-47c2-ba56-9630bcc58ed4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb5db0efb1418d913cc8583b863da5_I20210930" decimals="-6" name="elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNC0zLTEtMS03MDM2Mw_4d142247-d469-4ef5-9457-e1c84380a99f">375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaff25a1e31245299f7a5ef30e5e99d3_I20210930" decimals="-6" name="elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNC01LTEtMS03MDM2Mw_19410a85-dde5-4c43-92f4-9caf5550f6f7">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7580839926f4e24b08f10312dd69479_I20210930" decimals="-6" name="elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNC03LTEtMS03MDM2Mw_9078fd01-2d4f-4f2f-b54e-2fef97f0adf9">420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net incurred medical claims:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id192e31548bb42f29d1bf3d4dbb6cda2_D20210101-20210930" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNi0xLTEtMS03MDM2Mw_600bae3b-1fc8-4a3d-bce7-9a55e952ca1f">20,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b0ea34f1f294d20a310a2ef4c41c0f4_D20210101-20210930" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNi0zLTEtMS03MDM2Mw_5d999ca9-6ff9-4540-b532-394b2df73820">52,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5424e3c2015944248e4c1ead87f81144_D20210101-20210930" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNi01LTEtMS03MDM2Mw_1efa6547-e805-4dac-a002-30dd74a5f952">1,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNi03LTEtMS03MDM2Mw_7c33c5ce-a407-4cfe-be81-21b70fea570a">74,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods redundancies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id192e31548bb42f29d1bf3d4dbb6cda2_D20210101-20210930" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNy0xLTEtMS03MDM2Mw_107b3f5f-aed0-4dd8-8b57-49bc6653e30e">496</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b0ea34f1f294d20a310a2ef4c41c0f4_D20210101-20210930" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNy0zLTEtMS03MDM2Mw_084ed18f-1fa6-4124-8887-ee743026f75a">1,309</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5424e3c2015944248e4c1ead87f81144_D20210101-20210930" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNy01LTEtMS03MDM2Mw_8daf5ac2-dffc-490c-a93c-f72389f91656">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNy03LTEtMS03MDM2Mw_4847a17c-556b-46aa-b642-4578271b62b2">1,822</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net incurred medical claims</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id192e31548bb42f29d1bf3d4dbb6cda2_D20210101-20210930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfOC0xLTEtMS03MDM2Mw_4aefe7c6-94ac-42e7-87f3-43e3335b1a62">20,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b0ea34f1f294d20a310a2ef4c41c0f4_D20210101-20210930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfOC0zLTEtMS03MDM2Mw_f8b546ae-724d-4e90-83cf-f45937661525">51,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5424e3c2015944248e4c1ead87f81144_D20210101-20210930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfOC01LTEtMS03MDM2Mw_c97265c5-32a0-44ea-a672-e2f08e1f18b7">1,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfOC03LTEtMS03MDM2Mw_decc5745-5722-40a2-a96d-b5e3cf79fe3e">72,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net payments attributable to:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period medical claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id192e31548bb42f29d1bf3d4dbb6cda2_D20210101-20210930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTAtMS0xLTEtNzAzNjM_24a0d341-6031-444a-becf-c56f3ff60d31">16,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b0ea34f1f294d20a310a2ef4c41c0f4_D20210101-20210930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTAtMy0xLTEtNzAzNjM_8fe7a419-92b8-4bc2-92a3-675453096c20">44,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5424e3c2015944248e4c1ead87f81144_D20210101-20210930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTAtNS0xLTEtNzAzNjM_f8403456-9850-48a9-bb9a-02d8bec20bc2">978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTAtNy0xLTEtNzAzNjM_a3e08bb6-97a9-492a-90e4-1fa0d972b7f7">62,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods medical claims</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id192e31548bb42f29d1bf3d4dbb6cda2_D20210101-20210930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTEtMS0xLTEtNzAzNjM_1185293f-3dfb-44d4-92ed-f0d7fef6b586">2,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b0ea34f1f294d20a310a2ef4c41c0f4_D20210101-20210930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTEtMy0xLTEtNzAzNjM_5a01755e-9472-401a-9647-22eb815da77e">5,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5424e3c2015944248e4c1ead87f81144_D20210101-20210930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTEtNS0xLTEtNzAzNjM_db5b3215-e43a-4226-b62f-d08af0c8c0db">169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTEtNy0xLTEtNzAzNjM_a5d71b39-1dad-4028-9d01-6f9e011768b1">8,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id192e31548bb42f29d1bf3d4dbb6cda2_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTItMS0xLTEtNzAzNjM_af70735d-a377-41f7-9839-c84bf15b95c8">19,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b0ea34f1f294d20a310a2ef4c41c0f4_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTItMy0xLTEtNzAzNjM_1f5cd0dd-e9eb-4243-9c85-69ddcc690937">49,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5424e3c2015944248e4c1ead87f81144_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTItNS0xLTEtNzAzNjM_1a4e767e-a1ca-4e72-bc1d-ea844ccc518b">1,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTItNy0xLTEtNzAzNjM_2b6418a2-5195-471a-9b5c-b609887e7a14">70,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net medical claims payable, end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4182a920dc6d4e8cb42614e778766e1c_I20210930" decimals="-6" name="elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTMtMS0xLTEtNzAzNjM_6a2683d0-d882-4d54-966c-28d5cbbb7e79">3,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb5db0efb1418d913cc8583b863da5_I20210930" decimals="-6" name="elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTMtMy0xLTEtNzAzNjM_c3a60674-9395-4e7e-9afa-7c7a171ba650">9,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaff25a1e31245299f7a5ef30e5e99d3_I20210930" decimals="-6" name="elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTMtNS0xLTEtNzAzNjM_b8421720-56ec-4503-ac06-4fc859d71c42">252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7580839926f4e24b08f10312dd69479_I20210930" decimals="-6" name="elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTMtNy0xLTEtNzAzNjM_73bfecbc-db1e-4b7f-a784-5d2e8351bfba">13,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded medical claims payable, end of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4182a920dc6d4e8cb42614e778766e1c_I20210930" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTQtMS0xLTEtNzAzNjM_a6477a47-aec8-4b54-a320-edf43a658c83">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb5db0efb1418d913cc8583b863da5_I20210930" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTQtMy0xLTEtNzAzNjM_632c9d74-2dc1-4918-876c-6ef502dee2fc">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaff25a1e31245299f7a5ef30e5e99d3_I20210930" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTQtNS0xLTEtNzAzNjM_e37751e9-b090-4ff3-bb5b-b8a2e1a69365">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7580839926f4e24b08f10312dd69479_I20210930" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTQtNy0xLTEtNzAzNjM_532f104d-c867-421a-986e-d466ed5c15dc">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross medical claims payable, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4182a920dc6d4e8cb42614e778766e1c_I20210930" decimals="-6" name="elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTUtMS0xLTEtNzAzNjM_b0b0c984-a512-447d-869b-bfd5845634b9">3,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacb5db0efb1418d913cc8583b863da5_I20210930" decimals="-6" name="elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTUtMy0xLTEtNzAzNjM_1d707961-7e3c-427f-8812-f29427030d60">9,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaff25a1e31245299f7a5ef30e5e99d3_I20210930" decimals="-6" name="elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTUtNS0xLTEtNzAzNjM_f47cdba9-2917-4b4a-94ed-ff76432edfb5">252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7580839926f4e24b08f10312dd69479_I20210930" decimals="-6" name="elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTUtNy0xLTEtNzAzNjM_0db0d68c-d2e4-4314-a2b5-52ad1f707242">13,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The favorable development recognized in the nine months ended September 30, 2022 and 2021 resulted primarily from trend factors in late 2021 and late 2020, respectively, developing more favorably than originally expected. Favorable development in the completion factors resulting from the latter parts of 2020 developing faster than expected also contributed to the favorable development in the nine months ended September 30, 2021. The impact from COVID-19 on healthcare utilization and medical claims submission patterns continues to provide increased estimation uncertainty on our incurred but not reported liability at September&#160;30, 2022.</span></div></ix:continuation><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="elv:ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfMjA1NA_6c850785-85ab-4a42-bfea-670a1ded3bd8" continuedAt="ia05289525575491995ad9e1e312bfde8" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of net incurred medical claims to benefit expense included in our consolidated statements of income for periods in 2022 is as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.126%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.825%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net incurred medical claims:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial &amp; Specialty Business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e857bc4e13a4ae5a65583609fa0ba9a_D20220101-20220331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfNi0xLTEtMS03MDM2Mw_23d4443c-95fd-4821-84d2-3ecb9928a9aa">6,834</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64ce2ea324434d348d29360ed18b52c5_D20220401-20220630" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfNi0zLTEtMS03MDM2Mw_33689681-5943-46c7-b1c1-c50e841ad3fa">7,522</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9adaeacf598a42c3b72b8540b126e10b_D20220701-20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfNi01LTEtMS03MDM2Mw_2feea0c7-d52e-459f-960d-bb85fd37052e">7,510</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i518bf560bf5b42db9717fa1237d56fc5_D20220101-20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfNi03LTEtMS03MDM2Mw_cf9fbd33-5cc5-4c7e-8815-74ffbc5bf277">21,866</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2a144458c3940758b57b3397f45a257_D20220101-20220331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfNy0xLTEtMS03MDM2Mw_e98fa013-9f17-459c-8f23-e4edf6a0d951">19,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice7c432e6884478fb38f1d9ca1399f9d_D20220401-20220630" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfNy0zLTEtMS03MDM2Mw_60a39243-63ff-4166-8c20-20e024b7504d">19,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice7f613275f549788763308d4be93610_D20220701-20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfNy01LTEtMS03MDM2Mw_2ad79b6c-926e-4da2-8f03-23f2246c8115">20,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32803f4645204fb0b79a26f39fe31411_D20220101-20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfNy03LTEtMS03MDM2Mw_b8ef68e8-983a-4f87-8b5c-dc7094d54a0d">60,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id81fb73bd9e640338bfa72bb4f5aeb76_D20220101-20220331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfOC0xLTEtMS03MDM2Mw_89c8e846-efa1-45fa-bc89-51663b52322b">354</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bc19a6512f743a0a8a79c92a23c64a9_D20220401-20220630" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfOC0zLTEtMS03MDM2Mw_f3b0e5a9-2f81-47b9-be7c-fddfdbd15af8">324</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee58b3e2710246daa6dbe09d63e5064d_D20220701-20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfOC01LTEtMS03MDM2Mw_699a2fcc-9d92-4e9b-bb13-699cd54de0e6">400</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5866a8bbba704cf588b8904b077bac81_D20220101-20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfOC03LTEtMS03MDM2Mw_48f41b89-82db-49d4-b16c-ee90c2c4e6d6">1,078</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net incurred medical claims</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfOS0xLTEtMS03MDM2Mw_f3a622b8-b4b7-4eea-a5a0-9dfb070270a3">27,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfOS0zLTEtMS03MDM2Mw_197c83eb-6b66-4762-a7b4-acdd38453846">27,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfOS01LTEtMS03MDM2Mw_aa47228a-603a-47fc-b8f0-54d91bebd00d">28,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfOS03LTEtMS03MDM2Mw_60a58553-b214-4762-aadb-4859abd0b023">83,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quality improvement and other claims expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331" decimals="-6" name="us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfMTAtMS0xLTEtNzAzNjM_b6070fd0-277f-4634-b56f-35ad5082efd9">1,084</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630" decimals="-6" name="us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfMTAtMy0xLTEtNzAzNjM_9b066f2e-bc33-4912-a744-179e0d1d6c25">1,143</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfMTAtNS0xLTEtNzAzNjM_919cc8ae-542d-422b-b9a3-6b9e76b59cb9">893</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfMTAtNy0xLTEtNzAzNjM_975d833e-7d15-4198-a6d9-1d5dd0fe0520">3,120</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfMTEtMS0xLTEtNzAzNjM_c6635924-a412-4e82-849d-0988d7e4b8a9">28,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfMTEtMy0xLTEtNzAzNjM_53abf45c-9323-415c-ad36-80759a59b1e1">28,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfMTEtNS0xLTEtNzAzNjM_e3b87a58-4dc6-4335-9984-0b7efa4f4d28">29,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfMTEtNy0xLTEtNzAzNjM_6a8700f2-3740-4fda-813e-1c9d3fde7884">86,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the three months ended September 30, 2022, based on recent regulatory clarification, we realigned certain quality improvement costs from benefit expense to administrative expense that were previously allocated to benefit expense during the three months ended March 31, 2022 and the three months ended June 30, 2022.</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-25-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iabc0868708724b53b8274db78ff864bd"><ix:continuation id="ia05289525575491995ad9e1e312bfde8"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of net incurred medical claims to benefit expense included in our consolidated statements of income for periods in 2021 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.530%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net incurred medical claims:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial &amp; Specialty Business</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35884d0201ae464ebc6e5b8946fa1612_D20210101-20210331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNS0yLTEtMS03MDM2Mw_be876df8-0f95-4e21-aab0-e1a4b3e17592">6,072</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie653179541d1493c93be7e3886e9fb52_D20210401-20210630" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNS00LTEtMS03MDM2Mw_12537770-90b6-4d67-b6d8-02f1644cca72">6,718</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7c823f42d7a4c78b75c5623fcf615d7_D20210701-20210930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNS02LTEtMS03MDM2Mw_047e11a9-a827-4bd0-a142-be292d466235">7,213</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id192e31548bb42f29d1bf3d4dbb6cda2_D20210101-20210930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNS04LTEtMS03MDM2Mw_a5afd0bf-98c5-4c82-bf0c-65866a04c8fd">20,003</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Business</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef52ac747e64c7391e7c7a1120b53d2_D20210101-20210331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNi0yLTEtMS03MDM2Mw_1b917b2f-42ff-4337-a39e-9e5a6943301e">16,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8ff1fa5d8714816a640a8280fcee30a_D20210401-20210630" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNi00LTEtMS03MDM2Mw_af83b2c3-1363-4e17-8780-cd13d1ba31ab">16,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i757b9a9c9e7e4558a1cd9992f88382fc_D20210701-20210930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNi02LTEtMS03MDM2Mw_f6f211e6-bcb8-49c7-a620-1b742e117215">18,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b0ea34f1f294d20a310a2ef4c41c0f4_D20210101-20210930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNi04LTEtMS03MDM2Mw_6835f6d7-1b61-4ad4-8656-03ddfa273352">51,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b17535592154a3fb04e22ab93e36684_D20210101-20210331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNy0yLTEtMS03MDM2Mw_6c90e756-b4bf-461b-912e-0122862b21bb">336</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e4c924470664c728da0afbb46130f3e_D20210401-20210630" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNy00LTEtMS03MDM2Mw_8bd63fb9-6f9d-4b4f-8133-8dd206ca2b1e">403</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed55d475fdc4a698c26523269fb993b_D20210701-20210930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNy02LTEtMS03MDM2Mw_6a2c1424-83d8-4259-8e58-274c8ba722fc">420</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5424e3c2015944248e4c1ead87f81144_D20210101-20210930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNy04LTEtMS03MDM2Mw_bf9c50f0-8c23-4787-ab5f-7817ba6dc1eb">1,159</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net incurred medical claims</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfOC0yLTEtMS03MDM2Mw_ea73207a-1917-4105-86df-44b115d417a3">22,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfOC00LTEtMS03MDM2Mw_6b55f41b-b046-4893-8951-f820800115a2">23,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfOC02LTEtMS03MDM2Mw_d8c58949-22bd-4fc9-90ed-e92d93dc64da">25,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfOC04LTEtMS03MDM2Mw_4665c381-4412-4b9d-8895-89dcd9d949a4">72,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quality improvement and other claims expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331" decimals="-6" name="us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfOS0yLTEtMS03MDM2Mw_58fa1c88-8131-4361-984c-7a5cd1c1afe8">972</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630" decimals="-6" name="us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfOS00LTEtMS03MDM2Mw_e5e7e9af-8e30-4207-a65e-b3f9813b4713">919</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfOS02LTEtMS03MDM2Mw_c03c85ba-3c80-4561-a07a-a42152ad0b2f">941</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfOS04LTEtMS03MDM2Mw_87247614-6ca2-4531-a820-b1dde9759a15">2,832</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfMTAtMi0xLTEtNzAzNjM_18909c45-b8b7-4238-861e-3601407304b6">23,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfMTAtNC0xLTEtNzAzNjM_458421e5-23fa-40bd-852c-3dd267e5216c">24,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfMTAtNi0xLTEtNzAzNjM_f5131453-9af7-44b8-93ed-5724755b30dc">26,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfMTAtOC0xLTEtNzAzNjM_03f1ce01-a0dd-41a2-9367-80ffe8da6eca">75,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfMjA2NA_292ba49d-990b-4320-9b06-946a7500033d" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the medical claims payable reflected in the tables above to the consolidated ending balance for medical claims payable included in the consolidated balance sheet, as of September&#160;30, 2022, is as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.764%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial<br/>&amp; Specialty<br/>Business</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Government<br/>Business</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net medical claims payable, end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eef42da7d1c4cd495f66b68093f8dc3_I20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMS0xLTEtMS03MDM2Mw_c6fd60bd-d2bd-4fb1-b893-5618cbe86854">3,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17f3cb9f8c1d492197e639b5a0369fef_I20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMS0zLTEtMS03MDM2Mw_47750fa2-233a-47e4-adfa-7a8dac29327f">10,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8e9a443d6054bb489dd821a7385bab4_I20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMS01LTEtMS03MDM2Mw_1ddd521d-5291-453b-a80b-93975de27b51">273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMS03LTEtMS03MDM2Mw_964f1f21-6d6a-409a-b0e1-35899a2bf459">14,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded medical claims payable, end of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eef42da7d1c4cd495f66b68093f8dc3_I20220930" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMi0xLTEtMS03MDM2Mw_4791e498-89c9-4f30-a953-25a7eff92734">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17f3cb9f8c1d492197e639b5a0369fef_I20220930" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMi0zLTEtMS03MDM2Mw_adef9a48-bcb6-4b82-b8d6-f024a9f5cecc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8e9a443d6054bb489dd821a7385bab4_I20220930" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMi01LTEtMS03MDM2Mw_763f525e-70a0-415f-a899-8addc4fd4e40">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMi03LTEtMS03MDM2Mw_12512efe-26d4-4fa4-a370-15faa88c08ab">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance lines other than short duration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eef42da7d1c4cd495f66b68093f8dc3_I20220930" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMy0xLTEtMS03MDM2Mw_524f7009-8524-435b-88b1-563909f6bbd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17f3cb9f8c1d492197e639b5a0369fef_I20220930" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMy0zLTEtMS03MDM2Mw_a1a1d0e3-3eb1-41dc-a054-ba43a18f2de3">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8e9a443d6054bb489dd821a7385bab4_I20220930" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMy01LTEtMS03MDM2Mw_8ccae163-a4ce-401d-97d7-45e23a554766">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMy03LTEtMS03MDM2Mw_56cdc99f-0a08-46cc-8b12-0f6831fc3f15">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross medical claims payable, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eef42da7d1c4cd495f66b68093f8dc3_I20220930" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfNC0xLTEtMS03MDM2Mw_0521ac89-09af-4397-9391-5b65710f0757">3,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17f3cb9f8c1d492197e639b5a0369fef_I20220930" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfNC0zLTEtMS03MDM2Mw_154740e9-8c88-4235-813e-2ddf68916838">11,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8e9a443d6054bb489dd821a7385bab4_I20220930" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfNC01LTEtMS03MDM2Mw_9a38ef69-d5fd-48d5-bbf9-7c98771b76db">273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfNC03LTEtMS03MDM2Mw_fd97e0b9-f914-4995-a661-cec2adbfacd3">15,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i186e051878fe4219970efc72a9fcdad4_67"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNTQyNg_8f00d69f-a2f5-445a-84f1-a5d431584d27" continuedAt="ic5d97d67ade84ae79f21e5ace8b19bf8" escape="true">Debt</ix:nonNumeric></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.616%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><ix:continuation id="ic5d97d67ade84ae79f21e5ace8b19bf8" continuedAt="id43e832d90b346d0a0b6e20f9336eec6"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally issue senior unsecured notes for long-term borrowing purposes. At September&#160;30, 2022 and December&#160;31, 2021, we had $<ix:nonFraction unitRef="usd" contextRef="i3a16a462df304b1fbf48724140afd63c_I20220930" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMTE0_260e646a-1b6b-4e2f-b218-c7d2750b785d">22,722</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i94bbf9e2e436430ea18a870d630e7782_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMTIx_69cccadc-12c0-4aba-b4ff-3e95f5bf00af">22,359</ix:nonFraction>, respectively, outstanding under these notes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 16, 2022, we repaid, at maturity, the $<ix:nonFraction unitRef="usd" contextRef="i6b0d34ecb74d4c1499f643aa80821af3_I20220516" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMjE0_89cb562e-a096-4d22-a3c6-63738ccc690f">850</ix:nonFraction> outstanding balance of our <ix:nonFraction unitRef="number" contextRef="i6b0d34ecb74d4c1499f643aa80821af3_I20220516" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMjQ0_e24b5845-15ce-4b1d-bdcd-883b2414b371">3.125</ix:nonFraction>% senior unsecured notes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 29, 2022, we issued $<ix:nonFraction unitRef="usd" contextRef="i593ecd4bf79e46d2af49bec65e9db2cc_I20220429" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMzAw_e9b5e911-c618-4f1c-bd4c-64d48e580690">600</ix:nonFraction> aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i593ecd4bf79e46d2af49bec65e9db2cc_I20220429" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMzMz_e2095e37-c149-4116-a9c3-1faf39872c6e">4.100</ix:nonFraction>% Notes due 2032 (the &#8220;2032 Notes&#8221;) and $<ix:nonFraction unitRef="usd" contextRef="i3e26d0baf7484549aaadded8ad6a1ef1_I20220429" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMzc0_7f9790fe-6498-4703-aa9a-b5cff0d57af1">700</ix:nonFraction> aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i3e26d0baf7484549aaadded8ad6a1ef1_I20220429" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNDA3_6e00657d-fd96-410f-9f8a-5325e56c0466">4.550</ix:nonFraction>% Notes due 2052 (the &#8220;2052 Notes&#8221;) under our shelf registration statement. Interest on the 2032 Notes and 2052 Notes is payable semi-annually in arrears on May 15 and November 15 of each year, commencing November 15, 2022. We used the net proceeds for working capital and general corporate purposes, such as the funding of acquisitions, repayment of short-term and long-term debt and the repurchase of our common stock pursuant to our share repurchase program.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have an unsecured surplus note with an outstanding principal balance of $<ix:nonFraction unitRef="usd" contextRef="i447dee49344c463eb1ad142f17bbb55b_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfOTQ1_187c069d-d93d-4748-a85d-96fe09ea3062"><ix:nonFraction unitRef="usd" contextRef="i3ddfea0816d8449f8a18879a56b75aa3_I20220930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfOTQ1_e900ef24-ce41-4621-a320-bcb4065131a3">25</ix:nonFraction></ix:nonFraction> at both September&#160;30, 2022 and December&#160;31, 2021. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a senior revolving credit facility (the &#8220;5-Year Facility&#8221;) with a group of lenders for general corporate purposes. On April 18, 2022, we amended and restated the credit agreement for the 5-Year Facility to, among other things, extend the maturity date of the 5-Year Facility from June 2024 to April 2027 and increase the amount of credit available under the 5-Year Facility from $<ix:nonFraction unitRef="usd" contextRef="i6cfc7f22d3c342fc85354d517d3e8f44_I20220331" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMTM1NQ_567b61fb-05ef-4e15-86d9-b7444ea0c031">2,500</ix:nonFraction> to $<ix:nonFraction unitRef="usd" contextRef="i7e231fbcfa194a74b537f2bd7332d1ce_I20220418" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMTM2MQ_1bf67e97-03a7-49c7-882f-c196f3ccf053">4,000</ix:nonFraction>. <ix:nonNumeric contextRef="i9e6137b64fca4e85985b05a00cc0980e_D20220418-20220418" name="us-gaap:LineOfCreditFacilityDescription" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNTQyOA_380e20cc-240f-4a5e-92e9-305bf7721338">Also on April 18, 2022, concurrently with the amendment and restatement of the 5-Year Facility, we terminated our 364-day senior revolving credit facility that provided for credit in the amount of $<ix:nonFraction unitRef="usd" contextRef="id48e07a7766647e2a8bc809c7668f9aa_I20220331" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMTU2Mg_b856e168-0da0-4948-8108-17d7cb57b94b">1,000</ix:nonFraction>, which was scheduled to mature in June 2022</ix:nonNumeric> (the &#8220;2021 364-Day Facility&#8221;). In June 2021, we terminated our 364-day senior revolving credit facility (the &#8220;prior 364-Day Facility&#8221;), which was scheduled to mature in June 2021, and entered into the 2021 364-Day Facility with a group of lenders for general corporate purposes. <ix:nonNumeric contextRef="i8956e0659bb44abdac0434240d851087_D20220101-20220930" name="us-gaap:DebtInstrumentCovenantDescription" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNTQxMw_44abafd6-41e3-4606-b161-87cf805ffc4d">Our ability to borrow under the 5-Year Facility is subject to compliance with certain covenants, including covenants requiring us to maintain a defined debt-to-capital ratio of not more than 60%, subject to increase in certain circumstances set forth in the credit agreement for the 5-Year Facility.</ix:nonNumeric>&#160;<ix:nonNumeric contextRef="i8956e0659bb44abdac0434240d851087_D20220101-20220930" name="us-gaap:DebtInstrumentCovenantCompliance" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNTQyOQ_3068af00-5590-45d7-b1ca-2003af7f9bd0" continuedAt="i86cff17b5002451a94feb543cadc4297">As of September&#160;30, 2022, our debt-to-capital ratio, as defined and calculated under the 5-Year Facility, was 39.7%. We do not believe the restrictions contained in our 5-Year Facility covenants materially affect our financial or operating flexibility. As </ix:nonNumeric></span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-26-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id43e832d90b346d0a0b6e20f9336eec6"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i86cff17b5002451a94feb543cadc4297">of September&#160;30, 2022, we were in compliance with all of our debt covenants under the 5-Year Facility.</ix:continuation> There were no amounts outstanding under the 5-Year Facility, the 2021 364-Day Facility or the prior 364-Day Facility at any time during the nine months ended September&#160;30, 2022 or the year ended December&#160;31, 2021. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Through certain subsidiaries, we have entered into multiple 364-day lines of credit (the &#8220;Subsidiary Credit Facilities&#8221;) with separate lenders for general corporate purposes. The Subsidiary Credit Facilities provide combined credit of up to $<ix:nonFraction unitRef="usd" contextRef="i1994da759a8049c09f0ece33102e8d07_I20220930" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMjk4NQ_fa16a675-07a0-4fd3-94cd-3efe25f6ff5b">200</ix:nonFraction>. At September&#160;30, 2022 and December&#160;31, 2021, there were no amounts outstanding under our Subsidiary Credit Facilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have an authorized commercial paper program of up to $<ix:nonFraction unitRef="usd" contextRef="i4d538ffdcb394ef6b8ca39b9232da03f_I20220930" decimals="-6" name="elv:CommercialPaperMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMzEzMw_f52be4d0-dd85-4e53-8e26-7c6f3744ca70">4,000</ix:nonFraction>, the proceeds of which may be used for general corporate purposes. In July 2022, we increased the amount available under the commercial paper program from $<ix:nonFraction unitRef="usd" contextRef="iab9bfa7369d94d23b70eb52ac9d5c353_I20220630" decimals="-6" name="elv:CommercialPaperMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMzI5MQ_94c5a0d3-1106-4b69-be9b-315fc788e90b">3,500</ix:nonFraction> to $4,000. At September&#160;30, 2022 and December&#160;31, 2021, we had $<ix:nonFraction unitRef="usd" contextRef="i4d538ffdcb394ef6b8ca39b9232da03f_I20220930" decimals="-6" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMzMyNg_a583d036-fd6b-49bf-a4bd-8ef4af40b2b1">675</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i3177560ea74b47d094f58090cff05a3a_I20211231" decimals="-6" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMzMzMw_00ed4b7b-4cb8-42e4-85f5-ed1f8938d365">300</ix:nonFraction>, respectively, outstanding under this program.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have outstanding senior unsecured convertible debentures due 2042 (the &#8220;Debentures&#8221;), which are governed by an indenture (the &#8220;indenture&#8221;) between us and The Bank of New York Mellon Trust Company, N.A., as trustee. We accounted for the Debentures in accordance with the FASB cash conversion guidance for debt with conversion and other options at the time of issue. As a result, the value of the embedded conversion option (net of deferred taxes and equity issuance costs) was bifurcated from its debt host and recorded as a component of additional paid-in capital in our consolidated balance sheets. We adopted ASU 2020-06 on January 1, 2022 using the modified retrospective transition method, which resulted in an increase to our reported debt outstanding of $<ix:nonFraction unitRef="usd" contextRef="ic8291afc45194b679cb982efb46d0686_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNDE0Ng_c6f30ed5-5551-4a51-bda0-ca4076eda24c">31</ix:nonFraction>, a decrease of our deferred tax liabilities of $<ix:nonFraction unitRef="usd" contextRef="ic8291afc45194b679cb982efb46d0686_I20211231" decimals="-6" sign="-" name="us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNDE5Ng_b8310e9d-fda6-43d2-9417-6ded7e441012">8</ix:nonFraction> and a corresponding cumulative-effect reduction to our opening retained earnings of $<ix:nonFraction unitRef="usd" contextRef="ic8291afc45194b679cb982efb46d0686_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNDI4Mw_458f4f4b-beb5-4696-83b4-b761dbbd8efc">23</ix:nonFraction>, eliminating the bifurcation of the embedded conversion option. During the three and nine months ended September&#160;30, 2022, $<ix:nonFraction unitRef="usd" contextRef="i98f60619d5db44bdbcef4568c650ac97_D20220701-20220930" decimals="-6" name="elv:DebtConversionDebtPrincipalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNDM2OA_3da70fde-b614-4e31-9197-3e026ba94cf8">4</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i6c996ccf5375467690ef0a371d48e033_D20220101-20220930" decimals="-6" name="elv:DebtConversionDebtPrincipalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNDM3NQ_3e941551-aa52-47e5-8063-a646c7bcd473">19</ix:nonFraction> of aggregate principal amount of the Debentures was surrendered for conversion by certain holders in accordance with the terms and provisions of the indenture. We elected to settle the excess of the principal amount of the conversions with cash for total payments during the three and nine months ended September&#160;30, 2022 of $<ix:nonFraction unitRef="usd" contextRef="i98f60619d5db44bdbcef4568c650ac97_D20220701-20220930" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNDY2Mg_5f6e682a-95b6-4860-b5f9-80b03d771e12">25</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i6c996ccf5375467690ef0a371d48e033_D20220101-20220930" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNDY2OQ_aac670f8-b5be-4d88-824b-e0068d3e9e13">132</ix:nonFraction>, respectively.</span></div><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:ConvertibleDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNTQzNQ_b6cb2e47-7dcc-4c6e-aae8-2b1fb77bbc9d" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes at September&#160;30, 2022 the related balances, conversion rate and conversion price of the Debentures:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal amount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id074490de8a844b3947b679412d173b1_I20220930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RhYmxlOjA0NjUzNjMxOTdjNDQ3OGVhODlmNDUxY2ZiZjI0MmQ2L3RhYmxlcmFuZ2U6MDQ2NTM2MzE5N2M0NDc4ZWE4OWY0NTFjZmJmMjQyZDZfMC0xLTEtMS03MDM2Mw_27297942-1a87-4a05-96be-0fb8c7aad166">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net debt carrying amount</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id074490de8a844b3947b679412d173b1_I20220930" decimals="-6" name="us-gaap:ConvertibleDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RhYmxlOjA0NjUzNjMxOTdjNDQ3OGVhODlmNDUxY2ZiZjI0MmQ2L3RhYmxlcmFuZ2U6MDQ2NTM2MzE5N2M0NDc4ZWE4OWY0NTFjZmJmMjQyZDZfMi0xLTEtMS03MDM2Mw_2279f2d6-e10e-42fd-9ffb-6152b241cf76">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion rate (shares of common stock per $1,000 of principal amount)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6c996ccf5375467690ef0a371d48e033_D20220101-20220930" decimals="4" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RhYmxlOjA0NjUzNjMxOTdjNDQ3OGVhODlmNDUxY2ZiZjI0MmQ2L3RhYmxlcmFuZ2U6MDQ2NTM2MzE5N2M0NDc4ZWE4OWY0NTFjZmJmMjQyZDZfNC0xLTEtMS03MDM2Mw_8384a53d-3eb6-4e99-a895-edb316028ebc">14.2967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective conversion price (per $1,000 of principal amount)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id074490de8a844b3947b679412d173b1_I20220930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RhYmxlOjA0NjUzNjMxOTdjNDQ3OGVhODlmNDUxY2ZiZjI0MmQ2L3RhYmxlcmFuZ2U6MDQ2NTM2MzE5N2M0NDc4ZWE4OWY0NTFjZmJmMjQyZDZfNS0xLTEtMS03MDM2Mw_9bcc62cd-3776-4fb1-9422-aba9081ae4ca">69.9462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a member, through certain subsidiaries, of the Federal Home Loan Bank of Indianapolis, the Federal Home Loan Bank of Cincinnati, the Federal Home Loan Bank of Atlanta and the Federal Home Loan Bank of New York (collectively, the &#8220;FHLBs&#8221;). As a member, we have the ability to obtain short-term cash advances, subject to certain minimum collateral requirements. We had $<ix:nonFraction unitRef="usd" contextRef="ie3ce2a7827404c4b95ca73a4c71f739d_I20220930" decimals="-6" name="us-gaap:FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNTE3OQ_bc12f8e2-8d3d-4c7b-88b2-02cc4c9f8937">265</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="idadc7d2ec88044dcaa0a3de4ed833cec_I20211231" decimals="-6" name="us-gaap:FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNTE4Ng_34f91294-8e22-4e2c-8038-78ab0533c75e">275</ix:nonFraction> of outstanding short-term borrowings from the FHLBs at September&#160;30, 2022 and December&#160;31, 2021, respectively.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All debt is a direct obligation of Elevance Health, Inc., except for the surplus note, the FHLB borrowings, and the Subsidiary Credit Facilities.</span></div></ix:continuation><div id="i186e051878fe4219970efc72a9fcdad4_73"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160; <ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83My9mcmFnOmRhNzY1OGIxZmY1MjQzNWNiOGM4OWRmNmFkZGI2ODM0L3RleHRyZWdpb246ZGE3NjU4YjFmZjUyNDM1Y2I4Yzg5ZGY2YWRkYjY4MzRfMjE5NDQ_ee1fc028-f21a-49ef-a8b7-6e87a476b9e9" continuedAt="i41a786af4aa14d0aa1fe4bcd143ed412" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i41a786af4aa14d0aa1fe4bcd143ed412" continuedAt="i68fbb629497e42dc830143e8443789f7"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Proceedings </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we are defendants in, or parties to, a number of pending or threatened legal actions or proceedings. To the extent a plaintiff or plaintiffs in the following cases have specified in their complaint or in other court filings the amount of damages being sought, we have noted those alleged damages in the descriptions below. With respect to the cases described below, we contest liability and/or the amount of damages in each matter and believe we have meritorious defenses.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where available information indicates that it is probable that a loss has been incurred as of the date of the consolidated financial statements and we can reasonably estimate the amount of that loss, we accrue the estimated loss by a charge to </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-27-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i68fbb629497e42dc830143e8443789f7" continuedAt="i199abbab2496465ea56053c8750662e1"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">income. In many proceedings, however, it is difficult to determine whether any loss is probable or reasonably possible. In addition, even where loss is possible or an exposure to loss exists in excess of the liability already accrued with respect to a previously identified loss contingency, it is not always possible to reasonably estimate the amount of the possible loss or range of loss. </span></div><div style="margin-bottom:9pt;padding-right:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to many of the proceedings to which we are a party, we cannot provide an estimate of the possible losses, or the range of possible losses in excess of the amount, if any, accrued, for various reasons, including but not limited to some or all of the following: (i) there are novel or unsettled legal issues presented, (ii) the proceedings are in early stages, (iii) there is uncertainty as to the likelihood of a class being certified or decertified or the ultimate size and scope of the class, (iv) there is uncertainty as to the outcome of pending appeals or motions, (v) there are significant factual issues to be resolved, and/or (vi) in many cases, the plaintiffs have not specified damages in their complaint or in court filings. For those legal proceedings where a loss is probable, or reasonably possible, and for which it is possible to reasonably estimate the amount of the possible loss or range of losses, we currently believe that the range of possible losses, in excess of established reserves is, in the aggregate, from $<ix:nonFraction unitRef="usd" contextRef="iec40b9c51c114cbc9d3101bef95add9d_I20220930" decimals="-6" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83My9mcmFnOmRhNzY1OGIxZmY1MjQzNWNiOGM4OWRmNmFkZGI2ODM0L3RleHRyZWdpb246ZGE3NjU4YjFmZjUyNDM1Y2I4Yzg5ZGY2YWRkYjY4MzRfMjI3MQ_acb4694c-60e6-4939-9f5c-de255970391e">0</ix:nonFraction> to approximately $<ix:nonFraction unitRef="usd" contextRef="i5a1b6fdf93194651bf7efdc8011a5b9c_I20220930" decimals="-6" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83My9mcmFnOmRhNzY1OGIxZmY1MjQzNWNiOGM4OWRmNmFkZGI2ODM0L3RleHRyZWdpb246ZGE3NjU4YjFmZjUyNDM1Y2I4Yzg5ZGY2YWRkYjY4MzRfMjI5MQ_aa8c36cc-bf8c-4681-be9d-5621137d5db6">250</ix:nonFraction> at September&#160;30, 2022. This estimated aggregate range of reasonably possible losses is based upon currently available information taking into account our best estimate of such losses for which such an estimate can be made.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Blue Cross Blue Shield Antitrust Litigation</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a defendant in multiple lawsuits that were initially filed in 2012 against the BCBSA and Blue Cross and/or Blue Shield licensees (the &#8220;Blue plans&#8221;) across the country. Cases filed in twenty-eight states were consolidated into a single, multi-district proceeding captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re Blue Cross Blue Shield Antitrust Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that is pending in the U.S. District Court for the Northern District of Alabama (the &#8220;Court&#8221;). Generally, the suits allege that the BCBSA and the Blue plans have conspired to horizontally allocate geographic markets through license agreements, best efforts rules that limit the percentage of non-Blue revenue of each plan, restrictions on acquisitions, rules governing the BlueCard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and National Accounts programs and other arrangements in violation of the Sherman Antitrust Act (&#8220;Sherman Act&#8221;) and related state laws. The cases were brought by two putative nationwide classes of plaintiffs, health plan subscribers and providers.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2018, the Court issued an order on the parties&#8217; cross motions for partial summary judgment, determining that the defendants&#8217; aggregation of geographic market allocations and output restrictions are to be analyzed under a per se standard of review, and the BlueCard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">program and other alleged Section 1 Sherman Act violations are to be analyzed under the rule of reason standard of review. With respect to whether the defendants operate as a single entity with regard to the enforcement of the Blue Cross Blue Shield trademarks, the Court found that summary judgment was not appropriate due to the existence of genuine issues of material fact. In April 2019, the plaintiffs filed motions for class certification, which defendants opposed.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The BCBSA and Blue plans approved a settlement agreement and release with the subscriber plaintiffs (the &#8220;Subscriber Settlement Agreement&#8221;), which agreement required the Court&#8217;s approval to become effective. The Subscriber Settlement Agreement requires the defendants to make a monetary settlement payment and contains certain terms imposing non-monetary obligations including (i) eliminating the &#8220;national best efforts&#8221; rule in the BCBSA license agreements (which rule limits the percentage of non-Blue revenue permitted for each Blue plan) and (ii) allowing for some large national employers with self-funded benefit plans to request a bid for insurance coverage from a second Blue plan in addition to the local Blue plan. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, the Court issued an order preliminarily approving the Subscriber Settlement Agreement, following which members of the subscriber class were provided notice of the Subscriber Settlement Agreement and an opportunity to opt out of the class. A small number of subscribers submitted valid opt-outs by the July 2021 opt-out deadline. In excess of <ix:nonFraction unitRef="number" contextRef="ief81cd0e712a4475b910c6e1044349aa_I20220930" decimals="0" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83My9mcmFnOmRhNzY1OGIxZmY1MjQzNWNiOGM4OWRmNmFkZGI2ODM0L3RleHRyZWdpb246ZGE3NjU4YjFmZjUyNDM1Y2I4Yzg5ZGY2YWRkYjY4MzRfNTY3Mg_2c5fe95f-4d39-4a39-8754-1722bf793413">eight thousand</ix:nonFraction> claims were submitted by the November 2021 claims submission deadline. A fairness hearing was held in October 2021 and the Court took the request for final approval under advisement and requested supplemental briefing that was submitted. In February 2022, the Court ordered the issuance of a supplemental notice to self-funded account class members, which notice process was completed in March 2022. The deadline for objections to the supplemental notice along with opt-outs was in May 2022</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Court issued a final approval order for the Subscriber Settlement Agreement. The Court amended its final approval order in September 2022, further clarifying the injunctive relief that may be available to subscribers who submitted valid opt-outs. In September 2022, an objector filed a motion to amend the final approval order, which the Court </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-28-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i199abbab2496465ea56053c8750662e1" continuedAt="i55dce0d6702f4343a5011b00e7f5cff5"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">denied. In compliance with the Subscriber Settlement Agreement, the Company paid its remaining $<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:LossContingencyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83My9mcmFnOmRhNzY1OGIxZmY1MjQzNWNiOGM4OWRmNmFkZGI2ODM0L3RleHRyZWdpb246ZGE3NjU4YjFmZjUyNDM1Y2I4Yzg5ZGY2YWRkYjY4MzRfMTY0OTI2NzQ3NTU5MA_05e34a7b-8272-4906-8f08-18031d157af1">506</ix:nonFraction> portion of the settlement fund into an escrow account in September 2022, for an aggregate settlement payment by the Company of $<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83My9mcmFnOmRhNzY1OGIxZmY1MjQzNWNiOGM4OWRmNmFkZGI2ODM0L3RleHRyZWdpb246ZGE3NjU4YjFmZjUyNDM1Y2I4Yzg5ZGY2YWRkYjY4MzRfMTY0OTI2NzQ3NTU4NA_d17c505e-b07b-4a08-a14c-3cdb82626035">596</ix:nonFraction>.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Four notices of appeal of the final approval order were filed by the September 2022 deadline. Those appeals will proceed in the United States Court of Appeals for the Eleventh Circuit. In October 2022, the subscriber plaintiffs filed a motion to consolidate and expedite the four appeals. After all appellate rights have been exhausted in a manner that affirms the Court&#8217;s final order and judgment, the defendants&#8217; payment and non-monetary obligations under the Subscriber Settlement Agreement will become effective.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, after the Court lifted the stay as to the provider litigation, provider plaintiffs filed a renewed motion for class certification, which defendants opposed. In March 2021, the Court issued an order terminating the pending motion for class certification until the Court determines the standard of review applicable to providers&#8217; claims. In May 2021, the defendants and provider plaintiffs filed renewed standard of review motions. In June 2021, the parties filed summary judgment motions not critically dependent on class certification. In February 2022, the Court issued (i) an order granting certain defendants&#8217; motion for partial summary judgment against provider plaintiffs who had previously released claims against such defendants, and (ii) an order granting provider plaintiffs&#8217; motion for partial summary judgment, holding that </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ohio v. American Express Co</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. does not affect the standard of review in this case. In August 2022, the Court issued (i) an order granting in part the defendants&#8217; motion regarding the antitrust standard of review, holding that for the period of time after the elimination of the &#8220;national best efforts&#8221; rule, the rule of reason applies to the provider plaintiffs&#8217; market allocation conspiracy claims, and (ii) an order denying the provider plaintiffs&#8217; motion for partial summary judgment on the standard of review, reaffirming its prior holding that the providers&#8217; group boycott claims are subject to the rule of reason. We intend to continue to vigorously defend the provider litigation, which we believe is without merit; however, its ultimate outcome cannot be presently determined.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of follow-on cases involving entities that opted out of the Subscriber Settlement Agreement have been filed. Those actions are:  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alaska Air Group, Inc., et al. v. Anthem, Inc., et al.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No. 2:21-cv-01209-AMM (N.D. Ala.); </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">JetBlue Airways Corp., et al. v. Anthem, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 2:22-cv-00558-GMB (N.D. Ala.); </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Metropolitan Transportation Authority v. Blue Cross and Blue Shield of Alabama et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 2:22-cv-00265-RDP (N.D. Ala.); </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bed Bath &amp; Beyond Inc. v. Anthem, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 2:22-cv-01256-SGC (N.D. Ala.);</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Hoover, et al. v. Blue Cross Blue Shield Association, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 2:22-cv-00261-RDP (N.D. Ala.); and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">VHS Liquidating Trust v. Blue Cross of California, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. RG21106600 (Cal. Super.). We intend to continue to vigorously defend these follow-on cases, which we believe are without merit; however, their ultimate outcome cannot be presently determined.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Blue Cross of California Taxation Litigation</span></div><div style="margin-bottom:9pt;padding-right:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2013, our California affiliate Blue Cross of California (doing business as Anthem Blue Cross) (&#8220;BCC&#8221;) was named as a defendant in a California taxpayer action filed in Los Angeles County Superior Court (the &#8220;Superior Court&#8221;) captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Michael D. Myers v. State Board of Equalization, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This action was brought under a California statute that permits an individual taxpayer to sue a governmental agency when the taxpayer believes the agency has failed to enforce governing law. Plaintiff contends that BCC, a licensed Health Care Service Plan, is an &#8220;insurer&#8221; for purposes of taxation despite acknowledging it is not an &#8220;insurer&#8221; under regulatory law. At the time, under California law, &#8220;insurers&#8221; were required to pay a gross premiums tax (&#8220;GPT&#8221;) calculated as <ix:nonFraction unitRef="number" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="4" name="elv:GrossPremiumTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83My9mcmFnOmRhNzY1OGIxZmY1MjQzNWNiOGM4OWRmNmFkZGI2ODM0L3RleHRyZWdpb246ZGE3NjU4YjFmZjUyNDM1Y2I4Yzg5ZGY2YWRkYjY4MzRfODQ0Ng_1956b65b-fcb5-41aa-a111-3104f37f395c">2.35</ix:nonFraction>% on gross premiums. As a licensed Health Care Service Plan, BCC has paid the California Corporate Franchise Tax (&#8220;CFT&#8221;), the tax paid by California businesses generally. Plaintiff contends that BCC must pay the GPT rather than the CFT, and seeks a writ of mandate directing the taxing agencies to collect the GPT and an order requiring BCC to pay GPT back taxes, interest, and penalties for the eight-year period prior to the filing of the complaint.</span></div><div style="margin-bottom:9pt;padding-right:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the GPT is constitutionally imposed in lieu of certain other taxes, BCC has filed protective tax refund claims with the City of Los Angeles, the California Department of Health Care Services and the Franchise Tax Board to protect its rights to recover certain taxes previously paid should BCC eventually be determined to be subject to the GPT for the tax periods at issue in the litigation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, the Superior Court denied BCC&#8217;s motion for judgment on the pleadings and similar motions brought by other entities. BCC filed a motion for summary judgment with the Superior Court, which was heard in October 2020. In December 2020, the Superior Court granted BCC&#8217;s motion for summary judgment, dismissing the plaintiff&#8217;s lawsuit. In </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-29-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i55dce0d6702f4343a5011b00e7f5cff5" continuedAt="i4e63b18aad9d4e83b3a1ec67e6c804a1"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 2021, the plaintiff appealed the order granting BCC's motion for summary judgment. BCC&#8217;s responding brief was filed in March 2022. Plaintiff&#8217;s reply was filed in May 2022. We estimate that the appeal will be heard in the winter of 2022. We intend to vigorously defend the appeal of this lawsuit.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Express Scripts, Inc. Pharmacy Benefit Management Litigation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2016, we filed a lawsuit against Express Scripts, Inc. (&#8220;Express Scripts&#8221;), our vendor at the time for PBM services, captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anthem, Inc. v. Express Scripts, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in the U.S. District Court for the Southern District of New York (the &#8220;District Court&#8221;). The lawsuit seeks to recover over $<ix:nonFraction unitRef="usd" contextRef="ie706cb4d8ca64cb3aeb950d443b981ec_D20220101-20220930" decimals="-6" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83My9mcmFnOmRhNzY1OGIxZmY1MjQzNWNiOGM4OWRmNmFkZGI2ODM0L3RleHRyZWdpb246ZGE3NjU4YjFmZjUyNDM1Y2I4Yzg5ZGY2YWRkYjY4MzRfMTAyNzA_b6115dea-b1e0-47f0-a511-50e753793e37">14,800</ix:nonFraction> in damages for pharmacy pricing that is higher than competitive benchmark pricing under the agreement between the parties (the &#8220;ESI PBM Agreement&#8221;), over $<ix:nonFraction unitRef="usd" contextRef="ib999e2b9904743fc9d242837ba067eb4_D20220101-20220930" decimals="-6" name="us-gaap:LossContingencyDamagesSoughtValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83My9mcmFnOmRhNzY1OGIxZmY1MjQzNWNiOGM4OWRmNmFkZGI2ODM0L3RleHRyZWdpb246ZGE3NjU4YjFmZjUyNDM1Y2I4Yzg5ZGY2YWRkYjY4MzRfMTA0Mjc_d5333b5e-800e-409b-bd04-29d6de567e44">158</ix:nonFraction> in damages related to operational breaches, as well as various declarations under the ESI PBM Agreement, including that Express Scripts: (i) breached its obligation to negotiate in good faith and to agree in writing to new pricing terms; (ii) was required to provide competitive benchmark pricing to us through the term of the ESI PBM Agreement; (iii) has breached the ESI PBM Agreement; and (iv) is required under the ESI PBM Agreement to provide post-termination services, at competitive benchmark pricing, for one year following any termination. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Express Scripts has disputed our contractual claims and is seeking declaratory judgments: (i) regarding the timing of the periodic pricing review under the ESI PBM Agreement, and (ii) that it has no obligation to ensure that we receive any specific level of pricing, that we have no contractual right to any change in pricing under the ESI PBM Agreement and that its sole obligation is to negotiate proposed pricing terms in good faith. In the alternative, Express Scripts claims that we have been unjustly enriched by its payment of $<ix:nonFraction unitRef="usd" contextRef="if86d9fcaf90e4c74a4febd7d2876346b_D20220101-20220930" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83My9mcmFnOmRhNzY1OGIxZmY1MjQzNWNiOGM4OWRmNmFkZGI2ODM0L3RleHRyZWdpb246ZGE3NjU4YjFmZjUyNDM1Y2I4Yzg5ZGY2YWRkYjY4MzRfMTE1MTQ_59175b89-c92f-4a5e-bfa0-2fa45a6e7a79">4,675</ix:nonFraction> at the time we entered into the ESI PBM Agreement. In March 2017, the District Court granted our motion to dismiss Express Scripts&#8217; counterclaims for (i) breach of the implied covenant of good faith and fair dealing, and (ii) unjust enrichment with prejudice. After such action, the only remaining claims were for breach of contract and declaratory relief. In August 2021, Express Scripts filed a motion for summary judgment, which we opposed. In March 2022, the District Court granted in part and denied in part Express Scripts&#8217; motion for summary judgment. The District Court dismissed our declaratory judgment claim, our breach of contract claim for failure to prove damages and most of our operational breach claims. As a result of the summary judgment decision, the only remaining claims as of the filing of this Quarterly Report on Form 10-Q are (i) our operational breach claim based on Express Scripts&#8217; prior authorization processes and (ii) Express Scripts&#8217; counterclaim for breach of the market check provision of the ESI PBM Agreement. Express Scripts filed a second motion for summary judgment in June 2022, challenging our remaining operational breach claims, which we opposed in July 2022. We intend to appeal the earlier summary judgment decision at the appropriate time, vigorously pursue our claims and defend against counterclaims, which we believe are without merit; however, the ultimate outcome of this litigation cannot be presently determined.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicare Risk Adjustment Litigation</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the U.S. Department of Justice (&#8220;DOJ&#8221;) filed a civil lawsuit against Elevance Health, Inc. (f/k/a Anthem, Inc.) in the U.S. District Court for the Southern District of New York (the &#8220;New York District Court&#8221;) in a case captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States v. Anthem, Inc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The DOJ&#8217;s suit alleges, among other things, that we falsely certified the accuracy of the diagnosis data we submitted to the Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;) for risk-adjustment purposes under Medicare Part C and knowingly failed to delete inaccurate diagnosis codes. The DOJ further alleges that, as a result of these purported acts, we caused CMS to calculate the risk-adjustment payments based on inaccurate diagnosis information, which enabled us to obtain unspecified amounts of payments in Medicare funds in violation of the False Claims Act. The DOJ filed an amended complaint in July 2020, alleging the same causes of action but revising some of its allegations. In September 2020, we filed a motion to transfer the lawsuit to the Southern District of Ohio, a motion to dismiss part of the lawsuit, and a motion to strike certain allegations in the amended complaint. In an opinion and order issued October 3, 2022, the New York District Court denied our motions, and the case will now proceed in such court. We intend to continue to vigorously defend this suit, which we believe is without merit; however, the ultimate outcome cannot be presently determined.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investigations of CareMore and HealthSun</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the assistance of outside counsel, we are conducting investigations of risk-adjustment practices involving data submitted to CMS (unrelated to our retrospective chart review program) at CareMore Health Plans, Inc. (&#8220;CareMore&#8221;), one of our California subsidiaries, and HealthSun Health Plans, Inc. (&#8220;HealthSun&#8221;), one of our Florida subsidiaries. Our CareMore investigation has resulted in the termination of CareMore&#8217;s relationship with one contracted provider in California. Our </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-30-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4e63b18aad9d4e83b3a1ec67e6c804a1" continuedAt="i3c3fee6b7fb04821b67cd74dff13369e"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HealthSun investigation has focused on risk adjustment practices initiated prior to our acquisition of HealthSun in December 2017 that continued after the acquisition. We have voluntarily self-disclosed the existence of both of our investigations to CMS and the Criminal and Civil Divisions of the DOJ. We are cooperating with the ongoing investigations of the Criminal and Civil Divisions of the DOJ related to these risk adjustment practices, and have entered into a tolling agreement with the Civil Division of the DOJ related to its investigation. We are analyzing the scope of potential data corrections to be submitted to CMS and have begun to submit data corrections to CMS. We have also asserted indemnity claims for escrowed funds under the HealthSun purchase agreement for, among other things, breach of healthcare and financial representation provisions, based on the conduct discovered during our investigation. While certain elements of the escrow claims were resolved in the fourth quarter of 2021, litigation in the Delaware Court of Chancery related to the remaining indemnity claims for escrowed funds remains ongoing.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%">Other Contingencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we and certain of our subsidiaries are parties to various legal proceedings, many of which involve claims for coverage encountered in the ordinary course of business. We, like Health Maintenance Organizations (&#8220;HMOs&#8221;) and health insurers generally, exclude certain healthcare and other services from coverage under our HMO, Preferred Provider Organizations and other plans. We are, in the ordinary course of business, subject to the claims of our enrollees arising out of decisions to restrict or deny reimbursement for uncovered services. The loss of even one such claim, if it results in a significant punitive damage award, could have a material adverse effect on us. In addition, the risk of potential liability under punitive damage theories may increase significantly the difficulty of obtaining reasonable reimbursement of coverage claims. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the lawsuits described above, we are also involved in other pending and threatened litigation of the character incidental to our business and are from time to time involved as a party in various governmental investigations, audits, reviews and administrative proceedings. These investigations, audits, reviews and administrative proceedings include routine and special inquiries by state insurance departments, state attorneys general, the U.S. Attorney General and subcommittees of the U.S. Congress. Such investigations, audits, reviews and administrative proceedings could result in the imposition of civil or criminal fines, penalties, other sanctions and additional rules, regulations or other restrictions on our business operations. Any liability that may result from any one of these actions, or in the aggregate, could have a material adverse effect on our consolidated financial position or results of operations. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contractual Obligations and Commitments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, we entered into an agreement with a vendor for information technology infrastructure and related management and support services through June 2025. The new agreement supersedes certain prior agreements for such services and includes provisions for additional services not provided under those agreements. Our remaining commitment under this agreement at September&#160;30, 2022 is approximately $<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:LongTermPurchaseCommitmentAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83My9mcmFnOmRhNzY1OGIxZmY1MjQzNWNiOGM4OWRmNmFkZGI2ODM0L3RleHRyZWdpb246ZGE3NjU4YjFmZjUyNDM1Y2I4Yzg5ZGY2YWRkYjY4MzRfMjA5NTA_d28985e6-c372-4cac-ab7f-62478eada1e2">830</ix:nonFraction>. We will have the ability to terminate the agreement upon the occurrence of certain events, subject to early termination fees.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3c3fee6b7fb04821b67cd74dff13369e">In the second quarter of 2019, we began using our pharmacy benefits manager IngenioRx to market and offer PBM services to our affiliated health plan customers, as well as to external customers outside of the health plans we own. The comprehensive PBM services portfolio includes, but is not limited to, formulary management, pharmacy networks, prescription drug database, member services and mail order capabilities. IngenioRx delegates certain PBM administrative functions, such as claims processing and prescription fulfillment, to CaremarkPCS Health, L.L.C., which is a subsidiary of CVS Health Corporation, pursuant to a five-year agreement. With IngenioRx, we retain the responsibilities for clinical and formulary strategy and development, member and employer experiences, operations, sales, marketing, account management and retail network strategy.</ix:continuation> </span></div><div id="i186e051878fe4219970efc72a9fcdad4_76"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160; <ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfMzMyMA_3a0e4abb-ea4e-4984-a313-dce3de60148d" continuedAt="i025ec4ff2fb245fbb67f2df6e93bf474" escape="true">Capital Stock</ix:nonNumeric></span></div><ix:continuation id="i025ec4ff2fb245fbb67f2df6e93bf474" continuedAt="i1477be6f7c894d5c8df177a3632c3474"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Capital &#8211; Dividends and Stock Repurchase Program</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly review the appropriate use of capital, including acquisitions, common stock and debt security repurchases and dividends to shareholders. The declaration and payment of any dividends or repurchases of our common stock or debt is at the discretion of our Board of Directors and depends upon our financial condition, results of operations, future liquidity needs, regulatory and capital requirements and other factors deemed relevant by our Board of Directors. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-31-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1477be6f7c894d5c8df177a3632c3474" continuedAt="i8814f2cc7bb1465b9c8dbb8f1286434f"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:DividendsDeclaredTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfMzMwMw_feea82db-e900-4f61-a92a-1a04bae774c6" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our cash dividend activity for the nine months ended September 30, 2022 and 2021 is as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.553%"><tr><td style="width:1.0%"></td><td style="width:40.006%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.837%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.837%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.914%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.918%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Declaration Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Record&#160;Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Payment&#160;Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dividend</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">per&#160;Share</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331" name="us-gaap:DividendsPayableDateDeclaredDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMi0wLTEtMS03MDM2Mw_7e672788-8462-4d6a-8ee4-ee8b1425f691">January 25, 2022</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMi0yLTEtMS03MDM2Mw_40bdf22b-770c-4310-a998-c3ed039bec37">March 10, 2022</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331" name="us-gaap:DividendPayableDateToBePaidDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMi00LTEtMS03MDM2Mw_2c2bd43c-2dda-4864-ad07-b1f9deaaea51">March 25, 2022</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMi02LTEtMS03MDM2Mw_0427d940-ac4d-42c6-a75f-b9b26609d133">1.28</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMi04LTEtMS03MDM2Mw_f720cff0-5376-4794-9d20-de92adbb2df8">309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630" name="us-gaap:DividendsPayableDateDeclaredDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMy0wLTEtMS03MDM2Mw_10c75a85-3897-4455-a1b2-ebe06748594b">April 19, 2022</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMy0yLTEtMS03MDM2Mw_995494aa-8aba-4def-bc6d-23b693e4539c">June 10, 2022</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630" name="us-gaap:DividendPayableDateToBePaidDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMy00LTEtMS03MDM2Mw_cdc83058-e412-4185-b87f-82fb7c5264c7">June 24, 2022</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMy02LTEtMS03MDM2Mw_79097a6e-bddb-460b-b2d4-3b4809d656b3">1.28</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMy04LTEtMS03MDM2Mw_7496b180-dcb2-4292-bbbe-fe54951dc495">309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" name="us-gaap:DividendsPayableDateDeclaredDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfNC0wLTEtMS03MDM2Mw_d2f0823d-10b4-44ee-885d-1d325c29cc27">July 19, 2022</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfNC0yLTEtMS03MDM2Mw_e5e001bc-058d-4052-a619-93bbfde01b9e">September 9, 2022</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" name="us-gaap:DividendPayableDateToBePaidDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfNC00LTEtMS03MDM2Mw_77601be3-ce75-494d-80d6-e8633ab6d727">September 23, 2022</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfNC02LTEtMS03MDM2Mw_f97a5052-fc99-414e-8197-61008b45c381">1.28</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfNC04LTEtMS03MDM2Mw_442f253c-a75d-4eee-b922-17785eeeb0d8">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331" name="us-gaap:DividendsPayableDateDeclaredDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfOS0wLTEtMS03MDM2Mw_bc73217e-29b7-4a08-bffc-98f8acabbdcd">January 26, 2021</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfOS0yLTEtMS03MDM2Mw_21d9ba3b-c9a4-4c5b-adca-2202fff97dd7">March 10, 2021</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331" name="us-gaap:DividendPayableDateToBePaidDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfOS00LTEtMS03MDM2Mw_4135cb62-9402-43a6-b69b-01c3749bdbbf">March 25, 2021</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfOS02LTEtMS03MDM2Mw_2d75775d-6376-4796-b776-de1bc86d49cc">1.13</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfOS04LTEtMS03MDM2Mw_2a97e3f2-a4fc-4a61-bc61-cfce65bc6274">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630" name="us-gaap:DividendsPayableDateDeclaredDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMTAtMC0xLTEtNzAzNjM_12ae60bd-d58a-4c4b-9383-f965a21740fc">April 20, 2021</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMTAtMi0xLTEtNzAzNjM_32c09c9f-ab4f-491d-a686-06f251e5c930">June 10, 2021</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630" name="us-gaap:DividendPayableDateToBePaidDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMTAtNC0xLTEtNzAzNjM_41a6c538-38ae-4cb0-8e95-46d7e483fac6">June 25, 2021</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMTAtNi0xLTEtNzAzNjM_70d5679e-329a-41ed-a46a-c1bcbfe83307">1.13</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMTAtOC0xLTEtNzAzNjM_045bfdfd-14ba-43f0-a810-095abf5a84f3">278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" name="us-gaap:DividendsPayableDateDeclaredDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMTEtMC0xLTEtNzAzNjM_7d79fdfb-0fff-4965-95a0-b8f2c50ad662">July 20, 2021</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMTEtMi0xLTEtNzAzNjM_65ed36e8-a472-4a17-a6ed-b1b7349f3911">September 10, 2021</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" name="us-gaap:DividendPayableDateToBePaidDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMTEtNC0xLTEtNzAzNjM_82fce437-90da-4c42-920f-c16bf7df83b3">September 24, 2021</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMTEtNi0xLTEtNzAzNjM_b0a7141d-89e2-49ab-905e-c4db913c40e9">1.13</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMTEtOC0xLTEtNzAzNjM_22c4c17e-a53d-4dd5-9657-1e26af8a8369">276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 18, 2022, our Audit Committee declared a fourth quarter 2022 dividend to shareholders of $<ix:nonFraction unitRef="usdPerShare" contextRef="i593ccc71545a463aa762ea6a7a1efafc_I20221018" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfNzI0_f16bd257-8c6b-41a9-b8f8-15337f8493fd">1.28</ix:nonFraction> per share, payable on <ix:nonNumeric contextRef="if9e73fa43f474637904386532065813b_D20221018-20221018" name="us-gaap:DividendPayableDateToBePaidDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfNzQ5_a317c3fe-6da8-4cbd-8fa8-73dda8b0eb39">December 21, 2022</ix:nonNumeric> to shareholders of record at the close of business on <ix:nonNumeric contextRef="if9e73fa43f474637904386532065813b_D20221018-20221018" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfODA2_5cde05ab-efa5-4fc6-8b52-1182d1ca3195">December 5, 2022</ix:nonNumeric>.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our Board of Directors&#8217; authorization, we maintain a common stock repurchase program. On January 26, 2021, our Audit Committee, pursuant to authorization granted by the Board of Directors, authorized a $<ix:nonFraction unitRef="usd" contextRef="i90083e53041c4397abce83d13efa37ae_I20210126" decimals="-6" name="elv:IncreaseInStockRepurchaseProgramAuthorization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfMTAxOA_912a8d04-50c6-465f-be3e-9eaa1572d9cb">5,000</ix:nonFraction> increase to the common stock repurchase program. Repurchases may be made from time to time at prevailing market prices, subject to certain restrictions on volume, pricing and timing. The repurchases are effected from time to time in the open market, through negotiated transactions, including accelerated share repurchase agreements, and through plans designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Our stock repurchase program is discretionary, as we are under no obligation to repurchase shares. We repurchase shares under the program when we believe it is a prudent use of capital. The excess cost of the repurchased shares over par value is charged on a pro rata basis to additional paid-in capital and retained earnings. </span></div><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfMzI5Mw_9bb5a618-0613-4147-befc-7cb09a270acb" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of common stock repurchases for the nine months ended September 30, 2022 and 2021 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.847%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjAxZDRjMzVlOWYyNTQyOTM5ZTllZjVjNGVhN2UwODE4L3RhYmxlcmFuZ2U6MDFkNGMzNWU5ZjI1NDI5MzllOWVmNWM0ZWE3ZTA4MThfMi0yLTEtMS03MDM2Mw_9adb3b42-0704-418c-a76f-fd7cd0b9b263">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjAxZDRjMzVlOWYyNTQyOTM5ZTllZjVjNGVhN2UwODE4L3RhYmxlcmFuZ2U6MDFkNGMzNWU5ZjI1NDI5MzllOWVmNWM0ZWE3ZTA4MThfMi00LTEtMS03MDM2Mw_6f148e76-4f0f-4d18-9192-33cf515cb04d">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="2" name="elv:StockRepurchasedAndRetiredDuringPeriodAveragePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjAxZDRjMzVlOWYyNTQyOTM5ZTllZjVjNGVhN2UwODE4L3RhYmxlcmFuZ2U6MDFkNGMzNWU5ZjI1NDI5MzllOWVmNWM0ZWE3ZTA4MThfMy0yLTEtMS03MDM2Mw_f37bf6a5-c26a-48f2-83ce-e0b9e983fb2d">473.36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="2" name="elv:StockRepurchasedAndRetiredDuringPeriodAveragePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjAxZDRjMzVlOWYyNTQyOTM5ZTllZjVjNGVhN2UwODE4L3RhYmxlcmFuZ2U6MDFkNGMzNWU5ZjI1NDI5MzllOWVmNWM0ZWE3ZTA4MThfMy00LTEtMS03MDM2Mw_ef1fb990-bb8c-4342-980e-554aa3d9da2c">356.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjAxZDRjMzVlOWYyNTQyOTM5ZTllZjVjNGVhN2UwODE4L3RhYmxlcmFuZ2U6MDFkNGMzNWU5ZjI1NDI5MzllOWVmNWM0ZWE3ZTA4MThfNC0yLTEtMS03MDM2Mw_f79d2611-b024-48d8-8f4a-06c22a071f88">1,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjAxZDRjMzVlOWYyNTQyOTM5ZTllZjVjNGVhN2UwODE4L3RhYmxlcmFuZ2U6MDFkNGMzNWU5ZjI1NDI5MzllOWVmNWM0ZWE3ZTA4MThfNC00LTEtMS03MDM2Mw_806dbcb0-6f7b-4e4e-b92e-b8502976c26f">1,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorization remaining at the end of the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjAxZDRjMzVlOWYyNTQyOTM5ZTllZjVjNGVhN2UwODE4L3RhYmxlcmFuZ2U6MDFkNGMzNWU5ZjI1NDI5MzllOWVmNWM0ZWE3ZTA4MThfNS0yLTEtMS03MDM2Mw_805857a5-ad61-444c-a17d-ab4ef939b730">2,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7580839926f4e24b08f10312dd69479_I20210930" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjAxZDRjMzVlOWYyNTQyOTM5ZTllZjVjNGVhN2UwODE4L3RhYmxlcmFuZ2U6MDFkNGMzNWU5ZjI1NDI5MzllOWVmNWM0ZWE3ZTA4MThfNS00LTEtMS03MDM2Mw_edf4a7c4-245c-42a3-b221-a2aec6d4bbcb">4,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding the use of capital for debt security repurchases, see Note 10, &#8220;Debt,&#8221; included in this Form 10-Q and Note 13, &#8220;Debt,&#8221; to our audited consolidated financial statements as of and for the year ended December&#160;31, 2021 included in our 2021 Annual Report on Form 10-K. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-32-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8814f2cc7bb1465b9c8dbb8f1286434f" continuedAt="i6fc0fdecff3b4213a80a5878ddff381a"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Incentive Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">s</span></div><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfMzI5Nw_393efecb-647f-4653-9034-4371d2834304" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity for the nine months ended September 30, 2022 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:44.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.887%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Option&#160;Price<br/>per&#160;Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life&#160;(Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfMS0xLTEtMS03MDM2Mw_5a394bc8-681f-465a-895e-1583dac19ead">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfMS0zLTEtMS03MDM2Mw_d6ac1941-65b3-4747-a57c-0359fe25120d">255.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfMi0xLTEtMS03MDM2Mw_80b374ef-18ec-4824-aab9-e529f62afc55">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfMi0zLTEtMS03MDM2Mw_419ecac4-3836-4a41-bde0-eec75c55930d">452.34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfMy0xLTEtMS03MDM2Mw_12116a74-729c-4d3c-a138-6085832544d1">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfMy0zLTEtMS03MDM2Mw_5544cf4b-2b80-453c-99e6-4e8a91e5243a">243.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfNC0xLTEtMS03MDM2Mw_b92d94b7-b545-4406-a5f4-e3fecaad487a">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfNC0zLTEtMS03MDM2Mw_0963c932-7425-4c29-b2b8-5482e13eaeb3">339.52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfNS0xLTEtMS03MDM2Mw_57435f8b-a549-43c8-8977-40359caf7c1b">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfNS0zLTEtMS03MDM2Mw_123cc4cc-a1c6-4ab4-b53d-4b3d259725e2">291.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfNS01LTEtMS03MDM2Mw_5fe47ac2-fa5e-4083-8f11-a6c48221b4e6">6.56</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfNS03LTEtMS03MDM2Mw_1b374e1d-286f-4481-81f9-2ed04db8f217">477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfNi0xLTEtMS03MDM2Mw_fd8a76f4-6be9-41da-af04-bb0d207e5723">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfNi0zLTEtMS03MDM2Mw_45b39c71-e465-4a95-acdd-0a15eea2551a">239.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfNi01LTEtMS03MDM2Mw_8db85bb4-38ae-4826-a638-05f5ff2a664b">5.35</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfNi03LTEtMS03MDM2Mw_0657530e-f73d-4f0a-a31c-545877343ab9">370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfMzI5MA_55a2f08e-0a8a-49a7-a350-01778e3730f4" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the status of nonvested restricted stock activity, including restricted stock units and performance units, for the nine months ended September 30, 2022 is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:72.183%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.886%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted<br/>Stock&#160;Shares<br/>and Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant&#160;Date<br/>Fair&#160;Value<br/>per&#160;Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjFjNjUxNDZiMjI1MTQ5MTZiMDc4ZDE0YTZhODAyYjU0L3RhYmxlcmFuZ2U6MWM2NTE0NmIyMjUxNDkxNmIwNzhkMTRhNmE4MDJiNTRfMS0xLTEtMS03MDM2Mw_c0056a59-e6f1-43e1-b6ea-1d15ece17d6e">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjFjNjUxNDZiMjI1MTQ5MTZiMDc4ZDE0YTZhODAyYjU0L3RhYmxlcmFuZ2U6MWM2NTE0NmIyMjUxNDkxNmIwNzhkMTRhNmE4MDJiNTRfMS0zLTEtMS03MDM2Mw_00a1ce53-8107-4f2b-80c1-dbb35f4b33eb">299.65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjFjNjUxNDZiMjI1MTQ5MTZiMDc4ZDE0YTZhODAyYjU0L3RhYmxlcmFuZ2U6MWM2NTE0NmIyMjUxNDkxNmIwNzhkMTRhNmE4MDJiNTRfMi0xLTEtMS03MDM2Mw_b36c4f8a-73fd-47f7-aeff-d2d45c6b9dbc">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjFjNjUxNDZiMjI1MTQ5MTZiMDc4ZDE0YTZhODAyYjU0L3RhYmxlcmFuZ2U6MWM2NTE0NmIyMjUxNDkxNmIwNzhkMTRhNmE4MDJiNTRfMi0zLTEtMS03MDM2Mw_fea2ab62-4c20-40f7-b1ba-8b65f010b471">453.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjFjNjUxNDZiMjI1MTQ5MTZiMDc4ZDE0YTZhODAyYjU0L3RhYmxlcmFuZ2U6MWM2NTE0NmIyMjUxNDkxNmIwNzhkMTRhNmE4MDJiNTRfMy0xLTEtMS03MDM2Mw_bdce7066-060e-4649-a3ee-5eb83eb006d0">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjFjNjUxNDZiMjI1MTQ5MTZiMDc4ZDE0YTZhODAyYjU0L3RhYmxlcmFuZ2U6MWM2NTE0NmIyMjUxNDkxNmIwNzhkMTRhNmE4MDJiNTRfMy0zLTEtMS03MDM2Mw_54beb487-881e-4d7a-a804-75f3767e38e9">301.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjFjNjUxNDZiMjI1MTQ5MTZiMDc4ZDE0YTZhODAyYjU0L3RhYmxlcmFuZ2U6MWM2NTE0NmIyMjUxNDkxNmIwNzhkMTRhNmE4MDJiNTRfNC0xLTEtMS03MDM2Mw_86b2113d-c0c9-4209-b123-8298bd744500">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjFjNjUxNDZiMjI1MTQ5MTZiMDc4ZDE0YTZhODAyYjU0L3RhYmxlcmFuZ2U6MWM2NTE0NmIyMjUxNDkxNmIwNzhkMTRhNmE4MDJiNTRfNC0zLTEtMS03MDM2Mw_ff4e9e81-aad8-4ffd-8254-dc7a992893b8">345.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjFjNjUxNDZiMjI1MTQ5MTZiMDc4ZDE0YTZhODAyYjU0L3RhYmxlcmFuZ2U6MWM2NTE0NmIyMjUxNDkxNmIwNzhkMTRhNmE4MDJiNTRfNS0xLTEtMS03MDM2Mw_459baa5c-d5b1-41c6-bd7a-606f45b02d75">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjFjNjUxNDZiMjI1MTQ5MTZiMDc4ZDE0YTZhODAyYjU0L3RhYmxlcmFuZ2U6MWM2NTE0NmIyMjUxNDkxNmIwNzhkMTRhNmE4MDJiNTRfNS0zLTEtMS03MDM2Mw_6c6ed712-a49d-42fa-b4b2-21d4d8cca557">356.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2022, we granted approximately <ix:nonFraction unitRef="shares" contextRef="i59f143f05a8b4cdf99dd35b50717b3d8_D20220101-20220930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfMjQyMw_b63151f1-e809-408f-a827-b1b8d34cfd5d">0.2</ix:nonFraction> restricted stock units that are contingent upon us achieving earnings targets over the three year period from 2022 to 2024. These grants have been included in the activity shown above, but will be subject to adjustment at the end of 2024 based on results in the three year period.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use a binomial lattice valuation model to estimate the fair value of all stock options granted. For a more detailed discussion of our stock incentive plan fair value methodology, see Note 15, &#8220;Capital Stock,&#8221; to our audited consolidated financial statements as of and for the year ended December&#160;31, 2021 included in our 2021 Annual Report on Form 10-K. </span></div><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfMzI4Mw_27900621-2114-40c9-9857-ceef4e5dcd3b" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average assumptions were used to estimate the fair values of options granted during the nine months ended September 30, 2022 and 2021:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:72.183%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.886%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjg1YWE1MzhhYzNkNTRhZTdhMDg0NGYzY2QzOTdjOTRmL3RhYmxlcmFuZ2U6ODVhYTUzOGFjM2Q1NGFlN2EwODQ0ZjNjZDM5N2M5NGZfMi0xLTEtMS03MDM2Mw_3e55de1c-7105-4bd3-9f7e-273c2546216c">1.97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjg1YWE1MzhhYzNkNTRhZTdhMDg0NGYzY2QzOTdjOTRmL3RhYmxlcmFuZ2U6ODVhYTUzOGFjM2Q1NGFlN2EwODQ0ZjNjZDM5N2M5NGZfMi0zLTEtMS03MDM2Mw_ef6b241b-92c9-4829-ba31-b66909f8a88b">1.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility factor</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjg1YWE1MzhhYzNkNTRhZTdhMDg0NGYzY2QzOTdjOTRmL3RhYmxlcmFuZ2U6ODVhYTUzOGFjM2Q1NGFlN2EwODQ0ZjNjZDM5N2M5NGZfMy0xLTEtMS03MDM2Mw_de45eb4b-1588-40e6-8670-7c11d9817950">29.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjg1YWE1MzhhYzNkNTRhZTdhMDg0NGYzY2QzOTdjOTRmL3RhYmxlcmFuZ2U6ODVhYTUzOGFjM2Q1NGFlN2EwODQ0ZjNjZDM5N2M5NGZfMy0zLTEtMS03MDM2Mw_06af6052-b7b5-4223-a40e-8c6a72a43f54">30.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarterly dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjg1YWE1MzhhYzNkNTRhZTdhMDg0NGYzY2QzOTdjOTRmL3RhYmxlcmFuZ2U6ODVhYTUzOGFjM2Q1NGFlN2EwODQ0ZjNjZDM5N2M5NGZfNC0xLTEtMS03MDM2Mw_ac2f8b8c-3f7a-472d-b19b-31562ae43107">0.282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjg1YWE1MzhhYzNkNTRhZTdhMDg0NGYzY2QzOTdjOTRmL3RhYmxlcmFuZ2U6ODVhYTUzOGFjM2Q1NGFlN2EwODQ0ZjNjZDM5N2M5NGZfNC0zLTEtMS03MDM2Mw_c0a80567-fd77-4afb-80a4-2f4c69ad974d">0.360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average expected life (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjg1YWE1MzhhYzNkNTRhZTdhMDg0NGYzY2QzOTdjOTRmL3RhYmxlcmFuZ2U6ODVhYTUzOGFjM2Q1NGFlN2EwODQ0ZjNjZDM5N2M5NGZfNS0xLTEtMS03MDM2Mw_c0488406-5fb6-4c0b-bc58-974b7cebe37f">5.10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjg1YWE1MzhhYzNkNTRhZTdhMDg0NGYzY2QzOTdjOTRmL3RhYmxlcmFuZ2U6ODVhYTUzOGFjM2Q1NGFlN2EwODQ0ZjNjZDM5N2M5NGZfNS0zLTEtMS03MDM2Mw_7391decd-7fc6-4e94-9bfa-e0849b6d912e">5.50</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-33-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6fc0fdecff3b4213a80a5878ddff381a"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfMzI4NQ_bb9a9fb9-6083-40c9-9361-3e8a98917b44" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average fair values per option or share were determined for the nine months ended September 30, 2022 and 2021:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:72.183%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.886%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted during the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjQxNjdiNDkzOTJmNTRkODk4NTNmMDdlMmRhZDI3NWRhL3RhYmxlcmFuZ2U6NDE2N2I0OTM5MmY1NGQ4OTg1M2YwN2UyZGFkMjc1ZGFfMi0xLTEtMS03MDM2Mw_ae91e3dd-53fd-4cd9-9474-832a15d912ed">116.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjQxNjdiNDkzOTJmNTRkODk4NTNmMDdlMmRhZDI3NWRhL3RhYmxlcmFuZ2U6NDE2N2I0OTM5MmY1NGQ4OTg1M2YwN2UyZGFkMjc1ZGFfMi0zLTEtMS03MDM2Mw_5b88c9dc-76bc-407a-a97c-3c7fc6404599">79.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock awards granted during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjQxNjdiNDkzOTJmNTRkODk4NTNmMDdlMmRhZDI3NWRhL3RhYmxlcmFuZ2U6NDE2N2I0OTM5MmY1NGQ4OTg1M2YwN2UyZGFkMjc1ZGFfMy0xLTEtMS03MDM2Mw_42aa8a68-daf9-4a34-9267-5e8d01879b36">453.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjQxNjdiNDkzOTJmNTRkODk4NTNmMDdlMmRhZDI3NWRhL3RhYmxlcmFuZ2U6NDE2N2I0OTM5MmY1NGQ4OTg1M2YwN2UyZGFkMjc1ZGFfMy0zLTEtMS03MDM2Mw_9d292e6f-273f-4544-8d9f-ada74d7b04cb">315.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-34-</span></div></div></div><div id="i186e051878fe4219970efc72a9fcdad4_79"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160; <ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RleHRyZWdpb246MWMyNzAwYTQxY2U5NGViYjgwZTE1YTRhNTg5MDA3OTVfMTU1_c6108a0e-77e8-48f4-b68a-41175105a3a8" continuedAt="i57e4410cf5fe4901844b1a8dc3a66698" escape="true">Accumulated Other Comprehensive Loss </ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-indent:18pt"><ix:continuation id="i57e4410cf5fe4901844b1a8dc3a66698"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RleHRyZWdpb246MWMyNzAwYTQxY2U5NGViYjgwZTE1YTRhNTg5MDA3OTVfMTUx_5296ee18-74c7-4c6f-9218-fd69664df2ae" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the components of accumulated other comprehensive loss at September&#160;30, 2022 and 2021 is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.872%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended <br/>September 30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment (losses) gains:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0032fd5f2e3430db780393923fe52c6_I20220630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMy0xLTEtMS03MDM2Mw_16e9d0b1-53a7-452f-afd0-671d7898f186">1,489</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1666c9555de74b4dbc65fef3b1b917cd_I20210630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMy0zLTEtMS03MDM2Mw_40b98505-cdb3-4cdd-8267-7fcba352c72f">762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1506e71de0d34c81941b49a8af7876e9_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMy01LTEtMS03MDM2Mw_4aa3b4fa-ea31-424c-8c5e-79f8987f5252">494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1a95b18f4a549a9916b28653b0280e7_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMy03LTEtMS03MDM2Mw_952b897b-54b1-4498-bdf8-3ff488b4d840">949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications, net of tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i8cf014dd12e9477788ecb92ec4a95f02_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNC0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjI0ZmNhMzE4YTExMTRhNzE4ODMxNGU3MWExNTYxMzFjXzk2_0fed2c7b-fe76-4059-b8f7-719cd590272a">220</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i488068315a5d438e968d54c5b20cc063_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNC0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjI0ZmNhMzE4YTExMTRhNzE4ODMxNGU3MWExNTYxMzFjXzEwMA_7c531feb-1eef-462e-8b93-2feac596da60">25</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i2d87ef5b685049cc85f3a91696bb60cb_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNC0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjI0ZmNhMzE4YTExMTRhNzE4ODMxNGU3MWExNTYxMzFjXzEwNA_0d8cedce-2976-4339-9d0c-aff4288bae6f">896</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i6a64d441bc804e49bc8a45a553ba2057_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNC0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjI0ZmNhMzE4YTExMTRhNzE4ODMxNGU3MWExNTYxMzFjXzExMQ_a7d31df0-8bd9-4128-ac62-f06ab224b53b">71</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8cf014dd12e9477788ecb92ec4a95f02_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNC0xLTEtMS03MDM2Mw_8e938bf5-cda6-4964-8586-bae586be16f0">719</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488068315a5d438e968d54c5b20cc063_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNC0zLTEtMS03MDM2Mw_e7b8b8f4-6558-4292-af74-ba63128b7203">80</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d87ef5b685049cc85f3a91696bb60cb_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNC01LTEtMS03MDM2Mw_93974d7d-a025-4249-9103-8ed4e393ff48">2,914</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a64d441bc804e49bc8a45a553ba2057_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNC03LTEtMS03MDM2Mw_e8b59aff-c8ca-4527-ad93-4fd3a42af0da">203</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss, net of tax (expense) benefit of $(<ix:nonFraction unitRef="usd" contextRef="i8cf014dd12e9477788ecb92ec4a95f02_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNS0wLTEtMS03MDM2My90ZXh0cmVnaW9uOmMzYjQ4ZWJhOWE4ZjQzOWY5NTFiNWEwMjNmNWI4ZDViXzEwMA_2e9da788-b172-4b63-bb08-18d2cac8b3d5">21</ix:nonFraction>), $<ix:nonFraction unitRef="usd" contextRef="i488068315a5d438e968d54c5b20cc063_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNS0wLTEtMS03MDM2My90ZXh0cmVnaW9uOmMzYjQ4ZWJhOWE4ZjQzOWY5NTFiNWEwMjNmNWI4ZDViXzEwNA_8f38b111-90ad-491b-8ad8-6378eec87de6">5</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="i2d87ef5b685049cc85f3a91696bb60cb_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNS0wLTEtMS03MDM2My90ZXh0cmVnaW9uOmMzYjQ4ZWJhOWE4ZjQzOWY5NTFiNWEwMjNmNWI4ZDViXzEwOA_cb315003-e0f5-4f26-a7c8-9ecb4f76c493">75</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="i6a64d441bc804e49bc8a45a553ba2057_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNS0wLTEtMS03MDM2My90ZXh0cmVnaW9uOmMzYjQ4ZWJhOWE4ZjQzOWY5NTFiNWEwMjNmNWI4ZDViXzExNQ_fea21229-26be-4cff-a7cd-d84b4f4052a8">21</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cf014dd12e9477788ecb92ec4a95f02_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNS0xLTEtMS03MDM2Mw_74002007-cf3f-4da8-b284-363cf764cc33">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488068315a5d438e968d54c5b20cc063_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNS0zLTEtMS03MDM2Mw_551883fd-f4bc-4e7a-8fb0-02b57c063321">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d87ef5b685049cc85f3a91696bb60cb_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNS01LTEtMS03MDM2Mw_9ff254bf-9f01-487e-a8de-ae00ed62a8de">284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a64d441bc804e49bc8a45a553ba2057_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNS03LTEtMS03MDM2Mw_ad697c33-4e53-42d0-bdf3-01c3d7c04e20">81</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8cf014dd12e9477788ecb92ec4a95f02_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNi0xLTEtMS03MDM2Mw_e9d37686-6b15-4e1d-a763-273001905bce">639</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488068315a5d438e968d54c5b20cc063_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNi0zLTEtMS03MDM2Mw_bc966a56-ceee-4bc4-9406-f4aaa2be3791">97</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d87ef5b685049cc85f3a91696bb60cb_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNi01LTEtMS03MDM2Mw_0e36d2f6-df2a-40b2-a9b1-0f077ea063ae">2,630</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a64d441bc804e49bc8a45a553ba2057_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNi03LTEtMS03MDM2Mw_ea6abca0-eeef-466b-a368-32af53cee63e">284</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss attributable to noncontrolling interests, net of tax benefit of $(<ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNy0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjlhN2UyN2E1MzhlYjQ2NjI4OWRjNmJkM2Y4MzY1NTdhXzExMg_2cfa2cab-afab-46e0-b4cd-5d548572fb67">1</ix:nonFraction>), $<ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNy0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjlhN2UyN2E1MzhlYjQ2NjI4OWRjNmJkM2Y4MzY1NTdhXzExNg_477d87e2-ca51-44dc-bddd-2e2ba837bb8f">0</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNy0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjlhN2UyN2E1MzhlYjQ2NjI4OWRjNmJkM2Y4MzY1NTdhXzEyMA_ead5e4b6-2772-4383-93ce-b3d386d51160">4</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNy0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjlhN2UyN2E1MzhlYjQ2NjI4OWRjNmJkM2Y4MzY1NTdhXzEyNw_cc409444-547b-42ae-8eef-98125a54743f">1</ix:nonFraction>), respectively</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cf014dd12e9477788ecb92ec4a95f02_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNy0xLTEtMS03MDM2Mw_525ad36c-9cd4-4436-874d-ed7ded086797">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488068315a5d438e968d54c5b20cc063_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNy0zLTEtMS03MDM2Mw_c84ee4fa-c5f9-4f79-9a0f-75042ec5378b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d87ef5b685049cc85f3a91696bb60cb_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNy01LTEtMS03MDM2Mw_1ede2f22-a58d-432c-a943-e60f59ed20e8">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a64d441bc804e49bc8a45a553ba2057_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNy03LTEtMS03MDM2Mw_fb81c42c-fd94-4082-bf30-e4dd804f0082">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i38542daa11574b0aad0519ecfa5263ef_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfOC0xLTEtMS03MDM2Mw_5c2f0367-3c8d-470f-87bd-ef1c6ef2b9bf">2,125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93b560992cd743cb8ceceaf0b0b2e931_I20210930" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfOC0zLTEtMS03MDM2Mw_a966aaa8-f6b1-4003-a4b8-fb0b4bcf8f41">666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i38542daa11574b0aad0519ecfa5263ef_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfOC01LTEtMS03MDM2Mw_4f3136ef-0b65-4b7b-90a4-75ae92749dbc">2,125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93b560992cd743cb8ceceaf0b0b2e931_I20210930" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfOC03LTEtMS03MDM2Mw_fd6b5d3d-e586-4fdb-b197-75b98e6c08e0">666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-credit components of impairments on investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibeb89cf81873481eb8b9811ea6dfe3bc_I20220630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTEtMS0xLTEtNzAzNjM_285aceea-9489-4444-be0e-b36a89ab9562">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic35e765820354c2cafb66117c9ea4c7a_I20210630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTEtMy0xLTEtNzAzNjM_d6340200-f345-4deb-a11a-6c54a0be236e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96e9251b744b4f7e9ecbb677bd8634fa_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTEtNS0xLTEtNzAzNjM_e67bf1b6-eb9d-4da5-bd55-561d9aed9ddd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56a76ec5b38f428db6242e45a2f30037_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTEtNy0xLTEtNzAzNjM_1c3ce0fa-c6c6-4cfa-b149-3d574cfe653c">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax benefit (expense) of $<ix:nonFraction unitRef="usd" contextRef="i117df451326545f9986059648cfd22dc_D20220701-20220930" decimals="-6" name="elv:Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo1NmMzNWM3Yzk0OTE0ZjRlYjU0OWQ5MDQzMDk0MjIzOV83MQ_ee671136-4162-40ef-ad7e-6aff5f877082">0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i365146e911f1424ea5fe059db32e3d7d_D20210701-20210930" decimals="-6" name="elv:Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo1NmMzNWM3Yzk0OTE0ZjRlYjU0OWQ5MDQzMDk0MjIzOV83NQ_5c75864c-d19c-47d0-9a1c-343a7e6c3b13">0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i9a0fc272f1aa4de39b8e80fa4ef950f7_D20220101-20220930" decimals="-6" name="elv:Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo1NmMzNWM3Yzk0OTE0ZjRlYjU0OWQ5MDQzMDk0MjIzOV83OQ_c41a3e7d-e0a1-4662-a949-8a7d001dd9db">1</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="ic726783a65004c40a48a29cda9bf3769_D20210101-20210930" decimals="-6" sign="-" name="elv:Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo1NmMzNWM3Yzk0OTE0ZjRlYjU0OWQ5MDQzMDk0MjIzOV84Ng_6dfdd85a-a33d-4751-aeeb-cd0874e1e3c8">1</ix:nonFraction>), respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i117df451326545f9986059648cfd22dc_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTItMS0xLTEtNzAzNjM_3a7c08b1-cb88-41f9-88ca-5f00e09176f2">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i365146e911f1424ea5fe059db32e3d7d_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTItMy0xLTEtNzAzNjM_74f00094-02ed-4632-aae8-06c3682779b7">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a0fc272f1aa4de39b8e80fa4ef950f7_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTItNS0xLTEtNzAzNjM_f1735a73-145a-43a0-a20b-f5002f24ba11">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic726783a65004c40a48a29cda9bf3769_D20210101-20210930" decimals="-6" name="us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTItNy0xLTEtNzAzNjM_3fb83e9c-c620-4569-b092-f436df052e1e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e43378757a544d788aed5dc1dd1ce21_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTMtMS0xLTEtNzAzNjM_494325d2-eb96-4ad8-823f-fc8175170250">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3854b434ec0e41f19c683b643a2b65b0_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTMtMy0xLTEtNzAzNjM_813588dd-0096-4e9e-9512-e60d8183f602">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e43378757a544d788aed5dc1dd1ce21_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTMtNS0xLTEtNzAzNjM_a9400747-bf34-4593-8de4-e5726b9c433c">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3854b434ec0e41f19c683b643a2b65b0_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTMtNy0xLTEtNzAzNjM_ca1c8567-3269-459c-8a13-259fb7720a65">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6cae8c9b8e124d8f9c6a483e1f50d63a_I20220630" decimals="-6" sign="-" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTYtMS0xLTEtNzAzNjM_73e2e3d2-d57d-4d46-a6f1-6159d602d7ea">233</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6333d6f4a7f542d0a6c873c6d721b20f_I20210630" decimals="-6" sign="-" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTYtMy0xLTEtNzAzNjM_39528f48-008f-4d69-a3cc-dc87bbb8aa12">244</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f296ec510ae4b489100cc4e4401f16d_I20211231" decimals="-6" sign="-" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTYtNS0xLTEtNzAzNjM_f17b4d3a-3806-4297-8662-30926206b815">239</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7d0a14cf7b04d2689e8c00fe9ee50bc_I20201231" decimals="-6" sign="-" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTYtNy0xLTEtNzAzNjM_9571f651-ab3e-4a15-9aa1-443895ed647b">250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax expense of $<ix:nonFraction unitRef="usd" contextRef="ibce0012780de42b39687b8dc2c2d2645_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo3MzAyMjM5MTZjNzg0NDQ3YTJkNGI2OGNmNTFiYTE2Y181NA_ddf0ad9c-f99c-4968-8c56-cdaa01435a34">0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i9291c2ff4b2f443a9a229d05ba749f08_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo3MzAyMjM5MTZjNzg0NDQ3YTJkNGI2OGNmNTFiYTE2Y181OA_bf80715d-ca28-4d76-af4c-89f85b47aace">0</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="i35dbebbdfb3b4ab58592b593d907d827_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo3MzAyMjM5MTZjNzg0NDQ3YTJkNGI2OGNmNTFiYTE2Y182Mg_0b1a8aca-243e-4c15-a994-c7af7b72fbe8">2</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="if60627e1e84e4b339448c6d14a9087be_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo3MzAyMjM5MTZjNzg0NDQ3YTJkNGI2OGNmNTFiYTE2Y182OQ_0f32a353-1ba9-4f30-a44f-a447cc3a929d">2</ix:nonFraction>), respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce0012780de42b39687b8dc2c2d2645_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTctMS0xLTEtNzAzNjM_e1a98b34-c2a7-4417-a437-87212bfbb9dd">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9291c2ff4b2f443a9a229d05ba749f08_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTctMy0xLTEtNzAzNjM_da1a51ac-6961-40ea-a0ad-0db7c9d80ddd">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35dbebbdfb3b4ab58592b593d907d827_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTctNS0xLTEtNzAzNjM_aa433427-3b6c-416d-b51c-6596d575b582">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60627e1e84e4b339448c6d14a9087be_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTctNy0xLTEtNzAzNjM_334fce74-599d-4ef6-b470-1803a1b65556">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadc106beeb124c7ba342f63d01a137d2_I20220930" decimals="-6" sign="-" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTgtMS0xLTEtNzAzNjM_601cacc4-b8d3-4e68-939a-6e4186b2d35a">231</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b066b6520a04587be918ef721ac7343_I20210930" decimals="-6" sign="-" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTgtMy0xLTEtNzAzNjM_56292884-b8c2-4409-801f-17a55c76a245">240</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadc106beeb124c7ba342f63d01a137d2_I20220930" decimals="-6" sign="-" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTgtNS0xLTEtNzAzNjM_20dfbffc-9271-41d4-8723-8c38359648b9">231</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b066b6520a04587be918ef721ac7343_I20210930" decimals="-6" sign="-" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTgtNy0xLTEtNzAzNjM_16dbbbca-715f-4e3b-82eb-53ea060a14ae">240</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bc72b35cf17467ea46cbd502a8f690f_I20220630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjEtMS0xLTEtNzAzNjM_5a59c77f-2c68-4700-aee0-9840498529da">413</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib948503264de432899d049dd0575663c_I20210630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjEtMy0xLTEtNzAzNjM_295170df-00f8-4b7e-9a41-5154f3648446">534</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice4c66b286684bc78853a3bcc0e579a8_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjEtNS0xLTEtNzAzNjM_da52998f-4955-47b6-83be-b51496612d67">429</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9538c473eb54495b6cdee761ef557a7_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjEtNy0xLTEtNzAzNjM_bbc477cf-f71b-435c-b3e4-ae898147639e">552</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax expense of $(<ix:nonFraction unitRef="usd" contextRef="iff4c8270a3144c10bdf362046062d8a5_D20220701-20220930" decimals="-6" sign="-" name="elv:OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo4MDhmYWJjNTlhOTE0MDJiODE3MTFjYTJjZDlkMWFiMF81NA_73b47108-e5b0-45c7-88b8-1e612ac68095">3</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="ideb63a96f5c749ca9094200a8ba2b7e9_D20210701-20210930" decimals="-6" sign="-" name="elv:OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo4MDhmYWJjNTlhOTE0MDJiODE3MTFjYTJjZDlkMWFiMF81OA_426b4382-a3e5-41a3-98e9-15cb7a312976">4</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="i8a9aee5d11bb47bd9cb89fcdd8efe039_D20220101-20220930" decimals="-6" sign="-" name="elv:OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo4MDhmYWJjNTlhOTE0MDJiODE3MTFjYTJjZDlkMWFiMF82Mg_914dcf5c-5608-4178-8aec-b3d81aa1eaa2">9</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="iafaf34467ec1493eb045796ec8e537ed_D20210101-20210930" decimals="-6" sign="-" name="elv:OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo4MDhmYWJjNTlhOTE0MDJiODE3MTFjYTJjZDlkMWFiMF82OQ_b7ecdb34-69b6-48c7-9fbd-09e45a996baa">10</ix:nonFraction>), respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff4c8270a3144c10bdf362046062d8a5_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjItMS0xLTEtNzAzNjM_a89e3177-0b3e-4937-8a9a-3cd2830ada3e">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb63a96f5c749ca9094200a8ba2b7e9_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjItMy0xLTEtNzAzNjM_67bde13c-f632-47b9-a14f-8034abaa45c3">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a9aee5d11bb47bd9cb89fcdd8efe039_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjItNS0xLTEtNzAzNjM_7f3ecc14-f199-4e40-9fb2-ccbda9338511">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafaf34467ec1493eb045796ec8e537ed_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjItNy0xLTEtNzAzNjM_a5747902-00c9-433e-a69e-711d254f86ef">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7d788695b784dbea530ea0825b12aac_I20220930" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjMtMS0xLTEtNzAzNjM_69c95ea5-9ebc-4d95-aff8-598eeb53f9f1">406</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95f866b9b2ea4f848e8122f80341b0c2_I20210930" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjMtMy0xLTEtNzAzNjM_523fb9cf-072a-43a1-afd7-d44f5536e4ae">526</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7d788695b784dbea530ea0825b12aac_I20220930" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjMtNS0xLTEtNzAzNjM_4ccbbd30-e3f8-4aaa-abc6-828aed89d70d">406</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95f866b9b2ea4f848e8122f80341b0c2_I20210930" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjMtNy0xLTEtNzAzNjM_e407c758-304f-4b5b-b624-1d397262046b">526</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4c04580eba94b4d90b41a5d0c88cc4a_I20220630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjYtMS0xLTEtNzAzNjM_5426e7bb-6e6a-408f-8f2f-48c217d5804d">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834e9db2373b4b68b3452b49ef4aa755_I20210630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjYtMy0xLTEtNzAzNjM_75d5b8c7-fd58-4609-a6c9-d1c4c5bebcce">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8642636cf706437d9a3a0aba479b0966_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjYtNS0xLTEtNzAzNjM_ee771a27-ae7b-4aed-b3a4-4f7568a3a4ad">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56f8a70ced554e39b672ce48d8b75303_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjYtNy0xLTEtNzAzNjM_65031597-e424-41bc-b677-a7a457cb336a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax benefit of $<ix:nonFraction unitRef="usd" contextRef="if3ad1d3b885146b998e9a975d801f76b_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpjMjdiYzg5ZmE2ZmQ0N2MzYmQwY2Y5Njk4NTk0M2MzNl81Mg_14b7a8fb-0f9b-4933-92b8-514749eebcd5">2</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="idf3fd69d4d55450c8e871275758301b5_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpjMjdiYzg5ZmE2ZmQ0N2MzYmQwY2Y5Njk4NTk0M2MzNl81Ng_c8e8bcca-02b8-4438-a760-aa96e7b12a3f">1</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i967583dc4bba46948e14836718b94da9_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpjMjdiYzg5ZmE2ZmQ0N2MzYmQwY2Y5Njk4NTk0M2MzNl82MA_346b9a6a-2f1a-461c-a0ab-86c14afb3e57">4</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i54c1ad6c70e943cbb0219aed34cfe0fe_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpjMjdiYzg5ZmE2ZmQ0N2MzYmQwY2Y5Njk4NTk0M2MzNl82Nw_9d54a7d9-3c4d-4ca8-9b02-58ff78d64a7c">2</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3ad1d3b885146b998e9a975d801f76b_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjctMS0xLTEtNzAzNjM_cdf20b98-c3a3-4498-928e-075ec23aa995">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf3fd69d4d55450c8e871275758301b5_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjctMy0xLTEtNzAzNjM_e9ff8430-9470-4f9a-a35f-d5eb74403d68">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i967583dc4bba46948e14836718b94da9_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjctNS0xLTEtNzAzNjM_ef268d12-81db-42a4-b043-46c29db4b04d">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54c1ad6c70e943cbb0219aed34cfe0fe_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjctNy0xLTEtNzAzNjM_2d7c819c-9aec-4a85-acad-27259cee1523">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iada0e8e50ae7426592cf04d9556323d4_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjgtMS0xLTEtNzAzNjM_f869ffb2-f00b-4e00-8bfa-57b0c8675928">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i472f221347be479aa71a0a08747b91a3_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjgtMy0xLTEtNzAzNjM_cabae629-535e-4081-83df-6f315df9d8fe">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iada0e8e50ae7426592cf04d9556323d4_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjgtNS0xLTEtNzAzNjM_e4ca52b2-3b8d-41e4-a617-bf105f518ed8">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i472f221347be479aa71a0a08747b91a3_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjgtNy0xLTEtNzAzNjM_dc737b16-9b0d-4df6-9943-05327301ad80">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of period accumulated other comprehensive (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0a535c1ffe84e6da717792a25f25e09_I20220630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzEtMS0xLTEtNzAzNjM_2c0c2655-4a13-4b71-aa3d-032c2471fedf">2,149</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd7bbc6ac8054bf59b507514156a792b_I20210630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzEtMy0xLTEtNzAzNjM_9dce6dcd-5ffe-46f7-aad0-bb311c0740f9">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzEtNS0xLTEtNzAzNjM_d4fdefbd-0969-4e7c-b13e-7955b912e583">178</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aceaf2b19bf4d5d916eb0f2039e41de_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzEtNy0xLTEtNzAzNjM_fdf65a54-c255-42a2-a646-bbb6f64056a1">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive loss, net of tax benefit of $<ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjoxNmVhZjllZTJhOTk0YWYzOTk5YTZkMGNmMjZkOGExOF83Nw_6ace04a5-f243-4212-85f7-ac8f25b33d0b">198</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjoxNmVhZjllZTJhOTk0YWYzOTk5YTZkMGNmMjZkOGExOF84MQ_839b832f-5945-4897-a360-784a393dd4e6">27</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjoxNmVhZjllZTJhOTk0YWYzOTk5YTZkMGNmMjZkOGExOF84NQ_7f9bf8e2-08d7-48d6-a641-6e76531b3c23">815</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjoxNmVhZjllZTJhOTk0YWYzOTk5YTZkMGNmMjZkOGExOF85Mg_02bed2c0-95eb-4d86-82d3-e6ab633925ba">81</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzItMS0xLTEtNzAzNjM_c4c5cca4-9d61-4abf-98e7-dbcbe820d560">638</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzItMy0xLTEtNzAzNjM_c23b39ed-643c-4df7-aeeb-b1dcf793fc29">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzItNS0xLTEtNzAzNjM_b48ec617-7a59-4967-ab9c-a5bba3b91617">2,617</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzItNy0xLTEtNzAzNjM_47951948-0602-4572-a11a-392d4d78767f">254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive loss attributable to noncontrolling interests, net of tax benefit of $(<ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzMtMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjplOGY0NzA4ODU5Y2M0NWQ4ODA5NDJmZDBiODgyMDk3YV8xMTg_2cfa2cab-afab-46e0-b4cd-5d548572fb67">1</ix:nonFraction>), $<ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzMtMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjplOGY0NzA4ODU5Y2M0NWQ4ODA5NDJmZDBiODgyMDk3YV8xMjI_477d87e2-ca51-44dc-bddd-2e2ba837bb8f">0</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzMtMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjplOGY0NzA4ODU5Y2M0NWQ4ODA5NDJmZDBiODgyMDk3YV8xMjY_ead5e4b6-2772-4383-93ce-b3d386d51160">4</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzMtMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjplOGY0NzA4ODU5Y2M0NWQ4ODA5NDJmZDBiODgyMDk3YV8xMzM_cc409444-547b-42ae-8eef-98125a54743f">1</ix:nonFraction>), respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzMtMS0xLTEtNzAzNjM_afcd2d06-ff6a-42d7-853e-aed65125edc6">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzMtMy0xLTEtNzAzNjM_961cf142-4943-41ef-bb21-c1fdb0b19041">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzMtNS0xLTEtNzAzNjM_8f5f4f77-d60c-46a4-a605-adb59006b0b8">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzMtNy0xLTEtNzAzNjM_2e0f9d22-f783-4a3d-9935-ee94a31c5b67">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of period accumulated other comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzQtMS0xLTEtNzAzNjM_81f96198-ca65-4fba-9862-7261bfbe699d">2,784</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7580839926f4e24b08f10312dd69479_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzQtMy0xLTEtNzAzNjM_7fb16b73-7205-4f10-b628-d8d4587d9b91">103</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzQtNS0xLTEtNzAzNjM_e90771f1-18b4-439d-92eb-3f21308e10b2">2,784</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7580839926f4e24b08f10312dd69479_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzQtNy0xLTEtNzAzNjM_2e6be24d-e625-4ba4-8163-97cf44fcf91c">103</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-35-</span></div></div></div><div id="i186e051878fe4219970efc72a9fcdad4_85"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160; <ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfMTI1OA_0c453f6c-9ae3-44f9-b060-f8e685409694" continuedAt="i9650e89cfa794e3a95e2f5d61544f7f4" escape="true">Earnings per Share</ix:nonNumeric></span></div><ix:continuation id="i9650e89cfa794e3a95e2f5d61544f7f4"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfMTI1NA_8d80772d-1903-49e7-aee8-666ae521fa11" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The denominator for basic and diluted earnings per share for the three and nine months ended September&#160;30, 2022 and 2021 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for basic earnings per share &#8211; weighted-average shares</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfMi0xLTEtMS03MDM2Mw_c896c408-8626-4dec-9592-7693aed0e867">239.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfMi0zLTEtMS03MDM2Mw_c0534ba6-562b-4017-9973-2973b9559b0c">243.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfMi01LTEtMS03MDM2Mw_fab7e75e-b9c6-4888-85ba-ee78653e0ada">240.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfMi03LTEtMS03MDM2Mw_bd43e239-803e-435d-8cef-489f9f1cf53d">244.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities &#8211; employee stock options, nonvested restricted stock awards and convertible debentures</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfMy0xLTEtMS03MDM2Mw_35281dd8-3beb-43e3-a38c-4f9fe7c2ddc8">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfMy0zLTEtMS03MDM2Mw_1e9302dd-b55a-4a4d-87b5-9fc84597b3bd">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfMy01LTEtMS03MDM2Mw_df575306-da0c-42b4-8cd6-81d52c24ae49">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfMy03LTEtMS03MDM2Mw_cfe6ea47-23aa-4a76-bdcc-c157f789189b">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for diluted earnings per share</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfNC0xLTEtMS03MDM2Mw_b2edbf9b-25cc-425a-b4ec-acab3cd8aef4">242.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfNC0zLTEtMS03MDM2Mw_fb7cdec8-3adb-4189-aedc-811731c3af4e">246.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfNC01LTEtMS03MDM2Mw_86aa0b97-6f12-43d2-99e5-67b85e7093cb">243.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfNC03LTEtMS03MDM2Mw_75d85813-3ec6-4ca7-b2ca-e680b2a75b04">247.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the three months ended September 30, 2022 and 2021, weighted-average shares related to certain stock options of <ix:nonFraction unitRef="shares" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfMjIw_9eac0985-07cc-4af3-931f-0322e37c10f2">0.5</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfMjI3_9c7d7286-b928-4d12-99a2-988e8308f2b9">0.0</ix:nonFraction>, respectively, were excluded from the denominator for diluted earnings per share because the stock options were anti-dilutive. During the nine months ended September 30, 2022 and 2021, weighted-average shares related to certain stock options of <ix:nonFraction unitRef="shares" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfNDM5_3f53bb77-12ed-4f63-b1a9-1a0c45151f44">0.4</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfNDQ2_8373b5ef-f6df-44a3-9750-496c373eae54">0.3</ix:nonFraction>, respectively, were excluded from each of the denominators for diluted earnings per share because the stock options were anti-dilutive.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2022, we issued approximately <ix:nonFraction unitRef="shares" contextRef="id3126da39a5443229f14991bb4782574_D20220701-20220930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfNjI3_2133e623-253b-458e-84f3-93f0aa8d4a13">0.0</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i2d4742d632984f94b7fd17314cc4c078_D20220101-20220930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfNjM0_dc109f34-b4c0-4aa6-9c7b-3f962b63328f">0.6</ix:nonFraction> restricted stock units under our stock incentive plans, <ix:nonFraction unitRef="shares" contextRef="id3126da39a5443229f14991bb4782574_D20220701-20220930" decimals="-5" name="elv:PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfNjkz_4af02b9e-a2b7-4743-8a08-61847f3d91c1">0.0</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i2d4742d632984f94b7fd17314cc4c078_D20220101-20220930" decimals="-5" name="elv:PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfNzAw_7270ae75-ad72-4dbc-a090-40a626f0ead2">0.2</ix:nonFraction> of which vesting is contingent upon us meeting specified annual earnings targets for the three year period of 2022 through 2024. During the three and nine months ended September&#160;30, 2021, we issued approximately <ix:nonFraction unitRef="shares" contextRef="if6a892d97bb04fbca567d9781dcbbfb9_D20210701-20210930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfODcy_d6866995-9643-439f-9013-b3134fe12579">0.1</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i973466ad3bf64618843bf4007e0b486f_D20210101-20210930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfODc5_bb998106-f351-48b9-b1d2-8cd63ab39a74">1.0</ix:nonFraction> restricted stock units under our stock incentive plans, <ix:nonFraction unitRef="shares" contextRef="if6a892d97bb04fbca567d9781dcbbfb9_D20210701-20210930" decimals="-5" name="elv:PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfMTY0OTI2NzQ0Mjk5Nw_a398adf6-b9c9-46ae-9d9d-90ab6b2a9a38">0.0</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i973466ad3bf64618843bf4007e0b486f_D20210101-20210930" decimals="-5" name="elv:PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfOTQ1_04230005-e4fe-49b2-a2c2-5f32e3bfb141">0.3</ix:nonFraction> of which vesting is contingent upon us meeting specified annual earnings targets for the three year period of 2021 through 2023. The contingent restricted stock units have been excluded from the denominators for diluted earnings per share and will be included only if and when the contingency is met.</span></div></ix:continuation><div id="i186e051878fe4219970efc72a9fcdad4_88"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RleHRyZWdpb246OGExZWFlZDkwMThhNGJjMzk3NDgzZTA4ZDNiN2ViNWNfMzgyMg_ce2f58aa-1bc6-4995-a37d-ccd69832167a" continuedAt="i849fd8518325417da12b69002fec079d" escape="true">Segment Information</ix:nonNumeric></span></div><ix:continuation id="i849fd8518325417da12b69002fec079d" continuedAt="i5cc5578c483f4191a5fcd2a9fc4e75a6"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 1 &#8220;Organization&#8221;, we will be organizing our brand portfolio into three core go-to-market brands over the next several years. Our branding strategy reflects the evolution of our business from a traditional health insurance company to a lifetime, trusted health partner, and given this evolution we are in the process of reviewing and modifying how we will manage our businesses in the future. Currently, there are no changes to our segments associated with this branding strategy. The results of our operations continue to be described through <ix:nonFraction unitRef="segment" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RleHRyZWdpb246OGExZWFlZDkwMThhNGJjMzk3NDgzZTA4ZDNiN2ViNWNfMzI3_f2ad2bb3-ffa6-4783-8963-2cdb19e8b6d9">four</ix:nonFraction> reportable segments: Commercial &amp; Specialty Business, Government Business, IngenioRx and Other.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Commercial &amp; Specialty Business segment offers plans and services to our Individual, Group risk-based, Group fee-based and BlueCard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> members. The Commercial &amp; Specialty Business segment offers health products on a full-risk basis; provides a broad array of administrative managed care services to our fee-based customers; and provides a variety of specialty and other insurance products and services such as dental, vision, life, disability and supplemental health insurance benefits.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Government Business segment includes our Medicare and Medicaid businesses, National Government Services, and services provided to the federal government in connection with the FEHB program. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our IngenioRx segment includes our PBM business. IngenioRx markets and offers PBM services to our affiliated health plan customers, as well as to external customers outside of the health plans we own. IngenioRx has a comprehensive PBM services portfolio, which includes services such as formulary management, pharmacy networks, prescription drug database, member services and mail order capabilities. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Other segment includes our Diversified Business Group, now known as Carelon, which is our health services business focused on lowering the cost and improving the quality of healthcare by enabling and creating new care delivery and payment models, with a special emphasis on serving those with complex and chronic conditions. This segment also includes certain eliminations and corporate expenses not allocated to our other reportable segments.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-36-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5cc5578c483f4191a5fcd2a9fc4e75a6" continuedAt="i07b3b8881a15420fb16bf37d57ecf1ed"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define operating revenues to include premium income, product revenue and administrative fees and other revenues. Operating revenues are derived from premiums and fees received, primarily from the sale and administration of health benefits and pharmacy products and services. Operating gain is calculated as total operating revenue less benefit expense, cost of products sold and selling, general and administrative expense.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Affiliated revenues represent revenues or cost for services provided to our subsidiaries by IngenioRx and Carelon, formerly known as our Diversified Business Group, as well as certain back-office services provided by our international businesses, and are recorded at cost or management&#8217;s estimate of fair market value. These affiliated revenues are eliminated in consolidation.</span></div><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RleHRyZWdpb246OGExZWFlZDkwMThhNGJjMzk3NDgzZTA4ZDNiN2ViNWNfMzc5OQ_9a9f7780-c782-49f2-9749-eb4427b47435" escape="true"><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial data by reportable segment for the three and nine months ended September&#160;30, 2022 and 2021 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.358%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial<br/>&amp;&#160;Specialty<br/>Business</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Government<br/>Business</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">IngenioRx</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - unaffiliated</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i613f3949b7024615a0b0e144265e921b_D20220701-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMi0xLTEtMS03MDM2Mw_b4a39223-1092-4b95-a15d-917826106409">10,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9be59a634a40b88e6dbcaae7d7deac_D20220701-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMi0zLTEtMS03MDM2Mw_e9336dc9-b1a9-43a7-b7fd-c0d0ebe5b5dd">24,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78f61d39fc7a4472a65a1d69f1fa77e6_D20220701-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMi01LTEtMS03MDM2Mw_8b47d9a1-2324-4179-8a41-c0c0fe195a06">3,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fe4f30315e9486cab1e53788aa7d851_D20220701-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMi03LTEtMS03MDM2Mw_f73dde25-74ca-41f2-b2da-39474f071d3f">589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idec57493ab1e4934bf922237f912f0b6_D20220701-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMi0xMS0xLTEtNzAzNjM_fc8bdc9a-2621-4a5b-bb62-b6abb7d46034">39,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - affiliated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cfa8e1a475a4cdbbb5a9828060b71b3_D20220701-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMy01LTEtMS03MDM2Mw_9d4afa67-c009-4362-84dc-cb42ab28c42d">3,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32ced2539b8f4d329078b81a982fc92c_D20220701-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMy03LTEtMS03MDM2Mw_71af839c-e0c6-413b-b3a3-4dff5f4649aa">2,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6bd87a9fe9284c9382b2f66c6c0889e0_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMy05LTEtMS03MDM2Mw_8cd6d055-e491-4a14-b950-41f840ae3a53">6,054</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7fc6c71c6004a74ba6b839f6bb3ff09_D20220701-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMy0xMS0xLTEtNzAzNjM_91b478f2-2603-4616-bb7c-4efe2f7f090e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8f86bdb8cf2469aa0b7d726398ab429_D20220701-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNC0xLTEtMS03MDM2Mw_106720da-575e-42fb-9dac-def0dee833ea">785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if830019dcb7d41e7b0f6d3696e6ff1bb_D20220701-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNC0zLTEtMS03MDM2Mw_fe5737cd-e1de-4512-aebd-d54f8f807247">868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id770a0ff048944b9ba5c4f267af241c1_D20220701-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNC01LTEtMS03MDM2Mw_7c2d0d1b-afe2-4a3d-8719-a8ba6b13d9be">516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40ca534e715147f98238ecf1aaea0e0d_D20220701-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNC03LTEtMS03MDM2Mw_94b5bf32-59f8-410b-81b1-ba1a8c0b0ab9">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNC0xMS0xLTEtNzAzNjM_3df25839-0ca3-4e56-af1a-a6ece19bf8ca">2,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - unaffiliated</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42cb539441714260b2dac721cc7b7385_D20210701-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNi0xLTEtMS03MDM2Mw_863d453f-3a0b-4713-95e4-744151feabe8">9,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4396f9c7ead4882afe910b3265d1ae6_D20210701-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNi0zLTEtMS03MDM2Mw_296db130-3121-4528-9280-ec6120dc25e6">21,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b72584a9a44b80a8f513401ff64d97_D20210701-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNi01LTEtMS03MDM2Mw_12e0e060-898a-4cc6-b17f-bcdc371edd2c">3,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43f1507e8bcc4d748dfbaec841ee2693_D20210701-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNi03LTEtMS03MDM2Mw_c1eeadae-c2f8-4bdd-ba33-15f45575fb00">658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4cf254d155841919857d544d09721ab_D20210701-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNi0xMS0xLTEtNzAzNjM_60f6df4c-8339-4f9c-b165-b38b405719d6">35,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - affiliated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia289890cc9a84272b385fe830e5a181c_D20210701-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNy0xLTEtMS03MDM2Mw_8c2ec926-bf8d-4136-a8e8-f3c8e7f5daeb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice278b94888d4092b77546bceeb6bea5_D20210701-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNy0zLTEtMS03MDM2Mw_3f7c1f47-b1d5-4143-8a34-306303f3774a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic31a5ad6faf248238ec05a2850499106_D20210701-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNy01LTEtMS03MDM2Mw_0c2d4f33-5c12-487a-b573-dffb79dddd4c">3,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i535f1617c8544db396ede0c7f1da6d87_D20210701-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNy03LTEtMS03MDM2Mw_1f420b1a-0944-4d60-a2d5-d9248fad4acf">2,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6493eedb9ee14f9abe78a63b29dc2a76_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNy05LTEtMS03MDM2Mw_f60a85cf-9643-49fb-a7ef-16525dad3ef7">5,192</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3412b5e435444238a5abd7fdd03b86f_D20210701-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNy0xMS0xLTEtNzAzNjM_fa43fdff-25e8-49e8-99e3-3e866d6e04d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea48a3ae14cb42c597f9265f719b100c_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfOC0xLTEtMS03MDM2Mw_d7e306dc-e64d-4d48-9e4c-f4d905c7cb64">620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa92746fb4df4c01b8d7210e2ae19cf9_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfOC0zLTEtMS03MDM2Mw_503edd46-dec4-4780-a81e-f36159810eb6">967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i699414c0bc4847948f60c7721dfe388f_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfOC01LTEtMS03MDM2Mw_046ea395-4db3-465a-973d-cc14307959d8">445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49e4f34abd44464ba18d17589d4817f5_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfOC03LTEtMS03MDM2Mw_ff0e18de-4ece-415b-a7c8-e82e1590b404">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfOC0xMS0xLTEtNzAzNjM_467135b1-31c9-450c-a054-035ed7230383">2,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - unaffiliated</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib642ee435246417986a7c59ac081ac68_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTAtMS0xLTEtNzAzNjM_127b3f21-5f81-445b-98a2-ce8f3f2d1ef9">31,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife47ac82fe0345dc920d78c9e6c54bff_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTAtMy0xLTEtNzAzNjM_141aa1e9-1796-4938-8002-8bcea6e80eac">72,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b6a789eb76947a58a5f3eb47c31e312_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTAtNS0xLTEtNzAzNjM_cbc6eba2-7fa7-48c2-a6dd-fffe09ed88d1">10,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0e62d9102304c3abf2cad1b68e9c3f4_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTAtNy0xLTEtNzAzNjM_73a55e5f-0a87-4a29-89e9-359a3741b64c">1,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489b1390122443e2bb59851e5a3062fd_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTAtMTEtMS0xLTcwMzYz_e2985efa-64cd-49d8-86d0-22d818db80f3">115,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - affiliated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f47d7a5179d4dfc97384ed285da7911_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTEtMS0xLTEtNzAzNjM_5408f34c-5c01-45d4-be9e-b16fe001f86f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f08825ff0ad45c9a9bd4fcfbee83337_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTEtMy0xLTEtNzAzNjM_40ade36a-b971-44af-8fa7-46db6c3010c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i460716678d6242c19377280954cd4752_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTEtNS0xLTEtNzAzNjM_8a5c411a-a375-4fe1-837e-0498a6a3c74d">10,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie284f26c8937426abf5fb54b5296c8e3_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTEtNy0xLTEtNzAzNjM_0fd6be27-5f87-4257-bc37-6cc43ce3d09d">8,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67ab17589f884d1fbeb85f1ff8c7347b_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTEtOS0xLTEtNzAzNjM_5a14f8c4-4f51-4d65-b2ec-70f7b0f5be03">18,382</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia37eef0dbc8c45e3a79a0e793d82369b_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTEtMTEtMS0xLTcwMzYz_172f94b6-6d9a-4ff1-b663-d768126d7e47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48ef62bcfeb448e584ac8677641f5a48_D20220101-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTItMS0xLTEtNzAzNjM_b0bdb1b0-0e5d-46fc-973e-630e403a1a8a">2,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iade9083183e24a63a024e8c92ebde4f4_D20220101-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTItMy0xLTEtNzAzNjM_7d34e840-6142-4d20-8338-e628609f91ee">2,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84ba57a42d554362bd86af8887714be2_D20220101-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTItNS0xLTEtNzAzNjM_7739a287-4575-4e61-821a-d0eed988b790">1,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5a10db4f5de43ae9ca27fb423936d50_D20220101-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTItNy0xLTEtNzAzNjM_16f6bb53-838c-4c6e-af62-f462fd04beef">365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTItMTEtMS0xLTcwMzYz_59f49d5b-3bf5-484d-ad9d-db4fbaef17db">7,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - unaffiliated</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib035444b5f354e3599e287f69135039a_D20210101-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTQtMS0xLTEtNzAzNjM_aa72e87e-4a34-4623-a968-35af8e858e8e">28,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i250482f83321476e96b00f0a8172c63f_D20210101-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTQtMy0xLTEtNzAzNjM_11fcbe7f-7b19-4ee7-8328-c89a8fd2a927">61,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb6d5e1babc8461ba8510bfa1a69afaf_D20210101-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTQtNS0xLTEtNzAzNjM_0ae72233-db7a-4f2f-8cd1-b572dc0ee4d9">9,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib01b6477a138483b87a1c6749d60194d_D20210101-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTQtNy0xLTEtNzAzNjM_499fea51-c13c-4dba-ae42-5880073b8f36">1,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i070cb4af0e734e3b97f862746b92ef65_D20210101-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTQtMTEtMS0xLTcwMzYz_0f3f89d9-9d43-4e3a-aafe-a07793027b3a">100,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - affiliated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie38e2cab8d46445aa0e1d1b6c282a05a_D20210101-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTUtMS0xLTEtNzAzNjM_7a5c2387-912d-4a6f-a29d-28ecf37f8bda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09dc82dcd92645758117fe7914de65ad_D20210101-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTUtMy0xLTEtNzAzNjM_671c2b4e-6466-49b2-86f9-389d92fcb79a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a32ee4b8c040ed9b7f3e8951e03bb9_D20210101-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTUtNS0xLTEtNzAzNjM_445cf24b-b62b-4aba-9379-e4e101cc2862">9,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f17939a81c848e68bf70536f100b8f8_D20210101-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTUtNy0xLTEtNzAzNjM_d4952d35-2cf3-4af0-a367-fb99e4fb78b7">5,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc176686245540f388bb95d4741dab61_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTUtOS0xLTEtNzAzNjM_46ecfe7b-d7bf-47e3-98ff-92fcca710ffe">15,173</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95dfc1da6af04fd08d490195296eb3ed_D20210101-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTUtMTEtMS0xLTcwMzYz_34d32439-da51-454b-b392-bab2d25a3edb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e811d8b6a8a405db8cfa3af19e8d5e0_D20210101-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTYtMS0xLTEtNzAzNjM_5d764e68-6b81-483b-9127-45da1c97951d">2,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2afef55df394f80a6083eef46447e0c_D20210101-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTYtMy0xLTEtNzAzNjM_f67a3991-158c-4992-99c0-c4a389cee017">2,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d3be1d743ba40d2804be36571b03d27_D20210101-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTYtNS0xLTEtNzAzNjM_444ea983-6141-489f-87f3-75e694acaa39">1,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49ec233198524d05b69059ae1a04c04f_D20210101-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTYtNy0xLTEtNzAzNjM_9261482d-ad9b-4a20-94f5-0b56acfa67a5">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTYtMTEtMS0xLTcwMzYz_b297b808-73f5-41a5-9574-22a82de49c30">6,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-37-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i07b3b8881a15420fb16bf37d57ecf1ed" continuedAt="i1ebc87481eae47749d217b948ccc1bec"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="elv:MajorProductRevenueBySegmentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RleHRyZWdpb246OGExZWFlZDkwMThhNGJjMzk3NDgzZTA4ZDNiN2ViNWNfMzgxNg_bc333b3b-cb5f-45d2-b48d-8d60ed609ef1" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The major product revenues for each of the reportable segments for the three and nine months ended September&#160;30, 2022 and 2021 are as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.786%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial &amp; Specialty Business</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care products</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie50df0b7e812404f8ac6506d19378156_D20220701-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMy0xLTEtMS03MDM2Mw_98874036-4634-41df-9084-93b532a38355">8,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief5f8447f8f6441dab988369cb18391b_D20210701-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMy0zLTEtMS03MDM2Mw_79825d50-fb39-448c-ae72-7058f92c19f9">8,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e22b3359b804b6096c6db064b631db3_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMy01LTEtMS03MDM2Mw_b12e1089-c78e-4b18-88c3-3136096b3879">25,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a4fbec4a714f71b3cd75ec9f0deb96_D20210101-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMy03LTEtMS03MDM2Mw_adec0958-8220-432e-b55b-57bdba9139e1">23,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care services</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b41a0ca0abe41f19104d40411fe8b3c_D20220701-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNC0xLTEtMS03MDM2Mw_68788110-0673-4096-9181-1174ad434cc1">1,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a10c1e4505b4d6aa5128ba88498d53d_D20210701-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNC0zLTEtMS03MDM2Mw_b0393e6e-6ad8-4367-94d5-91b2d3494b3a">1,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bc040a46a814b49b1241f6aaa87b4e7_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNC01LTEtMS03MDM2Mw_5abcd86a-257f-4227-947f-616cdacee24e">4,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dfb62cf41374a68bb7efc705ab95d1f_D20210101-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNC03LTEtMS03MDM2Mw_a2b500ba-6e07-4f91-9863-c0a425fd67ab">4,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dental/Vision products and services</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2be8cfab42284be8ad0db60f8e9c7251_D20220701-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNS0xLTEtMS03MDM2Mw_31f3a937-0600-47a2-8e0f-f756d02e81da">360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic19125c669154425a6176b41f3b63e4a_D20210701-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNS0zLTEtMS03MDM2Mw_b8826764-a2da-4b6f-890d-179ac3204481">342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic71d76f1bed042819c52df0907d93ee5_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNS01LTEtMS03MDM2Mw_3b77e2a0-7238-4e69-97e7-bf7ba5c93e75">1,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf64a53a0693483598a35f9ecae91e19_D20210101-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNS03LTEtMS03MDM2Mw_33845f01-d4d3-4f89-b4f6-998918c55a4f">1,013</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c235873956f485f8766fe1f4a6dfd52_D20220701-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNi0xLTEtMS03MDM2Mw_f447f72d-028e-4dc8-8060-7a50198e6450">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47937f7e9daf42b98dfabfafd8f29aec_D20210701-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNi0zLTEtMS03MDM2Mw_ad54ecd1-fd2e-4258-8b2e-64df84d0f2a2">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5b0fcd0d81b45e1972a3219cc11a422_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNi01LTEtMS03MDM2Mw_4074c543-2bb4-4c79-867b-b03ebff7088d">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf7752a749a54daf8ecef7f516fccbbf_D20210101-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNi03LTEtMS03MDM2Mw_a033da70-19ba-45c8-816d-9cba2c051bdd">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Commercial &amp; Specialty Business</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9adaeacf598a42c3b72b8540b126e10b_D20220701-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNy0xLTEtMS03MDM2Mw_1239adf8-294a-48cd-986b-d8fc3c8ece0c">10,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7c823f42d7a4c78b75c5623fcf615d7_D20210701-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNy0zLTEtMS03MDM2Mw_f4518eb7-b915-481c-a676-b3ec95f2f26c">9,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i518bf560bf5b42db9717fa1237d56fc5_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNy01LTEtMS03MDM2Mw_93a926b0-4ef8-4bb4-9440-31116e98ef74">31,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id192e31548bb42f29d1bf3d4dbb6cda2_D20210101-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNy03LTEtMS03MDM2Mw_3fd70711-4a40-4ad9-a10a-8e21e253444b">28,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Government Business</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care products</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc016ae937c445185ef3dac290c94cb_D20220701-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfOS0xLTEtMS03MDM2Mw_12e94e86-cdf7-47a5-bdf6-608eb4727a9d">24,456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad555599326849b4986b0f696e0bc3b6_D20210701-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfOS0zLTEtMS03MDM2Mw_7b66dd43-8b13-45d4-a31b-b996ed7b7c8e">21,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9d03d05fa0487499d5eeb2019e07de_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfOS01LTEtMS03MDM2Mw_9f2dac41-2754-4a07-9ac3-3674defa5c83">71,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2b81e7a6c124962bb984bd28230e269_D20210101-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfOS03LTEtMS03MDM2Mw_6ca5f77c-a5bd-411b-bad4-b875f7cac357">60,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care services</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f22558ff60c480a8751522ee586cca6_D20220701-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTAtMS0xLTEtNzAzNjM_8c251ee6-f8d1-48bd-9d13-9140abf44096">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18518353f665475a9bb0d0e357886227_D20210701-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTAtMy0xLTEtNzAzNjM_5f642ed3-4a99-44d9-8eeb-dfc18af98c74">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c5f026845034ad7bf3ab1ee5be68a4b_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTAtNS0xLTEtNzAzNjM_8c338e29-4ad4-47fc-b690-5210acb5f1a5">341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea0bebe050d8402fac705ade0fc21e7a_D20210101-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTAtNy0xLTEtNzAzNjM_36ec4101-354a-4a9e-a125-de0c183096e2">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Government Business</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice7f613275f549788763308d4be93610_D20220701-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTEtMS0xLTEtNzAzNjM_d698a2f9-72fe-42e7-8bcc-f13bfbfe8161">24,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i757b9a9c9e7e4558a1cd9992f88382fc_D20210701-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTEtMy0xLTEtNzAzNjM_39b103ac-dbb7-4fc7-af9d-5eb37302f39c">21,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32803f4645204fb0b79a26f39fe31411_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTEtNS0xLTEtNzAzNjM_09078ff1-8c07-4987-b48a-8f0a33566ae4">72,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b0ea34f1f294d20a310a2ef4c41c0f4_D20210101-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTEtNy0xLTEtNzAzNjM_c43b8e1e-1a25-4b00-90b4-aa5df78588bd">61,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">IngenioRx</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy products and services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1c6d6e169f84a139863b8469ab9d241_D20220701-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTMtMS0xLTEtNzAzNjM_c3297134-3977-42d7-b0fc-943e389b7dab">7,249</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdd175f0fdb4015821b828ea0c2e286_D20210701-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTMtMy0xLTEtNzAzNjM_7dfb0ed4-8c31-4fc3-848a-e109ad155faa">6,549</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94aa51feb4bf48bf9c5bba05c04ac8d2_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTMtNS0xLTEtNzAzNjM_87a8d5f0-bc57-40c8-b101-ffebab4692f4">21,003</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f53ea737c1440078ec9ff5e42581227_D20210101-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTMtNy0xLTEtNzAzNjM_c2eec1ca-640c-40b7-bb0d-a71e9b47f794">18,630</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated health services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e39237895504dfea4708a360ce4fd9f_D20220701-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTctMS0xLTEtNzAzNjM_d01cc405-5437-4b0b-9a72-58b9aa0b11a9">3,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54804e82cd9d4171953e5f7a0443759d_D20210701-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTctMy0xLTEtNzAzNjM_ca9c7a4f-69fa-45e1-a621-1edf50e77d11">2,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaee2f1ec149648168e2cb6bec6fee839_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTctNS0xLTEtNzAzNjM_de540a2a-d71a-4668-a082-fc699244af92">9,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf128bf301b34428b46cea6538e515e6_D20210101-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTctNy0xLTEtNzAzNjM_b26e1b70-a0d2-439b-9d48-8ab781496848">7,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf78127a63ae4e2d9451e2182c5330af_D20220701-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTgtMS0xLTEtNzAzNjM_e22fe232-e42b-47c4-82f2-6d19b1e57531">212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfb2059876d84fbfa46eeb173a42357c_D20210701-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTgtMy0xLTEtNzAzNjM_ea1b79e9-9ddd-4681-b7a9-bd64d9cba63d">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4583bb7be664541bff123dc3d369c76_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTgtNS0xLTEtNzAzNjM_56ad7729-db42-4762-80aa-515a9cc685a0">801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i667448e355dd40e0bd386f14f3dfe774_D20210101-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTgtNy0xLTEtNzAzNjM_7aed0823-0228-4896-9fa9-35b43f920945">436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Other</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee58b3e2710246daa6dbe09d63e5064d_D20220701-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTktMS0xLTEtNzAzNjM_b2b6e602-793b-4498-b585-432687067e10">3,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed55d475fdc4a698c26523269fb993b_D20210701-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTktMy0xLTEtNzAzNjM_1e2c01c1-29d8-4d20-9b18-d9fc65b5129d">2,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5866a8bbba704cf588b8904b077bac81_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTktNS0xLTEtNzAzNjM_e9c5e461-2687-464e-8825-14dd0892fd0d">9,884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5424e3c2015944248e4c1ead87f81144_D20210101-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTktNy0xLTEtNzAzNjM_e969741c-228f-4aa7-87ac-e7b138fabd3a">7,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i401e0447e56649b8bf0e2ea99deca4b9_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMjEtMS0xLTEtNzAzNjM_72cb6548-9fd8-411f-a861-eba20ba8f420">6,054</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a4d250516594092a504c84e2ce84ea7_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMjEtMy0xLTEtNzAzNjM_706ea22b-c845-48ab-85ef-695dea9ed3b2">5,192</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i888bd500cb4e464fa25e8b7832db7c26_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMjEtNS0xLTEtNzAzNjM_ddff832e-cda0-4f3d-9687-f900a4a9856c">18,382</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7421e7130f5a434fbc857ff8e1006b5b_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMjEtNy0xLTEtNzAzNjM_54bb59ef-2df9-4b1b-8c8c-44a642566562">15,173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenues</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMjItMS0xLTEtNzAzNjM_b72c13a9-b7cf-449d-85a3-ad005c8b43ad">39,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMjItMy0xLTEtNzAzNjM_f72df800-50b6-49f3-8f51-0f2f13939892">35,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMjItNS0xLTEtNzAzNjM_9d90415d-5b11-49ec-9732-f6a28c02f502">115,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMjItNy0xLTEtNzAzNjM_3242af58-4ec8-4134-92cc-ae27fb384cd1">100,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classification between managed care products and managed care services in the above table primarily distinguishes between the levels of risk assumed. Managed care products represent insurance products where we bear the insurance risk, whereas managed care services represent product offerings where we provide claims adjudication and other administrative services to the customer, but the customer principally bears the insurance risk.&#160;</span></div><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RleHRyZWdpb246OGExZWFlZDkwMThhNGJjMzk3NDgzZTA4ZDNiN2ViNWNfMzgxMQ_5d917cbb-cba1-4820-bfc4-f79b16de887b" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of reportable segments&#8217; operating revenue to the amounts of total revenues included in our consolidated statements of income for the three and nine months ended September&#160;30, 2022 and 2021 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.786%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reportable segments&#8217; operating revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfMi0xLTEtMS03MDM2Mw_5986efb3-ff22-4f18-b49d-98a9e875a07d">39,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="elv:OperatingRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfMi0zLTEtMS03MDM2Mw_cb752263-9ccd-429b-9e06-7c48a50345cd">35,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfMi01LTEtMS03MDM2Mw_7a6b1cd2-f49a-4204-a59b-7cadc393c818">115,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="elv:OperatingRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfMi03LTEtMS03MDM2Mw_07bdaa2d-9b5f-45c5-9bad-997d456ea07b">100,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfMy0xLTEtMS03MDM2Mw_86dc72f5-f6f3-477e-9c8f-f57bc18990b3">371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfMy0zLTEtMS03MDM2Mw_584495f3-5588-4a71-b2b3-bf62efdd25af">335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfMy01LTEtMS03MDM2Mw_0b907670-793f-4e91-9912-b7eddfae997d">1,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfMy03LTEtMS03MDM2Mw_82dcbb47-948b-4252-81b6-9bf9c2d9a76b">1,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (losses) gains on financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" sign="-" name="elv:NetLossesGainsOnFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfNC0xLTEtMS03MDM2Mw_35366142-9fb5-4f8e-a191-41aac40ffe84">57</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" sign="-" name="elv:NetLossesGainsOnFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfNC0zLTEtMS03MDM2Mw_c4c32e90-c26f-43a2-957a-67849f02131f">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" sign="-" name="elv:NetLossesGainsOnFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfNC01LTEtMS03MDM2Mw_4fc52e99-bef7-4acf-ab17-40f3090564df">439</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="elv:NetLossesGainsOnFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfNC03LTEtMS03MDM2Mw_ec82f094-0dc7-4431-879a-78c45563deb3">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfNS0xLTEtMS03MDM2Mw_bd390054-ea2a-4a3e-a573-545c21df8275">39,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfNS0zLTEtMS03MDM2Mw_6ab6a214-8358-4baf-bf41-1fd1f334509c">35,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfNS01LTEtMS03MDM2Mw_8578ac67-c851-401a-babd-a3f5c7baffa6">116,666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfNS03LTEtMS03MDM2Mw_65c4c90b-2e34-46fe-9363-24c4671d787f">102,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-38-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1ebc87481eae47749d217b948ccc1bec"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RleHRyZWdpb246OGExZWFlZDkwMThhNGJjMzk3NDgzZTA4ZDNiN2ViNWNfMzgxOA_17fefc61-f477-4c8f-ba7c-4983a11cdb1d" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of income before income tax expense to reportable segments&#8217; operating gain included in our consolidated statements of income for the three and nine months ended September&#160;30, 2022 and 2021 is as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.786%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfMi0xLTEtMS03MDM2Mw_216d058d-2029-4527-a52f-cdb44c7c94a3">2,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfMi0zLTEtMS03MDM2Mw_2f18b6ef-4e2a-4c8a-a3e9-606094ee58c9">1,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfMi01LTEtMS03MDM2Mw_21736ce5-d8b9-4684-b3f8-f07b2247ed2b">6,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfMi03LTEtMS03MDM2Mw_c57c3953-d3ba-4d13-86c6-c14827570981">6,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfMy0xLTEtMS03MDM2Mw_4a3849df-0925-4d3d-bd8d-47c11e2f06f1">371</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfMy0zLTEtMS03MDM2Mw_b5e51100-db8c-4681-aaca-6cda82513d57">335</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfMy01LTEtMS03MDM2Mw_5c071675-3a72-4ea0-a414-ca09fa22a45a">1,112</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfMy03LTEtMS03MDM2Mw_fe1ad750-df5f-438a-8c83-d620f32f0999">1,026</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net losses (gains) on financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" sign="-" name="elv:NetLossesGainsOnFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNC0xLTEtMS03MDM2Mw_318b19f6-f777-4aac-a03f-bf22395c0ae4">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" sign="-" name="elv:NetLossesGainsOnFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNC0zLTEtMS03MDM2Mw_40b1e32a-ff0d-483c-9b94-6b1b624cfbd4">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" sign="-" name="elv:NetLossesGainsOnFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNC01LTEtMS03MDM2Mw_931745bb-2066-4a36-9a84-23241371267a">439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="elv:NetLossesGainsOnFinancialInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNC03LTEtMS03MDM2Mw_1d663cca-b5a9-4390-838d-d7af9fc4489a">107</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNS0xLTEtMS03MDM2Mw_aa7fd0ae-5b5b-4d0a-9246-480fe879126c">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNS0zLTEtMS03MDM2Mw_7eec7fbb-8cce-4463-91fe-f9c7fabb35a2">201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNS01LTEtMS03MDM2Mw_151a3dd9-7264-45e3-bbf4-80dc221e181e">622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNS03LTEtMS03MDM2Mw_f41ad372-d010-45e6-abd2-06bfd4cf9870">598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNi0xLTEtMS03MDM2Mw_ce66b2db-8770-49c1-9d90-86708745ef6c">225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNi0zLTEtMS03MDM2Mw_381a6c95-0bde-4b91-b57d-951862410233">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNi01LTEtMS03MDM2Mw_0e8e2c20-89d3-4ef9-8129-b4f7b3a26e5d">520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNi03LTEtMS03MDM2Mw_ea6b3570-efee-4a1a-8225-fef473895280">306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNy0xLTEtMS03MDM2Mw_25a372bb-e485-4ecb-b85d-c3db518f3524">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNy0zLTEtMS03MDM2Mw_70d53c08-f459-4d72-b105-89d80d37e236">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNy01LTEtMS03MDM2Mw_a91f2e2f-86cc-4015-98c1-889970192dc4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNy03LTEtMS03MDM2Mw_b76f05b8-899f-4c9b-bac3-4111458eac41">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reportable segments&#8217; operating gain</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfOC0xLTEtMS03MDM2Mw_783414f5-7856-4394-87b4-0a244de66dec">2,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfOC0zLTEtMS03MDM2Mw_2e8eb80e-b3d8-4129-b8a0-5620bc1bfe53">2,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfOC01LTEtMS03MDM2Mw_f8b391bd-47e7-4e58-b83d-bd96f5b6e543">7,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfOC03LTEtMS03MDM2Mw_b6bc9056-7907-4177-bcfa-e615dd86b827">6,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i186e051878fe4219970efc72a9fcdad4_91"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160; <ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RleHRyZWdpb246YTkwZTIzZjIxYzliNDY1MGJkNjlmOGJlYTAzMjhkZmRfNjUw_275597c1-22e9-4ca6-8f57-99eaab6128d8" continuedAt="i000fa24ae69242bfa8a55bb05e9ff13b" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="i000fa24ae69242bfa8a55bb05e9ff13b" continuedAt="i1ca4d5746cd14d5299ac52e0aadd3300"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease office space and certain computer and related equipment using noncancellable operating leases. Our leases have remaining lease terms of <ix:nonNumeric contextRef="iec40b9c51c114cbc9d3101bef95add9d_I20220930" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RleHRyZWdpb246YTkwZTIzZjIxYzliNDY1MGJkNjlmOGJlYTAzMjhkZmRfMTYy_75da70db-08b8-452a-9d70-a03551fabdef">1</ix:nonNumeric> year to <ix:nonNumeric contextRef="i5a1b6fdf93194651bf7efdc8011a5b9c_I20220930" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RleHRyZWdpb246YTkwZTIzZjIxYzliNDY1MGJkNjlmOGJlYTAzMjhkZmRfMTcz_4b9af8a2-602d-4429-9bba-c075c8aa221a">12</ix:nonNumeric> years.</span></div><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RleHRyZWdpb246YTkwZTIzZjIxYzliNDY1MGJkNjlmOGJlYTAzMjhkZmRfNjU0_f2b173f7-89a7-4e62-bea2-dbed80e7dd02" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information related to our leases is as follows:</span></div><div style="margin-bottom:7pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.255%"><tr><td style="width:1.0%"></td><td style="width:44.027%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.288%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.892%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.895%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMi0xLTEtMS03NzQ3Mg_35223446-da43-4885-b1af-792d126f0d02"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMi0xLTEtMS03NzQ3Mg_9be99ce3-7827-4188-b28e-80ce38a6cc7e">Other noncurrent assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMi0zLTEtMS03MDM2Mw_ae2cb5f3-97db-433d-9a8f-0d1577f3d281">600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMi01LTEtMS03MDM2Mw_88c62eec-91e3-45e7-879e-4b69ecc4b2f8">628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities, current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMy0xLTEtMS03NzQ4MQ_3f09f4af-f1d9-4a52-8c2e-e79a525ccc59"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMy0xLTEtMS03NzQ4MQ_ce213197-b1dc-4b00-96f5-82a38cd1810f">Other current liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMy0zLTEtMS03MDM2Mw_99843c6d-147d-4c48-b27e-67ffcad9838c">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMy01LTEtMS03MDM2Mw_963c2614-87bf-4bc4-a0a4-786ffcb5478d">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities, noncurrent</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfNC0xLTEtMS03NzQ5OQ_3538eea0-82a4-4a60-af7e-b84b7a69ca57"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfNC0xLTEtMS03NzQ5OQ_3bcb0bf3-e902-449c-94d0-fd8995ada510">Other noncurrent liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfNC0zLTEtMS03MDM2Mw_d3c23382-7d82-4bb8-a0ac-1d71dadb0058">739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfNC01LTEtMS03MDM2Mw_3e67ea3d-2ec5-4483-83cc-ca58bad05f17">864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease Expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfMy0yLTEtMS03MDM2Mw_f3c03032-eade-4dc8-b39c-0f6a8fd8aeac">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfMy00LTEtMS03MDM2Mw_3b5e96ea-f4fb-492c-baaa-7204c3764ddf">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfMy02LTEtMS03MDM2Mw_f07304dd-ee26-4d02-aeaa-8c5ab3cdc3f4">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfMy04LTEtMS03MDM2Mw_4e781704-37a2-4a0e-90bb-64426051204f">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNC0yLTEtMS03MDM2Mw_21278013-ba38-4104-a142-5edefb9a7a3b">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNC00LTEtMS03MDM2Mw_4c61f3ab-5d50-4e43-a911-eca2193cd09e">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNC02LTEtMS03MDM2Mw_cd7d1a10-ed9d-4247-bee3-d7ee12534816">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNC04LTEtMS03MDM2Mw_540f65a4-2afd-4968-b915-faf6769ecf8a">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNS0yLTEtMS03MDM2Mw_9208ee3a-58fd-4758-bc33-4ba9f64fb645">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNS00LTEtMS03MDM2Mw_dde46dbe-56b4-4a0f-8640-d3f438b942d1">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNS02LTEtMS03MDM2Mw_05e52443-38f0-43c4-9167-b513867fd241">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNS04LTEtMS03MDM2Mw_562203dc-d425-4854-b24f-77e136eee453">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNi0yLTEtMS03MDM2Mw_3a2658da-302d-4ea5-bccc-681d2696b616">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNi00LTEtMS03MDM2Mw_2b356442-31d6-4ae6-b34b-b9ee6f45941e">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNi02LTEtMS03MDM2Mw_694b5516-99fb-4a95-b9ca-9ef6a57d790c">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNi04LTEtMS03MDM2Mw_7b1aa4bf-b217-4446-9921-b7206a4cabe3">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 17.5pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Operating cash paid for amounts included in the measurement of lease liabilities, operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfOS0yLTEtMS03MDM2Mw_1e8f8349-92c2-4948-9d2b-4ec4f754ee39">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfOS00LTEtMS03MDM2Mw_80cfdc4c-3fe3-4647-90bb-7abfd83a2918">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfOS02LTEtMS03MDM2Mw_d252c468-fb46-40ea-8d27-a91a8a765831">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfOS04LTEtMS03MDM2Mw_7652c9ae-8ceb-4fce-b944-5b4f48733d20">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 17.5pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities, operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfMTAtMi0xLTEtNzAzNjM_17f34311-c61b-49c4-9736-28b273fd45ce">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfMTAtNC0xLTEtNzAzNjM_ec9be220-d89c-4f5d-9d6e-121798612c5c">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfMTAtNi0xLTEtNzAzNjM_ec3221a6-4060-43a9-a621-af49c14abb63">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfMTAtOC0xLTEtNzAzNjM_a3f69101-0592-41cd-aacf-ea291cdaf9f3">192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, the weighted average remaining lease term of our operating leases was <ix:nonNumeric contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RleHRyZWdpb246YTkwZTIzZjIxYzliNDY1MGJkNjlmOGJlYTAzMjhkZmRfMzI3_46bd73f2-7bb4-423f-9282-299399e680d9"><ix:nonNumeric contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RleHRyZWdpb246YTkwZTIzZjIxYzliNDY1MGJkNjlmOGJlYTAzMjhkZmRfMzI3_74c64bbf-c16b-4918-9185-2cd6c00e72ea">7</ix:nonNumeric></ix:nonNumeric> years for each period. The lease liabilities reflect a weighted average discount rate of <ix:nonFraction unitRef="number" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RleHRyZWdpb246YTkwZTIzZjIxYzliNDY1MGJkNjlmOGJlYTAzMjhkZmRfNDEz_c39ea7a4-0240-4116-99f6-902effcc47a9">2.79</ix:nonFraction>% at September&#160;30, 2022 and <ix:nonFraction unitRef="number" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RleHRyZWdpb246YTkwZTIzZjIxYzliNDY1MGJkNjlmOGJlYTAzMjhkZmRfNDI2_61304bf5-5ba4-4570-85fa-3e69c40a8fac">2.69</ix:nonFraction>% at December&#160;31, 2021.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-39-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1ca4d5746cd14d5299ac52e0aadd3300"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RleHRyZWdpb246YTkwZTIzZjIxYzliNDY1MGJkNjlmOGJlYTAzMjhkZmRfNjU3_572a874c-20f1-42d8-bf59-870c292fdb53" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future lease payments for noncancellable operating leases with initial or remaining terms of one year or more are as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.037%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (excluding the nine months ended September 30, 2022)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmM0NmQ1NzJkMWU5YzQ0NDViOWFhMDExOGMzNGMzMGJjL3RhYmxlcmFuZ2U6YzQ2ZDU3MmQxZTljNDQ0NWI5YWEwMTE4YzM0YzMwYmNfMC0xLTEtMS03MDM2Mw_9c0e789a-059a-4855-8dcf-d782356c6832">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmM0NmQ1NzJkMWU5YzQ0NDViOWFhMDExOGMzNGMzMGJjL3RhYmxlcmFuZ2U6YzQ2ZDU3MmQxZTljNDQ0NWI5YWEwMTE4YzM0YzMwYmNfMS0xLTEtMS03MDM2Mw_5b074386-9e7f-4782-9256-dc9704b6c090">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmM0NmQ1NzJkMWU5YzQ0NDViOWFhMDExOGMzNGMzMGJjL3RhYmxlcmFuZ2U6YzQ2ZDU3MmQxZTljNDQ0NWI5YWEwMTE4YzM0YzMwYmNfMi0xLTEtMS03MDM2Mw_679b58de-73b5-4e3d-828d-ec7ab45a6aab">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmM0NmQ1NzJkMWU5YzQ0NDViOWFhMDExOGMzNGMzMGJjL3RhYmxlcmFuZ2U6YzQ2ZDU3MmQxZTljNDQ0NWI5YWEwMTE4YzM0YzMwYmNfMy0xLTEtMS03MDM2Mw_6000933a-dbcc-41d6-8b18-09ca99b41e2f">142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmM0NmQ1NzJkMWU5YzQ0NDViOWFhMDExOGMzNGMzMGJjL3RhYmxlcmFuZ2U6YzQ2ZDU3MmQxZTljNDQ0NWI5YWEwMTE4YzM0YzMwYmNfNC0xLTEtMS03MDM2Mw_01a273ed-d179-4c00-931f-24309d66c713">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmM0NmQ1NzJkMWU5YzQ0NDViOWFhMDExOGMzNGMzMGJjL3RhYmxlcmFuZ2U6YzQ2ZDU3MmQxZTljNDQ0NWI5YWEwMTE4YzM0YzMwYmNfNS0xLTEtMS03MDM2Mw_e01bec86-8f95-4835-b6a5-d06acaf2648e">345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum payments </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmM0NmQ1NzJkMWU5YzQ0NDViOWFhMDExOGMzNGMzMGJjL3RhYmxlcmFuZ2U6YzQ2ZDU3MmQxZTljNDQ0NWI5YWEwMTE4YzM0YzMwYmNfNi0xLTEtMS03MDM2Mw_4f52a5f0-fe97-479a-a595-aae0cb62087b">1,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmM0NmQ1NzJkMWU5YzQ0NDViOWFhMDExOGMzNGMzMGJjL3RhYmxlcmFuZ2U6YzQ2ZDU3MmQxZTljNDQ0NWI5YWEwMTE4YzM0YzMwYmNfNy0xLTEtMS03MDM2Mw_a55a7b23-7ab0-4ba0-9bfb-0cd665dacbad">111</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmM0NmQ1NzJkMWU5YzQ0NDViOWFhMDExOGMzNGMzMGJjL3RhYmxlcmFuZ2U6YzQ2ZDU3MmQxZTljNDQ0NWI5YWEwMTE4YzM0YzMwYmNfOC0xLTEtMS03MDM2Mw_768e024c-58b9-4689-b900-d9dfd00f646d">921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, we have no new leases which will commence during the fourth quarter of 2022.</span></div></ix:continuation><div id="i186e051878fe4219970efc72a9fcdad4_97"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17. <ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RleHRyZWdpb246YTcwZTRiOGE5NmFmNDRiNjgwN2I2YTM2NDcyMGU2NGRfMTAyNg_cf68e8b2-9b0e-496d-9999-bc536461af17" continuedAt="ie3a4fc7910ca4e25a7bf3b3d62d5fa40" escape="true">Goodwill and Other Intangible Assets </ix:nonNumeric></span></div><ix:continuation id="ie3a4fc7910ca4e25a7bf3b3d62d5fa40" continuedAt="idd9605045df64ba5a1bd0e4779dc5bba"><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RleHRyZWdpb246YTcwZTRiOGE5NmFmNDRiNjgwN2I2YTM2NDcyMGU2NGRfMTAyNw_a5995d36-1b8d-41a3-9730-ca2f24405935" escape="true"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the change in the carrying amount of goodwill for our segments (see Note 15, &#8220;Segment Information&#8221;) for 2022 and 2021 is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.161%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial <br/>&amp; Specialty<br/>Business</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Government<br/>Business</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">IngenioRx</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c9a53d41b6411c8a7299de747052ee_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfMS0xLTEtMS03MDM2Mw_071898ba-d35a-4325-808d-5040a51d7c9b">11,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea0cd3e6f73d4c37a185721b7213f0fe_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfMS0zLTEtMS03MDM2Mw_71092459-d238-4d94-a5ad-d606adc7d8e2">8,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0372d0f0be2a4fa7ae88750cdaac34d5_I20201231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfMS01LTEtMS03MDM2Mw_2a76e617-49a6-4b40-a4cc-3a0a90d4e3e3">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1007523085804985812acc850dc8d6fe_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfMS03LTEtMS03MDM2Mw_ee97e42b-a2a7-434a-8064-ba2791430793">1,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aceaf2b19bf4d5d916eb0f2039e41de_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfMS05LTEtMS03MDM2Mw_aff85def-644f-4f7f-8353-0e13c14f824e">21,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35884d0201ae464ebc6e5b8946fa1612_D20210101-20210331" decimals="-6" name="us-gaap:GoodwillPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfMy0xLTEtMS03MDM2Mw_d17c3a1c-b5fe-4f1b-874d-d73ada873aa8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie530874bee08404db56ee4857d5efd5d_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfMy0zLTEtMS03MDM2Mw_c8698768-7cb3-45f3-a441-0f839a99670e">2,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6bbcf70f0bb4a6bbd6551b90da88d89_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfMy01LTEtMS03MDM2Mw_9472b322-9644-4048-8d01-1dc925383aa9">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c94be5ee16a47e7a9596ba6add05232_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfMy03LTEtMS03MDM2Mw_95401610-90ea-47d6-8130-75b4f1fe541b">508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id593e5d6da124d95ab48675ffd8977c9_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfMy05LTEtMS03MDM2Mw_c1e43568-edfd-4fa8-832c-505dfae59349">2,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib25ede8a88f9477dbd274859e7a2b1b1_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNC0xLTEtMS03MDM2Mw_aa9569c2-0841-43ff-b804-59f8045574a7">11,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bbc82c5b8774ddc80a06a94578b2a62_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNC0zLTEtMS03MDM2Mw_c9bd1709-f779-42e5-9622-4db3bbbf0e32">10,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14164de3b9fa4fbda3f76ea2a11abc8b_I20211231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNC01LTEtMS03MDM2Mw_36208eb1-2067-43f8-b5a9-98fb014b79b6">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7c1d9dfb7814c5da0eb0bcb78535511_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNC03LTEtMS03MDM2Mw_26c6c956-6561-4d75-94e5-6c744b8cc8ff">2,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNC05LTEtMS03MDM2Mw_d9a2dd88-a4ec-472b-8d2b-5d99d06f0093">24,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i518bf560bf5b42db9717fa1237d56fc5_D20220101-20220930" decimals="-6" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNS0xLTEtMS03MDM2Mw_2b81091b-c92d-48a8-abf4-007254f90f6f">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32803f4645204fb0b79a26f39fe31411_D20220101-20220930" decimals="-6" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNS0zLTEtMS03MDM2Mw_546dd3af-ea00-49ab-a2bc-1f386b22dab0">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52e3da93e21e46f280c3dae71bf5cb8c_D20220101-20220930" decimals="-6" name="us-gaap:GoodwillPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNS01LTEtMS03MDM2Mw_6c67e236-6886-4840-ac81-06c2d2081228">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5866a8bbba704cf588b8904b077bac81_D20220101-20220930" decimals="-6" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNS03LTEtMS03MDM2Mw_5546c565-5a3c-44a1-903c-620895f0a451">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNS05LTEtMS03MDM2Mw_a969910a-96a3-4a13-b2a2-e055bc717f71">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eef42da7d1c4cd495f66b68093f8dc3_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNi0xLTEtMS03MDM2Mw_67e60806-b487-4678-9e57-8408bcdacebe">11,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17f3cb9f8c1d492197e639b5a0369fef_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNi0zLTEtMS03MDM2Mw_9d1f0824-f1a6-431e-a41f-ef61c2c67397">10,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de2ea0a2eff4ca086ad80177a4451f3_I20220930" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNi01LTEtMS03MDM2Mw_f2a1f3df-1d63-415b-9a53-8b03e4b716d0">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8e9a443d6054bb489dd821a7385bab4_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNi03LTEtMS03MDM2Mw_01c63c6d-5f74-43cc-9b48-ed0441d06636">2,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNi05LTEtMS03MDM2Mw_5557fe27-565f-44f6-bf78-991b75c984b0">24,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment as of September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eef42da7d1c4cd495f66b68093f8dc3_I20220930" decimals="-6" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNy0xLTEtMS03MDM2Mw_8cd46395-deed-4dd6-9fc9-2c53aceac60f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17f3cb9f8c1d492197e639b5a0369fef_I20220930" decimals="-6" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNy0zLTEtMS03MDM2Mw_c892eae4-9669-445a-aaae-c9d3fc1f9080">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de2ea0a2eff4ca086ad80177a4451f3_I20220930" decimals="-6" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNy01LTEtMS03MDM2Mw_2c88302d-59a7-4d6b-87bb-cc5c82ffa03d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8e9a443d6054bb489dd821a7385bab4_I20220930" decimals="-6" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNy03LTEtMS03MDM2Mw_6ccb3486-e092-4a2c-ac64-5533d7c0a2e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNy05LTEtMS03MDM2Mw_91549032-ac29-4e8c-9bf5-c60a1efc8c1a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" name="us-gaap:PresentValueOfFutureInsuranceProfitsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RleHRyZWdpb246YTcwZTRiOGE5NmFmNDRiNjgwN2I2YTM2NDcyMGU2NGRfMTAyOA_570572e7-04f3-417a-ae38-98e93aa2f0f0" escape="true"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of other intangible assets as of September&#160;30, 2022 and December&#160;31, 2021 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.872%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:29pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets with finite lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13859b3a61354d53ab9916db584893cd_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMy0xLTEtMS03MDM2Mw_b8838171-a3cf-4147-9168-11e33f61a416">5,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13859b3a61354d53ab9916db584893cd_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMy0zLTEtMS03MDM2Mw_006b434d-5b04-4fc2-99bc-4408e2f5cc9f">3,580</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13859b3a61354d53ab9916db584893cd_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMy01LTEtMS03MDM2Mw_b368faff-8625-485b-b043-f4b6299e8b8e">2,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bc3de5499444f1ba422babbbc5f65b9_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMy03LTEtMS03MDM2Mw_ad971d73-88d6-4317-82b0-7fd94b5f2848">5,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bc3de5499444f1ba422babbbc5f65b9_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMy05LTEtMS03MDM2Mw_fafbbc98-739d-4404-85a9-5cfff017e0e3">3,236</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bc3de5499444f1ba422babbbc5f65b9_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMy0xMS0xLTEtNzAzNjM_4a67f0db-a04e-444b-b3ba-0b9a0b041a54">2,362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider and hospital relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbcb7d1337e04045a0fcd99dc012728f_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNC0xLTEtMS03MDM2Mw_bd8caef1-29a9-4bda-8315-9305a6747dad">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbcb7d1337e04045a0fcd99dc012728f_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNC0zLTEtMS03MDM2Mw_fb57416e-1d7d-48b3-810c-9146f5ae77db">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbcb7d1337e04045a0fcd99dc012728f_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNC01LTEtMS03MDM2Mw_962885de-f53a-4682-9f11-c55455ff2e08">184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3195b764ef2343888e4fdd71a0e4a7cc_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNC03LTEtMS03MDM2Mw_9b4f642d-2182-497f-a0cf-90a3d2621c27">324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3195b764ef2343888e4fdd71a0e4a7cc_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNC05LTEtMS03MDM2Mw_a845898b-1c96-4842-83b7-2bb266e63947">129</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3195b764ef2343888e4fdd71a0e4a7cc_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNC0xMS0xLTEtNzAzNjM_edb6a1ff-0e6f-4430-b867-5b0d1f4826b2">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4354544bc10d440fa1ec78849d381792_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNS0xLTEtMS03MDM2Mw_fc6c23f7-1141-4a45-8e39-7e87a5fb17b0">920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4354544bc10d440fa1ec78849d381792_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNS0zLTEtMS03MDM2Mw_5061ee47-b378-4b40-8bb4-198f83f417e1">310</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4354544bc10d440fa1ec78849d381792_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNS01LTEtMS03MDM2Mw_9c527ff5-7037-4ba5-9dcf-b48d5d3ae868">610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e8f393fc0344308ba714b6a9bbd73cb_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNS03LTEtMS03MDM2Mw_e887d3a3-7828-40c3-80b5-9276aa27e059">610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e8f393fc0344308ba714b6a9bbd73cb_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNS05LTEtMS03MDM2Mw_88865904-7493-4dc9-ab03-25bc1b69189c">141</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e8f393fc0344308ba714b6a9bbd73cb_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNS0xMS0xLTEtNzAzNjM_e81453ea-d6d3-41d7-82c6-11244c6edb3a">469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNi0xLTEtMS03MDM2Mw_a5be7e31-08ae-4b89-9727-8e756a96278a">7,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNi0zLTEtMS03MDM2Mw_153fe327-50bf-4b57-9bd5-c64a0fae7135">4,032</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNi01LTEtMS03MDM2Mw_00151a0f-a13d-4d03-99bc-db144b1decbf">3,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNi03LTEtMS03MDM2Mw_a3c23dda-b9b3-41fa-b76f-73eabd5aa2e6">6,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNi05LTEtMS03MDM2Mw_e9f45eed-fb44-4727-82d1-ebb8f701abc5">3,506</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNi0xMS0xLTEtNzAzNjM_23d0ab1e-2f2e-4874-8035-2c97ee2d2e0d">3,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets with indefinite lives:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blue Cross and Blue Shield and other trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic90c1cc5ab9f4b6093ae613918639e5e_I20220930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfOC0xLTEtMS03MDM2Mw_b5d95520-abc4-47ee-95dc-930ece771fe9">5,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic90c1cc5ab9f4b6093ae613918639e5e_I20220930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfOC01LTEtMS03MDM2Mw_65073f21-a795-4066-ab12-e2e922be7e8c">5,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab7acc5aba584173aa7d2d55cc110fc3_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfOC03LTEtMS03MDM2Mw_983ce212-adbd-4906-9187-3dead9f1f7dd">6,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab7acc5aba584173aa7d2d55cc110fc3_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfOC0xMS0xLTEtNzAzNjM_14b4381d-b5e2-4e31-9153-212c650c7d38">6,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State Medicaid licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic300e08f31844af79ab58566cb788e9a_I20220930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfOS0xLTEtMS03MDM2Mw_b2083c8d-b18c-4b13-8a6a-e6fe88c5c1dd">1,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic300e08f31844af79ab58566cb788e9a_I20220930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfOS01LTEtMS03MDM2Mw_d10e2605-5f27-4d62-addc-d7847c9ead58">1,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb088b3cd90a4e8a854fa32b4d4e5601_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfOS03LTEtMS03MDM2Mw_962adbc7-76a6-4d33-b4f2-c5d02c9718a2">1,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb088b3cd90a4e8a854fa32b4d4e5601_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfOS0xMS0xLTEtNzAzNjM_d42a70f3-0e4d-4948-9d2a-7bec49732501">1,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMTAtMS0xLTEtNzAzNjM_45fa34b7-441c-452d-a965-dc1ee1c9738f">7,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMTAtNS0xLTEtNzAzNjM_5ef9be50-0db1-4500-b01c-6e894902f880">7,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMTAtNy0xLTEtNzAzNjM_fdffadbf-793a-4a64-8a92-4882d99e433f">7,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMTAtMTEtMS0xLTcwMzYz_9476884a-9538-49e5-b8d1-ea70c3829c5a">7,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMTEtMS0xLTEtNzAzNjM_406a2c16-43f7-4767-bb96-bfa8fcb9dcc0">14,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="elv:IntangibleAssetsAccumulatedAmortizationExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMTEtMy0xLTEtNzAzNjM_6894edd6-06b9-42e2-ad42-54d199a42b4e">4,032</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMTEtNS0xLTEtNzAzNjM_32d8439a-a096-4c43-afc3-fbad3ebe6bc7">10,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMTEtNy0xLTEtNzAzNjM_cfaa518e-410f-4023-9840-55b778eb07cb">14,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="elv:IntangibleAssetsAccumulatedAmortizationExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMTEtOS0xLTEtNzAzNjM_f72ba793-bd9e-47d4-96d5-78a5d65b294c">3,506</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMTEtMTEtMS0xLTcwMzYz_e73ab55f-8a67-485d-8843-38c992d67ce2">10,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-40-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="idd9605045df64ba5a1bd0e4779dc5bba"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2022, we recorded intangible assets related to Integra and also reclassified $<ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RleHRyZWdpb246YTcwZTRiOGE5NmFmNDRiNjgwN2I2YTM2NDcyMGU2NGRfMzgy_5e4cf9a1-7df9-49b7-9724-675ada325de5"><ix:nonFraction unitRef="usd" contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RleHRyZWdpb246YTcwZTRiOGE5NmFmNDRiNjgwN2I2YTM2NDcyMGU2NGRfMzgy_87347d13-3d3e-4498-bb9d-c524c83b811c">308</ix:nonFraction></ix:nonFraction> of trademarks with indefinite lives to intangible assets with finite lives - Other, which relates to our new branding strategy. In addition, the amortization period of certain intangible assets was shortened to align with the anticipated dates the new branding will take place. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, along with the related accumulated amortization, are removed from the table above at the end of the fiscal year in which they become fully amortized.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the estimated amortization expense for the year ending December 31, 2022 and each of the five succeeding years is as follows: 2022, $<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RleHRyZWdpb246YTcwZTRiOGE5NmFmNDRiNjgwN2I2YTM2NDcyMGU2NGRfOTgw_3248c0fc-f191-42d1-928e-d9b0aa23cb37">748</ix:nonFraction>; 2023, $<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RleHRyZWdpb246YTcwZTRiOGE5NmFmNDRiNjgwN2I2YTM2NDcyMGU2NGRfOTg4_82ae9d2a-7211-434c-9c59-1e21b4424c8d">735</ix:nonFraction>; 2024, $<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RleHRyZWdpb246YTcwZTRiOGE5NmFmNDRiNjgwN2I2YTM2NDcyMGU2NGRfOTk2_400702a8-4701-4583-ba52-74a2066bbb6b">370</ix:nonFraction>; 2025, $<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RleHRyZWdpb246YTcwZTRiOGE5NmFmNDRiNjgwN2I2YTM2NDcyMGU2NGRfMTAwNA_012d2830-bfcb-44ee-83bd-d73c6c8a269b">311</ix:nonFraction>; 2026, $<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RleHRyZWdpb246YTcwZTRiOGE5NmFmNDRiNjgwN2I2YTM2NDcyMGU2NGRfMTAxMg_81a77a31-34e2-44b7-9da6-391fde19334d">258</ix:nonFraction>; and 2027, $<ix:nonFraction unitRef="usd" contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930" decimals="-6" name="elv:FiniteLivedIntangibleAssetExpectedAmortizationYearSix" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RleHRyZWdpb246YTcwZTRiOGE5NmFmNDRiNjgwN2I2YTM2NDcyMGU2NGRfMTAyNA_2bdc7649-e9d0-40d4-a61d-faa87cc052c1">219</ix:nonFraction>.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-41-</span></div></div></div><div id="i186e051878fe4219970efc72a9fcdad4_103"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In Millions, Except Per Share Data or as Otherwise Stated Herein)</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 18, 2022, our shareholders approved a proposal to amend our amended and restated articles of incorporation to change our name from Anthem, Inc. to Elevance Health, Inc. This amendment and name change went into effect on June 27, 2022. We began operating as Elevance Health, Inc. and trading under our new ticker symbol &#8220;ELV&#8221; on June 28, 2022. References to the terms &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; or &#8220;Elevance Health&#8221; used throughout this Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (&#8220;MD&amp;A&#8221;) refer to Elevance Health, Inc., an Indiana corporation, and unless the context otherwise requires, its direct and indirect subsidiaries. References to the &#8220;states&#8221; include the District of Columbia and Puerto Rico, unless the context otherwise requires.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This MD&amp;A should be read in conjunction with the accompanying consolidated financial statements and notes, our consolidated financial statements and notes as of and for the year ended December&#160;31, 2021 and the MD&amp;A included in our 2021 Annual Report on Form 10-K.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results of operations, cost of care trends, investment yields and other measures for the three and nine months ended September&#160;30, 2022 are not necessarily indicative of the results and trends that may be expected for the full year ending December&#160;31, 2022, or any other period. </span></div><div id="i186e051878fe4219970efc72a9fcdad4_106"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Elevance Health is a health company with the purpose of improving the health of humanity. We are the largest health insurer in the United States in terms of medical membership, serving over 47 million medical members through our affiliated health plans as of September&#160;30, 2022. We are an independent licensee of the Blue Cross and Blue Shield Association (&#8220;BCBSA&#8221;), an association of independent health benefit plans. We serve our members as the Blue Cross licensee for California and as the Blue Cross and Blue Shield (&#8220;BCBS&#8221;) licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (in the New York City metropolitan area and upstate New York), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.) and Wisconsin. In a majority of these service areas, we do business as Anthem Blue Cross, Anthem Blue Cross and Blue Shield, and Empire Blue Cross Blue Shield or Empire Blue Cross. In addition, we conduct business through arrangements with other BCBS licensees as well as other strategic partners. Through our subsidiaries, we also serve customers in numerous states as AIM Specialty Health, Amerigroup, Aspire Health, Beacon, CareMore, Freedom Health, HealthLink, HealthSun, Integra Managed Care, MMM, Optimum HealthCare, Simply Healthcare, and/or UniCare. We offer pharmacy benefits management (&#8220;PBM&#8221;) services through our IngenioRx, Inc. (&#8220;IngenioRx&#8221;) subsidiary. We are licensed to conduct insurance operations in all 50 states, the District of Columbia and Puerto Rico through our subsidiaries.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our name change to Elevance Health, on June 15, 2022 we announced that over the next several years we will organize our brand portfolio into the following core go-to-market brands:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Anthem Blue Cross/Anthem Blue Cross and Blue Shield &#8212; represents our existing Anthem-branded and affiliated Blue Cross and/or Blue Shield licensed plans;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Wellpoint &#8212; we intend to unite select non-BCBSA licensed Medicare, Medicaid and Commercial plans under the Wellpoint name; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Carelon &#8212; this brand will bring together our healthcare brands and capabilities, including our Diversified Business Group and IngenioRx business under a single brand name. We now refer to our Diversified Business Group as Carelon. In January 2023, IngenioRx will become CarelonRx.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are currently no segment changes associated with this branding strategy. Our branding strategy reflects the evolution of our business from a traditional health insurance company to a lifetime, trusted health partner, and given this evolution we are in the process of reviewing and modifying how we will manage our businesses in the future.</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information about our organization, see Part I, Item 1, &#8220;Business&#8221; and Part II, Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; included in our 2021 Annual Report on Form 10-</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-42-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">K. Additional information on our segments can be found in this MD&amp;A and in Note 15, &#8220;Segment Information&#8221; of the Notes to Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.</span></div><div id="i186e051878fe4219970efc72a9fcdad4_109"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve, impacting the global economy, causing market instability and uncertainty in the labor market and putting pressure on the healthcare system, and it has impacted, and will likely continue to impact, our membership, benefit expense and member behavior, including how members access healthcare services. The full extent of the impact of the COVID-19 pandemic will depend on future developments, which are highly uncertain and cannot be predicted at this time. We will continue to monitor the COVID-19 pandemic as well as resulting legislative and regulatory changes to manage our response and assess and mitigate potential adverse impacts to our business. For additional discussion regarding our risks related to the COVID-19 pandemic and our other risk factors, see Part I, Item 1A, &#8220;Risk Factors&#8221; included in our 2021 Annual Report on Form 10-K. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Trends</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We made the decision to modestly expand our participation in the Individual on-exchange products through state- or federally-facilitated marketplaces (the &#8220;Public Exchange&#8221;) for 2022 after also expanding in 2021. As a result, for 2022 we are offering Public Exchange products in 122 of the 143 rating regions in which we operate, in comparison to 103 of 143 rating regions in 2021. Our strategy has been, and will continue to be, to only participate in rating regions where we have an appropriate level of confidence that these markets are sustainable, given consideration to factors including, but not limited to, expected financial performance, regulatory environment and underlying market characteristics. Changes to our business environment are likely to continue as elected officials at the national and state levels continue to enact, and both elected officials and candidates for election continue to propose, significant modifications to existing laws and regulations, including changes to taxes and fees. In addition, the continuing growth in our government-sponsored business exposes us to increased regulatory oversight.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our IngenioRx subsidiary markets and offers PBM services to our affiliated health plan customers throughout the country, as well as to customers outside of the health plans we own. Our comprehensive PBM services portfolio includes features such as formulary management, pharmacy networks, a prescription drug database, member services and mail order capabilities. IngenioRx delegates certain PBM administrative functions, such as claims processing and prescription fulfillment, to CaremarkPCS Health, L.L.C., which is a subsidiary of CVS Health Corporation, pursuant to a five-year agreement. With IngenioRx, we retain the responsibilities for clinical and formulary strategy and development, member and employer experiences, operations, sales, marketing, account management and retail network strategy.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pricing Trends: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We strive to price our health benefit products consistent with anticipated underlying medical cost trends. We continue to closely monitor the COVID-19 pandemic (including new COVID-19 variants, which may be more contagious or severe, or less responsive to treatment or vaccines) and the impacts it may have on our pricing, such as surges in COVID-19 related hospitalizations, infection rates, the cost of COVID-19 vaccines, testing and treatment and the return of non-COVID-19 healthcare utilization to historical utilization patterns. We frequently make adjustments to respond to legislative and regulatory changes as well as pricing and other actions taken by existing competitors and new market entrants. Product pricing in our Commercial &amp; Specialty Business segment, including our Individual and small group lines of business, remains competitive. Revenues from the Medicare and Medicaid programs are dependent, in whole or in part, upon annual funding from the federal government and/or applicable state governments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Cost Trends:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our medical cost trends are primarily driven by increases in the utilization of services across all provider types and the unit cost increases of these services. We work to mitigate these trends through various medical management programs such as care and condition management, program integrity and specialty pharmacy management and utilization management, as well as benefit design changes. There are many drivers of medical cost trends that can cause variance from our estimates, such as changes in the level and mix of services utilized, regulatory changes, aging of the population, health status and other demographic characteristics of our members, epidemics, pandemics, advances in medical technology, new high-cost prescription drugs, provider contracting inflation and healthcare provider or member fraud.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At its onset, the COVID-19 pandemic caused a decrease in utilization of non-COVID-19 health services, which decreased our claim costs in 2020. As the pandemic continued through 2021, our non-COVID-19 healthcare utilization </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-43-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">experience gradually increased and largely normalized. Our COVID-19 related healthcare expenses increased during 2021 as new variants (Delta and Omicron) emerged and vaccinations and boosters became available.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 surge quickly declined during the first quarter of 2022, with COVID-19 inpatient authorizations, provider-based tests, visits and vaccinations all decreasing to lower levels by the end of the first nine months of 2022; concurrently, non-COVID-19 healthcare utilization throughout the first nine months of 2022 recovered from lower levels earlier in the year. We expect the fourth quarter of 2022 will have higher claim costs related to a more normal flu season as well as incremental COVID-19 related healthcare expenses compared to the second and third quarters of 2022. The ongoing cost and volume of covered services related to the COVID-19 pandemic may have a material adverse effect on our future claim costs. We continue to closely monitor the COVID-19 pandemic and its impacts on our business, financial condition, results of operations and medical cost trends.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional discussion regarding business trends, see Part I, Item 1, &#8220;Business&#8221; included in our 2021 Annual Report on Form 10-K.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Trends and Uncertainties</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal and state governments have enacted, and may continue to enact, legislation and regulations in response to the COVID-19 pandemic that have had, and we expect will continue to have, a significant impact on health benefits, consumer eligibility for public programs and our cash flows for all lines of business and which have introduced increased uncertainty around our cost structure. These actions, which are or have been in effect for various durations, provide, among other things: mandates to waive cost-sharing for COVID-19 testing, vaccines and related services; financial support to healthcare providers; and mandates related to prior authorizations, payment levels to providers, consumer enrollment windows and telehealth services.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current public health emergency (&#8220;PHE&#8221;) has been extended to January 2023. Medicaid eligibility recertification will resume when the PHE ends, meaning that if the PHE ends in January 2023, recertifications could begin as early as February 2023, but may not occur until later in certain states. When recertifications resume, we expect a decline in our Medicaid membership. At the same time, we expect growth in our Commercial risk-based and fee-based plans, including through the Public Exchange, as members exiting Medicaid in our fourteen Commercial states seek coverage elsewhere.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Inflation Reduction Act of 2022 (the &#8220;Inflation Reduction Act&#8221;), which was signed into law in August 2022,  contains a variety of provisions that impact our business including an extension of the American Rescue Plan Act of 2021&#8217;s enhanced Premium Tax Credits (&#8220;PTC&#8221;) through 2025; providing a one percent excise tax on  repurchases of stock made after December 31, 2022; allowing the Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;) to negotiate prices on a limited set of prescription drugs in Medicare Parts B and D beginning in 2026; instituting caps on insulin cost sharing in Medicare Parts B and D; redesigning of the Medicare Part D benefit; adding a requirement that drug manufacturers pay rebates if prices increase beyond inflation; and delaying implementation of the Trump Administration Medicare drug rebate rule to 2032. The extension of the enhanced PTC will likely allow for growth in Individual exchange market enrollment, as Medicaid  eligibility recertifications resume, supporting continuity of coverage for more people.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The health plan price transparency regulations issued in October 2020 by the U.S. Departments of Health and Human Services, Labor and Treasury required us to begin disclosing in July 2022, on a monthly basis, detailed pricing information regarding negotiated rates for all covered items and services between the plan or issuer and in-network providers and historical payments to, and billed charges from, out-of-network providers. Additionally, beginning in 2023, we will be required to make available to members personalized out-of-pocket cost information and the underlying negotiated rates for 500 covered healthcare items and services, including prescription drugs. In 2024, this requirement will expand to all items and services.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Appropriations Act of 2021 (the &#8220;Appropriations Act&#8221;) has impacted and in the future may have a material effect upon our business, including procedures and coverage requirements related to surprise medical bills and new mandates for continuity of care for certain patients, price comparison tools, disclosure of broker compensation, mental health parity reporting, and reporting on pharmacy benefits and drug costs. The requirements of the Appropriations Act applicable to us have varying effective dates, some of which were effective in December 2021 and others that have been extended since the enactment of the Appropriations Act.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-44-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since its enactment in 2010, the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010, as amended (collectively, the &#8220;ACA&#8221;), has introduced new risks, regulatory challenges and uncertainties, has impacted our business model and strategy and has required changes in the way our products are designed, underwritten, priced, distributed and administered. We expect the ACA will continue to significantly impact our business and results of operations, including pricing, minimum medical loss ratios and the geographies in which our products are available, and as a result of future modifications of, and guidance by federal regulatory agencies related to, the ACA and our businesses more broadly. We will continue to evaluate the impact of the ACA as any further developments occur.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional discussion regarding regulatory trends and uncertainties and risk factors, see Part I, Item 1, &#8220;Business &#8211; Regulation&#8221;, Part I, Item 1A, &#8220;Risk Factors&#8221;, and the &#8220;Regulatory Trends and Uncertainties&#8221; section of Part II, Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in our 2021 Annual Report on Form 10-K.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Significant Items</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Business and Operational Matters</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As mentioned above, we began operating as Elevance Health on June 28, 2022. This name change is intended to better reflect our business and our journey from a traditional health benefits organization to a lifetime, trusted health partner. Elevance Health supports health at every stage, offering health plans and clinical, behavioral, pharmacy and complex-care solutions that promote whole health.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 5, 2022, we completed our acquisition of Integra Managed Care (&#8220;Integra&#8221;). Integra is a managed long-term care plan that serves New York state Medicaid members, enabling adults with long-term care needs and disabilities to live safely and independently in their own homes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 29, 2021, we completed our acquisition of MMM Holdings, LLC (&#8220;MMM&#8221;) and its Medicare Advantage plan, Medicaid plan and other affiliated companies. MMM is a Puerto Rico-based integrated healthcare organization and seeks to provide its Medicare Advantage and Medicaid members with a whole health experience through its network of specialized clinics and wholly owned independent physician associations. This acquisition aligns with our vision to be an innovative, valuable and inclusive healthcare partner by providing care management programs that improve the lives of the people we serve.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 28, 2021, we completed our acquisition of myNEXUS, Inc. (&#8220;myNEXUS&#8221;). myNEXUS is a comprehensive home-based nursing management company for payors and, at the time of acquisition, delivered integrated clinical support services for Medicare Advantage members across twenty states. This acquisition aligns with our strategy to manage integrated, whole person multi-site care and support by providing national, large-scale expertise to manage nursing services in the home and facilitate transitions of care.</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For additional information, see Note 3, &#8220;Business Acquisitions,&#8221; of the Notes to Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we introduced enterprise-wide initiatives to optimize our business and as a result, recorded a charge of $653 in selling, general and administrative expenses. We believe these initiatives largely represent the next step forward in our progression towards becoming a more agile organization, including process automation and a reduction in our office space footprint. In the fourth quarter of 2021, we identified additional office space reductions and related fixed asset impairments due to the continuing COVID-19 pandemic and recorded a charge of $202 in selling, general and administrative expenses. For additional information, see Note 4, &#8220;Business Optimization Initiatives,&#8221; of the Notes to Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Litigation Matters</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the consolidated multi-district proceeding in the United States District Court for the Northern District of Alabama (the &#8220;Court&#8221;) captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re Blue Cross Blue Shield Antitrust Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;BCBSA Litigation&#8221;), the BCBSA and Blue Cross and/or Blue Shield licensees, including us (the &#8220;Blue plans&#8221;) previously approved a settlement agreement and release with the plaintiffs representing a putative nationwide class of health plan subscribers (the &#8220;Subscriber Settlement Agreement&#8221;), which </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-45-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">agreement required the Court&#8217;s approval to become effective. Generally, the lawsuits in the BCBSA Litigation challenge elements of the licensing agreements between the BCBSA and the independently owned and operated Blue plans. The cases were brought by two putative nationwide classes of plaintiffs, health plan subscribers and providers. The Subscriber Settlement Agreement applies only to the putative subscriber class. No settlement agreement has been reached with the provider plaintiffs at this time, and the defendants continue to contest the consolidated cases brought by the provider plaintiffs.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Court approved the Subscriber Settlement Agreement. In compliance with the Subscriber Settlement Agreement, in September 2022 the Company paid its remaining $506 portion of the settlement fund into an escrow account, for an aggregate settlement payment by the Company of $596. Four notices of appeal of the final approval order were filed by the September 2022 deadline. After all appellate rights have been exhausted in a manner that affirms the Court&#8217;s final order and judgment, the defendants&#8217; payment and non-monetary obligations under the Subscriber Settlement Agreement will become effective. For additional information regarding the BCBSA Litigation, see Note 11, &#8220;Commitments and Contingencies &#8211; Litigation and Regulatory Proceedings &#8211; Blue Cross Blue Shield Antitrust Litigation,&#8221; of the Notes to Consolidated Financial Statements included in Part I, Item&#160;1 of this Quarterly Report on Form 10-Q.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selected Operating Performance</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended September&#160;30, 2022, total medical membership increased by 2.2 million, or 4.9%. Our membership increase was primarily driven by organic growth in our Commercial &amp; Specialty Business segment, and in particular in our Group fee-based membership, and organic growth in our Government Business segment primarily driven by the continued temporary suspension of Medicaid eligibility recertification during the COVID-19 pandemic.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating revenue for the three months ended September 30, 2022 was $39,625, an increase of $4,077, or 11.5%, from the three months ended September 30, 2021. Operating revenue increased primarily as a result of higher premium revenue in our Medicaid business, including due to membership growth from the continued temporary suspension of Medicaid eligibility recertification during the COVID-19 pandemic, the acquisition of Integra in the second quarter of 2022 and the acquisition of Ohio Medicaid members through the purchase of a Medicaid contract in the first quarter of 2022. Premium rate increases to cover medical cost trends and membership growth in our Medicare Advantage and Commercial &amp; Specialty Business risk-based businesses also generated higher premium revenue. Finally, the increase in operating revenue was further attributable to increased pharmacy product revenue in our IngenioRx segment, resulting from growth in membership and higher script volume.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Operating revenue for the nine months ended September 30, 2022 was $115,993, an increase of $15,068, or 14.9%, from the nine months ended September 30, 2021. This increase in operating revenue was primarily driven by higher premium revenue in our Medicaid business, as noted above, the acquisition of MMM in the second quarter of 2021 and the retroactive reinstatement of a Medicaid directed payment program. Membership growth and premium rate increases to cover medical cost trends in our Medicare Advantage and Commercial &amp; Specialty Business risk-based businesses also generated higher premium revenue. Finally, the increase in operating revenue was further attributable to increased pharmacy product revenue in our IngenioRx segment resulting from higher script volume, the acquisition of Ohio Medicaid members through the purchase of a Medicaid contract in the first quarter of 2022 and the acquisition of Integra in the second quarter of 2022.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income for the three months ended September 30, 2022 was $1,613, an increase of $111, or 7.4%, from the three months ended September 30, 2021. The increase in net income was primarily due to operating gain increases in our Commercial &amp; Specialty Business, Other and IngenioRx segments, partially offset by increased intangible amortization in 2022 related to recent acquisitions and the rebranding of our products, as we expect to retire certain trade names in the future, and a decline in our Government Business segment operating results.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income for the nine months ended September 30, 2022 was $5,058, an increase of $88, or 1.8%, from the nine months ended September 30, 2021. The increase in net income was primarily due to operating gain increases in our Government Business, Other and IngenioRx segments, partially offset by losses on financial instruments in 2022 as compared to gains in 2021 and increased intangible amortization in 2022 related to recent acquisitions and the rebranding of our products, as we expect to retire certain trade names in the future. Our Commercial &amp; Specialty Business segment had a slight decline year over year.   </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-46-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fully-diluted shareholders&#8217; earnings per share (&#8220;EPS&#8221;) was $6.68 for the three months ended September 30, 2022, which represented a 9.0% increase from EPS of $6.13 for the three months ended September 30, 2021. Our diluted shares for the three months ended September&#160;30, 2022 were 242.2, a decrease of 3.8, or 1.5%, compared to the three months ended September 30, 2021. The increase in EPS for the three months ended September 30, 2022 resulted primarily from increased shareholders&#8217; income, as well as from the impact of fewer diluted shares outstanding.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fully-diluted shareholders&#8217; EPS was $20.86 for the nine months ended September 30, 2022, which represented a 3.8% increase from fully-diluted EPS of $20.09 for the nine months ended September 30, 2021. Our diluted shares for the nine months ended September 30, 2022 were 243.3, a decrease of 3.9, or 1.6%, compared to the nine months ended September 30, 2021. The increase in EPS for the nine months ended September 30, 2022 resulted primarily from increased shareholders&#8217; income, as well as from the impact of fewer diluted shares outstanding.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flow for the nine months ended September 30, 2022 and 2021 was $9,917 and $6,692, respectively. The increase was primarily due to the timing of CMS payments received in the current year, partially offset by the Subscriber Settlement Agreement payment made in September 2022.</span></div><div id="i186e051878fe4219970efc72a9fcdad4_115"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Membership</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our medical membership by reportable segment and customer type as of September&#160;30, 2022 and 2021. Also included below is other membership by product. The medical membership and other membership data presented are unaudited and in certain instances include estimates of the number of members represented by each contract at the end of the period.&#160;For a more detailed description of our medical membership, see the &#8220;Membership&#8221; section of Part II, Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in our 2021 Annual Report on Form 10-K.</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.786%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Medical Membership</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial &amp; Specialty Business:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Risk-Based</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Risk-Based</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,788&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BlueCard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Fee-Based</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Fee-Based</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,637&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,536&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,101&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Commercial &amp; Specialty Business</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,251&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Business:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,969&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,914&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal Employees Health Benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Government Business</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,858&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,820&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medical Membership</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,283&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,071&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,212</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Other Membership</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life and Disability Members</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dental Members</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dental Administration Members</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vision Members</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Part D Standalone Members</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-47-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Medical Membership</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical membership increased in both our Commercial &amp; Specialty Business and Government Business segments primarily due to organic growth. Our Commercial &amp; Specialty Business segment experienced organic growth in our Group fee-based and risk-based membership as sales exceeded lapses. BlueCard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> membership increased due to favorable membership activity at other BCBSA plans whose members reside in or travel to our licensed areas. Individual membership increased due to our Public Exchange expansion in 2022. Our Government Business segment organic growth was primarily driven by the continued temporary suspension of Medicaid eligibility recertification during the COVID-19 pandemic. In addition, Medicaid membership was positively impacted by the acquisition of Ohio Medicaid members through the purchase of a Medicaid contract in the first quarter of 2022 and the acquisition of Integra in the second quarter of 2022. Medicare Advantage organic growth due to sales exceeding lapses also contributed to the overall Government Business segment growth.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Other Membership</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our other membership can be impacted by changes in our medical membership, as our medical members often purchase our other products that are ancillary to our health business. Life and disability membership increased primarily due to new sales of disability products, partially offset by lapses and negative in-group change of life membership. Dental membership increased primarily due to sales exceeding lapses in our Group risk-based accounts and penetration increases in our Federal Employees Health Benefits (&#8220;FEHB&#8221;) program, partially offset by the loss of a significant Group fee-based account. Dental administration membership increased primarily due to increased sales to other BCBS plans associated with the FEHB program. Vision membership increased primarily due to the launch of a new entry level vision product in our Group markets. Medicare Part D Standalone membership declined as we discontinued certain legacy products.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-48-</span></div></div></div><div id="i186e051878fe4219970efc72a9fcdad4_121"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Results of Operations</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated summarized results of operations and other financial information for the three and nine months ended September&#160;30, 2022 and 2021 are as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.786%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.786%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.786%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.794%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,625</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,548</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">115,993</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,925</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,068&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">371</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">335</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,112</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net (losses) gains on financial instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(57)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(61)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(439)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(546)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,939</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,822</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">116,666</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">102,058</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,117&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,608&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Benefit expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,404</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,645</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86,396</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,107</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,759&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,437</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,898</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,389</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,825</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,514</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,946</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,124</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,692</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">438</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">337</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,142</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">909</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,793</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,826</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">110,051</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">95,533</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,967&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income before income tax expense</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,146</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,996</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,615</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,525</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">533</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">494</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,557</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,555</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,613</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,502</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,058</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,970</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net loss (income) attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shareholders&#8217; net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,618</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,509</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,076</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,967</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average diluted shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">242.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">246.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">243.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">247.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted shareholders&#8217; net income per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.68</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.13</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.86</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.09</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10 bp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30) bp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">3</span></div></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Benefit expense ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(50) bp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10 bp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">3</span></div></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selling, general and administrative expense ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30 bp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30) bp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">3</span></div></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income before income tax expense as a percentage of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(20) bp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(70) bp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">3</span></div></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shareholders&#8217; net income as a percentage of total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(20) bp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(60) bp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">3</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Certain of the following definitions are also applicable to all other results of operations tables in this discussion:</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">NM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Not meaningful.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Includes interest expense, amortization of other intangible assets and loss on extinguishment of debt.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Benefit expense ratio represents benefit expense as a percentage of premium revenue. Premiums for the three months ended September 30, 2022 and 2021 were $33,722 and $30,395, respectively. Premiums for the nine months ended September 30, 2022 and 2021 were $99,583 and $86,604, respectively. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">bp = basis point; one hundred basis points = 1%.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Selling, general and administrative expense ratio represents selling, general and administrative expense as a percentage of total operating revenue.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended September 30, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compared to the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended September 30, 2021 </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating revenue increased primarily as a result of higher premium revenue in our Medicaid business due to membership growth from the continued temporary suspension of Medicaid eligibility recertification during the COVID-19 pandemic, the acquisition of Integra in the second quarter of 2022 and the acquisition of Ohio Medicaid members through the purchase of a Medicaid contract in the first quarter of 2022. Membership growth in our Medicare Advantage and Commercial &amp; Specialty Business risk-based businesses, as well as premium rate increases to cover medical cost trends also generated higher premium revenue. Finally, the increase in operating revenue was further attributable to increased pharmacy product revenue in our IngenioRx segment, resulting from growth in membership and higher script volume.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-49-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net investment income increased primarily due to higher income from fixed maturity securities, partially offset by reduced investment income from alternative investments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefit expense increased primarily due to healthcare costs associated with organic membership growth in our Medicaid and Medicare businesses, the acquisition of Integra in the second quarter of 2022 and the acquisition of Ohio Medicaid members in the first quarter of 2022 through the purchase of a Medicaid contract. Membership growth in our Commercial risk-based business also contributed to the increased benefit expense.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our benefit expense ratio decreased and was driven by the realignment of certain quality improvement costs from benefit expense to administrative expense. Excluding the realignment, our benefit expense ratio would have been approximately flat year-over-year.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of products sold reflects the cost of pharmaceuticals dispensed by IngenioRx for our unaffiliated PBM customers. Cost of products sold increased as the corresponding pharmacy product revenues increased.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expense increased primarily due to increased costs to support growth and the prior period realignment of certain quality improvement costs from benefit expense to administrative expense described above.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our selling, general and administrative expense ratio increased primarily due to increased costs to support membership growth and the prior period realignment of certain quality improvement costs from benefit expense to administrative expense, partially offset by the impact of operating revenue growth in 2022.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense increased primarily due to additional amortization of intangible assets related to recent acquisitions and the rebranding of our products. The amortization period of certain intangible assets was shortened to align with anticipated dates the new branding will take place. In addition, certain indefinite-lived intangible assets have been reclassified as definite-lived, and therefore, are now being amortized. For additional information regarding intangible asset amortization, see Note 17, &#8220;Goodwill and Other Intangible Assets,&#8221; of the Notes to Consolidated Financial Statements included in Part I, Item&#160;1 of this Quarterly Report on Form 10-Q.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our shareholders&#8217; net income as a percentage of total revenues decreased in 2022 as compared to 2021 as a result of all factors discussed above.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nine Months Ended September 30, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compared to the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nine Months Ended September 30, 2021 </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating revenue increased primarily as a result of higher premium revenue in our Medicaid business due to membership growth from the continued temporary suspension of Medicaid eligibility recertification during the COVID-19 pandemic, the acquisition of MMM in the second quarter of 2021 and the retroactive reinstatement of a Medicaid directed payment program. Membership growth and premium rate increases to cover medical cost trends in our Medicare Advantage and Commercial &amp; Specialty Business risk-based businesses also contributed to higher premium revenue. Finally, the increase in operating revenue was further attributable to increased pharmacy product revenue in our IngenioRx segment resulting from higher script volume, the acquisition of Ohio Medicaid members through the purchase of a Medicaid contract in the first quarter of 2022 and the acquisition of Integra in the second quarter of 2022.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net investment income increased primarily due to higher income from fixed maturity securities, partially offset by reduced investment income from alternative investments. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had net losses on financial instruments in the first nine months of 2022, as compared to net gains in the first nine months of 2021, as a result of increased net losses on fixed maturity securities, reduced gains on sales of equity securities and increased mark-to-market losses on equity securities still held, partially offset by increased net gains in other investments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefit expense increased primarily due to healthcare costs associated with organic membership growth in our Medicaid and Medicare businesses, the acquisition of MMM in the second quarter of 2021 and the retroactive reinstatement of a Medicaid directed payment program. Membership growth and higher healthcare costs in our Commercial risk-based business also contributed to the higher benefit expense. The increase in benefit expense was also attributable to the acquisition of Ohio Medicaid members through the purchase of a Medicaid contract in the first quarter of 2022 and the acquisition of Integra in the second quarter of 2022.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-50-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our benefit expense ratio increased slightly primarily due to the impact of continued membership increases in our Government Business segment, which has a higher benefit expense ratio than our Commercial &amp; Specialty Business segment.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of products sold reflects the cost of pharmaceuticals dispensed by IngenioRx for our unaffiliated PBM customers. Cost of products sold increased as the corresponding pharmacy product revenues increased.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expense increased primarily due to increased costs to support membership growth and from our acquisitions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our selling, general and administrative expense ratio decreased primarily due to operating revenue growth in 2022, partially offset by increased costs to support membership growth. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense increased primarily due to additional amortization of intangible assets related to recent acquisitions and the rebranding of our products. The amortization period of certain intangible assets was shortened to align with anticipated dates the new branding will take place. In addition, certain indefinite-lived intangible assets have been reclassified as definite-lived, and therefore, are now being amortized. For additional information regarding intangible asset amortization, see Note 17, &#8220;Goodwill and Other Intangible Assets,&#8221; of the Notes to Consolidated Financial Statements included in Part I, Item&#160;1 of this Quarterly Report on Form 10-Q.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our shareholders&#8217; net income as a percentage of total revenues decreased in 2022 as compared to 2021 as a result of all factors discussed above.</span></div><div id="i186e051878fe4219970efc72a9fcdad4_127"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reportable Segments Results of Operations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our results of operations discussed throughout this MD&amp;A are determined in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;). We also calculate operating gain and operating margin to further aid investors in understanding and analyzing our core operating results and comparing them among periods. We define operating revenue as premium income, product revenue and administrative fees and other revenue. Operating gain is calculated as total operating revenue less benefit expense, cost of products sold and selling, general and administrative expense. It does not include net investment income, net (losses) gains on financial instruments, interest expense, amortization of other intangible assets, loss on extinguishment of debt or income taxes, as these items are managed in our corporate shared service environment and are not the responsibility of operating segment management. Operating margin is calculated as operating gain divided by operating revenue. We use these measures as a basis for evaluating segment performance, allocating resources, forecasting future operating periods and setting incentive compensation targets. This information is not intended to be considered in isolation or as a substitute for income before income tax expense, shareholders&#8217; net income or EPS prepared in accordance with GAAP, and may not be comparable to similarly titled measures reported by other companies. For a reconciliation of reportable segments&#8217; operating revenue to the amounts of total revenue included in the consolidated statements of income and a reconciliation of income before income tax expense to reportable segments&#8217; operating gain, see Note 15, &#8220;Segment Information,&#8221; of the Notes to Consolidated Financial Statements included in Part I, Item&#160;1 of this Form 10-Q.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously discussed, we will be organizing our brand portfolio into three core go-to-market brands over the next several years. Our branding strategy reflects the evolution of our business from a traditional health insurance company to a lifetime, trusted health partner, and given this evolution we are in the process of reviewing and modifying how we will manage our businesses in the future. There are currently no changes to our segments associated with this branding strategy. The results of our operations continue to be described through four reportable segments: Commercial &amp; Specialty Business, </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-51-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government Business, IngenioRx and Other. For additional information, see Note 15, &#8220;Segment Information,&#8221; of the Notes to Consolidated Financial Statements included in Part I, Item&#160;1 of this Form 10-Q. </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of the reportable segment financial information for the three and nine months ended September&#160;30, 2022 and 2021:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.834%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.786%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.786%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.786%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.793%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Revenue</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial &amp; Specialty Business</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,494</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,863</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,324</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,904</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government Business</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,571</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,658</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,164</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,007</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,913&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IngenioRx</span></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,249</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,549</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,003</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,630</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,365</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,670</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,884</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,557</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eliminations </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,054)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,192)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,382)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,173)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(862)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,209)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,625</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,548</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115,993</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,925</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,068&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial &amp; Specialty Business</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">785</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">620</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,673</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,679</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government Business</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">868</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">967</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,653</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,313</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IngenioRx</span></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">516</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">445</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,393</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,257</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">365</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NM</span></td></tr><tr style="height:15pt"><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Margin</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial &amp; Specialty Business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120 bp</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(80) bp</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government Business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100) bp</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10) bp</span></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IngenioRx</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30 bp</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10) bp</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended September 30, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compared to the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended September 30, 2021 </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Commercial &amp; Specialty Business</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating revenue increased primarily due to premium rate increases in our Commercial risk-based business designed to cover medical cost trends, higher premiums in our Commercial risk-based business due to membership growth and increased administrative fees in our Commercial fee-based business due to increased membership.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating gain increased primarily due to improved medical underwriting performance in our Commercial risk-based business, partially offset by increased costs to support membership growth.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Government Business</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating revenue increased primarily as a result of higher premium revenue in our Medicaid business, including due to membership growth from the continued temporary suspension of Medicaid eligibility recertification during the COVID-19 pandemic, the acquisition of Integra during the second quarter of 2022 and the acquisition of Ohio Medicaid members through the purchase of a Medicaid contract in the first quarter of 2022. Membership growth and premium rate increases to cover medical cost trends in our Medicare Advantage business also increased premium revenue.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in operating gain was primarily driven by increased administrative costs to support growth in our Government Business, partially offset by increased gross profit in the period.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-52-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">IngenioRx</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating revenue increased primarily due to higher prescription volume, driven by growth in integrated medical and pharmacy members in 2022. Operating revenue also increased due to a favorable out of period adjustment to fee-based revenue in the third quarter of 2022.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in operating gain was primarily driven by a favorable out of period adjustment to fee-based revenue in the third quarter of 2022 as well as the impact of higher prescription volume associated with growth in integrated medical and pharmacy members in 2022.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Other </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating revenue increased primarily due to higher revenue for expanded services performed by Carelon for our Commercial &amp; Specialty Business segment in 2022. These increases were partially offset by the reduction of external revenue due to the loss of a behavioral health contract.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating gain increased primarily due to improved performance in Carelon.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nine Months Ended September 30, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compared to the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nine Months Ended September 30, 2021 </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Commercial &amp; Specialty Business</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating revenue increased primarily due to higher premiums in our Commercial risk-based business due to membership growth, premium rate increases in our Commercial risk-based business to cover medical cost trends and increased administrative fees in our Commercial fee-based business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating gain decreased primarily due to the net unfavorable effect of COVID-19 in the first nine months of 2022 and increased spend to support growth. These impacts were partially offset by improved medical underwriting performance in our Commercial risk-based membership.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Government Business</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating revenue increased primarily as a result of higher premium revenue in our Medicaid business, including due to membership growth from the continued temporary suspension of Medicaid eligibility recertification during the COVID-19 pandemic and the retroactive reinstatement of a Medicaid directed payment program. Membership growth and premium rate increases to cover medical cost trends in our Medicare Advantage business also contributed to premium revenue, as did the acquisition of MMM at the end of the second quarter of 2021, the acquisition of Ohio Medicaid members through the purchase of a Medicaid contract in the first quarter of 2022 and the acquisition of Integra during the second quarter of 2022.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in operating gain was primarily driven by premium rate increases to cover medical cost trends in our Medicare business, the acquisition of MMM in the second quarter of 2021 and organic membership growth in our Medicaid membership from the continued suspension of eligibility recertifications during the COVID-19 pandemic. These increases were partially offset by additional administrative spend to support the growth in our Government Business.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">IngenioRx</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating revenue increased as a result of higher prescription volume, driven by growth in integrated medical and pharmacy members in 2022.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in operating gain was primarily a result of higher prescription volume, driven by growth in integrated medical and pharmacy members in 2022 and a favorable out of period adjustment to fee-based revenue in the third quarter of 2022. These increases were partially offset by the non-recurrence of a favorable out of period adjustment recorded in the first quarter of 2021 related to 2020.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-53-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Other </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating revenue increased primarily due to higher revenue for expanded services performed by Carelon for our Commercial &amp; Specialty Business segment in 2022. In addition, results in 2022 included revenue from myNEXUS for the full nine months of 2022, which was acquired in the second quarter of 2021. These increases were partially offset by the reduction of external revenue due to the loss of a behavioral health contract.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating gain increased primarily due to improved performance in Carelon and the acquisition of myNEXUS in 2021.</span></div><div id="i186e051878fe4219970efc72a9fcdad4_133"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We prepare our consolidated financial statements in conformity with GAAP. Application of GAAP requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes and within this MD&amp;A. We consider our most important accounting policies that require significant estimates and management judgment to be those policies with respect to liabilities for medical claims payable, income taxes, goodwill and other intangible assets, investments and retirement benefits. Our accounting policies related to these items are discussed in our 2021 Annual Report on Form 10-K in Note 2, &#8220;Basis of Presentation and Significant Accounting Policies,&#8221; to our audited consolidated financial statements as of and for the year ended December&#160;31, 2021, as well as in the &#8220;Critical Accounting Policies and Estimates&#8221; section of Part II, Item&#160;7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; As of September&#160;30, 2022, our critical accounting policies and estimates have not changed from those described in our 2021 Annual Report on Form 10-K.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Claims Payable</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most subjective accounting estimate in our consolidated financial statements is our liability for medical claims payable. Our accounting policies related to medical claims payable are discussed in the references cited above. As of September&#160;30, 2022, our critical accounting policies and estimates related to medical claims payable have not changed from those described in our 2021 Annual Report on Form 10-K. For a reconciliation of the beginning and ending balance for medical claims payable for the&#160;nine months ended September&#160;30, 2022 and 2021, see Note 9, &#8220;Medical Claims Payable,&#8221; of the Notes to Consolidated Financial Statements included in Part I, Item&#160;1 of this Form 10-Q.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the two key assumptions having the most significant impact on our incurred but not paid liability estimates for the nine months ended September 30, 2022 and 2021, which are the trend and completion factors. These two key assumptions can be influenced by utilization levels, unit costs, mix of business, benefit plan designs, provider reimbursement levels, processing system conversions and changes, claim inventory levels, claim processing patterns, claim submission patterns and operational changes resulting from business combinations.&#160;The impact from COVID-19 on healthcare utilization and medical claims submission patterns continues to provide increased estimation uncertainty on our incurred but not reported liability at September&#160;30, 2022.</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.679%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.849%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Favorable&#160;Developments&#160;by&#160;<br/>Changes&#160;in&#160;Key Assumptions</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed trend factors</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed completion factors</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The favorable development recognized in the nine months ended September 30, 2022 and 2021 resulted primarily from trend factors in late 2021 and late 2020, respectively, developing more favorably than originally expected. Favorable development in the completion factors resulting from the latter part of 2020 developing faster than expected also contributed to the favorable development for the nine months ended September 30, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ratio of current year medical claims paid as a percent of current year net medical claims incurred was 83.7% and 83.8% for the nine months ended September 30, 2022 and 2021, respectively. This ratio serves as an indicator of claims </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-54-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">processing speed whereby speed for claims payments was similar during the nine months ended September 30, 2022 as compared to the nine months ended September 30, 2021. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate the percentage of prior year redundancies in the current period as a percent of prior year net medical claims payable less prior year redundancies in the current period in order to demonstrate the development of prior year reserves. For the nine months ended September 30, 2022, this metric was 7.3%, largely driven by favorable trend factor development at the end of 2021. For the nine months ended September 30, 2021, this metric was 19.7%, largely driven by favorable trend factor development at the end of 2020 as well as favorable completion factor development from 2020.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate the percentage of prior year redundancies in the current period as a percent of prior year net incurred medical claims to indicate the percentage of redundancy included in the preceding year calculation of current year net incurred medical claims. We believe this calculation supports the reasonableness of our prior year estimate of incurred medical claims and the consistency in our methodology. For the nine months ended September 30, 2022, this metric was 0.9%, which was calculated using the redundancy of $901. For the nine months ended September 30, 2021, the comparable metric was 2.2%, which was calculated using the redundancy of $1,822. We believe these metrics demonstrate an appropriate level of reserve conservatism.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding new accounting pronouncements that were adopted and new accounting pronouncements that were issued during the nine months ended September 30, 2022, see the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Guidance Not Yet Adopted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; sections of Note 2, &#8220;Basis of Presentation and Significant Accounting Policies,&#8221; of the Notes to Consolidated Financial Statements included in Part I, Item&#160;1 of this Form 10-Q.</span></div><div id="i186e051878fe4219970efc72a9fcdad4_136"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources and Uses of Capital</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash receipts result primarily from premiums, product revenue, administrative fees and other revenue, investment income, proceeds from the sale or maturity of our investment securities, proceeds from borrowings, and proceeds from the issuance of common stock under our employee stock plans. Cash disbursements result mainly from claims payments, administrative expenses, taxes, purchases of investment securities, interest expense, payments on borrowings, acquisitions, capital expenditures, repurchases of our debt securities and common stock and the payment of cash dividends. Cash outflows fluctuate with the amount and timing of settlement of these transactions. Any future decline in our profitability would likely have an unfavorable impact on our liquidity.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a more detailed overview of our liquidity and capital resources management, see the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Introduction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; section included in the &#8220;Liquidity and Capital Resources&#8221; section of Part II, Item&#160;7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in our 2021 Annual Report on Form&#160;10-K.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding our sources and uses of capital during the three and nine months ended September&#160;30, 2022, see Note 6, &#8220;Derivative Financial Instruments,&#8221; Note 10, &#8220;Debt,&#8221; and Note 12, &#8220;Capital Stock &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Capital &#8211; Dividends and Stock Repurchase Program,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; of the Notes to Consolidated Financial Statements included in Part I, Item&#160;1 of this Form 10-Q.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-55-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our major sources and uses of cash and cash equivalents for the nine months ended September 30, 2022 and 2021 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.211%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sources of Cash:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,692&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances of commercial paper and short- and long-term debt, net of repayments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,864)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock under employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other sources of cash, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total sources of cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,761&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,559&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Uses of Cash:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of investments, net of proceeds from sales, maturities, calls and redemptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,604)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,403)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of subsidiaries, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(623)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,442)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase and retirement of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,748)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,378)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(854)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(747)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(924)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(831)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total uses of cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,753)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,801)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,048&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of foreign exchange rates on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,992&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(251)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,243&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in net cash provided by operating activities was primarily due to the timing of CMS payments received in the current year, partially offset by the Subscriber Settlement Agreement payment made in September 2022.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other significant changes in sources or uses of cash year-over-year included lower amounts for purchases of subsidiaries, net of cash acquired and reduced purchases of investments, net of proceeds from sales, maturities, calls and redemptions, partially offset by reduced proceeds from commercial paper and short- and long-term debt, net of repayments.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Condition</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintained a strong financial condition and liquidity position, with consolidated cash, cash equivalents and investments in fixed maturity and equity securities of $36,523 at September&#160;30, 2022. Since December&#160;31, 2021, total cash, cash equivalents and investments in fixed maturity and equity securities increased by $2,863, primarily due to cash generated from operations. This increase was partially offset by a decline in market value of our fixed maturity securities as well as cash used for common stock repurchases, dividends paid to shareholders, the purchase of property and equipment and acquisitions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our subsidiaries are subject to various government regulations that restrict the timing and amount of dividends and other distributions that may be paid to their respective parent companies. Certain accounting practices prescribed by insurance regulatory authorities, or statutory accounting practices, differ from GAAP. Changes that occur in statutory accounting practices, if any, could impact our subsidiaries&#8217; future dividend capacity. In addition, we have agreed to certain undertakings to regulatory authorities, including the requirement to maintain certain capital levels in certain of our subsidiaries.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, we held $1,045 of cash, cash equivalents and investments at the parent company, which are available for general corporate use, including investment in our businesses, acquisitions, potential future common stock repurchases and dividends to shareholders, repurchases of debt securities and debt and interest payments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, we access capital markets and issue debt (&#8220;Notes&#8221;) for long-term borrowing purposes, for example, to refinance debt, to finance acquisitions or for share repurchases. Certain of these Notes may have a call feature that allows us to redeem the Notes at any time at our option and/or a put feature that allows a Note holder to redeem the Notes upon the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-56-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">occurrence of both a change in control event and a downgrade of the Notes below an investment grade rating. For more information on our debt, including redemptions and issuances, see Note 10, &#8220;Debt,&#8221; of the Notes to Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate our consolidated debt-to-capital ratio, a non-GAAP measure, from the amounts presented on our consolidated balance sheets included in&#160;Part I, Item&#160;1 of this Form 10-Q. Our debt-to-capital ratio is calculated as total debt divided by total debt plus total shareholders&#8217; equity.&#160;Total debt is the sum of short-term borrowings, current portion of long-term debt and long-term debt, less current portion. We believe our debt-to-capital ratio assists investors and rating agencies in measuring our overall leverage and additional borrowing capacity. In addition, our bank covenants include a maximum debt-to-capital ratio that we cannot and did not exceed. Our debt-to-capital ratio may not be comparable to similarly titled measures reported by other companies. Our consolidated debt-to-capital ratio was 39.7% and 38.9% as of September&#160;30, 2022 and December&#160;31, 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior debt is rated &#8220;A&#8221; by S&amp;P Global Ratings, &#8220;BBB&#8221; by Fitch Ratings, Inc., &#8220;Baa2&#8221; by Moody&#8217;s Investor Service, Inc. and &#8220;bbb+&#8221; by AM Best Company, Inc. We intend to maintain our senior debt investment grade ratings. If our credit ratings are downgraded, our business, liquidity, financial condition and results of operations could be adversely impacted by limitations on future borrowings and a potential increase in our borrowing costs.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital Resources</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a shelf registration statement on file with the U.S. Securities and Exchange Commission to register an unlimited amount of any combination of debt or equity securities in one or more offerings. Specific information regarding terms and securities being offered will be provided at the time of an offering. Proceeds from future offerings are expected to be used for general corporate purposes, including, but not limited to, the repayment of debt, investments in or extensions of credit to our subsidiaries, the financing of possible acquisitions or business expansions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a senior revolving credit facility (the &#8220;5-Year Facility&#8221;) with a group of lenders for general corporate purposes. In April 2022, we amended and restated the credit agreement for the 5-Year Facility to, among other things, extend the maturity date of the 5-Year Facility from June 2024 to April 2027 and increase the amount of credit available under the 5-Year Facility from $2,500 to $4,000. Also in April 2022, concurrently with the amendment and restatement of the 5-Year Facility, we terminated our 364-day senior revolving credit facility that provided for credit in the amount of $1,000, which was scheduled to mature in June 2022. Our ability to borrow under the 5-Year Facility is subject to compliance with certain covenants, including covenants requiring us to maintain a defined debt-to-capital ratio of not more than 60%, subject to increase in certain circumstances set forth in the credit agreement for the 5-Year Facility.&#160;We do not believe the restrictions contained in our 5-Year Credit Facility covenants materially affect our financial or operating flexibility. As of September&#160;30, 2022, we were in compliance with all of the debt covenants under the 5-Year Facility. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through certain subsidiaries, we have entered into multiple 364-day lines of credit (the &#8220;Subsidiary Credit Facilities&#8221;) with separate lenders for general corporate purposes. The Subsidiary Credit Facilities provide combined credit up to $200. Our ability to borrow under the Subsidiary Credit Facilities is subject to compliance with certain covenants. At September&#160;30, 2022 and December 31, 2021, we had no outstanding borrowings under the Subsidiary Credit Facilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have an authorized commercial paper program of up to $4,000, the proceeds of which may be used for general corporate purposes. In July 2022, we increased the amount available under the commercial paper program from $3,500 to $4,000. Should commercial paper issuance become unavailable, we have the ability to use a combination of cash on hand and/or our 5-Year Facility, which provides for credit in the amount of $4,000, to redeem any outstanding commercial paper upon maturity. At September&#160;30, 2022, we had $675 outstanding under our commercial paper program.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are a member, through certain subsidiaries, of the Federal Home Loan Bank of Indianapolis, the Federal Home Loan Bank of Cincinnati, the Federal Home Loan Bank of Atlanta and the Federal Home Loan Bank of New York, collectively (the &#8220;FHLBs&#8221;). As a member, we have the ability to obtain short-term cash advances, subject to certain minimum collateral requirements. We had $265 and $275 of outstanding short-term borrowings from the FHLBs at September&#160;30, 2022 and December 31, 2021, respectively.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-57-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While there is no assurance in the current economic environment, we believe the lenders participating in our 5-Year Facility and Subsidiary Credit Facilities, if market conditions allow, would be willing to provide financing in accordance with their legal obligations. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly review the appropriate use of capital, including acquisitions, common stock and debt security repurchases and dividends to shareholders. The declaration and payment of any dividends or repurchases of our common stock or debt is at the discretion of our Board of Directors and depends upon our financial condition, results of operations, future liquidity needs, regulatory and capital requirements and other factors deemed relevant by our Board of Directors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding our sources and uses of capital at September&#160;30, 2022, see Note 5, &#8220;Investments,&#8221; Note 6, &#8220;Derivative Financial Instruments,&#8221; Note 10, &#8220;Debt,&#8221; and Note 12, &#8220;Capital Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Capital &#8211; Dividends and Stock Repurchase Program,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; of the Notes to Consolidated Financial Statements included in Part I, Item&#160;1 of this Form 10-Q.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to regulations regarding the timing and amount of dividends, our regulated subsidiaries&#8217; states of domicile have statutory risk-based capital (&#8220;RBC&#8221;) requirements for health and other insurance companies and health maintenance organizations largely based on the National Association of Insurance Commissioners (&#8220;NAIC&#8221;) Risk-Based Capital (RBC) for Health Organizations Model Act (the &#8220;RBC Model Act&#8221;). These RBC requirements are intended to measure capital adequacy, taking into account the risk characteristics of an insurer&#8217;s investments and products. The NAIC sets forth the formula for calculating the RBC requirements, which are designed to take into account asset risks, insurance risks, interest rate risks and other relevant risks with respect to an individual insurance company&#8217;s business. In general, under the RBC Model Act, an insurance company must submit a report of its RBC level to the state insurance department or insurance commissioner, as appropriate, at the end of each calendar year. Our regulated subsidiaries&#8217; respective RBC levels as of December&#160;31, 2021, which was the most recent date for which reporting was required, were in excess of all applicable mandatory RBC requirements. In addition to exceeding these RBC requirements, we are in compliance with the liquidity and capital requirements for a licensee of the BCBSA and with the tangible net worth requirements applicable to certain of our California subsidiaries. For additional information, see Note 22, &#8220;Statutory Information,&#8221; in our audited consolidated financial statements as of and for the year ended December 31, 2021 included in our 2021 Annual Report on Form 10-K.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future Sources and Uses of Liquidity</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that funds from cash on hand, future operating cash receipts, investments and funds available under our commercial paper program, our 5-Year Facility, our Subsidiary Credit Facilities and the FHLBs will be adequate to fund our expected cash disbursements over the next twelve months.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to our long-term liquidity requirements as disclosed in our 2021 Annual Report on Form 10-K. For additional updates regarding our estimated long-term liquidity requirements, see Note 6, &#8220;Derivative Financial Instruments,&#8221; Note 10, &#8220;Debt,&#8221; and the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; sections of Note 11 &#8220;Commitments and Contingencies,&#8221; of the Notes to Consolidated Financial Statements included in Part I, Item&#160;1 of this Form 10-Q. We believe that funds from future operating cash flows, cash and investments and funds available under our 5-Year Facility and/or from public or private financing sources will be sufficient for future operations and commitments, and for capital acquisitions and other strategic transactions. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-58-</span></div></div></div><div id="i186e051878fe4219970efc72a9fcdad4_139"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORWARD-LOOKING STATEMENTS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This document contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect our views about future events and financial performance and are generally not historical facts. Words such as &#8220;expect,&#8221; &#8220;feel,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;forecast,&#8221; &#8220;plan&#8221; and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to: financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof. You are also urged to carefully review and consider the various risks and other disclosures discussed in our reports filed with the U.S. Securities and Exchange Commission from time to time, which attempt to advise interested parties of the factors that affect our business. Except to the extent otherwise required by federal securities laws, we do not undertake any obligation to republish revised forward-looking statements to reflect events or circumstances after the date hereof. These risks and uncertainties include, but are not limited to: the impact of large scale medical emergencies, such as public health epidemics and pandemics, including COVID-19, and catastrophes; trends in healthcare costs and utilization rates; our ability to secure sufficient premium rates, including regulatory approval for and implementation of such rates; the impact of federal, state and international law and regulation, including changes in the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010, as amended; changes in economic and market conditions, as well as regulations that may negatively affect our liquidity and investment portfolios; our ability to contract with providers on cost-effective and competitive terms; competitive pressures and our ability to adapt to changes in the industry and develop and implement strategic growth opportunities; reduced enrollment; the impact of a cyber-attack or other cyber security breach resulting in unauthorized disclosure of member or employee sensitive or confidential information, including the impact and outcome of any investigations, inquiries, claims and litigation related thereto; risks and uncertainties regarding Medicare and Medicaid programs, including those related to non-compliance with the complex regulations imposed thereon; our ability to maintain and achieve improvement in Centers for Medicare and Medicaid Services Star ratings and other quality scores and funding risks with respect to revenue received from participation therein; a negative change in our healthcare product mix; costs and other liabilities associated with litigation, government investigations, audits or reviews; risks and uncertainties related to our pharmacy benefit management (&#8220;PBM&#8221;) business, including non-compliance by any party with the PBM services agreement between us and CaremarkPCS Health, L.L.C.; medical malpractice or professional liability claims or other risks related to healthcare and PBM services provided by our subsidiaries; general risks associated with mergers, acquisitions, joint ventures and strategic alliances; changes in tax laws; possible impairment of the value of our intangible assets if future results do not adequately support goodwill and other intangible assets; possible restrictions in the payment of dividends from our subsidiaries and increases in required minimum levels of capital; our ability to repurchase shares of our common stock and pay dividends on our common stock due to the adequacy of our cash flow and earnings and other considerations; the potential negative effect from our substantial amount of outstanding indebtedness; a downgrade in our financial strength ratings; the effects of any negative publicity related to the health benefits industry in general or us in particular; failure to effectively maintain and modernize our information systems; events that may negatively affect our licenses with the Blue Cross and Blue Shield Association; intense competition to attract and retain employees; risks associated with our international operations; and various laws and provisions in our governing documents that may prevent or discourage takeovers and business combinations. </span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-59-</span></div></div></div><div id="i186e051878fe4219970efc72a9fcdad4_142"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our market risks, refer to Item&#160;7A, &#8220;Quantitative and Qualitative Disclosures about Market Risk,&#8221; included in our 2021 Annual Report on Form 10-K. There have been no material changes to any of these risks since December&#160;31, 2021.</span></div><div style="margin-top:9pt;text-indent:18pt"><span><br/></span></div><div id="i186e051878fe4219970efc72a9fcdad4_145"></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;CONTROLS AND PROCEDURES</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carried out an evaluation as of September&#160;30, 2022, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective in timely alerting them to material information relating to us (including our consolidated subsidiaries) required to be disclosed in our reports under the Exchange Act. In addition, based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective in ensuring that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in our internal control over financial reporting that occurred during the three months ended September&#160;30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="text-indent:18pt"><span><br/></span></div><div id="i186e051878fe4219970efc72a9fcdad4_148"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. OTHER INFORMATION</span></div><div><span><br/></span></div><div id="i186e051878fe4219970efc72a9fcdad4_151"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding legal proceedings at September&#160;30, 2022, see the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation and Regulatory Proceedings,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; sections of Note 11, &#8220;Commitments and Contingencies&#8221; of the Notes to Consolidated Financial Statements included in Part I, Item&#160;1 of this Form 10-Q, which information is incorporated herein by reference.</span></div><div style="margin-top:9pt;text-indent:18pt"><span><br/></span></div><div id="i186e051878fe4219970efc72a9fcdad4_154"></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;&#160;&#160;RISK FACTORS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the risk factors disclosed in our 2021 Annual Report on Form 10-K.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-60-</span></div></div></div><div id="i186e051878fe4219970efc72a9fcdad4_157"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information related to our repurchases of common stock for the periods indicated:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"></td><td style="width:48.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total&#160;Number</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">of Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Purchased</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average<br/>Price&#160;Paid<br/>per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total&#160;Number</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">of Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Purchased</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">as Part</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">of Publicly</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Announced</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Approximate<br/>Dollar Value<br/>of Shares<br/>that May Yet<br/>Be&#160;Purchased<br/>Under the<br/>Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except share and per share data)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1, 2022 to July 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473.54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1, 2022 to August 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1, 2022 to September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455,898&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472.59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219,262&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213,791&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total number of shares purchased includes 5,471 shares delivered to or withheld by us in connection with employee payroll tax withholding upon the exercise or vesting of stock awards. Stock grants to employees and directors and stock issued for stock option plans and stock purchase plans in the consolidated statements of shareholders&#8217; equity are shown net of these shares purchased.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Represents the number of shares repurchased through the common stock repurchase program authorized by our Board of Directors, which the Board of Directors evaluates periodically. During the three months ended September&#160;30, 2022, we repurchased 1,213,791 shares at a total cost of $579 under the program, including the cost of options to purchase shares. The Board of Directors has authorized our common stock repurchase program since 2003. The most recent authorized increase to the program was $5,000 on January 26, 2021 by our Audit Committee, pursuant to authorization granted by the Board of Directors. No duration has been placed on our common stock repurchase program, and we reserve the right to discontinue the program at any time.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div id="i186e051878fe4219970efc72a9fcdad4_160"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;&#160;&#160;DEFAULTS UPON SENIOR SECURITIES</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-indent:18pt"><span><br/></span></div><div id="i186e051878fe4219970efc72a9fcdad4_163"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;MINE SAFETY DISCLOSURES</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-indent:18pt"><span><br/></span></div><div id="i186e051878fe4219970efc72a9fcdad4_166"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-61-</span></div></div></div><div id="i186e051878fe4219970efc72a9fcdad4_169"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.&#160;&#160;&#160;&#160;EXHIBITS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:5.904%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.035%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.270%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Number</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1156039/000119312522183957/d359422dex31.htm">Amended and Restated Articles of Incorporation of the Company, as amended and restated effective June 27, 2022, incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on June 28, 2022.</a></span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1156039/000119312522183957/d359422dex32.htm">Bylaws of the Company, as amended effective June 28, 2022, incorporated by reference to Exhibit 3.2 to the Company&#8217;s Current Report on Form 8-K filed on June 28, 2022.</a></span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upon the request of the U.S. Securities and Exchange Commission, the Company will furnish copies of any other instruments defining the rights of holders of long-term debt of the Company or its subsidiaries.</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311-20220930q32022.htm">Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Exchange Act Rules, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312-20220930q32022.htm">Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Exchange Act Rules, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-20220930q32022.htm">Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322-20220930q32022.htm">Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following material from Elevance Health, Inc.&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, formatted in Inline XBRL (Inline Extensible Business Reporting Language): (i) the Consolidated Balance Sheets; (ii) the Consolidated Statements of Income; (iii) the Consolidated Statements of Comprehensive Income; (iv) the Consolidated Statements of Cash Flows; (v) the Consolidated Statements of Changes in Equity; and (vi) Notes to Consolidated Financial Statements. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.<br/></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File formatted in Inline XBRL and contained in Exhibit 101.</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-62-</span></div></div></div><div id="i186e051878fe4219970efc72a9fcdad4_172"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:35.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.317%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.635%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.783%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ELEVANCE HEALTH,&#160;INC.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registrant</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 19, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160;&#160;J</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OHN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> E. G</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ALLINA</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John E. Gallina<br/>Executive Vice President and Chief Financial Officer<br/>(Duly Authorized Officer and Principal Financial Officer)</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 19, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160;&#160;R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ONALD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> W. P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ENCZEK</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ronald W. Penczek<br/>Chief Accounting Officer and Controller<br/>(Principal Accounting Officer)</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-63-</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit311-20220930q32022.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i0405aa8dd9a04c4c8e28b4304cd2b37e_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) AND RULE 15d-14(a) OF THE EXCHANGE ACT RULES,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Gail K. Boudreaux, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">I have reviewed this report on Form 10-Q of Elevance Health, Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.24pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:45.67pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.24pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:45.67pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent function)&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.24pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:45.67pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"></td><td style="width:50.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.491%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 19, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; GAIL K. BOUDREAUX</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit312-20220930q32022.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ic8b39ce52d9b4542978f2d26d86adf6c_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) AND RULE 15d-14(a) OF THE EXCHANGE ACT RULES,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, John E. Gallina, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">I have reviewed this report on Form 10-Q of Elevance Health, Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.24pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:45.67pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.24pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:45.67pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent function)&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.24pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:45.67pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"></td><td style="width:50.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.491%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 19, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; JOHN E. GALLINA</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Executive Vice President and<br>&#160;&#160;&#160;&#160;&#160;Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit321-20220930q32022.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i80cf9d3257b34848a0ed7cc6fd61b772_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Elevance Health, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended September&#160;30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Gail K. Boudreaux, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:63pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"></td><td style="width:44.938%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.862%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; GAIL K. BOUDREAUX</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gail K. Boudreaux</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 19, 2022</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>exhibit322-20220930q32022.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="iae9c95877a7f4159a39204d28c546a63_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Elevance Health, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended September&#160;30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, John E. Gallina, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:63pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"></td><td style="width:44.938%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.862%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; JOHN E. GALLINA</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John E. Gallina</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive&#160;Vice&#160;President&#160;and&#160;Chief&#160;Financial&#160;Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 19, 2022</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>elv-20220930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:975646a6-f010-4ab0-98cc-185c6d29d7c2,g:966d453b-5cd7-4ddd-af0c-9c9c0ae080e9-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:elv="http://www.elevancehealth.com/20220930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.elevancehealth.com/20220930">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="elv-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="elv-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="elv-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="elv-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentAndEntityInformationDocument" roleURI="http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument">
        <link:definition>0001001 - Document - Document And Entity Information Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.elevancehealth.com/role/ConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.elevancehealth.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfIncome" roleURI="http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome">
        <link:definition>1003004 - Statement - Consolidated Statements Of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome">
        <link:definition>1004005 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfCashFlows" roleURI="http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows">
        <link:definition>1005006 - Statement - Consolidated Statements Of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfChangesinEquity" roleURI="http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity">
        <link:definition>1006007 - Statement - Consolidated Statements Of Changes in Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Organization" roleURI="http://www.elevancehealth.com/role/Organization">
        <link:definition>2101101 - Disclosure - Organization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationDetails" roleURI="http://www.elevancehealth.com/role/OrganizationDetails">
        <link:definition>2402401 - Disclosure - Organization (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationandSignificantAccountingPolicies" roleURI="http://www.elevancehealth.com/role/BasisOfPresentationandSignificantAccountingPolicies">
        <link:definition>2103102 - Disclosure - Basis Of Presentation and Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSignificantAccountingPoliciesPolicies" roleURI="http://www.elevancehealth.com/role/BasisofPresentationandSignificantAccountingPoliciesPolicies">
        <link:definition>2204201 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails" roleURI="http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails">
        <link:definition>2405402 - Disclosure - Basis of Presentation and Signficant Accounting Policies Basis of Presentation and Significant Acconting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitions" roleURI="http://www.elevancehealth.com/role/BusinessAcquisitions">
        <link:definition>2106103 - Disclosure - Business Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsBusinessAcquisitionAssetsLiabilitiesAcquiredDetails" roleURI="http://www.elevancehealth.com/role/BusinessAcquisitionsBusinessAcquisitionAssetsLiabilitiesAcquiredDetails">
        <link:definition>2407403 - Disclosure - Business Acquisitions Business Acquisition (Assets Liabilities Acquired) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessOptimizationInitiatives" roleURI="http://www.elevancehealth.com/role/BusinessOptimizationInitiatives">
        <link:definition>2108104 - Disclosure - Business Optimization Initiatives</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessOptimizationInitiativesTables" roleURI="http://www.elevancehealth.com/role/BusinessOptimizationInitiativesTables">
        <link:definition>2309301 - Disclosure - Business Optimization Initiatives (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessOptimizationInitiativesEmployeeTerminationCostsDetails" roleURI="http://www.elevancehealth.com/role/BusinessOptimizationInitiativesEmployeeTerminationCostsDetails">
        <link:definition>2410404 - Disclosure - Business Optimization Initiatives (Employee Termination Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.elevancehealth.com/role/Investments">
        <link:definition>2111105 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.elevancehealth.com/role/InvestmentsTables">
        <link:definition>2312302 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails" roleURI="http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails">
        <link:definition>2413405 - Disclosure - Investments (Current And Long-Term Fixed Maturity Securities, Available-For-Sale) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails" roleURI="http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails">
        <link:definition>2414406 - Disclosure - Investments (Aggregate Fair Value And Gross Unrealized Loss Of Fixed Maturity Securities In An Unrealized Loss Position) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails" roleURI="http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails">
        <link:definition>2415407 - Disclosure - Investments (Amortized Cost And Fair Value Of Fixed Maturity Securities, By Contractual Maturity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsCurrentEquitySecuritiesDetails" roleURI="http://www.elevancehealth.com/role/InvestmentsCurrentEquitySecuritiesDetails">
        <link:definition>2416408 - Disclosure - Investments (Current Equity Securities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNetInvestmentGainsLossesDetails" roleURI="http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails">
        <link:definition>2417409 - Disclosure - Investments (Net Investment Gains/Losses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNarrativeDetails" roleURI="http://www.elevancehealth.com/role/InvestmentsNarrativeDetails">
        <link:definition>2418410 - Disclosure - Investments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstruments" roleURI="http://www.elevancehealth.com/role/DerivativeFinancialInstruments">
        <link:definition>2119106 - Disclosure - Derivative Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsFinancialStatementNarrativeDetails" roleURI="http://www.elevancehealth.com/role/DerivativeFinancialInstrumentsFinancialStatementNarrativeDetails">
        <link:definition>2420411 - Disclosure - Derivative Financial Instruments (Financial Statement Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValue" roleURI="http://www.elevancehealth.com/role/FairValue">
        <link:definition>2121107 - Disclosure - Fair Value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueTables" roleURI="http://www.elevancehealth.com/role/FairValueTables">
        <link:definition>2322303 - Disclosure - Fair Value (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails" roleURI="http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails">
        <link:definition>2423412 - Disclosure - Fair Value (Fair Value Measurements By Level For Assets Measured At Fair Value On A Recurring Basis) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails" roleURI="http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails">
        <link:definition>2424413 - Disclosure - Fair Value (Reconciliation Of The Beginning And Ending Balances Of Assets Measured At Fair Value On A Recurring Basis Using Level III Inputs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails" roleURI="http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails">
        <link:definition>2425414 - Disclosure - Fair Value (Carrying And Estimated Fair Values by Level Of Financial Instruments Not Recorded At Fair Value On Consolidated Balance Sheet) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueNarrativeDetails" roleURI="http://www.elevancehealth.com/role/FairValueNarrativeDetails">
        <link:definition>2426415 - Disclosure - Fair Value (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.elevancehealth.com/role/IncomeTaxes">
        <link:definition>2127108 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.elevancehealth.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>2428416 - Disclosure - Income Taxes (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalClaimsPayable" roleURI="http://www.elevancehealth.com/role/MedicalClaimsPayable">
        <link:definition>2129109 - Disclosure - Medical Claims Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalClaimsPayableTables" roleURI="http://www.elevancehealth.com/role/MedicalClaimsPayableTables">
        <link:definition>2330304 - Disclosure - Medical Claims Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails" roleURI="http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails">
        <link:definition>2431417 - Disclosure - Medical Claims Payable (Reconciliation Of The Beginning And Ending Balances For Medical Claims Payable By Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalClaimsPayableReconciliationOfNetIncurredMedicalClaimsToBenefitExpenseDetails" roleURI="http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfNetIncurredMedicalClaimsToBenefitExpenseDetails">
        <link:definition>2432418 - Disclosure - Medical Claims Payable (Reconciliation Of Net Incurred Medical Claims To Benefit Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalClaimsPayableMedicalClaimsPayableReconciliationoftheClaimsDevelopmenttotheClaimsLiabilityDetails" roleURI="http://www.elevancehealth.com/role/MedicalClaimsPayableMedicalClaimsPayableReconciliationoftheClaimsDevelopmenttotheClaimsLiabilityDetails">
        <link:definition>2433419 - Disclosure - Medical Claims Payable Medical Claims Payable (Reconciliation of the Claims Development to the Claims Liability) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalClaimsPayableNarrativeDetails" roleURI="http://www.elevancehealth.com/role/MedicalClaimsPayableNarrativeDetails">
        <link:definition>2434420 - Disclosure - Medical Claims Payable (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.elevancehealth.com/role/Debt">
        <link:definition>2135110 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.elevancehealth.com/role/DebtTables">
        <link:definition>2336305 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtConvertibleDebentureDetailsDetails" roleURI="http://www.elevancehealth.com/role/DebtConvertibleDebentureDetailsDetails">
        <link:definition>2437421 - Disclosure - Debt (Convertible Debenture Details) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://www.elevancehealth.com/role/DebtNarrativeDetails">
        <link:definition>2438422 - Disclosure - Debt (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAndContingencies" roleURI="http://www.elevancehealth.com/role/CommitmentsAndContingencies">
        <link:definition>2139111 - Disclosure - Commitments And Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAndContingenciesDetails" roleURI="http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails">
        <link:definition>2440423 - Disclosure - Commitments And Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStock" roleURI="http://www.elevancehealth.com/role/CapitalStock">
        <link:definition>2141112 - Disclosure - Capital Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockTables" roleURI="http://www.elevancehealth.com/role/CapitalStockTables">
        <link:definition>2342306 - Disclosure - Capital Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockSummaryofCashDividendActivityDetails" roleURI="http://www.elevancehealth.com/role/CapitalStockSummaryofCashDividendActivityDetails">
        <link:definition>2443424 - Disclosure - Capital Stock (Summary of Cash Dividend Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockSummaryofShareRepurchasesDetails" roleURI="http://www.elevancehealth.com/role/CapitalStockSummaryofShareRepurchasesDetails">
        <link:definition>2444425 - Disclosure - Capital Stock (Summary of Share Repurchases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockSummaryofStockOptionActivityDetails" roleURI="http://www.elevancehealth.com/role/CapitalStockSummaryofStockOptionActivityDetails">
        <link:definition>2445426 - Disclosure - Capital Stock (Summary of Stock Option Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockNonvestedRestrictedStockActivityIncludingRestrictedStockUnitsDetails" roleURI="http://www.elevancehealth.com/role/CapitalStockNonvestedRestrictedStockActivityIncludingRestrictedStockUnitsDetails">
        <link:definition>2446427 - Disclosure - Capital Stock (Nonvested Restricted Stock Activity Including Restricted Stock Units) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockFairValuesofOptionsGrantedDuringThePeriodEstimatedUsingWeightedAverageAssumptionsDetails" roleURI="http://www.elevancehealth.com/role/CapitalStockFairValuesofOptionsGrantedDuringThePeriodEstimatedUsingWeightedAverageAssumptionsDetails">
        <link:definition>2447428 - Disclosure - Capital Stock (Fair Values of Options Granted During The Period Estimated Using Weighted-Average Assumptions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockScheduleOfWeightedAverageFairValuesDeterminedForThePeriodsDetails" roleURI="http://www.elevancehealth.com/role/CapitalStockScheduleOfWeightedAverageFairValuesDeterminedForThePeriodsDetails">
        <link:definition>2448429 - Disclosure - Capital Stock (Schedule Of Weighted-Average Fair Values Determined For The Periods) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockNarrativeDetails" roleURI="http://www.elevancehealth.com/role/CapitalStockNarrativeDetails">
        <link:definition>2449430 - Disclosure - Capital Stock (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLoss" roleURI="http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLoss">
        <link:definition>2150113 - Disclosure - Accumulated Other Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossTables" roleURI="http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossTables">
        <link:definition>2351307 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails" roleURI="http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails">
        <link:definition>2452431 - Disclosure - Accumulated Other Comprehensive Loss (Reconciliation Of The Components Of Accumulated Other Comprehensive Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.elevancehealth.com/role/EarningsPerShare">
        <link:definition>2153114 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.elevancehealth.com/role/EarningsPerShareTables">
        <link:definition>2354308 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareDenominatorForBasicAndDilutedEarningsPerShareDetails" roleURI="http://www.elevancehealth.com/role/EarningsPerShareDenominatorForBasicAndDilutedEarningsPerShareDetails">
        <link:definition>2455432 - Disclosure - Earnings Per Share (Denominator For Basic And Diluted Earnings Per Share) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareNarrativeDetails" roleURI="http://www.elevancehealth.com/role/EarningsPerShareNarrativeDetails">
        <link:definition>2456433 - Disclosure - Earnings Per Share (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.elevancehealth.com/role/SegmentInformation">
        <link:definition>2157115 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.elevancehealth.com/role/SegmentInformationTables">
        <link:definition>2358309 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationFinancialDataByReportableSegmentDetails" roleURI="http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails">
        <link:definition>2459434 - Disclosure - Segment Information (Financial Data By Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails" roleURI="http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails">
        <link:definition>2460435 - Disclosure - Segment Information Segment Information (Major Product Revenues for Each Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationReconciliationOfReportableSegmentsOperatingRevenuesToTotalRevenuesReportedInTheConsolidatedStatementsOfIncomeDetails" roleURI="http://www.elevancehealth.com/role/SegmentInformationReconciliationOfReportableSegmentsOperatingRevenuesToTotalRevenuesReportedInTheConsolidatedStatementsOfIncomeDetails">
        <link:definition>2461436 - Disclosure - Segment Information (Reconciliation Of Reportable Segments Operating Revenues To Total Revenues Reported In The Consolidated Statements Of Income) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationReconciliationOfIncomeBeforeIncomeTaxExpenseToReportableSegmentsOperatingGainIncludedInTheConsolidatedStatementsOfIncomeDetails" roleURI="http://www.elevancehealth.com/role/SegmentInformationReconciliationOfIncomeBeforeIncomeTaxExpenseToReportableSegmentsOperatingGainIncludedInTheConsolidatedStatementsOfIncomeDetails">
        <link:definition>2462437 - Disclosure - Segment Information (Reconciliation Of Income Before Income Tax Expense To Reportable Segments Operating Gain Included In The Consolidated Statements Of Income) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSegmentInformationNarrativeDetails" roleURI="http://www.elevancehealth.com/role/SegmentInformationSegmentInformationNarrativeDetails">
        <link:definition>2463438 - Disclosure - Segment Information Segment Information (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.elevancehealth.com/role/Leases">
        <link:definition>2164116 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.elevancehealth.com/role/LeasesTables">
        <link:definition>2365310 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseandOtherInformationDetails" roleURI="http://www.elevancehealth.com/role/LeasesLeaseandOtherInformationDetails">
        <link:definition>2466439 - Disclosure - Leases (Lease and Other Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesDetails" roleURI="http://www.elevancehealth.com/role/LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesDetails">
        <link:definition>2467440 - Disclosure - Leases (Reconciliation of Future Lease Payments to Total Lease Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.elevancehealth.com/role/LeasesNarrativeDetails">
        <link:definition>2468441 - Disclosure - Leases (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://www.elevancehealth.com/role/GoodwillandOtherIntangibleAssets">
        <link:definition>2169117 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsTables" roleURI="http://www.elevancehealth.com/role/GoodwillandOtherIntangibleAssetsTables">
        <link:definition>2370311 - Disclosure - Goodwill and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndOtherIntangibleAssetsSummaryOfTheChangeInTheCarryingAmountOfGoodwillByReportableSegmentDetails" roleURI="http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsSummaryOfTheChangeInTheCarryingAmountOfGoodwillByReportableSegmentDetails">
        <link:definition>2471442 - Disclosure - Goodwill And Other Intangible Assets (Summary Of The Change In The Carrying Amount Of Goodwill By Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails" roleURI="http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails">
        <link:definition>2472443 - Disclosure - Goodwill And Other Intangible Assets (Components Of Other Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndOtherIntangibleAssetsNarrativeDetails" roleURI="http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails">
        <link:definition>2473444 - Disclosure - Goodwill And Other Intangible Assets (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="elv_StockRepurchasedAndRetiredDuringPeriodAveragePrice" abstract="false" name="StockRepurchasedAndRetiredDuringPeriodAveragePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="elv_CommercialSpecialtyMember" abstract="true" name="CommercialSpecialtyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet" abstract="false" name="ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock" abstract="false" name="ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="elv_ManagedCareServicesMember" abstract="true" name="ManagedCareServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_IntegratedHealthServicesMember" abstract="true" name="IntegratedHealthServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_AccountingPoliciesLineItems" abstract="true" name="AccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="elv_AffiliatedMember" abstract="true" name="AffiliatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_OtherProductsMember" abstract="true" name="OtherProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan" abstract="false" name="SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="elv_DentalVisionProductsAndServicesMember" abstract="true" name="DentalVisionProductsAndServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_BCBSAntitrustLitigationMember" abstract="true" name="BCBSAntitrustLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_OperationalMember" abstract="true" name="OperationalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense" abstract="false" name="OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_CommitmentsAndContingenciesTable" abstract="true" name="CommitmentsAndContingenciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="elv_NetLossesGainsOnFinancialInstruments" abstract="false" name="NetLossesGainsOnFinancialInstruments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_A2022To2024Member" abstract="true" name="A2022To2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_ReconciliationOfTheClaimsDevelopmentToTheClaimsLiabilityAbstract" abstract="true" name="ReconciliationOfTheClaimsDevelopmentToTheClaimsLiabilityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments" abstract="false" name="LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_SegmentEliminationsMember" abstract="true" name="SegmentEliminationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_CommercialSpecialtyBusinessSegmentMember" abstract="true" name="CommercialSpecialtyBusinessSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems" abstract="true" name="ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="elv_BusinessOptimizationInitiativesAbstract" abstract="true" name="BusinessOptimizationInitiativesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="elv_CommercialPaperMaximumBorrowingCapacity" abstract="false" name="CommercialPaperMaximumBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_NoncontrollingInterestPeriodIncreaseDecrease" abstract="false" name="NoncontrollingInterestPeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_InvestmentGainsLosses" abstract="false" name="InvestmentGainsLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_MajorProductRevenueBySegmentLineItems" abstract="true" name="MajorProductRevenueBySegmentLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="elv_IngenioRxSegmentMember" abstract="true" name="IngenioRxSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_AnthemInc.v.ExpressScriptsInc.Member" abstract="true" name="AnthemInc.v.ExpressScriptsInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_FiniteLivedIntangibleAssetExpectedAmortizationYearSix" abstract="false" name="FiniteLivedIntangibleAssetExpectedAmortizationYearSix" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_CommonEquitySecuritiesMember" abstract="true" name="CommonEquitySecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_SelffundedReceivablesAllowanceForDoubtfulAccounts" abstract="false" name="SelffundedReceivablesAllowanceForDoubtfulAccounts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember" abstract="true" name="FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_MajorProductRevenueBySegmentTableTextBlock" abstract="false" name="MajorProductRevenueBySegmentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="elv_OperatingRevenue" abstract="false" name="OperatingRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_A2021To2023Member" abstract="true" name="A2021To2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_UnaffiliatedMember" abstract="true" name="UnaffiliatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults" abstract="false" name="PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="elv_AccountingPoliciesTable" abstract="true" name="AccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="elv_SecuritiesLendingTransactionsInitialCollateralPercentageValue" abstract="false" name="SecuritiesLendingTransactionsInitialCollateralPercentageValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="elv_SelfFundedReceivablesNet" abstract="false" name="SelfFundedReceivablesNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_A5YearFacilityMember" abstract="true" name="A5YearFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_CommitmentsAndContingenciesLineItems" abstract="true" name="CommitmentsAndContingenciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="elv_GrossPremiumTaxRate" abstract="false" name="GrossPremiumTaxRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="elv_MedicalClaimsPayableReconciliationofNetIncurredMedicalClaimstoBenefitExpenseAbstract" abstract="true" name="MedicalClaimsPayableReconciliationofNetIncurredMedicalClaimstoBenefitExpenseAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="elv_ProductRevenue" abstract="false" name="ProductRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_IncreaseInStockRepurchaseProgramAuthorization" abstract="false" name="IncreaseInStockRepurchaseProgramAuthorization" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_DebtConversionDebtPrincipalAmount" abstract="false" name="DebtConversionDebtPrincipalAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock" abstract="false" name="CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="elv_ManagedCareProductsMember" abstract="true" name="ManagedCareProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_GainsFromOtherInvestments" abstract="false" name="GainsFromOtherInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_SurplusNotesMember" abstract="true" name="SurplusNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_NonCreditComponentsOfImpairmentsOnInvestmentsMember" abstract="true" name="NonCreditComponentsOfImpairmentsOnInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_IntangibleAssetsAccumulatedAmortizationExcludingGoodwill" abstract="false" name="IntangibleAssetsAccumulatedAmortizationExcludingGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense" abstract="false" name="ShortDurationContractLiabilityForClaimsAdjustmentExpense" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_InvestmentsinequitysecuritiesTableTextBlock" abstract="false" name="InvestmentsinequitysecuritiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="elv_SeniorUnsecuredNotesMember" abstract="true" name="SeniorUnsecuredNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_IntangibleAssetsLineItems" abstract="true" name="IntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember" abstract="true" name="FourPointOneZeroPercentDueTwoThousandThirtyTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_Proceedsfromsaleofequityandfixedmaturitysecurities" abstract="false" name="Proceedsfromsaleofequityandfixedmaturitysecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_Impairmentlossesreversalsoninvestments" abstract="false" name="Impairmentlossesreversalsoninvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_IntangibleAssetsTable" abstract="true" name="IntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="elv_NumberOfMedicalMembersServed" abstract="false" name="NumberOfMedicalMembersServed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="elv_OtherSegmentMember" abstract="true" name="OtherSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_EquitySecurities" abstract="false" name="EquitySecurities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract" abstract="true" name="LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="elv_PerformancemeasurementperiodAxis" abstract="true" name="PerformancemeasurementperiodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="elv_Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss" abstract="false" name="Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_PerformanceMeasurementPeriodDomain" abstract="true" name="PerformanceMeasurementPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_PharmacypricingMember" abstract="true" name="PharmacypricingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember" abstract="true" name="ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_GrossLossesFromOtherInvestments" abstract="false" name="GrossLossesFromOtherInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_MajorProductRevenueBySegmentTable" abstract="true" name="MajorProductRevenueBySegmentTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="elv_PharmacyproductsandservicesMember" abstract="true" name="PharmacyproductsandservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTable" abstract="true" name="ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="elv_NumberOfCountiesInStateOfKansasCompanyDoesNotServe" abstract="false" name="NumberOfCountiesInStateOfKansasCompanyDoesNotServe" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="elv_IntegraManagedCareMember" abstract="true" name="IntegraManagedCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_GovernmentBusinessSegmentMember" abstract="true" name="GovernmentBusinessSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax" abstract="false" name="Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_A2021364DayFacilityMember" abstract="true" name="A2021364DayFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>elv-20220930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:975646a6-f010-4ab0-98cc-185c6d29d7c2,g:966d453b-5cd7-4ddd-af0c-9c9c0ae080e9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.elevancehealth.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="elv-20220930.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.elevancehealth.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e7fe3b1f-0a10-4e12-8b12-6a59f6ebe371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8e0419c6-0a5f-41a9-bc47-f6c4f8ca29f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e7fe3b1f-0a10-4e12-8b12-6a59f6ebe371" xlink:to="loc_us-gaap_AssetsCurrent_8e0419c6-0a5f-41a9-bc47-f6c4f8ca29f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_a8a08fc4-60af-4bda-a516-a554a3196f08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e7fe3b1f-0a10-4e12-8b12-6a59f6ebe371" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_a8a08fc4-60af-4bda-a516-a554a3196f08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_564a41d0-9772-4c04-ad78-a44bfef0e9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e7fe3b1f-0a10-4e12-8b12-6a59f6ebe371" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_564a41d0-9772-4c04-ad78-a44bfef0e9bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_95b9f115-aa3b-4e79-9161-7d04c45ece6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e7fe3b1f-0a10-4e12-8b12-6a59f6ebe371" xlink:to="loc_us-gaap_Goodwill_95b9f115-aa3b-4e79-9161-7d04c45ece6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_66f78d8e-883d-47d0-8730-ce1b06c788b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e7fe3b1f-0a10-4e12-8b12-6a59f6ebe371" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_66f78d8e-883d-47d0-8730-ce1b06c788b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_6dbdee32-425d-4328-b541-a957cd933963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e7fe3b1f-0a10-4e12-8b12-6a59f6ebe371" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_6dbdee32-425d-4328-b541-a957cd933963" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_975d9fa7-6061-43fc-8f7c-48664876e3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e7fe3b1f-0a10-4e12-8b12-6a59f6ebe371" xlink:to="loc_us-gaap_OtherLongTermInvestments_975d9fa7-6061-43fc-8f7c-48664876e3fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f1759f13-c59e-4dca-927f-acae933757c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2ae031c3-e8e0-45ae-bf57-2a2e2a241a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f1759f13-c59e-4dca-927f-acae933757c7" xlink:to="loc_us-gaap_LiabilitiesCurrent_2ae031c3-e8e0-45ae-bf57-2a2e2a241a9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_b2e4b5c0-a052-4a2b-9a6f-37b553ecf08e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f1759f13-c59e-4dca-927f-acae933757c7" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_b2e4b5c0-a052-4a2b-9a6f-37b553ecf08e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_f916d3e3-6872-4ea1-b873-a343788ecf85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f1759f13-c59e-4dca-927f-acae933757c7" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefits_f916d3e3-6872-4ea1-b873-a343788ecf85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_61aa5696-c431-479b-9bfe-2deb3c27c5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f1759f13-c59e-4dca-927f-acae933757c7" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_61aa5696-c431-479b-9bfe-2deb3c27c5ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_01494d30-0859-41a8-a7b3-4752d77f1c68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f1759f13-c59e-4dca-927f-acae933757c7" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_01494d30-0859-41a8-a7b3-4752d77f1c68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_34078148-f0e4-42b8-af17-3fd0e3757379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a8f2f023-1790-4733-93cb-a7d70beea8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_34078148-f0e4-42b8-af17-3fd0e3757379" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a8f2f023-1790-4733-93cb-a7d70beea8dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_fefaa148-a34b-459f-a650-7709fcae00d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_34078148-f0e4-42b8-af17-3fd0e3757379" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_fefaa148-a34b-459f-a650-7709fcae00d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_b3ac9edb-d2e0-43d5-9566-f14ea56c3183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_34078148-f0e4-42b8-af17-3fd0e3757379" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_b3ac9edb-d2e0-43d5-9566-f14ea56c3183" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_8c865005-1e3b-4256-b6e5-a1d6cc24c7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_34078148-f0e4-42b8-af17-3fd0e3757379" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_8c865005-1e3b-4256-b6e5-a1d6cc24c7a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SelfFundedReceivablesNet_0c63dca1-936a-46b8-b2dd-854462a993dc" xlink:href="elv-20220930.xsd#elv_SelfFundedReceivablesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_34078148-f0e4-42b8-af17-3fd0e3757379" xlink:to="loc_elv_SelfFundedReceivablesNet_0c63dca1-936a-46b8-b2dd-854462a993dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_05ff49b1-740f-4fdd-a98a-a29ec5b13397" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_34078148-f0e4-42b8-af17-3fd0e3757379" xlink:to="loc_us-gaap_OtherReceivables_05ff49b1-740f-4fdd-a98a-a29ec5b13397" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_efbd1daa-b8d6-4efa-91db-2f6214f611f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_34078148-f0e4-42b8-af17-3fd0e3757379" xlink:to="loc_us-gaap_OtherAssetsCurrent_efbd1daa-b8d6-4efa-91db-2f6214f611f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7b743afa-aad5-4170-a3ce-49bf9936f205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_f0fe12f2-9552-4ee1-9aff-a2b495957d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7b743afa-aad5-4170-a3ce-49bf9936f205" xlink:to="loc_us-gaap_PreferredStockValue_f0fe12f2-9552-4ee1-9aff-a2b495957d01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_64e5e68c-8483-4650-833e-85c524df127c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7b743afa-aad5-4170-a3ce-49bf9936f205" xlink:to="loc_us-gaap_CommonStockValue_64e5e68c-8483-4650-833e-85c524df127c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_0fe4b4a1-1da3-4c46-9050-96cfaa707860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7b743afa-aad5-4170-a3ce-49bf9936f205" xlink:to="loc_us-gaap_AdditionalPaidInCapital_0fe4b4a1-1da3-4c46-9050-96cfaa707860" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_017d80fe-9593-49d6-9592-97131fc16fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7b743afa-aad5-4170-a3ce-49bf9936f205" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_017d80fe-9593-49d6-9592-97131fc16fa1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_20029707-f04e-4a3e-9d55-2d2dc8b3de8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7b743afa-aad5-4170-a3ce-49bf9936f205" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_20029707-f04e-4a3e-9d55-2d2dc8b3de8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_cdd77e06-088c-493b-81f8-78e02d01546f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_f7bf42b4-9ce2-4693-bfd1-dd20d0fd12f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cdd77e06-088c-493b-81f8-78e02d01546f" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_f7bf42b4-9ce2-4693-bfd1-dd20d0fd12f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds_2e5e0187-efc5-41a7-bafe-914fa70dc711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cdd77e06-088c-493b-81f8-78e02d01546f" xlink:to="loc_us-gaap_OtherPolicyholderFunds_2e5e0187-efc5-41a7-bafe-914fa70dc711" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnearnedPremiums_f082e878-76c6-4399-ad02-31a7b53f55af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnearnedPremiums"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cdd77e06-088c-493b-81f8-78e02d01546f" xlink:to="loc_us-gaap_UnearnedPremiums_f082e878-76c6-4399-ad02-31a7b53f55af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_abf9ffbd-59a1-4b17-bb38-c29711a0fa62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cdd77e06-088c-493b-81f8-78e02d01546f" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_abf9ffbd-59a1-4b17-bb38-c29711a0fa62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_f9c55549-0b66-4a13-a795-ac02a3a938ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cdd77e06-088c-493b-81f8-78e02d01546f" xlink:to="loc_us-gaap_ShortTermBorrowings_f9c55549-0b66-4a13-a795-ac02a3a938ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_a837ddcc-fa3f-49b8-9e74-ada95b32ee46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cdd77e06-088c-493b-81f8-78e02d01546f" xlink:to="loc_us-gaap_LongTermDebtCurrent_a837ddcc-fa3f-49b8-9e74-ada95b32ee46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_bd735f4e-3ee8-4b9a-bb4f-b9cb6ce13ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cdd77e06-088c-493b-81f8-78e02d01546f" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_bd735f4e-3ee8-4b9a-bb4f-b9cb6ce13ae1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_2fe8460c-9953-4673-a976-61ee207786de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_325d8d72-c92e-4e0d-a93f-f4e325da8fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2fe8460c-9953-4673-a976-61ee207786de" xlink:to="loc_us-gaap_Liabilities_325d8d72-c92e-4e0d-a93f-f4e325da8fb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_07f656f3-5d3e-4d9a-bcd5-9745a0ace3ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2fe8460c-9953-4673-a976-61ee207786de" xlink:to="loc_us-gaap_StockholdersEquity_07f656f3-5d3e-4d9a-bcd5-9745a0ace3ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_150b92bc-1f75-415f-86c2-d265f8226c77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2fe8460c-9953-4673-a976-61ee207786de" xlink:to="loc_us-gaap_CommitmentsAndContingencies_150b92bc-1f75-415f-86c2-d265f8226c77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_8e91bdb9-1a42-46c5-997a-ba4fb79e2886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2fe8460c-9953-4673-a976-61ee207786de" xlink:to="loc_us-gaap_MinorityInterest_8e91bdb9-1a42-46c5-997a-ba4fb79e2886" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4be23695-c620-40d4-a5a5-a9d4293ad214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3cac01e1-fa64-48bd-b6bf-a689c3da86ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4be23695-c620-40d4-a5a5-a9d4293ad214" xlink:to="loc_us-gaap_StockholdersEquity_3cac01e1-fa64-48bd-b6bf-a689c3da86ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_b0b51135-6adc-4d63-84e6-01343e3104c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4be23695-c620-40d4-a5a5-a9d4293ad214" xlink:to="loc_us-gaap_MinorityInterest_b0b51135-6adc-4d63-84e6-01343e3104c1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome" xlink:type="simple" xlink:href="elv-20220930.xsd#ConsolidatedStatementsOfIncome"/>
  <link:calculationLink xlink:role="http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1724085b-75ec-49e9-9aa4-890c127f102a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a41a5045-df16-4c49-a16c-8671e84132f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_1724085b-75ec-49e9-9aa4-890c127f102a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a41a5045-df16-4c49-a16c-8671e84132f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8a1859ba-4c70-40eb-81cb-5a331cb3cd2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_1724085b-75ec-49e9-9aa4-890c127f102a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8a1859ba-4c70-40eb-81cb-5a331cb3cd2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpenses_e6da2a7f-2a0d-4bd0-ac32-f7c12e099d60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_a77a7f5f-8564-4cdc-ad5e-913dcfac0e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BenefitsLossesAndExpenses_e6da2a7f-2a0d-4bd0-ac32-f7c12e099d60" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_a77a7f5f-8564-4cdc-ad5e-913dcfac0e3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_971ccf75-a995-4828-b96e-0aebf52ec376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BenefitsLossesAndExpenses_e6da2a7f-2a0d-4bd0-ac32-f7c12e099d60" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_971ccf75-a995-4828-b96e-0aebf52ec376" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_20155914-72a2-4089-95d2-07565071dc65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BenefitsLossesAndExpenses_e6da2a7f-2a0d-4bd0-ac32-f7c12e099d60" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_20155914-72a2-4089-95d2-07565071dc65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_6316ae9f-ee68-41ce-8567-1efbbc1e8ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BenefitsLossesAndExpenses_e6da2a7f-2a0d-4bd0-ac32-f7c12e099d60" xlink:to="loc_us-gaap_InterestExpense_6316ae9f-ee68-41ce-8567-1efbbc1e8ed7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a91a7ace-1c49-4ef8-bb17-fe0244ec49e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BenefitsLossesAndExpenses_e6da2a7f-2a0d-4bd0-ac32-f7c12e099d60" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a91a7ace-1c49-4ef8-bb17-fe0244ec49e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_64ec44aa-30bc-483c-a0b7-29a013057846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BenefitsLossesAndExpenses_e6da2a7f-2a0d-4bd0-ac32-f7c12e099d60" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_64ec44aa-30bc-483c-a0b7-29a013057846" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_389a88a2-f5a6-43c8-a5eb-20392933362b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8e3d001a-1ebe-4bf0-b7a6-d3cb23192cee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_389a88a2-f5a6-43c8-a5eb-20392933362b" xlink:to="loc_us-gaap_ProfitLoss_8e3d001a-1ebe-4bf0-b7a6-d3cb23192cee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6132b667-c253-490d-a4c6-14e02b73f745" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_389a88a2-f5a6-43c8-a5eb-20392933362b" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6132b667-c253-490d-a4c6-14e02b73f745" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_011997dd-447b-47b1-9318-aca6e9efc8fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OperatingRevenue_ad8a781c-2759-4aa0-a7ad-be9a099bbf4b" xlink:href="elv-20220930.xsd#elv_OperatingRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_011997dd-447b-47b1-9318-aca6e9efc8fa" xlink:to="loc_elv_OperatingRevenue_ad8a781c-2759-4aa0-a7ad-be9a099bbf4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_4d95c646-e6e4-488e-ba87-2e7d8a34116e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_011997dd-447b-47b1-9318-aca6e9efc8fa" xlink:to="loc_us-gaap_NetInvestmentIncome_4d95c646-e6e4-488e-ba87-2e7d8a34116e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_NetLossesGainsOnFinancialInstruments_cad79420-3897-456d-908f-ddc290fdae45" xlink:href="elv-20220930.xsd#elv_NetLossesGainsOnFinancialInstruments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_011997dd-447b-47b1-9318-aca6e9efc8fa" xlink:to="loc_elv_NetLossesGainsOnFinancialInstruments_cad79420-3897-456d-908f-ddc290fdae45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2924e9ee-348b-46f0-b7ed-74ec53590d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b95a7a1e-d2ba-408e-83f4-de55315cc656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2924e9ee-348b-46f0-b7ed-74ec53590d7b" xlink:to="loc_us-gaap_Revenues_b95a7a1e-d2ba-408e-83f4-de55315cc656" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpenses_aa51ffe2-7e4d-467d-bd1d-acc8fa95dae0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2924e9ee-348b-46f0-b7ed-74ec53590d7b" xlink:to="loc_us-gaap_BenefitsLossesAndExpenses_aa51ffe2-7e4d-467d-bd1d-acc8fa95dae0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OperatingRevenue_dd477a5f-fc78-46af-b297-4249168a424d" xlink:href="elv-20220930.xsd#elv_OperatingRevenue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_b13e6c26-acf0-479b-9c72-bb0e7b64ba8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_elv_OperatingRevenue_dd477a5f-fc78-46af-b297-4249168a424d" xlink:to="loc_us-gaap_PremiumsEarnedNet_b13e6c26-acf0-479b-9c72-bb0e7b64ba8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ProductRevenue_8ead7309-b282-4cdc-89f6-bfcf4042ccbd" xlink:href="elv-20220930.xsd#elv_ProductRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_elv_OperatingRevenue_dd477a5f-fc78-46af-b297-4249168a424d" xlink:to="loc_elv_ProductRevenue_8ead7309-b282-4cdc-89f6-bfcf4042ccbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_65d3260f-0bde-47dc-885c-d86c4714805c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_elv_OperatingRevenue_dd477a5f-fc78-46af-b297-4249168a424d" xlink:to="loc_us-gaap_OtherIncome_65d3260f-0bde-47dc-885c-d86c4714805c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="elv-20220930.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_5e92b9c6-1968-4e41-a258-f5ded3515bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e3c40c03-b580-4ec7-b619-9a3cd484750a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5e92b9c6-1968-4e41-a258-f5ded3515bdf" xlink:to="loc_us-gaap_ProfitLoss_e3c40c03-b580-4ec7-b619-9a3cd484750a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0e9bbef2-0226-428c-946b-bc9b03e4f33d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5e92b9c6-1968-4e41-a258-f5ded3515bdf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0e9bbef2-0226-428c-946b-bc9b03e4f33d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f1ff57b1-59ad-47e9-a246-80c9ebd6278f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5e92b9c6-1968-4e41-a258-f5ded3515bdf" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f1ff57b1-59ad-47e9-a246-80c9ebd6278f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_a43079b4-e2aa-4ca5-aa1d-fff77d3db18b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5e92b9c6-1968-4e41-a258-f5ded3515bdf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_a43079b4-e2aa-4ca5-aa1d-fff77d3db18b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_efaf6b75-b30c-4e83-8a0c-14f276b0328c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2ff56eb7-3ac1-467f-a3ab-003120a751ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_efaf6b75-b30c-4e83-8a0c-14f276b0328c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2ff56eb7-3ac1-467f-a3ab-003120a751ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax_013f02ce-3906-4ed0-ab68-fe6cc21f0b8e" xlink:href="elv-20220930.xsd#elv_Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_efaf6b75-b30c-4e83-8a0c-14f276b0328c" xlink:to="loc_elv_Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax_013f02ce-3906-4ed0-ab68-fe6cc21f0b8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_ea881fcc-2fd8-48d3-b3d9-74fd0b46c401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_efaf6b75-b30c-4e83-8a0c-14f276b0328c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_ea881fcc-2fd8-48d3-b3d9-74fd0b46c401" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9aa7ae35-0ef1-40a4-b39d-74e36bf51d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_efaf6b75-b30c-4e83-8a0c-14f276b0328c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9aa7ae35-0ef1-40a4-b39d-74e36bf51d7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_8747c37e-7bb4-4efc-9675-0b0ab4962bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_efaf6b75-b30c-4e83-8a0c-14f276b0328c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_8747c37e-7bb4-4efc-9675-0b0ab4962bfc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="elv-20220930.xsd#ConsolidatedStatementsOfCashFlows"/>
  <link:calculationLink xlink:role="http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_de6c62fe-d3d1-42cb-b343-ff5a832db57d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_287f5c75-0f4a-4176-adb9-3172bc45d241" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_de6c62fe-d3d1-42cb-b343-ff5a832db57d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_287f5c75-0f4a-4176-adb9-3172bc45d241" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9a681551-4c49-452e-9b05-988726860f14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_de6c62fe-d3d1-42cb-b343-ff5a832db57d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9a681551-4c49-452e-9b05-988726860f14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b913b037-9ddb-4f1a-be0c-9522450e678e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_de6c62fe-d3d1-42cb-b343-ff5a832db57d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b913b037-9ddb-4f1a-be0c-9522450e678e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d673126d-ffab-44dc-8ae8-11a96ff967be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_de6c62fe-d3d1-42cb-b343-ff5a832db57d" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d673126d-ffab-44dc-8ae8-11a96ff967be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6b7c0e4c-d323-404e-a0e6-52f07a106ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_NetLossesGainsOnFinancialInstruments_6d90d2d4-1b9e-46be-bc70-9515de858438" xlink:href="elv-20220930.xsd#elv_NetLossesGainsOnFinancialInstruments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6b7c0e4c-d323-404e-a0e6-52f07a106ff1" xlink:to="loc_elv_NetLossesGainsOnFinancialInstruments_6d90d2d4-1b9e-46be-bc70-9515de858438" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0c7cbf1d-009f-4291-b0df-2d5e6c732518" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6b7c0e4c-d323-404e-a0e6-52f07a106ff1" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0c7cbf1d-009f-4291-b0df-2d5e6c732518" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_98f0d1a9-6e66-42c2-9930-9401db063826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6b7c0e4c-d323-404e-a0e6-52f07a106ff1" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_98f0d1a9-6e66-42c2-9930-9401db063826" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fe5d1989-048b-4533-8a1a-941fdcfac155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6b7c0e4c-d323-404e-a0e6-52f07a106ff1" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fe5d1989-048b-4533-8a1a-941fdcfac155" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ede8617b-b755-40dc-85cf-191b7f8b1a76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6b7c0e4c-d323-404e-a0e6-52f07a106ff1" xlink:to="loc_us-gaap_ShareBasedCompensation_ede8617b-b755-40dc-85cf-191b7f8b1a76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_7ae0b361-64e3-491d-ae51-5c9912da03eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6b7c0e4c-d323-404e-a0e6-52f07a106ff1" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_7ae0b361-64e3-491d-ae51-5c9912da03eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTradingSecurities_4d2763ea-1989-4d7f-9599-493567d53d95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTradingSecurities"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6b7c0e4c-d323-404e-a0e6-52f07a106ff1" xlink:to="loc_us-gaap_IncreaseDecreaseInTradingSecurities_4d2763ea-1989-4d7f-9599-493567d53d95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_e2b341ff-80ab-45b4-8132-50bb14b15d60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6b7c0e4c-d323-404e-a0e6-52f07a106ff1" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_e2b341ff-80ab-45b4-8132-50bb14b15d60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_01ec5873-c18b-470b-af41-b5c9b750a94e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6b7c0e4c-d323-404e-a0e6-52f07a106ff1" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_01ec5873-c18b-470b-af41-b5c9b750a94e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_ba405332-2c5c-4ccd-8477-94c0e12c906b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6b7c0e4c-d323-404e-a0e6-52f07a106ff1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_ba405332-2c5c-4ccd-8477-94c0e12c906b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_b1a4e4c6-1839-4d77-84f1-f7e42d201b12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6b7c0e4c-d323-404e-a0e6-52f07a106ff1" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_b1a4e4c6-1839-4d77-84f1-f7e42d201b12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_e175bb31-a247-41c5-8e3f-85ed0474d9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6b7c0e4c-d323-404e-a0e6-52f07a106ff1" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_e175bb31-a247-41c5-8e3f-85ed0474d9d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_ba55eeab-5776-420b-96e9-263190a60be2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6b7c0e4c-d323-404e-a0e6-52f07a106ff1" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_ba55eeab-5776-420b-96e9-263190a60be2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9c63ef1b-13b1-4636-a42c-7194b145a208" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6b7c0e4c-d323-404e-a0e6-52f07a106ff1" xlink:to="loc_us-gaap_ProfitLoss_9c63ef1b-13b1-4636-a42c-7194b145a208" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b09a4236-92a8-4220-83cd-c8494ae56391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_42027fb8-d6ae-490c-b38d-9d0f0799e273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b09a4236-92a8-4220-83cd-c8494ae56391" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_42027fb8-d6ae-490c-b38d-9d0f0799e273" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_Proceedsfromsaleofequityandfixedmaturitysecurities_c0053b2f-87ca-4851-9322-6660749edf9f" xlink:href="elv-20220930.xsd#elv_Proceedsfromsaleofequityandfixedmaturitysecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b09a4236-92a8-4220-83cd-c8494ae56391" xlink:to="loc_elv_Proceedsfromsaleofequityandfixedmaturitysecurities_c0053b2f-87ca-4851-9322-6660749edf9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_a609d653-b211-43ec-ac09-9b2d2a70142d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b09a4236-92a8-4220-83cd-c8494ae56391" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_a609d653-b211-43ec-ac09-9b2d2a70142d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1409bc7c-25f5-4108-871b-f2a70803eb55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b09a4236-92a8-4220-83cd-c8494ae56391" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1409bc7c-25f5-4108-871b-f2a70803eb55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5d7a5929-19f1-49a9-8e51-7eea724fd841" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b09a4236-92a8-4220-83cd-c8494ae56391" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5d7a5929-19f1-49a9-8e51-7eea724fd841" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_60bc4444-3af1-45e3-ac1b-ec3460ca5dac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b09a4236-92a8-4220-83cd-c8494ae56391" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_60bc4444-3af1-45e3-ac1b-ec3460ca5dac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInCollateralHeldUnderSecuritiesLending_9b9e8792-6a2d-4349-b26b-7c59cdaf12bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInCollateralHeldUnderSecuritiesLending"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b09a4236-92a8-4220-83cd-c8494ae56391" xlink:to="loc_us-gaap_IncreaseDecreaseInCollateralHeldUnderSecuritiesLending_9b9e8792-6a2d-4349-b26b-7c59cdaf12bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_90afd369-a372-4b07-aab0-c342ea34af95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_c000bddc-9af4-4af4-9e8f-85b521e33425" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_90afd369-a372-4b07-aab0-c342ea34af95" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_c000bddc-9af4-4af4-9e8f-85b521e33425" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_42256ea8-a92e-4e2d-93a1-75f4f7a685ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_90afd369-a372-4b07-aab0-c342ea34af95" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_42256ea8-a92e-4e2d-93a1-75f4f7a685ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_9b161280-5046-4b86-8b43-6162dbec75ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_90afd369-a372-4b07-aab0-c342ea34af95" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_9b161280-5046-4b86-8b43-6162dbec75ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_741d52d2-21e4-408a-aa2e-d5a23db5a45e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_90afd369-a372-4b07-aab0-c342ea34af95" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_741d52d2-21e4-408a-aa2e-d5a23db5a45e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInSecuritiesLendingPayable_fdcbb32a-70d9-45df-9e43-f481a969c909" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInSecuritiesLendingPayable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_90afd369-a372-4b07-aab0-c342ea34af95" xlink:to="loc_us-gaap_IncreaseDecreaseInSecuritiesLendingPayable_fdcbb32a-70d9-45df-9e43-f481a969c909" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOutstandingChecksFinancingActivities_46daaf02-4181-4882-97ee-1f859267a96e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOutstandingChecksFinancingActivities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_90afd369-a372-4b07-aab0-c342ea34af95" xlink:to="loc_us-gaap_IncreaseDecreaseInOutstandingChecksFinancingActivities_46daaf02-4181-4882-97ee-1f859267a96e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ea686f96-7e94-41a4-a02e-cd1ea6d47c98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_90afd369-a372-4b07-aab0-c342ea34af95" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ea686f96-7e94-41a4-a02e-cd1ea6d47c98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_127dd73b-cc3a-47d7-93d7-ee7bf4300f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_90afd369-a372-4b07-aab0-c342ea34af95" xlink:to="loc_us-gaap_PaymentsOfDividends_127dd73b-cc3a-47d7-93d7-ee7bf4300f2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_166a358a-e240-4bd9-846e-b53f2d9809e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_90afd369-a372-4b07-aab0-c342ea34af95" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_166a358a-e240-4bd9-846e-b53f2d9809e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_5eac739f-6e1a-43db-b169-e2da90c18d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_90afd369-a372-4b07-aab0-c342ea34af95" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_5eac739f-6e1a-43db-b169-e2da90c18d4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_23d72f04-c441-48ba-a66c-29f0fba88019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_90afd369-a372-4b07-aab0-c342ea34af95" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_23d72f04-c441-48ba-a66c-29f0fba88019" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_6d274fe3-18ec-481b-9060-a9b6a0c90568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_90afd369-a372-4b07-aab0-c342ea34af95" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_6d274fe3-18ec-481b-9060-a9b6a0c90568" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b23aa11e-2af6-49bd-b7dd-9e7d971c7ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_fb804bcc-0d3e-43bf-bc02-0b5ebd347301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b23aa11e-2af6-49bd-b7dd-9e7d971c7ac0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_fb804bcc-0d3e-43bf-bc02-0b5ebd347301" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_a86946f3-38b2-4126-876f-df1e7c71376d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b23aa11e-2af6-49bd-b7dd-9e7d971c7ac0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_a86946f3-38b2-4126-876f-df1e7c71376d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_c65b8d46-cdd6-451b-a57d-f6c39c359dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b23aa11e-2af6-49bd-b7dd-9e7d971c7ac0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_c65b8d46-cdd6-451b-a57d-f6c39c359dc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_afefba1f-3900-4058-b2d2-7f07deb86651" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b23aa11e-2af6-49bd-b7dd-9e7d971c7ac0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_afefba1f-3900-4058-b2d2-7f07deb86651" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_ce2be87d-b239-40c6-b32c-98df3fef95a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b23aa11e-2af6-49bd-b7dd-9e7d971c7ac0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_ce2be87d-b239-40c6-b32c-98df3fef95a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ef2c4231-8bfd-409d-98e8-71ad09d14bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_180d8a97-4084-431a-be7b-4b56ac8862b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ef2c4231-8bfd-409d-98e8-71ad09d14bd0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_180d8a97-4084-431a-be7b-4b56ac8862b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_3a3cf6c3-3aad-4b25-a4ef-035d39c6ff2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ef2c4231-8bfd-409d-98e8-71ad09d14bd0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_3a3cf6c3-3aad-4b25-a4ef-035d39c6ff2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_c7832842-5f20-4e5c-9d54-666d7c5af499" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ef2c4231-8bfd-409d-98e8-71ad09d14bd0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_c7832842-5f20-4e5c-9d54-666d7c5af499" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_fed661a4-b342-4c9a-bd8a-e314599b1267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ef2c4231-8bfd-409d-98e8-71ad09d14bd0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_fed661a4-b342-4c9a-bd8a-e314599b1267" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_bda48649-1ec1-407b-b4cf-8c89f54aad7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ef2c4231-8bfd-409d-98e8-71ad09d14bd0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_bda48649-1ec1-407b-b4cf-8c89f54aad7f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails"/>
  <link:calculationLink xlink:role="http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_47fcab28-ae42-4483-add4-9df47ba64ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_ba75185d-1859-4cc9-9352-e1284b8271ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_47fcab28-ae42-4483-add4-9df47ba64ffc" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_ba75185d-1859-4cc9-9352-e1284b8271ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_e3f248e4-c02d-4fd7-9ac4-a0b9cf6ac8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_47fcab28-ae42-4483-add4-9df47ba64ffc" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_e3f248e4-c02d-4fd7-9ac4-a0b9cf6ac8e8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EarningsPerShareDenominatorForBasicAndDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#EarningsPerShareDenominatorForBasicAndDilutedEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.elevancehealth.com/role/EarningsPerShareDenominatorForBasicAndDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_073323e9-af2a-4e5f-925a-8c2463940f53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_396913ff-d7cd-466e-92cd-d0cb606f3519" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_073323e9-af2a-4e5f-925a-8c2463940f53" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_396913ff-d7cd-466e-92cd-d0cb606f3519" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_2253908f-c5d1-40e6-8ac5-a94162598685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_073323e9-af2a-4e5f-925a-8c2463940f53" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_2253908f-c5d1-40e6-8ac5-a94162598685" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>elv-20220930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:975646a6-f010-4ab0-98cc-185c6d29d7c2,g:966d453b-5cd7-4ddd-af0c-9c9c0ae080e9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument" xlink:type="simple" xlink:href="elv-20220930.xsd#DocumentAndEntityInformationDocument"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument" xlink:type="extended" id="ie27172dccf55469f9712363f3e4feced_DocumentAndEntityInformationDocument">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_22ccf8a3-e25d-4656-a634-f0b73a3d3157" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_DocumentType_22ccf8a3-e25d-4656-a634-f0b73a3d3157" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_809954ca-86fc-48a7-b23d-6bdc63988a42" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_DocumentQuarterlyReport_809954ca-86fc-48a7-b23d-6bdc63988a42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_19d6c4b7-4e57-4451-92d0-47882982a49c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_DocumentPeriodEndDate_19d6c4b7-4e57-4451-92d0-47882982a49c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_f4596a65-ed81-4f60-befe-82817d2b977e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_DocumentTransitionReport_f4596a65-ed81-4f60-befe-82817d2b977e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_55550011-fab4-4d22-b3c3-6db3742bf4b3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_AmendmentFlag_55550011-fab4-4d22-b3c3-6db3742bf4b3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_84fe80b5-7652-491d-ac76-849cd2563787" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_DocumentFiscalYearFocus_84fe80b5-7652-491d-ac76-849cd2563787" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_45fea47f-e45c-4cf3-bc9b-f66305b56fff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_DocumentFiscalPeriodFocus_45fea47f-e45c-4cf3-bc9b-f66305b56fff" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_d3e8b1e7-d69a-4a1b-a787-b4a5fe2460f9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_CurrentFiscalYearEndDate_d3e8b1e7-d69a-4a1b-a787-b4a5fe2460f9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_a6e120c4-daf8-428e-8e9d-9d18b71de097" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityCentralIndexKey_a6e120c4-daf8-428e-8e9d-9d18b71de097" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_f9ccfc42-e485-4039-8c64-28175e73c815" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityFileNumber_f9ccfc42-e485-4039-8c64-28175e73c815" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d6d50a3d-75f5-4e50-8746-93a629213d70" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityRegistrantName_d6d50a3d-75f5-4e50-8746-93a629213d70" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_668320fb-d729-4e83-af06-c0b645a9b019" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityIncorporationStateCountryCode_668320fb-d729-4e83-af06-c0b645a9b019" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_364b0de2-5547-4653-b069-9bb2384a04e5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityTaxIdentificationNumber_364b0de2-5547-4653-b069-9bb2384a04e5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_5b4a9a89-efea-408f-8940-533faa110c88" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityAddressAddressLine1_5b4a9a89-efea-408f-8940-533faa110c88" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_28faef3b-deac-4ad0-97ac-b4fdda064915" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityAddressCityOrTown_28faef3b-deac-4ad0-97ac-b4fdda064915" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f080d937-6980-4f11-9658-18d13b17abca" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityAddressStateOrProvince_f080d937-6980-4f11-9658-18d13b17abca" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c7021400-1298-4717-8f98-eab80f156cb9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityAddressPostalZipCode_c7021400-1298-4717-8f98-eab80f156cb9" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ea16c580-9be2-4a23-8ba2-e269a4166010" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_CityAreaCode_ea16c580-9be2-4a23-8ba2-e269a4166010" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_141e1968-4c8b-479f-8bf2-bf485e39a8ce" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_LocalPhoneNumber_141e1968-4c8b-479f-8bf2-bf485e39a8ce" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_f844970a-9a9e-451a-ba0d-9ca8c9598af3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_Security12bTitle_f844970a-9a9e-451a-ba0d-9ca8c9598af3" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_09699fcb-4481-4e5e-8b20-59c1e6e667e8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_TradingSymbol_09699fcb-4481-4e5e-8b20-59c1e6e667e8" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_7312c2c1-ca04-4035-b46b-16b965944b2f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_SecurityExchangeName_7312c2c1-ca04-4035-b46b-16b965944b2f" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_886a199d-8302-491e-ba62-c494f97f9654" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityCurrentReportingStatus_886a199d-8302-491e-ba62-c494f97f9654" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_391a6690-7321-4a47-8b9b-416588b404e2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityInteractiveDataCurrent_391a6690-7321-4a47-8b9b-416588b404e2" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_56d64517-87bb-4229-95b6-b1033beda89a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityFilerCategory_56d64517-87bb-4229-95b6-b1033beda89a" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_31f4d758-c782-4ef0-b1e9-b044f073cdc0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntitySmallBusiness_31f4d758-c782-4ef0-b1e9-b044f073cdc0" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_1cd0084a-0136-4699-9af1-c25b37f69bce" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityEmergingGrowthCompany_1cd0084a-0136-4699-9af1-c25b37f69bce" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_8ac1d5ff-773f-424b-8113-9d02fca8a76d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityShellCompany_8ac1d5ff-773f-424b-8113-9d02fca8a76d" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_1bd5d3c9-2c17-4881-87ee-08e75de5fe09" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_1bd5d3c9-2c17-4881-87ee-08e75de5fe09" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_1dbac513-1c2d-4889-a827-38b27facbcea" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntitiesTable_1dbac513-1c2d-4889-a827-38b27facbcea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_08fc3c62-7e86-4675-8943-6981a68fd3ec" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_1dbac513-1c2d-4889-a827-38b27facbcea" xlink:to="loc_dei_LegalEntityAxis_08fc3c62-7e86-4675-8943-6981a68fd3ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_08fc3c62-7e86-4675-8943-6981a68fd3ec_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_08fc3c62-7e86-4675-8943-6981a68fd3ec" xlink:to="loc_dei_EntityDomain_08fc3c62-7e86-4675-8943-6981a68fd3ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1ac7001f-78db-403a-89e4-f536f2629f08" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_08fc3c62-7e86-4675-8943-6981a68fd3ec" xlink:to="loc_dei_EntityDomain_1ac7001f-78db-403a-89e4-f536f2629f08" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity" xlink:type="simple" xlink:href="elv-20220930.xsd#ConsolidatedStatementsOfChangesinEquity"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity" xlink:type="extended" id="i37b9e43bd2ed4b0da4b4be655e10e53f_ConsolidatedStatementsOfChangesinEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7719a1c2-7c91-4ef8-a696-3d489598f4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_ad6501a1-2ddc-4b52-b59d-89692222bf9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7719a1c2-7c91-4ef8-a696-3d489598f4fb" xlink:to="loc_us-gaap_SharesOutstanding_ad6501a1-2ddc-4b52-b59d-89692222bf9a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d2e975f8-554f-45b1-a4d5-96c8cb4da56c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7719a1c2-7c91-4ef8-a696-3d489598f4fb" xlink:to="loc_us-gaap_StockholdersEquity_d2e975f8-554f-45b1-a4d5-96c8cb4da56c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_35e5bfe9-b096-4e94-aae3-9b7fb4f48141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7719a1c2-7c91-4ef8-a696-3d489598f4fb" xlink:to="loc_us-gaap_MinorityInterest_35e5bfe9-b096-4e94-aae3-9b7fb4f48141" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_af4f26fd-8259-4ad3-a82c-02e9d8703b96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7719a1c2-7c91-4ef8-a696-3d489598f4fb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_af4f26fd-8259-4ad3-a82c-02e9d8703b96" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7719a1c2-7c91-4ef8-a696-3d489598f4fb" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_48df6944-55af-4f48-8467-56d7253015c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_NetIncomeLoss_48df6944-55af-4f48-8467-56d7253015c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_deb250d2-a9dc-4a84-ac01-8b23cdcffd93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_deb250d2-a9dc-4a84-ac01-8b23cdcffd93" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9c6a61e7-9765-4d38-91ca-70ff4498f046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_ProfitLoss_9c6a61e7-9765-4d38-91ca-70ff4498f046" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4956032d-0fb3-4957-988b-a9b974e9e0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4956032d-0fb3-4957-988b-a9b974e9e0f7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_414732b7-f8a5-4a6b-9a7c-140381f2c149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_414732b7-f8a5-4a6b-9a7c-140381f2c149" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_95d03561-3699-4ecd-b83f-5102aa2067b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_95d03561-3699-4ecd-b83f-5102aa2067b0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_df798796-165a-4177-a91e-e428e8d01473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_df798796-165a-4177-a91e-e428e8d01473" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_NoncontrollingInterestPeriodIncreaseDecrease_ce8b5ce6-024e-43ae-aa30-a04fb892f39e" xlink:href="elv-20220930.xsd#elv_NoncontrollingInterestPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_elv_NoncontrollingInterestPeriodIncreaseDecrease_ce8b5ce6-024e-43ae-aa30-a04fb892f39e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_d3a2ed53-8f9b-4789-b1de-8b0cfb856421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_d3a2ed53-8f9b-4789-b1de-8b0cfb856421" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_9357b509-c182-4863-b269-1b03c12db722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_9357b509-c182-4863-b269-1b03c12db722" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_cebcc549-c44a-4722-9a89-095cfdf4993b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_DividendsCommonStock_cebcc549-c44a-4722-9a89-095cfdf4993b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_d34ec786-a4d9-44bc-941e-2ceee8f9fe03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_d34ec786-a4d9-44bc-941e-2ceee8f9fe03" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_94f05075-4119-47d5-8340-39ea09eec29f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_94f05075-4119-47d5-8340-39ea09eec29f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments_4632e2ee-75e0-4f34-b30a-54d2f959ac7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments_4632e2ee-75e0-4f34-b30a-54d2f959ac7c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_d0c09a13-c6cc-4653-8cc9-fe75682004a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_bfddf5dd-675f-4a2f-b7ee-5e5c962e6428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_39fbb1df-62a0-4a92-a4a1-c97a4a6543b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5201dc0c-69c1-412d-b796-d51995c07506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_120ce670-34c9-4236-9412-5d8f4c0af07a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_7719a1c2-7c91-4ef8-a696-3d489598f4fb" xlink:to="loc_us-gaap_StatementTable_120ce670-34c9-4236-9412-5d8f4c0af07a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6f6befb4-d3ce-47a1-affc-1a0e66303778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_120ce670-34c9-4236-9412-5d8f4c0af07a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6f6befb4-d3ce-47a1-affc-1a0e66303778" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6f6befb4-d3ce-47a1-affc-1a0e66303778_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6f6befb4-d3ce-47a1-affc-1a0e66303778" xlink:to="loc_us-gaap_EquityComponentDomain_6f6befb4-d3ce-47a1-affc-1a0e66303778_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c3928a5b-4af7-462d-954b-c99d35f1782e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6f6befb4-d3ce-47a1-affc-1a0e66303778" xlink:to="loc_us-gaap_EquityComponentDomain_c3928a5b-4af7-462d-954b-c99d35f1782e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8b51fca0-61fc-4494-9262-5d40d7152140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c3928a5b-4af7-462d-954b-c99d35f1782e" xlink:to="loc_us-gaap_CommonStockMember_8b51fca0-61fc-4494-9262-5d40d7152140" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_5b6a0a57-cee8-4c67-bfe4-4b614de14587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c3928a5b-4af7-462d-954b-c99d35f1782e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_5b6a0a57-cee8-4c67-bfe4-4b614de14587" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a40b6511-1cd4-4d54-9bde-adeba3f26f35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c3928a5b-4af7-462d-954b-c99d35f1782e" xlink:to="loc_us-gaap_RetainedEarningsMember_a40b6511-1cd4-4d54-9bde-adeba3f26f35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1ccc9655-823d-481c-ad0b-e79fd0fa0186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c3928a5b-4af7-462d-954b-c99d35f1782e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1ccc9655-823d-481c-ad0b-e79fd0fa0186" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_8e3cc9f7-54c6-45ca-afcf-1510f16197df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c3928a5b-4af7-462d-954b-c99d35f1782e" xlink:to="loc_us-gaap_NoncontrollingInterestMember_8e3cc9f7-54c6-45ca-afcf-1510f16197df" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8799ee6b-3250-4297-8a24-1948c1390130" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_120ce670-34c9-4236-9412-5d8f4c0af07a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8799ee6b-3250-4297-8a24-1948c1390130" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8799ee6b-3250-4297-8a24-1948c1390130_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8799ee6b-3250-4297-8a24-1948c1390130" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8799ee6b-3250-4297-8a24-1948c1390130_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_97db23ba-cd3f-4405-b9df-fd63ac8fd3a4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8799ee6b-3250-4297-8a24-1948c1390130" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_97db23ba-cd3f-4405-b9df-fd63ac8fd3a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_46c20a8d-aab9-4bbf-9d46-999060d18ea3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_97db23ba-cd3f-4405-b9df-fd63ac8fd3a4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_46c20a8d-aab9-4bbf-9d46-999060d18ea3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_d91503a7-bf2a-445d-a3b3-cbcbfb202033" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_97db23ba-cd3f-4405-b9df-fd63ac8fd3a4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_d91503a7-bf2a-445d-a3b3-cbcbfb202033" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7e0d1f18-8fdc-49b2-8199-ffba2b3384b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_120ce670-34c9-4236-9412-5d8f4c0af07a" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7e0d1f18-8fdc-49b2-8199-ffba2b3384b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_7e0d1f18-8fdc-49b2-8199-ffba2b3384b7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7e0d1f18-8fdc-49b2-8199-ffba2b3384b7" xlink:to="loc_us-gaap_TypeOfAdoptionMember_7e0d1f18-8fdc-49b2-8199-ffba2b3384b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_ff3150d9-a7bc-4836-bacf-28f2d14d4651" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7e0d1f18-8fdc-49b2-8199-ffba2b3384b7" xlink:to="loc_us-gaap_TypeOfAdoptionMember_ff3150d9-a7bc-4836-bacf-28f2d14d4651" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_c84b73b8-d6dc-4bf0-9e4e-03114dcd20c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_ff3150d9-a7bc-4836-bacf-28f2d14d4651" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_c84b73b8-d6dc-4bf0-9e4e-03114dcd20c4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails" xlink:type="extended" id="i5758c97d80684955938f989db1f4abb2_BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_elv_AccountingPoliciesLineItems_9095f622-3fd7-4a8c-a264-47ef6127429f" xlink:href="elv-20220930.xsd#elv_AccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_d50706ec-87bc-4891-8d02-866a91811909" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_AccountingPoliciesLineItems_9095f622-3fd7-4a8c-a264-47ef6127429f" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_d50706ec-87bc-4891-8d02-866a91811909" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SecuritiesLendingTransactionsInitialCollateralPercentageValue_314e2742-64b3-44f0-bac8-b5f374d2be05" xlink:href="elv-20220930.xsd#elv_SecuritiesLendingTransactionsInitialCollateralPercentageValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_AccountingPoliciesLineItems_9095f622-3fd7-4a8c-a264-47ef6127429f" xlink:to="loc_elv_SecuritiesLendingTransactionsInitialCollateralPercentageValue_314e2742-64b3-44f0-bac8-b5f374d2be05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_128159d0-42c7-4f67-9c55-e9f16bbd0f55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_AccountingPoliciesLineItems_9095f622-3fd7-4a8c-a264-47ef6127429f" xlink:to="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_128159d0-42c7-4f67-9c55-e9f16bbd0f55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SelffundedReceivablesAllowanceForDoubtfulAccounts_af811b20-136f-4a6d-a167-1145b523f003" xlink:href="elv-20220930.xsd#elv_SelffundedReceivablesAllowanceForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_AccountingPoliciesLineItems_9095f622-3fd7-4a8c-a264-47ef6127429f" xlink:to="loc_elv_SelffundedReceivablesAllowanceForDoubtfulAccounts_af811b20-136f-4a6d-a167-1145b523f003" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_0809f861-57ce-40b0-bf7b-ad33d2cb05d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_AccountingPoliciesLineItems_9095f622-3fd7-4a8c-a264-47ef6127429f" xlink:to="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_0809f861-57ce-40b0-bf7b-ad33d2cb05d0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_239c1cfc-23dd-4544-8a78-e48865694d47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_AccountingPoliciesLineItems_9095f622-3fd7-4a8c-a264-47ef6127429f" xlink:to="loc_us-gaap_LongTermDebt_239c1cfc-23dd-4544-8a78-e48865694d47" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_d904b595-a03c-444f-89f4-206855380b92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_AccountingPoliciesLineItems_9095f622-3fd7-4a8c-a264-47ef6127429f" xlink:to="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_d904b595-a03c-444f-89f4-206855380b92" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0b014cb5-4d6d-48ed-8ae8-5969d4c541ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_AccountingPoliciesLineItems_9095f622-3fd7-4a8c-a264-47ef6127429f" xlink:to="loc_us-gaap_StockholdersEquity_0b014cb5-4d6d-48ed-8ae8-5969d4c541ac" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_AccountingPoliciesTable_24ac398e-7836-495d-9673-7a933bd8e2e0" xlink:href="elv-20220930.xsd#elv_AccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_elv_AccountingPoliciesLineItems_9095f622-3fd7-4a8c-a264-47ef6127429f" xlink:to="loc_elv_AccountingPoliciesTable_24ac398e-7836-495d-9673-7a933bd8e2e0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ef7cc9c7-1138-4bf5-b6a3-c2e798635c5d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_elv_AccountingPoliciesTable_24ac398e-7836-495d-9673-7a933bd8e2e0" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ef7cc9c7-1138-4bf5-b6a3-c2e798635c5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ef7cc9c7-1138-4bf5-b6a3-c2e798635c5d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ef7cc9c7-1138-4bf5-b6a3-c2e798635c5d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ef7cc9c7-1138-4bf5-b6a3-c2e798635c5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ea35766c-3773-4da5-9ba6-4fc92ff15f46" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ef7cc9c7-1138-4bf5-b6a3-c2e798635c5d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ea35766c-3773-4da5-9ba6-4fc92ff15f46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_33e3a2e4-686b-4c7b-8df6-d2806e143365" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ea35766c-3773-4da5-9ba6-4fc92ff15f46" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_33e3a2e4-686b-4c7b-8df6-d2806e143365" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c2e3c037-bdee-48f5-b993-04354ce5b5db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_elv_AccountingPoliciesTable_24ac398e-7836-495d-9673-7a933bd8e2e0" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c2e3c037-bdee-48f5-b993-04354ce5b5db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_c2e3c037-bdee-48f5-b993-04354ce5b5db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c2e3c037-bdee-48f5-b993-04354ce5b5db" xlink:to="loc_us-gaap_TypeOfAdoptionMember_c2e3c037-bdee-48f5-b993-04354ce5b5db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_8f9e8bce-1b55-4eb8-915a-f7330c69313c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c2e3c037-bdee-48f5-b993-04354ce5b5db" xlink:to="loc_us-gaap_TypeOfAdoptionMember_8f9e8bce-1b55-4eb8-915a-f7330c69313c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_6e502541-1d33-4c07-b6bf-41fe75030b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_8f9e8bce-1b55-4eb8-915a-f7330c69313c" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_6e502541-1d33-4c07-b6bf-41fe75030b06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ceabbf8f-556c-4423-8a43-d46276cc9c09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_elv_AccountingPoliciesTable_24ac398e-7836-495d-9673-7a933bd8e2e0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ceabbf8f-556c-4423-8a43-d46276cc9c09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ceabbf8f-556c-4423-8a43-d46276cc9c09_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ceabbf8f-556c-4423-8a43-d46276cc9c09" xlink:to="loc_us-gaap_EquityComponentDomain_ceabbf8f-556c-4423-8a43-d46276cc9c09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_08a54974-ade1-4541-8564-3777b59a6e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ceabbf8f-556c-4423-8a43-d46276cc9c09" xlink:to="loc_us-gaap_EquityComponentDomain_08a54974-ade1-4541-8564-3777b59a6e9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d718a4fb-dba6-42cb-aae3-961667891961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_08a54974-ade1-4541-8564-3777b59a6e9b" xlink:to="loc_us-gaap_RetainedEarningsMember_d718a4fb-dba6-42cb-aae3-961667891961" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/BusinessAcquisitionsBusinessAcquisitionAssetsLiabilitiesAcquiredDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#BusinessAcquisitionsBusinessAcquisitionAssetsLiabilitiesAcquiredDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/BusinessAcquisitionsBusinessAcquisitionAssetsLiabilitiesAcquiredDetails" xlink:type="extended" id="ibbbeb317eac44a7883b1b2a845e0f2f9_BusinessAcquisitionsBusinessAcquisitionAssetsLiabilitiesAcquiredDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e6daf510-8643-47ea-8da5-4d3708ef09fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_5bd35b66-48dd-4987-961a-01b80084abff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e6daf510-8643-47ea-8da5-4d3708ef09fb" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_5bd35b66-48dd-4987-961a-01b80084abff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_c5b899c2-3174-4af4-a743-815142bbbb4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e6daf510-8643-47ea-8da5-4d3708ef09fb" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_c5b899c2-3174-4af4-a743-815142bbbb4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_72cd6cae-6eb1-4583-b64d-420fc284be22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e6daf510-8643-47ea-8da5-4d3708ef09fb" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_72cd6cae-6eb1-4583-b64d-420fc284be22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_80f44b37-d223-4503-b67f-e0c937be431b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e6daf510-8643-47ea-8da5-4d3708ef09fb" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_80f44b37-d223-4503-b67f-e0c937be431b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cf348dcc-97ed-455e-a177-b0d39974c1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e6daf510-8643-47ea-8da5-4d3708ef09fb" xlink:to="loc_us-gaap_Goodwill_cf348dcc-97ed-455e-a177-b0d39974c1dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_292fe3cf-55ca-43ab-a0f8-4fac22908574" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e6daf510-8643-47ea-8da5-4d3708ef09fb" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_292fe3cf-55ca-43ab-a0f8-4fac22908574" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_32db9580-3432-4a21-baf1-e72a8e3f28e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_292fe3cf-55ca-43ab-a0f8-4fac22908574" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_32db9580-3432-4a21-baf1-e72a8e3f28e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_32db9580-3432-4a21-baf1-e72a8e3f28e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_32db9580-3432-4a21-baf1-e72a8e3f28e5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_32db9580-3432-4a21-baf1-e72a8e3f28e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a271ec1a-d8aa-4fb8-8602-72f104245913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_32db9580-3432-4a21-baf1-e72a8e3f28e5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a271ec1a-d8aa-4fb8-8602-72f104245913" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IntegraManagedCareMember_1831282c-09b9-4a8e-9aca-073410cc0d5b" xlink:href="elv-20220930.xsd#elv_IntegraManagedCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a271ec1a-d8aa-4fb8-8602-72f104245913" xlink:to="loc_elv_IntegraManagedCareMember_1831282c-09b9-4a8e-9aca-073410cc0d5b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/BusinessOptimizationInitiativesEmployeeTerminationCostsDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#BusinessOptimizationInitiativesEmployeeTerminationCostsDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/BusinessOptimizationInitiativesEmployeeTerminationCostsDetails" xlink:type="extended" id="i0679122a50cc4e7c8cb6d81391abacc5_BusinessOptimizationInitiativesEmployeeTerminationCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_0a561aae-a1bd-47d4-aaa0-3edac56aa45b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_2133517c-09ab-4dbe-ae3d-7da8c0237932" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0a561aae-a1bd-47d4-aaa0-3edac56aa45b" xlink:to="loc_us-gaap_RestructuringReserve_2133517c-09ab-4dbe-ae3d-7da8c0237932" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_d584dd47-17c6-4cb5-8b5c-4eef732294b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0a561aae-a1bd-47d4-aaa0-3edac56aa45b" xlink:to="loc_us-gaap_PaymentsForRestructuring_d584dd47-17c6-4cb5-8b5c-4eef732294b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_24a98b5c-3a67-49f4-9210-d0f069c4e769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d78a206f-5614-4209-8ac6-53fa848d261b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0a561aae-a1bd-47d4-aaa0-3edac56aa45b" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d78a206f-5614-4209-8ac6-53fa848d261b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_07c71007-6af7-4ddf-bbe6-5297f468de67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d78a206f-5614-4209-8ac6-53fa848d261b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_07c71007-6af7-4ddf-bbe6-5297f468de67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_07c71007-6af7-4ddf-bbe6-5297f468de67_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_07c71007-6af7-4ddf-bbe6-5297f468de67" xlink:to="loc_us-gaap_SegmentDomain_07c71007-6af7-4ddf-bbe6-5297f468de67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_220ea3b6-24ef-4f94-a890-460323e1fdcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_07c71007-6af7-4ddf-bbe6-5297f468de67" xlink:to="loc_us-gaap_SegmentDomain_220ea3b6-24ef-4f94-a890-460323e1fdcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IngenioRxSegmentMember_1b3c5a7d-2968-4f29-aa3e-4e8148516ef5" xlink:href="elv-20220930.xsd#elv_IngenioRxSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_220ea3b6-24ef-4f94-a890-460323e1fdcb" xlink:to="loc_elv_IngenioRxSegmentMember_1b3c5a7d-2968-4f29-aa3e-4e8148516ef5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherSegmentMember_61c401f9-c3d0-456a-b5ef-3ab7f677813a" xlink:href="elv-20220930.xsd#elv_OtherSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_220ea3b6-24ef-4f94-a890-460323e1fdcb" xlink:to="loc_elv_OtherSegmentMember_61c401f9-c3d0-456a-b5ef-3ab7f677813a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GovernmentBusinessSegmentMember_d1740f36-5816-44a9-b84d-c6d006cce8bf" xlink:href="elv-20220930.xsd#elv_GovernmentBusinessSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_220ea3b6-24ef-4f94-a890-460323e1fdcb" xlink:to="loc_elv_GovernmentBusinessSegmentMember_d1740f36-5816-44a9-b84d-c6d006cce8bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommercialSpecialtyBusinessSegmentMember_d16b796c-b3ef-45d9-864f-fc1043df1668" xlink:href="elv-20220930.xsd#elv_CommercialSpecialtyBusinessSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_220ea3b6-24ef-4f94-a890-460323e1fdcb" xlink:to="loc_elv_CommercialSpecialtyBusinessSegmentMember_d16b796c-b3ef-45d9-864f-fc1043df1668" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_db5e4d5a-bab1-4238-9fab-59f945a13c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d78a206f-5614-4209-8ac6-53fa848d261b" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_db5e4d5a-bab1-4238-9fab-59f945a13c7e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_db5e4d5a-bab1-4238-9fab-59f945a13c7e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_db5e4d5a-bab1-4238-9fab-59f945a13c7e" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_db5e4d5a-bab1-4238-9fab-59f945a13c7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_017bf959-cb8b-4d83-87dc-dfbffd5a8f73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_db5e4d5a-bab1-4238-9fab-59f945a13c7e" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_017bf959-cb8b-4d83-87dc-dfbffd5a8f73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_2eaf6014-43c1-4ffc-bf75-df98a5de16e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_017bf959-cb8b-4d83-87dc-dfbffd5a8f73" xlink:to="loc_us-gaap_EmployeeSeveranceMember_2eaf6014-43c1-4ffc-bf75-df98a5de16e4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails" xlink:type="extended" id="i6bb269b2f53a44e5b7cad6e46a372e26_InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7ac7c766-b7ec-4980-bf75-61034b2af64d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_cbdbbf7c-6298-4d67-b42e-7301236aa0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7ac7c766-b7ec-4980-bf75-61034b2af64d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_cbdbbf7c-6298-4d67-b42e-7301236aa0e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_6d7255fc-e941-45a5-a6d9-d2067170014f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7ac7c766-b7ec-4980-bf75-61034b2af64d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_6d7255fc-e941-45a5-a6d9-d2067170014f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_00436801-22d0-4c48-b03e-28dc1591da16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7ac7c766-b7ec-4980-bf75-61034b2af64d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_00436801-22d0-4c48-b03e-28dc1591da16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_5da2554b-d525-4f2e-a117-ee99be59bbed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7ac7c766-b7ec-4980-bf75-61034b2af64d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_5da2554b-d525-4f2e-a117-ee99be59bbed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a65bc495-9b01-44a5-9548-9c772d8427b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7ac7c766-b7ec-4980-bf75-61034b2af64d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a65bc495-9b01-44a5-9548-9c772d8427b8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_c6eadea3-36c9-4b6c-bd0c-bf37fe13ded1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7ac7c766-b7ec-4980-bf75-61034b2af64d" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_c6eadea3-36c9-4b6c-bd0c-bf37fe13ded1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_779fb048-e9d3-473b-8844-20ffdf1c2b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_c6eadea3-36c9-4b6c-bd0c-bf37fe13ded1" xlink:to="loc_us-gaap_InvestmentTypeAxis_779fb048-e9d3-473b-8844-20ffdf1c2b4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_779fb048-e9d3-473b-8844-20ffdf1c2b4b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_779fb048-e9d3-473b-8844-20ffdf1c2b4b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_779fb048-e9d3-473b-8844-20ffdf1c2b4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_ad330a95-84bd-4f44-b409-06a22b47a850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_779fb048-e9d3-473b-8844-20ffdf1c2b4b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_ad330a95-84bd-4f44-b409-06a22b47a850" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_6eb20dcd-8e8e-46c0-808d-8fdbb68a3c92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ad330a95-84bd-4f44-b409-06a22b47a850" xlink:to="loc_us-gaap_FixedMaturitiesMember_6eb20dcd-8e8e-46c0-808d-8fdbb68a3c92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_cc638666-5be0-4e6f-9935-8a0163240d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_c6eadea3-36c9-4b6c-bd0c-bf37fe13ded1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_cc638666-5be0-4e6f-9935-8a0163240d23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cc638666-5be0-4e6f-9935-8a0163240d23_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cc638666-5be0-4e6f-9935-8a0163240d23" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cc638666-5be0-4e6f-9935-8a0163240d23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f72308d5-bddb-4769-920f-4e7cf1dbf355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cc638666-5be0-4e6f-9935-8a0163240d23" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f72308d5-bddb-4769-920f-4e7cf1dbf355" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_9f24c323-ce67-4ed9-8ec5-948b1361e40f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f72308d5-bddb-4769-920f-4e7cf1dbf355" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_9f24c323-ce67-4ed9-8ec5-948b1361e40f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_a486413c-0a9a-493b-bfd6-1dc1e6e3304a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f72308d5-bddb-4769-920f-4e7cf1dbf355" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_a486413c-0a9a-493b-bfd6-1dc1e6e3304a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtMember_ee21f131-6ef6-4876-a897-d483b66422ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f72308d5-bddb-4769-920f-4e7cf1dbf355" xlink:to="loc_us-gaap_ForeignGovernmentDebtMember_ee21f131-6ef6-4876-a897-d483b66422ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_0cc636d7-146e-496d-bcec-611181c606dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f72308d5-bddb-4769-920f-4e7cf1dbf355" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_0cc636d7-146e-496d-bcec-611181c606dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_ed8889ac-8456-41de-8e98-c9e19e12c800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f72308d5-bddb-4769-920f-4e7cf1dbf355" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_ed8889ac-8456-41de-8e98-c9e19e12c800" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_bb35163d-ab2e-4842-ae4d-7cce3e6978cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f72308d5-bddb-4769-920f-4e7cf1dbf355" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_bb35163d-ab2e-4842-ae4d-7cce3e6978cc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_b4cc86d8-865f-433d-9ad4-e4a826cef098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f72308d5-bddb-4769-920f-4e7cf1dbf355" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_b4cc86d8-865f-433d-9ad4-e4a826cef098" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAggregatedInvestmentsMember_e50183dd-e03a-43f3-b066-a28d117bf9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAggregatedInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f72308d5-bddb-4769-920f-4e7cf1dbf355" xlink:to="loc_us-gaap_OtherAggregatedInvestmentsMember_e50183dd-e03a-43f3-b066-a28d117bf9b9" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails" xlink:type="extended" id="i494bc2e1b5c8435ab679468864db0ac4_InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f87aac2a-dc13-4f8f-8d6b-e69997465650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_06fff694-fe61-485c-9adc-8e085ac29253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f87aac2a-dc13-4f8f-8d6b-e69997465650" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_06fff694-fe61-485c-9adc-8e085ac29253" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_64ab7074-5d7a-4e71-b04f-09c9a6a1eca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f87aac2a-dc13-4f8f-8d6b-e69997465650" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_64ab7074-5d7a-4e71-b04f-09c9a6a1eca6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_5b04a864-3fb6-47fe-bd64-69b325848818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f87aac2a-dc13-4f8f-8d6b-e69997465650" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_5b04a864-3fb6-47fe-bd64-69b325848818" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_ae6e221f-c3fd-4374-87b3-4ac0d96d7af8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f87aac2a-dc13-4f8f-8d6b-e69997465650" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_ae6e221f-c3fd-4374-87b3-4ac0d96d7af8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_1bbab645-e9b3-4b40-ae61-48cc97bc28d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f87aac2a-dc13-4f8f-8d6b-e69997465650" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_1bbab645-e9b3-4b40-ae61-48cc97bc28d9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_e0795f44-e0cd-4a12-a888-f1428008ffa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f87aac2a-dc13-4f8f-8d6b-e69997465650" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_e0795f44-e0cd-4a12-a888-f1428008ffa5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9a827e78-c61b-43d2-89f9-dd446b80990c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f87aac2a-dc13-4f8f-8d6b-e69997465650" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9a827e78-c61b-43d2-89f9-dd446b80990c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_a5879c37-0a24-4c9c-93b2-0b897995c654" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9a827e78-c61b-43d2-89f9-dd446b80990c" xlink:to="loc_us-gaap_InvestmentTypeAxis_a5879c37-0a24-4c9c-93b2-0b897995c654" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_a5879c37-0a24-4c9c-93b2-0b897995c654_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_a5879c37-0a24-4c9c-93b2-0b897995c654" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_a5879c37-0a24-4c9c-93b2-0b897995c654_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_069ececa-47fa-4157-86f8-36667e3a5663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_a5879c37-0a24-4c9c-93b2-0b897995c654" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_069ececa-47fa-4157-86f8-36667e3a5663" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_e2eb4241-59a1-4dbc-9b73-edfd5b00cbc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_069ececa-47fa-4157-86f8-36667e3a5663" xlink:to="loc_us-gaap_EquitySecuritiesMember_e2eb4241-59a1-4dbc-9b73-edfd5b00cbc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_aa0b4bdc-7ce8-4857-b0c9-ecefe1b20e29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_069ececa-47fa-4157-86f8-36667e3a5663" xlink:to="loc_us-gaap_FixedMaturitiesMember_aa0b4bdc-7ce8-4857-b0c9-ecefe1b20e29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ed042bea-50eb-4218-8293-c9ee0a769fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9a827e78-c61b-43d2-89f9-dd446b80990c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ed042bea-50eb-4218-8293-c9ee0a769fcc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ed042bea-50eb-4218-8293-c9ee0a769fcc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ed042bea-50eb-4218-8293-c9ee0a769fcc" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ed042bea-50eb-4218-8293-c9ee0a769fcc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8af7d449-be46-4c2a-8832-c0970491ef8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ed042bea-50eb-4218-8293-c9ee0a769fcc" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8af7d449-be46-4c2a-8832-c0970491ef8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_ceb31170-9b44-4882-92d7-ab8cb6208d82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8af7d449-be46-4c2a-8832-c0970491ef8f" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_ceb31170-9b44-4882-92d7-ab8cb6208d82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_d5d2660e-8643-4b0a-86d7-26204e84c406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8af7d449-be46-4c2a-8832-c0970491ef8f" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_d5d2660e-8643-4b0a-86d7-26204e84c406" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtMember_26ef9473-e549-40fa-8ef6-f3952766bf2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8af7d449-be46-4c2a-8832-c0970491ef8f" xlink:to="loc_us-gaap_ForeignGovernmentDebtMember_26ef9473-e549-40fa-8ef6-f3952766bf2e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_3e18c393-ee89-43fc-92ff-65d7fa26aa21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8af7d449-be46-4c2a-8832-c0970491ef8f" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_3e18c393-ee89-43fc-92ff-65d7fa26aa21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_99c6a9e6-cb17-4c41-ba5e-ef817eb62d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8af7d449-be46-4c2a-8832-c0970491ef8f" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_99c6a9e6-cb17-4c41-ba5e-ef817eb62d4b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_c1b81a65-8935-497f-9b7c-c0bd57056514" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8af7d449-be46-4c2a-8832-c0970491ef8f" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_c1b81a65-8935-497f-9b7c-c0bd57056514" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_f7f9017d-7b0c-4beb-830d-08f3bafaec29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8af7d449-be46-4c2a-8832-c0970491ef8f" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_f7f9017d-7b0c-4beb-830d-08f3bafaec29" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAggregatedInvestmentsMember_a659415a-acef-4908-9081-6f91770eab33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAggregatedInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8af7d449-be46-4c2a-8832-c0970491ef8f" xlink:to="loc_us-gaap_OtherAggregatedInvestmentsMember_a659415a-acef-4908-9081-6f91770eab33" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails" xlink:type="extended" id="i749ee93040de49d6b299c7f0f5413184_InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_f133404f-f641-44e5-9456-7b904a0c3709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_f133404f-f641-44e5-9456-7b904a0c3709" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_27d98224-b962-460b-9913-29c30a0d331c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_27d98224-b962-460b-9913-29c30a0d331c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_d00e347a-7238-4fbe-81ee-ea66f9b7407b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_d00e347a-7238-4fbe-81ee-ea66f9b7407b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_09963fde-a060-462a-9457-b4f314de6ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_09963fde-a060-462a-9457-b4f314de6ff7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_c80ebbfa-55d0-4500-9c7c-d437ee30b9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_c80ebbfa-55d0-4500-9c7c-d437ee30b9e5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2138bea3-b673-40ba-a696-bddc2854762e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2138bea3-b673-40ba-a696-bddc2854762e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_5148ef7c-7e37-4007-b220-860b10bd1ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_5148ef7c-7e37-4007-b220-860b10bd1ac3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_be3b0fcd-6353-44af-9be5-bdfc04bfa901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_be3b0fcd-6353-44af-9be5-bdfc04bfa901" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_02e08bde-2051-48cd-b972-86e386c70960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_02e08bde-2051-48cd-b972-86e386c70960" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_441482d2-9aaf-4e1b-b470-74f3d26c454a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_441482d2-9aaf-4e1b-b470-74f3d26c454a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_06803272-6036-4d2b-9071-460cd8c6b995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_06803272-6036-4d2b-9071-460cd8c6b995" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1540118c-f21b-4e9c-ab0d-b321ca24c7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1540118c-f21b-4e9c-ab0d-b321ca24c7a6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_22650117-19f8-42f3-bae5-2b123236cdf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_22650117-19f8-42f3-bae5-2b123236cdf7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_3eeb7a6a-387e-4a33-a8d1-9e1330a77633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_22650117-19f8-42f3-bae5-2b123236cdf7" xlink:to="loc_us-gaap_InvestmentTypeAxis_3eeb7a6a-387e-4a33-a8d1-9e1330a77633" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_3eeb7a6a-387e-4a33-a8d1-9e1330a77633_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_3eeb7a6a-387e-4a33-a8d1-9e1330a77633" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_3eeb7a6a-387e-4a33-a8d1-9e1330a77633_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_4456e9e8-cff9-4253-8782-2388a4f2c5fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_3eeb7a6a-387e-4a33-a8d1-9e1330a77633" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_4456e9e8-cff9-4253-8782-2388a4f2c5fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_be3ee490-7c7d-4d10-93c0-959f43cffbb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_4456e9e8-cff9-4253-8782-2388a4f2c5fd" xlink:to="loc_us-gaap_FixedMaturitiesMember_be3ee490-7c7d-4d10-93c0-959f43cffbb1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/InvestmentsCurrentEquitySecuritiesDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#InvestmentsCurrentEquitySecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/InvestmentsCurrentEquitySecuritiesDetails" xlink:type="extended" id="i8b96040b1de44d14a033a3049b477766_InvestmentsCurrentEquitySecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_751d603b-2f6b-4b86-8533-708ae4d8b626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_a9a1d333-eb73-4761-8086-2b90a7251506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_751d603b-2f6b-4b86-8533-708ae4d8b626" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_a9a1d333-eb73-4761-8086-2b90a7251506" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable_c54c9789-cbd4-47ac-b574-7a1ef51d370b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_751d603b-2f6b-4b86-8533-708ae4d8b626" xlink:to="loc_us-gaap_MarketableSecuritiesTable_c54c9789-cbd4-47ac-b574-7a1ef51d370b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_0e09a570-9dad-4db9-b105-6e60a9c65efd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MarketableSecuritiesTable_c54c9789-cbd4-47ac-b574-7a1ef51d370b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_0e09a570-9dad-4db9-b105-6e60a9c65efd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0e09a570-9dad-4db9-b105-6e60a9c65efd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0e09a570-9dad-4db9-b105-6e60a9c65efd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0e09a570-9dad-4db9-b105-6e60a9c65efd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eb8b7240-7a64-435a-9c87-4b4f2d5c55d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0e09a570-9dad-4db9-b105-6e60a9c65efd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eb8b7240-7a64-435a-9c87-4b4f2d5c55d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExchangeTradedFundsMember_e2ba110c-7354-4c3f-8e12-2d9d16948949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExchangeTradedFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eb8b7240-7a64-435a-9c87-4b4f2d5c55d4" xlink:to="loc_us-gaap_ExchangeTradedFundsMember_e2ba110c-7354-4c3f-8e12-2d9d16948949" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommonEquitySecuritiesMember_a96c13b6-ede3-45e0-b566-7145db378e20" xlink:href="elv-20220930.xsd#elv_CommonEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eb8b7240-7a64-435a-9c87-4b4f2d5c55d4" xlink:to="loc_elv_CommonEquitySecuritiesMember_a96c13b6-ede3-45e0-b566-7145db378e20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_c10cc1dc-ba4b-4300-b378-7f06ef5c3f41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eb8b7240-7a64-435a-9c87-4b4f2d5c55d4" xlink:to="loc_us-gaap_PrivateEquityFundsMember_c10cc1dc-ba4b-4300-b378-7f06ef5c3f41" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#InvestmentsNetInvestmentGainsLossesDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails" xlink:type="extended" id="ifef6ddc8bfa14edd9a90bccd2bca6b54_InvestmentsNetInvestmentGainsLossesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_09f0c160-cf9f-415f-b3d2-c69ba4adc928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_09f0c160-cf9f-415f-b3d2-c69ba4adc928" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_e62acac5-67f1-466a-b39a-5eb85091b4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_e62acac5-67f1-466a-b39a-5eb85091b4e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGain_935528f1-d0ec-4763-acc3-9de009a0ab69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGain_935528f1-d0ec-4763-acc3-9de009a0ab69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss_bfef6967-3c76-458b-9f82-9ef8a3ce5008" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss_bfef6967-3c76-458b-9f82-9ef8a3ce5008" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_3f573a70-59fa-4ac4-b64b-183d69e7e5a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_3f573a70-59fa-4ac4-b64b-183d69e7e5a8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_0427a871-f226-4db0-8b57-ada0e6da0bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_0427a871-f226-4db0-8b57-ada0e6da0bd7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_a413010c-34ff-4ad3-aa78-b319cd8b42d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_a413010c-34ff-4ad3-aa78-b319cd8b42d3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GainsFromOtherInvestments_1ef0817a-3093-49ae-84a8-8f7e1d0f2e50" xlink:href="elv-20220930.xsd#elv_GainsFromOtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_elv_GainsFromOtherInvestments_1ef0817a-3093-49ae-84a8-8f7e1d0f2e50" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GrossLossesFromOtherInvestments_5a80d033-ffbc-4d9c-bd41-1defb0538f17" xlink:href="elv-20220930.xsd#elv_GrossLossesFromOtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_elv_GrossLossesFromOtherInvestments_5a80d033-ffbc-4d9c-bd41-1defb0538f17" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_Impairmentlossesreversalsoninvestments_a3a9eb07-d86b-4f85-b03b-cd07aeb916d0" xlink:href="elv-20220930.xsd#elv_Impairmentlossesreversalsoninvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_elv_Impairmentlossesreversalsoninvestments_a3a9eb07-d86b-4f85-b03b-cd07aeb916d0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_405ec20b-babb-407b-a507-97bf78071762" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_405ec20b-babb-407b-a507-97bf78071762" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherInvestments_ec40e14f-4cf3-47b3-afc2-65c994617bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherInvestments_ec40e14f-4cf3-47b3-afc2-65c994617bb1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_InvestmentGainsLosses_a5f26b25-5311-464b-a888-3331b3238885" xlink:href="elv-20220930.xsd#elv_InvestmentGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_elv_InvestmentGainsLosses_a5f26b25-5311-464b-a888-3331b3238885" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_2b63c440-6c78-483a-8b1d-dc6ce441cf96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_2b63c440-6c78-483a-8b1d-dc6ce441cf96" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_f10842c1-796d-42fb-b0aa-04c05e60ac67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_2b63c440-6c78-483a-8b1d-dc6ce441cf96" xlink:to="loc_us-gaap_InvestmentTypeAxis_f10842c1-796d-42fb-b0aa-04c05e60ac67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_f10842c1-796d-42fb-b0aa-04c05e60ac67_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_f10842c1-796d-42fb-b0aa-04c05e60ac67" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_f10842c1-796d-42fb-b0aa-04c05e60ac67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_bfb3988c-d40e-4fcf-8917-2861baa951e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_f10842c1-796d-42fb-b0aa-04c05e60ac67" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_bfb3988c-d40e-4fcf-8917-2861baa951e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_aab06ed9-94a5-4c2c-929b-a7ecea7bd855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_bfb3988c-d40e-4fcf-8917-2861baa951e0" xlink:to="loc_us-gaap_FixedMaturitiesMember_aab06ed9-94a5-4c2c-929b-a7ecea7bd855" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_d8d0a825-d30b-434c-ab9f-c1a2fc761e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_bfb3988c-d40e-4fcf-8917-2861baa951e0" xlink:to="loc_us-gaap_EquitySecuritiesMember_d8d0a825-d30b-434c-ab9f-c1a2fc761e6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_f0a48096-9d43-4c43-9ef8-bd301d0b16d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_bfb3988c-d40e-4fcf-8917-2861baa951e0" xlink:to="loc_us-gaap_OtherInvestmentsMember_f0a48096-9d43-4c43-9ef8-bd301d0b16d4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#InvestmentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/InvestmentsNarrativeDetails" xlink:type="extended" id="ie7395ecc53a948daa2562850eab6917e_InvestmentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_89d9f497-8338-4a53-acec-3701a5b9f553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_d11e6591-3f1b-4f7d-9132-db4da5268709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_89d9f497-8338-4a53-acec-3701a5b9f553" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_d11e6591-3f1b-4f7d-9132-db4da5268709" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInvestmentIncomeReceivable_4e3ae741-69ff-4bda-8afd-32a6c1429127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedInvestmentIncomeReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_89d9f497-8338-4a53-acec-3701a5b9f553" xlink:to="loc_us-gaap_AccruedInvestmentIncomeReceivable_4e3ae741-69ff-4bda-8afd-32a6c1429127" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesLoanedFairValueOfCollateral_187204ce-f1f7-480d-86a9-e8054734deee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesLoanedFairValueOfCollateral"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_89d9f497-8338-4a53-acec-3701a5b9f553" xlink:to="loc_us-gaap_SecuritiesLoanedFairValueOfCollateral_187204ce-f1f7-480d-86a9-e8054734deee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan_b76c15ff-9a98-48e4-969c-79f96474432c" xlink:href="elv-20220930.xsd#elv_SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_89d9f497-8338-4a53-acec-3701a5b9f553" xlink:to="loc_elv_SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan_b76c15ff-9a98-48e4-969c-79f96474432c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsReceivedForSecuritiesLoanedAtCarryingValue_f42f1d5a-0f5f-4f5a-98a8-a59acc64df32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsReceivedForSecuritiesLoanedAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_89d9f497-8338-4a53-acec-3701a5b9f553" xlink:to="loc_us-gaap_DepositsReceivedForSecuritiesLoanedAtCarryingValue_f42f1d5a-0f5f-4f5a-98a8-a59acc64df32" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_a70cf203-f34e-448e-86c7-73f950bf3dad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_89d9f497-8338-4a53-acec-3701a5b9f553" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_a70cf203-f34e-448e-86c7-73f950bf3dad" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_704bfb54-5bf5-47a1-b564-0d93c51552f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_89d9f497-8338-4a53-acec-3701a5b9f553" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_704bfb54-5bf5-47a1-b564-0d93c51552f7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis_abdcf5b6-2f2d-4b9f-9a95-7b20abab3b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_704bfb54-5bf5-47a1-b564-0d93c51552f7" xlink:to="loc_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis_abdcf5b6-2f2d-4b9f-9a95-7b20abab3b9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodDomain_abdcf5b6-2f2d-4b9f-9a95-7b20abab3b9b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis_abdcf5b6-2f2d-4b9f-9a95-7b20abab3b9b" xlink:to="loc_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodDomain_abdcf5b6-2f2d-4b9f-9a95-7b20abab3b9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodDomain_b1b77c54-f0d5-4672-86bc-7cd847f0285a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis_abdcf5b6-2f2d-4b9f-9a95-7b20abab3b9b" xlink:to="loc_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodDomain_b1b77c54-f0d5-4672-86bc-7cd847f0285a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturityOvernightMember_5a7f3552-5fa3-4ad7-a482-b38722ed1c72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaturityOvernightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodDomain_b1b77c54-f0d5-4672-86bc-7cd847f0285a" xlink:to="loc_us-gaap_MaturityOvernightMember_5a7f3552-5fa3-4ad7-a482-b38722ed1c72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_aecc0653-9749-4d0c-87d2-59302d3d5e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_704bfb54-5bf5-47a1-b564-0d93c51552f7" xlink:to="loc_us-gaap_InvestmentTypeAxis_aecc0653-9749-4d0c-87d2-59302d3d5e6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_aecc0653-9749-4d0c-87d2-59302d3d5e6a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_aecc0653-9749-4d0c-87d2-59302d3d5e6a" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_aecc0653-9749-4d0c-87d2-59302d3d5e6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_a7351a4b-949f-47a4-b60d-ec97f00e8aae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_aecc0653-9749-4d0c-87d2-59302d3d5e6a" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_a7351a4b-949f-47a4-b60d-ec97f00e8aae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_59ff91a4-0f33-452c-b46a-d8618b156383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a7351a4b-949f-47a4-b60d-ec97f00e8aae" xlink:to="loc_us-gaap_FixedMaturitiesMember_59ff91a4-0f33-452c-b46a-d8618b156383" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_3b2fdacd-ea7d-44db-a683-29770fef4aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_704bfb54-5bf5-47a1-b564-0d93c51552f7" xlink:to="loc_us-gaap_FinancialInstrumentAxis_3b2fdacd-ea7d-44db-a683-29770fef4aa8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3b2fdacd-ea7d-44db-a683-29770fef4aa8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3b2fdacd-ea7d-44db-a683-29770fef4aa8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3b2fdacd-ea7d-44db-a683-29770fef4aa8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ccab8d95-d892-4a4f-bde0-1e7bff060a33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3b2fdacd-ea7d-44db-a683-29770fef4aa8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ccab8d95-d892-4a4f-bde0-1e7bff060a33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_0479c131-43e6-4ac7-bf98-ccc367d40b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ccab8d95-d892-4a4f-bde0-1e7bff060a33" xlink:to="loc_us-gaap_CashMember_0479c131-43e6-4ac7-bf98-ccc367d40b5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_a241b8f0-42b3-41db-a4bd-ec1711e7d720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ccab8d95-d892-4a4f-bde0-1e7bff060a33" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_a241b8f0-42b3-41db-a4bd-ec1711e7d720" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAggregatedInvestmentsMember_af77487b-4238-40c3-a765-2b71fad22f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAggregatedInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ccab8d95-d892-4a4f-bde0-1e7bff060a33" xlink:to="loc_us-gaap_OtherAggregatedInvestmentsMember_af77487b-4238-40c3-a765-2b71fad22f98" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/DerivativeFinancialInstrumentsFinancialStatementNarrativeDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#DerivativeFinancialInstrumentsFinancialStatementNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/DerivativeFinancialInstrumentsFinancialStatementNarrativeDetails" xlink:type="extended" id="i4fa4f062e79841f895882cb9a6ac69bf_DerivativeFinancialInstrumentsFinancialStatementNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_e7fd7b24-1e0e-481c-9ce7-06644ec8422d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_2399b36a-a7fb-426e-ba8b-a6312fb4d12d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_e7fd7b24-1e0e-481c-9ce7-06644ec8422d" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_2399b36a-a7fb-426e-ba8b-a6312fb4d12d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_615ce774-677d-4198-aa3f-5c04c73a1522" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_e7fd7b24-1e0e-481c-9ce7-06644ec8422d" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_615ce774-677d-4198-aa3f-5c04c73a1522" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_4aa3db2c-7f18-4724-99b7-62b5d3b27385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_e7fd7b24-1e0e-481c-9ce7-06644ec8422d" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_4aa3db2c-7f18-4724-99b7-62b5d3b27385" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a457927d-d235-4c17-9790-6e58cfca9a03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_4aa3db2c-7f18-4724-99b7-62b5d3b27385" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a457927d-d235-4c17-9790-6e58cfca9a03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a457927d-d235-4c17-9790-6e58cfca9a03_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a457927d-d235-4c17-9790-6e58cfca9a03" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a457927d-d235-4c17-9790-6e58cfca9a03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_bf5bcbd6-c743-412f-9f1a-7167d619af2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a457927d-d235-4c17-9790-6e58cfca9a03" xlink:to="loc_us-gaap_HedgingRelationshipDomain_bf5bcbd6-c743-412f-9f1a-7167d619af2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_34a277f5-b92c-46f8-bd76-fc4b27f53c54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bf5bcbd6-c743-412f-9f1a-7167d619af2d" xlink:to="loc_us-gaap_CashFlowHedgingMember_34a277f5-b92c-46f8-bd76-fc4b27f53c54" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails" xlink:type="extended" id="i36dd4f55b5054e02bbe16bd5ffc2639e_FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_42595713-d3a6-4061-8ff6-fa466c50daf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_2a40767d-2b2e-4cc2-bd06-5b811c3c9281" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_42595713-d3a6-4061-8ff6-fa466c50daf0" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_2a40767d-2b2e-4cc2-bd06-5b811c3c9281" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_010662a7-962d-4ee1-93bd-5ff5de0cb4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_42595713-d3a6-4061-8ff6-fa466c50daf0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_010662a7-962d-4ee1-93bd-5ff5de0cb4c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EquitySecurities_fb6e5aee-9705-4a0d-9832-50907d6fa3e8" xlink:href="elv-20220930.xsd#elv_EquitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_42595713-d3a6-4061-8ff6-fa466c50daf0" xlink:to="loc_elv_EquitySecurities_fb6e5aee-9705-4a0d-9832-50907d6fa3e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_405db8ac-d67f-447d-a6b6-f7b2b3639765" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_42595713-d3a6-4061-8ff6-fa466c50daf0" xlink:to="loc_us-gaap_OtherLongTermInvestments_405db8ac-d67f-447d-a6b6-f7b2b3639765" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesHeldAsCollateralAtFairValue_64591452-d1c3-4a72-bfae-e6526732b2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesHeldAsCollateralAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_42595713-d3a6-4061-8ff6-fa466c50daf0" xlink:to="loc_us-gaap_SecuritiesHeldAsCollateralAtFairValue_64591452-d1c3-4a72-bfae-e6526732b2bb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement_aefab2cf-4ee6-4776-8940-01b9532e3f28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_42595713-d3a6-4061-8ff6-fa466c50daf0" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement_aefab2cf-4ee6-4776-8940-01b9532e3f28" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_dd104d30-f528-4d0b-870b-2262a0095489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_42595713-d3a6-4061-8ff6-fa466c50daf0" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_dd104d30-f528-4d0b-870b-2262a0095489" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement_d60e60d6-a8f2-4802-83eb-9317e5e25a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_42595713-d3a6-4061-8ff6-fa466c50daf0" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement_d60e60d6-a8f2-4802-83eb-9317e5e25a4f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_85aac082-3785-4d7c-92f8-f5ea0fd20010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_42595713-d3a6-4061-8ff6-fa466c50daf0" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_85aac082-3785-4d7c-92f8-f5ea0fd20010" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_678369b9-87d1-4bd4-a3b4-d71515428d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_42595713-d3a6-4061-8ff6-fa466c50daf0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_678369b9-87d1-4bd4-a3b4-d71515428d23" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_445f0a13-662d-414e-90d8-434fd9a911ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_678369b9-87d1-4bd4-a3b4-d71515428d23" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_445f0a13-662d-414e-90d8-434fd9a911ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_445f0a13-662d-414e-90d8-434fd9a911ca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_445f0a13-662d-414e-90d8-434fd9a911ca" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_445f0a13-662d-414e-90d8-434fd9a911ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34e6ed01-d6fa-4c1c-803f-96e36c14ec7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_445f0a13-662d-414e-90d8-434fd9a911ca" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34e6ed01-d6fa-4c1c-803f-96e36c14ec7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8f70bf19-4b70-4c4a-ba2a-24bf4069dadf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34e6ed01-d6fa-4c1c-803f-96e36c14ec7a" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8f70bf19-4b70-4c4a-ba2a-24bf4069dadf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_2c989095-8b7a-4ef9-9650-ea1fdc6f8fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34e6ed01-d6fa-4c1c-803f-96e36c14ec7a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_2c989095-8b7a-4ef9-9650-ea1fdc6f8fa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b1f95c9d-fbda-412c-a70c-a20048fa8237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34e6ed01-d6fa-4c1c-803f-96e36c14ec7a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b1f95c9d-fbda-412c-a70c-a20048fa8237" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_e650b139-6e0d-40ab-8cdd-5c11375c130f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_678369b9-87d1-4bd4-a3b4-d71515428d23" xlink:to="loc_us-gaap_InvestmentTypeAxis_e650b139-6e0d-40ab-8cdd-5c11375c130f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_e650b139-6e0d-40ab-8cdd-5c11375c130f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_e650b139-6e0d-40ab-8cdd-5c11375c130f" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_e650b139-6e0d-40ab-8cdd-5c11375c130f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_29b193ce-abee-4eb7-8f49-b891d65ddd6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_e650b139-6e0d-40ab-8cdd-5c11375c130f" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_29b193ce-abee-4eb7-8f49-b891d65ddd6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_a41681fa-a706-4e5d-8630-f13f9915160e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_29b193ce-abee-4eb7-8f49-b891d65ddd6f" xlink:to="loc_us-gaap_FixedMaturitiesMember_a41681fa-a706-4e5d-8630-f13f9915160e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_2942faa9-5222-49c4-9c67-62cf1aa2e478" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_29b193ce-abee-4eb7-8f49-b891d65ddd6f" xlink:to="loc_us-gaap_EquitySecuritiesMember_2942faa9-5222-49c4-9c67-62cf1aa2e478" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_f03a7402-e7dc-4a7a-9282-ac7f20569a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_29b193ce-abee-4eb7-8f49-b891d65ddd6f" xlink:to="loc_us-gaap_OtherInvestmentsMember_f03a7402-e7dc-4a7a-9282-ac7f20569a8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMember_c6c7da35-6694-48fb-a634-c582d27d495f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_29b193ce-abee-4eb7-8f49-b891d65ddd6f" xlink:to="loc_us-gaap_DerivativeMember_c6c7da35-6694-48fb-a634-c582d27d495f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_76e5d9a2-c339-48a8-83a4-ba997d52d851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_678369b9-87d1-4bd4-a3b4-d71515428d23" xlink:to="loc_us-gaap_FinancialInstrumentAxis_76e5d9a2-c339-48a8-83a4-ba997d52d851" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_76e5d9a2-c339-48a8-83a4-ba997d52d851_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_76e5d9a2-c339-48a8-83a4-ba997d52d851" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_76e5d9a2-c339-48a8-83a4-ba997d52d851_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_76e5d9a2-c339-48a8-83a4-ba997d52d851" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_83ba7404-b19f-494f-8005-7af3f311b54d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_83ba7404-b19f-494f-8005-7af3f311b54d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_906f27bf-bfd3-49e1-b2c5-18716a44c603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_906f27bf-bfd3-49e1-b2c5-18716a44c603" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtMember_05484e18-492c-4a2b-adf7-8bfdc6967b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:to="loc_us-gaap_ForeignGovernmentDebtMember_05484e18-492c-4a2b-adf7-8bfdc6967b0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_d90a853a-beb0-45f3-bf9e-47fbd47bb362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_d90a853a-beb0-45f3-bf9e-47fbd47bb362" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_da9e758d-cd2a-4bb9-a7fd-de4921177463" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_da9e758d-cd2a-4bb9-a7fd-de4921177463" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_01dc0db4-cb39-4b36-bcad-e3cc81d07761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_01dc0db4-cb39-4b36-bcad-e3cc81d07761" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c6b26a61-bf75-4592-a30a-2411d4c18206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c6b26a61-bf75-4592-a30a-2411d4c18206" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_dba7e9b8-7852-4969-8368-3f7312775e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_dba7e9b8-7852-4969-8368-3f7312775e8e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExchangeTradedFundsMember_cd68d415-835b-4b0a-bc8e-d94fcb3804fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExchangeTradedFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:to="loc_us-gaap_ExchangeTradedFundsMember_cd68d415-835b-4b0a-bc8e-d94fcb3804fe" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommonEquitySecuritiesMember_e77ef7b8-543b-4a73-841a-b3ce600533da" xlink:href="elv-20220930.xsd#elv_CommonEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:to="loc_elv_CommonEquitySecuritiesMember_e77ef7b8-543b-4a73-841a-b3ce600533da" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_7ecca096-3884-4616-92e6-5ed721ccc9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:to="loc_us-gaap_PrivateEquityFundsMember_7ecca096-3884-4616-92e6-5ed721ccc9ad" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails" xlink:type="extended" id="i1e3c1148e5d9404b866dd18ecb20f303_FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_845c7a63-243a-40cd-80ca-dab7105a6d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4b9eb0b4-3fe1-47c1-9b5e-479f4d153aba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_845c7a63-243a-40cd-80ca-dab7105a6d6c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4b9eb0b4-3fe1-47c1-9b5e-479f4d153aba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_de19b1b9-57ae-4276-837b-a5763af2e4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4b9eb0b4-3fe1-47c1-9b5e-479f4d153aba" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_de19b1b9-57ae-4276-837b-a5763af2e4b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_955a4c11-42a4-4fe6-a58e-be7364ba82b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4b9eb0b4-3fe1-47c1-9b5e-479f4d153aba" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_955a4c11-42a4-4fe6-a58e-be7364ba82b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_ea6ae0e7-b552-4253-9199-69c127447560" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4b9eb0b4-3fe1-47c1-9b5e-479f4d153aba" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_ea6ae0e7-b552-4253-9199-69c127447560" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_86da5b2c-246b-4afc-9dfe-6711dad1ef17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4b9eb0b4-3fe1-47c1-9b5e-479f4d153aba" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_86da5b2c-246b-4afc-9dfe-6711dad1ef17" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_d8ea9048-cff6-4f81-b23c-2b8cb9da31f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4b9eb0b4-3fe1-47c1-9b5e-479f4d153aba" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_d8ea9048-cff6-4f81-b23c-2b8cb9da31f9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_5ad04b7b-f90c-455f-8f48-0454103fbc5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4b9eb0b4-3fe1-47c1-9b5e-479f4d153aba" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_5ad04b7b-f90c-455f-8f48-0454103fbc5e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_bc5a8363-782d-4e8d-a40f-c135c54ae664" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4b9eb0b4-3fe1-47c1-9b5e-479f4d153aba" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_bc5a8363-782d-4e8d-a40f-c135c54ae664" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_10a9400b-9c1f-4f79-ab8a-9eaaabc50588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4b9eb0b4-3fe1-47c1-9b5e-479f4d153aba" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_10a9400b-9c1f-4f79-ab8a-9eaaabc50588" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_6a89394a-6223-4179-8ef3-2078594135fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_adf326d1-c034-4e98-8a3b-3ed5983b43e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4b9eb0b4-3fe1-47c1-9b5e-479f4d153aba" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_adf326d1-c034-4e98-8a3b-3ed5983b43e4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ba328a61-f18d-421c-8b8c-d9baf6ad3b10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_845c7a63-243a-40cd-80ca-dab7105a6d6c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ba328a61-f18d-421c-8b8c-d9baf6ad3b10" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_528c6afc-0174-4fa0-9555-4e09ae208d15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ba328a61-f18d-421c-8b8c-d9baf6ad3b10" xlink:to="loc_us-gaap_FinancialInstrumentAxis_528c6afc-0174-4fa0-9555-4e09ae208d15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528c6afc-0174-4fa0-9555-4e09ae208d15_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_528c6afc-0174-4fa0-9555-4e09ae208d15" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528c6afc-0174-4fa0-9555-4e09ae208d15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e74d9472-2516-48b8-bcf5-8f0c75e7c9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_528c6afc-0174-4fa0-9555-4e09ae208d15" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e74d9472-2516-48b8-bcf5-8f0c75e7c9fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_5dff1a4c-5cf0-4670-b3df-8cbd61ed61af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e74d9472-2516-48b8-bcf5-8f0c75e7c9fa" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_5dff1a4c-5cf0-4670-b3df-8cbd61ed61af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_9b1126d8-32b2-4ff3-91a1-e83f70668537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e74d9472-2516-48b8-bcf5-8f0c75e7c9fa" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_9b1126d8-32b2-4ff3-91a1-e83f70668537" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_44df4dd8-29f6-48bd-bc93-33d2f4808177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e74d9472-2516-48b8-bcf5-8f0c75e7c9fa" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_44df4dd8-29f6-48bd-bc93-33d2f4808177" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_deed95d9-dd3e-415d-bbd2-89a7d0f60ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e74d9472-2516-48b8-bcf5-8f0c75e7c9fa" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_deed95d9-dd3e-415d-bbd2-89a7d0f60ff4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_0d4afbc5-bfce-4e69-8b26-9e77d4c13334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e74d9472-2516-48b8-bcf5-8f0c75e7c9fa" xlink:to="loc_us-gaap_EquitySecuritiesMember_0d4afbc5-bfce-4e69-8b26-9e77d4c13334" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails" xlink:type="extended" id="i08675bc7a19a47339582f6264ef9138e_FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0da96143-4e0d-4d9c-ba2f-8852a37d1fce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_f09516a8-2938-41b2-bd72-50fe30b64bac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0da96143-4e0d-4d9c-ba2f-8852a37d1fce" xlink:to="loc_us-gaap_OtherLongTermInvestments_f09516a8-2938-41b2-bd72-50fe30b64bac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_59177893-3227-48ee-af97-f8a0c59b8414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0da96143-4e0d-4d9c-ba2f-8852a37d1fce" xlink:to="loc_us-gaap_ShortTermBorrowings_59177893-3227-48ee-af97-f8a0c59b8414" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a70a5268-3693-466c-b352-5822f98d1f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0da96143-4e0d-4d9c-ba2f-8852a37d1fce" xlink:to="loc_us-gaap_LongTermDebt_a70a5268-3693-466c-b352-5822f98d1f2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_580589bb-0500-49b2-973d-f9279b71076c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0da96143-4e0d-4d9c-ba2f-8852a37d1fce" xlink:to="loc_us-gaap_CommercialPaper_580589bb-0500-49b2-973d-f9279b71076c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_c42c8caa-69dc-4aad-9ee7-141374a00a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0da96143-4e0d-4d9c-ba2f-8852a37d1fce" xlink:to="loc_us-gaap_NotesPayable_c42c8caa-69dc-4aad-9ee7-141374a00a7b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_1eb8aae0-f3c3-44a3-9d81-66110d445506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0da96143-4e0d-4d9c-ba2f-8852a37d1fce" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_1eb8aae0-f3c3-44a3-9d81-66110d445506" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13a02fca-036a-40c4-98ed-b105fe18598b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0da96143-4e0d-4d9c-ba2f-8852a37d1fce" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13a02fca-036a-40c4-98ed-b105fe18598b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_e871847a-b913-434a-bf6d-54769e2bf6ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13a02fca-036a-40c4-98ed-b105fe18598b" xlink:to="loc_us-gaap_InvestmentTypeAxis_e871847a-b913-434a-bf6d-54769e2bf6ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_e871847a-b913-434a-bf6d-54769e2bf6ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_e871847a-b913-434a-bf6d-54769e2bf6ec" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_e871847a-b913-434a-bf6d-54769e2bf6ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_6633b88a-f559-4bf4-bd37-687593b5ec87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_e871847a-b913-434a-bf6d-54769e2bf6ec" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_6633b88a-f559-4bf4-bd37-687593b5ec87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_2b4c63aa-9fd8-4b88-afda-e67d6b7dbe31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6633b88a-f559-4bf4-bd37-687593b5ec87" xlink:to="loc_us-gaap_OtherInvestmentsMember_2b4c63aa-9fd8-4b88-afda-e67d6b7dbe31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0ad1e10d-e73c-47f8-9005-4067e18bc6ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13a02fca-036a-40c4-98ed-b105fe18598b" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0ad1e10d-e73c-47f8-9005-4067e18bc6ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_0ad1e10d-e73c-47f8-9005-4067e18bc6ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0ad1e10d-e73c-47f8-9005-4067e18bc6ce" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_0ad1e10d-e73c-47f8-9005-4067e18bc6ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_fc13afc3-98b9-46ae-8112-7a5641e2e615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0ad1e10d-e73c-47f8-9005-4067e18bc6ce" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_fc13afc3-98b9-46ae-8112-7a5641e2e615" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_45e524f3-3e5c-4a25-a204-498b5e008985" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_fc13afc3-98b9-46ae-8112-7a5641e2e615" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_45e524f3-3e5c-4a25-a204-498b5e008985" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_266dae29-7e36-4832-97de-0fbd408617dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_fc13afc3-98b9-46ae-8112-7a5641e2e615" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_266dae29-7e36-4832-97de-0fbd408617dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5d260ea7-9bda-438c-9aa9-a0a02b9be86f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13a02fca-036a-40c4-98ed-b105fe18598b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5d260ea7-9bda-438c-9aa9-a0a02b9be86f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5d260ea7-9bda-438c-9aa9-a0a02b9be86f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5d260ea7-9bda-438c-9aa9-a0a02b9be86f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5d260ea7-9bda-438c-9aa9-a0a02b9be86f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92cdec95-bd7e-4ba1-aca5-c2c94a635406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5d260ea7-9bda-438c-9aa9-a0a02b9be86f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92cdec95-bd7e-4ba1-aca5-c2c94a635406" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_bc84ecb9-5266-42b6-9be2-182dd4504485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92cdec95-bd7e-4ba1-aca5-c2c94a635406" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_bc84ecb9-5266-42b6-9be2-182dd4504485" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_3d790ce1-bec2-4404-954b-50c205f84783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92cdec95-bd7e-4ba1-aca5-c2c94a635406" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_3d790ce1-bec2-4404-954b-50c205f84783" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_5da2159c-dbca-4130-9bda-949192604469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92cdec95-bd7e-4ba1-aca5-c2c94a635406" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_5da2159c-dbca-4130-9bda-949192604469" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails" xlink:type="extended" id="i3faaab918705409e81de418e9e487d8a_MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense_8274f663-64c2-4e58-918e-d1940460aabb" xlink:href="elv-20220930.xsd#elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense_8274f663-64c2-4e58-918e-d1940460aabb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_0f39b02a-e09a-4aaa-a502-f724652d0b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_0f39b02a-e09a-4aaa-a502-f724652d0b5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_d2434bf1-cc0b-465f-b95a-fb383ef84d77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_d2434bf1-cc0b-465f-b95a-fb383ef84d77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments_8057b6c8-c330-486b-9ed8-256ada6f8d95" xlink:href="elv-20220930.xsd#elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments_8057b6c8-c330-486b-9ed8-256ada6f8d95" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_087682d3-9fe6-41aa-ac9a-971aa2e9c65c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_087682d3-9fe6-41aa-ac9a-971aa2e9c65c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_ab4419ba-af73-40d4-8594-e4b5e0d7d6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_ab4419ba-af73-40d4-8594-e4b5e0d7d6a4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_f73436cb-d677-407a-b799-15d8068f74a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_f73436cb-d677-407a-b799-15d8068f74a5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_e2b2b4d4-fb23-48ea-96f7-30802017d166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_e2b2b4d4-fb23-48ea-96f7-30802017d166" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_d7237705-fada-4c02-a19f-8845ecacf844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_d7237705-fada-4c02-a19f-8845ecacf844" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_27aeab1a-a09c-439c-a1b9-f30247e45cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_27aeab1a-a09c-439c-a1b9-f30247e45cd2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet_05bb6242-4ccf-498b-9236-5e817e3cc6ef" xlink:href="elv-20220930.xsd#elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet_05bb6242-4ccf-498b-9236-5e817e3cc6ef" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_02806d72-cfe0-4c27-95ba-f08a9e1ed628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense_837e8767-b281-484a-ad7c-191dd257295b" xlink:href="elv-20220930.xsd#elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_b856008a-7c6f-4a8a-a060-4a2cbf0b27bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_b856008a-7c6f-4a8a-a060-4a2cbf0b27bb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f7302f32-5cf8-4be9-8c02-bfb1c6dcfe61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_b856008a-7c6f-4a8a-a060-4a2cbf0b27bb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f7302f32-5cf8-4be9-8c02-bfb1c6dcfe61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f7302f32-5cf8-4be9-8c02-bfb1c6dcfe61_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f7302f32-5cf8-4be9-8c02-bfb1c6dcfe61" xlink:to="loc_us-gaap_SegmentDomain_f7302f32-5cf8-4be9-8c02-bfb1c6dcfe61_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_15f2be91-a7f8-460e-b308-d15d1402b42c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f7302f32-5cf8-4be9-8c02-bfb1c6dcfe61" xlink:to="loc_us-gaap_SegmentDomain_15f2be91-a7f8-460e-b308-d15d1402b42c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommercialSpecialtyBusinessSegmentMember_f5c1388c-eac8-4a72-bf07-b4687b87ff06" xlink:href="elv-20220930.xsd#elv_CommercialSpecialtyBusinessSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_15f2be91-a7f8-460e-b308-d15d1402b42c" xlink:to="loc_elv_CommercialSpecialtyBusinessSegmentMember_f5c1388c-eac8-4a72-bf07-b4687b87ff06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GovernmentBusinessSegmentMember_feea2973-b286-4155-b02d-80a3d3a6119a" xlink:href="elv-20220930.xsd#elv_GovernmentBusinessSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_15f2be91-a7f8-460e-b308-d15d1402b42c" xlink:to="loc_elv_GovernmentBusinessSegmentMember_feea2973-b286-4155-b02d-80a3d3a6119a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherSegmentMember_c72ca9ab-ab5b-4b3a-a785-5bafe9bec415" xlink:href="elv-20220930.xsd#elv_OtherSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_15f2be91-a7f8-460e-b308-d15d1402b42c" xlink:to="loc_elv_OtherSegmentMember_c72ca9ab-ab5b-4b3a-a785-5bafe9bec415" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfNetIncurredMedicalClaimsToBenefitExpenseDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#MedicalClaimsPayableReconciliationOfNetIncurredMedicalClaimsToBenefitExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfNetIncurredMedicalClaimsToBenefitExpenseDetails" xlink:type="extended" id="i19ed4f188d5641788883d19ff052c500_MedicalClaimsPayableReconciliationOfNetIncurredMedicalClaimsToBenefitExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems_dda60c9c-783b-41c9-ad57-ccfa8d0b1fa7" xlink:href="elv-20220930.xsd#elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_530d26aa-4103-478f-b155-bcbf73fa7c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems_dda60c9c-783b-41c9-ad57-ccfa8d0b1fa7" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_530d26aa-4103-478f-b155-bcbf73fa7c96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense_0b13b3d3-4694-4c2d-8e55-25892fbc8571" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems_dda60c9c-783b-41c9-ad57-ccfa8d0b1fa7" xlink:to="loc_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense_0b13b3d3-4694-4c2d-8e55-25892fbc8571" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_03df43e7-9097-4279-838a-e3af0062b672" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems_dda60c9c-783b-41c9-ad57-ccfa8d0b1fa7" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_03df43e7-9097-4279-838a-e3af0062b672" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTable_e0856993-dad4-4a67-be3d-339f39a025ae" xlink:href="elv-20220930.xsd#elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems_dda60c9c-783b-41c9-ad57-ccfa8d0b1fa7" xlink:to="loc_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTable_e0856993-dad4-4a67-be3d-339f39a025ae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3d5756bc-7929-44d3-9199-5bf7acd99c73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTable_e0856993-dad4-4a67-be3d-339f39a025ae" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3d5756bc-7929-44d3-9199-5bf7acd99c73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3d5756bc-7929-44d3-9199-5bf7acd99c73_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3d5756bc-7929-44d3-9199-5bf7acd99c73" xlink:to="loc_us-gaap_SegmentDomain_3d5756bc-7929-44d3-9199-5bf7acd99c73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_aab4ddf1-e4b1-4b29-ab5d-80f5ce6f2d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3d5756bc-7929-44d3-9199-5bf7acd99c73" xlink:to="loc_us-gaap_SegmentDomain_aab4ddf1-e4b1-4b29-ab5d-80f5ce6f2d35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommercialSpecialtyBusinessSegmentMember_0ffdcb5e-7bf8-4fb7-a4e0-9bd50eaeb8c3" xlink:href="elv-20220930.xsd#elv_CommercialSpecialtyBusinessSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_aab4ddf1-e4b1-4b29-ab5d-80f5ce6f2d35" xlink:to="loc_elv_CommercialSpecialtyBusinessSegmentMember_0ffdcb5e-7bf8-4fb7-a4e0-9bd50eaeb8c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GovernmentBusinessSegmentMember_7e9a914e-9d78-4901-aea0-56cd299b9af5" xlink:href="elv-20220930.xsd#elv_GovernmentBusinessSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_aab4ddf1-e4b1-4b29-ab5d-80f5ce6f2d35" xlink:to="loc_elv_GovernmentBusinessSegmentMember_7e9a914e-9d78-4901-aea0-56cd299b9af5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherSegmentMember_6e15e262-633f-4e72-a953-ea2518229649" xlink:href="elv-20220930.xsd#elv_OtherSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_aab4ddf1-e4b1-4b29-ab5d-80f5ce6f2d35" xlink:to="loc_elv_OtherSegmentMember_6e15e262-633f-4e72-a953-ea2518229649" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/MedicalClaimsPayableMedicalClaimsPayableReconciliationoftheClaimsDevelopmenttotheClaimsLiabilityDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#MedicalClaimsPayableMedicalClaimsPayableReconciliationoftheClaimsDevelopmenttotheClaimsLiabilityDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/MedicalClaimsPayableMedicalClaimsPayableReconciliationoftheClaimsDevelopmenttotheClaimsLiabilityDetails" xlink:type="extended" id="i56d4f69806df492dbd572a1a6b7aea6d_MedicalClaimsPayableMedicalClaimsPayableReconciliationoftheClaimsDevelopmenttotheClaimsLiabilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_26a9b0b9-cb80-4d81-881a-4785300c93e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_1975b8e2-e736-4027-94b5-737674978a83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_26a9b0b9-cb80-4d81-881a-4785300c93e9" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_1975b8e2-e736-4027-94b5-737674978a83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_55dd3c5c-b01b-4695-a7f6-606135c17683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_26a9b0b9-cb80-4d81-881a-4785300c93e9" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_55dd3c5c-b01b-4695-a7f6-606135c17683" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_e1390ca8-3ac9-416c-95d0-aaeb7e67ea88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_26a9b0b9-cb80-4d81-881a-4785300c93e9" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_e1390ca8-3ac9-416c-95d0-aaeb7e67ea88" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_5cd27931-3607-41aa-91c8-3dc89121390c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_26a9b0b9-cb80-4d81-881a-4785300c93e9" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_5cd27931-3607-41aa-91c8-3dc89121390c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_9704d327-7f49-41ff-a73d-980438d2bda3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_26a9b0b9-cb80-4d81-881a-4785300c93e9" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_9704d327-7f49-41ff-a73d-980438d2bda3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_544b15a0-bca0-4c29-b535-2c4194376303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_9704d327-7f49-41ff-a73d-980438d2bda3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_544b15a0-bca0-4c29-b535-2c4194376303" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_544b15a0-bca0-4c29-b535-2c4194376303_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_544b15a0-bca0-4c29-b535-2c4194376303" xlink:to="loc_us-gaap_SegmentDomain_544b15a0-bca0-4c29-b535-2c4194376303_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3fdf04b2-a2fe-4f06-afca-79efb1e01d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_544b15a0-bca0-4c29-b535-2c4194376303" xlink:to="loc_us-gaap_SegmentDomain_3fdf04b2-a2fe-4f06-afca-79efb1e01d2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommercialSpecialtyBusinessSegmentMember_0fab918a-c37a-40ab-9f32-a94fb4513019" xlink:href="elv-20220930.xsd#elv_CommercialSpecialtyBusinessSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3fdf04b2-a2fe-4f06-afca-79efb1e01d2b" xlink:to="loc_elv_CommercialSpecialtyBusinessSegmentMember_0fab918a-c37a-40ab-9f32-a94fb4513019" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GovernmentBusinessSegmentMember_79c08b4e-a6e5-4777-88e8-abcc8c8a6428" xlink:href="elv-20220930.xsd#elv_GovernmentBusinessSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3fdf04b2-a2fe-4f06-afca-79efb1e01d2b" xlink:to="loc_elv_GovernmentBusinessSegmentMember_79c08b4e-a6e5-4777-88e8-abcc8c8a6428" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherSegmentMember_c3153c33-fb3c-4548-8d12-df763cf7ce72" xlink:href="elv-20220930.xsd#elv_OtherSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3fdf04b2-a2fe-4f06-afca-79efb1e01d2b" xlink:to="loc_elv_OtherSegmentMember_c3153c33-fb3c-4548-8d12-df763cf7ce72" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/MedicalClaimsPayableNarrativeDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#MedicalClaimsPayableNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/MedicalClaimsPayableNarrativeDetails" xlink:type="extended" id="i3a990b99806d415c83d1414c405aa0b5_MedicalClaimsPayableNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems_3d073d54-18c6-4f95-908f-40c0bc455315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_dd053524-01d2-43f1-8d21-739d7fb86fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_3d073d54-18c6-4f95-908f-40c0bc455315" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_dd053524-01d2-43f1-8d21-739d7fb86fb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_d9c6bb37-db68-4183-9112-1613654afb29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_3d073d54-18c6-4f95-908f-40c0bc455315" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_d9c6bb37-db68-4183-9112-1613654afb29" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_8f15b682-e38a-4fa0-a9d0-451ac0a1f4bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_d9c6bb37-db68-4183-9112-1613654afb29" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_8f15b682-e38a-4fa0-a9d0-451ac0a1f4bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_8f15b682-e38a-4fa0-a9d0-451ac0a1f4bb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_8f15b682-e38a-4fa0-a9d0-451ac0a1f4bb" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_8f15b682-e38a-4fa0-a9d0-451ac0a1f4bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_81f0363c-8bdc-4d5a-99de-220fc5742d19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_8f15b682-e38a-4fa0-a9d0-451ac0a1f4bb" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_81f0363c-8bdc-4d5a-99de-220fc5742d19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_7a911ec5-718f-497b-9eab-fb5c375158cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_81f0363c-8bdc-4d5a-99de-220fc5742d19" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_7a911ec5-718f-497b-9eab-fb5c375158cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_f843e3ce-da85-4495-9c79-0aa907370b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_81f0363c-8bdc-4d5a-99de-220fc5742d19" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_f843e3ce-da85-4495-9c79-0aa907370b3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_a9ccd876-2823-458a-afaf-639444bb6e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_81f0363c-8bdc-4d5a-99de-220fc5742d19" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_a9ccd876-2823-458a-afaf-639444bb6e08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a8bd28ce-5f49-4d2d-9a15-2c9970599080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_d9c6bb37-db68-4183-9112-1613654afb29" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a8bd28ce-5f49-4d2d-9a15-2c9970599080" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a8bd28ce-5f49-4d2d-9a15-2c9970599080_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a8bd28ce-5f49-4d2d-9a15-2c9970599080" xlink:to="loc_us-gaap_SegmentDomain_a8bd28ce-5f49-4d2d-9a15-2c9970599080_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bb666186-1fbd-4af7-8625-ed7330569f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a8bd28ce-5f49-4d2d-9a15-2c9970599080" xlink:to="loc_us-gaap_SegmentDomain_bb666186-1fbd-4af7-8625-ed7330569f3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommercialSpecialtyBusinessSegmentMember_cb57a7f9-8eb0-4cb7-9d08-fbf5d13d9141" xlink:href="elv-20220930.xsd#elv_CommercialSpecialtyBusinessSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bb666186-1fbd-4af7-8625-ed7330569f3e" xlink:to="loc_elv_CommercialSpecialtyBusinessSegmentMember_cb57a7f9-8eb0-4cb7-9d08-fbf5d13d9141" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GovernmentBusinessSegmentMember_3acf838d-862d-4abf-a0fd-cb02f8d2fbe4" xlink:href="elv-20220930.xsd#elv_GovernmentBusinessSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bb666186-1fbd-4af7-8625-ed7330569f3e" xlink:to="loc_elv_GovernmentBusinessSegmentMember_3acf838d-862d-4abf-a0fd-cb02f8d2fbe4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherSegmentMember_cfd76bb5-0c78-4af6-aeac-25479910ba6a" xlink:href="elv-20220930.xsd#elv_OtherSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bb666186-1fbd-4af7-8625-ed7330569f3e" xlink:to="loc_elv_OtherSegmentMember_cfd76bb5-0c78-4af6-aeac-25479910ba6a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/DebtConvertibleDebentureDetailsDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#DebtConvertibleDebentureDetailsDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/DebtConvertibleDebentureDetailsDetails" xlink:type="extended" id="i007adb507b2046dab09eb4b6a8f34703_DebtConvertibleDebentureDetailsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_deb096e9-ee59-488a-8568-409ed0d6828e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_f4b497b8-3f0e-42de-92dc-01db13611ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_deb096e9-ee59-488a-8568-409ed0d6828e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_f4b497b8-3f0e-42de-92dc-01db13611ae5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_ac11c480-6714-4ae1-9640-bd5bddca2101" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_deb096e9-ee59-488a-8568-409ed0d6828e" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_ac11c480-6714-4ae1-9640-bd5bddca2101" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_fa56b383-f008-426d-a4f3-82e8fefe0d03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_deb096e9-ee59-488a-8568-409ed0d6828e" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_fa56b383-f008-426d-a4f3-82e8fefe0d03" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_e3dac56a-529c-454b-ac0c-aeb814eac1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_deb096e9-ee59-488a-8568-409ed0d6828e" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_e3dac56a-529c-454b-ac0c-aeb814eac1b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2523da4a-288d-4c99-a96b-f425d0ab174c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_deb096e9-ee59-488a-8568-409ed0d6828e" xlink:to="loc_us-gaap_DebtInstrumentTable_2523da4a-288d-4c99-a96b-f425d0ab174c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f3d9ee32-8d5e-4933-8638-c7e1473b03b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2523da4a-288d-4c99-a96b-f425d0ab174c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f3d9ee32-8d5e-4933-8638-c7e1473b03b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f3d9ee32-8d5e-4933-8638-c7e1473b03b5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f3d9ee32-8d5e-4933-8638-c7e1473b03b5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f3d9ee32-8d5e-4933-8638-c7e1473b03b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d96e5300-29d4-4951-8f11-ce030c679ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f3d9ee32-8d5e-4933-8638-c7e1473b03b5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d96e5300-29d4-4951-8f11-ce030c679ae8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cfbf6915-bb5d-4f48-8eeb-56ddeb0f6df4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2523da4a-288d-4c99-a96b-f425d0ab174c" xlink:to="loc_us-gaap_DebtInstrumentAxis_cfbf6915-bb5d-4f48-8eeb-56ddeb0f6df4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cfbf6915-bb5d-4f48-8eeb-56ddeb0f6df4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_cfbf6915-bb5d-4f48-8eeb-56ddeb0f6df4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cfbf6915-bb5d-4f48-8eeb-56ddeb0f6df4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_127dc9ed-d62c-45c0-9584-a9216a03d55f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_cfbf6915-bb5d-4f48-8eeb-56ddeb0f6df4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_127dc9ed-d62c-45c0-9584-a9216a03d55f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_a6be8722-1da0-4bc5-83a1-91def0cf1a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_127dc9ed-d62c-45c0-9584-a9216a03d55f" xlink:to="loc_us-gaap_ConvertibleDebtMember_a6be8722-1da0-4bc5-83a1-91def0cf1a2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_4c6d6ae2-c268-41d6-8c6f-49f5839d8670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2523da4a-288d-4c99-a96b-f425d0ab174c" xlink:to="loc_us-gaap_VariableRateAxis_4c6d6ae2-c268-41d6-8c6f-49f5839d8670" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_4c6d6ae2-c268-41d6-8c6f-49f5839d8670_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_4c6d6ae2-c268-41d6-8c6f-49f5839d8670" xlink:to="loc_us-gaap_VariableRateDomain_4c6d6ae2-c268-41d6-8c6f-49f5839d8670_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_50abdad0-c506-4621-ae50-0e1773e6b83d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_4c6d6ae2-c268-41d6-8c6f-49f5839d8670" xlink:to="loc_us-gaap_VariableRateDomain_50abdad0-c506-4621-ae50-0e1773e6b83d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_91f45fda-e309-4ff3-8923-3802efa200bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2523da4a-288d-4c99-a96b-f425d0ab174c" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_91f45fda-e309-4ff3-8923-3802efa200bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_91f45fda-e309-4ff3-8923-3802efa200bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_91f45fda-e309-4ff3-8923-3802efa200bd" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_91f45fda-e309-4ff3-8923-3802efa200bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1a4bafab-1085-4ff0-a822-cf0660a433aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_91f45fda-e309-4ff3-8923-3802efa200bd" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1a4bafab-1085-4ff0-a822-cf0660a433aa" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#DebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/DebtNarrativeDetails" xlink:type="extended" id="ia20c31242f7840408c76f8c44830c10c_DebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_743ac451-3cb1-41a2-9e14-0755cad2a4bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_LongTermDebt_743ac451-3cb1-41a2-9e14-0755cad2a4bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ff187cd2-4733-481a-bb11-14b838fcf3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ff187cd2-4733-481a-bb11-14b838fcf3f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_2fd1bb65-7371-44c6-91c6-e38048c21675" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_2fd1bb65-7371-44c6-91c6-e38048c21675" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_dad61437-2159-4b00-9438-cfcf7ab3ec2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_dad61437-2159-4b00-9438-cfcf7ab3ec2c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_2fe0445e-2290-482d-86fa-91c630e37a49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_2fe0445e-2290-482d-86fa-91c630e37a49" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCovenantDescription_7f3aa078-71cd-4bd4-80d3-b5482aabd2c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCovenantDescription"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_DebtInstrumentCovenantDescription_7f3aa078-71cd-4bd4-80d3-b5482aabd2c7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCovenantCompliance_541a34cd-5136-4dd9-95a8-080c2154e5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCovenantCompliance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_DebtInstrumentCovenantCompliance_541a34cd-5136-4dd9-95a8-080c2154e5f6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_bba94606-d5a7-4e98-911b-577a4ede4007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_bba94606-d5a7-4e98-911b-577a4ede4007" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityDescription_8c94d761-9892-46f9-8b60-4defbabb6d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityDescription"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_LineOfCreditFacilityDescription_8c94d761-9892-46f9-8b60-4defbabb6d9b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommercialPaperMaximumBorrowingCapacity_490f80d7-7922-4db2-a114-22da433a83a4" xlink:href="elv-20220930.xsd#elv_CommercialPaperMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_elv_CommercialPaperMaximumBorrowingCapacity_490f80d7-7922-4db2-a114-22da433a83a4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_d4821046-d6c0-40c7-8702-12ce94f15d17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_CommercialPaper_d4821046-d6c0-40c7-8702-12ce94f15d17" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_DebtConversionDebtPrincipalAmount_6572cbd3-8839-49a6-a194-97b6032e3433" xlink:href="elv-20220930.xsd#elv_DebtConversionDebtPrincipalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_elv_DebtConversionDebtPrincipalAmount_6572cbd3-8839-49a6-a194-97b6032e3433" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5cda5d53-df66-4573-8693-115978697a83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_2b0e4968-920b-40b0-a7be-9e03dcb94063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_2b0e4968-920b-40b0-a7be-9e03dcb94063" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_07c07608-439b-495f-a689-50324ec3f8af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_StockholdersEquity_07c07608-439b-495f-a689-50324ec3f8af" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_557f86dc-9192-4a45-9605-4e7048b802e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_557f86dc-9192-4a45-9605-4e7048b802e0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_6a33cd49-c2ff-4c98-937c-8bdf165e01b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_ShortTermBorrowings_6a33cd49-c2ff-4c98-937c-8bdf165e01b9" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths_b6f7badd-6ebf-4980-b8b2-02c769ebc3d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths_b6f7badd-6ebf-4980-b8b2-02c769ebc3d1" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_cce1f854-6916-4bbf-b97e-843e6cf1086c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_us-gaap_CreditFacilityAxis_cce1f854-6916-4bbf-b97e-843e6cf1086c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_cce1f854-6916-4bbf-b97e-843e6cf1086c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_cce1f854-6916-4bbf-b97e-843e6cf1086c" xlink:to="loc_us-gaap_CreditFacilityDomain_cce1f854-6916-4bbf-b97e-843e6cf1086c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_88c3e7d6-0732-44e6-a46c-1ae7c1149dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_cce1f854-6916-4bbf-b97e-843e6cf1086c" xlink:to="loc_us-gaap_CreditFacilityDomain_88c3e7d6-0732-44e6-a46c-1ae7c1149dd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_A2021364DayFacilityMember_59fe8215-a999-411a-90ec-0725db7b3a61" xlink:href="elv-20220930.xsd#elv_A2021364DayFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_88c3e7d6-0732-44e6-a46c-1ae7c1149dd0" xlink:to="loc_elv_A2021364DayFacilityMember_59fe8215-a999-411a-90ec-0725db7b3a61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_A5YearFacilityMember_74c1bea8-133b-4cb9-98c8-867581d73717" xlink:href="elv-20220930.xsd#elv_A5YearFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_88c3e7d6-0732-44e6-a46c-1ae7c1149dd0" xlink:to="loc_elv_A5YearFacilityMember_74c1bea8-133b-4cb9-98c8-867581d73717" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_eb15936e-edd3-4ac5-8338-61f9317dfb87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_eb15936e-edd3-4ac5-8338-61f9317dfb87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_eb15936e-edd3-4ac5-8338-61f9317dfb87_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_eb15936e-edd3-4ac5-8338-61f9317dfb87" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_eb15936e-edd3-4ac5-8338-61f9317dfb87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4e34f768-b46e-4dba-bc28-6307e4259cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_eb15936e-edd3-4ac5-8338-61f9317dfb87" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4e34f768-b46e-4dba-bc28-6307e4259cd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_0a720411-a59c-4a59-b640-45efd10ac94d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_4e34f768-b46e-4dba-bc28-6307e4259cd6" xlink:to="loc_us-gaap_SubsequentEventMember_0a720411-a59c-4a59-b640-45efd10ac94d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9c2908d7-dcfd-4716-9ba0-5d55caf9db26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9c2908d7-dcfd-4716-9ba0-5d55caf9db26" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_9c2908d7-dcfd-4716-9ba0-5d55caf9db26_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9c2908d7-dcfd-4716-9ba0-5d55caf9db26" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_9c2908d7-dcfd-4716-9ba0-5d55caf9db26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_3c64e4b3-4248-44b5-9bcb-333a9e0d77bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9c2908d7-dcfd-4716-9ba0-5d55caf9db26" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_3c64e4b3-4248-44b5-9bcb-333a9e0d77bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4e1f44bb-7f00-46ad-8a30-2785012c8e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4e1f44bb-7f00-46ad-8a30-2785012c8e8c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4e1f44bb-7f00-46ad-8a30-2785012c8e8c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4e1f44bb-7f00-46ad-8a30-2785012c8e8c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4e1f44bb-7f00-46ad-8a30-2785012c8e8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_332cb5e1-33ae-4578-a754-31606df55d19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4e1f44bb-7f00-46ad-8a30-2785012c8e8c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_332cb5e1-33ae-4578-a754-31606df55d19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_c3c56ff1-ab24-4b9d-b65f-352c15a46ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_332cb5e1-33ae-4578-a754-31606df55d19" xlink:to="loc_us-gaap_LineOfCreditMember_c3c56ff1-ab24-4b9d-b65f-352c15a46ce1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SurplusNotesMember_420937f1-a8aa-4686-8830-03247740ad70" xlink:href="elv-20220930.xsd#elv_SurplusNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_332cb5e1-33ae-4578-a754-31606df55d19" xlink:to="loc_elv_SurplusNotesMember_420937f1-a8aa-4686-8830-03247740ad70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_6368c847-2693-42c2-85ba-81c10beb34fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_332cb5e1-33ae-4578-a754-31606df55d19" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_6368c847-2693-42c2-85ba-81c10beb34fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SeniorUnsecuredNotesMember_87129e07-80c9-46cb-9d8e-43693efb3b03" xlink:href="elv-20220930.xsd#elv_SeniorUnsecuredNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_332cb5e1-33ae-4578-a754-31606df55d19" xlink:to="loc_elv_SeniorUnsecuredNotesMember_87129e07-80c9-46cb-9d8e-43693efb3b03" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_dc22f1b1-62c5-4df7-b9f4-621b5ebdfb49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_332cb5e1-33ae-4578-a754-31606df55d19" xlink:to="loc_us-gaap_CommercialPaperMember_dc22f1b1-62c5-4df7-b9f4-621b5ebdfb49" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_78600d2a-ad2d-4156-a5d5-f09737b9d7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_78600d2a-ad2d-4156-a5d5-f09737b9d7e0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_78600d2a-ad2d-4156-a5d5-f09737b9d7e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_78600d2a-ad2d-4156-a5d5-f09737b9d7e0" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_78600d2a-ad2d-4156-a5d5-f09737b9d7e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_ea51b3f8-2949-4383-afd8-dc11981486e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_78600d2a-ad2d-4156-a5d5-f09737b9d7e0" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_ea51b3f8-2949-4383-afd8-dc11981486e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_5c200110-2962-4ee5-ab76-6ed4742345c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_ea51b3f8-2949-4383-afd8-dc11981486e3" xlink:to="loc_us-gaap_LineOfCreditMember_5c200110-2962-4ee5-ab76-6ed4742345c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesMember_b2bb8551-9fd7-4242-9814-b908ee283944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalHomeLoanBankAdvancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_ea51b3f8-2949-4383-afd8-dc11981486e3" xlink:to="loc_us-gaap_FederalHomeLoanBankAdvancesMember_b2bb8551-9fd7-4242-9814-b908ee283944" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fc1f094d-af17-4b88-b775-da3524886f21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fc1f094d-af17-4b88-b775-da3524886f21" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fc1f094d-af17-4b88-b775-da3524886f21_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fc1f094d-af17-4b88-b775-da3524886f21" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fc1f094d-af17-4b88-b775-da3524886f21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5b95701-2232-458b-9b55-d1a77baddf4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fc1f094d-af17-4b88-b775-da3524886f21" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5b95701-2232-458b-9b55-d1a77baddf4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_4318d0f2-21f8-4d69-912b-487af6950928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_4318d0f2-21f8-4d69-912b-487af6950928" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_4318d0f2-21f8-4d69-912b-487af6950928_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_4318d0f2-21f8-4d69-912b-487af6950928" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_4318d0f2-21f8-4d69-912b-487af6950928_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_5efa5ae2-e4a0-4526-b1c5-2fd60efb5e41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_4318d0f2-21f8-4d69-912b-487af6950928" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_5efa5ae2-e4a0-4526-b1c5-2fd60efb5e41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_ecb8b1a4-e821-4fff-b3ac-fb702091692d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_5efa5ae2-e4a0-4526-b1c5-2fd60efb5e41" xlink:to="loc_us-gaap_ConvertibleDebtMember_ecb8b1a4-e821-4fff-b3ac-fb702091692d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SeniorUnsecuredNotesMember_fcfd8226-0d7d-45e7-aa1f-730fdbc88138" xlink:href="elv-20220930.xsd#elv_SeniorUnsecuredNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_5efa5ae2-e4a0-4526-b1c5-2fd60efb5e41" xlink:to="loc_elv_SeniorUnsecuredNotesMember_fcfd8226-0d7d-45e7-aa1f-730fdbc88138" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b037fbc6-025e-4157-bdc7-f647699cf67b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_us-gaap_DebtInstrumentAxis_b037fbc6-025e-4157-bdc7-f647699cf67b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b037fbc6-025e-4157-bdc7-f647699cf67b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b037fbc6-025e-4157-bdc7-f647699cf67b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b037fbc6-025e-4157-bdc7-f647699cf67b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0230b75f-42ef-4308-bd23-afe0f576b4e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b037fbc6-025e-4157-bdc7-f647699cf67b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0230b75f-42ef-4308-bd23-afe0f576b4e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SeniorUnsecuredNotesMember_8a285333-3b2c-446d-a012-78087cc73a1e" xlink:href="elv-20220930.xsd#elv_SeniorUnsecuredNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0230b75f-42ef-4308-bd23-afe0f576b4e8" xlink:to="loc_elv_SeniorUnsecuredNotesMember_8a285333-3b2c-446d-a012-78087cc73a1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_10555e14-7536-4dcf-9c8c-97acff3986fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0230b75f-42ef-4308-bd23-afe0f576b4e8" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_10555e14-7536-4dcf-9c8c-97acff3986fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_67ff1eba-4a3c-498a-bc5e-0455730268fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0230b75f-42ef-4308-bd23-afe0f576b4e8" xlink:to="loc_us-gaap_CommercialPaperMember_67ff1eba-4a3c-498a-bc5e-0455730268fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SurplusNotesMember_1027c1b0-3b36-457b-ae88-5ad4c07b93ae" xlink:href="elv-20220930.xsd#elv_SurplusNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0230b75f-42ef-4308-bd23-afe0f576b4e8" xlink:to="loc_elv_SurplusNotesMember_1027c1b0-3b36-457b-ae88-5ad4c07b93ae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_f60cc131-c179-435e-bbf0-17417d49ef61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0230b75f-42ef-4308-bd23-afe0f576b4e8" xlink:to="loc_us-gaap_ConvertibleDebtMember_f60cc131-c179-435e-bbf0-17417d49ef61" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember_4daeb307-9681-4f8d-9d7a-2b1de82b36df" xlink:href="elv-20220930.xsd#elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0230b75f-42ef-4308-bd23-afe0f576b4e8" xlink:to="loc_elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember_4daeb307-9681-4f8d-9d7a-2b1de82b36df" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember_2a6179bf-5ad2-43c5-9f26-b95af9dc5e7e" xlink:href="elv-20220930.xsd#elv_FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0230b75f-42ef-4308-bd23-afe0f576b4e8" xlink:to="loc_elv_FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember_2a6179bf-5ad2-43c5-9f26-b95af9dc5e7e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember_3c5cd0f1-bf61-4fe2-9c46-9bc3e2819c95" xlink:href="elv-20220930.xsd#elv_ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0230b75f-42ef-4308-bd23-afe0f576b4e8" xlink:to="loc_elv_ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember_3c5cd0f1-bf61-4fe2-9c46-9bc3e2819c95" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_47e887c8-b7ab-49ca-b530-588d0510f937" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_srt_RangeAxis_47e887c8-b7ab-49ca-b530-588d0510f937" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_47e887c8-b7ab-49ca-b530-588d0510f937_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_47e887c8-b7ab-49ca-b530-588d0510f937" xlink:to="loc_srt_RangeMember_47e887c8-b7ab-49ca-b530-588d0510f937_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e91f858e-3987-4e38-a1a3-50ec7f639cd0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_47e887c8-b7ab-49ca-b530-588d0510f937" xlink:to="loc_srt_RangeMember_e91f858e-3987-4e38-a1a3-50ec7f639cd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_90adb9a1-8740-418e-a153-b96999ec7d8d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e91f858e-3987-4e38-a1a3-50ec7f639cd0" xlink:to="loc_srt_MinimumMember_90adb9a1-8740-418e-a153-b96999ec7d8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_39086a49-fee2-47d9-947d-864e8044c51c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e91f858e-3987-4e38-a1a3-50ec7f639cd0" xlink:to="loc_srt_MaximumMember_39086a49-fee2-47d9-947d-864e8044c51c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0474fa97-07c5-44ac-86d4-b4171c9fdb8d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0474fa97-07c5-44ac-86d4-b4171c9fdb8d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0474fa97-07c5-44ac-86d4-b4171c9fdb8d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0474fa97-07c5-44ac-86d4-b4171c9fdb8d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0474fa97-07c5-44ac-86d4-b4171c9fdb8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1e097223-4de4-415a-9f0b-12f24b8e45da" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0474fa97-07c5-44ac-86d4-b4171c9fdb8d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1e097223-4de4-415a-9f0b-12f24b8e45da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_512eb59d-2af3-472e-b1bc-e76d06826b6d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1e097223-4de4-415a-9f0b-12f24b8e45da" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_512eb59d-2af3-472e-b1bc-e76d06826b6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fc28dfa2-0a87-4437-ba7f-24ca7907937e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fc28dfa2-0a87-4437-ba7f-24ca7907937e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_fc28dfa2-0a87-4437-ba7f-24ca7907937e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fc28dfa2-0a87-4437-ba7f-24ca7907937e" xlink:to="loc_us-gaap_TypeOfAdoptionMember_fc28dfa2-0a87-4437-ba7f-24ca7907937e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_44e1fd70-b544-4daf-b475-eab849a0ebbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fc28dfa2-0a87-4437-ba7f-24ca7907937e" xlink:to="loc_us-gaap_TypeOfAdoptionMember_44e1fd70-b544-4daf-b475-eab849a0ebbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_a84f0b92-89d3-406a-9890-15b2b34bad84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_44e1fd70-b544-4daf-b475-eab849a0ebbc" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_a84f0b92-89d3-406a-9890-15b2b34bad84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d9edbf2d-28b2-4fd1-b8bb-4de1137fc5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d9edbf2d-28b2-4fd1-b8bb-4de1137fc5e2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d9edbf2d-28b2-4fd1-b8bb-4de1137fc5e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d9edbf2d-28b2-4fd1-b8bb-4de1137fc5e2" xlink:to="loc_us-gaap_EquityComponentDomain_d9edbf2d-28b2-4fd1-b8bb-4de1137fc5e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_73f81b1b-445d-4639-9a7b-53e59ab14b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d9edbf2d-28b2-4fd1-b8bb-4de1137fc5e2" xlink:to="loc_us-gaap_EquityComponentDomain_73f81b1b-445d-4639-9a7b-53e59ab14b0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_42ed345d-e91d-42a2-9629-5356301b36b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_73f81b1b-445d-4639-9a7b-53e59ab14b0d" xlink:to="loc_us-gaap_RetainedEarningsMember_42ed345d-e91d-42a2-9629-5356301b36b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e5942a20-7a6a-4187-934f-9eea8aee90a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f4023d42-54a1-4678-9f74-c0f39ccd0991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_45472796-e469-4a20-a51d-281d82593a20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_dcd09b82-09de-461b-8a64-48bd84c1fedc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f3b5ba65-e6d5-4bd4-b359-d16584bcf6de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f3b5ba65-e6d5-4bd4-b359-d16584bcf6de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3f1d822f-af25-42bc-bdea-25ba344f1fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember_2434cf47-4c71-4ab3-a899-f671791bb132" xlink:href="elv-20220930.xsd#elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6838f6a5-7958-4d5b-a93f-f640e888020f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6838f6a5-7958-4d5b-a93f-f640e888020f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_08a9fea3-dc0e-4548-9c17-8547b4d2a1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SurplusNotesMember_7a16f347-7d2f-40b2-840c-e1b6404510a1" xlink:href="elv-20220930.xsd#elv_SurplusNotesMember"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#CommitmentsAndContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails" xlink:type="extended" id="i98b92b59cf56412f9d1234c7c61457fc_CommitmentsAndContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommitmentsAndContingenciesLineItems_26c04cc8-19b3-4729-a4e3-1f8a89e0554d" xlink:href="elv-20220930.xsd#elv_CommitmentsAndContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_5efbd83a-9506-47d4-a3e2-093c64fd283e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_CommitmentsAndContingenciesLineItems_26c04cc8-19b3-4729-a4e3-1f8a89e0554d" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_5efbd83a-9506-47d4-a3e2-093c64fd283e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_42a690d5-2c48-4ba3-b0eb-23f6d309a81a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_CommitmentsAndContingenciesLineItems_26c04cc8-19b3-4729-a4e3-1f8a89e0554d" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_42a690d5-2c48-4ba3-b0eb-23f6d309a81a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_291bea0b-aae5-4de5-9e3a-323a20869cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_CommitmentsAndContingenciesLineItems_26c04cc8-19b3-4729-a4e3-1f8a89e0554d" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_291bea0b-aae5-4de5-9e3a-323a20869cd9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GrossPremiumTaxRate_3a9a70da-91f3-4992-bb90-c21fe72ee699" xlink:href="elv-20220930.xsd#elv_GrossPremiumTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_CommitmentsAndContingenciesLineItems_26c04cc8-19b3-4729-a4e3-1f8a89e0554d" xlink:to="loc_elv_GrossPremiumTaxRate_3a9a70da-91f3-4992-bb90-c21fe72ee699" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_03ad3bfb-c004-484d-970e-ab0ab0e6af64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_CommitmentsAndContingenciesLineItems_26c04cc8-19b3-4729-a4e3-1f8a89e0554d" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_03ad3bfb-c004-484d-970e-ab0ab0e6af64" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_bfddbc38-4b56-4a33-b772-3740741929ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_CommitmentsAndContingenciesLineItems_26c04cc8-19b3-4729-a4e3-1f8a89e0554d" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_bfddbc38-4b56-4a33-b772-3740741929ca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount_58677f7a-9026-4afc-95db-73b1aa3fa2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_CommitmentsAndContingenciesLineItems_26c04cc8-19b3-4729-a4e3-1f8a89e0554d" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentAmount_58677f7a-9026-4afc-95db-73b1aa3fa2ef" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommitmentsAndContingenciesTable_bfe48700-6c7c-4684-8317-1d8422cd5eb8" xlink:href="elv-20220930.xsd#elv_CommitmentsAndContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_elv_CommitmentsAndContingenciesLineItems_26c04cc8-19b3-4729-a4e3-1f8a89e0554d" xlink:to="loc_elv_CommitmentsAndContingenciesTable_bfe48700-6c7c-4684-8317-1d8422cd5eb8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_a3cf0afc-5fc9-4f24-bffa-cd6363f3aa7f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_elv_CommitmentsAndContingenciesTable_bfe48700-6c7c-4684-8317-1d8422cd5eb8" xlink:to="loc_srt_LitigationCaseAxis_a3cf0afc-5fc9-4f24-bffa-cd6363f3aa7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a3cf0afc-5fc9-4f24-bffa-cd6363f3aa7f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_a3cf0afc-5fc9-4f24-bffa-cd6363f3aa7f" xlink:to="loc_srt_LitigationCaseTypeDomain_a3cf0afc-5fc9-4f24-bffa-cd6363f3aa7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_c7fcbb19-fcdb-49c5-9503-5d4e30bbde6a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_a3cf0afc-5fc9-4f24-bffa-cd6363f3aa7f" xlink:to="loc_srt_LitigationCaseTypeDomain_c7fcbb19-fcdb-49c5-9503-5d4e30bbde6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_BCBSAntitrustLitigationMember_6afa8abe-23af-49ce-9958-dc0ff122015d" xlink:href="elv-20220930.xsd#elv_BCBSAntitrustLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c7fcbb19-fcdb-49c5-9503-5d4e30bbde6a" xlink:to="loc_elv_BCBSAntitrustLitigationMember_6afa8abe-23af-49ce-9958-dc0ff122015d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_AnthemInc.v.ExpressScriptsInc.Member_374651c0-c890-4abf-806d-96bae73bc67d" xlink:href="elv-20220930.xsd#elv_AnthemInc.v.ExpressScriptsInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c7fcbb19-fcdb-49c5-9503-5d4e30bbde6a" xlink:to="loc_elv_AnthemInc.v.ExpressScriptsInc.Member_374651c0-c890-4abf-806d-96bae73bc67d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8ac4e041-860b-492d-858e-4485c3e2f84b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_elv_CommitmentsAndContingenciesTable_bfe48700-6c7c-4684-8317-1d8422cd5eb8" xlink:to="loc_srt_RangeAxis_8ac4e041-860b-492d-858e-4485c3e2f84b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8ac4e041-860b-492d-858e-4485c3e2f84b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_8ac4e041-860b-492d-858e-4485c3e2f84b" xlink:to="loc_srt_RangeMember_8ac4e041-860b-492d-858e-4485c3e2f84b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_616d713d-452c-40ea-8bff-79a701441324" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_8ac4e041-860b-492d-858e-4485c3e2f84b" xlink:to="loc_srt_RangeMember_616d713d-452c-40ea-8bff-79a701441324" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_51fe1163-96ba-4567-9697-da248ab2bec7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_616d713d-452c-40ea-8bff-79a701441324" xlink:to="loc_srt_MinimumMember_51fe1163-96ba-4567-9697-da248ab2bec7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e1656412-1ef0-4f22-b442-63038bbc258b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_616d713d-452c-40ea-8bff-79a701441324" xlink:to="loc_srt_MaximumMember_e1656412-1ef0-4f22-b442-63038bbc258b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_525286d0-1d73-4f15-b9e3-92422f57e76e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_elv_CommitmentsAndContingenciesTable_bfe48700-6c7c-4684-8317-1d8422cd5eb8" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_525286d0-1d73-4f15-b9e3-92422f57e76e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_525286d0-1d73-4f15-b9e3-92422f57e76e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_525286d0-1d73-4f15-b9e3-92422f57e76e" xlink:to="loc_us-gaap_LossContingencyNatureDomain_525286d0-1d73-4f15-b9e3-92422f57e76e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_d7ecdaf3-b8cb-40aa-ad22-2597a7fbf937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_525286d0-1d73-4f15-b9e3-92422f57e76e" xlink:to="loc_us-gaap_LossContingencyNatureDomain_d7ecdaf3-b8cb-40aa-ad22-2597a7fbf937" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesByNatureAxis_e11264f0-66fc-45d1-ae5c-56fb241a052f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainContingenciesByNatureAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_elv_CommitmentsAndContingenciesTable_bfe48700-6c7c-4684-8317-1d8422cd5eb8" xlink:to="loc_us-gaap_GainContingenciesByNatureAxis_e11264f0-66fc-45d1-ae5c-56fb241a052f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyNatureDomain_e11264f0-66fc-45d1-ae5c-56fb241a052f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GainContingenciesByNatureAxis_e11264f0-66fc-45d1-ae5c-56fb241a052f" xlink:to="loc_us-gaap_GainContingencyNatureDomain_e11264f0-66fc-45d1-ae5c-56fb241a052f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyNatureDomain_7e864c88-ebe5-40d3-8dbc-991ceb1ff70b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GainContingenciesByNatureAxis_e11264f0-66fc-45d1-ae5c-56fb241a052f" xlink:to="loc_us-gaap_GainContingencyNatureDomain_7e864c88-ebe5-40d3-8dbc-991ceb1ff70b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_PharmacypricingMember_e8bef918-0ba0-4acf-96ab-ba28a15298c1" xlink:href="elv-20220930.xsd#elv_PharmacypricingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingencyNatureDomain_7e864c88-ebe5-40d3-8dbc-991ceb1ff70b" xlink:to="loc_elv_PharmacypricingMember_e8bef918-0ba0-4acf-96ab-ba28a15298c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OperationalMember_a78e8d96-a328-4e30-8cfa-fd793555a806" xlink:href="elv-20220930.xsd#elv_OperationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingencyNatureDomain_7e864c88-ebe5-40d3-8dbc-991ceb1ff70b" xlink:to="loc_elv_OperationalMember_a78e8d96-a328-4e30-8cfa-fd793555a806" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/CapitalStockSummaryofShareRepurchasesDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#CapitalStockSummaryofShareRepurchasesDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/CapitalStockSummaryofShareRepurchasesDetails" xlink:type="extended" id="i8b50f79255464a3f802b482b854a6973_CapitalStockSummaryofShareRepurchasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_dc6f833a-84d8-41b8-9a5f-8a04f7f9dea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_8af0e294-c093-4888-b02f-19b6131bbb3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_dc6f833a-84d8-41b8-9a5f-8a04f7f9dea4" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_8af0e294-c093-4888-b02f-19b6131bbb3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_StockRepurchasedAndRetiredDuringPeriodAveragePrice_68f33b50-cf11-49b1-8904-9a189059c7f8" xlink:href="elv-20220930.xsd#elv_StockRepurchasedAndRetiredDuringPeriodAveragePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_dc6f833a-84d8-41b8-9a5f-8a04f7f9dea4" xlink:to="loc_elv_StockRepurchasedAndRetiredDuringPeriodAveragePrice_68f33b50-cf11-49b1-8904-9a189059c7f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_9bab3618-588b-4f5a-9f8f-b69bcd6d39de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_dc6f833a-84d8-41b8-9a5f-8a04f7f9dea4" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_9bab3618-588b-4f5a-9f8f-b69bcd6d39de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_791f0111-68b0-4772-8bd9-7eeda05fcc46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_dc6f833a-84d8-41b8-9a5f-8a04f7f9dea4" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_791f0111-68b0-4772-8bd9-7eeda05fcc46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_055bccf1-7ac7-4450-8855-cd540839c8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_dc6f833a-84d8-41b8-9a5f-8a04f7f9dea4" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_055bccf1-7ac7-4450-8855-cd540839c8a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_712ea047-08ae-4491-b98c-48267fa0dea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_055bccf1-7ac7-4450-8855-cd540839c8a5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_712ea047-08ae-4491-b98c-48267fa0dea8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_712ea047-08ae-4491-b98c-48267fa0dea8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_712ea047-08ae-4491-b98c-48267fa0dea8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_712ea047-08ae-4491-b98c-48267fa0dea8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_061b5282-e96d-4afe-ac9c-9b9cb7085558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_712ea047-08ae-4491-b98c-48267fa0dea8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_061b5282-e96d-4afe-ac9c-9b9cb7085558" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e30cbc44-2bbb-4d80-a759-869597c0749b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_061b5282-e96d-4afe-ac9c-9b9cb7085558" xlink:to="loc_us-gaap_SubsequentEventMember_e30cbc44-2bbb-4d80-a759-869597c0749b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b56d08b2-9025-4600-ad5d-ad85aa086fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_055bccf1-7ac7-4450-8855-cd540839c8a5" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b56d08b2-9025-4600-ad5d-ad85aa086fb6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b56d08b2-9025-4600-ad5d-ad85aa086fb6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b56d08b2-9025-4600-ad5d-ad85aa086fb6" xlink:to="loc_us-gaap_ClassOfStockDomain_b56d08b2-9025-4600-ad5d-ad85aa086fb6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f54617fb-ccd5-4d9b-9b91-675244a23d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b56d08b2-9025-4600-ad5d-ad85aa086fb6" xlink:to="loc_us-gaap_ClassOfStockDomain_f54617fb-ccd5-4d9b-9b91-675244a23d3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_97105904-8700-40a2-9be2-9ca3c2cb3d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_055bccf1-7ac7-4450-8855-cd540839c8a5" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_97105904-8700-40a2-9be2-9ca3c2cb3d96" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_97105904-8700-40a2-9be2-9ca3c2cb3d96_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_97105904-8700-40a2-9be2-9ca3c2cb3d96" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_97105904-8700-40a2-9be2-9ca3c2cb3d96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_ffbf02a3-37ee-4f3e-8d36-6e3d7f619e92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_97105904-8700-40a2-9be2-9ca3c2cb3d96" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_ffbf02a3-37ee-4f3e-8d36-6e3d7f619e92" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/CapitalStockNarrativeDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#CapitalStockNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/CapitalStockNarrativeDetails" xlink:type="extended" id="i0042492f5bde4dd7b338aea2924982b0_CapitalStockNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_06dd5f1d-9b6e-4aac-9204-1cfa6c195eee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b1097883-579d-47b6-aa4b-466255229422" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_06dd5f1d-9b6e-4aac-9204-1cfa6c195eee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b1097883-579d-47b6-aa4b-466255229422" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_98ce308e-d06d-48b4-9b15-04ee2b2921bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_06dd5f1d-9b6e-4aac-9204-1cfa6c195eee" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_98ce308e-d06d-48b4-9b15-04ee2b2921bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_d92ec6a0-9707-49c5-be69-565b18ea7d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_06dd5f1d-9b6e-4aac-9204-1cfa6c195eee" xlink:to="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_d92ec6a0-9707-49c5-be69-565b18ea7d85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_6c1fa8d0-eb11-4d20-af4b-241afeaf769e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_06dd5f1d-9b6e-4aac-9204-1cfa6c195eee" xlink:to="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_6c1fa8d0-eb11-4d20-af4b-241afeaf769e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IncreaseInStockRepurchaseProgramAuthorization_3ea368d9-aacb-4629-82b0-b0f557d11416" xlink:href="elv-20220930.xsd#elv_IncreaseInStockRepurchaseProgramAuthorization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_06dd5f1d-9b6e-4aac-9204-1cfa6c195eee" xlink:to="loc_elv_IncreaseInStockRepurchaseProgramAuthorization_3ea368d9-aacb-4629-82b0-b0f557d11416" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_c4478cea-536d-4a33-b477-9a54c3cb5ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_06dd5f1d-9b6e-4aac-9204-1cfa6c195eee" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_c4478cea-536d-4a33-b477-9a54c3cb5ecc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_PerformancemeasurementperiodAxis_dcee94c3-0ad9-442d-a19a-31e17a2eeafb" xlink:href="elv-20220930.xsd#elv_PerformancemeasurementperiodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_c4478cea-536d-4a33-b477-9a54c3cb5ecc" xlink:to="loc_elv_PerformancemeasurementperiodAxis_dcee94c3-0ad9-442d-a19a-31e17a2eeafb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_PerformanceMeasurementPeriodDomain_dcee94c3-0ad9-442d-a19a-31e17a2eeafb_default" xlink:href="elv-20220930.xsd#elv_PerformanceMeasurementPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_elv_PerformancemeasurementperiodAxis_dcee94c3-0ad9-442d-a19a-31e17a2eeafb" xlink:to="loc_elv_PerformanceMeasurementPeriodDomain_dcee94c3-0ad9-442d-a19a-31e17a2eeafb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_PerformanceMeasurementPeriodDomain_e670e2c7-6b7c-476e-9af1-0792ad768d20" xlink:href="elv-20220930.xsd#elv_PerformanceMeasurementPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_elv_PerformancemeasurementperiodAxis_dcee94c3-0ad9-442d-a19a-31e17a2eeafb" xlink:to="loc_elv_PerformanceMeasurementPeriodDomain_e670e2c7-6b7c-476e-9af1-0792ad768d20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_A2022To2024Member_887a2fa0-8ffd-4583-abd8-6ea143d8451c" xlink:href="elv-20220930.xsd#elv_A2022To2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_PerformanceMeasurementPeriodDomain_e670e2c7-6b7c-476e-9af1-0792ad768d20" xlink:to="loc_elv_A2022To2024Member_887a2fa0-8ffd-4583-abd8-6ea143d8451c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_74970312-b96c-4c91-8bdb-09b922000388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_c4478cea-536d-4a33-b477-9a54c3cb5ecc" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_74970312-b96c-4c91-8bdb-09b922000388" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_74970312-b96c-4c91-8bdb-09b922000388_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_74970312-b96c-4c91-8bdb-09b922000388" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_74970312-b96c-4c91-8bdb-09b922000388_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a8795ac1-cb74-4558-bc1a-f7bcf692125c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_74970312-b96c-4c91-8bdb-09b922000388" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a8795ac1-cb74-4558-bc1a-f7bcf692125c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_98749011-6274-4545-950d-06a0079e1144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a8795ac1-cb74-4558-bc1a-f7bcf692125c" xlink:to="loc_us-gaap_SubsequentEventMember_98749011-6274-4545-950d-06a0079e1144" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ecf07c51-d6f3-4c23-840d-4a0bfbcfc59f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_c4478cea-536d-4a33-b477-9a54c3cb5ecc" xlink:to="loc_us-gaap_DebtInstrumentAxis_ecf07c51-d6f3-4c23-840d-4a0bfbcfc59f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ecf07c51-d6f3-4c23-840d-4a0bfbcfc59f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ecf07c51-d6f3-4c23-840d-4a0bfbcfc59f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ecf07c51-d6f3-4c23-840d-4a0bfbcfc59f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ab9a7d64-9311-4ea5-aedb-42e72312501d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ecf07c51-d6f3-4c23-840d-4a0bfbcfc59f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ab9a7d64-9311-4ea5-aedb-42e72312501d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_74864c2c-7ce1-4559-9b05-1018ac0f9e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_c4478cea-536d-4a33-b477-9a54c3cb5ecc" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_74864c2c-7ce1-4559-9b05-1018ac0f9e1b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_74864c2c-7ce1-4559-9b05-1018ac0f9e1b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_74864c2c-7ce1-4559-9b05-1018ac0f9e1b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_74864c2c-7ce1-4559-9b05-1018ac0f9e1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2ec4097f-e380-4f46-a7d9-9ddde792163b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_74864c2c-7ce1-4559-9b05-1018ac0f9e1b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2ec4097f-e380-4f46-a7d9-9ddde792163b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_6c33de8b-2721-4584-b7d5-82988cb34150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_c4478cea-536d-4a33-b477-9a54c3cb5ecc" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_6c33de8b-2721-4584-b7d5-82988cb34150" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_6c33de8b-2721-4584-b7d5-82988cb34150_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_6c33de8b-2721-4584-b7d5-82988cb34150" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_6c33de8b-2721-4584-b7d5-82988cb34150_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_c50a3a49-fa20-4c5d-8e03-d4708df14550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_6c33de8b-2721-4584-b7d5-82988cb34150" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_c50a3a49-fa20-4c5d-8e03-d4708df14550" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_d641abad-fa5d-4539-a078-9bf84169a83e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_c4478cea-536d-4a33-b477-9a54c3cb5ecc" xlink:to="loc_us-gaap_PositionAxis_d641abad-fa5d-4539-a078-9bf84169a83e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_d641abad-fa5d-4539-a078-9bf84169a83e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_d641abad-fa5d-4539-a078-9bf84169a83e" xlink:to="loc_us-gaap_PositionDomain_d641abad-fa5d-4539-a078-9bf84169a83e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_d6f54feb-635b-4356-be13-d2da662d9a84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_d641abad-fa5d-4539-a078-9bf84169a83e" xlink:to="loc_us-gaap_PositionDomain_d6f54feb-635b-4356-be13-d2da662d9a84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3fde2f4f-2a3d-4d48-a845-8c38829da9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_c4478cea-536d-4a33-b477-9a54c3cb5ecc" xlink:to="loc_us-gaap_AwardTypeAxis_3fde2f4f-2a3d-4d48-a845-8c38829da9c6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3fde2f4f-2a3d-4d48-a845-8c38829da9c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_3fde2f4f-2a3d-4d48-a845-8c38829da9c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3fde2f4f-2a3d-4d48-a845-8c38829da9c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_26e53a20-30b9-4f5f-9d35-b35ad6b24b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_3fde2f4f-2a3d-4d48-a845-8c38829da9c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_26e53a20-30b9-4f5f-9d35-b35ad6b24b0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_bd3ee45c-48e1-41ec-b06d-a107f9b9cc83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_26e53a20-30b9-4f5f-9d35-b35ad6b24b0f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_bd3ee45c-48e1-41ec-b06d-a107f9b9cc83" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails" xlink:type="extended" id="i1033d7601ecc4584a4a9f474f440e8a7_AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c544a9ec-bcc5-4f49-bc12-b6e52a0ee83b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c544a9ec-bcc5-4f49-bc12-b6e52a0ee83b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_692d6005-dd83-4466-a078-96f4f5d36c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_692d6005-dd83-4466-a078-96f4f5d36c3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4de42af0-9569-4df0-9653-4051a42d5f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4de42af0-9569-4df0-9653-4051a42d5f1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_8a54b1b4-88dd-4c26-aa03-2687b5d84a64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_8a54b1b4-88dd-4c26-aa03-2687b5d84a64" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_c5f9bd5d-d28e-405e-9136-ae28b3569f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_c5f9bd5d-d28e-405e-9136-ae28b3569f63" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_fea4d5ed-dff0-49c4-b0f6-bea4a6de35b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_fea4d5ed-dff0-49c4-b0f6-bea4a6de35b3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_669a3633-4db4-41ff-aa0f-aee048242fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax_e558493a-a8aa-4f61-8767-51231d72ae6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax_e558493a-a8aa-4f61-8767-51231d72ae6b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_af13b640-a61d-4925-b887-f888dbd2f950" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_af13b640-a61d-4925-b887-f888dbd2f950" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities_b617e3ee-babf-4009-bfa4-e7ddd733a36e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities_b617e3ee-babf-4009-bfa4-e7ddd733a36e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities_f40f5cf5-00bd-41d8-b8dc-4823165b3928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities_f40f5cf5-00bd-41d8-b8dc-4823165b3928" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities_1f261762-ad12-4db2-ad9c-6ac1ef921bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss_6c5a70f0-1139-4bef-8f49-0e516235d002" xlink:href="elv-20220930.xsd#elv_Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_elv_Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss_6c5a70f0-1139-4bef-8f49-0e516235d002" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_14de35ee-31bd-44a5-88c6-3dcc125aad66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_14de35ee-31bd-44a5-88c6-3dcc125aad66" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b7021d71-492b-430f-a144-249f852afad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b7021d71-492b-430f-a144-249f852afad9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_7388082f-301e-4dc8-8b50-cca108698cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_a9bd63ca-609a-47da-a203-8a4dd58b5ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_a9bd63ca-609a-47da-a203-8a4dd58b5ffd" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_bc5fcd04-566a-4c31-ba71-d62b8dce2178" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_bc5fcd04-566a-4c31-ba71-d62b8dce2178" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_b0582cbf-0e13-45b3-930c-0ff382d85c88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_b0582cbf-0e13-45b3-930c-0ff382d85c88" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_b725e8a4-1efa-4d38-aaa8-41b96ce08b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense_a75197ed-60ca-4d3e-bea9-6cab17c019c5" xlink:href="elv-20220930.xsd#elv_OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_elv_OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense_a75197ed-60ca-4d3e-bea9-6cab17c019c5" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_6a9cb808-f0d2-49bd-b1e2-a327ff5533ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_6a9cb808-f0d2-49bd-b1e2-a327ff5533ab" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_080f8ee0-d973-4cbf-8ef7-3f0956b19cac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_080f8ee0-d973-4cbf-8ef7-3f0956b19cac" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_fd741b6d-c152-458e-b436-11395b2d0644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_a500c8e5-11f1-4e33-b41c-02023bb5c612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_a500c8e5-11f1-4e33-b41c-02023bb5c612" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9536678e-3ddf-4901-b16c-ae093b4d90d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9536678e-3ddf-4901-b16c-ae093b4d90d0" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_da03e171-37d1-4bfa-9881-7aeb05571216" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_bda8ea83-8ac9-4f26-a97e-0d91542fe5e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_bda8ea83-8ac9-4f26-a97e-0d91542fe5e4" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest_d5188fd8-44d0-4550-b990-da2fb2ab8137" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest_d5188fd8-44d0-4550-b990-da2fb2ab8137" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a23afd70-28f1-415e-bae7-028778bcfbf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_StatementTable_a23afd70-28f1-415e-bae7-028778bcfbf6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_93238a19-2fec-4f2a-b5a8-a9f0a6a57fff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a23afd70-28f1-415e-bae7-028778bcfbf6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_93238a19-2fec-4f2a-b5a8-a9f0a6a57fff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_93238a19-2fec-4f2a-b5a8-a9f0a6a57fff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_93238a19-2fec-4f2a-b5a8-a9f0a6a57fff" xlink:to="loc_us-gaap_EquityComponentDomain_93238a19-2fec-4f2a-b5a8-a9f0a6a57fff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_52f65eba-636a-47d2-8524-5017a160f800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_93238a19-2fec-4f2a-b5a8-a9f0a6a57fff" xlink:to="loc_us-gaap_EquityComponentDomain_52f65eba-636a-47d2-8524-5017a160f800" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_87244f78-65a2-48a7-9372-6dc0ec8cee18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_52f65eba-636a-47d2-8524-5017a160f800" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_87244f78-65a2-48a7-9372-6dc0ec8cee18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_NonCreditComponentsOfImpairmentsOnInvestmentsMember_ceec4514-a25d-48df-88ae-630df8203fc3" xlink:href="elv-20220930.xsd#elv_NonCreditComponentsOfImpairmentsOnInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_52f65eba-636a-47d2-8524-5017a160f800" xlink:to="loc_elv_NonCreditComponentsOfImpairmentsOnInvestmentsMember_ceec4514-a25d-48df-88ae-630df8203fc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_0f30d0c8-6b71-45d7-b6b1-c5734cf5ca04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_52f65eba-636a-47d2-8524-5017a160f800" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_0f30d0c8-6b71-45d7-b6b1-c5734cf5ca04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_5d70240c-6bdc-4739-9b74-17764aa5e55d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_52f65eba-636a-47d2-8524-5017a160f800" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_5d70240c-6bdc-4739-9b74-17764aa5e55d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_00626606-98b4-4978-aff8-9991effd8796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_52f65eba-636a-47d2-8524-5017a160f800" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_00626606-98b4-4978-aff8-9991effd8796" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EarningsPerShareNarrativeDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#EarningsPerShareNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/EarningsPerShareNarrativeDetails" xlink:type="extended" id="i44421e4ba99140cf8127c617ee9dbde8_EarningsPerShareNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ab614b42-baaa-40ad-8d74-10baaca32cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_64acac35-22bb-4002-aec9-02a1438cc7ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ab614b42-baaa-40ad-8d74-10baaca32cec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_64acac35-22bb-4002-aec9-02a1438cc7ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults_049a76e2-754c-449e-a74f-e8706a92e101" xlink:href="elv-20220930.xsd#elv_PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ab614b42-baaa-40ad-8d74-10baaca32cec" xlink:to="loc_elv_PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults_049a76e2-754c-449e-a74f-e8706a92e101" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d786fa16-9ccf-430c-8253-99e09e5160a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ab614b42-baaa-40ad-8d74-10baaca32cec" xlink:to="loc_us-gaap_StatementTable_d786fa16-9ccf-430c-8253-99e09e5160a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_PerformancemeasurementperiodAxis_3745b151-3595-42d6-8805-59b27142f54f" xlink:href="elv-20220930.xsd#elv_PerformancemeasurementperiodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_d786fa16-9ccf-430c-8253-99e09e5160a5" xlink:to="loc_elv_PerformancemeasurementperiodAxis_3745b151-3595-42d6-8805-59b27142f54f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_PerformanceMeasurementPeriodDomain_3745b151-3595-42d6-8805-59b27142f54f_default" xlink:href="elv-20220930.xsd#elv_PerformanceMeasurementPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_elv_PerformancemeasurementperiodAxis_3745b151-3595-42d6-8805-59b27142f54f" xlink:to="loc_elv_PerformanceMeasurementPeriodDomain_3745b151-3595-42d6-8805-59b27142f54f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_PerformanceMeasurementPeriodDomain_038ec4fa-955f-4889-a40a-299124d63304" xlink:href="elv-20220930.xsd#elv_PerformanceMeasurementPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_elv_PerformancemeasurementperiodAxis_3745b151-3595-42d6-8805-59b27142f54f" xlink:to="loc_elv_PerformanceMeasurementPeriodDomain_038ec4fa-955f-4889-a40a-299124d63304" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_A2022To2024Member_f2b95082-d978-490e-af74-d3e2ea8e54de" xlink:href="elv-20220930.xsd#elv_A2022To2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_PerformanceMeasurementPeriodDomain_038ec4fa-955f-4889-a40a-299124d63304" xlink:to="loc_elv_A2022To2024Member_f2b95082-d978-490e-af74-d3e2ea8e54de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_A2021To2023Member_aaf4fe9f-2971-4628-955c-b52649618bc0" xlink:href="elv-20220930.xsd#elv_A2021To2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_PerformanceMeasurementPeriodDomain_038ec4fa-955f-4889-a40a-299124d63304" xlink:to="loc_elv_A2021To2023Member_aaf4fe9f-2971-4628-955c-b52649618bc0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#SegmentInformationFinancialDataByReportableSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails" xlink:type="extended" id="id5dc1bb1a630449c80c2a824e0d6f304_SegmentInformationFinancialDataByReportableSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_4723fa7f-c328-4c96-8567-0ca0bfc3cefd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceServicesRevenue_5b4c7bf1-48ef-4a0d-a91d-a04fc9162a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceServicesRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4723fa7f-c328-4c96-8567-0ca0bfc3cefd" xlink:to="loc_us-gaap_InsuranceServicesRevenue_5b4c7bf1-48ef-4a0d-a91d-a04fc9162a1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_eee995ea-349c-4b4f-8d40-be0ffc8bffe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4723fa7f-c328-4c96-8567-0ca0bfc3cefd" xlink:to="loc_us-gaap_OperatingIncomeLoss_eee995ea-349c-4b4f-8d40-be0ffc8bffe5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_31af6364-840a-438a-815c-60acff20f8ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4723fa7f-c328-4c96-8567-0ca0bfc3cefd" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_31af6364-840a-438a-815c-60acff20f8ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_a13e822e-f3f9-4145-9d93-b05a4b774e00" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_31af6364-840a-438a-815c-60acff20f8ad" xlink:to="loc_srt_MajorCustomersAxis_a13e822e-f3f9-4145-9d93-b05a4b774e00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_a13e822e-f3f9-4145-9d93-b05a4b774e00_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_a13e822e-f3f9-4145-9d93-b05a4b774e00" xlink:to="loc_srt_NameOfMajorCustomerDomain_a13e822e-f3f9-4145-9d93-b05a4b774e00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_1cfda6ff-74a2-41da-bf13-9bede8c5514c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_a13e822e-f3f9-4145-9d93-b05a4b774e00" xlink:to="loc_srt_NameOfMajorCustomerDomain_1cfda6ff-74a2-41da-bf13-9bede8c5514c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_UnaffiliatedMember_e7869bec-637e-4068-83e6-e5d7a4276f20" xlink:href="elv-20220930.xsd#elv_UnaffiliatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_1cfda6ff-74a2-41da-bf13-9bede8c5514c" xlink:to="loc_elv_UnaffiliatedMember_e7869bec-637e-4068-83e6-e5d7a4276f20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_AffiliatedMember_865b0e4f-b90d-44d2-9d26-effc0e457d95" xlink:href="elv-20220930.xsd#elv_AffiliatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_1cfda6ff-74a2-41da-bf13-9bede8c5514c" xlink:to="loc_elv_AffiliatedMember_865b0e4f-b90d-44d2-9d26-effc0e457d95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_0e7d4f94-59c1-478c-bd02-a5fed193bd0b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_31af6364-840a-438a-815c-60acff20f8ad" xlink:to="loc_srt_ConsolidatedEntitiesAxis_0e7d4f94-59c1-478c-bd02-a5fed193bd0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_0e7d4f94-59c1-478c-bd02-a5fed193bd0b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_0e7d4f94-59c1-478c-bd02-a5fed193bd0b" xlink:to="loc_srt_ConsolidatedEntitiesDomain_0e7d4f94-59c1-478c-bd02-a5fed193bd0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_f0268e55-99dd-43ee-be20-7a2c701adb4b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_0e7d4f94-59c1-478c-bd02-a5fed193bd0b" xlink:to="loc_srt_ConsolidatedEntitiesDomain_f0268e55-99dd-43ee-be20-7a2c701adb4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommercialSpecialtyMember_8aa81326-a68c-4930-9b74-786e18627aae" xlink:href="elv-20220930.xsd#elv_CommercialSpecialtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_f0268e55-99dd-43ee-be20-7a2c701adb4b" xlink:to="loc_elv_CommercialSpecialtyMember_8aa81326-a68c-4930-9b74-786e18627aae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GovernmentBusinessSegmentMember_d6c2163f-47a1-4c93-b050-70f7f252b795" xlink:href="elv-20220930.xsd#elv_GovernmentBusinessSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_f0268e55-99dd-43ee-be20-7a2c701adb4b" xlink:to="loc_elv_GovernmentBusinessSegmentMember_d6c2163f-47a1-4c93-b050-70f7f252b795" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IngenioRxSegmentMember_fa0e1e2c-acab-470a-b46d-924afcdd48a2" xlink:href="elv-20220930.xsd#elv_IngenioRxSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_f0268e55-99dd-43ee-be20-7a2c701adb4b" xlink:to="loc_elv_IngenioRxSegmentMember_fa0e1e2c-acab-470a-b46d-924afcdd48a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherSegmentMember_944a7c65-6407-40e9-b2cf-7ccf4024d689" xlink:href="elv-20220930.xsd#elv_OtherSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_f0268e55-99dd-43ee-be20-7a2c701adb4b" xlink:to="loc_elv_OtherSegmentMember_944a7c65-6407-40e9-b2cf-7ccf4024d689" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_c8a9ab73-2b18-4f1c-aa63-0193cb38cc31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_f0268e55-99dd-43ee-be20-7a2c701adb4b" xlink:to="loc_us-gaap_IntersegmentEliminationMember_c8a9ab73-2b18-4f1c-aa63-0193cb38cc31" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d3538254-37ab-4901-8b4a-cf24c2c7ab3b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_31af6364-840a-438a-815c-60acff20f8ad" xlink:to="loc_srt_ProductOrServiceAxis_d3538254-37ab-4901-8b4a-cf24c2c7ab3b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d3538254-37ab-4901-8b4a-cf24c2c7ab3b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d3538254-37ab-4901-8b4a-cf24c2c7ab3b" xlink:to="loc_srt_ProductsAndServicesDomain_d3538254-37ab-4901-8b4a-cf24c2c7ab3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2c7d6e4e-b4a2-43ef-8c24-a1ef684b7e6b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d3538254-37ab-4901-8b4a-cf24c2c7ab3b" xlink:to="loc_srt_ProductsAndServicesDomain_2c7d6e4e-b4a2-43ef-8c24-a1ef684b7e6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommercialSpecialtyMember_ff5a4ee0-6e1d-44ec-a107-fab57844e5b5" xlink:href="elv-20220930.xsd#elv_CommercialSpecialtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2c7d6e4e-b4a2-43ef-8c24-a1ef684b7e6b" xlink:to="loc_elv_CommercialSpecialtyMember_ff5a4ee0-6e1d-44ec-a107-fab57844e5b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GovernmentBusinessSegmentMember_c037a3c6-b797-4ca8-acd0-7c00361e5251" xlink:href="elv-20220930.xsd#elv_GovernmentBusinessSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2c7d6e4e-b4a2-43ef-8c24-a1ef684b7e6b" xlink:to="loc_elv_GovernmentBusinessSegmentMember_c037a3c6-b797-4ca8-acd0-7c00361e5251" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IngenioRxSegmentMember_61575e8d-9361-4e2a-abe7-0c3a5d45f900" xlink:href="elv-20220930.xsd#elv_IngenioRxSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2c7d6e4e-b4a2-43ef-8c24-a1ef684b7e6b" xlink:to="loc_elv_IngenioRxSegmentMember_61575e8d-9361-4e2a-abe7-0c3a5d45f900" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherSegmentMember_4f91e1cf-3df3-4e56-a730-8f638d5fa7a0" xlink:href="elv-20220930.xsd#elv_OtherSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2c7d6e4e-b4a2-43ef-8c24-a1ef684b7e6b" xlink:to="loc_elv_OtherSegmentMember_4f91e1cf-3df3-4e56-a730-8f638d5fa7a0" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails" xlink:type="extended" id="i518cd021d32f42cf8ba9d78cea3a37a3_SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_elv_MajorProductRevenueBySegmentLineItems_64d28779-4237-4d2f-9a70-68b05e28a0a7" xlink:href="elv-20220930.xsd#elv_MajorProductRevenueBySegmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceServicesRevenue_10322291-b0b9-46a8-a946-6eef152bdf25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceServicesRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_MajorProductRevenueBySegmentLineItems_64d28779-4237-4d2f-9a70-68b05e28a0a7" xlink:to="loc_us-gaap_InsuranceServicesRevenue_10322291-b0b9-46a8-a946-6eef152bdf25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_MajorProductRevenueBySegmentTable_cfd654f2-3651-42a3-958d-881ad35343a3" xlink:href="elv-20220930.xsd#elv_MajorProductRevenueBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_elv_MajorProductRevenueBySegmentLineItems_64d28779-4237-4d2f-9a70-68b05e28a0a7" xlink:to="loc_elv_MajorProductRevenueBySegmentTable_cfd654f2-3651-42a3-958d-881ad35343a3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3a124dc6-1d93-4df9-b9bb-7dea6883a5b2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_elv_MajorProductRevenueBySegmentTable_cfd654f2-3651-42a3-958d-881ad35343a3" xlink:to="loc_srt_ProductOrServiceAxis_3a124dc6-1d93-4df9-b9bb-7dea6883a5b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3a124dc6-1d93-4df9-b9bb-7dea6883a5b2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_3a124dc6-1d93-4df9-b9bb-7dea6883a5b2" xlink:to="loc_srt_ProductsAndServicesDomain_3a124dc6-1d93-4df9-b9bb-7dea6883a5b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_50fef059-533e-48c3-b703-2d9e8509fd09" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_3a124dc6-1d93-4df9-b9bb-7dea6883a5b2" xlink:to="loc_srt_ProductsAndServicesDomain_50fef059-533e-48c3-b703-2d9e8509fd09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ManagedCareProductsMember_30b47000-1cf1-46ce-950a-543af826999c" xlink:href="elv-20220930.xsd#elv_ManagedCareProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_50fef059-533e-48c3-b703-2d9e8509fd09" xlink:to="loc_elv_ManagedCareProductsMember_30b47000-1cf1-46ce-950a-543af826999c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ManagedCareServicesMember_ffca0060-7cfc-455e-b380-886a32a7e9fb" xlink:href="elv-20220930.xsd#elv_ManagedCareServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_50fef059-533e-48c3-b703-2d9e8509fd09" xlink:to="loc_elv_ManagedCareServicesMember_ffca0060-7cfc-455e-b380-886a32a7e9fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_DentalVisionProductsAndServicesMember_89149e65-56e7-4a2a-bfc2-895be2623db9" xlink:href="elv-20220930.xsd#elv_DentalVisionProductsAndServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_50fef059-533e-48c3-b703-2d9e8509fd09" xlink:to="loc_elv_DentalVisionProductsAndServicesMember_89149e65-56e7-4a2a-bfc2-895be2623db9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherProductsMember_d06f0a3e-213f-422f-b738-ed203dde07b4" xlink:href="elv-20220930.xsd#elv_OtherProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_50fef059-533e-48c3-b703-2d9e8509fd09" xlink:to="loc_elv_OtherProductsMember_d06f0a3e-213f-422f-b738-ed203dde07b4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_PharmacyproductsandservicesMember_c0226028-efbe-4d27-b448-87a2033dca41" xlink:href="elv-20220930.xsd#elv_PharmacyproductsandservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_50fef059-533e-48c3-b703-2d9e8509fd09" xlink:to="loc_elv_PharmacyproductsandservicesMember_c0226028-efbe-4d27-b448-87a2033dca41" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IntegratedHealthServicesMember_69c91b2e-f820-45a9-a39f-8cbf86db0455" xlink:href="elv-20220930.xsd#elv_IntegratedHealthServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_50fef059-533e-48c3-b703-2d9e8509fd09" xlink:to="loc_elv_IntegratedHealthServicesMember_69c91b2e-f820-45a9-a39f-8cbf86db0455" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c266b844-3b6d-49a7-a091-5a54bb440af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_elv_MajorProductRevenueBySegmentTable_cfd654f2-3651-42a3-958d-881ad35343a3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c266b844-3b6d-49a7-a091-5a54bb440af0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c266b844-3b6d-49a7-a091-5a54bb440af0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c266b844-3b6d-49a7-a091-5a54bb440af0" xlink:to="loc_us-gaap_SegmentDomain_c266b844-3b6d-49a7-a091-5a54bb440af0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fe639378-0199-4ea0-aae7-bc9a7483db8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c266b844-3b6d-49a7-a091-5a54bb440af0" xlink:to="loc_us-gaap_SegmentDomain_fe639378-0199-4ea0-aae7-bc9a7483db8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommercialSpecialtyBusinessSegmentMember_3207e427-da9f-45be-9e53-077650e3fd09" xlink:href="elv-20220930.xsd#elv_CommercialSpecialtyBusinessSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fe639378-0199-4ea0-aae7-bc9a7483db8d" xlink:to="loc_elv_CommercialSpecialtyBusinessSegmentMember_3207e427-da9f-45be-9e53-077650e3fd09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GovernmentBusinessSegmentMember_efcff626-37c7-4311-a83b-b5b2c6a04e06" xlink:href="elv-20220930.xsd#elv_GovernmentBusinessSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fe639378-0199-4ea0-aae7-bc9a7483db8d" xlink:to="loc_elv_GovernmentBusinessSegmentMember_efcff626-37c7-4311-a83b-b5b2c6a04e06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IngenioRxSegmentMember_5c7b7060-f33e-4037-bd10-57a1cbae5e32" xlink:href="elv-20220930.xsd#elv_IngenioRxSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fe639378-0199-4ea0-aae7-bc9a7483db8d" xlink:to="loc_elv_IngenioRxSegmentMember_5c7b7060-f33e-4037-bd10-57a1cbae5e32" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherSegmentMember_e00035ba-28c2-4dde-be2e-8e0cb85a0e34" xlink:href="elv-20220930.xsd#elv_OtherSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fe639378-0199-4ea0-aae7-bc9a7483db8d" xlink:to="loc_elv_OtherSegmentMember_e00035ba-28c2-4dde-be2e-8e0cb85a0e34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SegmentEliminationsMember_1807a45c-b904-449a-b87f-b9f0c3b51ff9" xlink:href="elv-20220930.xsd#elv_SegmentEliminationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fe639378-0199-4ea0-aae7-bc9a7483db8d" xlink:to="loc_elv_SegmentEliminationsMember_1807a45c-b904-449a-b87f-b9f0c3b51ff9" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/LeasesLeaseandOtherInformationDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#LeasesLeaseandOtherInformationDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/LeasesLeaseandOtherInformationDetails" xlink:type="extended" id="i07d005e120e2450eb53c5383cc3368d5_LeasesLeaseandOtherInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_218d0b11-a356-4e55-8c77-7d60d5c20a98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_218d0b11-a356-4e55-8c77-7d60d5c20a98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_33d7d4bf-6f93-465f-8a99-2efd487df1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_33d7d4bf-6f93-465f-8a99-2efd487df1dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fa19b43d-f428-4ffd-9ba1-27f2ee7829cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fa19b43d-f428-4ffd-9ba1-27f2ee7829cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_87e0aa81-4f6c-4033-bbcc-bddd5e681184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_OperatingLeaseCost_87e0aa81-4f6c-4033-bbcc-bddd5e681184" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_2e023137-c636-4ce8-b6c8-62aeb2c86437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_ShortTermLeaseCost_2e023137-c636-4ce8-b6c8-62aeb2c86437" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_932514a9-6c83-4aad-bed8-baa28d050c20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_SubleaseIncome_932514a9-6c83-4aad-bed8-baa28d050c20" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_56da18cb-a7bf-46fb-9b90-48c25cc7ae6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_LeaseCost_56da18cb-a7bf-46fb-9b90-48c25cc7ae6a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_493b746d-7e5e-4b36-94af-9f4cd66ec76d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_OperatingLeasePayments_493b746d-7e5e-4b36-94af-9f4cd66ec76d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_00b7e7c7-0f7f-4231-9906-d46e522fd518" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_00b7e7c7-0f7f-4231-9906-d46e522fd518" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_7ff9045f-d24a-4c64-8498-d66390c2c656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_7ff9045f-d24a-4c64-8498-d66390c2c656" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_0df12aa5-fe06-44da-87e4-cb76a3ce6607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_0df12aa5-fe06-44da-87e4-cb76a3ce6607" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_48fa51b0-820b-4670-9f96-66e0fdd3395a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_48fa51b0-820b-4670-9f96-66e0fdd3395a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f136f412-ca92-47e2-9d43-a5124576a446" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_StatementTable_f136f412-ca92-47e2-9d43-a5124576a446" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i6c0ea990abfb4f93abfd3bcffc448dd4_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_bb3fea92-713b-4761-b696-18e1f64e5ece" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_4308b44f-f9d6-4e13-aa6d-2727673ec4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bb3fea92-713b-4761-b696-18e1f64e5ece" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_4308b44f-f9d6-4e13-aa6d-2727673ec4ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_9a3204b7-0b60-416f-92ea-bcaf944e6932" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bb3fea92-713b-4761-b696-18e1f64e5ece" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_9a3204b7-0b60-416f-92ea-bcaf944e6932" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_bb0d852c-bf3d-45cf-b10c-f44bfa702bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bb3fea92-713b-4761-b696-18e1f64e5ece" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_bb0d852c-bf3d-45cf-b10c-f44bfa702bbd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_64920e33-73bd-4af9-a3b6-1579860da398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bb3fea92-713b-4761-b696-18e1f64e5ece" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_64920e33-73bd-4af9-a3b6-1579860da398" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_59e46a8f-6f04-4943-ad5c-eb7a3e74d72a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_64920e33-73bd-4af9-a3b6-1579860da398" xlink:to="loc_srt_RangeAxis_59e46a8f-6f04-4943-ad5c-eb7a3e74d72a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_59e46a8f-6f04-4943-ad5c-eb7a3e74d72a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_59e46a8f-6f04-4943-ad5c-eb7a3e74d72a" xlink:to="loc_srt_RangeMember_59e46a8f-6f04-4943-ad5c-eb7a3e74d72a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0a7bc473-6617-4f91-b08c-6f8c7af9c4a2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_59e46a8f-6f04-4943-ad5c-eb7a3e74d72a" xlink:to="loc_srt_RangeMember_0a7bc473-6617-4f91-b08c-6f8c7af9c4a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8eca50e9-fbfa-4030-84ca-3372e354d621" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0a7bc473-6617-4f91-b08c-6f8c7af9c4a2" xlink:to="loc_srt_MinimumMember_8eca50e9-fbfa-4030-84ca-3372e354d621" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ed7fddf4-2ef3-40cb-beff-ab941a6d3bc6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0a7bc473-6617-4f91-b08c-6f8c7af9c4a2" xlink:to="loc_srt_MaximumMember_ed7fddf4-2ef3-40cb-beff-ab941a6d3bc6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsSummaryOfTheChangeInTheCarryingAmountOfGoodwillByReportableSegmentDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#GoodwillAndOtherIntangibleAssetsSummaryOfTheChangeInTheCarryingAmountOfGoodwillByReportableSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsSummaryOfTheChangeInTheCarryingAmountOfGoodwillByReportableSegmentDetails" xlink:type="extended" id="i7e1da03918cd4315aee24f97728236dd_GoodwillAndOtherIntangibleAssetsSummaryOfTheChangeInTheCarryingAmountOfGoodwillByReportableSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_134cf1f7-fcca-487c-b624-c151d17b557b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_3bc90c67-b42f-40ef-aab3-beec346090c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_134cf1f7-fcca-487c-b624-c151d17b557b" xlink:to="loc_us-gaap_GoodwillRollForward_3bc90c67-b42f-40ef-aab3-beec346090c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_03579beb-11f4-4b5f-b347-efd91e888e96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_3bc90c67-b42f-40ef-aab3-beec346090c0" xlink:to="loc_us-gaap_Goodwill_03579beb-11f4-4b5f-b347-efd91e888e96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_7aeec004-0305-4dc2-a809-a8554f93498a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_3bc90c67-b42f-40ef-aab3-beec346090c0" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_7aeec004-0305-4dc2-a809-a8554f93498a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_be538f52-80c1-4982-8a03-26f2ada691bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_81145621-4a12-465a-b524-4045bd678a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_3bc90c67-b42f-40ef-aab3-beec346090c0" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_81145621-4a12-465a-b524-4045bd678a8f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_7e5bd8f2-87cb-429c-9259-4b5716405d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_134cf1f7-fcca-487c-b624-c151d17b557b" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_7e5bd8f2-87cb-429c-9259-4b5716405d8e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cf14a9ee-cad0-4c4d-a830-a95c34254d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7e5bd8f2-87cb-429c-9259-4b5716405d8e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cf14a9ee-cad0-4c4d-a830-a95c34254d9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cf14a9ee-cad0-4c4d-a830-a95c34254d9d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cf14a9ee-cad0-4c4d-a830-a95c34254d9d" xlink:to="loc_us-gaap_SegmentDomain_cf14a9ee-cad0-4c4d-a830-a95c34254d9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d179946e-4636-4684-931c-f41871e90c38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cf14a9ee-cad0-4c4d-a830-a95c34254d9d" xlink:to="loc_us-gaap_SegmentDomain_d179946e-4636-4684-931c-f41871e90c38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommercialSpecialtyBusinessSegmentMember_0185e2a0-f3f7-498f-8886-10fa3ed78300" xlink:href="elv-20220930.xsd#elv_CommercialSpecialtyBusinessSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d179946e-4636-4684-931c-f41871e90c38" xlink:to="loc_elv_CommercialSpecialtyBusinessSegmentMember_0185e2a0-f3f7-498f-8886-10fa3ed78300" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GovernmentBusinessSegmentMember_1cd74ed8-0a1b-4855-8983-5cd595b1c307" xlink:href="elv-20220930.xsd#elv_GovernmentBusinessSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d179946e-4636-4684-931c-f41871e90c38" xlink:to="loc_elv_GovernmentBusinessSegmentMember_1cd74ed8-0a1b-4855-8983-5cd595b1c307" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IngenioRxSegmentMember_80a0ebf7-3da5-4644-b038-66f222b1c8ca" xlink:href="elv-20220930.xsd#elv_IngenioRxSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d179946e-4636-4684-931c-f41871e90c38" xlink:to="loc_elv_IngenioRxSegmentMember_80a0ebf7-3da5-4644-b038-66f222b1c8ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherSegmentMember_06bbd832-3d59-49f0-bb3e-8ffbda3c2589" xlink:href="elv-20220930.xsd#elv_OtherSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d179946e-4636-4684-931c-f41871e90c38" xlink:to="loc_elv_OtherSegmentMember_06bbd832-3d59-49f0-bb3e-8ffbda3c2589" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails" xlink:type="extended" id="ie362e077160b493a8526d970d7b1e8a6_GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_elv_IntangibleAssetsLineItems_58ebd14c-55ce-4d06-abf3-cc7914e1ede6" xlink:href="elv-20220930.xsd#elv_IntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4efeca36-157a-4dd5-b0ee-3a4483a7b38c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_IntangibleAssetsLineItems_58ebd14c-55ce-4d06-abf3-cc7914e1ede6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4efeca36-157a-4dd5-b0ee-3a4483a7b38c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e5b74fb2-dedd-4e04-9e03-f3e57393fa55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_IntangibleAssetsLineItems_58ebd14c-55ce-4d06-abf3-cc7914e1ede6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e5b74fb2-dedd-4e04-9e03-f3e57393fa55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fd534045-13fe-477c-b8af-9a8a356690ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_IntangibleAssetsLineItems_58ebd14c-55ce-4d06-abf3-cc7914e1ede6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fd534045-13fe-477c-b8af-9a8a356690ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_1285a9fb-963e-45af-8bbb-e0c9f7c18b81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_IntangibleAssetsLineItems_58ebd14c-55ce-4d06-abf3-cc7914e1ede6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_1285a9fb-963e-45af-8bbb-e0c9f7c18b81" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_38f249b2-41ba-4bf4-9a7d-fc89ebbe3744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e1103a76-93d8-4c2b-a8db-8a9de0aa0475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_IntangibleAssetsLineItems_58ebd14c-55ce-4d06-abf3-cc7914e1ede6" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e1103a76-93d8-4c2b-a8db-8a9de0aa0475" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IntangibleAssetsAccumulatedAmortizationExcludingGoodwill_099035ff-a353-4be0-8d7a-2d8e36805742" xlink:href="elv-20220930.xsd#elv_IntangibleAssetsAccumulatedAmortizationExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_IntangibleAssetsLineItems_58ebd14c-55ce-4d06-abf3-cc7914e1ede6" xlink:to="loc_elv_IntangibleAssetsAccumulatedAmortizationExcludingGoodwill_099035ff-a353-4be0-8d7a-2d8e36805742" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f0e0f35c-00c6-4e3c-b5c5-5674e0d64ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_IntangibleAssetsLineItems_58ebd14c-55ce-4d06-abf3-cc7914e1ede6" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f0e0f35c-00c6-4e3c-b5c5-5674e0d64ab9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IntangibleAssetsTable_666fa259-e67a-48f7-b9aa-e393b64bfc40" xlink:href="elv-20220930.xsd#elv_IntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_elv_IntangibleAssetsLineItems_58ebd14c-55ce-4d06-abf3-cc7914e1ede6" xlink:to="loc_elv_IntangibleAssetsTable_666fa259-e67a-48f7-b9aa-e393b64bfc40" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c9f30889-4283-47e9-9226-16fe613d7e34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_elv_IntangibleAssetsTable_666fa259-e67a-48f7-b9aa-e393b64bfc40" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c9f30889-4283-47e9-9226-16fe613d7e34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c9f30889-4283-47e9-9226-16fe613d7e34_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c9f30889-4283-47e9-9226-16fe613d7e34" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c9f30889-4283-47e9-9226-16fe613d7e34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_287579fa-c04a-4bc5-a32c-8d6ef2dccd71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c9f30889-4283-47e9-9226-16fe613d7e34" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_287579fa-c04a-4bc5-a32c-8d6ef2dccd71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_a7490b75-6102-4132-b853-ed8d06191f62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_287579fa-c04a-4bc5-a32c-8d6ef2dccd71" xlink:to="loc_us-gaap_CustomerRelationshipsMember_a7490b75-6102-4132-b853-ed8d06191f62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_4ab91e4e-f00e-48d7-a070-605930847213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_287579fa-c04a-4bc5-a32c-8d6ef2dccd71" xlink:to="loc_us-gaap_ContractualRightsMember_4ab91e4e-f00e-48d7-a070-605930847213" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_389dc288-c8af-4f37-baab-98ab1441bf0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_287579fa-c04a-4bc5-a32c-8d6ef2dccd71" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_389dc288-c8af-4f37-baab-98ab1441bf0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_62c4db13-9d32-4216-81eb-6c921b49354d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_elv_IntangibleAssetsTable_666fa259-e67a-48f7-b9aa-e393b64bfc40" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_62c4db13-9d32-4216-81eb-6c921b49354d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_62c4db13-9d32-4216-81eb-6c921b49354d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_62c4db13-9d32-4216-81eb-6c921b49354d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_62c4db13-9d32-4216-81eb-6c921b49354d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b1968160-1cef-4a59-80fb-7343fe9df926" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_62c4db13-9d32-4216-81eb-6c921b49354d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b1968160-1cef-4a59-80fb-7343fe9df926" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_e4462ccd-f520-4429-8dc8-e50222280ade" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b1968160-1cef-4a59-80fb-7343fe9df926" xlink:to="loc_us-gaap_TrademarksMember_e4462ccd-f520-4429-8dc8-e50222280ade" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_703e14c7-2e58-41a4-b3bd-033e1b6c33a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b1968160-1cef-4a59-80fb-7343fe9df926" xlink:to="loc_us-gaap_LicensingAgreementsMember_703e14c7-2e58-41a4-b3bd-033e1b6c33a9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>elv-20220930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:975646a6-f010-4ab0-98cc-185c6d29d7c2,g:966d453b-5cd7-4ddd-af0c-9c9c0ae080e9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_a4f583cf-682d-40c1-9045-855fd63bf3dc_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in one year or less, Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_e23af701-60d1-41a1-a99e-5b83043f3c73_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7725225c-e618-4c54-88b2-3d829ad1dd2d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ff65deb2-c815-4b7f-bde8-e881f9e6102d_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract_0e0c1b46-16bb-4e1e-aac6-c79ec2fcaf3d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Abstract]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_252d0e68-8106-4d31-8db7-116b7a1e2d16_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_48b4a8e6-0847-487a-975c-84e89f0e7ba7_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_de15bbd0-70c9-4bf6-95f7-05dfc19095dd_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_4cc34e90-490f-4a7c-adb7-52965e744688_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_b4985424-5103-42b6-ab40-b1cf5b7160ea_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_afe1e446-09fa-40a2-94db-67e3c6a5a7d5_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance lines other than short duration</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Liability for Unpaid Claims and Claim Adjustment Expense, Other Reconciling Item</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_3dbd844b-c1bc-46d8-9dc3-5627c95b7ca0_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit expense</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_d1c16868-5d3a-40ba-a0b5-c2e737fc9ed6_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCovenantDescription_6d3c655f-fc2c-4d9c-b46c-665c9c90cb5d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCovenantDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant description</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCovenantDescription_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCovenantDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Description</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCovenantDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCovenantDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCovenantDescription" xlink:to="lab_us-gaap_DebtInstrumentCovenantDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_1af77f02-11ea-4d09-8140-374ff4d1f199_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities_6ae9c6e5-a920-49ea-b0d1-83845d84522c_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Other than Temporary Impairment, Not Credit Loss, Net of Tax, Debt Securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities_ee772d69-ca8c-4421-9dc9-0cc5179e773f_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Other than Temporary Impairment, Not Credit Loss, Ending Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Other than Temporary Impairment, Not Credit Loss, Net of Tax, Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_6ad619de-a4cc-4bf2-87ff-07327ffe7bb2_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_5d4a1d64-d3d6-43e5-8ee7-097d0a56b228_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of The Beginning And Ending Balances For Medical Claims Payable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_f3887cd6-3cc7-46da-b6da-6bcf394af382_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_CommercialPaperMaximumBorrowingCapacity_f99dfd08-1809-4977-b207-5f2198c71a79_terseLabel_en-US" xlink:label="lab_elv_CommercialPaperMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper authorized</link:label>
    <link:label id="lab_elv_CommercialPaperMaximumBorrowingCapacity_label_en-US" xlink:label="lab_elv_CommercialPaperMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper Maximum Borrowing Capacity</link:label>
    <link:label id="lab_elv_CommercialPaperMaximumBorrowingCapacity_documentation_en-US" xlink:label="lab_elv_CommercialPaperMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommercialPaperMaximumBorrowingCapacity" xlink:href="elv-20220930.xsd#elv_CommercialPaperMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_CommercialPaperMaximumBorrowingCapacity" xlink:to="lab_elv_CommercialPaperMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_13d4a3b9-4a18-4345-b9a0-1865a5ca3b20_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_f73e3a1b-2994-4b07-85cd-9459cf3fac93_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_SeniorUnsecuredNotesMember_ebbc4aa0-6851-4b2e-80d8-acbfb776208a_terseLabel_en-US" xlink:label="lab_elv_SeniorUnsecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes [Member]</link:label>
    <link:label id="lab_elv_SeniorUnsecuredNotesMember_label_en-US" xlink:label="lab_elv_SeniorUnsecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes [Member]</link:label>
    <link:label id="lab_elv_SeniorUnsecuredNotesMember_documentation_en-US" xlink:label="lab_elv_SeniorUnsecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SeniorUnsecuredNotesMember" xlink:href="elv-20220930.xsd#elv_SeniorUnsecuredNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_SeniorUnsecuredNotesMember" xlink:to="lab_elv_SeniorUnsecuredNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_28892b27-dafa-4e8a-952e-8d69b38acbff_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for employee terminations costs, beginning</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_98878699-55c5-4384-8980-7dcd70eac324_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for employee terminations costs, ending</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PresentValueOfFutureInsuranceProfitsTableTextBlock_f55a0d23-fac8-444e-a6c0-cdb3e990a630_terseLabel_en-US" xlink:label="lab_us-gaap_PresentValueOfFutureInsuranceProfitsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components Of Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_PresentValueOfFutureInsuranceProfitsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_PresentValueOfFutureInsuranceProfitsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present Value of Future Insurance Profits [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PresentValueOfFutureInsuranceProfitsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PresentValueOfFutureInsuranceProfitsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PresentValueOfFutureInsuranceProfitsTableTextBlock" xlink:to="lab_us-gaap_PresentValueOfFutureInsuranceProfitsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BenefitsLossesAndExpensesAbstract_aa06bac8-c412-4e52-a20f-26673f0ac048_terseLabel_en-US" xlink:label="lab_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses</link:label>
    <link:label id="lab_us-gaap_BenefitsLossesAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits, Losses and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:to="lab_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_b60bd7e9-621a-496c-a662-864f97e35671_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_f8671606-e0a6-4158-a579-a29babf8c74c_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical claims payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_938eca11-44fb-4e6e-8299-0889dae7eec4_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross medical claims payable, end of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_bd05ceb3-c3e5-4b31-b483-2df8a6ea2911_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through ten years, Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e7ed1033-1066-469a-b355-4f60856492e5_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths_c80bc072-dd9e-447e-a2eb-c0f463b5b4fd_verboseLabel_en-US" xlink:label="lab_us-gaap_FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Home Loan Bank, advances, short-term</link:label>
    <link:label id="lab_us-gaap_FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Home Loan Bank, Advances, Maturities Summary, Due in Next Rolling 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths" xlink:to="lab_us-gaap_FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_bffa51f9-71b7-4659-ad8a-212f97929e24_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_31421881-6733-4aa1-a171-d5c5ada4c657_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0d83eec6-5f7a-4494-854e-aa407782adde_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6e7836c4-4ddb-4794-9b41-f57729a3ea41_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised, Number of Shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_7a9a1da0-b3a8-41e3-a287-d99dc24d617f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_12ad6a71-a146-4d93-a4e2-4b53239d8209_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_474e873b-926a-4a18-9eda-1c935c8c678c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_54b2d717-0fdd-495a-b3fd-b5f63350d67d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_EquitySecurities_ae2d27c8-ad87-4074-af7d-79267a10f15f_terseLabel_en-US" xlink:label="lab_elv_EquitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities</link:label>
    <link:label id="lab_elv_EquitySecurities_label_en-US" xlink:label="lab_elv_EquitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities</link:label>
    <link:label id="lab_elv_EquitySecurities_documentation_en-US" xlink:label="lab_elv_EquitySecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of investments in equity securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EquitySecurities" xlink:href="elv-20220930.xsd#elv_EquitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_EquitySecurities" xlink:to="lab_elv_EquitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_NumberOfMedicalMembersServed_2e7614be-2a21-4090-ba8b-620e046f792b_verboseLabel_en-US" xlink:label="lab_elv_NumberOfMedicalMembersServed" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Medical Members</link:label>
    <link:label id="lab_elv_NumberOfMedicalMembersServed_label_en-US" xlink:label="lab_elv_NumberOfMedicalMembersServed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Medical Members Served</link:label>
    <link:label id="lab_elv_NumberOfMedicalMembersServed_documentation_en-US" xlink:label="lab_elv_NumberOfMedicalMembersServed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of medical members served</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_NumberOfMedicalMembersServed" xlink:href="elv-20220930.xsd#elv_NumberOfMedicalMembersServed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_NumberOfMedicalMembersServed" xlink:to="lab_elv_NumberOfMedicalMembersServed" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_SelfFundedReceivablesNet_bbb0475d-3393-466a-9030-52d30c98846e_terseLabel_en-US" xlink:label="lab_elv_SelfFundedReceivablesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-funded receivables</link:label>
    <link:label id="lab_elv_SelfFundedReceivablesNet_label_en-US" xlink:label="lab_elv_SelfFundedReceivablesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-Funded Receivables, Net</link:label>
    <link:label id="lab_elv_SelfFundedReceivablesNet_documentation_en-US" xlink:label="lab_elv_SelfFundedReceivablesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The carrying amount as of the balance sheet date due the entity from self-insured customers, net of the allowance for doubtful accounts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SelfFundedReceivablesNet" xlink:href="elv-20220930.xsd#elv_SelfFundedReceivablesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_SelfFundedReceivablesNet" xlink:to="lab_elv_SelfFundedReceivablesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_67f6e7d5-4bd1-4abb-b644-9f9db8f74726_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Claims Payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense_4bbd2b7b-8740-4fe7-8d7a-41708ab27acd_terseLabel_en-US" xlink:label="lab_elv_OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in unrecognized periodic benefit costs for defined benefit pension and postretirement benefit plans, tax expense</link:label>
    <link:label id="lab_elv_OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense_label_en-US" xlink:label="lab_elv_OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Net Change In Unrecognized Periodic Benefit Costs For Defined Benefit Pension And Postretirement Benefit Plans Tax Benefit Expense</link:label>
    <link:label id="lab_elv_OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense_documentation_en-US" xlink:label="lab_elv_OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense" xlink:href="elv-20220930.xsd#elv_OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense" xlink:to="lab_elv_OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis_10805df5-5f85-49ec-971b-746d1979f420_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity [Axis]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_8e3a2863-7610-41f8-a40e-ce3d07ef7cff_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_47b4de33-36b0-4c5f-bbf2-bbb33dbcbfc6_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_1d2f5560-3f69-4cf8-8c14-9a4ab6f14099_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember_8ae12133-99f5-4e8f-b865-1371df6e963a_terseLabel_en-US" xlink:label="lab_elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point One Zero Percent Due Two Thousand Thirty Two [Member]</link:label>
    <link:label id="lab_elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember_label_en-US" xlink:label="lab_elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point One Zero Percent Due Two Thousand Thirty Two [Member]</link:label>
    <link:label id="lab_elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember_documentation_en-US" xlink:label="lab_elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point One Zero Percent Due Two Thousand Thirty Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember" xlink:href="elv-20220930.xsd#elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember" xlink:to="lab_elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3c72e187-8a3a-4c4c-a831-0f99c983b96b_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares excluded from denominator for diluted earnings per share because the stock options were anti-dilutive</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0a53a47f-3317-4e78-813b-555d504cf494_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years, Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_55f6a675-3d80-4027-a215-117b28f13b74_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_e1443e39-8f63-4950-a6d3-e2e389c17d18_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_f788816a-2b48-45a7-833d-48f5a8814a79_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent_d2d60654-c934-418a-926e-07ec54b5c909_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed maturities, allowance for credit loss, current</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_441b60af-f847-4f63-bf46-d0ed321b97ba_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_1301b971-1737-4a15-8e67-2a80de5bc30f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_137be66f-8edc-4728-8290-deb7f5aa9839_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease payments, Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_a5f4fc42-19fa-4511-959d-40d12aeab6f2_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which the Company is licensed to conduct insurance operations</link:label>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of States in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest_657293a9-a6b9-49fa-9ed4-0e491fa2e16d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentIncome_ec95e245-0014-42c0-9a89-48f7a5323a52_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_NetInvestmentIncome_6b39ea73-081c-420a-8738-2554d3c38376_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_NetInvestmentIncome_label_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentIncome" xlink:to="lab_us-gaap_NetInvestmentIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_NumberOfCountiesInStateOfKansasCompanyDoesNotServe_e04701b6-7db0-482d-971b-46320834cb91_terseLabel_en-US" xlink:label="lab_elv_NumberOfCountiesInStateOfKansasCompanyDoesNotServe" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of counties in the Kansas City area the Company does not serve</link:label>
    <link:label id="lab_elv_NumberOfCountiesInStateOfKansasCompanyDoesNotServe_label_en-US" xlink:label="lab_elv_NumberOfCountiesInStateOfKansasCompanyDoesNotServe" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Counties In State Of Kansas Company Does Not Serve</link:label>
    <link:label id="lab_elv_NumberOfCountiesInStateOfKansasCompanyDoesNotServe_documentation_en-US" xlink:label="lab_elv_NumberOfCountiesInStateOfKansasCompanyDoesNotServe" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Counties In The State Of Kansas Company Does Not Serve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_NumberOfCountiesInStateOfKansasCompanyDoesNotServe" xlink:href="elv-20220930.xsd#elv_NumberOfCountiesInStateOfKansasCompanyDoesNotServe"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_NumberOfCountiesInStateOfKansasCompanyDoesNotServe" xlink:to="lab_elv_NumberOfCountiesInStateOfKansasCompanyDoesNotServe" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_f89fae97-a254-4e5b-9c79-dbe33fdfeec6_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_4b76fca0-ce75-47a2-9e8f-b3dd03ef0955_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_67c2c158-49ca-46de-95fe-ec52e0d842d7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_04aa3e88-4fd7-4412-8662-64c8e18fb10d_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Debt Securities, Beginning Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2ce8a13e-c4b4-4d6a-bb1f-68cf86632df5_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Debt Securities, Ending Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Debt Securities, Available-for-Sale, Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_4075f509-1480-4600-8d57-bfcf3f3b4930_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_ec6ab87c-304e-45f1-ae1d-de28f2ea898b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease_0134b3fe-7a73-4822-8311-26b988dc435e_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Period Decrease</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_75bbc4ef-6c73-46e5-82d9-23863c3a1a90_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate settlement amount</link:label>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:to="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_c050613d-689d-448b-b3a9-46cb15348489_terseLabel_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">States, Municipalities And Political Subdivisions [Member]</link:label>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_label_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US States and Political Subdivisions Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:to="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_15fddfe8-f71d-4f69-b658-7af09e354498_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_e50cfe16-020d-4601-87ca-6a7d20a15f4d_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Foreign Currency Translation Adjustment, Net of Tax, Beginning Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_a9dbc4ae-aaf3-4c00-953d-7f084cf69c21_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax, Ending Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_IntegraManagedCareMember_4da88a22-de38-4842-a51e-25031f17b58b_terseLabel_en-US" xlink:label="lab_elv_IntegraManagedCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integra Managed Care [Member]</link:label>
    <link:label id="lab_elv_IntegraManagedCareMember_label_en-US" xlink:label="lab_elv_IntegraManagedCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integra Managed Care [Member]</link:label>
    <link:label id="lab_elv_IntegraManagedCareMember_documentation_en-US" xlink:label="lab_elv_IntegraManagedCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integra Managed Care</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IntegraManagedCareMember" xlink:href="elv-20220930.xsd#elv_IntegraManagedCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_IntegraManagedCareMember" xlink:to="lab_elv_IntegraManagedCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_4979c179-55ed-42a0-8780-865550253450_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Defined Benefit Plan, Beginning Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_c3270732-6e74-4f8f-89c6-ea8d0e46dca4_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Defined Benefit Plan, Ending Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_283afae3-db49-4931-9042-323b45ce1f95_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_cd98a9cd-ec4b-4c1d-a288-1ace0eeb7f8e_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale securities, Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_8f31213b-3352-4438-8acf-74be38f6cd9d_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_1e53905a-e8d7-46e5-a317-25149b4bf485_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance sheet location of current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense_fd44cae5-fde1-4137-9de6-8578915a607c_periodStartLabel_en-US" xlink:label="lab_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross medical claims payable, beginning of period</link:label>
    <link:label id="lab_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense_ec71408c-695b-4c94-9274-058db518e8ff_periodEndLabel_en-US" xlink:label="lab_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross medical claims payable, end of period</link:label>
    <link:label id="lab_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense_label_en-US" xlink:label="lab_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Duration Contract Liability For Claims Adjustment Expense</link:label>
    <link:label id="lab_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense_documentation_en-US" xlink:label="lab_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount needed to reflect the estimated ultimate cost of settling short duration contract claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date for short duration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense" xlink:href="elv-20220930.xsd#elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense" xlink:to="lab_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_PharmacypricingMember_6b75dca4-cb0e-4c92-a6f8-db32ce7d16cc_terseLabel_en-US" xlink:label="lab_elv_PharmacypricingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages for Pharmacy Pricing [Member]</link:label>
    <link:label id="lab_elv_PharmacypricingMember_label_en-US" xlink:label="lab_elv_PharmacypricingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy pricing [Member]</link:label>
    <link:label id="lab_elv_PharmacypricingMember_documentation_en-US" xlink:label="lab_elv_PharmacypricingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy pricing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_PharmacypricingMember" xlink:href="elv-20220930.xsd#elv_PharmacypricingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_PharmacypricingMember" xlink:to="lab_elv_PharmacypricingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_c7cf82c5-e78f-4586-aa34-d1a03726e5f7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_IngenioRxSegmentMember_88de7839-dbba-4947-a1fa-33b59dac3429_terseLabel_en-US" xlink:label="lab_elv_IngenioRxSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IngenioRx Segment [Member]</link:label>
    <link:label id="lab_elv_IngenioRxSegmentMember_label_en-US" xlink:label="lab_elv_IngenioRxSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IngenioRx Segment [Member]</link:label>
    <link:label id="lab_elv_IngenioRxSegmentMember_documentation_en-US" xlink:label="lab_elv_IngenioRxSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IngenioRx Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IngenioRxSegmentMember" xlink:href="elv-20220930.xsd#elv_IngenioRxSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_IngenioRxSegmentMember" xlink:to="lab_elv_IngenioRxSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_9adccebc-b0e4-461f-b695-0d834d1f37b6_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_59701f02-167a-409a-bfb3-ed3db007c0be_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_71543f0c-262a-4dcf-b2cb-fb20cea0b831_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_OtherProductsMember_2c269d5e-07c2-4695-a67a-e370a6652c77_terseLabel_en-US" xlink:label="lab_elv_OtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products [Member]</link:label>
    <link:label id="lab_elv_OtherProductsMember_label_en-US" xlink:label="lab_elv_OtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products [Member]</link:label>
    <link:label id="lab_elv_OtherProductsMember_documentation_en-US" xlink:label="lab_elv_OtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherProductsMember" xlink:href="elv-20220930.xsd#elv_OtherProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_OtherProductsMember" xlink:to="lab_elv_OtherProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_50f02222-c93c-4167-b95c-b99dcb6cde34_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers out of Level III</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_f33ef938-38da-40e6-86e9-7c58e6ceee59_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level I [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_dcb254a6-ed2d-46ff-a04c-35f9be3fbc7a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a33e381d-ae43-42c8-b431-8de5c773c372_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income, net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6054b824-6e72-442b-a179-b2fc05dcbc11_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period, Weighted-Average Remaining Contractual Life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_b4f4fdbc-3b6e-48a8-8b1b-fa0b081f08fc_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_a90e3e05-8c1d-4cf4-8810-e5d583bd9973_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_c8a6cf37-dd48-4c81-99c7-7c77f9ad650f_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_13c08e04-1a4a-47d9-8a6a-72da5f7370ff_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_d9ec2dde-b03d-4b1f-a515-514736b2b3ac_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1391f134-e7a3-46b7-ad1f-c27cc0be96cb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_166ff199-04d9-4011-b943-393b2ebcdd75_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Nonvested Restricted Stock Activity Including Restricted Stock Units</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_fd8a5bf0-f80a-456c-b202-153106efd6f4_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds originally received at time of divestiture</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d766028c-dc05-4e2b-b619-d588887345b8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_9c1df488-4cea-41c9-84ad-fa6acd19a968_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_491aba85-5c2c-417f-8c60-4c6abb4f59cf_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherInvestments_56f6e38b-8265-4148-a240-2443d53b9b18_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net losses (gains) on other investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfOtherInvestments" xlink:to="lab_us-gaap_GainLossOnSaleOfOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_9702201e-470c-4a74-b025-0cf456dbe949_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_3899f5ef-1161-4b26-8996-b4b6d075dc2d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_238af049-c711-4b72-ab68-7323caf0ccad_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_251e34d8-2b4a-4edb-83d5-f2eb25a575e5_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionAxis_7bbc4617-b177-4e31-b1b5-b47dc80ebe9a_terseLabel_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:label id="lab_us-gaap_PositionAxis_label_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionAxis" xlink:to="lab_us-gaap_PositionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_0daa9be1-4e28-4311-9fd3-7757f6756ace_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net payments attributable to prior periods medical claims</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_eec13499-7c39-4074-9354-36384b620930_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentsAbstract_966dc40a-aaa1-45f8-81d3-00c0f4f623b3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instruments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentsAbstract_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instruments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentsAbstract" xlink:to="lab_us-gaap_DebtInstrumentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_37d49dc4-ad38-43d6-a708-dcecf2aa6631_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Claims Development [Table]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Claims Development [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d3323bd2-73ef-44e2-89ec-6fc299a97a0f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_31db816e-2cc3-4a99-bac7-d642a3f0ebe4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed maturities, amortized cost, current</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_177d7530-9227-498d-8d81-d0907b85e669_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_b9fe5531-61a1-4414-8fa0-85fb90b5b895_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_d7eb1942-9b86-4e56-83f3-49646cff1f37_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed maturities, current</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_dac84058-eb50-4c1d-b2be-0f8a723fdeae_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_36c6f792-ce9e-494b-84a5-56cbfb1a1f82_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax_28e9ccbd-eb63-4f8e-95f8-b6d67130fcb0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net holding gain (loss) on investment securities arising during the period, tax (expense) benefit</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9c9b4f07-9e48-4a88-b2a6-a88f2ef19254_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Option Price Per Share [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_4dfd09e2-94aa-453b-bddb-fea7bef94feb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Realized Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_818df735-664a-458e-91bc-4e58430afa37_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Shares and Units [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_222e67ef-801b-4d9a-ae9d-b829110e8893_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or expired, Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f493c9cb-043d-4517-8778-c8467be205c9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_2226a3b7-c711-4379-b214-65e048592235_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Optimization Initiatives by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_96f1f6f6-51bb-4169-92cb-052cf8032e67_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at Beginning Balance, Weighted-Average Grant Date Fair Value per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_24fa68b1-35ba-4a7f-b035-d559a484b4b1_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at Ending Balance, Weighted-Average Grant Date Fair Value per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_a0e00619-a078-4a58-bf13-d9e3ffed677d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_0adbb2d1-b16b-4606-a8ef-eb5b2babe03d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_OtherSegmentMember_fd2e33ca-739e-4f54-b9e1-2ee6058e339e_terseLabel_en-US" xlink:label="lab_elv_OtherSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segment [Member]</link:label>
    <link:label id="lab_elv_OtherSegmentMember_9552a0fb-cb9e-4064-b75e-156ccd5fe5e1_verboseLabel_en-US" xlink:label="lab_elv_OtherSegmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_elv_OtherSegmentMember_label_en-US" xlink:label="lab_elv_OtherSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segment [Member]</link:label>
    <link:label id="lab_elv_OtherSegmentMember_documentation_en-US" xlink:label="lab_elv_OtherSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherSegmentMember" xlink:href="elv-20220930.xsd#elv_OtherSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_OtherSegmentMember" xlink:to="lab_elv_OtherSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_1819ceee-05fe-4f19-8597-e725f426886a_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax_078ca07c-39f1-4d55-856c-f47dd32eb30a_terseLabel_en-US" xlink:label="lab_elv_Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in non-credit component of impairment losses on investments</link:label>
    <link:label id="lab_elv_Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax_label_en-US" xlink:label="lab_elv_Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in non-credit component of impairment losses on investments net of tax</link:label>
    <link:label id="lab_elv_Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax_documentation_en-US" xlink:label="lab_elv_Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in non-credit component of impairment losses on investments, net of tax effect.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax" xlink:href="elv-20220930.xsd#elv_Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax" xlink:to="lab_elv_Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_d18c3e1a-f7a6-429c-aeb2-0fb955a37d14_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_d907001f-3c66-4d86-8662-41a31dcd4ac2_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_60207163-cb61-413c-ac7d-38a530bdf243_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_624f9827-91d6-445c-bf24-6bfd85fcdcd4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_OperationalMember_fb5fd2e6-e309-496c-a85b-c8f165807fb6_terseLabel_en-US" xlink:label="lab_elv_OperationalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages for Operational Breaches [Member]</link:label>
    <link:label id="lab_elv_OperationalMember_label_en-US" xlink:label="lab_elv_OperationalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operational [Member]</link:label>
    <link:label id="lab_elv_OperationalMember_documentation_en-US" xlink:label="lab_elv_OperationalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operational [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OperationalMember" xlink:href="elv-20220930.xsd#elv_OperationalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_OperationalMember" xlink:to="lab_elv_OperationalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_67079934-4be5-4bc6-aa1a-309eaec076e6_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned income</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_a7807891-a7c5-4c85-9a11-557345ffb88c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Securities [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems" xlink:to="lab_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_388baaab-fc24-4f67-bafd-f0f157265350_terseLabel_en-US" xlink:label="lab_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Activity in Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Activity in Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:to="lab_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e7eaef5f-e6f1-4efd-93cc-e9d928c0af41_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease payments, 2022; excluding the nine months ended September 30, 2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_DentalVisionProductsAndServicesMember_cf9df05a-16ac-4b65-a44c-c8731da1ed11_terseLabel_en-US" xlink:label="lab_elv_DentalVisionProductsAndServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dental Vision Products And Services [Member]</link:label>
    <link:label id="lab_elv_DentalVisionProductsAndServicesMember_label_en-US" xlink:label="lab_elv_DentalVisionProductsAndServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dental Vision Products And Services [Member]</link:label>
    <link:label id="lab_elv_DentalVisionProductsAndServicesMember_documentation_en-US" xlink:label="lab_elv_DentalVisionProductsAndServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dental Vision Products And Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_DentalVisionProductsAndServicesMember" xlink:href="elv-20220930.xsd#elv_DentalVisionProductsAndServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_DentalVisionProductsAndServicesMember" xlink:to="lab_elv_DentalVisionProductsAndServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_48d1cb65-3b01-4fe5-a9d2-1fceca443581_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_bc3a8383-0b2a-4990-ac7b-639ed4fc5084_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance sheet location of noncurrent operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_4a42338f-c2e4-4b30-a7f4-3cb3135c76a7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gains (losses) recognized in net income</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignGovernmentDebtMember_c6e08497-5bb4-49b6-ba18-609311beaf81_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Government Securities [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignGovernmentDebtMember_label_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Government Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignGovernmentDebtMember" xlink:to="lab_us-gaap_ForeignGovernmentDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_5cec9837-cb58-4060-ae38-c53d982546d6_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_571781a5-ca10-4b3a-9d5a-7cfd28963142_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_0cb7287a-e3f2-4563-854d-ab00787a21b1_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_df4d9b55-8cc7-4125-8f51-093715e93724_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments [Member]</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentsMember" xlink:to="lab_us-gaap_OtherInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_CommitmentsAndContingenciesLineItems_2390bbdb-a7f0-48f6-b641-ad04ce09e434_terseLabel_en-US" xlink:label="lab_elv_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:label id="lab_elv_CommitmentsAndContingenciesLineItems_label_en-US" xlink:label="lab_elv_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:label id="lab_elv_CommitmentsAndContingenciesLineItems_documentation_en-US" xlink:label="lab_elv_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommitmentsAndContingenciesLineItems" xlink:href="elv-20220930.xsd#elv_CommitmentsAndContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_CommitmentsAndContingenciesLineItems" xlink:to="lab_elv_CommitmentsAndContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_498746ba-7e5e-4aa0-9c98-08377396c125_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 [Member]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_868a3e2e-551f-4e1c-9606-13b7a4d988d4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Components Of Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_26c8a90e-7605-4592-a35b-4aacfd1225b1_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_eaf439b3-c6ed-45e9-8c23-e18ec0d822f6_totalLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaturityOvernightMember_dcbddeeb-c1f0-4a88-99f0-d74635b5783d_terseLabel_en-US" xlink:label="lab_us-gaap_MaturityOvernightMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Overnight and Continuous [Member]</link:label>
    <link:label id="lab_us-gaap_MaturityOvernightMember_label_en-US" xlink:label="lab_us-gaap_MaturityOvernightMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity Overnight [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturityOvernightMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaturityOvernightMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaturityOvernightMember" xlink:to="lab_us-gaap_MaturityOvernightMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_efb26fab-f1b0-455a-94a3-50d761bb2326_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_552df124-91da-4801-a182-78ad6d0da13c_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; net income per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_981e0c87-42ef-4115-87a8-50ed89b6b81d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalHomeLoanBankAdvancesMember_4531c4ec-02fe-4942-a6eb-e58e6ee6c678_terseLabel_en-US" xlink:label="lab_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Home Loan Bank Advances [Member]</link:label>
    <link:label id="lab_us-gaap_FederalHomeLoanBankAdvancesMember_label_en-US" xlink:label="lab_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Home Loan Bank Advances [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalHomeLoanBankAdvancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:to="lab_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInCollateralHeldUnderSecuritiesLending_3c819a72-4e20-4bd4-9b8f-14c64319de13_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInCollateralHeldUnderSecuritiesLending" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in securities lending collateral</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInCollateralHeldUnderSecuritiesLending_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInCollateralHeldUnderSecuritiesLending" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Collateral Held under Securities Lending</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInCollateralHeldUnderSecuritiesLending" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInCollateralHeldUnderSecuritiesLending"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInCollateralHeldUnderSecuritiesLending" xlink:to="lab_us-gaap_IncreaseDecreaseInCollateralHeldUnderSecuritiesLending" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_f60949c9-6a35-4dfc-97de-0b81cd5fe9b1_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_258d611d-9562-4aaa-889d-c316aa26e536_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax (Expense) Benefit, Portion Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9123da8e-9d3d-41db-b33a-f13ada81bf0b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Optimization Initiatives [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_9e012523-d4d4-442a-9aa9-651237b783cf_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_IntangibleAssetsLineItems_dc736d3a-473d-4df8-94f4-74ac03f0405f_terseLabel_en-US" xlink:label="lab_elv_IntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Line Items]</link:label>
    <link:label id="lab_elv_IntangibleAssetsLineItems_label_en-US" xlink:label="lab_elv_IntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Line Items]</link:label>
    <link:label id="lab_elv_IntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_elv_IntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IntangibleAssetsLineItems" xlink:href="elv-20220930.xsd#elv_IntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_IntangibleAssetsLineItems" xlink:to="lab_elv_IntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_217c5096-9d0c-4baa-a5f1-bf22a1b38054_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease payments, 2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_cbdb4158-be5a-4bcc-9044-65f772e6b864_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised, Weighted-Average Option Price per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_edc7bc43-55fc-4847-b314-8f52edc5beb4_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_843d46c7-ab3e-4dfe-a022-e38720e41039_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_4f21e48d-275f-493c-a6dc-584d1c04afe5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_ProductRevenue_9414fa98-49f8-4885-8d50-275c7c0b2595_terseLabel_en-US" xlink:label="lab_elv_ProductRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product revenue</link:label>
    <link:label id="lab_elv_ProductRevenue_label_en-US" xlink:label="lab_elv_ProductRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Revenue</link:label>
    <link:label id="lab_elv_ProductRevenue_documentation_en-US" xlink:label="lab_elv_ProductRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of revenue recognized from goods sold.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ProductRevenue" xlink:href="elv-20220930.xsd#elv_ProductRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_ProductRevenue" xlink:to="lab_elv_ProductRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_28ca30c5-357d-4a83-a5af-2ddb11a42051_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary Credit Facilities [Member]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5062b848-757e-40c6-acdb-d897636adae6_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f65751bd-4ab9-45b8-b372-de96a1e2696b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_551f9e62-8588-4f6d-86c7-16cc42fcfc39_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_278ddd84-c477-46df-99a9-320e51b68ceb_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_aafa4970-f818-4bf2-bf34-c9b38bd63430_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_290b1a58-0920-4b7c-93fd-2fa19010e859_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_08579292-63ce-4f8f-b381-8eb8709997f7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_10e206af-4950-4c13-9785-130ce323ffcf_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_4027ec7c-c16a-4927-8f43-5b5b7eaf7348_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_0435bd64-8557-4315-81e8-767ae14bf578_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Weighted-Average Assumptions Used to Estimate the Fair Value of Options Granted During the Periods</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrivateEquityFundsMember_a2b90a52-c090-4bc8-9134-b8d531eff91f_terseLabel_en-US" xlink:label="lab_us-gaap_PrivateEquityFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Equity Funds [Member]</link:label>
    <link:label id="lab_us-gaap_PrivateEquityFundsMember_285131ac-ecfd-4495-a6b9-bbdd9a90e32d_verboseLabel_en-US" xlink:label="lab_us-gaap_PrivateEquityFundsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Equity Securities [Member]</link:label>
    <link:label id="lab_us-gaap_PrivateEquityFundsMember_label_en-US" xlink:label="lab_us-gaap_PrivateEquityFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Equity Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivateEquityFundsMember" xlink:to="lab_us-gaap_PrivateEquityFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_2254b76a-2c4a-4661-9c71-7917ea91fcb8_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_fdd85dfa-fa47-474b-8aed-a29169748566_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded medical claims payable, beginning of period</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_4f10a032-7d0f-4a17-b4fc-ffa6dd549857_periodEndLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded medical claims payable, end of period</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_534f8afd-73f7-4486-b6ae-000131d72c14_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded medical claims payable end of period</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable for Unpaid Claims and Claims Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:to="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_f655f957-fa4c-46d1-9a42-2ec33ac1a93c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_c33d895b-789c-462d-bb73-2dc972e9f2f7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_387fb08d-4776-4132-a213-584cbfd4a974_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5a7a85f3-c3e6-43e7-a507-85d884d07247_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_f035a0e6-c1a7-42c0-870e-3ba0ec68f3c0_terseLabel_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential Mortgage-Backed Securities [Member]</link:label>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential Mortgage-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_a6b62df2-2348-45c9-a615-288452798980_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_511db679-b97d-4fd3-83f6-29c09a2d200d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period, Weighted-Average Remaining Contractual Life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet_253ea51a-a3e1-45e1-a83a-a4b08fa94ad5_terseLabel_en-US" xlink:label="lab_elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net medical claims payable, end of period</link:label>
    <link:label id="lab_elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet_label_en-US" xlink:label="lab_elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short duration contract liability for unpaid claims and adjustment expense, Net</link:label>
    <link:label id="lab_elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet_documentation_en-US" xlink:label="lab_elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short duration contract liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for short duration contract claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid short duration contract claims.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet" xlink:href="elv-20220930.xsd#elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet" xlink:to="lab_elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_3e1c7fb1-5b3d-4d38-ac2b-0d095482d84b_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_68dd4f6b-9211-4564-a8dd-99570bbd9079_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_8892f223-021a-4523-aea8-26933ec32728_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_IncreaseInStockRepurchaseProgramAuthorization_08bc8414-1f0c-4ffd-a62a-b21fd2dc548d_terseLabel_en-US" xlink:label="lab_elv_IncreaseInStockRepurchaseProgramAuthorization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase In Stock Repurchase Program Authorization</link:label>
    <link:label id="lab_elv_IncreaseInStockRepurchaseProgramAuthorization_label_en-US" xlink:label="lab_elv_IncreaseInStockRepurchaseProgramAuthorization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase In Stock Repurchase Program Authorization</link:label>
    <link:label id="lab_elv_IncreaseInStockRepurchaseProgramAuthorization_documentation_en-US" xlink:label="lab_elv_IncreaseInStockRepurchaseProgramAuthorization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of an increase authorized by an entity's Board of Directors to a previously authorized stock repurchase program.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IncreaseInStockRepurchaseProgramAuthorization" xlink:href="elv-20220930.xsd#elv_IncreaseInStockRepurchaseProgramAuthorization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_IncreaseInStockRepurchaseProgramAuthorization" xlink:to="lab_elv_IncreaseInStockRepurchaseProgramAuthorization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTradingSecurities_0d565c61-f3b9-4750-9019-949a1edc9f34_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTradingSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other invested assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTradingSecurities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Debt Securities, Trading, and Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTradingSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTradingSecurities" xlink:to="lab_us-gaap_IncreaseDecreaseInTradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_846c31d1-73b1-4c3f-925a-99facf358378_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOutstandingChecksFinancingActivities_894d521e-10d3-4ef3-8f31-a261043fae7e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOutstandingChecksFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in bank overdrafts</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOutstandingChecksFinancingActivities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOutstandingChecksFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Outstanding Checks, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOutstandingChecksFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOutstandingChecksFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOutstandingChecksFinancingActivities" xlink:to="lab_us-gaap_IncreaseDecreaseInOutstandingChecksFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseNotYetCommencedDescriptionAbstract_79376e3f-04bf-490a-80fa-f69aed75e5f4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseNotYetCommencedDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Not yet Commenced, Description [Abstract]</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseNotYetCommencedDescriptionAbstract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseNotYetCommencedDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Not yet Commenced, Description [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseNotYetCommencedDescriptionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseNotYetCommencedDescriptionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseNotYetCommencedDescriptionAbstract" xlink:to="lab_us-gaap_LesseeOperatingLeaseNotYetCommencedDescriptionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_136b787b-7aad-4d08-86ed-a73fb7d7691d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instruments, repurchased face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_5fac0ad5-2f47-4f72-88af-0d0262695e28_terseLabel_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_2278f81a-281b-4ca6-b135-2f0820680ecf_periodStartLabel_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Beginning Balance</link:label>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_c7d6ed27-24bd-4a8e-85b8-e8482fb786ea_periodEndLabel_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Ending Balance</link:label>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_label_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:to="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceAbstract_98497704-26c8-4549-af82-eaf4b566309c_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:label id="lab_us-gaap_InsuranceAbstract_label_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceAbstract" xlink:to="lab_us-gaap_InsuranceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_CommercialSpecialtyMember_46212bc4-337b-4982-bd5a-a54ed5b19888_verboseLabel_en-US" xlink:label="lab_elv_CommercialSpecialtyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial &amp; Specialty [Member]</link:label>
    <link:label id="lab_elv_CommercialSpecialtyMember_label_en-US" xlink:label="lab_elv_CommercialSpecialtyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Specialty [Member]</link:label>
    <link:label id="lab_elv_CommercialSpecialtyMember_documentation_en-US" xlink:label="lab_elv_CommercialSpecialtyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial &amp; Specialty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommercialSpecialtyMember" xlink:href="elv-20220930.xsd#elv_CommercialSpecialtyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_CommercialSpecialtyMember" xlink:to="lab_elv_CommercialSpecialtyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_44b56162-89a4-47b5-967c-7dc914665b4e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_4bd7d446-6efe-4051-a970-4c06082d2a35_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2022 [Member]</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_8897c8b2-63e0-4f42-ad22-9e5151c476e2_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_6f14b136-bdc4-401b-847c-2702e6632f4c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_458ad11d-e244-4a0f-b748-eed5cae7e7eb_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage-backed securities, Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_0408e369-9bc6-4e51-b1d9-ed56bf7f3317_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_55cb7d9d-d9d1-4991-ac69-b8ca991320e8_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cbfaf370-1171-4d28-9459-5da520d9ae6f_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_55d37340-5aa1-45a2-b5bb-7dc8331d687f_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity, Beginning Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a41ece38-e519-49e3-9f4c-030a46179866_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity, Ending Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_794c8c21-5fe3-4286-9512-c4284b9eceb7_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_6377785f-c62b-4bcb-9399-614fc6e86158_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_CommitmentsAndContingenciesTable_eda437e1-31c5-40af-aea6-1e36fe1f65fe_terseLabel_en-US" xlink:label="lab_elv_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:label id="lab_elv_CommitmentsAndContingenciesTable_label_en-US" xlink:label="lab_elv_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:label id="lab_elv_CommitmentsAndContingenciesTable_documentation_en-US" xlink:label="lab_elv_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies [Table].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommitmentsAndContingenciesTable" xlink:href="elv-20220930.xsd#elv_CommitmentsAndContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_CommitmentsAndContingenciesTable" xlink:to="lab_elv_CommitmentsAndContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_07594950-4a1d-4b7f-a440-d898f7a2e5fc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion rate (shares of common stock per $1,000 of principal)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_243cb819-af6b-49e5-a05a-bf3b60e6a57e_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_bf205e99-d585-4964-b82c-6a75fe880af2_periodStartLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests, Beginning Balance</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_09e7844f-448a-49fc-af4d-8ae7e51ffbb3_periodEndLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests, Ending Balance</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_8116b16f-fac4-4694-abb8-477f91712c9a_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in one year or less, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_d8b809a2-ed97-4c05-996e-ef8ec89ff4c7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_9769155c-f52c-44cc-9a3c-ca5dd4ce78e6_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan_0048f02a-f56d-4973-9670-150b4239b403_terseLabel_en-US" xlink:label="lab_elv_SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities lending transactions ratio of fair value of collateral held to fair value of securities loaned</link:label>
    <link:label id="lab_elv_SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan_label_en-US" xlink:label="lab_elv_SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Lending Transactions Ratio of Fair Value of Collateral Held To Securities On Loan</link:label>
    <link:label id="lab_elv_SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan_documentation_en-US" xlink:label="lab_elv_SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ratio of fair value of collateral held to fair value of securities loaned in securities lending transactions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan" xlink:href="elv-20220930.xsd#elv_SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan" xlink:to="lab_elv_SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_3fea6ee6-971a-44c1-a12c-2971f5ac6bc1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClaimsDevelopmentLineItems_8d7a77f0-c5ca-4bc0-bda8-b92271903cae_terseLabel_en-US" xlink:label="lab_us-gaap_ClaimsDevelopmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims Development [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClaimsDevelopmentLineItems_label_en-US" xlink:label="lab_us-gaap_ClaimsDevelopmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims Development [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems" xlink:to="lab_us-gaap_ClaimsDevelopmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3a5f9260-d182-4163-b177-6333473b155f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b5f1a191-07e1-41c7-94bd-fb75fbf73de2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_a4540159-79c8-4b3a-bf22-cb45c3f4890b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_e542f775-3875-4182-92db-aa1a7b989071_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_c2e9baa4-6376-492f-99a2-f036c9b416db_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:to="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_0c43cca4-ce36-4abd-9c7f-84245557820a_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_9d888103-a181-4b39-ae6c-2eda123b0150_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c5ea22ea-1a37-41a2-ab5c-947aa9e145f1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_ReconciliationOfTheClaimsDevelopmentToTheClaimsLiabilityAbstract_c53f6ec2-6b90-44ac-9fa8-ce325afb2f51_terseLabel_en-US" xlink:label="lab_elv_ReconciliationOfTheClaimsDevelopmentToTheClaimsLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of The Claims Development To The Claims Liability [Abstract]</link:label>
    <link:label id="lab_elv_ReconciliationOfTheClaimsDevelopmentToTheClaimsLiabilityAbstract_label_en-US" xlink:label="lab_elv_ReconciliationOfTheClaimsDevelopmentToTheClaimsLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of The Claims Development To The Claims Liability [Abstract]</link:label>
    <link:label id="lab_elv_ReconciliationOfTheClaimsDevelopmentToTheClaimsLiabilityAbstract_documentation_en-US" xlink:label="lab_elv_ReconciliationOfTheClaimsDevelopmentToTheClaimsLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of The Claims Development To The Claims Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ReconciliationOfTheClaimsDevelopmentToTheClaimsLiabilityAbstract" xlink:href="elv-20220930.xsd#elv_ReconciliationOfTheClaimsDevelopmentToTheClaimsLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_ReconciliationOfTheClaimsDevelopmentToTheClaimsLiabilityAbstract" xlink:to="lab_elv_ReconciliationOfTheClaimsDevelopmentToTheClaimsLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent_375e3c35-217a-4446-bfdd-922f45824bf5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed maturities, allowance for credit Loss, noncurrent</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_A2022To2024Member_fe47f13b-703d-4443-9d76-53704eaa482d_terseLabel_en-US" xlink:label="lab_elv_A2022To2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 to 2024</link:label>
    <link:label id="lab_elv_A2022To2024Member_773edb28-3d4f-4f4e-abb1-c3ef7778fce4_verboseLabel_en-US" xlink:label="lab_elv_A2022To2024Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 to 2024 [Member]</link:label>
    <link:label id="lab_elv_A2022To2024Member_label_en-US" xlink:label="lab_elv_A2022To2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 to 2024 [Member]</link:label>
    <link:label id="lab_elv_A2022To2024Member_documentation_en-US" xlink:label="lab_elv_A2022To2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 to 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_A2022To2024Member" xlink:href="elv-20220930.xsd#elv_A2022To2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_A2022To2024Member" xlink:to="lab_elv_A2022To2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_4c326fa0-fc68-4d73-8eae-4f4b8dc678b0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_3a78fad4-1629-49c8-a125-54a8a4ac1e40_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesLineItems_c5bf2ce0-09cc-49db-bf62-7bab990e3c43_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Line Items]</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems" xlink:to="lab_us-gaap_MarketableSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_45f87f13-b3d6-4013-8917-f975e83dc3a4_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3a8fd471-0007-4733-8ddf-ceeb1ef1334d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted, Restricted Stock Shares and Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c87b91d9-90f6-47a2-b85d-9e7642f3573a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units issued under stock incentive plan</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_d82ba2f9-4963-4dab-a1bc-6b9431e6a2d7_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_87b482af-ace7-49f9-bd5b-76a0c4969096_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6947b8eb-a833-4052-abe8-0337f3690837_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_PerformanceMeasurementPeriodDomain_15f49cef-e7ea-47ed-99fd-6002bd96b09b_terseLabel_en-US" xlink:label="lab_elv_PerformanceMeasurementPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance measurement period [Domain]</link:label>
    <link:label id="lab_elv_PerformanceMeasurementPeriodDomain_label_en-US" xlink:label="lab_elv_PerformanceMeasurementPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance measurement period [Domain]</link:label>
    <link:label id="lab_elv_PerformanceMeasurementPeriodDomain_documentation_en-US" xlink:label="lab_elv_PerformanceMeasurementPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance measurement period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_PerformanceMeasurementPeriodDomain" xlink:href="elv-20220930.xsd#elv_PerformanceMeasurementPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_PerformanceMeasurementPeriodDomain" xlink:to="lab_elv_PerformanceMeasurementPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_GrossLossesFromOtherInvestments_2860118e-710f-47f6-91e3-3d4dbe65bb56_negatedTerseLabel_en-US" xlink:label="lab_elv_GrossLossesFromOtherInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross losses</link:label>
    <link:label id="lab_elv_GrossLossesFromOtherInvestments_label_en-US" xlink:label="lab_elv_GrossLossesFromOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Losses From Other Investments</link:label>
    <link:label id="lab_elv_GrossLossesFromOtherInvestments_documentation_en-US" xlink:label="lab_elv_GrossLossesFromOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Losses From Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GrossLossesFromOtherInvestments" xlink:href="elv-20220930.xsd#elv_GrossLossesFromOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_GrossLossesFromOtherInvestments" xlink:to="lab_elv_GrossLossesFromOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_a6fd99e0-aaf4-4d48-8d15-a5982bde0abc_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2bb83d41-927a-473e-85e6-7abadcb2f139_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in net unrealized gains/losses on cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_70bac85d-0c47-4b17-9b7e-5c2467b5e3bd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedges, holding gain (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_3e146976-6385-4803-8dc0-38726ac20841_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of securities, 12 months or greater</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_e23c91c9-85b0-455b-a215-4bb3f04e6de4_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_0ef5c3b6-c3d9-4638-a4b6-d39956cf5422_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract_801311c0-27bb-4e0b-918c-7a89cecd903c_terseLabel_en-US" xlink:label="lab_elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases (Reconciliation of Future Lease Payments to Total Lease Liabilities) [Abstract]</link:label>
    <link:label id="lab_elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract_label_en-US" xlink:label="lab_elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases (Reconciliation of Future Lease Payments to Total Lease Liabilities) [Abstract]</link:label>
    <link:label id="lab_elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract_documentation_en-US" xlink:label="lab_elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of future lease payments to total lease liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract" xlink:href="elv-20220930.xsd#elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract" xlink:to="lab_elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_c6d71be2-9d02-461a-b5c5-e4eba7473443_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_1513e69c-09c9-4abf-925e-1a3820803ea2_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value, 12 months or greater</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a7340750-85de-4963-b674-9a553c7ce263_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount, Total Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_ffc63863-996d-4eb9-ab45-9ba8ccdf81a9_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Record date</link:label>
    <link:label id="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_fa952f0e-2271-47c5-9da6-d13cb0fe0c6d_verboseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date of Record</link:label>
    <link:label id="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_label_en-US" xlink:label="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date of Record</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:to="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_f9e821d9-fdc3-427e-8d61-8faaff3924cc_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of other intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_7d664de7-5525-42d6-890f-6e1dd5b40720_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of The Change In The Carrying Amount Of Goodwill By Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_fa03ff4f-03a3-44bf-83b3-a963459de4f7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_fd666b6a-e7e8-4fbb-a5b3-1753532efaeb_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease payments, 2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_0e50b144-f495-48e0-adb2-9be04c1c14ef_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from (repayments of) commercial paper borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7cba1c5c-a1ec-41bb-85d7-095c76669d5f_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_ddf4a4ab-d9cf-46e1-9d73-2e6ba11e0237_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approximate amount of damages sought for breaches</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_be04fbec-4fa3-41ae-a77e-244e754e596f_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_6074ba36-5b6b-4f1a-ac04-8fd060f5d1ad_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders' equity, Beginning Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_bb1364fe-c835-4291-8c49-bd95b8931c1e_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders' equity, Ending Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_54ba8754-5f45-4cf0-94eb-caa62b243db2_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity attributable to parent</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_9ce1361d-5c35-4a8b-9e83-e5812e36caad_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_CommonEquitySecuritiesMember_83db4264-ea53-4a82-8985-3413797e06de_terseLabel_en-US" xlink:label="lab_elv_CommonEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Equity Securities [Member]</link:label>
    <link:label id="lab_elv_CommonEquitySecuritiesMember_label_en-US" xlink:label="lab_elv_CommonEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Equity Securities [Member]</link:label>
    <link:label id="lab_elv_CommonEquitySecuritiesMember_documentation_en-US" xlink:label="lab_elv_CommonEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommonEquitySecuritiesMember" xlink:href="elv-20220930.xsd#elv_CommonEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_CommonEquitySecuritiesMember" xlink:to="lab_elv_CommonEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_ca85f341-3a8c-4401-95ea-d652ff49a3fe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited, Weighted-Average Grant Date Fair Value per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_d64beba3-592d-4e77-9534-47129dacae22_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through ten years, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_ea895a61-0c15-4c56-8c75-009b4e896a4f_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends and dividend equivalents</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_eccf6644-449a-4fc1-97c1-cb36448d907f_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed maturities, allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_465cd2ee-fee6-4aa7-b66d-3441731cc16a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed maturities, allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingencyNatureDomain_4c2b2b89-262c-4e21-b359-93f654a11d9d_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_GainContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_GainContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingencyNatureDomain" xlink:to="lab_us-gaap_GainContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_8ae9b368-9cc3-4483-aa06-26579369b2b3_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_18234fcc-2b58-4a0f-9e59-29c0b9d46a11_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Mortgage-Backed Securities [Member]</link:label>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Mortgage-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_35c14d87-b466-4329-a355-692ff5af71fb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization, Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_f5437f41-b5b8-438d-b88f-02036e47eb5a_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Sponsored Securities [Member]</link:label>
    <link:label id="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government-sponsored Enterprises Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7664148e-7886-4741-bacd-99c6363d51de_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2ba07031-3b2a-4a63-bb38-9deeab87c897_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_ebff3d2d-ce4e-493c-8dab-eecaebac497d_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2021 [Member]</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_bd428f54-8c41-4e2c-9a38-3a1e7de8b3e1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Available-for-sale Securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_e14d44b7-d67f-4a73-8b0c-5d51815ebfe6_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_499a5e66-c8cc-448d-b443-c09a587620c6_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_329c2a48-9cc6-4ef0-8eaa-16ebd36fb81a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_3a03ca24-eb63-4481-aabd-3bd38af0c5e8_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total payment</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_55895e39-09a3-4552-a350-4abfe2469da9_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_f2b61c3b-d510-476f-b61e-28d9fed3da5b_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_A5YearFacilityMember_5e6fc797-1dcd-4aaf-8b94-52f6075b4b4d_terseLabel_en-US" xlink:label="lab_elv_A5YearFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5-Year Facility [Member]</link:label>
    <link:label id="lab_elv_A5YearFacilityMember_label_en-US" xlink:label="lab_elv_A5YearFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5-Year Facility [Member]</link:label>
    <link:label id="lab_elv_A5YearFacilityMember_documentation_en-US" xlink:label="lab_elv_A5YearFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5-Year Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_A5YearFacilityMember" xlink:href="elv-20220930.xsd#elv_A5YearFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_A5YearFacilityMember" xlink:to="lab_elv_A5YearFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_1d91e1c7-5502-4ced-b162-de2061fa2b3d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_90d0243b-a9d5-4f9f-99ec-4c95c0dfa1d9_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_IntegratedHealthServicesMember_1a1dd46e-8bca-4373-ad71-cf6e9d475e1a_terseLabel_en-US" xlink:label="lab_elv_IntegratedHealthServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integrated health services</link:label>
    <link:label id="lab_elv_IntegratedHealthServicesMember_label_en-US" xlink:label="lab_elv_IntegratedHealthServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integrated health services [Member]</link:label>
    <link:label id="lab_elv_IntegratedHealthServicesMember_documentation_en-US" xlink:label="lab_elv_IntegratedHealthServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integrated health services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IntegratedHealthServicesMember" xlink:href="elv-20220930.xsd#elv_IntegratedHealthServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_IntegratedHealthServicesMember" xlink:to="lab_elv_IntegratedHealthServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense_02d823ef-338a-479f-9070-bbae2c6574e6_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quality improvement and other claims expense</link:label>
    <link:label id="lab_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense_label_en-US" xlink:label="lab_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Operating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense" xlink:to="lab_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsReceivableAtCarryingValue_75b98b11-2362-49b0-8e81-f6faedd14005_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium receivables</link:label>
    <link:label id="lab_us-gaap_PremiumsReceivableAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsReceivableAtCarryingValue" xlink:to="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_dcd84d4f-6547-4ffa-aa0a-27a8121e6f46_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Disclosure [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_380d36c4-25a3-4640-89ad-a73e7613e9c2_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_729eb9f7-6778-4732-96bd-857839e3c38b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase and retirement of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_c454f08d-52ff-4500-be04-74755cabc281_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaper_67ac6f9a-ac96-4927-b5ae-51bbd1c58adb_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaper_label_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaper" xlink:to="lab_us-gaap_CommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_548acc40-d159-439f-a3ce-33051ed56199_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_18b19468-33fb-4336-9b02-bb2def7d0dd0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_afce70e7-4cee-46cf-bc69-95016f4c77f0_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested, Weighted-Average Grant Date Fair Value per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_IntangibleAssetsTable_5f3f4eb9-3056-4121-bdfd-26024a5192cf_terseLabel_en-US" xlink:label="lab_elv_IntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Table]</link:label>
    <link:label id="lab_elv_IntangibleAssetsTable_label_en-US" xlink:label="lab_elv_IntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Table]</link:label>
    <link:label id="lab_elv_IntangibleAssetsTable_documentation_en-US" xlink:label="lab_elv_IntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IntangibleAssetsTable" xlink:href="elv-20220930.xsd#elv_IntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_IntangibleAssetsTable" xlink:to="lab_elv_IntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_A2021364DayFacilityMember_80c6dea2-7d5b-4227-af20-b5585e430e88_terseLabel_en-US" xlink:label="lab_elv_A2021364DayFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 364-Day Facility [Member]</link:label>
    <link:label id="lab_elv_A2021364DayFacilityMember_label_en-US" xlink:label="lab_elv_A2021364DayFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 364-Day Facility [Member]</link:label>
    <link:label id="lab_elv_A2021364DayFacilityMember_documentation_en-US" xlink:label="lab_elv_A2021364DayFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 364-Day Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_A2021364DayFacilityMember" xlink:href="elv-20220930.xsd#elv_A2021364DayFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_A2021364DayFacilityMember" xlink:to="lab_elv_A2021364DayFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_ee921e19-3baa-4308-b13a-050fdf3a9e2f_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement_fbe722a7-615d-460e-8b17-56e857602131_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" xlink:to="lab_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_5d3c36ff-c602-4d38-af5e-cb2582cc44b7_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts, other receivables</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss, Receivable, Other, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_e8415a08-b0df-4401-bc98-c68bf4fcea80_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_83045456-a9c6-4e80-bc6e-dbb1350d6425_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_2d730044-6356-4fb6-8a48-9c9f562965a8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Share Repurchases</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_6536fc40-b1be-4571-9a9a-dff7b565bdf8_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_9c7c2d82-f1d9-4386-9ed5-482139442fd0_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized gains (losses) recognized on equity securities sold during the period</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGain_2ca27543-60ff-491b-bbe9-6c5ddc7e2015_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses) gains recognized on equity securities still held at the end of the period</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGain_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_fc48a336-bdaf-4ca3-ab58-39d487463372_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount, Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_03f2fbac-a15a-4771-9bf9-5a0368f64660_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount, Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_9a18b541-6f36-4c16-932c-46f523d253de_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_8d2d6e97-3234-4335-ae84-67fc7147b2a6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers into Level III</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_bd682230-4cbe-49a7-8b8d-f37b4e9a6a62_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after ten years, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_GovernmentBusinessSegmentMember_82deb5b4-d973-4f96-9c05-1b321851e24e_terseLabel_en-US" xlink:label="lab_elv_GovernmentBusinessSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Business Segment [Member]</link:label>
    <link:label id="lab_elv_GovernmentBusinessSegmentMember_76f9c7a9-e781-45ed-a3d8-a63316992417_verboseLabel_en-US" xlink:label="lab_elv_GovernmentBusinessSegmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Business [Member]</link:label>
    <link:label id="lab_elv_GovernmentBusinessSegmentMember_label_en-US" xlink:label="lab_elv_GovernmentBusinessSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Business Segment [Member]</link:label>
    <link:label id="lab_elv_GovernmentBusinessSegmentMember_documentation_en-US" xlink:label="lab_elv_GovernmentBusinessSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Business Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GovernmentBusinessSegmentMember" xlink:href="elv-20220930.xsd#elv_GovernmentBusinessSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_GovernmentBusinessSegmentMember" xlink:to="lab_elv_GovernmentBusinessSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_e42cb0b7-3fc8-4fe0-b939-2bebcb026892_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_c8c085ad-73c8-4aba-a059-b0138ca5c82f_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blue Cross And Blue Shield And Other Trademarks [Member]</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_953d00d6-b44c-415c-b9cf-2dc8ca7d7b71_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrealized gains (losses) included in net income related to assets still held</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_68529a85-84a7-4fc5-8fd0-e0103d9a3052_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Claim Year [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Accident Year [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_e47f58b8-fa6e-4113-a5f8-81e9973b10f6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_daeca57f-3f9b-42ae-9a92-73283fa96808_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ea63a94c-b9d7-46ef-9088-48bb8d01c769_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period, Weighted-Average Option Price per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_985b2674-6076-4233-9b23-65ba1cef472e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification adjustment for net realized loss (gain) on investment securities, tax (benefit) expense</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_ddd41a38-1292-415e-9674-bd49e884b1f0_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value, less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_dd386dc9-c02b-4188-b8af-c5e17365c65c_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_AccountingPoliciesLineItems_89ed2915-38aa-47bc-990e-ec2e68fa6e1f_terseLabel_en-US" xlink:label="lab_elv_AccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Line Items]</link:label>
    <link:label id="lab_elv_AccountingPoliciesLineItems_label_en-US" xlink:label="lab_elv_AccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Line Items]</link:label>
    <link:label id="lab_elv_AccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_elv_AccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_AccountingPoliciesLineItems" xlink:href="elv-20220930.xsd#elv_AccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_AccountingPoliciesLineItems" xlink:to="lab_elv_AccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember_cff39c12-9f96-4234-8bc7-8f7969654472_terseLabel_en-US" xlink:label="lab_elv_FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Five Five Zero Due Two Thousand Fifty Two [Member]</link:label>
    <link:label id="lab_elv_FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember_label_en-US" xlink:label="lab_elv_FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Five Five Zero Due Two Thousand Fifty Two [Member]</link:label>
    <link:label id="lab_elv_FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember_documentation_en-US" xlink:label="lab_elv_FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Five Five Zero Due Two Thousand Fifty Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember" xlink:href="elv-20220930.xsd#elv_FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember" xlink:to="lab_elv_FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0f175da7-5f40-4dd0-8916-48d60a619346_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_27ad2179-b839-4eea-b765-4ccfb594d157_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e590993d-3742-445f-91ac-b5857c014004_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at Beginning Balance, Restricted Stock Shares and Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d545945f-c797-433a-ace2-5ddbbfafdfda_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at Ending Balance, Restricted Stock Shares and Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_6329261f-a3e3-426c-bb78-60b4212a8e21_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Period Increase (Decrease)</link:label>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_43d16b56-8fb4-42e9-a9c3-571aebe79116_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_d2b547d2-dc35-4605-ae8d-0f2c34a42b32_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount, Finite Lived Intangibles</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_821bc6d3-4f44-44aa-ba76-9efa6aed85a1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_13318d41-b6d1-4b2d-af4a-3f892f10b015_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_ba0197e4-6bdc-4a25-8e84-a4f6711126ac_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_05273f42-6194-476e-9981-a1776fc3adcd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_InvestmentsinequitysecuritiesTableTextBlock_bbfd9af8-b8e9-495b-b4f5-d6b20c1358f5_terseLabel_en-US" xlink:label="lab_elv_InvestmentsinequitysecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In Equity Securities</link:label>
    <link:label id="lab_elv_InvestmentsinequitysecuritiesTableTextBlock_label_en-US" xlink:label="lab_elv_InvestmentsinequitysecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity securities [Table Text Block]</link:label>
    <link:label id="lab_elv_InvestmentsinequitysecuritiesTableTextBlock_documentation_en-US" xlink:label="lab_elv_InvestmentsinequitysecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_InvestmentsinequitysecuritiesTableTextBlock" xlink:href="elv-20220930.xsd#elv_InvestmentsinequitysecuritiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_InvestmentsinequitysecuritiesTableTextBlock" xlink:to="lab_elv_InvestmentsinequitysecuritiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_df7acbdd-ff9f-4264-9385-38d24f442e8d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Loss) Income [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceServicesRevenue_ea59e01f-d2e8-4002-a226-9dd20f07e4f6_verboseLabel_en-US" xlink:label="lab_us-gaap_InsuranceServicesRevenue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reportable segments operating revenues</link:label>
    <link:label id="lab_us-gaap_InsuranceServicesRevenue_fbe8a3c0-7f0c-4cc2-8d83-b1a21149b9d2_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceServicesRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Services Revenue</link:label>
    <link:label id="lab_us-gaap_InsuranceServicesRevenue_label_en-US" xlink:label="lab_us-gaap_InsuranceServicesRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Services Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceServicesRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceServicesRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceServicesRevenue" xlink:to="lab_us-gaap_InsuranceServicesRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_e25d63ab-60ad-49ee-bd12-c23a81c053ee_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_b24f9472-96dd-4891-87c9-b9914a013d39_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Optimization Initiatives by Type [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_4ab3976e-4620-4d75-a376-b14591b20226_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_dc153965-f192-421e-af67-01546985a254_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_74518e48-89a6-4646-92d8-9e155b63bcc1_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating gain (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_2d25ebb9-a746-4df6-b9dc-196c3b630f57_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reportable segments operating gain</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ac890f4b-78a1-4791-9d26-966b3ae3e76e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments_73e2fff7-a26e-4883-aaf2-70a00fdc9339_terseLabel_en-US" xlink:label="lab_elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combinations and purchase adjustments</link:label>
    <link:label id="lab_elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments_label_en-US" xlink:label="lab_elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense Purchase Adjustments</link:label>
    <link:label id="lab_elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments_documentation_en-US" xlink:label="lab_elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense Purchase Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments" xlink:href="elv-20220930.xsd#elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments" xlink:to="lab_elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_bed86318-ad5b-464d-b206-a0176af148b7_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPolicyholderFunds_3779408e-9df1-403b-9e56-c6905db8f27c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other policyholder liabilities</link:label>
    <link:label id="lab_us-gaap_OtherPolicyholderFunds_label_en-US" xlink:label="lab_us-gaap_OtherPolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Policyholder Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPolicyholderFunds" xlink:to="lab_us-gaap_OtherPolicyholderFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionDomain_f999508f-d93e-4b14-9b94-bb6e801e51d1_terseLabel_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:label id="lab_us-gaap_PositionDomain_label_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionDomain" xlink:to="lab_us-gaap_PositionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_e46993c7-b5d3-43f4-a57d-78d63af41a5e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_349deaa3-4790-41ac-9c3c-623bb93aa7fe_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_2b580bef-5d18-4a6f-8f0e-768d594e235d_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Beginning Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_7268edee-04bd-4822-b14d-14238134f36d_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Ending Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_AffiliatedMember_30c33a4f-b54a-4080-9681-060dfe4d6603_terseLabel_en-US" xlink:label="lab_elv_AffiliatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated [Member]</link:label>
    <link:label id="lab_elv_AffiliatedMember_label_en-US" xlink:label="lab_elv_AffiliatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated [Member]</link:label>
    <link:label id="lab_elv_AffiliatedMember_documentation_en-US" xlink:label="lab_elv_AffiliatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_AffiliatedMember" xlink:href="elv-20220930.xsd#elv_AffiliatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_AffiliatedMember" xlink:to="lab_elv_AffiliatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_MajorProductRevenueBySegmentTableTextBlock_7176b48e-8d01-4818-a522-27e94b7ea595_terseLabel_en-US" xlink:label="lab_elv_MajorProductRevenueBySegmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Product Revenue by Segment</link:label>
    <link:label id="lab_elv_MajorProductRevenueBySegmentTableTextBlock_label_en-US" xlink:label="lab_elv_MajorProductRevenueBySegmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Product Revenue By Segment [Table Text Block]</link:label>
    <link:label id="lab_elv_MajorProductRevenueBySegmentTableTextBlock_documentation_en-US" xlink:label="lab_elv_MajorProductRevenueBySegmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Table Text Block] for Major Product Revenue By Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_MajorProductRevenueBySegmentTableTextBlock" xlink:href="elv-20220930.xsd#elv_MajorProductRevenueBySegmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_MajorProductRevenueBySegmentTableTextBlock" xlink:to="lab_elv_MajorProductRevenueBySegmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayable_179ede0a-4085-4fff-9229-4073a7f96dda_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes</link:label>
    <link:label id="lab_us-gaap_NotesPayable_label_en-US" xlink:label="lab_us-gaap_NotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayable" xlink:to="lab_us-gaap_NotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_519d5156-2345-4752-a237-4c933183208c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized investment (losses) gains</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired_9714120e-477a-44e1-884f-73e47903ea2a_terseLabel_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets Acquired</link:label>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:to="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_bc6e1b71-97b9-44e9-a60b-44fdd7c214f5_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests adjustment</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Subsidiary Equity Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dcb16576-8281-49bd-8ea0-ed17b4dce0f7_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_f92bdc5a-6d39-4e8b-b8e8-7b6bca6445fd_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_d0df4476-d652-42b3-8ca4-37e799fdbc3d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositsReceivedForSecuritiesLoanedAtCarryingValue_6a311d6d-d6f2-4f45-87fd-b1c46e123266_terseLabel_en-US" xlink:label="lab_us-gaap_DepositsReceivedForSecuritiesLoanedAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateral received for securities loaned, at carrying value</link:label>
    <link:label id="lab_us-gaap_DepositsReceivedForSecuritiesLoanedAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_DepositsReceivedForSecuritiesLoanedAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits Received for Securities Loaned, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsReceivedForSecuritiesLoanedAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsReceivedForSecuritiesLoanedAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsReceivedForSecuritiesLoanedAtCarryingValue" xlink:to="lab_us-gaap_DepositsReceivedForSecuritiesLoanedAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_5b0333f5-a43b-45f7-bf59-6801b8f5af7c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_bdfd6cd6-c5ba-4200-bad0-cc8e59760aef_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_733ff9e8-11da-49aa-b14b-c055b3273ba9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease payments, 2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_fda29ace-01a6-4c33-b377-8d2f8a7b683c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_ad829425-0105-46ae-a4c7-adf141c0160a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_04de87e2-b491-4a8b-8238-bb29d70254e7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_68201566-6b11-4f90-b86c-df662ea4515b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_a1bec8ff-4b7f-40e2-9ec6-b0f4ef9f41dd_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_eef6985f-5ba6-4371-acae-4cf752dfcb02_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State Medicaid Licenses [Member]</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_da2be06d-4294-4946-aeaf-ca1c717ef112_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_412391e7-6c8f-4221-b6a2-6e711961e704_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjusted Balance</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjusted Balance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_960e0c91-a4e0-4a8e-a98b-8e4658cdd60f_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss_41bab11f-e924-4908-972e-b4d0d0e6876e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized gains (losses) recognized on equity securities sold during the period</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b7c76620-0726-4123-a06c-88851ee9a167_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator for diluted earnings per share</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_9b57711a-ee95-413e-bc4e-b4f233c67cbf_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_97c8d774-ba77-49f5-b8e1-4dc86ff5f11a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average expected life (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_0f63b96b-901a-4012-a78f-b109799c7154_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debentures</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_b838a2b5-0224-4be3-90b4-4adf48c676ff_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net debt carrying amount</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:to="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_17bb9d96-5f06-4e2e-81a8-92488788b8bb_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ca23832f-4b4a-49c2-8712-e2ad1e4dae18_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_aed1e593-ef57-435f-90f8-64f06210723f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current and Long-Term Investments, Available-For-Sale</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_5f6a26dc-8686-4dd4-9f2c-89a78ab7afde_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends per share</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_8cda10ca-3b7a-448d-b629-e988f6ae5da1_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCovenantCompliance_e1f72771-a9a5-43e9-8801-fcbd7a4de3f1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCovenantCompliance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant compliance</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCovenantCompliance_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCovenantCompliance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Compliance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCovenantCompliance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCovenantCompliance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCovenantCompliance" xlink:to="lab_us-gaap_DebtInstrumentCovenantCompliance" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock_490e88b0-a079-4ba7-84a7-1c8428d34c43_terseLabel_en-US" xlink:label="lab_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Net Incurred Medical Claims to Benefit Expense</link:label>
    <link:label id="lab_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock_label_en-US" xlink:label="lab_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Net Incurred Medical Claims to Benefit Expense [Table Text Block]</link:label>
    <link:label id="lab_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock_documentation_en-US" xlink:label="lab_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular Disclosure For Reconciliation of Net Incurred Medical Claims to Benefit Expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock" xlink:href="elv-20220930.xsd#elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock" xlink:to="lab_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_b41cfeda-06fd-46e4-9b31-1db2dacd32b1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.01, shares authorized &#8211; 900,000,000; shares issued and outstanding &#8211; 238,974,624 and 241,770,746</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_f669c01a-f695-44e9-ba17-ceb1ce087978_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_c4c466b1-6522-4f03-bad9-49413ce614ca_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_60ad3314-860f-471b-a972-38222a0ff2e6_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted, Weighted-Average Grant Date Fair Value per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_655f53fd-1e84-43c6-a365-b6afead4aeb9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock awards granted during the period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_3a997552-0496-436f-a34a-327221677622_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective conversion price (per $1,000 of principal amount) per share</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_74d8e051-b344-4c10-a3c7-51bcf5dc632e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements By Level For Assets Measured At Fair Value On A Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_e1575685-590b-4408-8efc-fe5a9b3c12dc_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_bc7ba665-91fd-410d-8317-0ed88956b39a_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncome_a56370c8-faa1-4034-95cb-4bb297d71fd8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Administrative fees and other revenue</link:label>
    <link:label id="lab_us-gaap_OtherIncome_label_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncome" xlink:to="lab_us-gaap_OtherIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityDescription_121aeca8-ab5c-4f6f-8089-188f41a7b7ee_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Description</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityDescription_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Description</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityDescription" xlink:to="lab_us-gaap_LineOfCreditFacilityDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_58cf1fab-ad4b-4ba6-9335-fd7b6f0879de_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults_857a5030-6ae2-4613-92e7-787c985ad6a4_terseLabel_en-US" xlink:label="lab_elv_PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units excluded from the denominator for diluted earnings per share</link:label>
    <link:label id="lab_elv_PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults_label_en-US" xlink:label="lab_elv_PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially Dilutive Restricted Stock Units Contingent On Operating Results</link:label>
    <link:label id="lab_elv_PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults_documentation_en-US" xlink:label="lab_elv_PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially Dilutive Restricted Stock Units Contingent On Operating Results</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults" xlink:href="elv-20220930.xsd#elv_PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults" xlink:to="lab_elv_PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_be3e25a7-0242-4715-8d9c-cf39e01ad326_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0a114264-8187-4ee2-a3e9-c1fd50c9f1f7_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_5d9723cd-1a93-45cb-ac9b-e4e37d4a41d3_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_cfeafc8c-be2f-4b94-9fc3-fcbd8f53cc9b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_59d88b6b-2033-49a5-aa3e-7acbb00bc2ca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss (income) attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9d05c315-51ac-4676-9180-429ae88022b2_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d88f0bc7-943b-4bbd-8d1d-fcce9e780b13_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_a3d2c4a1-16e3-414f-9417-683949889a44_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss as of September 30, 2022</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_d80a6bd2-a515-4736-8519-0093eb066e04_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_5dea76f3-854c-4902-8335-4f88f8698605_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock under employee stock plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_09e87f4c-b564-4e60-82c5-e66b67155234_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_e1b949b2-1dc0-4910-83ee-02a395de285b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_DebtConversionDebtPrincipalAmount_6d35905f-d828-4429-bee7-44d5fe64aab6_terseLabel_en-US" xlink:label="lab_elv_DebtConversionDebtPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion Debt Principal Amount</link:label>
    <link:label id="lab_elv_DebtConversionDebtPrincipalAmount_label_en-US" xlink:label="lab_elv_DebtConversionDebtPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion Debt Principal Amount</link:label>
    <link:label id="lab_elv_DebtConversionDebtPrincipalAmount_documentation_en-US" xlink:label="lab_elv_DebtConversionDebtPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The aggregate principal amount of the original debt instrument that was surrendered for conversion.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_DebtConversionDebtPrincipalAmount" xlink:href="elv-20220930.xsd#elv_DebtConversionDebtPrincipalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_DebtConversionDebtPrincipalAmount" xlink:to="lab_elv_DebtConversionDebtPrincipalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_de5d4f58-5b52-4058-8685-f0e261dba818_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6847252-b596-4d69-bb41-d8fd0f3524d2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_eab15097-1290-4081-ba82-ed1783613ef1_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_0a5d2627-fe16-4148-ba4b-e9fea3114101_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_49f642c6-ba7f-4052-89ca-c016cca9d493_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_468fa9b0-3156-427b-bbf9-d6057c14e50f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_AnthemInc.v.ExpressScriptsInc.Member_84a8d8e8-dcf5-4af8-aa95-091654f5b3c7_terseLabel_en-US" xlink:label="lab_elv_AnthemInc.v.ExpressScriptsInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anthem, Inc. v. Express Scripts, Inc. [Member]</link:label>
    <link:label id="lab_elv_AnthemInc.v.ExpressScriptsInc.Member_label_en-US" xlink:label="lab_elv_AnthemInc.v.ExpressScriptsInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anthem, Inc. v. Express Scripts, Inc. [Member]</link:label>
    <link:label id="lab_elv_AnthemInc.v.ExpressScriptsInc.Member_documentation_en-US" xlink:label="lab_elv_AnthemInc.v.ExpressScriptsInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anthem, Inc. v. Express Scripts, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_AnthemInc.v.ExpressScriptsInc.Member" xlink:href="elv-20220930.xsd#elv_AnthemInc.v.ExpressScriptsInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_AnthemInc.v.ExpressScriptsInc.Member" xlink:to="lab_elv_AnthemInc.v.ExpressScriptsInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_9b488fc3-7745-4d4a-a143-2ab5caf5360d_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_eafdd729-5d56-4e4c-a5b0-feb8b4c614a8_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_18d80823-ffb9-453d-86a8-9141232d8275_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_444633b1-fe88-421c-afbe-f2636949a09c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_fde8eaab-e026-4064-9c6d-a689981465f3_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_5943b998-9398-4df9-9abb-6c88a3a3b550_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_18e47c88-323a-4851-bd18-20c675cce63c_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2020 [Member]</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_fd382f5e-b345-45ab-addb-45ec80b0368c_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Short Duration Medical Claims Payable to the Consolidated Medical Claims Payable</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_ad7fc59f-8743-4fba-859e-b2c6d07d15e7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_67ac6c59-6a95-4675-879f-8a6235962be4_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_effa0224-0171-47dc-9160-8891ea8c2f42_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Data By Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_19c305b1-c196-4997-9ee2-2d5fd1137535_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_c06cad60-1bb1-4134-96dc-d7b91076faba_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_297dee29-e4c4-400e-b921-cb9f9b4a6333_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_e271a228-88d2-48ea-843b-cc56ae11a79c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_5b479842-8722-4030-8d7d-33c8b468dec9_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1c5302a2-45c9-4c6b-95e0-168e1e303086_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period, Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_953f1235-5783-478d-b941-f500adca5618_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_5f01a89a-f203-4a26-b064-e42e22acfb85_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Claims Payable [Line Items]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_839f7687-5c56-4e6e-b233-18cbc2b265d1_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Amount Per Share</link:label>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_label_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Amount Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableAmountPerShare" xlink:to="lab_us-gaap_DividendsPayableAmountPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_A2021To2023Member_7375c160-b114-4083-b159-8dbac6366b7b_terseLabel_en-US" xlink:label="lab_elv_A2021To2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 to 2023 [Member]</link:label>
    <link:label id="lab_elv_A2021To2023Member_label_en-US" xlink:label="lab_elv_A2021To2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 to 2023 [Member]</link:label>
    <link:label id="lab_elv_A2021To2023Member_documentation_en-US" xlink:label="lab_elv_A2021To2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 to 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_A2021To2023Member" xlink:href="elv-20220930.xsd#elv_A2021To2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_A2021To2023Member" xlink:to="lab_elv_A2021To2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_39b8f9f8-14a8-49ce-ab50-b0c7c6ea2e03_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_51011937-e251-4675-8b92-396c335be033_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period, Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_30f2cde5-890f-4f9d-a66f-ded14bc20399_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period, Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_UnaffiliatedMember_c1356e63-6f01-4604-b69a-f66e32a2dd08_terseLabel_en-US" xlink:label="lab_elv_UnaffiliatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unaffiliated</link:label>
    <link:label id="lab_elv_UnaffiliatedMember_label_en-US" xlink:label="lab_elv_UnaffiliatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unaffiliated [Member]</link:label>
    <link:label id="lab_elv_UnaffiliatedMember_documentation_en-US" xlink:label="lab_elv_UnaffiliatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unaffiliated [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_UnaffiliatedMember" xlink:href="elv-20220930.xsd#elv_UnaffiliatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_UnaffiliatedMember" xlink:to="lab_elv_UnaffiliatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_GrossPremiumTaxRate_91839208-7282-4b76-ad65-988cca20428b_terseLabel_en-US" xlink:label="lab_elv_GrossPremiumTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross premium tax rate, state of California</link:label>
    <link:label id="lab_elv_GrossPremiumTaxRate_label_en-US" xlink:label="lab_elv_GrossPremiumTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Premium Tax Rate</link:label>
    <link:label id="lab_elv_GrossPremiumTaxRate_documentation_en-US" xlink:label="lab_elv_GrossPremiumTaxRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross premium tax rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GrossPremiumTaxRate" xlink:href="elv-20220930.xsd#elv_GrossPremiumTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_GrossPremiumTaxRate" xlink:to="lab_elv_GrossPremiumTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_SecuritiesLendingTransactionsInitialCollateralPercentageValue_f318c45c-8cd2-4cbe-bea9-5ef8e55c8c47_terseLabel_en-US" xlink:label="lab_elv_SecuritiesLendingTransactionsInitialCollateralPercentageValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities lending transactions, initial collateral percentage value</link:label>
    <link:label id="lab_elv_SecuritiesLendingTransactionsInitialCollateralPercentageValue_label_en-US" xlink:label="lab_elv_SecuritiesLendingTransactionsInitialCollateralPercentageValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Lending Transactions Initial Collateral Percentage Value</link:label>
    <link:label id="lab_elv_SecuritiesLendingTransactionsInitialCollateralPercentageValue_documentation_en-US" xlink:label="lab_elv_SecuritiesLendingTransactionsInitialCollateralPercentageValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial minimum percentage of cash and/or securities collateral accepted as compared to the value of securities on loan in a securities lending transaction.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SecuritiesLendingTransactionsInitialCollateralPercentageValue" xlink:href="elv-20220930.xsd#elv_SecuritiesLendingTransactionsInitialCollateralPercentageValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_SecuritiesLendingTransactionsInitialCollateralPercentageValue" xlink:to="lab_elv_SecuritiesLendingTransactionsInitialCollateralPercentageValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities_3a0905dc-2b7f-4173-9e40-4ecc22288412_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policy liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Insurance Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems_99da485c-4975-48d5-9248-84703390459a_terseLabel_en-US" xlink:label="lab_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of net incurred medical claims to benefit expense [Line Items]</link:label>
    <link:label id="lab_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems_label_en-US" xlink:label="lab_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">reconciliation of net incurred medical claims to benefit expense [Line Items]</link:label>
    <link:label id="lab_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems_documentation_en-US" xlink:label="lab_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Reconciliation of net incurred medical claims to benefit expense [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems" xlink:href="elv-20220930.xsd#elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems" xlink:to="lab_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_88a69d19-759b-4cfb-adb8-5c941230fd00_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of securities, less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_386d0244-87c2-4ffd-ba1d-b96fab7fb044_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_3877c6a9-fc9b-472d-b3eb-4e43dbd1302d_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1e01f471-5e29-458f-9664-4810ad8acaa6_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign exchange rates on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_6f85a49d-3fdf-4ad6-9ccb-43e79e10bfdb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_e31da02b-1dce-4a05-989c-af03b421032a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_NonCreditComponentsOfImpairmentsOnInvestmentsMember_4a02c82c-aa97-4950-a869-e992fc144d63_terseLabel_en-US" xlink:label="lab_elv_NonCreditComponentsOfImpairmentsOnInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-credit components of impairments on investments [Member]</link:label>
    <link:label id="lab_elv_NonCreditComponentsOfImpairmentsOnInvestmentsMember_label_en-US" xlink:label="lab_elv_NonCreditComponentsOfImpairmentsOnInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-credit components of impairments on investments [Member]</link:label>
    <link:label id="lab_elv_NonCreditComponentsOfImpairmentsOnInvestmentsMember_documentation_en-US" xlink:label="lab_elv_NonCreditComponentsOfImpairmentsOnInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-credit components of impairments on investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_NonCreditComponentsOfImpairmentsOnInvestmentsMember" xlink:href="elv-20220930.xsd#elv_NonCreditComponentsOfImpairmentsOnInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_NonCreditComponentsOfImpairmentsOnInvestmentsMember" xlink:to="lab_elv_NonCreditComponentsOfImpairmentsOnInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_PerformancemeasurementperiodAxis_c46504f7-6691-4cf2-ba7e-993cc7149bca_terseLabel_en-US" xlink:label="lab_elv_PerformancemeasurementperiodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance measurement period [Axis]</link:label>
    <link:label id="lab_elv_PerformancemeasurementperiodAxis_label_en-US" xlink:label="lab_elv_PerformancemeasurementperiodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance measurement period [Axis]</link:label>
    <link:label id="lab_elv_PerformancemeasurementperiodAxis_documentation_en-US" xlink:label="lab_elv_PerformancemeasurementperiodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance measurement period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_PerformancemeasurementperiodAxis" xlink:href="elv-20220930.xsd#elv_PerformancemeasurementperiodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_PerformancemeasurementperiodAxis" xlink:to="lab_elv_PerformancemeasurementperiodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_d5bf23a1-f013-4315-a4f7-af986a62d1dd_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_label_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Amortization and Accretion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:to="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_7c4a0abc-3340-4af3-8ee8-634b2b03b64c_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_c5046d02-801b-4332-9d10-b8d9ead2903c_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_beed5d86-f745-4a9f-a99f-1a1a205f195f_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_60b206db-e3eb-41f9-bf81-01aa854c2d51_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Period Increase</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsDeclaredTableTextBlock_6d436b84-c9eb-4827-a41a-544ac282cb81_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsDeclaredTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Cash Dividend Activity</link:label>
    <link:label id="lab_us-gaap_DividendsDeclaredTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DividendsDeclaredTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Declared [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDeclaredTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsDeclaredTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsDeclaredTableTextBlock" xlink:to="lab_us-gaap_DividendsDeclaredTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9fd316ed-9cbe-44d3-b8ab-60e0be33d278_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in net periodic pension and postretirement costs</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c2cfb2a6-ed7a-411e-934e-50259431e760_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_802c9b01-e3bb-4580-8fc0-a196604b91e8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volatility factor</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_45c8f720-a2c5-4054-821c-7932d7772185_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember_1289ebb2-8191-4157-acaa-94892458b0b2_terseLabel_en-US" xlink:label="lab_elv_ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Point One Two Five Percent Due Two Thousand Twenty Two [Member]</link:label>
    <link:label id="lab_elv_ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember_label_en-US" xlink:label="lab_elv_ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Point One Two Five Percent Due Two Thousand Twenty Two [Member]</link:label>
    <link:label id="lab_elv_ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember_documentation_en-US" xlink:label="lab_elv_ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Point One Two Five Percent Due Two Thousand Twenty Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember" xlink:href="elv-20220930.xsd#elv_ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember" xlink:to="lab_elv_ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_14a2ee2e-9d31-4b06-9331-0681578193d4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock plans, net of related tax benefits</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7d78289a-d8d6-4b06-b22e-2087e210740d_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited, Restricted Stock Shares And Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_01a027f3-9c2c-4b77-a0bb-210e71b71433_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_9784d92e-b6b1-430e-96bc-fe60b9da5992_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior revolving credit facility</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_056b6907-ff54-43c7-9055-3fd5db00a4a9_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in net unrealized losses/gains on investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_e1d672b4-e6cc-4d14-8e9c-e1f209770488_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_c1ce273c-67b2-463b-b04b-fe8c7ce2d3c8_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Optimization Initiatives</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_679f531c-33e7-4359-9d0e-c71285c2508b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_95b0b62e-bc48-4642-af22-de571686d9d5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_b196817b-a94d-4235-b095-7c49aedc5041_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_87645fdf-e254-495d-87c9-f169842f794a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3a604316-1f7e-4586-935b-c97d3d07f7ac_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8bd5fa96-6365-4547-8775-22556313b8b5_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss, Beginning Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0aa55c08-260e-4f09-b76b-39f7f8da2e73_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss, Ending Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_BCBSAntitrustLitigationMember_1a2e96ff-c2e5-46ea-8e2c-a95199e3632f_terseLabel_en-US" xlink:label="lab_elv_BCBSAntitrustLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BCBS Antitrust Litigation [Member]</link:label>
    <link:label id="lab_elv_BCBSAntitrustLitigationMember_label_en-US" xlink:label="lab_elv_BCBSAntitrustLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BCBS Antitrust Litigation [Member]</link:label>
    <link:label id="lab_elv_BCBSAntitrustLitigationMember_documentation_en-US" xlink:label="lab_elv_BCBSAntitrustLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BCBS Antitrust Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_BCBSAntitrustLitigationMember" xlink:href="elv-20220930.xsd#elv_BCBSAntitrustLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_BCBSAntitrustLitigationMember" xlink:to="lab_elv_BCBSAntitrustLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cb0204b4-a4b9-4699-bc5f-09350542947d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_d657cff7-e97a-4288-82e2-abc7a9d5d467_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase and retirement of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_297b1f04-f7a5-4a4c-8962-8d4bc4b36681_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate cost</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_c1b9fdc1-1b88-4776-9d4e-a0b536117b91_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis_150dd825-6b36-422d-9b0f-8a97a92a7a50_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase Agreements and Similar Transactions, Maturity Periods [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis_label_en-US" xlink:label="lab_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase Agreements and Similar Transactions, Maturity Periods [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis" xlink:to="lab_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_1decdb48-992d-4195-ab00-2956f21c35a2_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net losses on equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_64734cab-a08f-4f56-9f74-9bac7d65f5e4_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_620b038b-7d40-4609-bc31-f371e8cee0b6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedges, holding gain (loss), tax (expense) benefit</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_FiniteLivedIntangibleAssetExpectedAmortizationYearSix_71144075-99e5-4c0d-b734-f17e47f00277_terseLabel_en-US" xlink:label="lab_elv_FiniteLivedIntangibleAssetExpectedAmortizationYearSix" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, 2027</link:label>
    <link:label id="lab_elv_FiniteLivedIntangibleAssetExpectedAmortizationYearSix_label_en-US" xlink:label="lab_elv_FiniteLivedIntangibleAssetExpectedAmortizationYearSix" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Six</link:label>
    <link:label id="lab_elv_FiniteLivedIntangibleAssetExpectedAmortizationYearSix_documentation_en-US" xlink:label="lab_elv_FiniteLivedIntangibleAssetExpectedAmortizationYearSix" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Six</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_FiniteLivedIntangibleAssetExpectedAmortizationYearSix" xlink:href="elv-20220930.xsd#elv_FiniteLivedIntangibleAssetExpectedAmortizationYearSix"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_FiniteLivedIntangibleAssetExpectedAmortizationYearSix" xlink:to="lab_elv_FiniteLivedIntangibleAssetExpectedAmortizationYearSix" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_14af5269-ae6a-4e88-83b8-8561f440783b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance sheet location of operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_6662e6b0-e3e1-4dd2-9e67-45cf6f92c65c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_193a4785-349b-462a-94eb-ada5b7fa5480_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_MajorProductRevenueBySegmentTable_d56a52b9-26fe-4ef3-bfc6-1c67e5976991_terseLabel_en-US" xlink:label="lab_elv_MajorProductRevenueBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Product Revenue By Segment [Table]</link:label>
    <link:label id="lab_elv_MajorProductRevenueBySegmentTable_label_en-US" xlink:label="lab_elv_MajorProductRevenueBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Product Revenue By Segment [Table]</link:label>
    <link:label id="lab_elv_MajorProductRevenueBySegmentTable_documentation_en-US" xlink:label="lab_elv_MajorProductRevenueBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Product Revenue By Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_MajorProductRevenueBySegmentTable" xlink:href="elv-20220930.xsd#elv_MajorProductRevenueBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_MajorProductRevenueBySegmentTable" xlink:to="lab_elv_MajorProductRevenueBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_47f09c1f-d393-46de-9d6a-42bac6b5a1f1_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares), Beginning</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_af05a268-2059-4c01-b409-213991092c20_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares), Ending</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_9b69e14b-7916-497b-b140-47ce7844f1b5_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Stock</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_e05c87e5-69a2-4b03-a3d8-0a50b10889ee_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_c11a1251-72c3-460e-a928-5462b1388a4f_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends per share</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_5e68ba02-bb23-44e7-9969-20856137e800_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_e75485f5-a4df-4adf-9618-22976c87dbfa_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount, Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock_13ca9122-c3b4-4fc1-be6e-1cc591e2e1f0_terseLabel_en-US" xlink:label="lab_elv_CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying And Fair Values By Level Of Financial Instruments Not Recorded At Fair Value On Consolidated Balance Sheet</link:label>
    <link:label id="lab_elv_CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_elv_CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying And Fair Values By Level Of Financial Instruments Not Recorded At Fair Value On Consolidated Balance Sheet [Table Text Block]</link:label>
    <link:label id="lab_elv_CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock_documentation_en-US" xlink:label="lab_elv_CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock" xlink:href="elv-20220930.xsd#elv_CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock" xlink:to="lab_elv_CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefits_69e4facb-6c40-4751-b361-f9a3935bc739_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves for future policy benefits, noncurrent</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefits_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, before Reinsurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefits" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_BusinessOptimizationInitiativesAbstract_label_en-US" xlink:label="lab_elv_BusinessOptimizationInitiativesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Optimization Initiatives [Abstract]</link:label>
    <link:label id="lab_elv_BusinessOptimizationInitiativesAbstract_documentation_en-US" xlink:label="lab_elv_BusinessOptimizationInitiativesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Optimization Initiatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_BusinessOptimizationInitiativesAbstract" xlink:href="elv-20220930.xsd#elv_BusinessOptimizationInitiativesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_BusinessOptimizationInitiativesAbstract" xlink:to="lab_elv_BusinessOptimizationInitiativesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_c8052168-bfc2-4eb1-99fc-3c2a0807a2cc_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_label_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsEarnedNet" xlink:to="lab_us-gaap_PremiumsEarnedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2256b084-dde4-43f5-907e-b07c80a57458_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermInvestments_d77e2492-f8c1-4f56-8d09-7b108dc1f4b4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other invested assets</link:label>
    <link:label id="lab_us-gaap_OtherLongTermInvestments_4c149a9b-6b11-4530-9ae4-2cd3eb280b29_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other invested assets</link:label>
    <link:label id="lab_us-gaap_OtherLongTermInvestments_label_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermInvestments" xlink:to="lab_us-gaap_OtherLongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_IntangibleAssetsAccumulatedAmortizationExcludingGoodwill_992698d4-5253-4cd1-b8db-dd04c5fe74a6_negatedTerseLabel_en-US" xlink:label="lab_elv_IntangibleAssetsAccumulatedAmortizationExcludingGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization, Total Intangible Assets</link:label>
    <link:label id="lab_elv_IntangibleAssetsAccumulatedAmortizationExcludingGoodwill_label_en-US" xlink:label="lab_elv_IntangibleAssetsAccumulatedAmortizationExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Accumulated Amortization Excluding Goodwill</link:label>
    <link:label id="lab_elv_IntangibleAssetsAccumulatedAmortizationExcludingGoodwill_documentation_en-US" xlink:label="lab_elv_IntangibleAssetsAccumulatedAmortizationExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Accumulated Amortization Excluding Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IntangibleAssetsAccumulatedAmortizationExcludingGoodwill" xlink:href="elv-20220930.xsd#elv_IntangibleAssetsAccumulatedAmortizationExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_IntangibleAssetsAccumulatedAmortizationExcludingGoodwill" xlink:to="lab_elv_IntangibleAssetsAccumulatedAmortizationExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_230bab6a-db1d-4bbb-9a12-863a66b60ff5_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage-backed securities, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_458404fc-2f5a-45af-92b9-5cea5545f9c6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_20cd668c-79c7-4b90-a716-13cd67341e94_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_18ecf29b-2855-4e59-978c-4714a6d702c5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase and retirement of common stock, shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_96e81eaf-3beb-4b4c-ab88-28ab424e2305_verboseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_2270c145-dd6c-45c1-a761-ea90b5ede031_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_c81be316-165e-465b-af9c-9993a040a075_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_bc1c6b21-cfdd-4796-ab65-634e16167a81_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_Proceedsfromsaleofequityandfixedmaturitysecurities_2716bff7-d514-473b-bf5e-67b43c752737_terseLabel_en-US" xlink:label="lab_elv_Proceedsfromsaleofequityandfixedmaturitysecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of investments</link:label>
    <link:label id="lab_elv_Proceedsfromsaleofequityandfixedmaturitysecurities_label_en-US" xlink:label="lab_elv_Proceedsfromsaleofequityandfixedmaturitysecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of equity and fixed maturity securities</link:label>
    <link:label id="lab_elv_Proceedsfromsaleofequityandfixedmaturitysecurities_documentation_en-US" xlink:label="lab_elv_Proceedsfromsaleofequityandfixedmaturitysecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of equity and fixed maturity securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_Proceedsfromsaleofequityandfixedmaturitysecurities" xlink:href="elv-20220930.xsd#elv_Proceedsfromsaleofequityandfixedmaturitysecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_Proceedsfromsaleofequityandfixedmaturitysecurities" xlink:to="lab_elv_Proceedsfromsaleofequityandfixedmaturitysecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_3bb45150-aad8-4775-ae5d-c3fef7d90ec2_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_2fb74ac3-cc44-435a-b96a-603abd785125_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_211be58a-1b2a-4a99-a1e9-2b4a2daf2254_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted, Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_1307ea5f-ed49-4f91-86f0-45b02c127747_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_Impairmentlossesreversalsoninvestments_e95945f7-efdf-4064-8c27-b5baad578003_negatedTerseLabel_en-US" xlink:label="lab_elv_Impairmentlossesreversalsoninvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment (losses) recoveries recognized in income</link:label>
    <link:label id="lab_elv_Impairmentlossesreversalsoninvestments_label_en-US" xlink:label="lab_elv_Impairmentlossesreversalsoninvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment (losses) reversals on investments</link:label>
    <link:label id="lab_elv_Impairmentlossesreversalsoninvestments_documentation_en-US" xlink:label="lab_elv_Impairmentlossesreversalsoninvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total impairment (losses) reversals on investments, before considering whether or not such amount is recognized in earnings or other comprehensive income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_Impairmentlossesreversalsoninvestments" xlink:href="elv-20220930.xsd#elv_Impairmentlossesreversalsoninvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_Impairmentlossesreversalsoninvestments" xlink:to="lab_elv_Impairmentlossesreversalsoninvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_82ae5695-e0fb-4f37-a365-1fc3b09cf2ec_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized loss, less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_29028f3d-ee18-4d4f-9c4b-4a50a86c3501_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock plans, net of related tax benefits, Shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_SelffundedReceivablesAllowanceForDoubtfulAccounts_a6ef3054-ffba-494c-9c17-2702a0e97a83_terseLabel_en-US" xlink:label="lab_elv_SelffundedReceivablesAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-funded receivables, allowance for doubtful accounts</link:label>
    <link:label id="lab_elv_SelffundedReceivablesAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_elv_SelffundedReceivablesAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-funded Receivables, Allowance For Doubtful Accounts</link:label>
    <link:label id="lab_elv_SelffundedReceivablesAllowanceForDoubtfulAccounts_documentation_en-US" xlink:label="lab_elv_SelffundedReceivablesAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The carrying value as of the balance sheet date of the estimated valuation allowance to reduce gross self-funded receivable to net realizable value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SelffundedReceivablesAllowanceForDoubtfulAccounts" xlink:href="elv-20220930.xsd#elv_SelffundedReceivablesAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_SelffundedReceivablesAllowanceForDoubtfulAccounts" xlink:to="lab_elv_SelffundedReceivablesAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_74ab5dc4-77d8-424e-8549-34734f095e91_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_8d4ac7b9-a9e4-400f-99e6-db097f558162_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States Government Securities [Member]</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_02905262-6703-4018-a20a-f5d7bd7a2420_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_SegmentEliminationsMember_3bc6252d-feb2-4883-9b79-3fa335198ff5_terseLabel_en-US" xlink:label="lab_elv_SegmentEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Eliminations [Member]</link:label>
    <link:label id="lab_elv_SegmentEliminationsMember_label_en-US" xlink:label="lab_elv_SegmentEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Eliminations [Member]</link:label>
    <link:label id="lab_elv_SegmentEliminationsMember_documentation_en-US" xlink:label="lab_elv_SegmentEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SegmentEliminationsMember" xlink:href="elv-20220930.xsd#elv_SegmentEliminationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_SegmentEliminationsMember" xlink:to="lab_elv_SegmentEliminationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_ManagedCareProductsMember_58fbb840-e46d-437f-9b01-b907a3a7980d_terseLabel_en-US" xlink:label="lab_elv_ManagedCareProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Managed Care Products [Member]</link:label>
    <link:label id="lab_elv_ManagedCareProductsMember_label_en-US" xlink:label="lab_elv_ManagedCareProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Managed Care Products [Member]</link:label>
    <link:label id="lab_elv_ManagedCareProductsMember_documentation_en-US" xlink:label="lab_elv_ManagedCareProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Managed Care Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ManagedCareProductsMember" xlink:href="elv-20220930.xsd#elv_ManagedCareProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_ManagedCareProductsMember" xlink:to="lab_elv_ManagedCareProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivables_dbf017e7-7946-4075-b87d-3b35f08713bc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivables_label_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivables" xlink:to="lab_us-gaap_OtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_363a2e2e-ee4b-48f6-adfe-0473d538d4d9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_fd4b43bb-d037-42fd-84f8-faf0587d80b2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) Recognized</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_2c506fe5-93cc-40e0-94b4-32a2f1ded779_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized loss, 12 months or greater</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a9c157df-137b-4983-ad7a-d940fcf2d9e7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and shareholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ab16935a-0842-4951-9d65-b95a3b8c6e63_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted, Weighted-Average Option Price per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_97ff31ff-aa23-4d63-bca4-785f9afac362_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_353f0a99-572b-47db-81c1-a7c406d9eb02_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost or Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_6bc65328-7eeb-4a34-acf8-fe8ab8d2cef4_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale securities, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_76670335-0719-4509-a350-e1f2d44fdc33_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or expired, Weighted-Average Option Price per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_bc0faeb1-b00b-407d-8bcc-0a76ea1dc27a_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current period net incurred medical claims</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_ManagedCareServicesMember_c1587df0-6fb6-47d8-bdd3-def26ab9dfd1_terseLabel_en-US" xlink:label="lab_elv_ManagedCareServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Managed Care Services [Member]</link:label>
    <link:label id="lab_elv_ManagedCareServicesMember_label_en-US" xlink:label="lab_elv_ManagedCareServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Managed Care Services [Member]</link:label>
    <link:label id="lab_elv_ManagedCareServicesMember_documentation_en-US" xlink:label="lab_elv_ManagedCareServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Managed Care Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ManagedCareServicesMember" xlink:href="elv-20220930.xsd#elv_ManagedCareServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_ManagedCareServicesMember" xlink:to="lab_elv_ManagedCareServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualRightsMember_e2604584-ed64-4a1c-abe7-6a379d3a1f8a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider And Hospital Relationships [Member]</link:label>
    <link:label id="lab_us-gaap_ContractualRightsMember_label_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualRightsMember" xlink:to="lab_us-gaap_ContractualRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodDomain_ab2e223e-9225-4045-8733-93e341a48ef9_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase Agreements and Similar Transactions, Maturity Periods [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodDomain_label_en-US" xlink:label="lab_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase Agreements and Similar Transactions, Maturity Periods [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodDomain" xlink:to="lab_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_65399654-10cf-425e-ae5b-915024834d91_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss_9cf2a431-50f4-408e-bcca-99474e266394_terseLabel_en-US" xlink:label="lab_elv_Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax (expense) benefit of non credit impairment on available-for-sale securities recognized in other comprehensive income (loss)</link:label>
    <link:label id="lab_elv_Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss_label_en-US" xlink:label="lab_elv_Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax (expense) benefit of non credit impairment on available-for-sale securities recognized in other comprehensive income (loss)</link:label>
    <link:label id="lab_elv_Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss_documentation_en-US" xlink:label="lab_elv_Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax (expense) benefit of non-credit component of impairment loss on available-for-sale securities recognized in other comprehensive income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss" xlink:href="elv-20220930.xsd#elv_Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss" xlink:to="lab_elv_Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_6267ca1c-204c-473b-bdd2-046f58a3f103_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_ca1efe38-b67f-45a0-b052-b063015e323e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost and Fair Value of Fixed Maturity Securities, By Contractual Maturity</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_c2868653-ca63-4a9e-90c5-4acd84ed79f6_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_12db73d3-ff80-42f9-bca5-a18a4459576b_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e0a3c68f-8834-4c02-9017-7d862d635495_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator for basic earnings per share - weighted-average shares</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGainLossOnInvestmentsTable_bf86dcc8-b060-4bcf-a0cf-33671baa6297_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGainLossOnInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGainLossOnInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGainLossOnInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gain (Loss) on Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfGainLossOnInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_ac84100e-6824-49bf-ae8b-17771a8bef62_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement_6e8cfc6e-d39f-4594-9a3f-78208ddb53e7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" xlink:to="lab_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_44154064-614a-4ee9-a119-9534682df81e_negatedLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior periods redundancies</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_01936106-64b7-4eaf-94a5-89cef1d8c901_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies &#8211; Note 11</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities_a948b896-7843-4e40-8676-f286e30959e7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than Temporary Impairment Losses, Investments, Portion in Other Comprehensive Loss, Net of Tax, Including Portion Attributable to Noncontrolling Interest, Available-for-sale Securities</link:label>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities_label_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than Temporary Impairment Losses, Investments, Portion in Other Comprehensive Loss, Net of Tax, Including Portion Attributable to Noncontrolling Interest, Available-for-Sale Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities" xlink:to="lab_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_256f303b-5097-4936-b2dc-d9c2c5e839be_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c3e5e9bd-1d6b-4a65-80f3-fed905cf1753_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period, Weighted-Average Option Price per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_04c67fbf-6b27-458d-b783-d21d0fc4cf94_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period, Weighted-Average Option Price per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInSecuritiesLendingPayable_8d06a163-4346-4b5b-8cb9-0173eca0d024_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInSecuritiesLendingPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in securities lending payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInSecuritiesLendingPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInSecuritiesLendingPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Securities Lending Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInSecuritiesLendingPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInSecuritiesLendingPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInSecuritiesLendingPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInSecuritiesLendingPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_d3427fa9-bec0-4c71-b6d8-e9e538861c63_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, without par value, shares authorized &#8211; 100,000,000; shares issued and outstanding &#8211; none</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_f9d13770-5876-4f58-961b-96979f500996_verboseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Reportable Segments Operating Revenues To Total Revenues Reported In The Consolidated Statements Of Income</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_InvestmentGainsLosses_a0eb5f9c-17da-4805-9d84-af3b78aebe3d_verboseLabel_en-US" xlink:label="lab_elv_InvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (losses) gains on investments</link:label>
    <link:label id="lab_elv_InvestmentGainsLosses_label_en-US" xlink:label="lab_elv_InvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Gains (Losses)</link:label>
    <link:label id="lab_elv_InvestmentGainsLosses_documentation_en-US" xlink:label="lab_elv_InvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_InvestmentGainsLosses" xlink:href="elv-20220930.xsd#elv_InvestmentGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_InvestmentGainsLosses" xlink:to="lab_elv_InvestmentGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_c1a7f973-8819-49bf-94d6-b476fd3bfd3b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_a02bef25-c0bb-4e8e-a36c-c1bc5067b6be_terseLabel_en-US" xlink:label="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment date</link:label>
    <link:label id="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_0916f50a-c1bd-4b46-80f4-11fdc616928a_verboseLabel_en-US" xlink:label="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date to be Paid</link:label>
    <link:label id="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_label_en-US" xlink:label="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:to="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_ffae0c95-2ab3-4025-8053-5d2ff8ca7887_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gains (losses) recognized in accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_4454e917-d829-4362-a2d9-cd94c7555c53_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Declaration date</link:label>
    <link:label id="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_label_en-US" xlink:label="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateDeclaredDayMonthAndYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:to="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_cb3d1d79-8e4b-4700-9dc2-50deaf55f1e5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of The Beginning And Ending Balances Of Assets Measured At Fair Value On A Recurring Basis Using Level III Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_d5c3e2e5-db38-414d-8fb4-5c4fd4e04ccd_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_07eb5838-7300-44f5-be4c-b956123e46b3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_617dff3a-f6a9-485b-ae6f-3663057ba667_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level III [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_39e0cb43-81ae-4538-8884-cbbfcd439ae2_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:to="lab_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_SurplusNotesMember_d0b904d2-7c58-4a6d-90ad-c252e60ea68d_terseLabel_en-US" xlink:label="lab_elv_SurplusNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surplus Notes [Member]</link:label>
    <link:label id="lab_elv_SurplusNotesMember_label_en-US" xlink:label="lab_elv_SurplusNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surplus Notes [Member]</link:label>
    <link:label id="lab_elv_SurplusNotesMember_documentation_en-US" xlink:label="lab_elv_SurplusNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surplus Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SurplusNotesMember" xlink:href="elv-20220930.xsd#elv_SurplusNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_SurplusNotesMember" xlink:to="lab_elv_SurplusNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_NetLossesGainsOnFinancialInstruments_ef7f08ed-c02a-46f5-bde4-df92a60b9060_terseLabel_en-US" xlink:label="lab_elv_NetLossesGainsOnFinancialInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (losses) gains on financial instruments</link:label>
    <link:label id="lab_elv_NetLossesGainsOnFinancialInstruments_92607278-138b-472c-8bee-d7f20d11fa4a_negatedLabel_en-US" xlink:label="lab_elv_NetLossesGainsOnFinancialInstruments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net losses (gains) on financial instruments</link:label>
    <link:label id="lab_elv_NetLossesGainsOnFinancialInstruments_b62be28f-e47f-4510-82b0-7661b86e7e61_negatedTerseLabel_en-US" xlink:label="lab_elv_NetLossesGainsOnFinancialInstruments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net losses (gains) on financial instruments</link:label>
    <link:label id="lab_elv_NetLossesGainsOnFinancialInstruments_label_en-US" xlink:label="lab_elv_NetLossesGainsOnFinancialInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (losses) gains on financial instruments</link:label>
    <link:label id="lab_elv_NetLossesGainsOnFinancialInstruments_documentation_en-US" xlink:label="lab_elv_NetLossesGainsOnFinancialInstruments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (losses) gains on financial instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_NetLossesGainsOnFinancialInstruments" xlink:href="elv-20220930.xsd#elv_NetLossesGainsOnFinancialInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_NetLossesGainsOnFinancialInstruments" xlink:to="lab_elv_NetLossesGainsOnFinancialInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0242da84-785f-447d-9350-68f00f9a63ee_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed maturities, long-term</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeMember_30a1a586-21a3-4a96-824d-762faa26b1f1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives [Member]</link:label>
    <link:label id="lab_us-gaap_DerivativeMember_label_en-US" xlink:label="lab_us-gaap_DerivativeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeMember" xlink:to="lab_us-gaap_DerivativeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FixedMaturitiesMember_9efcc4a2-b35f-470a-8b20-92c10c9750bd_terseLabel_en-US" xlink:label="lab_us-gaap_FixedMaturitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Maturities [Member]</link:label>
    <link:label id="lab_us-gaap_FixedMaturitiesMember_label_en-US" xlink:label="lab_us-gaap_FixedMaturitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Maturities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FixedMaturitiesMember" xlink:to="lab_us-gaap_FixedMaturitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_86ac609b-b59e-4faf-8efa-9990ed967b2e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_5d8e93b3-d4e0-4aed-8a8d-2ed7aad6126e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_409fc159-9b9a-44c4-8669-11bc147e38e3_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_b5848bbe-d909-43a7-9b06-5e571c45ff5d_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium receivable, allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_76e286d3-54b1-493b-adc7-5ec3600de88e_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7df7b0b5-0c26-4d5a-8029-35411d43d620_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_f30043c0-e1b4-44e1-aa2f-7baab1f36336_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid through withholding of common stock under employee stock plans</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_6c01e506-f757-4468-b393-fb3bca94105d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_1e92609f-7dfd-4599-ae60-c579be7e99bd_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net payments attributable to current period medical claims</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_14e6b346-581f-43e9-a9b0-4ab795661213_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_cde8bb5b-38ac-4e1b-a056-64b64550eac2_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_818ae2af-d6d1-438c-941a-6c6121869d37_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorization remaining at the end of the period</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_4a854073-f966-4e26-80e8-05af445a5362_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_6746fa16-5afd-4c33-b0a4-d4506e21eedd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_54b4fff1-b304-461f-8f2d-6352bbc7e2bc_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_StockRepurchasedAndRetiredDuringPeriodAveragePrice_fff1ab03-9d06-499f-9a1e-76c5a620e6eb_terseLabel_en-US" xlink:label="lab_elv_StockRepurchasedAndRetiredDuringPeriodAveragePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average price per share</link:label>
    <link:label id="lab_elv_StockRepurchasedAndRetiredDuringPeriodAveragePrice_label_en-US" xlink:label="lab_elv_StockRepurchasedAndRetiredDuringPeriodAveragePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period Average Price</link:label>
    <link:label id="lab_elv_StockRepurchasedAndRetiredDuringPeriodAveragePrice_documentation_en-US" xlink:label="lab_elv_StockRepurchasedAndRetiredDuringPeriodAveragePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period Average Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_StockRepurchasedAndRetiredDuringPeriodAveragePrice" xlink:href="elv-20220930.xsd#elv_StockRepurchasedAndRetiredDuringPeriodAveragePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_StockRepurchasedAndRetiredDuringPeriodAveragePrice" xlink:to="lab_elv_StockRepurchasedAndRetiredDuringPeriodAveragePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_NoncontrollingInterestPeriodIncreaseDecrease_1b26ae08-de4e-4578-a7fb-432778b88941_terseLabel_en-US" xlink:label="lab_elv_NoncontrollingInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests adjustment</link:label>
    <link:label id="lab_elv_NoncontrollingInterestPeriodIncreaseDecrease_label_en-US" xlink:label="lab_elv_NoncontrollingInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:label id="lab_elv_NoncontrollingInterestPeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_elv_NoncontrollingInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_NoncontrollingInterestPeriodIncreaseDecrease" xlink:href="elv-20220930.xsd#elv_NoncontrollingInterestPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_NoncontrollingInterestPeriodIncreaseDecrease" xlink:to="lab_elv_NoncontrollingInterestPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_db52ef66-8ecb-4914-acc6-835ce0d07131_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of subsidiaries, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments_4def221b-85ad-4c07-b67b-b3bf388f892c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debenture repurchases, conversions and tax adjustments</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_c6be9761-1381-4593-a46a-273a3d7e99a5_verboseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Income Before Income Tax Expense To Reportable Segments Operating Gain Included In The Consolidated Statements Of Income</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_6d699b73-bb6a-4e99-b854-4aaec78b9cdb_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_ea7d2f3b-2b86-40b1-b12a-8956927a452b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level II [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_8dcf4179-9dbd-4cc3-9ccd-adf5c0470486_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_9355b505-598e-4488-82e7-008cc85e2d6e_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_a5163dd4-6cb5-4651-b554-c4f847f10c5e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_dc9a7a12-1481-4d65-a3d4-cc97d685cabb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Realized Gain</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_8e899df3-8a57-43df-885d-0623e5deb827_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imputed Interest, Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_c59ef381-489d-47fb-b443-48dcc79148b3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_3d9e20ee-db80-4fec-9c56-6539e01ba5bc_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_7b426f8b-3e0c-4b2e-adca-712f1976bde0_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount, Total Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_GainsFromOtherInvestments_5a65e0bb-d906-4188-98da-70e8326353dd_terseLabel_en-US" xlink:label="lab_elv_GainsFromOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross gains</link:label>
    <link:label id="lab_elv_GainsFromOtherInvestments_label_en-US" xlink:label="lab_elv_GainsFromOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains From Other Investments</link:label>
    <link:label id="lab_elv_GainsFromOtherInvestments_documentation_en-US" xlink:label="lab_elv_GainsFromOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains From Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GainsFromOtherInvestments" xlink:href="elv-20220930.xsd#elv_GainsFromOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_GainsFromOtherInvestments" xlink:to="lab_elv_GainsFromOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_0fd32af0-54b5-45d6-ae85-f02ba31278b5_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Maturities, long-term, amortized cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_637bd8ba-69d0-44eb-8e56-0574505e0af1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_8cd0d6fb-41b6-4a35-8566-02f5a71df6e8_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_bdf286db-4cd6-4b7d-8545-1d186cc26870_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease payments, 2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestmentsAbstract_575b3a0d-514f-4262-989a-1a22fa6bb4f8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments:</link:label>
    <link:label id="lab_us-gaap_LongTermInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestmentsAbstract" xlink:to="lab_us-gaap_LongTermInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_621c2c32-d82d-42a0-a894-91df1476f53a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_78c20fd3-ed3c-4108-a844-0cd764f56511_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after ten years, Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsCurrent_eb565f08-b21b-45ea-b3c8-f4c16e5adedb_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer funds and cash and cash equivalents on deposit for regulatory requirements</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Investments, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:to="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_f9855318-88ee-401c-98b4-e9b116fb04d0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_078bfbab-5b54-45f6-8aeb-1f8cc06d6106_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net medical claims payable, beginning of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_e7c71d7a-5949-4d5e-802e-1f9a19e45ddd_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net medical claims payable, end of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTable_80635087-21cf-4384-9f56-39b165d5aa28_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Table]</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTable" xlink:to="lab_us-gaap_MarketableSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_6b32a3c6-10de-4a0e-96d4-1f79393a478a_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_55dd27ee-195c-4922-b4ca-624fd9abd812_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Optimization Initiatives [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_PharmacyproductsandservicesMember_4beebce1-0fc9-4854-b45a-3698ca9843c0_terseLabel_en-US" xlink:label="lab_elv_PharmacyproductsandservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy products and services [Member]</link:label>
    <link:label id="lab_elv_PharmacyproductsandservicesMember_label_en-US" xlink:label="lab_elv_PharmacyproductsandservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy products and services [Member]</link:label>
    <link:label id="lab_elv_PharmacyproductsandservicesMember_documentation_en-US" xlink:label="lab_elv_PharmacyproductsandservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy products and services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_PharmacyproductsandservicesMember" xlink:href="elv-20220930.xsd#elv_PharmacyproductsandservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_PharmacyproductsandservicesMember" xlink:to="lab_elv_PharmacyproductsandservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_70625df0-7b5a-4f9d-9540-9de0bf12c5ac_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_25303150-5ad0-44dc-b358-36bff33d1e7e_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Securities [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_5a7e304c-f8eb-4099-8f5f-ceb99d8a5090_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_e1764587-6ef1-4372-8186-ca9379774df6_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses) gains recognized on equity securities still held at the end of the period</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_55fc0897-ca7e-4280-a1bf-806628a4d0c8_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_4631c85a-26b5-40c1-aa19-4d5545f45493_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_a0abe681-aebd-49af-86d8-468e4c1e9f76_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_15b3f0c8-26ab-4bca-979e-147aa34c3fd5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BenefitsLossesAndExpenses_8cbaf7ee-01e8-403d-adb0-a4bdb164d8c3_totalLabel_en-US" xlink:label="lab_us-gaap_BenefitsLossesAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total expenses</link:label>
    <link:label id="lab_us-gaap_BenefitsLossesAndExpenses_label_en-US" xlink:label="lab_us-gaap_BenefitsLossesAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits, Losses and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BenefitsLossesAndExpenses" xlink:to="lab_us-gaap_BenefitsLossesAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ba405657-5fc6-467a-8ec2-892858a68314_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_0002d6b9-8723-4ed0-aea1-d4da9af020d3_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_6dfb75c4-db7f-4e78-b790-50c718fb6c42_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTable_8a1da9ad-ff6e-4357-9f4b-3a9b96bface2_terseLabel_en-US" xlink:label="lab_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Net Incurred Medical Claims to Benefit Expense [Table]</link:label>
    <link:label id="lab_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTable_label_en-US" xlink:label="lab_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Net Incurred Medical Claims to Benefit Expense [Table]</link:label>
    <link:label id="lab_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTable_documentation_en-US" xlink:label="lab_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of net incurred medical claims to benefit expense [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTable" xlink:href="elv-20220930.xsd#elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTable" xlink:to="lab_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTable" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_CommercialSpecialtyBusinessSegmentMember_f579d64a-4e1c-4e87-a59a-066702a5780f_terseLabel_en-US" xlink:label="lab_elv_CommercialSpecialtyBusinessSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial &amp; Specialty Business Segment [Member]</link:label>
    <link:label id="lab_elv_CommercialSpecialtyBusinessSegmentMember_label_en-US" xlink:label="lab_elv_CommercialSpecialtyBusinessSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial &amp; Specialty Business Segment [Member]</link:label>
    <link:label id="lab_elv_CommercialSpecialtyBusinessSegmentMember_documentation_en-US" xlink:label="lab_elv_CommercialSpecialtyBusinessSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial and Specialty Business Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommercialSpecialtyBusinessSegmentMember" xlink:href="elv-20220930.xsd#elv_CommercialSpecialtyBusinessSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_CommercialSpecialtyBusinessSegmentMember" xlink:to="lab_elv_CommercialSpecialtyBusinessSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_851447ae-86d1-474e-8dd4-b675648e479b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_ed6b58cf-a2d4-4a50-9b54-0df728c597a9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net incurred medical claims</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_0f6196e4-333e-4707-8fa5-8366275d9559_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_3a570f97-0c69-480c-b583-79f1465fafae_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2192d2a9-ced0-4207-be69-b85b5445bb1a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_9db919a6-068c-489d-9444-8045e6aae265_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_1d4e1b52-5202-4a5a-8896-63ffb69ff256_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_AccountingPoliciesTable_a7ff25c8-323c-4cb5-b447-fc69f4fb0958_terseLabel_en-US" xlink:label="lab_elv_AccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Table]</link:label>
    <link:label id="lab_elv_AccountingPoliciesTable_label_en-US" xlink:label="lab_elv_AccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Table]</link:label>
    <link:label id="lab_elv_AccountingPoliciesTable_documentation_en-US" xlink:label="lab_elv_AccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_AccountingPoliciesTable" xlink:href="elv-20220930.xsd#elv_AccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_AccountingPoliciesTable" xlink:to="lab_elv_AccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_698ac540-b356-4235-bf59-5a47fb358d59_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested, Restricted Stock Shares And Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_49f5ae32-e50f-4960-99b2-07a5cff64a49_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuritiesLoanedFairValueOfCollateral_488674f1-c54f-45d5-ab84-660d27b25eaa_verboseLabel_en-US" xlink:label="lab_us-gaap_SecuritiesLoanedFairValueOfCollateral" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of collateral received at time of securities lending transactions</link:label>
    <link:label id="lab_us-gaap_SecuritiesLoanedFairValueOfCollateral_label_en-US" xlink:label="lab_us-gaap_SecuritiesLoanedFairValueOfCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Loaned, Fair Value of Collateral</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesLoanedFairValueOfCollateral" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesLoanedFairValueOfCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuritiesLoanedFairValueOfCollateral" xlink:to="lab_us-gaap_SecuritiesLoanedFairValueOfCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_79ff44cf-345d-44c0-8f31-a0ef3ad65e77_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted-Average Fair Values Determined for the Periods</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_6f013720-8940-4bc9-a296-665655a9a4f5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Claims payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalAbstract_fce293c9-3d43-4d08-a87c-60f78784ff24_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital [Abstract]</link:label>
    <link:label id="lab_us-gaap_CapitalAbstract_label_en-US" xlink:label="lab_us-gaap_CapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Banking Regulation, Total Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalAbstract" xlink:to="lab_us-gaap_CapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAggregatedInvestmentsMember_bb8a683b-c6fe-40d1-ab6c-bd9097a53e33_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAggregatedInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Securities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherAggregatedInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherAggregatedInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Security Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAggregatedInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAggregatedInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAggregatedInvestmentsMember" xlink:to="lab_us-gaap_OtherAggregatedInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_da8fa8fb-3439-443f-8ce5-e9715934c0e0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax and Other Liabilities, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax and Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExchangeTradedFundsMember_5525999b-3043-41ad-b23b-1c27958a63f2_terseLabel_en-US" xlink:label="lab_us-gaap_ExchangeTradedFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange Traded Funds [Member]</link:label>
    <link:label id="lab_us-gaap_ExchangeTradedFundsMember_label_en-US" xlink:label="lab_us-gaap_ExchangeTradedFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange Traded Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExchangeTradedFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExchangeTradedFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExchangeTradedFundsMember" xlink:to="lab_us-gaap_ExchangeTradedFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuritiesHeldAsCollateralAtFairValue_f8c64fbe-e16e-4e9c-852d-b2534a888eb9_terseLabel_en-US" xlink:label="lab_us-gaap_SecuritiesHeldAsCollateralAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities lending collateral</link:label>
    <link:label id="lab_us-gaap_SecuritiesHeldAsCollateralAtFairValue_label_en-US" xlink:label="lab_us-gaap_SecuritiesHeldAsCollateralAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Held as Collateral, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesHeldAsCollateralAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesHeldAsCollateralAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuritiesHeldAsCollateralAtFairValue" xlink:to="lab_us-gaap_SecuritiesHeldAsCollateralAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_3d0118db-eef9-4c89-b140-5f76c009a2e9_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashMember_b1452f6e-1b4c-46b9-96a4-3f6276f29a35_terseLabel_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash [Member]</link:label>
    <link:label id="lab_us-gaap_CashMember_label_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashMember" xlink:to="lab_us-gaap_CashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7ac61e3c-6bae-4352-a695-52a38a5d13ed_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedInvestmentIncomeReceivable_77afda5a-81de-417b-a9b8-d7dbd23b7599_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedInvestmentIncomeReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued investment income receivable</link:label>
    <link:label id="lab_us-gaap_AccruedInvestmentIncomeReceivable_label_en-US" xlink:label="lab_us-gaap_AccruedInvestmentIncomeReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Investment Income Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInvestmentIncomeReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedInvestmentIncomeReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedInvestmentIncomeReceivable" xlink:to="lab_us-gaap_AccruedInvestmentIncomeReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_f738183e-0ef0-44e4-910d-e9cec9b55986_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities &#8211; employee stock options, nonvested restricted stock awards and convertible debentures</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_e4f92fd0-6caf-48ea-8175-8f0775e8a2b5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Optimization Initiatives</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_e8a09e79-c8b8-4ee3-ac09-8cfb639b43ef_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_30ea6866-9607-49a7-9688-239ab2f9a9f9_verboseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper Program</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1a92e2ba-66c7-4964-96ce-9a916927d8c4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_92bde770-3c6f-4c69-8f7d-2c6cadc479d5_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_9cfe1c89-e161-4ed0-a08d-162e2cb969ff_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Claim Year [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Accident Year [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_980c5e24-57f0-4d48-b9d1-b3ff6c9ba6d8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_MajorProductRevenueBySegmentLineItems_2917e8c3-6daf-44f9-b1f8-70d9fd0556b0_terseLabel_en-US" xlink:label="lab_elv_MajorProductRevenueBySegmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Product Revenue By Segment [Line Items]</link:label>
    <link:label id="lab_elv_MajorProductRevenueBySegmentLineItems_label_en-US" xlink:label="lab_elv_MajorProductRevenueBySegmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Product Revenue By Segment [Line Items]</link:label>
    <link:label id="lab_elv_MajorProductRevenueBySegmentLineItems_documentation_en-US" xlink:label="lab_elv_MajorProductRevenueBySegmentLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Major Product Revenue By Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_MajorProductRevenueBySegmentLineItems" xlink:href="elv-20220930.xsd#elv_MajorProductRevenueBySegmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_MajorProductRevenueBySegmentLineItems" xlink:to="lab_elv_MajorProductRevenueBySegmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a4c3ba43-9a11-4f58-9f0d-0e96665f8d37_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value Per Share [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a37be0f6-dc1f-4340-a995-143bf91cf8e1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_b4c3aab0-967d-4eb8-923d-17f9c39af9a5_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_1d08ef16-a758-4d5f-9b46-221e189fd4bc_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_486d6641-4233-45c6-b0bc-3dacc3831c7c_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_357eb962-e507-465b-bd17-82369ac15345_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_b7acbbef-3c58-408a-91db-f658c21be2eb_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_13faaa1b-3ea4-46e7-910b-3c7b593f890f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_bf9b28eb-2e63-49a3-b19d-8fbcd26dd0f1_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_aafd2fba-4db7-4581-8e84-f56d269c365a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Securities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDebtSecuritiesMember" xlink:to="lab_us-gaap_OtherDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_9f67a4f2-9204-4238-8567-698307c45dec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Fair Value and Gross Unrealized Loss of Fixed Maturity Securities in an Unrealized Loss Position</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrealized Loss on Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_94ae59fd-5317-4f9b-a6de-52b05ce4d6ee_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_6b96b9f8-fd88-47d6-8167-822a5ee68b8b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_2124b1a2-80f6-490c-86d5-567ba757e251_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_9db38113-2f7a-41bf-a523-eb59d9bbadba_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_888baeb4-3e80-4951-a252-a29a8a1f4a6f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities, calls and redemptions from investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_29b17f38-8af4-4c07-972e-4151df2e6bc4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3d74d810-3a4d-4914-8dcd-e33faf67d9ad_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsTextBlock_08da76f6-acec-4c16-bc09-3b1e761fda24_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Gains (Losses)</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestmentsTextBlock" xlink:to="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_56571650-892a-478d-93f9-959f7b237094_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_7f54d271-ebbc-47a3-9200-833c4200bd4e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Loss) Income, Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_bef35ef8-606d-4f2a-b5fa-e2fcfa6b005e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_77572df0-7313-47e8-b0a1-1a9c3bc13e5c_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of short-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_ced80abe-855d-44fa-a96f-9dcda1c93873_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f7b56c0d-9376-45b5-a4a3-8b5db2857f91_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted during the period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_OperatingRevenue_326dbab5-4a21-4471-a94c-fd5813892fd5_totalLabel_en-US" xlink:label="lab_elv_OperatingRevenue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating revenue</link:label>
    <link:label id="lab_elv_OperatingRevenue_label_en-US" xlink:label="lab_elv_OperatingRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Revenue</link:label>
    <link:label id="lab_elv_OperatingRevenue_documentation_en-US" xlink:label="lab_elv_OperatingRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from insurance services and products sold.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OperatingRevenue" xlink:href="elv-20220930.xsd#elv_OperatingRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_OperatingRevenue" xlink:to="lab_elv_OperatingRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_be6d5fb3-c60d-426d-9915-ebc0413d0f0f_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_9e580263-b207-42e0-8de4-bb64cb035809_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_MedicalClaimsPayableReconciliationofNetIncurredMedicalClaimstoBenefitExpenseAbstract_9c7c3870-d904-402b-9fe3-a6fbc8531d39_terseLabel_en-US" xlink:label="lab_elv_MedicalClaimsPayableReconciliationofNetIncurredMedicalClaimstoBenefitExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Claims Payable (Reconciliation of Net Incurred Medical Claims to Benefit Expense) [Abstract]</link:label>
    <link:label id="lab_elv_MedicalClaimsPayableReconciliationofNetIncurredMedicalClaimstoBenefitExpenseAbstract_label_en-US" xlink:label="lab_elv_MedicalClaimsPayableReconciliationofNetIncurredMedicalClaimstoBenefitExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Claims Payable (Reconciliation of Net Incurred Medical Claims to Benefit Expense) [Abstract]</link:label>
    <link:label id="lab_elv_MedicalClaimsPayableReconciliationofNetIncurredMedicalClaimstoBenefitExpenseAbstract_documentation_en-US" xlink:label="lab_elv_MedicalClaimsPayableReconciliationofNetIncurredMedicalClaimstoBenefitExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Claims Payable (Reconciliation of Net Incurred Medical Claims to Benefit Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_MedicalClaimsPayableReconciliationofNetIncurredMedicalClaimstoBenefitExpenseAbstract" xlink:href="elv-20220930.xsd#elv_MedicalClaimsPayableReconciliationofNetIncurredMedicalClaimstoBenefitExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_MedicalClaimsPayableReconciliationofNetIncurredMedicalClaimstoBenefitExpenseAbstract" xlink:to="lab_elv_MedicalClaimsPayableReconciliationofNetIncurredMedicalClaimstoBenefitExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_e61a2e45-e2f2-4d93-b901-4b76396ad2b1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in net earnings of other invested assets</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingenciesByNatureAxis_fc96677a-5389-4126-a6f1-2776d8fd941a_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingenciesByNatureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingency, Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_GainContingenciesByNatureAxis_label_en-US" xlink:label="lab_us-gaap_GainContingenciesByNatureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies, Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesByNatureAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainContingenciesByNatureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingenciesByNatureAxis" xlink:to="lab_us-gaap_GainContingenciesByNatureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_a655d061-521e-44aa-bd95-2eb11eab8c58_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Payments</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualPayments" xlink:to="lab_us-gaap_LossContingencyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d19ac7e4-3447-4132-8d74-6e016ee54637_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentAmount_e6943a65-cc21-4cd6-84e1-e4e2e3334e71_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term purchase commitment, amount</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentAmount_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Purchase Commitment, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentAmount" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b11d2350-c577-4a5d-a7b1-50fbc104a97c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_207d38ab-709c-4f29-83ae-087ad0566ffe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator for Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_41eeb799-5755-4704-94b3-75829852fa29_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax (Expense) Benefit</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_8dee497f-b06e-4103-b070-86bff5e7e813_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for new operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_91562281-d01d-4d15-9a58-872792104413_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Realized Loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnearnedPremiums_c4929eea-d6a3-4673-bfd5-0dc6f16a4561_verboseLabel_en-US" xlink:label="lab_us-gaap_UnearnedPremiums" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned income</link:label>
    <link:label id="lab_us-gaap_UnearnedPremiums_label_en-US" xlink:label="lab_us-gaap_UnearnedPremiums" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned Premiums</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnearnedPremiums" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnearnedPremiums"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnearnedPremiums" xlink:to="lab_us-gaap_UnearnedPremiums" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtTableTextBlock_8e157344-8a37-4595-87c7-7510fb78efa8_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debenture Terms</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtTableTextBlock" xlink:to="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_85be5815-c7d9-4fef-8954-928d13f9532d_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>elv-20220930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:975646a6-f010-4ab0-98cc-185c6d29d7c2,g:966d453b-5cd7-4ddd-af0c-9c9c0ae080e9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument" xlink:type="simple" xlink:href="elv-20220930.xsd#DocumentAndEntityInformationDocument"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_449ff37d-2185-40e9-b415-1cbdc1c4b9b9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_1dbac513-1c2d-4889-a827-38b27facbcea" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_449ff37d-2185-40e9-b415-1cbdc1c4b9b9" xlink:to="loc_dei_EntitiesTable_1dbac513-1c2d-4889-a827-38b27facbcea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_08fc3c62-7e86-4675-8943-6981a68fd3ec" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_1dbac513-1c2d-4889-a827-38b27facbcea" xlink:to="loc_dei_LegalEntityAxis_08fc3c62-7e86-4675-8943-6981a68fd3ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1ac7001f-78db-403a-89e4-f536f2629f08" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_08fc3c62-7e86-4675-8943-6981a68fd3ec" xlink:to="loc_dei_EntityDomain_1ac7001f-78db-403a-89e4-f536f2629f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_1dbac513-1c2d-4889-a827-38b27facbcea" xlink:to="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_22ccf8a3-e25d-4656-a634-f0b73a3d3157" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_DocumentType_22ccf8a3-e25d-4656-a634-f0b73a3d3157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_809954ca-86fc-48a7-b23d-6bdc63988a42" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_DocumentQuarterlyReport_809954ca-86fc-48a7-b23d-6bdc63988a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_19d6c4b7-4e57-4451-92d0-47882982a49c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_DocumentPeriodEndDate_19d6c4b7-4e57-4451-92d0-47882982a49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_f4596a65-ed81-4f60-befe-82817d2b977e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_DocumentTransitionReport_f4596a65-ed81-4f60-befe-82817d2b977e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_55550011-fab4-4d22-b3c3-6db3742bf4b3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_AmendmentFlag_55550011-fab4-4d22-b3c3-6db3742bf4b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_84fe80b5-7652-491d-ac76-849cd2563787" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_DocumentFiscalYearFocus_84fe80b5-7652-491d-ac76-849cd2563787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_45fea47f-e45c-4cf3-bc9b-f66305b56fff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_DocumentFiscalPeriodFocus_45fea47f-e45c-4cf3-bc9b-f66305b56fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_d3e8b1e7-d69a-4a1b-a787-b4a5fe2460f9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_CurrentFiscalYearEndDate_d3e8b1e7-d69a-4a1b-a787-b4a5fe2460f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_a6e120c4-daf8-428e-8e9d-9d18b71de097" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityCentralIndexKey_a6e120c4-daf8-428e-8e9d-9d18b71de097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_f9ccfc42-e485-4039-8c64-28175e73c815" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityFileNumber_f9ccfc42-e485-4039-8c64-28175e73c815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d6d50a3d-75f5-4e50-8746-93a629213d70" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityRegistrantName_d6d50a3d-75f5-4e50-8746-93a629213d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_668320fb-d729-4e83-af06-c0b645a9b019" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityIncorporationStateCountryCode_668320fb-d729-4e83-af06-c0b645a9b019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_364b0de2-5547-4653-b069-9bb2384a04e5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityTaxIdentificationNumber_364b0de2-5547-4653-b069-9bb2384a04e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_5b4a9a89-efea-408f-8940-533faa110c88" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityAddressAddressLine1_5b4a9a89-efea-408f-8940-533faa110c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_28faef3b-deac-4ad0-97ac-b4fdda064915" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityAddressCityOrTown_28faef3b-deac-4ad0-97ac-b4fdda064915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f080d937-6980-4f11-9658-18d13b17abca" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityAddressStateOrProvince_f080d937-6980-4f11-9658-18d13b17abca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c7021400-1298-4717-8f98-eab80f156cb9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityAddressPostalZipCode_c7021400-1298-4717-8f98-eab80f156cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ea16c580-9be2-4a23-8ba2-e269a4166010" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_CityAreaCode_ea16c580-9be2-4a23-8ba2-e269a4166010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_141e1968-4c8b-479f-8bf2-bf485e39a8ce" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_LocalPhoneNumber_141e1968-4c8b-479f-8bf2-bf485e39a8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_f844970a-9a9e-451a-ba0d-9ca8c9598af3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_Security12bTitle_f844970a-9a9e-451a-ba0d-9ca8c9598af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_09699fcb-4481-4e5e-8b20-59c1e6e667e8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_TradingSymbol_09699fcb-4481-4e5e-8b20-59c1e6e667e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_7312c2c1-ca04-4035-b46b-16b965944b2f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_SecurityExchangeName_7312c2c1-ca04-4035-b46b-16b965944b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_886a199d-8302-491e-ba62-c494f97f9654" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityCurrentReportingStatus_886a199d-8302-491e-ba62-c494f97f9654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_391a6690-7321-4a47-8b9b-416588b404e2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityInteractiveDataCurrent_391a6690-7321-4a47-8b9b-416588b404e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_56d64517-87bb-4229-95b6-b1033beda89a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityFilerCategory_56d64517-87bb-4229-95b6-b1033beda89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_31f4d758-c782-4ef0-b1e9-b044f073cdc0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntitySmallBusiness_31f4d758-c782-4ef0-b1e9-b044f073cdc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_1cd0084a-0136-4699-9af1-c25b37f69bce" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityEmergingGrowthCompany_1cd0084a-0136-4699-9af1-c25b37f69bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_8ac1d5ff-773f-424b-8113-9d02fca8a76d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityShellCompany_8ac1d5ff-773f-424b-8113-9d02fca8a76d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_1bd5d3c9-2c17-4881-87ee-08e75de5fe09" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_572035e1-2a04-4cc7-9542-6ce5b2f31c47" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_1bd5d3c9-2c17-4881-87ee-08e75de5fe09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="elv-20220930.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_eb283f1e-55c1-4367-9ec0-38223fcafff5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_3bf8eee2-6ce6-4bfa-a730-33b8f7d4557e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_eb283f1e-55c1-4367-9ec0-38223fcafff5" xlink:to="loc_us-gaap_AssetsAbstract_3bf8eee2-6ce6-4bfa-a730-33b8f7d4557e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_58969bb9-194f-40ee-87d1-281ce582063f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3bf8eee2-6ce6-4bfa-a730-33b8f7d4557e" xlink:to="loc_us-gaap_AssetsCurrentAbstract_58969bb9-194f-40ee-87d1-281ce582063f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ae0620d4-2fb9-4290-aa3e-baec75fa8aef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_58969bb9-194f-40ee-87d1-281ce582063f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ae0620d4-2fb9-4290-aa3e-baec75fa8aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_e478e901-27f9-4691-91fe-9806bf3ae721" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_58969bb9-194f-40ee-87d1-281ce582063f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_e478e901-27f9-4691-91fe-9806bf3ae721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_a1109cd6-bf56-48f1-a227-634d37ee92dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_58969bb9-194f-40ee-87d1-281ce582063f" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_a1109cd6-bf56-48f1-a227-634d37ee92dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_6feec9e5-6fe6-418a-9674-250c9da8a16a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_58969bb9-194f-40ee-87d1-281ce582063f" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_6feec9e5-6fe6-418a-9674-250c9da8a16a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SelfFundedReceivablesNet_43507c3a-8622-4445-b8a9-aa152b55696e" xlink:href="elv-20220930.xsd#elv_SelfFundedReceivablesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_58969bb9-194f-40ee-87d1-281ce582063f" xlink:to="loc_elv_SelfFundedReceivablesNet_43507c3a-8622-4445-b8a9-aa152b55696e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_8260d5d9-cf67-4386-a6ab-fd928f3d006c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_58969bb9-194f-40ee-87d1-281ce582063f" xlink:to="loc_us-gaap_OtherReceivables_8260d5d9-cf67-4386-a6ab-fd928f3d006c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_ff47d350-2232-48ed-adfc-9242349dddb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_58969bb9-194f-40ee-87d1-281ce582063f" xlink:to="loc_us-gaap_OtherAssetsCurrent_ff47d350-2232-48ed-adfc-9242349dddb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c70a43ed-6d34-45f0-9014-1ab39026d175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_58969bb9-194f-40ee-87d1-281ce582063f" xlink:to="loc_us-gaap_AssetsCurrent_c70a43ed-6d34-45f0-9014-1ab39026d175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestmentsAbstract_cb387c10-4e19-493c-93dd-5d0ad69d44fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestmentsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3bf8eee2-6ce6-4bfa-a730-33b8f7d4557e" xlink:to="loc_us-gaap_LongTermInvestmentsAbstract_cb387c10-4e19-493c-93dd-5d0ad69d44fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_e58115de-7f96-4c50-806a-d6c327e6fad6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermInvestmentsAbstract_cb387c10-4e19-493c-93dd-5d0ad69d44fc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_e58115de-7f96-4c50-806a-d6c327e6fad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_a2991ff5-9dc3-4fb5-b6d3-691a167fc479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermInvestmentsAbstract_cb387c10-4e19-493c-93dd-5d0ad69d44fc" xlink:to="loc_us-gaap_OtherLongTermInvestments_a2991ff5-9dc3-4fb5-b6d3-691a167fc479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8876d490-4a93-44f4-a11c-57811091ada4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3bf8eee2-6ce6-4bfa-a730-33b8f7d4557e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8876d490-4a93-44f4-a11c-57811091ada4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_72906cb6-e19f-4e93-b35a-b2970b0afd21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3bf8eee2-6ce6-4bfa-a730-33b8f7d4557e" xlink:to="loc_us-gaap_Goodwill_72906cb6-e19f-4e93-b35a-b2970b0afd21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0556af2e-38ad-4832-bece-08b0da764105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3bf8eee2-6ce6-4bfa-a730-33b8f7d4557e" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0556af2e-38ad-4832-bece-08b0da764105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_809bd7dc-57c8-4af8-b47f-95e9c9456844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3bf8eee2-6ce6-4bfa-a730-33b8f7d4557e" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_809bd7dc-57c8-4af8-b47f-95e9c9456844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_1fac15b8-2b6c-4b27-bc5b-545860c9219c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3bf8eee2-6ce6-4bfa-a730-33b8f7d4557e" xlink:to="loc_us-gaap_Assets_1fac15b8-2b6c-4b27-bc5b-545860c9219c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ef6cff3-100f-48d7-8a5b-98d45d1c6db5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_eb283f1e-55c1-4367-9ec0-38223fcafff5" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ef6cff3-100f-48d7-8a5b-98d45d1c6db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_6f755458-a39e-4be6-bed4-cc7b07f239d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ef6cff3-100f-48d7-8a5b-98d45d1c6db5" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_6f755458-a39e-4be6-bed4-cc7b07f239d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_93ea57d6-cb44-4e14-a441-fc63d41a0be8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6f755458-a39e-4be6-bed4-cc7b07f239d3" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_93ea57d6-cb44-4e14-a441-fc63d41a0be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds_4f85a167-b482-4b63-bc6a-72fe5fdf0fca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6f755458-a39e-4be6-bed4-cc7b07f239d3" xlink:to="loc_us-gaap_OtherPolicyholderFunds_4f85a167-b482-4b63-bc6a-72fe5fdf0fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnearnedPremiums_c48cc46d-da49-4699-967f-b4c4e569021d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnearnedPremiums"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6f755458-a39e-4be6-bed4-cc7b07f239d3" xlink:to="loc_us-gaap_UnearnedPremiums_c48cc46d-da49-4699-967f-b4c4e569021d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_4bf42d98-dc5d-45e4-8d61-b1f8181b06ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6f755458-a39e-4be6-bed4-cc7b07f239d3" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_4bf42d98-dc5d-45e4-8d61-b1f8181b06ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_5defb0a6-7055-489f-a01a-3a3efb133868" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6f755458-a39e-4be6-bed4-cc7b07f239d3" xlink:to="loc_us-gaap_ShortTermBorrowings_5defb0a6-7055-489f-a01a-3a3efb133868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_3f5f7ed1-2c58-4408-bf56-6ca7bbe5b8b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6f755458-a39e-4be6-bed4-cc7b07f239d3" xlink:to="loc_us-gaap_LongTermDebtCurrent_3f5f7ed1-2c58-4408-bf56-6ca7bbe5b8b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_47c5a530-5c29-419b-a6b9-7fd8d126c178" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6f755458-a39e-4be6-bed4-cc7b07f239d3" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_47c5a530-5c29-419b-a6b9-7fd8d126c178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f41fe5ab-3fa1-4294-9a66-2604a4311f55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ef6cff3-100f-48d7-8a5b-98d45d1c6db5" xlink:to="loc_us-gaap_LiabilitiesCurrent_f41fe5ab-3fa1-4294-9a66-2604a4311f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_430fa166-9f8b-4db7-86c2-c9cbd67c8a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ef6cff3-100f-48d7-8a5b-98d45d1c6db5" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_430fa166-9f8b-4db7-86c2-c9cbd67c8a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_2f81bd95-4bd5-4bbd-a802-8831d5cd9e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ef6cff3-100f-48d7-8a5b-98d45d1c6db5" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefits_2f81bd95-4bd5-4bbd-a802-8831d5cd9e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_58a15e84-6184-486b-87be-9901fb66a053" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ef6cff3-100f-48d7-8a5b-98d45d1c6db5" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_58a15e84-6184-486b-87be-9901fb66a053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_17f5aae4-fd52-4813-b2fd-30a17144f66d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ef6cff3-100f-48d7-8a5b-98d45d1c6db5" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_17f5aae4-fd52-4813-b2fd-30a17144f66d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_bd41f07b-99b3-459d-bf94-902ef2501e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ef6cff3-100f-48d7-8a5b-98d45d1c6db5" xlink:to="loc_us-gaap_Liabilities_bd41f07b-99b3-459d-bf94-902ef2501e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_c842011c-1c23-4090-a558-20348bc5d2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ef6cff3-100f-48d7-8a5b-98d45d1c6db5" xlink:to="loc_us-gaap_CommitmentsAndContingencies_c842011c-1c23-4090-a558-20348bc5d2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_866309d0-76d9-420d-9a80-bcf1f5b03708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ef6cff3-100f-48d7-8a5b-98d45d1c6db5" xlink:to="loc_us-gaap_StockholdersEquityAbstract_866309d0-76d9-420d-9a80-bcf1f5b03708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_323bdafd-ec89-4296-8c31-5a81324492a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_866309d0-76d9-420d-9a80-bcf1f5b03708" xlink:to="loc_us-gaap_PreferredStockValue_323bdafd-ec89-4296-8c31-5a81324492a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_80eff8ac-a3e6-40ee-9129-c0768d298266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_866309d0-76d9-420d-9a80-bcf1f5b03708" xlink:to="loc_us-gaap_CommonStockValue_80eff8ac-a3e6-40ee-9129-c0768d298266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_4dfa23d6-cc21-4bee-bb3d-cbb5af423d65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_866309d0-76d9-420d-9a80-bcf1f5b03708" xlink:to="loc_us-gaap_AdditionalPaidInCapital_4dfa23d6-cc21-4bee-bb3d-cbb5af423d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9fd13743-1586-4db1-90a1-7741e34c8341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_866309d0-76d9-420d-9a80-bcf1f5b03708" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9fd13743-1586-4db1-90a1-7741e34c8341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_63730fbe-6e18-4032-80e0-8624f4e2dfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_866309d0-76d9-420d-9a80-bcf1f5b03708" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_63730fbe-6e18-4032-80e0-8624f4e2dfc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_75178462-9f53-4df7-931a-2f1b07e32d06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_866309d0-76d9-420d-9a80-bcf1f5b03708" xlink:to="loc_us-gaap_StockholdersEquity_75178462-9f53-4df7-931a-2f1b07e32d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_688a7c02-86df-49c1-b346-9b712066bb3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_866309d0-76d9-420d-9a80-bcf1f5b03708" xlink:to="loc_us-gaap_MinorityInterest_688a7c02-86df-49c1-b346-9b712066bb3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e5d468ce-6746-4536-b398-8c4757ea937e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_866309d0-76d9-420d-9a80-bcf1f5b03708" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e5d468ce-6746-4536-b398-8c4757ea937e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a2fd6578-dfe8-412b-94f0-355c33e40269" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7ef6cff3-100f-48d7-8a5b-98d45d1c6db5" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_a2fd6578-dfe8-412b-94f0-355c33e40269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="elv-20220930.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_088ff49d-1dbd-4c24-a913-a7c8de1e83de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_354ed91d-0dae-4b3d-a9c1-f4af0a6c89ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_088ff49d-1dbd-4c24-a913-a7c8de1e83de" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_354ed91d-0dae-4b3d-a9c1-f4af0a6c89ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent_1c87797b-79c3-455c-aa72-b4ef17b78bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_088ff49d-1dbd-4c24-a913-a7c8de1e83de" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent_1c87797b-79c3-455c-aa72-b4ef17b78bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_eee95cb2-626a-4f24-b1b4-9a96b562da09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_088ff49d-1dbd-4c24-a913-a7c8de1e83de" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_eee95cb2-626a-4f24-b1b4-9a96b562da09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent_e8350df7-234b-4e06-bfdf-8ba88f80b152" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_088ff49d-1dbd-4c24-a913-a7c8de1e83de" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent_e8350df7-234b-4e06-bfdf-8ba88f80b152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f46395d2-980c-4e1f-82be-ab661e9dc546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_088ff49d-1dbd-4c24-a913-a7c8de1e83de" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f46395d2-980c-4e1f-82be-ab661e9dc546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_eade9c3e-cac7-454f-a6b1-141a834b5960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_088ff49d-1dbd-4c24-a913-a7c8de1e83de" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_eade9c3e-cac7-454f-a6b1-141a834b5960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_4676e86d-10dd-49db-b704-9a806cd1d662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_088ff49d-1dbd-4c24-a913-a7c8de1e83de" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_4676e86d-10dd-49db-b704-9a806cd1d662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_f619dd19-1c41-46ae-b847-d278fabd28b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_088ff49d-1dbd-4c24-a913-a7c8de1e83de" xlink:to="loc_us-gaap_CommonStockSharesIssued_f619dd19-1c41-46ae-b847-d278fabd28b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ae1d6711-7ea3-462d-b6fe-f60f970f165f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_088ff49d-1dbd-4c24-a913-a7c8de1e83de" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ae1d6711-7ea3-462d-b6fe-f60f970f165f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_d898d05f-2be6-4de3-af3e-119c2f12c10e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_088ff49d-1dbd-4c24-a913-a7c8de1e83de" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_d898d05f-2be6-4de3-af3e-119c2f12c10e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_b630f6c3-1c05-4aa1-96cc-16087fb6fae3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_088ff49d-1dbd-4c24-a913-a7c8de1e83de" xlink:to="loc_us-gaap_PreferredStockSharesIssued_b630f6c3-1c05-4aa1-96cc-16087fb6fae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_400b5184-259a-4e2c-974b-fd531f343d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_088ff49d-1dbd-4c24-a913-a7c8de1e83de" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_400b5184-259a-4e2c-974b-fd531f343d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome" xlink:type="simple" xlink:href="elv-20220930.xsd#ConsolidatedStatementsOfIncome"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_02c353ca-73ce-437b-a075-c48b6c9227c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_9b9f86a4-3135-49f6-8684-b64993d44f50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_02c353ca-73ce-437b-a075-c48b6c9227c3" xlink:to="loc_us-gaap_RevenuesAbstract_9b9f86a4-3135-49f6-8684-b64993d44f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_e31f06ce-e501-43aa-82ca-fc0bce9a7e00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_9b9f86a4-3135-49f6-8684-b64993d44f50" xlink:to="loc_us-gaap_PremiumsEarnedNet_e31f06ce-e501-43aa-82ca-fc0bce9a7e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ProductRevenue_db134076-ff56-4380-97ba-a83a34daaaf6" xlink:href="elv-20220930.xsd#elv_ProductRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_9b9f86a4-3135-49f6-8684-b64993d44f50" xlink:to="loc_elv_ProductRevenue_db134076-ff56-4380-97ba-a83a34daaaf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_7ebed2ce-dfb8-45cd-92b7-3379898c4c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_9b9f86a4-3135-49f6-8684-b64993d44f50" xlink:to="loc_us-gaap_OtherIncome_7ebed2ce-dfb8-45cd-92b7-3379898c4c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OperatingRevenue_6f04af3c-b374-4b9a-9f04-2b67b73ea524" xlink:href="elv-20220930.xsd#elv_OperatingRevenue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_9b9f86a4-3135-49f6-8684-b64993d44f50" xlink:to="loc_elv_OperatingRevenue_6f04af3c-b374-4b9a-9f04-2b67b73ea524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_b9751f45-1d0d-4503-94df-ca7561f09128" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_9b9f86a4-3135-49f6-8684-b64993d44f50" xlink:to="loc_us-gaap_NetInvestmentIncome_b9751f45-1d0d-4503-94df-ca7561f09128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_NetLossesGainsOnFinancialInstruments_6a92b356-1b6d-47e1-8b80-a2d1e6cc9589" xlink:href="elv-20220930.xsd#elv_NetLossesGainsOnFinancialInstruments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_9b9f86a4-3135-49f6-8684-b64993d44f50" xlink:to="loc_elv_NetLossesGainsOnFinancialInstruments_6a92b356-1b6d-47e1-8b80-a2d1e6cc9589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_77ff9492-482b-4398-b9f4-415e24953193" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_9b9f86a4-3135-49f6-8684-b64993d44f50" xlink:to="loc_us-gaap_Revenues_77ff9492-482b-4398-b9f4-415e24953193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpensesAbstract_5b97dfb7-2523-4182-a5d9-d0d9d44ebcd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_02c353ca-73ce-437b-a075-c48b6c9227c3" xlink:to="loc_us-gaap_BenefitsLossesAndExpensesAbstract_5b97dfb7-2523-4182-a5d9-d0d9d44ebcd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_a16f1aca-1e74-4425-a40e-a3793c7a4099" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_5b97dfb7-2523-4182-a5d9-d0d9d44ebcd7" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_a16f1aca-1e74-4425-a40e-a3793c7a4099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_7339cdf3-54a9-4466-bc0f-3e1598ba53fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_5b97dfb7-2523-4182-a5d9-d0d9d44ebcd7" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_7339cdf3-54a9-4466-bc0f-3e1598ba53fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d3d85a60-a1a2-4ba8-a10f-f850bc568089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_5b97dfb7-2523-4182-a5d9-d0d9d44ebcd7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d3d85a60-a1a2-4ba8-a10f-f850bc568089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_26510529-698f-45ac-b5b8-06c8eeeac68c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_5b97dfb7-2523-4182-a5d9-d0d9d44ebcd7" xlink:to="loc_us-gaap_InterestExpense_26510529-698f-45ac-b5b8-06c8eeeac68c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a8a0a622-78ed-4d39-b629-0609b481a260" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_5b97dfb7-2523-4182-a5d9-d0d9d44ebcd7" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a8a0a622-78ed-4d39-b629-0609b481a260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e9fd0362-9889-4963-aba9-5108b5efd45f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_5b97dfb7-2523-4182-a5d9-d0d9d44ebcd7" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e9fd0362-9889-4963-aba9-5108b5efd45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpenses_685b8276-196b-423b-933b-461f4325c606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_5b97dfb7-2523-4182-a5d9-d0d9d44ebcd7" xlink:to="loc_us-gaap_BenefitsLossesAndExpenses_685b8276-196b-423b-933b-461f4325c606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_44cfa168-6159-4b3d-9a4a-66220f8091a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_02c353ca-73ce-437b-a075-c48b6c9227c3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_44cfa168-6159-4b3d-9a4a-66220f8091a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e747c240-9d41-43a3-8cba-1009a5c273a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_02c353ca-73ce-437b-a075-c48b6c9227c3" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e747c240-9d41-43a3-8cba-1009a5c273a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3694af29-60c1-491b-a79f-8da8289596bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_02c353ca-73ce-437b-a075-c48b6c9227c3" xlink:to="loc_us-gaap_ProfitLoss_3694af29-60c1-491b-a79f-8da8289596bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_fff2dfcd-07ab-498a-97ca-21dc249bc31f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_02c353ca-73ce-437b-a075-c48b6c9227c3" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_fff2dfcd-07ab-498a-97ca-21dc249bc31f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a8819ca8-891c-4d92-812e-44e23d074b24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_02c353ca-73ce-437b-a075-c48b6c9227c3" xlink:to="loc_us-gaap_NetIncomeLoss_a8819ca8-891c-4d92-812e-44e23d074b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7f5ade5f-d40f-4f55-9464-6876cdfadfbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_02c353ca-73ce-437b-a075-c48b6c9227c3" xlink:to="loc_us-gaap_EarningsPerShareAbstract_7f5ade5f-d40f-4f55-9464-6876cdfadfbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_607db95c-2ca4-46f3-b03c-5820af501d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7f5ade5f-d40f-4f55-9464-6876cdfadfbf" xlink:to="loc_us-gaap_EarningsPerShareBasic_607db95c-2ca4-46f3-b03c-5820af501d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_b66e25c1-8234-4cc6-8163-1f59253a33ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7f5ade5f-d40f-4f55-9464-6876cdfadfbf" xlink:to="loc_us-gaap_EarningsPerShareDiluted_b66e25c1-8234-4cc6-8163-1f59253a33ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_ef39191a-16e9-4dad-b4c9-ee8adb4e888a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_02c353ca-73ce-437b-a075-c48b6c9227c3" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_ef39191a-16e9-4dad-b4c9-ee8adb4e888a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="elv-20220930.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_765b3716-3ae0-4924-bd51-cda5f7f7d11e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2a4fad60-5098-42bc-9b0f-db1f3bb98af9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_765b3716-3ae0-4924-bd51-cda5f7f7d11e" xlink:to="loc_us-gaap_ProfitLoss_2a4fad60-5098-42bc-9b0f-db1f3bb98af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c53ac700-7492-4a43-a730-f1e8d9748aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_765b3716-3ae0-4924-bd51-cda5f7f7d11e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c53ac700-7492-4a43-a730-f1e8d9748aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_86ceca02-4b17-47fa-926b-4263e9b5688d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c53ac700-7492-4a43-a730-f1e8d9748aa0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_86ceca02-4b17-47fa-926b-4263e9b5688d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax_4b47107f-f6f2-4933-b2e0-d0dd9369b8d6" xlink:href="elv-20220930.xsd#elv_Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c53ac700-7492-4a43-a730-f1e8d9748aa0" xlink:to="loc_elv_Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax_4b47107f-f6f2-4933-b2e0-d0dd9369b8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_478082c9-5432-4906-8a46-70133e4610c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c53ac700-7492-4a43-a730-f1e8d9748aa0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_478082c9-5432-4906-8a46-70133e4610c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_2a1994ac-7791-4530-8817-90e39f8b20d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c53ac700-7492-4a43-a730-f1e8d9748aa0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_2a1994ac-7791-4530-8817-90e39f8b20d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_097eff7e-1e59-4e0c-97b3-8b9e390b6d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c53ac700-7492-4a43-a730-f1e8d9748aa0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_097eff7e-1e59-4e0c-97b3-8b9e390b6d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a74978ba-15e0-4add-a545-f3a25fc83018" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_765b3716-3ae0-4924-bd51-cda5f7f7d11e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a74978ba-15e0-4add-a545-f3a25fc83018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_99c9ccec-7789-4eeb-9a25-dfed81339239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_765b3716-3ae0-4924-bd51-cda5f7f7d11e" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_99c9ccec-7789-4eeb-9a25-dfed81339239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_408ec673-89c0-47f1-b601-3f4dbe014f04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_765b3716-3ae0-4924-bd51-cda5f7f7d11e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_408ec673-89c0-47f1-b601-3f4dbe014f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_7fa08525-5d91-4f50-8b4e-81f5f6c1e133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_765b3716-3ae0-4924-bd51-cda5f7f7d11e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_7fa08525-5d91-4f50-8b4e-81f5f6c1e133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="elv-20220930.xsd#ConsolidatedStatementsOfCashFlows"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_94844e1e-5dc7-45da-8ea0-61167fccd84a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3116a847-7325-4489-beb6-b3923980e41a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94844e1e-5dc7-45da-8ea0-61167fccd84a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3116a847-7325-4489-beb6-b3923980e41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2978702c-e805-4e2d-8a0e-61549b7851cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3116a847-7325-4489-beb6-b3923980e41a" xlink:to="loc_us-gaap_ProfitLoss_2978702c-e805-4e2d-8a0e-61549b7851cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9641e6cd-b4f4-4353-b6c9-29b387199162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3116a847-7325-4489-beb6-b3923980e41a" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9641e6cd-b4f4-4353-b6c9-29b387199162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_NetLossesGainsOnFinancialInstruments_f997210f-f911-49ed-855c-a0b8e42cac61" xlink:href="elv-20220930.xsd#elv_NetLossesGainsOnFinancialInstruments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9641e6cd-b4f4-4353-b6c9-29b387199162" xlink:to="loc_elv_NetLossesGainsOnFinancialInstruments_f997210f-f911-49ed-855c-a0b8e42cac61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c798ecb2-a39d-46ac-bc99-484f64e102de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9641e6cd-b4f4-4353-b6c9-29b387199162" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c798ecb2-a39d-46ac-bc99-484f64e102de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_2d134374-d3a6-4e88-9edf-5c49bec1f2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9641e6cd-b4f4-4353-b6c9-29b387199162" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_2d134374-d3a6-4e88-9edf-5c49bec1f2fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7ec996fd-9a5a-4645-8dbe-de10b83627fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9641e6cd-b4f4-4353-b6c9-29b387199162" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7ec996fd-9a5a-4645-8dbe-de10b83627fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_3bc14c76-350d-4f6c-8406-59bc92c54677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9641e6cd-b4f4-4353-b6c9-29b387199162" xlink:to="loc_us-gaap_ShareBasedCompensation_3bc14c76-350d-4f6c-8406-59bc92c54677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca220217-b20a-47c9-b6a6-b9c640febafb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9641e6cd-b4f4-4353-b6c9-29b387199162" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca220217-b20a-47c9-b6a6-b9c640febafb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_9e45104d-5cbb-4bba-827d-a22438edf901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca220217-b20a-47c9-b6a6-b9c640febafb" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_9e45104d-5cbb-4bba-827d-a22438edf901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTradingSecurities_4667eae6-b808-48a2-9e31-98c866bfb2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTradingSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca220217-b20a-47c9-b6a6-b9c640febafb" xlink:to="loc_us-gaap_IncreaseDecreaseInTradingSecurities_4667eae6-b808-48a2-9e31-98c866bfb2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_5e490b58-daae-42b9-bf83-1862b2b270c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca220217-b20a-47c9-b6a6-b9c640febafb" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_5e490b58-daae-42b9-bf83-1862b2b270c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_42a6ef8f-4fb9-47a9-8b18-1b516332302f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca220217-b20a-47c9-b6a6-b9c640febafb" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_42a6ef8f-4fb9-47a9-8b18-1b516332302f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_33fee889-1817-498b-a8a7-448cd452f2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca220217-b20a-47c9-b6a6-b9c640febafb" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_33fee889-1817-498b-a8a7-448cd452f2bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_263e8e58-ea96-4280-aacf-34dd14f6dcb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca220217-b20a-47c9-b6a6-b9c640febafb" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_263e8e58-ea96-4280-aacf-34dd14f6dcb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_99f67176-cf8e-4bf9-b0cd-1231757157c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca220217-b20a-47c9-b6a6-b9c640febafb" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_99f67176-cf8e-4bf9-b0cd-1231757157c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_d2d5ee05-df38-469a-92f4-422fe83f99b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca220217-b20a-47c9-b6a6-b9c640febafb" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_d2d5ee05-df38-469a-92f4-422fe83f99b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a78420a8-3b27-4db5-b4ca-bf4710be74d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3116a847-7325-4489-beb6-b3923980e41a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a78420a8-3b27-4db5-b4ca-bf4710be74d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_da1931eb-18e6-432f-a96d-2bf86db8b0d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94844e1e-5dc7-45da-8ea0-61167fccd84a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_da1931eb-18e6-432f-a96d-2bf86db8b0d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_b3a7fa58-4c13-40b6-842e-44e6a6d37fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_da1931eb-18e6-432f-a96d-2bf86db8b0d9" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_b3a7fa58-4c13-40b6-842e-44e6a6d37fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_Proceedsfromsaleofequityandfixedmaturitysecurities_dc2b3f4c-334a-4e2e-a86f-1b8424a24303" xlink:href="elv-20220930.xsd#elv_Proceedsfromsaleofequityandfixedmaturitysecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_da1931eb-18e6-432f-a96d-2bf86db8b0d9" xlink:to="loc_elv_Proceedsfromsaleofequityandfixedmaturitysecurities_dc2b3f4c-334a-4e2e-a86f-1b8424a24303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_553f8ffe-9a36-40b3-b40e-a18d41ebb2d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_da1931eb-18e6-432f-a96d-2bf86db8b0d9" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_553f8ffe-9a36-40b3-b40e-a18d41ebb2d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInCollateralHeldUnderSecuritiesLending_7b886c4f-2a31-4b6c-89bd-9eb711f17b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInCollateralHeldUnderSecuritiesLending"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_da1931eb-18e6-432f-a96d-2bf86db8b0d9" xlink:to="loc_us-gaap_IncreaseDecreaseInCollateralHeldUnderSecuritiesLending_7b886c4f-2a31-4b6c-89bd-9eb711f17b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8b3a0519-2a0a-4786-97dd-93e43d5cec7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_da1931eb-18e6-432f-a96d-2bf86db8b0d9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8b3a0519-2a0a-4786-97dd-93e43d5cec7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_83f57219-186d-4cbd-9cdc-88c7ac068bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_da1931eb-18e6-432f-a96d-2bf86db8b0d9" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_83f57219-186d-4cbd-9cdc-88c7ac068bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6a59df4c-4a0e-4840-bb0b-af1f8e0e4ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_da1931eb-18e6-432f-a96d-2bf86db8b0d9" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6a59df4c-4a0e-4840-bb0b-af1f8e0e4ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_42aa1139-0b7c-4005-820f-a8918cb87070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_da1931eb-18e6-432f-a96d-2bf86db8b0d9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_42aa1139-0b7c-4005-820f-a8918cb87070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_50573d4d-19b6-4762-90d7-6375cd16abad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94844e1e-5dc7-45da-8ea0-61167fccd84a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_50573d4d-19b6-4762-90d7-6375cd16abad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_e972fc4c-7fa3-4e1a-81f7-e8a70a7a902f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_50573d4d-19b6-4762-90d7-6375cd16abad" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_e972fc4c-7fa3-4e1a-81f7-e8a70a7a902f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_73bb81ad-b599-43d3-b828-90e1e0856185" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_50573d4d-19b6-4762-90d7-6375cd16abad" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_73bb81ad-b599-43d3-b828-90e1e0856185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_96514634-4bcc-4ea7-af01-9174d0e3c95f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_50573d4d-19b6-4762-90d7-6375cd16abad" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_96514634-4bcc-4ea7-af01-9174d0e3c95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_3bcc6f68-31b9-4a63-b8a3-f467d1279e59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_50573d4d-19b6-4762-90d7-6375cd16abad" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_3bcc6f68-31b9-4a63-b8a3-f467d1279e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_5ebdf4dc-66bc-4b93-96ce-e4dd8cda7b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_50573d4d-19b6-4762-90d7-6375cd16abad" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_5ebdf4dc-66bc-4b93-96ce-e4dd8cda7b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInSecuritiesLendingPayable_c85d0536-ebd5-4361-b5ee-d392fb450887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInSecuritiesLendingPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_50573d4d-19b6-4762-90d7-6375cd16abad" xlink:to="loc_us-gaap_IncreaseDecreaseInSecuritiesLendingPayable_c85d0536-ebd5-4361-b5ee-d392fb450887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOutstandingChecksFinancingActivities_a10e1496-20fd-4d7d-80a8-be2f28dbdd8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOutstandingChecksFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_50573d4d-19b6-4762-90d7-6375cd16abad" xlink:to="loc_us-gaap_IncreaseDecreaseInOutstandingChecksFinancingActivities_a10e1496-20fd-4d7d-80a8-be2f28dbdd8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_40a3474c-17f2-424e-a337-569da42ee775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_50573d4d-19b6-4762-90d7-6375cd16abad" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_40a3474c-17f2-424e-a337-569da42ee775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_ea7666d5-04f0-4db6-ba52-322bfb6fc484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_50573d4d-19b6-4762-90d7-6375cd16abad" xlink:to="loc_us-gaap_PaymentsOfDividends_ea7666d5-04f0-4db6-ba52-322bfb6fc484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_1901aee2-7d0f-4b83-ac8a-14a9c4df8178" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_50573d4d-19b6-4762-90d7-6375cd16abad" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_1901aee2-7d0f-4b83-ac8a-14a9c4df8178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_eacfd6ef-fdfe-4b91-b68d-d7f80d53121b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_50573d4d-19b6-4762-90d7-6375cd16abad" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_eacfd6ef-fdfe-4b91-b68d-d7f80d53121b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b1892159-4687-4fd0-b650-8fcf0d14ff4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_50573d4d-19b6-4762-90d7-6375cd16abad" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b1892159-4687-4fd0-b650-8fcf0d14ff4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_793b748e-1658-4819-940a-33d766e485fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_50573d4d-19b6-4762-90d7-6375cd16abad" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_793b748e-1658-4819-940a-33d766e485fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5beab512-1d46-48bb-ae68-a855a1be725e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94844e1e-5dc7-45da-8ea0-61167fccd84a" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5beab512-1d46-48bb-ae68-a855a1be725e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_889de7b0-d4f6-4820-aa2d-d5942a34091d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94844e1e-5dc7-45da-8ea0-61167fccd84a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_889de7b0-d4f6-4820-aa2d-d5942a34091d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c6460b3f-212b-4b9c-9faa-f0e2fbb74862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94844e1e-5dc7-45da-8ea0-61167fccd84a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c6460b3f-212b-4b9c-9faa-f0e2fbb74862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_32657a03-e452-4934-8044-31cd0f5a749a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94844e1e-5dc7-45da-8ea0-61167fccd84a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_32657a03-e452-4934-8044-31cd0f5a749a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity" xlink:type="simple" xlink:href="elv-20220930.xsd#ConsolidatedStatementsOfChangesinEquity"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0b3431d1-6637-41c9-a73e-0d9f5c9dbe8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_120ce670-34c9-4236-9412-5d8f4c0af07a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0b3431d1-6637-41c9-a73e-0d9f5c9dbe8a" xlink:to="loc_us-gaap_StatementTable_120ce670-34c9-4236-9412-5d8f4c0af07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6f6befb4-d3ce-47a1-affc-1a0e66303778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_120ce670-34c9-4236-9412-5d8f4c0af07a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6f6befb4-d3ce-47a1-affc-1a0e66303778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c3928a5b-4af7-462d-954b-c99d35f1782e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6f6befb4-d3ce-47a1-affc-1a0e66303778" xlink:to="loc_us-gaap_EquityComponentDomain_c3928a5b-4af7-462d-954b-c99d35f1782e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8b51fca0-61fc-4494-9262-5d40d7152140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c3928a5b-4af7-462d-954b-c99d35f1782e" xlink:to="loc_us-gaap_CommonStockMember_8b51fca0-61fc-4494-9262-5d40d7152140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_5b6a0a57-cee8-4c67-bfe4-4b614de14587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c3928a5b-4af7-462d-954b-c99d35f1782e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_5b6a0a57-cee8-4c67-bfe4-4b614de14587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a40b6511-1cd4-4d54-9bde-adeba3f26f35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c3928a5b-4af7-462d-954b-c99d35f1782e" xlink:to="loc_us-gaap_RetainedEarningsMember_a40b6511-1cd4-4d54-9bde-adeba3f26f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1ccc9655-823d-481c-ad0b-e79fd0fa0186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c3928a5b-4af7-462d-954b-c99d35f1782e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1ccc9655-823d-481c-ad0b-e79fd0fa0186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_8e3cc9f7-54c6-45ca-afcf-1510f16197df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c3928a5b-4af7-462d-954b-c99d35f1782e" xlink:to="loc_us-gaap_NoncontrollingInterestMember_8e3cc9f7-54c6-45ca-afcf-1510f16197df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8799ee6b-3250-4297-8a24-1948c1390130" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_120ce670-34c9-4236-9412-5d8f4c0af07a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8799ee6b-3250-4297-8a24-1948c1390130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_97db23ba-cd3f-4405-b9df-fd63ac8fd3a4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8799ee6b-3250-4297-8a24-1948c1390130" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_97db23ba-cd3f-4405-b9df-fd63ac8fd3a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_46c20a8d-aab9-4bbf-9d46-999060d18ea3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_97db23ba-cd3f-4405-b9df-fd63ac8fd3a4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_46c20a8d-aab9-4bbf-9d46-999060d18ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_d91503a7-bf2a-445d-a3b3-cbcbfb202033" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_97db23ba-cd3f-4405-b9df-fd63ac8fd3a4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_d91503a7-bf2a-445d-a3b3-cbcbfb202033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7e0d1f18-8fdc-49b2-8199-ffba2b3384b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_120ce670-34c9-4236-9412-5d8f4c0af07a" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7e0d1f18-8fdc-49b2-8199-ffba2b3384b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_ff3150d9-a7bc-4836-bacf-28f2d14d4651" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7e0d1f18-8fdc-49b2-8199-ffba2b3384b7" xlink:to="loc_us-gaap_TypeOfAdoptionMember_ff3150d9-a7bc-4836-bacf-28f2d14d4651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_c84b73b8-d6dc-4bf0-9e4e-03114dcd20c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_ff3150d9-a7bc-4836-bacf-28f2d14d4651" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_c84b73b8-d6dc-4bf0-9e4e-03114dcd20c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7719a1c2-7c91-4ef8-a696-3d489598f4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_120ce670-34c9-4236-9412-5d8f4c0af07a" xlink:to="loc_us-gaap_StatementLineItems_7719a1c2-7c91-4ef8-a696-3d489598f4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_ad6501a1-2ddc-4b52-b59d-89692222bf9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7719a1c2-7c91-4ef8-a696-3d489598f4fb" xlink:to="loc_us-gaap_SharesOutstanding_ad6501a1-2ddc-4b52-b59d-89692222bf9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d2e975f8-554f-45b1-a4d5-96c8cb4da56c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7719a1c2-7c91-4ef8-a696-3d489598f4fb" xlink:to="loc_us-gaap_StockholdersEquity_d2e975f8-554f-45b1-a4d5-96c8cb4da56c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_35e5bfe9-b096-4e94-aae3-9b7fb4f48141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7719a1c2-7c91-4ef8-a696-3d489598f4fb" xlink:to="loc_us-gaap_MinorityInterest_35e5bfe9-b096-4e94-aae3-9b7fb4f48141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_af4f26fd-8259-4ad3-a82c-02e9d8703b96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7719a1c2-7c91-4ef8-a696-3d489598f4fb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_af4f26fd-8259-4ad3-a82c-02e9d8703b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7719a1c2-7c91-4ef8-a696-3d489598f4fb" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_48df6944-55af-4f48-8467-56d7253015c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_NetIncomeLoss_48df6944-55af-4f48-8467-56d7253015c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_deb250d2-a9dc-4a84-ac01-8b23cdcffd93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_deb250d2-a9dc-4a84-ac01-8b23cdcffd93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9c6a61e7-9765-4d38-91ca-70ff4498f046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_ProfitLoss_9c6a61e7-9765-4d38-91ca-70ff4498f046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4956032d-0fb3-4957-988b-a9b974e9e0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4956032d-0fb3-4957-988b-a9b974e9e0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_414732b7-f8a5-4a6b-9a7c-140381f2c149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_414732b7-f8a5-4a6b-9a7c-140381f2c149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_95d03561-3699-4ecd-b83f-5102aa2067b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_95d03561-3699-4ecd-b83f-5102aa2067b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_df798796-165a-4177-a91e-e428e8d01473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_df798796-165a-4177-a91e-e428e8d01473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_NoncontrollingInterestPeriodIncreaseDecrease_ce8b5ce6-024e-43ae-aa30-a04fb892f39e" xlink:href="elv-20220930.xsd#elv_NoncontrollingInterestPeriodIncreaseDecrease"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_elv_NoncontrollingInterestPeriodIncreaseDecrease_ce8b5ce6-024e-43ae-aa30-a04fb892f39e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_d3a2ed53-8f9b-4789-b1de-8b0cfb856421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_d3a2ed53-8f9b-4789-b1de-8b0cfb856421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_9357b509-c182-4863-b269-1b03c12db722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_9357b509-c182-4863-b269-1b03c12db722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_cebcc549-c44a-4722-9a89-095cfdf4993b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_DividendsCommonStock_cebcc549-c44a-4722-9a89-095cfdf4993b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_d34ec786-a4d9-44bc-941e-2ceee8f9fe03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_d34ec786-a4d9-44bc-941e-2ceee8f9fe03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_94f05075-4119-47d5-8340-39ea09eec29f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_94f05075-4119-47d5-8340-39ea09eec29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments_4632e2ee-75e0-4f34-b30a-54d2f959ac7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_056cfc9e-d828-4965-832a-d30a6c9cfd2c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments_4632e2ee-75e0-4f34-b30a-54d2f959ac7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_d0c09a13-c6cc-4653-8cc9-fe75682004a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7719a1c2-7c91-4ef8-a696-3d489598f4fb" xlink:to="loc_us-gaap_SharesOutstanding_d0c09a13-c6cc-4653-8cc9-fe75682004a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_bfddf5dd-675f-4a2f-b7ee-5e5c962e6428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7719a1c2-7c91-4ef8-a696-3d489598f4fb" xlink:to="loc_us-gaap_StockholdersEquity_bfddf5dd-675f-4a2f-b7ee-5e5c962e6428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_39fbb1df-62a0-4a92-a4a1-c97a4a6543b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7719a1c2-7c91-4ef8-a696-3d489598f4fb" xlink:to="loc_us-gaap_MinorityInterest_39fbb1df-62a0-4a92-a4a1-c97a4a6543b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5201dc0c-69c1-412d-b796-d51995c07506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7719a1c2-7c91-4ef8-a696-3d489598f4fb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5201dc0c-69c1-412d-b796-d51995c07506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/Organization" xlink:type="simple" xlink:href="elv-20220930.xsd#Organization"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/Organization" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_623a006c-b9bb-4825-aefe-c9f84983ec1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_3f2faa09-6f76-43a1-8798-d80b92e4eebe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_623a006c-b9bb-4825-aefe-c9f84983ec1b" xlink:to="loc_us-gaap_NatureOfOperations_3f2faa09-6f76-43a1-8798-d80b92e4eebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/OrganizationDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#OrganizationDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/OrganizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5c108dca-f5f0-4074-a4a7-afd13ad41d38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_NumberOfMedicalMembersServed_f44b7fd4-33c6-406d-8309-f23b0636d432" xlink:href="elv-20220930.xsd#elv_NumberOfMedicalMembersServed"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5c108dca-f5f0-4074-a4a7-afd13ad41d38" xlink:to="loc_elv_NumberOfMedicalMembersServed_f44b7fd4-33c6-406d-8309-f23b0636d432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_NumberOfCountiesInStateOfKansasCompanyDoesNotServe_bde96911-c5cd-4530-b55c-c318de852ec8" xlink:href="elv-20220930.xsd#elv_NumberOfCountiesInStateOfKansasCompanyDoesNotServe"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5c108dca-f5f0-4074-a4a7-afd13ad41d38" xlink:to="loc_elv_NumberOfCountiesInStateOfKansasCompanyDoesNotServe_bde96911-c5cd-4530-b55c-c318de852ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_26a7cc79-bcdb-41bf-8891-7bd21027abb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5c108dca-f5f0-4074-a4a7-afd13ad41d38" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_26a7cc79-bcdb-41bf-8891-7bd21027abb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/BasisOfPresentationandSignificantAccountingPolicies" xlink:type="simple" xlink:href="elv-20220930.xsd#BasisOfPresentationandSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/BasisOfPresentationandSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b9490306-3bb9-46e8-9f22-7425a16914b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_f5ee43e0-553c-4e98-8668-cc8355c4d704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b9490306-3bb9-46e8-9f22-7425a16914b2" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_f5ee43e0-553c-4e98-8668-cc8355c4d704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/BasisofPresentationandSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="elv-20220930.xsd#BasisofPresentationandSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/BasisofPresentationandSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2a2f3df0-74b7-4f45-a670-806ec6b1fa34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_47bc1ccb-fa70-4aeb-804c-5255cbb97dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2a2f3df0-74b7-4f45-a670-806ec6b1fa34" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_47bc1ccb-fa70-4aeb-804c-5255cbb97dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_043a760b-a290-4a01-add8-b4418ecea499" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2a2f3df0-74b7-4f45-a670-806ec6b1fa34" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_043a760b-a290-4a01-add8-b4418ecea499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1092e171-a57e-4550-b90e-ca0d897bdbed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2a2f3df0-74b7-4f45-a670-806ec6b1fa34" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1092e171-a57e-4550-b90e-ca0d897bdbed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_24d7b60a-54fd-4377-947d-87c7c8296396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2a2f3df0-74b7-4f45-a670-806ec6b1fa34" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_24d7b60a-54fd-4377-947d-87c7c8296396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_82d06a7d-0770-4c67-aa47-64acec303c44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2a2f3df0-74b7-4f45-a670-806ec6b1fa34" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_82d06a7d-0770-4c67-aa47-64acec303c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_4d6ccc4f-26c0-4eec-a122-6cc643c2df98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2a2f3df0-74b7-4f45-a670-806ec6b1fa34" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_4d6ccc4f-26c0-4eec-a122-6cc643c2df98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ceaee043-b022-4d03-8c3d-5d21c2451590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2a2f3df0-74b7-4f45-a670-806ec6b1fa34" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ceaee043-b022-4d03-8c3d-5d21c2451590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ef9ea4f1-d937-4dca-8046-5705ae1b4240" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_AccountingPoliciesTable_24ac398e-7836-495d-9673-7a933bd8e2e0" xlink:href="elv-20220930.xsd#elv_AccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef9ea4f1-d937-4dca-8046-5705ae1b4240" xlink:to="loc_elv_AccountingPoliciesTable_24ac398e-7836-495d-9673-7a933bd8e2e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ef7cc9c7-1138-4bf5-b6a3-c2e798635c5d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_AccountingPoliciesTable_24ac398e-7836-495d-9673-7a933bd8e2e0" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ef7cc9c7-1138-4bf5-b6a3-c2e798635c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ea35766c-3773-4da5-9ba6-4fc92ff15f46" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ef7cc9c7-1138-4bf5-b6a3-c2e798635c5d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ea35766c-3773-4da5-9ba6-4fc92ff15f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_33e3a2e4-686b-4c7b-8df6-d2806e143365" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ea35766c-3773-4da5-9ba6-4fc92ff15f46" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_33e3a2e4-686b-4c7b-8df6-d2806e143365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c2e3c037-bdee-48f5-b993-04354ce5b5db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_AccountingPoliciesTable_24ac398e-7836-495d-9673-7a933bd8e2e0" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c2e3c037-bdee-48f5-b993-04354ce5b5db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_8f9e8bce-1b55-4eb8-915a-f7330c69313c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c2e3c037-bdee-48f5-b993-04354ce5b5db" xlink:to="loc_us-gaap_TypeOfAdoptionMember_8f9e8bce-1b55-4eb8-915a-f7330c69313c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_6e502541-1d33-4c07-b6bf-41fe75030b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_8f9e8bce-1b55-4eb8-915a-f7330c69313c" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_6e502541-1d33-4c07-b6bf-41fe75030b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ceabbf8f-556c-4423-8a43-d46276cc9c09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_AccountingPoliciesTable_24ac398e-7836-495d-9673-7a933bd8e2e0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ceabbf8f-556c-4423-8a43-d46276cc9c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_08a54974-ade1-4541-8564-3777b59a6e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ceabbf8f-556c-4423-8a43-d46276cc9c09" xlink:to="loc_us-gaap_EquityComponentDomain_08a54974-ade1-4541-8564-3777b59a6e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d718a4fb-dba6-42cb-aae3-961667891961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_08a54974-ade1-4541-8564-3777b59a6e9b" xlink:to="loc_us-gaap_RetainedEarningsMember_d718a4fb-dba6-42cb-aae3-961667891961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_AccountingPoliciesLineItems_9095f622-3fd7-4a8c-a264-47ef6127429f" xlink:href="elv-20220930.xsd#elv_AccountingPoliciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_AccountingPoliciesTable_24ac398e-7836-495d-9673-7a933bd8e2e0" xlink:to="loc_elv_AccountingPoliciesLineItems_9095f622-3fd7-4a8c-a264-47ef6127429f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_d50706ec-87bc-4891-8d02-866a91811909" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_AccountingPoliciesLineItems_9095f622-3fd7-4a8c-a264-47ef6127429f" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_d50706ec-87bc-4891-8d02-866a91811909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SecuritiesLendingTransactionsInitialCollateralPercentageValue_314e2742-64b3-44f0-bac8-b5f374d2be05" xlink:href="elv-20220930.xsd#elv_SecuritiesLendingTransactionsInitialCollateralPercentageValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_AccountingPoliciesLineItems_9095f622-3fd7-4a8c-a264-47ef6127429f" xlink:to="loc_elv_SecuritiesLendingTransactionsInitialCollateralPercentageValue_314e2742-64b3-44f0-bac8-b5f374d2be05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_128159d0-42c7-4f67-9c55-e9f16bbd0f55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_AccountingPoliciesLineItems_9095f622-3fd7-4a8c-a264-47ef6127429f" xlink:to="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts_128159d0-42c7-4f67-9c55-e9f16bbd0f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SelffundedReceivablesAllowanceForDoubtfulAccounts_af811b20-136f-4a6d-a167-1145b523f003" xlink:href="elv-20220930.xsd#elv_SelffundedReceivablesAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_AccountingPoliciesLineItems_9095f622-3fd7-4a8c-a264-47ef6127429f" xlink:to="loc_elv_SelffundedReceivablesAllowanceForDoubtfulAccounts_af811b20-136f-4a6d-a167-1145b523f003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_0809f861-57ce-40b0-bf7b-ad33d2cb05d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_AccountingPoliciesLineItems_9095f622-3fd7-4a8c-a264-47ef6127429f" xlink:to="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_0809f861-57ce-40b0-bf7b-ad33d2cb05d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_239c1cfc-23dd-4544-8a78-e48865694d47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_AccountingPoliciesLineItems_9095f622-3fd7-4a8c-a264-47ef6127429f" xlink:to="loc_us-gaap_LongTermDebt_239c1cfc-23dd-4544-8a78-e48865694d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_d904b595-a03c-444f-89f4-206855380b92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_AccountingPoliciesLineItems_9095f622-3fd7-4a8c-a264-47ef6127429f" xlink:to="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_d904b595-a03c-444f-89f4-206855380b92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0b014cb5-4d6d-48ed-8ae8-5969d4c541ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_AccountingPoliciesLineItems_9095f622-3fd7-4a8c-a264-47ef6127429f" xlink:to="loc_us-gaap_StockholdersEquity_0b014cb5-4d6d-48ed-8ae8-5969d4c541ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/BusinessAcquisitions" xlink:type="simple" xlink:href="elv-20220930.xsd#BusinessAcquisitions"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/BusinessAcquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_fadee3e5-dab5-4577-9c8d-6bb771623b17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_fc03526e-9891-41fb-9fc2-6b55a9b7bf2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_fadee3e5-dab5-4577-9c8d-6bb771623b17" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_fc03526e-9891-41fb-9fc2-6b55a9b7bf2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/BusinessAcquisitionsBusinessAcquisitionAssetsLiabilitiesAcquiredDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#BusinessAcquisitionsBusinessAcquisitionAssetsLiabilitiesAcquiredDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/BusinessAcquisitionsBusinessAcquisitionAssetsLiabilitiesAcquiredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_3092e2b8-95dd-4dce-af7f-440c681729e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_292fe3cf-55ca-43ab-a0f8-4fac22908574" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_3092e2b8-95dd-4dce-af7f-440c681729e7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_292fe3cf-55ca-43ab-a0f8-4fac22908574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_32db9580-3432-4a21-baf1-e72a8e3f28e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_292fe3cf-55ca-43ab-a0f8-4fac22908574" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_32db9580-3432-4a21-baf1-e72a8e3f28e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a271ec1a-d8aa-4fb8-8602-72f104245913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_32db9580-3432-4a21-baf1-e72a8e3f28e5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a271ec1a-d8aa-4fb8-8602-72f104245913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IntegraManagedCareMember_1831282c-09b9-4a8e-9aca-073410cc0d5b" xlink:href="elv-20220930.xsd#elv_IntegraManagedCareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a271ec1a-d8aa-4fb8-8602-72f104245913" xlink:to="loc_elv_IntegraManagedCareMember_1831282c-09b9-4a8e-9aca-073410cc0d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e6daf510-8643-47ea-8da5-4d3708ef09fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_292fe3cf-55ca-43ab-a0f8-4fac22908574" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_e6daf510-8643-47ea-8da5-4d3708ef09fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_5bd35b66-48dd-4987-961a-01b80084abff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e6daf510-8643-47ea-8da5-4d3708ef09fb" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_5bd35b66-48dd-4987-961a-01b80084abff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_c5b899c2-3174-4af4-a743-815142bbbb4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e6daf510-8643-47ea-8da5-4d3708ef09fb" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_c5b899c2-3174-4af4-a743-815142bbbb4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_72cd6cae-6eb1-4583-b64d-420fc284be22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e6daf510-8643-47ea-8da5-4d3708ef09fb" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_72cd6cae-6eb1-4583-b64d-420fc284be22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_80f44b37-d223-4503-b67f-e0c937be431b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e6daf510-8643-47ea-8da5-4d3708ef09fb" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_80f44b37-d223-4503-b67f-e0c937be431b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cf348dcc-97ed-455e-a177-b0d39974c1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e6daf510-8643-47ea-8da5-4d3708ef09fb" xlink:to="loc_us-gaap_Goodwill_cf348dcc-97ed-455e-a177-b0d39974c1dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/BusinessOptimizationInitiatives" xlink:type="simple" xlink:href="elv-20220930.xsd#BusinessOptimizationInitiatives"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/BusinessOptimizationInitiatives" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_elv_BusinessOptimizationInitiativesAbstract_3d0758c5-aaaa-44ad-8f7d-00ce9bd2bb99" xlink:href="elv-20220930.xsd#elv_BusinessOptimizationInitiativesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_f9097ac7-dab5-4fa6-86d1-5c13f9a13442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_BusinessOptimizationInitiativesAbstract_3d0758c5-aaaa-44ad-8f7d-00ce9bd2bb99" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_f9097ac7-dab5-4fa6-86d1-5c13f9a13442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/BusinessOptimizationInitiativesTables" xlink:type="simple" xlink:href="elv-20220930.xsd#BusinessOptimizationInitiativesTables"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/BusinessOptimizationInitiativesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_elv_BusinessOptimizationInitiativesAbstract_38fabb14-6be6-43d1-aaff-6edd960a0b5b" xlink:href="elv-20220930.xsd#elv_BusinessOptimizationInitiativesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_299fc3d1-196e-4c19-b241-31f6e913309b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_BusinessOptimizationInitiativesAbstract_38fabb14-6be6-43d1-aaff-6edd960a0b5b" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_299fc3d1-196e-4c19-b241-31f6e913309b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/BusinessOptimizationInitiativesEmployeeTerminationCostsDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#BusinessOptimizationInitiativesEmployeeTerminationCostsDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/BusinessOptimizationInitiativesEmployeeTerminationCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_elv_BusinessOptimizationInitiativesAbstract_87f9b843-edaa-4e73-bbbd-35b7505086bd" xlink:href="elv-20220930.xsd#elv_BusinessOptimizationInitiativesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d78a206f-5614-4209-8ac6-53fa848d261b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_BusinessOptimizationInitiativesAbstract_87f9b843-edaa-4e73-bbbd-35b7505086bd" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d78a206f-5614-4209-8ac6-53fa848d261b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_07c71007-6af7-4ddf-bbe6-5297f468de67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d78a206f-5614-4209-8ac6-53fa848d261b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_07c71007-6af7-4ddf-bbe6-5297f468de67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_220ea3b6-24ef-4f94-a890-460323e1fdcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_07c71007-6af7-4ddf-bbe6-5297f468de67" xlink:to="loc_us-gaap_SegmentDomain_220ea3b6-24ef-4f94-a890-460323e1fdcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IngenioRxSegmentMember_1b3c5a7d-2968-4f29-aa3e-4e8148516ef5" xlink:href="elv-20220930.xsd#elv_IngenioRxSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_220ea3b6-24ef-4f94-a890-460323e1fdcb" xlink:to="loc_elv_IngenioRxSegmentMember_1b3c5a7d-2968-4f29-aa3e-4e8148516ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherSegmentMember_61c401f9-c3d0-456a-b5ef-3ab7f677813a" xlink:href="elv-20220930.xsd#elv_OtherSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_220ea3b6-24ef-4f94-a890-460323e1fdcb" xlink:to="loc_elv_OtherSegmentMember_61c401f9-c3d0-456a-b5ef-3ab7f677813a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GovernmentBusinessSegmentMember_d1740f36-5816-44a9-b84d-c6d006cce8bf" xlink:href="elv-20220930.xsd#elv_GovernmentBusinessSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_220ea3b6-24ef-4f94-a890-460323e1fdcb" xlink:to="loc_elv_GovernmentBusinessSegmentMember_d1740f36-5816-44a9-b84d-c6d006cce8bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommercialSpecialtyBusinessSegmentMember_d16b796c-b3ef-45d9-864f-fc1043df1668" xlink:href="elv-20220930.xsd#elv_CommercialSpecialtyBusinessSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_220ea3b6-24ef-4f94-a890-460323e1fdcb" xlink:to="loc_elv_CommercialSpecialtyBusinessSegmentMember_d16b796c-b3ef-45d9-864f-fc1043df1668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_db5e4d5a-bab1-4238-9fab-59f945a13c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d78a206f-5614-4209-8ac6-53fa848d261b" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_db5e4d5a-bab1-4238-9fab-59f945a13c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_017bf959-cb8b-4d83-87dc-dfbffd5a8f73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_db5e4d5a-bab1-4238-9fab-59f945a13c7e" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_017bf959-cb8b-4d83-87dc-dfbffd5a8f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_2eaf6014-43c1-4ffc-bf75-df98a5de16e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_017bf959-cb8b-4d83-87dc-dfbffd5a8f73" xlink:to="loc_us-gaap_EmployeeSeveranceMember_2eaf6014-43c1-4ffc-bf75-df98a5de16e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_0a561aae-a1bd-47d4-aaa0-3edac56aa45b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d78a206f-5614-4209-8ac6-53fa848d261b" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_0a561aae-a1bd-47d4-aaa0-3edac56aa45b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_2133517c-09ab-4dbe-ae3d-7da8c0237932" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0a561aae-a1bd-47d4-aaa0-3edac56aa45b" xlink:to="loc_us-gaap_RestructuringReserve_2133517c-09ab-4dbe-ae3d-7da8c0237932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_d584dd47-17c6-4cb5-8b5c-4eef732294b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0a561aae-a1bd-47d4-aaa0-3edac56aa45b" xlink:to="loc_us-gaap_PaymentsForRestructuring_d584dd47-17c6-4cb5-8b5c-4eef732294b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_24a98b5c-3a67-49f4-9210-d0f069c4e769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0a561aae-a1bd-47d4-aaa0-3edac56aa45b" xlink:to="loc_us-gaap_RestructuringReserve_24a98b5c-3a67-49f4-9210-d0f069c4e769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/Investments" xlink:type="simple" xlink:href="elv-20220930.xsd#Investments"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_963b4d40-375a-4521-bf69-00a2175e62f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_e5152221-faf6-4e3f-bbb8-1fa763de6931" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_963b4d40-375a-4521-bf69-00a2175e62f9" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_e5152221-faf6-4e3f-bbb8-1fa763de6931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/InvestmentsTables" xlink:type="simple" xlink:href="elv-20220930.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_8bce94fb-e397-44db-9906-ae3df1df492f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_a83f8e5f-9ef7-484d-b419-1703a3d01718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_8bce94fb-e397-44db-9906-ae3df1df492f" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_a83f8e5f-9ef7-484d-b419-1703a3d01718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_89519c44-5657-41ab-a60b-d9a385bd4fec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_8bce94fb-e397-44db-9906-ae3df1df492f" xlink:to="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_89519c44-5657-41ab-a60b-d9a385bd4fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_fdeeec15-cf3f-4c91-b385-633b43f81213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_8bce94fb-e397-44db-9906-ae3df1df492f" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_fdeeec15-cf3f-4c91-b385-633b43f81213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_InvestmentsinequitysecuritiesTableTextBlock_4b12a73a-14df-4bfc-8d0b-d324eab418b8" xlink:href="elv-20220930.xsd#elv_InvestmentsinequitysecuritiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_8bce94fb-e397-44db-9906-ae3df1df492f" xlink:to="loc_elv_InvestmentsinequitysecuritiesTableTextBlock_4b12a73a-14df-4bfc-8d0b-d324eab418b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsTextBlock_80af6bc4-95db-4d0d-8171-48c6c1be3bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestmentsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_8bce94fb-e397-44db-9906-ae3df1df492f" xlink:to="loc_us-gaap_GainLossOnInvestmentsTextBlock_80af6bc4-95db-4d0d-8171-48c6c1be3bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_f577741d-fb48-4aa1-9fbb-22eefa67b879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_c6eadea3-36c9-4b6c-bd0c-bf37fe13ded1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_f577741d-fb48-4aa1-9fbb-22eefa67b879" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_c6eadea3-36c9-4b6c-bd0c-bf37fe13ded1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_779fb048-e9d3-473b-8844-20ffdf1c2b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_c6eadea3-36c9-4b6c-bd0c-bf37fe13ded1" xlink:to="loc_us-gaap_InvestmentTypeAxis_779fb048-e9d3-473b-8844-20ffdf1c2b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_ad330a95-84bd-4f44-b409-06a22b47a850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_779fb048-e9d3-473b-8844-20ffdf1c2b4b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_ad330a95-84bd-4f44-b409-06a22b47a850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_6eb20dcd-8e8e-46c0-808d-8fdbb68a3c92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ad330a95-84bd-4f44-b409-06a22b47a850" xlink:to="loc_us-gaap_FixedMaturitiesMember_6eb20dcd-8e8e-46c0-808d-8fdbb68a3c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_cc638666-5be0-4e6f-9935-8a0163240d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_c6eadea3-36c9-4b6c-bd0c-bf37fe13ded1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_cc638666-5be0-4e6f-9935-8a0163240d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f72308d5-bddb-4769-920f-4e7cf1dbf355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cc638666-5be0-4e6f-9935-8a0163240d23" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f72308d5-bddb-4769-920f-4e7cf1dbf355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_9f24c323-ce67-4ed9-8ec5-948b1361e40f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f72308d5-bddb-4769-920f-4e7cf1dbf355" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_9f24c323-ce67-4ed9-8ec5-948b1361e40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_a486413c-0a9a-493b-bfd6-1dc1e6e3304a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f72308d5-bddb-4769-920f-4e7cf1dbf355" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_a486413c-0a9a-493b-bfd6-1dc1e6e3304a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtMember_ee21f131-6ef6-4876-a897-d483b66422ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f72308d5-bddb-4769-920f-4e7cf1dbf355" xlink:to="loc_us-gaap_ForeignGovernmentDebtMember_ee21f131-6ef6-4876-a897-d483b66422ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_0cc636d7-146e-496d-bcec-611181c606dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f72308d5-bddb-4769-920f-4e7cf1dbf355" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_0cc636d7-146e-496d-bcec-611181c606dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_ed8889ac-8456-41de-8e98-c9e19e12c800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f72308d5-bddb-4769-920f-4e7cf1dbf355" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_ed8889ac-8456-41de-8e98-c9e19e12c800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_bb35163d-ab2e-4842-ae4d-7cce3e6978cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f72308d5-bddb-4769-920f-4e7cf1dbf355" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_bb35163d-ab2e-4842-ae4d-7cce3e6978cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_b4cc86d8-865f-433d-9ad4-e4a826cef098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f72308d5-bddb-4769-920f-4e7cf1dbf355" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_b4cc86d8-865f-433d-9ad4-e4a826cef098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAggregatedInvestmentsMember_e50183dd-e03a-43f3-b066-a28d117bf9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAggregatedInvestmentsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f72308d5-bddb-4769-920f-4e7cf1dbf355" xlink:to="loc_us-gaap_OtherAggregatedInvestmentsMember_e50183dd-e03a-43f3-b066-a28d117bf9b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7ac7c766-b7ec-4980-bf75-61034b2af64d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_c6eadea3-36c9-4b6c-bd0c-bf37fe13ded1" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7ac7c766-b7ec-4980-bf75-61034b2af64d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_cbdbbf7c-6298-4d67-b42e-7301236aa0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7ac7c766-b7ec-4980-bf75-61034b2af64d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_cbdbbf7c-6298-4d67-b42e-7301236aa0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_6d7255fc-e941-45a5-a6d9-d2067170014f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7ac7c766-b7ec-4980-bf75-61034b2af64d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_6d7255fc-e941-45a5-a6d9-d2067170014f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_00436801-22d0-4c48-b03e-28dc1591da16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7ac7c766-b7ec-4980-bf75-61034b2af64d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_00436801-22d0-4c48-b03e-28dc1591da16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_5da2554b-d525-4f2e-a117-ee99be59bbed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7ac7c766-b7ec-4980-bf75-61034b2af64d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_5da2554b-d525-4f2e-a117-ee99be59bbed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a65bc495-9b01-44a5-9548-9c772d8427b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7ac7c766-b7ec-4980-bf75-61034b2af64d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a65bc495-9b01-44a5-9548-9c772d8427b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_ce56ec01-c219-429a-a14b-0ae128de07ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9a827e78-c61b-43d2-89f9-dd446b80990c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_ce56ec01-c219-429a-a14b-0ae128de07ee" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9a827e78-c61b-43d2-89f9-dd446b80990c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_a5879c37-0a24-4c9c-93b2-0b897995c654" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9a827e78-c61b-43d2-89f9-dd446b80990c" xlink:to="loc_us-gaap_InvestmentTypeAxis_a5879c37-0a24-4c9c-93b2-0b897995c654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_069ececa-47fa-4157-86f8-36667e3a5663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_a5879c37-0a24-4c9c-93b2-0b897995c654" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_069ececa-47fa-4157-86f8-36667e3a5663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_e2eb4241-59a1-4dbc-9b73-edfd5b00cbc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_069ececa-47fa-4157-86f8-36667e3a5663" xlink:to="loc_us-gaap_EquitySecuritiesMember_e2eb4241-59a1-4dbc-9b73-edfd5b00cbc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_aa0b4bdc-7ce8-4857-b0c9-ecefe1b20e29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_069ececa-47fa-4157-86f8-36667e3a5663" xlink:to="loc_us-gaap_FixedMaturitiesMember_aa0b4bdc-7ce8-4857-b0c9-ecefe1b20e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ed042bea-50eb-4218-8293-c9ee0a769fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9a827e78-c61b-43d2-89f9-dd446b80990c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ed042bea-50eb-4218-8293-c9ee0a769fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8af7d449-be46-4c2a-8832-c0970491ef8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ed042bea-50eb-4218-8293-c9ee0a769fcc" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8af7d449-be46-4c2a-8832-c0970491ef8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_ceb31170-9b44-4882-92d7-ab8cb6208d82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8af7d449-be46-4c2a-8832-c0970491ef8f" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_ceb31170-9b44-4882-92d7-ab8cb6208d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_d5d2660e-8643-4b0a-86d7-26204e84c406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8af7d449-be46-4c2a-8832-c0970491ef8f" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_d5d2660e-8643-4b0a-86d7-26204e84c406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtMember_26ef9473-e549-40fa-8ef6-f3952766bf2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8af7d449-be46-4c2a-8832-c0970491ef8f" xlink:to="loc_us-gaap_ForeignGovernmentDebtMember_26ef9473-e549-40fa-8ef6-f3952766bf2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_3e18c393-ee89-43fc-92ff-65d7fa26aa21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8af7d449-be46-4c2a-8832-c0970491ef8f" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_3e18c393-ee89-43fc-92ff-65d7fa26aa21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_99c6a9e6-cb17-4c41-ba5e-ef817eb62d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8af7d449-be46-4c2a-8832-c0970491ef8f" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_99c6a9e6-cb17-4c41-ba5e-ef817eb62d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_c1b81a65-8935-497f-9b7c-c0bd57056514" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8af7d449-be46-4c2a-8832-c0970491ef8f" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_c1b81a65-8935-497f-9b7c-c0bd57056514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_f7f9017d-7b0c-4beb-830d-08f3bafaec29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8af7d449-be46-4c2a-8832-c0970491ef8f" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_f7f9017d-7b0c-4beb-830d-08f3bafaec29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAggregatedInvestmentsMember_a659415a-acef-4908-9081-6f91770eab33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAggregatedInvestmentsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8af7d449-be46-4c2a-8832-c0970491ef8f" xlink:to="loc_us-gaap_OtherAggregatedInvestmentsMember_a659415a-acef-4908-9081-6f91770eab33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f87aac2a-dc13-4f8f-8d6b-e69997465650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9a827e78-c61b-43d2-89f9-dd446b80990c" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f87aac2a-dc13-4f8f-8d6b-e69997465650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_06fff694-fe61-485c-9adc-8e085ac29253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f87aac2a-dc13-4f8f-8d6b-e69997465650" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_06fff694-fe61-485c-9adc-8e085ac29253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_64ab7074-5d7a-4e71-b04f-09c9a6a1eca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f87aac2a-dc13-4f8f-8d6b-e69997465650" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_64ab7074-5d7a-4e71-b04f-09c9a6a1eca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_5b04a864-3fb6-47fe-bd64-69b325848818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f87aac2a-dc13-4f8f-8d6b-e69997465650" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_5b04a864-3fb6-47fe-bd64-69b325848818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_ae6e221f-c3fd-4374-87b3-4ac0d96d7af8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f87aac2a-dc13-4f8f-8d6b-e69997465650" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_ae6e221f-c3fd-4374-87b3-4ac0d96d7af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_1bbab645-e9b3-4b40-ae61-48cc97bc28d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f87aac2a-dc13-4f8f-8d6b-e69997465650" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_1bbab645-e9b3-4b40-ae61-48cc97bc28d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_e0795f44-e0cd-4a12-a888-f1428008ffa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f87aac2a-dc13-4f8f-8d6b-e69997465650" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_e0795f44-e0cd-4a12-a888-f1428008ffa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_2b3d4f20-43d8-4d6e-8184-c83acd595839" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_22650117-19f8-42f3-bae5-2b123236cdf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_2b3d4f20-43d8-4d6e-8184-c83acd595839" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_22650117-19f8-42f3-bae5-2b123236cdf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_3eeb7a6a-387e-4a33-a8d1-9e1330a77633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_22650117-19f8-42f3-bae5-2b123236cdf7" xlink:to="loc_us-gaap_InvestmentTypeAxis_3eeb7a6a-387e-4a33-a8d1-9e1330a77633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_4456e9e8-cff9-4253-8782-2388a4f2c5fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_3eeb7a6a-387e-4a33-a8d1-9e1330a77633" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_4456e9e8-cff9-4253-8782-2388a4f2c5fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_be3ee490-7c7d-4d10-93c0-959f43cffbb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_4456e9e8-cff9-4253-8782-2388a4f2c5fd" xlink:to="loc_us-gaap_FixedMaturitiesMember_be3ee490-7c7d-4d10-93c0-959f43cffbb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_22650117-19f8-42f3-bae5-2b123236cdf7" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_f133404f-f641-44e5-9456-7b904a0c3709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_f133404f-f641-44e5-9456-7b904a0c3709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_27d98224-b962-460b-9913-29c30a0d331c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_27d98224-b962-460b-9913-29c30a0d331c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_d00e347a-7238-4fbe-81ee-ea66f9b7407b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_d00e347a-7238-4fbe-81ee-ea66f9b7407b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_09963fde-a060-462a-9457-b4f314de6ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_09963fde-a060-462a-9457-b4f314de6ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_c80ebbfa-55d0-4500-9c7c-d437ee30b9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_c80ebbfa-55d0-4500-9c7c-d437ee30b9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2138bea3-b673-40ba-a696-bddc2854762e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2138bea3-b673-40ba-a696-bddc2854762e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_5148ef7c-7e37-4007-b220-860b10bd1ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_5148ef7c-7e37-4007-b220-860b10bd1ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_be3b0fcd-6353-44af-9be5-bdfc04bfa901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_be3b0fcd-6353-44af-9be5-bdfc04bfa901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_02e08bde-2051-48cd-b972-86e386c70960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_02e08bde-2051-48cd-b972-86e386c70960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_441482d2-9aaf-4e1b-b470-74f3d26c454a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_441482d2-9aaf-4e1b-b470-74f3d26c454a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_06803272-6036-4d2b-9071-460cd8c6b995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_06803272-6036-4d2b-9071-460cd8c6b995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1540118c-f21b-4e9c-ab0d-b321ca24c7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aa2ca377-a942-41b8-ad6a-b8a49c927775" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1540118c-f21b-4e9c-ab0d-b321ca24c7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/InvestmentsCurrentEquitySecuritiesDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#InvestmentsCurrentEquitySecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/InvestmentsCurrentEquitySecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_b15d34b2-1a96-4e0e-84d9-148a8f11bbe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable_c54c9789-cbd4-47ac-b574-7a1ef51d370b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_b15d34b2-1a96-4e0e-84d9-148a8f11bbe6" xlink:to="loc_us-gaap_MarketableSecuritiesTable_c54c9789-cbd4-47ac-b574-7a1ef51d370b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_0e09a570-9dad-4db9-b105-6e60a9c65efd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_c54c9789-cbd4-47ac-b574-7a1ef51d370b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_0e09a570-9dad-4db9-b105-6e60a9c65efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eb8b7240-7a64-435a-9c87-4b4f2d5c55d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0e09a570-9dad-4db9-b105-6e60a9c65efd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eb8b7240-7a64-435a-9c87-4b4f2d5c55d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExchangeTradedFundsMember_e2ba110c-7354-4c3f-8e12-2d9d16948949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExchangeTradedFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eb8b7240-7a64-435a-9c87-4b4f2d5c55d4" xlink:to="loc_us-gaap_ExchangeTradedFundsMember_e2ba110c-7354-4c3f-8e12-2d9d16948949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommonEquitySecuritiesMember_a96c13b6-ede3-45e0-b566-7145db378e20" xlink:href="elv-20220930.xsd#elv_CommonEquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eb8b7240-7a64-435a-9c87-4b4f2d5c55d4" xlink:to="loc_elv_CommonEquitySecuritiesMember_a96c13b6-ede3-45e0-b566-7145db378e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_c10cc1dc-ba4b-4300-b378-7f06ef5c3f41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eb8b7240-7a64-435a-9c87-4b4f2d5c55d4" xlink:to="loc_us-gaap_PrivateEquityFundsMember_c10cc1dc-ba4b-4300-b378-7f06ef5c3f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_751d603b-2f6b-4b86-8533-708ae4d8b626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_c54c9789-cbd4-47ac-b574-7a1ef51d370b" xlink:to="loc_us-gaap_MarketableSecuritiesLineItems_751d603b-2f6b-4b86-8533-708ae4d8b626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_a9a1d333-eb73-4761-8086-2b90a7251506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_751d603b-2f6b-4b86-8533-708ae4d8b626" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_a9a1d333-eb73-4761-8086-2b90a7251506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#InvestmentsNetInvestmentGainsLossesDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_08f0400e-1fe9-416f-83a3-066551f0b373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_2b63c440-6c78-483a-8b1d-dc6ce441cf96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_08f0400e-1fe9-416f-83a3-066551f0b373" xlink:to="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_2b63c440-6c78-483a-8b1d-dc6ce441cf96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_f10842c1-796d-42fb-b0aa-04c05e60ac67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_2b63c440-6c78-483a-8b1d-dc6ce441cf96" xlink:to="loc_us-gaap_InvestmentTypeAxis_f10842c1-796d-42fb-b0aa-04c05e60ac67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_bfb3988c-d40e-4fcf-8917-2861baa951e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_f10842c1-796d-42fb-b0aa-04c05e60ac67" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_bfb3988c-d40e-4fcf-8917-2861baa951e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_aab06ed9-94a5-4c2c-929b-a7ecea7bd855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_bfb3988c-d40e-4fcf-8917-2861baa951e0" xlink:to="loc_us-gaap_FixedMaturitiesMember_aab06ed9-94a5-4c2c-929b-a7ecea7bd855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_d8d0a825-d30b-434c-ab9f-c1a2fc761e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_bfb3988c-d40e-4fcf-8917-2861baa951e0" xlink:to="loc_us-gaap_EquitySecuritiesMember_d8d0a825-d30b-434c-ab9f-c1a2fc761e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_f0a48096-9d43-4c43-9ef8-bd301d0b16d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_bfb3988c-d40e-4fcf-8917-2861baa951e0" xlink:to="loc_us-gaap_OtherInvestmentsMember_f0a48096-9d43-4c43-9ef8-bd301d0b16d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_2b63c440-6c78-483a-8b1d-dc6ce441cf96" xlink:to="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_09f0c160-cf9f-415f-b3d2-c69ba4adc928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_09f0c160-cf9f-415f-b3d2-c69ba4adc928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_e62acac5-67f1-466a-b39a-5eb85091b4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_e62acac5-67f1-466a-b39a-5eb85091b4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGain_935528f1-d0ec-4763-acc3-9de009a0ab69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGain"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGain_935528f1-d0ec-4763-acc3-9de009a0ab69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss_bfef6967-3c76-458b-9f82-9ef8a3ce5008" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss_bfef6967-3c76-458b-9f82-9ef8a3ce5008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_3f573a70-59fa-4ac4-b64b-183d69e7e5a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_3f573a70-59fa-4ac4-b64b-183d69e7e5a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_0427a871-f226-4db0-8b57-ada0e6da0bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_0427a871-f226-4db0-8b57-ada0e6da0bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_a413010c-34ff-4ad3-aa78-b319cd8b42d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_a413010c-34ff-4ad3-aa78-b319cd8b42d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GainsFromOtherInvestments_1ef0817a-3093-49ae-84a8-8f7e1d0f2e50" xlink:href="elv-20220930.xsd#elv_GainsFromOtherInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_elv_GainsFromOtherInvestments_1ef0817a-3093-49ae-84a8-8f7e1d0f2e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GrossLossesFromOtherInvestments_5a80d033-ffbc-4d9c-bd41-1defb0538f17" xlink:href="elv-20220930.xsd#elv_GrossLossesFromOtherInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_elv_GrossLossesFromOtherInvestments_5a80d033-ffbc-4d9c-bd41-1defb0538f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_Impairmentlossesreversalsoninvestments_a3a9eb07-d86b-4f85-b03b-cd07aeb916d0" xlink:href="elv-20220930.xsd#elv_Impairmentlossesreversalsoninvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_elv_Impairmentlossesreversalsoninvestments_a3a9eb07-d86b-4f85-b03b-cd07aeb916d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_405ec20b-babb-407b-a507-97bf78071762" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_405ec20b-babb-407b-a507-97bf78071762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherInvestments_ec40e14f-4cf3-47b3-afc2-65c994617bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherInvestments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherInvestments_ec40e14f-4cf3-47b3-afc2-65c994617bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_InvestmentGainsLosses_a5f26b25-5311-464b-a888-3331b3238885" xlink:href="elv-20220930.xsd#elv_InvestmentGainsLosses"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_d03172af-3254-4db7-a495-34279cba5f1c" xlink:to="loc_elv_InvestmentGainsLosses_a5f26b25-5311-464b-a888-3331b3238885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#InvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/InvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_9d38152d-4ff4-493e-b789-12656ec19ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_704bfb54-5bf5-47a1-b564-0d93c51552f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_9d38152d-4ff4-493e-b789-12656ec19ce9" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_704bfb54-5bf5-47a1-b564-0d93c51552f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis_abdcf5b6-2f2d-4b9f-9a95-7b20abab3b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_704bfb54-5bf5-47a1-b564-0d93c51552f7" xlink:to="loc_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis_abdcf5b6-2f2d-4b9f-9a95-7b20abab3b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodDomain_b1b77c54-f0d5-4672-86bc-7cd847f0285a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis_abdcf5b6-2f2d-4b9f-9a95-7b20abab3b9b" xlink:to="loc_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodDomain_b1b77c54-f0d5-4672-86bc-7cd847f0285a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturityOvernightMember_5a7f3552-5fa3-4ad7-a482-b38722ed1c72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaturityOvernightMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodDomain_b1b77c54-f0d5-4672-86bc-7cd847f0285a" xlink:to="loc_us-gaap_MaturityOvernightMember_5a7f3552-5fa3-4ad7-a482-b38722ed1c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_aecc0653-9749-4d0c-87d2-59302d3d5e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_704bfb54-5bf5-47a1-b564-0d93c51552f7" xlink:to="loc_us-gaap_InvestmentTypeAxis_aecc0653-9749-4d0c-87d2-59302d3d5e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_a7351a4b-949f-47a4-b60d-ec97f00e8aae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_aecc0653-9749-4d0c-87d2-59302d3d5e6a" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_a7351a4b-949f-47a4-b60d-ec97f00e8aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_59ff91a4-0f33-452c-b46a-d8618b156383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a7351a4b-949f-47a4-b60d-ec97f00e8aae" xlink:to="loc_us-gaap_FixedMaturitiesMember_59ff91a4-0f33-452c-b46a-d8618b156383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_3b2fdacd-ea7d-44db-a683-29770fef4aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_704bfb54-5bf5-47a1-b564-0d93c51552f7" xlink:to="loc_us-gaap_FinancialInstrumentAxis_3b2fdacd-ea7d-44db-a683-29770fef4aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ccab8d95-d892-4a4f-bde0-1e7bff060a33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3b2fdacd-ea7d-44db-a683-29770fef4aa8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ccab8d95-d892-4a4f-bde0-1e7bff060a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_0479c131-43e6-4ac7-bf98-ccc367d40b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ccab8d95-d892-4a4f-bde0-1e7bff060a33" xlink:to="loc_us-gaap_CashMember_0479c131-43e6-4ac7-bf98-ccc367d40b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_a241b8f0-42b3-41db-a4bd-ec1711e7d720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ccab8d95-d892-4a4f-bde0-1e7bff060a33" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_a241b8f0-42b3-41db-a4bd-ec1711e7d720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAggregatedInvestmentsMember_af77487b-4238-40c3-a765-2b71fad22f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAggregatedInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ccab8d95-d892-4a4f-bde0-1e7bff060a33" xlink:to="loc_us-gaap_OtherAggregatedInvestmentsMember_af77487b-4238-40c3-a765-2b71fad22f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_89d9f497-8338-4a53-acec-3701a5b9f553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_704bfb54-5bf5-47a1-b564-0d93c51552f7" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_89d9f497-8338-4a53-acec-3701a5b9f553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_d11e6591-3f1b-4f7d-9132-db4da5268709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_89d9f497-8338-4a53-acec-3701a5b9f553" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_d11e6591-3f1b-4f7d-9132-db4da5268709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInvestmentIncomeReceivable_4e3ae741-69ff-4bda-8afd-32a6c1429127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedInvestmentIncomeReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_89d9f497-8338-4a53-acec-3701a5b9f553" xlink:to="loc_us-gaap_AccruedInvestmentIncomeReceivable_4e3ae741-69ff-4bda-8afd-32a6c1429127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesLoanedFairValueOfCollateral_187204ce-f1f7-480d-86a9-e8054734deee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesLoanedFairValueOfCollateral"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_89d9f497-8338-4a53-acec-3701a5b9f553" xlink:to="loc_us-gaap_SecuritiesLoanedFairValueOfCollateral_187204ce-f1f7-480d-86a9-e8054734deee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan_b76c15ff-9a98-48e4-969c-79f96474432c" xlink:href="elv-20220930.xsd#elv_SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_89d9f497-8338-4a53-acec-3701a5b9f553" xlink:to="loc_elv_SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan_b76c15ff-9a98-48e4-969c-79f96474432c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsReceivedForSecuritiesLoanedAtCarryingValue_f42f1d5a-0f5f-4f5a-98a8-a59acc64df32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsReceivedForSecuritiesLoanedAtCarryingValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_89d9f497-8338-4a53-acec-3701a5b9f553" xlink:to="loc_us-gaap_DepositsReceivedForSecuritiesLoanedAtCarryingValue_f42f1d5a-0f5f-4f5a-98a8-a59acc64df32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_a70cf203-f34e-448e-86c7-73f950bf3dad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_89d9f497-8338-4a53-acec-3701a5b9f553" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_a70cf203-f34e-448e-86c7-73f950bf3dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/DerivativeFinancialInstruments" xlink:type="simple" xlink:href="elv-20220930.xsd#DerivativeFinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/DerivativeFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b668cb8e-b81c-4ad1-81a6-b9feab0155c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_4a3ff721-6cf0-4412-8669-14fc1d6e1f81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b668cb8e-b81c-4ad1-81a6-b9feab0155c4" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_4a3ff721-6cf0-4412-8669-14fc1d6e1f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/DerivativeFinancialInstrumentsFinancialStatementNarrativeDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#DerivativeFinancialInstrumentsFinancialStatementNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/DerivativeFinancialInstrumentsFinancialStatementNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_26db01e0-7bc1-47c4-9830-61a63bd7f4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_4aa3db2c-7f18-4724-99b7-62b5d3b27385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_26db01e0-7bc1-47c4-9830-61a63bd7f4b6" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_4aa3db2c-7f18-4724-99b7-62b5d3b27385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a457927d-d235-4c17-9790-6e58cfca9a03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_4aa3db2c-7f18-4724-99b7-62b5d3b27385" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a457927d-d235-4c17-9790-6e58cfca9a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_bf5bcbd6-c743-412f-9f1a-7167d619af2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a457927d-d235-4c17-9790-6e58cfca9a03" xlink:to="loc_us-gaap_HedgingRelationshipDomain_bf5bcbd6-c743-412f-9f1a-7167d619af2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_34a277f5-b92c-46f8-bd76-fc4b27f53c54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bf5bcbd6-c743-412f-9f1a-7167d619af2d" xlink:to="loc_us-gaap_CashFlowHedgingMember_34a277f5-b92c-46f8-bd76-fc4b27f53c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_e7fd7b24-1e0e-481c-9ce7-06644ec8422d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_4aa3db2c-7f18-4724-99b7-62b5d3b27385" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_e7fd7b24-1e0e-481c-9ce7-06644ec8422d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_2399b36a-a7fb-426e-ba8b-a6312fb4d12d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_e7fd7b24-1e0e-481c-9ce7-06644ec8422d" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_2399b36a-a7fb-426e-ba8b-a6312fb4d12d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_615ce774-677d-4198-aa3f-5c04c73a1522" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_e7fd7b24-1e0e-481c-9ce7-06644ec8422d" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_615ce774-677d-4198-aa3f-5c04c73a1522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/FairValue" xlink:type="simple" xlink:href="elv-20220930.xsd#FairValue"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/FairValue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_fb46e8e4-d853-4ff1-94fe-bb8b7901473b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_5e480a99-6749-48fd-af13-9636cc8d99f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_fb46e8e4-d853-4ff1-94fe-bb8b7901473b" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_5e480a99-6749-48fd-af13-9636cc8d99f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/FairValueTables" xlink:type="simple" xlink:href="elv-20220930.xsd#FairValueTables"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/FairValueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7da5c7b2-2946-483d-ad8e-5543df0da267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_e79a2868-5295-47be-98e5-c480a566e0fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7da5c7b2-2946-483d-ad8e-5543df0da267" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_e79a2868-5295-47be-98e5-c480a566e0fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_efb9cfb5-36d6-4dab-8d9a-cb4f33b23b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7da5c7b2-2946-483d-ad8e-5543df0da267" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_efb9cfb5-36d6-4dab-8d9a-cb4f33b23b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock_dd4f007f-8a22-4e43-850c-44e267220996" xlink:href="elv-20220930.xsd#elv_CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7da5c7b2-2946-483d-ad8e-5543df0da267" xlink:to="loc_elv_CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock_dd4f007f-8a22-4e43-850c-44e267220996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2290278d-1be2-47a6-b806-d60fd1fc8747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_678369b9-87d1-4bd4-a3b4-d71515428d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2290278d-1be2-47a6-b806-d60fd1fc8747" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_678369b9-87d1-4bd4-a3b4-d71515428d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_445f0a13-662d-414e-90d8-434fd9a911ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_678369b9-87d1-4bd4-a3b4-d71515428d23" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_445f0a13-662d-414e-90d8-434fd9a911ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34e6ed01-d6fa-4c1c-803f-96e36c14ec7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_445f0a13-662d-414e-90d8-434fd9a911ca" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34e6ed01-d6fa-4c1c-803f-96e36c14ec7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8f70bf19-4b70-4c4a-ba2a-24bf4069dadf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34e6ed01-d6fa-4c1c-803f-96e36c14ec7a" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8f70bf19-4b70-4c4a-ba2a-24bf4069dadf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_2c989095-8b7a-4ef9-9650-ea1fdc6f8fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34e6ed01-d6fa-4c1c-803f-96e36c14ec7a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_2c989095-8b7a-4ef9-9650-ea1fdc6f8fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b1f95c9d-fbda-412c-a70c-a20048fa8237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34e6ed01-d6fa-4c1c-803f-96e36c14ec7a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b1f95c9d-fbda-412c-a70c-a20048fa8237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_e650b139-6e0d-40ab-8cdd-5c11375c130f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_678369b9-87d1-4bd4-a3b4-d71515428d23" xlink:to="loc_us-gaap_InvestmentTypeAxis_e650b139-6e0d-40ab-8cdd-5c11375c130f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_29b193ce-abee-4eb7-8f49-b891d65ddd6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_e650b139-6e0d-40ab-8cdd-5c11375c130f" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_29b193ce-abee-4eb7-8f49-b891d65ddd6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedMaturitiesMember_a41681fa-a706-4e5d-8630-f13f9915160e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedMaturitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_29b193ce-abee-4eb7-8f49-b891d65ddd6f" xlink:to="loc_us-gaap_FixedMaturitiesMember_a41681fa-a706-4e5d-8630-f13f9915160e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_2942faa9-5222-49c4-9c67-62cf1aa2e478" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_29b193ce-abee-4eb7-8f49-b891d65ddd6f" xlink:to="loc_us-gaap_EquitySecuritiesMember_2942faa9-5222-49c4-9c67-62cf1aa2e478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_f03a7402-e7dc-4a7a-9282-ac7f20569a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_29b193ce-abee-4eb7-8f49-b891d65ddd6f" xlink:to="loc_us-gaap_OtherInvestmentsMember_f03a7402-e7dc-4a7a-9282-ac7f20569a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMember_c6c7da35-6694-48fb-a634-c582d27d495f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_29b193ce-abee-4eb7-8f49-b891d65ddd6f" xlink:to="loc_us-gaap_DerivativeMember_c6c7da35-6694-48fb-a634-c582d27d495f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_76e5d9a2-c339-48a8-83a4-ba997d52d851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_678369b9-87d1-4bd4-a3b4-d71515428d23" xlink:to="loc_us-gaap_FinancialInstrumentAxis_76e5d9a2-c339-48a8-83a4-ba997d52d851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_76e5d9a2-c339-48a8-83a4-ba997d52d851" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_83ba7404-b19f-494f-8005-7af3f311b54d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_83ba7404-b19f-494f-8005-7af3f311b54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_906f27bf-bfd3-49e1-b2c5-18716a44c603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_906f27bf-bfd3-49e1-b2c5-18716a44c603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtMember_05484e18-492c-4a2b-adf7-8bfdc6967b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:to="loc_us-gaap_ForeignGovernmentDebtMember_05484e18-492c-4a2b-adf7-8bfdc6967b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_d90a853a-beb0-45f3-bf9e-47fbd47bb362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_d90a853a-beb0-45f3-bf9e-47fbd47bb362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_da9e758d-cd2a-4bb9-a7fd-de4921177463" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_da9e758d-cd2a-4bb9-a7fd-de4921177463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_01dc0db4-cb39-4b36-bcad-e3cc81d07761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_01dc0db4-cb39-4b36-bcad-e3cc81d07761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c6b26a61-bf75-4592-a30a-2411d4c18206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c6b26a61-bf75-4592-a30a-2411d4c18206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_dba7e9b8-7852-4969-8368-3f7312775e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_dba7e9b8-7852-4969-8368-3f7312775e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExchangeTradedFundsMember_cd68d415-835b-4b0a-bc8e-d94fcb3804fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExchangeTradedFundsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:to="loc_us-gaap_ExchangeTradedFundsMember_cd68d415-835b-4b0a-bc8e-d94fcb3804fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommonEquitySecuritiesMember_e77ef7b8-543b-4a73-841a-b3ce600533da" xlink:href="elv-20220930.xsd#elv_CommonEquitySecuritiesMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:to="loc_elv_CommonEquitySecuritiesMember_e77ef7b8-543b-4a73-841a-b3ce600533da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_7ecca096-3884-4616-92e6-5ed721ccc9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9fb6d167-de9d-4a45-a162-ede8ebb743dd" xlink:to="loc_us-gaap_PrivateEquityFundsMember_7ecca096-3884-4616-92e6-5ed721ccc9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_42595713-d3a6-4061-8ff6-fa466c50daf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_678369b9-87d1-4bd4-a3b4-d71515428d23" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_42595713-d3a6-4061-8ff6-fa466c50daf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_2a40767d-2b2e-4cc2-bd06-5b811c3c9281" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_42595713-d3a6-4061-8ff6-fa466c50daf0" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_2a40767d-2b2e-4cc2-bd06-5b811c3c9281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_010662a7-962d-4ee1-93bd-5ff5de0cb4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_42595713-d3a6-4061-8ff6-fa466c50daf0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_010662a7-962d-4ee1-93bd-5ff5de0cb4c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EquitySecurities_fb6e5aee-9705-4a0d-9832-50907d6fa3e8" xlink:href="elv-20220930.xsd#elv_EquitySecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_42595713-d3a6-4061-8ff6-fa466c50daf0" xlink:to="loc_elv_EquitySecurities_fb6e5aee-9705-4a0d-9832-50907d6fa3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_405db8ac-d67f-447d-a6b6-f7b2b3639765" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_42595713-d3a6-4061-8ff6-fa466c50daf0" xlink:to="loc_us-gaap_OtherLongTermInvestments_405db8ac-d67f-447d-a6b6-f7b2b3639765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesHeldAsCollateralAtFairValue_64591452-d1c3-4a72-bfae-e6526732b2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesHeldAsCollateralAtFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_42595713-d3a6-4061-8ff6-fa466c50daf0" xlink:to="loc_us-gaap_SecuritiesHeldAsCollateralAtFairValue_64591452-d1c3-4a72-bfae-e6526732b2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement_aefab2cf-4ee6-4776-8940-01b9532e3f28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_42595713-d3a6-4061-8ff6-fa466c50daf0" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement_aefab2cf-4ee6-4776-8940-01b9532e3f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_dd104d30-f528-4d0b-870b-2262a0095489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_42595713-d3a6-4061-8ff6-fa466c50daf0" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_dd104d30-f528-4d0b-870b-2262a0095489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement_d60e60d6-a8f2-4802-83eb-9317e5e25a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_42595713-d3a6-4061-8ff6-fa466c50daf0" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement_d60e60d6-a8f2-4802-83eb-9317e5e25a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_85aac082-3785-4d7c-92f8-f5ea0fd20010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_42595713-d3a6-4061-8ff6-fa466c50daf0" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_85aac082-3785-4d7c-92f8-f5ea0fd20010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_b0c7b1a8-2352-4783-99ef-36efb233097a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ba328a61-f18d-421c-8b8c-d9baf6ad3b10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_b0c7b1a8-2352-4783-99ef-36efb233097a" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ba328a61-f18d-421c-8b8c-d9baf6ad3b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_528c6afc-0174-4fa0-9555-4e09ae208d15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ba328a61-f18d-421c-8b8c-d9baf6ad3b10" xlink:to="loc_us-gaap_FinancialInstrumentAxis_528c6afc-0174-4fa0-9555-4e09ae208d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e74d9472-2516-48b8-bcf5-8f0c75e7c9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_528c6afc-0174-4fa0-9555-4e09ae208d15" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e74d9472-2516-48b8-bcf5-8f0c75e7c9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_5dff1a4c-5cf0-4670-b3df-8cbd61ed61af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e74d9472-2516-48b8-bcf5-8f0c75e7c9fa" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_5dff1a4c-5cf0-4670-b3df-8cbd61ed61af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_9b1126d8-32b2-4ff3-91a1-e83f70668537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e74d9472-2516-48b8-bcf5-8f0c75e7c9fa" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_9b1126d8-32b2-4ff3-91a1-e83f70668537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_44df4dd8-29f6-48bd-bc93-33d2f4808177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e74d9472-2516-48b8-bcf5-8f0c75e7c9fa" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_44df4dd8-29f6-48bd-bc93-33d2f4808177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_deed95d9-dd3e-415d-bbd2-89a7d0f60ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e74d9472-2516-48b8-bcf5-8f0c75e7c9fa" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_deed95d9-dd3e-415d-bbd2-89a7d0f60ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_0d4afbc5-bfce-4e69-8b26-9e77d4c13334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e74d9472-2516-48b8-bcf5-8f0c75e7c9fa" xlink:to="loc_us-gaap_EquitySecuritiesMember_0d4afbc5-bfce-4e69-8b26-9e77d4c13334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_845c7a63-243a-40cd-80ca-dab7105a6d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ba328a61-f18d-421c-8b8c-d9baf6ad3b10" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_845c7a63-243a-40cd-80ca-dab7105a6d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4b9eb0b4-3fe1-47c1-9b5e-479f4d153aba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_845c7a63-243a-40cd-80ca-dab7105a6d6c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4b9eb0b4-3fe1-47c1-9b5e-479f4d153aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_de19b1b9-57ae-4276-837b-a5763af2e4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4b9eb0b4-3fe1-47c1-9b5e-479f4d153aba" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_de19b1b9-57ae-4276-837b-a5763af2e4b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_955a4c11-42a4-4fe6-a58e-be7364ba82b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4b9eb0b4-3fe1-47c1-9b5e-479f4d153aba" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_955a4c11-42a4-4fe6-a58e-be7364ba82b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_ea6ae0e7-b552-4253-9199-69c127447560" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4b9eb0b4-3fe1-47c1-9b5e-479f4d153aba" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_ea6ae0e7-b552-4253-9199-69c127447560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_86da5b2c-246b-4afc-9dfe-6711dad1ef17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4b9eb0b4-3fe1-47c1-9b5e-479f4d153aba" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_86da5b2c-246b-4afc-9dfe-6711dad1ef17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_d8ea9048-cff6-4f81-b23c-2b8cb9da31f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4b9eb0b4-3fe1-47c1-9b5e-479f4d153aba" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_d8ea9048-cff6-4f81-b23c-2b8cb9da31f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_5ad04b7b-f90c-455f-8f48-0454103fbc5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4b9eb0b4-3fe1-47c1-9b5e-479f4d153aba" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_5ad04b7b-f90c-455f-8f48-0454103fbc5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_bc5a8363-782d-4e8d-a40f-c135c54ae664" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4b9eb0b4-3fe1-47c1-9b5e-479f4d153aba" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_bc5a8363-782d-4e8d-a40f-c135c54ae664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_10a9400b-9c1f-4f79-ab8a-9eaaabc50588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4b9eb0b4-3fe1-47c1-9b5e-479f4d153aba" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_10a9400b-9c1f-4f79-ab8a-9eaaabc50588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_6a89394a-6223-4179-8ef3-2078594135fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4b9eb0b4-3fe1-47c1-9b5e-479f4d153aba" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_6a89394a-6223-4179-8ef3-2078594135fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_adf326d1-c034-4e98-8a3b-3ed5983b43e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4b9eb0b4-3fe1-47c1-9b5e-479f4d153aba" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_adf326d1-c034-4e98-8a3b-3ed5983b43e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_947773dd-b733-40b2-9033-600c93fabfe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13a02fca-036a-40c4-98ed-b105fe18598b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_947773dd-b733-40b2-9033-600c93fabfe7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13a02fca-036a-40c4-98ed-b105fe18598b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_e871847a-b913-434a-bf6d-54769e2bf6ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13a02fca-036a-40c4-98ed-b105fe18598b" xlink:to="loc_us-gaap_InvestmentTypeAxis_e871847a-b913-434a-bf6d-54769e2bf6ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_6633b88a-f559-4bf4-bd37-687593b5ec87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_e871847a-b913-434a-bf6d-54769e2bf6ec" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_6633b88a-f559-4bf4-bd37-687593b5ec87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_2b4c63aa-9fd8-4b88-afda-e67d6b7dbe31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6633b88a-f559-4bf4-bd37-687593b5ec87" xlink:to="loc_us-gaap_OtherInvestmentsMember_2b4c63aa-9fd8-4b88-afda-e67d6b7dbe31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0ad1e10d-e73c-47f8-9005-4067e18bc6ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13a02fca-036a-40c4-98ed-b105fe18598b" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0ad1e10d-e73c-47f8-9005-4067e18bc6ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_fc13afc3-98b9-46ae-8112-7a5641e2e615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0ad1e10d-e73c-47f8-9005-4067e18bc6ce" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_fc13afc3-98b9-46ae-8112-7a5641e2e615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_45e524f3-3e5c-4a25-a204-498b5e008985" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_fc13afc3-98b9-46ae-8112-7a5641e2e615" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_45e524f3-3e5c-4a25-a204-498b5e008985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_266dae29-7e36-4832-97de-0fbd408617dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_fc13afc3-98b9-46ae-8112-7a5641e2e615" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_266dae29-7e36-4832-97de-0fbd408617dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5d260ea7-9bda-438c-9aa9-a0a02b9be86f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13a02fca-036a-40c4-98ed-b105fe18598b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5d260ea7-9bda-438c-9aa9-a0a02b9be86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92cdec95-bd7e-4ba1-aca5-c2c94a635406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5d260ea7-9bda-438c-9aa9-a0a02b9be86f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92cdec95-bd7e-4ba1-aca5-c2c94a635406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_bc84ecb9-5266-42b6-9be2-182dd4504485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92cdec95-bd7e-4ba1-aca5-c2c94a635406" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_bc84ecb9-5266-42b6-9be2-182dd4504485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_3d790ce1-bec2-4404-954b-50c205f84783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92cdec95-bd7e-4ba1-aca5-c2c94a635406" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_3d790ce1-bec2-4404-954b-50c205f84783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_5da2159c-dbca-4130-9bda-949192604469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_92cdec95-bd7e-4ba1-aca5-c2c94a635406" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_5da2159c-dbca-4130-9bda-949192604469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0da96143-4e0d-4d9c-ba2f-8852a37d1fce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13a02fca-036a-40c4-98ed-b105fe18598b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0da96143-4e0d-4d9c-ba2f-8852a37d1fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_f09516a8-2938-41b2-bd72-50fe30b64bac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0da96143-4e0d-4d9c-ba2f-8852a37d1fce" xlink:to="loc_us-gaap_OtherLongTermInvestments_f09516a8-2938-41b2-bd72-50fe30b64bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_59177893-3227-48ee-af97-f8a0c59b8414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0da96143-4e0d-4d9c-ba2f-8852a37d1fce" xlink:to="loc_us-gaap_ShortTermBorrowings_59177893-3227-48ee-af97-f8a0c59b8414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a70a5268-3693-466c-b352-5822f98d1f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0da96143-4e0d-4d9c-ba2f-8852a37d1fce" xlink:to="loc_us-gaap_LongTermDebt_a70a5268-3693-466c-b352-5822f98d1f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_580589bb-0500-49b2-973d-f9279b71076c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0da96143-4e0d-4d9c-ba2f-8852a37d1fce" xlink:to="loc_us-gaap_CommercialPaper_580589bb-0500-49b2-973d-f9279b71076c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_c42c8caa-69dc-4aad-9ee7-141374a00a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0da96143-4e0d-4d9c-ba2f-8852a37d1fce" xlink:to="loc_us-gaap_NotesPayable_c42c8caa-69dc-4aad-9ee7-141374a00a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_1eb8aae0-f3c3-44a3-9d81-66110d445506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0da96143-4e0d-4d9c-ba2f-8852a37d1fce" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_1eb8aae0-f3c3-44a3-9d81-66110d445506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/FairValueNarrativeDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#FairValueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/FairValueNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/IncomeTaxes" xlink:type="simple" xlink:href="elv-20220930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3e1d49e0-c73f-4359-af19-4c63aac359ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_d5d9278d-c92c-4b0a-b3f4-dbd928b34c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3e1d49e0-c73f-4359-af19-4c63aac359ea" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_d5d9278d-c92c-4b0a-b3f4-dbd928b34c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ccf2e0dc-bf8d-41b2-9f4e-269bdb200a15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d51b8470-0f42-4ab7-8875-3fc86eba5f60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ccf2e0dc-bf8d-41b2-9f4e-269bdb200a15" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d51b8470-0f42-4ab7-8875-3fc86eba5f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_fef4a51f-d92a-4834-a6cb-82d387971048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ccf2e0dc-bf8d-41b2-9f4e-269bdb200a15" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_fef4a51f-d92a-4834-a6cb-82d387971048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_a6e96da6-1e2f-41d3-80b2-db866f179843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ccf2e0dc-bf8d-41b2-9f4e-269bdb200a15" xlink:to="loc_us-gaap_IncomeTaxesReceivable_a6e96da6-1e2f-41d3-80b2-db866f179843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/MedicalClaimsPayable" xlink:type="simple" xlink:href="elv-20220930.xsd#MedicalClaimsPayable"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/MedicalClaimsPayable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract_2a2a526f-1d18-4dc7-ad7c-364629ca8d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_465d23b0-2751-429d-b1c1-6603e7336289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract_2a2a526f-1d18-4dc7-ad7c-364629ca8d3c" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_465d23b0-2751-429d-b1c1-6603e7336289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/MedicalClaimsPayableTables" xlink:type="simple" xlink:href="elv-20220930.xsd#MedicalClaimsPayableTables"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/MedicalClaimsPayableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract_055ad9c7-efa7-44cd-9a88-c12899beb81e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_6a66aed8-3c1f-45e5-9645-5ae73989bd78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract_055ad9c7-efa7-44cd-9a88-c12899beb81e" xlink:to="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_6a66aed8-3c1f-45e5-9645-5ae73989bd78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock_298b77fb-3985-488c-9500-2f7e5eab2ff7" xlink:href="elv-20220930.xsd#elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract_055ad9c7-efa7-44cd-9a88-c12899beb81e" xlink:to="loc_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock_298b77fb-3985-488c-9500-2f7e5eab2ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_e9797f6b-f846-4c72-9e9f-a9d2ee028058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract_055ad9c7-efa7-44cd-9a88-c12899beb81e" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_e9797f6b-f846-4c72-9e9f-a9d2ee028058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_2a3a6ce8-a651-46b9-8434-2c73fafa735d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_b856008a-7c6f-4a8a-a060-4a2cbf0b27bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_2a3a6ce8-a651-46b9-8434-2c73fafa735d" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_b856008a-7c6f-4a8a-a060-4a2cbf0b27bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f7302f32-5cf8-4be9-8c02-bfb1c6dcfe61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_b856008a-7c6f-4a8a-a060-4a2cbf0b27bb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f7302f32-5cf8-4be9-8c02-bfb1c6dcfe61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_15f2be91-a7f8-460e-b308-d15d1402b42c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f7302f32-5cf8-4be9-8c02-bfb1c6dcfe61" xlink:to="loc_us-gaap_SegmentDomain_15f2be91-a7f8-460e-b308-d15d1402b42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommercialSpecialtyBusinessSegmentMember_f5c1388c-eac8-4a72-bf07-b4687b87ff06" xlink:href="elv-20220930.xsd#elv_CommercialSpecialtyBusinessSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_15f2be91-a7f8-460e-b308-d15d1402b42c" xlink:to="loc_elv_CommercialSpecialtyBusinessSegmentMember_f5c1388c-eac8-4a72-bf07-b4687b87ff06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GovernmentBusinessSegmentMember_feea2973-b286-4155-b02d-80a3d3a6119a" xlink:href="elv-20220930.xsd#elv_GovernmentBusinessSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_15f2be91-a7f8-460e-b308-d15d1402b42c" xlink:to="loc_elv_GovernmentBusinessSegmentMember_feea2973-b286-4155-b02d-80a3d3a6119a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherSegmentMember_c72ca9ab-ab5b-4b3a-a785-5bafe9bec415" xlink:href="elv-20220930.xsd#elv_OtherSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_15f2be91-a7f8-460e-b308-d15d1402b42c" xlink:to="loc_elv_OtherSegmentMember_c72ca9ab-ab5b-4b3a-a785-5bafe9bec415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_b856008a-7c6f-4a8a-a060-4a2cbf0b27bb" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense_8274f663-64c2-4e58-918e-d1940460aabb" xlink:href="elv-20220930.xsd#elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense_8274f663-64c2-4e58-918e-d1940460aabb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_0f39b02a-e09a-4aaa-a502-f724652d0b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_0f39b02a-e09a-4aaa-a502-f724652d0b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_d2434bf1-cc0b-465f-b95a-fb383ef84d77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_d2434bf1-cc0b-465f-b95a-fb383ef84d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments_8057b6c8-c330-486b-9ed8-256ada6f8d95" xlink:href="elv-20220930.xsd#elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments_8057b6c8-c330-486b-9ed8-256ada6f8d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_087682d3-9fe6-41aa-ac9a-971aa2e9c65c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_087682d3-9fe6-41aa-ac9a-971aa2e9c65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_ab4419ba-af73-40d4-8594-e4b5e0d7d6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_ab4419ba-af73-40d4-8594-e4b5e0d7d6a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_f73436cb-d677-407a-b799-15d8068f74a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_f73436cb-d677-407a-b799-15d8068f74a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_e2b2b4d4-fb23-48ea-96f7-30802017d166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_e2b2b4d4-fb23-48ea-96f7-30802017d166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_d7237705-fada-4c02-a19f-8845ecacf844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_d7237705-fada-4c02-a19f-8845ecacf844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_27aeab1a-a09c-439c-a1b9-f30247e45cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_27aeab1a-a09c-439c-a1b9-f30247e45cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet_05bb6242-4ccf-498b-9236-5e817e3cc6ef" xlink:href="elv-20220930.xsd#elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet_05bb6242-4ccf-498b-9236-5e817e3cc6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_02806d72-cfe0-4c27-95ba-f08a9e1ed628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_02806d72-cfe0-4c27-95ba-f08a9e1ed628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense_837e8767-b281-484a-ad7c-191dd257295b" xlink:href="elv-20220930.xsd#elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_975969c1-f242-4411-87fc-20d06d5d101e" xlink:to="loc_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense_837e8767-b281-484a-ad7c-191dd257295b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfNetIncurredMedicalClaimsToBenefitExpenseDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#MedicalClaimsPayableReconciliationOfNetIncurredMedicalClaimsToBenefitExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfNetIncurredMedicalClaimsToBenefitExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_elv_MedicalClaimsPayableReconciliationofNetIncurredMedicalClaimstoBenefitExpenseAbstract_96782023-0df3-4aed-af93-fd27772a396d" xlink:href="elv-20220930.xsd#elv_MedicalClaimsPayableReconciliationofNetIncurredMedicalClaimstoBenefitExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTable_e0856993-dad4-4a67-be3d-339f39a025ae" xlink:href="elv-20220930.xsd#elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_MedicalClaimsPayableReconciliationofNetIncurredMedicalClaimstoBenefitExpenseAbstract_96782023-0df3-4aed-af93-fd27772a396d" xlink:to="loc_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTable_e0856993-dad4-4a67-be3d-339f39a025ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3d5756bc-7929-44d3-9199-5bf7acd99c73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTable_e0856993-dad4-4a67-be3d-339f39a025ae" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3d5756bc-7929-44d3-9199-5bf7acd99c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_aab4ddf1-e4b1-4b29-ab5d-80f5ce6f2d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3d5756bc-7929-44d3-9199-5bf7acd99c73" xlink:to="loc_us-gaap_SegmentDomain_aab4ddf1-e4b1-4b29-ab5d-80f5ce6f2d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommercialSpecialtyBusinessSegmentMember_0ffdcb5e-7bf8-4fb7-a4e0-9bd50eaeb8c3" xlink:href="elv-20220930.xsd#elv_CommercialSpecialtyBusinessSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_aab4ddf1-e4b1-4b29-ab5d-80f5ce6f2d35" xlink:to="loc_elv_CommercialSpecialtyBusinessSegmentMember_0ffdcb5e-7bf8-4fb7-a4e0-9bd50eaeb8c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GovernmentBusinessSegmentMember_7e9a914e-9d78-4901-aea0-56cd299b9af5" xlink:href="elv-20220930.xsd#elv_GovernmentBusinessSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_aab4ddf1-e4b1-4b29-ab5d-80f5ce6f2d35" xlink:to="loc_elv_GovernmentBusinessSegmentMember_7e9a914e-9d78-4901-aea0-56cd299b9af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherSegmentMember_6e15e262-633f-4e72-a953-ea2518229649" xlink:href="elv-20220930.xsd#elv_OtherSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_aab4ddf1-e4b1-4b29-ab5d-80f5ce6f2d35" xlink:to="loc_elv_OtherSegmentMember_6e15e262-633f-4e72-a953-ea2518229649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems_dda60c9c-783b-41c9-ad57-ccfa8d0b1fa7" xlink:href="elv-20220930.xsd#elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTable_e0856993-dad4-4a67-be3d-339f39a025ae" xlink:to="loc_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems_dda60c9c-783b-41c9-ad57-ccfa8d0b1fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_530d26aa-4103-478f-b155-bcbf73fa7c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems_dda60c9c-783b-41c9-ad57-ccfa8d0b1fa7" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_530d26aa-4103-478f-b155-bcbf73fa7c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense_0b13b3d3-4694-4c2d-8e55-25892fbc8571" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems_dda60c9c-783b-41c9-ad57-ccfa8d0b1fa7" xlink:to="loc_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense_0b13b3d3-4694-4c2d-8e55-25892fbc8571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_03df43e7-9097-4279-838a-e3af0062b672" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems_dda60c9c-783b-41c9-ad57-ccfa8d0b1fa7" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_03df43e7-9097-4279-838a-e3af0062b672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/MedicalClaimsPayableMedicalClaimsPayableReconciliationoftheClaimsDevelopmenttotheClaimsLiabilityDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#MedicalClaimsPayableMedicalClaimsPayableReconciliationoftheClaimsDevelopmenttotheClaimsLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/MedicalClaimsPayableMedicalClaimsPayableReconciliationoftheClaimsDevelopmenttotheClaimsLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_elv_ReconciliationOfTheClaimsDevelopmentToTheClaimsLiabilityAbstract_f1a482f1-7640-4c23-958f-6bc947f265b2" xlink:href="elv-20220930.xsd#elv_ReconciliationOfTheClaimsDevelopmentToTheClaimsLiabilityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_9704d327-7f49-41ff-a73d-980438d2bda3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_ReconciliationOfTheClaimsDevelopmentToTheClaimsLiabilityAbstract_f1a482f1-7640-4c23-958f-6bc947f265b2" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_9704d327-7f49-41ff-a73d-980438d2bda3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_544b15a0-bca0-4c29-b535-2c4194376303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_9704d327-7f49-41ff-a73d-980438d2bda3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_544b15a0-bca0-4c29-b535-2c4194376303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3fdf04b2-a2fe-4f06-afca-79efb1e01d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_544b15a0-bca0-4c29-b535-2c4194376303" xlink:to="loc_us-gaap_SegmentDomain_3fdf04b2-a2fe-4f06-afca-79efb1e01d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommercialSpecialtyBusinessSegmentMember_0fab918a-c37a-40ab-9f32-a94fb4513019" xlink:href="elv-20220930.xsd#elv_CommercialSpecialtyBusinessSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3fdf04b2-a2fe-4f06-afca-79efb1e01d2b" xlink:to="loc_elv_CommercialSpecialtyBusinessSegmentMember_0fab918a-c37a-40ab-9f32-a94fb4513019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GovernmentBusinessSegmentMember_79c08b4e-a6e5-4777-88e8-abcc8c8a6428" xlink:href="elv-20220930.xsd#elv_GovernmentBusinessSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3fdf04b2-a2fe-4f06-afca-79efb1e01d2b" xlink:to="loc_elv_GovernmentBusinessSegmentMember_79c08b4e-a6e5-4777-88e8-abcc8c8a6428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherSegmentMember_c3153c33-fb3c-4548-8d12-df763cf7ce72" xlink:href="elv-20220930.xsd#elv_OtherSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3fdf04b2-a2fe-4f06-afca-79efb1e01d2b" xlink:to="loc_elv_OtherSegmentMember_c3153c33-fb3c-4548-8d12-df763cf7ce72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_26a9b0b9-cb80-4d81-881a-4785300c93e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_9704d327-7f49-41ff-a73d-980438d2bda3" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_26a9b0b9-cb80-4d81-881a-4785300c93e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_1975b8e2-e736-4027-94b5-737674978a83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_26a9b0b9-cb80-4d81-881a-4785300c93e9" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_1975b8e2-e736-4027-94b5-737674978a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_55dd3c5c-b01b-4695-a7f6-606135c17683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_26a9b0b9-cb80-4d81-881a-4785300c93e9" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_55dd3c5c-b01b-4695-a7f6-606135c17683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_e1390ca8-3ac9-416c-95d0-aaeb7e67ea88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_26a9b0b9-cb80-4d81-881a-4785300c93e9" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_e1390ca8-3ac9-416c-95d0-aaeb7e67ea88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_5cd27931-3607-41aa-91c8-3dc89121390c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_26a9b0b9-cb80-4d81-881a-4785300c93e9" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_5cd27931-3607-41aa-91c8-3dc89121390c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/MedicalClaimsPayableNarrativeDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#MedicalClaimsPayableNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/MedicalClaimsPayableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_ea66c0e9-2ff5-4679-a65b-14bc061bf992" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_d9c6bb37-db68-4183-9112-1613654afb29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_ea66c0e9-2ff5-4679-a65b-14bc061bf992" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_d9c6bb37-db68-4183-9112-1613654afb29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_8f15b682-e38a-4fa0-a9d0-451ac0a1f4bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_d9c6bb37-db68-4183-9112-1613654afb29" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_8f15b682-e38a-4fa0-a9d0-451ac0a1f4bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_81f0363c-8bdc-4d5a-99de-220fc5742d19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_8f15b682-e38a-4fa0-a9d0-451ac0a1f4bb" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_81f0363c-8bdc-4d5a-99de-220fc5742d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_7a911ec5-718f-497b-9eab-fb5c375158cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_81f0363c-8bdc-4d5a-99de-220fc5742d19" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_7a911ec5-718f-497b-9eab-fb5c375158cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_f843e3ce-da85-4495-9c79-0aa907370b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_81f0363c-8bdc-4d5a-99de-220fc5742d19" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_f843e3ce-da85-4495-9c79-0aa907370b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_a9ccd876-2823-458a-afaf-639444bb6e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_81f0363c-8bdc-4d5a-99de-220fc5742d19" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_a9ccd876-2823-458a-afaf-639444bb6e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a8bd28ce-5f49-4d2d-9a15-2c9970599080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_d9c6bb37-db68-4183-9112-1613654afb29" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a8bd28ce-5f49-4d2d-9a15-2c9970599080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bb666186-1fbd-4af7-8625-ed7330569f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a8bd28ce-5f49-4d2d-9a15-2c9970599080" xlink:to="loc_us-gaap_SegmentDomain_bb666186-1fbd-4af7-8625-ed7330569f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommercialSpecialtyBusinessSegmentMember_cb57a7f9-8eb0-4cb7-9d08-fbf5d13d9141" xlink:href="elv-20220930.xsd#elv_CommercialSpecialtyBusinessSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bb666186-1fbd-4af7-8625-ed7330569f3e" xlink:to="loc_elv_CommercialSpecialtyBusinessSegmentMember_cb57a7f9-8eb0-4cb7-9d08-fbf5d13d9141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GovernmentBusinessSegmentMember_3acf838d-862d-4abf-a0fd-cb02f8d2fbe4" xlink:href="elv-20220930.xsd#elv_GovernmentBusinessSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bb666186-1fbd-4af7-8625-ed7330569f3e" xlink:to="loc_elv_GovernmentBusinessSegmentMember_3acf838d-862d-4abf-a0fd-cb02f8d2fbe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherSegmentMember_cfd76bb5-0c78-4af6-aeac-25479910ba6a" xlink:href="elv-20220930.xsd#elv_OtherSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bb666186-1fbd-4af7-8625-ed7330569f3e" xlink:to="loc_elv_OtherSegmentMember_cfd76bb5-0c78-4af6-aeac-25479910ba6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems_3d073d54-18c6-4f95-908f-40c0bc455315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_d9c6bb37-db68-4183-9112-1613654afb29" xlink:to="loc_us-gaap_ClaimsDevelopmentLineItems_3d073d54-18c6-4f95-908f-40c0bc455315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_dd053524-01d2-43f1-8d21-739d7fb86fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_3d073d54-18c6-4f95-908f-40c0bc455315" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_dd053524-01d2-43f1-8d21-739d7fb86fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/Debt" xlink:type="simple" xlink:href="elv-20220930.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_69224ae9-6609-4866-b24e-aa4025faf580" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_7938afb2-b475-43a7-804a-4dd6992e90b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_69224ae9-6609-4866-b24e-aa4025faf580" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_7938afb2-b475-43a7-804a-4dd6992e90b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/DebtTables" xlink:type="simple" xlink:href="elv-20220930.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f98f3c0c-2931-4905-a4ea-ec9a669d7b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtTableTextBlock_fe7282ff-1d2e-446a-9d10-3eb733b523f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f98f3c0c-2931-4905-a4ea-ec9a669d7b8a" xlink:to="loc_us-gaap_ConvertibleDebtTableTextBlock_fe7282ff-1d2e-446a-9d10-3eb733b523f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/DebtConvertibleDebentureDetailsDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#DebtConvertibleDebentureDetailsDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/DebtConvertibleDebentureDetailsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3b5045d6-5cc9-480f-b6a4-fd2ac903089d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2523da4a-288d-4c99-a96b-f425d0ab174c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3b5045d6-5cc9-480f-b6a4-fd2ac903089d" xlink:to="loc_us-gaap_DebtInstrumentTable_2523da4a-288d-4c99-a96b-f425d0ab174c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f3d9ee32-8d5e-4933-8638-c7e1473b03b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2523da4a-288d-4c99-a96b-f425d0ab174c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f3d9ee32-8d5e-4933-8638-c7e1473b03b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d96e5300-29d4-4951-8f11-ce030c679ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f3d9ee32-8d5e-4933-8638-c7e1473b03b5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d96e5300-29d4-4951-8f11-ce030c679ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cfbf6915-bb5d-4f48-8eeb-56ddeb0f6df4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2523da4a-288d-4c99-a96b-f425d0ab174c" xlink:to="loc_us-gaap_DebtInstrumentAxis_cfbf6915-bb5d-4f48-8eeb-56ddeb0f6df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_127dc9ed-d62c-45c0-9584-a9216a03d55f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_cfbf6915-bb5d-4f48-8eeb-56ddeb0f6df4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_127dc9ed-d62c-45c0-9584-a9216a03d55f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_a6be8722-1da0-4bc5-83a1-91def0cf1a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_127dc9ed-d62c-45c0-9584-a9216a03d55f" xlink:to="loc_us-gaap_ConvertibleDebtMember_a6be8722-1da0-4bc5-83a1-91def0cf1a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_4c6d6ae2-c268-41d6-8c6f-49f5839d8670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2523da4a-288d-4c99-a96b-f425d0ab174c" xlink:to="loc_us-gaap_VariableRateAxis_4c6d6ae2-c268-41d6-8c6f-49f5839d8670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_50abdad0-c506-4621-ae50-0e1773e6b83d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_4c6d6ae2-c268-41d6-8c6f-49f5839d8670" xlink:to="loc_us-gaap_VariableRateDomain_50abdad0-c506-4621-ae50-0e1773e6b83d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_91f45fda-e309-4ff3-8923-3802efa200bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2523da4a-288d-4c99-a96b-f425d0ab174c" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_91f45fda-e309-4ff3-8923-3802efa200bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1a4bafab-1085-4ff0-a822-cf0660a433aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_91f45fda-e309-4ff3-8923-3802efa200bd" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1a4bafab-1085-4ff0-a822-cf0660a433aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_deb096e9-ee59-488a-8568-409ed0d6828e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2523da4a-288d-4c99-a96b-f425d0ab174c" xlink:to="loc_us-gaap_DebtInstrumentLineItems_deb096e9-ee59-488a-8568-409ed0d6828e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_f4b497b8-3f0e-42de-92dc-01db13611ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_deb096e9-ee59-488a-8568-409ed0d6828e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_f4b497b8-3f0e-42de-92dc-01db13611ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_ac11c480-6714-4ae1-9640-bd5bddca2101" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_deb096e9-ee59-488a-8568-409ed0d6828e" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_ac11c480-6714-4ae1-9640-bd5bddca2101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_fa56b383-f008-426d-a4f3-82e8fefe0d03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_deb096e9-ee59-488a-8568-409ed0d6828e" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_fa56b383-f008-426d-a4f3-82e8fefe0d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_e3dac56a-529c-454b-ac0c-aeb814eac1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_deb096e9-ee59-488a-8568-409ed0d6828e" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_e3dac56a-529c-454b-ac0c-aeb814eac1b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_91a63fc8-7485-4c59-8a87-beb0d9f5f997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_0890b495-f528-4cec-b6e1-503d0115f3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_91a63fc8-7485-4c59-8a87-beb0d9f5f997" xlink:to="loc_us-gaap_DebtInstrumentsAbstract_0890b495-f528-4cec-b6e1-503d0115f3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_0890b495-f528-4cec-b6e1-503d0115f3d8" xlink:to="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_cce1f854-6916-4bbf-b97e-843e6cf1086c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_us-gaap_CreditFacilityAxis_cce1f854-6916-4bbf-b97e-843e6cf1086c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_88c3e7d6-0732-44e6-a46c-1ae7c1149dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_cce1f854-6916-4bbf-b97e-843e6cf1086c" xlink:to="loc_us-gaap_CreditFacilityDomain_88c3e7d6-0732-44e6-a46c-1ae7c1149dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_A2021364DayFacilityMember_59fe8215-a999-411a-90ec-0725db7b3a61" xlink:href="elv-20220930.xsd#elv_A2021364DayFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_88c3e7d6-0732-44e6-a46c-1ae7c1149dd0" xlink:to="loc_elv_A2021364DayFacilityMember_59fe8215-a999-411a-90ec-0725db7b3a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_A5YearFacilityMember_74c1bea8-133b-4cb9-98c8-867581d73717" xlink:href="elv-20220930.xsd#elv_A5YearFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_88c3e7d6-0732-44e6-a46c-1ae7c1149dd0" xlink:to="loc_elv_A5YearFacilityMember_74c1bea8-133b-4cb9-98c8-867581d73717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_eb15936e-edd3-4ac5-8338-61f9317dfb87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_eb15936e-edd3-4ac5-8338-61f9317dfb87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4e34f768-b46e-4dba-bc28-6307e4259cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_eb15936e-edd3-4ac5-8338-61f9317dfb87" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4e34f768-b46e-4dba-bc28-6307e4259cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_0a720411-a59c-4a59-b640-45efd10ac94d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_4e34f768-b46e-4dba-bc28-6307e4259cd6" xlink:to="loc_us-gaap_SubsequentEventMember_0a720411-a59c-4a59-b640-45efd10ac94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9c2908d7-dcfd-4716-9ba0-5d55caf9db26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9c2908d7-dcfd-4716-9ba0-5d55caf9db26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_3c64e4b3-4248-44b5-9bcb-333a9e0d77bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9c2908d7-dcfd-4716-9ba0-5d55caf9db26" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_3c64e4b3-4248-44b5-9bcb-333a9e0d77bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4e1f44bb-7f00-46ad-8a30-2785012c8e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4e1f44bb-7f00-46ad-8a30-2785012c8e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_332cb5e1-33ae-4578-a754-31606df55d19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4e1f44bb-7f00-46ad-8a30-2785012c8e8c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_332cb5e1-33ae-4578-a754-31606df55d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_c3c56ff1-ab24-4b9d-b65f-352c15a46ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_332cb5e1-33ae-4578-a754-31606df55d19" xlink:to="loc_us-gaap_LineOfCreditMember_c3c56ff1-ab24-4b9d-b65f-352c15a46ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SurplusNotesMember_420937f1-a8aa-4686-8830-03247740ad70" xlink:href="elv-20220930.xsd#elv_SurplusNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_332cb5e1-33ae-4578-a754-31606df55d19" xlink:to="loc_elv_SurplusNotesMember_420937f1-a8aa-4686-8830-03247740ad70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_6368c847-2693-42c2-85ba-81c10beb34fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_332cb5e1-33ae-4578-a754-31606df55d19" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_6368c847-2693-42c2-85ba-81c10beb34fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SeniorUnsecuredNotesMember_87129e07-80c9-46cb-9d8e-43693efb3b03" xlink:href="elv-20220930.xsd#elv_SeniorUnsecuredNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_332cb5e1-33ae-4578-a754-31606df55d19" xlink:to="loc_elv_SeniorUnsecuredNotesMember_87129e07-80c9-46cb-9d8e-43693efb3b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_dc22f1b1-62c5-4df7-b9f4-621b5ebdfb49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_332cb5e1-33ae-4578-a754-31606df55d19" xlink:to="loc_us-gaap_CommercialPaperMember_dc22f1b1-62c5-4df7-b9f4-621b5ebdfb49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_78600d2a-ad2d-4156-a5d5-f09737b9d7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_78600d2a-ad2d-4156-a5d5-f09737b9d7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_ea51b3f8-2949-4383-afd8-dc11981486e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_78600d2a-ad2d-4156-a5d5-f09737b9d7e0" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_ea51b3f8-2949-4383-afd8-dc11981486e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_5c200110-2962-4ee5-ab76-6ed4742345c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_ea51b3f8-2949-4383-afd8-dc11981486e3" xlink:to="loc_us-gaap_LineOfCreditMember_5c200110-2962-4ee5-ab76-6ed4742345c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesMember_b2bb8551-9fd7-4242-9814-b908ee283944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalHomeLoanBankAdvancesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_ea51b3f8-2949-4383-afd8-dc11981486e3" xlink:to="loc_us-gaap_FederalHomeLoanBankAdvancesMember_b2bb8551-9fd7-4242-9814-b908ee283944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fc1f094d-af17-4b88-b775-da3524886f21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fc1f094d-af17-4b88-b775-da3524886f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5b95701-2232-458b-9b55-d1a77baddf4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fc1f094d-af17-4b88-b775-da3524886f21" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5b95701-2232-458b-9b55-d1a77baddf4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_4318d0f2-21f8-4d69-912b-487af6950928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_4318d0f2-21f8-4d69-912b-487af6950928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_5efa5ae2-e4a0-4526-b1c5-2fd60efb5e41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_4318d0f2-21f8-4d69-912b-487af6950928" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_5efa5ae2-e4a0-4526-b1c5-2fd60efb5e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_ecb8b1a4-e821-4fff-b3ac-fb702091692d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_5efa5ae2-e4a0-4526-b1c5-2fd60efb5e41" xlink:to="loc_us-gaap_ConvertibleDebtMember_ecb8b1a4-e821-4fff-b3ac-fb702091692d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SeniorUnsecuredNotesMember_fcfd8226-0d7d-45e7-aa1f-730fdbc88138" xlink:href="elv-20220930.xsd#elv_SeniorUnsecuredNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_5efa5ae2-e4a0-4526-b1c5-2fd60efb5e41" xlink:to="loc_elv_SeniorUnsecuredNotesMember_fcfd8226-0d7d-45e7-aa1f-730fdbc88138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b037fbc6-025e-4157-bdc7-f647699cf67b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_us-gaap_DebtInstrumentAxis_b037fbc6-025e-4157-bdc7-f647699cf67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0230b75f-42ef-4308-bd23-afe0f576b4e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b037fbc6-025e-4157-bdc7-f647699cf67b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0230b75f-42ef-4308-bd23-afe0f576b4e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SeniorUnsecuredNotesMember_8a285333-3b2c-446d-a012-78087cc73a1e" xlink:href="elv-20220930.xsd#elv_SeniorUnsecuredNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0230b75f-42ef-4308-bd23-afe0f576b4e8" xlink:to="loc_elv_SeniorUnsecuredNotesMember_8a285333-3b2c-446d-a012-78087cc73a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_10555e14-7536-4dcf-9c8c-97acff3986fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0230b75f-42ef-4308-bd23-afe0f576b4e8" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_10555e14-7536-4dcf-9c8c-97acff3986fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_67ff1eba-4a3c-498a-bc5e-0455730268fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0230b75f-42ef-4308-bd23-afe0f576b4e8" xlink:to="loc_us-gaap_CommercialPaperMember_67ff1eba-4a3c-498a-bc5e-0455730268fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SurplusNotesMember_1027c1b0-3b36-457b-ae88-5ad4c07b93ae" xlink:href="elv-20220930.xsd#elv_SurplusNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0230b75f-42ef-4308-bd23-afe0f576b4e8" xlink:to="loc_elv_SurplusNotesMember_1027c1b0-3b36-457b-ae88-5ad4c07b93ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_f60cc131-c179-435e-bbf0-17417d49ef61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0230b75f-42ef-4308-bd23-afe0f576b4e8" xlink:to="loc_us-gaap_ConvertibleDebtMember_f60cc131-c179-435e-bbf0-17417d49ef61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember_4daeb307-9681-4f8d-9d7a-2b1de82b36df" xlink:href="elv-20220930.xsd#elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0230b75f-42ef-4308-bd23-afe0f576b4e8" xlink:to="loc_elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember_4daeb307-9681-4f8d-9d7a-2b1de82b36df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember_2a6179bf-5ad2-43c5-9f26-b95af9dc5e7e" xlink:href="elv-20220930.xsd#elv_FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0230b75f-42ef-4308-bd23-afe0f576b4e8" xlink:to="loc_elv_FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember_2a6179bf-5ad2-43c5-9f26-b95af9dc5e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember_3c5cd0f1-bf61-4fe2-9c46-9bc3e2819c95" xlink:href="elv-20220930.xsd#elv_ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0230b75f-42ef-4308-bd23-afe0f576b4e8" xlink:to="loc_elv_ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember_3c5cd0f1-bf61-4fe2-9c46-9bc3e2819c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_47e887c8-b7ab-49ca-b530-588d0510f937" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_srt_RangeAxis_47e887c8-b7ab-49ca-b530-588d0510f937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e91f858e-3987-4e38-a1a3-50ec7f639cd0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_47e887c8-b7ab-49ca-b530-588d0510f937" xlink:to="loc_srt_RangeMember_e91f858e-3987-4e38-a1a3-50ec7f639cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_90adb9a1-8740-418e-a153-b96999ec7d8d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e91f858e-3987-4e38-a1a3-50ec7f639cd0" xlink:to="loc_srt_MinimumMember_90adb9a1-8740-418e-a153-b96999ec7d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_39086a49-fee2-47d9-947d-864e8044c51c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e91f858e-3987-4e38-a1a3-50ec7f639cd0" xlink:to="loc_srt_MaximumMember_39086a49-fee2-47d9-947d-864e8044c51c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0474fa97-07c5-44ac-86d4-b4171c9fdb8d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0474fa97-07c5-44ac-86d4-b4171c9fdb8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1e097223-4de4-415a-9f0b-12f24b8e45da" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0474fa97-07c5-44ac-86d4-b4171c9fdb8d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1e097223-4de4-415a-9f0b-12f24b8e45da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_512eb59d-2af3-472e-b1bc-e76d06826b6d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1e097223-4de4-415a-9f0b-12f24b8e45da" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_512eb59d-2af3-472e-b1bc-e76d06826b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fc28dfa2-0a87-4437-ba7f-24ca7907937e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fc28dfa2-0a87-4437-ba7f-24ca7907937e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_44e1fd70-b544-4daf-b475-eab849a0ebbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fc28dfa2-0a87-4437-ba7f-24ca7907937e" xlink:to="loc_us-gaap_TypeOfAdoptionMember_44e1fd70-b544-4daf-b475-eab849a0ebbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_a84f0b92-89d3-406a-9890-15b2b34bad84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_44e1fd70-b544-4daf-b475-eab849a0ebbc" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_a84f0b92-89d3-406a-9890-15b2b34bad84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d9edbf2d-28b2-4fd1-b8bb-4de1137fc5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d9edbf2d-28b2-4fd1-b8bb-4de1137fc5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_73f81b1b-445d-4639-9a7b-53e59ab14b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d9edbf2d-28b2-4fd1-b8bb-4de1137fc5e2" xlink:to="loc_us-gaap_EquityComponentDomain_73f81b1b-445d-4639-9a7b-53e59ab14b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_42ed345d-e91d-42a2-9629-5356301b36b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_73f81b1b-445d-4639-9a7b-53e59ab14b0d" xlink:to="loc_us-gaap_RetainedEarningsMember_42ed345d-e91d-42a2-9629-5356301b36b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6388369-dbdb-46f3-bded-2ae438c8969f" xlink:to="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_743ac451-3cb1-41a2-9e14-0755cad2a4bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_LongTermDebt_743ac451-3cb1-41a2-9e14-0755cad2a4bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ff187cd2-4733-481a-bb11-14b838fcf3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ff187cd2-4733-481a-bb11-14b838fcf3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_2fd1bb65-7371-44c6-91c6-e38048c21675" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_2fd1bb65-7371-44c6-91c6-e38048c21675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_dad61437-2159-4b00-9438-cfcf7ab3ec2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_dad61437-2159-4b00-9438-cfcf7ab3ec2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_2fe0445e-2290-482d-86fa-91c630e37a49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_2fe0445e-2290-482d-86fa-91c630e37a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCovenantDescription_7f3aa078-71cd-4bd4-80d3-b5482aabd2c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCovenantDescription"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_DebtInstrumentCovenantDescription_7f3aa078-71cd-4bd4-80d3-b5482aabd2c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCovenantCompliance_541a34cd-5136-4dd9-95a8-080c2154e5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCovenantCompliance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_DebtInstrumentCovenantCompliance_541a34cd-5136-4dd9-95a8-080c2154e5f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_bba94606-d5a7-4e98-911b-577a4ede4007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_bba94606-d5a7-4e98-911b-577a4ede4007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityDescription_8c94d761-9892-46f9-8b60-4defbabb6d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityDescription"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_LineOfCreditFacilityDescription_8c94d761-9892-46f9-8b60-4defbabb6d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommercialPaperMaximumBorrowingCapacity_490f80d7-7922-4db2-a114-22da433a83a4" xlink:href="elv-20220930.xsd#elv_CommercialPaperMaximumBorrowingCapacity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_elv_CommercialPaperMaximumBorrowingCapacity_490f80d7-7922-4db2-a114-22da433a83a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_d4821046-d6c0-40c7-8702-12ce94f15d17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_CommercialPaper_d4821046-d6c0-40c7-8702-12ce94f15d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_DebtConversionDebtPrincipalAmount_6572cbd3-8839-49a6-a194-97b6032e3433" xlink:href="elv-20220930.xsd#elv_DebtConversionDebtPrincipalAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_elv_DebtConversionDebtPrincipalAmount_6572cbd3-8839-49a6-a194-97b6032e3433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5cda5d53-df66-4573-8693-115978697a83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_2b0e4968-920b-40b0-a7be-9e03dcb94063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_2b0e4968-920b-40b0-a7be-9e03dcb94063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_07c07608-439b-495f-a689-50324ec3f8af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_StockholdersEquity_07c07608-439b-495f-a689-50324ec3f8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_557f86dc-9192-4a45-9605-4e7048b802e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_557f86dc-9192-4a45-9605-4e7048b802e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_6a33cd49-c2ff-4c98-937c-8bdf165e01b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_ShortTermBorrowings_6a33cd49-c2ff-4c98-937c-8bdf165e01b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths_b6f7badd-6ebf-4980-b8b2-02c769ebc3d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3accee56-878e-4bdd-ad6c-2f5ef1a13b3c" xlink:to="loc_us-gaap_FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths_b6f7badd-6ebf-4980-b8b2-02c769ebc3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_dcd09b82-09de-461b-8a64-48bd84c1fedc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_91a63fc8-7485-4c59-8a87-beb0d9f5f997" xlink:to="loc_us-gaap_DebtInstrumentTable_dcd09b82-09de-461b-8a64-48bd84c1fedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f3b5ba65-e6d5-4bd4-b359-d16584bcf6de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3f1d822f-af25-42bc-bdea-25ba344f1fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember_2434cf47-4c71-4ab3-a899-f671791bb132" xlink:href="elv-20220930.xsd#elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6838f6a5-7958-4d5b-a93f-f640e888020f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_08a9fea3-dc0e-4548-9c17-8547b4d2a1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SurplusNotesMember_7a16f347-7d2f-40b2-840c-e1b6404510a1" xlink:href="elv-20220930.xsd#elv_SurplusNotesMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e5942a20-7a6a-4187-934f-9eea8aee90a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f4023d42-54a1-4678-9f74-c0f39ccd0991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_45472796-e469-4a20-a51d-281d82593a20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/CommitmentsAndContingencies" xlink:type="simple" xlink:href="elv-20220930.xsd#CommitmentsAndContingencies"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/CommitmentsAndContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b41d6474-c574-48f2-8b12-88670ef1bc67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0694b131-c932-4119-ba8d-7a711355878f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b41d6474-c574-48f2-8b12-88670ef1bc67" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0694b131-c932-4119-ba8d-7a711355878f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#CommitmentsAndContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_29517e60-e334-48d9-a7b3-97fa555d8682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommitmentsAndContingenciesTable_bfe48700-6c7c-4684-8317-1d8422cd5eb8" xlink:href="elv-20220930.xsd#elv_CommitmentsAndContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_29517e60-e334-48d9-a7b3-97fa555d8682" xlink:to="loc_elv_CommitmentsAndContingenciesTable_bfe48700-6c7c-4684-8317-1d8422cd5eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_a3cf0afc-5fc9-4f24-bffa-cd6363f3aa7f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_CommitmentsAndContingenciesTable_bfe48700-6c7c-4684-8317-1d8422cd5eb8" xlink:to="loc_srt_LitigationCaseAxis_a3cf0afc-5fc9-4f24-bffa-cd6363f3aa7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_c7fcbb19-fcdb-49c5-9503-5d4e30bbde6a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_a3cf0afc-5fc9-4f24-bffa-cd6363f3aa7f" xlink:to="loc_srt_LitigationCaseTypeDomain_c7fcbb19-fcdb-49c5-9503-5d4e30bbde6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_BCBSAntitrustLitigationMember_6afa8abe-23af-49ce-9958-dc0ff122015d" xlink:href="elv-20220930.xsd#elv_BCBSAntitrustLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c7fcbb19-fcdb-49c5-9503-5d4e30bbde6a" xlink:to="loc_elv_BCBSAntitrustLitigationMember_6afa8abe-23af-49ce-9958-dc0ff122015d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_AnthemInc.v.ExpressScriptsInc.Member_374651c0-c890-4abf-806d-96bae73bc67d" xlink:href="elv-20220930.xsd#elv_AnthemInc.v.ExpressScriptsInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c7fcbb19-fcdb-49c5-9503-5d4e30bbde6a" xlink:to="loc_elv_AnthemInc.v.ExpressScriptsInc.Member_374651c0-c890-4abf-806d-96bae73bc67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8ac4e041-860b-492d-858e-4485c3e2f84b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_CommitmentsAndContingenciesTable_bfe48700-6c7c-4684-8317-1d8422cd5eb8" xlink:to="loc_srt_RangeAxis_8ac4e041-860b-492d-858e-4485c3e2f84b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_616d713d-452c-40ea-8bff-79a701441324" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_8ac4e041-860b-492d-858e-4485c3e2f84b" xlink:to="loc_srt_RangeMember_616d713d-452c-40ea-8bff-79a701441324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_51fe1163-96ba-4567-9697-da248ab2bec7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_616d713d-452c-40ea-8bff-79a701441324" xlink:to="loc_srt_MinimumMember_51fe1163-96ba-4567-9697-da248ab2bec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e1656412-1ef0-4f22-b442-63038bbc258b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_616d713d-452c-40ea-8bff-79a701441324" xlink:to="loc_srt_MaximumMember_e1656412-1ef0-4f22-b442-63038bbc258b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_525286d0-1d73-4f15-b9e3-92422f57e76e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_CommitmentsAndContingenciesTable_bfe48700-6c7c-4684-8317-1d8422cd5eb8" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_525286d0-1d73-4f15-b9e3-92422f57e76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_d7ecdaf3-b8cb-40aa-ad22-2597a7fbf937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_525286d0-1d73-4f15-b9e3-92422f57e76e" xlink:to="loc_us-gaap_LossContingencyNatureDomain_d7ecdaf3-b8cb-40aa-ad22-2597a7fbf937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesByNatureAxis_e11264f0-66fc-45d1-ae5c-56fb241a052f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainContingenciesByNatureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_CommitmentsAndContingenciesTable_bfe48700-6c7c-4684-8317-1d8422cd5eb8" xlink:to="loc_us-gaap_GainContingenciesByNatureAxis_e11264f0-66fc-45d1-ae5c-56fb241a052f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyNatureDomain_7e864c88-ebe5-40d3-8dbc-991ceb1ff70b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesByNatureAxis_e11264f0-66fc-45d1-ae5c-56fb241a052f" xlink:to="loc_us-gaap_GainContingencyNatureDomain_7e864c88-ebe5-40d3-8dbc-991ceb1ff70b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_PharmacypricingMember_e8bef918-0ba0-4acf-96ab-ba28a15298c1" xlink:href="elv-20220930.xsd#elv_PharmacypricingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingencyNatureDomain_7e864c88-ebe5-40d3-8dbc-991ceb1ff70b" xlink:to="loc_elv_PharmacypricingMember_e8bef918-0ba0-4acf-96ab-ba28a15298c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OperationalMember_a78e8d96-a328-4e30-8cfa-fd793555a806" xlink:href="elv-20220930.xsd#elv_OperationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingencyNatureDomain_7e864c88-ebe5-40d3-8dbc-991ceb1ff70b" xlink:to="loc_elv_OperationalMember_a78e8d96-a328-4e30-8cfa-fd793555a806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommitmentsAndContingenciesLineItems_26c04cc8-19b3-4729-a4e3-1f8a89e0554d" xlink:href="elv-20220930.xsd#elv_CommitmentsAndContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_CommitmentsAndContingenciesTable_bfe48700-6c7c-4684-8317-1d8422cd5eb8" xlink:to="loc_elv_CommitmentsAndContingenciesLineItems_26c04cc8-19b3-4729-a4e3-1f8a89e0554d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_5efbd83a-9506-47d4-a3e2-093c64fd283e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_CommitmentsAndContingenciesLineItems_26c04cc8-19b3-4729-a4e3-1f8a89e0554d" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_5efbd83a-9506-47d4-a3e2-093c64fd283e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_42a690d5-2c48-4ba3-b0eb-23f6d309a81a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_CommitmentsAndContingenciesLineItems_26c04cc8-19b3-4729-a4e3-1f8a89e0554d" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_42a690d5-2c48-4ba3-b0eb-23f6d309a81a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_291bea0b-aae5-4de5-9e3a-323a20869cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_CommitmentsAndContingenciesLineItems_26c04cc8-19b3-4729-a4e3-1f8a89e0554d" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_291bea0b-aae5-4de5-9e3a-323a20869cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GrossPremiumTaxRate_3a9a70da-91f3-4992-bb90-c21fe72ee699" xlink:href="elv-20220930.xsd#elv_GrossPremiumTaxRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_CommitmentsAndContingenciesLineItems_26c04cc8-19b3-4729-a4e3-1f8a89e0554d" xlink:to="loc_elv_GrossPremiumTaxRate_3a9a70da-91f3-4992-bb90-c21fe72ee699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_03ad3bfb-c004-484d-970e-ab0ab0e6af64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_CommitmentsAndContingenciesLineItems_26c04cc8-19b3-4729-a4e3-1f8a89e0554d" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_03ad3bfb-c004-484d-970e-ab0ab0e6af64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_bfddbc38-4b56-4a33-b772-3740741929ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_CommitmentsAndContingenciesLineItems_26c04cc8-19b3-4729-a4e3-1f8a89e0554d" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_bfddbc38-4b56-4a33-b772-3740741929ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount_58677f7a-9026-4afc-95db-73b1aa3fa2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_CommitmentsAndContingenciesLineItems_26c04cc8-19b3-4729-a4e3-1f8a89e0554d" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentAmount_58677f7a-9026-4afc-95db-73b1aa3fa2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/CapitalStock" xlink:type="simple" xlink:href="elv-20220930.xsd#CapitalStock"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/CapitalStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalAbstract_cc91c8d0-1c8e-4a62-96fe-ef29dc652799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6c59d734-d90f-43c2-b988-352fd73458ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_cc91c8d0-1c8e-4a62-96fe-ef29dc652799" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6c59d734-d90f-43c2-b988-352fd73458ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/CapitalStockTables" xlink:type="simple" xlink:href="elv-20220930.xsd#CapitalStockTables"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/CapitalStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalAbstract_e587d630-f9c5-4a90-b732-ec1dda665ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDeclaredTableTextBlock_c69e5907-381a-4af6-9a32-ef9a9c7364b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsDeclaredTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_e587d630-f9c5-4a90-b732-ec1dda665ef7" xlink:to="loc_us-gaap_DividendsDeclaredTableTextBlock_c69e5907-381a-4af6-9a32-ef9a9c7364b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_bd122911-aa41-412b-be39-58a2cbd6a599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_e587d630-f9c5-4a90-b732-ec1dda665ef7" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_bd122911-aa41-412b-be39-58a2cbd6a599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e065b429-0e50-42af-911d-bf60f32f558f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_e587d630-f9c5-4a90-b732-ec1dda665ef7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e065b429-0e50-42af-911d-bf60f32f558f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_cc98103f-773e-4353-8282-b2782ecd82b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_e587d630-f9c5-4a90-b732-ec1dda665ef7" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_cc98103f-773e-4353-8282-b2782ecd82b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_fcffa1a1-6f8c-479b-bffa-27ca8b0b44dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_e587d630-f9c5-4a90-b732-ec1dda665ef7" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_fcffa1a1-6f8c-479b-bffa-27ca8b0b44dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_952ba1dd-7e1e-413f-b014-0061aaeeef98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_e587d630-f9c5-4a90-b732-ec1dda665ef7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_952ba1dd-7e1e-413f-b014-0061aaeeef98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/CapitalStockSummaryofCashDividendActivityDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#CapitalStockSummaryofCashDividendActivityDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/CapitalStockSummaryofCashDividendActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalAbstract_a95933da-d6a2-4b2b-9238-a928188d13c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_d9170dd9-4ea3-44af-aef0-42a5fba40bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateDeclaredDayMonthAndYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_a95933da-d6a2-4b2b-9238-a928188d13c1" xlink:to="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_d9170dd9-4ea3-44af-aef0-42a5fba40bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_f2a06cdb-7c28-4014-a932-1040fc345da3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_a95933da-d6a2-4b2b-9238-a928188d13c1" xlink:to="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_f2a06cdb-7c28-4014-a932-1040fc345da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_36dbc349-baff-467b-bd3c-11b9c9f632cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_a95933da-d6a2-4b2b-9238-a928188d13c1" xlink:to="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_36dbc349-baff-467b-bd3c-11b9c9f632cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_99ac4102-4875-4e2a-bf46-aed5ee0362db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_a95933da-d6a2-4b2b-9238-a928188d13c1" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_99ac4102-4875-4e2a-bf46-aed5ee0362db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_fe902b31-3c4d-48c7-981f-d8e39f79e21c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_a95933da-d6a2-4b2b-9238-a928188d13c1" xlink:to="loc_us-gaap_PaymentsOfDividends_fe902b31-3c4d-48c7-981f-d8e39f79e21c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/CapitalStockSummaryofShareRepurchasesDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#CapitalStockSummaryofShareRepurchasesDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/CapitalStockSummaryofShareRepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalAbstract_7151950d-d8f3-4f55-8cf4-69145fc6c08a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_055bccf1-7ac7-4450-8855-cd540839c8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_7151950d-d8f3-4f55-8cf4-69145fc6c08a" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_055bccf1-7ac7-4450-8855-cd540839c8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_712ea047-08ae-4491-b98c-48267fa0dea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_055bccf1-7ac7-4450-8855-cd540839c8a5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_712ea047-08ae-4491-b98c-48267fa0dea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_061b5282-e96d-4afe-ac9c-9b9cb7085558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_712ea047-08ae-4491-b98c-48267fa0dea8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_061b5282-e96d-4afe-ac9c-9b9cb7085558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e30cbc44-2bbb-4d80-a759-869597c0749b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_061b5282-e96d-4afe-ac9c-9b9cb7085558" xlink:to="loc_us-gaap_SubsequentEventMember_e30cbc44-2bbb-4d80-a759-869597c0749b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b56d08b2-9025-4600-ad5d-ad85aa086fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_055bccf1-7ac7-4450-8855-cd540839c8a5" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b56d08b2-9025-4600-ad5d-ad85aa086fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f54617fb-ccd5-4d9b-9b91-675244a23d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b56d08b2-9025-4600-ad5d-ad85aa086fb6" xlink:to="loc_us-gaap_ClassOfStockDomain_f54617fb-ccd5-4d9b-9b91-675244a23d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_97105904-8700-40a2-9be2-9ca3c2cb3d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_055bccf1-7ac7-4450-8855-cd540839c8a5" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_97105904-8700-40a2-9be2-9ca3c2cb3d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_ffbf02a3-37ee-4f3e-8d36-6e3d7f619e92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_97105904-8700-40a2-9be2-9ca3c2cb3d96" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_ffbf02a3-37ee-4f3e-8d36-6e3d7f619e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_dc6f833a-84d8-41b8-9a5f-8a04f7f9dea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_055bccf1-7ac7-4450-8855-cd540839c8a5" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_dc6f833a-84d8-41b8-9a5f-8a04f7f9dea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_8af0e294-c093-4888-b02f-19b6131bbb3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_dc6f833a-84d8-41b8-9a5f-8a04f7f9dea4" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_8af0e294-c093-4888-b02f-19b6131bbb3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_StockRepurchasedAndRetiredDuringPeriodAveragePrice_68f33b50-cf11-49b1-8904-9a189059c7f8" xlink:href="elv-20220930.xsd#elv_StockRepurchasedAndRetiredDuringPeriodAveragePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_dc6f833a-84d8-41b8-9a5f-8a04f7f9dea4" xlink:to="loc_elv_StockRepurchasedAndRetiredDuringPeriodAveragePrice_68f33b50-cf11-49b1-8904-9a189059c7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_9bab3618-588b-4f5a-9f8f-b69bcd6d39de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_dc6f833a-84d8-41b8-9a5f-8a04f7f9dea4" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_9bab3618-588b-4f5a-9f8f-b69bcd6d39de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_791f0111-68b0-4772-8bd9-7eeda05fcc46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_dc6f833a-84d8-41b8-9a5f-8a04f7f9dea4" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_791f0111-68b0-4772-8bd9-7eeda05fcc46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/CapitalStockSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#CapitalStockSummaryofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/CapitalStockSummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalAbstract_76511466-ad7e-43f2-b356-2e6a374559ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8efc18a9-4802-4dc5-a23c-2997ce6af64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_76511466-ad7e-43f2-b356-2e6a374559ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8efc18a9-4802-4dc5-a23c-2997ce6af64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6899acd4-f133-4332-9fa5-ad5cbadcee15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8efc18a9-4802-4dc5-a23c-2997ce6af64e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6899acd4-f133-4332-9fa5-ad5cbadcee15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_2d8efa8f-b1d1-408c-be9c-9ca4183b0139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8efc18a9-4802-4dc5-a23c-2997ce6af64e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_2d8efa8f-b1d1-408c-be9c-9ca4183b0139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5c07fda6-531e-4760-a592-ada05a4daeab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8efc18a9-4802-4dc5-a23c-2997ce6af64e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5c07fda6-531e-4760-a592-ada05a4daeab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_ef5e02ac-69e7-49d3-ba8c-e94ebaf271e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8efc18a9-4802-4dc5-a23c-2997ce6af64e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_ef5e02ac-69e7-49d3-ba8c-e94ebaf271e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a504e739-9ebb-42be-9fe0-9a46aa75b287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8efc18a9-4802-4dc5-a23c-2997ce6af64e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a504e739-9ebb-42be-9fe0-9a46aa75b287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_3d5ec3c6-fd90-472a-8138-f504215961f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_76511466-ad7e-43f2-b356-2e6a374559ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_3d5ec3c6-fd90-472a-8138-f504215961f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_fd421528-be2f-4792-a5c8-8ecd64248ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_76511466-ad7e-43f2-b356-2e6a374559ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_fd421528-be2f-4792-a5c8-8ecd64248ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3994284d-97e6-4000-b3ba-0a27cbb210e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_fd421528-be2f-4792-a5c8-8ecd64248ba7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3994284d-97e6-4000-b3ba-0a27cbb210e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_cd320607-d964-4f44-8bc1-d3d794f66dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_fd421528-be2f-4792-a5c8-8ecd64248ba7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_cd320607-d964-4f44-8bc1-d3d794f66dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_7ec94e71-1449-43aa-b10d-1649c965105e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_fd421528-be2f-4792-a5c8-8ecd64248ba7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_7ec94e71-1449-43aa-b10d-1649c965105e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_5b809148-691a-4ade-b839-63791e1ef067" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_fd421528-be2f-4792-a5c8-8ecd64248ba7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_5b809148-691a-4ade-b839-63791e1ef067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3e918bae-6b95-4eb7-b493-62b582bf8de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_fd421528-be2f-4792-a5c8-8ecd64248ba7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3e918bae-6b95-4eb7-b493-62b582bf8de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a1fe25af-fc12-46d2-9aef-c18aadcb750b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_76511466-ad7e-43f2-b356-2e6a374559ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a1fe25af-fc12-46d2-9aef-c18aadcb750b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0b6b1827-675d-4aa1-9475-516e69da7799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_76511466-ad7e-43f2-b356-2e6a374559ec" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0b6b1827-675d-4aa1-9475-516e69da7799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_9dd94b19-b6d4-4dbc-92f1-e195c6b59d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_76511466-ad7e-43f2-b356-2e6a374559ec" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_9dd94b19-b6d4-4dbc-92f1-e195c6b59d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c4299b4f-fcec-44df-95f5-51d09d7d3fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_76511466-ad7e-43f2-b356-2e6a374559ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c4299b4f-fcec-44df-95f5-51d09d7d3fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_969bff6a-a13e-4c83-a469-427f72683f49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_76511466-ad7e-43f2-b356-2e6a374559ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_969bff6a-a13e-4c83-a469-427f72683f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/CapitalStockNonvestedRestrictedStockActivityIncludingRestrictedStockUnitsDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#CapitalStockNonvestedRestrictedStockActivityIncludingRestrictedStockUnitsDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/CapitalStockNonvestedRestrictedStockActivityIncludingRestrictedStockUnitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalAbstract_179501f6-5cc0-48b1-9677-69c33c961f77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_39c0a67c-7ec2-4662-9f32-cc856674625d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_179501f6-5cc0-48b1-9677-69c33c961f77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_39c0a67c-7ec2-4662-9f32-cc856674625d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7a02f22a-d25b-4b7d-a09b-52dfbf246c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_39c0a67c-7ec2-4662-9f32-cc856674625d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7a02f22a-d25b-4b7d-a09b-52dfbf246c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_aabfe2da-255c-4ae3-b935-eaa874c5d3e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_39c0a67c-7ec2-4662-9f32-cc856674625d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_aabfe2da-255c-4ae3-b935-eaa874c5d3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_bcb80abf-48bb-4873-988f-5b46edf4913e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_39c0a67c-7ec2-4662-9f32-cc856674625d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_bcb80abf-48bb-4873-988f-5b46edf4913e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9135d504-a2da-4512-8523-dbaedbb6733e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_39c0a67c-7ec2-4662-9f32-cc856674625d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9135d504-a2da-4512-8523-dbaedbb6733e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_385c7200-ff21-4886-bd4f-77c368e344a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_39c0a67c-7ec2-4662-9f32-cc856674625d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_385c7200-ff21-4886-bd4f-77c368e344a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_21b906ee-1093-43d6-8de8-1a273753f3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_179501f6-5cc0-48b1-9677-69c33c961f77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_21b906ee-1093-43d6-8de8-1a273753f3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e7b48124-667b-4d56-b44f-dce681b5743e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_21b906ee-1093-43d6-8de8-1a273753f3d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e7b48124-667b-4d56-b44f-dce681b5743e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_90662ea6-94a2-41df-97cc-1a275de879e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_21b906ee-1093-43d6-8de8-1a273753f3d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_90662ea6-94a2-41df-97cc-1a275de879e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_7a9d79fa-0c56-4717-9b9c-fe1a96260cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_21b906ee-1093-43d6-8de8-1a273753f3d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_7a9d79fa-0c56-4717-9b9c-fe1a96260cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d8cdda4b-4b3a-45c3-bef6-f1b6b594d6ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_21b906ee-1093-43d6-8de8-1a273753f3d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d8cdda4b-4b3a-45c3-bef6-f1b6b594d6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_362b538c-6e40-46ec-a09d-f0f27596e229" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_21b906ee-1093-43d6-8de8-1a273753f3d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_362b538c-6e40-46ec-a09d-f0f27596e229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/CapitalStockFairValuesofOptionsGrantedDuringThePeriodEstimatedUsingWeightedAverageAssumptionsDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#CapitalStockFairValuesofOptionsGrantedDuringThePeriodEstimatedUsingWeightedAverageAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/CapitalStockFairValuesofOptionsGrantedDuringThePeriodEstimatedUsingWeightedAverageAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalAbstract_a8820493-af62-41ef-952b-1e9945247b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0da8cc23-bd47-402b-a045-5f8ea722070f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_a8820493-af62-41ef-952b-1e9945247b8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0da8cc23-bd47-402b-a045-5f8ea722070f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_5f43f70f-e952-418a-a300-548d5026fef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_a8820493-af62-41ef-952b-1e9945247b8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_5f43f70f-e952-418a-a300-548d5026fef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6ac27b64-9bf2-46a6-ba0e-179eb019dae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_a8820493-af62-41ef-952b-1e9945247b8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6ac27b64-9bf2-46a6-ba0e-179eb019dae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1515f2b3-9633-4d50-baa8-1d1f3dc5f204" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_a8820493-af62-41ef-952b-1e9945247b8b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1515f2b3-9633-4d50-baa8-1d1f3dc5f204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/CapitalStockScheduleOfWeightedAverageFairValuesDeterminedForThePeriodsDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#CapitalStockScheduleOfWeightedAverageFairValuesDeterminedForThePeriodsDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/CapitalStockScheduleOfWeightedAverageFairValuesDeterminedForThePeriodsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalAbstract_eb015ac2-1c1b-4a81-85e6-d68b4477bff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_582205f5-aba3-4d9a-abe6-c954c172c084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_eb015ac2-1c1b-4a81-85e6-d68b4477bff3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_582205f5-aba3-4d9a-abe6-c954c172c084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f168fc04-2fda-4069-b99e-ad5ed0cf84a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_eb015ac2-1c1b-4a81-85e6-d68b4477bff3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f168fc04-2fda-4069-b99e-ad5ed0cf84a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/CapitalStockNarrativeDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#CapitalStockNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/CapitalStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalAbstract_2cfc0c19-4632-4515-befc-80918bf12c56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_c4478cea-536d-4a33-b477-9a54c3cb5ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalAbstract_2cfc0c19-4632-4515-befc-80918bf12c56" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_c4478cea-536d-4a33-b477-9a54c3cb5ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_PerformancemeasurementperiodAxis_dcee94c3-0ad9-442d-a19a-31e17a2eeafb" xlink:href="elv-20220930.xsd#elv_PerformancemeasurementperiodAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_c4478cea-536d-4a33-b477-9a54c3cb5ecc" xlink:to="loc_elv_PerformancemeasurementperiodAxis_dcee94c3-0ad9-442d-a19a-31e17a2eeafb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_PerformanceMeasurementPeriodDomain_e670e2c7-6b7c-476e-9af1-0792ad768d20" xlink:href="elv-20220930.xsd#elv_PerformanceMeasurementPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_PerformancemeasurementperiodAxis_dcee94c3-0ad9-442d-a19a-31e17a2eeafb" xlink:to="loc_elv_PerformanceMeasurementPeriodDomain_e670e2c7-6b7c-476e-9af1-0792ad768d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_A2022To2024Member_887a2fa0-8ffd-4583-abd8-6ea143d8451c" xlink:href="elv-20220930.xsd#elv_A2022To2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_PerformanceMeasurementPeriodDomain_e670e2c7-6b7c-476e-9af1-0792ad768d20" xlink:to="loc_elv_A2022To2024Member_887a2fa0-8ffd-4583-abd8-6ea143d8451c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_74970312-b96c-4c91-8bdb-09b922000388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_c4478cea-536d-4a33-b477-9a54c3cb5ecc" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_74970312-b96c-4c91-8bdb-09b922000388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a8795ac1-cb74-4558-bc1a-f7bcf692125c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_74970312-b96c-4c91-8bdb-09b922000388" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a8795ac1-cb74-4558-bc1a-f7bcf692125c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_98749011-6274-4545-950d-06a0079e1144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a8795ac1-cb74-4558-bc1a-f7bcf692125c" xlink:to="loc_us-gaap_SubsequentEventMember_98749011-6274-4545-950d-06a0079e1144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ecf07c51-d6f3-4c23-840d-4a0bfbcfc59f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_c4478cea-536d-4a33-b477-9a54c3cb5ecc" xlink:to="loc_us-gaap_DebtInstrumentAxis_ecf07c51-d6f3-4c23-840d-4a0bfbcfc59f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ab9a7d64-9311-4ea5-aedb-42e72312501d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ecf07c51-d6f3-4c23-840d-4a0bfbcfc59f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ab9a7d64-9311-4ea5-aedb-42e72312501d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_74864c2c-7ce1-4559-9b05-1018ac0f9e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_c4478cea-536d-4a33-b477-9a54c3cb5ecc" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_74864c2c-7ce1-4559-9b05-1018ac0f9e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2ec4097f-e380-4f46-a7d9-9ddde792163b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_74864c2c-7ce1-4559-9b05-1018ac0f9e1b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2ec4097f-e380-4f46-a7d9-9ddde792163b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_6c33de8b-2721-4584-b7d5-82988cb34150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_c4478cea-536d-4a33-b477-9a54c3cb5ecc" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_6c33de8b-2721-4584-b7d5-82988cb34150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_c50a3a49-fa20-4c5d-8e03-d4708df14550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_6c33de8b-2721-4584-b7d5-82988cb34150" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_c50a3a49-fa20-4c5d-8e03-d4708df14550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_d641abad-fa5d-4539-a078-9bf84169a83e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_c4478cea-536d-4a33-b477-9a54c3cb5ecc" xlink:to="loc_us-gaap_PositionAxis_d641abad-fa5d-4539-a078-9bf84169a83e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_d6f54feb-635b-4356-be13-d2da662d9a84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_d641abad-fa5d-4539-a078-9bf84169a83e" xlink:to="loc_us-gaap_PositionDomain_d6f54feb-635b-4356-be13-d2da662d9a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3fde2f4f-2a3d-4d48-a845-8c38829da9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_c4478cea-536d-4a33-b477-9a54c3cb5ecc" xlink:to="loc_us-gaap_AwardTypeAxis_3fde2f4f-2a3d-4d48-a845-8c38829da9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_26e53a20-30b9-4f5f-9d35-b35ad6b24b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3fde2f4f-2a3d-4d48-a845-8c38829da9c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_26e53a20-30b9-4f5f-9d35-b35ad6b24b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_bd3ee45c-48e1-41ec-b06d-a107f9b9cc83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_26e53a20-30b9-4f5f-9d35-b35ad6b24b0f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_bd3ee45c-48e1-41ec-b06d-a107f9b9cc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_06dd5f1d-9b6e-4aac-9204-1cfa6c195eee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_c4478cea-536d-4a33-b477-9a54c3cb5ecc" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_06dd5f1d-9b6e-4aac-9204-1cfa6c195eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b1097883-579d-47b6-aa4b-466255229422" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_06dd5f1d-9b6e-4aac-9204-1cfa6c195eee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b1097883-579d-47b6-aa4b-466255229422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_98ce308e-d06d-48b4-9b15-04ee2b2921bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_06dd5f1d-9b6e-4aac-9204-1cfa6c195eee" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_98ce308e-d06d-48b4-9b15-04ee2b2921bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_d92ec6a0-9707-49c5-be69-565b18ea7d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_06dd5f1d-9b6e-4aac-9204-1cfa6c195eee" xlink:to="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_d92ec6a0-9707-49c5-be69-565b18ea7d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_6c1fa8d0-eb11-4d20-af4b-241afeaf769e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_06dd5f1d-9b6e-4aac-9204-1cfa6c195eee" xlink:to="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_6c1fa8d0-eb11-4d20-af4b-241afeaf769e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IncreaseInStockRepurchaseProgramAuthorization_3ea368d9-aacb-4629-82b0-b0f557d11416" xlink:href="elv-20220930.xsd#elv_IncreaseInStockRepurchaseProgramAuthorization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_06dd5f1d-9b6e-4aac-9204-1cfa6c195eee" xlink:to="loc_elv_IncreaseInStockRepurchaseProgramAuthorization_3ea368d9-aacb-4629-82b0-b0f557d11416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="elv-20220930.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_79819837-fa41-4d1e-967d-4436c257887c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_95d09d1a-5ff5-4b49-ab58-c9a57bf86bae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_79819837-fa41-4d1e-967d-4436c257887c" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_95d09d1a-5ff5-4b49-ab58-c9a57bf86bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="elv-20220930.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_c18a2076-062d-4a3d-ba58-5d4eee4fcdf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_9bd9af89-f41c-47df-a738-c7e3214ab266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_c18a2076-062d-4a3d-ba58-5d4eee4fcdf1" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_9bd9af89-f41c-47df-a738-c7e3214ab266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_7e70a80e-6192-4ccb-b8c8-de621d7126fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a23afd70-28f1-415e-bae7-028778bcfbf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_7e70a80e-6192-4ccb-b8c8-de621d7126fa" xlink:to="loc_us-gaap_StatementTable_a23afd70-28f1-415e-bae7-028778bcfbf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_93238a19-2fec-4f2a-b5a8-a9f0a6a57fff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a23afd70-28f1-415e-bae7-028778bcfbf6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_93238a19-2fec-4f2a-b5a8-a9f0a6a57fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_52f65eba-636a-47d2-8524-5017a160f800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_93238a19-2fec-4f2a-b5a8-a9f0a6a57fff" xlink:to="loc_us-gaap_EquityComponentDomain_52f65eba-636a-47d2-8524-5017a160f800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_87244f78-65a2-48a7-9372-6dc0ec8cee18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_52f65eba-636a-47d2-8524-5017a160f800" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_87244f78-65a2-48a7-9372-6dc0ec8cee18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_NonCreditComponentsOfImpairmentsOnInvestmentsMember_ceec4514-a25d-48df-88ae-630df8203fc3" xlink:href="elv-20220930.xsd#elv_NonCreditComponentsOfImpairmentsOnInvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_52f65eba-636a-47d2-8524-5017a160f800" xlink:to="loc_elv_NonCreditComponentsOfImpairmentsOnInvestmentsMember_ceec4514-a25d-48df-88ae-630df8203fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_0f30d0c8-6b71-45d7-b6b1-c5734cf5ca04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_52f65eba-636a-47d2-8524-5017a160f800" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_0f30d0c8-6b71-45d7-b6b1-c5734cf5ca04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_5d70240c-6bdc-4739-9b74-17764aa5e55d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_52f65eba-636a-47d2-8524-5017a160f800" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_5d70240c-6bdc-4739-9b74-17764aa5e55d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_00626606-98b4-4978-aff8-9991effd8796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_52f65eba-636a-47d2-8524-5017a160f800" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_00626606-98b4-4978-aff8-9991effd8796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a23afd70-28f1-415e-bae7-028778bcfbf6" xlink:to="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c544a9ec-bcc5-4f49-bc12-b6e52a0ee83b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c544a9ec-bcc5-4f49-bc12-b6e52a0ee83b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_692d6005-dd83-4466-a078-96f4f5d36c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_692d6005-dd83-4466-a078-96f4f5d36c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4de42af0-9569-4df0-9653-4051a42d5f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4de42af0-9569-4df0-9653-4051a42d5f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_8a54b1b4-88dd-4c26-aa03-2687b5d84a64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_8a54b1b4-88dd-4c26-aa03-2687b5d84a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_c5f9bd5d-d28e-405e-9136-ae28b3569f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_c5f9bd5d-d28e-405e-9136-ae28b3569f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_fea4d5ed-dff0-49c4-b0f6-bea4a6de35b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_fea4d5ed-dff0-49c4-b0f6-bea4a6de35b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_669a3633-4db4-41ff-aa0f-aee048242fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_669a3633-4db4-41ff-aa0f-aee048242fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax_e558493a-a8aa-4f61-8767-51231d72ae6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax_e558493a-a8aa-4f61-8767-51231d72ae6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_af13b640-a61d-4925-b887-f888dbd2f950" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_af13b640-a61d-4925-b887-f888dbd2f950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities_b617e3ee-babf-4009-bfa4-e7ddd733a36e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities_b617e3ee-babf-4009-bfa4-e7ddd733a36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities_f40f5cf5-00bd-41d8-b8dc-4823165b3928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities_f40f5cf5-00bd-41d8-b8dc-4823165b3928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities_1f261762-ad12-4db2-ad9c-6ac1ef921bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities_1f261762-ad12-4db2-ad9c-6ac1ef921bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss_6c5a70f0-1139-4bef-8f49-0e516235d002" xlink:href="elv-20220930.xsd#elv_Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_elv_Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss_6c5a70f0-1139-4bef-8f49-0e516235d002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_14de35ee-31bd-44a5-88c6-3dcc125aad66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_14de35ee-31bd-44a5-88c6-3dcc125aad66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b7021d71-492b-430f-a144-249f852afad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b7021d71-492b-430f-a144-249f852afad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_7388082f-301e-4dc8-8b50-cca108698cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_7388082f-301e-4dc8-8b50-cca108698cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_a9bd63ca-609a-47da-a203-8a4dd58b5ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_a9bd63ca-609a-47da-a203-8a4dd58b5ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_bc5fcd04-566a-4c31-ba71-d62b8dce2178" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_bc5fcd04-566a-4c31-ba71-d62b8dce2178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_b0582cbf-0e13-45b3-930c-0ff382d85c88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_b0582cbf-0e13-45b3-930c-0ff382d85c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_b725e8a4-1efa-4d38-aaa8-41b96ce08b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_b725e8a4-1efa-4d38-aaa8-41b96ce08b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense_a75197ed-60ca-4d3e-bea9-6cab17c019c5" xlink:href="elv-20220930.xsd#elv_OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_elv_OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense_a75197ed-60ca-4d3e-bea9-6cab17c019c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_6a9cb808-f0d2-49bd-b1e2-a327ff5533ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_6a9cb808-f0d2-49bd-b1e2-a327ff5533ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_080f8ee0-d973-4cbf-8ef7-3f0956b19cac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_080f8ee0-d973-4cbf-8ef7-3f0956b19cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_fd741b6d-c152-458e-b436-11395b2d0644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_fd741b6d-c152-458e-b436-11395b2d0644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_a500c8e5-11f1-4e33-b41c-02023bb5c612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_a500c8e5-11f1-4e33-b41c-02023bb5c612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9536678e-3ddf-4901-b16c-ae093b4d90d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9536678e-3ddf-4901-b16c-ae093b4d90d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_da03e171-37d1-4bfa-9881-7aeb05571216" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_da03e171-37d1-4bfa-9881-7aeb05571216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_bda8ea83-8ac9-4f26-a97e-0d91542fe5e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_bda8ea83-8ac9-4f26-a97e-0d91542fe5e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest_d5188fd8-44d0-4550-b990-da2fb2ab8137" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd7cab7c-0bfa-4c37-873e-c02634819cb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest_d5188fd8-44d0-4550-b990-da2fb2ab8137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EarningsPerShare" xlink:type="simple" xlink:href="elv-20220930.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_748180c4-f93b-4a04-b3c5-22bff7f26253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_859e77b5-735e-470f-8d56-6d6390b3bc73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_748180c4-f93b-4a04-b3c5-22bff7f26253" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_859e77b5-735e-470f-8d56-6d6390b3bc73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="elv-20220930.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_df55da41-1ab2-4cba-95e2-2c0a96558e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9a8e8f47-011f-4af5-a864-d5b8d2fb0264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_df55da41-1ab2-4cba-95e2-2c0a96558e63" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9a8e8f47-011f-4af5-a864-d5b8d2fb0264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EarningsPerShareDenominatorForBasicAndDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#EarningsPerShareDenominatorForBasicAndDilutedEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/EarningsPerShareDenominatorForBasicAndDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_63c7aeb0-ac19-44bb-87dc-035f07637f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ccfdb11d-6c2e-415f-89dd-0bc49cc050ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_63c7aeb0-ac19-44bb-87dc-035f07637f06" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ccfdb11d-6c2e-415f-89dd-0bc49cc050ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_f4a57d34-8385-42ca-b2b5-aab512106686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_63c7aeb0-ac19-44bb-87dc-035f07637f06" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_f4a57d34-8385-42ca-b2b5-aab512106686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_26d6862c-285f-43c5-968c-9c81119bf413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_63c7aeb0-ac19-44bb-87dc-035f07637f06" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_26d6862c-285f-43c5-968c-9c81119bf413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EarningsPerShareNarrativeDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#EarningsPerShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/EarningsPerShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5ae8baf3-18f7-4b92-a287-77798b32f9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_fce207f5-7e56-4002-9e5c-fc24072c63f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5ae8baf3-18f7-4b92-a287-77798b32f9d5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_fce207f5-7e56-4002-9e5c-fc24072c63f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d786fa16-9ccf-430c-8253-99e09e5160a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5ae8baf3-18f7-4b92-a287-77798b32f9d5" xlink:to="loc_us-gaap_StatementTable_d786fa16-9ccf-430c-8253-99e09e5160a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_PerformancemeasurementperiodAxis_3745b151-3595-42d6-8805-59b27142f54f" xlink:href="elv-20220930.xsd#elv_PerformancemeasurementperiodAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d786fa16-9ccf-430c-8253-99e09e5160a5" xlink:to="loc_elv_PerformancemeasurementperiodAxis_3745b151-3595-42d6-8805-59b27142f54f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_PerformanceMeasurementPeriodDomain_038ec4fa-955f-4889-a40a-299124d63304" xlink:href="elv-20220930.xsd#elv_PerformanceMeasurementPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_PerformancemeasurementperiodAxis_3745b151-3595-42d6-8805-59b27142f54f" xlink:to="loc_elv_PerformanceMeasurementPeriodDomain_038ec4fa-955f-4889-a40a-299124d63304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_A2022To2024Member_f2b95082-d978-490e-af74-d3e2ea8e54de" xlink:href="elv-20220930.xsd#elv_A2022To2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_PerformanceMeasurementPeriodDomain_038ec4fa-955f-4889-a40a-299124d63304" xlink:to="loc_elv_A2022To2024Member_f2b95082-d978-490e-af74-d3e2ea8e54de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_A2021To2023Member_aaf4fe9f-2971-4628-955c-b52649618bc0" xlink:href="elv-20220930.xsd#elv_A2021To2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_PerformanceMeasurementPeriodDomain_038ec4fa-955f-4889-a40a-299124d63304" xlink:to="loc_elv_A2021To2023Member_aaf4fe9f-2971-4628-955c-b52649618bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ab614b42-baaa-40ad-8d74-10baaca32cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d786fa16-9ccf-430c-8253-99e09e5160a5" xlink:to="loc_us-gaap_StatementLineItems_ab614b42-baaa-40ad-8d74-10baaca32cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_64acac35-22bb-4002-aec9-02a1438cc7ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ab614b42-baaa-40ad-8d74-10baaca32cec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_64acac35-22bb-4002-aec9-02a1438cc7ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults_049a76e2-754c-449e-a74f-e8706a92e101" xlink:href="elv-20220930.xsd#elv_PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ab614b42-baaa-40ad-8d74-10baaca32cec" xlink:to="loc_elv_PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults_049a76e2-754c-449e-a74f-e8706a92e101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/SegmentInformation" xlink:type="simple" xlink:href="elv-20220930.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_70075775-7723-4043-bfc1-c447e9aea343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_bf4c21ac-4c69-40d1-a64f-8e6ee5a04ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_70075775-7723-4043-bfc1-c447e9aea343" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_bf4c21ac-4c69-40d1-a64f-8e6ee5a04ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="elv-20220930.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bdb823ce-bbe4-4f95-ada3-929bd73b1403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_e19a36e1-398f-4e02-8633-748419df8f09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bdb823ce-bbe4-4f95-ada3-929bd73b1403" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_e19a36e1-398f-4e02-8633-748419df8f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_MajorProductRevenueBySegmentTableTextBlock_e99e81fa-9a79-490f-b992-5611660b43f0" xlink:href="elv-20220930.xsd#elv_MajorProductRevenueBySegmentTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bdb823ce-bbe4-4f95-ada3-929bd73b1403" xlink:to="loc_elv_MajorProductRevenueBySegmentTableTextBlock_e99e81fa-9a79-490f-b992-5611660b43f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_7252f232-425b-481e-b1d9-291aa0e6ee00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bdb823ce-bbe4-4f95-ada3-929bd73b1403" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_7252f232-425b-481e-b1d9-291aa0e6ee00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_6f215f43-426a-4ef6-9026-03e8c9b62a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bdb823ce-bbe4-4f95-ada3-929bd73b1403" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_6f215f43-426a-4ef6-9026-03e8c9b62a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#SegmentInformationFinancialDataByReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_49340cf8-fcaf-49f9-9928-eb34d5baf80d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_31af6364-840a-438a-815c-60acff20f8ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_49340cf8-fcaf-49f9-9928-eb34d5baf80d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_31af6364-840a-438a-815c-60acff20f8ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_a13e822e-f3f9-4145-9d93-b05a4b774e00" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_31af6364-840a-438a-815c-60acff20f8ad" xlink:to="loc_srt_MajorCustomersAxis_a13e822e-f3f9-4145-9d93-b05a4b774e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_1cfda6ff-74a2-41da-bf13-9bede8c5514c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_a13e822e-f3f9-4145-9d93-b05a4b774e00" xlink:to="loc_srt_NameOfMajorCustomerDomain_1cfda6ff-74a2-41da-bf13-9bede8c5514c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_UnaffiliatedMember_e7869bec-637e-4068-83e6-e5d7a4276f20" xlink:href="elv-20220930.xsd#elv_UnaffiliatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_1cfda6ff-74a2-41da-bf13-9bede8c5514c" xlink:to="loc_elv_UnaffiliatedMember_e7869bec-637e-4068-83e6-e5d7a4276f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_AffiliatedMember_865b0e4f-b90d-44d2-9d26-effc0e457d95" xlink:href="elv-20220930.xsd#elv_AffiliatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_1cfda6ff-74a2-41da-bf13-9bede8c5514c" xlink:to="loc_elv_AffiliatedMember_865b0e4f-b90d-44d2-9d26-effc0e457d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_0e7d4f94-59c1-478c-bd02-a5fed193bd0b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_31af6364-840a-438a-815c-60acff20f8ad" xlink:to="loc_srt_ConsolidatedEntitiesAxis_0e7d4f94-59c1-478c-bd02-a5fed193bd0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_f0268e55-99dd-43ee-be20-7a2c701adb4b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_0e7d4f94-59c1-478c-bd02-a5fed193bd0b" xlink:to="loc_srt_ConsolidatedEntitiesDomain_f0268e55-99dd-43ee-be20-7a2c701adb4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommercialSpecialtyMember_8aa81326-a68c-4930-9b74-786e18627aae" xlink:href="elv-20220930.xsd#elv_CommercialSpecialtyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_f0268e55-99dd-43ee-be20-7a2c701adb4b" xlink:to="loc_elv_CommercialSpecialtyMember_8aa81326-a68c-4930-9b74-786e18627aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GovernmentBusinessSegmentMember_d6c2163f-47a1-4c93-b050-70f7f252b795" xlink:href="elv-20220930.xsd#elv_GovernmentBusinessSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_f0268e55-99dd-43ee-be20-7a2c701adb4b" xlink:to="loc_elv_GovernmentBusinessSegmentMember_d6c2163f-47a1-4c93-b050-70f7f252b795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IngenioRxSegmentMember_fa0e1e2c-acab-470a-b46d-924afcdd48a2" xlink:href="elv-20220930.xsd#elv_IngenioRxSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_f0268e55-99dd-43ee-be20-7a2c701adb4b" xlink:to="loc_elv_IngenioRxSegmentMember_fa0e1e2c-acab-470a-b46d-924afcdd48a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherSegmentMember_944a7c65-6407-40e9-b2cf-7ccf4024d689" xlink:href="elv-20220930.xsd#elv_OtherSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_f0268e55-99dd-43ee-be20-7a2c701adb4b" xlink:to="loc_elv_OtherSegmentMember_944a7c65-6407-40e9-b2cf-7ccf4024d689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_c8a9ab73-2b18-4f1c-aa63-0193cb38cc31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_f0268e55-99dd-43ee-be20-7a2c701adb4b" xlink:to="loc_us-gaap_IntersegmentEliminationMember_c8a9ab73-2b18-4f1c-aa63-0193cb38cc31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d3538254-37ab-4901-8b4a-cf24c2c7ab3b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_31af6364-840a-438a-815c-60acff20f8ad" xlink:to="loc_srt_ProductOrServiceAxis_d3538254-37ab-4901-8b4a-cf24c2c7ab3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2c7d6e4e-b4a2-43ef-8c24-a1ef684b7e6b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_d3538254-37ab-4901-8b4a-cf24c2c7ab3b" xlink:to="loc_srt_ProductsAndServicesDomain_2c7d6e4e-b4a2-43ef-8c24-a1ef684b7e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommercialSpecialtyMember_ff5a4ee0-6e1d-44ec-a107-fab57844e5b5" xlink:href="elv-20220930.xsd#elv_CommercialSpecialtyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2c7d6e4e-b4a2-43ef-8c24-a1ef684b7e6b" xlink:to="loc_elv_CommercialSpecialtyMember_ff5a4ee0-6e1d-44ec-a107-fab57844e5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GovernmentBusinessSegmentMember_c037a3c6-b797-4ca8-acd0-7c00361e5251" xlink:href="elv-20220930.xsd#elv_GovernmentBusinessSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2c7d6e4e-b4a2-43ef-8c24-a1ef684b7e6b" xlink:to="loc_elv_GovernmentBusinessSegmentMember_c037a3c6-b797-4ca8-acd0-7c00361e5251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IngenioRxSegmentMember_61575e8d-9361-4e2a-abe7-0c3a5d45f900" xlink:href="elv-20220930.xsd#elv_IngenioRxSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2c7d6e4e-b4a2-43ef-8c24-a1ef684b7e6b" xlink:to="loc_elv_IngenioRxSegmentMember_61575e8d-9361-4e2a-abe7-0c3a5d45f900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherSegmentMember_4f91e1cf-3df3-4e56-a730-8f638d5fa7a0" xlink:href="elv-20220930.xsd#elv_OtherSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2c7d6e4e-b4a2-43ef-8c24-a1ef684b7e6b" xlink:to="loc_elv_OtherSegmentMember_4f91e1cf-3df3-4e56-a730-8f638d5fa7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_4723fa7f-c328-4c96-8567-0ca0bfc3cefd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_31af6364-840a-438a-815c-60acff20f8ad" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_4723fa7f-c328-4c96-8567-0ca0bfc3cefd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceServicesRevenue_5b4c7bf1-48ef-4a0d-a91d-a04fc9162a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceServicesRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4723fa7f-c328-4c96-8567-0ca0bfc3cefd" xlink:to="loc_us-gaap_InsuranceServicesRevenue_5b4c7bf1-48ef-4a0d-a91d-a04fc9162a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_eee995ea-349c-4b4f-8d40-be0ffc8bffe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4723fa7f-c328-4c96-8567-0ca0bfc3cefd" xlink:to="loc_us-gaap_OperatingIncomeLoss_eee995ea-349c-4b4f-8d40-be0ffc8bffe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_94ffd6a4-dcbe-421a-a1e9-b677cebe0dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_MajorProductRevenueBySegmentTable_cfd654f2-3651-42a3-958d-881ad35343a3" xlink:href="elv-20220930.xsd#elv_MajorProductRevenueBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_94ffd6a4-dcbe-421a-a1e9-b677cebe0dd4" xlink:to="loc_elv_MajorProductRevenueBySegmentTable_cfd654f2-3651-42a3-958d-881ad35343a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3a124dc6-1d93-4df9-b9bb-7dea6883a5b2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_MajorProductRevenueBySegmentTable_cfd654f2-3651-42a3-958d-881ad35343a3" xlink:to="loc_srt_ProductOrServiceAxis_3a124dc6-1d93-4df9-b9bb-7dea6883a5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_50fef059-533e-48c3-b703-2d9e8509fd09" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_3a124dc6-1d93-4df9-b9bb-7dea6883a5b2" xlink:to="loc_srt_ProductsAndServicesDomain_50fef059-533e-48c3-b703-2d9e8509fd09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ManagedCareProductsMember_30b47000-1cf1-46ce-950a-543af826999c" xlink:href="elv-20220930.xsd#elv_ManagedCareProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_50fef059-533e-48c3-b703-2d9e8509fd09" xlink:to="loc_elv_ManagedCareProductsMember_30b47000-1cf1-46ce-950a-543af826999c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_ManagedCareServicesMember_ffca0060-7cfc-455e-b380-886a32a7e9fb" xlink:href="elv-20220930.xsd#elv_ManagedCareServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_50fef059-533e-48c3-b703-2d9e8509fd09" xlink:to="loc_elv_ManagedCareServicesMember_ffca0060-7cfc-455e-b380-886a32a7e9fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_DentalVisionProductsAndServicesMember_89149e65-56e7-4a2a-bfc2-895be2623db9" xlink:href="elv-20220930.xsd#elv_DentalVisionProductsAndServicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_50fef059-533e-48c3-b703-2d9e8509fd09" xlink:to="loc_elv_DentalVisionProductsAndServicesMember_89149e65-56e7-4a2a-bfc2-895be2623db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherProductsMember_d06f0a3e-213f-422f-b738-ed203dde07b4" xlink:href="elv-20220930.xsd#elv_OtherProductsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_50fef059-533e-48c3-b703-2d9e8509fd09" xlink:to="loc_elv_OtherProductsMember_d06f0a3e-213f-422f-b738-ed203dde07b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_PharmacyproductsandservicesMember_c0226028-efbe-4d27-b448-87a2033dca41" xlink:href="elv-20220930.xsd#elv_PharmacyproductsandservicesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_50fef059-533e-48c3-b703-2d9e8509fd09" xlink:to="loc_elv_PharmacyproductsandservicesMember_c0226028-efbe-4d27-b448-87a2033dca41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IntegratedHealthServicesMember_69c91b2e-f820-45a9-a39f-8cbf86db0455" xlink:href="elv-20220930.xsd#elv_IntegratedHealthServicesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_50fef059-533e-48c3-b703-2d9e8509fd09" xlink:to="loc_elv_IntegratedHealthServicesMember_69c91b2e-f820-45a9-a39f-8cbf86db0455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c266b844-3b6d-49a7-a091-5a54bb440af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_MajorProductRevenueBySegmentTable_cfd654f2-3651-42a3-958d-881ad35343a3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c266b844-3b6d-49a7-a091-5a54bb440af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fe639378-0199-4ea0-aae7-bc9a7483db8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c266b844-3b6d-49a7-a091-5a54bb440af0" xlink:to="loc_us-gaap_SegmentDomain_fe639378-0199-4ea0-aae7-bc9a7483db8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommercialSpecialtyBusinessSegmentMember_3207e427-da9f-45be-9e53-077650e3fd09" xlink:href="elv-20220930.xsd#elv_CommercialSpecialtyBusinessSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fe639378-0199-4ea0-aae7-bc9a7483db8d" xlink:to="loc_elv_CommercialSpecialtyBusinessSegmentMember_3207e427-da9f-45be-9e53-077650e3fd09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GovernmentBusinessSegmentMember_efcff626-37c7-4311-a83b-b5b2c6a04e06" xlink:href="elv-20220930.xsd#elv_GovernmentBusinessSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fe639378-0199-4ea0-aae7-bc9a7483db8d" xlink:to="loc_elv_GovernmentBusinessSegmentMember_efcff626-37c7-4311-a83b-b5b2c6a04e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IngenioRxSegmentMember_5c7b7060-f33e-4037-bd10-57a1cbae5e32" xlink:href="elv-20220930.xsd#elv_IngenioRxSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fe639378-0199-4ea0-aae7-bc9a7483db8d" xlink:to="loc_elv_IngenioRxSegmentMember_5c7b7060-f33e-4037-bd10-57a1cbae5e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherSegmentMember_e00035ba-28c2-4dde-be2e-8e0cb85a0e34" xlink:href="elv-20220930.xsd#elv_OtherSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fe639378-0199-4ea0-aae7-bc9a7483db8d" xlink:to="loc_elv_OtherSegmentMember_e00035ba-28c2-4dde-be2e-8e0cb85a0e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_SegmentEliminationsMember_1807a45c-b904-449a-b87f-b9f0c3b51ff9" xlink:href="elv-20220930.xsd#elv_SegmentEliminationsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fe639378-0199-4ea0-aae7-bc9a7483db8d" xlink:to="loc_elv_SegmentEliminationsMember_1807a45c-b904-449a-b87f-b9f0c3b51ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_MajorProductRevenueBySegmentLineItems_64d28779-4237-4d2f-9a70-68b05e28a0a7" xlink:href="elv-20220930.xsd#elv_MajorProductRevenueBySegmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_MajorProductRevenueBySegmentTable_cfd654f2-3651-42a3-958d-881ad35343a3" xlink:to="loc_elv_MajorProductRevenueBySegmentLineItems_64d28779-4237-4d2f-9a70-68b05e28a0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceServicesRevenue_10322291-b0b9-46a8-a946-6eef152bdf25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceServicesRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_MajorProductRevenueBySegmentLineItems_64d28779-4237-4d2f-9a70-68b05e28a0a7" xlink:to="loc_us-gaap_InsuranceServicesRevenue_10322291-b0b9-46a8-a946-6eef152bdf25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/SegmentInformationReconciliationOfReportableSegmentsOperatingRevenuesToTotalRevenuesReportedInTheConsolidatedStatementsOfIncomeDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#SegmentInformationReconciliationOfReportableSegmentsOperatingRevenuesToTotalRevenuesReportedInTheConsolidatedStatementsOfIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/SegmentInformationReconciliationOfReportableSegmentsOperatingRevenuesToTotalRevenuesReportedInTheConsolidatedStatementsOfIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_866cc4a8-228a-4aaa-ac36-aedea04dcae9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceServicesRevenue_52d093e5-08b9-4bfb-86d3-ef10bbf8843e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceServicesRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_866cc4a8-228a-4aaa-ac36-aedea04dcae9" xlink:to="loc_us-gaap_InsuranceServicesRevenue_52d093e5-08b9-4bfb-86d3-ef10bbf8843e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_3a5cc2eb-9588-4a81-af49-734694a7437b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_866cc4a8-228a-4aaa-ac36-aedea04dcae9" xlink:to="loc_us-gaap_NetInvestmentIncome_3a5cc2eb-9588-4a81-af49-734694a7437b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_NetLossesGainsOnFinancialInstruments_3dfb6396-deea-4062-ba39-b34b39432c04" xlink:href="elv-20220930.xsd#elv_NetLossesGainsOnFinancialInstruments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_866cc4a8-228a-4aaa-ac36-aedea04dcae9" xlink:to="loc_elv_NetLossesGainsOnFinancialInstruments_3dfb6396-deea-4062-ba39-b34b39432c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_32c750d3-6cd7-475f-877b-f784f1731c19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_866cc4a8-228a-4aaa-ac36-aedea04dcae9" xlink:to="loc_us-gaap_Revenues_32c750d3-6cd7-475f-877b-f784f1731c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/SegmentInformationReconciliationOfIncomeBeforeIncomeTaxExpenseToReportableSegmentsOperatingGainIncludedInTheConsolidatedStatementsOfIncomeDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#SegmentInformationReconciliationOfIncomeBeforeIncomeTaxExpenseToReportableSegmentsOperatingGainIncludedInTheConsolidatedStatementsOfIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/SegmentInformationReconciliationOfIncomeBeforeIncomeTaxExpenseToReportableSegmentsOperatingGainIncludedInTheConsolidatedStatementsOfIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_219cc67b-0069-4499-a6b4-59b80221de12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bfb30782-4b59-4acd-ab53-d2f17c2e2398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_219cc67b-0069-4499-a6b4-59b80221de12" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bfb30782-4b59-4acd-ab53-d2f17c2e2398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_ec4f7314-0726-47bd-9026-fc6fe5a186ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_219cc67b-0069-4499-a6b4-59b80221de12" xlink:to="loc_us-gaap_NetInvestmentIncome_ec4f7314-0726-47bd-9026-fc6fe5a186ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_NetLossesGainsOnFinancialInstruments_ab4d3f3e-54f4-4ea0-b37b-e145edbd1306" xlink:href="elv-20220930.xsd#elv_NetLossesGainsOnFinancialInstruments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_219cc67b-0069-4499-a6b4-59b80221de12" xlink:to="loc_elv_NetLossesGainsOnFinancialInstruments_ab4d3f3e-54f4-4ea0-b37b-e145edbd1306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e715d7f2-5f98-488a-bd09-2d6c3eeef749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_219cc67b-0069-4499-a6b4-59b80221de12" xlink:to="loc_us-gaap_InterestExpense_e715d7f2-5f98-488a-bd09-2d6c3eeef749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_b45fa1ec-6d8d-404c-be51-48217f223a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_219cc67b-0069-4499-a6b4-59b80221de12" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_b45fa1ec-6d8d-404c-be51-48217f223a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1403c3fc-5697-48ee-9bd6-5229d3217065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_219cc67b-0069-4499-a6b4-59b80221de12" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1403c3fc-5697-48ee-9bd6-5229d3217065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_735b1412-092e-4b93-930a-13fda2ee35fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_219cc67b-0069-4499-a6b4-59b80221de12" xlink:to="loc_us-gaap_OperatingIncomeLoss_735b1412-092e-4b93-930a-13fda2ee35fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/SegmentInformationSegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#SegmentInformationSegmentInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/SegmentInformationSegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_eabdd8e9-c339-4f28-a50b-aff2512efebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_53144b4c-e489-4b61-ab1f-f4fa48fdee10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_eabdd8e9-c339-4f28-a50b-aff2512efebc" xlink:to="loc_us-gaap_NumberOfReportableSegments_53144b4c-e489-4b61-ab1f-f4fa48fdee10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/Leases" xlink:type="simple" xlink:href="elv-20220930.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_419aedf5-a459-4038-9526-5648475394e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_da9d269d-2e52-4664-9e7d-c76c9ee4e660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_419aedf5-a459-4038-9526-5648475394e5" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_da9d269d-2e52-4664-9e7d-c76c9ee4e660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/LeasesTables" xlink:type="simple" xlink:href="elv-20220930.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_efc87ed7-e2db-468d-be04-6c68f9882350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_65a9998d-922c-44c6-bafd-9575f16bfcc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_efc87ed7-e2db-468d-be04-6c68f9882350" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_65a9998d-922c-44c6-bafd-9575f16bfcc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_065e2798-2175-4fed-92ff-9a9c27dd399c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_efc87ed7-e2db-468d-be04-6c68f9882350" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_065e2798-2175-4fed-92ff-9a9c27dd399c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/LeasesLeaseandOtherInformationDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#LeasesLeaseandOtherInformationDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/LeasesLeaseandOtherInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_62db2232-7e4c-4d0f-b915-a4f7b80ecb16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f136f412-ca92-47e2-9d43-a5124576a446" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_62db2232-7e4c-4d0f-b915-a4f7b80ecb16" xlink:to="loc_us-gaap_StatementTable_f136f412-ca92-47e2-9d43-a5124576a446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f136f412-ca92-47e2-9d43-a5124576a446" xlink:to="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_218d0b11-a356-4e55-8c77-7d60d5c20a98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_218d0b11-a356-4e55-8c77-7d60d5c20a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_33d7d4bf-6f93-465f-8a99-2efd487df1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_33d7d4bf-6f93-465f-8a99-2efd487df1dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fa19b43d-f428-4ffd-9ba1-27f2ee7829cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fa19b43d-f428-4ffd-9ba1-27f2ee7829cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_87e0aa81-4f6c-4033-bbcc-bddd5e681184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_OperatingLeaseCost_87e0aa81-4f6c-4033-bbcc-bddd5e681184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_2e023137-c636-4ce8-b6c8-62aeb2c86437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_ShortTermLeaseCost_2e023137-c636-4ce8-b6c8-62aeb2c86437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_932514a9-6c83-4aad-bed8-baa28d050c20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_SubleaseIncome_932514a9-6c83-4aad-bed8-baa28d050c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_56da18cb-a7bf-46fb-9b90-48c25cc7ae6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_LeaseCost_56da18cb-a7bf-46fb-9b90-48c25cc7ae6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_493b746d-7e5e-4b36-94af-9f4cd66ec76d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_OperatingLeasePayments_493b746d-7e5e-4b36-94af-9f4cd66ec76d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_00b7e7c7-0f7f-4231-9906-d46e522fd518" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_00b7e7c7-0f7f-4231-9906-d46e522fd518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_7ff9045f-d24a-4c64-8498-d66390c2c656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_7ff9045f-d24a-4c64-8498-d66390c2c656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_0df12aa5-fe06-44da-87e4-cb76a3ce6607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_0df12aa5-fe06-44da-87e4-cb76a3ce6607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_48fa51b0-820b-4670-9f96-66e0fdd3395a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0be5191-330c-48b4-bbee-68524c929539" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_48fa51b0-820b-4670-9f96-66e0fdd3395a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract_a3977150-fe06-4656-9449-25f65f538fd4" xlink:href="elv-20220930.xsd#elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_fdc57daa-a018-4063-9944-365fcf3f4720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract_a3977150-fe06-4656-9449-25f65f538fd4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_fdc57daa-a018-4063-9944-365fcf3f4720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_bf826604-d080-4df1-a183-f64bee75a612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract_a3977150-fe06-4656-9449-25f65f538fd4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_bf826604-d080-4df1-a183-f64bee75a612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_dafcc46a-2380-49f7-a6be-b38e0376c767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract_a3977150-fe06-4656-9449-25f65f538fd4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_dafcc46a-2380-49f7-a6be-b38e0376c767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_13fe6cae-5549-43b5-aeca-a376af41197c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract_a3977150-fe06-4656-9449-25f65f538fd4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_13fe6cae-5549-43b5-aeca-a376af41197c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4a5c2f7b-249c-4244-9d62-0dee7fcb41ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract_a3977150-fe06-4656-9449-25f65f538fd4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4a5c2f7b-249c-4244-9d62-0dee7fcb41ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_fda1339a-b8c9-480e-bc2d-636c4d0841dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract_a3977150-fe06-4656-9449-25f65f538fd4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_fda1339a-b8c9-480e-bc2d-636c4d0841dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_50f78bab-7c39-4eb7-8287-8a9236451e06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract_a3977150-fe06-4656-9449-25f65f538fd4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_50f78bab-7c39-4eb7-8287-8a9236451e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_56928358-f594-43b2-b015-67bff17152c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract_a3977150-fe06-4656-9449-25f65f538fd4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_56928358-f594-43b2-b015-67bff17152c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ccfeb3c7-8cb4-4df9-b19e-0f4df5796005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract_a3977150-fe06-4656-9449-25f65f538fd4" xlink:to="loc_us-gaap_OperatingLeaseLiability_ccfeb3c7-8cb4-4df9-b19e-0f4df5796005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2fc49348-6bbc-4e6b-bcd6-7c1cfc6b3a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_64920e33-73bd-4af9-a3b6-1579860da398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2fc49348-6bbc-4e6b-bcd6-7c1cfc6b3a3e" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_64920e33-73bd-4af9-a3b6-1579860da398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_59e46a8f-6f04-4943-ad5c-eb7a3e74d72a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_64920e33-73bd-4af9-a3b6-1579860da398" xlink:to="loc_srt_RangeAxis_59e46a8f-6f04-4943-ad5c-eb7a3e74d72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0a7bc473-6617-4f91-b08c-6f8c7af9c4a2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_59e46a8f-6f04-4943-ad5c-eb7a3e74d72a" xlink:to="loc_srt_RangeMember_0a7bc473-6617-4f91-b08c-6f8c7af9c4a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8eca50e9-fbfa-4030-84ca-3372e354d621" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0a7bc473-6617-4f91-b08c-6f8c7af9c4a2" xlink:to="loc_srt_MinimumMember_8eca50e9-fbfa-4030-84ca-3372e354d621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ed7fddf4-2ef3-40cb-beff-ab941a6d3bc6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0a7bc473-6617-4f91-b08c-6f8c7af9c4a2" xlink:to="loc_srt_MaximumMember_ed7fddf4-2ef3-40cb-beff-ab941a6d3bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_bb3fea92-713b-4761-b696-18e1f64e5ece" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_64920e33-73bd-4af9-a3b6-1579860da398" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_bb3fea92-713b-4761-b696-18e1f64e5ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_4308b44f-f9d6-4e13-aa6d-2727673ec4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bb3fea92-713b-4761-b696-18e1f64e5ece" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_4308b44f-f9d6-4e13-aa6d-2727673ec4ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_9a3204b7-0b60-416f-92ea-bcaf944e6932" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bb3fea92-713b-4761-b696-18e1f64e5ece" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_9a3204b7-0b60-416f-92ea-bcaf944e6932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_bb0d852c-bf3d-45cf-b10c-f44bfa702bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bb3fea92-713b-4761-b696-18e1f64e5ece" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_bb0d852c-bf3d-45cf-b10c-f44bfa702bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseNotYetCommencedDescriptionAbstract_53e7b6db-46cf-4ec8-a095-c6745f0bfb12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseNotYetCommencedDescriptionAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2fc49348-6bbc-4e6b-bcd6-7c1cfc6b3a3e" xlink:to="loc_us-gaap_LesseeOperatingLeaseNotYetCommencedDescriptionAbstract_53e7b6db-46cf-4ec8-a095-c6745f0bfb12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="elv-20220930.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b78c0e8e-ead0-4ba3-a642-084655db19b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e684b6ad-be7b-4b43-b073-8abc9cabfb00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b78c0e8e-ead0-4ba3-a642-084655db19b4" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e684b6ad-be7b-4b43-b073-8abc9cabfb00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="elv-20220930.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fcfd3d31-034e-4ef4-9f0c-16d7fd0d6da9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_5ea7cbb8-f791-4b32-aaa5-267fc3d480ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fcfd3d31-034e-4ef4-9f0c-16d7fd0d6da9" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_5ea7cbb8-f791-4b32-aaa5-267fc3d480ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PresentValueOfFutureInsuranceProfitsTableTextBlock_85a00bd1-1d6c-4763-8711-14821adfd3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PresentValueOfFutureInsuranceProfitsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fcfd3d31-034e-4ef4-9f0c-16d7fd0d6da9" xlink:to="loc_us-gaap_PresentValueOfFutureInsuranceProfitsTableTextBlock_85a00bd1-1d6c-4763-8711-14821adfd3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsSummaryOfTheChangeInTheCarryingAmountOfGoodwillByReportableSegmentDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#GoodwillAndOtherIntangibleAssetsSummaryOfTheChangeInTheCarryingAmountOfGoodwillByReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsSummaryOfTheChangeInTheCarryingAmountOfGoodwillByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fac66010-1f45-47de-9801-32ba0048f594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_7e5bd8f2-87cb-429c-9259-4b5716405d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fac66010-1f45-47de-9801-32ba0048f594" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_7e5bd8f2-87cb-429c-9259-4b5716405d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cf14a9ee-cad0-4c4d-a830-a95c34254d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7e5bd8f2-87cb-429c-9259-4b5716405d8e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cf14a9ee-cad0-4c4d-a830-a95c34254d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d179946e-4636-4684-931c-f41871e90c38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cf14a9ee-cad0-4c4d-a830-a95c34254d9d" xlink:to="loc_us-gaap_SegmentDomain_d179946e-4636-4684-931c-f41871e90c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_CommercialSpecialtyBusinessSegmentMember_0185e2a0-f3f7-498f-8886-10fa3ed78300" xlink:href="elv-20220930.xsd#elv_CommercialSpecialtyBusinessSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d179946e-4636-4684-931c-f41871e90c38" xlink:to="loc_elv_CommercialSpecialtyBusinessSegmentMember_0185e2a0-f3f7-498f-8886-10fa3ed78300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_GovernmentBusinessSegmentMember_1cd74ed8-0a1b-4855-8983-5cd595b1c307" xlink:href="elv-20220930.xsd#elv_GovernmentBusinessSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d179946e-4636-4684-931c-f41871e90c38" xlink:to="loc_elv_GovernmentBusinessSegmentMember_1cd74ed8-0a1b-4855-8983-5cd595b1c307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IngenioRxSegmentMember_80a0ebf7-3da5-4644-b038-66f222b1c8ca" xlink:href="elv-20220930.xsd#elv_IngenioRxSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d179946e-4636-4684-931c-f41871e90c38" xlink:to="loc_elv_IngenioRxSegmentMember_80a0ebf7-3da5-4644-b038-66f222b1c8ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_OtherSegmentMember_06bbd832-3d59-49f0-bb3e-8ffbda3c2589" xlink:href="elv-20220930.xsd#elv_OtherSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d179946e-4636-4684-931c-f41871e90c38" xlink:to="loc_elv_OtherSegmentMember_06bbd832-3d59-49f0-bb3e-8ffbda3c2589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_134cf1f7-fcca-487c-b624-c151d17b557b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7e5bd8f2-87cb-429c-9259-4b5716405d8e" xlink:to="loc_us-gaap_GoodwillLineItems_134cf1f7-fcca-487c-b624-c151d17b557b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_3bc90c67-b42f-40ef-aab3-beec346090c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_134cf1f7-fcca-487c-b624-c151d17b557b" xlink:to="loc_us-gaap_GoodwillRollForward_3bc90c67-b42f-40ef-aab3-beec346090c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_03579beb-11f4-4b5f-b347-efd91e888e96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3bc90c67-b42f-40ef-aab3-beec346090c0" xlink:to="loc_us-gaap_Goodwill_03579beb-11f4-4b5f-b347-efd91e888e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_7aeec004-0305-4dc2-a809-a8554f93498a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3bc90c67-b42f-40ef-aab3-beec346090c0" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_7aeec004-0305-4dc2-a809-a8554f93498a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_be538f52-80c1-4982-8a03-26f2ada691bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3bc90c67-b42f-40ef-aab3-beec346090c0" xlink:to="loc_us-gaap_Goodwill_be538f52-80c1-4982-8a03-26f2ada691bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_81145621-4a12-465a-b524-4045bd678a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3bc90c67-b42f-40ef-aab3-beec346090c0" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_81145621-4a12-465a-b524-4045bd678a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_452f57ff-fa33-4401-af50-98be289444c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IntangibleAssetsTable_666fa259-e67a-48f7-b9aa-e393b64bfc40" xlink:href="elv-20220930.xsd#elv_IntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_452f57ff-fa33-4401-af50-98be289444c1" xlink:to="loc_elv_IntangibleAssetsTable_666fa259-e67a-48f7-b9aa-e393b64bfc40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c9f30889-4283-47e9-9226-16fe613d7e34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_IntangibleAssetsTable_666fa259-e67a-48f7-b9aa-e393b64bfc40" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c9f30889-4283-47e9-9226-16fe613d7e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_287579fa-c04a-4bc5-a32c-8d6ef2dccd71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c9f30889-4283-47e9-9226-16fe613d7e34" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_287579fa-c04a-4bc5-a32c-8d6ef2dccd71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_a7490b75-6102-4132-b853-ed8d06191f62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_287579fa-c04a-4bc5-a32c-8d6ef2dccd71" xlink:to="loc_us-gaap_CustomerRelationshipsMember_a7490b75-6102-4132-b853-ed8d06191f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_4ab91e4e-f00e-48d7-a070-605930847213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_287579fa-c04a-4bc5-a32c-8d6ef2dccd71" xlink:to="loc_us-gaap_ContractualRightsMember_4ab91e4e-f00e-48d7-a070-605930847213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_389dc288-c8af-4f37-baab-98ab1441bf0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_287579fa-c04a-4bc5-a32c-8d6ef2dccd71" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_389dc288-c8af-4f37-baab-98ab1441bf0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_62c4db13-9d32-4216-81eb-6c921b49354d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_IntangibleAssetsTable_666fa259-e67a-48f7-b9aa-e393b64bfc40" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_62c4db13-9d32-4216-81eb-6c921b49354d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b1968160-1cef-4a59-80fb-7343fe9df926" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_62c4db13-9d32-4216-81eb-6c921b49354d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b1968160-1cef-4a59-80fb-7343fe9df926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_e4462ccd-f520-4429-8dc8-e50222280ade" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b1968160-1cef-4a59-80fb-7343fe9df926" xlink:to="loc_us-gaap_TrademarksMember_e4462ccd-f520-4429-8dc8-e50222280ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_703e14c7-2e58-41a4-b3bd-033e1b6c33a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b1968160-1cef-4a59-80fb-7343fe9df926" xlink:to="loc_us-gaap_LicensingAgreementsMember_703e14c7-2e58-41a4-b3bd-033e1b6c33a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IntangibleAssetsLineItems_58ebd14c-55ce-4d06-abf3-cc7914e1ede6" xlink:href="elv-20220930.xsd#elv_IntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_IntangibleAssetsTable_666fa259-e67a-48f7-b9aa-e393b64bfc40" xlink:to="loc_elv_IntangibleAssetsLineItems_58ebd14c-55ce-4d06-abf3-cc7914e1ede6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4efeca36-157a-4dd5-b0ee-3a4483a7b38c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_IntangibleAssetsLineItems_58ebd14c-55ce-4d06-abf3-cc7914e1ede6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4efeca36-157a-4dd5-b0ee-3a4483a7b38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e5b74fb2-dedd-4e04-9e03-f3e57393fa55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_IntangibleAssetsLineItems_58ebd14c-55ce-4d06-abf3-cc7914e1ede6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e5b74fb2-dedd-4e04-9e03-f3e57393fa55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fd534045-13fe-477c-b8af-9a8a356690ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_IntangibleAssetsLineItems_58ebd14c-55ce-4d06-abf3-cc7914e1ede6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fd534045-13fe-477c-b8af-9a8a356690ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_1285a9fb-963e-45af-8bbb-e0c9f7c18b81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_IntangibleAssetsLineItems_58ebd14c-55ce-4d06-abf3-cc7914e1ede6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_1285a9fb-963e-45af-8bbb-e0c9f7c18b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_38f249b2-41ba-4bf4-9a7d-fc89ebbe3744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_IntangibleAssetsLineItems_58ebd14c-55ce-4d06-abf3-cc7914e1ede6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_38f249b2-41ba-4bf4-9a7d-fc89ebbe3744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e1103a76-93d8-4c2b-a8db-8a9de0aa0475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_IntangibleAssetsLineItems_58ebd14c-55ce-4d06-abf3-cc7914e1ede6" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e1103a76-93d8-4c2b-a8db-8a9de0aa0475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_IntangibleAssetsAccumulatedAmortizationExcludingGoodwill_099035ff-a353-4be0-8d7a-2d8e36805742" xlink:href="elv-20220930.xsd#elv_IntangibleAssetsAccumulatedAmortizationExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_IntangibleAssetsLineItems_58ebd14c-55ce-4d06-abf3-cc7914e1ede6" xlink:to="loc_elv_IntangibleAssetsAccumulatedAmortizationExcludingGoodwill_099035ff-a353-4be0-8d7a-2d8e36805742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f0e0f35c-00c6-4e3c-b5c5-5674e0d64ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_IntangibleAssetsLineItems_58ebd14c-55ce-4d06-abf3-cc7914e1ede6" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f0e0f35c-00c6-4e3c-b5c5-5674e0d64ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="elv-20220930.xsd#GoodwillAndOtherIntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3e5ce4ac-aaa7-44fe-adf7-d315f130f302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_8d23e0fa-1bef-493f-b160-a4f99589349d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3e5ce4ac-aaa7-44fe-adf7-d315f130f302" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_8d23e0fa-1bef-493f-b160-a4f99589349d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease_23d5d8f7-d9c9-48ff-b2ec-a27625fe56bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3e5ce4ac-aaa7-44fe-adf7-d315f130f302" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease_23d5d8f7-d9c9-48ff-b2ec-a27625fe56bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_8244f0c1-a7b4-4e97-9650-618913858832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3e5ce4ac-aaa7-44fe-adf7-d315f130f302" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_8244f0c1-a7b4-4e97-9650-618913858832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0f2958d4-84a8-4f8c-870f-3c99d55e6da2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3e5ce4ac-aaa7-44fe-adf7-d315f130f302" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0f2958d4-84a8-4f8c-870f-3c99d55e6da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_1de82515-1c80-4b71-b9dd-3987e4a65f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3e5ce4ac-aaa7-44fe-adf7-d315f130f302" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_1de82515-1c80-4b71-b9dd-3987e4a65f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_53eedba1-3768-4c96-8a4e-a4e37dbe8c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3e5ce4ac-aaa7-44fe-adf7-d315f130f302" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_53eedba1-3768-4c96-8a4e-a4e37dbe8c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e34c466b-aea6-443c-8239-2bbfd6ed48de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3e5ce4ac-aaa7-44fe-adf7-d315f130f302" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e34c466b-aea6-443c-8239-2bbfd6ed48de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_FiniteLivedIntangibleAssetExpectedAmortizationYearSix_13f37f32-32fd-452f-9481-b865c7c39df4" xlink:href="elv-20220930.xsd#elv_FiniteLivedIntangibleAssetExpectedAmortizationYearSix"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3e5ce4ac-aaa7-44fe-adf7-d315f130f302" xlink:to="loc_elv_FiniteLivedIntangibleAssetExpectedAmortizationYearSix_13f37f32-32fd-452f-9481-b865c7c39df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>elv-20220930_g1.jpg
<DESCRIPTION>ELEVANCE HEALTH LOGO
<TEXT>
begin 644 elv-20220930_g1.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #. >8# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_/UXN_Y&O6O^
MOV;_ -&-64JEV"CJ3BM7Q=_R->M?]?LW_HQJS(/]<G^\*_7([(^.>Y]H1_\
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M1_%&BVFLV$RX,=S&"5]U;JI'8@@U\Y'/_>]ZGIZZGIO+M-):GX$Y(Z45[_\
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M^H#_ .# _P#Q%?K#9_\ 'G!_US7^535\'_;>*\ON/H/J-'S/R8_X=D_&+_J
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MN)6F<1KM4%B2<#L.>E??/_#IN_\ ^BAVW_@M;_XNC_ATW?\ _10[;_P6M_\
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MD)M-,A8-<W;=E1/3/5CP.YK5^$/Q7T/XU> =,\5^'YM]G>)\\+$&2WE'WXG
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M/;(OEH,C+ ]0:_5BBNS!XR>"FYP2=U;4QK48UXJ,F?BE_P ,4_&[_HGNI_\
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MR)!:.D>/7>P"_K7V+\!?^"8-[)>6^K?%+4(X+9#O_L'39=[R>TLPX4>R9/\
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M][K_ -$M7V5'"4)9=[5P7-RO7[SQ)UJBQ/(GI='[#4445\:>V%%%% !1110
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M %Z&DZV*C[\KI>A^QWP-_:"\'_M!>&FU;PM>LTD.%N]/N0$N;5CT#KD\'G#
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M_#V#PK_T(FL?^!<7^%?"?Q]\?:%\4?BQKWBOP]I$VAV&JRBX:RF96*2E1YC
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M3P/[:LO_ $>E>IE7^X?><F,_WC[C]\****^!/HC\S?\ @J]_R4;P/_V"9?\
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MV%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]M_ZL+"U*\YWD[H^8?\ @J]_R4;P/_V"9?\ T<:\K_X)W_\ )TWAS_KWNO\
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@/RKW\ZQ-+$1I^S=[7[^1YV!I3IN7,C1HHHKY<]8__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898683485488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information Document - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Oct. 12, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001156039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-16751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ELEVANCE HEALTH, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">IN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">35-2145715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">220 Virginia Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Indianapolis<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">46204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">401-1577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ELV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">238,827,582<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898684020928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 8,872<span></span>
</td>
<td class="nump">$ 4,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Fixed maturities, current</a></td>
<td class="nump">25,526<span></span>
</td>
<td class="nump">26,267<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">1,503<span></span>
</td>
<td class="nump">1,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsReceivableAtCarryingValue', window );">Premium receivables</a></td>
<td class="nump">6,682<span></span>
</td>
<td class="nump">5,681<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_SelfFundedReceivablesNet', window );">Self-funded receivables</a></td>
<td class="nump">3,873<span></span>
</td>
<td class="nump">4,010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Other receivables</a></td>
<td class="nump">3,651<span></span>
</td>
<td class="nump">3,749<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">5,496<span></span>
</td>
<td class="nump">4,654<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">55,603<span></span>
</td>
<td class="nump">51,122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestmentsAbstract', window );"><strong>Long-term investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Fixed maturities, long-term</a></td>
<td class="nump">622<span></span>
</td>
<td class="nump">632<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Other invested assets</a></td>
<td class="nump">5,516<span></span>
</td>
<td class="nump">5,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">4,197<span></span>
</td>
<td class="nump">3,919<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">24,381<span></span>
</td>
<td class="nump">24,228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">10,536<span></span>
</td>
<td class="nump">10,615<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other noncurrent assets</a></td>
<td class="nump">2,171<span></span>
</td>
<td class="nump">1,719<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">103,026<span></span>
</td>
<td class="nump">97,460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical claims payable</a></td>
<td class="nump">15,242<span></span>
</td>
<td class="nump">13,518<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPolicyholderFunds', window );">Other policyholder liabilities</a></td>
<td class="nump">5,482<span></span>
</td>
<td class="nump">5,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnearnedPremiums', window );">Unearned income</a></td>
<td class="nump">3,702<span></span>
</td>
<td class="nump">1,153<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">4,963<span></span>
</td>
<td class="nump">4,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">265<span></span>
</td>
<td class="nump">275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">2,249<span></span>
</td>
<td class="nump">1,599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">9,384<span></span>
</td>
<td class="nump">7,849<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">41,287<span></span>
</td>
<td class="nump">34,885<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">21,258<span></span>
</td>
<td class="nump">21,157<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefits', window );">Reserves for future policy benefits, noncurrent</a></td>
<td class="nump">825<span></span>
</td>
<td class="nump">802<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities, net</a></td>
<td class="nump">1,825<span></span>
</td>
<td class="nump">2,805<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other noncurrent liabilities</a></td>
<td class="nump">1,788<span></span>
</td>
<td class="nump">1,683<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">66,983<span></span>
</td>
<td class="nump">61,332<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies &#8211; Note 11</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, without par value, shares authorized &#8211; 100,000,000; shares issued and outstanding &#8211; none</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.01, shares authorized &#8211; 900,000,000; shares issued and outstanding &#8211; 238,974,624 and 241,770,746</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">9,169<span></span>
</td>
<td class="nump">9,148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">29,604<span></span>
</td>
<td class="nump">27,088<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(2,784)<span></span>
</td>
<td class="num">(178)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity</a></td>
<td class="nump">35,991<span></span>
</td>
<td class="nump">36,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">36,043<span></span>
</td>
<td class="nump">36,128<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="nump">$ 103,026<span></span>
</td>
<td class="nump">$ 97,460<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_SelfFundedReceivablesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date due the entity from self-insured customers, net of the allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_SelfFundedReceivablesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance, of present value of future benefit to be paid to or on behalf of policyholder and related expense less present value of future net premium receivable under insurance contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPolicyholderFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due to policyholders for funds held that are returnable under the terms of insurance contracts, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.14)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPolicyholderFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsReceivableAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),5)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsReceivableAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnearnedPremiums">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(13)(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnearnedPremiums</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898684327680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent', window );">Fixed maturities, amortized cost, current</a></td>
<td class="nump">$ 28,306<span></span>
</td>
<td class="nump">$ 25,641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent', window );">Fixed maturities, allowance for credit loss, current</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent', window );">Fixed Maturities, long-term, amortized cost</a></td>
<td class="nump">671<span></span>
</td>
<td class="nump">616<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent', window );">Fixed maturities, allowance for credit Loss, noncurrent</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">900,000,000<span></span>
</td>
<td class="nump">900,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">238,974,624<span></span>
</td>
<td class="nump">241,770,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">238,974,624<span></span>
</td>
<td class="nump">241,770,746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898680753392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements Of Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">$ 33,722<span></span>
</td>
<td class="nump">$ 30,395<span></span>
</td>
<td class="nump">$ 99,583<span></span>
</td>
<td class="nump">$ 86,604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_ProductRevenue', window );">Product revenue</a></td>
<td class="nump">3,972<span></span>
</td>
<td class="nump">3,353<span></span>
</td>
<td class="nump">10,841<span></span>
</td>
<td class="nump">9,132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Administrative fees and other revenue</a></td>
<td class="nump">1,931<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="nump">5,569<span></span>
</td>
<td class="nump">5,189<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_OperatingRevenue', window );">Total operating revenue</a></td>
<td class="nump">39,625<span></span>
</td>
<td class="nump">35,548<span></span>
</td>
<td class="nump">115,993<span></span>
</td>
<td class="nump">100,925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">371<span></span>
</td>
<td class="nump">335<span></span>
</td>
<td class="nump">1,112<span></span>
</td>
<td class="nump">1,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_NetLossesGainsOnFinancialInstruments', window );">Net (losses) gains on financial instruments</a></td>
<td class="num">(57)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="num">(439)<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">39,939<span></span>
</td>
<td class="nump">35,822<span></span>
</td>
<td class="nump">116,666<span></span>
</td>
<td class="nump">102,058<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BenefitsLossesAndExpensesAbstract', window );"><strong>Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet', window );">Benefit expense</a></td>
<td class="nump">29,404<span></span>
</td>
<td class="nump">26,645<span></span>
</td>
<td class="nump">86,396<span></span>
</td>
<td class="nump">75,107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">3,437<span></span>
</td>
<td class="nump">2,898<span></span>
</td>
<td class="nump">9,389<span></span>
</td>
<td class="nump">7,825<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expense</a></td>
<td class="nump">4,514<span></span>
</td>
<td class="nump">3,946<span></span>
</td>
<td class="nump">13,124<span></span>
</td>
<td class="nump">11,692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">213<span></span>
</td>
<td class="nump">201<span></span>
</td>
<td class="nump">622<span></span>
</td>
<td class="nump">598<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of other intangible assets</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="nump">520<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BenefitsLossesAndExpenses', window );">Total expenses</a></td>
<td class="nump">37,793<span></span>
</td>
<td class="nump">33,826<span></span>
</td>
<td class="nump">110,051<span></span>
</td>
<td class="nump">95,533<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income tax expense</a></td>
<td class="nump">2,146<span></span>
</td>
<td class="nump">1,996<span></span>
</td>
<td class="nump">6,615<span></span>
</td>
<td class="nump">6,525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">533<span></span>
</td>
<td class="nump">494<span></span>
</td>
<td class="nump">1,557<span></span>
</td>
<td class="nump">1,555<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">1,613<span></span>
</td>
<td class="nump">1,502<span></span>
</td>
<td class="nump">5,058<span></span>
</td>
<td class="nump">4,970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss (income) attributable to noncontrolling interests</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Shareholders&#8217; net income</a></td>
<td class="nump">$ 1,618<span></span>
</td>
<td class="nump">$ 1,509<span></span>
</td>
<td class="nump">$ 5,076<span></span>
</td>
<td class="nump">$ 4,967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Shareholders&#8217; net income per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share</a></td>
<td class="nump">$ 6.75<span></span>
</td>
<td class="nump">$ 6.20<span></span>
</td>
<td class="nump">$ 21.11<span></span>
</td>
<td class="nump">$ 20.33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share</a></td>
<td class="nump">6.68<span></span>
</td>
<td class="nump">6.13<span></span>
</td>
<td class="nump">20.86<span></span>
</td>
<td class="nump">20.09<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends per share</a></td>
<td class="nump">$ 1.28<span></span>
</td>
<td class="nump">$ 1.13<span></span>
</td>
<td class="nump">$ 3.84<span></span>
</td>
<td class="nump">$ 3.39<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_NetLossesGainsOnFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net (losses) gains on financial instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_NetLossesGainsOnFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_OperatingRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue from insurance services and products sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_OperatingRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_ProductRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_ProductRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BenefitsLossesAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5,6,7)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BenefitsLossesAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BenefitsLossesAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BenefitsLossesAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6811-158387<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898683370992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 1,613<span></span>
</td>
<td class="nump">$ 1,502<span></span>
</td>
<td class="nump">$ 5,058<span></span>
</td>
<td class="nump">$ 4,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive (loss) income, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Change in net unrealized losses/gains on investments</a></td>
<td class="num">(639)<span></span>
</td>
<td class="num">(97)<span></span>
</td>
<td class="num">(2,630)<span></span>
</td>
<td class="num">(284)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax', window );">Change in non-credit component of impairment losses on investments</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Change in net unrealized gains/losses on cash flow hedges</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Change in net periodic pension and postretirement costs</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(638)<span></span>
</td>
<td class="num">(87)<span></span>
</td>
<td class="num">(2,617)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss (income) attributable to noncontrolling interests</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive loss attributable to noncontrolling interests</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total shareholders&#8217; comprehensive income</a></td>
<td class="nump">$ 983<span></span>
</td>
<td class="nump">$ 1,423<span></span>
</td>
<td class="nump">$ 2,470<span></span>
</td>
<td class="nump">$ 4,714<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in non-credit component of impairment losses on investments, net of tax effect.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898680854544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements Of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 5,058<span></span>
</td>
<td class="nump">$ 4,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_NetLossesGainsOnFinancialInstruments', window );">Net losses (gains) on financial instruments</a></td>
<td class="nump">439<span></span>
</td>
<td class="num">(107)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net earnings of other invested assets</a></td>
<td class="num">(304)<span></span>
</td>
<td class="num">(437)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">1,202<span></span>
</td>
<td class="nump">942<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(170)<span></span>
</td>
<td class="nump">114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">191<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables, net</a></td>
<td class="num">(678)<span></span>
</td>
<td class="num">(1,751)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTradingSecurities', window );">Other invested assets</a></td>
<td class="nump">46<span></span>
</td>
<td class="num">(56)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(474)<span></span>
</td>
<td class="num">(470)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities', window );">Policy liabilities</a></td>
<td class="nump">1,537<span></span>
</td>
<td class="nump">2,328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Unearned income</a></td>
<td class="nump">2,548<span></span>
</td>
<td class="num">(308)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities', window );">Accounts payable and other liabilities</a></td>
<td class="nump">598<span></span>
</td>
<td class="nump">1,093<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable', window );">Income taxes</a></td>
<td class="num">(41)<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other, net</a></td>
<td class="num">(35)<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">9,917<span></span>
</td>
<td class="nump">6,692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(19,612)<span></span>
</td>
<td class="num">(15,130)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_Proceedsfromsaleofequityandfixedmaturitysecurities', window );">Proceeds from sale of investments</a></td>
<td class="nump">9,402<span></span>
</td>
<td class="nump">8,339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Maturities, calls and redemptions from investments</a></td>
<td class="nump">7,606<span></span>
</td>
<td class="nump">3,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInCollateralHeldUnderSecuritiesLending', window );">Changes in securities lending collateral</a></td>
<td class="num">(677)<span></span>
</td>
<td class="num">(1,030)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Purchases of subsidiaries, net of cash acquired</a></td>
<td class="num">(623)<span></span>
</td>
<td class="num">(3,442)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(854)<span></span>
</td>
<td class="num">(747)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other, net</a></td>
<td class="num">(91)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(4,849)<span></span>
</td>
<td class="num">(8,672)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper', window );">Net proceeds from (repayments of) commercial paper borrowings</a></td>
<td class="nump">375<span></span>
</td>
<td class="num">(150)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from long-term borrowings</a></td>
<td class="nump">1,286<span></span>
</td>
<td class="nump">3,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term borrowings</a></td>
<td class="num">(982)<span></span>
</td>
<td class="num">(954)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term borrowings</a></td>
<td class="nump">1,365<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Repayments of short-term borrowings</a></td>
<td class="num">(1,375)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInSecuritiesLendingPayable', window );">Changes in securities lending payable</a></td>
<td class="nump">685<span></span>
</td>
<td class="nump">1,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOutstandingChecksFinancingActivities', window );">Changes in bank overdrafts</a></td>
<td class="nump">181<span></span>
</td>
<td class="nump">316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase and retirement of common stock</a></td>
<td class="num">(1,748)<span></span>
</td>
<td class="num">(1,378)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Cash dividends</a></td>
<td class="num">(924)<span></span>
</td>
<td class="num">(831)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from issuance of common stock under employee stock plans</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid through withholding of common stock under employee stock plans</a></td>
<td class="num">(91)<span></span>
</td>
<td class="num">(101)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other, net</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(1,060)<span></span>
</td>
<td class="nump">1,738<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign exchange rates on cash and cash equivalents</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Change in cash and cash equivalents</a></td>
<td class="nump">3,992<span></span>
</td>
<td class="num">(251)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">4,880<span></span>
</td>
<td class="nump">5,741<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 8,872<span></span>
</td>
<td class="nump">$ 5,490<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_NetLossesGainsOnFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net (losses) gains on financial instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_NetLossesGainsOnFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_Proceedsfromsaleofequityandfixedmaturitysecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of equity and fixed maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_Proceedsfromsaleofequityandfixedmaturitysecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAmortizationAndAccretionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAmortizationAndAccretionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInCollateralHeldUnderSecuritiesLending">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the carrying amount of assets, which may include but are not limited to cash and investments, received as collateral pertaining to securities loaned to a counterparty to the transaction. Includes the change during the period in any unrealized gain or loss on such investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInCollateralHeldUnderSecuritiesLending</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in insurance liability balances during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInsuranceLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOutstandingChecksFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The change in cash during the period due to the net increase or decrease in outstanding checks, the liability that represents checks that have been issued but that have not cleared. The entity may classify these cash flows as financing or operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3098-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3095-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOutstandingChecksFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInSecuritiesLendingPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the carrying amount of the liability pertaining to obligations to return collateral that the entity received when it loaned securities to the counterparty to the transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInSecuritiesLendingPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of investment in debt and equity securities, measured at fair value with changes in fair value recognized in net income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3444-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3098-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898673725488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements Of Changes in Equity - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjusted Balance</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-In Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th">
<div>Retained Earnings [Member] </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th">
<div>Retained Earnings [Member] </div>
<div>Cumulative Effect, Period of Adoption, Adjusted Balance</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive (Loss) Income [Member]</div></th>
<th class="th"><div>Noncontrolling Interest [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares), Beginning at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity, Beginning Balance at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 9,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,802<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests, Beginning Balance at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity, Beginning Balance at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Shareholders' net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income (Loss) Attributable to Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 1,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Shareholders' other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(345)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other Comprehensive (Loss) Income, Attributable to Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(347)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_NoncontrollingInterestPeriodIncreaseDecrease', window );">Noncontrolling interests adjustment</a></td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase and retirement of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock</a></td>
<td class="num">(447)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="num">(393)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends and dividend equivalents</a></td>
<td class="num">(281)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(281)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock plans, net of related tax benefits, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock under employee stock plans, net of related tax benefits</a></td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares), Ending at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">244.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity, Ending Balance at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">9,253<span></span>
</td>
<td class="nump">24,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(195)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests, Ending Balance at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity, Ending Balance at Mar. 31, 2021</a></td>
<td class="nump">33,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares), Beginning at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity, Beginning Balance at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">9,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,802<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests, Beginning Balance at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity, Beginning Balance at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Shareholders' net income</a></td>
<td class="nump">4,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income (Loss) Attributable to Noncontrolling Interest</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">4,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other Comprehensive (Loss) Income, Attributable to Noncontrolling Interest</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">$ (254)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase and retirement of common stock, shares</a></td>
<td class="num">(3.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock</a></td>
<td class="num">$ (1,378)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares), Ending at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity, Ending Balance at Sep. 30, 2021</a></td>
<td class="nump">35,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">9,138<span></span>
</td>
<td class="nump">26,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(103)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests, Ending Balance at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares), Beginning at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">244.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity, Beginning Balance at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">9,253<span></span>
</td>
<td class="nump">24,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(195)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests, Beginning Balance at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity, Beginning Balance at Mar. 31, 2021</a></td>
<td class="nump">33,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Shareholders' net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income (Loss) Attributable to Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">1,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Shareholders' other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other Comprehensive (Loss) Income, Attributable to Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_NoncontrollingInterestPeriodIncreaseDecrease', window );">Noncontrolling interests adjustment</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase and retirement of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock</a></td>
<td class="num">(480)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="num">(433)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends and dividend equivalents</a></td>
<td class="num">(279)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(279)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock plans, net of related tax benefits, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock under employee stock plans, net of related tax benefits</a></td>
<td class="nump">119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments', window );">Convertible debenture repurchases, conversions and tax adjustments</a></td>
<td class="num">(216)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(216)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares), Ending at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">243.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity, Ending Balance at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">9,109<span></span>
</td>
<td class="nump">25,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests, Ending Balance at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity, Ending Balance at Jun. 30, 2021</a></td>
<td class="nump">35,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Shareholders' net income</a></td>
<td class="nump">1,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income (Loss) Attributable to Noncontrolling Interest</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">1,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Shareholders' other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(86)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other Comprehensive (Loss) Income, Attributable to Noncontrolling Interest</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(87)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_NoncontrollingInterestPeriodIncreaseDecrease', window );">Noncontrolling interests adjustment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase and retirement of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock</a></td>
<td class="num">(451)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(44)<span></span>
</td>
<td class="num">(407)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends and dividend equivalents</a></td>
<td class="num">(276)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(276)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock plans, net of related tax benefits, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock under employee stock plans, net of related tax benefits</a></td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments', window );">Convertible debenture repurchases, conversions and tax adjustments</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares), Ending at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity, Ending Balance at Sep. 30, 2021</a></td>
<td class="nump">35,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">9,138<span></span>
</td>
<td class="nump">26,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(103)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests, Ending Balance at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares), Beginning at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">241.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity, Beginning Balance at Dec. 31, 2021</a></td>
<td class="nump">36,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">9,148<span></span>
</td>
<td class="nump">27,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,065<span></span>
</td>
<td class="num">(178)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity, Beginning Balance (Accounting Standards Update 2020-06 [Member]) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests, Beginning Balance at Dec. 31, 2021</a></td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity, Beginning Balance at Dec. 31, 2021</a></td>
<td class="nump">36,128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity, Beginning Balance (Accounting Standards Update 2020-06 [Member]) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Shareholders' net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income (Loss) Attributable to Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">1,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Shareholders' other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,058)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other Comprehensive (Loss) Income, Attributable to Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(1,063)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_NoncontrollingInterestPeriodIncreaseDecrease', window );">Noncontrolling interests adjustment</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase and retirement of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock</a></td>
<td class="num">(545)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="num">(500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends and dividend equivalents</a></td>
<td class="num">(312)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(312)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock plans, net of related tax benefits, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock under employee stock plans, net of related tax benefits</a></td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments', window );">Convertible debenture repurchases, conversions and tax adjustments</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares), Ending at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">241.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity, Ending Balance at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">9,151<span></span>
</td>
<td class="nump">28,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,236)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests, Ending Balance at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity, Ending Balance at Mar. 31, 2022</a></td>
<td class="nump">36,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares), Beginning at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">241.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity, Beginning Balance at Dec. 31, 2021</a></td>
<td class="nump">36,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">9,148<span></span>
</td>
<td class="nump">27,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,065<span></span>
</td>
<td class="num">(178)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity, Beginning Balance (Accounting Standards Update 2020-06 [Member]) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests, Beginning Balance at Dec. 31, 2021</a></td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity, Beginning Balance at Dec. 31, 2021</a></td>
<td class="nump">36,128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity, Beginning Balance (Accounting Standards Update 2020-06 [Member]) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Shareholders' net income</a></td>
<td class="nump">5,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income (Loss) Attributable to Noncontrolling Interest</a></td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">5,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other Comprehensive (Loss) Income, Attributable to Noncontrolling Interest</a></td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">$ (2,617)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase and retirement of common stock, shares</a></td>
<td class="num">(3.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock</a></td>
<td class="num">$ (1,748)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares), Ending at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity, Ending Balance at Sep. 30, 2022</a></td>
<td class="nump">35,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">9,169<span></span>
</td>
<td class="nump">29,604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,784)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests, Ending Balance at Sep. 30, 2022</a></td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity, Ending Balance at Sep. 30, 2022</a></td>
<td class="nump">36,043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares), Beginning at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">241.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity, Beginning Balance at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">9,151<span></span>
</td>
<td class="nump">28,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,236)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests, Beginning Balance at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity, Beginning Balance at Mar. 31, 2022</a></td>
<td class="nump">36,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Shareholders' net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income (Loss) Attributable to Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">1,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Shareholders' other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(913)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other Comprehensive (Loss) Income, Attributable to Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(916)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_NoncontrollingInterestPeriodIncreaseDecrease', window );">Noncontrolling interests adjustment</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase and retirement of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock</a></td>
<td class="num">(624)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="num">(576)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends and dividend equivalents</a></td>
<td class="num">(310)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(310)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock plans, net of related tax benefits, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock under employee stock plans, net of related tax benefits</a></td>
<td class="nump">111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments', window );">Convertible debenture repurchases, conversions and tax adjustments</a></td>
<td class="num">(80)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares), Ending at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity, Ending Balance at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">9,134<span></span>
</td>
<td class="nump">28,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,149)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests, Ending Balance at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity, Ending Balance at Jun. 30, 2022</a></td>
<td class="nump">35,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Shareholders' net income</a></td>
<td class="nump">1,618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income (Loss) Attributable to Noncontrolling Interest</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">1,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Shareholders' other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(635)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other Comprehensive (Loss) Income, Attributable to Noncontrolling Interest</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(638)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Noncontrolling interests adjustment</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_NoncontrollingInterestPeriodIncreaseDecrease', window );">Noncontrolling interests adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase and retirement of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock</a></td>
<td class="num">(579)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="num">(532)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends and dividend equivalents</a></td>
<td class="num">(307)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(307)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock plans, net of related tax benefits, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock under employee stock plans, net of related tax benefits</a></td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments', window );">Convertible debenture repurchases, conversions and tax adjustments</a></td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares), Ending at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity, Ending Balance at Sep. 30, 2022</a></td>
<td class="nump">35,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 9,169<span></span>
</td>
<td class="nump">$ 29,604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,784)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests, Ending Balance at Sep. 30, 2022</a></td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity, Ending Balance at Sep. 30, 2022</a></td>
<td class="nump">$ 36,043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_NoncontrollingInterestPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Period Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_NoncontrollingInterestPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of subsequent adjustments to additional paid in capital for convertible financial instruments where a component of equity and a component of debt are recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569655-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898689675312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Organization</a></td>
<td class="text">Organization<div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 18, 2022, our shareholders approved a proposal to amend our amended and restated articles of incorporation to change our name from Anthem, Inc. to Elevance Health, Inc. This amendment and name change went into effect on June 27, 2022. We began operating as Elevance Health, Inc. and trading under our new ticker symbol &#8220;ELV&#8221; on June 28, 2022. References to the terms &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221; or &#8220;Elevance Health&#8221; used throughout these Notes to Consolidated Financial Statements refer to Elevance Health, Inc., an Indiana corporation, and unless the context otherwise requires, its direct and indirect subsidiaries. References to the &#8220;states&#8221; include the District of Columbia and Puerto Rico, unless the context otherwise requires.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Elevance Health is a health company with the purpose of improving the health of humanity. We are the largest health insurer in the United States in terms of medical membership, serving over 47 million medical members through our affiliated health plans as of September&#160;30, 2022. We offer a broad spectrum of network-based managed care risk-based plans to Individual, Group, Medicaid and Medicare markets. In addition, we provide a broad array of managed care services to fee-based customers, including claims processing, stop loss insurance, provider network access, medical management, care management and wellness programs, actuarial services and other administrative services. We also provide services to the federal government in connection with our Federal Health Products &amp; Services business, which administers the Federal Employees Health Benefits (&#8220;FEHB&#8221;) Program. We provide an array of specialty services both to our subsidiary health plans and also unaffiliated health plans, including pharmacy benefits management (&#8220;PBM&#8221;) services and dental, vision, life, disability and supplemental health insurance benefits, as well as integrated health services. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an independent licensee of the Blue Cross and Blue Shield Association (&#8220;BCBSA&#8221;), an association of independent health benefit plans. We serve our members as the Blue Cross licensee for California and as the Blue Cross and Blue Shield (&#8220;BCBS&#8221;) licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (in the New York City metropolitan area and upstate New York), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.) and Wisconsin. In a majority of these service areas, we do business as Anthem Blue Cross, Anthem Blue Cross and Blue Shield, and Empire Blue Cross Blue Shield or Empire Blue Cross. In addition, we conduct business through arrangements with other BCBS licensees as well as other strategic partners. Through our subsidiaries, we also serve customers in numerous states as AIM Specialty Health, Amerigroup, Aspire Health, Beacon, CareMore, Freedom Health, HealthLink, HealthSun, Integra Managed Care, MMM, Optimum HealthCare, Simply Healthcare, and/or UniCare. We offer PBM services through our IngenioRx, Inc. (&#8220;IngenioRx&#8221;) subsidiary. We are licensed to conduct insurance operations in all 50 states, the District of Columbia and Puerto Rico through our subsidiaries.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our name change to Elevance Health, on June 15, 2022 we announced that over the next several years we will organize our brand portfolio into the following core go-to-market brands:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Anthem Blue Cross/Anthem Blue Cross and Blue Shield &#8212; represents our existing Anthem-branded and affiliated Blue Cross and/or Blue Shield licensed plans;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Wellpoint &#8212; we intend to unite select non-BCBSA licensed Medicare, Medicaid and Commercial plans under the Wellpoint name; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Carelon &#8212; this brand will bring together our healthcare brands and capabilities, including our Diversified Business Group and IngenioRx business under a single brand name. We now refer to our Diversified Business Group as Carelon. In January 2023, IngenioRx will become CarelonRx.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are currently no segment changes associated with this branding strategy. Our branding strategy reflects the evolution of our business from a traditional health insurance company to a lifetime, trusted health partner, and given this evolution we are in the process of reviewing and modifying how we will manage our businesses in the future.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898687354496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis Of Presentation and Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Significant Accounting Policies</a></td>
<td class="text">Basis of Presentation and Significant Accounting Policies<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for annual financial statements. We have omitted certain footnote disclosures that would substantially duplicate the disclosures in our 2021 Annual Report on Form 10-K, unless the information contained in those disclosures materially changed or is required by GAAP. In the opinion of management, all adjustments, including normal recurring adjustments, necessary for a fair statement of the consolidated financial statements as of and for the three and nine months ended September&#160;30, 2022 and 2021 have been recorded. The results of operations for the three and nine months ended September&#160;30, 2022 are not necessarily indicative of the results that may be expected for the full year ending December&#160;31, 2022, or any other period. The seasonal nature of portions of our health care and related benefits business, competitive and other market conditions, as well as COVID-19 related impacts, may cause full-year results to differ from estimates based upon our interim results of operations. These unaudited consolidated financial statements should be read in conjunction with our audited consolidated financial statements as of and for the year ended December&#160;31, 2021 included in our 2021 Annual Report on Form 10-K.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our subsidiaries operate outside of the United States and have functional currencies other than the U.S. dollar (&#8220;USD&#8221;). We translate the assets and liabilities of those subsidiaries to USD using the exchange rate in effect at the end of the period. We translate the revenues and expenses of those subsidiaries to USD using the average exchange rates in effect during the period. The net effect of these translation adjustments is included in &#8220;Foreign currency translation adjustments&#8221; in our consolidated statements of comprehensive income.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We control a number of bank accounts that are used exclusively to hold customer funds for the administration of customer benefits and we have cash and cash equivalents on deposit to meet certain regulatory requirements. These amounts totaled $291 and $173 at September&#160;30, 2022 and December&#160;31, 2021, respectively, and are included in the cash and cash equivalents line on our consolidated balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classify fixed maturity securities in our investment portfolio as &#8220;available-for-sale&#8221; and report those securities at fair value. Certain fixed maturity securities are available to support current operations and, accordingly, we classify such investments as current assets without regard to their contractual maturity. Investments used to satisfy contractual, regulatory or other requirements are classified as long-term, without regard to contractual maturity.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a fixed maturity security is in an unrealized loss position and we have the intent to sell the fixed maturity security, or it is more likely than not that we will have to sell the fixed maturity security before recovery of its amortized cost basis, we write down the fixed maturity security&#8217;s cost basis to fair value and record an impairment loss in our consolidated statements of income. For impaired fixed maturity securities that we do not intend to sell or if it is more likely than not that we will not have to sell such securities, but we expect that we will not fully recover the amortized cost basis, we recognize the credit component of the impairment as an allowance for credit loss in our consolidated balance sheets and record an impairment loss in our consolidated statements of income. The non-credit component of the impairment is recognized in accumulated other comprehensive loss. Furthermore, unrealized losses entirely caused by non-credit-related factors related to fixed maturity securities for which we expect to fully recover the amortized cost basis continue to be recognized in accumulated other comprehensive loss. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit component of an impairment is determined primarily by comparing the net present value of projected future cash flows with the amortized cost basis of the fixed maturity security. The net present value is calculated by discounting our best estimate of projected future cash flows at the effective interest rate implicit in the fixed maturity security at the date of purchase. For mortgage-backed and asset-backed securities, cash flow estimates are based on assumptions regarding the underlying collateral, including prepayment speeds, vintage, type of underlying asset, geographic concentrations, default rates, recoveries and changes in value. For all other securities, cash flow estimates are driven by assumptions regarding probability of default, including changes in credit ratings and estimates regarding timing and amount of recoveries associated with a default.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For asset-backed securities included in fixed maturity securities, we recognize income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The net investment in the </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">securities is adjusted to the amount that would have existed had the new effective yield been applied since the purchase date of the securities. Such adjustments are reported within net investment income.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The changes in fair value of our marketable equity securities are recognized in our results of operations within net gains and losses on financial instruments. Certain marketable equity securities are held to satisfy contractual obligations, and are reported under the caption &#8220;Other invested assets&#8221; in our consolidated balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have corporate-owned life insurance policies on certain participants in our deferred compensation plans and other members of management. The cash surrender value of the corporate-owned life insurance policies is reported under the caption &#8220;Other invested assets&#8221; in our consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the equity method of accounting for investments in companies in which our ownership interest may enable us to influence the operating or financial decisions of the investee company. Our proportionate share of equity in net income of these unconsolidated affiliates is reported within net investment income. The equity method investments are reported under the caption &#8220;Other invested assets&#8221; in our consolidated balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment income is recorded when earned. All securities sold resulting in investment gains and losses are recorded on the trade date. Realized gains and losses are determined on the basis of the cost or amortized cost of the specific securities sold.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in securities lending programs whereby marketable securities in our investment portfolio are transferred to independent brokers or dealers in exchange for cash and securities collateral. We recognize the collateral as an asset, which is reported under the caption &#8220;Other current assets&#8221; in our consolidated balance sheets, and we record a corresponding liability for the obligation to return the collateral to the borrower, which is reported under the caption &#8220;Other current liabilities&#8221; in our consolidated balance sheets. The securities on loan are reported in the applicable investment category on our consolidated balance sheets. Unrealized gains or losses on securities lending collateral are included in accumulated other comprehensive loss as a separate component of shareholders&#8217; equity. The market value of loaned securities and that of the collateral pledged can fluctuate in non-synchronized fashions.&#160;To the extent the loaned securities&#8217; value appreciates faster or depreciates slower than the value of the collateral pledged, we are exposed to the risk of the shortfall.&#160;As a primary mitigating mechanism, the loaned securities and collateral pledged are marked to market on a daily basis and the shortfall, if any, is collected accordingly.&#160;Secondarily, the collateral level is set at 102% of the value of the loaned securities, which provides a cushion before any shortfall arises. The investment of the cash collateral is subject to market risk, which is managed by limiting the investments to higher quality and shorter duration instruments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Receivables are reported net of amounts for expected credit losses. The allowance for doubtful accounts is based on historical collection trends, future forecasts and our judgment regarding the ability to collect specific accounts.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Premium receivables include the uncollected amounts from risk-based groups, individuals and government programs for insurance services. Premium receivables are reported net of an allowance for doubtful accounts of $140 and $142 at September&#160;30, 2022 and December&#160;31, 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Self-funded receivables include administrative fees, claims and other amounts due from fee-based customers for administrative services. Self-funded receivables are reported net of an allowance for doubtful accounts of $82 and $50 at September&#160;30, 2022 and December&#160;31, 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other receivables include pharmacy rebates, provider advances, claims recoveries, reinsurance receivables, proceeds due from brokers on investment trades, accrued investment income, and other miscellaneous amounts due to us. These receivables are reported net of an allowance for doubtful accounts of $709 and $648 at September&#160;30, 2022 and December&#160;31, 2021, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For our non-risk-based contracts, we had no material contract assets, contract liabilities or deferred contract costs&#160;recorded on our consolidated balance sheet at September&#160;30, 2022. For the three and nine months ended September&#160;30, 2022 and 2021, revenue recognized from performance obligations related to prior periods, such as due to changes in transaction price, was not material. For contracts that have an original expected duration of greater than one year, revenue expected to be recognized in future periods related to unfulfilled contractual performance obligations and contracts with variable consideration related to undelivered performance obligations is not material.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Guidance: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update No. 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2021-01&#8221;). The amendments in ASU 2021-01 provide optional expedients and exceptions for applying GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference the London Interbank Offered Rate (&#8220;LIBOR&#8221;) or another reference rate expected to be discontinued because of the reference rate reform. The provisions must be applied at a Topic, Subtopic, or Industry Subtopic level for all transactions other than derivatives, which may be applied at a hedging relationship level. We adopted ASU 2021-01 on January 7, 2021, and the adoption did not have an impact on our consolidated financial position, results of operations or cash flows.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued Accounting Standards Update No. 2020-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements to Subtopic 310-20, Receivables&#8212;Nonrefundable Fees and Other Costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-08&#8221;). The amendments in ASU 2020-08 clarify when an entity should assess whether a callable debt security is within the scope of accounting guidance, which impacts the amortization period for nonrefundable fees and other costs. ASU 2020-08 became effective for interim and annual reporting periods beginning after December 15, 2020. The amendments were to be applied on a prospective basis as of the beginning of the period of adoption for existing or newly purchased callable debt securities. We adopted ASU 2020-08 on January 1, 2021, and the adoption did not have an impact on our consolidated financial position, results of operations or cash flows.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued Accounting Standards Update No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-06&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments eliminate two of the three accounting models that require separate accounting for convertible features of debt securities, simplify the contract settlement assessment for equity classification, require the use of the if-converted method for all convertible instruments in the diluted earnings per share calculation and expand disclosure requirements. The amendments became effective for our annual and interim reporting periods beginning after December 15, 2021. We adopted ASU 2020-06 on January 1, 2022 using the modified retrospective transition method, which resulted in an increase to our reported debt outstanding of $31, a decrease to our deferred tax liabilities of $8, and a corresponding cumulative-effect reduction to our opening retained earnings of $23; these amounts are not material to our overall consolidated financial position. The adoption of ASU 2020-06 did not have an impact on our results of operations or our consolidated cash flows. Use of the if-converted method did not have an impact on our overall earnings per share calculation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued Accounting Standards Update No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2019-12&#8221;). The amendments in ASU 2019-12 remove certain exceptions to the general principles in Accounting Standards Codification Topic 740. The amendments also clarify and amend existing guidance to improve consistent application. The amendments became effective for our annual reporting periods beginning after December 15, 2020. The transition method (retrospective, modified retrospective, or prospective basis) related to the amendments depends on the applicable guidance, and all amendments for which there is no transition guidance specified are to be applied on a prospective basis. We adopted ASU 2019-12 on January 1, 2021, and the adoption did not have an impact on our consolidated financial position, results of operations or cash flows.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Guidance Not Yet Adopted: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, the FASB issued Accounting Standards Update No. 2020-11,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Financial Services&#8212;Insurance (Topic 944): Effective Date and Early Application </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-11&#8221;). The amendments in ASU 2020-11 make changes to the effective date and early application of Accounting Standards Update No. 2018-12,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Financial Services&#8212;Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2018-12&#8221;), which was issued in November 2018. The amendments in ASU 2020-11 have extended the original effective date by one year, and now the amendments are required for our interim and annual reporting periods beginning after December 15, 2022. The amendments in ASU 2018-12 make changes to a variety of areas to simplify or improve the existing recognition, measurement, presentation and disclosure requirements for long-duration contracts issued by an insurance entity. The amendments require insurers to annually review the assumptions they make about their policyholders and update the liabilities for future policy benefits if the assumptions change. The amendments also simplify the amortization of deferred contract acquisition costs and add new disclosure requirements about the assumptions insurers use to measure their liabilities and how they may affect future cash flows. The amendments related to the liability for future policy benefits for traditional and limited-payment contracts and deferred acquisition costs are to be applied to contracts in force as of the beginning of the earliest period presented, with an option to apply such amendments retrospectively with a cumulative-effect adjustment to the opening balance of retained earnings as of the earliest period presented. The amendments </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for market risk benefits are to be applied retrospectively. We do not believe the adoption of ASU 2020-11 and ASU 2018-12 will have a material impact on our consolidated financial position, results of operations, cash flows, and related disclosures.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other new accounting pronouncements that were issued or became effective since the issuance of our 2021 Annual Report on Form 10-K that had, or are expected to have, a material impact on our consolidated financial position, results of operations or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898773602848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Business Acquisitions</a></td>
<td class="text">Business Acquisitions<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Completed Acquisitions </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 5, 2022, we completed our acquisition of Integra Managed Care (&#8220;Integra&#8221;) from Personal Touch Holding Corporation. Integra is a managed long-term care plan that serves New York state Medicaid members, enabling adults with long-term care needs and disabilities to live safely and independently in their own homes. The purchase price was allocated to the tangible and intangible net assets acquired based on management&#8217;s initial estimates of their fair values, of which $89 has been allocated to finite-lived intangible assets, $250 to indefinite-lived intangible assets, and $123 to goodwill, including measurement period adjustments to goodwill of $13 during the quarter ended September 30, 2022. The majority of goodwill is deductible for income tax purposes. As of September&#160;30, 2022, the initial accounting for the acquisition had not been finalized. Any subsequent adjustments made to the assets acquired or liabilities assumed during the measurement period will be recorded as an adjustment to goodwill. The proforma effects of this acquisition for prior periods were not material to our consolidated results of operations.</span></div>Acquisitions completed during the year ended December 31, 2021, for which the initial accounting was finalized during the three months ended June 30, 2022 included myNEXUS, Inc. (&#8220;myNEXUS&#8221;), a comprehensive home-based nursing management company for payors, and MMM Holdings, LLC (&#8220;MMM&#8221;), including its Medicare Advantage plan, Medicaid plan and other affiliated companies. As of September&#160;30, 2022, the purchase price of each transaction was allocated to the tangible and intangible net assets acquired based on management&#8217;s final estimates of their fair values, of which $1,577 has been allocated to finite-lived intangible assets, $20 to indefinite-lived intangible assets, and $2,531 to goodwill. The majority of goodwill is not deductible for income tax purposes.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898691579264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Optimization Initiatives<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_BusinessOptimizationInitiativesAbstract', window );"><strong>Business Optimization Initiatives [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Business Optimization Initiatives</a></td>
<td class="text">Business Optimization Initiatives<div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provided below is a summary of the activity, by reportable segment, related to the liability for employee termination costs previously incurred in connection with our enterprise-wide business optimization initiatives introduced in 2020.</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial &amp; Specialty Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Government Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">IngenioRx</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020 Business Optimization Initiatives</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for employee termination costs at            January 1, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for employee termination costs at September&#160;30, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_BusinessOptimizationInitiativesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Optimization Initiatives</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_BusinessOptimizationInitiativesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898772775056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">Investments <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed Maturity Securities</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our available-for-sale fixed maturity securities for declines based on qualitative and quantitative factors. We have established an allowance for credit loss and recorded credit loss expense as a reflection of our expected impairment losses. We continue to review our investment portfolios under our impairment review policy. Given the inherent uncertainty of changes in market conditions and the significant judgments involved, there is a continuing risk that declines in fair value may occur and additional material impairment losses for credit losses on investments may be recorded in future periods.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of current and long-term fixed maturity securities, available-for-sale, at September&#160;30, 2022 and December&#160;31, 2021 is as follows:</span></div><div style="margin-bottom:4pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost or Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance <br/>For Credit <br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair&#160;Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States Government securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government sponsored securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(355)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,560)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(506)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,977&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,877)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States Government securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government sponsored securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,257&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,899&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For fixed maturity securities in an unrealized loss position at September&#160;30, 2022 and December&#160;31, 2021, the following table summarizes the aggregate fair values and gross unrealized losses by length of time those securities have continuously been in an unrealized loss position:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.358%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Securities are whole amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States Government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government sponsored securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,165)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(395)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,056)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(821)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States Government securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government sponsored securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,846&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,571&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,755&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although not material to our consolidated results of operations, during the nine months ended September&#160;30, 2022, we recorded a combination of credit losses, losses on sales of fixed maturity securities and impairments related to our exposure resulting from investments in Russia and Ukraine. At September&#160;30, 2022, our remaining holdings of Russia and Ukraine fixed maturity securities were not material.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized losses on our securities shown in the table above have not been recognized into income because, as of September 30, 2022, we do not intend to sell these investments and it is likely that we will not be required to sell these investments prior to their maturity or anticipated recovery. The declines in fair values are largely due to increasing interest rates driven by the high rate of inflation and other market conditions and not by unfavorable changes in the credit quality characteristics that impact our assessment on collectability of principal and interest. We have evaluated qualitative and quantitative factors for indications of credit losses on our securities, including factors such as credit rating, foreign political conflicts, uncertainties around future ability to collect payment, significant declines in fair value and industry conditions, market data, and notifications of maturity and coupon default, and have recorded an allowance for credit losses in the amount of $10 and $6 at September 30, 2022 and December 31, 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of fixed maturity securities at September&#160;30, 2022, by contractual maturity, are shown below. Expected maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations.</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.780%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.782%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,977&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,148&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2022, we received total proceeds from sales, maturities, calls or redemptions of fixed maturity securities of $5,281 and $15,953, respectively. During the three and nine months ended September&#160;30, 2021, we received total proceeds from sales, maturities, calls or redemptions of fixed maturity securities of $2,620 and $8,570, respectively.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we may sell securities at a loss for a number of reasons, including, but not limited to: (i)&#160;changes in the investment environment; (ii)&#160;expectation that the fair value could deteriorate further; (iii)&#160;desire to reduce exposure to an issuer or an industry; (iv)&#160;changes in credit quality; or (v)&#160;changes in expected cash flow.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All securities sold resulting in investment gains and losses are recorded on the trade date. Realized gains and losses are determined on the basis of the cost or amortized cost of the specific securities sold.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Securities </span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of marketable equity securities at September&#160;30, 2022 and December&#160;31, 2021 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"/><td style="width:68.211%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.871%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange traded funds</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common equity securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,503&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,881&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Invested Assets</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other invested assets include primarily our investments in limited partnerships, joint ventures and other non-controlled corporations, mortgage loans and the cash surrender value of corporate-owned life insurance policies. Investments in limited partnerships, joint ventures and other non-controlled corporations are carried at our share in the entities&#8217; undistributed earnings, which approximates fair value. Financial information for certain of these investments are reported on a one or three month lag due to the timing of when we receive financial information from the companies.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Gains and Losses</span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net investment (losses) gains for the three and nine months ended September&#160;30, 2022 and 2021 are as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.873%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended <br/>September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (losses) gains:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized gains from sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized losses from sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment (losses) recoveries recognized in income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized (losses) gains from sales of fixed maturity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(334)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses) gains recognized on equity securities still held at the end of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gains (losses) recognized on equity securities sold during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net losses on equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment (losses) recoveries recognized in income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net losses (gains) on other investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (losses) gains on investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(482)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Investment Income</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022 and December&#160;31, 2021, accrued investment income totaled $228 and $205, respectively. We recognize accrued investment income under the caption &#8220;Other receivables&#8221; on our consolidated balance sheets.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securities Lending Programs</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in securities lending programs whereby marketable securities in our investment portfolio are transferred to independent brokers or dealers in exchange for cash and securities collateral. The fair value of the collateral received at the time of the transactions amounted to $2,841 and $2,155 at September&#160;30, 2022 and December&#160;31, 2021, respectively. The value of the collateral represented 102% of the market value of the securities on loan at each of September&#160;30, 2022 and December&#160;31, 2021. We recognize the collateral as an asset under the caption &#8220;Other current assets&#8221; in our consolidated balance sheets, and we recognize a corresponding liability for the obligation to return the collateral to the borrower under the caption &#8220;Other current liabilities.&#8221; The securities on loan are reported in the applicable investment category on our consolidated balance sheets. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022 and December&#160;31, 2021, the remaining contractual maturity of our securities lending agreements included overnight and continuous transactions of cash for $2,636 and $1,874, respectively, of United States Government securities for $180 and $281, respectively, and of Other securities for $25 and $0, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898687383328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">Derivative Financial Instruments<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We primarily invest in the following types of derivative financial instruments: interest rate swaps, futures, forward contracts, put and call options, swaptions, embedded derivatives and warrants. We also enter into master netting agreements, which reduce credit risk by permitting net settlement of transactions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into various interest rate swap contracts to convert a portion of our interest rate exposure on our long-term debt from fixed rates to floating rates. The floating rates payable on all of our fair value hedges are benchmarked to </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIBOR or the Secured Overnight Financing Rate (&#8220;SOFR&#8221;). Any amounts recognized for changes in fair value of these derivatives are included in the captions &#8220;Other current assets,&#8221; &#8220;Other noncurrent assets,&#8221; &#8220;Other current liabilities&#8221; or &#8220;Other noncurrent liabilities&#8221; in our consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unrecognized loss for all expired and terminated cash flow hedges included in accumulated other comprehensive loss, net of tax, was $231 and $239 at September&#160;30, 2022 and December&#160;31, 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">three and nine months ended September&#160;30, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, we recognized net (losses) gains on non-hedging derivatives of $(3) and $43, respectively. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">three and nine months ended September&#160;30, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, we recognized net gains on non-hedging derivatives of $12 and $59, respectively.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information relating to the fair value of our derivative assets and liabilities, see Note 7, &#8220;Fair Value,&#8221; of this Form 10-Q.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898689572272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value</a></td>
<td class="text">Fair Value<div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities recorded at fair value in our consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Level inputs, as defined by FASB guidance for fair value measurements and disclosures, are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.553%"><tr><td style="width:1.0%"/><td style="width:8.317%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:88.736%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Level&#160;Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Input Definition</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs that reflect management&#8217;s best estimate of what market participants would use in pricing the asset or liability at the measurement date.</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:4pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following methods, assumptions and inputs were used to determine the fair value of each class of the following assets and liabilities recorded at fair value in our consolidated balance sheets:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash equivalents:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cash equivalents primarily consist of highly rated money market funds with maturities of three months or less and are purchased daily at par value with specified yield rates. Due to the high ratings and short-term nature of the funds, we designate all cash equivalents as Level I.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fixed maturity securities, available-for-sale:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair values of available-for-sale fixed maturity securities are based on quoted market prices, where available. These fair values are obtained primarily from third-party pricing services, which generally use Level I or Level II inputs for the determination of fair value to facilitate fair value measurements and disclosures. Level II securities primarily include corporate securities, securities from states, municipalities and political subdivisions, mortgage-backed securities, United States government securities, foreign government securities, and certain other asset-backed securities. For securities not actively traded, the pricing services may use quoted market prices of comparable instruments or discounted cash flow analyses, incorporating inputs that are currently observable in the markets for similar securities. We have controls in place to review the pricing services&#8217; qualifications and procedures used to determine fair values. In addition, we periodically review the pricing services&#8217; pricing methodologies, data sources and pricing inputs to ensure the fair values obtained are reasonable. Inputs that are often used in the valuation methodologies include, but are not limited to, broker quotes, benchmark yields, credit spreads, default rates and prepayment speeds. We also have certain fixed maturity securities, primarily corporate debt securities, which are designated Level III securities. For these securities, the valuation methodologies may incorporate broker quotes or discounted cash flow analyses using assumptions for inputs such as expected cash flows, benchmark yields, credit spreads, default rates and prepayment speeds that are not observable in the markets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity securities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair values of equity securities are generally designated as Level I and are based on quoted market prices. For certain equity securities, quoted market prices for the identical security are not always available, and the fair value is estimated by reference to similar securities for which quoted prices are available. These securities are designated Level II. We also have certain equity securities, including private equity securities, for which the fair value is estimated based on each security&#8217;s current condition and future cash flow projections. Such securities are designated Level III. The fair values of these private equity securities are generally based on either broker quotes or discounted cash flow projections using assumptions </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for inputs such as the weighted-average cost of capital, long-term revenue growth rates and earnings before interest, taxes, depreciation and amortization, and/or revenue multiples that are not observable in the markets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Securities lending collateral:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair values of securities lending collateral are based on quoted market prices, where available. These fair values are obtained primarily from third-party pricing services, which generally use Level I or Level II inputs for the determination of fair value, to facilitate fair value measurements and disclosures.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair values are based on the quoted market prices by the financial institution that is the counterparty to the derivative transaction. We independently verify prices provided by the counterparties using valuation models that incorporate observable market inputs for similar derivative transactions. Derivatives are designated as Level II securities. Derivatives presented within the fair value hierarchy table below are presented on a gross basis and not on a master netting basis by counterparty.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of fair value measurements by level for assets and liabilities measured at fair value on a recurring basis at September&#160;30, 2022 and December&#160;31, 2021 is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.786%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;III</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities, available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States Government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government sponsored securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions, tax-exempt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities, available-for-sale</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,708&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange traded funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,409&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,503&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other invested assets - common equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities lending collateral</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives - other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,352&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,573&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,460&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives - other liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities, available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States Government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government sponsored securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions, tax-exempt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities, available-for-sale</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,539&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,899&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange traded funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,758&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,881&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other invested assets - common equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities lending collateral</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives - other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,311&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,747&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,507&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives - other liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balances of assets measured at fair value on a recurring basis using Level III inputs for the three months ended September 30, 2022 and 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Residential<br/>Mortgage-<br/>backed<br/>Securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance at July 1, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total losses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers out of Level III</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance at September 30, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-5.4pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrealized losses included in net income related to assets still held at September 30, 2022</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance at July 1, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total gains:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers out of Level III</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance at September 30, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-5.4pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrealized gains included in net income related to assets still held at September 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balances of assets measured at fair value on a recurring basis using Level III inputs for the nine months ended September 30, 2022 and 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Residential<br/>Mortgage-<br/>backed<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance at January 1, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total losses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(201)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers into Level III</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers out of Level III</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance at September 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrealized gains included in net income related to assets still held at September 30, 2022</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance at January 1, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total gains:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers out of Level III</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance at September 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrealized gains included in net income related to assets still held at September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no individually material transfers into or out of Level III during the three and nine months ended September&#160;30, 2022 or 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain assets and liabilities are measured at fair value on a nonrecurring basis; that is, the instruments are not measured at fair value on an ongoing basis but are subject to fair value adjustments only in certain circumstances. As disclosed in Note&#160;3, &#8220;Business Acquisitions,&#8221; we completed our acquisition of Integra in the second quarter of 2022 and the acquisitions&#160;of&#160;myNEXUS and MMM during the second quarter of 2021. The net assets acquired in our acquisitions of Integra, myNEXUS and MMM and resulting goodwill and other intangible assets were recorded at fair value&#160;primarily&#160;using Level III inputs. The majority of&#160;assets acquired and liabilities assumed were recorded at their carrying values as of the respective date of acquisition, as their carrying values approximated their fair values due to their short-term nature. The fair values of goodwill and other intangible assets acquired in our acquisitions of Integra, myNEXUS and MMM were internally estimated based on the income approach. The income approach estimates fair value based on the present value of the cash flows that the assets could be expected to generate in the future. We developed internal estimates for the expected cash flows and discount rate in the present value calculation.&#160;Other than the assets acquired and liabilities assumed in our acquisitions of Integra, myNEXUS and MMM described above, there were no material assets or liabilities measured at fair value on a nonrecurring basis during the three and nine months ended September&#160;30, 2022 or 2021.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our valuation policy is determined by members of our treasury and accounting departments. Whenever possible, our policy is to obtain quoted market prices in active markets to estimate fair values for recognition and disclosure purposes. Where quoted market prices in active markets are not available, fair values are estimated using discounted cash flow analyses, broker quotes, unobservable inputs or other valuation techniques. These techniques are significantly affected by our assumptions, including discount rates and estimates of future cash flows. The use of assumptions for unobservable inputs for the determination of fair value involves a level of judgment and uncertainty. Changes in assumptions that reasonably could have been different at the reporting date may result in a higher or lower determination of fair value. Changes in fair value measurements, if significant, may affect performance of cash flows.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Potential taxes and other transaction costs are not considered in estimating fair values. Our valuation policy is generally to obtain quoted prices for each security from third-party pricing services, which are derived through recently reported trades for identical or similar securities making adjustments through the reporting date based upon available market observable information. As we are responsible for the determination of fair value, we perform analysis on the prices received from the pricing services to determine whether the prices are reasonable estimates of fair value. This analysis is performed by our internal treasury personnel who are familiar with our investment portfolios, the pricing services engaged and the valuation techniques and inputs used. Our analysis includes procedures such as a review of month-to-month price fluctuations and price comparisons to secondary pricing services. There were no adjustments to quoted market prices obtained from the pricing services during the three and nine months ended September&#160;30, 2022 or 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the preceding disclosures on assets recorded at fair value in the consolidated balance sheets, FASB guidance also requires the disclosure of fair values for certain other financial instruments for which it is practicable to estimate fair value, whether or not such values are recognized in our consolidated balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-financial instruments such as real estate, property and equipment, other current assets, deferred income taxes, intangible assets and certain financial instruments, such as policy liabilities, are excluded from the fair value disclosures. Therefore, the fair value amounts cannot be aggregated to determine our underlying economic value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts reported in the consolidated balance sheets for cash, premium receivables, self-funded receivables, other receivables, unearned income, accounts payable and accrued expenses, and certain other current liabilities approximate fair value because of the short-term nature of these items. These assets and liabilities are not listed in the table below.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following methods and assumptions were used to estimate the fair value of each class of financial instrument that is recorded at its carrying value in our consolidated balance sheets:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other invested assets:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other invested assets include primarily our investments in limited partnerships, joint ventures and other non-controlled corporations and mortgage loans, as well as the cash surrender value of corporate-owned life insurance policies. Investments in limited partnerships, joint ventures and other non-controlled corporations are carried at our share in the entities&#8217; undistributed earnings, which approximates fair value. Mortgage loans are carried at amortized cost, which approximates fair value. The carrying value of corporate-owned life insurance policies represents the cash surrender value as reported by the respective insurer, which approximates fair value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short-term borrowings:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The fair value of our short-term borrowings is based on quoted market prices for the same or similar debt, or, if no quoted market prices were available, on the current market interest rates estimated to be available to us for debt of similar terms and remaining maturities. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term debt&#8212;commercial paper:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The carrying amount for commercial paper approximates fair value, as the underlying instruments have variable interest rates at market value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term debt&#8212;senior unsecured notes and surplus notes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The fair values of our notes are based on quoted market prices in active markets for the same or similar debt, or, if no quoted market prices are available, on the current market observable rates estimated to be available to us for debt of similar terms and remaining maturities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term debt&#8212;convertible debentures:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The fair value of our convertible debentures is based on the quoted market price in the active private market in which the convertible debentures trade.</span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the estimated fair values by level of each class of financial instrument that is recorded at its carrying value on our consolidated balance sheets at September&#160;30, 2022 and December&#160;31, 2021 is as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;I</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other invested assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debentures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other invested assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debentures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898685079696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended September 30, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021, we recognized income tax expense of $533 and $494, respectively, which represent effective income tax rates of 24.8% and 24.7%, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021, we recognized income tax expense of $1,557 and $1,555, respectively, which represent effective income tax rates of 23.5% and 23.8%, respectively. The decrease in our effective tax rate from the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was primarily related to the tax impact of expected geographic changes in our mix of 2022 earnings.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes receivable totaled $214 and $173 at September&#160;30, 2022 and December&#160;31, 2021, respectively. We recognized the income taxes receivable as an asset under the caption &#8220;Other current assets&#8221; in our consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898689633568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Claims Payable<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract', window );"><strong>Liability for Claims and Claims Adjustment Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock', window );">Medical Claims payable</a></td>
<td class="text">Medical Claims Payable<div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balances for medical claims payable, by segment (see Note 15, &#8220;Segment Information&#8221;), for the nine months ended September 30, 2022 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.764%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial<br/>&amp; Specialty<br/>Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Government<br/>Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross medical claims payable, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,847&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,282&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded medical claims payable, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net medical claims payable, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,834&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business combinations and purchase adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net incurred medical claims:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods redundancies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(901)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net incurred medical claims</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,866&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,332&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,276&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net payments attributable to:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period medical claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods medical claims</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,785&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,804&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,672&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net medical claims payable, end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,918&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,998&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded medical claims payable, end of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross medical claims payable, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,921&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,807&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,001&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, the total of net incurred but not reported liabilities plus expected development on reported claims for the Commercial &amp; Specialty Business was $81, $388 and $3,449 for the claim years 2020 and prior, 2021 and 2022, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, the total of net incurred but not reported liabilities plus expected development on reported claims for the Government Business was $148, $508 and $10,151 for the claim years 2020 and prior, 2021 and 2022, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, the total of net incurred but not reported liabilities plus expected development on reported claims for Other was $2, $14 and $257 for the claim years 2020 and prior, 2021 and 2022, respectively.</span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balances for medical claims payable, by segment (see Note 15, &#8220;Segment Information&#8221;), for the nine months ended September 30, 2021 is as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.764%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial<br/>&amp; Specialty<br/>Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Government<br/>Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross medical claims payable, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,646&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded medical claims payable, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net medical claims payable, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,281&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,613&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,089&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business combinations and purchase adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net incurred medical claims:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods redundancies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(496)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,309)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,822)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net incurred medical claims</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,003&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,113&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,275&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net payments attributable to:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period medical claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods medical claims</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,435&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,941&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,523&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net medical claims payable, end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,849&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded medical claims payable, end of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross medical claims payable, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,864&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,183&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,299&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The favorable development recognized in the nine months ended September 30, 2022 and 2021 resulted primarily from trend factors in late 2021 and late 2020, respectively, developing more favorably than originally expected. Favorable development in the completion factors resulting from the latter parts of 2020 developing faster than expected also contributed to the favorable development in the nine months ended September 30, 2021. The impact from COVID-19 on healthcare utilization and medical claims submission patterns continues to provide increased estimation uncertainty on our incurred but not reported liability at September&#160;30, 2022.</span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of net incurred medical claims to benefit expense included in our consolidated statements of income for periods in 2022 is as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.825%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net incurred medical claims:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial &amp; Specialty Business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,834&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,522&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,510&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,866&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net incurred medical claims</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,634&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quality improvement and other claims expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,120&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,215&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,777&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,404&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,396&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the three months ended September 30, 2022, based on recent regulatory clarification, we realigned certain quality improvement costs from benefit expense to administrative expense that were previously allocated to benefit expense during the three months ended March 31, 2022 and the three months ended June 30, 2022.</span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of net incurred medical claims to benefit expense included in our consolidated statements of income for periods in 2021 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.530%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.826%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net incurred medical claims:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial &amp; Specialty Business</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,072&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,718&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,213&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,003&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Business</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net incurred medical claims</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,844&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,704&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,275&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quality improvement and other claims expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,832&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,699&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,763&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,645&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,107&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the medical claims payable reflected in the tables above to the consolidated ending balance for medical claims payable included in the consolidated balance sheet, as of September&#160;30, 2022, is as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.764%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial<br/>&amp; Specialty<br/>Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Government<br/>Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net medical claims payable, end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,918&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,998&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded medical claims payable, end of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance lines other than short duration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross medical claims payable, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,921&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,048&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,242&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -URI https://asc.fasb.org/subtopic&amp;trid=2560295<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898685067776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally issue senior unsecured notes for long-term borrowing purposes. At September&#160;30, 2022 and December&#160;31, 2021, we had $22,722 and $22,359, respectively, outstanding under these notes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 16, 2022, we repaid, at maturity, the $850 outstanding balance of our 3.125% senior unsecured notes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 29, 2022, we issued $600 aggregate principal amount of 4.100% Notes due 2032 (the &#8220;2032 Notes&#8221;) and $700 aggregate principal amount of 4.550% Notes due 2052 (the &#8220;2052 Notes&#8221;) under our shelf registration statement. Interest on the 2032 Notes and 2052 Notes is payable semi-annually in arrears on May 15 and November 15 of each year, commencing November 15, 2022. We used the net proceeds for working capital and general corporate purposes, such as the funding of acquisitions, repayment of short-term and long-term debt and the repurchase of our common stock pursuant to our share repurchase program.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have an unsecured surplus note with an outstanding principal balance of $25 at both September&#160;30, 2022 and December&#160;31, 2021. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a senior revolving credit facility (the &#8220;5-Year Facility&#8221;) with a group of lenders for general corporate purposes. On April 18, 2022, we amended and restated the credit agreement for the 5-Year Facility to, among other things, extend the maturity date of the 5-Year Facility from June 2024 to April 2027 and increase the amount of credit available under the 5-Year Facility from $2,500 to $4,000. Also on April 18, 2022, concurrently with the amendment and restatement of the 5-Year Facility, we terminated our 364-day senior revolving credit facility that provided for credit in the amount of $1,000, which was scheduled to mature in June 2022 (the &#8220;2021 364-Day Facility&#8221;). In June 2021, we terminated our 364-day senior revolving credit facility (the &#8220;prior 364-Day Facility&#8221;), which was scheduled to mature in June 2021, and entered into the 2021 364-Day Facility with a group of lenders for general corporate purposes. Our ability to borrow under the 5-Year Facility is subject to compliance with certain covenants, including covenants requiring us to maintain a defined debt-to-capital ratio of not more than 60%, subject to increase in certain circumstances set forth in the credit agreement for the 5-Year Facility.&#160;As of September&#160;30, 2022, our debt-to-capital ratio, as defined and calculated under the 5-Year Facility, was 39.7%. We do not believe the restrictions contained in our 5-Year Facility covenants materially affect our financial or operating flexibility. As </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of September&#160;30, 2022, we were in compliance with all of our debt covenants under the 5-Year Facility. There were no amounts outstanding under the 5-Year Facility, the 2021 364-Day Facility or the prior 364-Day Facility at any time during the nine months ended September&#160;30, 2022 or the year ended December&#160;31, 2021. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Through certain subsidiaries, we have entered into multiple 364-day lines of credit (the &#8220;Subsidiary Credit Facilities&#8221;) with separate lenders for general corporate purposes. The Subsidiary Credit Facilities provide combined credit of up to $200. At September&#160;30, 2022 and December&#160;31, 2021, there were no amounts outstanding under our Subsidiary Credit Facilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have an authorized commercial paper program of up to $4,000, the proceeds of which may be used for general corporate purposes. In July 2022, we increased the amount available under the commercial paper program from $3,500 to $4,000. At September&#160;30, 2022 and December&#160;31, 2021, we had $675 and $300, respectively, outstanding under this program.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have outstanding senior unsecured convertible debentures due 2042 (the &#8220;Debentures&#8221;), which are governed by an indenture (the &#8220;indenture&#8221;) between us and The Bank of New York Mellon Trust Company, N.A., as trustee. We accounted for the Debentures in accordance with the FASB cash conversion guidance for debt with conversion and other options at the time of issue. As a result, the value of the embedded conversion option (net of deferred taxes and equity issuance costs) was bifurcated from its debt host and recorded as a component of additional paid-in capital in our consolidated balance sheets. We adopted ASU 2020-06 on January 1, 2022 using the modified retrospective transition method, which resulted in an increase to our reported debt outstanding of $31, a decrease of our deferred tax liabilities of $8 and a corresponding cumulative-effect reduction to our opening retained earnings of $23, eliminating the bifurcation of the embedded conversion option. During the three and nine months ended September&#160;30, 2022, $4 and $19 of aggregate principal amount of the Debentures was surrendered for conversion by certain holders in accordance with the terms and provisions of the indenture. We elected to settle the excess of the principal amount of the conversions with cash for total payments during the three and nine months ended September&#160;30, 2022 of $25 and $132, respectively.</span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes at September&#160;30, 2022 the related balances, conversion rate and conversion price of the Debentures:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.060%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.740%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal amount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net debt carrying amount</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion rate (shares of common stock per $1,000 of principal amount)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2967&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective conversion price (per $1,000 of principal amount)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.9462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a member, through certain subsidiaries, of the Federal Home Loan Bank of Indianapolis, the Federal Home Loan Bank of Cincinnati, the Federal Home Loan Bank of Atlanta and the Federal Home Loan Bank of New York (collectively, the &#8220;FHLBs&#8221;). As a member, we have the ability to obtain short-term cash advances, subject to certain minimum collateral requirements. We had $265 and $275 of outstanding short-term borrowings from the FHLBs at September&#160;30, 2022 and December&#160;31, 2021, respectively.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All debt is a direct obligation of Elevance Health, Inc., except for the surplus note, the FHLB borrowings, and the Subsidiary Credit Facilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898689710144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments And Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments And Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Proceedings </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we are defendants in, or parties to, a number of pending or threatened legal actions or proceedings. To the extent a plaintiff or plaintiffs in the following cases have specified in their complaint or in other court filings the amount of damages being sought, we have noted those alleged damages in the descriptions below. With respect to the cases described below, we contest liability and/or the amount of damages in each matter and believe we have meritorious defenses.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where available information indicates that it is probable that a loss has been incurred as of the date of the consolidated financial statements and we can reasonably estimate the amount of that loss, we accrue the estimated loss by a charge to </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">income. In many proceedings, however, it is difficult to determine whether any loss is probable or reasonably possible. In addition, even where loss is possible or an exposure to loss exists in excess of the liability already accrued with respect to a previously identified loss contingency, it is not always possible to reasonably estimate the amount of the possible loss or range of loss. </span></div><div style="margin-bottom:9pt;padding-right:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to many of the proceedings to which we are a party, we cannot provide an estimate of the possible losses, or the range of possible losses in excess of the amount, if any, accrued, for various reasons, including but not limited to some or all of the following: (i) there are novel or unsettled legal issues presented, (ii) the proceedings are in early stages, (iii) there is uncertainty as to the likelihood of a class being certified or decertified or the ultimate size and scope of the class, (iv) there is uncertainty as to the outcome of pending appeals or motions, (v) there are significant factual issues to be resolved, and/or (vi) in many cases, the plaintiffs have not specified damages in their complaint or in court filings. For those legal proceedings where a loss is probable, or reasonably possible, and for which it is possible to reasonably estimate the amount of the possible loss or range of losses, we currently believe that the range of possible losses, in excess of established reserves is, in the aggregate, from $0 to approximately $250 at September&#160;30, 2022. This estimated aggregate range of reasonably possible losses is based upon currently available information taking into account our best estimate of such losses for which such an estimate can be made.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Blue Cross Blue Shield Antitrust Litigation</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a defendant in multiple lawsuits that were initially filed in 2012 against the BCBSA and Blue Cross and/or Blue Shield licensees (the &#8220;Blue plans&#8221;) across the country. Cases filed in twenty-eight states were consolidated into a single, multi-district proceeding captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re Blue Cross Blue Shield Antitrust Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that is pending in the U.S. District Court for the Northern District of Alabama (the &#8220;Court&#8221;). Generally, the suits allege that the BCBSA and the Blue plans have conspired to horizontally allocate geographic markets through license agreements, best efforts rules that limit the percentage of non-Blue revenue of each plan, restrictions on acquisitions, rules governing the BlueCard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and National Accounts programs and other arrangements in violation of the Sherman Antitrust Act (&#8220;Sherman Act&#8221;) and related state laws. The cases were brought by two putative nationwide classes of plaintiffs, health plan subscribers and providers.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2018, the Court issued an order on the parties&#8217; cross motions for partial summary judgment, determining that the defendants&#8217; aggregation of geographic market allocations and output restrictions are to be analyzed under a per se standard of review, and the BlueCard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">program and other alleged Section 1 Sherman Act violations are to be analyzed under the rule of reason standard of review. With respect to whether the defendants operate as a single entity with regard to the enforcement of the Blue Cross Blue Shield trademarks, the Court found that summary judgment was not appropriate due to the existence of genuine issues of material fact. In April 2019, the plaintiffs filed motions for class certification, which defendants opposed.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The BCBSA and Blue plans approved a settlement agreement and release with the subscriber plaintiffs (the &#8220;Subscriber Settlement Agreement&#8221;), which agreement required the Court&#8217;s approval to become effective. The Subscriber Settlement Agreement requires the defendants to make a monetary settlement payment and contains certain terms imposing non-monetary obligations including (i) eliminating the &#8220;national best efforts&#8221; rule in the BCBSA license agreements (which rule limits the percentage of non-Blue revenue permitted for each Blue plan) and (ii) allowing for some large national employers with self-funded benefit plans to request a bid for insurance coverage from a second Blue plan in addition to the local Blue plan. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, the Court issued an order preliminarily approving the Subscriber Settlement Agreement, following which members of the subscriber class were provided notice of the Subscriber Settlement Agreement and an opportunity to opt out of the class. A small number of subscribers submitted valid opt-outs by the July 2021 opt-out deadline. In excess of eight thousand claims were submitted by the November 2021 claims submission deadline. A fairness hearing was held in October 2021 and the Court took the request for final approval under advisement and requested supplemental briefing that was submitted. In February 2022, the Court ordered the issuance of a supplemental notice to self-funded account class members, which notice process was completed in March 2022. The deadline for objections to the supplemental notice along with opt-outs was in May 2022</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Court issued a final approval order for the Subscriber Settlement Agreement. The Court amended its final approval order in September 2022, further clarifying the injunctive relief that may be available to subscribers who submitted valid opt-outs. In September 2022, an objector filed a motion to amend the final approval order, which the Court </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">denied. In compliance with the Subscriber Settlement Agreement, the Company paid its remaining $506 portion of the settlement fund into an escrow account in September 2022, for an aggregate settlement payment by the Company of $596.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Four notices of appeal of the final approval order were filed by the September 2022 deadline. Those appeals will proceed in the United States Court of Appeals for the Eleventh Circuit. In October 2022, the subscriber plaintiffs filed a motion to consolidate and expedite the four appeals. After all appellate rights have been exhausted in a manner that affirms the Court&#8217;s final order and judgment, the defendants&#8217; payment and non-monetary obligations under the Subscriber Settlement Agreement will become effective.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, after the Court lifted the stay as to the provider litigation, provider plaintiffs filed a renewed motion for class certification, which defendants opposed. In March 2021, the Court issued an order terminating the pending motion for class certification until the Court determines the standard of review applicable to providers&#8217; claims. In May 2021, the defendants and provider plaintiffs filed renewed standard of review motions. In June 2021, the parties filed summary judgment motions not critically dependent on class certification. In February 2022, the Court issued (i) an order granting certain defendants&#8217; motion for partial summary judgment against provider plaintiffs who had previously released claims against such defendants, and (ii) an order granting provider plaintiffs&#8217; motion for partial summary judgment, holding that </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ohio v. American Express Co</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. does not affect the standard of review in this case. In August 2022, the Court issued (i) an order granting in part the defendants&#8217; motion regarding the antitrust standard of review, holding that for the period of time after the elimination of the &#8220;national best efforts&#8221; rule, the rule of reason applies to the provider plaintiffs&#8217; market allocation conspiracy claims, and (ii) an order denying the provider plaintiffs&#8217; motion for partial summary judgment on the standard of review, reaffirming its prior holding that the providers&#8217; group boycott claims are subject to the rule of reason. We intend to continue to vigorously defend the provider litigation, which we believe is without merit; however, its ultimate outcome cannot be presently determined.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of follow-on cases involving entities that opted out of the Subscriber Settlement Agreement have been filed. Those actions are:  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alaska Air Group, Inc., et al. v. Anthem, Inc., et al.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No. 2:21-cv-01209-AMM (N.D. Ala.); </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">JetBlue Airways Corp., et al. v. Anthem, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 2:22-cv-00558-GMB (N.D. Ala.); </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Metropolitan Transportation Authority v. Blue Cross and Blue Shield of Alabama et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 2:22-cv-00265-RDP (N.D. Ala.); </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bed Bath &amp; Beyond Inc. v. Anthem, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 2:22-cv-01256-SGC (N.D. Ala.);</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Hoover, et al. v. Blue Cross Blue Shield Association, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 2:22-cv-00261-RDP (N.D. Ala.); and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">VHS Liquidating Trust v. Blue Cross of California, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. RG21106600 (Cal. Super.). We intend to continue to vigorously defend these follow-on cases, which we believe are without merit; however, their ultimate outcome cannot be presently determined.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Blue Cross of California Taxation Litigation</span></div><div style="margin-bottom:9pt;padding-right:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2013, our California affiliate Blue Cross of California (doing business as Anthem Blue Cross) (&#8220;BCC&#8221;) was named as a defendant in a California taxpayer action filed in Los Angeles County Superior Court (the &#8220;Superior Court&#8221;) captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Michael D. Myers v. State Board of Equalization, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This action was brought under a California statute that permits an individual taxpayer to sue a governmental agency when the taxpayer believes the agency has failed to enforce governing law. Plaintiff contends that BCC, a licensed Health Care Service Plan, is an &#8220;insurer&#8221; for purposes of taxation despite acknowledging it is not an &#8220;insurer&#8221; under regulatory law. At the time, under California law, &#8220;insurers&#8221; were required to pay a gross premiums tax (&#8220;GPT&#8221;) calculated as 2.35% on gross premiums. As a licensed Health Care Service Plan, BCC has paid the California Corporate Franchise Tax (&#8220;CFT&#8221;), the tax paid by California businesses generally. Plaintiff contends that BCC must pay the GPT rather than the CFT, and seeks a writ of mandate directing the taxing agencies to collect the GPT and an order requiring BCC to pay GPT back taxes, interest, and penalties for the eight-year period prior to the filing of the complaint.</span></div><div style="margin-bottom:9pt;padding-right:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the GPT is constitutionally imposed in lieu of certain other taxes, BCC has filed protective tax refund claims with the City of Los Angeles, the California Department of Health Care Services and the Franchise Tax Board to protect its rights to recover certain taxes previously paid should BCC eventually be determined to be subject to the GPT for the tax periods at issue in the litigation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, the Superior Court denied BCC&#8217;s motion for judgment on the pleadings and similar motions brought by other entities. BCC filed a motion for summary judgment with the Superior Court, which was heard in October 2020. In December 2020, the Superior Court granted BCC&#8217;s motion for summary judgment, dismissing the plaintiff&#8217;s lawsuit. In </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 2021, the plaintiff appealed the order granting BCC's motion for summary judgment. BCC&#8217;s responding brief was filed in March 2022. Plaintiff&#8217;s reply was filed in May 2022. We estimate that the appeal will be heard in the winter of 2022. We intend to vigorously defend the appeal of this lawsuit.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Express Scripts, Inc. Pharmacy Benefit Management Litigation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2016, we filed a lawsuit against Express Scripts, Inc. (&#8220;Express Scripts&#8221;), our vendor at the time for PBM services, captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anthem, Inc. v. Express Scripts, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in the U.S. District Court for the Southern District of New York (the &#8220;District Court&#8221;). The lawsuit seeks to recover over $14,800 in damages for pharmacy pricing that is higher than competitive benchmark pricing under the agreement between the parties (the &#8220;ESI PBM Agreement&#8221;), over $158 in damages related to operational breaches, as well as various declarations under the ESI PBM Agreement, including that Express Scripts: (i) breached its obligation to negotiate in good faith and to agree in writing to new pricing terms; (ii) was required to provide competitive benchmark pricing to us through the term of the ESI PBM Agreement; (iii) has breached the ESI PBM Agreement; and (iv) is required under the ESI PBM Agreement to provide post-termination services, at competitive benchmark pricing, for one year following any termination. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Express Scripts has disputed our contractual claims and is seeking declaratory judgments: (i) regarding the timing of the periodic pricing review under the ESI PBM Agreement, and (ii) that it has no obligation to ensure that we receive any specific level of pricing, that we have no contractual right to any change in pricing under the ESI PBM Agreement and that its sole obligation is to negotiate proposed pricing terms in good faith. In the alternative, Express Scripts claims that we have been unjustly enriched by its payment of $4,675 at the time we entered into the ESI PBM Agreement. In March 2017, the District Court granted our motion to dismiss Express Scripts&#8217; counterclaims for (i) breach of the implied covenant of good faith and fair dealing, and (ii) unjust enrichment with prejudice. After such action, the only remaining claims were for breach of contract and declaratory relief. In August 2021, Express Scripts filed a motion for summary judgment, which we opposed. In March 2022, the District Court granted in part and denied in part Express Scripts&#8217; motion for summary judgment. The District Court dismissed our declaratory judgment claim, our breach of contract claim for failure to prove damages and most of our operational breach claims. As a result of the summary judgment decision, the only remaining claims as of the filing of this Quarterly Report on Form 10-Q are (i) our operational breach claim based on Express Scripts&#8217; prior authorization processes and (ii) Express Scripts&#8217; counterclaim for breach of the market check provision of the ESI PBM Agreement. Express Scripts filed a second motion for summary judgment in June 2022, challenging our remaining operational breach claims, which we opposed in July 2022. We intend to appeal the earlier summary judgment decision at the appropriate time, vigorously pursue our claims and defend against counterclaims, which we believe are without merit; however, the ultimate outcome of this litigation cannot be presently determined.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicare Risk Adjustment Litigation</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the U.S. Department of Justice (&#8220;DOJ&#8221;) filed a civil lawsuit against Elevance Health, Inc. (f/k/a Anthem, Inc.) in the U.S. District Court for the Southern District of New York (the &#8220;New York District Court&#8221;) in a case captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States v. Anthem, Inc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The DOJ&#8217;s suit alleges, among other things, that we falsely certified the accuracy of the diagnosis data we submitted to the Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;) for risk-adjustment purposes under Medicare Part C and knowingly failed to delete inaccurate diagnosis codes. The DOJ further alleges that, as a result of these purported acts, we caused CMS to calculate the risk-adjustment payments based on inaccurate diagnosis information, which enabled us to obtain unspecified amounts of payments in Medicare funds in violation of the False Claims Act. The DOJ filed an amended complaint in July 2020, alleging the same causes of action but revising some of its allegations. In September 2020, we filed a motion to transfer the lawsuit to the Southern District of Ohio, a motion to dismiss part of the lawsuit, and a motion to strike certain allegations in the amended complaint. In an opinion and order issued October 3, 2022, the New York District Court denied our motions, and the case will now proceed in such court. We intend to continue to vigorously defend this suit, which we believe is without merit; however, the ultimate outcome cannot be presently determined.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Investigations of CareMore and HealthSun</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the assistance of outside counsel, we are conducting investigations of risk-adjustment practices involving data submitted to CMS (unrelated to our retrospective chart review program) at CareMore Health Plans, Inc. (&#8220;CareMore&#8221;), one of our California subsidiaries, and HealthSun Health Plans, Inc. (&#8220;HealthSun&#8221;), one of our Florida subsidiaries. Our CareMore investigation has resulted in the termination of CareMore&#8217;s relationship with one contracted provider in California. Our </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HealthSun investigation has focused on risk adjustment practices initiated prior to our acquisition of HealthSun in December 2017 that continued after the acquisition. We have voluntarily self-disclosed the existence of both of our investigations to CMS and the Criminal and Civil Divisions of the DOJ. We are cooperating with the ongoing investigations of the Criminal and Civil Divisions of the DOJ related to these risk adjustment practices, and have entered into a tolling agreement with the Civil Division of the DOJ related to its investigation. We are analyzing the scope of potential data corrections to be submitted to CMS and have begun to submit data corrections to CMS. We have also asserted indemnity claims for escrowed funds under the HealthSun purchase agreement for, among other things, breach of healthcare and financial representation provisions, based on the conduct discovered during our investigation. While certain elements of the escrow claims were resolved in the fourth quarter of 2021, litigation in the Delaware Court of Chancery related to the remaining indemnity claims for escrowed funds remains ongoing.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%">Other Contingencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we and certain of our subsidiaries are parties to various legal proceedings, many of which involve claims for coverage encountered in the ordinary course of business. We, like Health Maintenance Organizations (&#8220;HMOs&#8221;) and health insurers generally, exclude certain healthcare and other services from coverage under our HMO, Preferred Provider Organizations and other plans. We are, in the ordinary course of business, subject to the claims of our enrollees arising out of decisions to restrict or deny reimbursement for uncovered services. The loss of even one such claim, if it results in a significant punitive damage award, could have a material adverse effect on us. In addition, the risk of potential liability under punitive damage theories may increase significantly the difficulty of obtaining reasonable reimbursement of coverage claims. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the lawsuits described above, we are also involved in other pending and threatened litigation of the character incidental to our business and are from time to time involved as a party in various governmental investigations, audits, reviews and administrative proceedings. These investigations, audits, reviews and administrative proceedings include routine and special inquiries by state insurance departments, state attorneys general, the U.S. Attorney General and subcommittees of the U.S. Congress. Such investigations, audits, reviews and administrative proceedings could result in the imposition of civil or criminal fines, penalties, other sanctions and additional rules, regulations or other restrictions on our business operations. Any liability that may result from any one of these actions, or in the aggregate, could have a material adverse effect on our consolidated financial position or results of operations. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contractual Obligations and Commitments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, we entered into an agreement with a vendor for information technology infrastructure and related management and support services through June 2025. The new agreement supersedes certain prior agreements for such services and includes provisions for additional services not provided under those agreements. Our remaining commitment under this agreement at September&#160;30, 2022 is approximately $830. We will have the ability to terminate the agreement upon the occurrence of certain events, subject to early termination fees.</span></div>In the second quarter of 2019, we began using our pharmacy benefits manager IngenioRx to market and offer PBM services to our affiliated health plan customers, as well as to external customers outside of the health plans we own. The comprehensive PBM services portfolio includes, but is not limited to, formulary management, pharmacy networks, prescription drug database, member services and mail order capabilities. IngenioRx delegates certain PBM administrative functions, such as claims processing and prescription fulfillment, to CaremarkPCS Health, L.L.C., which is a subsidiary of CVS Health Corporation, pursuant to a five-year agreement. With IngenioRx, we retain the responsibilities for clinical and formulary strategy and development, member and employer experiences, operations, sales, marketing, account management and retail network strategy.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898689767968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalAbstract', window );"><strong>Banking Regulation, Total Capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Capital Stock</a></td>
<td class="text">Capital Stock<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Capital &#8211; Dividends and Stock Repurchase Program</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly review the appropriate use of capital, including acquisitions, common stock and debt security repurchases and dividends to shareholders. The declaration and payment of any dividends or repurchases of our common stock or debt is at the discretion of our Board of Directors and depends upon our financial condition, results of operations, future liquidity needs, regulatory and capital requirements and other factors deemed relevant by our Board of Directors. </span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our cash dividend activity for the nine months ended September 30, 2022 and 2021 is as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.553%"><tr><td style="width:1.0%"/><td style="width:40.006%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.837%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.837%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.914%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.918%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Declaration Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Record&#160;Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Payment&#160;Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dividend</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">per&#160;Share</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 25, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 10, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 25, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.28</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 19, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 10, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 24, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.28</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 19, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 9, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 23, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.28</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 26, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 10, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 25, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.13</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 20, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 10, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 25, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 20, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 10, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 24, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.13</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 18, 2022, our Audit Committee declared a fourth quarter 2022 dividend to shareholders of $1.28 per share, payable on December 21, 2022 to shareholders of record at the close of business on December 5, 2022.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our Board of Directors&#8217; authorization, we maintain a common stock repurchase program. On January 26, 2021, our Audit Committee, pursuant to authorization granted by the Board of Directors, authorized a $5,000 increase to the common stock repurchase program. Repurchases may be made from time to time at prevailing market prices, subject to certain restrictions on volume, pricing and timing. The repurchases are effected from time to time in the open market, through negotiated transactions, including accelerated share repurchase agreements, and through plans designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Our stock repurchase program is discretionary, as we are under no obligation to repurchase shares. We repurchase shares under the program when we believe it is a prudent use of capital. The excess cost of the repurchased shares over par value is charged on a pro rata basis to additional paid-in capital and retained earnings. </span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of common stock repurchases for the nine months ended September 30, 2022 and 2021 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorization remaining at the end of the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding the use of capital for debt security repurchases, see Note 10, &#8220;Debt,&#8221; included in this Form 10-Q and Note 13, &#8220;Debt,&#8221; to our audited consolidated financial statements as of and for the year ended December&#160;31, 2021 included in our 2021 Annual Report on Form 10-K. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Incentive Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">s</span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity for the nine months ended September 30, 2022 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"/><td style="width:44.720%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.887%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Option&#160;Price<br/>per&#160;Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life&#160;(Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.56</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.35</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the status of nonvested restricted stock activity, including restricted stock units and performance units, for the nine months ended September 30, 2022 is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"/><td style="width:72.183%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted<br/>Stock&#160;Shares<br/>and Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant&#160;Date<br/>Fair&#160;Value<br/>per&#160;Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2022, we granted approximately 0.2 restricted stock units that are contingent upon us achieving earnings targets over the three year period from 2022 to 2024. These grants have been included in the activity shown above, but will be subject to adjustment at the end of 2024 based on results in the three year period.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use a binomial lattice valuation model to estimate the fair value of all stock options granted. For a more detailed discussion of our stock incentive plan fair value methodology, see Note 15, &#8220;Capital Stock,&#8221; to our audited consolidated financial statements as of and for the year ended December&#160;31, 2021 included in our 2021 Annual Report on Form 10-K. </span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average assumptions were used to estimate the fair values of options granted during the nine months ended September 30, 2022 and 2021:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"/><td style="width:72.183%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility factor</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarterly dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average expected life (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.50</span></td></tr></table></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average fair values per option or share were determined for the nine months ended September 30, 2022 and 2021:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"/><td style="width:72.183%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted during the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock awards granted during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898687383328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">Accumulated Other Comprehensive Loss <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the components of accumulated other comprehensive loss at September&#160;30, 2022 and 2021 is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended <br/>September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment (losses) gains:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,489)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications, net of tax benefit of $220, $25, $896 and $71, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(719)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,914)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(203)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss, net of tax (expense) benefit of $(21), $5, $(75) and $21, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,630)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(284)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss attributable to noncontrolling interests, net of tax benefit of $(1), $0, $(4) and $(1), respectively</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,125)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,125)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-credit components of impairments on investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax benefit (expense) of $0, $0, $1 and $(1), respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax expense of $0, $0, $(2) and $(2), respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(413)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(534)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(429)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(552)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax expense of $(3), $(4), $(9) and $(10), respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(406)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(526)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(406)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(526)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax benefit of $2, $1, $4 and $2, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of period accumulated other comprehensive (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive loss, net of tax benefit of $198, $27, $815 and $81, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(638)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,617)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive loss attributable to noncontrolling interests, net of tax benefit of $(1), $0, $(4) and $(1), respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of period accumulated other comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,784)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,784)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898684916720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings per Share<div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The denominator for basic and diluted earnings per share for the three and nine months ended September&#160;30, 2022 and 2021 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.084%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for basic earnings per share &#8211; weighted-average shares</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities &#8211; employee stock options, nonvested restricted stock awards and convertible debentures</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for diluted earnings per share</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the three months ended September 30, 2022 and 2021, weighted-average shares related to certain stock options of 0.5 and 0.0, respectively, were excluded from the denominator for diluted earnings per share because the stock options were anti-dilutive. During the nine months ended September 30, 2022 and 2021, weighted-average shares related to certain stock options of 0.4 and 0.3, respectively, were excluded from each of the denominators for diluted earnings per share because the stock options were anti-dilutive.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2022, we issued approximately 0.0 and 0.6 restricted stock units under our stock incentive plans, 0.0 and 0.2 of which vesting is contingent upon us meeting specified annual earnings targets for the three year period of 2022 through 2024. During the three and nine months ended September&#160;30, 2021, we issued approximately 0.1 and 1.0 restricted stock units under our stock incentive plans, 0.0 and 0.3 of which vesting is contingent upon us meeting specified annual earnings targets for the three year period of 2021 through 2023. The contingent restricted stock units have been excluded from the denominators for diluted earnings per share and will be included only if and when the contingency is met.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898689767968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 1 &#8220;Organization&#8221;, we will be organizing our brand portfolio into three core go-to-market brands over the next several years. Our branding strategy reflects the evolution of our business from a traditional health insurance company to a lifetime, trusted health partner, and given this evolution we are in the process of reviewing and modifying how we will manage our businesses in the future. Currently, there are no changes to our segments associated with this branding strategy. The results of our operations continue to be described through four reportable segments: Commercial &amp; Specialty Business, Government Business, IngenioRx and Other.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Commercial &amp; Specialty Business segment offers plans and services to our Individual, Group risk-based, Group fee-based and BlueCard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> members. The Commercial &amp; Specialty Business segment offers health products on a full-risk basis; provides a broad array of administrative managed care services to our fee-based customers; and provides a variety of specialty and other insurance products and services such as dental, vision, life, disability and supplemental health insurance benefits.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Government Business segment includes our Medicare and Medicaid businesses, National Government Services, and services provided to the federal government in connection with the FEHB program. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our IngenioRx segment includes our PBM business. IngenioRx markets and offers PBM services to our affiliated health plan customers, as well as to external customers outside of the health plans we own. IngenioRx has a comprehensive PBM services portfolio, which includes services such as formulary management, pharmacy networks, prescription drug database, member services and mail order capabilities. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Other segment includes our Diversified Business Group, now known as Carelon, which is our health services business focused on lowering the cost and improving the quality of healthcare by enabling and creating new care delivery and payment models, with a special emphasis on serving those with complex and chronic conditions. This segment also includes certain eliminations and corporate expenses not allocated to our other reportable segments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define operating revenues to include premium income, product revenue and administrative fees and other revenues. Operating revenues are derived from premiums and fees received, primarily from the sale and administration of health benefits and pharmacy products and services. Operating gain is calculated as total operating revenue less benefit expense, cost of products sold and selling, general and administrative expense.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Affiliated revenues represent revenues or cost for services provided to our subsidiaries by IngenioRx and Carelon, formerly known as our Diversified Business Group, as well as certain back-office services provided by our international businesses, and are recorded at cost or management&#8217;s estimate of fair market value. These affiliated revenues are eliminated in consolidation.</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial data by reportable segment for the three and nine months ended September&#160;30, 2022 and 2021 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.358%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial<br/>&amp;&#160;Specialty<br/>Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Government<br/>Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">IngenioRx</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - unaffiliated</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - affiliated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,054)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - unaffiliated</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - affiliated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,192)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">967&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - unaffiliated</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - affiliated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,382)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - unaffiliated</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - affiliated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,173)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The major product revenues for each of the reportable segments for the three and nine months ended September&#160;30, 2022 and 2021 are as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.786%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial &amp; Specialty Business</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care products</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care services</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dental/Vision products and services</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Commercial &amp; Specialty Business</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,494&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,863&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,324&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,904&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Government Business</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care products</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care services</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Government Business</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,571&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,658&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,164&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,007&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">IngenioRx</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy products and services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,249&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,549&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,003&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,630&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated health services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Other</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,365&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,670&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,884&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,557&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,054)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,192)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenues</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,625&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,548&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,993&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,925&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classification between managed care products and managed care services in the above table primarily distinguishes between the levels of risk assumed. Managed care products represent insurance products where we bear the insurance risk, whereas managed care services represent product offerings where we provide claims adjudication and other administrative services to the customer, but the customer principally bears the insurance risk.&#160;</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of reportable segments&#8217; operating revenue to the amounts of total revenues included in our consolidated statements of income for the three and nine months ended September&#160;30, 2022 and 2021 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.786%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reportable segments&#8217; operating revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,625&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,548&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,993&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,925&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (losses) gains on financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(439)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,939&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,822&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,666&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,058&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of income before income tax expense to reportable segments&#8217; operating gain included in our consolidated statements of income for the three and nine months ended September&#160;30, 2022 and 2021 is as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.786%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,996&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,525&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(371)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,112)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,026)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net losses (gains) on financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reportable segments&#8217; operating gain</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,270&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,059&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,084&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,301&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898689565008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease office space and certain computer and related equipment using noncancellable operating leases. Our leases have remaining lease terms of 1 year to 12 years.</span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information related to our leases is as follows:</span></div><div style="margin-bottom:7pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.255%"><tr><td style="width:1.0%"/><td style="width:44.027%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.892%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.895%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMi0xLTEtMS03NzQ3Mg_35223446-da43-4885-b1af-792d126f0d02"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMi0xLTEtMS03NzQ3Mg_9be99ce3-7827-4188-b28e-80ce38a6cc7e">Other noncurrent assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities, current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMy0xLTEtMS03NzQ4MQ_3f09f4af-f1d9-4a52-8c2e-e79a525ccc59"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMy0xLTEtMS03NzQ4MQ_ce213197-b1dc-4b00-96f5-82a38cd1810f">Other current liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities, noncurrent</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfNC0xLTEtMS03NzQ5OQ_3538eea0-82a4-4a60-af7e-b84b7a69ca57"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfNC0xLTEtMS03NzQ5OQ_3bcb0bf3-e902-449c-94d0-fd8995ada510">Other noncurrent liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.191%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease Expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 17.5pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Operating cash paid for amounts included in the measurement of lease liabilities, operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 17.5pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities, operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, the weighted average remaining lease term of our operating leases was 7 years for each period. The lease liabilities reflect a weighted average discount rate of 2.79% at September&#160;30, 2022 and 2.69% at December&#160;31, 2021.</span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future lease payments for noncancellable operating leases with initial or remaining terms of one year or more are as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.763%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.037%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (excluding the nine months ended September 30, 2022)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum payments </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, we have no new leases which will commence during the fourth quarter of 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898684954864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets Disclosure [Text Block]</a></td>
<td class="text">Goodwill and Other Intangible Assets <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the change in the carrying amount of goodwill for our segments (see Note 15, &#8220;Segment Information&#8221;) for 2022 and 2021 is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.161%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.060%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial <br/>&amp; Specialty<br/>Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Government<br/>Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">IngenioRx</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,331&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,691&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,227&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,611&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment as of September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of other intangible assets as of September&#160;30, 2022 and December&#160;31, 2021 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:29pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets with finite lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,580)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,236)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider and hospital relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,037&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,032)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,506)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,026&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets with indefinite lives:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blue Cross and Blue Shield and other trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State Medicaid licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,531&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,531&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,568&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,032)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,536&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,121&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,506)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,615&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2022, we recorded intangible assets related to Integra and also reclassified $308 of trademarks with indefinite lives to intangible assets with finite lives - Other, which relates to our new branding strategy. In addition, the amortization period of certain intangible assets was shortened to align with the anticipated dates the new branding will take place. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, along with the related accumulated amortization, are removed from the table above at the end of the fiscal year in which they become fully amortized.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the estimated amortization expense for the year ending December 31, 2022 and each of the five succeeding years is as follows: 2022, $748; 2023, $735; 2024, $370; 2025, $311; 2026, $258; and 2027, $219.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898683251984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for annual financial statements. We have omitted certain footnote disclosures that would substantially duplicate the disclosures in our 2021 Annual Report on Form 10-K, unless the information contained in those disclosures materially changed or is required by GAAP. In the opinion of management, all adjustments, including normal recurring adjustments, necessary for a fair statement of the consolidated financial statements as of and for the three and nine months ended September&#160;30, 2022 and 2021 have been recorded. The results of operations for the three and nine months ended September&#160;30, 2022 are not necessarily indicative of the results that may be expected for the full year ending December&#160;31, 2022, or any other period. The seasonal nature of portions of our health care and related benefits business, competitive and other market conditions, as well as COVID-19 related impacts, may cause full-year results to differ from estimates based upon our interim results of operations. These unaudited consolidated financial statements should be read in conjunction with our audited consolidated financial statements as of and for the year ended December&#160;31, 2021 included in our 2021 Annual Report on Form 10-K.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency</a></td>
<td class="text">Certain of our subsidiaries operate outside of the United States and have functional currencies other than the U.S. dollar (&#8220;USD&#8221;). We translate the assets and liabilities of those subsidiaries to USD using the exchange rate in effect at the end of the period. We translate the revenues and expenses of those subsidiaries to USD using the average exchange rates in effect during the period. The net effect of these translation adjustments is included in &#8220;Foreign currency translation adjustments&#8221; in our consolidated statements of comprehensive income.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We control a number of bank accounts that are used exclusively to hold customer funds for the administration of customer benefits and we have cash and cash equivalents on deposit to meet certain regulatory requirements. These amounts totaled $291 and $173 at September&#160;30, 2022 and December&#160;31, 2021, respectively, and are included in the cash and cash equivalents line on our consolidated balance sheets.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment, Policy</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classify fixed maturity securities in our investment portfolio as &#8220;available-for-sale&#8221; and report those securities at fair value. Certain fixed maturity securities are available to support current operations and, accordingly, we classify such investments as current assets without regard to their contractual maturity. Investments used to satisfy contractual, regulatory or other requirements are classified as long-term, without regard to contractual maturity.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a fixed maturity security is in an unrealized loss position and we have the intent to sell the fixed maturity security, or it is more likely than not that we will have to sell the fixed maturity security before recovery of its amortized cost basis, we write down the fixed maturity security&#8217;s cost basis to fair value and record an impairment loss in our consolidated statements of income. For impaired fixed maturity securities that we do not intend to sell or if it is more likely than not that we will not have to sell such securities, but we expect that we will not fully recover the amortized cost basis, we recognize the credit component of the impairment as an allowance for credit loss in our consolidated balance sheets and record an impairment loss in our consolidated statements of income. The non-credit component of the impairment is recognized in accumulated other comprehensive loss. Furthermore, unrealized losses entirely caused by non-credit-related factors related to fixed maturity securities for which we expect to fully recover the amortized cost basis continue to be recognized in accumulated other comprehensive loss. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit component of an impairment is determined primarily by comparing the net present value of projected future cash flows with the amortized cost basis of the fixed maturity security. The net present value is calculated by discounting our best estimate of projected future cash flows at the effective interest rate implicit in the fixed maturity security at the date of purchase. For mortgage-backed and asset-backed securities, cash flow estimates are based on assumptions regarding the underlying collateral, including prepayment speeds, vintage, type of underlying asset, geographic concentrations, default rates, recoveries and changes in value. For all other securities, cash flow estimates are driven by assumptions regarding probability of default, including changes in credit ratings and estimates regarding timing and amount of recoveries associated with a default.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For asset-backed securities included in fixed maturity securities, we recognize income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The net investment in the </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">securities is adjusted to the amount that would have existed had the new effective yield been applied since the purchase date of the securities. Such adjustments are reported within net investment income.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The changes in fair value of our marketable equity securities are recognized in our results of operations within net gains and losses on financial instruments. Certain marketable equity securities are held to satisfy contractual obligations, and are reported under the caption &#8220;Other invested assets&#8221; in our consolidated balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have corporate-owned life insurance policies on certain participants in our deferred compensation plans and other members of management. The cash surrender value of the corporate-owned life insurance policies is reported under the caption &#8220;Other invested assets&#8221; in our consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the equity method of accounting for investments in companies in which our ownership interest may enable us to influence the operating or financial decisions of the investee company. Our proportionate share of equity in net income of these unconsolidated affiliates is reported within net investment income. The equity method investments are reported under the caption &#8220;Other invested assets&#8221; in our consolidated balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment income is recorded when earned. All securities sold resulting in investment gains and losses are recorded on the trade date. Realized gains and losses are determined on the basis of the cost or amortized cost of the specific securities sold.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in securities lending programs whereby marketable securities in our investment portfolio are transferred to independent brokers or dealers in exchange for cash and securities collateral. We recognize the collateral as an asset, which is reported under the caption &#8220;Other current assets&#8221; in our consolidated balance sheets, and we record a corresponding liability for the obligation to return the collateral to the borrower, which is reported under the caption &#8220;Other current liabilities&#8221; in our consolidated balance sheets. The securities on loan are reported in the applicable investment category on our consolidated balance sheets. Unrealized gains or losses on securities lending collateral are included in accumulated other comprehensive loss as a separate component of shareholders&#8217; equity. The market value of loaned securities and that of the collateral pledged can fluctuate in non-synchronized fashions.&#160;To the extent the loaned securities&#8217; value appreciates faster or depreciates slower than the value of the collateral pledged, we are exposed to the risk of the shortfall.&#160;As a primary mitigating mechanism, the loaned securities and collateral pledged are marked to market on a daily basis and the shortfall, if any, is collected accordingly.&#160;Secondarily, the collateral level is set at 102% of the value of the loaned securities, which provides a cushion before any shortfall arises. The investment of the cash collateral is subject to market risk, which is managed by limiting the investments to higher quality and shorter duration instruments.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Receivable</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Receivables are reported net of amounts for expected credit losses. The allowance for doubtful accounts is based on historical collection trends, future forecasts and our judgment regarding the ability to collect specific accounts.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Premium receivables include the uncollected amounts from risk-based groups, individuals and government programs for insurance services. Premium receivables are reported net of an allowance for doubtful accounts of $140 and $142 at September&#160;30, 2022 and December&#160;31, 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Self-funded receivables include administrative fees, claims and other amounts due from fee-based customers for administrative services. Self-funded receivables are reported net of an allowance for doubtful accounts of $82 and $50 at September&#160;30, 2022 and December&#160;31, 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other receivables include pharmacy rebates, provider advances, claims recoveries, reinsurance receivables, proceeds due from brokers on investment trades, accrued investment income, and other miscellaneous amounts due to us. These receivables are reported net of an allowance for doubtful accounts of $709 and $648 at September&#160;30, 2022 and December&#160;31, 2021, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For our non-risk-based contracts, we had no material contract assets, contract liabilities or deferred contract costs&#160;recorded on our consolidated balance sheet at September&#160;30, 2022. For the three and nine months ended September&#160;30, 2022 and 2021, revenue recognized from performance obligations related to prior periods, such as due to changes in transaction price, was not material. For contracts that have an original expected duration of greater than one year, revenue expected to be recognized in future periods related to unfulfilled contractual performance obligations and contracts with variable consideration related to undelivered performance obligations is not material.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Guidance: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update No. 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2021-01&#8221;). The amendments in ASU 2021-01 provide optional expedients and exceptions for applying GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference the London Interbank Offered Rate (&#8220;LIBOR&#8221;) or another reference rate expected to be discontinued because of the reference rate reform. The provisions must be applied at a Topic, Subtopic, or Industry Subtopic level for all transactions other than derivatives, which may be applied at a hedging relationship level. We adopted ASU 2021-01 on January 7, 2021, and the adoption did not have an impact on our consolidated financial position, results of operations or cash flows.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued Accounting Standards Update No. 2020-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements to Subtopic 310-20, Receivables&#8212;Nonrefundable Fees and Other Costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-08&#8221;). The amendments in ASU 2020-08 clarify when an entity should assess whether a callable debt security is within the scope of accounting guidance, which impacts the amortization period for nonrefundable fees and other costs. ASU 2020-08 became effective for interim and annual reporting periods beginning after December 15, 2020. The amendments were to be applied on a prospective basis as of the beginning of the period of adoption for existing or newly purchased callable debt securities. We adopted ASU 2020-08 on January 1, 2021, and the adoption did not have an impact on our consolidated financial position, results of operations or cash flows.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued Accounting Standards Update No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-06&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments eliminate two of the three accounting models that require separate accounting for convertible features of debt securities, simplify the contract settlement assessment for equity classification, require the use of the if-converted method for all convertible instruments in the diluted earnings per share calculation and expand disclosure requirements. The amendments became effective for our annual and interim reporting periods beginning after December 15, 2021. We adopted ASU 2020-06 on January 1, 2022 using the modified retrospective transition method, which resulted in an increase to our reported debt outstanding of $31, a decrease to our deferred tax liabilities of $8, and a corresponding cumulative-effect reduction to our opening retained earnings of $23; these amounts are not material to our overall consolidated financial position. The adoption of ASU 2020-06 did not have an impact on our results of operations or our consolidated cash flows. Use of the if-converted method did not have an impact on our overall earnings per share calculation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued Accounting Standards Update No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2019-12&#8221;). The amendments in ASU 2019-12 remove certain exceptions to the general principles in Accounting Standards Codification Topic 740. The amendments also clarify and amend existing guidance to improve consistent application. The amendments became effective for our annual reporting periods beginning after December 15, 2020. The transition method (retrospective, modified retrospective, or prospective basis) related to the amendments depends on the applicable guidance, and all amendments for which there is no transition guidance specified are to be applied on a prospective basis. We adopted ASU 2019-12 on January 1, 2021, and the adoption did not have an impact on our consolidated financial position, results of operations or cash flows.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Guidance Not Yet Adopted: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, the FASB issued Accounting Standards Update No. 2020-11,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Financial Services&#8212;Insurance (Topic 944): Effective Date and Early Application </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-11&#8221;). The amendments in ASU 2020-11 make changes to the effective date and early application of Accounting Standards Update No. 2018-12,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Financial Services&#8212;Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2018-12&#8221;), which was issued in November 2018. The amendments in ASU 2020-11 have extended the original effective date by one year, and now the amendments are required for our interim and annual reporting periods beginning after December 15, 2022. The amendments in ASU 2018-12 make changes to a variety of areas to simplify or improve the existing recognition, measurement, presentation and disclosure requirements for long-duration contracts issued by an insurance entity. The amendments require insurers to annually review the assumptions they make about their policyholders and update the liabilities for future policy benefits if the assumptions change. The amendments also simplify the amortization of deferred contract acquisition costs and add new disclosure requirements about the assumptions insurers use to measure their liabilities and how they may affect future cash flows. The amendments related to the liability for future policy benefits for traditional and limited-payment contracts and deferred acquisition costs are to be applied to contracts in force as of the beginning of the earliest period presented, with an option to apply such amendments retrospectively with a cumulative-effect adjustment to the opening balance of retained earnings as of the earliest period presented. The amendments </span></div>for market risk benefits are to be applied retrospectively. We do not believe the adoption of ASU 2020-11 and ASU 2018-12 will have a material impact on our consolidated financial position, results of operations, cash flows, and related disclosures.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898689570608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Optimization Initiatives (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_BusinessOptimizationInitiativesAbstract', window );"><strong>Business Optimization Initiatives [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Business Optimization Initiatives</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provided below is a summary of the activity, by reportable segment, related to the liability for employee termination costs previously incurred in connection with our enterprise-wide business optimization initiatives introduced in 2020.</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial &amp; Specialty Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Government Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">IngenioRx</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020 Business Optimization Initiatives</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for employee termination costs at            January 1, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for employee termination costs at September&#160;30, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_BusinessOptimizationInitiativesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Optimization Initiatives</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_BusinessOptimizationInitiativesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898687395184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Current and Long-Term Investments, Available-For-Sale</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of current and long-term fixed maturity securities, available-for-sale, at September&#160;30, 2022 and December&#160;31, 2021 is as follows:</span></div><div style="margin-bottom:4pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost or Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance <br/>For Credit <br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair&#160;Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States Government securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government sponsored securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(355)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,560)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(506)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,977&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,877)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States Government securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government sponsored securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,257&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,899&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock', window );">Aggregate Fair Value and Gross Unrealized Loss of Fixed Maturity Securities in an Unrealized Loss Position</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For fixed maturity securities in an unrealized loss position at September&#160;30, 2022 and December&#160;31, 2021, the following table summarizes the aggregate fair values and gross unrealized losses by length of time those securities have continuously been in an unrealized loss position:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.358%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Securities are whole amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States Government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government sponsored securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,165)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(395)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,056)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(821)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States Government securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government sponsored securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,846&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,571&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,755&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Amortized Cost and Fair Value of Fixed Maturity Securities, By Contractual Maturity</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of fixed maturity securities at September&#160;30, 2022, by contractual maturity, are shown below. Expected maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations.</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.780%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.782%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,977&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,148&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_InvestmentsinequitysecuritiesTableTextBlock', window );">Investments In Equity Securities</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of marketable equity securities at September&#160;30, 2022 and December&#160;31, 2021 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"/><td style="width:68.211%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.871%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange traded funds</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common equity securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,503&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,881&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestmentsTextBlock', window );">Net Investment Gains (Losses)</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net investment (losses) gains for the three and nine months ended September&#160;30, 2022 and 2021 are as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.873%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended <br/>September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (losses) gains:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized gains from sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized losses from sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment (losses) recoveries recognized in income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized (losses) gains from sales of fixed maturity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(334)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses) gains recognized on equity securities still held at the end of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gains (losses) recognized on equity securities sold during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net losses on equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment (losses) recoveries recognized in income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net losses (gains) on other investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (losses) gains on investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(482)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_InvestmentsinequitysecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments in equity securities [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_InvestmentsinequitysecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of realized and unrealized gain (loss) on investment in security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898683344624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair Value Measurements By Level For Assets Measured At Fair Value On A Recurring Basis</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of fair value measurements by level for assets and liabilities measured at fair value on a recurring basis at September&#160;30, 2022 and December&#160;31, 2021 is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.786%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;III</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities, available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States Government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government sponsored securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions, tax-exempt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities, available-for-sale</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,708&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange traded funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,409&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,503&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other invested assets - common equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities lending collateral</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives - other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,352&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,573&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,460&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives - other liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed maturity securities, available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States Government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government sponsored securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions, tax-exempt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fixed maturity securities, available-for-sale</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,539&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,899&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange traded funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,758&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,881&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other invested assets - common equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities lending collateral</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives - other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,311&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,747&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,507&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives - other liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Reconciliation Of The Beginning And Ending Balances Of Assets Measured At Fair Value On A Recurring Basis Using Level III Inputs</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balances of assets measured at fair value on a recurring basis using Level III inputs for the three months ended September 30, 2022 and 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Residential<br/>Mortgage-<br/>backed<br/>Securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance at July 1, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total losses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers out of Level III</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance at September 30, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-5.4pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrealized losses included in net income related to assets still held at September 30, 2022</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance at July 1, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total gains:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers out of Level III</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance at September 30, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-5.4pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrealized gains included in net income related to assets still held at September 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balances of assets measured at fair value on a recurring basis using Level III inputs for the nine months ended September 30, 2022 and 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Residential<br/>Mortgage-<br/>backed<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance at January 1, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total losses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(201)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers into Level III</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers out of Level III</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance at September 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrealized gains included in net income related to assets still held at September 30, 2022</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance at January 1, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total gains:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers out of Level III</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance at September 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrealized gains included in net income related to assets still held at September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock', window );">Carrying And Fair Values By Level Of Financial Instruments Not Recorded At Fair Value On Consolidated Balance Sheet</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the estimated fair values by level of each class of financial instrument that is recorded at its carrying value on our consolidated balance sheets at September&#160;30, 2022 and December&#160;31, 2021 is as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;I</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other invested assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debentures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other invested assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debentures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898687317920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Claims Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract', window );"><strong>Liability for Claims and Claims Adjustment Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense', window );">Reconciliation Of The Beginning And Ending Balances For Medical Claims Payable</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balances for medical claims payable, by segment (see Note 15, &#8220;Segment Information&#8221;), for the nine months ended September 30, 2022 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.764%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial<br/>&amp; Specialty<br/>Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Government<br/>Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross medical claims payable, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,847&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,282&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded medical claims payable, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net medical claims payable, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,834&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business combinations and purchase adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net incurred medical claims:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods redundancies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(901)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net incurred medical claims</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,866&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,332&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,276&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net payments attributable to:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period medical claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods medical claims</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,785&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,804&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,672&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net medical claims payable, end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,918&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,998&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded medical claims payable, end of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross medical claims payable, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,921&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,807&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,001&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, the total of net incurred but not reported liabilities plus expected development on reported claims for the Commercial &amp; Specialty Business was $81, $388 and $3,449 for the claim years 2020 and prior, 2021 and 2022, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, the total of net incurred but not reported liabilities plus expected development on reported claims for the Government Business was $148, $508 and $10,151 for the claim years 2020 and prior, 2021 and 2022, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, the total of net incurred but not reported liabilities plus expected development on reported claims for Other was $2, $14 and $257 for the claim years 2020 and prior, 2021 and 2022, respectively.</span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balances for medical claims payable, by segment (see Note 15, &#8220;Segment Information&#8221;), for the nine months ended September 30, 2021 is as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.764%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial<br/>&amp; Specialty<br/>Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Government<br/>Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross medical claims payable, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,646&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded medical claims payable, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net medical claims payable, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,281&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,613&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,089&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business combinations and purchase adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net incurred medical claims:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods redundancies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(496)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,309)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,822)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net incurred medical claims</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,003&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,113&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,275&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net payments attributable to:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period medical claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods medical claims</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,435&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,941&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,523&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net medical claims payable, end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,849&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded medical claims payable, end of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross medical claims payable, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,864&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,183&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,299&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The favorable development recognized in the nine months ended September 30, 2022 and 2021 resulted primarily from trend factors in late 2021 and late 2020, respectively, developing more favorably than originally expected. Favorable development in the completion factors resulting from the latter parts of 2020 developing faster than expected also contributed to the favorable development in the nine months ended September 30, 2021. The impact from COVID-19 on healthcare utilization and medical claims submission patterns continues to provide increased estimation uncertainty on our incurred but not reported liability at September&#160;30, 2022.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock', window );">Reconciliation of Net Incurred Medical Claims to Benefit Expense</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of net incurred medical claims to benefit expense included in our consolidated statements of income for periods in 2022 is as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.825%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net incurred medical claims:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial &amp; Specialty Business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,834&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,522&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,510&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,866&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net incurred medical claims</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,634&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quality improvement and other claims expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,120&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,215&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,777&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,404&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,396&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the three months ended September 30, 2022, based on recent regulatory clarification, we realigned certain quality improvement costs from benefit expense to administrative expense that were previously allocated to benefit expense during the three months ended March 31, 2022 and the three months ended June 30, 2022.</span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of net incurred medical claims to benefit expense included in our consolidated statements of income for periods in 2021 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.530%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.826%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net incurred medical claims:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial &amp; Specialty Business</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,072&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,718&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,213&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,003&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Business</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net incurred medical claims</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,844&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,704&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,275&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quality improvement and other claims expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,832&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,699&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,763&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,645&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,107&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock', window );">Reconciliation of Short Duration Medical Claims Payable to the Consolidated Medical Claims Payable</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the medical claims payable reflected in the tables above to the consolidated ending balance for medical claims payable included in the consolidated balance sheet, as of September&#160;30, 2022, is as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.764%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial<br/>&amp; Specialty<br/>Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Government<br/>Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net medical claims payable, end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,918&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,998&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded medical claims payable, end of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance lines other than short duration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross medical claims payable, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,921&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,048&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,242&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular Disclosure For Reconciliation of Net Incurred Medical Claims to Benefit Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for the reconciliation of claims development to the liability for unpaid claims and claim adjustment expense for short-duration insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671315-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898689580400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Convertible Debenture Terms</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes at September&#160;30, 2022 the related balances, conversion rate and conversion price of the Debentures:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.060%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.740%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal amount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net debt carrying amount</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion rate (shares of common stock per $1,000 of principal amount)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2967&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective conversion price (per $1,000 of principal amount)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.9462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898680794144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalAbstract', window );"><strong>Banking Regulation, Total Capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsDeclaredTableTextBlock', window );">Summary of Cash Dividend Activity</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our cash dividend activity for the nine months ended September 30, 2022 and 2021 is as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.553%"><tr><td style="width:1.0%"/><td style="width:40.006%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.837%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.837%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.914%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.918%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Declaration Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Record&#160;Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Payment&#160;Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dividend</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">per&#160;Share</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 25, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 10, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 25, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.28</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 19, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 10, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 24, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.28</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 19, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 9, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 23, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.28</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 26, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 10, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 25, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.13</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 20, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 10, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 25, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 20, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 10, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 24, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.13</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Summary of Share Repurchases</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of common stock repurchases for the nine months ended September 30, 2022 and 2021 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorization remaining at the end of the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity for the nine months ended September 30, 2022 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"/><td style="width:44.720%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.887%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Option&#160;Price<br/>per&#160;Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life&#160;(Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.56</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.35</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Summary of Nonvested Restricted Stock Activity Including Restricted Stock Units</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the status of nonvested restricted stock activity, including restricted stock units and performance units, for the nine months ended September 30, 2022 is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"/><td style="width:72.183%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted<br/>Stock&#160;Shares<br/>and Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant&#160;Date<br/>Fair&#160;Value<br/>per&#160;Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of Weighted-Average Assumptions Used to Estimate the Fair Value of Options Granted During the Periods</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average assumptions were used to estimate the fair values of options granted during the nine months ended September 30, 2022 and 2021:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"/><td style="width:72.183%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility factor</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarterly dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average expected life (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.50</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock', window );">Schedule of Weighted-Average Fair Values Determined for the Periods</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average fair values per option or share were determined for the nine months ended September 30, 2022 and 2021:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"/><td style="width:72.183%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted during the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock awards granted during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsDeclaredTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to dividends declared, including paid and unpaid dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsDeclaredTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898683380416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Reconciliation Of Components Of Accumulated Other Comprehensive Loss</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the components of accumulated other comprehensive loss at September&#160;30, 2022 and 2021 is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended <br/>September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment (losses) gains:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,489)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications, net of tax benefit of $220, $25, $896 and $71, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(719)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,914)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(203)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss, net of tax (expense) benefit of $(21), $5, $(75) and $21, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,630)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(284)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss attributable to noncontrolling interests, net of tax benefit of $(1), $0, $(4) and $(1), respectively</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,125)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,125)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-credit components of impairments on investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax benefit (expense) of $0, $0, $1 and $(1), respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax expense of $0, $0, $(2) and $(2), respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(413)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(534)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(429)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(552)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax expense of $(3), $(4), $(9) and $(10), respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(406)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(526)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(406)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(526)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax benefit of $2, $1, $4 and $2, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of period accumulated other comprehensive (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive loss, net of tax benefit of $198, $27, $815 and $81, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(638)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,617)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive loss attributable to noncontrolling interests, net of tax benefit of $(1), $0, $(4) and $(1), respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of period accumulated other comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,784)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,784)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898684916720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Denominator for Basic and Diluted Earnings Per Share</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The denominator for basic and diluted earnings per share for the three and nine months ended September&#160;30, 2022 and 2021 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.084%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for basic earnings per share &#8211; weighted-average shares</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities &#8211; employee stock options, nonvested restricted stock awards and convertible debentures</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for diluted earnings per share</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898687436368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Financial Data By Reportable Segment</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial data by reportable segment for the three and nine months ended September&#160;30, 2022 and 2021 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.358%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial<br/>&amp;&#160;Specialty<br/>Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Government<br/>Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">IngenioRx</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - unaffiliated</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - affiliated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,054)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - unaffiliated</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - affiliated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,192)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">967&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - unaffiliated</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - affiliated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,382)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - unaffiliated</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue - affiliated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,173)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_MajorProductRevenueBySegmentTableTextBlock', window );">Major Product Revenue by Segment</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The major product revenues for each of the reportable segments for the three and nine months ended September&#160;30, 2022 and 2021 are as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.786%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial &amp; Specialty Business</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care products</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care services</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dental/Vision products and services</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Commercial &amp; Specialty Business</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,494&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,863&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,324&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,904&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Government Business</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care products</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care services</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Government Business</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,571&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,658&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,164&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,007&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">IngenioRx</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy products and services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,249&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,549&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,003&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,630&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated health services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Other</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,365&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,670&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,884&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,557&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,054)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,192)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenues</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,625&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,548&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,993&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,925&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock', window );">Reconciliation Of Reportable Segments Operating Revenues To Total Revenues Reported In The Consolidated Statements Of Income</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of reportable segments&#8217; operating revenue to the amounts of total revenues included in our consolidated statements of income for the three and nine months ended September&#160;30, 2022 and 2021 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.786%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reportable segments&#8217; operating revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,625&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,548&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,993&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,925&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (losses) gains on financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(439)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,939&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,822&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,666&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,058&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Reconciliation Of Income Before Income Tax Expense To Reportable Segments Operating Gain Included In The Consolidated Statements Of Income</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of income before income tax expense to reportable segments&#8217; operating gain included in our consolidated statements of income for the three and nine months ended September&#160;30, 2022 and 2021 is as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.786%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,996&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,525&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(371)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,112)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,026)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net losses (gains) on financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reportable segments&#8217; operating gain</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,270&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,059&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,084&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,301&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_MajorProductRevenueBySegmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for Major Product Revenue By Segment [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_MajorProductRevenueBySegmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898683263504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lessee, Operating Lease, Disclosure [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information related to our leases is as follows:</span></div><div style="margin-bottom:7pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.255%"><tr><td style="width:1.0%"/><td style="width:44.027%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.892%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.895%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMi0xLTEtMS03NzQ3Mg_35223446-da43-4885-b1af-792d126f0d02"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMi0xLTEtMS03NzQ3Mg_9be99ce3-7827-4188-b28e-80ce38a6cc7e">Other noncurrent assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities, current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMy0xLTEtMS03NzQ4MQ_3f09f4af-f1d9-4a52-8c2e-e79a525ccc59"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMy0xLTEtMS03NzQ4MQ_ce213197-b1dc-4b00-96f5-82a38cd1810f">Other current liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities, noncurrent</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfNC0xLTEtMS03NzQ5OQ_3538eea0-82a4-4a60-af7e-b84b7a69ca57"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfNC0xLTEtMS03NzQ5OQ_3bcb0bf3-e902-449c-94d0-fd8995ada510">Other noncurrent liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.191%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended&#160;<br/>&#160;September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease Expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 17.5pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Operating cash paid for amounts included in the measurement of lease liabilities, operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 17.5pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities, operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future lease payments for noncancellable operating leases with initial or remaining terms of one year or more are as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.763%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.037%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (excluding the nine months ended September 30, 2022)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum payments </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898772721072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Summary Of The Change In The Carrying Amount Of Goodwill By Reportable Segment</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the change in the carrying amount of goodwill for our segments (see Note 15, &#8220;Segment Information&#8221;) for 2022 and 2021 is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.161%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.060%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial <br/>&amp; Specialty<br/>Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Government<br/>Business</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">IngenioRx</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,331&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,691&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,227&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,611&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment as of September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PresentValueOfFutureInsuranceProfitsTableTextBlock', window );">Components Of Other Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of other intangible assets as of September&#160;30, 2022 and December&#160;31, 2021 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.763%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:29pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets with finite lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,580)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,236)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider and hospital relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,037&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,032)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,506)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,026&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets with indefinite lives:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blue Cross and Blue Shield and other trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State Medicaid licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,531&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,531&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,568&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,032)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,536&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,121&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,506)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,615&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PresentValueOfFutureInsuranceProfitsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of present value of future profits of insurance contract acquired in business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=122135039&amp;loc=d3e569990-122904<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PresentValueOfFutureInsuranceProfitsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898683439952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Organization (Details)<br> medical_member in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>medical_member </div>
<div>county </div>
<div>states</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_NumberOfMedicalMembersServed', window );">Number of Medical Members | medical_member</a></td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_NumberOfCountiesInStateOfKansasCompanyDoesNotServe', window );">Number of counties in the Kansas City area the Company does not serve | county</a></td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfStatesInWhichEntityOperates', window );">Number of states in which the Company is licensed to conduct insurance operations | states</a></td>
<td class="nump">50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_NumberOfCountiesInStateOfKansasCompanyDoesNotServe">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Counties In The State Of Kansas Company Does Not Serve</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_NumberOfCountiesInStateOfKansasCompanyDoesNotServe</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_NumberOfMedicalMembersServed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of medical members served</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_NumberOfMedicalMembersServed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStatesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of states the entity operates in as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStatesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898680879632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Signficant Accounting Policies Basis of Presentation and Significant Acconting Policies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Customer funds and cash and cash equivalents on deposit for regulatory requirements</a></td>
<td class="nump">$ 291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_SecuritiesLendingTransactionsInitialCollateralPercentageValue', window );">Securities lending transactions, initial collateral percentage value</a></td>
<td class="nump">102.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts', window );">Premium receivable, allowance for doubtful accounts</a></td>
<td class="nump">$ 140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_SelffundedReceivablesAllowanceForDoubtfulAccounts', window );">Self-funded receivables, allowance for doubtful accounts</a></td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent', window );">Allowance for doubtful accounts, other receivables</a></td>
<td class="nump">709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity attributable to parent</a></td>
<td class="nump">35,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,060<span></span>
</td>
<td class="nump">$ 35,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity attributable to parent</a></td>
<td class="nump">$ 29,604<span></span>
</td>
<td class="nump">$ 28,825<span></span>
</td>
<td class="nump">$ 28,058<span></span>
</td>
<td class="nump">27,088<span></span>
</td>
<td class="nump">$ 26,700<span></span>
</td>
<td class="nump">$ 25,874<span></span>
</td>
<td class="nump">$ 24,793<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2020-06 [Member] | Retained Earnings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent', window );">Deferred Tax and Other Liabilities, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity attributable to parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_AccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_AccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_SecuritiesLendingTransactionsInitialCollateralPercentageValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial minimum percentage of cash and/or securities collateral accepted as compared to the value of securities on loan in a securities lending transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_SecuritiesLendingTransactionsInitialCollateralPercentageValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_SelffundedReceivablesAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the estimated valuation allowance to reduce gross self-funded receivable to net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_SelffundedReceivablesAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on receivable, classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting, and liabilities classified as noncurrent and other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the estimated valuation allowance to reduce gross premiums receivable to net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=127002003&amp;loc=SL6242269-115581<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898684213728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions Business Acquisition (Assets Liabilities Acquired) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 1,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired', window );">Indefinite-lived Intangible Assets Acquired</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">2,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">24,381<span></span>
</td>
<td class="nump">$ 24,228<span></span>
</td>
<td class="nump">$ 21,691<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=elv_IntegraManagedCareMember', window );">Integra Managed Care [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired', window );">Indefinite-lived Intangible Assets Acquired</a></td>
<td class="nump">250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill, Purchase Accounting Adjustments</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefinitelivedIntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=elv_IntegraManagedCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=elv_IntegraManagedCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898679321136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Optimization Initiatives (Employee Termination Costs) (Details) - Employee Severance [Member]<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Business Optimization Initiatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Liability for employee terminations costs, beginning</a></td>
<td class="nump">$ 122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Liability for employee terminations costs, ending</a></td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=elv_IngenioRxSegmentMember', window );">IngenioRx Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Business Optimization Initiatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Liability for employee terminations costs, beginning</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Liability for employee terminations costs, ending</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=elv_OtherSegmentMember', window );">Other Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Business Optimization Initiatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Liability for employee terminations costs, beginning</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Liability for employee terminations costs, ending</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=elv_GovernmentBusinessSegmentMember', window );">Government Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Business Optimization Initiatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Liability for employee terminations costs, beginning</a></td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Liability for employee terminations costs, ending</a></td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=elv_CommercialSpecialtyBusinessSegmentMember', window );">Commercial &amp; Specialty Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Business Optimization Initiatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Liability for employee terminations costs, beginning</a></td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Liability for employee terminations costs, ending</a></td>
<td class="nump">$ 45<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_IngenioRxSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_IngenioRxSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_OtherSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_OtherSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_GovernmentBusinessSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_GovernmentBusinessSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_CommercialSpecialtyBusinessSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_CommercialSpecialtyBusinessSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898680585280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments (Current And Long-Term Fixed Maturity Securities, Available-For-Sale) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost or Amortized Cost</a></td>
<td class="nump">$ 28,977<span></span>
</td>
<td class="nump">$ 26,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">830<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(2,877)<span></span>
</td>
<td class="num">(182)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Fixed maturities, allowance for credit loss</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">26,148<span></span>
</td>
<td class="nump">26,899<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">United States Government Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost or Amortized Cost</a></td>
<td class="nump">1,673<span></span>
</td>
<td class="nump">1,443<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(125)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Fixed maturities, allowance for credit loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">1,548<span></span>
</td>
<td class="nump">1,432<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember', window );">Government Sponsored Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost or Amortized Cost</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Fixed maturities, allowance for credit loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtMember', window );">Foreign Government Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost or Amortized Cost</a></td>
<td class="nump">322<span></span>
</td>
<td class="nump">353<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(70)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Fixed maturities, allowance for credit loss</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">251<span></span>
</td>
<td class="nump">347<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, Municipalities And Political Subdivisions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost or Amortized Cost</a></td>
<td class="nump">4,431<span></span>
</td>
<td class="nump">5,321<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(355)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Fixed maturities, allowance for credit loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">4,081<span></span>
</td>
<td class="nump">5,621<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost or Amortized Cost</a></td>
<td class="nump">13,766<span></span>
</td>
<td class="nump">12,044<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1,560)<span></span>
</td>
<td class="num">(78)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Fixed maturities, allowance for credit loss</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">12,208<span></span>
</td>
<td class="nump">12,363<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost or Amortized Cost</a></td>
<td class="nump">4,748<span></span>
</td>
<td class="nump">4,059<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(506)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Fixed maturities, allowance for credit loss</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">4,247<span></span>
</td>
<td class="nump">4,097<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost or Amortized Cost</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Fixed maturities, allowance for credit loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherAggregatedInvestmentsMember', window );">Other Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost or Amortized Cost</a></td>
<td class="nump">3,895<span></span>
</td>
<td class="nump">2,907<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(250)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Fixed maturities, allowance for credit loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">$ 3,682<span></span>
</td>
<td class="nump">$ 2,907<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherAggregatedInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_OtherAggregatedInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898671801680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments (Aggregate Fair Value And Gross Unrealized Loss Of Fixed Maturity Securities In An Unrealized Loss Position) (Details) - Fixed Maturities [Member]<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>securities</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>securities</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of securities, less than 12 months | securities</a></td>
<td class="nump">9,606<span></span>
</td>
<td class="nump">3,571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Estimated fair value, less than 12 months</a></td>
<td class="nump">$ 20,511<span></span>
</td>
<td class="nump">$ 8,755<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Gross unrealized loss, less than 12 months</a></td>
<td class="num">$ (2,056)<span></span>
</td>
<td class="num">$ (131)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of securities, 12 months or greater | securities</a></td>
<td class="nump">2,444<span></span>
</td>
<td class="nump">686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Estimated fair value, 12 months or greater</a></td>
<td class="nump">$ 4,128<span></span>
</td>
<td class="nump">$ 985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Gross unrealized loss, 12 months or greater</a></td>
<td class="num">$ (821)<span></span>
</td>
<td class="num">$ (51)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedMaturitiesMember', window );">United States Government Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of securities, less than 12 months | securities</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Estimated fair value, less than 12 months</a></td>
<td class="nump">$ 911<span></span>
</td>
<td class="nump">$ 990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Gross unrealized loss, less than 12 months</a></td>
<td class="num">$ (77)<span></span>
</td>
<td class="num">$ (11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of securities, 12 months or greater | securities</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Estimated fair value, 12 months or greater</a></td>
<td class="nump">$ 303<span></span>
</td>
<td class="nump">$ 176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Gross unrealized loss, 12 months or greater</a></td>
<td class="num">$ (48)<span></span>
</td>
<td class="num">$ (7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedMaturitiesMember', window );">Government Sponsored Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of securities, less than 12 months | securities</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Estimated fair value, less than 12 months</a></td>
<td class="nump">$ 61<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Gross unrealized loss, less than 12 months</a></td>
<td class="num">$ (4)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of securities, 12 months or greater | securities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Estimated fair value, 12 months or greater</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Gross unrealized loss, 12 months or greater</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedMaturitiesMember', window );">Foreign Government Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of securities, less than 12 months | securities</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Estimated fair value, less than 12 months</a></td>
<td class="nump">$ 169<span></span>
</td>
<td class="nump">$ 143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Gross unrealized loss, less than 12 months</a></td>
<td class="num">$ (34)<span></span>
</td>
<td class="num">$ (8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of securities, 12 months or greater | securities</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Estimated fair value, 12 months or greater</a></td>
<td class="nump">$ 81<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Gross unrealized loss, 12 months or greater</a></td>
<td class="num">$ (36)<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedMaturitiesMember', window );">States, Municipalities And Political Subdivisions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of securities, less than 12 months | securities</a></td>
<td class="nump">1,964<span></span>
</td>
<td class="nump">281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Estimated fair value, less than 12 months</a></td>
<td class="nump">$ 3,602<span></span>
</td>
<td class="nump">$ 634<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Gross unrealized loss, less than 12 months</a></td>
<td class="num">$ (314)<span></span>
</td>
<td class="num">$ (9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of securities, 12 months or greater | securities</a></td>
<td class="nump">139<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Estimated fair value, 12 months or greater</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Gross unrealized loss, 12 months or greater</a></td>
<td class="num">$ (41)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedMaturitiesMember', window );">Corporate Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of securities, less than 12 months | securities</a></td>
<td class="nump">4,322<span></span>
</td>
<td class="nump">1,846<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Estimated fair value, less than 12 months</a></td>
<td class="nump">$ 10,228<span></span>
</td>
<td class="nump">$ 3,310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Gross unrealized loss, less than 12 months</a></td>
<td class="num">$ (1,165)<span></span>
</td>
<td class="num">$ (57)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of securities, 12 months or greater | securities</a></td>
<td class="nump">1,318<span></span>
</td>
<td class="nump">403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Estimated fair value, 12 months or greater</a></td>
<td class="nump">$ 1,679<span></span>
</td>
<td class="nump">$ 485<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Gross unrealized loss, 12 months or greater</a></td>
<td class="num">$ (395)<span></span>
</td>
<td class="num">$ (21)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedMaturitiesMember', window );">Residential Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of securities, less than 12 months | securities</a></td>
<td class="nump">2,035<span></span>
</td>
<td class="nump">692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Estimated fair value, less than 12 months</a></td>
<td class="nump">$ 2,949<span></span>
</td>
<td class="nump">$ 1,967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Gross unrealized loss, less than 12 months</a></td>
<td class="num">$ (294)<span></span>
</td>
<td class="num">$ (26)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of securities, 12 months or greater | securities</a></td>
<td class="nump">530<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Estimated fair value, 12 months or greater</a></td>
<td class="nump">$ 1,182<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Gross unrealized loss, 12 months or greater</a></td>
<td class="num">$ (212)<span></span>
</td>
<td class="num">$ (9)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedMaturitiesMember', window );">Commercial Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of securities, less than 12 months | securities</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Estimated fair value, less than 12 months</a></td>
<td class="nump">$ 56<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Gross unrealized loss, less than 12 months</a></td>
<td class="num">$ (3)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of securities, 12 months or greater | securities</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Estimated fair value, 12 months or greater</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Gross unrealized loss, 12 months or greater</a></td>
<td class="num">$ (4)<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedMaturitiesMember', window );">Other Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of securities, less than 12 months | securities</a></td>
<td class="nump">921<span></span>
</td>
<td class="nump">511<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Estimated fair value, less than 12 months</a></td>
<td class="nump">$ 2,535<span></span>
</td>
<td class="nump">$ 1,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Gross unrealized loss, less than 12 months</a></td>
<td class="num">$ (165)<span></span>
</td>
<td class="num">$ (19)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of securities, 12 months or greater | securities</a></td>
<td class="nump">269<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Estimated fair value, 12 months or greater</a></td>
<td class="nump">$ 670<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Gross unrealized loss, 12 months or greater</a></td>
<td class="num">$ (85)<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedMaturitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_FixedMaturitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherAggregatedInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_OtherAggregatedInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898679564192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments (Amortized Cost And Fair Value Of Fixed Maturity Securities, By Contractual Maturity) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Due in one year or less, Amortized Cost</a></td>
<td class="nump">$ 911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Due after one year through five years, Amortized Cost</a></td>
<td class="nump">7,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost', window );">Due after five years through ten years, Amortized Cost</a></td>
<td class="nump">9,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost', window );">Due after ten years, Amortized Cost</a></td>
<td class="nump">6,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost', window );">Mortgage-backed securities, Amortized Cost</a></td>
<td class="nump">4,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale securities, Amortized Cost</a></td>
<td class="nump">28,977<span></span>
</td>
<td class="nump">$ 26,257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in one year or less, Estimated Fair Value</a></td>
<td class="nump">901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years, Estimated Fair Value</a></td>
<td class="nump">6,871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">Due after five years through ten years, Estimated Fair Value</a></td>
<td class="nump">8,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Due after ten years, Estimated Fair Value</a></td>
<td class="nump">5,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Mortgage-backed securities, Estimated Fair Value</a></td>
<td class="nump">4,317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities, Estimated Fair Value</a></td>
<td class="nump">$ 26,148<span></span>
</td>
<td class="nump">$ 26,899<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898687268112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments (Current Equity Securities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Equity Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">$ 1,503<span></span>
</td>
<td class="nump">$ 1,881<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ExchangeTradedFundsMember', window );">Exchange Traded Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Equity Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">1,403<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=elv_CommonEquitySecuritiesMember', window );">Common Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Equity Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_PrivateEquityFundsMember', window );">Private Equity Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Equity Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">$ 95<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ExchangeTradedFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ExchangeTradedFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=elv_CommonEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=elv_CommonEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_PrivateEquityFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_PrivateEquityFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898680556384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Net Investment Gains/Losses) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems', window );"><strong>Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_InvestmentGainsLosses', window );">Net (losses) gains on investments</a></td>
<td class="num">$ (54)<span></span>
</td>
<td class="num">$ (73)<span></span>
</td>
<td class="num">$ (482)<span></span>
</td>
<td class="nump">$ 48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedMaturitiesMember', window );">Fixed Maturities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems', window );"><strong>Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain', window );">Debt Securities, Available-for-sale, Realized Gain</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss', window );">Debt Securities, Available-for-sale, Realized Loss</a></td>
<td class="num">(99)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(353)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_Impairmentlossesreversalsoninvestments', window );">Impairment (losses) recoveries recognized in income</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss', window );">Debt Securities, Available-for-sale, Realized Gain (Loss)</a></td>
<td class="num">(96)<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="num">(334)<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems', window );"><strong>Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Unrealized (losses) gains recognized on equity securities still held at the end of the period</a></td>
<td class="num">(43)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(192)<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss', window );">Net realized gains (losses) recognized on equity securities sold during the period</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">(57)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Net losses on equity securities</a></td>
<td class="num">(39)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(212)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember', window );">Other Investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems', window );"><strong>Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_GainsFromOtherInvestments', window );">Gross gains</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_GrossLossesFromOtherInvestments', window );">Gross losses</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(93)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_Impairmentlossesreversalsoninvestments', window );">Impairment (losses) recoveries recognized in income</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherInvestments', window );">Net losses (gains) on other investments</a></td>
<td class="nump">$ 81<span></span>
</td>
<td class="num">$ (90)<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_GainsFromOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gains From Other Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_GainsFromOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_GrossLossesFromOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross Losses From Other Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_GrossLossesFromOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_Impairmentlossesreversalsoninvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total impairment (losses) reversals on investments, before considering whether or not such amount is recognized in earnings or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_Impairmentlossesreversalsoninvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_InvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Gains (Losses)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_InvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) included in earnings for investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedMaturitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_FixedMaturitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898671644400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedInvestmentIncomeReceivable', window );">Accrued investment income receivable</a></td>
<td class="nump">$ 228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesLoanedFairValueOfCollateral', window );">Fair value of collateral received at time of securities lending transactions</a></td>
<td class="nump">$ 2,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan', window );">Securities lending transactions ratio of fair value of collateral held to fair value of securities loaned</a></td>
<td class="nump">102.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Fixed maturities, allowance for credit losses</a></td>
<td class="num">$ (10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">United States Government Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Fixed maturities, allowance for credit losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherAggregatedInvestmentsMember', window );">Other Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Fixed maturities, allowance for credit losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedMaturitiesMember', window );">Fixed Maturities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from Sale of Available-for-sale Securities</a></td>
<td class="nump">5,281<span></span>
</td>
<td class="nump">$ 2,620<span></span>
</td>
<td class="nump">15,953<span></span>
</td>
<td class="nump">$ 8,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis=us-gaap_MaturityOvernightMember', window );">Overnight and Continuous [Member] | Cash [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsReceivedForSecuritiesLoanedAtCarryingValue', window );">Collateral received for securities loaned, at carrying value</a></td>
<td class="nump">2,636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,874<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis=us-gaap_MaturityOvernightMember', window );">Overnight and Continuous [Member] | United States Government Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsReceivedForSecuritiesLoanedAtCarryingValue', window );">Collateral received for securities loaned, at carrying value</a></td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">281<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis=us-gaap_MaturityOvernightMember', window );">Overnight and Continuous [Member] | Other Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsReceivedForSecuritiesLoanedAtCarryingValue', window );">Collateral received for securities loaned, at carrying value</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio of fair value of collateral held to fair value of securities loaned in securities lending transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedInvestmentIncomeReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest, dividends, rents, ancillary and other revenues earned but not yet received by the entity on its investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedInvestmentIncomeReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsReceivedForSecuritiesLoanedAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash received as security in return for loaning securities to another party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsReceivedForSecuritiesLoanedAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesLoanedFairValueOfCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the securities pledged as collateral against securities loaned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226013-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesLoanedFairValueOfCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherAggregatedInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_OtherAggregatedInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedMaturitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_FixedMaturitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis=us-gaap_MaturityOvernightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis=us-gaap_MaturityOvernightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898690972432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments (Financial Statement Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Derivative, Gain (Loss) Recognized</a></td>
<td class="num">$ (3)<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</a></td>
<td class="num">$ (231)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (231)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (239)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898672495088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value (Fair Value Measurements By Level For Assets Measured At Fair Value On A Recurring Basis) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 5,794<span></span>
</td>
<td class="nump">$ 2,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">26,148<span></span>
</td>
<td class="nump">26,899<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Other invested assets</a></td>
<td class="nump">5,516<span></span>
</td>
<td class="nump">5,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesHeldAsCollateralAtFairValue', window );">Securities lending collateral</a></td>
<td class="nump">2,841<span></span>
</td>
<td class="nump">2,155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">36,460<span></span>
</td>
<td class="nump">33,507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="num">(70)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">United States Government Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">1,548<span></span>
</td>
<td class="nump">1,432<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember', window );">Government Sponsored Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtMember', window );">Foreign Government Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">251<span></span>
</td>
<td class="nump">347<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, Municipalities And Political Subdivisions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">4,081<span></span>
</td>
<td class="nump">5,621<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">12,208<span></span>
</td>
<td class="nump">12,363<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">4,247<span></span>
</td>
<td class="nump">4,097<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">3,682<span></span>
</td>
<td class="nump">2,907<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EquitySecurities', window );">Equity Securities</a></td>
<td class="nump">1,503<span></span>
</td>
<td class="nump">1,881<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member] | Exchange Traded Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EquitySecurities', window );">Equity Securities</a></td>
<td class="nump">1,403<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member] | Common Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EquitySecurities', window );">Equity Securities</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member] | Private Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EquitySecurities', window );">Equity Securities</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember', window );">Other Investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Other invested assets</a></td>
<td class="nump">5,367<span></span>
</td>
<td class="nump">5,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember', window );">Other Investments [Member] | Common Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Other invested assets</a></td>
<td class="nump">149<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_DerivativeMember', window );">Derivatives [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement', window );">Derivative assets</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement', window );">Derivative liabilities</a></td>
<td class="num">(70)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">5,794<span></span>
</td>
<td class="nump">2,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesHeldAsCollateralAtFairValue', window );">Securities lending collateral</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">7,352<span></span>
</td>
<td class="nump">4,311<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I [Member] | United States Government Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I [Member] | Government Sponsored Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I [Member] | Foreign Government Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I [Member] | States, Municipalities And Political Subdivisions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I [Member] | Corporate Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I [Member] | Residential Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I [Member] | Commercial Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I [Member] | Other Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I [Member] | Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EquitySecurities', window );">Equity Securities</a></td>
<td class="nump">1,409<span></span>
</td>
<td class="nump">1,758<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I [Member] | Equity Securities [Member] | Exchange Traded Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EquitySecurities', window );">Equity Securities</a></td>
<td class="nump">1,403<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I [Member] | Equity Securities [Member] | Common Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EquitySecurities', window );">Equity Securities</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I [Member] | Equity Securities [Member] | Private Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EquitySecurities', window );">Equity Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I [Member] | Other Investments [Member] | Common Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Other invested assets</a></td>
<td class="nump">149<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I [Member] | Derivatives [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">25,708<span></span>
</td>
<td class="nump">26,539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesHeldAsCollateralAtFairValue', window );">Securities lending collateral</a></td>
<td class="nump">2,841<span></span>
</td>
<td class="nump">2,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">28,573<span></span>
</td>
<td class="nump">28,747<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="num">(70)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II [Member] | United States Government Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">1,548<span></span>
</td>
<td class="nump">1,432<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II [Member] | Government Sponsored Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II [Member] | Foreign Government Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">251<span></span>
</td>
<td class="nump">347<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II [Member] | States, Municipalities And Political Subdivisions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">4,081<span></span>
</td>
<td class="nump">5,621<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II [Member] | Corporate Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">12,079<span></span>
</td>
<td class="nump">12,027<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II [Member] | Residential Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">4,247<span></span>
</td>
<td class="nump">4,092<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II [Member] | Commercial Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II [Member] | Other Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">3,371<span></span>
</td>
<td class="nump">2,888<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II [Member] | Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EquitySecurities', window );">Equity Securities</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II [Member] | Equity Securities [Member] | Exchange Traded Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EquitySecurities', window );">Equity Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II [Member] | Equity Securities [Member] | Common Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EquitySecurities', window );">Equity Securities</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II [Member] | Equity Securities [Member] | Private Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EquitySecurities', window );">Equity Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II [Member] | Other Investments [Member] | Common Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Other invested assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II [Member] | Derivatives [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement', window );">Derivative assets</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement', window );">Derivative liabilities</a></td>
<td class="num">(70)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level III [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">440<span></span>
</td>
<td class="nump">360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesHeldAsCollateralAtFairValue', window );">Securities lending collateral</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">535<span></span>
</td>
<td class="nump">449<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level III [Member] | United States Government Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level III [Member] | Government Sponsored Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level III [Member] | Foreign Government Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level III [Member] | States, Municipalities And Political Subdivisions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level III [Member] | Corporate Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">336<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level III [Member] | Residential Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level III [Member] | Commercial Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level III [Member] | Other Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">311<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level III [Member] | Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EquitySecurities', window );">Equity Securities</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level III [Member] | Equity Securities [Member] | Exchange Traded Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EquitySecurities', window );">Equity Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level III [Member] | Equity Securities [Member] | Common Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EquitySecurities', window );">Equity Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level III [Member] | Equity Securities [Member] | Private Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EquitySecurities', window );">Equity Securities</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level III [Member] | Other Investments [Member] | Common Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Other invested assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level III [Member] | Derivatives [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement', window );">Derivative liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_EquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investments in equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_EquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and elected not to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and elected not to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesHeldAsCollateralAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount (fair value) as of the balance sheet date of securities held that had been pledged by counterparties under financing and lending arrangements, pursuant to which the entity has the right by agreement or custom to sell or re-pledge such securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5086-111524<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesHeldAsCollateralAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ExchangeTradedFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ExchangeTradedFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=elv_CommonEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=elv_CommonEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_PrivateEquityFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_PrivateEquityFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_DerivativeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_DerivativeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898680662480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value (Reconciliation Of The Beginning And Ending Balances Of Assets Measured At Fair Value On A Recurring Basis Using Level III Inputs) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">$ 467<span></span>
</td>
<td class="nump">$ 437<span></span>
</td>
<td class="nump">$ 449<span></span>
</td>
<td class="nump">$ 392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Total gains (losses) recognized in net income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Total gains (losses) recognized in accumulated other comprehensive loss</a></td>
<td class="nump">18<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">345<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(221)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="num">(119)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Transfers into Level III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Transfers out of Level III</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">535<span></span>
</td>
<td class="nump">421<span></span>
</td>
<td class="nump">535<span></span>
</td>
<td class="nump">421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss', window );">Change in unrealized gains (losses) included in net income related to assets still held</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">351<span></span>
</td>
<td class="nump">336<span></span>
</td>
<td class="nump">325<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Total gains (losses) recognized in net income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Total gains (losses) recognized in accumulated other comprehensive loss</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="num">(26)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(201)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="num">(118)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Transfers into Level III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Transfers out of Level III</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">334<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="nump">334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss', window );">Change in unrealized gains (losses) included in net income related to assets still held</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Total gains (losses) recognized in net income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Total gains (losses) recognized in accumulated other comprehensive loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Transfers into Level III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Transfers out of Level III</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss', window );">Change in unrealized gains (losses) included in net income related to assets still held</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">218<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Total gains (losses) recognized in net income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Total gains (losses) recognized in accumulated other comprehensive loss</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">281<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Transfers into Level III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Transfers out of Level III</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">311<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">311<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss', window );">Change in unrealized gains (losses) included in net income related to assets still held</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Total gains (losses) recognized in net income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Total gains (losses) recognized in accumulated other comprehensive loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Transfers into Level III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Transfers out of Level III</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss', window );">Change in unrealized gains (losses) included in net income related to assets still held</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3) and still held.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898671661440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value (Carrying And Estimated Fair Values by Level Of Financial Instruments Not Recorded At Fair Value On Consolidated Balance Sheet) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Other invested assets</a></td>
<td class="nump">$ 5,516<span></span>
</td>
<td class="nump">$ 5,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">265<span></span>
</td>
<td class="nump">275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Commercial paper</a></td>
<td class="nump">675<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes</a></td>
<td class="nump">20,163<span></span>
</td>
<td class="nump">25,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible debentures</a></td>
<td class="nump">554<span></span>
</td>
<td class="nump">687<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level III [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Commercial paper</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible debentures</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level II [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">265<span></span>
</td>
<td class="nump">275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Commercial paper</a></td>
<td class="nump">675<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes</a></td>
<td class="nump">20,163<span></span>
</td>
<td class="nump">25,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible debentures</a></td>
<td class="nump">554<span></span>
</td>
<td class="nump">687<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level I [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Commercial paper</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible debentures</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Other invested assets</a></td>
<td class="nump">5,367<span></span>
</td>
<td class="nump">5,087<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">265<span></span>
</td>
<td class="nump">275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Commercial paper</a></td>
<td class="nump">675<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes</a></td>
<td class="nump">22,747<span></span>
</td>
<td class="nump">22,384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible debentures</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember', window );">Other Investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Other invested assets</a></td>
<td class="nump">5,367<span></span>
</td>
<td class="nump">5,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember', window );">Other Investments [Member] | Fair Value, Recurring [Member] | Level III [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Other invested assets</a></td>
<td class="nump">5,367<span></span>
</td>
<td class="nump">5,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember', window );">Other Investments [Member] | Fair Value, Recurring [Member] | Level II [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Other invested assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember', window );">Other Investments [Member] | Fair Value, Recurring [Member] | Level I [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Other invested assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898691120976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 533<span></span>
</td>
<td class="nump">$ 494<span></span>
</td>
<td class="nump">$ 1,557<span></span>
</td>
<td class="nump">$ 1,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">24.80%<span></span>
</td>
<td class="nump">24.70%<span></span>
</td>
<td class="nump">23.50%<span></span>
</td>
<td class="nump">23.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="nump">$ 214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898685143904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Claims Payable (Reconciliation Of The Beginning And Ending Balances For Medical Claims Payable By Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Medical Claims Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense', window );">Gross medical claims payable, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,135<span></span>
</td>
<td class="nump">$ 13,282<span></span>
</td>
<td class="nump">$ 11,135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Ceded medical claims payable, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Net medical claims payable, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,089<span></span>
</td>
<td class="nump">13,261<span></span>
</td>
<td class="nump">11,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments', window );">Business combinations and purchase adjustments</a></td>
<td class="nump">$ 133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="nump">420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current period net incurred medical claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,177<span></span>
</td>
<td class="nump">74,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior periods redundancies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(901)<span></span>
</td>
<td class="num">(1,822)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total net incurred medical claims</a></td>
<td class="nump">28,511<span></span>
</td>
<td class="nump">$ 27,634<span></span>
</td>
<td class="nump">27,131<span></span>
</td>
<td class="nump">25,704<span></span>
</td>
<td class="nump">$ 23,844<span></span>
</td>
<td class="nump">22,727<span></span>
</td>
<td class="nump">83,276<span></span>
</td>
<td class="nump">72,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Net payments attributable to current period medical claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,453<span></span>
</td>
<td class="nump">62,123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Net payments attributable to prior periods medical claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,219<span></span>
</td>
<td class="nump">8,400<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total net payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,672<span></span>
</td>
<td class="nump">70,523<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet', window );">Net medical claims payable, end of period</a></td>
<td class="nump">14,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,998<span></span>
</td>
<td class="nump">13,261<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Ceded medical claims payable, end of period</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense', window );">Gross medical claims payable, end of period</a></td>
<td class="nump">15,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,001<span></span>
</td>
<td class="nump">13,299<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=elv_CommercialSpecialtyBusinessSegmentMember', window );">Commercial &amp; Specialty Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Medical Claims Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense', window );">Gross medical claims payable, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,294<span></span>
</td>
<td class="nump">3,847<span></span>
</td>
<td class="nump">3,294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Ceded medical claims payable, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Net medical claims payable, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,281<span></span>
</td>
<td class="nump">3,834<span></span>
</td>
<td class="nump">3,281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments', window );">Business combinations and purchase adjustments</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current period net incurred medical claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,049<span></span>
</td>
<td class="nump">20,499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior periods redundancies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(183)<span></span>
</td>
<td class="num">(496)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total net incurred medical claims</a></td>
<td class="nump">7,510<span></span>
</td>
<td class="nump">7,522<span></span>
</td>
<td class="nump">6,834<span></span>
</td>
<td class="nump">7,213<span></span>
</td>
<td class="nump">6,718<span></span>
</td>
<td class="nump">6,072<span></span>
</td>
<td class="nump">21,866<span></span>
</td>
<td class="nump">20,003<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Net payments attributable to current period medical claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,604<span></span>
</td>
<td class="nump">16,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Net payments attributable to prior periods medical claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,181<span></span>
</td>
<td class="nump">2,450<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total net payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,785<span></span>
</td>
<td class="nump">19,435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet', window );">Net medical claims payable, end of period</a></td>
<td class="nump">3,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,918<span></span>
</td>
<td class="nump">3,849<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Ceded medical claims payable, end of period</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense', window );">Gross medical claims payable, end of period</a></td>
<td class="nump">3,921<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,921<span></span>
</td>
<td class="nump">3,864<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=elv_GovernmentBusinessSegmentMember', window );">Government Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Medical Claims Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense', window );">Gross medical claims payable, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,646<span></span>
</td>
<td class="nump">9,157<span></span>
</td>
<td class="nump">7,646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Ceded medical claims payable, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Net medical claims payable, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,613<span></span>
</td>
<td class="nump">9,149<span></span>
</td>
<td class="nump">7,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments', window );">Business combinations and purchase adjustments</a></td>
<td class="nump">130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="nump">375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current period net incurred medical claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,971<span></span>
</td>
<td class="nump">52,422<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior periods redundancies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(639)<span></span>
</td>
<td class="num">(1,309)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total net incurred medical claims</a></td>
<td class="nump">20,601<span></span>
</td>
<td class="nump">19,788<span></span>
</td>
<td class="nump">19,943<span></span>
</td>
<td class="nump">18,071<span></span>
</td>
<td class="nump">16,723<span></span>
</td>
<td class="nump">16,319<span></span>
</td>
<td class="nump">60,332<span></span>
</td>
<td class="nump">51,113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Net payments attributable to current period medical claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,950<span></span>
</td>
<td class="nump">44,160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Net payments attributable to prior periods medical claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,854<span></span>
</td>
<td class="nump">5,781<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total net payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,804<span></span>
</td>
<td class="nump">49,941<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet', window );">Net medical claims payable, end of period</a></td>
<td class="nump">10,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,807<span></span>
</td>
<td class="nump">9,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Ceded medical claims payable, end of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense', window );">Gross medical claims payable, end of period</a></td>
<td class="nump">10,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,807<span></span>
</td>
<td class="nump">9,183<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=elv_OtherSegmentMember', window );">Other Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Medical Claims Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense', window );">Gross medical claims payable, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195<span></span>
</td>
<td class="nump">278<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Ceded medical claims payable, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Net medical claims payable, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195<span></span>
</td>
<td class="nump">278<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments', window );">Business combinations and purchase adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current period net incurred medical claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,157<span></span>
</td>
<td class="nump">1,176<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior periods redundancies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total net incurred medical claims</a></td>
<td class="nump">400<span></span>
</td>
<td class="nump">$ 324<span></span>
</td>
<td class="nump">$ 354<span></span>
</td>
<td class="nump">420<span></span>
</td>
<td class="nump">$ 403<span></span>
</td>
<td class="nump">$ 336<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
<td class="nump">1,159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Net payments attributable to current period medical claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">899<span></span>
</td>
<td class="nump">978<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Net payments attributable to prior periods medical claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="nump">169<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total net payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,083<span></span>
</td>
<td class="nump">1,147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet', window );">Net medical claims payable, end of period</a></td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="nump">252<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Ceded medical claims payable, end of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense', window );">Gross medical claims payable, end of period</a></td>
<td class="nump">$ 273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 273<span></span>
</td>
<td class="nump">$ 252<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Unpaid Claims And Claims Adjustment Expense Purchase Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling short duration contract claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date for short duration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short duration contract liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for short duration contract claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid short duration contract claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLossesAndLossAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_CommercialSpecialtyBusinessSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_CommercialSpecialtyBusinessSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_GovernmentBusinessSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_GovernmentBusinessSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_OtherSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_OtherSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898683028816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Claims Payable (Reconciliation Of Net Incurred Medical Claims To Benefit Expense) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems', window );"><strong>Reconciliation of net incurred medical claims to benefit expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total net incurred medical claims</a></td>
<td class="nump">$ 28,511<span></span>
</td>
<td class="nump">$ 27,634<span></span>
</td>
<td class="nump">$ 27,131<span></span>
</td>
<td class="nump">$ 25,704<span></span>
</td>
<td class="nump">$ 23,844<span></span>
</td>
<td class="nump">$ 22,727<span></span>
</td>
<td class="nump">$ 83,276<span></span>
</td>
<td class="nump">$ 72,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense', window );">Quality improvement and other claims expense</a></td>
<td class="nump">893<span></span>
</td>
<td class="nump">1,143<span></span>
</td>
<td class="nump">1,084<span></span>
</td>
<td class="nump">941<span></span>
</td>
<td class="nump">919<span></span>
</td>
<td class="nump">972<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
<td class="nump">2,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet', window );">Benefit expense</a></td>
<td class="nump">29,404<span></span>
</td>
<td class="nump">28,777<span></span>
</td>
<td class="nump">28,215<span></span>
</td>
<td class="nump">26,645<span></span>
</td>
<td class="nump">24,763<span></span>
</td>
<td class="nump">23,699<span></span>
</td>
<td class="nump">86,396<span></span>
</td>
<td class="nump">75,107<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=elv_CommercialSpecialtyBusinessSegmentMember', window );">Commercial &amp; Specialty Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems', window );"><strong>Reconciliation of net incurred medical claims to benefit expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total net incurred medical claims</a></td>
<td class="nump">7,510<span></span>
</td>
<td class="nump">7,522<span></span>
</td>
<td class="nump">6,834<span></span>
</td>
<td class="nump">7,213<span></span>
</td>
<td class="nump">6,718<span></span>
</td>
<td class="nump">6,072<span></span>
</td>
<td class="nump">21,866<span></span>
</td>
<td class="nump">20,003<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=elv_GovernmentBusinessSegmentMember', window );">Government Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems', window );"><strong>Reconciliation of net incurred medical claims to benefit expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total net incurred medical claims</a></td>
<td class="nump">20,601<span></span>
</td>
<td class="nump">19,788<span></span>
</td>
<td class="nump">19,943<span></span>
</td>
<td class="nump">18,071<span></span>
</td>
<td class="nump">16,723<span></span>
</td>
<td class="nump">16,319<span></span>
</td>
<td class="nump">60,332<span></span>
</td>
<td class="nump">51,113<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=elv_OtherSegmentMember', window );">Other Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems', window );"><strong>Reconciliation of net incurred medical claims to benefit expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total net incurred medical claims</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 324<span></span>
</td>
<td class="nump">$ 354<span></span>
</td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 403<span></span>
</td>
<td class="nump">$ 336<span></span>
</td>
<td class="nump">$ 1,078<span></span>
</td>
<td class="nump">$ 1,159<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Reconciliation of net incurred medical claims to benefit expense [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6811-158387<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating expense classified as other, disclosed in supplementary insurance information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-16(Column J))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574960-122915<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_CommercialSpecialtyBusinessSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_CommercialSpecialtyBusinessSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_GovernmentBusinessSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_GovernmentBusinessSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_OtherSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_OtherSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898672470704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Medical Claims Payable Medical Claims Payable (Reconciliation of the Claims Development to the Claims Liability) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems', window );"><strong>Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Net medical claims payable, end of period</a></td>
<td class="nump">$ 14,998<span></span>
</td>
<td class="nump">$ 13,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Ceded medical claims payable end of period</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem', window );">Insurance lines other than short duration</a></td>
<td class="nump">241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Gross medical claims payable, end of period</a></td>
<td class="nump">15,242<span></span>
</td>
<td class="nump">13,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=elv_CommercialSpecialtyBusinessSegmentMember', window );">Commercial &amp; Specialty Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems', window );"><strong>Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Net medical claims payable, end of period</a></td>
<td class="nump">3,918<span></span>
</td>
<td class="nump">3,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Ceded medical claims payable end of period</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem', window );">Insurance lines other than short duration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Gross medical claims payable, end of period</a></td>
<td class="nump">3,921<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=elv_GovernmentBusinessSegmentMember', window );">Government Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems', window );"><strong>Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Net medical claims payable, end of period</a></td>
<td class="nump">10,807<span></span>
</td>
<td class="nump">9,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Ceded medical claims payable end of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem', window );">Insurance lines other than short duration</a></td>
<td class="nump">241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Gross medical claims payable, end of period</a></td>
<td class="nump">11,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=elv_OtherSegmentMember', window );">Other Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems', window );"><strong>Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Net medical claims payable, end of period</a></td>
<td class="nump">273<span></span>
</td>
<td class="nump">278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Ceded medical claims payable end of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem', window );">Insurance lines other than short duration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Gross medical claims payable, end of period</a></td>
<td class="nump">$ 273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reconciling item for the reconciliation of the liability in the disclosure of claims development (in excess of) less than the liability for unpaid claims and claims adjustment expense for short-duration insurance contracts, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671315-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_CommercialSpecialtyBusinessSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_CommercialSpecialtyBusinessSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_GovernmentBusinessSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_GovernmentBusinessSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_OtherSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_OtherSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898690737440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Medical Claims Payable (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2020Member', window );">Short-Duration Insurance Contract, Accident Year 2020 [Member] | Commercial &amp; Specialty Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet', window );">Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net</a></td>
<td class="nump">$ 81<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2020Member', window );">Short-Duration Insurance Contract, Accident Year 2020 [Member] | Government Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet', window );">Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net</a></td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2020Member', window );">Short-Duration Insurance Contract, Accident Year 2020 [Member] | Other Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet', window );">Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2021Member', window );">Short-Duration Insurance Contract, Accident Year 2021 [Member] | Commercial &amp; Specialty Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet', window );">Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net</a></td>
<td class="nump">388<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2021Member', window );">Short-Duration Insurance Contract, Accident Year 2021 [Member] | Government Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet', window );">Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net</a></td>
<td class="nump">508<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2021Member', window );">Short-Duration Insurance Contract, Accident Year 2021 [Member] | Other Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet', window );">Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net</a></td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2022Member', window );">Short-Duration Insurance Contract, Accident Year 2022 [Member] | Commercial &amp; Specialty Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet', window );">Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net</a></td>
<td class="nump">3,449<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2022Member', window );">Short-Duration Insurance Contract, Accident Year 2022 [Member] | Government Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet', window );">Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net</a></td>
<td class="nump">10,151<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2022Member', window );">Short-Duration Insurance Contract, Accident Year 2022 [Member] | Other Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet', window );">Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net</a></td>
<td class="nump">$ 257<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClaimsDevelopmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClaimsDevelopmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4E<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671321-158438<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671317-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_CommercialSpecialtyBusinessSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_CommercialSpecialtyBusinessSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_GovernmentBusinessSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_GovernmentBusinessSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_OtherSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_OtherSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898690984720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Convertible Debenture Details) (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Net debt carrying amount</a></td>
<td class="nump">$ 554<span></span>
</td>
<td class="nump">$ 687<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding principal amount</a></td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Net debt carrying amount</a></td>
<td class="nump">$ 86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion rate (shares of common stock per $1,000 of principal)</a></td>
<td class="nump">14.2967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Effective conversion price (per $1,000 of principal amount) per share | $ / shares</a></td>
<td class="nump">$ 69.9462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898673353936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 18, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>May 16, 2022</div></th>
<th class="th"><div>Apr. 29, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">675<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">675<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity attributable to parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,991<span></span>
</td>
<td class="nump">35,808<span></span>
</td>
<td class="nump">35,991<span></span>
</td>
<td class="nump">35,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">982<span></span>
</td>
<td class="nump">954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity attributable to parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,604<span></span>
</td>
<td class="nump">$ 26,700<span></span>
</td>
<td class="nump">$ 29,604<span></span>
</td>
<td class="nump">$ 26,700<span></span>
</td>
<td class="nump">$ 28,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,058<span></span>
</td>
<td class="nump">27,088<span></span>
</td>
<td class="nump">$ 25,874<span></span>
</td>
<td class="nump">$ 24,793<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2020-06 [Member] | Retained Earnings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent', window );">Deferred Tax and Other Liabilities, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity attributable to parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember', window );">Senior Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCovenantDescription', window );">Covenant description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Our ability to borrow under the 5-Year Facility is subject to compliance with certain covenants, including covenants requiring us to maintain a defined debt-to-capital ratio of not more than 60%, subject to increase in certain circumstances set forth in the credit agreement for the 5-Year Facility.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCovenantCompliance', window );">Covenant compliance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">As of September&#160;30, 2022, our debt-to-capital ratio, as defined and calculated under the 5-Year Facility, was 39.7%. We do not believe the restrictions contained in our 5-Year Facility covenants materially affect our financial or operating flexibility. As of September&#160;30, 2022, we were in compliance with all of our debt covenants under the 5-Year Facility.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_DebtConversionDebtPrincipalAmount', window );">Debt Conversion Debt Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Subsidiary Credit Facilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_FederalHomeLoanBankAdvancesMember', window );">Federal Home Loan Bank Advances [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths', window );">Federal Home Loan Bank, advances, short-term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=elv_SurplusNotesMember', window );">Surplus Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=elv_SeniorUnsecuredNotesMember', window );">Senior Unsecured Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=elv_SeniorUnsecuredNotesMember', window );">Senior Unsecured Notes [Member] | Four Point One Zero Percent Due Two Thousand Thirty Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=elv_SeniorUnsecuredNotesMember', window );">Senior Unsecured Notes [Member] | Four Point Five Five Zero Due Two Thousand Fifty Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=elv_SeniorUnsecuredNotesMember', window );">Senior Unsecured Notes [Member] | Three Point One Two Five Percent Due Two Thousand Twenty Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt instruments, repurchased face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_CommercialPaperMaximumBorrowingCapacity', window );">Commercial paper authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 675<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 675<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=elv_A2021364DayFacilityMember', window );">2021 364-Day Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityDescription', window );">Line of Credit Facility, Description</a></td>
<td class="text">Also on April 18, 2022, concurrently with the amendment and restatement of the 5-Year Facility, we terminated our 364-day senior revolving credit facility that provided for credit in the amount of $1,000, which was scheduled to mature in June 2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=elv_A2021364DayFacilityMember', window );">2021 364-Day Facility [Member] | Senior Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=elv_A5YearFacilityMember', window );">5-Year Facility [Member] | Senior Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_CommercialPaperMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commercial Paper, Maximum Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_CommercialPaperMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_DebtConversionDebtPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate principal amount of the original debt instrument that was surrendered for conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_DebtConversionDebtPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCovenantCompliance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>States whether the entity was in compliance with the debt covenants throughout the reporting period, and describes facts and circumstances of any compliance failure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCovenantCompliance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCovenantDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of minimum financial levels (for example, tangible net worth and working capital) and achievement of certain financial ratios (for example, working capital ratio and debt service coverage ratio), and adherence to certain clauses which generally require or restrict certain actions (for example, entering into a debt arrangement with equal or greater seniority, and selling or discontinuing a certain business segment or material subsidiary) to be in compliance with the covenant clauses of the debt agreement. May also include a discussion of the adverse consequences that would result if the entity violates or fails to satisfy the covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCovenantDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting, and liabilities classified as noncurrent and other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of advances from Federal Home Loan Bank (FHLBank) maturing in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the terms of a credit facility arrangement. Terms typically include interest rate, collateral required, guarantees required, repayment requirements, and restrictions on use of assets and activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_FederalHomeLoanBankAdvancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_FederalHomeLoanBankAdvancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=elv_SurplusNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=elv_SurplusNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=elv_SeniorUnsecuredNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=elv_SeniorUnsecuredNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=elv_FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=elv_FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=elv_ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=elv_ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=elv_A2021364DayFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=elv_A2021364DayFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=elv_A5YearFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=elv_A5YearFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898672016064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments And Contingencies (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Aggregate settlement amount</a></td>
<td class="nump">$ 596<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualPayments', window );">Loss Contingency Accrual, Payments</a></td>
<td class="nump">$ 506<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_GrossPremiumTaxRate', window );">Gross premium tax rate, state of California</a></td>
<td class="nump">2.35%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentAmount', window );">Long-term purchase commitment, amount</a></td>
<td class="nump">$ 830<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Aggregate settlement amount</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Aggregate settlement amount</a></td>
<td class="nump">$ 250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=elv_BCBSAntitrustLitigationMember', window );">BCBS Antitrust Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Loss Contingency, Pending Claims, Number</a></td>
<td class="nump">8,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=elv_AnthemInc.v.ExpressScriptsInc.Member', window );">Anthem, Inc. v. Express Scripts, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds originally received at time of divestiture</a></td>
<td class="nump">$ 4,675<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=elv_AnthemInc.v.ExpressScriptsInc.Member', window );">Anthem, Inc. v. Express Scripts, Inc. [Member] | Damages for Pharmacy Pricing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Approximate amount of damages sought for breaches</a></td>
<td class="nump">14,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=elv_AnthemInc.v.ExpressScriptsInc.Member', window );">Anthem, Inc. v. Express Scripts, Inc. [Member] | Damages for Operational Breaches [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Approximate amount of damages sought for breaches</a></td>
<td class="nump">$ 158<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments And Contingencies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_GrossPremiumTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross premium tax rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_GrossPremiumTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum amount the entity agreed to spend under the long-term purchase commitment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow reducing loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=elv_BCBSAntitrustLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=elv_BCBSAntitrustLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=elv_AnthemInc.v.ExpressScriptsInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=elv_AnthemInc.v.ExpressScriptsInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainContingenciesByNatureAxis=elv_PharmacypricingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainContingenciesByNatureAxis=elv_PharmacypricingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainContingenciesByNatureAxis=elv_OperationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainContingenciesByNatureAxis=elv_OperationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898691131712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Summary of Cash Dividend Activity) (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalAbstract', window );"><strong>Banking Regulation, Total Capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear', window );">Declaration date</a></td>
<td class="text">Jul. 19,  2022<span></span>
</td>
<td class="text">Apr. 19,  2022<span></span>
</td>
<td class="text">Jan. 25,  2022<span></span>
</td>
<td class="text">Jul. 20,  2021<span></span>
</td>
<td class="text">Apr. 20,  2021<span></span>
</td>
<td class="text">Jan. 26,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear', window );">Record date</a></td>
<td class="text">Sep.  09,  2022<span></span>
</td>
<td class="text">Jun. 10,  2022<span></span>
</td>
<td class="text">Mar. 10,  2022<span></span>
</td>
<td class="text">Sep. 10,  2021<span></span>
</td>
<td class="text">Jun. 10,  2021<span></span>
</td>
<td class="text">Mar. 10,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendPayableDateToBePaidDayMonthAndYear', window );">Payment date</a></td>
<td class="text">Sep. 23,  2022<span></span>
</td>
<td class="text">Jun. 24,  2022<span></span>
</td>
<td class="text">Mar. 25,  2022<span></span>
</td>
<td class="text">Sep. 24,  2021<span></span>
</td>
<td class="text">Jun. 25,  2021<span></span>
</td>
<td class="text">Mar. 25,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Cash dividends per share</a></td>
<td class="nump">$ 1.28<span></span>
</td>
<td class="nump">$ 1.28<span></span>
</td>
<td class="nump">$ 1.28<span></span>
</td>
<td class="nump">$ 1.13<span></span>
</td>
<td class="nump">$ 1.13<span></span>
</td>
<td class="nump">$ 1.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Total payment</a></td>
<td class="nump">$ 306<span></span>
</td>
<td class="nump">$ 309<span></span>
</td>
<td class="nump">$ 309<span></span>
</td>
<td class="nump">$ 276<span></span>
</td>
<td class="nump">$ 278<span></span>
</td>
<td class="nump">$ 277<span></span>
</td>
<td class="nump">$ 924<span></span>
</td>
<td class="nump">$ 831<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendPayableDateToBePaidDayMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the declared dividend will be paid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendPayableDateToBePaidDayMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the dividend to be paid was declared, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableDateDeclaredDayMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the holder must own the stock to be entitled to the dividend, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableDateOfRecordDayMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898671600928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Summary of Share Repurchases) (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_StockRepurchasedAndRetiredDuringPeriodAveragePrice', window );">Average price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 473.36<span></span>
</td>
<td class="nump">$ 356.43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Aggregate cost</a></td>
<td class="nump">$ 579<span></span>
</td>
<td class="nump">$ 624<span></span>
</td>
<td class="nump">$ 545<span></span>
</td>
<td class="nump">$ 451<span></span>
</td>
<td class="nump">$ 480<span></span>
</td>
<td class="nump">$ 447<span></span>
</td>
<td class="nump">$ 1,748<span></span>
</td>
<td class="nump">$ 1,378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Authorization remaining at the end of the period</a></td>
<td class="nump">$ 2,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,444<span></span>
</td>
<td class="nump">$ 4,714<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_StockRepurchasedAndRetiredDuringPeriodAveragePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchased and Retired During Period Average Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_StockRepurchasedAndRetiredDuringPeriodAveragePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898679286880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Summary of Stock Option Activity) (Details)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of period, Number of Shares | shares</a></td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted, Number of Shares | shares</a></td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised, Number of Shares | shares</a></td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Forfeited or expired, Number of Shares | shares</a></td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of period, Number of Shares | shares</a></td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of period, Number of Shares | shares</a></td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Option Price Per Share [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of period, Weighted-Average Option Price per Share | $ / shares</a></td>
<td class="nump">$ 255.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted, Weighted-Average Option Price per Share | $ / shares</a></td>
<td class="nump">452.34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised, Weighted-Average Option Price per Share | $ / shares</a></td>
<td class="nump">243.39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited or expired, Weighted-Average Option Price per Share | $ / shares</a></td>
<td class="nump">339.52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period, Weighted-Average Option Price per Share | $ / shares</a></td>
<td class="nump">291.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at end of period, Weighted-Average Option Price per Share | $ / shares</a></td>
<td class="nump">$ 239.27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding at end of period, Weighted-Average Remaining Contractual Life</a></td>
<td class="text">6 years 6 months 21 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable at end of period, Weighted-Average Remaining Contractual Life</a></td>
<td class="text">5 years 4 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding at end of period, Aggregate Intrinsic Value | $</a></td>
<td class="nump">$ 477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Exercisable at end of period, Aggregate Intrinsic Value | $</a></td>
<td class="nump">$ 370<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898684224784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Nonvested Restricted Stock Activity Including Restricted Stock Units) (Details) - $ / shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Restricted Stock Shares and Units [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at Beginning Balance, Restricted Stock Shares and Units</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted, Restricted Stock Shares and Units</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested, Restricted Stock Shares And Units</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited, Restricted Stock Shares And Units</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at Ending Balance, Restricted Stock Shares and Units</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value Per Share [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at Beginning Balance, Weighted-Average Grant Date Fair Value per Share</a></td>
<td class="nump">$ 299.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, Weighted-Average Grant Date Fair Value per Share</a></td>
<td class="nump">453.16<span></span>
</td>
<td class="nump">$ 315.54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested, Weighted-Average Grant Date Fair Value per Share</a></td>
<td class="nump">301.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited, Weighted-Average Grant Date Fair Value per Share</a></td>
<td class="nump">345.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at Ending Balance, Weighted-Average Grant Date Fair Value per Share</a></td>
<td class="nump">$ 356.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898683882384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Fair Values of Options Granted During The Period Estimated Using Weighted-Average Assumptions) (Details)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalAbstract', window );"><strong>Banking Regulation, Total Capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.97%<span></span>
</td>
<td class="nump">1.44%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility factor</a></td>
<td class="nump">29.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Quarterly dividend yield</a></td>
<td class="nump">0.282%<span></span>
</td>
<td class="nump">0.36%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Weighted-average expected life (years)</a></td>
<td class="text">5 years 1 month 6 days<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898684945344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Schedule Of Weighted-Average Fair Values Determined For The Periods) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalAbstract', window );"><strong>Banking Regulation, Total Capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Options granted during the period</a></td>
<td class="nump">$ 116.85<span></span>
</td>
<td class="nump">$ 79.51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock awards granted during the period</a></td>
<td class="nump">$ 453.16<span></span>
</td>
<td class="nump">$ 315.54<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898683230272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Narrative) (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 18, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jan. 26, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendPayableDateToBePaidDayMonthAndYear', window );">Dividends Payable, Date to be Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 23,  2022<span></span>
</td>
<td class="text">Jun. 24,  2022<span></span>
</td>
<td class="text">Mar. 25,  2022<span></span>
</td>
<td class="text">Sep. 24,  2021<span></span>
</td>
<td class="text">Jun. 25,  2021<span></span>
</td>
<td class="text">Mar. 25,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear', window );">Dividends Payable, Date of Record</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep.  09,  2022<span></span>
</td>
<td class="text">Jun. 10,  2022<span></span>
</td>
<td class="text">Mar. 10,  2022<span></span>
</td>
<td class="text">Sep. 10,  2021<span></span>
</td>
<td class="text">Jun. 10,  2021<span></span>
</td>
<td class="text">Mar. 10,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_IncreaseInStockRepurchaseProgramAuthorization', window );">Increase In Stock Repurchase Program Authorization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Dividends Payable, Amount Per Share</a></td>
<td class="nump">$ 1.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendPayableDateToBePaidDayMonthAndYear', window );">Dividends Payable, Date to be Paid</a></td>
<td class="text">Dec. 21,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear', window );">Dividends Payable, Date of Record</a></td>
<td class="text">Dec.  05,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_PerformancemeasurementperiodAxis=elv_A2022To2024Member', window );">2022 to 2024 | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_IncreaseInStockRepurchaseProgramAuthorization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an increase authorized by an entity's Board of Directors to a previously authorized stock repurchase program.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_IncreaseInStockRepurchaseProgramAuthorization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendPayableDateToBePaidDayMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the declared dividend will be paid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendPayableDateToBePaidDayMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share amount of a dividend declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the holder must own the stock to be entitled to the dividend, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableDateOfRecordDayMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_PerformancemeasurementperiodAxis=elv_A2022To2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_PerformancemeasurementperiodAxis=elv_A2022To2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898683208864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss (Reconciliation Of The Components Of Accumulated Other Comprehensive Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Loss, Beginning Balance</a></td>
<td class="num">$ (2,149)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (178)<span></span>
</td>
<td class="num">$ (17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="num">$ (178)<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</a></td>
<td class="num">(639)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(97)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,630)<span></span>
</td>
<td class="num">(284)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive loss attributable to noncontrolling interests</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Cash flow hedges, holding gain (loss), net of tax</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, net of tax</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(638)<span></span>
</td>
<td class="num">$ (916)<span></span>
</td>
<td class="num">(1,063)<span></span>
</td>
<td class="num">(87)<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
<td class="num">(347)<span></span>
</td>
<td class="num">(2,617)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Loss, Ending Balance</a></td>
<td class="num">(2,784)<span></span>
</td>
<td class="num">(2,149)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(103)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,784)<span></span>
</td>
<td class="num">(103)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Other Comprehensive Income (Loss), Tax (Expense) Benefit, Portion Attributable to Parent</a></td>
<td class="nump">198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">815<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest', window );">Other Comprehensive Income (Loss), Tax, Portion Attributable to Noncontrolling Interest</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Net unrealized investment (losses) gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">AOCI, Debt Securities, Beginning Balance</a></td>
<td class="num">(1,489)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">494<span></span>
</td>
<td class="nump">762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">949<span></span>
</td>
<td class="nump">494<span></span>
</td>
<td class="nump">949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</a></td>
<td class="num">(719)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,914)<span></span>
</td>
<td class="num">(203)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</a></td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">284<span></span>
</td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</a></td>
<td class="num">(639)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(97)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,630)<span></span>
</td>
<td class="num">(284)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive loss attributable to noncontrolling interests</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">AOCI, Debt Securities, Ending Balance</a></td>
<td class="num">(2,125)<span></span>
</td>
<td class="num">(1,489)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">666<span></span>
</td>
<td class="nump">762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,125)<span></span>
</td>
<td class="nump">666<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax', window );">Net holding gain (loss) on investment securities arising during the period, tax (expense) benefit</a></td>
<td class="nump">220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">896<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax', window );">Reclassification adjustment for net realized loss (gain) on investment securities, tax (benefit) expense</a></td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=elv_NonCreditComponentsOfImpairmentsOnInvestmentsMember', window );">Non-credit components of impairments on investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities', window );">Accumulated Other Comprehensive Income (Loss), Other than Temporary Impairment, Not Credit Loss, Net of Tax, Debt Securities</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities', window );">Other than Temporary Impairment Losses, Investments, Portion in Other Comprehensive Loss, Net of Tax, Including Portion Attributable to Noncontrolling Interest, Available-for-sale Securities</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities', window );">AOCI, Other than Temporary Impairment, Not Credit Loss, Ending Balance</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss', window );">Tax (expense) benefit of non credit impairment on available-for-sale securities recognized in other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember', window );">Net cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">AOCI, Cash Flow Hedge, Beginning Balance</a></td>
<td class="num">(233)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(239)<span></span>
</td>
<td class="num">(244)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(250)<span></span>
</td>
<td class="num">(239)<span></span>
</td>
<td class="num">(250)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Cash flow hedges, holding gain (loss), net of tax</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">AOCI, Cash Flow Hedge, Ending Balance</a></td>
<td class="num">(231)<span></span>
</td>
<td class="num">(233)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(240)<span></span>
</td>
<td class="num">(244)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(231)<span></span>
</td>
<td class="num">(240)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Cash flow hedges, holding gain (loss), tax (expense) benefit</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Pension and other postretirement benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">AOCI, Defined Benefit Plan, Beginning Balance</a></td>
<td class="num">(413)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(429)<span></span>
</td>
<td class="num">(534)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(552)<span></span>
</td>
<td class="num">(429)<span></span>
</td>
<td class="num">(552)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">AOCI, Defined Benefit Plan, Ending Balance</a></td>
<td class="num">(406)<span></span>
</td>
<td class="num">(413)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(526)<span></span>
</td>
<td class="num">(534)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(406)<span></span>
</td>
<td class="num">(526)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense', window );">Net change in unrecognized periodic benefit costs for defined benefit pension and postretirement benefit plans, tax expense</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">AOCI, Foreign Currency Translation Adjustment, Net of Tax, Beginning Balance</a></td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, net of tax</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax, Ending Balance</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">$ (12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax (Expense) Benefit</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax (expense) benefit of non-credit component of impairment loss on available-for-sale securities recognized in other comprehensive income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of accumulated other comprehensive loss related to that portion of other than temporary impairment (OTTI) due to factors other than credit losses on debt securities categorized either as available-for-sale or held-to-maturity that an entity does not intend to sell and which it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis of the debt security. The amount represented by this item is net of tax, as applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9A<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=SL6284427-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other than temporary impairment (OTTI) loss on investment in available-for-sale debt security, recognized in other comprehensive loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 35<br> -Paragraph 35<br> -URI https://asc.fasb.org/extlink&amp;oid=124260725&amp;loc=d3e25362-111560<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=elv_NonCreditComponentsOfImpairmentsOnInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=elv_NonCreditComponentsOfImpairmentsOnInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898690053936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Denominator For Basic And Diluted Earnings Per Share) (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Denominator for basic earnings per share - weighted-average shares</a></td>
<td class="nump">239.6<span></span>
</td>
<td class="nump">243.4<span></span>
</td>
<td class="nump">240.5<span></span>
</td>
<td class="nump">244.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive securities &#8211; employee stock options, nonvested restricted stock awards and convertible debentures</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Denominator for diluted earnings per share</a></td>
<td class="nump">242.2<span></span>
</td>
<td class="nump">246.0<span></span>
</td>
<td class="nump">243.3<span></span>
</td>
<td class="nump">247.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898672498240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Narrative) (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted average shares excluded from denominator for diluted earnings per share because the stock options were anti-dilutive</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock units issued under stock incentive plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_PerformancemeasurementperiodAxis=elv_A2022To2024Member', window );">2022 to 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock units issued under stock incentive plan</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults', window );">Restricted stock units excluded from the denominator for diluted earnings per share</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_PerformancemeasurementperiodAxis=elv_A2021To2023Member', window );">2021 to 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock units issued under stock incentive plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults', window );">Restricted stock units excluded from the denominator for diluted earnings per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Potentially Dilutive Restricted Stock Units Contingent On Operating Results</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_PerformancemeasurementperiodAxis=elv_A2022To2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_PerformancemeasurementperiodAxis=elv_A2022To2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_PerformancemeasurementperiodAxis=elv_A2021To2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_PerformancemeasurementperiodAxis=elv_A2021To2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898673293088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Financial Data By Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Reportable segments operating revenues</a></td>
<td class="nump">$ 39,625<span></span>
</td>
<td class="nump">$ 35,548<span></span>
</td>
<td class="nump">$ 115,993<span></span>
</td>
<td class="nump">$ 100,925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating gain (loss)</a></td>
<td class="nump">2,270<span></span>
</td>
<td class="nump">2,059<span></span>
</td>
<td class="nump">7,084<span></span>
</td>
<td class="nump">6,301<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=elv_CommercialSpecialtyMember', window );">Commercial &amp; Specialty [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating gain (loss)</a></td>
<td class="nump">785<span></span>
</td>
<td class="nump">620<span></span>
</td>
<td class="nump">2,673<span></span>
</td>
<td class="nump">2,679<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=elv_GovernmentBusinessSegmentMember', window );">Government Business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating gain (loss)</a></td>
<td class="nump">868<span></span>
</td>
<td class="nump">967<span></span>
</td>
<td class="nump">2,653<span></span>
</td>
<td class="nump">2,313<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=elv_IngenioRxSegmentMember', window );">IngenioRx Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating gain (loss)</a></td>
<td class="nump">516<span></span>
</td>
<td class="nump">445<span></span>
</td>
<td class="nump">1,393<span></span>
</td>
<td class="nump">1,257<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=elv_OtherSegmentMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating gain (loss)</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Reportable segments operating revenues</a></td>
<td class="num">(6,054)<span></span>
</td>
<td class="num">(5,192)<span></span>
</td>
<td class="num">(18,382)<span></span>
</td>
<td class="num">(15,173)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=elv_UnaffiliatedMember', window );">Unaffiliated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Reportable segments operating revenues</a></td>
<td class="nump">39,625<span></span>
</td>
<td class="nump">35,548<span></span>
</td>
<td class="nump">115,993<span></span>
</td>
<td class="nump">100,925<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=elv_UnaffiliatedMember', window );">Unaffiliated | Commercial &amp; Specialty [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Reportable segments operating revenues</a></td>
<td class="nump">10,494<span></span>
</td>
<td class="nump">9,863<span></span>
</td>
<td class="nump">31,324<span></span>
</td>
<td class="nump">28,904<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=elv_UnaffiliatedMember', window );">Unaffiliated | Government Business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Reportable segments operating revenues</a></td>
<td class="nump">24,571<span></span>
</td>
<td class="nump">21,658<span></span>
</td>
<td class="nump">72,164<span></span>
</td>
<td class="nump">61,007<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=elv_UnaffiliatedMember', window );">Unaffiliated | IngenioRx Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Reportable segments operating revenues</a></td>
<td class="nump">3,971<span></span>
</td>
<td class="nump">3,369<span></span>
</td>
<td class="nump">10,838<span></span>
</td>
<td class="nump">9,131<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=elv_UnaffiliatedMember', window );">Unaffiliated | Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Reportable segments operating revenues</a></td>
<td class="nump">589<span></span>
</td>
<td class="nump">658<span></span>
</td>
<td class="nump">1,667<span></span>
</td>
<td class="nump">1,883<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=elv_AffiliatedMember', window );">Affiliated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Reportable segments operating revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=elv_AffiliatedMember', window );">Affiliated [Member] | Commercial &amp; Specialty [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Reportable segments operating revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=elv_AffiliatedMember', window );">Affiliated [Member] | Government Business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Reportable segments operating revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=elv_AffiliatedMember', window );">Affiliated [Member] | IngenioRx Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Reportable segments operating revenues</a></td>
<td class="nump">3,278<span></span>
</td>
<td class="nump">3,180<span></span>
</td>
<td class="nump">10,165<span></span>
</td>
<td class="nump">9,499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=elv_AffiliatedMember', window );">Affiliated [Member] | Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Reportable segments operating revenues</a></td>
<td class="nump">$ 2,776<span></span>
</td>
<td class="nump">$ 2,012<span></span>
</td>
<td class="nump">$ 8,217<span></span>
</td>
<td class="nump">$ 5,674<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceServicesRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue from insurance services, including net premiums earned, gain on sale of insurance block, agency management fees and insurance contract fees and commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.1,4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceServicesRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=elv_CommercialSpecialtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=elv_CommercialSpecialtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=elv_GovernmentBusinessSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=elv_GovernmentBusinessSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=elv_IngenioRxSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=elv_IngenioRxSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=elv_OtherSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=elv_OtherSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=elv_UnaffiliatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=elv_UnaffiliatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=elv_AffiliatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=elv_AffiliatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=elv_CommercialSpecialtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=elv_CommercialSpecialtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=elv_GovernmentBusinessSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=elv_GovernmentBusinessSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=elv_IngenioRxSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=elv_IngenioRxSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=elv_OtherSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=elv_OtherSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898680595472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information Segment Information (Major Product Revenues for Each Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_MajorProductRevenueBySegmentLineItems', window );"><strong>Major Product Revenue By Segment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Insurance Services Revenue</a></td>
<td class="nump">$ 39,625<span></span>
</td>
<td class="nump">$ 35,548<span></span>
</td>
<td class="nump">$ 115,993<span></span>
</td>
<td class="nump">$ 100,925<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=elv_CommercialSpecialtyBusinessSegmentMember', window );">Commercial &amp; Specialty Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_MajorProductRevenueBySegmentLineItems', window );"><strong>Major Product Revenue By Segment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Insurance Services Revenue</a></td>
<td class="nump">10,494<span></span>
</td>
<td class="nump">9,863<span></span>
</td>
<td class="nump">31,324<span></span>
</td>
<td class="nump">28,904<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=elv_GovernmentBusinessSegmentMember', window );">Government Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_MajorProductRevenueBySegmentLineItems', window );"><strong>Major Product Revenue By Segment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Insurance Services Revenue</a></td>
<td class="nump">24,571<span></span>
</td>
<td class="nump">21,658<span></span>
</td>
<td class="nump">72,164<span></span>
</td>
<td class="nump">61,007<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=elv_OtherSegmentMember', window );">Other Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_MajorProductRevenueBySegmentLineItems', window );"><strong>Major Product Revenue By Segment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Insurance Services Revenue</a></td>
<td class="nump">3,365<span></span>
</td>
<td class="nump">2,670<span></span>
</td>
<td class="nump">9,884<span></span>
</td>
<td class="nump">7,557<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=elv_SegmentEliminationsMember', window );">Segment Eliminations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_MajorProductRevenueBySegmentLineItems', window );"><strong>Major Product Revenue By Segment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Insurance Services Revenue</a></td>
<td class="num">(6,054)<span></span>
</td>
<td class="num">(5,192)<span></span>
</td>
<td class="num">(18,382)<span></span>
</td>
<td class="num">(15,173)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=elv_ManagedCareProductsMember', window );">Managed Care Products [Member] | Commercial &amp; Specialty Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_MajorProductRevenueBySegmentLineItems', window );"><strong>Major Product Revenue By Segment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Insurance Services Revenue</a></td>
<td class="nump">8,478<span></span>
</td>
<td class="nump">8,005<span></span>
</td>
<td class="nump">25,500<span></span>
</td>
<td class="nump">23,481<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=elv_ManagedCareProductsMember', window );">Managed Care Products [Member] | Government Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_MajorProductRevenueBySegmentLineItems', window );"><strong>Major Product Revenue By Segment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Insurance Services Revenue</a></td>
<td class="nump">24,456<span></span>
</td>
<td class="nump">21,565<span></span>
</td>
<td class="nump">71,823<span></span>
</td>
<td class="nump">60,711<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=elv_ManagedCareServicesMember', window );">Managed Care Services [Member] | Commercial &amp; Specialty Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_MajorProductRevenueBySegmentLineItems', window );"><strong>Major Product Revenue By Segment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Insurance Services Revenue</a></td>
<td class="nump">1,610<span></span>
</td>
<td class="nump">1,489<span></span>
</td>
<td class="nump">4,618<span></span>
</td>
<td class="nump">4,291<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=elv_ManagedCareServicesMember', window );">Managed Care Services [Member] | Government Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_MajorProductRevenueBySegmentLineItems', window );"><strong>Major Product Revenue By Segment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Insurance Services Revenue</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="nump">341<span></span>
</td>
<td class="nump">296<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=elv_DentalVisionProductsAndServicesMember', window );">Dental Vision Products And Services [Member] | Commercial &amp; Specialty Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_MajorProductRevenueBySegmentLineItems', window );"><strong>Major Product Revenue By Segment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Insurance Services Revenue</a></td>
<td class="nump">360<span></span>
</td>
<td class="nump">342<span></span>
</td>
<td class="nump">1,075<span></span>
</td>
<td class="nump">1,013<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=elv_OtherProductsMember', window );">Other Products [Member] | Commercial &amp; Specialty Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_MajorProductRevenueBySegmentLineItems', window );"><strong>Major Product Revenue By Segment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Insurance Services Revenue</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=elv_OtherProductsMember', window );">Other Products [Member] | Other Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_MajorProductRevenueBySegmentLineItems', window );"><strong>Major Product Revenue By Segment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Insurance Services Revenue</a></td>
<td class="nump">212<span></span>
</td>
<td class="nump">164<span></span>
</td>
<td class="nump">801<span></span>
</td>
<td class="nump">436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=elv_PharmacyproductsandservicesMember', window );">Pharmacy products and services [Member] | IngenioRx Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_MajorProductRevenueBySegmentLineItems', window );"><strong>Major Product Revenue By Segment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Insurance Services Revenue</a></td>
<td class="nump">7,249<span></span>
</td>
<td class="nump">6,549<span></span>
</td>
<td class="nump">21,003<span></span>
</td>
<td class="nump">18,630<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=elv_IntegratedHealthServicesMember', window );">Integrated health services | Other Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_MajorProductRevenueBySegmentLineItems', window );"><strong>Major Product Revenue By Segment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Insurance Services Revenue</a></td>
<td class="nump">$ 3,153<span></span>
</td>
<td class="nump">$ 2,506<span></span>
</td>
<td class="nump">$ 9,083<span></span>
</td>
<td class="nump">$ 7,121<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_MajorProductRevenueBySegmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Major Product Revenue By Segment [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_MajorProductRevenueBySegmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceServicesRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue from insurance services, including net premiums earned, gain on sale of insurance block, agency management fees and insurance contract fees and commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.1,4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceServicesRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_CommercialSpecialtyBusinessSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_CommercialSpecialtyBusinessSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_GovernmentBusinessSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_GovernmentBusinessSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_OtherSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_OtherSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_SegmentEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_SegmentEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=elv_ManagedCareProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=elv_ManagedCareProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=elv_ManagedCareServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=elv_ManagedCareServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=elv_DentalVisionProductsAndServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=elv_DentalVisionProductsAndServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=elv_OtherProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=elv_OtherProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=elv_PharmacyproductsandservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=elv_PharmacyproductsandservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_IngenioRxSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_IngenioRxSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=elv_IntegratedHealthServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=elv_IntegratedHealthServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898679526928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Reconciliation Of Reportable Segments Operating Revenues To Total Revenues Reported In The Consolidated Statements Of Income) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Reportable segments operating revenues</a></td>
<td class="nump">$ 39,625<span></span>
</td>
<td class="nump">$ 35,548<span></span>
</td>
<td class="nump">$ 115,993<span></span>
</td>
<td class="nump">$ 100,925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">371<span></span>
</td>
<td class="nump">335<span></span>
</td>
<td class="nump">1,112<span></span>
</td>
<td class="nump">1,026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_NetLossesGainsOnFinancialInstruments', window );">Net (losses) gains on financial instruments</a></td>
<td class="num">(57)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="num">(439)<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 39,939<span></span>
</td>
<td class="nump">$ 35,822<span></span>
</td>
<td class="nump">$ 116,666<span></span>
</td>
<td class="nump">$ 102,058<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_NetLossesGainsOnFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net (losses) gains on financial instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_NetLossesGainsOnFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceServicesRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue from insurance services, including net premiums earned, gain on sale of insurance block, agency management fees and insurance contract fees and commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.1,4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceServicesRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898690731952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Reconciliation Of Income Before Income Tax Expense To Reportable Segments Operating Gain Included In The Consolidated Statements Of Income) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income tax expense</a></td>
<td class="nump">$ 2,146<span></span>
</td>
<td class="nump">$ 1,996<span></span>
</td>
<td class="nump">$ 6,615<span></span>
</td>
<td class="nump">$ 6,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="num">(371)<span></span>
</td>
<td class="num">(335)<span></span>
</td>
<td class="num">(1,112)<span></span>
</td>
<td class="num">(1,026)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_NetLossesGainsOnFinancialInstruments', window );">Net losses (gains) on financial instruments</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="nump">439<span></span>
</td>
<td class="num">(107)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">213<span></span>
</td>
<td class="nump">201<span></span>
</td>
<td class="nump">622<span></span>
</td>
<td class="nump">598<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of other intangible assets</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="nump">520<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Reportable segments operating gain</a></td>
<td class="nump">$ 2,270<span></span>
</td>
<td class="nump">$ 2,059<span></span>
</td>
<td class="nump">$ 7,084<span></span>
</td>
<td class="nump">$ 6,301<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_NetLossesGainsOnFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net (losses) gains on financial instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_NetLossesGainsOnFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898689628304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information Segment Information (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract', window );"><strong>Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of Reportable Segments</a></td>
<td class="nump">4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898680661424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Lease and Other Information) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 628<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 864<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating Lease, Cost</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term Lease, Cost</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease Income</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease, Cost</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating Lease, Payments</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="nump">141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for new operating lease liabilities</a></td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
<td class="nump">$ 192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Balance sheet location of operating lease right-of-use assets</a></td>
<td class="text">Other noncurrent assets<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Other noncurrent assets<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Other noncurrent assets<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Balance sheet location of current operating lease liabilities</a></td>
<td class="text">Other current liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Other current liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Other current liabilities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Balance sheet location of noncurrent operating lease liabilities</a></td>
<td class="text">Other noncurrent liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Other noncurrent liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Other noncurrent liabilities<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898671756816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Reconciliation of Future Lease Payments to Total Lease Liabilities) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract', window );"><strong>Leases (Reconciliation of Future Lease Payments to Total Lease Liabilities) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Operating lease payments, 2022; excluding the nine months ended September 30, 2022</a></td>
<td class="nump">$ 54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Operating lease payments, 2023</a></td>
<td class="nump">207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Operating lease payments, 2024</a></td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">Operating lease payments, 2025</a></td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">Operating lease payments, 2026</a></td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Operating lease payments, Thereafter</a></td>
<td class="nump">345<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum payments</a></td>
<td class="nump">1,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Imputed Interest, Leases</a></td>
<td class="num">(111)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease Liabilities</a></td>
<td class="nump">$ 921<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reconciliation of future lease payments to total lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898671599952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Narrative) (Details)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted Average Discount Rate, Percent</a></td>
<td class="nump">2.79%<span></span>
</td>
<td class="nump">2.69%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898680905712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill And Other Intangible Assets (Summary Of The Change In The Carrying Amount Of Goodwill By Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">$ 21,691<span></span>
</td>
<td class="nump">$ 24,228<span></span>
</td>
<td class="nump">$ 21,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Goodwill, Period Increase (Decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153<span></span>
</td>
<td class="nump">2,537<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,381<span></span>
</td>
<td class="nump">24,228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Goodwill, Impaired, Accumulated Impairment Loss as of September 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=elv_CommercialSpecialtyBusinessSegmentMember', window );">Commercial &amp; Specialty Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">11,593<span></span>
</td>
<td class="nump">11,593<span></span>
</td>
<td class="nump">11,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Goodwill, Period Increase (Decrease)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,611<span></span>
</td>
<td class="nump">11,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Goodwill, Impaired, Accumulated Impairment Loss as of September 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=elv_GovernmentBusinessSegmentMember', window );">Government Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">8,331<span></span>
</td>
<td class="nump">10,349<span></span>
</td>
<td class="nump">8,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Goodwill, Period Increase (Decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="nump">2,018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,475<span></span>
</td>
<td class="nump">10,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Goodwill, Impaired, Accumulated Impairment Loss as of September 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=elv_IngenioRxSegmentMember', window );">IngenioRx Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Goodwill, Period Increase (Decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Goodwill, Impaired, Accumulated Impairment Loss as of September 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=elv_OtherSegmentMember', window );">Other Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">$ 1,719<span></span>
</td>
<td class="nump">2,227<span></span>
</td>
<td class="nump">1,719<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Goodwill, Period Increase (Decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,236<span></span>
</td>
<td class="nump">$ 2,227<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Goodwill, Impaired, Accumulated Impairment Loss as of September 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_CommercialSpecialtyBusinessSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_CommercialSpecialtyBusinessSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_GovernmentBusinessSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_GovernmentBusinessSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_IngenioRxSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_IngenioRxSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=elv_OtherSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=elv_OtherSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898679261664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill And Other Intangible Assets (Components Of Other Intangible Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_IntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount, Finite Lived Intangibles</a></td>
<td class="nump">$ 7,037<span></span>
</td>
<td class="nump">$ 6,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization, Finite-Lived Intangible Assets</a></td>
<td class="num">(4,032)<span></span>
</td>
<td class="num">(3,506)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount, Finite-Lived Intangible Assets</a></td>
<td class="nump">3,005<span></span>
</td>
<td class="nump">3,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Gross Carrying Amount, Indefinite-Lived Intangible Assets</a></td>
<td class="nump">7,531<span></span>
</td>
<td class="nump">7,589<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Net Carrying Amount, Indefinite-Lived Intangible Assets</a></td>
<td class="nump">7,531<span></span>
</td>
<td class="nump">7,589<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount, Total Intangible Assets</a></td>
<td class="nump">14,568<span></span>
</td>
<td class="nump">14,121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_IntangibleAssetsAccumulatedAmortizationExcludingGoodwill', window );">Accumulated Amortization, Total Intangible Assets</a></td>
<td class="num">(4,032)<span></span>
</td>
<td class="num">(3,506)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Carrying Amount, Total Intangible Assets</a></td>
<td class="nump">10,536<span></span>
</td>
<td class="nump">10,615<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Blue Cross And Blue Shield And Other Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_IntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Gross Carrying Amount, Indefinite-Lived Intangible Assets</a></td>
<td class="nump">5,991<span></span>
</td>
<td class="nump">6,299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Net Carrying Amount, Indefinite-Lived Intangible Assets</a></td>
<td class="nump">5,991<span></span>
</td>
<td class="nump">6,299<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">State Medicaid Licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_IntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Gross Carrying Amount, Indefinite-Lived Intangible Assets</a></td>
<td class="nump">1,540<span></span>
</td>
<td class="nump">1,290<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Net Carrying Amount, Indefinite-Lived Intangible Assets</a></td>
<td class="nump">1,540<span></span>
</td>
<td class="nump">1,290<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_IntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount, Finite Lived Intangibles</a></td>
<td class="nump">5,791<span></span>
</td>
<td class="nump">5,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization, Finite-Lived Intangible Assets</a></td>
<td class="num">(3,580)<span></span>
</td>
<td class="num">(3,236)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount, Finite-Lived Intangible Assets</a></td>
<td class="nump">2,211<span></span>
</td>
<td class="nump">2,362<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember', window );">Provider And Hospital Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_IntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount, Finite Lived Intangibles</a></td>
<td class="nump">326<span></span>
</td>
<td class="nump">324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization, Finite-Lived Intangible Assets</a></td>
<td class="num">(142)<span></span>
</td>
<td class="num">(129)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount, Finite-Lived Intangible Assets</a></td>
<td class="nump">184<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_IntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount, Finite Lived Intangibles</a></td>
<td class="nump">920<span></span>
</td>
<td class="nump">610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization, Finite-Lived Intangible Assets</a></td>
<td class="num">(310)<span></span>
</td>
<td class="num">(141)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount, Finite-Lived Intangible Assets</a></td>
<td class="nump">$ 610<span></span>
</td>
<td class="nump">$ 469<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_IntangibleAssetsAccumulatedAmortizationExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets Accumulated Amortization Excluding Goodwill</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_IntangibleAssetsAccumulatedAmortizationExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_IntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_IntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139898673289744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill And Other Intangible Assets (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease', window );">Finite-Lived Intangible Assets, Period Increase</a></td>
<td class="nump">$ 308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease', window );">Indefinite-Lived Intangible Assets, Period Decrease</a></td>
<td class="nump">308<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Finite-Lived Intangible Asset, Expected Amortization, 2022</a></td>
<td class="nump">748<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Finite-Lived Intangible Asset, Expected Amortization, 2023</a></td>
<td class="nump">735<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Finite-Lived Intangible Asset, Expected Amortization, 2024</a></td>
<td class="nump">370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Finite-Lived Intangible Asset, Expected Amortization, 2025</a></td>
<td class="nump">311<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Finite-Lived Intangible Asset, Expected Amortization, 2026</a></td>
<td class="nump">258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_FiniteLivedIntangibleAssetExpectedAmortizationYearSix', window );">Finite-Lived Intangible Asset, Expected Amortization, 2027</a></td>
<td class="nump">$ 219<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_FiniteLivedIntangibleAssetExpectedAmortizationYearSix">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Asset, Expected Amortization, Year Six</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_FiniteLivedIntangibleAssetExpectedAmortizationYearSix</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in carrying value of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>elv-20220930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:elv="http://www.elevancehealth.com/20220930"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="elv-20220930.xsd" xlink:type="simple"/>
    <context id="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5ffea20b96c2462c92744a6e44bb6555_I20221012">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
        </entity>
        <period>
            <instant>2022-10-12</instant>
        </period>
    </context>
    <context id="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9aceaf2b19bf4d5d916eb0f2039e41de_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id7580839926f4e24b08f10312dd69479_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i76e906fcfdeb4832b77b338196e38474_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib0197b6d912c4e2c944e0737a73738ae_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if80200fe052042f58072c2a346401da5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibe28dcb0adc145abbec6cb9c3accca38_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3dffb789514e442d91844bfa2454ef52_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic8291afc45194b679cb982efb46d0686_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0227e2707e394244aed3f2fd57a0e03a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9c5ee8ddad2f413fa5b819e04a12bc1e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8d548577ea164af88a7545c8710fbb5d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6a7c1fc826a441d7bce0a7af3b9d916c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1f1b74a9d46a4c919ed5a0017b50fe3c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iab76c5a7b7904191b99afa7db58ad7f2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iedbdb762566945d88726ef37a57f9349_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2eb86bcfdff541038fc2cecb77088e6d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i18c7f78957fb4eb298325eb813673f5d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie3f5943c567e426a969bf7881111eeb8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i621d34b256184efca4a6e336041bad02_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i88a00773c76441adab343709fb0e30d1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibc88fa2fe41a476fa802a9582efda818_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4cbead8991b44f1e8a37f09fb333172d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iaa8050991ea141e9b2f0cc25ecfbe2d6_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i235ece1dc7f94255b99200f736f634e0_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8bd5ffed39c44ee5bf9209ae6a1336e6_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic32281f0fb4a46c1bd7c7cf96160ceac_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i93a6de0ab799413e882ff2eac44ac62c_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i25fd263bfa4b408cb320d07c5b039a60_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8c004427a7414fc8897f44bcaea19bf9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i754312c63f4847bda9a7fff60f065564_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3cdce901c495496b82564eaa2135b662_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i86841404e36945a0a2b5a2801b6585e3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia0a535c1ffe84e6da717792a25f25e09_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i65acda5bd384478ba43ea184238b1adb_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8b8abccde0624b77a8a1712e55378767_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i205ff9c272f244b9a2a2473a5d2d0aa2_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i15035aec9b66494a932fa4d9f722665b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2f7b2e2c4f76452991af9030ab9b7ec1_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8a417cc9e3284886a04a57fe479fce58_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iae11bd779d7e4ef58f1fb3d8564575a0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i38ec61ed676c4597b3ce8d3bb80f93a4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if2cbc4d0d7964a2681d5c5fa0021cf8b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic8e22949ca024e19a7be910f7fb72de0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9bcdceadaae34b568b184717c1feb64d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i40273135b4c443249ac1e3576b1f8880_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i34ca5d23dd9d4c319c952057c4c553af_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1636ce35b3f44cc59d3c0058be2140e7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i43c107c4cc114c2994db1a2d71a9a4a9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia2cd31b0b2f047d489ecdade092e7658_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3fe61236f9a84e4fb0548f191cf989dd_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i22199380ce254d5e8f1a20db003d38e1_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i46b2d401ea4a43a8b53425d8ac39c3cc_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i90fc51345bd34cceaa9d7388a64ab064_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i32778a5cba784b46a29f834b6b7d8ffd_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia3596a4a5edf4aca9700a1210c5e82cb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibb48a1922b7e435cb7c30da74d59221f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i62d7a38b20f74260a57c7b27f73b7906_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id2573eaa31b44cd6abfa3facbdb6292a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3cfb30e0735e44c5aa78cf9d1eb3d3a8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i23a4bf41cfe343828c4306abe17a0154_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i68316ab96a734ae2b0f2dd2591bf303f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8fb01790dc8947cc9fa28938b654f73f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id1c5b423fd0049679c05d61c789fee90_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0d28810bc7644f938e65b4df5ea870b9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib068c2f2d2f9451e85b8ebefd20a58b9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i12e2179304f94f76a1f8fa22e0c596d7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if71d617a922b4549a876a2aeb86d0fb3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i58e67abfbcd74df68e8cc1c6309c6fa7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifa6a2ab38f55454590fbcb0d8bf0cb81_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8ad7dc64de9f4333a507db7171be2b9f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idd7bbc6ac8054bf59b507514156a792b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i89e5268adb4e41acac42b6e71ed6a956_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8ce5dd3a2a6441349bc5e6572d8958ca_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iec47e227732d4b219990442f8321eb49_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i72cc3c90ae37402bb1a3406ca8ec8281_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i50902a61a4dd4c3abe12641611a989d0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i07b85a9cf8364984ad848fb7ac29fcc6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8e1170d9414d4932b37104a99abbfcd7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iad1b58d99a92454aaecc9a643c16c0c1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id08298fdd1324292a7e56ccb4754a37f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5d2e1c82b14b435aa3b898cd3e04de1b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2bc73b260c78413bbf502ba5c1050cce_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">elv:IntegraManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i67668f78684042f3ae9dc8e1ad62b947_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">elv:IntegraManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i26a408574c2c4c619b3f6a7fb2eb52ef_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4d84cf76f3a74a17bfd21c61cad87a45_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib724e06caec84704b13a828ba8b9b8fc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6ab5335cb1b5494eba34054f0ef63dc2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3ce8730226514909b48e611420368522_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5dd22b7bb98e4e4f844ecae3c390bdd0_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idba3a272e1b8405eaeead18d34613b77_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i266f1d31e2b94bbcba7b6d2f8441491f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie72e88979b5548e48539cc5d886e25fd_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie4f6b49781dc450db479bd159632e422_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i51b351f32e2a4a91830c15bcaca2d1a7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i67eb9d5cdedf417fa6217167e453f99b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i708db0a3275f4fd58d30b7138cf68571_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i08ff1fe2d3cf4ba1a7a645773295ee0d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8ea9c5ffa135471d84290457cc62b377_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if46ba3a6ed924704ab80b46d4892ce9c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i582c7462a2a24ee19ae7c3e8b13e6258_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9e3fb6e7405848e39ed7671d9a9683da_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie05876f14e3546779aaacef9d285ee2c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib5a6260b0cc245e3ad18420b5dda8138_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id54f0058c591469baef2d1557dcb55a8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2340f4d1ac2b47dfbe6521a9386a70f4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia9b964677bcb4f018f7b0e35a345ad57_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifc53677b69024b148f62349f82fe723c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6bd8e4d367e5434c93d5ed2fb93b9c90_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifcad3b58ad0a402e9c5f36c2257b46ad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0b05039f1d944a39a5f7c4a08ecd9386_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3fe0fa1cefe04a9ab9bd771236eb24fd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1998952a2fec4ef987e45747bc6a365e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibf59770742dd4e0c909bf664464f6f51_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i962a4141a6934bd0b79803a5e587f115_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9b33199b5e8040e88c3779bab1338a41_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifcf9e5652a88433fa305f979016b813a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6df5bdfdef2f4265b69076190eb614fd_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="icff2cdd7573a4a7cb6c9db9fbe416a43_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib856546a61004b9daf43ccbcaf623bae_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i082f7dec90e34caa9e126e175c14b069_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2d1cb440b1e64fc3a441588000782d1b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i97d6a8ee2de34d46b8a9b30fcdfac191_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic06c4cd0bfbf4349bb38d37c2a08f1d5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i03fb8a2f17234cf88446cfa6c92be531_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i306fe04bc56d46bda85faed45e988b22_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0bae2ef9bb1f4ef789325dd8bddd7037_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4d30de3c97a84918b22998e42c90804e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i25961790b2e241c39e1d9b6ee2a7abf8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6e76ffeb19be42d4a1e2d44c3205ecab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i47e63f11825d402e9000e5995d8b173f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i85e2285118fb48818a1361310a8c779d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7a60715792a94db5a003dde44cc00d7d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i808391c8a062488da8dfcc76e14f106b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ieaad01ac86274516a2427e2324cbdace_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic6ef12a8ed884a10a5de9971fb0a2ef8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i341b56b7c33d48c6ad350fd7fbaf27d5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4fddf0df137b450988ab2a4425925e2c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ieb05027535a4458e88a535ee3031f6ae_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i67d0a155fc6f462db3e652e6e997c5a6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i33efd1a573514923804d15df68fbc169_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7efa70157d8f49d1932d09a94dfe1529_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7d4cd6b13d62409ea6135442dfd3c169_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idd1d2d7db12846a4a3ec11dffaaa857a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib08d03a09c464eb5bc34b1ee5faf7ea2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i525deba77845499db8929bee8586f509_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if83fa79c889143edbd4e4ba481c5106e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i76d0d6767c2146a4aa94f20b9f15ea40_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icbe9a6627d614becb080363c4cc79132_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9e6a553b24d9430485f058f6dabd9ef0_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i623def1f7d994412a99937dd097a9306_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibf2a7ef2990b49d18dfaee52d861df7a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis">us-gaap:MaturityOvernightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6d66732359c54c7ba0fed0dc86c8903a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis">us-gaap:MaturityOvernightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i55aa272b38d249cf8f65430d3ab7ec89_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis">us-gaap:MaturityOvernightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6575af0d7a33465d80ae8b7e123eb574_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis">us-gaap:MaturityOvernightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i82413feb72304cfd9028728f729361cc_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis">us-gaap:MaturityOvernightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iee555febc7b1489c841bed85cfdde1c7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis">us-gaap:MaturityOvernightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifdb7c3f4f8e543b8a2df60e3edae8983_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia0ee2e1f5c8c43419e04e58cfb917f9c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i98e1be64addb482ea782f65135d60a05_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1fc2e84bcad34027932d35097b9f9bdb_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8bebbc6255564194a65092412ac06f67_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8ed17b4bb7f34660b7206d12cd763384_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8a3b331afc414af99ac6c1599df2287a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i79076969c3024e269accd9bc7038ee4d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i83c6fbea402043d5841f091c58e82693_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5832f9a26ea3435bbd561c28893f542e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i54b54a3342e648a4af00533f1570f055_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i80f80d23604d47ea9d6d5d3db271166b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0630c845d0544c8fb78216ec9ee4246a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6ea6ffa026ed49ad880282333c15e05b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i09ec78a8f2934ad988a5a84ed45afe95_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9963152709494c7192e65f8d93db6abd_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia3bd3a5e8f4e46668a696ae3513051dc_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i879983c43359419d9305755bc21b11e8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1bae3ca7f392419cb36507af34fd85e1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if54e2a09642243b0af22bd387b96cc86_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i319c0932f552442f91e807fadf6869b2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id72f5fdb790d488389e012081716a861_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifd52d310cc6249de9d64e53d7b7f960d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7954908cb6bc4a09af7d436befca47cf_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib6d1fbf1b64a48d993287eda3253e59e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6c77fcbcf9014952b22ac069325f92a6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8679b29bd646468da600ed87da53d36b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5ffe957d5ff14ba187fff4116dcf8991_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic0fe98e383084014b1bc9ab32ce423dd_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i30a0f87e5ab9493cbf1db457f967922d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id225b53b5eb14421a1c1ea44abf2ab1f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i572ccbdc7947481c8deddaa8e2068caa_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i67e47d6156fe4e30a2db3dbc795c804e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie17e65ae944d47f1b80529dd1e22cea8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib2b35a0942fa4be398836e787b4033fe_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i194d8de15f8b4abe9a293c428ef86751_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ibd6037d7dd8543e2a047fa4c031268df_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3c4b8b65febc483694f935949190933a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i359143f746854b4a9c1ab808c68d5640_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if36f830bb3c64269a716998cc4d3631d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i60026054e5d341ac957c97a96698628d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i97d580beda144d4491df94dbd14b5e63_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iaa2c59dfa7804e66a650f900b9d23c9e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie3a7f443bdad4168b5798971706c5f40_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iece93ac436104fd6a1cd99c3cd0e562a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i484f5fd44cb84fbc9b4c45aae397c186_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if4609d385fde4f5e8ed90e175cff6320_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2998bb1d7c3e43cb9610ba10dc2f2d9c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic0b480fb15b94cdcb1a697f67988e588_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8518fee768764a0f95c228de9e1ea364_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0add331b12f44d51b7ece36e400dc1f5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2c5802f494354611a73f807c38dce059_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9e550fd94b994ce49630d8444c71806b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="icad4a668efc449218c1bacb86f5187e1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id12430cdfde949268546e42fae69aacb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5f7e82e807e34b52b194ae404cbff7c8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i39708ec10b1d42fc910b98395c8b0d03_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i52d00975607245648c820ae081dffc76_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i52e0633755af4f07991cc898c84730a5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iec5d8d8c36b445f181d4b0e14e790e50_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1dc525e82e4f4b78b55e13f877d9d212_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i059ab6a34c854d4590c340b2aa206fc2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i017bb4e3633b454f85f310109f119763_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6c4f3be4159040cca4c6330bada73b9f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idd0cddd1e2704317822ec1aa4b6a8d50_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifa1f82c236bf4e9fa6b63e8a1dd059b3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i480713ec0004444aae07ba823a2a3710_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iac7e634bfc3043a3b61901be4796c354_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if77a6a1ea8a845e1b8f8f10a6494dd9d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i52ea3e0c81e449c4aabaeaba693601b4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6d9263de42c24bbeb3029c5c835d1b7e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8d73240dd06c484fb3d57ea0c58ca9f6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0a51c1b83ca44cebb3cb541c6c1ffd23_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0ebb31481dbc46e3a7f18240069b415d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0107aa86d0304c8c820c9d1f402f3a58_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i43e3349630db458383c85c2d30827d66_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ide59a28c7a594301ab29f18f850bbebb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6c0368bfa4554cd2952ff8415fba1e2d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9cd0cba106b646758a3d426fe4185e71_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ide71a36d93e440ac9bbd26d0f1185292_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic3f130bdbeda4a229139760fe1a5256c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9b17717cfed84a8695f0ebee25d6d1b0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5595401992294f4db26af9c67d94813c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i247198472ac444b4a705c2d6d3870893_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id70934c0fdca477cbb28d1fa3a921841_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i16e26cf91f824b138d31ee3ccbbc2486_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if08d21b298724dbe87a66843d0d5ec37_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibcc2f3cd485c43e0a5b93811cbad0040_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id97d07a393824fba8c5a533ddc17248b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9d9daa1bf9aa49618c67c4fe0feca8a1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia67cf78d5c9e49c386e4366d79e071f5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3e39bd703c7c487eb5d185ba13bfcc36_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i66059c1693064085997c288e33979c72_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4693331b053e467aa44d2753305e57c5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i55dbd61667064a73939c76e993f892e4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia1ea0fca2f2f4b16904060514710f24b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id73c6074257a4797b02f0bb8c9813727_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6cda0b9d394240d5bed36877535df125_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia570c61ac2774f2c9b61f2b04614af6f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f9ec3d81af44e958f1beabb66a20af5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i77434cd540454880bbde697445471783_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iae3f929a16f5495498ceb553e33f710f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">elv:CommonEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iab52a629947044ddb6c7a30c64d60ec1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i18aaf10638ba48758ecf2c6f063e2eef_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i49bbc62b7c9a4dbfaa94dc46b4ed4750_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibc70625496934ce88087fd178a0df18b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6b40fde7beb04a09997961c706c7c577_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i93e6bc23bb5d43ee9937560149125ce1_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id4cd3d9e543549eaa00430a7132f99eb_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8152f64e6f1140eeb2ee778012282130_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i87cc99f09b354f98929e5403fc89254a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3a4e9a98582e440e8a5c609a87e70538_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8c398eb1a12b438d8cf5d7ed7a27c98d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if55f75de2be747fb9680406ea945d82f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i18f0ad9f943549f6888eff0dae5c5a2e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie02e43daa33841138e86f2e8ac128f8a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id659cd826a1649d69ea5d4c304dc4002_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i59df98c5cae2479d82b25b79673a28bc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i05e4435be64e4eadacb9d5b77a7762b8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7e5801b0241a4a7596c82b85f6595b87_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4eb613993924401da535c4ab70affa54_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0b050ebc022448918209b90933f84fd1_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i59c52d2dd9a244878f20d09c30559d47_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5c3c0ca17622496e8271489dbd81a554_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="idd53ebecdb7c4377a7e274fef86d5b98_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i51a6e283ad82499983038a1294335516_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id012155f0536487e80c5f21ecb0cff93_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i956f35bd2d5e479b8fc6a91a40089b3d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3f0ecc541cf74ed2a635167eb7164491_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iafd89c3d325847c59f8b3bc903c4c035_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i964bac3f30f64868a6e633166235cda5_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i37e5af918e28462f98ca407c5455389f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i553640a02dc34c459280bd0390c2547a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i221dfdac7a494b34b788cabffbef260c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i65f9f1ca30204478a443b52bedc3c6a1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i991cee8de28a4252a7c5e88856804403_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i43ab9adfffbb4e97a0584ba6cb437018_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1a83a959df4a4ea893a96ae9001a4dac_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8c5c7d954c4c45a3b0db4aa4accc3482_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idfaad08561af4facb21116cd28f9c4d5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id13f4c069f824d9e8ada49274ed13fc6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if9ee845b2ef44f35b34e439f2a98463e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib31555a5dc6d48e9a6d0c3e812552916_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i47db3e3b640944bd98e5bc0d5641a14f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id23aa1cee27e4b5ba329c79f052b0f8d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i63d36abe1cfe4cdeab60b3c14cb6960b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="idf4ef63bd2e548af937bde8217b31fd0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iabe0feb61e774f4db61e3b30a3a23479_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i207053455c4d4c45b53e5fa230ebb0ae_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3a7e8295eb174731af155b02715f0698_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaeb1d12977ce4b2aa244d83f0a51489a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia381401dee2b49a69141fac81ccda064_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if1c0c8330af1412c8daa5f4cc313c34b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie12564db4311425aa96c7f9f9b74dc88_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id36628eb07534a42afaaae7affc76a88_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if3c6abfca5ec440eb693997af5ab6d46_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib25ede8a88f9477dbd274859e7a2b1b1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1bbc82c5b8774ddc80a06a94578b2a62_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if7c1d9dfb7814c5da0eb0bcb78535511_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2eef42da7d1c4cd495f66b68093f8dc3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i17f3cb9f8c1d492197e639b5a0369fef_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id8e9a443d6054bb489dd821a7385bab4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i518bf560bf5b42db9717fa1237d56fc5_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i32803f4645204fb0b79a26f39fe31411_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5866a8bbba704cf588b8904b077bac81_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic61874748541445bb5346014604b1e2f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9cf718e43d2d431aab9e48ee4460c848_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0c42a359a2a345cd9ba70d1ac59c63f2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i013231985bd7411185b88460522d8b36_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3995587e895e4e8e900e6e6a4ad92b08_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i979bf304459b469a85f5dbd972a86ebf_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id0595bb2db424b7bac7ac1ec8646dd16_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie6f5962645aa44dd9e99d61abdd0873a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ice322a96213244e6b5ed9fa8b2fd063c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie2c9a53d41b6411c8a7299de747052ee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iea0cd3e6f73d4c37a185721b7213f0fe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1007523085804985812acc850dc8d6fe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4182a920dc6d4e8cb42614e778766e1c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibacb5db0efb1418d913cc8583b863da5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="icaff25a1e31245299f7a5ef30e5e99d3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id192e31548bb42f29d1bf3d4dbb6cda2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6b0ea34f1f294d20a310a2ef4c41c0f4_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5424e3c2015944248e4c1ead87f81144_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8e857bc4e13a4ae5a65583609fa0ba9a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i64ce2ea324434d348d29360ed18b52c5_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9adaeacf598a42c3b72b8540b126e10b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia2a144458c3940758b57b3397f45a257_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ice7c432e6884478fb38f1d9ca1399f9d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ice7f613275f549788763308d4be93610_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id81fb73bd9e640338bfa72bb4f5aeb76_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3bc19a6512f743a0a8a79c92a23c64a9_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iee58b3e2710246daa6dbe09d63e5064d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i35884d0201ae464ebc6e5b8946fa1612_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie653179541d1493c93be7e3886e9fb52_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id7c823f42d7a4c78b75c5623fcf615d7_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ieef52ac747e64c7391e7c7a1120b53d2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib8ff1fa5d8714816a640a8280fcee30a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i757b9a9c9e7e4558a1cd9992f88382fc_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0b17535592154a3fb04e22ab93e36684_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0e4c924470664c728da0afbb46130f3e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4ed55d475fdc4a698c26523269fb993b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3a16a462df304b1fbf48724140afd63c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">elv:SeniorUnsecuredNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i94bbf9e2e436430ea18a870d630e7782_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">elv:SeniorUnsecuredNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6b0d34ecb74d4c1499f643aa80821af3_I20220516">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">elv:ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">elv:SeniorUnsecuredNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-16</instant>
        </period>
    </context>
    <context id="i593ecd4bf79e46d2af49bec65e9db2cc_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">elv:FourPointOneZeroPercentDueTwoThousandThirtyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">elv:SeniorUnsecuredNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i3e26d0baf7484549aaadded8ad6a1ef1_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">elv:FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">elv:SeniorUnsecuredNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i447dee49344c463eb1ad142f17bbb55b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">elv:SurplusNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3ddfea0816d8449f8a18879a56b75aa3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">elv:SurplusNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6cfc7f22d3c342fc85354d517d3e8f44_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">elv:A5YearFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7e231fbcfa194a74b537f2bd7332d1ce_I20220418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">elv:A5YearFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-18</instant>
        </period>
    </context>
    <context id="i9e6137b64fca4e85985b05a00cc0980e_D20220418-20220418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">elv:A2021364DayFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-18</startDate>
            <endDate>2022-04-18</endDate>
        </period>
    </context>
    <context id="id48e07a7766647e2a8bc809c7668f9aa_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">elv:A2021364DayFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8956e0659bb44abdac0434240d851087_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1994da759a8049c09f0ece33102e8d07_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4d538ffdcb394ef6b8ca39b9232da03f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iab9bfa7369d94d23b70eb52ac9d5c353_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3177560ea74b47d094f58090cff05a3a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i98f60619d5db44bdbcef4568c650ac97_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6c996ccf5375467690ef0a371d48e033_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id074490de8a844b3947b679412d173b1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie3ce2a7827404c4b95ca73a4c71f739d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:FederalHomeLoanBankAdvancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="idadc7d2ec88044dcaa0a3de4ed833cec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:FederalHomeLoanBankAdvancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iec40b9c51c114cbc9d3101bef95add9d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5a1b6fdf93194651bf7efdc8011a5b9c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ief81cd0e712a4475b910c6e1044349aa_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">elv:BCBSAntitrustLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie706cb4d8ca64cb3aeb950d443b981ec_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">elv:AnthemInc.v.ExpressScriptsInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GainContingenciesByNatureAxis">elv:PharmacypricingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib999e2b9904743fc9d242837ba067eb4_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">elv:AnthemInc.v.ExpressScriptsInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GainContingenciesByNatureAxis">elv:OperationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if86d9fcaf90e4c74a4febd7d2876346b_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">elv:AnthemInc.v.ExpressScriptsInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i593ccc71545a463aa762ea6a7a1efafc_I20221018">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-18</instant>
        </period>
    </context>
    <context id="if9e73fa43f474637904386532065813b_D20221018-20221018">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-18</startDate>
            <endDate>2022-10-18</endDate>
        </period>
    </context>
    <context id="i90083e53041c4397abce83d13efa37ae_I20210126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
        </entity>
        <period>
            <instant>2021-01-26</instant>
        </period>
    </context>
    <context id="i59f143f05a8b4cdf99dd35b50717b3d8_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="elv:PerformancemeasurementperiodAxis">elv:A2022To2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie0032fd5f2e3430db780393923fe52c6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1666c9555de74b4dbc65fef3b1b917cd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1506e71de0d34c81941b49a8af7876e9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia1a95b18f4a549a9916b28653b0280e7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8cf014dd12e9477788ecb92ec4a95f02_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i488068315a5d438e968d54c5b20cc063_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2d87ef5b685049cc85f3a91696bb60cb_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6a64d441bc804e49bc8a45a553ba2057_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i38542daa11574b0aad0519ecfa5263ef_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i93b560992cd743cb8ceceaf0b0b2e931_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibeb89cf81873481eb8b9811ea6dfe3bc_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">elv:NonCreditComponentsOfImpairmentsOnInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic35e765820354c2cafb66117c9ea4c7a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">elv:NonCreditComponentsOfImpairmentsOnInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i96e9251b744b4f7e9ecbb677bd8634fa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">elv:NonCreditComponentsOfImpairmentsOnInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i56a76ec5b38f428db6242e45a2f30037_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">elv:NonCreditComponentsOfImpairmentsOnInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i117df451326545f9986059648cfd22dc_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">elv:NonCreditComponentsOfImpairmentsOnInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i365146e911f1424ea5fe059db32e3d7d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">elv:NonCreditComponentsOfImpairmentsOnInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9a0fc272f1aa4de39b8e80fa4ef950f7_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">elv:NonCreditComponentsOfImpairmentsOnInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic726783a65004c40a48a29cda9bf3769_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">elv:NonCreditComponentsOfImpairmentsOnInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1e43378757a544d788aed5dc1dd1ce21_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">elv:NonCreditComponentsOfImpairmentsOnInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3854b434ec0e41f19c683b643a2b65b0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">elv:NonCreditComponentsOfImpairmentsOnInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6cae8c9b8e124d8f9c6a483e1f50d63a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6333d6f4a7f542d0a6c873c6d721b20f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0f296ec510ae4b489100cc4e4401f16d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie7d0a14cf7b04d2689e8c00fe9ee50bc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibce0012780de42b39687b8dc2c2d2645_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9291c2ff4b2f443a9a229d05ba749f08_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i35dbebbdfb3b4ab58592b593d907d827_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if60627e1e84e4b339448c6d14a9087be_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iadc106beeb124c7ba342f63d01a137d2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5b066b6520a04587be918ef721ac7343_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7bc72b35cf17467ea46cbd502a8f690f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib948503264de432899d049dd0575663c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ice4c66b286684bc78853a3bcc0e579a8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia9538c473eb54495b6cdee761ef557a7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iff4c8270a3144c10bdf362046062d8a5_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ideb63a96f5c749ca9094200a8ba2b7e9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8a9aee5d11bb47bd9cb89fcdd8efe039_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iafaf34467ec1493eb045796ec8e537ed_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic7d788695b784dbea530ea0825b12aac_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i95f866b9b2ea4f848e8122f80341b0c2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie4c04580eba94b4d90b41a5d0c88cc4a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i834e9db2373b4b68b3452b49ef4aa755_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8642636cf706437d9a3a0aba479b0966_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i56f8a70ced554e39b672ce48d8b75303_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if3ad1d3b885146b998e9a975d801f76b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idf3fd69d4d55450c8e871275758301b5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i967583dc4bba46948e14836718b94da9_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i54c1ad6c70e943cbb0219aed34cfe0fe_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iada0e8e50ae7426592cf04d9556323d4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i472f221347be479aa71a0a08747b91a3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id3126da39a5443229f14991bb4782574_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="elv:PerformancemeasurementperiodAxis">elv:A2022To2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2d4742d632984f94b7fd17314cc4c078_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="elv:PerformancemeasurementperiodAxis">elv:A2022To2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if6a892d97bb04fbca567d9781dcbbfb9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="elv:PerformancemeasurementperiodAxis">elv:A2021To2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i973466ad3bf64618843bf4007e0b486f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="elv:PerformancemeasurementperiodAxis">elv:A2021To2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i613f3949b7024615a0b0e144265e921b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:CommercialSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5f9be59a634a40b88e6dbcaae7d7deac_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i78f61d39fc7a4472a65a1d69f1fa77e6_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0fe4f30315e9486cab1e53788aa7d851_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idec57493ab1e4934bf922237f912f0b6_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8cfa8e1a475a4cdbbb5a9828060b71b3_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i32ced2539b8f4d329078b81a982fc92c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6bd87a9fe9284c9382b2f66c6c0889e0_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id7fc6c71c6004a74ba6b839f6bb3ff09_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id8f86bdb8cf2469aa0b7d726398ab429_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:CommercialSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if830019dcb7d41e7b0f6d3696e6ff1bb_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id770a0ff048944b9ba5c4f267af241c1_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i40ca534e715147f98238ecf1aaea0e0d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i42cb539441714260b2dac721cc7b7385_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:CommercialSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if4396f9c7ead4882afe910b3265d1ae6_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie2b72584a9a44b80a8f513401ff64d97_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i43f1507e8bcc4d748dfbaec841ee2693_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id4cf254d155841919857d544d09721ab_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia289890cc9a84272b385fe830e5a181c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:CommercialSpecialtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ice278b94888d4092b77546bceeb6bea5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic31a5ad6faf248238ec05a2850499106_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i535f1617c8544db396ede0c7f1da6d87_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6493eedb9ee14f9abe78a63b29dc2a76_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if3412b5e435444238a5abd7fdd03b86f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iea48a3ae14cb42c597f9265f719b100c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:CommercialSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaa92746fb4df4c01b8d7210e2ae19cf9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i699414c0bc4847948f60c7721dfe388f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i49e4f34abd44464ba18d17589d4817f5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib642ee435246417986a7c59ac081ac68_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:CommercialSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ife47ac82fe0345dc920d78c9e6c54bff_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0b6a789eb76947a58a5f3eb47c31e312_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia0e62d9102304c3abf2cad1b68e9c3f4_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i489b1390122443e2bb59851e5a3062fd_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4f47d7a5179d4dfc97384ed285da7911_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:CommercialSpecialtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7f08825ff0ad45c9a9bd4fcfbee83337_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i460716678d6242c19377280954cd4752_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie284f26c8937426abf5fb54b5296c8e3_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i67ab17589f884d1fbeb85f1ff8c7347b_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia37eef0dbc8c45e3a79a0e793d82369b_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i48ef62bcfeb448e584ac8677641f5a48_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:CommercialSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iade9083183e24a63a024e8c92ebde4f4_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i84ba57a42d554362bd86af8887714be2_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if5a10db4f5de43ae9ca27fb423936d50_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib035444b5f354e3599e287f69135039a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:CommercialSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i250482f83321476e96b00f0a8172c63f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifb6d5e1babc8461ba8510bfa1a69afaf_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib01b6477a138483b87a1c6749d60194d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i070cb4af0e734e3b97f862746b92ef65_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:UnaffiliatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie38e2cab8d46445aa0e1d1b6c282a05a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:CommercialSpecialtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i09dc82dcd92645758117fe7914de65ad_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i42a32ee4b8c040ed9b7f3e8951e03bb9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4f17939a81c848e68bf70536f100b8f8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idc176686245540f388bb95d4741dab61_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i95dfc1da6af04fd08d490195296eb3ed_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">elv:AffiliatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4e811d8b6a8a405db8cfa3af19e8d5e0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:CommercialSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie2afef55df394f80a6083eef46447e0c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0d3be1d743ba40d2804be36571b03d27_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i49ec233198524d05b69059ae1a04c04f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie50df0b7e812404f8ac6506d19378156_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ief5f8447f8f6441dab988369cb18391b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3e22b3359b804b6096c6db064b631db3_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i98a4fbec4a714f71b3cd75ec9f0deb96_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3b41a0ca0abe41f19104d40411fe8b3c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8a10c1e4505b4d6aa5128ba88498d53d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0bc040a46a814b49b1241f6aaa87b4e7_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2dfb62cf41374a68bb7efc705ab95d1f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2be8cfab42284be8ad0db60f8e9c7251_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:DentalVisionProductsAndServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic19125c669154425a6176b41f3b63e4a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:DentalVisionProductsAndServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic71d76f1bed042819c52df0907d93ee5_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:DentalVisionProductsAndServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idf64a53a0693483598a35f9ecae91e19_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:DentalVisionProductsAndServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5c235873956f485f8766fe1f4a6dfd52_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i47937f7e9daf42b98dfabfafd8f29aec_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie5b0fcd0d81b45e1972a3219cc11a422_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iaf7752a749a54daf8ecef7f516fccbbf_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:CommercialSpecialtyBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifdc016ae937c445185ef3dac290c94cb_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iad555599326849b4986b0f696e0bc3b6_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8d9d03d05fa0487499d5eeb2019e07de_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib2b81e7a6c124962bb984bd28230e269_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0f22558ff60c480a8751522ee586cca6_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i18518353f665475a9bb0d0e357886227_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3c5f026845034ad7bf3ab1ee5be68a4b_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iea0bebe050d8402fac705ade0fc21e7a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:ManagedCareServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib1c6d6e169f84a139863b8469ab9d241_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:PharmacyproductsandservicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9bdd175f0fdb4015821b828ea0c2e286_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:PharmacyproductsandservicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i94aa51feb4bf48bf9c5bba05c04ac8d2_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:PharmacyproductsandservicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0f53ea737c1440078ec9ff5e42581227_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:PharmacyproductsandservicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3e39237895504dfea4708a360ce4fd9f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IntegratedHealthServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i54804e82cd9d4171953e5f7a0443759d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IntegratedHealthServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaee2f1ec149648168e2cb6bec6fee839_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IntegratedHealthServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibf128bf301b34428b46cea6538e515e6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:IntegratedHealthServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icf78127a63ae4e2d9451e2182c5330af_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idfb2059876d84fbfa46eeb173a42357c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia4583bb7be664541bff123dc3d369c76_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i667448e355dd40e0bd386f14f3dfe774_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">elv:OtherProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i401e0447e56649b8bf0e2ea99deca4b9_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:SegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8a4d250516594092a504c84e2ce84ea7_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:SegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i888bd500cb4e464fa25e8b7832db7c26_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:SegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7421e7130f5a434fbc857ff8e1006b5b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:SegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0372d0f0be2a4fa7ae88750cdaac34d5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie530874bee08404db56ee4857d5efd5d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:GovernmentBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if6bbcf70f0bb4a6bbd6551b90da88d89_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3c94be5ee16a47e7a9596ba6add05232_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:OtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id593e5d6da124d95ab48675ffd8977c9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i14164de3b9fa4fbda3f76ea2a11abc8b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i52e3da93e21e46f280c3dae71bf5cb8c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4de2ea0a2eff4ca086ad80177a4451f3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">elv:IngenioRxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i13859b3a61354d53ab9916db584893cd_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3bc3de5499444f1ba422babbbc5f65b9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibbcb7d1337e04045a0fcd99dc012728f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3195b764ef2343888e4fdd71a0e4a7cc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4354544bc10d440fa1ec78849d381792_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3e8f393fc0344308ba714b6a9bbd73cb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic90c1cc5ab9f4b6093ae613918639e5e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iab7acc5aba584173aa7d2d55cc110fc3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic300e08f31844af79ab58566cb788e9a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="icb088b3cd90a4e8a854fa32b4d4e5601_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="medical_member">
        <measure>elv:medical_member</measure>
    </unit>
    <unit id="county">
        <measure>elv:county</measure>
    </unit>
    <unit id="states">
        <measure>elv:states</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="securities">
        <measure>elv:securities</measure>
    </unit>
    <unit id="segment">
        <measure>elv:segment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80L2ZyYWc6YTE5MjRjYzczNGQyNGRhOWJjN2NhZTg1NTM1MzBlZWYvdGFibGU6MDljZjgzM2VhYjg4NGMwODg3MzZkZGEyYzYwYTJjM2EvdGFibGVyYW5nZTowOWNmODMzZWFiODg0YzA4ODczNmRkYTJjNjBhMmMzYV8zLTEtMS0xLTcwMzYz_3f8346b1-9706-4d10-bc72-ae8493c78d8b">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80L2ZyYWc6YTE5MjRjYzczNGQyNGRhOWJjN2NhZTg1NTM1MzBlZWYvdGFibGU6MDljZjgzM2VhYjg4NGMwODg3MzZkZGEyYzYwYTJjM2EvdGFibGVyYW5nZTowOWNmODMzZWFiODg0YzA4ODczNmRkYTJjNjBhMmMzYV80LTEtMS0xLTcwMzYz_92a529a6-71e3-4875-a9d2-ced96143ee52">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80L2ZyYWc6YTE5MjRjYzczNGQyNGRhOWJjN2NhZTg1NTM1MzBlZWYvdGFibGU6MDljZjgzM2VhYjg4NGMwODg3MzZkZGEyYzYwYTJjM2EvdGFibGVyYW5nZTowOWNmODMzZWFiODg0YzA4ODczNmRkYTJjNjBhMmMzYV81LTEtMS0xLTcwMzYz_b69997cd-9ab0-449e-8b64-c53c813ac050">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80L2ZyYWc6YTE5MjRjYzczNGQyNGRhOWJjN2NhZTg1NTM1MzBlZWYvdGFibGU6MDljZjgzM2VhYjg4NGMwODg3MzZkZGEyYzYwYTJjM2EvdGFibGVyYW5nZTowOWNmODMzZWFiODg0YzA4ODczNmRkYTJjNjBhMmMzYV82LTEtMS0xLTcwMzYz_590de4c7-e705-4453-928d-3642df5d7875">0001156039</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80L2ZyYWc6YTE5MjRjYzczNGQyNGRhOWJjN2NhZTg1NTM1MzBlZWYvdGFibGU6MDljZjgzM2VhYjg4NGMwODg3MzZkZGEyYzYwYTJjM2EvdGFibGVyYW5nZTowOWNmODMzZWFiODg0YzA4ODczNmRkYTJjNjBhMmMzYV83LTEtMS0xLTcwMzYz_7ba497b3-e12f-49b5-9d82-0b1fa73c3019">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMS0xLTEtMS03MDM2Mw_0a867403-6163-4051-82f3-50402c642766"
      unitRef="usd">28306000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMS0zLTEtMS03MDM2Mw_5f118897-1645-4ee1-a748-afc09cd8b8b3"
      unitRef="usd">25641000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMi0xLTEtMS03MDM2Mw_9039c42d-2375-449c-8741-c1606109e8f6"
      unitRef="usd">10000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMi0zLTEtMS03MDM2Mw_7053144a-90e4-4cba-b0f9-d28ece74226f"
      unitRef="usd">6000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfNC0xLTEtMS03MDM2Mw_d48685df-74ba-41a6-ad4b-d31b0eba4ca9"
      unitRef="usd">671000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfNC0zLTEtMS03MDM2Mw_5a952f47-aa31-4ce2-8b3a-f860344e37eb"
      unitRef="usd">616000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfNS0xLTEtMS03MDM2Mw_fa82274b-0538-4f43-90c2-e9fffad1fc7b"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfNS0zLTEtMS03MDM2Mw_04efe429-4e0b-486a-a2fc-7b5fa1605a84"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfOC0xLTEtMS03MDM2Mw_ca0fb707-1d71-4af4-bbd5-e5106da977e0"
      unitRef="usdPerShare">0</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfOC0zLTEtMS03MDM2Mw_7427c26d-ff6f-4863-844d-cad5a9777f37"
      unitRef="usdPerShare">0</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfOS0xLTEtMS03MDM2Mw_5db77eb5-5906-4d08-a9e9-16dfa246239b"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfOS0zLTEtMS03MDM2Mw_7d4abdea-b813-454f-950e-cfc1f6298d3a"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTAtMS0xLTEtNzAzNjM_079347cf-0b40-46d9-ad98-d6b066acbc6d"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTAtMy0xLTEtNzAzNjM_fc00af15-fdb5-404f-9a32-6d14e144665a"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTEtMS0xLTEtNzAzNjM_c7cf99a6-f5da-4a47-a33f-f42a16e1a840"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTEtMy0xLTEtNzAzNjM_f6f8f886-6f8b-4c52-bbf0-64e4dfb0c823"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTMtMS0xLTEtNzAzNjM_3d241e5d-5c29-46d2-be94-0b8fe7946f48"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTMtMy0xLTEtNzAzNjM_2461a54c-7a42-464d-93a8-56cf16280947"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTQtMS0xLTEtNzAzNjM_e773574d-9f44-4b45-bf90-86861bfe6b53"
      unitRef="shares">900000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTQtMy0xLTEtNzAzNjM_36b8cd6a-a991-4ac0-9222-121b3d2e210b"
      unitRef="shares">900000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTUtMS0xLTEtNzAzNjM_8bcc349e-4f7f-4ef1-bde7-d7564b3eb503"
      unitRef="shares">238974624</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTUtMy0xLTEtNzAzNjM_298a62d1-dc69-4888-aab8-30c42d33b1f3"
      unitRef="shares">241770746</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTYtMS0xLTEtNzAzNjM_fca7bf09-372d-45c3-9b2a-5c42dce69b68"
      unitRef="shares">238974624</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xOS9mcmFnOmYzYjlmZjM2YTllMzRlOTViNGU5ZTcxNjg3ZTQ2MTgyL3RhYmxlOmYwNGU2MmU4NTA1ZDRhN2E4NTFhYWZjNTMxMmQxZDYyL3RhYmxlcmFuZ2U6ZjA0ZTYyZTg1MDVkNGE3YTg1MWFhZmM1MzEyZDFkNjJfMTYtMy0xLTEtNzAzNjM_f3edb303-4811-4fb2-9262-5887ac63358e"
      unitRef="shares">241770746</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMi0xLTEtMS03NzQ3Mg_35223446-da43-4885-b1af-792d126f0d02">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMi0xLTEtMS03NzQ3Mg_9be99ce3-7827-4188-b28e-80ce38a6cc7e">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMy0xLTEtMS03NzQ4MQ_3f09f4af-f1d9-4a52-8c2e-e79a525ccc59">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMy0xLTEtMS03NzQ4MQ_ce213197-b1dc-4b00-96f5-82a38cd1810f">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfNC0xLTEtMS03NzQ5OQ_3538eea0-82a4-4a60-af7e-b84b7a69ca57">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfNC0xLTEtMS03NzQ5OQ_3bcb0bf3-e902-449c-94d0-fd8995ada510">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTgw_29320d33-fdd0-4a28-b6af-b59569c4707a">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGFibGU6NzAwMjcxMGUxZmE1NDEzNjlmZWVlZmRiM2U4NzkyZTQvdGFibGVyYW5nZTo3MDAyNzEwZTFmYTU0MTM2OWZlZWVmZGIzZTg3OTJlNF8wLTAtMS0xLTcwMzYz_370e520d-bcd1-4698-b125-31c6505d2d98">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8xMzQ_37e78253-d4f5-4094-bfec-07b65a667e26">2022-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGFibGU6YzMwZDhlNmE4ZDk2NDQ2YmJlZjY2ZTM1MTQxNzg2ODgvdGFibGVyYW5nZTpjMzBkOGU2YThkOTY0NDZiYmVmNjZlMzUxNDE3ODY4OF8wLTAtMS0xLTcwMzYz_26d34172-2223-407c-9b93-ca5153eac286">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTc1_c6b4c897-be16-41d2-ac45-ed61385dc34e">001-16751</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTc2_c5574828-f98a-498c-8a61-9fc022e335d9">ELEVANCE HEALTH, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGFibGU6MWNlYWMyNGRlMWMwNDJkOTkyODFlMWJmYjliYjM3YzYvdGFibGVyYW5nZToxY2VhYzI0ZGUxYzA0MmQ5OTI4MWUxYmZiOWJiMzdjNl8wLTAtMS0xLTcwMzYz_ac2d1310-9fdf-447a-bdb2-a86748b7d38d">IN</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGFibGU6MWNlYWMyNGRlMWMwNDJkOTkyODFlMWJmYjliYjM3YzYvdGFibGVyYW5nZToxY2VhYzI0ZGUxYzA0MmQ5OTI4MWUxYmZiOWJiMzdjNl8wLTItMS0xLTcwMzYz_754b336a-3ae1-4d5e-bd3c-38551ac77bba">35-2145715</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTgx_f57745f9-bcbe-4fc6-8eab-256f13d951e2">220 Virginia Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTc3_4160fabb-2ce0-4817-98f7-d79a7433c657">Indianapolis</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTgy_d8d29d9c-1188-4fc7-b4f4-e89d81b9ec7f">IN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTgz_d850084e-a753-4a69-9412-3d7967c63d84">46204</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTg0_20f379c6-171e-4505-ba14-d695d847d56d">833</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTg1_9004e950-9e81-4975-80e4-2cd83e7f254c">401-1577</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGFibGU6NDA5ZWFkNThhZWQ4NGM1MDk5MmEyMjM3ODIwZDgzYjMvdGFibGVyYW5nZTo0MDllYWQ1OGFlZDg0YzUwOTkyYTIyMzc4MjBkODNiM18xLTAtMS0xLTcwMzYz_3efafcbd-54e8-4f56-8ffd-1091db13c068">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGFibGU6NDA5ZWFkNThhZWQ4NGM1MDk5MmEyMjM3ODIwZDgzYjMvdGFibGVyYW5nZTo0MDllYWQ1OGFlZDg0YzUwOTkyYTIyMzc4MjBkODNiM18xLTItMS0xLTcwMzYz_39fb8d15-a5a5-4844-bf14-27a8ea6eced5">ELV</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGFibGU6NDA5ZWFkNThhZWQ4NGM1MDk5MmEyMjM3ODIwZDgzYjMvdGFibGVyYW5nZTo0MDllYWQ1OGFlZDg0YzUwOTkyYTIyMzc4MjBkODNiM18xLTQtMS0xLTcwMzYz_cafb3729-3397-41ec-8b0b-d050c78c687e">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTg2_cfc9ac97-0b30-4436-883f-470041321a05">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTc5_b584b0f7-c274-4669-9f7b-1d5ce2d83756">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGFibGU6ODZjNTkwZjIzNDYwNDM1OWI5NWMxYmFhZTRiOGZjMzgvdGFibGVyYW5nZTo4NmM1OTBmMjM0NjA0MzU5Yjk1YzFiYWFlNGI4ZmMzOF8wLTAtMS0xLTcwMzYz_1690b136-a930-466a-b7fd-334a87d58f0e">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGFibGU6ODZjNTkwZjIzNDYwNDM1OWI5NWMxYmFhZTRiOGZjMzgvdGFibGVyYW5nZTo4NmM1OTBmMjM0NjA0MzU5Yjk1YzFiYWFlNGI4ZmMzOF8xLTUtMS0xLTcwMzYz_65e25eb1-0639-4894-ab52-a16ba4e59021">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGFibGU6ODZjNTkwZjIzNDYwNDM1OWI5NWMxYmFhZTRiOGZjMzgvdGFibGVyYW5nZTo4NmM1OTBmMjM0NjA0MzU5Yjk1YzFiYWFlNGI4ZmMzOF8yLTEtMS0xLTcwMzYz_b30ba526-fbde-478f-bae7-0a0d9451dfc2">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTc4_99ba8c13-e81e-4705-b767-c887e4f26865">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i5ffea20b96c2462c92744a6e44bb6555_I20221012"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xL2ZyYWc6ZmRiZmQwZGQyYjc3NDA0OTg1YjlhYTIxZWYyNTJmNzkvdGV4dHJlZ2lvbjpmZGJmZDBkZDJiNzc0MDQ5ODViOWFhMjFlZjI1MmY3OV8yMTE2_a8f4f962-e5d4-426b-b845-cbbde3b4ef3d"
      unitRef="shares">238827582</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNC0xLTEtMS03MDM2Mw_b25c02b7-9cf4-4775-96eb-c9ab7ea32557"
      unitRef="usd">8872000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNC0zLTEtMS03MDM2Mw_ff7b57da-afb1-4405-b2d8-cc15d71183bc"
      unitRef="usd">4880000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNS0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjYwYWZiNmM0NWJjODQ0YWViMmU1ZDQ3ZjYxNmY0NWI1XzQ5_0a867403-6163-4051-82f3-50402c642766"
      unitRef="usd">28306000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNS0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjYwYWZiNmM0NWJjODQ0YWViMmU1ZDQ3ZjYxNmY0NWI1XzU2_5f118897-1645-4ee1-a748-afc09cd8b8b3"
      unitRef="usd">25641000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNS0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjYwYWZiNmM0NWJjODQ0YWViMmU1ZDQ3ZjYxNmY0NWI1Xzkx_9039c42d-2375-449c-8741-c1606109e8f6"
      unitRef="usd">10000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNS0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjYwYWZiNmM0NWJjODQ0YWViMmU1ZDQ3ZjYxNmY0NWI1Xzk4_7053144a-90e4-4cba-b0f9-d28ece74226f"
      unitRef="usd">6000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNS0xLTEtMS03MDM2Mw_4cfb29ea-c82e-4bfa-b12c-62f5bfb75e04"
      unitRef="usd">25526000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNS0zLTEtMS03MDM2Mw_bcea3af4-ebef-4de8-b4ae-e90c02f2273a"
      unitRef="usd">26267000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNi0xLTEtMS03MDM2Mw_48751797-4c9e-4a51-a8cc-77b70b6d97d3"
      unitRef="usd">1503000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNi0zLTEtMS03MDM2Mw_8c90f301-cadd-4efd-bc35-2a8dce6b57af"
      unitRef="usd">1881000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:PremiumsReceivableAtCarryingValue
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfOS0xLTEtMS03MDM2Mw_166a9215-217c-4e15-967f-29d3a0fd77f3"
      unitRef="usd">6682000000</us-gaap:PremiumsReceivableAtCarryingValue>
    <us-gaap:PremiumsReceivableAtCarryingValue
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfOS0zLTEtMS03MDM2Mw_edac5729-41ea-4c26-8909-a7fdfe6d55a3"
      unitRef="usd">5681000000</us-gaap:PremiumsReceivableAtCarryingValue>
    <elv:SelfFundedReceivablesNet
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTAtMS0xLTEtNzAzNjM_bd08ae4d-a26f-46bd-b8a1-08479d2b63c0"
      unitRef="usd">3873000000</elv:SelfFundedReceivablesNet>
    <elv:SelfFundedReceivablesNet
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTAtMy0xLTEtNzAzNjM_96a6b8bd-5dae-4e0d-b69f-703152538d7e"
      unitRef="usd">4010000000</elv:SelfFundedReceivablesNet>
    <us-gaap:OtherReceivables
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTEtMS0xLTEtNzAzNjM_76331aad-de26-420b-8b58-27232a072789"
      unitRef="usd">3651000000</us-gaap:OtherReceivables>
    <us-gaap:OtherReceivables
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTEtMy0xLTEtNzAzNjM_842cc9a2-0196-43c0-b0e2-c30033adfe79"
      unitRef="usd">3749000000</us-gaap:OtherReceivables>
    <us-gaap:OtherAssetsCurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTQtMS0xLTEtNzAzNjM_3caaae89-67e3-40a5-84d6-502ce172f8d8"
      unitRef="usd">5496000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTQtMy0xLTEtNzAzNjM_7a234402-edb8-4ff0-82d2-f625fbcbd5df"
      unitRef="usd">4654000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTUtMS0xLTEtNzAzNjM_84938057-6d23-4cc0-b262-00d18c4adc7c"
      unitRef="usd">55603000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTUtMy0xLTEtNzAzNjM_cab522dc-69cd-4066-af3c-048df9886fda"
      unitRef="usd">51122000000</us-gaap:AssetsCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpmZmIzNzU5ZDUyMTQ0ZmU5YjA1ZmZkNzIwZTBhZDBhZV80OQ_d48685df-74ba-41a6-ad4b-d31b0eba4ca9"
      unitRef="usd">671000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpmZmIzNzU5ZDUyMTQ0ZmU5YjA1ZmZkNzIwZTBhZDBhZV81Ng_5a952f47-aa31-4ce2-8b3a-f860344e37eb"
      unitRef="usd">616000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpmZmIzNzU5ZDUyMTQ0ZmU5YjA1ZmZkNzIwZTBhZDBhZV85MQ_fa82274b-0538-4f43-90c2-e9fffad1fc7b"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpmZmIzNzU5ZDUyMTQ0ZmU5YjA1ZmZkNzIwZTBhZDBhZV85OA_04efe429-4e0b-486a-a2fc-7b5fa1605a84"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTctMS0xLTEtNzAzNjM_2327fa46-16dd-41d0-aa96-0416d61db1fc"
      unitRef="usd">622000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTctMy0xLTEtNzAzNjM_d9a9aec6-404d-4ef8-ad58-b1e04e0a9bb4"
      unitRef="usd">632000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:OtherLongTermInvestments
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTktMS0xLTEtNzAzNjM_c69a1481-7ae0-4516-88eb-0bd8e049893a"
      unitRef="usd">5516000000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMTktMy0xLTEtNzAzNjM_ea6a34e0-412d-43bc-92a9-e468c5c1f7cd"
      unitRef="usd">5225000000</us-gaap:OtherLongTermInvestments>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMjAtMS0xLTEtNzAzNjM_b8836ef9-e790-4f6d-8438-754e9ff3a567"
      unitRef="usd">4197000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMjAtMy0xLTEtNzAzNjM_114141a2-5afe-459b-85d5-b5111ee632bd"
      unitRef="usd">3919000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMjEtMS0xLTEtNzAzNjM_2b75a546-a681-4508-a4e1-6153cb8ffc16"
      unitRef="usd">24381000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMjEtMy0xLTEtNzAzNjM_f5287ea6-e791-4eea-a46b-e3d0d74281fa"
      unitRef="usd">24228000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMjItMS0xLTEtNzAzNjM_e9fa2db0-1a3a-42dc-9ff6-f6891b38df82"
      unitRef="usd">10536000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMjItMy0xLTEtNzAzNjM_b25bf039-365c-49d0-8c68-e478eed4e3bc"
      unitRef="usd">10615000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMjMtMS0xLTEtNzAzNjM_a460baed-4f38-4cc5-a5e5-1e1fdac19243"
      unitRef="usd">2171000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMjMtMy0xLTEtNzAzNjM_b552b1d9-17c8-4adb-a621-e91f7b764d6a"
      unitRef="usd">1719000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMjQtMS0xLTEtNzAzNjM_7418ad33-6fb5-46b8-90cb-7ea5961bf618"
      unitRef="usd">103026000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMjQtMy0xLTEtNzAzNjM_2f0c9fc9-c3db-43cf-bbb0-82d52afb016d"
      unitRef="usd">97460000000</us-gaap:Assets>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMzAtMS0xLTEtNzAzNjM_61307a7e-54e5-4584-8b8a-1b2e11b3dc34"
      unitRef="usd">15242000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMzAtMy0xLTEtNzAzNjM_f9e0feca-50da-418b-b2e2-1235b972022e"
      unitRef="usd">13518000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:OtherPolicyholderFunds
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMzItMS0xLTEtNzAzNjM_235935d8-178b-4c72-90c5-3f883e36310c"
      unitRef="usd">5482000000</us-gaap:OtherPolicyholderFunds>
    <us-gaap:OtherPolicyholderFunds
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMzItMy0xLTEtNzAzNjM_e2bc35a3-5c50-457e-9bd3-7376352ccc73"
      unitRef="usd">5521000000</us-gaap:OtherPolicyholderFunds>
    <us-gaap:UnearnedPremiums
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMzQtMS0xLTEtNzAzNjM_ae309075-65f3-4837-8355-3853af55da30"
      unitRef="usd">3702000000</us-gaap:UnearnedPremiums>
    <us-gaap:UnearnedPremiums
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMzQtMy0xLTEtNzAzNjM_1af84325-46bb-48a8-b946-cd7e15ef18be"
      unitRef="usd">1153000000</us-gaap:UnearnedPremiums>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMzUtMS0xLTEtNzAzNjM_7846ae37-98b8-40ef-b7a0-795fc5dcf108"
      unitRef="usd">4963000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMzUtMy0xLTEtNzAzNjM_ce320689-9058-4d1c-aa13-cb7cc3674e8c"
      unitRef="usd">4970000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:ShortTermBorrowings
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMzktMS0xLTEtNzAzNjM_266984c2-6046-4797-822f-82a5e3ea605f"
      unitRef="usd">265000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfMzktMy0xLTEtNzAzNjM_af9a11d5-753f-4a5f-85aa-c3dad025ea61"
      unitRef="usd">275000000</us-gaap:ShortTermBorrowings>
    <us-gaap:LongTermDebtCurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDAtMS0xLTEtNzAzNjM_919f29e3-1ecb-48e6-bac8-d56799c0e4c0"
      unitRef="usd">2249000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDAtMy0xLTEtNzAzNjM_3eea9d83-2d8a-4dd2-9f9f-074415b73865"
      unitRef="usd">1599000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDEtMS0xLTEtNzAzNjM_aac8e14c-350b-4c9a-91aa-e50e39a4d9f7"
      unitRef="usd">9384000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDEtMy0xLTEtNzAzNjM_be0130ba-d2fc-45e1-8952-c916d457844a"
      unitRef="usd">7849000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDItMS0xLTEtNzAzNjM_8e8c798d-ab8a-477e-a0a2-91f61af71215"
      unitRef="usd">41287000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDItMy0xLTEtNzAzNjM_27344730-47bc-4591-b8a7-316cac7a9fd1"
      unitRef="usd">34885000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDMtMS0xLTEtNzAzNjM_df9c9711-a4ac-4d38-90ae-0417b0cc7730"
      unitRef="usd">21258000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDMtMy0xLTEtNzAzNjM_1e04c5f9-0a0f-49f2-84d8-61e604180c74"
      unitRef="usd">21157000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDQtMS0xLTEtNzAzNjM_cc1255b8-edc6-4ba5-b802-8b4a5b79191e"
      unitRef="usd">825000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDQtMy0xLTEtNzAzNjM_1915fb7a-3102-4098-9e7d-e733c07b42fb"
      unitRef="usd">802000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDUtMS0xLTEtNzAzNjM_9ecaf131-6a7c-404d-ae4d-074646f3f0ab"
      unitRef="usd">1825000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDUtMy0xLTEtNzAzNjM_0a0c99a1-0a96-4b73-b83c-f0c60d716733"
      unitRef="usd">2805000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDYtMS0xLTEtNzAzNjM_9e9b5437-4052-4638-87c5-51509e92d062"
      unitRef="usd">1788000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDYtMy0xLTEtNzAzNjM_8ca96023-e1d8-4df1-bdc6-c81400693a9d"
      unitRef="usd">1683000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDctMS0xLTEtNzAzNjM_127aa7bc-c9de-4936-8177-5cdefe48d4d2"
      unitRef="usd">66983000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDctMy0xLTEtNzAzNjM_73fa3eab-e34b-46ce-9379-f640dc5293b4"
      unitRef="usd">61332000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDktMS0xLTEtNzAzNjM_0d4c64e5-6e1b-409d-9e60-8a4d1a5d6336"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNDktMy0xLTEtNzAzNjM_403a9fef-9320-43a1-bd54-9a1fd03708ee"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo1NjU1MjhhNWU2Njg0NmVjYjNjYTYwOWQ0NWZjYzczOV82MA_5db77eb5-5906-4d08-a9e9-16dfa246239b"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo1NjU1MjhhNWU2Njg0NmVjYjNjYTYwOWQ0NWZjYzczOV85Ng_079347cf-0b40-46d9-ad98-d6b066acbc6d"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTItMS0xLTEtNzAzNjM_e9fe6978-82cc-4bd2-b66f-6a771622b827"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTItMy0xLTEtNzAzNjM_35a00a2e-18d0-4569-8ac8-2b141719eca6"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTMtMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpjMTI4ZjdjMzNkM2Q0ZWUwOTc0ZjQyNmVmMTQ3YWIzZF8yOA_3d241e5d-5c29-46d2-be94-0b8fe7946f48"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTMtMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpjMTI4ZjdjMzNkM2Q0ZWUwOTc0ZjQyNmVmMTQ3YWIzZF81Mg_e773574d-9f44-4b45-bf90-86861bfe6b53"
      unitRef="shares">900000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTMtMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpjMTI4ZjdjMzNkM2Q0ZWUwOTc0ZjQyNmVmMTQ3YWIzZF84OQ_8bcc349e-4f7f-4ef1-bde7-d7564b3eb503"
      unitRef="shares">238974624</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTMtMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpjMTI4ZjdjMzNkM2Q0ZWUwOTc0ZjQyNmVmMTQ3YWIzZF85Ng_298a62d1-dc69-4888-aab8-30c42d33b1f3"
      unitRef="shares">241770746</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTMtMS0xLTEtNzAzNjM_36eaecf3-b0aa-47b3-bd1d-f629b4e8ce6a"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTMtMy0xLTEtNzAzNjM_d3e445ba-dd2e-4531-b163-6e4912e630a7"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTQtMS0xLTEtNzAzNjM_70a22655-55b4-4dda-8231-89035d764d5e"
      unitRef="usd">9169000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTQtMy0xLTEtNzAzNjM_759a49fc-b4fd-4915-bc43-05e96bd469c2"
      unitRef="usd">9148000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTUtMS0xLTEtNzAzNjM_b506d1d7-5f47-41a3-b6a5-58a94c4be61c"
      unitRef="usd">29604000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTUtMy0xLTEtNzAzNjM_f2f01902-784a-4e68-bef4-56232bac1c6c"
      unitRef="usd">27088000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTYtMS0xLTEtNzAzNjM_3770ab9b-53f4-4f53-9d6f-6669dee9271c"
      unitRef="usd">-2784000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTYtMy0xLTEtNzAzNjM_3daec55a-2abe-4ad0-8559-d0cd20a1c003"
      unitRef="usd">-178000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTctMS0xLTEtNzAzNjM_82e14b1b-e7b4-49d4-9746-e8c5586ddfda"
      unitRef="usd">35991000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTctMy0xLTEtNzAzNjM_c84f4e15-614c-44b3-9268-3818a2a00327"
      unitRef="usd">36060000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTgtMS0xLTEtNzAzNjM_59859c1d-e318-46f9-9c09-b1781b08dba6"
      unitRef="usd">52000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTgtMy0xLTEtNzAzNjM_f9808274-0dce-48cc-beaa-cb5fae0c8948"
      unitRef="usd">68000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTktMS0xLTEtNzAzNjM_e7ac78f1-05ca-47ea-8d27-6fcca280da93"
      unitRef="usd">36043000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNTktMy0xLTEtNzAzNjM_73e0e7f7-4405-4757-96f4-0075a6c64a6a"
      unitRef="usd">36128000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNjAtMS0xLTEtNzAzNjM_f062241a-f017-4960-a597-3001d3b35f0f"
      unitRef="usd">103026000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8xNi9mcmFnOmY4Y2ViZTY5MjcyNjQyZmU4ZTBmYzE5ZjJkNTE0Njk1L3RhYmxlOmNjZGYzM2U4ZjQ3ZDQ1NDRhYTJmNzMyZmIzZmM5ZWE5L3RhYmxlcmFuZ2U6Y2NkZjMzZThmNDdkNDU0NGFhMmY3MzJmYjNmYzllYTlfNjAtMy0xLTEtNzAzNjM_d9d8f038-f934-49df-a317-b85bdcaa1ae0"
      unitRef="usd">97460000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:PremiumsEarnedNet
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMy0xLTEtMS03MDM2Mw_a1aebfb1-c223-4fcd-a559-798fa30ea5ba"
      unitRef="usd">33722000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMy0zLTEtMS03MDM2Mw_ce15d6a7-354e-4a6c-bb34-cf345e2379c8"
      unitRef="usd">30395000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMy01LTEtMS03MDM2Mw_8b8e041c-c6e3-4c95-94bd-b1cb11336f29"
      unitRef="usd">99583000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMy03LTEtMS03MDM2Mw_bbeb9578-abd7-45d7-9bc7-04e04bc8444d"
      unitRef="usd">86604000000</us-gaap:PremiumsEarnedNet>
    <elv:ProductRevenue
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNC0xLTEtMS03MDM2Mw_29b16c6d-7b55-4572-b009-c211e862a175"
      unitRef="usd">3972000000</elv:ProductRevenue>
    <elv:ProductRevenue
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNC0zLTEtMS03MDM2Mw_10c24259-1d66-4621-a62e-0d0f5acb74ec"
      unitRef="usd">3353000000</elv:ProductRevenue>
    <elv:ProductRevenue
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNC01LTEtMS03MDM2Mw_a1a6050d-f8ae-4bc1-a20a-6174e4cc5680"
      unitRef="usd">10841000000</elv:ProductRevenue>
    <elv:ProductRevenue
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNC03LTEtMS03MDM2Mw_060dbcb3-5e19-43b4-8344-17c1662467c3"
      unitRef="usd">9132000000</elv:ProductRevenue>
    <us-gaap:OtherIncome
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNS0xLTEtMS03MDM2Mw_02e46e60-a3c7-45c2-9398-b367d72e2bfa"
      unitRef="usd">1931000000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNS0zLTEtMS03MDM2Mw_a472ffaa-c7e1-4560-9c3d-fe3e024cb318"
      unitRef="usd">1800000000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNS01LTEtMS03MDM2Mw_659b7395-4bb3-4ed2-a7c1-f279e529e70f"
      unitRef="usd">5569000000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNS03LTEtMS03MDM2Mw_6cb10f95-c09a-4923-9f0a-2c1318b9f0c3"
      unitRef="usd">5189000000</us-gaap:OtherIncome>
    <elv:OperatingRevenue
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNi0xLTEtMS03MDM2Mw_84299c95-1878-4428-96d0-7a7de1a5dd94"
      unitRef="usd">39625000000</elv:OperatingRevenue>
    <elv:OperatingRevenue
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNi0zLTEtMS03MDM2Mw_cb752263-9ccd-429b-9e06-7c48a50345cd"
      unitRef="usd">35548000000</elv:OperatingRevenue>
    <elv:OperatingRevenue
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNi01LTEtMS03MDM2Mw_04bd5b5d-620a-4da2-8359-d2f5ec5b2ccf"
      unitRef="usd">115993000000</elv:OperatingRevenue>
    <elv:OperatingRevenue
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNi03LTEtMS03MDM2Mw_07bdaa2d-9b5f-45c5-9bad-997d456ea07b"
      unitRef="usd">100925000000</elv:OperatingRevenue>
    <us-gaap:NetInvestmentIncome
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNy0xLTEtMS03MDM2Mw_86dc72f5-f6f3-477e-9c8f-f57bc18990b3"
      unitRef="usd">371000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNy0zLTEtMS03MDM2Mw_584495f3-5588-4a71-b2b3-bf62efdd25af"
      unitRef="usd">335000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNy01LTEtMS03MDM2Mw_0b907670-793f-4e91-9912-b7eddfae997d"
      unitRef="usd">1112000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfNy03LTEtMS03MDM2Mw_82dcbb47-948b-4252-81b6-9bf9c2d9a76b"
      unitRef="usd">1026000000</us-gaap:NetInvestmentIncome>
    <elv:NetLossesGainsOnFinancialInstruments
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfOC0xLTEtMS03MDM2Mw_35366142-9fb5-4f8e-a191-41aac40ffe84"
      unitRef="usd">-57000000</elv:NetLossesGainsOnFinancialInstruments>
    <elv:NetLossesGainsOnFinancialInstruments
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfOC0zLTEtMS03MDM2Mw_c4c32e90-c26f-43a2-957a-67849f02131f"
      unitRef="usd">-61000000</elv:NetLossesGainsOnFinancialInstruments>
    <elv:NetLossesGainsOnFinancialInstruments
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfOC01LTEtMS03MDM2Mw_4fc52e99-bef7-4acf-ab17-40f3090564df"
      unitRef="usd">-439000000</elv:NetLossesGainsOnFinancialInstruments>
    <elv:NetLossesGainsOnFinancialInstruments
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfOC03LTEtMS03MDM2Mw_ec82f094-0dc7-4431-879a-78c45563deb3"
      unitRef="usd">107000000</elv:NetLossesGainsOnFinancialInstruments>
    <us-gaap:Revenues
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfOS0xLTEtMS03MDM2Mw_05be369e-c6e1-4fab-8bc6-5ea021f94bfa"
      unitRef="usd">39939000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfOS0zLTEtMS03MDM2Mw_5d75a6ec-5c1e-467c-a1dc-7d0d37d125eb"
      unitRef="usd">35822000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfOS01LTEtMS03MDM2Mw_0a692752-b460-4a0d-9501-fd9d8fcf5ce0"
      unitRef="usd">116666000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfOS03LTEtMS03MDM2Mw_40b13063-fbb7-4d2f-bb50-3934d6fafa00"
      unitRef="usd">102058000000</us-gaap:Revenues>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredNet
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTEtMS0xLTEtNzAzNjM_a2cadb98-011d-47c1-9b94-1e058418c1f7"
      unitRef="usd">29404000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredNet>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredNet
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTEtMy0xLTEtNzAzNjM_8d796097-8d97-41b5-b7b6-495ff634fa12"
      unitRef="usd">26645000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredNet>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredNet
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTEtNS0xLTEtNzAzNjM_f06033a6-790c-447b-844f-9b5d59587ea2"
      unitRef="usd">86396000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredNet>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredNet
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTEtNy0xLTEtNzAzNjM_6a6fe7a9-94de-4a74-8499-cbc563e4610a"
      unitRef="usd">75107000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredNet>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTItMS0xLTEtNzAzNjM_31ee173b-9fe8-45da-ba51-bde4bf9af270"
      unitRef="usd">3437000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTItMy0xLTEtNzAzNjM_c8f5bed4-69f4-4266-aba2-17dc6a1c14e3"
      unitRef="usd">2898000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTItNS0xLTEtNzAzNjM_c8b47490-32c8-44a0-b5ae-3ef6402e57ec"
      unitRef="usd">9389000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTItNy0xLTEtNzAzNjM_5498ca33-fcb6-4fb8-a533-6bcc0d26ffc7"
      unitRef="usd">7825000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTMtMS0xLTEtNzAzNjM_17189a79-647c-4d92-82c1-d0867fc20b9b"
      unitRef="usd">4514000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTMtMy0xLTEtNzAzNjM_629576e5-f984-4af8-8932-b942d31da47f"
      unitRef="usd">3946000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTMtNS0xLTEtNzAzNjM_6884e06d-156c-4999-8b26-81d0dda7cd18"
      unitRef="usd">13124000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTMtNy0xLTEtNzAzNjM_8c0a45d5-b50c-4e66-9619-d1ee0fc04a0a"
      unitRef="usd">11692000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:InterestExpense
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTQtMS0xLTEtNzAzNjM_6093ba63-3840-48a5-bcc3-75ee5ca1b3c0"
      unitRef="usd">213000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTQtMy0xLTEtNzAzNjM_783be160-648b-486b-aa35-65e7b4fdfda0"
      unitRef="usd">201000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTQtNS0xLTEtNzAzNjM_121552a3-432c-4337-b07b-7239ff042dfd"
      unitRef="usd">622000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTQtNy0xLTEtNzAzNjM_afc6fecd-5a3d-41c0-b911-3bec2b36e72c"
      unitRef="usd">598000000</us-gaap:InterestExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTUtMS0xLTEtNzAzNjM_7da01f2c-4239-4c93-820e-5c62976801c0"
      unitRef="usd">225000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTUtMy0xLTEtNzAzNjM_07b4e7e2-44ce-4685-8acf-058b2c8ea3c0"
      unitRef="usd">136000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTUtNS0xLTEtNzAzNjM_bd4d37e1-4fd2-4075-8c38-2a498c738f08"
      unitRef="usd">520000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTUtNy0xLTEtNzAzNjM_2068a02f-1a10-43a2-af9c-8cadbaf57e69"
      unitRef="usd">306000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTYtMS0xLTEtNzAzNjM_36f086f4-a769-47d6-8e80-e21708e83cd8"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTYtMy0xLTEtNzAzNjM_eb1ab1f3-0abc-4962-933d-04637bce2921"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTYtNS0xLTEtNzAzNjM_cb13feea-11c1-4a6f-8460-3d3557729844"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTYtNy0xLTEtNzAzNjM_40539981-f293-4291-b951-e4e3b965a2cf"
      unitRef="usd">-5000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTgtMS0xLTEtNzAzNjM_5dc0b4b9-46bf-4ca8-b1b2-e1bffdab9b10"
      unitRef="usd">37793000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTgtMy0xLTEtNzAzNjM_114b7fa0-fbf3-4773-9ba6-e0b50347dcfa"
      unitRef="usd">33826000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTgtNS0xLTEtNzAzNjM_f8f91b85-f1e4-4a75-8370-b6d98831c987"
      unitRef="usd">110051000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTgtNy0xLTEtNzAzNjM_f150a5cf-e4e5-429d-b087-6ee2d1f0dc8d"
      unitRef="usd">95533000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTktMS0xLTEtNzAzNjM_216d058d-2029-4527-a52f-cdb44c7c94a3"
      unitRef="usd">2146000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTktMy0xLTEtNzAzNjM_2f18b6ef-4e2a-4c8a-a3e9-606094ee58c9"
      unitRef="usd">1996000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTktNS0xLTEtNzAzNjM_21736ce5-d8b9-4684-b3f8-f07b2247ed2b"
      unitRef="usd">6615000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMTktNy0xLTEtNzAzNjM_c57c3953-d3ba-4d13-86c6-c14827570981"
      unitRef="usd">6525000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjAtMS0xLTEtNzAzNjM_9209cfd3-cdef-47f6-9568-c6c0192b84ea"
      unitRef="usd">533000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjAtMy0xLTEtNzAzNjM_cc73fd27-e2f7-4390-a4ca-b2b9f8fc66d5"
      unitRef="usd">494000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjAtNS0xLTEtNzAzNjM_f2d9e4a8-0fe5-41d0-936c-c75e4db5efd5"
      unitRef="usd">1557000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjAtNy0xLTEtNzAzNjM_21abaddb-3db3-40f7-8cfe-1ae1c08998ff"
      unitRef="usd">1555000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjMtMS0xLTEtNzAzNjM_07fc90db-2d29-4159-a4ee-93ce25660af3"
      unitRef="usd">1613000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjMtMy0xLTEtNzAzNjM_4f3b2149-58e6-438f-832e-a132c438432b"
      unitRef="usd">1502000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjMtNS0xLTEtNzAzNjM_b4a76474-3410-4ce2-9226-46439cfea8ba"
      unitRef="usd">5058000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjMtNy0xLTEtNzAzNjM_68536a74-caa5-488b-8e76-e1d309418b4d"
      unitRef="usd">4970000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjQtMS0xLTEtNzAzNjM_dd665f31-fe84-4f74-8871-a6420b34cb2e"
      unitRef="usd">-5000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjQtMy0xLTEtNzAzNjM_4ed56cef-8695-44ad-9aa9-c1de4127c0d9"
      unitRef="usd">-7000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjQtNS0xLTEtNzAzNjM_b7a8e27e-ea5e-497e-970a-4dda854a0d23"
      unitRef="usd">-18000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjQtNy0xLTEtNzAzNjM_d1fc3417-da39-44d6-b3ed-a1be23000733"
      unitRef="usd">3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjUtMS0xLTEtNzAzNjM_b77e2de2-f4ed-4d01-a644-68f4c1671426"
      unitRef="usd">1618000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjUtMy0xLTEtNzAzNjM_55f0c62f-09f0-44d5-9867-92249b0cd77d"
      unitRef="usd">1509000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjUtNS0xLTEtNzAzNjM_4fcff109-d39b-4594-8d64-2b440e89b2c0"
      unitRef="usd">5076000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjUtNy0xLTEtNzAzNjM_5e8dd00f-28ad-49d1-8699-bd08ae10cae4"
      unitRef="usd">4967000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjktMS0xLTEtNzAzNjM_f5c2603d-ddf7-4e51-a73b-ec7d9d43a6e0"
      unitRef="usdPerShare">6.75</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjktMy0xLTEtNzAzNjM_46b83318-de0b-403f-81c0-d817681d9f86"
      unitRef="usdPerShare">6.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjktNS0xLTEtNzAzNjM_0d93ca97-c5d5-4076-8af3-a7de2d7788d5"
      unitRef="usdPerShare">21.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMjktNy0xLTEtNzAzNjM_79369056-3879-4525-9c6d-7645e3d4ab3b"
      unitRef="usdPerShare">20.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMzMtMS0xLTEtNzAzNjM_950d68e3-cf7f-4b09-9fa5-79dbdc6b76d8"
      unitRef="usdPerShare">6.68</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMzMtMy0xLTEtNzAzNjM_86edfc47-c721-4c62-9e8d-c7add9ebe251"
      unitRef="usdPerShare">6.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMzMtNS0xLTEtNzAzNjM_3d7c0952-d830-4965-af9e-1bde9c4cd365"
      unitRef="usdPerShare">20.86</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMzMtNy0xLTEtNzAzNjM_bf4f3948-53af-40ef-b513-0383aa6b4df8"
      unitRef="usdPerShare">20.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMzQtMS0xLTEtNzAzNjM_e9613c2a-c7cb-4b92-b30d-f7276104381e"
      unitRef="usdPerShare">1.28</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMzQtMy0xLTEtNzAzNjM_13fb18da-fa13-403e-8319-29af654d6acd"
      unitRef="usdPerShare">1.13</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMzQtNS0xLTEtNzAzNjM_69709bd3-e194-44f5-8b4a-8d5e0f0d7e98"
      unitRef="usdPerShare">3.84</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yMi9mcmFnOmRlOWY1OGUwODdmOTRjYmViNmNmZGRkMWQ3ZDMyODQ2L3RhYmxlOmE3NzgzZTQwOTI4MTRiZWY5MTQ3MTAzZWMyZTNlMTY1L3RhYmxlcmFuZ2U6YTc3ODNlNDA5MjgxNGJlZjkxNDcxMDNlYzJlM2UxNjVfMzQtNy0xLTEtNzAzNjM_dbad93e3-5368-4ba6-a3f4-728fccc7c16d"
      unitRef="usdPerShare">3.39</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ProfitLoss
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMi0yLTEtMS03MDM2Mw_07fc90db-2d29-4159-a4ee-93ce25660af3"
      unitRef="usd">1613000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMi00LTEtMS03MDM2Mw_4f3b2149-58e6-438f-832e-a132c438432b"
      unitRef="usd">1502000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMi02LTEtMS03MDM2Mw_b4a76474-3410-4ce2-9226-46439cfea8ba"
      unitRef="usd">5058000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMi04LTEtMS03MDM2Mw_68536a74-caa5-488b-8e76-e1d309418b4d"
      unitRef="usd">4970000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNC0yLTEtMS03MDM2Mw_6c4d61bc-943f-43bc-8ead-71ea9934723e"
      unitRef="usd">-639000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNC00LTEtMS03MDM2Mw_587ff9c5-2252-4304-b884-352130fc421c"
      unitRef="usd">-97000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNC02LTEtMS03MDM2Mw_a3d835e8-b66b-4844-baf9-368ef26c8bbd"
      unitRef="usd">-2630000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNC04LTEtMS03MDM2Mw_ad7e3326-5b61-4d5d-837f-8882018f926d"
      unitRef="usd">-284000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <elv:Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNS0yLTEtMS03MDM2Mw_9e75a41f-656b-4be5-aa04-7316152c193d"
      unitRef="usd">-1000000</elv:Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax>
    <elv:Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNS00LTEtMS03MDM2Mw_a9704881-1342-4fa5-adca-b5a622265553"
      unitRef="usd">-1000000</elv:Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax>
    <elv:Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNS02LTEtMS03MDM2Mw_530e4ab5-5377-42ff-ad69-a3def2303e5f"
      unitRef="usd">-3000000</elv:Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax>
    <elv:Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNS04LTEtMS03MDM2Mw_6e593c25-cfd6-4cbf-9ec3-5b6bef60e23e"
      unitRef="usd">1000000</elv:Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNi0yLTEtMS03MDM2Mw_6f8829dc-3aca-4fee-b193-df80c4d86cc8"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNi00LTEtMS03MDM2Mw_056c4500-adcc-44a0-a744-dc99ff0147b8"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNi02LTEtMS03MDM2Mw_d2dd1f1f-a362-4d65-bedc-aa52f948607c"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNi04LTEtMS03MDM2Mw_bd7206ba-1b0c-4249-8076-25dd4e8d2d72"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNy0yLTEtMS03MDM2Mw_bfc93804-9305-42de-93aa-32369406e196"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNy00LTEtMS03MDM2Mw_8a9fda7f-57d8-48dc-9cbd-6ec8d6de6c2f"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNy02LTEtMS03MDM2Mw_329b046b-189e-4d99-9e42-bda75b23296f"
      unitRef="usd">-23000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfNy04LTEtMS03MDM2Mw_9df14152-70f7-4b47-8293-786a98d70edb"
      unitRef="usd">-26000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfOC0yLTEtMS03MDM2Mw_3b19b880-cee3-45ea-8344-a07b09cb7401"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfOC00LTEtMS03MDM2Mw_e9b5875f-8e95-4b90-9971-fd17c75eb296"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfOC02LTEtMS03MDM2Mw_5b94f8e6-8f07-40c7-8329-715e0121ca77"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfOC04LTEtMS03MDM2Mw_1685b84e-b1b6-4730-b297-fefbf8d83798"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfOS0yLTEtMS03MDM2Mw_f1de3961-bd4b-47ad-871d-8c8b0f874929"
      unitRef="usd">-638000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfOS00LTEtMS03MDM2Mw_c4860713-0ede-495a-9b15-f593c82be1ed"
      unitRef="usd">-87000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfOS02LTEtMS03MDM2Mw_9cf3dc15-fb61-4057-a86b-e45cc2171289"
      unitRef="usd">-2617000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfOS04LTEtMS03MDM2Mw_6a8ad056-ada3-4b6f-bb50-36db80698fec"
      unitRef="usd">-254000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTAtMi0xLTEtNzAzNjM_15a68b92-17e9-4ced-96a7-b24848e968a2"
      unitRef="usd">-5000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTAtNC0xLTEtNzAzNjM_9f87d48f-aa6f-4e7f-9b18-8dedae7c65b5"
      unitRef="usd">-7000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTAtNi0xLTEtNzAzNjM_ef97573a-5821-4ee8-9731-068521e0b950"
      unitRef="usd">-18000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTAtOC0xLTEtNzAzNjM_470adeb7-cf77-4d22-bcac-8903cb74dedb"
      unitRef="usd">3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTEtMi0xLTEtNzAzNjM_d6f461b2-8412-45ec-99dd-114ad2cf6391"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTEtNC0xLTEtNzAzNjM_2fe0250a-be68-41c9-8922-9102045dc136"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTEtNi0xLTEtNzAzNjM_c783fcdb-6049-47f7-a296-e75a038f3642"
      unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTEtOC0xLTEtNzAzNjM_ecf478f4-9857-4e7b-9896-e06c023da622"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTItMi0xLTEtNzAzNjM_c94bc44d-74d5-4f65-848f-2b73d5cbda66"
      unitRef="usd">983000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTItNC0xLTEtNzAzNjM_de8f3409-1424-484b-9e29-245267c88831"
      unitRef="usd">1423000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTItNi0xLTEtNzAzNjM_345bf6cf-8e24-4977-92de-3769521b083c"
      unitRef="usd">2470000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yNS9mcmFnOjFkNzI0ODM0ODU1ODRjMzQ5YmE0NjMzODhiNzBjMDdjL3RhYmxlOjI3NzhiMjYxMTE4MDQ0NGU5YjY4YmNjYzZmY2YzMTYxL3RhYmxlcmFuZ2U6Mjc3OGIyNjExMTgwNDQ0ZTliNjhiY2NjNmZjZjMxNjFfMTItOC0xLTEtNzAzNjM_ad03ec6a-14d1-4fbc-a4e6-8100e049c92a"
      unitRef="usd">4714000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMy0xLTEtMS03MDM2Mw_b4a76474-3410-4ce2-9226-46439cfea8ba"
      unitRef="usd">5058000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMy0zLTEtMS03MDM2Mw_2849565b-81f5-4193-857f-f9686c17b1dd"
      unitRef="usd">4970000000</us-gaap:ProfitLoss>
    <elv:NetLossesGainsOnFinancialInstruments
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNS0xLTEtMS03MDM2Mw_fe702a20-403c-4f86-8401-ef850577f0d9"
      unitRef="usd">-439000000</elv:NetLossesGainsOnFinancialInstruments>
    <elv:NetLossesGainsOnFinancialInstruments
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNS0zLTEtMS03MDM2Mw_d2327fc5-a47a-4f35-910e-2150236b77b3"
      unitRef="usd">107000000</elv:NetLossesGainsOnFinancialInstruments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNi0xLTEtMS03MDM2Mw_d3ef4e5e-e344-45c4-9949-f2ba1803c9a4"
      unitRef="usd">304000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNi0zLTEtMS03MDM2Mw_54592a6b-120a-4116-ac94-d0abcaa22aee"
      unitRef="usd">437000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNy0xLTEtMS03MDM2Mw_d02f3b22-f481-4250-a7f6-82e9fc87df10"
      unitRef="usd">1202000000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNy0zLTEtMS03MDM2Mw_8bc8bae8-fe0b-43ab-97ec-0db7df6e12f1"
      unitRef="usd">942000000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMTItMS0xLTEtNzAzNjM_6a20793c-1b92-4471-bac7-6f7076d0a122"
      unitRef="usd">-170000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMTItMy0xLTEtNzAzNjM_af49a705-b525-4a67-bdb0-9d73f814bd3b"
      unitRef="usd">114000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMTYtMS0xLTEtNzAzNjM_db83d731-6d51-4539-87bc-b3030d8c4d84"
      unitRef="usd">191000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMTYtMy0xLTEtNzAzNjM_348b45a3-b21c-458b-b932-ed58b8d9e645"
      unitRef="usd">196000000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMTktMS0xLTEtNzAzNjM_0577167c-be54-4d96-b526-2f31d03ba117"
      unitRef="usd">678000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMTktMy0xLTEtNzAzNjM_731453c0-e035-40af-a390-8d2f983f5b34"
      unitRef="usd">1751000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInTradingSecurities
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjAtMS0xLTEtNzAzNjM_a8e60d7c-1810-464c-9bd8-26624f86eec2"
      unitRef="usd">-46000000</us-gaap:IncreaseDecreaseInTradingSecurities>
    <us-gaap:IncreaseDecreaseInTradingSecurities
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjAtMy0xLTEtNzAzNjM_aabc0132-87bf-47f9-98ad-3a94aaa7aa8a"
      unitRef="usd">56000000</us-gaap:IncreaseDecreaseInTradingSecurities>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjEtMS0xLTEtNzAzNjM_a37f2316-1a8d-4ae7-b31f-fda8bb64fa1c"
      unitRef="usd">474000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjEtMy0xLTEtNzAzNjM_9f3a8ac8-d964-44fd-bf7e-de8ada129bbd"
      unitRef="usd">470000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjItMS0xLTEtNzAzNjM_f8da7829-514a-4a60-8e5e-aa9d71894faa"
      unitRef="usd">1537000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjItMy0xLTEtNzAzNjM_1a4f4790-bf57-4b5b-bca7-aea994cdae42"
      unitRef="usd">2328000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjMtMS0xLTEtNzAzNjM_900178db-9643-48a4-b778-1f40956f322a"
      unitRef="usd">2548000000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjMtMy0xLTEtNzAzNjM_502d199f-2d89-49a1-907e-2867c7ed7b9c"
      unitRef="usd">-308000000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjQtMS0xLTEtNzAzNjM_013f6c62-1259-4f80-ba69-88035e6be37e"
      unitRef="usd">598000000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjQtMy0xLTEtNzAzNjM_65f10258-020d-474c-90c5-453c7e1cd35d"
      unitRef="usd">1093000000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjctMS0xLTEtNzAzNjM_d2db5723-b2ef-4818-ad6b-c4ea45f233ed"
      unitRef="usd">-41000000</us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjctMy0xLTEtNzAzNjM_1a526070-a4e5-4392-9941-cdb55954a16b"
      unitRef="usd">168000000</us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjgtMS0xLTEtNzAzNjM_46811483-5b64-4be4-a6c8-127f45865bdf"
      unitRef="usd">35000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjgtMy0xLTEtNzAzNjM_bc5ba57b-b1f0-4c02-b736-50da2a3b520f"
      unitRef="usd">-10000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjktMS0xLTEtNzAzNjM_3164f8bb-ec1a-48e6-8bac-96d5f8d8472c"
      unitRef="usd">9917000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMjktMy0xLTEtNzAzNjM_e10aeefc-8094-4e31-93f2-1f548f48cbb8"
      unitRef="usd">6692000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMzQtMS0xLTEtNzAzNjM_60dd2acb-e21c-434c-9236-0fc5cf9f327f"
      unitRef="usd">19612000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMzQtMy0xLTEtNzAzNjM_1dc5eb7f-7c8d-4a56-b082-2d433c436a4a"
      unitRef="usd">15130000000</us-gaap:PaymentsToAcquireInvestments>
    <elv:Proceedsfromsaleofequityandfixedmaturitysecurities
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMzUtMS0xLTEtNzAzNjM_7a2adc67-4d73-4a19-8c33-d305eb642c0a"
      unitRef="usd">9402000000</elv:Proceedsfromsaleofequityandfixedmaturitysecurities>
    <elv:Proceedsfromsaleofequityandfixedmaturitysecurities
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMzUtMy0xLTEtNzAzNjM_24823eef-4bfd-483b-9434-1813a1b19248"
      unitRef="usd">8339000000</elv:Proceedsfromsaleofequityandfixedmaturitysecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMzYtMS0xLTEtNzAzNjM_10a0ee6f-28ec-45d3-b0c7-438a209dc53a"
      unitRef="usd">7606000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfMzYtMy0xLTEtNzAzNjM_237d1501-4892-4a15-a003-806fb9f8d5ed"
      unitRef="usd">3388000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:IncreaseDecreaseInCollateralHeldUnderSecuritiesLending
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNDItMS0xLTEtNzAzNjM_73454faa-6c37-4a5d-b3b1-c6ccb4decca8"
      unitRef="usd">677000000</us-gaap:IncreaseDecreaseInCollateralHeldUnderSecuritiesLending>
    <us-gaap:IncreaseDecreaseInCollateralHeldUnderSecuritiesLending
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNDItMy0xLTEtNzAzNjM_6b648c05-e565-4d0a-96fd-14af89bd577b"
      unitRef="usd">1030000000</us-gaap:IncreaseDecreaseInCollateralHeldUnderSecuritiesLending>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNDMtMS0xLTEtNzAzNjM_dfbdca23-0e9d-41b1-b62e-14c331c05251"
      unitRef="usd">623000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNDMtMy0xLTEtNzAzNjM_500092af-76a4-451b-bae5-b5df8ed01c55"
      unitRef="usd">3442000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNDUtMS0xLTEtNzAzNjM_9fb06078-07e2-4ae0-a120-7e2543a3e517"
      unitRef="usd">854000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNDUtMy0xLTEtNzAzNjM_898a48ff-ba4f-44ad-bba2-0d7a8567e133"
      unitRef="usd">747000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNDctMS0xLTEtNzAzNjM_8bb31ddb-d70d-4c7d-9e70-b2adbf0d58e8"
      unitRef="usd">91000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNDctMy0xLTEtNzAzNjM_19c96dd9-6192-49d2-b668-371aeb6d9d4d"
      unitRef="usd">50000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNDgtMS0xLTEtNzAzNjM_3e212242-fad7-4caa-8974-161e7a770fd8"
      unitRef="usd">-4849000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNDgtMy0xLTEtNzAzNjM_fe13c711-afcc-4d1e-89a5-9fd678b7e6a6"
      unitRef="usd">-8672000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTAtMS0xLTEtNzAzNjM_83d64320-e67f-4cfb-94e0-fccbac56f9ca"
      unitRef="usd">375000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTAtMy0xLTEtNzAzNjM_c97fc879-d04c-455c-927d-54f2dc618cb8"
      unitRef="usd">-150000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTEtMS0xLTEtNzAzNjM_dee294b7-ef7e-4b86-b05f-26ee9dcc5509"
      unitRef="usd">1286000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTEtMy0xLTEtNzAzNjM_af7ac265-8cc7-400a-b57a-03aa3135d624"
      unitRef="usd">3462000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTItMS0xLTEtNzAzNjM_1a6258b4-f4eb-4657-be1c-f9508e0c2a17"
      unitRef="usd">982000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTItMy0xLTEtNzAzNjM_eecad325-569a-4865-806b-a074238ed0e6"
      unitRef="usd">954000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTMtMS0xLTEtNzAzNjM_32716d5c-8e78-43e3-a986-20a18e15abf3"
      unitRef="usd">1365000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTMtMy0xLTEtNzAzNjM_fae2a976-20e9-4121-a11f-cc41c6019a06"
      unitRef="usd">175000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTQtMS0xLTEtNzAzNjM_6063834f-922b-46ba-9b8a-1f37a88a83eb"
      unitRef="usd">1375000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTQtMy0xLTEtNzAzNjM_9c2ee4d0-abac-4570-b0e7-b32f47a9776b"
      unitRef="usd">0</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:IncreaseDecreaseInSecuritiesLendingPayable
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTUtMS0xLTEtNzAzNjM_222a21e9-cfff-4062-97b7-e614f6d83091"
      unitRef="usd">685000000</us-gaap:IncreaseDecreaseInSecuritiesLendingPayable>
    <us-gaap:IncreaseDecreaseInSecuritiesLendingPayable
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTUtMy0xLTEtNzAzNjM_d27fee32-e00e-4085-a456-b93ade0d119a"
      unitRef="usd">1030000000</us-gaap:IncreaseDecreaseInSecuritiesLendingPayable>
    <us-gaap:IncreaseDecreaseInOutstandingChecksFinancingActivities
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTYtMS0xLTEtNzAzNjM_ba6f1f3a-947f-4682-81db-6a735dddf84d"
      unitRef="usd">181000000</us-gaap:IncreaseDecreaseInOutstandingChecksFinancingActivities>
    <us-gaap:IncreaseDecreaseInOutstandingChecksFinancingActivities
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNTYtMy0xLTEtNzAzNjM_da58dffd-52cf-47a2-bf3d-7032c7054c7b"
      unitRef="usd">316000000</us-gaap:IncreaseDecreaseInOutstandingChecksFinancingActivities>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjAtMS0xLTEtNzAzNjM_2d03039a-0744-4195-9f9d-b3bc327a6c2f"
      unitRef="usd">1748000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjAtMy0xLTEtNzAzNjM_5d37c5f1-5cb8-4231-8430-d359ce06b67f"
      unitRef="usd">1378000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividends
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjItMS0xLTEtNzAzNjM_89126e3a-b11e-4ed4-94ad-eb90eca68e3c"
      unitRef="usd">924000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjItMy0xLTEtNzAzNjM_61cde3d8-50bf-40d0-b463-4d53d1c3c72a"
      unitRef="usd">831000000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjMtMS0xLTEtNzAzNjM_ebd16222-e643-4503-9f44-b8c167dc73da"
      unitRef="usd">152000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjMtMy0xLTEtNzAzNjM_95691029-b4c7-4a4c-a927-02f06d063f65"
      unitRef="usd">161000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjQtMS0xLTEtNzAzNjM_60ee13ca-53a3-42ec-a10e-22be4397365a"
      unitRef="usd">91000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjQtMy0xLTEtNzAzNjM_bcf3cf2a-cf48-4138-a915-618671a2f218"
      unitRef="usd">101000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjYtMS0xLTEtNzAzNjM_ae6bc819-bc4f-44b2-ad89-ed5bbf9a210c"
      unitRef="usd">16000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjYtMy0xLTEtNzAzNjM_f333991a-10cd-4014-b4da-cd1b857fb406"
      unitRef="usd">8000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjctMS0xLTEtNzAzNjM_cb26265c-798c-4892-8ee3-68af064bbcdd"
      unitRef="usd">-1060000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjctMy0xLTEtNzAzNjM_a40fdee5-5747-40d5-b7dc-61666df6952e"
      unitRef="usd">1738000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjgtMS0xLTEtNzAzNjM_08c3f605-b395-452d-8391-83d961c53eca"
      unitRef="usd">-16000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjgtMy0xLTEtNzAzNjM_e2e105a8-88ee-493d-948a-7b4e644c0fc9"
      unitRef="usd">-9000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjktMS0xLTEtNzAzNjM_c3cffddf-0a33-4a32-a150-700e94375417"
      unitRef="usd">3992000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNjktMy0xLTEtNzAzNjM_8ef25136-a3cb-4892-93ab-12b4be184b2b"
      unitRef="usd">-251000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNzAtMS0xLTEtNzAzNjM_cdf60764-8046-4458-9bb5-6c3d0f0f8d58"
      unitRef="usd">4880000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9aceaf2b19bf4d5d916eb0f2039e41de_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNzAtMy0xLTEtNzAzNjM_17eb493c-168f-4d8c-8dc5-6a0428934895"
      unitRef="usd">5741000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNzEtMS0xLTEtNzAzNjM_fe14d069-d869-4979-99ce-107441f3c574"
      unitRef="usd">8872000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id7580839926f4e24b08f10312dd69479_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8yOC9mcmFnOjRkNWNhOGJiMjNmNTRjMmNiODIxZWI0NDQ4MmNkNTliL3RhYmxlOmEzYjMxMDVlMDM4ZDRiNTVhYmZiYWE2MGE2MDUyOTAwL3RhYmxlcmFuZ2U6YTNiMzEwNWUwMzhkNGI1NWFiZmJhYTYwYTYwNTI5MDBfNzEtMy0xLTEtNzAzNjM_8f2be329-bb53-4d37-ad3e-b310d97f8f5f"
      unitRef="usd">5490000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:SharesOutstanding
      contextRef="i76e906fcfdeb4832b77b338196e38474_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNS0xLTEtMS03MDM2Mw_ab738709-64c2-4e7d-b74c-135b57d207b7"
      unitRef="shares">241800000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i76e906fcfdeb4832b77b338196e38474_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNS0zLTEtMS03MDM2Mw_9fb66a90-865e-4c70-a397-29028d328f4f"
      unitRef="usd">2000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib0197b6d912c4e2c944e0737a73738ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNS01LTEtMS03MDM2Mw_600c1654-c9b2-49a1-b675-2da02bbf3bee"
      unitRef="usd">9148000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if80200fe052042f58072c2a346401da5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNS03LTEtMS03MDM2Mw_068b84cc-0498-47cc-9413-36464faead5f"
      unitRef="usd">27088000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibe28dcb0adc145abbec6cb9c3accca38_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNS05LTEtMS03MDM2Mw_a9b4a507-b26f-4277-b286-a90fcbb706fd"
      unitRef="usd">-178000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i3dffb789514e442d91844bfa2454ef52_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNS0xMS0xLTEtNzAzNjM_b103163c-8abb-4ac1-87dd-d0e4b51237b2"
      unitRef="usd">68000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNS0xMy0xLTEtNzAzNjM_bc3081aa-7b94-4a16-a2e2-94e356ca9231"
      unitRef="usd">36128000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquity
      contextRef="ic8291afc45194b679cb982efb46d0686_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNi03LTEtMS03MDM2Mw_42244242-50f6-414d-9213-650198b362c2"
      unitRef="usd">-23000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0227e2707e394244aed3f2fd57a0e03a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNi0xMy0xLTEtNzAzNjM_e22e21ef-a643-41c0-a438-0d6b6f6784d2"
      unitRef="usd">-23000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i76e906fcfdeb4832b77b338196e38474_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNy0xLTEtMS03MDM2Mw_7a99a140-4a86-4c84-a737-5cd19d13349f"
      unitRef="shares">241800000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i76e906fcfdeb4832b77b338196e38474_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNy0zLTEtMS03MDM2Mw_0ede5f9b-c733-458c-a506-194c49042e48"
      unitRef="usd">2000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib0197b6d912c4e2c944e0737a73738ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNy01LTEtMS03MDM2Mw_46ff1f05-36c3-4678-999e-f1ea8c83d799"
      unitRef="usd">9148000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9c5ee8ddad2f413fa5b819e04a12bc1e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNy03LTEtMS03MDM2Mw_9b781994-4d89-403f-8670-a5190818cd03"
      unitRef="usd">27065000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibe28dcb0adc145abbec6cb9c3accca38_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNy05LTEtMS03MDM2Mw_4cfb1796-fd6b-4e70-808d-81bc66904da0"
      unitRef="usd">-178000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i3dffb789514e442d91844bfa2454ef52_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNy0xMS0xLTEtNzAzNjM_b103163c-8abb-4ac1-87dd-d0e4b51237b2"
      unitRef="usd">68000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8d548577ea164af88a7545c8710fbb5d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfNy0xMy0xLTEtNzAzNjM_a33d66a5-d2c4-49cc-b8f9-b90dfa120a03"
      unitRef="usd">36105000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i6a7c1fc826a441d7bce0a7af3b9d916c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfOC03LTEtMS03MDM2Mw_1a2c367e-3d9f-4b70-b067-caa3fdde87f1"
      unitRef="usd">1805000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i1f1b74a9d46a4c919ed5a0017b50fe3c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfOC0xMS0xLTEtNzAzNjM_4017e767-2047-47ae-ab40-c0523170a369"
      unitRef="usd">-10000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfOC0xMy0xLTEtNzAzNjM_8e6247f5-92d1-4cff-a6ab-8eaa80a0a6a6"
      unitRef="usd">1795000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iab76c5a7b7904191b99afa7db58ad7f2_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfOS05LTEtMS03MDM2Mw_323493b9-0a47-4d69-9258-7e6649406fec"
      unitRef="usd">-1058000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i1f1b74a9d46a4c919ed5a0017b50fe3c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfOS0xMS0xLTEtNzAzNjM_5000b216-eb99-40a3-98ec-8ba935aeba3f"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfOS0xMy0xLTEtNzAzNjM_ed0be1d6-720b-4d20-8b4c-4231f1396c4a"
      unitRef="usd">-1063000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <elv:NoncontrollingInterestPeriodIncreaseDecrease
      contextRef="i1f1b74a9d46a4c919ed5a0017b50fe3c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTItMTEtMS0xLTcwMzYz_cd164c10-9620-4676-bf57-4cd9a7293b1a"
      unitRef="usd">3000000</elv:NoncontrollingInterestPeriodIncreaseDecrease>
    <elv:NoncontrollingInterestPeriodIncreaseDecrease
      contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTItMTMtMS0xLTcwMzYz_50ff4ae6-5a79-42f5-84a7-22949edbe188"
      unitRef="usd">3000000</elv:NoncontrollingInterestPeriodIncreaseDecrease>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="iedbdb762566945d88726ef37a57f9349_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTMtMS0xLTEtNzAzNjM_b68a1b4d-b5ab-495b-97e4-d2001a0ef0d5"
      unitRef="shares">1200000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i2eb86bcfdff541038fc2cecb77088e6d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTMtNS0xLTEtNzAzNjM_d441d75d-ed66-430c-b005-d0e9d8c7cc06"
      unitRef="usd">45000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i6a7c1fc826a441d7bce0a7af3b9d916c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTMtNy0xLTEtNzAzNjM_6dc6a853-cc87-4d3c-b29e-1c35d0dfc2e9"
      unitRef="usd">500000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTMtMTMtMS0xLTcwMzYz_5d8a0e00-01ae-45c2-b721-15904c2e0074"
      unitRef="usd">545000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:DividendsCommonStock
      contextRef="i6a7c1fc826a441d7bce0a7af3b9d916c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTQtNy0xLTEtNzAzNjM_9c536f59-10d0-4369-84d2-22ff31425b46"
      unitRef="usd">312000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTQtMTMtMS0xLTcwMzYz_c0a68609-d4c1-4a64-8858-ff31655bd9ac"
      unitRef="usd">312000000</us-gaap:DividendsCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="iedbdb762566945d88726ef37a57f9349_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTUtMS0xLTEtNzAzNjM_8b4ed2c7-1284-4809-9fbd-20fb96ed77f0"
      unitRef="shares">500000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2eb86bcfdff541038fc2cecb77088e6d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTUtNS0xLTEtNzAzNjM_1a978fcb-7552-4760-b531-ced4408bba26"
      unitRef="usd">39000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTUtMTMtMS0xLTcwMzYz_610b8cb1-538b-490e-a772-e7f5fe99886f"
      unitRef="usd">39000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments
      contextRef="i2eb86bcfdff541038fc2cecb77088e6d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTYtNS0xLTEtNzAzNjM_1e3e737e-9836-4d10-a577-6ea89544ce0f"
      unitRef="usd">9000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments
      contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTYtMTMtMS0xLTcwMzYz_496a4436-af2a-4eba-8251-3175fb7281a0"
      unitRef="usd">9000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments>
    <us-gaap:SharesOutstanding
      contextRef="i18c7f78957fb4eb298325eb813673f5d_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTctMS0xLTEtNzAzNjM_deb37648-8501-428c-8e92-329fc9028866"
      unitRef="shares">241100000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i18c7f78957fb4eb298325eb813673f5d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTctMy0xLTEtNzAzNjM_0719c607-73dc-4f5c-af47-f6931036f001"
      unitRef="usd">2000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie3f5943c567e426a969bf7881111eeb8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTctNS0xLTEtNzAzNjM_48b4329a-d422-4c80-b053-1dcdd5c7449f"
      unitRef="usd">9151000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i621d34b256184efca4a6e336041bad02_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTctNy0xLTEtNzAzNjM_129db2c3-88c2-4f0c-9211-bb18001f860c"
      unitRef="usd">28058000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i88a00773c76441adab343709fb0e30d1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTctOS0xLTEtNzAzNjM_3ad5c1f5-82f1-4e39-b2f5-03229df70a9e"
      unitRef="usd">-1236000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="ibc88fa2fe41a476fa802a9582efda818_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTctMTEtMS0xLTcwMzYz_60879d39-daac-4e98-adce-4bf541d4f69f"
      unitRef="usd">56000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4cbead8991b44f1e8a37f09fb333172d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTctMTMtMS0xLTcwMzYz_f957414e-cb88-4b0f-aea6-6cf919e298c9"
      unitRef="usd">36031000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="iaa8050991ea141e9b2f0cc25ecfbe2d6_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTgtNy0xLTEtNzAzNjM_81cb30d4-d9d1-4146-8abf-4b4a82b7daf5"
      unitRef="usd">1653000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i235ece1dc7f94255b99200f736f634e0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTgtMTEtMS0xLTcwMzYz_3d5da46c-a549-4ca6-84bc-23861ad9277b"
      unitRef="usd">-3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTgtMTMtMS0xLTcwMzYz_7a54279e-be15-4966-9152-0cc633b3c488"
      unitRef="usd">1650000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8bd5ffed39c44ee5bf9209ae6a1336e6_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTktOS0xLTEtNzAzNjM_a12ed51d-883d-434a-8e69-4f71a88a1b64"
      unitRef="usd">-913000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i235ece1dc7f94255b99200f736f634e0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTktMTEtMS0xLTcwMzYz_6140d397-193c-4841-b8a7-60ee37309ae1"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMTktMTMtMS0xLTcwMzYz_59172a88-84c6-4361-ab68-09b4da00088e"
      unitRef="usd">-916000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <elv:NoncontrollingInterestPeriodIncreaseDecrease
      contextRef="i235ece1dc7f94255b99200f736f634e0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjAtMTEtMS0xLTcwMzYz_bf47a5ac-a1c3-467c-9410-1fb6f097ddd2"
      unitRef="usd">5000000</elv:NoncontrollingInterestPeriodIncreaseDecrease>
    <elv:NoncontrollingInterestPeriodIncreaseDecrease
      contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjAtMTMtMS0xLTcwMzYz_f99433d6-bec8-47d7-856c-36994aa77900"
      unitRef="usd">5000000</elv:NoncontrollingInterestPeriodIncreaseDecrease>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="ic32281f0fb4a46c1bd7c7cf96160ceac_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjMtMS0xLTEtNzAzNjM_6240aea2-f360-4ba9-9c43-f91a0923f219"
      unitRef="shares">1300000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i93a6de0ab799413e882ff2eac44ac62c_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjMtNS0xLTEtNzAzNjM_19b9b0d2-3660-4ede-ad27-08b8a469788f"
      unitRef="usd">48000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="iaa8050991ea141e9b2f0cc25ecfbe2d6_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjMtNy0xLTEtNzAzNjM_d229d4d4-5b6b-449d-a9a6-989ceaa46401"
      unitRef="usd">576000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjMtMTMtMS0xLTcwMzYz_9a950e4c-30c4-46b7-8967-c4a4e1ffd8dc"
      unitRef="usd">624000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:DividendsCommonStock
      contextRef="iaa8050991ea141e9b2f0cc25ecfbe2d6_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjQtNy0xLTEtNzAzNjM_0929d02c-e36d-41cd-bc24-a423a6348831"
      unitRef="usd">310000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjQtMTMtMS0xLTcwMzYz_bf757cd2-3fa0-4acd-8ac9-d9401ca46838"
      unitRef="usd">310000000</us-gaap:DividendsCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ic32281f0fb4a46c1bd7c7cf96160ceac_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjUtMS0xLTEtNzAzNjM_999fa1d2-895d-4b4b-a7b5-2813803f4702"
      unitRef="shares">200000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i93a6de0ab799413e882ff2eac44ac62c_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjUtNS0xLTEtNzAzNjM_7a831dab-ed84-4ead-9375-0a5fa9baf85a"
      unitRef="usd">111000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjUtMTMtMS0xLTcwMzYz_65b0d53c-3efb-40a6-9a1e-8a5574b47ab9"
      unitRef="usd">111000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments
      contextRef="i93a6de0ab799413e882ff2eac44ac62c_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjYtNS0xLTEtNzAzNjM_edb7bb40-fb36-4561-abac-cb4b8202571b"
      unitRef="usd">-80000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments
      contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjYtMTMtMS0xLTcwMzYz_a891d44c-60f1-4831-a44a-109948909bb0"
      unitRef="usd">-80000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments>
    <us-gaap:SharesOutstanding
      contextRef="i25fd263bfa4b408cb320d07c5b039a60_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjgtMS0xLTEtNzAzNjM_1d7e959c-251c-43ef-977f-fdf53b2fadb1"
      unitRef="shares">240000000.0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i25fd263bfa4b408cb320d07c5b039a60_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjgtMy0xLTEtNzAzNjM_76739f4a-65a2-4133-a444-1a212d580d9b"
      unitRef="usd">2000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8c004427a7414fc8897f44bcaea19bf9_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjgtNS0xLTEtNzAzNjM_6fabf038-732a-4001-8f39-b552be66b733"
      unitRef="usd">9134000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i754312c63f4847bda9a7fff60f065564_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjgtNy0xLTEtNzAzNjM_02e3a019-d3bd-4587-a05e-74689d323c72"
      unitRef="usd">28825000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3cdce901c495496b82564eaa2135b662_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjgtOS0xLTEtNzAzNjM_69f95a52-635f-4fac-a0b6-17a445befbbc"
      unitRef="usd">-2149000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i86841404e36945a0a2b5a2801b6585e3_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjgtMTEtMS0xLTcwMzYz_a6cdb6ad-34cd-4e6f-a617-f07e45a29742"
      unitRef="usd">55000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia0a535c1ffe84e6da717792a25f25e09_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjgtMTMtMS0xLTcwMzYz_0312384b-659c-4274-bc0c-c021351c37c6"
      unitRef="usd">35867000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i65acda5bd384478ba43ea184238b1adb_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjktNy0xLTEtNzAzNjM_c4bf6fea-58a9-4584-a180-00e7ba183633"
      unitRef="usd">1618000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i8b8abccde0624b77a8a1712e55378767_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjktMTEtMS0xLTcwMzYz_13b91e72-6128-4dd1-bc6e-ef989fe3f38c"
      unitRef="usd">-5000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMjktMTMtMS0xLTcwMzYz_0444eedb-1e6c-4eb5-a550-130b59c2e63c"
      unitRef="usd">1613000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i205ff9c272f244b9a2a2473a5d2d0aa2_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzAtOS0xLTEtNzAzNjM_b27cb043-c772-40ab-bf0c-e3c8d1897d4e"
      unitRef="usd">-635000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i8b8abccde0624b77a8a1712e55378767_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzAtMTEtMS0xLTcwMzYz_50411e5d-5a62-490f-b26f-ee42503bfa30"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzAtMTMtMS0xLTcwMzYz_ab0e6914-b965-4d95-a720-63093282973a"
      unitRef="usd">-638000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <elv:NoncontrollingInterestPeriodIncreaseDecrease
      contextRef="i8b8abccde0624b77a8a1712e55378767_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzEtMTEtMS0xLTcwMzYz_0f68a1d0-21b3-43eb-89c4-df9d941572e1"
      unitRef="usd">5000000</elv:NoncontrollingInterestPeriodIncreaseDecrease>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzEtMTMtMS0xLTcwMzYz_d83626ad-2735-44a5-99d8-ab8bf1e18f5b"
      unitRef="usd">5000000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i15035aec9b66494a932fa4d9f722665b_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzQtMS0xLTEtNzAzNjM_0582aa9a-ebd0-4b91-8e10-65db34d209be"
      unitRef="shares">1200000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i2f7b2e2c4f76452991af9030ab9b7ec1_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzQtNS0xLTEtNzAzNjM_04901c20-0cca-42ec-a55f-984add25e920"
      unitRef="usd">47000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i65acda5bd384478ba43ea184238b1adb_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzQtNy0xLTEtNzAzNjM_a9d06089-c5f5-44f5-b4c5-27cd365ded61"
      unitRef="usd">532000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzQtMTMtMS0xLTcwMzYz_727ffcc4-7d36-4975-82be-127a8d78de3f"
      unitRef="usd">579000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:DividendsCommonStock
      contextRef="i65acda5bd384478ba43ea184238b1adb_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzUtNy0xLTEtNzAzNjM_2c10b7e5-0aa1-4712-bba1-299b81663b0a"
      unitRef="usd">307000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzUtMTMtMS0xLTcwMzYz_8a97dcdd-f41a-4119-98bd-376ed242e486"
      unitRef="usd">307000000</us-gaap:DividendsCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i15035aec9b66494a932fa4d9f722665b_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzYtMS0xLTEtNzAzNjM_c0b6a367-0298-4956-94af-fde24c6cfde3"
      unitRef="shares">200000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2f7b2e2c4f76452991af9030ab9b7ec1_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzYtNS0xLTEtNzAzNjM_64e0eba1-71a7-451a-8733-bd699429d6e5"
      unitRef="usd">103000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzYtMTMtMS0xLTcwMzYz_b501ec45-f515-4a97-8d83-6aab02c6ff50"
      unitRef="usd">103000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments
      contextRef="i2f7b2e2c4f76452991af9030ab9b7ec1_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzctNS0xLTEtNzAzNjM_c420276e-aba1-413a-b4c3-0e0ff175ba0f"
      unitRef="usd">-21000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzctMTMtMS0xLTcwMzYz_ace6ec2c-680b-4cff-811b-bf077a23f0e5"
      unitRef="usd">-21000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments>
    <us-gaap:SharesOutstanding
      contextRef="i8a417cc9e3284886a04a57fe479fce58_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzktMS0xLTEtNzAzNjM_e2aff9a2-6ba4-4096-90a3-e1cbdc5272cc"
      unitRef="shares">239000000.0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i8a417cc9e3284886a04a57fe479fce58_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzktMy0xLTEtNzAzNjM_afa3cb50-fe5f-4f30-a2f0-6ea4d9851f3f"
      unitRef="usd">2000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iae11bd779d7e4ef58f1fb3d8564575a0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzktNS0xLTEtNzAzNjM_932c3596-f692-4231-a894-ce182e4a0560"
      unitRef="usd">9169000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i38ec61ed676c4597b3ce8d3bb80f93a4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzktNy0xLTEtNzAzNjM_aeef03a8-af05-4f27-a576-48e80b4316b0"
      unitRef="usd">29604000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if2cbc4d0d7964a2681d5c5fa0021cf8b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzktOS0xLTEtNzAzNjM_7666c8dd-7bca-492d-8c0e-90342081e9e2"
      unitRef="usd">-2784000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="ic8e22949ca024e19a7be910f7fb72de0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzktMTEtMS0xLTcwMzYz_a56728f8-6dd3-4e5b-b67e-da3696173540"
      unitRef="usd">52000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjc0NTY0Yzc2YmIyYTQ1ZWU5ZWRiM2VhZjMzZTY1ZWE2L3RhYmxlcmFuZ2U6NzQ1NjRjNzZiYjJhNDVlZTllZGIzZWFmMzNlNjVlYTZfMzktMTMtMS0xLTcwMzYz_65fa22bc-438c-460c-b13c-2ca53fe33847"
      unitRef="usd">36043000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i9bcdceadaae34b568b184717c1feb64d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfNi0xLTEtMS03MDM2Mw_57bda2ac-cf5e-417c-90ca-9b989b3e20eb"
      unitRef="shares">245400000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i9bcdceadaae34b568b184717c1feb64d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfNi0zLTEtMS03MDM2Mw_c119b623-d4ef-42d5-ad80-5b131622bd22"
      unitRef="usd">3000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i40273135b4c443249ac1e3576b1f8880_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfNi01LTEtMS03MDM2Mw_c74af2a4-8fad-419b-a2d1-1a71add186e8"
      unitRef="usd">9244000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i34ca5d23dd9d4c319c952057c4c553af_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfNi03LTEtMS03MDM2Mw_9fabf912-d43a-4d38-819a-b24646ea306a"
      unitRef="usd">23802000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1636ce35b3f44cc59d3c0058be2140e7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfNi05LTEtMS03MDM2Mw_bbeac06d-4246-432c-a0c5-b214a1a15833"
      unitRef="usd">150000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i43c107c4cc114c2994db1a2d71a9a4a9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfNi0xMS0xLTEtNzAzNjM_957c8cdc-6226-4621-8176-5b9dde63e5b7"
      unitRef="usd">0</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia2cd31b0b2f047d489ecdade092e7658_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfNi0xMy0xLTEtNzAzNjM_3e51eecb-b818-413d-b14e-825cbdabc3c2"
      unitRef="usd">33199000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i3fe61236f9a84e4fb0548f191cf989dd_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfNy03LTEtMS03MDM2Mw_05dda133-d1e3-4335-ab0e-af131c7a9a1d"
      unitRef="usd">1665000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i22199380ce254d5e8f1a20db003d38e1_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfNy0xMS0xLTEtNzAzNjM_a954a059-73e7-4a2c-8e02-f7c1741bc1e9"
      unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfNy0xMy0xLTEtNzAzNjM_45b8a857-268a-4a20-a256-4f712cc878b5"
      unitRef="usd">1667000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i46b2d401ea4a43a8b53425d8ac39c3cc_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfOC05LTEtMS03MDM2Mw_0406c18e-b3bc-41b7-a84b-44f335940626"
      unitRef="usd">-345000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i22199380ce254d5e8f1a20db003d38e1_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfOC0xMS0xLTEtNzAzNjM_98c72e14-4da0-4ee3-b905-86d4f49159d3"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfOC0xMy0xLTEtNzAzNjM_9e4b5319-c6a1-4556-91f5-0bf4852782e5"
      unitRef="usd">-347000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <elv:NoncontrollingInterestPeriodIncreaseDecrease
      contextRef="i22199380ce254d5e8f1a20db003d38e1_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfOS0xMS0xLTEtNzAzNjM_b18d8fb8-1a3e-4acd-9628-09e37e126a90"
      unitRef="usd">65000000</elv:NoncontrollingInterestPeriodIncreaseDecrease>
    <elv:NoncontrollingInterestPeriodIncreaseDecrease
      contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfOS0xMy0xLTEtNzAzNjM_03f71477-7f2b-4dc6-a0fc-52ef13892d55"
      unitRef="usd">65000000</elv:NoncontrollingInterestPeriodIncreaseDecrease>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i90fc51345bd34cceaa9d7388a64ab064_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTAtMS0xLTEtNzAzNjM_a3d52942-9e2a-417e-9544-2abb3dc65a3a"
      unitRef="shares">1400000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i90fc51345bd34cceaa9d7388a64ab064_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTAtMy0xLTEtNzAzNjM_21142a5c-957b-4e5f-be44-101d0e8fa190"
      unitRef="usd">1000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i32778a5cba784b46a29f834b6b7d8ffd_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTAtNS0xLTEtNzAzNjM_f742a97a-697c-410e-926f-2849ca650cb1"
      unitRef="usd">53000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i3fe61236f9a84e4fb0548f191cf989dd_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTAtNy0xLTEtNzAzNjM_5f182f22-6ee1-4e8d-850c-715a04c02877"
      unitRef="usd">393000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTAtMTMtMS0xLTcwMzYz_72676e0c-2bbd-4183-929c-1a8f76b2a08f"
      unitRef="usd">447000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:DividendsCommonStock
      contextRef="i3fe61236f9a84e4fb0548f191cf989dd_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTEtNy0xLTEtNzAzNjM_9869e9f2-6967-4f30-978c-fae717871f29"
      unitRef="usd">281000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTEtMTMtMS0xLTcwMzYz_6a361749-a73b-48f1-bc9e-058c3e7a1af3"
      unitRef="usd">281000000</us-gaap:DividendsCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i90fc51345bd34cceaa9d7388a64ab064_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTItMS0xLTEtNzAzNjM_70c399c1-652e-45de-8b7e-72cbc568dfe6"
      unitRef="shares">900000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i32778a5cba784b46a29f834b6b7d8ffd_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTItNS0xLTEtNzAzNjM_54df4f0c-4351-41fc-b71c-f39eae230c48"
      unitRef="usd">62000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTItMTMtMS0xLTcwMzYz_0042bc7f-01ed-4a34-9fcf-3f62131a66ff"
      unitRef="usd">62000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:SharesOutstanding
      contextRef="ia3596a4a5edf4aca9700a1210c5e82cb_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTQtMS0xLTEtNzAzNjM_99ebf2d8-03e3-4ae1-97f8-e85e8b8b092b"
      unitRef="shares">244900000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ia3596a4a5edf4aca9700a1210c5e82cb_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTQtMy0xLTEtNzAzNjM_24ba610d-e9af-4977-9e78-b3a306a04e1c"
      unitRef="usd">2000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibb48a1922b7e435cb7c30da74d59221f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTQtNS0xLTEtNzAzNjM_fb11b625-ad35-4bc6-ac28-8ba0e50d648a"
      unitRef="usd">9253000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i62d7a38b20f74260a57c7b27f73b7906_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTQtNy0xLTEtNzAzNjM_682bb275-b665-46fa-928b-34f9ea34ae18"
      unitRef="usd">24793000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id2573eaa31b44cd6abfa3facbdb6292a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTQtOS0xLTEtNzAzNjM_54bff426-4af7-4f22-8762-fbfc6af9e50a"
      unitRef="usd">-195000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i3cfb30e0735e44c5aa78cf9d1eb3d3a8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTQtMTEtMS0xLTcwMzYz_ebb0b6e6-5c7b-4131-81fa-c2b75c876460"
      unitRef="usd">65000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i23a4bf41cfe343828c4306abe17a0154_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTQtMTMtMS0xLTcwMzYz_3d813677-b3af-415e-9694-55e5d1a4b2c7"
      unitRef="usd">33918000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i68316ab96a734ae2b0f2dd2591bf303f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTUtNy0xLTEtNzAzNjM_8eb895ef-7c1e-4033-be08-20c344e67c59"
      unitRef="usd">1793000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i8fb01790dc8947cc9fa28938b654f73f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTUtMTEtMS0xLTcwMzYz_20d598f0-f73b-4fb9-b9cd-f2da8971d6a7"
      unitRef="usd">8000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTUtMTMtMS0xLTcwMzYz_d905d9d3-e48a-4801-aeea-d5e12cfdeaaa"
      unitRef="usd">1801000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="id1c5b423fd0049679c05d61c789fee90_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTYtOS0xLTEtNzAzNjM_37c6b770-e6b8-4942-b44b-938b553dfcf4"
      unitRef="usd">178000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i8fb01790dc8947cc9fa28938b654f73f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTYtMTEtMS0xLTcwMzYz_3a760008-402e-4373-9f54-b5e59a0d304c"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTYtMTMtMS0xLTcwMzYz_ad13d601-011a-45ad-a0a4-53a88e7e7b76"
      unitRef="usd">180000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <elv:NoncontrollingInterestPeriodIncreaseDecrease
      contextRef="i8fb01790dc8947cc9fa28938b654f73f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTctMTEtMS0xLTcwMzYz_ff87d7bf-3aea-4bf3-a0da-11df20465996"
      unitRef="usd">3000000</elv:NoncontrollingInterestPeriodIncreaseDecrease>
    <elv:NoncontrollingInterestPeriodIncreaseDecrease
      contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTctMTMtMS0xLTcwMzYz_ac593ad3-95a4-45aa-b974-4f45ffad62ba"
      unitRef="usd">3000000</elv:NoncontrollingInterestPeriodIncreaseDecrease>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i0d28810bc7644f938e65b4df5ea870b9_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTktMS0xLTEtNzAzNjM_4c00df5d-4e71-4481-8ce0-6fbdabae3f7d"
      unitRef="shares">1300000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i0d28810bc7644f938e65b4df5ea870b9_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTktMy0xLTEtNzAzNjM_9cd5d10d-5e19-461a-8030-c38529814f0f"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ib068c2f2d2f9451e85b8ebefd20a58b9_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTktNS0xLTEtNzAzNjM_9b94ca12-c936-47a5-9b43-b5942e2dafe3"
      unitRef="usd">47000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i68316ab96a734ae2b0f2dd2591bf303f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTktNy0xLTEtNzAzNjM_df6ca11f-40df-412c-b918-cb97c3308d06"
      unitRef="usd">433000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMTktMTMtMS0xLTcwMzYz_63078fba-9ae8-4714-a034-14741cf680d0"
      unitRef="usd">480000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:DividendsCommonStock
      contextRef="i68316ab96a734ae2b0f2dd2591bf303f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjAtNy0xLTEtNzAzNjM_00ae1046-90d0-4d5d-bfbe-8bca027848a1"
      unitRef="usd">279000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjAtMTMtMS0xLTcwMzYz_9aeb0b76-4e25-4666-a7bc-9d4f7c57bbab"
      unitRef="usd">279000000</us-gaap:DividendsCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i0d28810bc7644f938e65b4df5ea870b9_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjEtMS0xLTEtNzAzNjM_bc705f74-cf6c-41e1-ba89-9c73f2bb571e"
      unitRef="shares">300000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib068c2f2d2f9451e85b8ebefd20a58b9_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjEtNS0xLTEtNzAzNjM_20387bf5-079d-433c-866e-6e9125b26689"
      unitRef="usd">119000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjEtMTMtMS0xLTcwMzYz_9bf72abb-7271-47d5-b8bd-7d9e3fb17426"
      unitRef="usd">119000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments
      contextRef="ib068c2f2d2f9451e85b8ebefd20a58b9_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjItNS0xLTEtNzAzNjM_169b2736-c988-4864-a11a-4841ccfaf5b0"
      unitRef="usd">-216000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments
      contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjItMTMtMS0xLTcwMzYz_59b13b48-b586-40c0-8971-9d3637c90495"
      unitRef="usd">-216000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments>
    <us-gaap:SharesOutstanding
      contextRef="i12e2179304f94f76a1f8fa22e0c596d7_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjQtMS0xLTEtNzAzNjM_cc1c8033-4a80-488e-9cc1-603eb1e1e9ab"
      unitRef="shares">243900000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i12e2179304f94f76a1f8fa22e0c596d7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjQtMy0xLTEtNzAzNjM_7162ddd0-5524-4f23-9c89-ebaa100d7c7f"
      unitRef="usd">2000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if71d617a922b4549a876a2aeb86d0fb3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjQtNS0xLTEtNzAzNjM_6ac4b7e0-f1e5-4350-b6df-0bcc3b109612"
      unitRef="usd">9109000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i58e67abfbcd74df68e8cc1c6309c6fa7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjQtNy0xLTEtNzAzNjM_88d6c83e-c96a-4760-8523-580e45910529"
      unitRef="usd">25874000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifa6a2ab38f55454590fbcb0d8bf0cb81_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjQtOS0xLTEtNzAzNjM_aecbfa1e-1b52-4ad7-8077-29339277688f"
      unitRef="usd">-17000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i8ad7dc64de9f4333a507db7171be2b9f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjQtMTEtMS0xLTcwMzYz_5c8fe8cf-fbbd-446c-ad74-77614c22ebce"
      unitRef="usd">78000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idd7bbc6ac8054bf59b507514156a792b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjQtMTMtMS0xLTcwMzYz_7be85060-8bc8-4194-acba-03c73c9aa32c"
      unitRef="usd">35046000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i89e5268adb4e41acac42b6e71ed6a956_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjUtNy0xLTEtNzAzNjM_03860f59-ef44-43ac-bb63-f7e0d782eace"
      unitRef="usd">1509000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i8ce5dd3a2a6441349bc5e6572d8958ca_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjUtMTEtMS0xLTc3NDQ4_df8379d8-13f1-4e3c-b34e-03a3d6ebc074"
      unitRef="usd">-7000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjUtMTMtMS0xLTcwMzYz_8f72eafd-0459-4735-a6ac-65c090b9bb41"
      unitRef="usd">1502000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iec47e227732d4b219990442f8321eb49_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjYtOS0xLTEtNzAzNjM_202753fe-632c-4d2c-831e-0cfb8160e903"
      unitRef="usd">-86000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i8ce5dd3a2a6441349bc5e6572d8958ca_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjYtMTEtMS0xLTc3NDUx_388de8e5-40a2-4a4f-9d8c-752aa0a0df57"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjYtMTMtMS0xLTcwMzYz_b01c395d-28df-444f-a0ef-7861a32b37d1"
      unitRef="usd">-87000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <elv:NoncontrollingInterestPeriodIncreaseDecrease
      contextRef="i8ce5dd3a2a6441349bc5e6572d8958ca_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjctMTEtMS0xLTc3NDUz_041b3169-cc85-487d-8474-f36c5763b524"
      unitRef="usd">1000000</elv:NoncontrollingInterestPeriodIncreaseDecrease>
    <elv:NoncontrollingInterestPeriodIncreaseDecrease
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjctMTMtMS0xLTcwMzYz_c0577fda-1a66-4f24-a2b9-1a597e37b9ef"
      unitRef="usd">1000000</elv:NoncontrollingInterestPeriodIncreaseDecrease>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i72cc3c90ae37402bb1a3406ca8ec8281_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjktMS0xLTEtNzAzNjM_0efa336f-5725-49d8-b45d-a192af5af372"
      unitRef="shares">1200000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i72cc3c90ae37402bb1a3406ca8ec8281_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjktMy0xLTEtNzAzNjM_6ba1b529-a0d1-4686-8d28-b60b67aa6a20"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i50902a61a4dd4c3abe12641611a989d0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjktNS0xLTEtNzAzNjM_6685c2a1-e994-4bb5-83a2-fb420a29d541"
      unitRef="usd">44000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i89e5268adb4e41acac42b6e71ed6a956_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjktNy0xLTEtNzAzNjM_02582152-8762-45fb-a747-369018ebc9ef"
      unitRef="usd">407000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMjktMTMtMS0xLTcwMzYz_1fee2d42-0250-4f63-9da1-72c916426bf8"
      unitRef="usd">451000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:DividendsCommonStock
      contextRef="i89e5268adb4e41acac42b6e71ed6a956_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzAtNy0xLTEtNzAzNjM_1176915b-5733-4228-af06-671a286bcc09"
      unitRef="usd">276000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzAtMTMtMS0xLTcwMzYz_b8ca8d02-8faf-4a24-9cc1-b701bb905453"
      unitRef="usd">276000000</us-gaap:DividendsCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i72cc3c90ae37402bb1a3406ca8ec8281_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzEtMS0xLTEtNzAzNjM_095a524a-72fd-41b0-99f5-0e17b2c12a2a"
      unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i50902a61a4dd4c3abe12641611a989d0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzEtNS0xLTEtNzAzNjM_a78445c5-936b-4ae2-86c5-f08a77da847d"
      unitRef="usd">75000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzEtMTMtMS0xLTcwMzYz_e9345665-a525-4144-9a3c-b3fa51a1f474"
      unitRef="usd">75000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments
      contextRef="i50902a61a4dd4c3abe12641611a989d0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzItNS0xLTEtNzAzNjM_9384abe5-119e-43aa-9f55-f1a99cb4c33f"
      unitRef="usd">-2000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzItMTMtMS0xLTcwMzYz_e189f4d2-d5f9-482c-a1e0-36c4a435ce04"
      unitRef="usd">-2000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments>
    <us-gaap:SharesOutstanding
      contextRef="i07b85a9cf8364984ad848fb7ac29fcc6_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzMtMS0xLTEtNzAzNjM_fd87de62-8849-4145-9b07-a332ac725b88"
      unitRef="shares">242800000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i07b85a9cf8364984ad848fb7ac29fcc6_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzMtMy0xLTEtNzAzNjM_cedfa0ec-d9fb-43f8-a4ab-f3d9a3a5969b"
      unitRef="usd">2000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8e1170d9414d4932b37104a99abbfcd7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzMtNS0xLTEtNzAzNjM_365a1dbb-8543-4b7c-b3c6-d4249a8cf02e"
      unitRef="usd">9138000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iad1b58d99a92454aaecc9a643c16c0c1_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzMtNy0xLTEtNzAzNjM_3b15b03f-8184-49af-a697-bba421423491"
      unitRef="usd">26700000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id08298fdd1324292a7e56ccb4754a37f_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzMtOS0xLTEtNzAzNjM_5a55c149-4463-42ab-9ad3-e6dce514930b"
      unitRef="usd">-103000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i5d2e1c82b14b435aa3b898cd3e04de1b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzItMTEtMS0xLTc3NTI3_59d0a261-79fd-4dd0-8065-a16c3097cd83"
      unitRef="usd">71000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquity
      contextRef="id7580839926f4e24b08f10312dd69479_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zMS9mcmFnOmU2ZWNjYWQ3ZTcwNDQ5N2Y4NWMwNzNmMWY0NTg1MzI0L3RhYmxlOjg5MWUxYmNhMDBjMDQ3NzZhNzc1N2ZlYWQ1ZDc0MmFlL3RhYmxlcmFuZ2U6ODkxZTFiY2EwMGMwNDc3NmE3NzU3ZmVhZDVkNzQyYWVfMzMtMTMtMS0xLTcwMzYz_7777d776-e1bd-45a1-8b28-dff5a05e344d"
      unitRef="usd">35808000000</us-gaap:StockholdersEquity>
    <us-gaap:NatureOfOperations
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zNy9mcmFnOjc4NWU5Zjk1ZTZhZDQyMDdhYTk4OTdjZmM5ZDZmNWJiL3RleHRyZWdpb246Nzg1ZTlmOTVlNmFkNDIwN2FhOTg5N2NmYzlkNmY1YmJfNDA1NA_a9694de4-7d63-453d-bd9a-8cf909decafa">Organization&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 18, 2022, our shareholders approved a proposal to amend our amended and restated articles of incorporation to change our name from Anthem, Inc. to Elevance Health, Inc. This amendment and name change went into effect on June 27, 2022. We began operating as Elevance Health, Inc. and trading under our new ticker symbol &#x201c;ELV&#x201d; on June 28, 2022. References to the terms &#x201c;we,&#x201d; &#x201c;our,&#x201d; &#x201c;us&#x201d; or &#x201c;Elevance Health&#x201d; used throughout these Notes to Consolidated Financial Statements refer to Elevance Health, Inc., an Indiana corporation, and unless the context otherwise requires, its direct and indirect subsidiaries. References to the &#x201c;states&#x201d; include the District of Columbia and Puerto Rico, unless the context otherwise requires.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Elevance Health is a health company with the purpose of improving the health of humanity. We are the largest health insurer in the United States in terms of medical membership, serving over 47 million medical members through our affiliated health plans as of September&#160;30, 2022. We offer a broad spectrum of network-based managed care risk-based plans to Individual, Group, Medicaid and Medicare markets. In addition, we provide a broad array of managed care services to fee-based customers, including claims processing, stop loss insurance, provider network access, medical management, care management and wellness programs, actuarial services and other administrative services. We also provide services to the federal government in connection with our Federal Health Products &amp;amp; Services business, which administers the Federal Employees Health Benefits (&#x201c;FEHB&#x201d;) Program. We provide an array of specialty services both to our subsidiary health plans and also unaffiliated health plans, including pharmacy benefits management (&#x201c;PBM&#x201d;) services and dental, vision, life, disability and supplemental health insurance benefits, as well as integrated health services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are an independent licensee of the Blue Cross and Blue Shield Association (&#x201c;BCBSA&#x201d;), an association of independent health benefit plans. We serve our members as the Blue Cross licensee for California and as the Blue Cross and Blue Shield (&#x201c;BCBS&#x201d;) licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (in the New York City metropolitan area and upstate New York), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.) and Wisconsin. In a majority of these service areas, we do business as Anthem Blue Cross, Anthem Blue Cross and Blue Shield, and Empire Blue Cross Blue Shield or Empire Blue Cross. In addition, we conduct business through arrangements with other BCBS licensees as well as other strategic partners. Through our subsidiaries, we also serve customers in numerous states as AIM Specialty Health, Amerigroup, Aspire Health, Beacon, CareMore, Freedom Health, HealthLink, HealthSun, Integra Managed Care, MMM, Optimum HealthCare, Simply Healthcare, and/or UniCare. We offer PBM services through our IngenioRx, Inc. (&#x201c;IngenioRx&#x201d;) subsidiary. We are licensed to conduct insurance operations in all 50 states, the District of Columbia and Puerto Rico through our subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of our name change to Elevance Health, on June 15, 2022 we announced that over the next several years we will organize our brand portfolio into the following core go-to-market brands:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Anthem Blue Cross/Anthem Blue Cross and Blue Shield &#x2014; represents our existing Anthem-branded and affiliated Blue Cross and/or Blue Shield licensed plans;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Wellpoint &#x2014; we intend to unite select non-BCBSA licensed Medicare, Medicaid and Commercial plans under the Wellpoint name; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Carelon &#x2014; this brand will bring together our healthcare brands and capabilities, including our Diversified Business Group and IngenioRx business under a single brand name. We now refer to our Diversified Business Group as Carelon. In January 2023, IngenioRx will become CarelonRx.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There are currently no segment changes associated with this branding strategy. Our branding strategy reflects the evolution of our business from a traditional health insurance company to a lifetime, trusted health partner, and given this evolution we are in the process of reviewing and modifying how we will manage our businesses in the future.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <elv:NumberOfMedicalMembersServed
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zNy9mcmFnOjc4NWU5Zjk1ZTZhZDQyMDdhYTk4OTdjZmM5ZDZmNWJiL3RleHRyZWdpb246Nzg1ZTlmOTVlNmFkNDIwN2FhOTg5N2NmYzlkNmY1YmJfOTQ1_c5b46c45-97b6-4b93-b7fb-d28512566499"
      unitRef="medical_member">47000000</elv:NumberOfMedicalMembersServed>
    <elv:NumberOfCountiesInStateOfKansasCompanyDoesNotServe
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zNy9mcmFnOjc4NWU5Zjk1ZTZhZDQyMDdhYTk4OTdjZmM5ZDZmNWJiL3RleHRyZWdpb246Nzg1ZTlmOTVlNmFkNDIwN2FhOTg5N2NmYzlkNmY1YmJfMjI0NA_e6897a2e-f099-4741-b744-ef214194ecda"
      unitRef="county">30</elv:NumberOfCountiesInStateOfKansasCompanyDoesNotServe>
    <us-gaap:NumberOfStatesInWhichEntityOperates
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF8zNy9mcmFnOjc4NWU5Zjk1ZTZhZDQyMDdhYTk4OTdjZmM5ZDZmNWJiL3RleHRyZWdpb246Nzg1ZTlmOTVlNmFkNDIwN2FhOTg5N2NmYzlkNmY1YmJfMzE0Mw_61c2cb15-0aa5-4ec4-9c0d-8f0cf853f34e"
      unitRef="states">50</us-gaap:NumberOfStatesInWhichEntityOperates>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTYyNDA_8013aa47-179b-46a6-990e-3311cf3afcdc">Basis of Presentation and Significant Accounting Policies&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;) for interim financial reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for annual financial statements. We have omitted certain footnote disclosures that would substantially duplicate the disclosures in our 2021 Annual Report on Form 10-K, unless the information contained in those disclosures materially changed or is required by GAAP. In the opinion of management, all adjustments, including normal recurring adjustments, necessary for a fair statement of the consolidated financial statements as of and for the three and nine months ended September&#160;30, 2022 and 2021 have been recorded. The results of operations for the three and nine months ended September&#160;30, 2022 are not necessarily indicative of the results that may be expected for the full year ending December&#160;31, 2022, or any other period. The seasonal nature of portions of our health care and related benefits business, competitive and other market conditions, as well as COVID-19 related impacts, may cause full-year results to differ from estimates based upon our interim results of operations. These unaudited consolidated financial statements should be read in conjunction with our audited consolidated financial statements as of and for the year ended December&#160;31, 2021 included in our 2021 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of our subsidiaries operate outside of the United States and have functional currencies other than the U.S. dollar (&#x201c;USD&#x201d;). We translate the assets and liabilities of those subsidiaries to USD using the exchange rate in effect at the end of the period. We translate the revenues and expenses of those subsidiaries to USD using the average exchange rates in effect during the period. The net effect of these translation adjustments is included in &#x201c;Foreign currency translation adjustments&#x201d; in our consolidated statements of comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We control a number of bank accounts that are used exclusively to hold customer funds for the administration of customer benefits and we have cash and cash equivalents on deposit to meet certain regulatory requirements. These amounts totaled $291 and $173 at September&#160;30, 2022 and December&#160;31, 2021, respectively, and are included in the cash and cash equivalents line on our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We classify fixed maturity securities in our investment portfolio as &#x201c;available-for-sale&#x201d; and report those securities at fair value. Certain fixed maturity securities are available to support current operations and, accordingly, we classify such investments as current assets without regard to their contractual maturity. Investments used to satisfy contractual, regulatory or other requirements are classified as long-term, without regard to contractual maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If a fixed maturity security is in an unrealized loss position and we have the intent to sell the fixed maturity security, or it is more likely than not that we will have to sell the fixed maturity security before recovery of its amortized cost basis, we write down the fixed maturity security&#x2019;s cost basis to fair value and record an impairment loss in our consolidated statements of income. For impaired fixed maturity securities that we do not intend to sell or if it is more likely than not that we will not have to sell such securities, but we expect that we will not fully recover the amortized cost basis, we recognize the credit component of the impairment as an allowance for credit loss in our consolidated balance sheets and record an impairment loss in our consolidated statements of income. The non-credit component of the impairment is recognized in accumulated other comprehensive loss. Furthermore, unrealized losses entirely caused by non-credit-related factors related to fixed maturity securities for which we expect to fully recover the amortized cost basis continue to be recognized in accumulated other comprehensive loss. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The credit component of an impairment is determined primarily by comparing the net present value of projected future cash flows with the amortized cost basis of the fixed maturity security. The net present value is calculated by discounting our best estimate of projected future cash flows at the effective interest rate implicit in the fixed maturity security at the date of purchase. For mortgage-backed and asset-backed securities, cash flow estimates are based on assumptions regarding the underlying collateral, including prepayment speeds, vintage, type of underlying asset, geographic concentrations, default rates, recoveries and changes in value. For all other securities, cash flow estimates are driven by assumptions regarding probability of default, including changes in credit ratings and estimates regarding timing and amount of recoveries associated with a default.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For asset-backed securities included in fixed maturity securities, we recognize income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The net investment in the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;securities is adjusted to the amount that would have existed had the new effective yield been applied since the purchase date of the securities. Such adjustments are reported within net investment income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The changes in fair value of our marketable equity securities are recognized in our results of operations within net gains and losses on financial instruments. Certain marketable equity securities are held to satisfy contractual obligations, and are reported under the caption &#x201c;Other invested assets&#x201d; in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have corporate-owned life insurance policies on certain participants in our deferred compensation plans and other members of management. The cash surrender value of the corporate-owned life insurance policies is reported under the caption &#x201c;Other invested assets&#x201d; in our consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use the equity method of accounting for investments in companies in which our ownership interest may enable us to influence the operating or financial decisions of the investee company. Our proportionate share of equity in net income of these unconsolidated affiliates is reported within net investment income. The equity method investments are reported under the caption &#x201c;Other invested assets&#x201d; in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investment income is recorded when earned. All securities sold resulting in investment gains and losses are recorded on the trade date. Realized gains and losses are determined on the basis of the cost or amortized cost of the specific securities sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We participate in securities lending programs whereby marketable securities in our investment portfolio are transferred to independent brokers or dealers in exchange for cash and securities collateral. We recognize the collateral as an asset, which is reported under the caption &#x201c;Other current assets&#x201d; in our consolidated balance sheets, and we record a corresponding liability for the obligation to return the collateral to the borrower, which is reported under the caption &#x201c;Other current liabilities&#x201d; in our consolidated balance sheets. The securities on loan are reported in the applicable investment category on our consolidated balance sheets. Unrealized gains or losses on securities lending collateral are included in accumulated other comprehensive loss as a separate component of shareholders&#x2019; equity. The market value of loaned securities and that of the collateral pledged can fluctuate in non-synchronized fashions.&#160;To the extent the loaned securities&#x2019; value appreciates faster or depreciates slower than the value of the collateral pledged, we are exposed to the risk of the shortfall.&#160;As a primary mitigating mechanism, the loaned securities and collateral pledged are marked to market on a daily basis and the shortfall, if any, is collected accordingly.&#160;Secondarily, the collateral level is set at 102% of the value of the loaned securities, which provides a cushion before any shortfall arises. The investment of the cash collateral is subject to market risk, which is managed by limiting the investments to higher quality and shorter duration instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Receivables:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Receivables are reported net of amounts for expected credit losses. The allowance for doubtful accounts is based on historical collection trends, future forecasts and our judgment regarding the ability to collect specific accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Premium receivables include the uncollected amounts from risk-based groups, individuals and government programs for insurance services. Premium receivables are reported net of an allowance for doubtful accounts of $140 and $142 at September&#160;30, 2022 and December&#160;31, 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Self-funded receivables include administrative fees, claims and other amounts due from fee-based customers for administrative services. Self-funded receivables are reported net of an allowance for doubtful accounts of $82 and $50 at September&#160;30, 2022 and December&#160;31, 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other receivables include pharmacy rebates, provider advances, claims recoveries, reinsurance receivables, proceeds due from brokers on investment trades, accrued investment income, and other miscellaneous amounts due to us. These receivables are reported net of an allowance for doubtful accounts of $709 and $648 at September&#160;30, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; For our non-risk-based contracts, we had no material contract assets, contract liabilities or deferred contract costs&#160;recorded on our consolidated balance sheet at September&#160;30, 2022. For the three and nine months ended September&#160;30, 2022 and 2021, revenue recognized from performance obligations related to prior periods, such as due to changes in transaction price, was not material. For contracts that have an original expected duration of greater than one year, revenue expected to be recognized in future periods related to unfulfilled contractual performance obligations and contracts with variable consideration related to undelivered performance obligations is not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Guidance: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update No. 2021-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2021-01&#x201d;). The amendments in ASU 2021-01 provide optional expedients and exceptions for applying GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;) or another reference rate expected to be discontinued because of the reference rate reform. The provisions must be applied at a Topic, Subtopic, or Industry Subtopic level for all transactions other than derivatives, which may be applied at a hedging relationship level. We adopted ASU 2021-01 on January 7, 2021, and the adoption did not have an impact on our consolidated financial position, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the FASB issued Accounting Standards Update No. 2020-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Codification Improvements to Subtopic 310-20, Receivables&#x2014;Nonrefundable Fees and Other Costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2020-08&#x201d;). The amendments in ASU 2020-08 clarify when an entity should assess whether a callable debt security is within the scope of accounting guidance, which impacts the amortization period for nonrefundable fees and other costs. ASU 2020-08 became effective for interim and annual reporting periods beginning after December 15, 2020. The amendments were to be applied on a prospective basis as of the beginning of the period of adoption for existing or newly purchased callable debt securities. We adopted ASU 2020-08 on January 1, 2021, and the adoption did not have an impact on our consolidated financial position, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued Accounting Standards Update No. 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2020-06&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amendments eliminate two of the three accounting models that require separate accounting for convertible features of debt securities, simplify the contract settlement assessment for equity classification, require the use of the if-converted method for all convertible instruments in the diluted earnings per share calculation and expand disclosure requirements. The amendments became effective for our annual and interim reporting periods beginning after December 15, 2021. We adopted ASU 2020-06 on January 1, 2022 using the modified retrospective transition method, which resulted in an increase to our reported debt outstanding of $31, a decrease to our deferred tax liabilities of $8, and a corresponding cumulative-effect reduction to our opening retained earnings of $23; these amounts are not material to our overall consolidated financial position. The adoption of ASU 2020-06 did not have an impact on our results of operations or our consolidated cash flows. Use of the if-converted method did not have an impact on our overall earnings per share calculation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued Accounting Standards Update No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2019-12&#x201d;). The amendments in ASU 2019-12 remove certain exceptions to the general principles in Accounting Standards Codification Topic 740. The amendments also clarify and amend existing guidance to improve consistent application. The amendments became effective for our annual reporting periods beginning after December 15, 2020. The transition method (retrospective, modified retrospective, or prospective basis) related to the amendments depends on the applicable guidance, and all amendments for which there is no transition guidance specified are to be applied on a prospective basis. We adopted ASU 2019-12 on January 1, 2021, and the adoption did not have an impact on our consolidated financial position, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Guidance Not Yet Adopted: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2020, the FASB issued Accounting Standards Update No. 2020-11,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Financial Services&#x2014;Insurance (Topic 944): Effective Date and Early Application &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2020-11&#x201d;). The amendments in ASU 2020-11 make changes to the effective date and early application of Accounting Standards Update No. 2018-12,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Financial Services&#x2014;Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2018-12&#x201d;), which was issued in November 2018. The amendments in ASU 2020-11 have extended the original effective date by one year, and now the amendments are required for our interim and annual reporting periods beginning after December 15, 2022. The amendments in ASU 2018-12 make changes to a variety of areas to simplify or improve the existing recognition, measurement, presentation and disclosure requirements for long-duration contracts issued by an insurance entity. The amendments require insurers to annually review the assumptions they make about their policyholders and update the liabilities for future policy benefits if the assumptions change. The amendments also simplify the amortization of deferred contract acquisition costs and add new disclosure requirements about the assumptions insurers use to measure their liabilities and how they may affect future cash flows. The amendments related to the liability for future policy benefits for traditional and limited-payment contracts and deferred acquisition costs are to be applied to contracts in force as of the beginning of the earliest period presented, with an option to apply such amendments retrospectively with a cumulative-effect adjustment to the opening balance of retained earnings as of the earliest period presented. The amendments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for market risk benefits are to be applied retrospectively. We do not believe the adoption of ASU 2020-11 and ASU 2018-12 will have a material impact on our consolidated financial position, results of operations, cash flows, and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no other new accounting pronouncements that were issued or became effective since the issuance of our 2021 Annual Report on Form 10-K that had, or are expected to have, a material impact on our consolidated financial position, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTYyMjU_b89989e9-de19-4407-9eaa-be30c2a883a4">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;) for interim financial reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for annual financial statements. We have omitted certain footnote disclosures that would substantially duplicate the disclosures in our 2021 Annual Report on Form 10-K, unless the information contained in those disclosures materially changed or is required by GAAP. In the opinion of management, all adjustments, including normal recurring adjustments, necessary for a fair statement of the consolidated financial statements as of and for the three and nine months ended September&#160;30, 2022 and 2021 have been recorded. The results of operations for the three and nine months ended September&#160;30, 2022 are not necessarily indicative of the results that may be expected for the full year ending December&#160;31, 2022, or any other period. The seasonal nature of portions of our health care and related benefits business, competitive and other market conditions, as well as COVID-19 related impacts, may cause full-year results to differ from estimates based upon our interim results of operations. These unaudited consolidated financial statements should be read in conjunction with our audited consolidated financial statements as of and for the year ended December&#160;31, 2021 included in our 2021 Annual Report on Form 10-K.&lt;/span&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTYyNDc_0abb0ab3-7914-479d-8f1f-1d8b337a81af">Certain of our subsidiaries operate outside of the United States and have functional currencies other than the U.S. dollar (&#x201c;USD&#x201d;). We translate the assets and liabilities of those subsidiaries to USD using the exchange rate in effect at the end of the period. We translate the revenues and expenses of those subsidiaries to USD using the average exchange rates in effect during the period. The net effect of these translation adjustments is included in &#x201c;Foreign currency translation adjustments&#x201d; in our consolidated statements of comprehensive income.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTYyNDE_274f5144-0240-44a3-a0d8-b9f616ec3692">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We control a number of bank accounts that are used exclusively to hold customer funds for the administration of customer benefits and we have cash and cash equivalents on deposit to meet certain regulatory requirements. These amounts totaled $291 and $173 at September&#160;30, 2022 and December&#160;31, 2021, respectively, and are included in the cash and cash equivalents line on our consolidated balance sheets.&lt;/span&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:RestrictedCashAndInvestmentsCurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMjA1Mw_47b5ca11-78ab-4f2f-b1de-e03fcfa0ff0b"
      unitRef="usd">291000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMjA2MA_dbc73ce1-725d-4d7c-b6da-429679d0a7da"
      unitRef="usd">173000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTYyMDk_01d69204-a2fb-403c-ae02-8295cac355eb">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We classify fixed maturity securities in our investment portfolio as &#x201c;available-for-sale&#x201d; and report those securities at fair value. Certain fixed maturity securities are available to support current operations and, accordingly, we classify such investments as current assets without regard to their contractual maturity. Investments used to satisfy contractual, regulatory or other requirements are classified as long-term, without regard to contractual maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If a fixed maturity security is in an unrealized loss position and we have the intent to sell the fixed maturity security, or it is more likely than not that we will have to sell the fixed maturity security before recovery of its amortized cost basis, we write down the fixed maturity security&#x2019;s cost basis to fair value and record an impairment loss in our consolidated statements of income. For impaired fixed maturity securities that we do not intend to sell or if it is more likely than not that we will not have to sell such securities, but we expect that we will not fully recover the amortized cost basis, we recognize the credit component of the impairment as an allowance for credit loss in our consolidated balance sheets and record an impairment loss in our consolidated statements of income. The non-credit component of the impairment is recognized in accumulated other comprehensive loss. Furthermore, unrealized losses entirely caused by non-credit-related factors related to fixed maturity securities for which we expect to fully recover the amortized cost basis continue to be recognized in accumulated other comprehensive loss. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The credit component of an impairment is determined primarily by comparing the net present value of projected future cash flows with the amortized cost basis of the fixed maturity security. The net present value is calculated by discounting our best estimate of projected future cash flows at the effective interest rate implicit in the fixed maturity security at the date of purchase. For mortgage-backed and asset-backed securities, cash flow estimates are based on assumptions regarding the underlying collateral, including prepayment speeds, vintage, type of underlying asset, geographic concentrations, default rates, recoveries and changes in value. For all other securities, cash flow estimates are driven by assumptions regarding probability of default, including changes in credit ratings and estimates regarding timing and amount of recoveries associated with a default.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For asset-backed securities included in fixed maturity securities, we recognize income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The net investment in the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;securities is adjusted to the amount that would have existed had the new effective yield been applied since the purchase date of the securities. Such adjustments are reported within net investment income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The changes in fair value of our marketable equity securities are recognized in our results of operations within net gains and losses on financial instruments. Certain marketable equity securities are held to satisfy contractual obligations, and are reported under the caption &#x201c;Other invested assets&#x201d; in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have corporate-owned life insurance policies on certain participants in our deferred compensation plans and other members of management. The cash surrender value of the corporate-owned life insurance policies is reported under the caption &#x201c;Other invested assets&#x201d; in our consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use the equity method of accounting for investments in companies in which our ownership interest may enable us to influence the operating or financial decisions of the investee company. Our proportionate share of equity in net income of these unconsolidated affiliates is reported within net investment income. The equity method investments are reported under the caption &#x201c;Other invested assets&#x201d; in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investment income is recorded when earned. All securities sold resulting in investment gains and losses are recorded on the trade date. Realized gains and losses are determined on the basis of the cost or amortized cost of the specific securities sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We participate in securities lending programs whereby marketable securities in our investment portfolio are transferred to independent brokers or dealers in exchange for cash and securities collateral. We recognize the collateral as an asset, which is reported under the caption &#x201c;Other current assets&#x201d; in our consolidated balance sheets, and we record a corresponding liability for the obligation to return the collateral to the borrower, which is reported under the caption &#x201c;Other current liabilities&#x201d; in our consolidated balance sheets. The securities on loan are reported in the applicable investment category on our consolidated balance sheets. Unrealized gains or losses on securities lending collateral are included in accumulated other comprehensive loss as a separate component of shareholders&#x2019; equity. The market value of loaned securities and that of the collateral pledged can fluctuate in non-synchronized fashions.&#160;To the extent the loaned securities&#x2019; value appreciates faster or depreciates slower than the value of the collateral pledged, we are exposed to the risk of the shortfall.&#160;As a primary mitigating mechanism, the loaned securities and collateral pledged are marked to market on a daily basis and the shortfall, if any, is collected accordingly.&#160;Secondarily, the collateral level is set at 102% of the value of the loaned securities, which provides a cushion before any shortfall arises. The investment of the cash collateral is subject to market risk, which is managed by limiting the investments to higher quality and shorter duration instruments.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <elv:SecuritiesLendingTransactionsInitialCollateralPercentageValue
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfNzg5OQ_b7985803-2bbf-4e96-97e5-ce0d347f2cf7"
      unitRef="number">1.02</elv:SecuritiesLendingTransactionsInitialCollateralPercentageValue>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTYyMDY_95d4b6f9-b037-40ab-8632-2a7f2f6a2634">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Receivables:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Receivables are reported net of amounts for expected credit losses. The allowance for doubtful accounts is based on historical collection trends, future forecasts and our judgment regarding the ability to collect specific accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Premium receivables include the uncollected amounts from risk-based groups, individuals and government programs for insurance services. Premium receivables are reported net of an allowance for doubtful accounts of $140 and $142 at September&#160;30, 2022 and December&#160;31, 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Self-funded receivables include administrative fees, claims and other amounts due from fee-based customers for administrative services. Self-funded receivables are reported net of an allowance for doubtful accounts of $82 and $50 at September&#160;30, 2022 and December&#160;31, 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other receivables include pharmacy rebates, provider advances, claims recoveries, reinsurance receivables, proceeds due from brokers on investment trades, accrued investment income, and other miscellaneous amounts due to us. These receivables are reported net of an allowance for doubtful accounts of $709 and $648 at September&#160;30, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfODYxNg_7c92a3cf-d8ed-4f03-94d3-bf8bd500cce5"
      unitRef="usd">140000000</us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts>
    <us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfODYyMw_4537415f-1299-489a-b1a7-5263d1698bc1"
      unitRef="usd">142000000</us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts>
    <elv:SelffundedReceivablesAllowanceForDoubtfulAccounts
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfODg3Mw_4ca7dbd4-2641-46bf-b3f3-bbe47e3f2962"
      unitRef="usd">82000000</elv:SelffundedReceivablesAllowanceForDoubtfulAccounts>
    <elv:SelffundedReceivablesAllowanceForDoubtfulAccounts
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfODg4MA_b6198c18-14da-46c0-9b69-817b30452a82"
      unitRef="usd">50000000</elv:SelffundedReceivablesAllowanceForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfOTIxMw_14e67373-f988-48ea-a6fa-59f5dacb82f8"
      unitRef="usd">709000000</us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent>
    <us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfOTIyMA_503ca952-c826-4797-9e49-4a992b9f850c"
      unitRef="usd">648000000</us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTYyMDc_e19f9c31-f1e8-4539-b478-f94937431404">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; For our non-risk-based contracts, we had no material contract assets, contract liabilities or deferred contract costs&#160;recorded on our consolidated balance sheet at September&#160;30, 2022. For the three and nine months ended September&#160;30, 2022 and 2021, revenue recognized from performance obligations related to prior periods, such as due to changes in transaction price, was not material. For contracts that have an original expected duration of greater than one year, revenue expected to be recognized in future periods related to unfulfilled contractual performance obligations and contracts with variable consideration related to undelivered performance obligations is not material.&lt;/span&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTYyNDM_6463b266-c16c-41eb-89d9-273e1f8115fa">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; For our non-risk-based contracts, we had no material contract assets, contract liabilities or deferred contract costs&#160;recorded on our consolidated balance sheet at September&#160;30, 2022. For the three and nine months ended September&#160;30, 2022 and 2021, revenue recognized from performance obligations related to prior periods, such as due to changes in transaction price, was not material. For contracts that have an original expected duration of greater than one year, revenue expected to be recognized in future periods related to unfulfilled contractual performance obligations and contracts with variable consideration related to undelivered performance obligations is not material.&lt;/span&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTYyMzg_2c374fa9-70b1-499a-8006-738ee041c3bd">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Guidance: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update No. 2021-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2021-01&#x201d;). The amendments in ASU 2021-01 provide optional expedients and exceptions for applying GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;) or another reference rate expected to be discontinued because of the reference rate reform. The provisions must be applied at a Topic, Subtopic, or Industry Subtopic level for all transactions other than derivatives, which may be applied at a hedging relationship level. We adopted ASU 2021-01 on January 7, 2021, and the adoption did not have an impact on our consolidated financial position, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the FASB issued Accounting Standards Update No. 2020-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Codification Improvements to Subtopic 310-20, Receivables&#x2014;Nonrefundable Fees and Other Costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2020-08&#x201d;). The amendments in ASU 2020-08 clarify when an entity should assess whether a callable debt security is within the scope of accounting guidance, which impacts the amortization period for nonrefundable fees and other costs. ASU 2020-08 became effective for interim and annual reporting periods beginning after December 15, 2020. The amendments were to be applied on a prospective basis as of the beginning of the period of adoption for existing or newly purchased callable debt securities. We adopted ASU 2020-08 on January 1, 2021, and the adoption did not have an impact on our consolidated financial position, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued Accounting Standards Update No. 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2020-06&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amendments eliminate two of the three accounting models that require separate accounting for convertible features of debt securities, simplify the contract settlement assessment for equity classification, require the use of the if-converted method for all convertible instruments in the diluted earnings per share calculation and expand disclosure requirements. The amendments became effective for our annual and interim reporting periods beginning after December 15, 2021. We adopted ASU 2020-06 on January 1, 2022 using the modified retrospective transition method, which resulted in an increase to our reported debt outstanding of $31, a decrease to our deferred tax liabilities of $8, and a corresponding cumulative-effect reduction to our opening retained earnings of $23; these amounts are not material to our overall consolidated financial position. The adoption of ASU 2020-06 did not have an impact on our results of operations or our consolidated cash flows. Use of the if-converted method did not have an impact on our overall earnings per share calculation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued Accounting Standards Update No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2019-12&#x201d;). The amendments in ASU 2019-12 remove certain exceptions to the general principles in Accounting Standards Codification Topic 740. The amendments also clarify and amend existing guidance to improve consistent application. The amendments became effective for our annual reporting periods beginning after December 15, 2020. The transition method (retrospective, modified retrospective, or prospective basis) related to the amendments depends on the applicable guidance, and all amendments for which there is no transition guidance specified are to be applied on a prospective basis. We adopted ASU 2019-12 on January 1, 2021, and the adoption did not have an impact on our consolidated financial position, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Guidance Not Yet Adopted: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2020, the FASB issued Accounting Standards Update No. 2020-11,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Financial Services&#x2014;Insurance (Topic 944): Effective Date and Early Application &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2020-11&#x201d;). The amendments in ASU 2020-11 make changes to the effective date and early application of Accounting Standards Update No. 2018-12,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Financial Services&#x2014;Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2018-12&#x201d;), which was issued in November 2018. The amendments in ASU 2020-11 have extended the original effective date by one year, and now the amendments are required for our interim and annual reporting periods beginning after December 15, 2022. The amendments in ASU 2018-12 make changes to a variety of areas to simplify or improve the existing recognition, measurement, presentation and disclosure requirements for long-duration contracts issued by an insurance entity. The amendments require insurers to annually review the assumptions they make about their policyholders and update the liabilities for future policy benefits if the assumptions change. The amendments also simplify the amortization of deferred contract acquisition costs and add new disclosure requirements about the assumptions insurers use to measure their liabilities and how they may affect future cash flows. The amendments related to the liability for future policy benefits for traditional and limited-payment contracts and deferred acquisition costs are to be applied to contracts in force as of the beginning of the earliest period presented, with an option to apply such amendments retrospectively with a cumulative-effect adjustment to the opening balance of retained earnings as of the earliest period presented. The amendments &lt;/span&gt;&lt;/div&gt;for market risk benefits are to be applied retrospectively. We do not believe the adoption of ASU 2020-11 and ASU 2018-12 will have a material impact on our consolidated financial position, results of operations, cash flows, and related disclosures.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:LongTermDebt
      contextRef="ic8291afc45194b679cb982efb46d0686_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTI1Njc_c5342a1d-cb82-47b3-888d-52515fd89795"
      unitRef="usd">31000000</us-gaap:LongTermDebt>
    <us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent
      contextRef="ic8291afc45194b679cb982efb46d0686_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTI2MTc_b209a8ff-17c4-4885-bf87-f793dde00411"
      unitRef="usd">-8000000</us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent>
    <us-gaap:StockholdersEquity
      contextRef="ic8291afc45194b679cb982efb46d0686_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80MC9mcmFnOmZkMzJjOGVhNTNjYjQzMjk5MTcyMWY0MDQxOWZjNDhlL3RleHRyZWdpb246ZmQzMmM4ZWE1M2NiNDMyOTkxNzIxZjQwNDE5ZmM0OGVfMTI3MDU_e9a116c8-e970-4c9d-ae9f-d8ed062b1b8a"
      unitRef="usd">-23000000</us-gaap:StockholdersEquity>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80My9mcmFnOjliOWMxNzAxMmU0ZTQ0ODY4ZTBhZjFmOTdkY2E5MWQ3L3RleHRyZWdpb246OWI5YzE3MDEyZTRlNDQ4NjhlMGFmMWY5N2RjYTkxZDdfMTYxMw_59033067-7666-45eb-b5b6-882b010d6de7">Business Acquisitions&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Completed Acquisitions &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 5, 2022, we completed our acquisition of Integra Managed Care (&#x201c;Integra&#x201d;) from Personal Touch Holding Corporation. Integra is a managed long-term care plan that serves New York state Medicaid members, enabling adults with long-term care needs and disabilities to live safely and independently in their own homes. The purchase price was allocated to the tangible and intangible net assets acquired based on management&#x2019;s initial estimates of their fair values, of which $89 has been allocated to finite-lived intangible assets, $250 to indefinite-lived intangible assets, and $123 to goodwill, including measurement period adjustments to goodwill of $13 during the quarter ended September 30, 2022. The majority of goodwill is deductible for income tax purposes. As of September&#160;30, 2022, the initial accounting for the acquisition had not been finalized. Any subsequent adjustments made to the assets acquired or liabilities assumed during the measurement period will be recorded as an adjustment to goodwill. The proforma effects of this acquisition for prior periods were not material to our consolidated results of operations.&lt;/span&gt;&lt;/div&gt;Acquisitions completed during the year ended December 31, 2021, for which the initial accounting was finalized during the three months ended June 30, 2022 included myNEXUS, Inc. (&#x201c;myNEXUS&#x201d;), a comprehensive home-based nursing management company for payors, and MMM Holdings, LLC (&#x201c;MMM&#x201d;), including its Medicare Advantage plan, Medicaid plan and other affiliated companies. As of September&#160;30, 2022, the purchase price of each transaction was allocated to the tangible and intangible net assets acquired based on management&#x2019;s final estimates of their fair values, of which $1,577 has been allocated to finite-lived intangible assets, $20 to indefinite-lived intangible assets, and $2,531 to goodwill. The majority of goodwill is not deductible for income tax purposes.</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i2bc73b260c78413bbf502ba5c1050cce_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80My9mcmFnOjliOWMxNzAxMmU0ZTQ0ODY4ZTBhZjFmOTdkY2E5MWQ3L3RleHRyZWdpb246OWI5YzE3MDEyZTRlNDQ4NjhlMGFmMWY5N2RjYTkxZDdfNTI5_f02807d7-fd46-46dc-8d50-233242c4f20b"
      unitRef="usd">89000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:IndefinitelivedIntangibleAssetsAcquired
      contextRef="i2bc73b260c78413bbf502ba5c1050cce_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80My9mcmFnOjliOWMxNzAxMmU0ZTQ0ODY4ZTBhZjFmOTdkY2E5MWQ3L3RleHRyZWdpb246OWI5YzE3MDEyZTRlNDQ4NjhlMGFmMWY5N2RjYTkxZDdfNTg2_f26d7a92-eb28-4b7e-90db-f272d58a2a28"
      unitRef="usd">250000000</us-gaap:IndefinitelivedIntangibleAssetsAcquired>
    <us-gaap:Goodwill
      contextRef="i67668f78684042f3ae9dc8e1ad62b947_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80My9mcmFnOjliOWMxNzAxMmU0ZTQ0ODY4ZTBhZjFmOTdkY2E5MWQ3L3RleHRyZWdpb246OWI5YzE3MDEyZTRlNDQ4NjhlMGFmMWY5N2RjYTkxZDdfNjMy_52287ba0-13e4-4e5e-8221-eece199cc4c9"
      unitRef="usd">123000000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i2bc73b260c78413bbf502ba5c1050cce_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80My9mcmFnOjliOWMxNzAxMmU0ZTQ0ODY4ZTBhZjFmOTdkY2E5MWQ3L3RleHRyZWdpb246OWI5YzE3MDEyZTRlNDQ4NjhlMGFmMWY5N2RjYTkxZDdfMTA5OTUxMTYzMTYwMg_4b551f7e-0128-4f02-9cd2-a3ad665c10a4"
      unitRef="usd">13000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80My9mcmFnOjliOWMxNzAxMmU0ZTQ0ODY4ZTBhZjFmOTdkY2E5MWQ3L3RleHRyZWdpb246OWI5YzE3MDEyZTRlNDQ4NjhlMGFmMWY5N2RjYTkxZDdfMTIzNg_0c7fe715-3b97-4fe2-aed6-abf51553b000"
      unitRef="usd">1577000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:IndefinitelivedIntangibleAssetsAcquired
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80My9mcmFnOjliOWMxNzAxMmU0ZTQ0ODY4ZTBhZjFmOTdkY2E5MWQ3L3RleHRyZWdpb246OWI5YzE3MDEyZTRlNDQ4NjhlMGFmMWY5N2RjYTkxZDdfMTI5Mw_fc01178b-7572-4beb-a374-c3efe4b87605"
      unitRef="usd">20000000</us-gaap:IndefinitelivedIntangibleAssetsAcquired>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80My9mcmFnOjliOWMxNzAxMmU0ZTQ0ODY4ZTBhZjFmOTdkY2E5MWQ3L3RleHRyZWdpb246OWI5YzE3MDEyZTRlNDQ4NjhlMGFmMWY5N2RjYTkxZDdfMTMzOQ_a17f3546-f225-429c-b11b-62f189441805"
      unitRef="usd">2531000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RleHRyZWdpb246OTUyNTkzMWNkYzk1NGYyMjk1NTk0OTI4ZjE0ZDQ3ZDJfMjgw_d525050f-b52f-4ea5-9554-8516349fa58d">Business Optimization Initiatives&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Provided below is a summary of the activity, by reportable segment, related to the liability for employee termination costs previously incurred in connection with our enterprise-wide business optimization initiatives introduced in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.072%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Commercial &amp;amp; Specialty Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Government Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;IngenioRx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020 Business Optimization Initiatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for employee termination costs at            January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:15pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for employee termination costs at September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RleHRyZWdpb246OTUyNTkzMWNkYzk1NGYyMjk1NTk0OTI4ZjE0ZDQ3ZDJfMjgy_b9da77fe-5b71-450f-aa56-49dd5aa1e72a">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Provided below is a summary of the activity, by reportable segment, related to the liability for employee termination costs previously incurred in connection with our enterprise-wide business optimization initiatives introduced in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.072%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Commercial &amp;amp; Specialty Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Government Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;IngenioRx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020 Business Optimization Initiatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for employee termination costs at            January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:15pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for employee termination costs at September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i26a408574c2c4c619b3f6a7fb2eb52ef_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfMy0xLTEtMS03MDM2Mw_9d7c91f9-2e3f-4132-b4e3-addf25ae1d93"
      unitRef="usd">61000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i4d84cf76f3a74a17bfd21c61cad87a45_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfMy0zLTEtMS03MDM2Mw_f3974a7b-a6c0-4b86-a82c-b5692f50aa1e"
      unitRef="usd">57000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ib724e06caec84704b13a828ba8b9b8fc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfMy01LTEtMS03MDM2Mw_8b038cef-110e-4f0c-a5f4-f99607f7ad8a"
      unitRef="usd">1000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i6ab5335cb1b5494eba34054f0ef63dc2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfMy03LTEtMS03MDM2Mw_a61e3d7b-5dce-4160-96a4-c5ac00e982bf"
      unitRef="usd">3000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i3ce8730226514909b48e611420368522_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfMy05LTEtMS03MDM2Mw_7ac20fce-c301-495d-b511-39da99136eaa"
      unitRef="usd">122000000</us-gaap:RestructuringReserve>
    <us-gaap:PaymentsForRestructuring
      contextRef="i5dd22b7bb98e4e4f844ecae3c390bdd0_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfNS0xLTEtMS03MDM2Mw_487800de-3a9f-4420-97cc-feb6cd63894d"
      unitRef="usd">16000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="idba3a272e1b8405eaeead18d34613b77_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfNS0zLTEtMS03MDM2Mw_d74b1471-33eb-4ffb-b765-0585a4d335b8"
      unitRef="usd">14000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i266f1d31e2b94bbcba7b6d2f8441491f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfNS01LTEtMS03MDM2Mw_18063b04-f063-490d-870e-dda3ac444ba8"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ie72e88979b5548e48539cc5d886e25fd_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfNS03LTEtMS03MDM2Mw_d5e6bbfe-366d-4539-8526-a3415bbf858b"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ie4f6b49781dc450db479bd159632e422_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfNS05LTEtMS03MDM2Mw_1ce645be-e541-40bb-96da-ee4c23f7832d"
      unitRef="usd">30000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i51b351f32e2a4a91830c15bcaca2d1a7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfNi0xLTEtMS03MDM2Mw_894ff9bd-b96a-47d1-a401-1453481b9b79"
      unitRef="usd">45000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i67eb9d5cdedf417fa6217167e453f99b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfNi0zLTEtMS03MDM2Mw_b025c8c2-0799-4cd7-8da0-473b19774450"
      unitRef="usd">43000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i708db0a3275f4fd58d30b7138cf68571_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfNi01LTEtMS03MDM2Mw_14082ab3-df3f-4641-9e71-3852fa9e71d3"
      unitRef="usd">1000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i08ff1fe2d3cf4ba1a7a645773295ee0d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfNi03LTEtMS03MDM2Mw_71949408-c0f5-46cb-8ef8-9ba862a98d67"
      unitRef="usd">3000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i8ea9c5ffa135471d84290457cc62b377_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80Ni9mcmFnOjk1MjU5MzFjZGM5NTRmMjI5NTU5NDkyOGYxNGQ0N2QyL3RhYmxlOmRmZWFiNzc4ODgzMTRjZjViM2FkOTE5ZGU3OGJhNzQyL3RhYmxlcmFuZ2U6ZGZlYWI3Nzg4ODMxNGNmNWIzYWQ5MTlkZTc4YmE3NDJfNi05LTEtMS03MDM2Mw_e047241f-ceac-4529-b7b6-6668b4107485"
      unitRef="usd">92000000</us-gaap:RestructuringReserve>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzY3Ng_2b2c299c-e698-4162-be3a-51e8f1e4c39c">Investments &lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fixed Maturity Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate our available-for-sale fixed maturity securities for declines based on qualitative and quantitative factors. We have established an allowance for credit loss and recorded credit loss expense as a reflection of our expected impairment losses. We continue to review our investment portfolios under our impairment review policy. Given the inherent uncertainty of changes in market conditions and the significant judgments involved, there is a continuing risk that declines in fair value may occur and additional material impairment losses for credit losses on investments may be recorded in future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of current and long-term fixed maturity securities, available-for-sale, at September&#160;30, 2022 and December&#160;31, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.072%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost or Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Allowance &lt;br/&gt;For Credit &lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed maturity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States Government securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government sponsored securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,560)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fixed maturity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,877)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed maturity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States Government securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government sponsored securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fixed maturity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For fixed maturity securities in an unrealized loss position at September&#160;30, 2022 and December&#160;31, 2021, the following table summarizes the aggregate fair values and gross unrealized losses by length of time those securities have continuously been in an unrealized loss position:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.358%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 Months or Greater&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(Securities are whole amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed maturity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States Government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government sponsored securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign government securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(314)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(395)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fixed maturity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(821)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed maturity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States Government securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government sponsored securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign government securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fixed maturity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although not material to our consolidated results of operations, during the nine months ended September&#160;30, 2022, we recorded a combination of credit losses, losses on sales of fixed maturity securities and impairments related to our exposure resulting from investments in Russia and Ukraine. At September&#160;30, 2022, our remaining holdings of Russia and Ukraine fixed maturity securities were not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrealized losses on our securities shown in the table above have not been recognized into income because, as of September 30, 2022, we do not intend to sell these investments and it is likely that we will not be required to sell these investments prior to their maturity or anticipated recovery. The declines in fair values are largely due to increasing interest rates driven by the high rate of inflation and other market conditions and not by unfavorable changes in the credit quality characteristics that impact our assessment on collectability of principal and interest. We have evaluated qualitative and quantitative factors for indications of credit losses on our securities, including factors such as credit rating, foreign political conflicts, uncertainties around future ability to collect payment, significant declines in fair value and industry conditions, market data, and notifications of maturity and coupon default, and have recorded an allowance for credit losses in the amount of $10 and $6 at September 30, 2022 and December 31, 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost and fair value of fixed maturity securities at September&#160;30, 2022, by contractual maturity, are shown below. Expected maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fixed maturity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:1pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended September&#160;30, 2022, we received total proceeds from sales, maturities, calls or redemptions of fixed maturity securities of $5,281 and $15,953, respectively. During the three and nine months ended September&#160;30, 2021, we received total proceeds from sales, maturities, calls or redemptions of fixed maturity securities of $2,620 and $8,570, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, we may sell securities at a loss for a number of reasons, including, but not limited to: (i)&#160;changes in the investment environment; (ii)&#160;expectation that the fair value could deteriorate further; (iii)&#160;desire to reduce exposure to an issuer or an industry; (iv)&#160;changes in credit quality; or (v)&#160;changes in expected cash flow.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All securities sold resulting in investment gains and losses are recorded on the trade date. Realized gains and losses are determined on the basis of the cost or amortized cost of the specific securities sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Securities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of marketable equity securities at September&#160;30, 2022 and December&#160;31, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.211%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exchange traded funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Invested Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other invested assets include primarily our investments in limited partnerships, joint ventures and other non-controlled corporations, mortgage loans and the cash surrender value of corporate-owned life insurance policies. Investments in limited partnerships, joint ventures and other non-controlled corporations are carried at our share in the entities&#x2019; undistributed earnings, which approximates fair value. Financial information for certain of these investments are reported on a one or three month lag due to the timing of when we receive financial information from the companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investment Gains and Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net investment (losses) gains for the three and nine months ended September&#160;30, 2022 and 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.873%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended &lt;br/&gt;September 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (losses) gains:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed maturity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized gains from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized losses from sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(353)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment (losses) recoveries recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized (losses) gains from sales of fixed maturity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized (losses) gains recognized on equity securities still held at the end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized gains (losses) recognized on equity securities sold during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net losses on equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment (losses) recoveries recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net losses (gains) on other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (losses) gains on investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(482)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued Investment Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2022 and December&#160;31, 2021, accrued investment income totaled $228 and $205, respectively. We recognize accrued investment income under the caption &#x201c;Other receivables&#x201d; on our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Securities Lending Programs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We participate in securities lending programs whereby marketable securities in our investment portfolio are transferred to independent brokers or dealers in exchange for cash and securities collateral. The fair value of the collateral received at the time of the transactions amounted to $2,841 and $2,155 at September&#160;30, 2022 and December&#160;31, 2021, respectively. The value of the collateral represented 102% of the market value of the securities on loan at each of September&#160;30, 2022 and December&#160;31, 2021. We recognize the collateral as an asset under the caption &#x201c;Other current assets&#x201d; in our consolidated balance sheets, and we recognize a corresponding liability for the obligation to return the collateral to the borrower under the caption &#x201c;Other current liabilities.&#x201d; The securities on loan are reported in the applicable investment category on our consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2022 and December&#160;31, 2021, the remaining contractual maturity of our securities lending agreements included overnight and continuous transactions of cash for $2,636 and $1,874, respectively, of United States Government securities for $180 and $281, respectively, and of Other securities for $25 and $0, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzY3Mg_dc899ee7-ba42-423d-893c-8b1abdae93cc">&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of current and long-term fixed maturity securities, available-for-sale, at September&#160;30, 2022 and December&#160;31, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.072%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost or Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Allowance &lt;br/&gt;For Credit &lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed maturity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States Government securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government sponsored securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,560)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fixed maturity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,877)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed maturity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States Government securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government sponsored securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fixed maturity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if46ba3a6ed924704ab80b46d4892ce9c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNC0xLTEtMS03MDM2Mw_026334ea-9ad8-41bb-9175-bc42f0dfcdbd"
      unitRef="usd">1673000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if46ba3a6ed924704ab80b46d4892ce9c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNC0zLTEtMS03MDM2Mw_6d396840-abbf-4e0a-92a0-f4fbb73f766f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if46ba3a6ed924704ab80b46d4892ce9c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNC01LTEtMS03MDM2Mw_22867b7a-6a6f-445c-9b9b-d96fb752fe7d"
      unitRef="usd">125000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="if46ba3a6ed924704ab80b46d4892ce9c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNC03LTEtMS03MDM2Mw_caae6ccf-5657-40c5-9044-10d8ce7c2025"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if46ba3a6ed924704ab80b46d4892ce9c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNC05LTEtMS03MDM2Mw_a1d6f041-9061-4fe0-b359-c80464f3eb30"
      unitRef="usd">1548000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i582c7462a2a24ee19ae7c3e8b13e6258_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNS0xLTEtMS03MDM2Mw_a184c2e4-3c42-4a81-9509-dc395fe84326"
      unitRef="usd">65000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i582c7462a2a24ee19ae7c3e8b13e6258_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNS0zLTEtMS03MDM2Mw_00332aeb-1d9c-4d6d-a787-1af10da1308a"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i582c7462a2a24ee19ae7c3e8b13e6258_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNS01LTEtMS03MDM2Mw_195fdcd5-9f6f-447d-a14d-2b83ed436d1d"
      unitRef="usd">4000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i582c7462a2a24ee19ae7c3e8b13e6258_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNS03LTEtMS03MDM2Mw_a0b4dd91-2cb0-4eee-80da-955abb73085c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i582c7462a2a24ee19ae7c3e8b13e6258_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNS05LTEtMS03MDM2Mw_798b89db-6fa1-4313-aa7a-d985cbbea49e"
      unitRef="usd">61000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9e3fb6e7405848e39ed7671d9a9683da_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNi0xLTEtMS03MDM2Mw_ec5ea18a-e31c-4a54-b77e-96b3f75ec852"
      unitRef="usd">322000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9e3fb6e7405848e39ed7671d9a9683da_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNi0zLTEtMS03MDM2Mw_b5e920f3-67d7-4a07-aeab-aeb631e9f1c0"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9e3fb6e7405848e39ed7671d9a9683da_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNi01LTEtMS03MDM2Mw_7b2607c9-992d-40c2-8e1f-b91eee8a5489"
      unitRef="usd">70000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i9e3fb6e7405848e39ed7671d9a9683da_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNi03LTEtMS03MDM2Mw_072e8007-dbb9-4298-a25a-56e7779f8a2b"
      unitRef="usd">-1000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9e3fb6e7405848e39ed7671d9a9683da_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNi05LTEtMS03MDM2Mw_0e573c60-5302-4b85-982a-9422c2464034"
      unitRef="usd">251000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie05876f14e3546779aaacef9d285ee2c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNy0xLTEtMS03MDM2Mw_abb0cd43-36c8-4b61-ac94-50f920462115"
      unitRef="usd">4431000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie05876f14e3546779aaacef9d285ee2c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNy0zLTEtMS03MDM2Mw_c4250aba-50fd-41d4-bb79-582fb319158a"
      unitRef="usd">5000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie05876f14e3546779aaacef9d285ee2c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNy01LTEtMS03MDM2Mw_7514025e-1705-4827-8f0d-b4ab21939fe8"
      unitRef="usd">355000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ie05876f14e3546779aaacef9d285ee2c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNy03LTEtMS03MDM2Mw_fdea8827-1132-47d6-a958-43f68808a498"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie05876f14e3546779aaacef9d285ee2c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfNy05LTEtMS03MDM2Mw_fe61a0cb-3338-4322-b0bd-ce5d5615b10b"
      unitRef="usd">4081000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib5a6260b0cc245e3ad18420b5dda8138_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfOC0xLTEtMS03MDM2Mw_a534938d-c367-40b8-ac08-3ab7838330dd"
      unitRef="usd">13766000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib5a6260b0cc245e3ad18420b5dda8138_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfOC0zLTEtMS03MDM2Mw_aa756af8-3c3f-47b8-b3c3-430fe1c60e40"
      unitRef="usd">9000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib5a6260b0cc245e3ad18420b5dda8138_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfOC01LTEtMS03MDM2Mw_036a2451-39ff-469b-8682-5b4cdb9a1809"
      unitRef="usd">1560000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ib5a6260b0cc245e3ad18420b5dda8138_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfOC03LTEtMS03MDM2Mw_03bae6c4-5e80-496f-90f2-2c87ace43a2e"
      unitRef="usd">-7000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib5a6260b0cc245e3ad18420b5dda8138_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfOC05LTEtMS03MDM2Mw_08dc1d79-16c7-465d-9f87-99c42f828a87"
      unitRef="usd">12208000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id54f0058c591469baef2d1557dcb55a8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfOS0xLTEtMS03MDM2Mw_4bdce773-db95-494c-b16f-9e9070789859"
      unitRef="usd">4748000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id54f0058c591469baef2d1557dcb55a8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfOS0zLTEtMS03MDM2Mw_5c76ce44-88e6-4328-aee5-24cc919d3dee"
      unitRef="usd">7000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id54f0058c591469baef2d1557dcb55a8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfOS01LTEtMS03MDM2Mw_a7bed922-4116-4b21-a5d6-3780bbe575a2"
      unitRef="usd">506000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="id54f0058c591469baef2d1557dcb55a8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfOS03LTEtMS03MDM2Mw_bd76b123-1060-461e-9c6b-0c37b3b7ff5b"
      unitRef="usd">-2000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id54f0058c591469baef2d1557dcb55a8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfOS05LTEtMS03MDM2Mw_0b7711d0-46d8-43af-86c5-048ee309d62d"
      unitRef="usd">4247000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2340f4d1ac2b47dfbe6521a9386a70f4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTAtMS0xLTEtNzAzNjM_e0bb3588-ab16-457f-ba4a-a8194892a0a9"
      unitRef="usd">77000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2340f4d1ac2b47dfbe6521a9386a70f4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTAtMy0xLTEtNzAzNjM_1563c570-d8b4-43ef-9713-8c2ea03f412c"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2340f4d1ac2b47dfbe6521a9386a70f4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTAtNS0xLTEtNzAzNjM_18c22b18-e147-4389-aa91-2f0ff22c9dfb"
      unitRef="usd">7000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i2340f4d1ac2b47dfbe6521a9386a70f4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTAtNy0xLTEtNzAzNjM_099bf890-cb1e-4b0d-ba20-21fcd8e42c0a"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2340f4d1ac2b47dfbe6521a9386a70f4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTAtOS0xLTEtNzAzNjM_4e327c39-29a0-491a-a5fe-a647f7a900ea"
      unitRef="usd">70000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia9b964677bcb4f018f7b0e35a345ad57_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTEtMS0xLTEtNzAzNjM_8733edeb-d533-4e14-b44f-cf2a94fd4b3d"
      unitRef="usd">3895000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia9b964677bcb4f018f7b0e35a345ad57_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTEtMy0xLTEtNzAzNjM_578cc442-f73b-4ce5-b6a8-eb18576036f7"
      unitRef="usd">37000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia9b964677bcb4f018f7b0e35a345ad57_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTEtNS0xLTEtNzAzNjM_53eced14-8edf-4021-9403-90848dc6f7c4"
      unitRef="usd">250000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ia9b964677bcb4f018f7b0e35a345ad57_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTEtNy0xLTEtNzAzNjM_799a8687-d509-4b6d-880a-af7cb52ea35a"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia9b964677bcb4f018f7b0e35a345ad57_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTEtOS0xLTEtNzAzNjM_d2d2eb1c-002f-4bc3-980d-60dedc174f74"
      unitRef="usd">3682000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTItMS0xLTEtNzAzNjM_6e021212-d0ef-4aee-b682-bf2a5670795f"
      unitRef="usd">28977000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTItMy0xLTEtNzAzNjM_38543df2-e8f0-485f-8135-dcbf8e5091a8"
      unitRef="usd">58000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTItNS0xLTEtNzAzNjM_bc921858-6bc8-4222-8f38-31f4f757d852"
      unitRef="usd">2877000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTItNy0xLTEtNzAzNjM_741ab323-2b85-4fe8-ad1b-4aaa90846409"
      unitRef="usd">-10000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTItOS0xLTEtNzAzNjM_6dba7d2a-0f1c-436c-8a12-b109885d38ca"
      unitRef="usd">26148000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ifc53677b69024b148f62349f82fe723c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTUtMS0xLTEtNzAzNjM_4d0f322a-4613-4299-a93f-597fd6c2f78a"
      unitRef="usd">1443000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ifc53677b69024b148f62349f82fe723c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTUtMy0xLTEtNzAzNjM_ed60c78d-fc6e-4a9f-9b08-d73f732a3908"
      unitRef="usd">7000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ifc53677b69024b148f62349f82fe723c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTUtNS0xLTEtNzAzNjM_fc887cf7-7530-42e7-9a9e-312af4dbfe9a"
      unitRef="usd">18000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ifc53677b69024b148f62349f82fe723c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTUtNy0xLTEtNzAzNjM_bf1087f5-76af-466a-90cb-ab4d749fce3b"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifc53677b69024b148f62349f82fe723c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTUtOS0xLTEtNzAzNjM_abacf052-a7b4-453a-a469-826c2fa06ef6"
      unitRef="usd">1432000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6bd8e4d367e5434c93d5ed2fb93b9c90_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTYtMS0xLTEtNzAzNjM_f1e51f66-fa16-4118-917f-17eeb0f6ae71"
      unitRef="usd">65000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6bd8e4d367e5434c93d5ed2fb93b9c90_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTYtMy0xLTEtNzAzNjM_70ed0dd8-b31b-4d35-9db2-bbbc6259058d"
      unitRef="usd">4000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6bd8e4d367e5434c93d5ed2fb93b9c90_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTYtNS0xLTEtNzAzNjM_382d91c4-db25-4cd9-8d4f-b29ac2b28231"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i6bd8e4d367e5434c93d5ed2fb93b9c90_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTYtNy0xLTEtNzAzNjM_eb48433e-a959-4bf9-9164-01d90d740d80"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6bd8e4d367e5434c93d5ed2fb93b9c90_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTYtOS0xLTEtNzAzNjM_4ad044d2-7f4e-497b-9b55-f3ff41f7d9f9"
      unitRef="usd">68000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ifcad3b58ad0a402e9c5f36c2257b46ad_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTctMS0xLTEtNzAzNjM_503d15d3-5a41-4a9f-b0e9-d23ede2df0b6"
      unitRef="usd">353000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ifcad3b58ad0a402e9c5f36c2257b46ad_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTctMy0xLTEtNzAzNjM_cf715e06-64d0-486b-a3b2-84630b77d433"
      unitRef="usd">7000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ifcad3b58ad0a402e9c5f36c2257b46ad_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTctNS0xLTEtNzAzNjM_ca58aa2b-fc15-4a43-9b55-7e3f6c3e0460"
      unitRef="usd">13000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ifcad3b58ad0a402e9c5f36c2257b46ad_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTctNy0xLTEtNzAzNjM_338ddd1c-0d16-4a7b-8a98-a09ea7952f80"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifcad3b58ad0a402e9c5f36c2257b46ad_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTctOS0xLTEtNzAzNjM_da80239d-071b-421b-83ca-1451942a419b"
      unitRef="usd">347000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i0b05039f1d944a39a5f7c4a08ecd9386_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTgtMS0xLTEtNzAzNjM_24f32d87-bb69-4b03-8ace-f5e837171e3b"
      unitRef="usd">5321000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0b05039f1d944a39a5f7c4a08ecd9386_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTgtMy0xLTEtNzAzNjM_4be1f899-bf05-4b00-bfdc-0eb266beeeab"
      unitRef="usd">310000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0b05039f1d944a39a5f7c4a08ecd9386_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTgtNS0xLTEtNzAzNjM_68fe4d16-dfe4-453b-9f14-a8ad16a35a9d"
      unitRef="usd">10000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i0b05039f1d944a39a5f7c4a08ecd9386_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTgtNy0xLTEtNzAzNjM_1053c63b-a0a8-42b5-9cf7-6798603e7023"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0b05039f1d944a39a5f7c4a08ecd9386_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTgtOS0xLTEtNzAzNjM_79931052-1994-4d6d-adc4-7e83dee96985"
      unitRef="usd">5621000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3fe0fa1cefe04a9ab9bd771236eb24fd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTktMS0xLTEtNzAzNjM_8c0029b4-c3e4-4bd1-883d-f16bd676d4b3"
      unitRef="usd">12044000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3fe0fa1cefe04a9ab9bd771236eb24fd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTktMy0xLTEtNzAzNjM_4105e612-b1cb-47f5-91f9-f19a0fa829c9"
      unitRef="usd">401000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3fe0fa1cefe04a9ab9bd771236eb24fd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTktNS0xLTEtNzAzNjM_cea127dc-f27f-496b-9831-c8b1883e9795"
      unitRef="usd">78000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i3fe0fa1cefe04a9ab9bd771236eb24fd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTktNy0xLTEtNzAzNjM_2caa5f19-bf82-4347-bb85-863501f277d8"
      unitRef="usd">-4000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3fe0fa1cefe04a9ab9bd771236eb24fd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMTktOS0xLTEtNzAzNjM_5b8dd115-4aab-4e16-8f23-c1205c319b88"
      unitRef="usd">12363000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1998952a2fec4ef987e45747bc6a365e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjAtMS0xLTEtNzAzNjM_fb7385f2-1d1b-43ee-ba1b-2633c3eade15"
      unitRef="usd">4059000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1998952a2fec4ef987e45747bc6a365e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjAtMy0xLTEtNzAzNjM_671c251d-73ae-49ce-99b4-f85162c85908"
      unitRef="usd">75000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1998952a2fec4ef987e45747bc6a365e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjAtNS0xLTEtNzAzNjM_dbd4d693-5bb7-4e27-8d27-10d8d985494f"
      unitRef="usd">35000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i1998952a2fec4ef987e45747bc6a365e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjAtNy0xLTEtNzAzNjM_ff90f1fe-bf6d-436a-8399-73b847b5eb6f"
      unitRef="usd">-2000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1998952a2fec4ef987e45747bc6a365e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjAtOS0xLTEtNzAzNjM_77f9937c-b6db-416e-b1ae-58e1325887d2"
      unitRef="usd">4097000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ibf59770742dd4e0c909bf664464f6f51_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjEtMS0xLTEtNzAzNjM_9da86dc4-c101-4c06-b04a-a30e766bbbde"
      unitRef="usd">65000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibf59770742dd4e0c909bf664464f6f51_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjEtMy0xLTEtNzAzNjM_17a45140-9350-4f62-9f98-72b12837d07b"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibf59770742dd4e0c909bf664464f6f51_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjEtNS0xLTEtNzAzNjM_c4d0a0b6-a27b-4240-a0b4-cc86838999a7"
      unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ibf59770742dd4e0c909bf664464f6f51_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjEtNy0xLTEtNzAzNjM_690f5aca-1bd1-496c-b4a2-dd244d2e44c7"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibf59770742dd4e0c909bf664464f6f51_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjEtOS0xLTEtNzAzNjM_8954cb4b-999b-4272-b38c-52b3dd2ba9b5"
      unitRef="usd">64000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i962a4141a6934bd0b79803a5e587f115_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjItMS0xLTEtNzAzNjM_a9ae5fc2-a7ce-41d9-b4d0-134acc4827bb"
      unitRef="usd">2907000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i962a4141a6934bd0b79803a5e587f115_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjItMy0xLTEtNzAzNjM_daa14a7c-b2e6-4c58-a043-882232ba8c1d"
      unitRef="usd">24000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i962a4141a6934bd0b79803a5e587f115_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjItNS0xLTEtNzAzNjM_493481c3-4309-46bb-9f4a-263f7ff5a082"
      unitRef="usd">24000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i962a4141a6934bd0b79803a5e587f115_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjItNy0xLTEtNzAzNjM_b68d04c0-8cb6-4618-bee6-13ed1c27f6c1"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i962a4141a6934bd0b79803a5e587f115_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjItOS0xLTEtNzAzNjM_ae734963-4f51-46b1-8152-87d66ec2c943"
      unitRef="usd">2907000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjMtMS0xLTEtNzAzNjM_0eb94afb-f19f-4e5e-9f68-0ba8797b2d61"
      unitRef="usd">26257000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjMtMy0xLTEtNzAzNjM_73806c59-3471-4b3e-a224-157128bbe1eb"
      unitRef="usd">830000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjMtNS0xLTEtNzAzNjM_656a1f0d-9552-4a51-8bdb-3d7ecaeb6208"
      unitRef="usd">182000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjMtNy0xLTEtNzAzNjM_991fbb57-b17a-4d80-ac36-38dc2cf0de8b"
      unitRef="usd">-6000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjg2ZTY5YjJjOTM1ODQ4ZGE5YWQyMTEwYThhMjlhMWIzL3RhYmxlcmFuZ2U6ODZlNjliMmM5MzU4NDhkYTlhZDIxMTBhOGEyOWExYjNfMjMtOS0xLTEtNzAzNjM_ae2a8f4e-94ca-418c-84e6-bfa1b6562404"
      unitRef="usd">26899000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzY1Mw_60a738ec-30c6-4921-90af-4423859fb5c8">&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For fixed maturity securities in an unrealized loss position at September&#160;30, 2022 and December&#160;31, 2021, the following table summarizes the aggregate fair values and gross unrealized losses by length of time those securities have continuously been in an unrealized loss position:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.358%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 Months or Greater&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(Securities are whole amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed maturity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States Government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government sponsored securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign government securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(314)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(395)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fixed maturity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(821)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed maturity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States Government securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government sponsored securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign government securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fixed maturity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i9b33199b5e8040e88c3779bab1338a41_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNC0xLTEtMS03MDM2Mw_0126608e-a088-4114-9eb4-534a1c01db02"
      unitRef="securities">65</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i9b33199b5e8040e88c3779bab1338a41_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNC0zLTEtMS03MDM2Mw_b3049ee5-07d4-473d-800c-5735a58d7302"
      unitRef="usd">911000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i9b33199b5e8040e88c3779bab1338a41_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNC01LTEtMS03MDM2Mw_879c20bf-a747-47e8-b074-7412fb1ee5b9"
      unitRef="usd">77000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i9b33199b5e8040e88c3779bab1338a41_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNC03LTEtMS03MDM2Mw_866d20a1-131c-49b8-a3b1-c407191f7c5a"
      unitRef="securities">29</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i9b33199b5e8040e88c3779bab1338a41_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNC05LTEtMS03MDM2Mw_80664865-37b4-449c-b5c7-ba6ed2774c2e"
      unitRef="usd">303000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i9b33199b5e8040e88c3779bab1338a41_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNC0xMS0xLTEtNzAzNjM_09dd5c10-1eed-481d-828b-83184b7e4510"
      unitRef="usd">48000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ifcf9e5652a88433fa305f979016b813a_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNS0xLTEtMS03MDM2Mw_c34a808b-71f2-4a18-a815-a3a1d224b951"
      unitRef="securities">40</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ifcf9e5652a88433fa305f979016b813a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNS0zLTEtMS03MDM2Mw_6638b439-071d-411f-8aa7-59882b5fe4ed"
      unitRef="usd">61000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ifcf9e5652a88433fa305f979016b813a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNS01LTEtMS03MDM2Mw_98832ccc-a061-4ead-8976-7eaf642cc231"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ifcf9e5652a88433fa305f979016b813a_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNS03LTEtMS03MDM2Mw_8cd04ed9-8f19-4880-8147-5dc7d91d25c5"
      unitRef="securities">1</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ifcf9e5652a88433fa305f979016b813a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNS05LTEtMS03MDM2Mw_f7d19899-f7f4-4e8f-8ea4-a659b7f53ace"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ifcf9e5652a88433fa305f979016b813a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNS0xMS0xLTEtNzAzNjM_6d6da5bf-1e92-48ea-9d4c-216a85a888e9"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i6df5bdfdef2f4265b69076190eb614fd_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNi0xLTEtMS03MDM2Mw_93431c62-74b2-49f3-931e-4b880df7019b"
      unitRef="securities">225</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i6df5bdfdef2f4265b69076190eb614fd_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNi0zLTEtMS03MDM2Mw_efc93508-f7a4-48e1-b25f-08137cfabf5e"
      unitRef="usd">169000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i6df5bdfdef2f4265b69076190eb614fd_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNi01LTEtMS03MDM2Mw_99862734-a01b-436d-aff4-d84d5a292c80"
      unitRef="usd">34000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i6df5bdfdef2f4265b69076190eb614fd_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNi03LTEtMS03MDM2Mw_b3a9c034-c295-4f14-b2d4-560aca8be890"
      unitRef="securities">151</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i6df5bdfdef2f4265b69076190eb614fd_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNi05LTEtMS03MDM2Mw_de68b15d-5d8c-415b-8b11-5b05df0c9307"
      unitRef="usd">81000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i6df5bdfdef2f4265b69076190eb614fd_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNi0xMS0xLTEtNzAzNjM_78f98260-a0bd-44c4-b91f-5e898d09c9d7"
      unitRef="usd">36000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="icff2cdd7573a4a7cb6c9db9fbe416a43_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNy0xLTEtMS03MDM2Mw_e2d6bba7-39c4-461a-801d-5eb4420b355d"
      unitRef="securities">1964</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="icff2cdd7573a4a7cb6c9db9fbe416a43_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNy0zLTEtMS03MDM2Mw_1eba52c4-9dcd-42a1-b82b-b52ead920a7a"
      unitRef="usd">3602000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="icff2cdd7573a4a7cb6c9db9fbe416a43_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNy01LTEtMS03MDM2Mw_20fd906e-a73f-4a02-a790-2cd05a8ed200"
      unitRef="usd">314000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="icff2cdd7573a4a7cb6c9db9fbe416a43_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNy03LTEtMS03MDM2Mw_05afab4c-1c32-4487-9053-12690bf901d0"
      unitRef="securities">139</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="icff2cdd7573a4a7cb6c9db9fbe416a43_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNy05LTEtMS03MDM2Mw_75e080e2-9d0a-4fab-a69b-e939b93d138e"
      unitRef="usd">200000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="icff2cdd7573a4a7cb6c9db9fbe416a43_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfNy0xMS0xLTEtNzAzNjM_3d2fb1e0-36b9-49e7-b6c5-e021fe499f3f"
      unitRef="usd">41000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ib856546a61004b9daf43ccbcaf623bae_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOC0xLTEtMS03MDM2Mw_7947c617-1de6-4d97-af50-982611187610"
      unitRef="securities">4322</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ib856546a61004b9daf43ccbcaf623bae_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOC0zLTEtMS03MDM2Mw_31029c8d-4ae8-4039-b61e-110138c13c45"
      unitRef="usd">10228000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ib856546a61004b9daf43ccbcaf623bae_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOC01LTEtMS03MDM2Mw_d71e67e6-23a9-4e21-a355-f58ef2e5b5a7"
      unitRef="usd">1165000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ib856546a61004b9daf43ccbcaf623bae_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOC03LTEtMS03MDM2Mw_88dfb6a9-2e0f-42bb-a706-c59e18499528"
      unitRef="securities">1318</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ib856546a61004b9daf43ccbcaf623bae_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOC05LTEtMS03MDM2Mw_a8c066c6-a44b-4a31-b04c-2cb7df858d04"
      unitRef="usd">1679000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ib856546a61004b9daf43ccbcaf623bae_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOC0xMS0xLTEtNzAzNjM_fd79b5fb-d32b-41fa-a693-e0607b939e89"
      unitRef="usd">395000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i082f7dec90e34caa9e126e175c14b069_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOS0xLTEtMS03MDM2Mw_aa6a4bee-c19b-426d-8f4c-b5d339ead060"
      unitRef="securities">2035</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i082f7dec90e34caa9e126e175c14b069_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOS0zLTEtMS03MDM2Mw_b34a2575-f0a2-40e9-bffd-277d51d155c6"
      unitRef="usd">2949000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i082f7dec90e34caa9e126e175c14b069_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOS01LTEtMS03MDM2Mw_62b511f5-c732-423e-bf1c-b6d188d6b5f1"
      unitRef="usd">294000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i082f7dec90e34caa9e126e175c14b069_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOS03LTEtMS03MDM2Mw_3119b9bb-f369-454f-bb92-39c29a978d2b"
      unitRef="securities">530</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i082f7dec90e34caa9e126e175c14b069_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOS05LTEtMS03MDM2Mw_b68992ee-79f3-4536-92e9-8ed3aef3d5aa"
      unitRef="usd">1182000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i082f7dec90e34caa9e126e175c14b069_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfOS0xMS0xLTEtNzAzNjM_e7e34acc-b9c6-4922-96fb-d1a4dd39c754"
      unitRef="usd">212000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i2d1cb440b1e64fc3a441588000782d1b_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTAtMS0xLTEtNzAzNjM_2047dd3b-3126-4e29-99e1-4dd8fa64aa45"
      unitRef="securities">34</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i2d1cb440b1e64fc3a441588000782d1b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTAtMy0xLTEtNzAzNjM_2458b3d7-893b-4fd4-91f2-162f5c9979c9"
      unitRef="usd">56000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i2d1cb440b1e64fc3a441588000782d1b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTAtNS0xLTEtNzAzNjM_d08068bc-1d0e-48eb-bb54-857c2354faf7"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i2d1cb440b1e64fc3a441588000782d1b_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTAtNy0xLTEtNzAzNjM_ec13ef90-6445-47c0-ba7c-06b440932bee"
      unitRef="securities">7</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i2d1cb440b1e64fc3a441588000782d1b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTAtOS0xLTEtNzAzNjM_cc96c445-b69e-44cf-af83-aae2ebe0a977"
      unitRef="usd">13000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i2d1cb440b1e64fc3a441588000782d1b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTAtMTEtMS0xLTcwMzYz_d46599ea-c432-46eb-8c1d-b44b6e6c11aa"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i97d6a8ee2de34d46b8a9b30fcdfac191_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTEtMS0xLTEtNzAzNjM_4f8e6404-acfe-4793-a832-524dbea184db"
      unitRef="securities">921</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i97d6a8ee2de34d46b8a9b30fcdfac191_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTEtMy0xLTEtNzAzNjM_caad35a8-cf03-4154-9be4-71a943737a04"
      unitRef="usd">2535000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i97d6a8ee2de34d46b8a9b30fcdfac191_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTEtNS0xLTEtNzAzNjM_42f9d362-072f-4337-9fbb-75cbe9cc44a6"
      unitRef="usd">165000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i97d6a8ee2de34d46b8a9b30fcdfac191_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTEtNy0xLTEtNzAzNjM_f84a6692-25b8-40cc-b073-9b122e9e7234"
      unitRef="securities">269</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i97d6a8ee2de34d46b8a9b30fcdfac191_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTEtOS0xLTEtNzAzNjM_9f308256-c654-4e9d-bee4-457fac133620"
      unitRef="usd">670000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i97d6a8ee2de34d46b8a9b30fcdfac191_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTEtMTEtMS0xLTcwMzYz_702cd87f-03cd-41a1-b8de-8442a64c60e8"
      unitRef="usd">85000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ic06c4cd0bfbf4349bb38d37c2a08f1d5_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTItMS0xLTEtNzAzNjM_6c136bbd-0620-41ea-9366-3005a1ea4d80"
      unitRef="securities">9606</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ic06c4cd0bfbf4349bb38d37c2a08f1d5_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTItMy0xLTEtNzAzNjM_57789a0c-b6ae-4fbd-8b16-54c0ceed8a85"
      unitRef="usd">20511000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ic06c4cd0bfbf4349bb38d37c2a08f1d5_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTItNS0xLTEtNzAzNjM_eee6e49d-7c6c-44ef-aadd-9be5d8541d15"
      unitRef="usd">2056000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ic06c4cd0bfbf4349bb38d37c2a08f1d5_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTItNy0xLTEtNzAzNjM_3e62b70e-ec8e-49e5-abb6-dc2219e9d8f4"
      unitRef="securities">2444</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ic06c4cd0bfbf4349bb38d37c2a08f1d5_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTItOS0xLTEtNzAzNjM_b62ecdd3-7472-4d79-a93d-d07f97fabdcf"
      unitRef="usd">4128000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ic06c4cd0bfbf4349bb38d37c2a08f1d5_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTItMTEtMS0xLTcwMzYz_3dab8ffb-0e75-4143-9fac-0fbcafbfc9ed"
      unitRef="usd">821000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i03fb8a2f17234cf88446cfa6c92be531_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTctMS0xLTEtNzAzNjM_e8a50a90-a5ef-45c9-bbd7-c4c8ce7606c2"
      unitRef="securities">51</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i03fb8a2f17234cf88446cfa6c92be531_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTctMy0xLTEtNzAzNjM_91fdf948-26f8-43eb-aeb3-32b27279507b"
      unitRef="usd">990000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i03fb8a2f17234cf88446cfa6c92be531_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTctNS0xLTEtNzAzNjM_d192eaa5-0fa5-4932-a0a2-fcc466141577"
      unitRef="usd">11000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i03fb8a2f17234cf88446cfa6c92be531_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTctNy0xLTEtNzAzNjM_f4403e52-d07b-4387-b67a-dfa7d5e413a1"
      unitRef="securities">27</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i03fb8a2f17234cf88446cfa6c92be531_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTctOS0xLTEtNzAzNjM_4f9e86b9-a837-4c46-9c8b-a97cf8173894"
      unitRef="usd">176000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i03fb8a2f17234cf88446cfa6c92be531_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTctMTEtMS0xLTcwMzYz_9c28987c-d1e7-45e1-a2e5-12cc9e9127db"
      unitRef="usd">7000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i306fe04bc56d46bda85faed45e988b22_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTgtMS0xLTEtNzAzNjM_25afa4ee-f0be-43d0-8a27-6e5f1f2a6a30"
      unitRef="securities">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i306fe04bc56d46bda85faed45e988b22_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTgtMy0xLTEtNzAzNjM_53a17fce-3560-4647-ae15-98d756f29996"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i306fe04bc56d46bda85faed45e988b22_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTgtNS0xLTEtNzAzNjM_2d4a5b97-9a15-43aa-92fd-220b5440501c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i306fe04bc56d46bda85faed45e988b22_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTgtNy0xLTEtNzAzNjM_8cbba628-5854-49db-bea9-51df82a029cd"
      unitRef="securities">1</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i306fe04bc56d46bda85faed45e988b22_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTgtOS0xLTEtNzAzNjM_acd21f24-9cec-42b7-a125-e334bba3be54"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i306fe04bc56d46bda85faed45e988b22_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTgtMTEtMS0xLTcwMzYz_83a8f576-99c4-4be2-a33c-55f88f09480e"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i0bae2ef9bb1f4ef789325dd8bddd7037_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTktMS0xLTEtNzAzNjM_2d600e76-a27c-4078-99e0-c58170cab356"
      unitRef="securities">188</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i0bae2ef9bb1f4ef789325dd8bddd7037_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTktMy0xLTEtNzAzNjM_d1e78571-a0dd-4467-a060-687669d14dfc"
      unitRef="usd">143000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i0bae2ef9bb1f4ef789325dd8bddd7037_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTktNS0xLTEtNzAzNjM_4ab4fbbb-61f8-4eb7-9671-fb8b17869256"
      unitRef="usd">8000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i0bae2ef9bb1f4ef789325dd8bddd7037_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTktNy0xLTEtNzAzNjM_13fd5c96-faa8-496d-b673-28ed953af0d0"
      unitRef="securities">68</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i0bae2ef9bb1f4ef789325dd8bddd7037_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTktOS0xLTEtNzAzNjM_2d71f527-3952-45de-be18-c942110ecba8"
      unitRef="usd">41000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i0bae2ef9bb1f4ef789325dd8bddd7037_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMTktMTEtMS0xLTcwMzYz_f4ae4121-e715-4e34-a7e5-0122e6413cea"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i4d30de3c97a84918b22998e42c90804e_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjAtMS0xLTEtNzAzNjM_1e54fb0d-ebed-4285-8ab3-8892441e9fe3"
      unitRef="securities">281</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i4d30de3c97a84918b22998e42c90804e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjAtMy0xLTEtNzAzNjM_2ffdbce4-321c-46bb-9e92-c8c349b6c48f"
      unitRef="usd">634000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i4d30de3c97a84918b22998e42c90804e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjAtNS0xLTEtNzAzNjM_9a110d74-0e53-493d-ae56-1e04d09117b7"
      unitRef="usd">9000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i4d30de3c97a84918b22998e42c90804e_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjAtNy0xLTEtNzAzNjM_883b4245-04fa-4cb0-9b91-730b2deb78db"
      unitRef="securities">8</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i4d30de3c97a84918b22998e42c90804e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjAtOS0xLTEtNzAzNjM_ba456091-3da5-4536-aea6-e958668c4462"
      unitRef="usd">16000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i4d30de3c97a84918b22998e42c90804e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjAtMTEtMS0xLTcwMzYz_13a5be22-6e2f-4ffd-a91e-e34d32573789"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i25961790b2e241c39e1d9b6ee2a7abf8_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjEtMS0xLTEtNzAzNjM_426c662a-f39d-4e55-902b-1298dbb819c6"
      unitRef="securities">1846</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i25961790b2e241c39e1d9b6ee2a7abf8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjEtMy0xLTEtNzAzNjM_198af97d-b09e-4deb-af35-80bfcc4ac278"
      unitRef="usd">3310000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i25961790b2e241c39e1d9b6ee2a7abf8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjEtNS0xLTEtNzAzNjM_652a1b5f-78f9-4cf4-bd11-91c32753cd73"
      unitRef="usd">57000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i25961790b2e241c39e1d9b6ee2a7abf8_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjEtNy0xLTEtNzAzNjM_a068183f-4c03-4902-b2a0-2f50df567029"
      unitRef="securities">403</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i25961790b2e241c39e1d9b6ee2a7abf8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjEtOS0xLTEtNzAzNjM_b6f823ad-554e-45a1-b147-f25f1e06fab9"
      unitRef="usd">485000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i25961790b2e241c39e1d9b6ee2a7abf8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjEtMTEtMS0xLTcwMzYz_472663ca-ed00-44bf-9665-9a95d0131103"
      unitRef="usd">21000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i6e76ffeb19be42d4a1e2d44c3205ecab_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjItMS0xLTEtNzAzNjM_a344848c-c4f7-48d3-81c8-6c37969965a1"
      unitRef="securities">692</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i6e76ffeb19be42d4a1e2d44c3205ecab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjItMy0xLTEtNzAzNjM_2e6d2aa0-e31d-42a2-816b-1edd78bf1ed8"
      unitRef="usd">1967000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i6e76ffeb19be42d4a1e2d44c3205ecab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjItNS0xLTEtNzAzNjM_a9098e15-711f-4eba-b9d5-03bdbe7574b2"
      unitRef="usd">26000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i6e76ffeb19be42d4a1e2d44c3205ecab_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjItNy0xLTEtNzAzNjM_fc863673-310a-4c96-a24c-25ff3d6ac3d1"
      unitRef="securities">125</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i6e76ffeb19be42d4a1e2d44c3205ecab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjItOS0xLTEtNzAzNjM_cf89194f-3778-49e5-8310-42e427d1dafc"
      unitRef="usd">173000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i6e76ffeb19be42d4a1e2d44c3205ecab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjItMTEtMS0xLTcwMzYz_e867467d-bdff-40de-bc25-93bf7c90e8b2"
      unitRef="usd">9000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i47e63f11825d402e9000e5995d8b173f_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjMtMS0xLTEtNzAzNjM_24cc7eed-e6f8-4b7d-8778-8feca83377c9"
      unitRef="securities">2</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i47e63f11825d402e9000e5995d8b173f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjMtMy0xLTEtNzAzNjM_3ba28983-2310-4d22-a6c2-2cf20f53b8b0"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i47e63f11825d402e9000e5995d8b173f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjMtNS0xLTEtNzAzNjM_84f783e8-2b71-4a9d-b151-f90148484f2e"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i47e63f11825d402e9000e5995d8b173f_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjMtNy0xLTEtNzAzNjM_5f101ce9-6f97-4423-8a82-53d4a513652e"
      unitRef="securities">4</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i47e63f11825d402e9000e5995d8b173f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjMtOS0xLTEtNzAzNjM_0baa9fea-e6b3-403c-8e3f-e4603bf23c83"
      unitRef="usd">8000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i47e63f11825d402e9000e5995d8b173f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjMtMTEtMS0xLTcwMzYz_6bfdcfae-df5b-4277-9049-479ce26ecdc5"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i85e2285118fb48818a1361310a8c779d_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjQtMS0xLTEtNzAzNjM_dac4b9eb-5dcb-4996-8834-d53996d8ed7c"
      unitRef="securities">511</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i85e2285118fb48818a1361310a8c779d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjQtMy0xLTEtNzAzNjM_08af4fb2-be0c-4a3b-a3b7-7a896ece8f3f"
      unitRef="usd">1707000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i85e2285118fb48818a1361310a8c779d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjQtNS0xLTEtNzAzNjM_2333ffc0-27f9-4bf0-8a9d-14e031acdd29"
      unitRef="usd">19000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i85e2285118fb48818a1361310a8c779d_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjQtNy0xLTEtNzAzNjM_2c4373da-0c7b-4333-b9e7-5dca2c24fae8"
      unitRef="securities">50</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i85e2285118fb48818a1361310a8c779d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjQtOS0xLTEtNzAzNjM_96949e66-9e6f-4e94-bcf9-98805008db4f"
      unitRef="usd">85000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i85e2285118fb48818a1361310a8c779d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjQtMTEtMS0xLTcwMzYz_a1aa1a6d-3718-4473-b0ec-a85bd2f8df77"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i7a60715792a94db5a003dde44cc00d7d_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjUtMS0xLTEtNzAzNjM_5f03bcde-8213-4216-b37d-fe6a04f52f9e"
      unitRef="securities">3571</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i7a60715792a94db5a003dde44cc00d7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjUtMy0xLTEtNzAzNjM_1db9578a-2b62-4b2d-a66d-53c880aec595"
      unitRef="usd">8755000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i7a60715792a94db5a003dde44cc00d7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjUtNS0xLTEtNzAzNjM_fd31bd81-8e3a-4e05-b6a5-53153683f363"
      unitRef="usd">131000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i7a60715792a94db5a003dde44cc00d7d_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjUtNy0xLTEtNzAzNjM_b84e2961-27ee-44b0-acce-c69514592669"
      unitRef="securities">686</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i7a60715792a94db5a003dde44cc00d7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjUtOS0xLTEtNzAzNjM_714fe19c-5b04-4e0e-b11d-a16779cb03ab"
      unitRef="usd">985000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i7a60715792a94db5a003dde44cc00d7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOmU5MzM1YWVhODM3MzQ4NjE4N2JkMTVkZTg0MjA1Y2Y5L3RhYmxlcmFuZ2U6ZTkzMzVhZWE4MzczNDg2MTg3YmQxNWRlODQyMDVjZjlfMjUtMTEtMS0xLTcwMzYz_4a65cfb7-f835-4665-9913-dd0b8c427f72"
      unitRef="usd">51000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfMzI5ODUzNDg5NTA5MQ_2547dffe-e454-4812-b566-b2fa90258334"
      unitRef="usd">-10000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfMzI5ODUzNDg5NTA5Ng_5b724c86-1c56-47ce-8408-b499b44076ab"
      unitRef="usd">-6000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzY1MQ_7accf119-cb36-4ae7-8dfa-20ccd074be2d">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost and fair value of fixed maturity securities at September&#160;30, 2022, by contractual maturity, are shown below. Expected maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fixed maturity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfMS0xLTEtMS03MDM2Mw_db7a7578-2114-4ea4-9446-1065d6261e2e"
      unitRef="usd">911000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfMS0zLTEtMS03MDM2Mw_6542d94b-5e13-4dec-8ff8-ff984a510525"
      unitRef="usd">901000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfMi0xLTEtMS03MDM2Mw_928db848-3296-4256-8149-d7b91ca2bc12"
      unitRef="usd">7364000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfMi0zLTEtMS03MDM2Mw_baf063a8-1795-4053-ab8c-6cece977eab9"
      unitRef="usd">6871000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfMy0xLTEtMS03MDM2Mw_acf0da85-89c1-485f-8404-3307d7d1d52e"
      unitRef="usd">9535000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfMy0zLTEtMS03MDM2Mw_5c9d4e82-14c0-4209-9b6a-93b8ae736fa5"
      unitRef="usd">8467000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfNC0xLTEtMS03MDM2Mw_03fe26e4-badd-4755-b359-75f77db9be36"
      unitRef="usd">6342000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfNC0zLTEtMS03MDM2Mw_af3812c9-4ac3-4ac4-ac86-7404ac105226"
      unitRef="usd">5592000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfNS0xLTEtMS03MDM2Mw_e50fe243-7256-4a1d-8a2e-7142f401fe2d"
      unitRef="usd">4825000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfNS0zLTEtMS03MDM2Mw_60d923d0-0e8b-4b77-bf0d-5c6b80a9e2ea"
      unitRef="usd">4317000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfNi0xLTEtMS03MDM2Mw_4193d61b-85ff-4e7b-a530-4e536973a2d0"
      unitRef="usd">28977000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjlmNDU0ZjgxZThiMzRkNzg4YTJjNjE1ZTMzYzFiNjAzL3RhYmxlcmFuZ2U6OWY0NTRmODFlOGIzNGQ3ODhhMmM2MTVlMzNjMWI2MDNfNi0zLTEtMS03MDM2Mw_8869f2a3-05e7-431b-8703-c280aa752f70"
      unitRef="usd">26148000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i808391c8a062488da8dfcc76e14f106b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNDcyMw_e402ba77-f7b6-4a49-a952-92c60c173733"
      unitRef="usd">5281000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="ieaad01ac86274516a2427e2324cbdace_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNDczMA_2cfcaa63-ef20-4508-a44d-f6a61d07185a"
      unitRef="usd">15953000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="ic6ef12a8ed884a10a5de9971fb0a2ef8_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNDg4Mw_d43fd478-69dc-4f90-bc39-1491078bbde6"
      unitRef="usd">2620000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i341b56b7c33d48c6ad350fd7fbaf27d5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNDg5MA_fd695cd3-aa38-4767-a0c9-5dcc6e65fa10"
      unitRef="usd">8570000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <elv:InvestmentsinequitysecuritiesTableTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzYzOQ_ffa8e40f-e1da-4047-b304-72d2426a7172">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of marketable equity securities at September&#160;30, 2022 and December&#160;31, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.211%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exchange traded funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</elv:InvestmentsinequitysecuritiesTableTextBlock>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i4fddf0df137b450988ab2a4425925e2c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjI1OWFhNDJkZWQ4ODRkNTZiNGNkZDMzZDEyMGVlM2ZlL3RhYmxlcmFuZ2U6MjU5YWE0MmRlZDg4NGQ1NmI0Y2RkMzNkMTIwZWUzZmVfMi01LTEtMS03MDM2Mw_cfb5d5f1-5f5e-4572-8d3b-a6df476a6df1"
      unitRef="usd">1403000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ieb05027535a4458e88a535ee3031f6ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjI1OWFhNDJkZWQ4ODRkNTZiNGNkZDMzZDEyMGVlM2ZlL3RhYmxlcmFuZ2U6MjU5YWE0MmRlZDg4NGQ1NmI0Y2RkMzNkMTIwZWUzZmVfMi03LTEtMS03MDM2Mw_36572866-c664-4df6-b99e-a2cbc3dda1bb"
      unitRef="usd">1750000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i67d0a155fc6f462db3e652e6e997c5a6_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjI1OWFhNDJkZWQ4ODRkNTZiNGNkZDMzZDEyMGVlM2ZlL3RhYmxlcmFuZ2U6MjU5YWE0MmRlZDg4NGQ1NmI0Y2RkMzNkMTIwZWUzZmVfNC01LTEtMS03MDM2Mw_e706112a-ded6-4083-88de-0ebb7a288410"
      unitRef="usd">5000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i33efd1a573514923804d15df68fbc169_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjI1OWFhNDJkZWQ4ODRkNTZiNGNkZDMzZDEyMGVlM2ZlL3RhYmxlcmFuZ2U6MjU5YWE0MmRlZDg4NGQ1NmI0Y2RkMzNkMTIwZWUzZmVfNC03LTEtMS03MDM2Mw_d6c60308-ede0-4811-9c81-5dc14abcffee"
      unitRef="usd">42000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i7efa70157d8f49d1932d09a94dfe1529_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjI1OWFhNDJkZWQ4ODRkNTZiNGNkZDMzZDEyMGVlM2ZlL3RhYmxlcmFuZ2U6MjU5YWE0MmRlZDg4NGQ1NmI0Y2RkMzNkMTIwZWUzZmVfNS01LTEtMS03MDM2Mw_2bb79fd1-fee7-4f8f-bde1-a91f245533ba"
      unitRef="usd">95000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i7d4cd6b13d62409ea6135442dfd3c169_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjI1OWFhNDJkZWQ4ODRkNTZiNGNkZDMzZDEyMGVlM2ZlL3RhYmxlcmFuZ2U6MjU5YWE0MmRlZDg4NGQ1NmI0Y2RkMzNkMTIwZWUzZmVfNS03LTEtMS03MDM2Mw_47a6d5f4-5dfd-4ee7-9993-746e67b70f39"
      unitRef="usd">89000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjI1OWFhNDJkZWQ4ODRkNTZiNGNkZDMzZDEyMGVlM2ZlL3RhYmxlcmFuZ2U6MjU5YWE0MmRlZDg4NGQ1NmI0Y2RkMzNkMTIwZWUzZmVfNi01LTEtMS03MDM2Mw_95753e35-3d66-4be9-873d-cb8043b2910b"
      unitRef="usd">1503000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjI1OWFhNDJkZWQ4ODRkNTZiNGNkZDMzZDEyMGVlM2ZlL3RhYmxlcmFuZ2U6MjU5YWE0MmRlZDg4NGQ1NmI0Y2RkMzNkMTIwZWUzZmVfNi03LTEtMS03MDM2Mw_c07b63ca-e5b0-4f81-9bec-72974174528e"
      unitRef="usd">1881000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:GainLossOnInvestmentsTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzY3NQ_908a62ff-fb3b-432f-8dad-c6d2c4253419">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net investment (losses) gains for the three and nine months ended September&#160;30, 2022 and 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.873%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended &lt;br/&gt;September 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (losses) gains:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed maturity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized gains from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized losses from sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(353)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment (losses) recoveries recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized (losses) gains from sales of fixed maturity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized (losses) gains recognized on equity securities still held at the end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized gains (losses) recognized on equity securities sold during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net losses on equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment (losses) recoveries recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net losses (gains) on other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (losses) gains on investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(482)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GainLossOnInvestmentsTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i808391c8a062488da8dfcc76e14f106b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNC0xLTEtMS03MDM2Mw_73832c28-97a1-406b-8a91-239c65675ac3"
      unitRef="usd">8000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="ic6ef12a8ed884a10a5de9971fb0a2ef8_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNC0zLTEtMS03MDM2Mw_9746b5b7-a4fb-43e0-86fe-0d512c20c7ec"
      unitRef="usd">30000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="ieaad01ac86274516a2427e2324cbdace_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNC01LTEtMS03MDM2Mw_e884ea6b-7ea0-4dca-afe5-4242330ddbb0"
      unitRef="usd">44000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i341b56b7c33d48c6ad350fd7fbaf27d5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNC03LTEtMS03MDM2Mw_30b3e25a-f2cb-4553-83aa-ab4419ae4a9f"
      unitRef="usd">133000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i808391c8a062488da8dfcc76e14f106b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNS0xLTEtMS03MDM2Mw_62894cb1-1e10-45d1-b449-10e5ce978388"
      unitRef="usd">-99000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="ic6ef12a8ed884a10a5de9971fb0a2ef8_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNS0zLTEtMS03MDM2Mw_34740849-091e-4bb4-b5e9-0821a2006ad2"
      unitRef="usd">-8000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="ieaad01ac86274516a2427e2324cbdace_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNS01LTEtMS03MDM2Mw_9f2f0723-bca6-474c-b464-ba0f17bb9fd2"
      unitRef="usd">-353000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i341b56b7c33d48c6ad350fd7fbaf27d5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNS03LTEtMS03MDM2Mw_deeac256-7cfd-4052-9f1b-b6c36e57c65e"
      unitRef="usd">-32000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <elv:Impairmentlossesreversalsoninvestments
      contextRef="i808391c8a062488da8dfcc76e14f106b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNi0xLTEtMS03MDM2Mw_dad0275b-7957-49bc-866f-77de749bac76"
      unitRef="usd">5000000</elv:Impairmentlossesreversalsoninvestments>
    <elv:Impairmentlossesreversalsoninvestments
      contextRef="ic6ef12a8ed884a10a5de9971fb0a2ef8_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNi0zLTEtMS03MDM2Mw_c9a085bf-4df0-4000-bc7a-b473e440de34"
      unitRef="usd">0</elv:Impairmentlossesreversalsoninvestments>
    <elv:Impairmentlossesreversalsoninvestments
      contextRef="ieaad01ac86274516a2427e2324cbdace_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNi01LTEtMS03MDM2Mw_8f13b5ba-de29-4244-a66b-4ba470c627cc"
      unitRef="usd">25000000</elv:Impairmentlossesreversalsoninvestments>
    <elv:Impairmentlossesreversalsoninvestments
      contextRef="i341b56b7c33d48c6ad350fd7fbaf27d5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNi03LTEtMS03MDM2Mw_25afab26-db64-4ade-9a30-62369f1cabd1"
      unitRef="usd">-1000000</elv:Impairmentlossesreversalsoninvestments>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss
      contextRef="i808391c8a062488da8dfcc76e14f106b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNy0xLTEtMS03MDM2Mw_a8ce7513-ecb4-4407-a493-03decc532b9a"
      unitRef="usd">-96000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss
      contextRef="ic6ef12a8ed884a10a5de9971fb0a2ef8_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNy0zLTEtMS03MDM2Mw_a1ef21b2-cd97-46c7-b0dd-a0a3b6c575f8"
      unitRef="usd">22000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss
      contextRef="ieaad01ac86274516a2427e2324cbdace_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNy01LTEtMS03MDM2Mw_13a95b5e-3c7b-46b9-983f-e10d583bf036"
      unitRef="usd">-334000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss
      contextRef="i341b56b7c33d48c6ad350fd7fbaf27d5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfNy03LTEtMS03MDM2Mw_26dfa4d5-c2f9-417a-a3cd-06dbc8e430b1"
      unitRef="usd">102000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="idd1d2d7db12846a4a3ec11dffaaa857a_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfOS0xLTEtMS03MDM2Mw_496bfe16-e75b-44ff-9553-999c14e15029"
      unitRef="usd">-43000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="ib08d03a09c464eb5bc34b1ee5faf7ea2_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfOS0zLTEtMS03MDM2Mw_84a92956-dfab-4430-aaba-6de30b7ea9ba"
      unitRef="usd">-4000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i525deba77845499db8929bee8586f509_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfOS01LTEtMS03MDM2Mw_b49377b3-67a9-40e8-873e-1fcc89a980fc"
      unitRef="usd">-192000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="if83fa79c889143edbd4e4ba481c5106e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfOS03LTEtMS03MDM2Mw_05ced053-5c81-460a-9493-6a0cd749063b"
      unitRef="usd">4000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="idd1d2d7db12846a4a3ec11dffaaa857a_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTAtMS0xLTEtNzAzNjM_66375a3c-2253-4e5d-8768-3dde7b791418"
      unitRef="usd">4000000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="ib08d03a09c464eb5bc34b1ee5faf7ea2_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTAtMy0xLTEtNzAzNjM_16035d55-d445-443c-8b8c-3db30ec3c1cf"
      unitRef="usd">-1000000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="i525deba77845499db8929bee8586f509_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTAtNS0xLTEtNzAzNjM_24cec831-be1f-4813-894a-909a52f36d4d"
      unitRef="usd">-20000000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="if83fa79c889143edbd4e4ba481c5106e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTAtNy0xLTEtNzAzNjM_894ab211-3869-441f-825c-26a6cfb889fa"
      unitRef="usd">-57000000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="idd1d2d7db12846a4a3ec11dffaaa857a_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTEtMS0xLTEtNzAzNjM_a788e90e-5240-45c4-b298-d66538210b32"
      unitRef="usd">-39000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="ib08d03a09c464eb5bc34b1ee5faf7ea2_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTEtMy0xLTEtNzAzNjM_bfe809bb-6635-492f-92eb-210bea003103"
      unitRef="usd">-5000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i525deba77845499db8929bee8586f509_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTEtNS0xLTEtNzAzNjM_712a8774-9636-47fd-b9ee-4f19e0e994a4"
      unitRef="usd">-212000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="if83fa79c889143edbd4e4ba481c5106e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTEtNy0xLTEtNzAzNjM_551865b7-6b8b-445f-a60a-53cef965f9ae"
      unitRef="usd">-53000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <elv:GainsFromOtherInvestments
      contextRef="i76d0d6767c2146a4aa94f20b9f15ea40_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTMtMS0xLTEtNzAzNjM_137a3c15-d6a4-445d-8337-e2de2149a768"
      unitRef="usd">95000000</elv:GainsFromOtherInvestments>
    <elv:GainsFromOtherInvestments
      contextRef="icbe9a6627d614becb080363c4cc79132_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTMtMy0xLTEtNzAzNjM_0bd06864-733c-40da-bb28-7416ead6d8e9"
      unitRef="usd">2000000</elv:GainsFromOtherInvestments>
    <elv:GainsFromOtherInvestments
      contextRef="i9e6a553b24d9430485f058f6dabd9ef0_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTMtNS0xLTEtNzAzNjM_c09bb098-37af-4a43-ac85-f4e391163dd0"
      unitRef="usd">126000000</elv:GainsFromOtherInvestments>
    <elv:GainsFromOtherInvestments
      contextRef="i623def1f7d994412a99937dd097a9306_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTMtNy0xLTEtNzAzNjM_8cbc1d9b-8948-42f5-a7a3-1d31287e4206"
      unitRef="usd">9000000</elv:GainsFromOtherInvestments>
    <elv:GrossLossesFromOtherInvestments
      contextRef="i76d0d6767c2146a4aa94f20b9f15ea40_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTQtMS0xLTEtNzAzNjM_659fa136-0a14-44d2-a8f5-1a1ba937a53a"
      unitRef="usd">2000000</elv:GrossLossesFromOtherInvestments>
    <elv:GrossLossesFromOtherInvestments
      contextRef="icbe9a6627d614becb080363c4cc79132_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTQtMy0xLTEtNzAzNjM_d1ef209c-ab6e-4356-a123-7267fe4c9eee"
      unitRef="usd">93000000</elv:GrossLossesFromOtherInvestments>
    <elv:GrossLossesFromOtherInvestments
      contextRef="i9e6a553b24d9430485f058f6dabd9ef0_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTQtNS0xLTEtNzAzNjM_52bbf305-8539-4e49-9d5c-0f38f11e6e21"
      unitRef="usd">45000000</elv:GrossLossesFromOtherInvestments>
    <elv:GrossLossesFromOtherInvestments
      contextRef="i623def1f7d994412a99937dd097a9306_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTQtNy0xLTEtNzAzNjM_ceb2a4ff-2c7b-4740-81d2-0c40a0f5cc3b"
      unitRef="usd">5000000</elv:GrossLossesFromOtherInvestments>
    <elv:Impairmentlossesreversalsoninvestments
      contextRef="i76d0d6767c2146a4aa94f20b9f15ea40_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTUtMS0xLTEtNzAzNjM_bbe2669c-1c53-4228-8255-ea072ae7a404"
      unitRef="usd">12000000</elv:Impairmentlossesreversalsoninvestments>
    <elv:Impairmentlossesreversalsoninvestments
      contextRef="icbe9a6627d614becb080363c4cc79132_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTUtMy0xLTEtNzAzNjM_c8afd86f-c7f3-4c8b-a9d2-cd5a50c7e20b"
      unitRef="usd">-1000000</elv:Impairmentlossesreversalsoninvestments>
    <elv:Impairmentlossesreversalsoninvestments
      contextRef="i9e6a553b24d9430485f058f6dabd9ef0_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTUtNS0xLTEtNzAzNjM_50237d38-74be-4c6b-902f-8d5221f13b2d"
      unitRef="usd">17000000</elv:Impairmentlossesreversalsoninvestments>
    <elv:Impairmentlossesreversalsoninvestments
      contextRef="i623def1f7d994412a99937dd097a9306_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTUtNy0xLTEtNzAzNjM_2dfb51dd-d8f3-4f2a-b9ea-88accad4cdc4"
      unitRef="usd">5000000</elv:Impairmentlossesreversalsoninvestments>
    <us-gaap:GainLossOnSaleOfOtherInvestments
      contextRef="i76d0d6767c2146a4aa94f20b9f15ea40_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTYtMS0xLTEtNzAzNjM_44c1f90a-a1f8-4a6e-a3e6-46694451d1f8"
      unitRef="usd">81000000</us-gaap:GainLossOnSaleOfOtherInvestments>
    <us-gaap:GainLossOnSaleOfOtherInvestments
      contextRef="icbe9a6627d614becb080363c4cc79132_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTYtMy0xLTEtNzAzNjM_20434646-9eb6-4613-a5e2-825661869d61"
      unitRef="usd">-90000000</us-gaap:GainLossOnSaleOfOtherInvestments>
    <us-gaap:GainLossOnSaleOfOtherInvestments
      contextRef="i9e6a553b24d9430485f058f6dabd9ef0_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTYtNS0xLTEtNzAzNjM_29e92fd9-ac10-466c-93e6-a3bce63a6865"
      unitRef="usd">64000000</us-gaap:GainLossOnSaleOfOtherInvestments>
    <us-gaap:GainLossOnSaleOfOtherInvestments
      contextRef="i623def1f7d994412a99937dd097a9306_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTYtNy0xLTEtNzAzNjM_73b749cf-c7a7-45ca-9222-69bf6f31f3d3"
      unitRef="usd">-1000000</us-gaap:GainLossOnSaleOfOtherInvestments>
    <elv:InvestmentGainsLosses
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTctMS0xLTEtNzAzNjM_bfc1a45d-104f-46cb-9d68-12ef6286af50"
      unitRef="usd">-54000000</elv:InvestmentGainsLosses>
    <elv:InvestmentGainsLosses
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTctMy0xLTEtNzAzNjM_c391f4e2-c708-4737-b3b3-e96fda1c7c47"
      unitRef="usd">-73000000</elv:InvestmentGainsLosses>
    <elv:InvestmentGainsLosses
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTctNS0xLTEtNzAzNjM_f9177582-192b-4295-bc79-a34c3ac77aa2"
      unitRef="usd">-482000000</elv:InvestmentGainsLosses>
    <elv:InvestmentGainsLosses
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RhYmxlOjVjYWE4NTg4ODY4YTRiYWU4ZDI5NGZkNTMwMjRhYzFhL3RhYmxlcmFuZ2U6NWNhYTg1ODg4NjhhNGJhZThkMjk0ZmQ1MzAyNGFjMWFfMTctNy0xLTEtNzAzNjM_22a82c3f-ec79-438f-bc49-c5934cab34e6"
      unitRef="usd">48000000</elv:InvestmentGainsLosses>
    <us-gaap:AccruedInvestmentIncomeReceivable
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNjM2NQ_9f12b5dc-880a-4ed8-9d14-517fa55b8b65"
      unitRef="usd">228000000</us-gaap:AccruedInvestmentIncomeReceivable>
    <us-gaap:AccruedInvestmentIncomeReceivable
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNjM3Mg_a2033e7f-5f68-48eb-83ae-b7000c074074"
      unitRef="usd">205000000</us-gaap:AccruedInvestmentIncomeReceivable>
    <us-gaap:SecuritiesLoanedFairValueOfCollateral
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNjgxOQ_4a74aab8-b527-40dc-9e01-cc263654dab5"
      unitRef="usd">2841000000</us-gaap:SecuritiesLoanedFairValueOfCollateral>
    <us-gaap:SecuritiesLoanedFairValueOfCollateral
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNjgyNg_7e784a7d-15f3-4731-8810-4a274a3c8434"
      unitRef="usd">2155000000</us-gaap:SecuritiesLoanedFairValueOfCollateral>
    <elv:SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNjg5Nw_c57bee45-ac34-4278-82d4-676401419e75"
      unitRef="number">1.02</elv:SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan>
    <elv:SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNjg5Nw_d0ad560a-46d2-47f8-82f8-187d4b43e43e"
      unitRef="number">1.02</elv:SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan>
    <us-gaap:DepositsReceivedForSecuritiesLoanedAtCarryingValue
      contextRef="ibf2a7ef2990b49d18dfaee52d861df7a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzQ5MQ_d3da1895-8a58-4667-9f1b-345ee6c57ed0"
      unitRef="usd">2636000000</us-gaap:DepositsReceivedForSecuritiesLoanedAtCarryingValue>
    <us-gaap:DepositsReceivedForSecuritiesLoanedAtCarryingValue
      contextRef="i6d66732359c54c7ba0fed0dc86c8903a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzQ5OA_be0cc82a-6b32-4006-b500-d44038d4df96"
      unitRef="usd">1874000000</us-gaap:DepositsReceivedForSecuritiesLoanedAtCarryingValue>
    <us-gaap:DepositsReceivedForSecuritiesLoanedAtCarryingValue
      contextRef="i55aa272b38d249cf8f65430d3ab7ec89_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzU1OQ_0edd9b9d-b14f-4aca-901a-647b3af9ed3b"
      unitRef="usd">180000000</us-gaap:DepositsReceivedForSecuritiesLoanedAtCarryingValue>
    <us-gaap:DepositsReceivedForSecuritiesLoanedAtCarryingValue
      contextRef="i6575af0d7a33465d80ae8b7e123eb574_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzU2Ng_effe326c-f218-4967-a2b4-3946167df572"
      unitRef="usd">281000000</us-gaap:DepositsReceivedForSecuritiesLoanedAtCarryingValue>
    <us-gaap:DepositsReceivedForSecuritiesLoanedAtCarryingValue
      contextRef="i82413feb72304cfd9028728f729361cc_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzYxMg_533aac7e-2d05-4c55-9c2e-3ea6b08d7aa7"
      unitRef="usd">25000000</us-gaap:DepositsReceivedForSecuritiesLoanedAtCarryingValue>
    <us-gaap:DepositsReceivedForSecuritiesLoanedAtCarryingValue
      contextRef="iee555febc7b1489c841bed85cfdde1c7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF80OS9mcmFnOjU4MDRhYjg2YzY0NTRmOThiNmViNjUxZjQwZTFkMTVjL3RleHRyZWdpb246NTgwNGFiODZjNjQ1NGY5OGI2ZWI2NTFmNDBlMWQxNWNfNzYxOQ_fe894076-19a6-433b-bb78-e31deaa8157d"
      unitRef="usd">0</us-gaap:DepositsReceivedForSecuritiesLoanedAtCarryingValue>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81NS9mcmFnOmFlMmM4ZTM0YmY2YjRkOWFhNDA4ZmYzNWI1NDBkY2EyL3RleHRyZWdpb246YWUyYzhlMzRiZjZiNGQ5YWE0MDhmZjM1YjU0MGRjYTJfMTQzMw_241f54a1-966b-4ba4-9b94-46f303010e43">Derivative Financial Instruments&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We primarily invest in the following types of derivative financial instruments: interest rate swaps, futures, forward contracts, put and call options, swaptions, embedded derivatives and warrants. We also enter into master netting agreements, which reduce credit risk by permitting net settlement of transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into various interest rate swap contracts to convert a portion of our interest rate exposure on our long-term debt from fixed rates to floating rates. The floating rates payable on all of our fair value hedges are benchmarked to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LIBOR or the Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;). Any amounts recognized for changes in fair value of these derivatives are included in the captions &#x201c;Other current assets,&#x201d; &#x201c;Other noncurrent assets,&#x201d; &#x201c;Other current liabilities&#x201d; or &#x201c;Other noncurrent liabilities&#x201d; in our consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unrecognized loss for all expired and terminated cash flow hedges included in accumulated other comprehensive loss, net of tax, was $231 and $239 at September&#160;30, 2022 and December&#160;31, 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;three and nine months ended September&#160;30, 2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, we recognized net (losses) gains on non-hedging derivatives of $(3) and $43, respectively. During the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;three and nine months ended September&#160;30, 2021&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, we recognized net gains on non-hedging derivatives of $12 and $59, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For additional information relating to the fair value of our derivative assets and liabilities, see Note 7, &#x201c;Fair Value,&#x201d; of this Form 10-Q.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="ifdb7c3f4f8e543b8a2df60e3edae8983_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81NS9mcmFnOmFlMmM4ZTM0YmY2YjRkOWFhNDA4ZmYzNWI1NDBkY2EyL3RleHRyZWdpb246YWUyYzhlMzRiZjZiNGQ5YWE0MDhmZjM1YjU0MGRjYTJfMTA0Nw_b36833e1-6316-41ba-a75d-3150327cd984"
      unitRef="usd">-231000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="ia0ee2e1f5c8c43419e04e58cfb917f9c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81NS9mcmFnOmFlMmM4ZTM0YmY2YjRkOWFhNDA4ZmYzNWI1NDBkY2EyL3RleHRyZWdpb246YWUyYzhlMzRiZjZiNGQ5YWE0MDhmZjM1YjU0MGRjYTJfMTA1NQ_483bd706-0c2e-4214-9456-4e9efebbe735"
      unitRef="usd">-239000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81NS9mcmFnOmFlMmM4ZTM0YmY2YjRkOWFhNDA4ZmYzNWI1NDBkY2EyL3RleHRyZWdpb246YWUyYzhlMzRiZjZiNGQ5YWE0MDhmZjM1YjU0MGRjYTJfMTE1OQ_7f8068d1-840d-42b8-9ad7-c0d6d6457c41"
      unitRef="usd">-3000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81NS9mcmFnOmFlMmM4ZTM0YmY2YjRkOWFhNDA4ZmYzNWI1NDBkY2EyL3RleHRyZWdpb246YWUyYzhlMzRiZjZiNGQ5YWE0MDhmZjM1YjU0MGRjYTJfMTE2Ng_c933dc0a-3976-4cec-908c-07c4527586b2"
      unitRef="usd">43000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81NS9mcmFnOmFlMmM4ZTM0YmY2YjRkOWFhNDA4ZmYzNWI1NDBkY2EyL3RleHRyZWdpb246YWUyYzhlMzRiZjZiNGQ5YWE0MDhmZjM1YjU0MGRjYTJfMTI1Ng_d530a5d6-09cf-4c5e-989b-83cdd220ca43"
      unitRef="usd">12000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81NS9mcmFnOmFlMmM4ZTM0YmY2YjRkOWFhNDA4ZmYzNWI1NDBkY2EyL3RleHRyZWdpb246YWUyYzhlMzRiZjZiNGQ5YWE0MDhmZjM1YjU0MGRjYTJfMTI2Mw_c41e5fce-48fe-46b9-bbf9-179be647e460"
      unitRef="usd">59000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RleHRyZWdpb246ZTIyYTVkZjliODYyNDAwOWJhY2RlNjY5ZmIxMGEzYTNfMTE1OTg_f1668bd1-3fc9-4e3e-9b9d-1f0bf76e537a">Fair Value&lt;div style="margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities recorded at fair value in our consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Level inputs, as defined by FASB guidance for fair value measurements and disclosures, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.553%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.317%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Level&#160;Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Input Definition&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unobservable inputs that reflect management&#x2019;s best estimate of what market participants would use in pricing the asset or liability at the measurement date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:4pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following methods, assumptions and inputs were used to determine the fair value of each class of the following assets and liabilities recorded at fair value in our consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Cash equivalents primarily consist of highly rated money market funds with maturities of three months or less and are purchased daily at par value with specified yield rates. Due to the high ratings and short-term nature of the funds, we designate all cash equivalents as Level I.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fixed maturity securities, available-for-sale:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Fair values of available-for-sale fixed maturity securities are based on quoted market prices, where available. These fair values are obtained primarily from third-party pricing services, which generally use Level I or Level II inputs for the determination of fair value to facilitate fair value measurements and disclosures. Level II securities primarily include corporate securities, securities from states, municipalities and political subdivisions, mortgage-backed securities, United States government securities, foreign government securities, and certain other asset-backed securities. For securities not actively traded, the pricing services may use quoted market prices of comparable instruments or discounted cash flow analyses, incorporating inputs that are currently observable in the markets for similar securities. We have controls in place to review the pricing services&#x2019; qualifications and procedures used to determine fair values. In addition, we periodically review the pricing services&#x2019; pricing methodologies, data sources and pricing inputs to ensure the fair values obtained are reasonable. Inputs that are often used in the valuation methodologies include, but are not limited to, broker quotes, benchmark yields, credit spreads, default rates and prepayment speeds. We also have certain fixed maturity securities, primarily corporate debt securities, which are designated Level III securities. For these securities, the valuation methodologies may incorporate broker quotes or discounted cash flow analyses using assumptions for inputs such as expected cash flows, benchmark yields, credit spreads, default rates and prepayment speeds that are not observable in the markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity securities:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Fair values of equity securities are generally designated as Level I and are based on quoted market prices. For certain equity securities, quoted market prices for the identical security are not always available, and the fair value is estimated by reference to similar securities for which quoted prices are available. These securities are designated Level II. We also have certain equity securities, including private equity securities, for which the fair value is estimated based on each security&#x2019;s current condition and future cash flow projections. Such securities are designated Level III. The fair values of these private equity securities are generally based on either broker quotes or discounted cash flow projections using assumptions &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for inputs such as the weighted-average cost of capital, long-term revenue growth rates and earnings before interest, taxes, depreciation and amortization, and/or revenue multiples that are not observable in the markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Securities lending collateral:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Fair values of securities lending collateral are based on quoted market prices, where available. These fair values are obtained primarily from third-party pricing services, which generally use Level I or Level II inputs for the determination of fair value, to facilitate fair value measurements and disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Fair values are based on the quoted market prices by the financial institution that is the counterparty to the derivative transaction. We independently verify prices provided by the counterparties using valuation models that incorporate observable market inputs for similar derivative transactions. Derivatives are designated as Level II securities. Derivatives presented within the fair value hierarchy table below are presented on a gross basis and not on a master netting basis by counterparty.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of fair value measurements by level for assets and liabilities measured at fair value on a recurring basis at September&#160;30, 2022 and December&#160;31, 2021 is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed maturity securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States Government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government sponsored securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions, tax-exempt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fixed maturity securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exchange traded funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other invested assets - common equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Securities lending collateral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives - other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives - other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed maturity securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States Government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government sponsored securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions, tax-exempt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fixed maturity securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exchange traded funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other invested assets - common equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Securities lending collateral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives - other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives - other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending balances of assets measured at fair value on a recurring basis using Level III inputs for the three months ended September 30, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.072%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Residential&lt;br/&gt;Mortgage-&lt;br/&gt;backed&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&#160;&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance at July 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total losses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recognized in net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recognized in accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers out of Level III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-5.4pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in unrealized losses included in net income related to assets still held at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance at July 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total gains:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recognized in net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recognized in accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers out of Level III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-5.4pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in unrealized gains included in net income related to assets still held at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending balances of assets measured at fair value on a recurring basis using Level III inputs for the nine months ended September 30, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.072%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Residential&lt;br/&gt;Mortgage-&lt;br/&gt;backed&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&#160;&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total losses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recognized in net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recognized in accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(201)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers into Level III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers out of Level III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in unrealized gains included in net income related to assets still held at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total gains:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recognized in net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recognized in accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers out of Level III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in unrealized gains included in net income related to assets still held at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no individually material transfers into or out of Level III during the three and nine months ended September&#160;30, 2022 or 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain assets and liabilities are measured at fair value on a nonrecurring basis; that is, the instruments are not measured at fair value on an ongoing basis but are subject to fair value adjustments only in certain circumstances. As disclosed in Note&#160;3, &#x201c;Business Acquisitions,&#x201d; we completed our acquisition of Integra in the second quarter of 2022 and the acquisitions&#160;of&#160;myNEXUS and MMM during the second quarter of 2021. The net assets acquired in our acquisitions of Integra, myNEXUS and MMM and resulting goodwill and other intangible assets were recorded at fair value&#160;primarily&#160;using Level III inputs. The majority of&#160;assets acquired and liabilities assumed were recorded at their carrying values as of the respective date of acquisition, as their carrying values approximated their fair values due to their short-term nature. The fair values of goodwill and other intangible assets acquired in our acquisitions of Integra, myNEXUS and MMM were internally estimated based on the income approach. The income approach estimates fair value based on the present value of the cash flows that the assets could be expected to generate in the future. We developed internal estimates for the expected cash flows and discount rate in the present value calculation.&#160;Other than the assets acquired and liabilities assumed in our acquisitions of Integra, myNEXUS and MMM described above, there were no material assets or liabilities measured at fair value on a nonrecurring basis during the three and nine months ended September&#160;30, 2022 or 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our valuation policy is determined by members of our treasury and accounting departments. Whenever possible, our policy is to obtain quoted market prices in active markets to estimate fair values for recognition and disclosure purposes. Where quoted market prices in active markets are not available, fair values are estimated using discounted cash flow analyses, broker quotes, unobservable inputs or other valuation techniques. These techniques are significantly affected by our assumptions, including discount rates and estimates of future cash flows. The use of assumptions for unobservable inputs for the determination of fair value involves a level of judgment and uncertainty. Changes in assumptions that reasonably could have been different at the reporting date may result in a higher or lower determination of fair value. Changes in fair value measurements, if significant, may affect performance of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Potential taxes and other transaction costs are not considered in estimating fair values. Our valuation policy is generally to obtain quoted prices for each security from third-party pricing services, which are derived through recently reported trades for identical or similar securities making adjustments through the reporting date based upon available market observable information. As we are responsible for the determination of fair value, we perform analysis on the prices received from the pricing services to determine whether the prices are reasonable estimates of fair value. This analysis is performed by our internal treasury personnel who are familiar with our investment portfolios, the pricing services engaged and the valuation techniques and inputs used. Our analysis includes procedures such as a review of month-to-month price fluctuations and price comparisons to secondary pricing services. There were no adjustments to quoted market prices obtained from the pricing services during the three and nine months ended September&#160;30, 2022 or 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the preceding disclosures on assets recorded at fair value in the consolidated balance sheets, FASB guidance also requires the disclosure of fair values for certain other financial instruments for which it is practicable to estimate fair value, whether or not such values are recognized in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-financial instruments such as real estate, property and equipment, other current assets, deferred income taxes, intangible assets and certain financial instruments, such as policy liabilities, are excluded from the fair value disclosures. Therefore, the fair value amounts cannot be aggregated to determine our underlying economic value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts reported in the consolidated balance sheets for cash, premium receivables, self-funded receivables, other receivables, unearned income, accounts payable and accrued expenses, and certain other current liabilities approximate fair value because of the short-term nature of these items. These assets and liabilities are not listed in the table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following methods and assumptions were used to estimate the fair value of each class of financial instrument that is recorded at its carrying value in our consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other invested assets:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Other invested assets include primarily our investments in limited partnerships, joint ventures and other non-controlled corporations and mortgage loans, as well as the cash surrender value of corporate-owned life insurance policies. Investments in limited partnerships, joint ventures and other non-controlled corporations are carried at our share in the entities&#x2019; undistributed earnings, which approximates fair value. Mortgage loans are carried at amortized cost, which approximates fair value. The carrying value of corporate-owned life insurance policies represents the cash surrender value as reported by the respective insurer, which approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Short-term borrowings:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The fair value of our short-term borrowings is based on quoted market prices for the same or similar debt, or, if no quoted market prices were available, on the current market interest rates estimated to be available to us for debt of similar terms and remaining maturities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-term debt&#x2014;commercial paper:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The carrying amount for commercial paper approximates fair value, as the underlying instruments have variable interest rates at market value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-term debt&#x2014;senior unsecured notes and surplus notes:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The fair values of our notes are based on quoted market prices in active markets for the same or similar debt, or, if no quoted market prices are available, on the current market observable rates estimated to be available to us for debt of similar terms and remaining maturities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-term debt&#x2014;convertible debentures:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The fair value of our convertible debentures is based on the quoted market price in the active private market in which the convertible debentures trade.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the estimated fair values by level of each class of financial instrument that is recorded at its carrying value on our consolidated balance sheets at September&#160;30, 2022 and December&#160;31, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.072%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other invested assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible debentures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other invested assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible debentures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RleHRyZWdpb246ZTIyYTVkZjliODYyNDAwOWJhY2RlNjY5ZmIxMGEzYTNfMTE2MTM_de3fcc4d-3bef-436a-beae-3d0a85a86c81">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of fair value measurements by level for assets and liabilities measured at fair value on a recurring basis at September&#160;30, 2022 and December&#160;31, 2021 is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed maturity securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States Government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government sponsored securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions, tax-exempt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fixed maturity securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exchange traded funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other invested assets - common equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Securities lending collateral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives - other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives - other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed maturity securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States Government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government sponsored securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions, tax-exempt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fixed maturity securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exchange traded funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other invested assets - common equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Securities lending collateral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives - other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives - other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i98e1be64addb482ea782f65135d60a05_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMy0xLTEtMS03MDM2Mw_e8f75415-c416-4615-ad61-bebc6ddcdac0"
      unitRef="usd">5794000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i1fc2e84bcad34027932d35097b9f9bdb_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMy0zLTEtMS03MDM2Mw_57725ab8-86a2-4969-a4cc-bd916012d6a1"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i8bebbc6255564194a65092412ac06f67_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMy01LTEtMS03MDM2Mw_7c25e956-c065-42aa-9813-dbc20b8ec6ba"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMy03LTEtMS03MDM2Mw_ada658ee-10c4-4292-9154-e20bc5a9fe42"
      unitRef="usd">5794000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8ed17b4bb7f34660b7206d12cd763384_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNS0xLTEtMS03MDM2Mw_0d2344b4-457e-4716-8042-a196ca9b157f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8a3b331afc414af99ac6c1599df2287a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNS0zLTEtMS03MDM2Mw_dcb5e57b-6d0a-4b77-90f4-f6eb573cdfd2"
      unitRef="usd">1548000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i79076969c3024e269accd9bc7038ee4d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNS01LTEtMS03MDM2Mw_9a0bf0f6-26d5-4bb8-b1b4-e8a96e5b12af"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if46ba3a6ed924704ab80b46d4892ce9c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNS03LTEtMS03MDM2Mw_cd0e535d-4620-4d0b-a8ae-09d239be385f"
      unitRef="usd">1548000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i83c6fbea402043d5841f091c58e82693_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNi0xLTEtMS03MDM2Mw_63722c19-2b1f-4ba6-8fd6-38c35114b4fb"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5832f9a26ea3435bbd561c28893f542e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNi0zLTEtMS03MDM2Mw_22ecc788-bb3f-4c19-977d-3e341dd75fcb"
      unitRef="usd">61000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i54b54a3342e648a4af00533f1570f055_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNi01LTEtMS03MDM2Mw_41685c28-2d15-4485-bd69-843121cd8852"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i582c7462a2a24ee19ae7c3e8b13e6258_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNi03LTEtMS03MDM2Mw_9b30aa15-9b55-46ec-8275-c29aa723d457"
      unitRef="usd">61000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i80f80d23604d47ea9d6d5d3db271166b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNy0xLTEtMS03MDM2Mw_f2d25d6d-443c-4662-925f-fde6ac19cd30"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0630c845d0544c8fb78216ec9ee4246a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNy0zLTEtMS03MDM2Mw_15d632f4-d4e8-4e9c-9152-7a8c55b39786"
      unitRef="usd">251000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6ea6ffa026ed49ad880282333c15e05b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNy01LTEtMS03MDM2Mw_59871fd0-f8a7-44f3-9ff3-945dfec26092"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9e3fb6e7405848e39ed7671d9a9683da_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNy03LTEtMS03MDM2Mw_f1176f1c-e0ab-4ef2-bcd5-509269f32902"
      unitRef="usd">251000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i09ec78a8f2934ad988a5a84ed45afe95_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfOC0xLTEtMS03MDM2Mw_919b5517-4ac0-40d2-8c67-33c1721a13a2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9963152709494c7192e65f8d93db6abd_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfOC0zLTEtMS03MDM2Mw_953ac71e-efa8-4361-95e3-a92fb3b25dd3"
      unitRef="usd">4081000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia3bd3a5e8f4e46668a696ae3513051dc_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfOC01LTEtMS03MDM2Mw_97b9482e-c108-4043-b890-580895d4fa43"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie05876f14e3546779aaacef9d285ee2c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfOC03LTEtMS03MDM2Mw_0639ccc2-9254-44ec-b5c4-e3f222c00022"
      unitRef="usd">4081000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i879983c43359419d9305755bc21b11e8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfOS0xLTEtMS03MDM2Mw_d6e72fce-89e6-437c-808a-803761c8436c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1bae3ca7f392419cb36507af34fd85e1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfOS0zLTEtMS03MDM2Mw_d9d3958c-6a5a-4c1b-9c45-0e3d33e5f755"
      unitRef="usd">12079000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if54e2a09642243b0af22bd387b96cc86_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfOS01LTEtMS03MDM2Mw_d99ac5ce-5bf3-4123-9210-15f96c560d2a"
      unitRef="usd">129000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib5a6260b0cc245e3ad18420b5dda8138_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfOS03LTEtMS03MDM2Mw_b38fdc5d-8698-4f36-a661-e33977ae8a92"
      unitRef="usd">12208000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i319c0932f552442f91e807fadf6869b2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTAtMS0xLTEtNzAzNjM_1f39649d-fa96-44d6-a08e-7cd110f253dc"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id72f5fdb790d488389e012081716a861_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTAtMy0xLTEtNzAzNjM_66cd1156-4551-47fb-8cc5-9e13957cb55a"
      unitRef="usd">4247000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifd52d310cc6249de9d64e53d7b7f960d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTAtNS0xLTEtNzAzNjM_ed592c5d-b0bf-4598-b3cd-1cc295e10fed"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id54f0058c591469baef2d1557dcb55a8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTAtNy0xLTEtNzAzNjM_2a6adbb2-f5ed-4780-b2ce-e8ae82da8643"
      unitRef="usd">4247000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7954908cb6bc4a09af7d436befca47cf_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTEtMS0xLTEtNzAzNjM_a4e9b76d-f136-44b5-b7b2-4e328a458aa9"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib6d1fbf1b64a48d993287eda3253e59e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTEtMy0xLTEtNzAzNjM_e8660a88-185d-4143-9225-aa4c19f4ca95"
      unitRef="usd">70000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6c77fcbcf9014952b22ac069325f92a6_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTEtNS0xLTEtNzAzNjM_45fbfec9-b995-4456-b235-e8b237de859d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2340f4d1ac2b47dfbe6521a9386a70f4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTEtNy0xLTEtNzAzNjM_5ef5b0bc-b6de-4ea5-8cf5-2a7ce36c55bc"
      unitRef="usd">70000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8679b29bd646468da600ed87da53d36b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTItMS0xLTEtNzAzNjM_a82af760-23d6-4f00-8282-868e11c19767"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5ffe957d5ff14ba187fff4116dcf8991_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTItMy0xLTEtNzAzNjM_eba66374-0664-43e7-bb7c-8fca9180ba1e"
      unitRef="usd">3371000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic0fe98e383084014b1bc9ab32ce423dd_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTItNS0xLTEtNzAzNjM_52edb3b9-b505-491b-9f98-57b0376e6b32"
      unitRef="usd">311000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i30a0f87e5ab9493cbf1db457f967922d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTItNy0xLTEtNzAzNjM_5b190e4a-00ba-441a-ae0e-3ec060bf972f"
      unitRef="usd">3682000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i98e1be64addb482ea782f65135d60a05_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTMtMS0xLTEtNzAzNjM_abc28bab-9997-487c-a132-75b371fa33d9"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1fc2e84bcad34027932d35097b9f9bdb_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTMtMy0xLTEtNzAzNjM_6a3338a3-aaaa-474b-af19-b03674a2f043"
      unitRef="usd">25708000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8bebbc6255564194a65092412ac06f67_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTMtNS0xLTEtNzAzNjM_7231c176-86f9-45ac-9838-7329f402cb48"
      unitRef="usd">440000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTMtNy0xLTEtNzAzNjM_e34f3e57-0c90-49cf-abdf-860c5b5ce2cc"
      unitRef="usd">26148000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <elv:EquitySecurities
      contextRef="id225b53b5eb14421a1c1ea44abf2ab1f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTUtMS0xLTEtNzAzNjM_30acd456-2169-4bbe-a34f-781d1e4f536b"
      unitRef="usd">1403000000</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="i572ccbdc7947481c8deddaa8e2068caa_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTUtMy0xLTEtNzAzNjM_d5e2c05f-ee07-4c3c-bdd2-a1f8d98ae8f1"
      unitRef="usd">0</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="i67e47d6156fe4e30a2db3dbc795c804e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTUtNS0xLTEtNzAzNjM_259d3df3-98cf-4d43-9be3-daae4a22e862"
      unitRef="usd">0</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="ie17e65ae944d47f1b80529dd1e22cea8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTUtNy0xLTEtNzAzNjM_7ae7c4d8-da32-40e9-841c-f9c7edd0748e"
      unitRef="usd">1403000000</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="ib2b35a0942fa4be398836e787b4033fe_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTctMS0xLTEtNzAzNjM_0b8a4890-faa5-4184-a73c-2c03b282f377"
      unitRef="usd">6000000</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="i194d8de15f8b4abe9a293c428ef86751_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTctMy0xLTEtNzAzNjM_8f8e3e09-43d0-47de-aa3e-e9e494e916d1"
      unitRef="usd">-1000000</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="ibd6037d7dd8543e2a047fa4c031268df_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTctNS0xLTEtNzAzNjM_51ac7a6d-db4f-4148-8ea0-504d578107fd"
      unitRef="usd">0</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="i3c4b8b65febc483694f935949190933a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTctNy0xLTEtNzAzNjM_c9ffaaa2-eecb-4490-a360-dbd8e5e5710c"
      unitRef="usd">5000000</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="i359143f746854b4a9c1ab808c68d5640_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTgtMS0xLTEtNzAzNjM_85c1bc51-189f-4f47-8df5-20b1f97a7ce1"
      unitRef="usd">0</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="if36f830bb3c64269a716998cc4d3631d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTgtMy0xLTEtNzAzNjM_eebf1f0c-b031-49f0-9448-45070462c1af"
      unitRef="usd">0</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="i60026054e5d341ac957c97a96698628d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTgtNS0xLTEtNzAzNjM_11adc892-fbdf-463b-bebc-4cc7c374aa85"
      unitRef="usd">95000000</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="i97d580beda144d4491df94dbd14b5e63_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTgtNy0xLTEtNzAzNjM_7c1fd6fc-45f5-4072-8f6f-77a2367aeb9c"
      unitRef="usd">95000000</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="iaa2c59dfa7804e66a650f900b9d23c9e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTktMS0xLTEtNzAzNjM_89627344-7447-4c1f-84a4-0c76dabc905e"
      unitRef="usd">1409000000</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="ie3a7f443bdad4168b5798971706c5f40_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTktMy0xLTEtNzAzNjM_30c8b927-f640-41e0-8768-f166c9dfc631"
      unitRef="usd">-1000000</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="iece93ac436104fd6a1cd99c3cd0e562a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTktNS0xLTEtNzAzNjM_3f0b969a-c822-4c25-ac8f-85474401800c"
      unitRef="usd">95000000</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="i484f5fd44cb84fbc9b4c45aae397c186_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMTktNy0xLTEtNzAzNjM_80fd7dae-a019-4d97-9068-1881c7c28cca"
      unitRef="usd">1503000000</elv:EquitySecurities>
    <us-gaap:OtherLongTermInvestments
      contextRef="if4609d385fde4f5e8ed90e175cff6320_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjAtMS0xLTEtNzAzNjM_e529cd0b-fbdd-40ea-93c3-16a0882f894a"
      unitRef="usd">149000000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="i2998bb1d7c3e43cb9610ba10dc2f2d9c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjAtMy0xLTEtNzAzNjM_e7fb9c5d-cd68-4740-bf25-56534610d4bc"
      unitRef="usd">0</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="ic0b480fb15b94cdcb1a697f67988e588_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjAtNS0xLTEtNzAzNjM_2b0f87a0-9cc1-478e-ba16-17340f031934"
      unitRef="usd">0</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="i8518fee768764a0f95c228de9e1ea364_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjAtNy0xLTEtNzAzNjM_3d725e6a-9414-4bd3-a7fe-86daec1639df"
      unitRef="usd">149000000</us-gaap:OtherLongTermInvestments>
    <us-gaap:SecuritiesHeldAsCollateralAtFairValue
      contextRef="i98e1be64addb482ea782f65135d60a05_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjEtMS0xLTEtNzAzNjM_117d375e-c3f4-40a6-9ee5-27b82763ffb8"
      unitRef="usd">0</us-gaap:SecuritiesHeldAsCollateralAtFairValue>
    <us-gaap:SecuritiesHeldAsCollateralAtFairValue
      contextRef="i1fc2e84bcad34027932d35097b9f9bdb_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjEtMy0xLTEtNzAzNjM_8178f26b-7c84-4359-95ca-086b17b6d4cb"
      unitRef="usd">2841000000</us-gaap:SecuritiesHeldAsCollateralAtFairValue>
    <us-gaap:SecuritiesHeldAsCollateralAtFairValue
      contextRef="i8bebbc6255564194a65092412ac06f67_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjEtNS0xLTEtNzAzNjM_20570912-dee2-4c12-ba0a-ed0a96941927"
      unitRef="usd">0</us-gaap:SecuritiesHeldAsCollateralAtFairValue>
    <us-gaap:SecuritiesHeldAsCollateralAtFairValue
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjEtNy0xLTEtNzAzNjM_27b5c617-cf6c-4d97-a9bd-24387299c8b4"
      unitRef="usd">2841000000</us-gaap:SecuritiesHeldAsCollateralAtFairValue>
    <us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
      contextRef="i0add331b12f44d51b7ece36e400dc1f5_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjItMS0xLTEtNzAzNjM_08e5de7c-1953-4696-a4a0-5b5b0394c240"
      unitRef="usd">0</us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
      contextRef="i2c5802f494354611a73f807c38dce059_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjItMy0xLTEtNzAzNjM_6d334b03-93bd-4b2d-afe6-624b733c9403"
      unitRef="usd">25000000</us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
      contextRef="i9e550fd94b994ce49630d8444c71806b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjItNS0xLTEtNzAzNjM_642648fe-67e2-4a4e-804e-d9553270922c"
      unitRef="usd">0</us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
      contextRef="icad4a668efc449218c1bacb86f5187e1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjItNy0xLTEtNzAzNjM_dc52b2dd-fc1e-4e2e-a0a9-bad0a3a6ba60"
      unitRef="usd">25000000</us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i98e1be64addb482ea782f65135d60a05_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjMtMS0xLTEtNzAzNjM_738d0a99-1407-4820-9b28-bc7649af26df"
      unitRef="usd">7352000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1fc2e84bcad34027932d35097b9f9bdb_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjMtMy0xLTEtNzAzNjM_0b745de8-f7fc-4ebf-90b2-6f16e00aecbb"
      unitRef="usd">28573000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8bebbc6255564194a65092412ac06f67_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjMtNS0xLTEtNzAzNjM_3a27232a-f871-43db-9b0f-05a17765dce2"
      unitRef="usd">535000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjMtNy0xLTEtNzAzNjM_d99aa05c-ea01-4f70-bc45-add28cbd9add"
      unitRef="usd">36460000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
      contextRef="i0add331b12f44d51b7ece36e400dc1f5_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjUtMS0xLTEtNzAzNjM_c7313a9c-9d23-4836-9d64-f8108ade30d9"
      unitRef="usd">0</us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
      contextRef="i2c5802f494354611a73f807c38dce059_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjUtMy0xLTEtNzAzNjM_ac52aba1-d784-49d7-bcba-8836f4bca3cc"
      unitRef="usd">70000000</us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
      contextRef="i9e550fd94b994ce49630d8444c71806b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjUtNS0xLTEtNzAzNjM_5e53d56b-1bbe-44f0-b4f5-82673813ef0b"
      unitRef="usd">0</us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
      contextRef="icad4a668efc449218c1bacb86f5187e1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjUtNy0xLTEtNzAzNjM_03fcf62e-fab8-438b-a78b-d9374894d2df"
      unitRef="usd">70000000</us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i98e1be64addb482ea782f65135d60a05_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjYtMS0xLTEtNzAzNjM_a4c3fa82-4647-4f30-8dad-559a4317c0b4"
      unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i1fc2e84bcad34027932d35097b9f9bdb_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjYtMy0xLTEtNzAzNjM_da921449-22da-49a9-9b17-757e4b5275f8"
      unitRef="usd">70000000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i8bebbc6255564194a65092412ac06f67_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjYtNS0xLTEtNzAzNjM_36c715a5-51b2-490a-8370-230fb52e1c18"
      unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMjYtNy0xLTEtNzAzNjM_ffbbc5a7-8db9-4183-aec0-9f5bb1e4ec75"
      unitRef="usd">70000000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="id12430cdfde949268546e42fae69aacb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzAtMS0xLTEtNzAzNjM_10176f25-5520-44e1-bb1d-9c48d4f8375b"
      unitRef="usd">2415000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i5f7e82e807e34b52b194ae404cbff7c8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzAtMy0xLTEtNzAzNjM_f632b4d6-93ce-4fd9-b50f-302b807e2227"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i39708ec10b1d42fc910b98395c8b0d03_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzAtNS0xLTEtNzAzNjM_8a775841-7457-4fe2-a18e-e8819a7477f3"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzAtNy0xLTEtNzAzNjM_d13f1444-8090-46fb-8d62-51a3b85d71e1"
      unitRef="usd">2415000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i52d00975607245648c820ae081dffc76_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzItMS0xLTEtNzAzNjM_7dfe5551-bbfc-4805-b338-e20d97d98e12"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i52e0633755af4f07991cc898c84730a5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzItMy0xLTEtNzAzNjM_8e3f57c1-3fc0-4f08-9d64-c67046757d1a"
      unitRef="usd">1432000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iec5d8d8c36b445f181d4b0e14e790e50_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzItNS0xLTEtNzAzNjM_a2f24423-5ada-40d4-b52c-d75788c2fa48"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifc53677b69024b148f62349f82fe723c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzItNy0xLTEtNzAzNjM_3badeec4-3d7b-4505-af73-7dfddaba17d5"
      unitRef="usd">1432000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1dc525e82e4f4b78b55e13f877d9d212_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzMtMS0xLTEtNzAzNjM_8f9dedb2-7a27-47bc-8a64-c8cc53888af1"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i059ab6a34c854d4590c340b2aa206fc2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzMtMy0xLTEtNzAzNjM_ee8114a8-a23a-4cbe-b462-1e3956b5975b"
      unitRef="usd">68000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i017bb4e3633b454f85f310109f119763_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzMtNS0xLTEtNzAzNjM_1e36db3d-fc0b-4e53-94e9-ae9598b92b9d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6bd8e4d367e5434c93d5ed2fb93b9c90_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzMtNy0xLTEtNzAzNjM_c8f3acbc-d938-4343-9da7-c677aa693faa"
      unitRef="usd">68000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6c4f3be4159040cca4c6330bada73b9f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzQtMS0xLTEtNzAzNjM_188aeb2a-e960-48aa-b9fa-22d88e467d85"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idd0cddd1e2704317822ec1aa4b6a8d50_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzQtMy0xLTEtNzAzNjM_532f984f-37ee-46e1-a8a3-05dfb9ea61e1"
      unitRef="usd">347000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifa1f82c236bf4e9fa6b63e8a1dd059b3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzQtNS0xLTEtNzAzNjM_f3e6d398-1c57-4861-93b0-8bc0b12fe741"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifcad3b58ad0a402e9c5f36c2257b46ad_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzQtNy0xLTEtNzAzNjM_cd1cc902-42eb-4ef7-b541-91c045631ad5"
      unitRef="usd">347000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i480713ec0004444aae07ba823a2a3710_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzUtMS0xLTEtNzAzNjM_f884bfb2-7afa-42ee-8a70-11817a046a25"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iac7e634bfc3043a3b61901be4796c354_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzUtMy0xLTEtNzAzNjM_5f561fe4-3240-4efd-91cd-2c18786ba289"
      unitRef="usd">5621000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if77a6a1ea8a845e1b8f8f10a6494dd9d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzUtNS0xLTEtNzAzNjM_c540c42c-b265-4021-82c6-9de3ba434f2b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0b05039f1d944a39a5f7c4a08ecd9386_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzUtNy0xLTEtNzAzNjM_b9355276-2da0-489d-b45c-9d95bac4b40c"
      unitRef="usd">5621000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i52ea3e0c81e449c4aabaeaba693601b4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzYtMS0xLTEtNzAzNjM_ca3684e4-5897-4287-a822-d49982364272"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6d9263de42c24bbeb3029c5c835d1b7e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzYtMy0xLTEtNzAzNjM_09d72d30-3dcd-42fe-b994-6291901c74ee"
      unitRef="usd">12027000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8d73240dd06c484fb3d57ea0c58ca9f6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzYtNS0xLTEtNzAzNjM_ea800974-f808-4a43-a4f9-d8722f68d405"
      unitRef="usd">336000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3fe0fa1cefe04a9ab9bd771236eb24fd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzYtNy0xLTEtNzAzNjM_562a9a6e-219c-4550-95b2-50217239095d"
      unitRef="usd">12363000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0a51c1b83ca44cebb3cb541c6c1ffd23_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzctMS0xLTEtNzAzNjM_ebdd724f-0e34-4d88-8ae2-0ac5a7615602"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0ebb31481dbc46e3a7f18240069b415d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzctMy0xLTEtNzAzNjM_8d872492-b261-42c2-ab0b-ffb219d09bdf"
      unitRef="usd">4092000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0107aa86d0304c8c820c9d1f402f3a58_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzctNS0xLTEtNzAzNjM_25688419-6b38-4c11-b4e8-e051f5743bc3"
      unitRef="usd">5000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1998952a2fec4ef987e45747bc6a365e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzctNy0xLTEtNzAzNjM_328c8d15-3327-4c82-bebd-a43a9e3d93ae"
      unitRef="usd">4097000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i43e3349630db458383c85c2d30827d66_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzgtMS0xLTEtNzAzNjM_ba2a9232-6e3c-4a56-9d65-37ae122da462"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ide59a28c7a594301ab29f18f850bbebb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzgtMy0xLTEtNzAzNjM_707bf8c3-6f22-4b5c-b095-e22fb9ef1d2a"
      unitRef="usd">64000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6c0368bfa4554cd2952ff8415fba1e2d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzgtNS0xLTEtNzAzNjM_d1df3636-317e-4da5-abfd-2361b9b51ee1"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibf59770742dd4e0c909bf664464f6f51_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzgtNy0xLTEtNzAzNjM_c5ce6c61-37e5-42a3-922e-1d6c13a8f6e0"
      unitRef="usd">64000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9cd0cba106b646758a3d426fe4185e71_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzktMS0xLTEtNzAzNjM_ed68c9e0-ff39-44ee-8627-4ba65273b3f2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ide71a36d93e440ac9bbd26d0f1185292_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzktMy0xLTEtNzAzNjM_cf36bbcb-280c-4718-a92d-329752ebc32d"
      unitRef="usd">2888000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic3f130bdbeda4a229139760fe1a5256c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzktNS0xLTEtNzAzNjM_6daa8140-b529-40be-b591-d040cbe3ed11"
      unitRef="usd">19000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9b17717cfed84a8695f0ebee25d6d1b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfMzktNy0xLTEtNzAzNjM_fd94c03f-1792-4a05-a121-c478ce915010"
      unitRef="usd">2907000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id12430cdfde949268546e42fae69aacb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDAtMS0xLTEtNzAzNjM_55b721a5-de1e-4ad3-b902-552be252e343"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5f7e82e807e34b52b194ae404cbff7c8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDAtMy0xLTEtNzAzNjM_891ef9dc-adb0-4983-9ed3-93ad8151a32c"
      unitRef="usd">26539000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i39708ec10b1d42fc910b98395c8b0d03_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDAtNS0xLTEtNzAzNjM_23d6c0ce-7a59-4ad7-8e4d-c66e7a92aefe"
      unitRef="usd">360000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDAtNy0xLTEtNzAzNjM_c872339b-2bb6-419f-95c1-0ea4278c7b82"
      unitRef="usd">26899000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <elv:EquitySecurities
      contextRef="i5595401992294f4db26af9c67d94813c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDItMS0xLTEtNzAzNjM_11245b0d-bc5d-4c74-8db3-a062e276fe35"
      unitRef="usd">1750000000</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="i247198472ac444b4a705c2d6d3870893_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDItMy0xLTEtNzAzNjM_13b45ae0-8583-43a7-aba8-914547674d2e"
      unitRef="usd">0</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="id70934c0fdca477cbb28d1fa3a921841_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDItNS0xLTEtNzAzNjM_7b998c5c-eeae-41c6-902c-e8925e859ca3"
      unitRef="usd">0</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="i16e26cf91f824b138d31ee3ccbbc2486_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDItNy0xLTEtNzAzNjM_b53debef-67b4-4224-96de-528a66713e72"
      unitRef="usd">1750000000</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="if08d21b298724dbe87a66843d0d5ec37_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDQtMS0xLTEtNzAzNjM_c1b326a9-57fc-4798-996f-5a05106e2cab"
      unitRef="usd">8000000</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="ibcc2f3cd485c43e0a5b93811cbad0040_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDQtMy0xLTEtNzAzNjM_6b30489c-9812-472c-a117-6b852698923a"
      unitRef="usd">34000000</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="id97d07a393824fba8c5a533ddc17248b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDQtNS0xLTEtNzAzNjM_c6a900f0-915b-46a6-b088-606a9374de5a"
      unitRef="usd">0</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="i9d9daa1bf9aa49618c67c4fe0feca8a1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDQtNy0xLTEtNzAzNjM_8156e1a0-18fa-4f5c-bdb7-89b33496285d"
      unitRef="usd">42000000</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="ia67cf78d5c9e49c386e4366d79e071f5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDUtMS0xLTEtNzAzNjM_ea8968f9-e5e6-4034-a336-71368226cf6c"
      unitRef="usd">0</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="i3e39bd703c7c487eb5d185ba13bfcc36_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDUtMy0xLTEtNzAzNjM_89c027df-7fd5-414b-99d4-0d92b1a1af6a"
      unitRef="usd">0</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="i66059c1693064085997c288e33979c72_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDUtNS0xLTEtNzAzNjM_a77ba8ad-a751-44f7-94b2-7dc397931c12"
      unitRef="usd">89000000</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="i4693331b053e467aa44d2753305e57c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDUtNy0xLTEtNzAzNjM_a0b7617b-f7a4-457f-9912-a32d32d2a521"
      unitRef="usd">89000000</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="i55dbd61667064a73939c76e993f892e4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDYtMS0xLTEtNzAzNjM_f9c0c8aa-7ec3-4e26-b998-f47945923bcb"
      unitRef="usd">1758000000</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="ia1ea0fca2f2f4b16904060514710f24b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDYtMy0xLTEtNzAzNjM_20748f0b-473e-49b3-a751-33d313d69f75"
      unitRef="usd">34000000</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="id73c6074257a4797b02f0bb8c9813727_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDYtNS0xLTEtNzAzNjM_7587f3be-74ba-4ce9-958a-7827513057d4"
      unitRef="usd">89000000</elv:EquitySecurities>
    <elv:EquitySecurities
      contextRef="i6cda0b9d394240d5bed36877535df125_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDYtNy0xLTEtNzAzNjM_63f4fea7-4add-4355-ac32-a038d08403e6"
      unitRef="usd">1881000000</elv:EquitySecurities>
    <us-gaap:OtherLongTermInvestments
      contextRef="ia570c61ac2774f2c9b61f2b04614af6f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDctMS0xLTEtNzAzNjM_456c8659-d822-4545-a534-53348e8ad1f7"
      unitRef="usd">138000000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="i1f9ec3d81af44e958f1beabb66a20af5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDctMy0xLTEtNzAzNjM_e4c4aa6b-891e-47c7-aadb-cf8c234a95c5"
      unitRef="usd">0</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="i77434cd540454880bbde697445471783_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDctNS0xLTEtNzAzNjM_029b1073-832b-483d-9db8-53ca8a58a47b"
      unitRef="usd">0</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="iae3f929a16f5495498ceb553e33f710f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDctNy0xLTEtNzAzNjM_089ee275-fcbd-4992-bd26-dac7b7c09633"
      unitRef="usd">138000000</us-gaap:OtherLongTermInvestments>
    <us-gaap:SecuritiesHeldAsCollateralAtFairValue
      contextRef="id12430cdfde949268546e42fae69aacb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDgtMS0xLTEtNzAzNjM_912d01b0-e9cf-455e-968e-37d839ce4e3c"
      unitRef="usd">0</us-gaap:SecuritiesHeldAsCollateralAtFairValue>
    <us-gaap:SecuritiesHeldAsCollateralAtFairValue
      contextRef="i5f7e82e807e34b52b194ae404cbff7c8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDgtMy0xLTEtNzAzNjM_418fd121-5d6e-419d-80c7-9f9c3dd9baa6"
      unitRef="usd">2155000000</us-gaap:SecuritiesHeldAsCollateralAtFairValue>
    <us-gaap:SecuritiesHeldAsCollateralAtFairValue
      contextRef="i39708ec10b1d42fc910b98395c8b0d03_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDgtNS0xLTEtNzAzNjM_bb391564-b1f5-4b87-a508-a65b60cdc514"
      unitRef="usd">0</us-gaap:SecuritiesHeldAsCollateralAtFairValue>
    <us-gaap:SecuritiesHeldAsCollateralAtFairValue
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDgtNy0xLTEtNzAzNjM_21e9cc90-2e35-4c9b-be8b-e14391b9b377"
      unitRef="usd">2155000000</us-gaap:SecuritiesHeldAsCollateralAtFairValue>
    <us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
      contextRef="iab52a629947044ddb6c7a30c64d60ec1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDktMS0xLTEtNzAzNjM_a8fecc93-fd37-4380-ad37-ce2e766d26f2"
      unitRef="usd">0</us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
      contextRef="i18aaf10638ba48758ecf2c6f063e2eef_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDktMy0xLTEtNzAzNjM_e8e4620b-9187-43de-8f4b-de2ddfd5a528"
      unitRef="usd">19000000</us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
      contextRef="i49bbc62b7c9a4dbfaa94dc46b4ed4750_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDktNS0xLTEtNzAzNjM_9e1df719-3cd8-47df-a77d-f77449a7863d"
      unitRef="usd">0</us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
      contextRef="ibc70625496934ce88087fd178a0df18b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNDktNy0xLTEtNzAzNjM_74a35a43-28e4-4e04-af18-08b0d68dba57"
      unitRef="usd">19000000</us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id12430cdfde949268546e42fae69aacb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTAtMS0xLTEtNzAzNjM_b66e165c-8c55-4092-b88a-141f6b38a86e"
      unitRef="usd">4311000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5f7e82e807e34b52b194ae404cbff7c8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTAtMy0xLTEtNzAzNjM_8b35cfca-64f5-4e09-a16c-943ecef2c107"
      unitRef="usd">28747000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i39708ec10b1d42fc910b98395c8b0d03_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTAtNS0xLTEtNzAzNjM_16d42da2-454b-481c-83de-d7de254068ba"
      unitRef="usd">449000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTAtNy0xLTEtNzAzNjM_c1d36586-1df6-4de9-843b-bf468a97871e"
      unitRef="usd">33507000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
      contextRef="iab52a629947044ddb6c7a30c64d60ec1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTItMS0xLTEtNzAzNjM_1c39d883-e70b-4219-91d5-264c24b2e347"
      unitRef="usd">0</us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
      contextRef="i18aaf10638ba48758ecf2c6f063e2eef_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTItMy0xLTEtNzAzNjM_1a25abf3-be59-45e9-a284-cae0765569f7"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
      contextRef="i49bbc62b7c9a4dbfaa94dc46b4ed4750_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTItNS0xLTEtNzAzNjM_d5158e1a-88a9-4b40-b1e3-169203c709ec"
      unitRef="usd">0</us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
      contextRef="ibc70625496934ce88087fd178a0df18b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTItNy0xLTEtNzAzNjM_33f81231-e408-47d4-903b-e8197e9014f6"
      unitRef="usd">1000000</us-gaap:DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="id12430cdfde949268546e42fae69aacb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTMtMS0xLTEtNzAzNjM_b86e2bc3-b076-470c-afc8-207b00a51c89"
      unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i5f7e82e807e34b52b194ae404cbff7c8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTMtMy0xLTEtNzAzNjM_6262ae5e-2b13-437b-beb6-527ca10571dc"
      unitRef="usd">1000000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i39708ec10b1d42fc910b98395c8b0d03_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTMtNS0xLTEtNzAzNjM_5a33793e-38c5-40a1-8471-f56f96f45765"
      unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOmU5OTg2OTMzOGZkYzRiYTZiY2ZhMWQwNWRmNzA1MTcxL3RhYmxlcmFuZ2U6ZTk5ODY5MzM4ZmRjNGJhNmJjZmExZDA1ZGY3MDUxNzFfNTMtNy0xLTEtNzAzNjM_6f65e0b9-9dac-42cb-94c4-283f9fb98b5d"
      unitRef="usd">1000000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RleHRyZWdpb246ZTIyYTVkZjliODYyNDAwOWJhY2RlNjY5ZmIxMGEzYTNfMTE1ODc_2b42225b-ddfd-494c-b595-aa47f4534baf">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending balances of assets measured at fair value on a recurring basis using Level III inputs for the three months ended September 30, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.072%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Residential&lt;br/&gt;Mortgage-&lt;br/&gt;backed&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&#160;&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance at July 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total losses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recognized in net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recognized in accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers out of Level III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-5.4pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in unrealized losses included in net income related to assets still held at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance at July 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total gains:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recognized in net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recognized in accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers out of Level III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-5.4pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in unrealized gains included in net income related to assets still held at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending balances of assets measured at fair value on a recurring basis using Level III inputs for the nine months ended September 30, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.072%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Residential&lt;br/&gt;Mortgage-&lt;br/&gt;backed&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&#160;&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total losses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recognized in net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recognized in accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(201)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers into Level III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers out of Level III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in unrealized gains included in net income related to assets still held at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total gains:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recognized in net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recognized in accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers out of Level III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in unrealized gains included in net income related to assets still held at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i6b40fde7beb04a09997961c706c7c577_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfNS0xLTEtMS03MDM2Mw_7a8d0cae-fbb5-492f-a192-0a88b082ad69"
      unitRef="usd">155000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i93e6bc23bb5d43ee9937560149125ce1_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfNS0zLTEtMS03MDM2Mw_a01cba5c-0194-4980-b6e8-3ae04be0efea"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="id4cd3d9e543549eaa00430a7132f99eb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfNS03LTEtMS03MDM2Mw_5cf11884-efaf-4fc3-9eee-f8d6f8f2dd6b"
      unitRef="usd">218000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i8152f64e6f1140eeb2ee778012282130_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfNS05LTEtMS03MDM2Mw_9ae975b0-d174-4c70-ab62-e39d8deb6afd"
      unitRef="usd">94000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ia0a535c1ffe84e6da717792a25f25e09_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfNS0xMy0xLTEtNzAzNjM_228433e7-7f26-47ec-8717-8cb4cbdcd5a5"
      unitRef="usd">467000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i87cc99f09b354f98929e5403fc89254a_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfNy0xLTEtMS03MDM2Mw_751073b5-19a4-41f8-8757-7af4912a5c58"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i3a4e9a98582e440e8a5c609a87e70538_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfNy0zLTEtMS03MDM2Mw_18179a95-db23-4316-8fff-60c8b0c24e9e"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i8c398eb1a12b438d8cf5d7ed7a27c98d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfNy03LTEtMS03MDM2Mw_6c8e7ca6-459f-4bba-995a-76eec8bbce79"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="if55f75de2be747fb9680406ea945d82f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfNy05LTEtMS03MDM2Mw_2bb4c48c-0a02-4860-a6db-701301162d1f"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfNy0xMy0xLTEtNzAzNjM_a25d2682-0cf0-426c-89e6-09dcbc5b6398"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i87cc99f09b354f98929e5403fc89254a_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfOC0xLTEtMS03MDM2Mw_dee61587-a968-42b4-9814-7202aaa732ab"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i3a4e9a98582e440e8a5c609a87e70538_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfOC0zLTEtMS03MDM2Mw_0f26cf63-ab48-4b40-8239-f609b1b6d002"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i8c398eb1a12b438d8cf5d7ed7a27c98d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfOC03LTEtMS03MDM2Mw_4431abe0-109d-4e56-bf89-21b80e5ea9e3"
      unitRef="usd">17000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="if55f75de2be747fb9680406ea945d82f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfOC05LTEtMS03MDM2Mw_70ef5b82-3ffd-4108-8c56-58068eff1579"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfOC0xMy0xLTEtNzAzNjM_56840250-cbc1-48f2-ba73-74c1c4ba2e5f"
      unitRef="usd">18000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i87cc99f09b354f98929e5403fc89254a_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfOS0xLTEtMS03MDM2Mw_22a138fc-6288-4772-8426-81d62b509949"
      unitRef="usd">15000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i3a4e9a98582e440e8a5c609a87e70538_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfOS0zLTEtMS03MDM2Mw_2a64cf3b-100b-4c76-bf86-aaa0960d352f"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i8c398eb1a12b438d8cf5d7ed7a27c98d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfOS03LTEtMS03MDM2Mw_855aebf1-7d5f-4a69-9cf3-2c15a49e1c55"
      unitRef="usd">77000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="if55f75de2be747fb9680406ea945d82f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfOS05LTEtMS03MDM2Mw_22c16bf7-dfc5-41ac-aa06-08a409e290c0"
      unitRef="usd">3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfOS0xMy0xLTEtNzAzNjM_bc4d67c1-78f6-4e3a-ad64-c88533415bd6"
      unitRef="usd">95000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i87cc99f09b354f98929e5403fc89254a_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTAtMS0xLTEtNzAzNjM_e53931dd-f7dc-491a-a252-82da47b9b827"
      unitRef="usd">26000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i3a4e9a98582e440e8a5c609a87e70538_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTAtMy0xLTEtNzAzNjM_da6a6fb9-3be8-4d81-9ef9-e69c95e59181"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i8c398eb1a12b438d8cf5d7ed7a27c98d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTAtNy0xLTEtNzAzNjM_38b1350c-96cb-4830-9ebd-a8218d3f96ac"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="if55f75de2be747fb9680406ea945d82f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTAtOS0xLTEtNzAzNjM_042ae16f-9850-4261-95b1-4dea8cddcc43"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTAtMTMtMS0xLTcwMzYz_e7e38fdd-a2dc-48b5-8b6f-4f77ff0dc209"
      unitRef="usd">29000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i87cc99f09b354f98929e5403fc89254a_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTEtMS0xLTEtNzAzNjM_1b6359b6-24f5-4951-8d25-ade30fd97bab"
      unitRef="usd">10000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i3a4e9a98582e440e8a5c609a87e70538_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTEtMy0xLTEtNzAzNjM_dafebbc3-bc6e-4aee-9c13-381fe8963a7e"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i8c398eb1a12b438d8cf5d7ed7a27c98d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTEtNy0xLTEtNzAzNjM_91d375f6-0232-4181-af3b-fb35fddc68bb"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="if55f75de2be747fb9680406ea945d82f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTEtOS0xLTEtNzAzNjM_05a95f01-21ae-4b79-9ffa-c690dbd21d1a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTEtMTMtMS0xLTcwMzYz_ca2e05a4-a459-4a97-8d49-a916a83cb270"
      unitRef="usd">10000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i87cc99f09b354f98929e5403fc89254a_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTMtMS0xLTEtNzAzNjM_b6bf3aab-9d80-4b4a-9d91-a5453b908b9e"
      unitRef="usd">6000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i3a4e9a98582e440e8a5c609a87e70538_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTMtMy0xLTEtNzAzNjM_0a514483-c640-4d58-9900-1929ecd8595d"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i8c398eb1a12b438d8cf5d7ed7a27c98d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTMtNy0xLTEtNzAzNjM_3894ffa4-962c-4a32-a5ef-07e1204f45ba"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="if55f75de2be747fb9680406ea945d82f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTMtOS0xLTEtNzAzNjM_3d04c32e-a086-445b-a9dc-5afa1b60a972"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTMtMTMtMS0xLTcwMzYz_f8ef0c6e-f885-41c9-8ab5-252944a21cc3"
      unitRef="usd">6000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ib5a6260b0cc245e3ad18420b5dda8138_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTQtMS0xLTEtNzAzNjM_e9ce3cce-4348-422e-aa0d-4b5460d67c0b"
      unitRef="usd">129000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="id54f0058c591469baef2d1557dcb55a8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTQtMy0xLTEtNzAzNjM_502fce7e-fd0e-4244-a30b-8ddfcad6f266"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i30a0f87e5ab9493cbf1db457f967922d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTQtNy0xLTEtNzAzNjM_65dbbcdb-b631-491f-b36b-0999b59eda41"
      unitRef="usd">311000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i18f0ad9f943549f6888eff0dae5c5a2e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTQtOS0xLTEtNzAzNjM_39964bcd-d939-46d5-aef7-ccbfb1c780ca"
      unitRef="usd">95000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTQtMTMtMS0xLTcwMzYz_0dffb59c-9507-4c66-b287-47e7040e2903"
      unitRef="usd">535000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="i87cc99f09b354f98929e5403fc89254a_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTUtMS0xLTEtNzAzNjM_47a4f498-e727-47e6-ac3b-63261b198f83"
      unitRef="usd">0</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="i3a4e9a98582e440e8a5c609a87e70538_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTUtMy0xLTEtNzAzNjM_6bfa1764-73ae-44d6-a385-2a6182fc438f"
      unitRef="usd">0</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="i8c398eb1a12b438d8cf5d7ed7a27c98d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTUtNy0xLTEtNzAzNjM_bca5bb58-e447-4563-b2b8-83cf2ee5c415"
      unitRef="usd">0</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="if55f75de2be747fb9680406ea945d82f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTUtOS0xLTEtNzAzNjM_67d5ae43-8725-4adb-945c-0b6103b7c930"
      unitRef="usd">0</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTUtMTMtMS0xLTcwMzYz_62ec1e34-0849-4826-9f9b-3d25110402ea"
      unitRef="usd">0</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ie02e43daa33841138e86f2e8ac128f8a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTgtMS0xLTEtNzAzNjM_4e9e0b6d-51a5-4f84-ac7c-b32af307426f"
      unitRef="usd">351000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="id659cd826a1649d69ea5d4c304dc4002_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTgtMy0xLTEtNzAzNjM_99b2b79b-f8b2-4fb6-8bf8-48728b6acfb1"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i59df98c5cae2479d82b25b79673a28bc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTgtNy0xLTEtNzAzNjM_84860620-ae97-4424-97a8-aa40ba6dc20d"
      unitRef="usd">7000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i05e4435be64e4eadacb9d5b77a7762b8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTgtOS0xLTEtNzAzNjM_c02a421f-5cab-48af-a9ee-d46570468589"
      unitRef="usd">77000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="idd7bbc6ac8054bf59b507514156a792b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMTgtMTMtMS0xLTcwMzYz_cd2c78ce-1079-4d76-abda-e85750b138f8"
      unitRef="usd">437000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i7e5801b0241a4a7596c82b85f6595b87_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjAtMS0xLTEtNzAzNjM_b1998775-5dba-472e-be27-90676dd93cf2"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i4eb613993924401da535c4ab70affa54_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjAtMy0xLTEtNzAzNjM_d1810d28-c192-4c96-b3c3-2bde8fdbfd05"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i0b050ebc022448918209b90933f84fd1_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjAtNy0xLTEtNzAzNjM_d5a758bc-59e2-4588-972d-19afc9d0359d"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i59c52d2dd9a244878f20d09c30559d47_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjAtOS0xLTEtNzAzNjM_ac8226c0-50fe-42b8-99db-740ff70998c8"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjAtMTMtMS0xLTcwMzYz_acd38e00-89b0-47c7-b999-3f46391eba50"
      unitRef="usd">6000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i7e5801b0241a4a7596c82b85f6595b87_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjEtMS0xLTEtNzAzNjM_ef0b95fd-60eb-4bff-a4c5-03a0a4946944"
      unitRef="usd">-1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i4eb613993924401da535c4ab70affa54_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjEtMy0xLTEtNzAzNjM_0044eaec-0e05-45a0-b163-c6ae7326a4c3"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i0b050ebc022448918209b90933f84fd1_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjEtNy0xLTEtNzAzNjM_ef849248-b6a8-44b2-9ecd-af8137627deb"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i59c52d2dd9a244878f20d09c30559d47_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjEtOS0xLTEtNzAzNjM_d92b1269-cf21-4ce7-adcf-8252b8f99276"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjEtMTMtMS0xLTcwMzYz_69fda2e3-5051-4d0b-8dcc-01f9e6833d6f"
      unitRef="usd">-1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i7e5801b0241a4a7596c82b85f6595b87_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjItMS0xLTEtNzAzNjM_f88a2248-ed32-4380-a6f3-ec36b03c4e6c"
      unitRef="usd">34000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i4eb613993924401da535c4ab70affa54_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjItMy0xLTEtNzAzNjM_3d2c4f7a-addd-4932-a7f5-cc8809b34713"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i0b050ebc022448918209b90933f84fd1_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjItNy0xLTEtNzAzNjM_c26050fa-24e1-4e52-b6a3-fd61efa85d6c"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i59c52d2dd9a244878f20d09c30559d47_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjItOS0xLTEtNzAzNjM_7c3b93a1-6bb9-49a8-8db9-ec38b4f0fbff"
      unitRef="usd">3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjItMTMtMS0xLTcwMzYz_03e6e7e9-4c17-4699-9c3d-ed3a894bc7db"
      unitRef="usd">37000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i7e5801b0241a4a7596c82b85f6595b87_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjMtMS0xLTEtNzAzNjM_9f0f9803-67c0-4caf-99a2-60307e8c9a08"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i4eb613993924401da535c4ab70affa54_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjMtMy0xLTEtNzAzNjM_5a7d91e1-ab4d-4398-af55-6bbb41b92ead"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i0b050ebc022448918209b90933f84fd1_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjMtNy0xLTEtNzAzNjM_f0eb1ab2-e320-4cff-8207-fd6d8a5e8f75"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i59c52d2dd9a244878f20d09c30559d47_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjMtOS0xLTEtNzAzNjM_012fb98f-29e9-4ec4-b40c-db1e1574e1cc"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjMtMTMtMS0xLTcwMzYz_768bd0e7-3887-497f-b10a-29c6c5c7d963"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i7e5801b0241a4a7596c82b85f6595b87_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjQtMS0xLTEtNzAzNjM_ee5104f2-6a87-4b69-87c1-627b5fc28546"
      unitRef="usd">47000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i4eb613993924401da535c4ab70affa54_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjQtMy0xLTEtNzAzNjM_d4a34427-8bd4-4e02-8f36-1e6f86c42db7"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i0b050ebc022448918209b90933f84fd1_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjQtNy0xLTEtNzAzNjM_b69fdb0a-0a06-4f4a-887d-2c469ada0145"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i59c52d2dd9a244878f20d09c30559d47_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjQtOS0xLTEtNzAzNjM_a79321c9-ee34-4f2e-8a20-19ee69249ca8"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjQtMTMtMS0xLTcwMzYz_9ac53965-3662-434f-a517-af9dd9ae3390"
      unitRef="usd">47000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i7e5801b0241a4a7596c82b85f6595b87_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjYtMS0xLTEtNzAzNjM_37150e05-f685-40e5-9545-308ef585f2f9"
      unitRef="usd">4000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i4eb613993924401da535c4ab70affa54_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjYtMy0xLTEtNzAzNjM_4f181901-a309-4c74-8de6-c2e01616ba71"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i0b050ebc022448918209b90933f84fd1_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjYtNy0xLTEtNzAzNjM_111830aa-0e03-42d9-86f5-f65300e400e4"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i59c52d2dd9a244878f20d09c30559d47_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjYtOS0xLTEtNzAzNjM_dfde69f6-edc5-411d-8a04-ac566815b93b"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjYtMTMtMS0xLTcwMzYz_41befb67-01b6-4f90-8142-97c767306f09"
      unitRef="usd">10000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i5c3c0ca17622496e8271489dbd81a554_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjctMS0xLTEtNzAzNjM_a909d93e-eb3a-4502-87c0-c7bbbd4cce3a"
      unitRef="usd">334000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="idd53ebecdb7c4377a7e274fef86d5b98_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjctMy0xLTEtNzAzNjM_beca998d-c89a-400c-96d7-c47e24a69f04"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i51a6e283ad82499983038a1294335516_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjctNy0xLTEtNzAzNjM_1f82a721-c3d9-4662-9db4-ce2a8da9b3e9"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="id012155f0536487e80c5f21ecb0cff93_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjctOS0xLTEtNzAzNjM_d0d2af18-9ae5-42b6-bd40-f53bf3a44e29"
      unitRef="usd">84000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="id7580839926f4e24b08f10312dd69479_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjctMTMtMS0xLTcwMzYz_a0b2c713-b181-4a2d-ad54-1c43addc2a52"
      unitRef="usd">421000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="i7e5801b0241a4a7596c82b85f6595b87_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjgtMS0xLTEtNzAzNjM_349c8410-6c40-443f-8efd-332a70941098"
      unitRef="usd">0</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="i4eb613993924401da535c4ab70affa54_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjgtMy0xLTEtNzAzNjM_a370660e-a3c8-4e37-9ac4-562ebfc116d8"
      unitRef="usd">0</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="i0b050ebc022448918209b90933f84fd1_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjgtNy0xLTEtNzAzNjM_cad52866-59f1-4844-be02-8a2395697228"
      unitRef="usd">0</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="i59c52d2dd9a244878f20d09c30559d47_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjgtOS0xLTEtNzAzNjM_f7e5c80f-7d8e-4fa1-ba6b-b50b464bb60c"
      unitRef="usd">5000000</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjkwYWU0ZWE1ZDE3ODQ5NzBhZWVjYThkMmE4N2FjY2Q0L3RhYmxlcmFuZ2U6OTBhZTRlYTVkMTc4NDk3MGFlZWNhOGQyYTg3YWNjZDRfMjgtMTMtMS0xLTcwMzYz_d015323a-ac49-4e6c-b505-a3949435c406"
      unitRef="usd">5000000</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i3fe0fa1cefe04a9ab9bd771236eb24fd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMy0xLTEtMS03MDM2Mw_eac75d08-15c8-4421-885b-8085325604bc"
      unitRef="usd">336000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i1998952a2fec4ef987e45747bc6a365e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMy0zLTEtMS03MDM2Mw_859ba166-7577-43f9-9980-130f1ee054bd"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i9b17717cfed84a8695f0ebee25d6d1b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMy03LTEtMS03MDM2Mw_78c171d0-fd3a-46b8-8246-3107e978f27f"
      unitRef="usd">19000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i956f35bd2d5e479b8fc6a91a40089b3d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMy05LTEtMS03MDM2Mw_d12dfd27-9580-4242-83c5-4be2aeb9a3e7"
      unitRef="usd">89000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMy0xMy0xLTEtNzAzNjM_ba900181-9976-46da-959d-ff072653c634"
      unitRef="usd">449000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i3f0ecc541cf74ed2a635167eb7164491_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNS0xLTEtMS03MDM2Mw_726bc08d-22dc-4c5c-ac2d-5a6391afd8ef"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="iafd89c3d325847c59f8b3bc903c4c035_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNS0zLTEtMS03MDM2Mw_f69c37c9-33c7-4715-b9d6-81d2644032fe"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i964bac3f30f64868a6e633166235cda5_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNS03LTEtMS03MDM2Mw_1fa60ab1-9ab6-4d8f-b2e0-cc65612dc2ae"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i37e5af918e28462f98ca407c5455389f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNS05LTEtMS03MDM2Mw_2a1f0763-8b5d-4948-94bc-194c3d1e9330"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNS0xMy0xLTEtNzAzNjM_2fc9a7a0-56d4-407d-b65e-4e28120f6315"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i3f0ecc541cf74ed2a635167eb7164491_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNi0xLTEtMS03MDM2Mw_929f32f7-7920-4b20-b21c-e941c7c0bf21"
      unitRef="usd">-1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="iafd89c3d325847c59f8b3bc903c4c035_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNi0zLTEtMS03MDM2Mw_8b4c64e7-d9ad-4a42-9cb0-2f0686521787"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i964bac3f30f64868a6e633166235cda5_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNi03LTEtMS03MDM2Mw_29a81e42-c17e-4bc2-86c0-7ab6e95f9a17"
      unitRef="usd">17000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i37e5af918e28462f98ca407c5455389f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNi05LTEtMS03MDM2Mw_8504244f-ce7f-4870-87d6-b63383cac575"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNi0xMy0xLTEtNzAzNjM_2b65eb7e-9789-4e09-a4e7-6ff7ad0c179c"
      unitRef="usd">16000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i3f0ecc541cf74ed2a635167eb7164491_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNy0xLTEtMS03MDM2Mw_80885c27-8837-495e-af71-de91c8a6c27b"
      unitRef="usd">40000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="iafd89c3d325847c59f8b3bc903c4c035_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNy0zLTEtMS03MDM2Mw_c1a8ba3a-5241-4f04-984b-32293bd88e67"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i964bac3f30f64868a6e633166235cda5_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNy03LTEtMS03MDM2Mw_c7d9d3c6-7f2c-4ee2-b781-9c92fd7fce55"
      unitRef="usd">281000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i37e5af918e28462f98ca407c5455389f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNy05LTEtMS03MDM2Mw_8e2853db-f8ae-4129-ad9c-46b663a52b4f"
      unitRef="usd">24000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfNy0xMy0xLTEtNzAzNjM_6674ac73-bc74-485c-b92a-c0246fc622f9"
      unitRef="usd">345000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i3f0ecc541cf74ed2a635167eb7164491_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfOC0xLTEtMS03MDM2Mw_31700694-301f-41a1-b506-07190bb857a0"
      unitRef="usd">201000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="iafd89c3d325847c59f8b3bc903c4c035_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfOC0zLTEtMS03MDM2Mw_bda0c03d-a3ee-4538-9b72-13f9688add86"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i964bac3f30f64868a6e633166235cda5_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfOC03LTEtMS03MDM2Mw_953911ca-3c27-4528-86be-ff0ae1823190"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i37e5af918e28462f98ca407c5455389f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfOC05LTEtMS03MDM2Mw_f8fad6f6-3ea4-45b4-acd6-7e3fe07286c9"
      unitRef="usd">19000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfOC0xMy0xLTEtNzAzNjM_18af83e8-49d6-4762-8954-bbac7eefec7d"
      unitRef="usd">221000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i3f0ecc541cf74ed2a635167eb7164491_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfOS0xLTEtMS03MDM2Mw_64f1328e-0501-4c66-844b-7fa2cd2bcc64"
      unitRef="usd">42000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="iafd89c3d325847c59f8b3bc903c4c035_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfOS0zLTEtMS03MDM2Mw_5c6f9a4b-ec77-4596-bb87-1db4f0d7004d"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i964bac3f30f64868a6e633166235cda5_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfOS03LTEtMS03MDM2Mw_a6ebf810-4849-4150-8c65-d58825c86faa"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i37e5af918e28462f98ca407c5455389f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfOS05LTEtMS03MDM2Mw_38b58f0a-162f-46e0-bc22-24725c3ac5b2"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfOS0xMy0xLTEtNzAzNjM_41035f99-85d7-4a9c-b77c-09e865cef513"
      unitRef="usd">42000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="i3f0ecc541cf74ed2a635167eb7164491_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTAtMS0xLTEtNzAzNjM_988543e2-3308-4587-86e9-7910d68dc5eb"
      unitRef="usd">9000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="iafd89c3d325847c59f8b3bc903c4c035_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTAtMy0xLTEtNzAzNjM_888a7c2d-8516-4a78-91c8-0a44c88f741a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="i964bac3f30f64868a6e633166235cda5_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTAtNy0xLTEtNzAzNjM_17833122-40cc-45c9-9dbe-b3599a48437a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="i37e5af918e28462f98ca407c5455389f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTAtOS0xLTEtNzAzNjM_e0917061-ee49-4cc1-8d17-72883e5dea19"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTAtMTMtMS0xLTcwMzYz_bd336d56-dec1-48b0-9c52-0d998687b9b4"
      unitRef="usd">9000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i3f0ecc541cf74ed2a635167eb7164491_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTEtMS0xLTEtNzAzNjM_184f97b9-ff82-4214-bdff-88b0254d36af"
      unitRef="usd">12000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="iafd89c3d325847c59f8b3bc903c4c035_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTEtMy0xLTEtNzAzNjM_9617dbd4-8ed4-412a-a3f8-de873fe90497"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i964bac3f30f64868a6e633166235cda5_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTEtNy0xLTEtNzAzNjM_d3457771-82a4-4d84-9273-cd5e36ac548e"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i37e5af918e28462f98ca407c5455389f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTEtOS0xLTEtNzAzNjM_2b6be980-3f84-4481-a8d8-65e94b7ceae5"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTEtMTMtMS0xLTcwMzYz_b34324dd-ec1d-4940-8466-6713b50f69aa"
      unitRef="usd">22000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ib5a6260b0cc245e3ad18420b5dda8138_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTItMS0xLTEtNzAzNjM_8420cc06-29ff-4ee7-9048-16ff2f7b0966"
      unitRef="usd">129000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="id54f0058c591469baef2d1557dcb55a8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTItMy0xLTEtNzAzNjM_b857c06d-4d78-40c5-9b97-52330df5fbfb"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i30a0f87e5ab9493cbf1db457f967922d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTItNy0xLTEtNzAzNjM_cc3e3e59-2a26-4b38-9392-f4f94867d8bd"
      unitRef="usd">311000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i18f0ad9f943549f6888eff0dae5c5a2e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTItOS0xLTEtNzAzNjM_fa948c5a-b416-496b-91aa-fa7d443554bc"
      unitRef="usd">95000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTItMTMtMS0xLTcwMzYz_6339e84d-4712-44bb-9e3b-a5259971783e"
      unitRef="usd">535000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="i3f0ecc541cf74ed2a635167eb7164491_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTMtMS0xLTEtNzAzNjM_4a907513-4d2b-4956-acd6-2a8830ec5c0e"
      unitRef="usd">0</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="iafd89c3d325847c59f8b3bc903c4c035_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTMtMy0xLTEtNzAzNjM_15e32249-a88e-496f-b62a-b4ed880a5404"
      unitRef="usd">0</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="i964bac3f30f64868a6e633166235cda5_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTMtNy0xLTEtNzAzNjM_a40b3421-b81d-43ca-8906-5de7ff398255"
      unitRef="usd">0</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="i37e5af918e28462f98ca407c5455389f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTMtOS0xLTEtNzAzNjM_f1b6a323-bd9d-4af0-8ff4-ed1aad3ceb4f"
      unitRef="usd">1000000</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTMtMTMtMS0xLTcwMzYz_ce802bb7-5d1f-490b-a97d-a7d331d01971"
      unitRef="usd">1000000</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i553640a02dc34c459280bd0390c2547a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTYtMS0xLTEtNzAzNjM_5eadac17-ec0c-455d-a5e9-95dc2cfe2311"
      unitRef="usd">325000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i221dfdac7a494b34b788cabffbef260c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTYtMy0xLTEtNzAzNjM_33168d87-c524-4811-a3ac-775191dce143"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i65f9f1ca30204478a443b52bedc3c6a1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTYtNy0xLTEtNzAzNjM_e666fff9-89d5-4951-8211-7701223d5cf9"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i991cee8de28a4252a7c5e88856804403_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTYtOS0xLTEtNzAzNjM_84356ca4-3895-4cba-ace2-79bd87235202"
      unitRef="usd">60000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i9aceaf2b19bf4d5d916eb0f2039e41de_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTYtMTMtMS0xLTcwMzYz_a73e4c81-0b8b-4e21-a3c2-456d29bf4b77"
      unitRef="usd">392000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i43ab9adfffbb4e97a0584ba6cb437018_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTgtMS0xLTEtNzAzNjM_683cdac6-5875-4a95-979c-dc64ed06d7f0"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i1a83a959df4a4ea893a96ae9001a4dac_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTgtMy0xLTEtNzAzNjM_bad25342-8400-47ad-8dc4-9ccdb64bc234"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i8c5c7d954c4c45a3b0db4aa4accc3482_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTgtNy0xLTEtNzAzNjM_f564110a-d21b-48cb-8e4d-1be984ec9826"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="idfaad08561af4facb21116cd28f9c4d5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTgtOS0xLTEtNzAzNjM_b9f30bff-773e-4405-8d30-98fcb4e76479"
      unitRef="usd">17000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTgtMTMtMS0xLTcwMzYz_7759aa2f-315c-48ed-beb3-174c7e165570"
      unitRef="usd">19000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i43ab9adfffbb4e97a0584ba6cb437018_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTktMS0xLTEtNzAzNjM_c95c56ef-71c6-4020-b6c5-2d9b0f527cda"
      unitRef="usd">4000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i1a83a959df4a4ea893a96ae9001a4dac_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTktMy0xLTEtNzAzNjM_73147fe4-1e8e-4f80-8a41-7f10e7e1a92c"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i8c5c7d954c4c45a3b0db4aa4accc3482_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTktNy0xLTEtNzAzNjM_3cd7229b-c615-477f-bf45-06be5a949704"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="idfaad08561af4facb21116cd28f9c4d5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTktOS0xLTEtNzAzNjM_e749a566-4564-441a-bab1-08b4e5f876db"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMTktMTMtMS0xLTcwMzYz_76a34470-4193-4898-85f0-4cf5bd0d35f8"
      unitRef="usd">4000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i43ab9adfffbb4e97a0584ba6cb437018_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjAtMS0xLTEtNzAzNjM_ab93d82b-9541-445a-bfce-9c6f56592c90"
      unitRef="usd">135000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i1a83a959df4a4ea893a96ae9001a4dac_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjAtMy0xLTEtNzAzNjM_ca8ca65b-2c7a-4faa-a1cf-d5d19e04af58"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i8c5c7d954c4c45a3b0db4aa4accc3482_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjAtNy0xLTEtNzAzNjM_fe2e9fd0-9d64-4b8a-926d-5db5bba019d5"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="idfaad08561af4facb21116cd28f9c4d5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjAtOS0xLTEtNzAzNjM_3d1cbbe2-0f30-45d0-8f61-693ecb1507e0"
      unitRef="usd">11000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjAtMTMtMS0xLTcwMzYz_6ff87408-18ac-408c-9b98-083f2269f85e"
      unitRef="usd">146000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i43ab9adfffbb4e97a0584ba6cb437018_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjEtMS0xLTEtNzAzNjM_baa58536-aaef-4a72-9400-1881aec561df"
      unitRef="usd">12000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i1a83a959df4a4ea893a96ae9001a4dac_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjEtMy0xLTEtNzAzNjM_868a5670-225a-4539-9f70-b65ada7bb463"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i8c5c7d954c4c45a3b0db4aa4accc3482_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjEtNy0xLTEtNzAzNjM_3521269d-66b0-44a4-abab-01c16d2bc8d4"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="idfaad08561af4facb21116cd28f9c4d5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjEtOS0xLTEtNzAzNjM_3424b830-d77a-4701-aa39-9855f391b388"
      unitRef="usd">4000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjEtMTMtMS0xLTcwMzYz_02647908-f052-4581-8e71-65e05c9e1bf1"
      unitRef="usd">16000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i43ab9adfffbb4e97a0584ba6cb437018_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjItMS0xLTEtNzAzNjM_77337826-8127-4f06-bcb7-6c404b788819"
      unitRef="usd">118000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i1a83a959df4a4ea893a96ae9001a4dac_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjItMy0xLTEtNzAzNjM_1e7859bf-d6d9-4390-981e-1367d8341e19"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i8c5c7d954c4c45a3b0db4aa4accc3482_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjItNy0xLTEtNzAzNjM_7f4ce19f-5f0b-4827-b122-a01e5b0d03ec"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="idfaad08561af4facb21116cd28f9c4d5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjItOS0xLTEtNzAzNjM_811d9cd8-1285-4600-91ac-9b61545a18ac"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjItMTMtMS0xLTcwMzYz_d7e37dbc-8fbe-4971-88ea-48346ce6ad48"
      unitRef="usd">119000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i43ab9adfffbb4e97a0584ba6cb437018_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjQtMS0xLTEtNzAzNjM_c14363d4-7ede-4ebe-ba17-304cfc0b5232"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i1a83a959df4a4ea893a96ae9001a4dac_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjQtMy0xLTEtNzAzNjM_6fa330c0-2738-4921-b498-79a0e40219d2"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i8c5c7d954c4c45a3b0db4aa4accc3482_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjQtNy0xLTEtNzAzNjM_2087294e-16ab-4a70-b081-1862482ce2f6"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="idfaad08561af4facb21116cd28f9c4d5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjQtOS0xLTEtNzAzNjM_65377797-6fea-4823-b7f6-eeea2ac94a57"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjQtMTMtMS0xLTcwMzYz_410f82f5-7534-4248-bcb9-71fa2ad7fe5b"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i5c3c0ca17622496e8271489dbd81a554_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjUtMS0xLTEtNzAzNjM_c843bd8e-0c8e-4402-91e8-93663be493dc"
      unitRef="usd">334000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="idd53ebecdb7c4377a7e274fef86d5b98_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjUtMy0xLTEtNzAzNjM_39141372-970a-4555-ba02-831693700c69"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i51a6e283ad82499983038a1294335516_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjUtNy0xLTEtNzAzNjM_2ae13b52-27e2-4412-b589-3d71906aae36"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="id012155f0536487e80c5f21ecb0cff93_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjUtOS0xLTEtNzAzNjM_9eb408aa-5e2d-4771-9e47-5b5c9589ff08"
      unitRef="usd">84000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="id7580839926f4e24b08f10312dd69479_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjUtMTMtMS0xLTcwMzYz_29e50067-5184-4884-ac02-125f504f28cf"
      unitRef="usd">421000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="i43ab9adfffbb4e97a0584ba6cb437018_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjYtMS0xLTEtNzAzNjM_2e331202-6d5b-4475-a360-f25aa102dca1"
      unitRef="usd">0</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="i1a83a959df4a4ea893a96ae9001a4dac_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjYtMy0xLTEtNzAzNjM_4c08fd03-2fdb-4795-b21c-55fce8664ffd"
      unitRef="usd">0</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="i8c5c7d954c4c45a3b0db4aa4accc3482_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjYtNy0xLTEtNzAzNjM_0e6dc493-4ac2-403a-854d-3f719ec0995a"
      unitRef="usd">0</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="idfaad08561af4facb21116cd28f9c4d5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjYtOS0xLTEtNzAzNjM_414e565c-5c21-4163-86eb-8bae931e3846"
      unitRef="usd">17000000</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjFhNDQyZDdiMzExYzQxZTQ5YzUxYTNmMjUwMTBhMTU2L3RhYmxlcmFuZ2U6MWE0NDJkN2IzMTFjNDFlNDljNTFhM2YyNTAxMGExNTZfMjYtMTMtMS0xLTcwMzYz_5f1fb610-600c-44ab-8495-9f1e1c45735e"
      unitRef="usd">17000000</us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <elv:CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RleHRyZWdpb246ZTIyYTVkZjliODYyNDAwOWJhY2RlNjY5ZmIxMGEzYTNfMTE1OTI_78e2ef85-ae35-48d2-9b25-199d357c8682">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the estimated fair values by level of each class of financial instrument that is recorded at its carrying value on our consolidated balance sheets at September&#160;30, 2022 and December&#160;31, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.072%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other invested assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible debentures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other invested assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible debentures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</elv:CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock>
    <us-gaap:OtherLongTermInvestments
      contextRef="id13f4c069f824d9e8ada49274ed13fc6_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfNC0xLTEtMS03MDM2Mw_01751f70-4ea6-43fe-8128-93853ef7c6e1"
      unitRef="usd">5367000000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="if9ee845b2ef44f35b34e439f2a98463e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfNC0zLTEtMS03MDM2Mw_d3438c53-aa4c-434e-9111-f47d100f2cc4"
      unitRef="usd">0</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="ib31555a5dc6d48e9a6d0c3e812552916_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfNC01LTEtMS03MDM2Mw_8b760c26-edb0-467a-a0ce-cad90831bbf7"
      unitRef="usd">0</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="i47db3e3b640944bd98e5bc0d5641a14f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfNC03LTEtMS03MDM2Mw_ddd9fc01-d7eb-49ec-b81e-369eccf1e078"
      unitRef="usd">5367000000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="id23aa1cee27e4b5ba329c79f052b0f8d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfNC05LTEtMS03MDM2Mw_f7b0832e-2f29-4c79-a07e-73fc53c73a7b"
      unitRef="usd">5367000000</us-gaap:OtherLongTermInvestments>
    <us-gaap:ShortTermBorrowings
      contextRef="id13f4c069f824d9e8ada49274ed13fc6_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfNy0xLTEtMS03MDM2Mw_f1a79f15-d672-440a-8031-fb400c2bf3a0"
      unitRef="usd">265000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i63d36abe1cfe4cdeab60b3c14cb6960b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfNy0zLTEtMS03MDM2Mw_31edfcd8-b81f-4587-a076-73f41dd60dd4"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="idf4ef63bd2e548af937bde8217b31fd0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfNy01LTEtMS03MDM2Mw_9113b55d-e2fe-4d30-8720-ccb6ef284302"
      unitRef="usd">265000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="iabe0feb61e774f4db61e3b30a3a23479_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfNy03LTEtMS03MDM2Mw_fdb8b065-b5b2-4e61-97f0-bb7439b88633"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfNy05LTEtMS03MDM2Mw_b0fed781-6995-4e92-99a0-c8175e5b23bc"
      unitRef="usd">265000000</us-gaap:ShortTermBorrowings>
    <us-gaap:CommercialPaper
      contextRef="id13f4c069f824d9e8ada49274ed13fc6_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfOS0xLTEtMS03MDM2Mw_5eae4cad-9b9c-4ede-8347-6ba23719298a"
      unitRef="usd">675000000</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper
      contextRef="i63d36abe1cfe4cdeab60b3c14cb6960b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfOS0zLTEtMS03MDM2Mw_d032d70a-4eee-4c3d-856e-46b0569e03ba"
      unitRef="usd">0</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper
      contextRef="idf4ef63bd2e548af937bde8217b31fd0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfOS01LTEtMS03MDM2Mw_55508bd7-d142-4f1e-a3eb-867e77aacabc"
      unitRef="usd">675000000</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper
      contextRef="iabe0feb61e774f4db61e3b30a3a23479_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfOS03LTEtMS03MDM2Mw_1ee94a35-164d-4146-ad0d-7f3814f339a2"
      unitRef="usd">0</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfOS05LTEtMS03MDM2Mw_7e6675eb-3c46-473b-b512-b6d6fcd03a0b"
      unitRef="usd">675000000</us-gaap:CommercialPaper>
    <us-gaap:NotesPayable
      contextRef="id13f4c069f824d9e8ada49274ed13fc6_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTAtMS0xLTEtNzAzNjM_31386dfd-a108-4399-ab00-7faa43726743"
      unitRef="usd">22747000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i63d36abe1cfe4cdeab60b3c14cb6960b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTAtMy0xLTEtNzAzNjM_55dac73c-83b2-419a-ad9e-976e4af63e7a"
      unitRef="usd">0</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="idf4ef63bd2e548af937bde8217b31fd0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTAtNS0xLTEtNzAzNjM_50974f44-b561-42a5-95a1-0a4ffcfe4c59"
      unitRef="usd">20163000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="iabe0feb61e774f4db61e3b30a3a23479_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTAtNy0xLTEtNzAzNjM_1cdab1b7-89ee-435c-942c-59c6b6a6d828"
      unitRef="usd">0</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTAtOS0xLTEtNzAzNjM_1f957cac-6370-4be6-b1e1-86282d4120b1"
      unitRef="usd">20163000000</us-gaap:NotesPayable>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="id13f4c069f824d9e8ada49274ed13fc6_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTEtMS0xLTEtNzAzNjM_5ac13f50-b990-4888-a681-45aed7ae1a54"
      unitRef="usd">86000000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i63d36abe1cfe4cdeab60b3c14cb6960b_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTEtMy0xLTEtNzAzNjM_18bdfafa-652e-4522-9782-a25a9e405507"
      unitRef="usd">0</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="idf4ef63bd2e548af937bde8217b31fd0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTEtNS0xLTEtNzAzNjM_b65dde94-bbff-4aa6-a744-4408bad3ab96"
      unitRef="usd">554000000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="iabe0feb61e774f4db61e3b30a3a23479_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTEtNy0xLTEtNzAzNjM_cf44e703-e8af-43cc-8e18-1d1ffa3faca3"
      unitRef="usd">0</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTEtOS0xLTEtNzAzNjM_ce314576-2363-48f3-80fc-db1bf56d5d23"
      unitRef="usd">554000000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:OtherLongTermInvestments
      contextRef="i207053455c4d4c45b53e5fa230ebb0ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTUtMS0xLTEtNzAzNjM_de4d2764-2fea-4b10-847e-f183eb58667b"
      unitRef="usd">5087000000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="i3a7e8295eb174731af155b02715f0698_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTUtMy0xLTEtNzAzNjM_d587944a-d915-4139-8fc8-e3753a72c051"
      unitRef="usd">0</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="iaeb1d12977ce4b2aa244d83f0a51489a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTUtNS0xLTEtNzAzNjM_c7d341fb-41ea-4675-9775-a73a73098732"
      unitRef="usd">0</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="ia381401dee2b49a69141fac81ccda064_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTUtNy0xLTEtNzAzNjM_eb2be4b0-a1bf-4abd-b1ab-2a8ebf7cd985"
      unitRef="usd">5087000000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="if1c0c8330af1412c8daa5f4cc313c34b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTUtOS0xLTEtNzAzNjM_7f99b006-994d-4a89-928f-634206163288"
      unitRef="usd">5087000000</us-gaap:OtherLongTermInvestments>
    <us-gaap:ShortTermBorrowings
      contextRef="i207053455c4d4c45b53e5fa230ebb0ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTgtMS0xLTEtNzAzNjM_efc347a0-6443-47da-a8cf-58ef8f51db4f"
      unitRef="usd">275000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="ie12564db4311425aa96c7f9f9b74dc88_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTgtMy0xLTEtNzAzNjM_e9f764cc-717c-46f2-a81f-d84a5c43a503"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="id36628eb07534a42afaaae7affc76a88_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTgtNS0xLTEtNzAzNjM_3459864a-41ae-491d-913f-ebcd9ba8f10b"
      unitRef="usd">275000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="if3c6abfca5ec440eb693997af5ab6d46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTgtNy0xLTEtNzAzNjM_9a383c71-0167-441f-abf2-9654873eebd5"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTgtOS0xLTEtNzAzNjM_59ec2371-afae-4da5-8ded-86b31fe8572e"
      unitRef="usd">275000000</us-gaap:ShortTermBorrowings>
    <us-gaap:CommercialPaper
      contextRef="i207053455c4d4c45b53e5fa230ebb0ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTktMS0xLTEtNzAzNjM_0cf7a4a3-0b36-43f5-bedf-5cea45773f77"
      unitRef="usd">300000000</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper
      contextRef="ie12564db4311425aa96c7f9f9b74dc88_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTktMy0xLTEtNzAzNjM_9aab3739-461e-4289-9348-47973b719c73"
      unitRef="usd">0</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper
      contextRef="id36628eb07534a42afaaae7affc76a88_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTktNS0xLTEtNzAzNjM_8830aac7-86ae-40b8-9e54-670b71a01b00"
      unitRef="usd">300000000</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper
      contextRef="if3c6abfca5ec440eb693997af5ab6d46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTktNy0xLTEtNzAzNjM_3379a02e-ce94-45d2-ab5e-0abe220fbb1a"
      unitRef="usd">0</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMTktOS0xLTEtNzAzNjM_69dbb90d-7b0d-44cf-8c10-ff7d14370e88"
      unitRef="usd">300000000</us-gaap:CommercialPaper>
    <us-gaap:NotesPayable
      contextRef="i207053455c4d4c45b53e5fa230ebb0ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMjAtMS0xLTEtNzAzNjM_d8271ff5-df32-4caa-b8f2-da1c5b1d6dc8"
      unitRef="usd">22384000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="ie12564db4311425aa96c7f9f9b74dc88_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMjAtMy0xLTEtNzAzNjM_77308575-0cae-41c3-a1c9-549a8c3e87fa"
      unitRef="usd">0</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="id36628eb07534a42afaaae7affc76a88_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMjAtNS0xLTEtNzAzNjM_d9da5258-ad42-43ef-937c-be382a10f96e"
      unitRef="usd">25150000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="if3c6abfca5ec440eb693997af5ab6d46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMjAtNy0xLTEtNzAzNjM_9aff5827-408e-49a8-a83a-9d56fa6ef6b7"
      unitRef="usd">0</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMjAtOS0xLTEtNzAzNjM_0dd77bfc-fb94-4c1b-b8c0-5cddff5f1c22"
      unitRef="usd">25150000000</us-gaap:NotesPayable>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i207053455c4d4c45b53e5fa230ebb0ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMjEtMS0xLTEtNzAzNjM_78e0b2e8-98c7-4096-81a3-be4517cebb38"
      unitRef="usd">72000000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="ie12564db4311425aa96c7f9f9b74dc88_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMjEtMy0xLTEtNzAzNjM_3c4a26b9-79e7-41c9-add4-ba0794dd1f4a"
      unitRef="usd">0</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="id36628eb07534a42afaaae7affc76a88_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMjEtNS0xLTEtNzAzNjM_efa9aa26-beb6-4a6b-9646-a92f9d230d3f"
      unitRef="usd">687000000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="if3c6abfca5ec440eb693997af5ab6d46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMjEtNy0xLTEtNzAzNjM_31d0f6b5-84dd-43e4-941d-aeda1c7d6ce6"
      unitRef="usd">0</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF81OC9mcmFnOmUyMmE1ZGY5Yjg2MjQwMDliYWNkZTY2OWZiMTBhM2EzL3RhYmxlOjIxZmQ1YWQ2NjdlNDQwMmViZTk2NjUyZGM1MzA5MzM5L3RhYmxlcmFuZ2U6MjFmZDVhZDY2N2U0NDAyZWJlOTY2NTJkYzUzMDkzMzlfMjEtOS0xLTEtNzAzNjM_1ddfddb5-d188-4ac1-8b73-f3485e1005f8"
      unitRef="usd">687000000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82MS9mcmFnOjljZjk2YmNmZjFkZTQ3Zjk5OWU2ZGZlMGYyYjc2NTAwL3RleHRyZWdpb246OWNmOTZiY2ZmMWRlNDdmOTk5ZTZkZmUwZjJiNzY1MDBfODMx_c7e35546-eb2d-4f5a-94be-b28419af9708">Income Taxes&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three months ended September 30, 2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and 2021, we recognized income tax expense of $533 and $494, respectively, which represent effective income tax rates of 24.8% and 24.7%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended September 30, 2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and 2021, we recognized income tax expense of $1,557 and $1,555, respectively, which represent effective income tax rates of 23.5% and 23.8%, respectively. The decrease in our effective tax rate from the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended September 30, 2021&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was primarily related to the tax impact of expected geographic changes in our mix of 2022 earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes receivable totaled $214 and $173 at September&#160;30, 2022 and December&#160;31, 2021, respectively. We recognized the income taxes receivable as an asset under the caption &#x201c;Other current assets&#x201d; in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82MS9mcmFnOjljZjk2YmNmZjFkZTQ3Zjk5OWU2ZGZlMGYyYjc2NTAwL3RleHRyZWdpb246OWNmOTZiY2ZmMWRlNDdmOTk5ZTZkZmUwZjJiNzY1MDBfODA_9209cfd3-cdef-47f6-9568-c6c0192b84ea"
      unitRef="usd">533000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82MS9mcmFnOjljZjk2YmNmZjFkZTQ3Zjk5OWU2ZGZlMGYyYjc2NTAwL3RleHRyZWdpb246OWNmOTZiY2ZmMWRlNDdmOTk5ZTZkZmUwZjJiNzY1MDBfODc_cc73fd27-e2f7-4390-a4ca-b2b9f8fc66d5"
      unitRef="usd">494000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82MS9mcmFnOjljZjk2YmNmZjFkZTQ3Zjk5OWU2ZGZlMGYyYjc2NTAwL3RleHRyZWdpb246OWNmOTZiY2ZmMWRlNDdmOTk5ZTZkZmUwZjJiNzY1MDBfMTUx_c8e42b56-a3a7-43f1-98b9-ed65b332e6c0"
      unitRef="number">0.248</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82MS9mcmFnOjljZjk2YmNmZjFkZTQ3Zjk5OWU2ZGZlMGYyYjc2NTAwL3RleHRyZWdpb246OWNmOTZiY2ZmMWRlNDdmOTk5ZTZkZmUwZjJiNzY1MDBfMTU4_a38bf58e-d798-45ce-83f7-8fccdf4387d8"
      unitRef="number">0.247</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82MS9mcmFnOjljZjk2YmNmZjFkZTQ3Zjk5OWU2ZGZlMGYyYjc2NTAwL3RleHRyZWdpb246OWNmOTZiY2ZmMWRlNDdmOTk5ZTZkZmUwZjJiNzY1MDBfMzg0_f2d9e4a8-0fe5-41d0-936c-c75e4db5efd5"
      unitRef="usd">1557000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82MS9mcmFnOjljZjk2YmNmZjFkZTQ3Zjk5OWU2ZGZlMGYyYjc2NTAwL3RleHRyZWdpb246OWNmOTZiY2ZmMWRlNDdmOTk5ZTZkZmUwZjJiNzY1MDBfMzkx_21abaddb-3db3-40f7-8cfe-1ae1c08998ff"
      unitRef="usd">1555000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82MS9mcmFnOjljZjk2YmNmZjFkZTQ3Zjk5OWU2ZGZlMGYyYjc2NTAwL3RleHRyZWdpb246OWNmOTZiY2ZmMWRlNDdmOTk5ZTZkZmUwZjJiNzY1MDBfNDU1_68117518-0086-4255-8bcf-1ea373df2770"
      unitRef="number">0.235</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82MS9mcmFnOjljZjk2YmNmZjFkZTQ3Zjk5OWU2ZGZlMGYyYjc2NTAwL3RleHRyZWdpb246OWNmOTZiY2ZmMWRlNDdmOTk5ZTZkZmUwZjJiNzY1MDBfNDYy_f68acc29-eea6-4523-91ef-ec2777c7847b"
      unitRef="number">0.238</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82MS9mcmFnOjljZjk2YmNmZjFkZTQ3Zjk5OWU2ZGZlMGYyYjc2NTAwL3RleHRyZWdpb246OWNmOTZiY2ZmMWRlNDdmOTk5ZTZkZmUwZjJiNzY1MDBfNjYy_3ce9f430-d8a1-4ea1-be92-2ae83a70fd94"
      unitRef="usd">214000000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82MS9mcmFnOjljZjk2YmNmZjFkZTQ3Zjk5OWU2ZGZlMGYyYjc2NTAwL3RleHRyZWdpb246OWNmOTZiY2ZmMWRlNDdmOTk5ZTZkZmUwZjJiNzY1MDBfNjY5_7a3c69e6-6375-430a-be22-68172bd371a9"
      unitRef="usd">173000000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfMjA1Nw_1c3aab61-0ddf-4627-8f3b-8e0d5fa38077">Medical Claims Payable&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending balances for medical claims payable, by segment (see Note 15, &#x201c;Segment Information&#x201d;), for the nine months ended September 30, 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.764%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Commercial&lt;br/&gt;&amp;amp; Specialty&lt;br/&gt;Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Government&lt;br/&gt;Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross medical claims payable, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceded medical claims payable, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net medical claims payable, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business combinations and purchase adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net incurred medical claims:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior periods redundancies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(901)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net incurred medical claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net payments attributable to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period medical claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior periods medical claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net medical claims payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceded medical claims payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross medical claims payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2022, the total of net incurred but not reported liabilities plus expected development on reported claims for the Commercial &amp;amp; Specialty Business was $81, $388 and $3,449 for the claim years 2020 and prior, 2021 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2022, the total of net incurred but not reported liabilities plus expected development on reported claims for the Government Business was $148, $508 and $10,151 for the claim years 2020 and prior, 2021 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2022, the total of net incurred but not reported liabilities plus expected development on reported claims for Other was $2, $14 and $257 for the claim years 2020 and prior, 2021 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending balances for medical claims payable, by segment (see Note 15, &#x201c;Segment Information&#x201d;), for the nine months ended September 30, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.764%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Commercial&lt;br/&gt;&amp;amp; Specialty&lt;br/&gt;Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Government&lt;br/&gt;Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross medical claims payable, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceded medical claims payable, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net medical claims payable, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business combinations and purchase adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net incurred medical claims:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior periods redundancies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(496)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,309)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,822)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net incurred medical claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net payments attributable to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period medical claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior periods medical claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net medical claims payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceded medical claims payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross medical claims payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The favorable development recognized in the nine months ended September 30, 2022 and 2021 resulted primarily from trend factors in late 2021 and late 2020, respectively, developing more favorably than originally expected. Favorable development in the completion factors resulting from the latter parts of 2020 developing faster than expected also contributed to the favorable development in the nine months ended September 30, 2021. The impact from COVID-19 on healthcare utilization and medical claims submission patterns continues to provide increased estimation uncertainty on our incurred but not reported liability at September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of net incurred medical claims to benefit expense included in our consolidated statements of income for periods in 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.126%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.825%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net incurred medical claims:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial &amp;amp; Specialty Business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net incurred medical claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quality improvement and other claims expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; During the three months ended September 30, 2022, based on recent regulatory clarification, we realigned certain quality improvement costs from benefit expense to administrative expense that were previously allocated to benefit expense during the three months ended March 31, 2022 and the three months ended June 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of net incurred medical claims to benefit expense included in our consolidated statements of income for periods in 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net incurred medical claims:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial &amp;amp; Specialty Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net incurred medical claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quality improvement and other claims expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of the medical claims payable reflected in the tables above to the consolidated ending balance for medical claims payable included in the consolidated balance sheet, as of September&#160;30, 2022, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.764%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Commercial&lt;br/&gt;&amp;amp; Specialty&lt;br/&gt;Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Government&lt;br/&gt;Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net medical claims payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceded medical claims payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance lines other than short duration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross medical claims payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock>
    <us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfMjA1MQ_cee36f9d-2bfd-4820-bbbb-362fb4fc4bee">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending balances for medical claims payable, by segment (see Note 15, &#x201c;Segment Information&#x201d;), for the nine months ended September 30, 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.764%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Commercial&lt;br/&gt;&amp;amp; Specialty&lt;br/&gt;Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Government&lt;br/&gt;Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross medical claims payable, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceded medical claims payable, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net medical claims payable, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business combinations and purchase adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net incurred medical claims:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior periods redundancies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(901)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net incurred medical claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net payments attributable to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period medical claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior periods medical claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net medical claims payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceded medical claims payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross medical claims payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2022, the total of net incurred but not reported liabilities plus expected development on reported claims for the Commercial &amp;amp; Specialty Business was $81, $388 and $3,449 for the claim years 2020 and prior, 2021 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2022, the total of net incurred but not reported liabilities plus expected development on reported claims for the Government Business was $148, $508 and $10,151 for the claim years 2020 and prior, 2021 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2022, the total of net incurred but not reported liabilities plus expected development on reported claims for Other was $2, $14 and $257 for the claim years 2020 and prior, 2021 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending balances for medical claims payable, by segment (see Note 15, &#x201c;Segment Information&#x201d;), for the nine months ended September 30, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.764%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Commercial&lt;br/&gt;&amp;amp; Specialty&lt;br/&gt;Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Government&lt;br/&gt;Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross medical claims payable, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceded medical claims payable, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net medical claims payable, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business combinations and purchase adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net incurred medical claims:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior periods redundancies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(496)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,309)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,822)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net incurred medical claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net payments attributable to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period medical claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior periods medical claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net medical claims payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceded medical claims payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross medical claims payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The favorable development recognized in the nine months ended September 30, 2022 and 2021 resulted primarily from trend factors in late 2021 and late 2020, respectively, developing more favorably than originally expected. Favorable development in the completion factors resulting from the latter parts of 2020 developing faster than expected also contributed to the favorable development in the nine months ended September 30, 2021. The impact from COVID-19 on healthcare utilization and medical claims submission patterns continues to provide increased estimation uncertainty on our incurred but not reported liability at September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense
      contextRef="ib25ede8a88f9477dbd274859e7a2b1b1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMS0xLTEtMS03MDM2Mw_bd300db1-40fe-4828-a67d-63768786041c"
      unitRef="usd">3847000000</elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense>
    <elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense
      contextRef="i1bbc82c5b8774ddc80a06a94578b2a62_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMS0zLTEtMS03MDM2Mw_0becc51d-d6a8-43a6-9942-6e880ffd3867"
      unitRef="usd">9157000000</elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense>
    <elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense
      contextRef="if7c1d9dfb7814c5da0eb0bcb78535511_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMS01LTEtMS03MDM2Mw_d9ef7952-2903-4fdb-a495-f958ede2ae55"
      unitRef="usd">278000000</elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense>
    <elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMS03LTEtMS03MDM2Mw_9a744ecc-9905-40b3-9458-b76f15001ba1"
      unitRef="usd">13282000000</elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="ib25ede8a88f9477dbd274859e7a2b1b1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMi0xLTEtMS03MDM2Mw_f4a8601e-e01b-45c0-a8f0-e812029e3b4f"
      unitRef="usd">13000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i1bbc82c5b8774ddc80a06a94578b2a62_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMi0zLTEtMS03MDM2Mw_d08f854e-1c72-42a8-81b9-b774d45af7b6"
      unitRef="usd">8000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="if7c1d9dfb7814c5da0eb0bcb78535511_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMi01LTEtMS03MDM2Mw_4e35f806-1434-40e8-9c3b-227a7ec2d1d7"
      unitRef="usd">0</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMi03LTEtMS03MDM2Mw_2a82e90a-d6e1-4f1c-9504-d0c95684ee11"
      unitRef="usd">21000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="ib25ede8a88f9477dbd274859e7a2b1b1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMy0xLTEtMS03MDM2Mw_f25d069d-fbae-47c8-b065-6d245c1147d6"
      unitRef="usd">3834000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i1bbc82c5b8774ddc80a06a94578b2a62_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMy0zLTEtMS03MDM2Mw_cab477ad-80e1-4578-9a41-77afa1e76c96"
      unitRef="usd">9149000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="if7c1d9dfb7814c5da0eb0bcb78535511_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMy01LTEtMS03MDM2Mw_80dd3741-f617-4a27-94ee-e517da7a1ee9"
      unitRef="usd">278000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMy03LTEtMS03MDM2Mw_6e5e31a5-3a01-42a7-97c0-7ff2fa4f31ef"
      unitRef="usd">13261000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments
      contextRef="i2eef42da7d1c4cd495f66b68093f8dc3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNC0xLTEtMS03MDM2Mw_10a8dff2-2296-4ab9-b38f-d01120c43d5e"
      unitRef="usd">3000000</elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments>
    <elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments
      contextRef="i17f3cb9f8c1d492197e639b5a0369fef_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNC0zLTEtMS03MDM2Mw_eca2860d-9488-44d2-b539-bae9b5a24f12"
      unitRef="usd">130000000</elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments>
    <elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments
      contextRef="id8e9a443d6054bb489dd821a7385bab4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNC01LTEtMS03MDM2Mw_009cc6f2-a9a1-4674-b022-b8ae189ab6f1"
      unitRef="usd">0</elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments>
    <elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNC03LTEtMS03MDM2Mw_bfa53440-c95b-41fc-9d5f-e7f8583aefae"
      unitRef="usd">133000000</elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i518bf560bf5b42db9717fa1237d56fc5_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNi0xLTEtMS03MDM2Mw_b709f846-30fa-4ce0-acb1-eafc2e233251"
      unitRef="usd">22049000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i32803f4645204fb0b79a26f39fe31411_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNi0zLTEtMS03MDM2Mw_01150bc0-20c8-4f48-b83e-53bb320c5b80"
      unitRef="usd">60971000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i5866a8bbba704cf588b8904b077bac81_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNi01LTEtMS03MDM2Mw_c44b0242-c903-4834-970c-af80d85867ed"
      unitRef="usd">1157000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNi03LTEtMS03MDM2Mw_091c7d49-4e5a-48d3-8b5c-532afed01d19"
      unitRef="usd">84177000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i518bf560bf5b42db9717fa1237d56fc5_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNy0xLTEtMS03MDM2Mw_bc9545f4-0771-466d-ba95-01b7f9237719"
      unitRef="usd">183000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i32803f4645204fb0b79a26f39fe31411_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNy0zLTEtMS03MDM2Mw_21b764ac-6a7f-482b-82c3-051f18e7720a"
      unitRef="usd">639000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i5866a8bbba704cf588b8904b077bac81_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNy01LTEtMS03MDM2Mw_e20d78ae-f914-4761-b236-f595741d5bbe"
      unitRef="usd">79000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfNy03LTEtMS03MDM2Mw_2d366951-80ea-466c-870f-5a4c0600b821"
      unitRef="usd">901000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i518bf560bf5b42db9717fa1237d56fc5_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfOC0xLTEtMS03MDM2Mw_9e294d34-fc3d-4acb-abb2-342f1bc9af93"
      unitRef="usd">21866000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i32803f4645204fb0b79a26f39fe31411_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfOC0zLTEtMS03MDM2Mw_8530e2d4-f13c-4384-a3f8-6f2023d9fda3"
      unitRef="usd">60332000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i5866a8bbba704cf588b8904b077bac81_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfOC01LTEtMS03MDM2Mw_1851838a-4567-4cce-beb3-f9392656dcb5"
      unitRef="usd">1078000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfOC03LTEtMS03MDM2Mw_419a3057-1de6-4288-afb2-a3edf3696456"
      unitRef="usd">83276000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i518bf560bf5b42db9717fa1237d56fc5_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTAtMS0xLTEtNzAzNjM_280f1b07-8906-47b2-a599-a9dd32dfefcf"
      unitRef="usd">18604000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i32803f4645204fb0b79a26f39fe31411_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTAtMy0xLTEtNzAzNjM_13e027bf-f22d-4609-96e7-e1e40377a07c"
      unitRef="usd">50950000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i5866a8bbba704cf588b8904b077bac81_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTAtNS0xLTEtNzAzNjM_18dd131c-a2fb-4a40-8251-47e6f9f49fcf"
      unitRef="usd">899000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTAtNy0xLTEtNzAzNjM_95c6af18-39ec-4dd7-9b4a-e4a83b9a2319"
      unitRef="usd">70453000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i518bf560bf5b42db9717fa1237d56fc5_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTEtMS0xLTEtNzAzNjM_5e9aa492-5942-48fe-b53a-4f83bbdebf09"
      unitRef="usd">3181000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i32803f4645204fb0b79a26f39fe31411_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTEtMy0xLTEtNzAzNjM_de8a0e44-0111-4fa8-a657-4b1862098010"
      unitRef="usd">7854000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i5866a8bbba704cf588b8904b077bac81_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTEtNS0xLTEtNzAzNjM_803cd570-dcae-4050-9c1a-903fb77b1136"
      unitRef="usd">184000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTEtNy0xLTEtNzAzNjM_0088f39a-e9b7-4c9f-a8e4-9f8e7b99fd6b"
      unitRef="usd">11219000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i518bf560bf5b42db9717fa1237d56fc5_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTItMS0xLTEtNzAzNjM_29ce81fc-95a9-422d-8a74-02c40b5a9043"
      unitRef="usd">21785000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i32803f4645204fb0b79a26f39fe31411_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTItMy0xLTEtNzAzNjM_df1f0fcd-7b1b-46d9-8e62-c6073cfcc647"
      unitRef="usd">58804000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i5866a8bbba704cf588b8904b077bac81_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTItNS0xLTEtNzAzNjM_46d59599-e4f7-4ebb-a62f-5228a4588fd7"
      unitRef="usd">1083000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTItNy0xLTEtNzAzNjM_6b350583-6bdf-4722-a2bd-187270eaa55f"
      unitRef="usd">81672000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet
      contextRef="i2eef42da7d1c4cd495f66b68093f8dc3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTMtMS0xLTEtNzAzNjM_943508c7-58ab-42e3-aec8-c3953abea237"
      unitRef="usd">3918000000</elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet>
    <elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet
      contextRef="i17f3cb9f8c1d492197e639b5a0369fef_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTMtMy0xLTEtNzAzNjM_f25ded52-64ad-40e7-85c8-051b338410d8"
      unitRef="usd">10807000000</elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet>
    <elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet
      contextRef="id8e9a443d6054bb489dd821a7385bab4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTMtNS0xLTEtNzAzNjM_9d424c4a-240d-471d-b9a0-3f31c783cda2"
      unitRef="usd">273000000</elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet>
    <elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTMtNy0xLTEtNzAzNjM_40324b84-da3f-4275-8888-02c7bedf20cd"
      unitRef="usd">14998000000</elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i2eef42da7d1c4cd495f66b68093f8dc3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTQtMS0xLTEtNzAzNjM_123913f9-2df4-4f68-b89a-d8cc1d39cd60"
      unitRef="usd">3000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i17f3cb9f8c1d492197e639b5a0369fef_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTQtMy0xLTEtNzAzNjM_9f2fe880-1b59-4831-bef2-3fbf741924a4"
      unitRef="usd">0</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="id8e9a443d6054bb489dd821a7385bab4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTQtNS0xLTEtNzAzNjM_08742301-02f5-4e0b-9310-2e8e3daae123"
      unitRef="usd">0</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTQtNy0xLTEtNzAzNjM_11006ac0-44e6-4bf1-80aa-42e746269a59"
      unitRef="usd">3000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense
      contextRef="i2eef42da7d1c4cd495f66b68093f8dc3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTUtMS0xLTEtNzAzNjM_f41be0dd-b641-4d65-9280-d78f10250f80"
      unitRef="usd">3921000000</elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense>
    <elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense
      contextRef="i17f3cb9f8c1d492197e639b5a0369fef_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTUtMy0xLTEtNzAzNjM_91c62e0e-4434-4827-9054-73aee01c2b2d"
      unitRef="usd">10807000000</elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense>
    <elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense
      contextRef="id8e9a443d6054bb489dd821a7385bab4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTUtNS0xLTEtNzAzNjM_484cff98-568d-41c7-aad0-f20610847c75"
      unitRef="usd">273000000</elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense>
    <elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmI3ZjYwODE0NmMzMjRhZDJiOTNiNWExZTRkY2Y0YjU1L3RhYmxlcmFuZ2U6YjdmNjA4MTQ2YzMyNGFkMmI5M2I1YTFlNGRjZjRiNTVfMTUtNy0xLTEtNzAzNjM_752b6751-7f8f-4b8a-9b08-ec58c5379720"
      unitRef="usd">15001000000</elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense>
    <us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet
      contextRef="ic61874748541445bb5346014604b1e2f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfMzQx_263504ad-b8cd-4d12-817a-987923a208c3"
      unitRef="usd">81000000</us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet
      contextRef="i9cf718e43d2d431aab9e48ee4460c848_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfMzQ1_4284365f-a30c-4b3b-899e-ec98986569eb"
      unitRef="usd">388000000</us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet
      contextRef="i0c42a359a2a345cd9ba70d1ac59c63f2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfMzUy_5386877b-653f-4a5c-8485-34fcd9346a60"
      unitRef="usd">3449000000</us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet
      contextRef="i013231985bd7411185b88460522d8b36_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfNTUz_f6c0e07a-73f3-47ac-978c-c1ce51c92054"
      unitRef="usd">148000000</us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet
      contextRef="i3995587e895e4e8e900e6e6a4ad92b08_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfNTU3_f28ccc36-f369-4711-bd7a-3e2f973d5fe8"
      unitRef="usd">508000000</us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet
      contextRef="i979bf304459b469a85f5dbd972a86ebf_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfNTY0_ce801818-16be-4e82-9e47-490fea42cf8a"
      unitRef="usd">10151000000</us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet
      contextRef="id0595bb2db424b7bac7ac1ec8646dd16_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfNzQ3_e8ee377d-14ba-4618-9ad8-24824ceae6ce"
      unitRef="usd">2000000</us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet
      contextRef="ie6f5962645aa44dd9e99d61abdd0873a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfNzUx_7ce1e190-b7a4-4c75-81f4-6a6d8bde473f"
      unitRef="usd">14000000</us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet
      contextRef="ice322a96213244e6b5ed9fa8b2fd063c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfNzU4_cf81ede2-83e3-4cf2-819b-0b7fe124930a"
      unitRef="usd">257000000</us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet>
    <elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense
      contextRef="ie2c9a53d41b6411c8a7299de747052ee_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMS0xLTEtMS03MDM2Mw_01ae6b44-de73-4f3a-9be4-54abcdae55e6"
      unitRef="usd">3294000000</elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense>
    <elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense
      contextRef="iea0cd3e6f73d4c37a185721b7213f0fe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMS0zLTEtMS03MDM2Mw_460961d7-d5f2-4bf5-94d5-efd2701bbd6f"
      unitRef="usd">7646000000</elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense>
    <elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense
      contextRef="i1007523085804985812acc850dc8d6fe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMS01LTEtMS03MDM2Mw_cfa6deb3-08d9-4100-b9de-cce121351637"
      unitRef="usd">195000000</elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense>
    <elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense
      contextRef="i9aceaf2b19bf4d5d916eb0f2039e41de_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMS03LTEtMS03MDM2Mw_b5b6d2c3-3c9d-4e13-8bca-5509d4aa7499"
      unitRef="usd">11135000000</elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="ie2c9a53d41b6411c8a7299de747052ee_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMi0xLTEtMS03MDM2Mw_d17ee7bd-6ca2-4e79-be8f-f6df2ac68f5a"
      unitRef="usd">13000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="iea0cd3e6f73d4c37a185721b7213f0fe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMi0zLTEtMS03MDM2Mw_11dcb89b-6c37-4905-bd00-76707716ae66"
      unitRef="usd">33000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i1007523085804985812acc850dc8d6fe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMi01LTEtMS03MDM2Mw_79e8ba00-4596-4c90-90d9-16921beec95d"
      unitRef="usd">0</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i9aceaf2b19bf4d5d916eb0f2039e41de_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMi03LTEtMS03MDM2Mw_291963af-4874-4566-8fe4-fc693a2ecb8b"
      unitRef="usd">46000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="ie2c9a53d41b6411c8a7299de747052ee_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMy0xLTEtMS03MDM2Mw_4792a5a7-3d40-400a-b77b-31359aceede3"
      unitRef="usd">3281000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="iea0cd3e6f73d4c37a185721b7213f0fe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMy0zLTEtMS03MDM2Mw_7ac15117-aa6f-4cc9-83e8-cd6aa3f3955d"
      unitRef="usd">7613000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i1007523085804985812acc850dc8d6fe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMy01LTEtMS03MDM2Mw_465feb59-250c-41ee-8bdc-aa3056f1a4ff"
      unitRef="usd">195000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i9aceaf2b19bf4d5d916eb0f2039e41de_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMy03LTEtMS03MDM2Mw_1f49da38-adbb-4bc9-a873-c022050c314e"
      unitRef="usd">11089000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments
      contextRef="i4182a920dc6d4e8cb42614e778766e1c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNC0xLTEtMS03MDM2Mw_dfccb110-5265-47c2-ba56-9630bcc58ed4"
      unitRef="usd">0</elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments>
    <elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments
      contextRef="ibacb5db0efb1418d913cc8583b863da5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNC0zLTEtMS03MDM2Mw_4d142247-d469-4ef5-9457-e1c84380a99f"
      unitRef="usd">375000000</elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments>
    <elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments
      contextRef="icaff25a1e31245299f7a5ef30e5e99d3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNC01LTEtMS03MDM2Mw_19410a85-dde5-4c43-92f4-9caf5550f6f7"
      unitRef="usd">45000000</elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments>
    <elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments
      contextRef="id7580839926f4e24b08f10312dd69479_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNC03LTEtMS03MDM2Mw_9078fd01-2d4f-4f2f-b54e-2fef97f0adf9"
      unitRef="usd">420000000</elv:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="id192e31548bb42f29d1bf3d4dbb6cda2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNi0xLTEtMS03MDM2Mw_600bae3b-1fc8-4a3d-bce7-9a55e952ca1f"
      unitRef="usd">20499000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i6b0ea34f1f294d20a310a2ef4c41c0f4_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNi0zLTEtMS03MDM2Mw_5d999ca9-6ff9-4540-b532-394b2df73820"
      unitRef="usd">52422000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i5424e3c2015944248e4c1ead87f81144_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNi01LTEtMS03MDM2Mw_1efa6547-e805-4dac-a002-30dd74a5f952"
      unitRef="usd">1176000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNi03LTEtMS03MDM2Mw_7c33c5ce-a407-4cfe-be81-21b70fea570a"
      unitRef="usd">74097000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="id192e31548bb42f29d1bf3d4dbb6cda2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNy0xLTEtMS03MDM2Mw_107b3f5f-aed0-4dd8-8b57-49bc6653e30e"
      unitRef="usd">496000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i6b0ea34f1f294d20a310a2ef4c41c0f4_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNy0zLTEtMS03MDM2Mw_084ed18f-1fa6-4124-8887-ee743026f75a"
      unitRef="usd">1309000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i5424e3c2015944248e4c1ead87f81144_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNy01LTEtMS03MDM2Mw_8daf5ac2-dffc-490c-a93c-f72389f91656"
      unitRef="usd">17000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfNy03LTEtMS03MDM2Mw_4847a17c-556b-46aa-b642-4578271b62b2"
      unitRef="usd">1822000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="id192e31548bb42f29d1bf3d4dbb6cda2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfOC0xLTEtMS03MDM2Mw_4aefe7c6-94ac-42e7-87f3-43e3335b1a62"
      unitRef="usd">20003000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i6b0ea34f1f294d20a310a2ef4c41c0f4_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfOC0zLTEtMS03MDM2Mw_f8b546ae-724d-4e90-83cf-f45937661525"
      unitRef="usd">51113000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i5424e3c2015944248e4c1ead87f81144_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfOC01LTEtMS03MDM2Mw_c97265c5-32a0-44ea-a672-e2f08e1f18b7"
      unitRef="usd">1159000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfOC03LTEtMS03MDM2Mw_decc5745-5722-40a2-a96d-b5e3cf79fe3e"
      unitRef="usd">72275000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="id192e31548bb42f29d1bf3d4dbb6cda2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTAtMS0xLTEtNzAzNjM_24a0d341-6031-444a-becf-c56f3ff60d31"
      unitRef="usd">16985000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i6b0ea34f1f294d20a310a2ef4c41c0f4_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTAtMy0xLTEtNzAzNjM_8fe7a419-92b8-4bc2-92a3-675453096c20"
      unitRef="usd">44160000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i5424e3c2015944248e4c1ead87f81144_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTAtNS0xLTEtNzAzNjM_f8403456-9850-48a9-bb9a-02d8bec20bc2"
      unitRef="usd">978000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTAtNy0xLTEtNzAzNjM_a3e08bb6-97a9-492a-90e4-1fa0d972b7f7"
      unitRef="usd">62123000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="id192e31548bb42f29d1bf3d4dbb6cda2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTEtMS0xLTEtNzAzNjM_1185293f-3dfb-44d4-92ed-f0d7fef6b586"
      unitRef="usd">2450000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i6b0ea34f1f294d20a310a2ef4c41c0f4_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTEtMy0xLTEtNzAzNjM_5a01755e-9472-401a-9647-22eb815da77e"
      unitRef="usd">5781000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i5424e3c2015944248e4c1ead87f81144_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTEtNS0xLTEtNzAzNjM_db5b3215-e43a-4226-b62f-d08af0c8c0db"
      unitRef="usd">169000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTEtNy0xLTEtNzAzNjM_a5d71b39-1dad-4028-9d01-6f9e011768b1"
      unitRef="usd">8400000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="id192e31548bb42f29d1bf3d4dbb6cda2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTItMS0xLTEtNzAzNjM_af70735d-a377-41f7-9839-c84bf15b95c8"
      unitRef="usd">19435000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i6b0ea34f1f294d20a310a2ef4c41c0f4_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTItMy0xLTEtNzAzNjM_1f5cd0dd-e9eb-4243-9c85-69ddcc690937"
      unitRef="usd">49941000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i5424e3c2015944248e4c1ead87f81144_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTItNS0xLTEtNzAzNjM_1a4e767e-a1ca-4e72-bc1d-ea844ccc518b"
      unitRef="usd">1147000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTItNy0xLTEtNzAzNjM_2b6418a2-5195-471a-9b5c-b609887e7a14"
      unitRef="usd">70523000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet
      contextRef="i4182a920dc6d4e8cb42614e778766e1c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTMtMS0xLTEtNzAzNjM_6a2683d0-d882-4d54-966c-28d5cbbb7e79"
      unitRef="usd">3849000000</elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet>
    <elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet
      contextRef="ibacb5db0efb1418d913cc8583b863da5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTMtMy0xLTEtNzAzNjM_c3a60674-9395-4e7e-9afa-7c7a171ba650"
      unitRef="usd">9160000000</elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet>
    <elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet
      contextRef="icaff25a1e31245299f7a5ef30e5e99d3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTMtNS0xLTEtNzAzNjM_b8421720-56ec-4503-ac06-4fc859d71c42"
      unitRef="usd">252000000</elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet>
    <elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet
      contextRef="id7580839926f4e24b08f10312dd69479_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTMtNy0xLTEtNzAzNjM_73bfecbc-db1e-4b7f-a784-5d2e8351bfba"
      unitRef="usd">13261000000</elv:ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i4182a920dc6d4e8cb42614e778766e1c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTQtMS0xLTEtNzAzNjM_a6477a47-aec8-4b54-a320-edf43a658c83"
      unitRef="usd">15000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="ibacb5db0efb1418d913cc8583b863da5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTQtMy0xLTEtNzAzNjM_632c9d74-2dc1-4918-876c-6ef502dee2fc"
      unitRef="usd">23000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="icaff25a1e31245299f7a5ef30e5e99d3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTQtNS0xLTEtNzAzNjM_e37751e9-b090-4ff3-bb5b-b8a2e1a69365"
      unitRef="usd">0</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="id7580839926f4e24b08f10312dd69479_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTQtNy0xLTEtNzAzNjM_532f104d-c867-421a-986e-d466ed5c15dc"
      unitRef="usd">38000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense
      contextRef="i4182a920dc6d4e8cb42614e778766e1c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTUtMS0xLTEtNzAzNjM_b0b0c984-a512-447d-869b-bfd5845634b9"
      unitRef="usd">3864000000</elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense>
    <elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense
      contextRef="ibacb5db0efb1418d913cc8583b863da5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTUtMy0xLTEtNzAzNjM_1d707961-7e3c-427f-8812-f29427030d60"
      unitRef="usd">9183000000</elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense>
    <elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense
      contextRef="icaff25a1e31245299f7a5ef30e5e99d3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTUtNS0xLTEtNzAzNjM_f47cdba9-2917-4b4a-94ed-ff76432edfb5"
      unitRef="usd">252000000</elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense>
    <elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense
      contextRef="id7580839926f4e24b08f10312dd69479_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjA2NGU4NGEzYzIxMjQ5N2I4NWQ0Y2E2MjVjYzFlMWQ0L3RhYmxlcmFuZ2U6MDY0ZTg0YTNjMjEyNDk3Yjg1ZDRjYTYyNWNjMWUxZDRfMTUtNy0xLTEtNzAzNjM_0db0d68c-d2e4-4314-a2b5-52ad1f707242"
      unitRef="usd">13299000000</elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense>
    <elv:ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfMjA1NA_6c850785-85ab-4a42-bfea-670a1ded3bd8">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of net incurred medical claims to benefit expense included in our consolidated statements of income for periods in 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.126%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.825%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net incurred medical claims:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial &amp;amp; Specialty Business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net incurred medical claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quality improvement and other claims expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; During the three months ended September 30, 2022, based on recent regulatory clarification, we realigned certain quality improvement costs from benefit expense to administrative expense that were previously allocated to benefit expense during the three months ended March 31, 2022 and the three months ended June 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of net incurred medical claims to benefit expense included in our consolidated statements of income for periods in 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net incurred medical claims:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial &amp;amp; Specialty Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net incurred medical claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quality improvement and other claims expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</elv:ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i8e857bc4e13a4ae5a65583609fa0ba9a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfNi0xLTEtMS03MDM2Mw_23d4443c-95fd-4821-84d2-3ecb9928a9aa"
      unitRef="usd">6834000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i64ce2ea324434d348d29360ed18b52c5_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfNi0zLTEtMS03MDM2Mw_33689681-5943-46c7-b1c1-c50e841ad3fa"
      unitRef="usd">7522000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i9adaeacf598a42c3b72b8540b126e10b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfNi01LTEtMS03MDM2Mw_2feea0c7-d52e-459f-960d-bb85fd37052e"
      unitRef="usd">7510000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i518bf560bf5b42db9717fa1237d56fc5_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfNi03LTEtMS03MDM2Mw_cf9fbd33-5cc5-4c7e-8815-74ffbc5bf277"
      unitRef="usd">21866000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="ia2a144458c3940758b57b3397f45a257_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfNy0xLTEtMS03MDM2Mw_e98fa013-9f17-459c-8f23-e4edf6a0d951"
      unitRef="usd">19943000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="ice7c432e6884478fb38f1d9ca1399f9d_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfNy0zLTEtMS03MDM2Mw_60a39243-63ff-4166-8c20-20e024b7504d"
      unitRef="usd">19788000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="ice7f613275f549788763308d4be93610_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfNy01LTEtMS03MDM2Mw_2ad79b6c-926e-4da2-8f03-23f2246c8115"
      unitRef="usd">20601000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i32803f4645204fb0b79a26f39fe31411_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfNy03LTEtMS03MDM2Mw_b8ef68e8-983a-4f87-8b5c-dc7094d54a0d"
      unitRef="usd">60332000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="id81fb73bd9e640338bfa72bb4f5aeb76_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfOC0xLTEtMS03MDM2Mw_89c8e846-efa1-45fa-bc89-51663b52322b"
      unitRef="usd">354000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i3bc19a6512f743a0a8a79c92a23c64a9_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfOC0zLTEtMS03MDM2Mw_f3b0e5a9-2f81-47b9-be7c-fddfdbd15af8"
      unitRef="usd">324000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="iee58b3e2710246daa6dbe09d63e5064d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfOC01LTEtMS03MDM2Mw_699a2fcc-9d92-4e9b-bb13-699cd54de0e6"
      unitRef="usd">400000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i5866a8bbba704cf588b8904b077bac81_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfOC03LTEtMS03MDM2Mw_48f41b89-82db-49d4-b16c-ee90c2c4e6d6"
      unitRef="usd">1078000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfOS0xLTEtMS03MDM2Mw_f3a622b8-b4b7-4eea-a5a0-9dfb070270a3"
      unitRef="usd">27131000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfOS0zLTEtMS03MDM2Mw_197c83eb-6b66-4762-a7b4-acdd38453846"
      unitRef="usd">27634000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfOS01LTEtMS03MDM2Mw_aa47228a-603a-47fc-b8f0-54d91bebd00d"
      unitRef="usd">28511000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfOS03LTEtMS03MDM2Mw_60a58553-b214-4762-aadb-4859abd0b023"
      unitRef="usd">83276000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense
      contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfMTAtMS0xLTEtNzAzNjM_b6070fd0-277f-4634-b56f-35ad5082efd9"
      unitRef="usd">1084000000</us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense>
    <us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense
      contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfMTAtMy0xLTEtNzAzNjM_9b066f2e-bc33-4912-a744-179e0d1d6c25"
      unitRef="usd">1143000000</us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense>
    <us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfMTAtNS0xLTEtNzAzNjM_919cc8ae-542d-422b-b9a3-6b9e76b59cb9"
      unitRef="usd">893000000</us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense>
    <us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfMTAtNy0xLTEtNzAzNjM_975d833e-7d15-4198-a6d9-1d5dd0fe0520"
      unitRef="usd">3120000000</us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredNet
      contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfMTEtMS0xLTEtNzAzNjM_c6635924-a412-4e82-849d-0988d7e4b8a9"
      unitRef="usd">28215000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredNet>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredNet
      contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfMTEtMy0xLTEtNzAzNjM_53abf45c-9323-415c-ad36-80759a59b1e1"
      unitRef="usd">28777000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredNet>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredNet
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfMTEtNS0xLTEtNzAzNjM_e3b87a58-4dc6-4335-9984-0b7efa4f4d28"
      unitRef="usd">29404000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredNet>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredNet
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOjU3MjU1MDUwZjE0NDQxNGI5YzBkYzRkYWM0NjBkYWEwL3RhYmxlcmFuZ2U6NTcyNTUwNTBmMTQ0NDE0YjljMGRjNGRhYzQ2MGRhYTBfMTEtNy0xLTEtNzAzNjM_6a8700f2-3740-4fda-813e-1c9d3fde7884"
      unitRef="usd">86396000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i35884d0201ae464ebc6e5b8946fa1612_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNS0yLTEtMS03MDM2Mw_be876df8-0f95-4e21-aab0-e1a4b3e17592"
      unitRef="usd">6072000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="ie653179541d1493c93be7e3886e9fb52_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNS00LTEtMS03MDM2Mw_12537770-90b6-4d67-b6d8-02f1644cca72"
      unitRef="usd">6718000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="id7c823f42d7a4c78b75c5623fcf615d7_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNS02LTEtMS03MDM2Mw_047e11a9-a827-4bd0-a142-be292d466235"
      unitRef="usd">7213000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="id192e31548bb42f29d1bf3d4dbb6cda2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNS04LTEtMS03MDM2Mw_a5afd0bf-98c5-4c82-bf0c-65866a04c8fd"
      unitRef="usd">20003000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="ieef52ac747e64c7391e7c7a1120b53d2_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNi0yLTEtMS03MDM2Mw_1b917b2f-42ff-4337-a39e-9e5a6943301e"
      unitRef="usd">16319000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="ib8ff1fa5d8714816a640a8280fcee30a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNi00LTEtMS03MDM2Mw_af83b2c3-1363-4e17-8780-cd13d1ba31ab"
      unitRef="usd">16723000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i757b9a9c9e7e4558a1cd9992f88382fc_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNi02LTEtMS03MDM2Mw_f6f211e6-bcb8-49c7-a620-1b742e117215"
      unitRef="usd">18071000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i6b0ea34f1f294d20a310a2ef4c41c0f4_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNi04LTEtMS03MDM2Mw_6835f6d7-1b61-4ad4-8656-03ddfa273352"
      unitRef="usd">51113000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i0b17535592154a3fb04e22ab93e36684_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNy0yLTEtMS03MDM2Mw_6c90e756-b4bf-461b-912e-0122862b21bb"
      unitRef="usd">336000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i0e4c924470664c728da0afbb46130f3e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNy00LTEtMS03MDM2Mw_8bd63fb9-6f9d-4b4f-8133-8dd206ca2b1e"
      unitRef="usd">403000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i4ed55d475fdc4a698c26523269fb993b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNy02LTEtMS03MDM2Mw_6a2c1424-83d8-4259-8e58-274c8ba722fc"
      unitRef="usd">420000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i5424e3c2015944248e4c1ead87f81144_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfNy04LTEtMS03MDM2Mw_bf9c50f0-8c23-4787-ab5f-7817ba6dc1eb"
      unitRef="usd">1159000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfOC0yLTEtMS03MDM2Mw_ea73207a-1917-4105-86df-44b115d417a3"
      unitRef="usd">22727000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfOC00LTEtMS03MDM2Mw_6b55f41b-b046-4893-8951-f820800115a2"
      unitRef="usd">23844000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfOC02LTEtMS03MDM2Mw_d8c58949-22bd-4fc9-90ed-e92d93dc64da"
      unitRef="usd">25704000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfOC04LTEtMS03MDM2Mw_4665c381-4412-4b9d-8895-89dcd9d949a4"
      unitRef="usd">72275000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense
      contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfOS0yLTEtMS03MDM2Mw_58fa1c88-8131-4361-984c-7a5cd1c1afe8"
      unitRef="usd">972000000</us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense>
    <us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense
      contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfOS00LTEtMS03MDM2Mw_e5e7e9af-8e30-4207-a65e-b3f9813b4713"
      unitRef="usd">919000000</us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense>
    <us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfOS02LTEtMS03MDM2Mw_c03c85ba-3c80-4561-a07a-a42152ad0b2f"
      unitRef="usd">941000000</us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense>
    <us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfOS04LTEtMS03MDM2Mw_87247614-6ca2-4531-a820-b1dde9759a15"
      unitRef="usd">2832000000</us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredNet
      contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfMTAtMi0xLTEtNzAzNjM_18909c45-b8b7-4238-861e-3601407304b6"
      unitRef="usd">23699000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredNet>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredNet
      contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfMTAtNC0xLTEtNzAzNjM_458421e5-23fa-40bd-852c-3dd267e5216c"
      unitRef="usd">24763000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredNet>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredNet
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfMTAtNi0xLTEtNzAzNjM_f5131453-9af7-44b8-93ed-5724755b30dc"
      unitRef="usd">26645000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredNet>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredNet
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmMzNTk0YWE4ZTQ0MzQ5ZmNhYzIxMzUyYmU2NDc4ZGVmL3RhYmxlcmFuZ2U6YzM1OTRhYThlNDQzNDlmY2FjMjEzNTJiZTY0NzhkZWZfMTAtOC0xLTEtNzAzNjM_03f1ce01-a0dd-41a2-9367-80ffe8da6eca"
      unitRef="usd">75107000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredNet>
    <us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RleHRyZWdpb246ZTk3ZTA5MzlmZDc5NGZhYzhmNThhNDM0MGJlNTE3M2JfMjA2NA_292ba49d-990b-4320-9b06-946a7500033d">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of the medical claims payable reflected in the tables above to the consolidated ending balance for medical claims payable included in the consolidated balance sheet, as of September&#160;30, 2022, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.764%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Commercial&lt;br/&gt;&amp;amp; Specialty&lt;br/&gt;Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Government&lt;br/&gt;Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net medical claims payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceded medical claims payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance lines other than short duration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross medical claims payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i2eef42da7d1c4cd495f66b68093f8dc3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMS0xLTEtMS03MDM2Mw_c6fd60bd-d2bd-4fb1-b893-5618cbe86854"
      unitRef="usd">3918000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i17f3cb9f8c1d492197e639b5a0369fef_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMS0zLTEtMS03MDM2Mw_47750fa2-233a-47e4-adfa-7a8dac29327f"
      unitRef="usd">10807000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="id8e9a443d6054bb489dd821a7385bab4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMS01LTEtMS03MDM2Mw_1ddd521d-5291-453b-a80b-93975de27b51"
      unitRef="usd">273000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMS03LTEtMS03MDM2Mw_964f1f21-6d6a-409a-b0e1-35899a2bf459"
      unitRef="usd">14998000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i2eef42da7d1c4cd495f66b68093f8dc3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMi0xLTEtMS03MDM2Mw_4791e498-89c9-4f30-a953-25a7eff92734"
      unitRef="usd">3000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i17f3cb9f8c1d492197e639b5a0369fef_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMi0zLTEtMS03MDM2Mw_adef9a48-bcb6-4b82-b8d6-f024a9f5cecc"
      unitRef="usd">0</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="id8e9a443d6054bb489dd821a7385bab4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMi01LTEtMS03MDM2Mw_763f525e-70a0-415f-a899-8addc4fd4e40"
      unitRef="usd">0</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMi03LTEtMS03MDM2Mw_12512efe-26d4-4fa4-a370-15faa88c08ab"
      unitRef="usd">3000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem
      contextRef="i2eef42da7d1c4cd495f66b68093f8dc3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMy0xLTEtMS03MDM2Mw_524f7009-8524-435b-88b1-563909f6bbd5"
      unitRef="usd">0</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem
      contextRef="i17f3cb9f8c1d492197e639b5a0369fef_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMy0zLTEtMS03MDM2Mw_a1a1d0e3-3eb1-41dc-a054-ba43a18f2de3"
      unitRef="usd">241000000</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem
      contextRef="id8e9a443d6054bb489dd821a7385bab4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMy01LTEtMS03MDM2Mw_8ccae163-a4ce-401d-97d7-45e23a554766"
      unitRef="usd">0</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfMy03LTEtMS03MDM2Mw_56cdc99f-0a08-46cc-8b12-0f6831fc3f15"
      unitRef="usd">241000000</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i2eef42da7d1c4cd495f66b68093f8dc3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfNC0xLTEtMS03MDM2Mw_0521ac89-09af-4397-9391-5b65710f0757"
      unitRef="usd">3921000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i17f3cb9f8c1d492197e639b5a0369fef_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfNC0zLTEtMS03MDM2Mw_154740e9-8c88-4235-813e-2ddf68916838"
      unitRef="usd">11048000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="id8e9a443d6054bb489dd821a7385bab4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfNC01LTEtMS03MDM2Mw_9a38ef69-d5fd-48d5-bbf9-7c98771b76db"
      unitRef="usd">273000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82NC9mcmFnOmU5N2UwOTM5ZmQ3OTRmYWM4ZjU4YTQzNDBiZTUxNzNiL3RhYmxlOmRjZjc2Y2I5YzYxYzQ0YjE4YzdkYTBhMDI1MThhYjVkL3RhYmxlcmFuZ2U6ZGNmNzZjYjljNjFjNDRiMThjN2RhMGEwMjUxOGFiNWRfNC03LTEtMS03MDM2Mw_fd97e0b9-f914-4995-a661-cec2adbfacd3"
      unitRef="usd">15242000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNTQyNg_8f00d69f-a2f5-445a-84f1-a5d431584d27">Debt&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally issue senior unsecured notes for long-term borrowing purposes. At September&#160;30, 2022 and December&#160;31, 2021, we had $22,722 and $22,359, respectively, outstanding under these notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 16, 2022, we repaid, at maturity, the $850 outstanding balance of our 3.125% senior unsecured notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 29, 2022, we issued $600 aggregate principal amount of 4.100% Notes due 2032 (the &#x201c;2032 Notes&#x201d;) and $700 aggregate principal amount of 4.550% Notes due 2052 (the &#x201c;2052 Notes&#x201d;) under our shelf registration statement. Interest on the 2032 Notes and 2052 Notes is payable semi-annually in arrears on May 15 and November 15 of each year, commencing November 15, 2022. We used the net proceeds for working capital and general corporate purposes, such as the funding of acquisitions, repayment of short-term and long-term debt and the repurchase of our common stock pursuant to our share repurchase program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have an unsecured surplus note with an outstanding principal balance of $25 at both September&#160;30, 2022 and December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have a senior revolving credit facility (the &#x201c;5-Year Facility&#x201d;) with a group of lenders for general corporate purposes. On April 18, 2022, we amended and restated the credit agreement for the 5-Year Facility to, among other things, extend the maturity date of the 5-Year Facility from June 2024 to April 2027 and increase the amount of credit available under the 5-Year Facility from $2,500 to $4,000. Also on April 18, 2022, concurrently with the amendment and restatement of the 5-Year Facility, we terminated our 364-day senior revolving credit facility that provided for credit in the amount of $1,000, which was scheduled to mature in June 2022 (the &#x201c;2021 364-Day Facility&#x201d;). In June 2021, we terminated our 364-day senior revolving credit facility (the &#x201c;prior 364-Day Facility&#x201d;), which was scheduled to mature in June 2021, and entered into the 2021 364-Day Facility with a group of lenders for general corporate purposes. Our ability to borrow under the 5-Year Facility is subject to compliance with certain covenants, including covenants requiring us to maintain a defined debt-to-capital ratio of not more than 60%, subject to increase in certain circumstances set forth in the credit agreement for the 5-Year Facility.&#160;As of September&#160;30, 2022, our debt-to-capital ratio, as defined and calculated under the 5-Year Facility, was 39.7%. We do not believe the restrictions contained in our 5-Year Facility covenants materially affect our financial or operating flexibility. As &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of September&#160;30, 2022, we were in compliance with all of our debt covenants under the 5-Year Facility. There were no amounts outstanding under the 5-Year Facility, the 2021 364-Day Facility or the prior 364-Day Facility at any time during the nine months ended September&#160;30, 2022 or the year ended December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Through certain subsidiaries, we have entered into multiple 364-day lines of credit (the &#x201c;Subsidiary Credit Facilities&#x201d;) with separate lenders for general corporate purposes. The Subsidiary Credit Facilities provide combined credit of up to $200. At September&#160;30, 2022 and December&#160;31, 2021, there were no amounts outstanding under our Subsidiary Credit Facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have an authorized commercial paper program of up to $4,000, the proceeds of which may be used for general corporate purposes. In July 2022, we increased the amount available under the commercial paper program from $3,500 to $4,000. At September&#160;30, 2022 and December&#160;31, 2021, we had $675 and $300, respectively, outstanding under this program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have outstanding senior unsecured convertible debentures due 2042 (the &#x201c;Debentures&#x201d;), which are governed by an indenture (the &#x201c;indenture&#x201d;) between us and The Bank of New York Mellon Trust Company, N.A., as trustee. We accounted for the Debentures in accordance with the FASB cash conversion guidance for debt with conversion and other options at the time of issue. As a result, the value of the embedded conversion option (net of deferred taxes and equity issuance costs) was bifurcated from its debt host and recorded as a component of additional paid-in capital in our consolidated balance sheets. We adopted ASU 2020-06 on January 1, 2022 using the modified retrospective transition method, which resulted in an increase to our reported debt outstanding of $31, a decrease of our deferred tax liabilities of $8 and a corresponding cumulative-effect reduction to our opening retained earnings of $23, eliminating the bifurcation of the embedded conversion option. During the three and nine months ended September&#160;30, 2022, $4 and $19 of aggregate principal amount of the Debentures was surrendered for conversion by certain holders in accordance with the terms and provisions of the indenture. We elected to settle the excess of the principal amount of the conversions with cash for total payments during the three and nine months ended September&#160;30, 2022 of $25 and $132, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes at September&#160;30, 2022 the related balances, conversion rate and conversion price of the Debentures:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding principal amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net debt carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Conversion rate (shares of common stock per $1,000 of principal amount)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.2967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective conversion price (per $1,000 of principal amount)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.9462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a member, through certain subsidiaries, of the Federal Home Loan Bank of Indianapolis, the Federal Home Loan Bank of Cincinnati, the Federal Home Loan Bank of Atlanta and the Federal Home Loan Bank of New York (collectively, the &#x201c;FHLBs&#x201d;). As a member, we have the ability to obtain short-term cash advances, subject to certain minimum collateral requirements. We had $265 and $275 of outstanding short-term borrowings from the FHLBs at September&#160;30, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All debt is a direct obligation of Elevance Health, Inc., except for the surplus note, the FHLB borrowings, and the Subsidiary Credit Facilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i3a16a462df304b1fbf48724140afd63c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMTE0_260e646a-1b6b-4e2f-b218-c7d2750b785d"
      unitRef="usd">22722000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i94bbf9e2e436430ea18a870d630e7782_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMTIx_69cccadc-12c0-4aba-b4ff-3e95f5bf00af"
      unitRef="usd">22359000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i6b0d34ecb74d4c1499f643aa80821af3_I20220516"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMjE0_89cb562e-a096-4d22-a3c6-63738ccc690f"
      unitRef="usd">850000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6b0d34ecb74d4c1499f643aa80821af3_I20220516"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMjQ0_e24b5845-15ce-4b1d-bdcd-883b2414b371"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i593ecd4bf79e46d2af49bec65e9db2cc_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMzAw_e9b5e911-c618-4f1c-bd4c-64d48e580690"
      unitRef="usd">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i593ecd4bf79e46d2af49bec65e9db2cc_I20220429"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMzMz_e2095e37-c149-4116-a9c3-1faf39872c6e"
      unitRef="number">0.04100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i3e26d0baf7484549aaadded8ad6a1ef1_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMzc0_7f9790fe-6498-4703-aa9a-b5cff0d57af1"
      unitRef="usd">700000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3e26d0baf7484549aaadded8ad6a1ef1_I20220429"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNDA3_6e00657d-fd96-410f-9f8a-5325e56c0466"
      unitRef="number">0.04550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i447dee49344c463eb1ad142f17bbb55b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfOTQ1_187c069d-d93d-4748-a85d-96fe09ea3062"
      unitRef="usd">25000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i3ddfea0816d8449f8a18879a56b75aa3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfOTQ1_e900ef24-ce41-4621-a320-bcb4065131a3"
      unitRef="usd">25000000</us-gaap:LongTermDebt>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i6cfc7f22d3c342fc85354d517d3e8f44_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMTM1NQ_567b61fb-05ef-4e15-86d9-b7444ea0c031"
      unitRef="usd">2500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i7e231fbcfa194a74b537f2bd7332d1ce_I20220418"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMTM2MQ_1bf67e97-03a7-49c7-882f-c196f3ccf053"
      unitRef="usd">4000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityDescription
      contextRef="i9e6137b64fca4e85985b05a00cc0980e_D20220418-20220418"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNTQyOA_380e20cc-240f-4a5e-92e9-305bf7721338">Also on April 18, 2022, concurrently with the amendment and restatement of the 5-Year Facility, we terminated our 364-day senior revolving credit facility that provided for credit in the amount of $1,000, which was scheduled to mature in June 2022</us-gaap:LineOfCreditFacilityDescription>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="id48e07a7766647e2a8bc809c7668f9aa_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMTU2Mg_b856e168-0da0-4948-8108-17d7cb57b94b"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentCovenantDescription
      contextRef="i8956e0659bb44abdac0434240d851087_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNTQxMw_44abafd6-41e3-4606-b161-87cf805ffc4d">Our ability to borrow under the 5-Year Facility is subject to compliance with certain covenants, including covenants requiring us to maintain a defined debt-to-capital ratio of not more than 60%, subject to increase in certain circumstances set forth in the credit agreement for the 5-Year Facility.</us-gaap:DebtInstrumentCovenantDescription>
    <us-gaap:DebtInstrumentCovenantCompliance
      contextRef="i8956e0659bb44abdac0434240d851087_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNTQyOQ_3068af00-5590-45d7-b1ca-2003af7f9bd0">As of September&#160;30, 2022, our debt-to-capital ratio, as defined and calculated under the 5-Year Facility, was 39.7%. We do not believe the restrictions contained in our 5-Year Facility covenants materially affect our financial or operating flexibility. As of September&#160;30, 2022, we were in compliance with all of our debt covenants under the 5-Year Facility.</us-gaap:DebtInstrumentCovenantCompliance>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i1994da759a8049c09f0ece33102e8d07_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMjk4NQ_fa16a675-07a0-4fd3-94cd-3efe25f6ff5b"
      unitRef="usd">200000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <elv:CommercialPaperMaximumBorrowingCapacity
      contextRef="i4d538ffdcb394ef6b8ca39b9232da03f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMzEzMw_f52be4d0-dd85-4e53-8e26-7c6f3744ca70"
      unitRef="usd">4000000000</elv:CommercialPaperMaximumBorrowingCapacity>
    <elv:CommercialPaperMaximumBorrowingCapacity
      contextRef="iab9bfa7369d94d23b70eb52ac9d5c353_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMzI5MQ_94c5a0d3-1106-4b69-be9b-315fc788e90b"
      unitRef="usd">3500000000</elv:CommercialPaperMaximumBorrowingCapacity>
    <us-gaap:CommercialPaper
      contextRef="i4d538ffdcb394ef6b8ca39b9232da03f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMzMyNg_a583d036-fd6b-49bf-a4bd-8ef4af40b2b1"
      unitRef="usd">675000000</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper
      contextRef="i3177560ea74b47d094f58090cff05a3a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfMzMzMw_00ed4b7b-4cb8-42e4-85f5-ed1f8938d365"
      unitRef="usd">300000000</us-gaap:CommercialPaper>
    <us-gaap:LongTermDebt
      contextRef="ic8291afc45194b679cb982efb46d0686_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNDE0Ng_c6f30ed5-5551-4a51-bda0-ca4076eda24c"
      unitRef="usd">31000000</us-gaap:LongTermDebt>
    <us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent
      contextRef="ic8291afc45194b679cb982efb46d0686_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNDE5Ng_b8310e9d-fda6-43d2-9417-6ded7e441012"
      unitRef="usd">-8000000</us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent>
    <us-gaap:StockholdersEquity
      contextRef="ic8291afc45194b679cb982efb46d0686_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNDI4Mw_458f4f4b-beb5-4696-83b4-b761dbbd8efc"
      unitRef="usd">-23000000</us-gaap:StockholdersEquity>
    <elv:DebtConversionDebtPrincipalAmount
      contextRef="i98f60619d5db44bdbcef4568c650ac97_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNDM2OA_3da70fde-b614-4e31-9197-3e026ba94cf8"
      unitRef="usd">4000000</elv:DebtConversionDebtPrincipalAmount>
    <elv:DebtConversionDebtPrincipalAmount
      contextRef="i6c996ccf5375467690ef0a371d48e033_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNDM3NQ_3e941551-aa52-47e5-8063-a646c7bcd473"
      unitRef="usd">19000000</elv:DebtConversionDebtPrincipalAmount>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i98f60619d5db44bdbcef4568c650ac97_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNDY2Mg_5f6e682a-95b6-4860-b5f9-80b03d771e12"
      unitRef="usd">25000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i6c996ccf5375467690ef0a371d48e033_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNDY2OQ_aac670f8-b5be-4d88-824b-e0068d3e9e13"
      unitRef="usd">132000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ConvertibleDebtTableTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNTQzNQ_b6cb2e47-7dcc-4c6e-aae8-2b1fb77bbc9d">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes at September&#160;30, 2022 the related balances, conversion rate and conversion price of the Debentures:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding principal amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net debt carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Conversion rate (shares of common stock per $1,000 of principal amount)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.2967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective conversion price (per $1,000 of principal amount)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.9462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id074490de8a844b3947b679412d173b1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RhYmxlOjA0NjUzNjMxOTdjNDQ3OGVhODlmNDUxY2ZiZjI0MmQ2L3RhYmxlcmFuZ2U6MDQ2NTM2MzE5N2M0NDc4ZWE4OWY0NTFjZmJmMjQyZDZfMC0xLTEtMS03MDM2Mw_27297942-1a87-4a05-96be-0fb8c7aad166"
      unitRef="usd">86000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="id074490de8a844b3947b679412d173b1_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RhYmxlOjA0NjUzNjMxOTdjNDQ3OGVhODlmNDUxY2ZiZjI0MmQ2L3RhYmxlcmFuZ2U6MDQ2NTM2MzE5N2M0NDc4ZWE4OWY0NTFjZmJmMjQyZDZfMi0xLTEtMS03MDM2Mw_2279f2d6-e10e-42fd-9ffb-6152b241cf76"
      unitRef="usd">86000000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i6c996ccf5375467690ef0a371d48e033_D20220101-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RhYmxlOjA0NjUzNjMxOTdjNDQ3OGVhODlmNDUxY2ZiZjI0MmQ2L3RhYmxlcmFuZ2U6MDQ2NTM2MzE5N2M0NDc4ZWE4OWY0NTFjZmJmMjQyZDZfNC0xLTEtMS03MDM2Mw_8384a53d-3eb6-4e99-a895-edb316028ebc"
      unitRef="number">14.2967</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="id074490de8a844b3947b679412d173b1_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RhYmxlOjA0NjUzNjMxOTdjNDQ3OGVhODlmNDUxY2ZiZjI0MmQ2L3RhYmxlcmFuZ2U6MDQ2NTM2MzE5N2M0NDc4ZWE4OWY0NTFjZmJmMjQyZDZfNS0xLTEtMS03MDM2Mw_9bcc62cd-3776-4fb1-9422-aba9081ae4ca"
      unitRef="usdPerShare">69.9462</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths
      contextRef="ie3ce2a7827404c4b95ca73a4c71f739d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNTE3OQ_bc12f8e2-8d3d-4c7b-88b2-02cc4c9f8937"
      unitRef="usd">265000000</us-gaap:FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths>
    <us-gaap:FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths
      contextRef="idadc7d2ec88044dcaa0a3de4ed833cec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF82Ny9mcmFnOjBlYWQ2MjViMjA0YjQ3MTg5NGMxMjgyYTgyNGQ2MWM5L3RleHRyZWdpb246MGVhZDYyNWIyMDRiNDcxODk0YzEyODJhODI0ZDYxYzlfNTE4Ng_34f91294-8e22-4e2c-8038-78ab0533c75e"
      unitRef="usd">275000000</us-gaap:FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83My9mcmFnOmRhNzY1OGIxZmY1MjQzNWNiOGM4OWRmNmFkZGI2ODM0L3RleHRyZWdpb246ZGE3NjU4YjFmZjUyNDM1Y2I4Yzg5ZGY2YWRkYjY4MzRfMjE5NDQ_ee1fc028-f21a-49ef-a8b7-6e87a476b9e9">Commitments and Contingencies&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation and Regulatory Proceedings &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, we are defendants in, or parties to, a number of pending or threatened legal actions or proceedings. To the extent a plaintiff or plaintiffs in the following cases have specified in their complaint or in other court filings the amount of damages being sought, we have noted those alleged damages in the descriptions below. With respect to the cases described below, we contest liability and/or the amount of damages in each matter and believe we have meritorious defenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Where available information indicates that it is probable that a loss has been incurred as of the date of the consolidated financial statements and we can reasonably estimate the amount of that loss, we accrue the estimated loss by a charge to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;income. In many proceedings, however, it is difficult to determine whether any loss is probable or reasonably possible. In addition, even where loss is possible or an exposure to loss exists in excess of the liability already accrued with respect to a previously identified loss contingency, it is not always possible to reasonably estimate the amount of the possible loss or range of loss. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-right:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to many of the proceedings to which we are a party, we cannot provide an estimate of the possible losses, or the range of possible losses in excess of the amount, if any, accrued, for various reasons, including but not limited to some or all of the following: (i) there are novel or unsettled legal issues presented, (ii) the proceedings are in early stages, (iii) there is uncertainty as to the likelihood of a class being certified or decertified or the ultimate size and scope of the class, (iv) there is uncertainty as to the outcome of pending appeals or motions, (v) there are significant factual issues to be resolved, and/or (vi) in many cases, the plaintiffs have not specified damages in their complaint or in court filings. For those legal proceedings where a loss is probable, or reasonably possible, and for which it is possible to reasonably estimate the amount of the possible loss or range of losses, we currently believe that the range of possible losses, in excess of established reserves is, in the aggregate, from $0 to approximately $250 at September&#160;30, 2022. This estimated aggregate range of reasonably possible losses is based upon currently available information taking into account our best estimate of such losses for which such an estimate can be made.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Blue Cross Blue Shield Antitrust Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a defendant in multiple lawsuits that were initially filed in 2012 against the BCBSA and Blue Cross and/or Blue Shield licensees (the &#x201c;Blue plans&#x201d;) across the country. Cases filed in twenty-eight states were consolidated into a single, multi-district proceeding captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re Blue Cross Blue Shield Antitrust Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; that is pending in the U.S. District Court for the Northern District of Alabama (the &#x201c;Court&#x201d;). Generally, the suits allege that the BCBSA and the Blue plans have conspired to horizontally allocate geographic markets through license agreements, best efforts rules that limit the percentage of non-Blue revenue of each plan, restrictions on acquisitions, rules governing the BlueCard&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and National Accounts programs and other arrangements in violation of the Sherman Antitrust Act (&#x201c;Sherman Act&#x201d;) and related state laws. The cases were brought by two putative nationwide classes of plaintiffs, health plan subscribers and providers.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2018, the Court issued an order on the parties&#x2019; cross motions for partial summary judgment, determining that the defendants&#x2019; aggregation of geographic market allocations and output restrictions are to be analyzed under a per se standard of review, and the BlueCard&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;program and other alleged Section 1 Sherman Act violations are to be analyzed under the rule of reason standard of review. With respect to whether the defendants operate as a single entity with regard to the enforcement of the Blue Cross Blue Shield trademarks, the Court found that summary judgment was not appropriate due to the existence of genuine issues of material fact. In April 2019, the plaintiffs filed motions for class certification, which defendants opposed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The BCBSA and Blue plans approved a settlement agreement and release with the subscriber plaintiffs (the &#x201c;Subscriber Settlement Agreement&#x201d;), which agreement required the Court&#x2019;s approval to become effective. The Subscriber Settlement Agreement requires the defendants to make a monetary settlement payment and contains certain terms imposing non-monetary obligations including (i) eliminating the &#x201c;national best efforts&#x201d; rule in the BCBSA license agreements (which rule limits the percentage of non-Blue revenue permitted for each Blue plan) and (ii) allowing for some large national employers with self-funded benefit plans to request a bid for insurance coverage from a second Blue plan in addition to the local Blue plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2020, the Court issued an order preliminarily approving the Subscriber Settlement Agreement, following which members of the subscriber class were provided notice of the Subscriber Settlement Agreement and an opportunity to opt out of the class. A small number of subscribers submitted valid opt-outs by the July 2021 opt-out deadline. In excess of eight thousand claims were submitted by the November 2021 claims submission deadline. A fairness hearing was held in October 2021 and the Court took the request for final approval under advisement and requested supplemental briefing that was submitted. In February 2022, the Court ordered the issuance of a supplemental notice to self-funded account class members, which notice process was completed in March 2022. The deadline for objections to the supplemental notice along with opt-outs was in May 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2022, the Court issued a final approval order for the Subscriber Settlement Agreement. The Court amended its final approval order in September 2022, further clarifying the injunctive relief that may be available to subscribers who submitted valid opt-outs. In September 2022, an objector filed a motion to amend the final approval order, which the Court &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;denied. In compliance with the Subscriber Settlement Agreement, the Company paid its remaining $506 portion of the settlement fund into an escrow account in September 2022, for an aggregate settlement payment by the Company of $596.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Four notices of appeal of the final approval order were filed by the September 2022 deadline. Those appeals will proceed in the United States Court of Appeals for the Eleventh Circuit. In October 2022, the subscriber plaintiffs filed a motion to consolidate and expedite the four appeals. After all appellate rights have been exhausted in a manner that affirms the Court&#x2019;s final order and judgment, the defendants&#x2019; payment and non-monetary obligations under the Subscriber Settlement Agreement will become effective.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, after the Court lifted the stay as to the provider litigation, provider plaintiffs filed a renewed motion for class certification, which defendants opposed. In March 2021, the Court issued an order terminating the pending motion for class certification until the Court determines the standard of review applicable to providers&#x2019; claims. In May 2021, the defendants and provider plaintiffs filed renewed standard of review motions. In June 2021, the parties filed summary judgment motions not critically dependent on class certification. In February 2022, the Court issued (i) an order granting certain defendants&#x2019; motion for partial summary judgment against provider plaintiffs who had previously released claims against such defendants, and (ii) an order granting provider plaintiffs&#x2019; motion for partial summary judgment, holding that &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Ohio v. American Express Co&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. does not affect the standard of review in this case. In August 2022, the Court issued (i) an order granting in part the defendants&#x2019; motion regarding the antitrust standard of review, holding that for the period of time after the elimination of the &#x201c;national best efforts&#x201d; rule, the rule of reason applies to the provider plaintiffs&#x2019; market allocation conspiracy claims, and (ii) an order denying the provider plaintiffs&#x2019; motion for partial summary judgment on the standard of review, reaffirming its prior holding that the providers&#x2019; group boycott claims are subject to the rule of reason. We intend to continue to vigorously defend the provider litigation, which we believe is without merit; however, its ultimate outcome cannot be presently determined.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A number of follow-on cases involving entities that opted out of the Subscriber Settlement Agreement have been filed. Those actions are:  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Alaska Air Group, Inc., et al. v. Anthem, Inc., et al.,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; No. 2:21-cv-01209-AMM (N.D. Ala.); &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;JetBlue Airways Corp., et al. v. Anthem, Inc., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 2:22-cv-00558-GMB (N.D. Ala.); &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Metropolitan Transportation Authority v. Blue Cross and Blue Shield of Alabama et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 2:22-cv-00265-RDP (N.D. Ala.); &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Bed Bath &amp;amp; Beyond Inc. v. Anthem, Inc.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 2:22-cv-01256-SGC (N.D. Ala.);&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Hoover, et al. v. Blue Cross Blue Shield Association, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 2:22-cv-00261-RDP (N.D. Ala.); and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;VHS Liquidating Trust v. Blue Cross of California, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. RG21106600 (Cal. Super.). We intend to continue to vigorously defend these follow-on cases, which we believe are without merit; however, their ultimate outcome cannot be presently determined.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Blue Cross of California Taxation Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-right:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2013, our California affiliate Blue Cross of California (doing business as Anthem Blue Cross) (&#x201c;BCC&#x201d;) was named as a defendant in a California taxpayer action filed in Los Angeles County Superior Court (the &#x201c;Superior Court&#x201d;) captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Michael D. Myers v. State Board of Equalization, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; This action was brought under a California statute that permits an individual taxpayer to sue a governmental agency when the taxpayer believes the agency has failed to enforce governing law. Plaintiff contends that BCC, a licensed Health Care Service Plan, is an &#x201c;insurer&#x201d; for purposes of taxation despite acknowledging it is not an &#x201c;insurer&#x201d; under regulatory law. At the time, under California law, &#x201c;insurers&#x201d; were required to pay a gross premiums tax (&#x201c;GPT&#x201d;) calculated as 2.35% on gross premiums. As a licensed Health Care Service Plan, BCC has paid the California Corporate Franchise Tax (&#x201c;CFT&#x201d;), the tax paid by California businesses generally. Plaintiff contends that BCC must pay the GPT rather than the CFT, and seeks a writ of mandate directing the taxing agencies to collect the GPT and an order requiring BCC to pay GPT back taxes, interest, and penalties for the eight-year period prior to the filing of the complaint.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-right:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because the GPT is constitutionally imposed in lieu of certain other taxes, BCC has filed protective tax refund claims with the City of Los Angeles, the California Department of Health Care Services and the Franchise Tax Board to protect its rights to recover certain taxes previously paid should BCC eventually be determined to be subject to the GPT for the tax periods at issue in the litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2018, the Superior Court denied BCC&#x2019;s motion for judgment on the pleadings and similar motions brought by other entities. BCC filed a motion for summary judgment with the Superior Court, which was heard in October 2020. In December 2020, the Superior Court granted BCC&#x2019;s motion for summary judgment, dismissing the plaintiff&#x2019;s lawsuit. In &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;November 2021, the plaintiff appealed the order granting BCC's motion for summary judgment. BCC&#x2019;s responding brief was filed in March 2022. Plaintiff&#x2019;s reply was filed in May 2022. We estimate that the appeal will be heard in the winter of 2022. We intend to vigorously defend the appeal of this lawsuit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Express Scripts, Inc. Pharmacy Benefit Management Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2016, we filed a lawsuit against Express Scripts, Inc. (&#x201c;Express Scripts&#x201d;), our vendor at the time for PBM services, captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Anthem, Inc. v. Express Scripts, Inc.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, in the U.S. District Court for the Southern District of New York (the &#x201c;District Court&#x201d;). The lawsuit seeks to recover over $14,800 in damages for pharmacy pricing that is higher than competitive benchmark pricing under the agreement between the parties (the &#x201c;ESI PBM Agreement&#x201d;), over $158 in damages related to operational breaches, as well as various declarations under the ESI PBM Agreement, including that Express Scripts: (i) breached its obligation to negotiate in good faith and to agree in writing to new pricing terms; (ii) was required to provide competitive benchmark pricing to us through the term of the ESI PBM Agreement; (iii) has breached the ESI PBM Agreement; and (iv) is required under the ESI PBM Agreement to provide post-termination services, at competitive benchmark pricing, for one year following any termination. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Express Scripts has disputed our contractual claims and is seeking declaratory judgments: (i) regarding the timing of the periodic pricing review under the ESI PBM Agreement, and (ii) that it has no obligation to ensure that we receive any specific level of pricing, that we have no contractual right to any change in pricing under the ESI PBM Agreement and that its sole obligation is to negotiate proposed pricing terms in good faith. In the alternative, Express Scripts claims that we have been unjustly enriched by its payment of $4,675 at the time we entered into the ESI PBM Agreement. In March 2017, the District Court granted our motion to dismiss Express Scripts&#x2019; counterclaims for (i) breach of the implied covenant of good faith and fair dealing, and (ii) unjust enrichment with prejudice. After such action, the only remaining claims were for breach of contract and declaratory relief. In August 2021, Express Scripts filed a motion for summary judgment, which we opposed. In March 2022, the District Court granted in part and denied in part Express Scripts&#x2019; motion for summary judgment. The District Court dismissed our declaratory judgment claim, our breach of contract claim for failure to prove damages and most of our operational breach claims. As a result of the summary judgment decision, the only remaining claims as of the filing of this Quarterly Report on Form 10-Q are (i) our operational breach claim based on Express Scripts&#x2019; prior authorization processes and (ii) Express Scripts&#x2019; counterclaim for breach of the market check provision of the ESI PBM Agreement. Express Scripts filed a second motion for summary judgment in June 2022, challenging our remaining operational breach claims, which we opposed in July 2022. We intend to appeal the earlier summary judgment decision at the appropriate time, vigorously pursue our claims and defend against counterclaims, which we believe are without merit; however, the ultimate outcome of this litigation cannot be presently determined.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Medicare Risk Adjustment Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the U.S. Department of Justice (&#x201c;DOJ&#x201d;) filed a civil lawsuit against Elevance Health, Inc. (f/k/a Anthem, Inc.) in the U.S. District Court for the Southern District of New York (the &#x201c;New York District Court&#x201d;) in a case captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States v. Anthem, Inc&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The DOJ&#x2019;s suit alleges, among other things, that we falsely certified the accuracy of the diagnosis data we submitted to the Centers for Medicare and Medicaid Services (&#x201c;CMS&#x201d;) for risk-adjustment purposes under Medicare Part C and knowingly failed to delete inaccurate diagnosis codes. The DOJ further alleges that, as a result of these purported acts, we caused CMS to calculate the risk-adjustment payments based on inaccurate diagnosis information, which enabled us to obtain unspecified amounts of payments in Medicare funds in violation of the False Claims Act. The DOJ filed an amended complaint in July 2020, alleging the same causes of action but revising some of its allegations. In September 2020, we filed a motion to transfer the lawsuit to the Southern District of Ohio, a motion to dismiss part of the lawsuit, and a motion to strike certain allegations in the amended complaint. In an opinion and order issued October 3, 2022, the New York District Court denied our motions, and the case will now proceed in such court. We intend to continue to vigorously defend this suit, which we believe is without merit; however, the ultimate outcome cannot be presently determined.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Investigations of CareMore and HealthSun&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With the assistance of outside counsel, we are conducting investigations of risk-adjustment practices involving data submitted to CMS (unrelated to our retrospective chart review program) at CareMore Health Plans, Inc. (&#x201c;CareMore&#x201d;), one of our California subsidiaries, and HealthSun Health Plans, Inc. (&#x201c;HealthSun&#x201d;), one of our Florida subsidiaries. Our CareMore investigation has resulted in the termination of CareMore&#x2019;s relationship with one contracted provider in California. Our &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;HealthSun investigation has focused on risk adjustment practices initiated prior to our acquisition of HealthSun in December 2017 that continued after the acquisition. We have voluntarily self-disclosed the existence of both of our investigations to CMS and the Criminal and Civil Divisions of the DOJ. We are cooperating with the ongoing investigations of the Criminal and Civil Divisions of the DOJ related to these risk adjustment practices, and have entered into a tolling agreement with the Civil Division of the DOJ related to its investigation. We are analyzing the scope of potential data corrections to be submitted to CMS and have begun to submit data corrections to CMS. We have also asserted indemnity claims for escrowed funds under the HealthSun purchase agreement for, among other things, breach of healthcare and financial representation provisions, based on the conduct discovered during our investigation. While certain elements of the escrow claims were resolved in the fourth quarter of 2021, litigation in the Delaware Court of Chancery related to the remaining indemnity claims for escrowed funds remains ongoing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%"&gt;Other Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we and certain of our subsidiaries are parties to various legal proceedings, many of which involve claims for coverage encountered in the ordinary course of business. We, like Health Maintenance Organizations (&#x201c;HMOs&#x201d;) and health insurers generally, exclude certain healthcare and other services from coverage under our HMO, Preferred Provider Organizations and other plans. We are, in the ordinary course of business, subject to the claims of our enrollees arising out of decisions to restrict or deny reimbursement for uncovered services. The loss of even one such claim, if it results in a significant punitive damage award, could have a material adverse effect on us. In addition, the risk of potential liability under punitive damage theories may increase significantly the difficulty of obtaining reasonable reimbursement of coverage claims. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the lawsuits described above, we are also involved in other pending and threatened litigation of the character incidental to our business and are from time to time involved as a party in various governmental investigations, audits, reviews and administrative proceedings. These investigations, audits, reviews and administrative proceedings include routine and special inquiries by state insurance departments, state attorneys general, the U.S. Attorney General and subcommittees of the U.S. Congress. Such investigations, audits, reviews and administrative proceedings could result in the imposition of civil or criminal fines, penalties, other sanctions and additional rules, regulations or other restrictions on our business operations. Any liability that may result from any one of these actions, or in the aggregate, could have a material adverse effect on our consolidated financial position or results of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contractual Obligations and Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, we entered into an agreement with a vendor for information technology infrastructure and related management and support services through June 2025. The new agreement supersedes certain prior agreements for such services and includes provisions for additional services not provided under those agreements. Our remaining commitment under this agreement at September&#160;30, 2022 is approximately $830. We will have the ability to terminate the agreement upon the occurrence of certain events, subject to early termination fees.&lt;/span&gt;&lt;/div&gt;In the second quarter of 2019, we began using our pharmacy benefits manager IngenioRx to market and offer PBM services to our affiliated health plan customers, as well as to external customers outside of the health plans we own. The comprehensive PBM services portfolio includes, but is not limited to, formulary management, pharmacy networks, prescription drug database, member services and mail order capabilities. IngenioRx delegates certain PBM administrative functions, such as claims processing and prescription fulfillment, to CaremarkPCS Health, L.L.C., which is a subsidiary of CVS Health Corporation, pursuant to a five-year agreement. With IngenioRx, we retain the responsibilities for clinical and formulary strategy and development, member and employer experiences, operations, sales, marketing, account management and retail network strategy.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="iec40b9c51c114cbc9d3101bef95add9d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83My9mcmFnOmRhNzY1OGIxZmY1MjQzNWNiOGM4OWRmNmFkZGI2ODM0L3RleHRyZWdpb246ZGE3NjU4YjFmZjUyNDM1Y2I4Yzg5ZGY2YWRkYjY4MzRfMjI3MQ_acb4694c-60e6-4939-9f5c-de255970391e"
      unitRef="usd">0</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i5a1b6fdf93194651bf7efdc8011a5b9c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83My9mcmFnOmRhNzY1OGIxZmY1MjQzNWNiOGM4OWRmNmFkZGI2ODM0L3RleHRyZWdpb246ZGE3NjU4YjFmZjUyNDM1Y2I4Yzg5ZGY2YWRkYjY4MzRfMjI5MQ_aa8c36cc-bf8c-4681-be9d-5621137d5db6"
      unitRef="usd">250000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ief81cd0e712a4475b910c6e1044349aa_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83My9mcmFnOmRhNzY1OGIxZmY1MjQzNWNiOGM4OWRmNmFkZGI2ODM0L3RleHRyZWdpb246ZGE3NjU4YjFmZjUyNDM1Y2I4Yzg5ZGY2YWRkYjY4MzRfNTY3Mg_2c5fe95f-4d39-4a39-8754-1722bf793413"
      unitRef="number">8000</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83My9mcmFnOmRhNzY1OGIxZmY1MjQzNWNiOGM4OWRmNmFkZGI2ODM0L3RleHRyZWdpb246ZGE3NjU4YjFmZjUyNDM1Y2I4Yzg5ZGY2YWRkYjY4MzRfMTY0OTI2NzQ3NTU5MA_05e34a7b-8272-4906-8f08-18031d157af1"
      unitRef="usd">506000000</us-gaap:LossContingencyAccrualPayments>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83My9mcmFnOmRhNzY1OGIxZmY1MjQzNWNiOGM4OWRmNmFkZGI2ODM0L3RleHRyZWdpb246ZGE3NjU4YjFmZjUyNDM1Y2I4Yzg5ZGY2YWRkYjY4MzRfMTY0OTI2NzQ3NTU4NA_d17c505e-b07b-4a08-a14c-3cdb82626035"
      unitRef="usd">596000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <elv:GrossPremiumTaxRate
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83My9mcmFnOmRhNzY1OGIxZmY1MjQzNWNiOGM4OWRmNmFkZGI2ODM0L3RleHRyZWdpb246ZGE3NjU4YjFmZjUyNDM1Y2I4Yzg5ZGY2YWRkYjY4MzRfODQ0Ng_1956b65b-fcb5-41aa-a111-3104f37f395c"
      unitRef="number">0.0235</elv:GrossPremiumTaxRate>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="ie706cb4d8ca64cb3aeb950d443b981ec_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83My9mcmFnOmRhNzY1OGIxZmY1MjQzNWNiOGM4OWRmNmFkZGI2ODM0L3RleHRyZWdpb246ZGE3NjU4YjFmZjUyNDM1Y2I4Yzg5ZGY2YWRkYjY4MzRfMTAyNzA_b6115dea-b1e0-47f0-a511-50e753793e37"
      unitRef="usd">14800000000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="ib999e2b9904743fc9d242837ba067eb4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83My9mcmFnOmRhNzY1OGIxZmY1MjQzNWNiOGM4OWRmNmFkZGI2ODM0L3RleHRyZWdpb246ZGE3NjU4YjFmZjUyNDM1Y2I4Yzg5ZGY2YWRkYjY4MzRfMTA0Mjc_d5333b5e-800e-409b-bd04-29d6de567e44"
      unitRef="usd">158000000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="if86d9fcaf90e4c74a4febd7d2876346b_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83My9mcmFnOmRhNzY1OGIxZmY1MjQzNWNiOGM4OWRmNmFkZGI2ODM0L3RleHRyZWdpb246ZGE3NjU4YjFmZjUyNDM1Y2I4Yzg5ZGY2YWRkYjY4MzRfMTE1MTQ_59175b89-c92f-4a5e-bfa0-2fa45a6e7a79"
      unitRef="usd">4675000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:LongTermPurchaseCommitmentAmount
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83My9mcmFnOmRhNzY1OGIxZmY1MjQzNWNiOGM4OWRmNmFkZGI2ODM0L3RleHRyZWdpb246ZGE3NjU4YjFmZjUyNDM1Y2I4Yzg5ZGY2YWRkYjY4MzRfMjA5NTA_d28985e6-c372-4cac-ab7f-62478eada1e2"
      unitRef="usd">830000000</us-gaap:LongTermPurchaseCommitmentAmount>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfMzMyMA_3a0e4abb-ea4e-4984-a313-dce3de60148d">Capital Stock&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Capital &#x2013; Dividends and Stock Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We regularly review the appropriate use of capital, including acquisitions, common stock and debt security repurchases and dividends to shareholders. The declaration and payment of any dividends or repurchases of our common stock or debt is at the discretion of our Board of Directors and depends upon our financial condition, results of operations, future liquidity needs, regulatory and capital requirements and other factors deemed relevant by our Board of Directors. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of our cash dividend activity for the nine months ended September 30, 2022 and 2021 is as follows:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.553%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.918%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Declaration Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Record&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Payment&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Dividend&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;per&#160;Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 25, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 10, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 25, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 19, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 10, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 24, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 19, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 9, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 23, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 10, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 20, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 10, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 20, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 10, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 24, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 18, 2022, our Audit Committee declared a fourth quarter 2022 dividend to shareholders of $1.28 per share, payable on December 21, 2022 to shareholders of record at the close of business on December 5, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under our Board of Directors&#x2019; authorization, we maintain a common stock repurchase program. On January 26, 2021, our Audit Committee, pursuant to authorization granted by the Board of Directors, authorized a $5,000 increase to the common stock repurchase program. Repurchases may be made from time to time at prevailing market prices, subject to certain restrictions on volume, pricing and timing. The repurchases are effected from time to time in the open market, through negotiated transactions, including accelerated share repurchase agreements, and through plans designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Our stock repurchase program is discretionary, as we are under no obligation to repurchase shares. We repurchase shares under the program when we believe it is a prudent use of capital. The excess cost of the repurchased shares over par value is charged on a pro rata basis to additional paid-in capital and retained earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of common stock repurchases for the nine months ended September 30, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Authorization remaining at the end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For additional information regarding the use of capital for debt security repurchases, see Note 10, &#x201c;Debt,&#x201d; included in this Form 10-Q and Note 13, &#x201c;Debt,&#x201d; to our audited consolidated financial statements as of and for the year ended December&#160;31, 2021 included in our 2021 Annual Report on Form 10-K. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Incentive Plan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;s&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of stock option activity for the nine months ended September 30, 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Option&#160;Price&lt;br/&gt;per&#160;Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life&#160;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.56&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.35&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the status of nonvested restricted stock activity, including restricted stock units and performance units, for the nine months ended September 30, 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted&lt;br/&gt;Stock&#160;Shares&lt;br/&gt;and Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair&#160;Value&lt;br/&gt;per&#160;Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September 30, 2022, we granted approximately 0.2 restricted stock units that are contingent upon us achieving earnings targets over the three year period from 2022 to 2024. These grants have been included in the activity shown above, but will be subject to adjustment at the end of 2024 based on results in the three year period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use a binomial lattice valuation model to estimate the fair value of all stock options granted. For a more detailed discussion of our stock incentive plan fair value methodology, see Note 15, &#x201c;Capital Stock,&#x201d; to our audited consolidated financial statements as of and for the year ended December&#160;31, 2021 included in our 2021 Annual Report on Form 10-K. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted-average assumptions were used to estimate the fair values of options granted during the nine months ended September 30, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility factor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quarterly dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average expected life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted-average fair values per option or share were determined for the nine months ended September 30, 2022 and 2021:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted during the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock awards granted during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:DividendsDeclaredTableTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfMzMwMw_feea82db-e900-4f61-a92a-1a04bae774c6">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of our cash dividend activity for the nine months ended September 30, 2022 and 2021 is as follows:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.553%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.918%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Declaration Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Record&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Payment&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Dividend&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;per&#160;Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 25, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 10, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 25, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 19, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 10, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 24, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 19, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 9, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 23, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 10, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 20, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 10, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 20, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 10, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 24, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DividendsDeclaredTableTextBlock>
    <us-gaap:DividendsPayableDateDeclaredDayMonthAndYear
      contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMi0wLTEtMS03MDM2Mw_7e672788-8462-4d6a-8ee4-ee8b1425f691">2022-01-25</us-gaap:DividendsPayableDateDeclaredDayMonthAndYear>
    <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear
      contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMi0yLTEtMS03MDM2Mw_40bdf22b-770c-4310-a998-c3ed039bec37">2022-03-10</us-gaap:DividendsPayableDateOfRecordDayMonthAndYear>
    <us-gaap:DividendPayableDateToBePaidDayMonthAndYear
      contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMi00LTEtMS03MDM2Mw_2c2bd43c-2dda-4864-ad07-b1f9deaaea51">2022-03-25</us-gaap:DividendPayableDateToBePaidDayMonthAndYear>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMi02LTEtMS03MDM2Mw_0427d940-ac4d-42c6-a75f-b9b26609d133"
      unitRef="usdPerShare">1.28</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividends
      contextRef="i6a62e4a660ce4a95916638c3f57173f5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMi04LTEtMS03MDM2Mw_f720cff0-5376-4794-9d20-de92adbb2df8"
      unitRef="usd">309000000</us-gaap:PaymentsOfDividends>
    <us-gaap:DividendsPayableDateDeclaredDayMonthAndYear
      contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMy0wLTEtMS03MDM2Mw_10c75a85-3897-4455-a1b2-ebe06748594b">2022-04-19</us-gaap:DividendsPayableDateDeclaredDayMonthAndYear>
    <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear
      contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMy0yLTEtMS03MDM2Mw_995494aa-8aba-4def-bc6d-23b693e4539c">2022-06-10</us-gaap:DividendsPayableDateOfRecordDayMonthAndYear>
    <us-gaap:DividendPayableDateToBePaidDayMonthAndYear
      contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMy00LTEtMS03MDM2Mw_cdc83058-e412-4185-b87f-82fb7c5264c7">2022-06-24</us-gaap:DividendPayableDateToBePaidDayMonthAndYear>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMy02LTEtMS03MDM2Mw_79097a6e-bddb-460b-b2d4-3b4809d656b3"
      unitRef="usdPerShare">1.28</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividends
      contextRef="id28a179244f447fe92ba4ac7665a38c0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMy04LTEtMS03MDM2Mw_7496b180-dcb2-4292-bbbe-fe54951dc495"
      unitRef="usd">309000000</us-gaap:PaymentsOfDividends>
    <us-gaap:DividendsPayableDateDeclaredDayMonthAndYear
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfNC0wLTEtMS03MDM2Mw_d2f0823d-10b4-44ee-885d-1d325c29cc27">2022-07-19</us-gaap:DividendsPayableDateDeclaredDayMonthAndYear>
    <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfNC0yLTEtMS03MDM2Mw_e5e001bc-058d-4052-a619-93bbfde01b9e">2022-09-09</us-gaap:DividendsPayableDateOfRecordDayMonthAndYear>
    <us-gaap:DividendPayableDateToBePaidDayMonthAndYear
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfNC00LTEtMS03MDM2Mw_77601be3-ce75-494d-80d6-e8633ab6d727">2022-09-23</us-gaap:DividendPayableDateToBePaidDayMonthAndYear>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfNC02LTEtMS03MDM2Mw_f97a5052-fc99-414e-8197-61008b45c381"
      unitRef="usdPerShare">1.28</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividends
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfNC04LTEtMS03MDM2Mw_442f253c-a75d-4eee-b922-17785eeeb0d8"
      unitRef="usd">306000000</us-gaap:PaymentsOfDividends>
    <us-gaap:DividendsPayableDateDeclaredDayMonthAndYear
      contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfOS0wLTEtMS03MDM2Mw_bc73217e-29b7-4a08-bffc-98f8acabbdcd">2021-01-26</us-gaap:DividendsPayableDateDeclaredDayMonthAndYear>
    <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear
      contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfOS0yLTEtMS03MDM2Mw_21d9ba3b-c9a4-4c5b-adca-2202fff97dd7">2021-03-10</us-gaap:DividendsPayableDateOfRecordDayMonthAndYear>
    <us-gaap:DividendPayableDateToBePaidDayMonthAndYear
      contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfOS00LTEtMS03MDM2Mw_4135cb62-9402-43a6-b69b-01c3749bdbbf">2021-03-25</us-gaap:DividendPayableDateToBePaidDayMonthAndYear>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfOS02LTEtMS03MDM2Mw_2d75775d-6376-4796-b776-de1bc86d49cc"
      unitRef="usdPerShare">1.13</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividends
      contextRef="i064b0e14ded544559c0f72ee76f28a88_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfOS04LTEtMS03MDM2Mw_2a97e3f2-a4fc-4a61-bc61-cfce65bc6274"
      unitRef="usd">277000000</us-gaap:PaymentsOfDividends>
    <us-gaap:DividendsPayableDateDeclaredDayMonthAndYear
      contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMTAtMC0xLTEtNzAzNjM_12ae60bd-d58a-4c4b-9383-f965a21740fc">2021-04-20</us-gaap:DividendsPayableDateDeclaredDayMonthAndYear>
    <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear
      contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMTAtMi0xLTEtNzAzNjM_32c09c9f-ab4f-491d-a686-06f251e5c930">2021-06-10</us-gaap:DividendsPayableDateOfRecordDayMonthAndYear>
    <us-gaap:DividendPayableDateToBePaidDayMonthAndYear
      contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMTAtNC0xLTEtNzAzNjM_41a6c538-38ae-4cb0-8e95-46d7e483fac6">2021-06-25</us-gaap:DividendPayableDateToBePaidDayMonthAndYear>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMTAtNi0xLTEtNzAzNjM_70d5679e-329a-41ed-a46a-c1bcbfe83307"
      unitRef="usdPerShare">1.13</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividends
      contextRef="i15ec95ce20434bc7a0b220752067edd8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMTAtOC0xLTEtNzAzNjM_045bfdfd-14ba-43f0-a810-095abf5a84f3"
      unitRef="usd">278000000</us-gaap:PaymentsOfDividends>
    <us-gaap:DividendsPayableDateDeclaredDayMonthAndYear
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMTEtMC0xLTEtNzAzNjM_7d79fdfb-0fff-4965-95a0-b8f2c50ad662">2021-07-20</us-gaap:DividendsPayableDateDeclaredDayMonthAndYear>
    <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMTEtMi0xLTEtNzAzNjM_65ed36e8-a472-4a17-a6ed-b1b7349f3911">2021-09-10</us-gaap:DividendsPayableDateOfRecordDayMonthAndYear>
    <us-gaap:DividendPayableDateToBePaidDayMonthAndYear
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMTEtNC0xLTEtNzAzNjM_82fce437-90da-4c42-920f-c16bf7df83b3">2021-09-24</us-gaap:DividendPayableDateToBePaidDayMonthAndYear>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMTEtNi0xLTEtNzAzNjM_b0a7141d-89e2-49ab-905e-c4db913c40e9"
      unitRef="usdPerShare">1.13</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividends
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOmIxZGU4MzAwODIzNTQzNzJhNmIzMzQ4NDMwNzJhNDk0L3RhYmxlcmFuZ2U6YjFkZTgzMDA4MjM1NDM3MmE2YjMzNDg0MzA3MmE0OTRfMTEtOC0xLTEtNzAzNjM_22c4c17e-a53d-4dd5-9657-1e26af8a8369"
      unitRef="usd">276000000</us-gaap:PaymentsOfDividends>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="i593ccc71545a463aa762ea6a7a1efafc_I20221018"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfNzI0_f16bd257-8c6b-41a9-b8f8-15337f8493fd"
      unitRef="usdPerShare">1.28</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendPayableDateToBePaidDayMonthAndYear
      contextRef="if9e73fa43f474637904386532065813b_D20221018-20221018"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfNzQ5_a317c3fe-6da8-4cbd-8fa8-73dda8b0eb39">2022-12-21</us-gaap:DividendPayableDateToBePaidDayMonthAndYear>
    <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear
      contextRef="if9e73fa43f474637904386532065813b_D20221018-20221018"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfODA2_5cde05ab-efa5-4fc6-8b52-1182d1ca3195">2022-12-05</us-gaap:DividendsPayableDateOfRecordDayMonthAndYear>
    <elv:IncreaseInStockRepurchaseProgramAuthorization
      contextRef="i90083e53041c4397abce83d13efa37ae_I20210126"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfMTAxOA_912a8d04-50c6-465f-be3e-9eaa1572d9cb"
      unitRef="usd">5000000000</elv:IncreaseInStockRepurchaseProgramAuthorization>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfMzI5Mw_9bb5a618-0613-4147-befc-7cb09a270acb">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of common stock repurchases for the nine months ended September 30, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Authorization remaining at the end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjAxZDRjMzVlOWYyNTQyOTM5ZTllZjVjNGVhN2UwODE4L3RhYmxlcmFuZ2U6MDFkNGMzNWU5ZjI1NDI5MzllOWVmNWM0ZWE3ZTA4MThfMi0yLTEtMS03MDM2Mw_9adb3b42-0704-418c-a76f-fd7cd0b9b263"
      unitRef="shares">3700000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjAxZDRjMzVlOWYyNTQyOTM5ZTllZjVjNGVhN2UwODE4L3RhYmxlcmFuZ2U6MDFkNGMzNWU5ZjI1NDI5MzllOWVmNWM0ZWE3ZTA4MThfMi00LTEtMS03MDM2Mw_6f148e76-4f0f-4d18-9192-33cf515cb04d"
      unitRef="shares">3900000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <elv:StockRepurchasedAndRetiredDuringPeriodAveragePrice
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjAxZDRjMzVlOWYyNTQyOTM5ZTllZjVjNGVhN2UwODE4L3RhYmxlcmFuZ2U6MDFkNGMzNWU5ZjI1NDI5MzllOWVmNWM0ZWE3ZTA4MThfMy0yLTEtMS03MDM2Mw_f37bf6a5-c26a-48f2-83ce-e0b9e983fb2d"
      unitRef="usdPerShare">473.36</elv:StockRepurchasedAndRetiredDuringPeriodAveragePrice>
    <elv:StockRepurchasedAndRetiredDuringPeriodAveragePrice
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjAxZDRjMzVlOWYyNTQyOTM5ZTllZjVjNGVhN2UwODE4L3RhYmxlcmFuZ2U6MDFkNGMzNWU5ZjI1NDI5MzllOWVmNWM0ZWE3ZTA4MThfMy00LTEtMS03MDM2Mw_ef1fb990-bb8c-4342-980e-554aa3d9da2c"
      unitRef="usdPerShare">356.43</elv:StockRepurchasedAndRetiredDuringPeriodAveragePrice>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjAxZDRjMzVlOWYyNTQyOTM5ZTllZjVjNGVhN2UwODE4L3RhYmxlcmFuZ2U6MDFkNGMzNWU5ZjI1NDI5MzllOWVmNWM0ZWE3ZTA4MThfNC0yLTEtMS03MDM2Mw_f79d2611-b024-48d8-8f4a-06c22a071f88"
      unitRef="usd">1748000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjAxZDRjMzVlOWYyNTQyOTM5ZTllZjVjNGVhN2UwODE4L3RhYmxlcmFuZ2U6MDFkNGMzNWU5ZjI1NDI5MzllOWVmNWM0ZWE3ZTA4MThfNC00LTEtMS03MDM2Mw_806dbcb0-6f7b-4e4e-b92e-b8502976c26f"
      unitRef="usd">1378000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjAxZDRjMzVlOWYyNTQyOTM5ZTllZjVjNGVhN2UwODE4L3RhYmxlcmFuZ2U6MDFkNGMzNWU5ZjI1NDI5MzllOWVmNWM0ZWE3ZTA4MThfNS0yLTEtMS03MDM2Mw_805857a5-ad61-444c-a17d-ab4ef939b730"
      unitRef="usd">2444000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="id7580839926f4e24b08f10312dd69479_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjAxZDRjMzVlOWYyNTQyOTM5ZTllZjVjNGVhN2UwODE4L3RhYmxlcmFuZ2U6MDFkNGMzNWU5ZjI1NDI5MzllOWVmNWM0ZWE3ZTA4MThfNS00LTEtMS03MDM2Mw_edf4a7c4-245c-42a3-b221-a2aec6d4bbcb"
      unitRef="usd">4714000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfMzI5Nw_393efecb-647f-4653-9034-4371d2834304">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of stock option activity for the nine months ended September 30, 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Option&#160;Price&lt;br/&gt;per&#160;Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life&#160;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.56&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.35&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfMS0xLTEtMS03MDM2Mw_5a394bc8-681f-465a-895e-1583dac19ead"
      unitRef="shares">2900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfMS0zLTEtMS03MDM2Mw_d6ac1941-65b3-4747-a57c-0359fe25120d"
      unitRef="usdPerShare">255.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfMi0xLTEtMS03MDM2Mw_80b374ef-18ec-4824-aab9-e529f62afc55"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfMi0zLTEtMS03MDM2Mw_419ecac4-3836-4a41-bde0-eec75c55930d"
      unitRef="usdPerShare">452.34</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfMy0xLTEtMS03MDM2Mw_12116a74-729c-4d3c-a138-6085832544d1"
      unitRef="shares">400000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfMy0zLTEtMS03MDM2Mw_5544cf4b-2b80-453c-99e6-4e8a91e5243a"
      unitRef="usdPerShare">243.39</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfNC0xLTEtMS03MDM2Mw_b92d94b7-b545-4406-a5f4-e3fecaad487a"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfNC0zLTEtMS03MDM2Mw_0963c932-7425-4c29-b2b8-5482e13eaeb3"
      unitRef="usdPerShare">339.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfNS0xLTEtMS03MDM2Mw_57435f8b-a549-43c8-8977-40359caf7c1b"
      unitRef="shares">2900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfNS0zLTEtMS03MDM2Mw_123cc4cc-a1c6-4ab4-b53d-4b3d259725e2"
      unitRef="usdPerShare">291.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfNS01LTEtMS03MDM2Mw_5fe47ac2-fa5e-4083-8f11-a6c48221b4e6">P6Y6M21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfNS03LTEtMS03MDM2Mw_1b374e1d-286f-4481-81f9-2ed04db8f217"
      unitRef="usd">477000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfNi0xLTEtMS03MDM2Mw_fd8a76f4-6be9-41da-af04-bb0d207e5723"
      unitRef="shares">1700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfNi0zLTEtMS03MDM2Mw_45b39c71-e465-4a95-acdd-0a15eea2551a"
      unitRef="usdPerShare">239.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfNi01LTEtMS03MDM2Mw_8db85bb4-38ae-4826-a638-05f5ff2a664b">P5Y4M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjIxMWRkYjFmY2I5YTQyODJhNjY0NGE5OWYxZDk2NWMxL3RhYmxlcmFuZ2U6MjExZGRiMWZjYjlhNDI4MmE2NjQ0YTk5ZjFkOTY1YzFfNi03LTEtMS03MDM2Mw_0657530e-f73d-4f0a-a31c-545877343ab9"
      unitRef="usd">370000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfMzI5MA_55a2f08e-0a8a-49a7-a350-01778e3730f4">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the status of nonvested restricted stock activity, including restricted stock units and performance units, for the nine months ended September 30, 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted&lt;br/&gt;Stock&#160;Shares&lt;br/&gt;and Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair&#160;Value&lt;br/&gt;per&#160;Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjFjNjUxNDZiMjI1MTQ5MTZiMDc4ZDE0YTZhODAyYjU0L3RhYmxlcmFuZ2U6MWM2NTE0NmIyMjUxNDkxNmIwNzhkMTRhNmE4MDJiNTRfMS0xLTEtMS03MDM2Mw_c0056a59-e6f1-43e1-b6ea-1d15ece17d6e"
      unitRef="shares">1300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjFjNjUxNDZiMjI1MTQ5MTZiMDc4ZDE0YTZhODAyYjU0L3RhYmxlcmFuZ2U6MWM2NTE0NmIyMjUxNDkxNmIwNzhkMTRhNmE4MDJiNTRfMS0zLTEtMS03MDM2Mw_00a1ce53-8107-4f2b-80c1-dbb35f4b33eb"
      unitRef="usdPerShare">299.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjFjNjUxNDZiMjI1MTQ5MTZiMDc4ZDE0YTZhODAyYjU0L3RhYmxlcmFuZ2U6MWM2NTE0NmIyMjUxNDkxNmIwNzhkMTRhNmE4MDJiNTRfMi0xLTEtMS03MDM2Mw_b36c4f8a-73fd-47f7-aeff-d2d45c6b9dbc"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjFjNjUxNDZiMjI1MTQ5MTZiMDc4ZDE0YTZhODAyYjU0L3RhYmxlcmFuZ2U6MWM2NTE0NmIyMjUxNDkxNmIwNzhkMTRhNmE4MDJiNTRfMi0zLTEtMS03MDM2Mw_fea2ab62-4c20-40f7-b1ba-8b65f010b471"
      unitRef="usdPerShare">453.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjFjNjUxNDZiMjI1MTQ5MTZiMDc4ZDE0YTZhODAyYjU0L3RhYmxlcmFuZ2U6MWM2NTE0NmIyMjUxNDkxNmIwNzhkMTRhNmE4MDJiNTRfMy0xLTEtMS03MDM2Mw_bdce7066-060e-4649-a3ee-5eb83eb006d0"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjFjNjUxNDZiMjI1MTQ5MTZiMDc4ZDE0YTZhODAyYjU0L3RhYmxlcmFuZ2U6MWM2NTE0NmIyMjUxNDkxNmIwNzhkMTRhNmE4MDJiNTRfMy0zLTEtMS03MDM2Mw_54beb487-881e-4d7a-a804-75f3767e38e9"
      unitRef="usdPerShare">301.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjFjNjUxNDZiMjI1MTQ5MTZiMDc4ZDE0YTZhODAyYjU0L3RhYmxlcmFuZ2U6MWM2NTE0NmIyMjUxNDkxNmIwNzhkMTRhNmE4MDJiNTRfNC0xLTEtMS03MDM2Mw_86b2113d-c0c9-4209-b123-8298bd744500"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjFjNjUxNDZiMjI1MTQ5MTZiMDc4ZDE0YTZhODAyYjU0L3RhYmxlcmFuZ2U6MWM2NTE0NmIyMjUxNDkxNmIwNzhkMTRhNmE4MDJiNTRfNC0zLTEtMS03MDM2Mw_ff4e9e81-aad8-4ffd-8254-dc7a992893b8"
      unitRef="usdPerShare">345.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjFjNjUxNDZiMjI1MTQ5MTZiMDc4ZDE0YTZhODAyYjU0L3RhYmxlcmFuZ2U6MWM2NTE0NmIyMjUxNDkxNmIwNzhkMTRhNmE4MDJiNTRfNS0xLTEtMS03MDM2Mw_459baa5c-d5b1-41c6-bd7a-606f45b02d75"
      unitRef="shares">1200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjFjNjUxNDZiMjI1MTQ5MTZiMDc4ZDE0YTZhODAyYjU0L3RhYmxlcmFuZ2U6MWM2NTE0NmIyMjUxNDkxNmIwNzhkMTRhNmE4MDJiNTRfNS0zLTEtMS03MDM2Mw_6c6ed712-a49d-42fa-b4b2-21d4d8cca557"
      unitRef="usdPerShare">356.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i59f143f05a8b4cdf99dd35b50717b3d8_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfMjQyMw_b63151f1-e809-408f-a827-b1b8d34cfd5d"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfMzI4Mw_27900621-2114-40c9-9857-ceef4e5dcd3b">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted-average assumptions were used to estimate the fair values of options granted during the nine months ended September 30, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility factor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quarterly dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average expected life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjg1YWE1MzhhYzNkNTRhZTdhMDg0NGYzY2QzOTdjOTRmL3RhYmxlcmFuZ2U6ODVhYTUzOGFjM2Q1NGFlN2EwODQ0ZjNjZDM5N2M5NGZfMi0xLTEtMS03MDM2Mw_3e55de1c-7105-4bd3-9f7e-273c2546216c"
      unitRef="number">0.0197</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjg1YWE1MzhhYzNkNTRhZTdhMDg0NGYzY2QzOTdjOTRmL3RhYmxlcmFuZ2U6ODVhYTUzOGFjM2Q1NGFlN2EwODQ0ZjNjZDM5N2M5NGZfMi0zLTEtMS03MDM2Mw_ef6b241b-92c9-4829-ba31-b66909f8a88b"
      unitRef="number">0.0144</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjg1YWE1MzhhYzNkNTRhZTdhMDg0NGYzY2QzOTdjOTRmL3RhYmxlcmFuZ2U6ODVhYTUzOGFjM2Q1NGFlN2EwODQ0ZjNjZDM5N2M5NGZfMy0xLTEtMS03MDM2Mw_de45eb4b-1588-40e6-8670-7c11d9817950"
      unitRef="number">0.2900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjg1YWE1MzhhYzNkNTRhZTdhMDg0NGYzY2QzOTdjOTRmL3RhYmxlcmFuZ2U6ODVhYTUzOGFjM2Q1NGFlN2EwODQ0ZjNjZDM5N2M5NGZfMy0zLTEtMS03MDM2Mw_06af6052-b7b5-4223-a40e-8c6a72a43f54"
      unitRef="number">0.3000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjg1YWE1MzhhYzNkNTRhZTdhMDg0NGYzY2QzOTdjOTRmL3RhYmxlcmFuZ2U6ODVhYTUzOGFjM2Q1NGFlN2EwODQ0ZjNjZDM5N2M5NGZfNC0xLTEtMS03MDM2Mw_ac2f8b8c-3f7a-472d-b19b-31562ae43107"
      unitRef="number">0.00282</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjg1YWE1MzhhYzNkNTRhZTdhMDg0NGYzY2QzOTdjOTRmL3RhYmxlcmFuZ2U6ODVhYTUzOGFjM2Q1NGFlN2EwODQ0ZjNjZDM5N2M5NGZfNC0zLTEtMS03MDM2Mw_c0a80567-fd77-4afb-80a4-2f4c69ad974d"
      unitRef="number">0.00360</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjg1YWE1MzhhYzNkNTRhZTdhMDg0NGYzY2QzOTdjOTRmL3RhYmxlcmFuZ2U6ODVhYTUzOGFjM2Q1NGFlN2EwODQ0ZjNjZDM5N2M5NGZfNS0xLTEtMS03MDM2Mw_c0488406-5fb6-4c0b-bc58-974b7cebe37f">P5Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjg1YWE1MzhhYzNkNTRhZTdhMDg0NGYzY2QzOTdjOTRmL3RhYmxlcmFuZ2U6ODVhYTUzOGFjM2Q1NGFlN2EwODQ0ZjNjZDM5N2M5NGZfNS0zLTEtMS03MDM2Mw_7391decd-7fc6-4e94-9bfa-e0849b6d912e">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RleHRyZWdpb246OWUxOTZjNDk5MWU4NDNiNWExYjA5ZmU3NTFjNWY2ODlfMzI4NQ_bb9a9fb9-6083-40c9-9361-3e8a98917b44">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted-average fair values per option or share were determined for the nine months ended September 30, 2022 and 2021:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted during the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock awards granted during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjQxNjdiNDkzOTJmNTRkODk4NTNmMDdlMmRhZDI3NWRhL3RhYmxlcmFuZ2U6NDE2N2I0OTM5MmY1NGQ4OTg1M2YwN2UyZGFkMjc1ZGFfMi0xLTEtMS03MDM2Mw_ae91e3dd-53fd-4cd9-9474-832a15d912ed"
      unitRef="usdPerShare">116.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjQxNjdiNDkzOTJmNTRkODk4NTNmMDdlMmRhZDI3NWRhL3RhYmxlcmFuZ2U6NDE2N2I0OTM5MmY1NGQ4OTg1M2YwN2UyZGFkMjc1ZGFfMi0zLTEtMS03MDM2Mw_5b88c9dc-76bc-407a-a97c-3c7fc6404599"
      unitRef="usdPerShare">79.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjQxNjdiNDkzOTJmNTRkODk4NTNmMDdlMmRhZDI3NWRhL3RhYmxlcmFuZ2U6NDE2N2I0OTM5MmY1NGQ4OTg1M2YwN2UyZGFkMjc1ZGFfMy0xLTEtMS03MDM2Mw_42aa8a68-daf9-4a34-9267-5e8d01879b36"
      unitRef="usdPerShare">453.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83Ni9mcmFnOjllMTk2YzQ5OTFlODQzYjVhMWIwOWZlNzUxYzVmNjg5L3RhYmxlOjQxNjdiNDkzOTJmNTRkODk4NTNmMDdlMmRhZDI3NWRhL3RhYmxlcmFuZ2U6NDE2N2I0OTM5MmY1NGQ4OTg1M2YwN2UyZGFkMjc1ZGFfMy0zLTEtMS03MDM2Mw_9d292e6f-273f-4544-8d9f-ada74d7b04cb"
      unitRef="usdPerShare">315.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RleHRyZWdpb246MWMyNzAwYTQxY2U5NGViYjgwZTE1YTRhNTg5MDA3OTVfMTU1_c6108a0e-77e8-48f4-b68a-41175105a3a8">Accumulated Other Comprehensive Loss &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the components of accumulated other comprehensive loss at September&#160;30, 2022 and 2021 is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended &lt;br/&gt;September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net unrealized investment (losses) gains:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,489)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications, net of tax benefit of $220, $25, $896 and $71, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(719)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,914)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss, net of tax (expense) benefit of $(21), $5, $(75) and $21, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss attributable to noncontrolling interests, net of tax benefit of $(1), $0, $(4) and $(1), respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-credit components of impairments on investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income, net of tax benefit (expense) of $0, $0, $1 and $(1), respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(233)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income, net of tax expense of $0, $0, $(2) and $(2), respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension and other postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income, net of tax expense of $(3), $(4), $(9) and $(10), respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(406)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(406)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss, net of tax benefit of $2, $1, $4 and $2, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total beginning of period accumulated other comprehensive (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive loss, net of tax benefit of $198, $27, $815 and $81, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(638)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,617)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive loss attributable to noncontrolling interests, net of tax benefit of $(1), $0, $(4) and $(1), respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total end of period accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,784)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,784)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RleHRyZWdpb246MWMyNzAwYTQxY2U5NGViYjgwZTE1YTRhNTg5MDA3OTVfMTUx_5296ee18-74c7-4c6f-9218-fd69664df2ae">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the components of accumulated other comprehensive loss at September&#160;30, 2022 and 2021 is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended &lt;br/&gt;September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net unrealized investment (losses) gains:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,489)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications, net of tax benefit of $220, $25, $896 and $71, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(719)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,914)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss, net of tax (expense) benefit of $(21), $5, $(75) and $21, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss attributable to noncontrolling interests, net of tax benefit of $(1), $0, $(4) and $(1), respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-credit components of impairments on investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income, net of tax benefit (expense) of $0, $0, $1 and $(1), respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(233)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income, net of tax expense of $0, $0, $(2) and $(2), respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension and other postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income, net of tax expense of $(3), $(4), $(9) and $(10), respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(406)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(406)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss, net of tax benefit of $2, $1, $4 and $2, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total beginning of period accumulated other comprehensive (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive loss, net of tax benefit of $198, $27, $815 and $81, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(638)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,617)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive loss attributable to noncontrolling interests, net of tax benefit of $(1), $0, $(4) and $(1), respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total end of period accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,784)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,784)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ie0032fd5f2e3430db780393923fe52c6_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMy0xLTEtMS03MDM2Mw_16e9d0b1-53a7-452f-afd0-671d7898f186"
      unitRef="usd">-1489000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i1666c9555de74b4dbc65fef3b1b917cd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMy0zLTEtMS03MDM2Mw_40b98505-cdb3-4cdd-8267-7fcba352c72f"
      unitRef="usd">762000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i1506e71de0d34c81941b49a8af7876e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMy01LTEtMS03MDM2Mw_4aa3b4fa-ea31-424c-8c5e-79f8987f5252"
      unitRef="usd">494000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ia1a95b18f4a549a9916b28653b0280e7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMy03LTEtMS03MDM2Mw_952b897b-54b1-4498-bdf8-3ff488b4d840"
      unitRef="usd">949000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
      contextRef="i8cf014dd12e9477788ecb92ec4a95f02_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNC0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjI0ZmNhMzE4YTExMTRhNzE4ODMxNGU3MWExNTYxMzFjXzk2_0fed2c7b-fe76-4059-b8f7-719cd590272a"
      unitRef="usd">220000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
      contextRef="i488068315a5d438e968d54c5b20cc063_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNC0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjI0ZmNhMzE4YTExMTRhNzE4ODMxNGU3MWExNTYxMzFjXzEwMA_7c531feb-1eef-462e-8b93-2feac596da60"
      unitRef="usd">25000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
      contextRef="i2d87ef5b685049cc85f3a91696bb60cb_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNC0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjI0ZmNhMzE4YTExMTRhNzE4ODMxNGU3MWExNTYxMzFjXzEwNA_0d8cedce-2976-4339-9d0c-aff4288bae6f"
      unitRef="usd">896000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
      contextRef="i6a64d441bc804e49bc8a45a553ba2057_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNC0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjI0ZmNhMzE4YTExMTRhNzE4ODMxNGU3MWExNTYxMzFjXzExMQ_a7d31df0-8bd9-4128-ac62-f06ab224b53b"
      unitRef="usd">71000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i8cf014dd12e9477788ecb92ec4a95f02_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNC0xLTEtMS03MDM2Mw_8e938bf5-cda6-4964-8586-bae586be16f0"
      unitRef="usd">-719000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i488068315a5d438e968d54c5b20cc063_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNC0zLTEtMS03MDM2Mw_e7b8b8f4-6558-4292-af74-ba63128b7203"
      unitRef="usd">-80000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i2d87ef5b685049cc85f3a91696bb60cb_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNC01LTEtMS03MDM2Mw_93974d7d-a025-4249-9103-8ed4e393ff48"
      unitRef="usd">-2914000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i6a64d441bc804e49bc8a45a553ba2057_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNC03LTEtMS03MDM2Mw_e8b59aff-c8ca-4527-ad93-4fd3a42af0da"
      unitRef="usd">-203000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="i8cf014dd12e9477788ecb92ec4a95f02_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNS0wLTEtMS03MDM2My90ZXh0cmVnaW9uOmMzYjQ4ZWJhOWE4ZjQzOWY5NTFiNWEwMjNmNWI4ZDViXzEwMA_2e9da788-b172-4b63-bb08-18d2cac8b3d5"
      unitRef="usd">21000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="i488068315a5d438e968d54c5b20cc063_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNS0wLTEtMS03MDM2My90ZXh0cmVnaW9uOmMzYjQ4ZWJhOWE4ZjQzOWY5NTFiNWEwMjNmNWI4ZDViXzEwNA_8f38b111-90ad-491b-8ad8-6378eec87de6"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="i2d87ef5b685049cc85f3a91696bb60cb_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNS0wLTEtMS03MDM2My90ZXh0cmVnaW9uOmMzYjQ4ZWJhOWE4ZjQzOWY5NTFiNWEwMjNmNWI4ZDViXzEwOA_cb315003-e0f5-4f26-a7c8-9ecb4f76c493"
      unitRef="usd">75000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="i6a64d441bc804e49bc8a45a553ba2057_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNS0wLTEtMS03MDM2My90ZXh0cmVnaW9uOmMzYjQ4ZWJhOWE4ZjQzOWY5NTFiNWEwMjNmNWI4ZDViXzExNQ_fea21229-26be-4cff-a7cd-d84b4f4052a8"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i8cf014dd12e9477788ecb92ec4a95f02_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNS0xLTEtMS03MDM2Mw_74002007-cf3f-4da8-b284-363cf764cc33"
      unitRef="usd">80000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i488068315a5d438e968d54c5b20cc063_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNS0zLTEtMS03MDM2Mw_551883fd-f4bc-4e7a-8fb0-02b57c063321"
      unitRef="usd">-17000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i2d87ef5b685049cc85f3a91696bb60cb_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNS01LTEtMS03MDM2Mw_9ff254bf-9f01-487e-a8de-ae00ed62a8de"
      unitRef="usd">284000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i6a64d441bc804e49bc8a45a553ba2057_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNS03LTEtMS03MDM2Mw_ad697c33-4e53-42d0-bdf3-01c3d7c04e20"
      unitRef="usd">-81000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i8cf014dd12e9477788ecb92ec4a95f02_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNi0xLTEtMS03MDM2Mw_e9d37686-6b15-4e1d-a763-273001905bce"
      unitRef="usd">-639000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i488068315a5d438e968d54c5b20cc063_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNi0zLTEtMS03MDM2Mw_bc966a56-ceee-4bc4-9406-f4aaa2be3791"
      unitRef="usd">-97000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i2d87ef5b685049cc85f3a91696bb60cb_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNi01LTEtMS03MDM2Mw_0e36d2f6-df2a-40b2-a9b1-0f077ea063ae"
      unitRef="usd">-2630000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i6a64d441bc804e49bc8a45a553ba2057_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNi03LTEtMS03MDM2Mw_ea6abca0-eeef-466b-a368-32af53cee63e"
      unitRef="usd">-284000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNy0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjlhN2UyN2E1MzhlYjQ2NjI4OWRjNmJkM2Y4MzY1NTdhXzExMg_2cfa2cab-afab-46e0-b4cd-5d548572fb67"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNy0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjlhN2UyN2E1MzhlYjQ2NjI4OWRjNmJkM2Y4MzY1NTdhXzExNg_477d87e2-ca51-44dc-bddd-2e2ba837bb8f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNy0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjlhN2UyN2E1MzhlYjQ2NjI4OWRjNmJkM2Y4MzY1NTdhXzEyMA_ead5e4b6-2772-4383-93ce-b3d386d51160"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNy0wLTEtMS03MDM2My90ZXh0cmVnaW9uOjlhN2UyN2E1MzhlYjQ2NjI4OWRjNmJkM2Y4MzY1NTdhXzEyNw_cc409444-547b-42ae-8eef-98125a54743f"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i8cf014dd12e9477788ecb92ec4a95f02_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNy0xLTEtMS03MDM2Mw_525ad36c-9cd4-4436-874d-ed7ded086797"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i488068315a5d438e968d54c5b20cc063_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNy0zLTEtMS03MDM2Mw_c84ee4fa-c5f9-4f79-9a0f-75042ec5378b"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i2d87ef5b685049cc85f3a91696bb60cb_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNy01LTEtMS03MDM2Mw_1ede2f22-a58d-432c-a943-e60f59ed20e8"
      unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i6a64d441bc804e49bc8a45a553ba2057_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfNy03LTEtMS03MDM2Mw_fb81c42c-fd94-4082-bf30-e4dd804f0082"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i38542daa11574b0aad0519ecfa5263ef_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfOC0xLTEtMS03MDM2Mw_5c2f0367-3c8d-470f-87bd-ef1c6ef2b9bf"
      unitRef="usd">-2125000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i93b560992cd743cb8ceceaf0b0b2e931_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfOC0zLTEtMS03MDM2Mw_a966aaa8-f6b1-4003-a4b8-fb0b4bcf8f41"
      unitRef="usd">666000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i38542daa11574b0aad0519ecfa5263ef_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfOC01LTEtMS03MDM2Mw_4f3136ef-0b65-4b7b-90a4-75ae92749dbc"
      unitRef="usd">-2125000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i93b560992cd743cb8ceceaf0b0b2e931_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfOC03LTEtMS03MDM2Mw_fd6b5d3d-e586-4fdb-b197-75b98e6c08e0"
      unitRef="usd">666000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities
      contextRef="ibeb89cf81873481eb8b9811ea6dfe3bc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTEtMS0xLTEtNzAzNjM_285aceea-9489-4444-be0e-b36a89ab9562"
      unitRef="usd">-2000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities
      contextRef="ic35e765820354c2cafb66117c9ea4c7a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTEtMy0xLTEtNzAzNjM_d6340200-f345-4deb-a11a-6c54a0be236e"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities
      contextRef="i96e9251b744b4f7e9ecbb677bd8634fa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTEtNS0xLTEtNzAzNjM_e67bf1b6-eb9d-4da5-bd55-561d9aed9ddd"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities
      contextRef="i56a76ec5b38f428db6242e45a2f30037_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTEtNy0xLTEtNzAzNjM_1c3ce0fa-c6c6-4cfa-b149-3d574cfe653c"
      unitRef="usd">-2000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities>
    <elv:Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss
      contextRef="i117df451326545f9986059648cfd22dc_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo1NmMzNWM3Yzk0OTE0ZjRlYjU0OWQ5MDQzMDk0MjIzOV83MQ_ee671136-4162-40ef-ad7e-6aff5f877082"
      unitRef="usd">0</elv:Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss>
    <elv:Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss
      contextRef="i365146e911f1424ea5fe059db32e3d7d_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo1NmMzNWM3Yzk0OTE0ZjRlYjU0OWQ5MDQzMDk0MjIzOV83NQ_5c75864c-d19c-47d0-9a1c-343a7e6c3b13"
      unitRef="usd">0</elv:Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss>
    <elv:Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss
      contextRef="i9a0fc272f1aa4de39b8e80fa4ef950f7_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo1NmMzNWM3Yzk0OTE0ZjRlYjU0OWQ5MDQzMDk0MjIzOV83OQ_c41a3e7d-e0a1-4662-a949-8a7d001dd9db"
      unitRef="usd">1000000</elv:Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss>
    <elv:Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss
      contextRef="ic726783a65004c40a48a29cda9bf3769_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo1NmMzNWM3Yzk0OTE0ZjRlYjU0OWQ5MDQzMDk0MjIzOV84Ng_6dfdd85a-a33d-4751-aeeb-cd0874e1e3c8"
      unitRef="usd">-1000000</elv:Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss>
    <us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities
      contextRef="i117df451326545f9986059648cfd22dc_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTItMS0xLTEtNzAzNjM_3a7c08b1-cb88-41f9-88ca-5f00e09176f2"
      unitRef="usd">-1000000</us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities>
    <us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities
      contextRef="i365146e911f1424ea5fe059db32e3d7d_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTItMy0xLTEtNzAzNjM_74f00094-02ed-4632-aae8-06c3682779b7"
      unitRef="usd">-1000000</us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities>
    <us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities
      contextRef="i9a0fc272f1aa4de39b8e80fa4ef950f7_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTItNS0xLTEtNzAzNjM_f1735a73-145a-43a0-a20b-f5002f24ba11"
      unitRef="usd">-3000000</us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities>
    <us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities
      contextRef="ic726783a65004c40a48a29cda9bf3769_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTItNy0xLTEtNzAzNjM_3fb83e9c-c620-4569-b092-f436df052e1e"
      unitRef="usd">1000000</us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities
      contextRef="i1e43378757a544d788aed5dc1dd1ce21_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTMtMS0xLTEtNzAzNjM_494325d2-eb96-4ad8-823f-fc8175170250"
      unitRef="usd">-3000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities
      contextRef="i3854b434ec0e41f19c683b643a2b65b0_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTMtMy0xLTEtNzAzNjM_813588dd-0096-4e9e-9512-e60d8183f602"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities
      contextRef="i1e43378757a544d788aed5dc1dd1ce21_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTMtNS0xLTEtNzAzNjM_a9400747-bf34-4593-8de4-e5726b9c433c"
      unitRef="usd">-3000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities
      contextRef="i3854b434ec0e41f19c683b643a2b65b0_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTMtNy0xLTEtNzAzNjM_ca1c8567-3269-459c-8a13-259fb7720a65"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i6cae8c9b8e124d8f9c6a483e1f50d63a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTYtMS0xLTEtNzAzNjM_73e2e3d2-d57d-4d46-a6f1-6159d602d7ea"
      unitRef="usd">-233000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i6333d6f4a7f542d0a6c873c6d721b20f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTYtMy0xLTEtNzAzNjM_39528f48-008f-4d69-a3cc-dc87bbb8aa12"
      unitRef="usd">-244000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i0f296ec510ae4b489100cc4e4401f16d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTYtNS0xLTEtNzAzNjM_f17b4d3a-3806-4297-8662-30926206b815"
      unitRef="usd">-239000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="ie7d0a14cf7b04d2689e8c00fe9ee50bc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTYtNy0xLTEtNzAzNjM_9571f651-ab3e-4a15-9aa1-443895ed647b"
      unitRef="usd">-250000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="ibce0012780de42b39687b8dc2c2d2645_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo3MzAyMjM5MTZjNzg0NDQ3YTJkNGI2OGNmNTFiYTE2Y181NA_ddf0ad9c-f99c-4968-8c56-cdaa01435a34"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i9291c2ff4b2f443a9a229d05ba749f08_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo3MzAyMjM5MTZjNzg0NDQ3YTJkNGI2OGNmNTFiYTE2Y181OA_bf80715d-ca28-4d76-af4c-89f85b47aace"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i35dbebbdfb3b4ab58592b593d907d827_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo3MzAyMjM5MTZjNzg0NDQ3YTJkNGI2OGNmNTFiYTE2Y182Mg_0b1a8aca-243e-4c15-a994-c7af7b72fbe8"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="if60627e1e84e4b339448c6d14a9087be_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo3MzAyMjM5MTZjNzg0NDQ3YTJkNGI2OGNmNTFiYTE2Y182OQ_0f32a353-1ba9-4f30-a44f-a447cc3a929d"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ibce0012780de42b39687b8dc2c2d2645_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTctMS0xLTEtNzAzNjM_e1a98b34-c2a7-4417-a437-87212bfbb9dd"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i9291c2ff4b2f443a9a229d05ba749f08_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTctMy0xLTEtNzAzNjM_da1a51ac-6961-40ea-a0ad-0db7c9d80ddd"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i35dbebbdfb3b4ab58592b593d907d827_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTctNS0xLTEtNzAzNjM_aa433427-3b6c-416d-b51c-6596d575b582"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="if60627e1e84e4b339448c6d14a9087be_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTctNy0xLTEtNzAzNjM_334fce74-599d-4ef6-b470-1803a1b65556"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="iadc106beeb124c7ba342f63d01a137d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTgtMS0xLTEtNzAzNjM_601cacc4-b8d3-4e68-939a-6e4186b2d35a"
      unitRef="usd">-231000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i5b066b6520a04587be918ef721ac7343_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTgtMy0xLTEtNzAzNjM_56292884-b8c2-4409-801f-17a55c76a245"
      unitRef="usd">-240000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="iadc106beeb124c7ba342f63d01a137d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTgtNS0xLTEtNzAzNjM_20dfbffc-9271-41d4-8723-8c38359648b9"
      unitRef="usd">-231000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i5b066b6520a04587be918ef721ac7343_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMTgtNy0xLTEtNzAzNjM_16dbbbca-715f-4e3b-82eb-53ea060a14ae"
      unitRef="usd">-240000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i7bc72b35cf17467ea46cbd502a8f690f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjEtMS0xLTEtNzAzNjM_5a59c77f-2c68-4700-aee0-9840498529da"
      unitRef="usd">413000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ib948503264de432899d049dd0575663c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjEtMy0xLTEtNzAzNjM_295170df-00f8-4b7e-9a41-5154f3648446"
      unitRef="usd">534000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ice4c66b286684bc78853a3bcc0e579a8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjEtNS0xLTEtNzAzNjM_da52998f-4955-47b6-83be-b51496612d67"
      unitRef="usd">429000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ia9538c473eb54495b6cdee761ef557a7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjEtNy0xLTEtNzAzNjM_bbc477cf-f71b-435c-b3e4-ae898147639e"
      unitRef="usd">552000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <elv:OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense
      contextRef="iff4c8270a3144c10bdf362046062d8a5_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo4MDhmYWJjNTlhOTE0MDJiODE3MTFjYTJjZDlkMWFiMF81NA_73b47108-e5b0-45c7-88b8-1e612ac68095"
      unitRef="usd">-3000000</elv:OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense>
    <elv:OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense
      contextRef="ideb63a96f5c749ca9094200a8ba2b7e9_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo4MDhmYWJjNTlhOTE0MDJiODE3MTFjYTJjZDlkMWFiMF81OA_426b4382-a3e5-41a3-98e9-15cb7a312976"
      unitRef="usd">-4000000</elv:OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense>
    <elv:OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense
      contextRef="i8a9aee5d11bb47bd9cb89fcdd8efe039_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo4MDhmYWJjNTlhOTE0MDJiODE3MTFjYTJjZDlkMWFiMF82Mg_914dcf5c-5608-4178-8aec-b3d81aa1eaa2"
      unitRef="usd">-9000000</elv:OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense>
    <elv:OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense
      contextRef="iafaf34467ec1493eb045796ec8e537ed_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjo4MDhmYWJjNTlhOTE0MDJiODE3MTFjYTJjZDlkMWFiMF82OQ_b7ecdb34-69b6-48c7-9fbd-09e45a996baa"
      unitRef="usd">-10000000</elv:OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="iff4c8270a3144c10bdf362046062d8a5_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjItMS0xLTEtNzAzNjM_a89e3177-0b3e-4937-8a9a-3cd2830ada3e"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ideb63a96f5c749ca9094200a8ba2b7e9_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjItMy0xLTEtNzAzNjM_67bde13c-f632-47b9-a14f-8034abaa45c3"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i8a9aee5d11bb47bd9cb89fcdd8efe039_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjItNS0xLTEtNzAzNjM_7f3ecc14-f199-4e40-9fb2-ccbda9338511"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="iafaf34467ec1493eb045796ec8e537ed_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjItNy0xLTEtNzAzNjM_a5747902-00c9-433e-a69e-711d254f86ef"
      unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ic7d788695b784dbea530ea0825b12aac_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjMtMS0xLTEtNzAzNjM_69c95ea5-9ebc-4d95-aff8-598eeb53f9f1"
      unitRef="usd">406000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i95f866b9b2ea4f848e8122f80341b0c2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjMtMy0xLTEtNzAzNjM_523fb9cf-072a-43a1-afd7-d44f5536e4ae"
      unitRef="usd">526000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ic7d788695b784dbea530ea0825b12aac_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjMtNS0xLTEtNzAzNjM_4ccbbd30-e3f8-4aaa-abc6-828aed89d70d"
      unitRef="usd">406000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i95f866b9b2ea4f848e8122f80341b0c2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjMtNy0xLTEtNzAzNjM_e407c758-304f-4b5b-b624-1d397262046b"
      unitRef="usd">526000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ie4c04580eba94b4d90b41a5d0c88cc4a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjYtMS0xLTEtNzAzNjM_5426e7bb-6e6a-408f-8f2f-48c217d5804d"
      unitRef="usd">-12000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i834e9db2373b4b68b3452b49ef4aa755_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjYtMy0xLTEtNzAzNjM_75d5b8c7-fd58-4609-a6c9-d1c4c5bebcce"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i8642636cf706437d9a3a0aba479b0966_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjYtNS0xLTEtNzAzNjM_ee771a27-ae7b-4aed-b3a4-4f7568a3a4ad"
      unitRef="usd">-4000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i56f8a70ced554e39b672ce48d8b75303_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjYtNy0xLTEtNzAzNjM_65031597-e424-41bc-b677-a7a457cb336a"
      unitRef="usd">5000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="if3ad1d3b885146b998e9a975d801f76b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpjMjdiYzg5ZmE2ZmQ0N2MzYmQwY2Y5Njk4NTk0M2MzNl81Mg_14b7a8fb-0f9b-4933-92b8-514749eebcd5"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="idf3fd69d4d55450c8e871275758301b5_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpjMjdiYzg5ZmE2ZmQ0N2MzYmQwY2Y5Njk4NTk0M2MzNl81Ng_c8e8bcca-02b8-4438-a760-aa96e7b12a3f"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i967583dc4bba46948e14836718b94da9_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpjMjdiYzg5ZmE2ZmQ0N2MzYmQwY2Y5Njk4NTk0M2MzNl82MA_346b9a6a-2f1a-461c-a0ab-86c14afb3e57"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i54c1ad6c70e943cbb0219aed34cfe0fe_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjctMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjpjMjdiYzg5ZmE2ZmQ0N2MzYmQwY2Y5Njk4NTk0M2MzNl82Nw_9d54a7d9-3c4d-4ca8-9b02-58ff78d64a7c"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if3ad1d3b885146b998e9a975d801f76b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjctMS0xLTEtNzAzNjM_cdf20b98-c3a3-4498-928e-075ec23aa995"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="idf3fd69d4d55450c8e871275758301b5_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjctMy0xLTEtNzAzNjM_e9ff8430-9470-4f9a-a35f-d5eb74403d68"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i967583dc4bba46948e14836718b94da9_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjctNS0xLTEtNzAzNjM_ef268d12-81db-42a4-b043-46c29db4b04d"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i54c1ad6c70e943cbb0219aed34cfe0fe_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjctNy0xLTEtNzAzNjM_2d7c819c-9aec-4a85-acad-27259cee1523"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="iada0e8e50ae7426592cf04d9556323d4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjgtMS0xLTEtNzAzNjM_f869ffb2-f00b-4e00-8bfa-57b0c8675928"
      unitRef="usd">-19000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i472f221347be479aa71a0a08747b91a3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjgtMy0xLTEtNzAzNjM_cabae629-535e-4081-83df-6f315df9d8fe"
      unitRef="usd">-2000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="iada0e8e50ae7426592cf04d9556323d4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjgtNS0xLTEtNzAzNjM_e4ca52b2-3b8d-41e4-a617-bf105f518ed8"
      unitRef="usd">-19000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i472f221347be479aa71a0a08747b91a3_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMjgtNy0xLTEtNzAzNjM_dc737b16-9b0d-4df6-9943-05327301ad80"
      unitRef="usd">-2000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia0a535c1ffe84e6da717792a25f25e09_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzEtMS0xLTEtNzAzNjM_2c0c2655-4a13-4b71-aa3d-032c2471fedf"
      unitRef="usd">-2149000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="idd7bbc6ac8054bf59b507514156a792b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzEtMy0xLTEtNzAzNjM_9dce6dcd-5ffe-46f7-aad0-bb311c0740f9"
      unitRef="usd">-17000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzEtNS0xLTEtNzAzNjM_d4fdefbd-0969-4e7c-b13e-7955b912e583"
      unitRef="usd">-178000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9aceaf2b19bf4d5d916eb0f2039e41de_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzEtNy0xLTEtNzAzNjM_fdf65a54-c255-42a2-a646-bbb6f64056a1"
      unitRef="usd">150000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjoxNmVhZjllZTJhOTk0YWYzOTk5YTZkMGNmMjZkOGExOF83Nw_6ace04a5-f243-4212-85f7-ac8f25b33d0b"
      unitRef="usd">198000000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjoxNmVhZjllZTJhOTk0YWYzOTk5YTZkMGNmMjZkOGExOF84MQ_839b832f-5945-4897-a360-784a393dd4e6"
      unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjoxNmVhZjllZTJhOTk0YWYzOTk5YTZkMGNmMjZkOGExOF84NQ_7f9bf8e2-08d7-48d6-a641-6e76531b3c23"
      unitRef="usd">815000000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzItMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjoxNmVhZjllZTJhOTk0YWYzOTk5YTZkMGNmMjZkOGExOF85Mg_02bed2c0-95eb-4d86-82d3-e6ab633925ba"
      unitRef="usd">81000000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzItMS0xLTEtNzAzNjM_c4c5cca4-9d61-4abf-98e7-dbcbe820d560"
      unitRef="usd">-638000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzItMy0xLTEtNzAzNjM_c23b39ed-643c-4df7-aeeb-b1dcf793fc29"
      unitRef="usd">-87000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzItNS0xLTEtNzAzNjM_b48ec617-7a59-4967-ab9c-a5bba3b91617"
      unitRef="usd">-2617000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzItNy0xLTEtNzAzNjM_47951948-0602-4572-a11a-392d4d78767f"
      unitRef="usd">-254000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzMtMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjplOGY0NzA4ODU5Y2M0NWQ4ODA5NDJmZDBiODgyMDk3YV8xMTg_2cfa2cab-afab-46e0-b4cd-5d548572fb67"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzMtMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjplOGY0NzA4ODU5Y2M0NWQ4ODA5NDJmZDBiODgyMDk3YV8xMjI_477d87e2-ca51-44dc-bddd-2e2ba837bb8f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzMtMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjplOGY0NzA4ODU5Y2M0NWQ4ODA5NDJmZDBiODgyMDk3YV8xMjY_ead5e4b6-2772-4383-93ce-b3d386d51160"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzMtMC0xLTEtNzAzNjMvdGV4dHJlZ2lvbjplOGY0NzA4ODU5Y2M0NWQ4ODA5NDJmZDBiODgyMDk3YV8xMzM_cc409444-547b-42ae-8eef-98125a54743f"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzMtMS0xLTEtNzAzNjM_afcd2d06-ff6a-42d7-853e-aed65125edc6"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzMtMy0xLTEtNzAzNjM_961cf142-4943-41ef-bb21-c1fdb0b19041"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzMtNS0xLTEtNzAzNjM_8f5f4f77-d60c-46a4-a605-adb59006b0b8"
      unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzMtNy0xLTEtNzAzNjM_2e0f9d22-f783-4a3d-9935-ee94a31c5b67"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzQtMS0xLTEtNzAzNjM_81f96198-ca65-4fba-9862-7261bfbe699d"
      unitRef="usd">-2784000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id7580839926f4e24b08f10312dd69479_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzQtMy0xLTEtNzAzNjM_7fb16b73-7205-4f10-b628-d8d4587d9b91"
      unitRef="usd">-103000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzQtNS0xLTEtNzAzNjM_e90771f1-18b4-439d-92eb-3f21308e10b2"
      unitRef="usd">-2784000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id7580839926f4e24b08f10312dd69479_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF83OS9mcmFnOjFjMjcwMGE0MWNlOTRlYmI4MGUxNWE0YTU4OTAwNzk1L3RhYmxlOjU2MWI3NDlmMDc1YjRlNzM4MWNjNTU1YzI2YzM5ZjM4L3RhYmxlcmFuZ2U6NTYxYjc0OWYwNzViNGU3MzgxY2M1NTVjMjZjMzlmMzhfMzQtNy0xLTEtNzAzNjM_2e6be24d-e625-4ba4-8163-97cf44fcf91c"
      unitRef="usd">-103000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfMTI1OA_0c453f6c-9ae3-44f9-b060-f8e685409694">Earnings per Share&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The denominator for basic and diluted earnings per share for the three and nine months ended September&#160;30, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&#160;&lt;br/&gt;&#160;September 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for basic earnings per share &#x2013; weighted-average shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities &#x2013; employee stock options, nonvested restricted stock awards and convertible debentures&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for diluted earnings per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; During the three months ended September 30, 2022 and 2021, weighted-average shares related to certain stock options of 0.5 and 0.0, respectively, were excluded from the denominator for diluted earnings per share because the stock options were anti-dilutive. During the nine months ended September 30, 2022 and 2021, weighted-average shares related to certain stock options of 0.4 and 0.3, respectively, were excluded from each of the denominators for diluted earnings per share because the stock options were anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended September&#160;30, 2022, we issued approximately 0.0 and 0.6 restricted stock units under our stock incentive plans, 0.0 and 0.2 of which vesting is contingent upon us meeting specified annual earnings targets for the three year period of 2022 through 2024. During the three and nine months ended September&#160;30, 2021, we issued approximately 0.1 and 1.0 restricted stock units under our stock incentive plans, 0.0 and 0.3 of which vesting is contingent upon us meeting specified annual earnings targets for the three year period of 2021 through 2023. The contingent restricted stock units have been excluded from the denominators for diluted earnings per share and will be included only if and when the contingency is met.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfMTI1NA_8d80772d-1903-49e7-aee8-666ae521fa11">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The denominator for basic and diluted earnings per share for the three and nine months ended September&#160;30, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&#160;&lt;br/&gt;&#160;September 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for basic earnings per share &#x2013; weighted-average shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities &#x2013; employee stock options, nonvested restricted stock awards and convertible debentures&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for diluted earnings per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfMi0xLTEtMS03MDM2Mw_c896c408-8626-4dec-9592-7693aed0e867"
      unitRef="shares">239600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfMi0zLTEtMS03MDM2Mw_c0534ba6-562b-4017-9973-2973b9559b0c"
      unitRef="shares">243400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfMi01LTEtMS03MDM2Mw_fab7e75e-b9c6-4888-85ba-ee78653e0ada"
      unitRef="shares">240500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfMi03LTEtMS03MDM2Mw_bd43e239-803e-435d-8cef-489f9f1cf53d"
      unitRef="shares">244300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfMy0xLTEtMS03MDM2Mw_35281dd8-3beb-43e3-a38c-4f9fe7c2ddc8"
      unitRef="shares">2600000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfMy0zLTEtMS03MDM2Mw_1e9302dd-b55a-4a4d-87b5-9fc84597b3bd"
      unitRef="shares">2600000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfMy01LTEtMS03MDM2Mw_df575306-da0c-42b4-8cd6-81d52c24ae49"
      unitRef="shares">2800000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfMy03LTEtMS03MDM2Mw_cfe6ea47-23aa-4a76-bdcc-c157f789189b"
      unitRef="shares">2900000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfNC0xLTEtMS03MDM2Mw_b2edbf9b-25cc-425a-b4ec-acab3cd8aef4"
      unitRef="shares">242200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfNC0zLTEtMS03MDM2Mw_fb7cdec8-3adb-4189-aedc-811731c3af4e"
      unitRef="shares">246000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfNC01LTEtMS03MDM2Mw_86aa0b97-6f12-43d2-99e5-67b85e7093cb"
      unitRef="shares">243300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RhYmxlOjgxYWRhMDQ0MGI1YTRlYTU5YjYzODBlYTY3ZTU2YzgzL3RhYmxlcmFuZ2U6ODFhZGEwNDQwYjVhNGVhNTliNjM4MGVhNjdlNTZjODNfNC03LTEtMS03MDM2Mw_75d85813-3ec6-4ca7-b2ca-e680b2a75b04"
      unitRef="shares">247200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfMjIw_9eac0985-07cc-4af3-931f-0322e37c10f2"
      unitRef="shares">500000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfMjI3_9c7d7286-b928-4d12-99a2-988e8308f2b9"
      unitRef="shares">0.0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfNDM5_3f53bb77-12ed-4f63-b1a9-1a0c45151f44"
      unitRef="shares">400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfNDQ2_8373b5ef-f6df-44a3-9750-496c373eae54"
      unitRef="shares">300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="id3126da39a5443229f14991bb4782574_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfNjI3_2133e623-253b-458e-84f3-93f0aa8d4a13"
      unitRef="shares">0.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i2d4742d632984f94b7fd17314cc4c078_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfNjM0_dc109f34-b4c0-4aa6-9c7b-3f962b63328f"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <elv:PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults
      contextRef="id3126da39a5443229f14991bb4782574_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfNjkz_4af02b9e-a2b7-4743-8a08-61847f3d91c1"
      unitRef="shares">0.0</elv:PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults>
    <elv:PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults
      contextRef="i2d4742d632984f94b7fd17314cc4c078_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfNzAw_7270ae75-ad72-4dbc-a090-40a626f0ead2"
      unitRef="shares">200000</elv:PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="if6a892d97bb04fbca567d9781dcbbfb9_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfODcy_d6866995-9643-439f-9013-b3134fe12579"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i973466ad3bf64618843bf4007e0b486f_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfODc5_bb998106-f351-48b9-b1d2-8cd63ab39a74"
      unitRef="shares">1000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <elv:PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults
      contextRef="if6a892d97bb04fbca567d9781dcbbfb9_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfMTY0OTI2NzQ0Mjk5Nw_a398adf6-b9c9-46ae-9d9d-90ab6b2a9a38"
      unitRef="shares">0.0</elv:PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults>
    <elv:PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults
      contextRef="i973466ad3bf64618843bf4007e0b486f_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84NS9mcmFnOmQ5ZTYxMTFhYTk3NDQ2ZDZiNjQ3ZWE0NTA0MmJiYmU1L3RleHRyZWdpb246ZDllNjExMWFhOTc0NDZkNmI2NDdlYTQ1MDQyYmJiZTVfOTQ1_04230005-e4fe-49b2-a2c2-5f32e3bfb141"
      unitRef="shares">300000</elv:PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RleHRyZWdpb246OGExZWFlZDkwMThhNGJjMzk3NDgzZTA4ZDNiN2ViNWNfMzgyMg_ce2f58aa-1bc6-4995-a37d-ccd69832167a">Segment Information&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As discussed in Note 1 &#x201c;Organization&#x201d;, we will be organizing our brand portfolio into three core go-to-market brands over the next several years. Our branding strategy reflects the evolution of our business from a traditional health insurance company to a lifetime, trusted health partner, and given this evolution we are in the process of reviewing and modifying how we will manage our businesses in the future. Currently, there are no changes to our segments associated with this branding strategy. The results of our operations continue to be described through four reportable segments: Commercial &amp;amp; Specialty Business, Government Business, IngenioRx and Other.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Commercial &amp;amp; Specialty Business segment offers plans and services to our Individual, Group risk-based, Group fee-based and BlueCard&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; members. The Commercial &amp;amp; Specialty Business segment offers health products on a full-risk basis; provides a broad array of administrative managed care services to our fee-based customers; and provides a variety of specialty and other insurance products and services such as dental, vision, life, disability and supplemental health insurance benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Government Business segment includes our Medicare and Medicaid businesses, National Government Services, and services provided to the federal government in connection with the FEHB program. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our IngenioRx segment includes our PBM business. IngenioRx markets and offers PBM services to our affiliated health plan customers, as well as to external customers outside of the health plans we own. IngenioRx has a comprehensive PBM services portfolio, which includes services such as formulary management, pharmacy networks, prescription drug database, member services and mail order capabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Other segment includes our Diversified Business Group, now known as Carelon, which is our health services business focused on lowering the cost and improving the quality of healthcare by enabling and creating new care delivery and payment models, with a special emphasis on serving those with complex and chronic conditions. This segment also includes certain eliminations and corporate expenses not allocated to our other reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We define operating revenues to include premium income, product revenue and administrative fees and other revenues. Operating revenues are derived from premiums and fees received, primarily from the sale and administration of health benefits and pharmacy products and services. Operating gain is calculated as total operating revenue less benefit expense, cost of products sold and selling, general and administrative expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Affiliated revenues represent revenues or cost for services provided to our subsidiaries by IngenioRx and Carelon, formerly known as our Diversified Business Group, as well as certain back-office services provided by our international businesses, and are recorded at cost or management&#x2019;s estimate of fair market value. These affiliated revenues are eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial data by reportable segment for the three and nine months ended September&#160;30, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.358%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Commercial&lt;br/&gt;&amp;amp;&#160;Specialty&lt;br/&gt;Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Government&lt;br/&gt;Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;IngenioRx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating revenue - unaffiliated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating revenue - affiliated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,054)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating revenue - unaffiliated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating revenue - affiliated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating revenue - unaffiliated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating revenue - affiliated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating revenue - unaffiliated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating revenue - affiliated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The major product revenues for each of the reportable segments for the three and nine months ended September&#160;30, 2022 and 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&#160;&lt;br/&gt;&#160;September 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Commercial &amp;amp; Specialty Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care products&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care services&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dental/Vision products and services&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Commercial &amp;amp; Specialty Business&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Government Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care products&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care services&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Government Business&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;IngenioRx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy products and services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integrated health services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,054)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total product revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The classification between managed care products and managed care services in the above table primarily distinguishes between the levels of risk assumed. Managed care products represent insurance products where we bear the insurance risk, whereas managed care services represent product offerings where we provide claims adjudication and other administrative services to the customer, but the customer principally bears the insurance risk.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of reportable segments&#x2019; operating revenue to the amounts of total revenues included in our consolidated statements of income for the three and nine months ended September&#160;30, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&#160;&lt;br/&gt;&#160;September 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reportable segments&#x2019; operating revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (losses) gains on financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of income before income tax expense to reportable segments&#x2019; operating gain included in our consolidated statements of income for the three and nine months ended September&#160;30, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&#160;&lt;br/&gt;&#160;September 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,026)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net losses (gains) on financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on extinguishment of debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reportable segments&#x2019; operating gain&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RleHRyZWdpb246OGExZWFlZDkwMThhNGJjMzk3NDgzZTA4ZDNiN2ViNWNfMzI3_f2ad2bb3-ffa6-4783-8963-2cdb19e8b6d9"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RleHRyZWdpb246OGExZWFlZDkwMThhNGJjMzk3NDgzZTA4ZDNiN2ViNWNfMzc5OQ_9a9f7780-c782-49f2-9749-eb4427b47435">&lt;div style="margin-top:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial data by reportable segment for the three and nine months ended September&#160;30, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.358%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Commercial&lt;br/&gt;&amp;amp;&#160;Specialty&lt;br/&gt;Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Government&lt;br/&gt;Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;IngenioRx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating revenue - unaffiliated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating revenue - affiliated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,054)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating revenue - unaffiliated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating revenue - affiliated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating revenue - unaffiliated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating revenue - affiliated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating revenue - unaffiliated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating revenue - affiliated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i613f3949b7024615a0b0e144265e921b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMi0xLTEtMS03MDM2Mw_b4a39223-1092-4b95-a15d-917826106409"
      unitRef="usd">10494000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i5f9be59a634a40b88e6dbcaae7d7deac_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMi0zLTEtMS03MDM2Mw_e9336dc9-b1a9-43a7-b7fd-c0d0ebe5b5dd"
      unitRef="usd">24571000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i78f61d39fc7a4472a65a1d69f1fa77e6_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMi01LTEtMS03MDM2Mw_8b47d9a1-2324-4179-8a41-c0c0fe195a06"
      unitRef="usd">3971000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i0fe4f30315e9486cab1e53788aa7d851_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMi03LTEtMS03MDM2Mw_f73dde25-74ca-41f2-b2da-39474f071d3f"
      unitRef="usd">589000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="idec57493ab1e4934bf922237f912f0b6_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMi0xMS0xLTEtNzAzNjM_fc8bdc9a-2621-4a5b-bb62-b6abb7d46034"
      unitRef="usd">39625000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i8cfa8e1a475a4cdbbb5a9828060b71b3_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMy01LTEtMS03MDM2Mw_9d4afa67-c009-4362-84dc-cb42ab28c42d"
      unitRef="usd">3278000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i32ced2539b8f4d329078b81a982fc92c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMy03LTEtMS03MDM2Mw_71af839c-e0c6-413b-b3a3-4dff5f4649aa"
      unitRef="usd">2776000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i6bd87a9fe9284c9382b2f66c6c0889e0_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMy05LTEtMS03MDM2Mw_8cd6d055-e491-4a14-b950-41f840ae3a53"
      unitRef="usd">-6054000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="id7fc6c71c6004a74ba6b839f6bb3ff09_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMy0xMS0xLTEtNzAzNjM_91b478f2-2603-4616-bb7c-4efe2f7f090e"
      unitRef="usd">0</us-gaap:InsuranceServicesRevenue>
    <us-gaap:OperatingIncomeLoss
      contextRef="id8f86bdb8cf2469aa0b7d726398ab429_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNC0xLTEtMS03MDM2Mw_106720da-575e-42fb-9dac-def0dee833ea"
      unitRef="usd">785000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if830019dcb7d41e7b0f6d3696e6ff1bb_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNC0zLTEtMS03MDM2Mw_fe5737cd-e1de-4512-aebd-d54f8f807247"
      unitRef="usd">868000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id770a0ff048944b9ba5c4f267af241c1_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNC01LTEtMS03MDM2Mw_7c2d0d1b-afe2-4a3d-8719-a8ba6b13d9be"
      unitRef="usd">516000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i40ca534e715147f98238ecf1aaea0e0d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNC03LTEtMS03MDM2Mw_94b5bf32-59f8-410b-81b1-ba1a8c0b0ab9"
      unitRef="usd">101000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNC0xMS0xLTEtNzAzNjM_3df25839-0ca3-4e56-af1a-a6ece19bf8ca"
      unitRef="usd">2270000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i42cb539441714260b2dac721cc7b7385_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNi0xLTEtMS03MDM2Mw_863d453f-3a0b-4713-95e4-744151feabe8"
      unitRef="usd">9863000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="if4396f9c7ead4882afe910b3265d1ae6_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNi0zLTEtMS03MDM2Mw_296db130-3121-4528-9280-ec6120dc25e6"
      unitRef="usd">21658000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ie2b72584a9a44b80a8f513401ff64d97_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNi01LTEtMS03MDM2Mw_12e0e060-898a-4cc6-b17f-bcdc371edd2c"
      unitRef="usd">3369000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i43f1507e8bcc4d748dfbaec841ee2693_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNi03LTEtMS03MDM2Mw_c1eeadae-c2f8-4bdd-ba33-15f45575fb00"
      unitRef="usd">658000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="id4cf254d155841919857d544d09721ab_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNi0xMS0xLTEtNzAzNjM_60f6df4c-8339-4f9c-b165-b38b405719d6"
      unitRef="usd">35548000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ia289890cc9a84272b385fe830e5a181c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNy0xLTEtMS03MDM2Mw_8c2ec926-bf8d-4136-a8e8-f3c8e7f5daeb"
      unitRef="usd">0</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ice278b94888d4092b77546bceeb6bea5_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNy0zLTEtMS03MDM2Mw_3f7c1f47-b1d5-4143-8a34-306303f3774a"
      unitRef="usd">0</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ic31a5ad6faf248238ec05a2850499106_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNy01LTEtMS03MDM2Mw_0c2d4f33-5c12-487a-b573-dffb79dddd4c"
      unitRef="usd">3180000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i535f1617c8544db396ede0c7f1da6d87_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNy03LTEtMS03MDM2Mw_1f420b1a-0944-4d60-a2d5-d9248fad4acf"
      unitRef="usd">2012000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i6493eedb9ee14f9abe78a63b29dc2a76_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNy05LTEtMS03MDM2Mw_f60a85cf-9643-49fb-a7ef-16525dad3ef7"
      unitRef="usd">-5192000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="if3412b5e435444238a5abd7fdd03b86f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfNy0xMS0xLTEtNzAzNjM_fa43fdff-25e8-49e8-99e3-3e866d6e04d2"
      unitRef="usd">0</us-gaap:InsuranceServicesRevenue>
    <us-gaap:OperatingIncomeLoss
      contextRef="iea48a3ae14cb42c597f9265f719b100c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfOC0xLTEtMS03MDM2Mw_d7e306dc-e64d-4d48-9e4c-f4d905c7cb64"
      unitRef="usd">620000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iaa92746fb4df4c01b8d7210e2ae19cf9_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfOC0zLTEtMS03MDM2Mw_503edd46-dec4-4780-a81e-f36159810eb6"
      unitRef="usd">967000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i699414c0bc4847948f60c7721dfe388f_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfOC01LTEtMS03MDM2Mw_046ea395-4db3-465a-973d-cc14307959d8"
      unitRef="usd">445000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i49e4f34abd44464ba18d17589d4817f5_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfOC03LTEtMS03MDM2Mw_ff0e18de-4ece-415b-a7c8-e82e1590b404"
      unitRef="usd">27000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfOC0xMS0xLTEtNzAzNjM_467135b1-31c9-450c-a054-035ed7230383"
      unitRef="usd">2059000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ib642ee435246417986a7c59ac081ac68_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTAtMS0xLTEtNzAzNjM_127b3f21-5f81-445b-98a2-ce8f3f2d1ef9"
      unitRef="usd">31324000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ife47ac82fe0345dc920d78c9e6c54bff_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTAtMy0xLTEtNzAzNjM_141aa1e9-1796-4938-8002-8bcea6e80eac"
      unitRef="usd">72164000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i0b6a789eb76947a58a5f3eb47c31e312_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTAtNS0xLTEtNzAzNjM_cbc6eba2-7fa7-48c2-a6dd-fffe09ed88d1"
      unitRef="usd">10838000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ia0e62d9102304c3abf2cad1b68e9c3f4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTAtNy0xLTEtNzAzNjM_73a55e5f-0a87-4a29-89e9-359a3741b64c"
      unitRef="usd">1667000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i489b1390122443e2bb59851e5a3062fd_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTAtMTEtMS0xLTcwMzYz_e2985efa-64cd-49d8-86d0-22d818db80f3"
      unitRef="usd">115993000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i4f47d7a5179d4dfc97384ed285da7911_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTEtMS0xLTEtNzAzNjM_5408f34c-5c01-45d4-be9e-b16fe001f86f"
      unitRef="usd">0</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i7f08825ff0ad45c9a9bd4fcfbee83337_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTEtMy0xLTEtNzAzNjM_40ade36a-b971-44af-8fa7-46db6c3010c9"
      unitRef="usd">0</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i460716678d6242c19377280954cd4752_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTEtNS0xLTEtNzAzNjM_8a5c411a-a375-4fe1-837e-0498a6a3c74d"
      unitRef="usd">10165000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ie284f26c8937426abf5fb54b5296c8e3_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTEtNy0xLTEtNzAzNjM_0fd6be27-5f87-4257-bc37-6cc43ce3d09d"
      unitRef="usd">8217000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i67ab17589f884d1fbeb85f1ff8c7347b_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTEtOS0xLTEtNzAzNjM_5a14f8c4-4f51-4d65-b2ec-70f7b0f5be03"
      unitRef="usd">-18382000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ia37eef0dbc8c45e3a79a0e793d82369b_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTEtMTEtMS0xLTcwMzYz_172f94b6-6d9a-4ff1-b663-d768126d7e47"
      unitRef="usd">0</us-gaap:InsuranceServicesRevenue>
    <us-gaap:OperatingIncomeLoss
      contextRef="i48ef62bcfeb448e584ac8677641f5a48_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTItMS0xLTEtNzAzNjM_b0bdb1b0-0e5d-46fc-973e-630e403a1a8a"
      unitRef="usd">2673000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iade9083183e24a63a024e8c92ebde4f4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTItMy0xLTEtNzAzNjM_7d34e840-6142-4d20-8338-e628609f91ee"
      unitRef="usd">2653000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i84ba57a42d554362bd86af8887714be2_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTItNS0xLTEtNzAzNjM_7739a287-4575-4e61-821a-d0eed988b790"
      unitRef="usd">1393000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if5a10db4f5de43ae9ca27fb423936d50_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTItNy0xLTEtNzAzNjM_16f6bb53-838c-4c6e-af62-f462fd04beef"
      unitRef="usd">365000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTItMTEtMS0xLTcwMzYz_59f49d5b-3bf5-484d-ad9d-db4fbaef17db"
      unitRef="usd">7084000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ib035444b5f354e3599e287f69135039a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTQtMS0xLTEtNzAzNjM_aa72e87e-4a34-4623-a968-35af8e858e8e"
      unitRef="usd">28904000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i250482f83321476e96b00f0a8172c63f_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTQtMy0xLTEtNzAzNjM_11fcbe7f-7b19-4ee7-8328-c89a8fd2a927"
      unitRef="usd">61007000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ifb6d5e1babc8461ba8510bfa1a69afaf_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTQtNS0xLTEtNzAzNjM_0ae72233-db7a-4f2f-8cd1-b572dc0ee4d9"
      unitRef="usd">9131000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ib01b6477a138483b87a1c6749d60194d_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTQtNy0xLTEtNzAzNjM_499fea51-c13c-4dba-ae42-5880073b8f36"
      unitRef="usd">1883000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i070cb4af0e734e3b97f862746b92ef65_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTQtMTEtMS0xLTcwMzYz_0f3f89d9-9d43-4e3a-aafe-a07793027b3a"
      unitRef="usd">100925000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ie38e2cab8d46445aa0e1d1b6c282a05a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTUtMS0xLTEtNzAzNjM_7a5c2387-912d-4a6f-a29d-28ecf37f8bda"
      unitRef="usd">0</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i09dc82dcd92645758117fe7914de65ad_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTUtMy0xLTEtNzAzNjM_671c2b4e-6466-49b2-86f9-389d92fcb79a"
      unitRef="usd">0</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i42a32ee4b8c040ed9b7f3e8951e03bb9_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTUtNS0xLTEtNzAzNjM_445cf24b-b62b-4aba-9379-e4e101cc2862"
      unitRef="usd">9499000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i4f17939a81c848e68bf70536f100b8f8_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTUtNy0xLTEtNzAzNjM_d4952d35-2cf3-4af0-a367-fb99e4fb78b7"
      unitRef="usd">5674000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="idc176686245540f388bb95d4741dab61_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTUtOS0xLTEtNzAzNjM_46ecfe7b-d7bf-47e3-98ff-92fcca710ffe"
      unitRef="usd">-15173000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i95dfc1da6af04fd08d490195296eb3ed_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTUtMTEtMS0xLTcwMzYz_34d32439-da51-454b-b392-bab2d25a3edb"
      unitRef="usd">0</us-gaap:InsuranceServicesRevenue>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4e811d8b6a8a405db8cfa3af19e8d5e0_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTYtMS0xLTEtNzAzNjM_5d764e68-6b81-483b-9127-45da1c97951d"
      unitRef="usd">2679000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie2afef55df394f80a6083eef46447e0c_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTYtMy0xLTEtNzAzNjM_f67a3991-158c-4992-99c0-c4a389cee017"
      unitRef="usd">2313000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0d3be1d743ba40d2804be36571b03d27_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTYtNS0xLTEtNzAzNjM_444ea983-6141-489f-87f3-75e694acaa39"
      unitRef="usd">1257000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i49ec233198524d05b69059ae1a04c04f_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTYtNy0xLTEtNzAzNjM_9261482d-ad9b-4a20-94f5-0b56acfa67a5"
      unitRef="usd">52000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmEzZGZhZjkyZGY2MzRjMTE4YmFiMDJjMGJhM2IyMmU5L3RhYmxlcmFuZ2U6YTNkZmFmOTJkZjYzNGMxMThiYWIwMmMwYmEzYjIyZTlfMTYtMTEtMS0xLTcwMzYz_b297b808-73f5-41a5-9574-22a82de49c30"
      unitRef="usd">6301000000</us-gaap:OperatingIncomeLoss>
    <elv:MajorProductRevenueBySegmentTableTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RleHRyZWdpb246OGExZWFlZDkwMThhNGJjMzk3NDgzZTA4ZDNiN2ViNWNfMzgxNg_bc333b3b-cb5f-45d2-b48d-8d60ed609ef1">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The major product revenues for each of the reportable segments for the three and nine months ended September&#160;30, 2022 and 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&#160;&lt;br/&gt;&#160;September 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Commercial &amp;amp; Specialty Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care products&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care services&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dental/Vision products and services&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Commercial &amp;amp; Specialty Business&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Government Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care products&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care services&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Government Business&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;IngenioRx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy products and services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integrated health services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,054)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total product revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</elv:MajorProductRevenueBySegmentTableTextBlock>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ie50df0b7e812404f8ac6506d19378156_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMy0xLTEtMS03MDM2Mw_98874036-4634-41df-9084-93b532a38355"
      unitRef="usd">8478000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ief5f8447f8f6441dab988369cb18391b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMy0zLTEtMS03MDM2Mw_79825d50-fb39-448c-ae72-7058f92c19f9"
      unitRef="usd">8005000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i3e22b3359b804b6096c6db064b631db3_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMy01LTEtMS03MDM2Mw_b12e1089-c78e-4b18-88c3-3136096b3879"
      unitRef="usd">25500000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i98a4fbec4a714f71b3cd75ec9f0deb96_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMy03LTEtMS03MDM2Mw_adec0958-8220-432e-b55b-57bdba9139e1"
      unitRef="usd">23481000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i3b41a0ca0abe41f19104d40411fe8b3c_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNC0xLTEtMS03MDM2Mw_68788110-0673-4096-9181-1174ad434cc1"
      unitRef="usd">1610000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i8a10c1e4505b4d6aa5128ba88498d53d_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNC0zLTEtMS03MDM2Mw_b0393e6e-6ad8-4367-94d5-91b2d3494b3a"
      unitRef="usd">1489000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i0bc040a46a814b49b1241f6aaa87b4e7_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNC01LTEtMS03MDM2Mw_5abcd86a-257f-4227-947f-616cdacee24e"
      unitRef="usd">4618000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i2dfb62cf41374a68bb7efc705ab95d1f_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNC03LTEtMS03MDM2Mw_a2b500ba-6e07-4f91-9863-c0a425fd67ab"
      unitRef="usd">4291000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i2be8cfab42284be8ad0db60f8e9c7251_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNS0xLTEtMS03MDM2Mw_31f3a937-0600-47a2-8e0f-f756d02e81da"
      unitRef="usd">360000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ic19125c669154425a6176b41f3b63e4a_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNS0zLTEtMS03MDM2Mw_b8826764-a2da-4b6f-890d-179ac3204481"
      unitRef="usd">342000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ic71d76f1bed042819c52df0907d93ee5_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNS01LTEtMS03MDM2Mw_3b77e2a0-7238-4e69-97e7-bf7ba5c93e75"
      unitRef="usd">1075000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="idf64a53a0693483598a35f9ecae91e19_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNS03LTEtMS03MDM2Mw_33845f01-d4d3-4f89-b4f6-998918c55a4f"
      unitRef="usd">1013000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i5c235873956f485f8766fe1f4a6dfd52_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNi0xLTEtMS03MDM2Mw_f447f72d-028e-4dc8-8060-7a50198e6450"
      unitRef="usd">46000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i47937f7e9daf42b98dfabfafd8f29aec_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNi0zLTEtMS03MDM2Mw_ad54ecd1-fd2e-4258-8b2e-64df84d0f2a2"
      unitRef="usd">27000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ie5b0fcd0d81b45e1972a3219cc11a422_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNi01LTEtMS03MDM2Mw_4074c543-2bb4-4c79-867b-b03ebff7088d"
      unitRef="usd">131000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="iaf7752a749a54daf8ecef7f516fccbbf_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNi03LTEtMS03MDM2Mw_a033da70-19ba-45c8-816d-9cba2c051bdd"
      unitRef="usd">119000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i9adaeacf598a42c3b72b8540b126e10b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNy0xLTEtMS03MDM2Mw_1239adf8-294a-48cd-986b-d8fc3c8ece0c"
      unitRef="usd">10494000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="id7c823f42d7a4c78b75c5623fcf615d7_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNy0zLTEtMS03MDM2Mw_f4518eb7-b915-481c-a676-b3ec95f2f26c"
      unitRef="usd">9863000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i518bf560bf5b42db9717fa1237d56fc5_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNy01LTEtMS03MDM2Mw_93a926b0-4ef8-4bb4-9440-31116e98ef74"
      unitRef="usd">31324000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="id192e31548bb42f29d1bf3d4dbb6cda2_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfNy03LTEtMS03MDM2Mw_3fd70711-4a40-4ad9-a10a-8e21e253444b"
      unitRef="usd">28904000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ifdc016ae937c445185ef3dac290c94cb_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfOS0xLTEtMS03MDM2Mw_12e94e86-cdf7-47a5-bdf6-608eb4727a9d"
      unitRef="usd">24456000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="iad555599326849b4986b0f696e0bc3b6_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfOS0zLTEtMS03MDM2Mw_7b66dd43-8b13-45d4-a31b-b996ed7b7c8e"
      unitRef="usd">21565000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i8d9d03d05fa0487499d5eeb2019e07de_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfOS01LTEtMS03MDM2Mw_9f2dac41-2754-4a07-9ac3-3674defa5c83"
      unitRef="usd">71823000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ib2b81e7a6c124962bb984bd28230e269_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfOS03LTEtMS03MDM2Mw_6ca5f77c-a5bd-411b-bad4-b875f7cac357"
      unitRef="usd">60711000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i0f22558ff60c480a8751522ee586cca6_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTAtMS0xLTEtNzAzNjM_8c251ee6-f8d1-48bd-9d13-9140abf44096"
      unitRef="usd">115000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i18518353f665475a9bb0d0e357886227_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTAtMy0xLTEtNzAzNjM_5f642ed3-4a99-44d9-8eeb-dfc18af98c74"
      unitRef="usd">93000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i3c5f026845034ad7bf3ab1ee5be68a4b_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTAtNS0xLTEtNzAzNjM_8c338e29-4ad4-47fc-b690-5210acb5f1a5"
      unitRef="usd">341000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="iea0bebe050d8402fac705ade0fc21e7a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTAtNy0xLTEtNzAzNjM_36ec4101-354a-4a9e-a125-de0c183096e2"
      unitRef="usd">296000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ice7f613275f549788763308d4be93610_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTEtMS0xLTEtNzAzNjM_d698a2f9-72fe-42e7-8bcc-f13bfbfe8161"
      unitRef="usd">24571000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i757b9a9c9e7e4558a1cd9992f88382fc_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTEtMy0xLTEtNzAzNjM_39b103ac-dbb7-4fc7-af9d-5eb37302f39c"
      unitRef="usd">21658000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i32803f4645204fb0b79a26f39fe31411_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTEtNS0xLTEtNzAzNjM_09078ff1-8c07-4987-b48a-8f0a33566ae4"
      unitRef="usd">72164000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i6b0ea34f1f294d20a310a2ef4c41c0f4_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTEtNy0xLTEtNzAzNjM_c43b8e1e-1a25-4b00-90b4-aa5df78588bd"
      unitRef="usd">61007000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ib1c6d6e169f84a139863b8469ab9d241_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTMtMS0xLTEtNzAzNjM_c3297134-3977-42d7-b0fc-943e389b7dab"
      unitRef="usd">7249000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i9bdd175f0fdb4015821b828ea0c2e286_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTMtMy0xLTEtNzAzNjM_7dfb0ed4-8c31-4fc3-848a-e109ad155faa"
      unitRef="usd">6549000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i94aa51feb4bf48bf9c5bba05c04ac8d2_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTMtNS0xLTEtNzAzNjM_87a8d5f0-bc57-40c8-b101-ffebab4692f4"
      unitRef="usd">21003000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i0f53ea737c1440078ec9ff5e42581227_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTMtNy0xLTEtNzAzNjM_c2eec1ca-640c-40b7-bb0d-a71e9b47f794"
      unitRef="usd">18630000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i3e39237895504dfea4708a360ce4fd9f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTctMS0xLTEtNzAzNjM_d01cc405-5437-4b0b-9a72-58b9aa0b11a9"
      unitRef="usd">3153000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i54804e82cd9d4171953e5f7a0443759d_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTctMy0xLTEtNzAzNjM_ca9c7a4f-69fa-45e1-a621-1edf50e77d11"
      unitRef="usd">2506000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="iaee2f1ec149648168e2cb6bec6fee839_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTctNS0xLTEtNzAzNjM_de540a2a-d71a-4668-a082-fc699244af92"
      unitRef="usd">9083000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ibf128bf301b34428b46cea6538e515e6_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTctNy0xLTEtNzAzNjM_b26e1b70-a0d2-439b-9d48-8ab781496848"
      unitRef="usd">7121000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="icf78127a63ae4e2d9451e2182c5330af_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTgtMS0xLTEtNzAzNjM_e22fe232-e42b-47c4-82f2-6d19b1e57531"
      unitRef="usd">212000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="idfb2059876d84fbfa46eeb173a42357c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTgtMy0xLTEtNzAzNjM_ea1b79e9-9ddd-4681-b7a9-bd64d9cba63d"
      unitRef="usd">164000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="ia4583bb7be664541bff123dc3d369c76_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTgtNS0xLTEtNzAzNjM_56ad7729-db42-4762-80aa-515a9cc685a0"
      unitRef="usd">801000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i667448e355dd40e0bd386f14f3dfe774_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTgtNy0xLTEtNzAzNjM_7aed0823-0228-4896-9fa9-35b43f920945"
      unitRef="usd">436000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="iee58b3e2710246daa6dbe09d63e5064d_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTktMS0xLTEtNzAzNjM_b2b6e602-793b-4498-b585-432687067e10"
      unitRef="usd">3365000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i4ed55d475fdc4a698c26523269fb993b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTktMy0xLTEtNzAzNjM_1e2c01c1-29d8-4d20-9b18-d9fc65b5129d"
      unitRef="usd">2670000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i5866a8bbba704cf588b8904b077bac81_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTktNS0xLTEtNzAzNjM_e9c5e461-2687-464e-8825-14dd0892fd0d"
      unitRef="usd">9884000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i5424e3c2015944248e4c1ead87f81144_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMTktNy0xLTEtNzAzNjM_e969741c-228f-4aa7-87ac-e7b138fabd3a"
      unitRef="usd">7557000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i401e0447e56649b8bf0e2ea99deca4b9_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMjEtMS0xLTEtNzAzNjM_72cb6548-9fd8-411f-a861-eba20ba8f420"
      unitRef="usd">-6054000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i8a4d250516594092a504c84e2ce84ea7_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMjEtMy0xLTEtNzAzNjM_706ea22b-c845-48ab-85ef-695dea9ed3b2"
      unitRef="usd">-5192000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i888bd500cb4e464fa25e8b7832db7c26_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMjEtNS0xLTEtNzAzNjM_ddff832e-cda0-4f3d-9687-f900a4a9856c"
      unitRef="usd">-18382000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i7421e7130f5a434fbc857ff8e1006b5b_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMjEtNy0xLTEtNzAzNjM_54bb59ef-2df9-4b1b-8c8c-44a642566562"
      unitRef="usd">-15173000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMjItMS0xLTEtNzAzNjM_b72c13a9-b7cf-449d-85a3-ad005c8b43ad"
      unitRef="usd">39625000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMjItMy0xLTEtNzAzNjM_f72df800-50b6-49f3-8f51-0f2f13939892"
      unitRef="usd">35548000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMjItNS0xLTEtNzAzNjM_9d90415d-5b11-49ec-9732-f6a28c02f502"
      unitRef="usd">115993000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjJiMWRlNzM0MzRjNTRiMzViN2MyZWQxZTBlOWI4YTBiL3RhYmxlcmFuZ2U6MmIxZGU3MzQzNGM1NGIzNWI3YzJlZDFlMGU5YjhhMGJfMjItNy0xLTEtNzAzNjM_3242af58-4ec8-4134-92cc-ae27fb384cd1"
      unitRef="usd">100925000000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RleHRyZWdpb246OGExZWFlZDkwMThhNGJjMzk3NDgzZTA4ZDNiN2ViNWNfMzgxMQ_5d917cbb-cba1-4820-bfc4-f79b16de887b">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of reportable segments&#x2019; operating revenue to the amounts of total revenues included in our consolidated statements of income for the three and nine months ended September&#160;30, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&#160;&lt;br/&gt;&#160;September 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reportable segments&#x2019; operating revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (losses) gains on financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock>
    <us-gaap:InsuranceServicesRevenue
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfMi0xLTEtMS03MDM2Mw_5986efb3-ff22-4f18-b49d-98a9e875a07d"
      unitRef="usd">39625000000</us-gaap:InsuranceServicesRevenue>
    <elv:OperatingRevenue
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfMi0zLTEtMS03MDM2Mw_cb752263-9ccd-429b-9e06-7c48a50345cd"
      unitRef="usd">35548000000</elv:OperatingRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfMi01LTEtMS03MDM2Mw_7a6b1cd2-f49a-4204-a59b-7cadc393c818"
      unitRef="usd">115993000000</us-gaap:InsuranceServicesRevenue>
    <elv:OperatingRevenue
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfMi03LTEtMS03MDM2Mw_07bdaa2d-9b5f-45c5-9bad-997d456ea07b"
      unitRef="usd">100925000000</elv:OperatingRevenue>
    <us-gaap:NetInvestmentIncome
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfMy0xLTEtMS03MDM2Mw_86dc72f5-f6f3-477e-9c8f-f57bc18990b3"
      unitRef="usd">371000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfMy0zLTEtMS03MDM2Mw_584495f3-5588-4a71-b2b3-bf62efdd25af"
      unitRef="usd">335000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfMy01LTEtMS03MDM2Mw_0b907670-793f-4e91-9912-b7eddfae997d"
      unitRef="usd">1112000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfMy03LTEtMS03MDM2Mw_82dcbb47-948b-4252-81b6-9bf9c2d9a76b"
      unitRef="usd">1026000000</us-gaap:NetInvestmentIncome>
    <elv:NetLossesGainsOnFinancialInstruments
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfNC0xLTEtMS03MDM2Mw_35366142-9fb5-4f8e-a191-41aac40ffe84"
      unitRef="usd">-57000000</elv:NetLossesGainsOnFinancialInstruments>
    <elv:NetLossesGainsOnFinancialInstruments
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfNC0zLTEtMS03MDM2Mw_c4c32e90-c26f-43a2-957a-67849f02131f"
      unitRef="usd">-61000000</elv:NetLossesGainsOnFinancialInstruments>
    <elv:NetLossesGainsOnFinancialInstruments
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfNC01LTEtMS03MDM2Mw_4fc52e99-bef7-4acf-ab17-40f3090564df"
      unitRef="usd">-439000000</elv:NetLossesGainsOnFinancialInstruments>
    <elv:NetLossesGainsOnFinancialInstruments
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfNC03LTEtMS03MDM2Mw_ec82f094-0dc7-4431-879a-78c45563deb3"
      unitRef="usd">107000000</elv:NetLossesGainsOnFinancialInstruments>
    <us-gaap:Revenues
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfNS0xLTEtMS03MDM2Mw_bd390054-ea2a-4a3e-a573-545c21df8275"
      unitRef="usd">39939000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfNS0zLTEtMS03MDM2Mw_6ab6a214-8358-4baf-bf41-1fd1f334509c"
      unitRef="usd">35822000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfNS01LTEtMS03MDM2Mw_8578ac67-c851-401a-babd-a3f5c7baffa6"
      unitRef="usd">116666000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOmViNmU2NmNlOTVhNDQ3NDRiNTdiOGI4ZDg2MmM2OGE3L3RhYmxlcmFuZ2U6ZWI2ZTY2Y2U5NWE0NDc0NGI1N2I4YjhkODYyYzY4YTdfNS03LTEtMS03MDM2Mw_65c4c90b-2e34-46fe-9363-24c4671d787f"
      unitRef="usd">102058000000</us-gaap:Revenues>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RleHRyZWdpb246OGExZWFlZDkwMThhNGJjMzk3NDgzZTA4ZDNiN2ViNWNfMzgxOA_17fefc61-f477-4c8f-ba7c-4983a11cdb1d">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of income before income tax expense to reportable segments&#x2019; operating gain included in our consolidated statements of income for the three and nine months ended September&#160;30, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&#160;&lt;br/&gt;&#160;September 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,026)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net losses (gains) on financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on extinguishment of debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reportable segments&#x2019; operating gain&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfMi0xLTEtMS03MDM2Mw_216d058d-2029-4527-a52f-cdb44c7c94a3"
      unitRef="usd">2146000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfMi0zLTEtMS03MDM2Mw_2f18b6ef-4e2a-4c8a-a3e9-606094ee58c9"
      unitRef="usd">1996000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfMi01LTEtMS03MDM2Mw_21736ce5-d8b9-4684-b3f8-f07b2247ed2b"
      unitRef="usd">6615000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfMi03LTEtMS03MDM2Mw_c57c3953-d3ba-4d13-86c6-c14827570981"
      unitRef="usd">6525000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetInvestmentIncome
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfMy0xLTEtMS03MDM2Mw_4a3849df-0925-4d3d-bd8d-47c11e2f06f1"
      unitRef="usd">371000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfMy0zLTEtMS03MDM2Mw_b5e51100-db8c-4681-aaca-6cda82513d57"
      unitRef="usd">335000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfMy01LTEtMS03MDM2Mw_5c071675-3a72-4ea0-a414-ca09fa22a45a"
      unitRef="usd">1112000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfMy03LTEtMS03MDM2Mw_fe1ad750-df5f-438a-8c83-d620f32f0999"
      unitRef="usd">1026000000</us-gaap:NetInvestmentIncome>
    <elv:NetLossesGainsOnFinancialInstruments
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNC0xLTEtMS03MDM2Mw_318b19f6-f777-4aac-a03f-bf22395c0ae4"
      unitRef="usd">-57000000</elv:NetLossesGainsOnFinancialInstruments>
    <elv:NetLossesGainsOnFinancialInstruments
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNC0zLTEtMS03MDM2Mw_40b1e32a-ff0d-483c-9b94-6b1b624cfbd4"
      unitRef="usd">-61000000</elv:NetLossesGainsOnFinancialInstruments>
    <elv:NetLossesGainsOnFinancialInstruments
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNC01LTEtMS03MDM2Mw_931745bb-2066-4a36-9a84-23241371267a"
      unitRef="usd">-439000000</elv:NetLossesGainsOnFinancialInstruments>
    <elv:NetLossesGainsOnFinancialInstruments
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNC03LTEtMS03MDM2Mw_1d663cca-b5a9-4390-838d-d7af9fc4489a"
      unitRef="usd">107000000</elv:NetLossesGainsOnFinancialInstruments>
    <us-gaap:InterestExpense
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNS0xLTEtMS03MDM2Mw_aa7fd0ae-5b5b-4d0a-9246-480fe879126c"
      unitRef="usd">213000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNS0zLTEtMS03MDM2Mw_7eec7fbb-8cce-4463-91fe-f9c7fabb35a2"
      unitRef="usd">201000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNS01LTEtMS03MDM2Mw_151a3dd9-7264-45e3-bbf4-80dc221e181e"
      unitRef="usd">622000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNS03LTEtMS03MDM2Mw_f41ad372-d010-45e6-abd2-06bfd4cf9870"
      unitRef="usd">598000000</us-gaap:InterestExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNi0xLTEtMS03MDM2Mw_ce66b2db-8770-49c1-9d90-86708745ef6c"
      unitRef="usd">225000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNi0zLTEtMS03MDM2Mw_381a6c95-0bde-4b91-b57d-951862410233"
      unitRef="usd">136000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNi01LTEtMS03MDM2Mw_0e8e2c20-89d3-4ef9-8129-b4f7b3a26e5d"
      unitRef="usd">520000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNi03LTEtMS03MDM2Mw_ea6b3570-efee-4a1a-8225-fef473895280"
      unitRef="usd">306000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNy0xLTEtMS03MDM2Mw_25a372bb-e485-4ecb-b85d-c3db518f3524"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNy0zLTEtMS03MDM2Mw_70d53c08-f459-4d72-b105-89d80d37e236"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNy01LTEtMS03MDM2Mw_a91f2e2f-86cc-4015-98c1-889970192dc4"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfNy03LTEtMS03MDM2Mw_b76f05b8-899f-4c9b-bac3-4111458eac41"
      unitRef="usd">-5000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OperatingIncomeLoss
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfOC0xLTEtMS03MDM2Mw_783414f5-7856-4394-87b4-0a244de66dec"
      unitRef="usd">2270000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfOC0zLTEtMS03MDM2Mw_2e8eb80e-b3d8-4129-b8a0-5620bc1bfe53"
      unitRef="usd">2059000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfOC01LTEtMS03MDM2Mw_f8b391bd-47e7-4e58-b83d-bd96f5b6e543"
      unitRef="usd">7084000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF84OC9mcmFnOjhhMWVhZWQ5MDE4YTRiYzM5NzQ4M2UwOGQzYjdlYjVjL3RhYmxlOjExYTM0YWVlYWUwNDQxYzE5YWNlODc0MTZhZjc3ZGZmL3RhYmxlcmFuZ2U6MTFhMzRhZWVhZTA0NDFjMTlhY2U4NzQxNmFmNzdkZmZfOC03LTEtMS03MDM2Mw_b6bc9056-7907-4177-bcfa-e615dd86b827"
      unitRef="usd">6301000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RleHRyZWdpb246YTkwZTIzZjIxYzliNDY1MGJkNjlmOGJlYTAzMjhkZmRfNjUw_275597c1-22e9-4ca6-8f57-99eaab6128d8">Leases&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We lease office space and certain computer and related equipment using noncancellable operating leases. Our leases have remaining lease terms of 1 year to 12 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The information related to our leases is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.255%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.895%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMi0xLTEtMS03NzQ3Mg_35223446-da43-4885-b1af-792d126f0d02"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMi0xLTEtMS03NzQ3Mg_9be99ce3-7827-4188-b28e-80ce38a6cc7e"&gt;Other noncurrent assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMy0xLTEtMS03NzQ4MQ_3f09f4af-f1d9-4a52-8c2e-e79a525ccc59"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMy0xLTEtMS03NzQ4MQ_ce213197-b1dc-4b00-96f5-82a38cd1810f"&gt;Other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities, noncurrent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfNC0xLTEtMS03NzQ5OQ_3538eea0-82a4-4a60-af7e-b84b7a69ca57"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfNC0xLTEtMS03NzQ5OQ_3bcb0bf3-e902-449c-94d0-fd8995ada510"&gt;Other noncurrent liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&#160;&lt;br/&gt;&#160;September 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lease Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 17.5pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Operating cash paid for amounts included in the measurement of lease liabilities, operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 17.5pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new lease liabilities, operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022 and December&#160;31, 2021, the weighted average remaining lease term of our operating leases was 7 years for each period. The lease liabilities reflect a weighted average discount rate of 2.79% at September&#160;30, 2022 and 2.69% at December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future lease payments for noncancellable operating leases with initial or remaining terms of one year or more are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 (excluding the nine months ended September 30, 2022)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum payments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, we have no new leases which will commence during the fourth quarter of 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="iec40b9c51c114cbc9d3101bef95add9d_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RleHRyZWdpb246YTkwZTIzZjIxYzliNDY1MGJkNjlmOGJlYTAzMjhkZmRfMTYy_75da70db-08b8-452a-9d70-a03551fabdef">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i5a1b6fdf93194651bf7efdc8011a5b9c_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RleHRyZWdpb246YTkwZTIzZjIxYzliNDY1MGJkNjlmOGJlYTAzMjhkZmRfMTcz_4b9af8a2-602d-4429-9bba-c075c8aa221a">P12Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RleHRyZWdpb246YTkwZTIzZjIxYzliNDY1MGJkNjlmOGJlYTAzMjhkZmRfNjU0_f2b173f7-89a7-4e62-bea2-dbed80e7dd02">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The information related to our leases is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.255%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.895%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMi0xLTEtMS03NzQ3Mg_35223446-da43-4885-b1af-792d126f0d02"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMi0xLTEtMS03NzQ3Mg_9be99ce3-7827-4188-b28e-80ce38a6cc7e"&gt;Other noncurrent assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMy0xLTEtMS03NzQ4MQ_3f09f4af-f1d9-4a52-8c2e-e79a525ccc59"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMy0xLTEtMS03NzQ4MQ_ce213197-b1dc-4b00-96f5-82a38cd1810f"&gt;Other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities, noncurrent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfNC0xLTEtMS03NzQ5OQ_3538eea0-82a4-4a60-af7e-b84b7a69ca57"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfNC0xLTEtMS03NzQ5OQ_3bcb0bf3-e902-449c-94d0-fd8995ada510"&gt;Other noncurrent liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&#160;&lt;br/&gt;&#160;September 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lease Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 17.5pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Operating cash paid for amounts included in the measurement of lease liabilities, operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 17.5pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new lease liabilities, operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMi0zLTEtMS03MDM2Mw_ae2cb5f3-97db-433d-9a8f-0d1577f3d281"
      unitRef="usd">600000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMi01LTEtMS03MDM2Mw_88c62eec-91e3-45e7-879e-4b69ecc4b2f8"
      unitRef="usd">628000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMy0zLTEtMS03MDM2Mw_99843c6d-147d-4c48-b27e-67ffcad9838c"
      unitRef="usd">182000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfMy01LTEtMS03MDM2Mw_963c2614-87bf-4bc4-a0a4-786ffcb5478d"
      unitRef="usd">133000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfNC0zLTEtMS03MDM2Mw_d3c23382-7d82-4bb8-a0ac-1d71dadb0058"
      unitRef="usd">739000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmFjOWNjYmViMmMyZDQ1Yzc4ZGYxMWJmNDhkZTQ3Yjk2L3RhYmxlcmFuZ2U6YWM5Y2NiZWIyYzJkNDVjNzhkZjExYmY0OGRlNDdiOTZfNC01LTEtMS03MDM2Mw_3e67ea3d-2ec5-4483-83cc-ca58bad05f17"
      unitRef="usd">864000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseCost
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfMy0yLTEtMS03MDM2Mw_f3c03032-eade-4dc8-b39c-0f6a8fd8aeac"
      unitRef="usd">35000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfMy00LTEtMS03MDM2Mw_3b5e96ea-f4fb-492c-baaa-7204c3764ddf"
      unitRef="usd">37000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfMy02LTEtMS03MDM2Mw_f07304dd-ee26-4d02-aeaa-8c5ab3cdc3f4"
      unitRef="usd">100000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfMy04LTEtMS03MDM2Mw_4e781704-37a2-4a0e-90bb-64426051204f"
      unitRef="usd">100000000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNC0yLTEtMS03MDM2Mw_21278013-ba38-4104-a142-5edefb9a7a3b"
      unitRef="usd">11000000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNC00LTEtMS03MDM2Mw_4c61f3ab-5d50-4e43-a911-eca2193cd09e"
      unitRef="usd">10000000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNC02LTEtMS03MDM2Mw_cd7d1a10-ed9d-4247-bee3-d7ee12534816"
      unitRef="usd">35000000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNC04LTEtMS03MDM2Mw_540f65a4-2afd-4968-b915-faf6769ecf8a"
      unitRef="usd">34000000</us-gaap:ShortTermLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNS0yLTEtMS03MDM2Mw_9208ee3a-58fd-4758-bc33-4ba9f64fb645"
      unitRef="usd">1000000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNS00LTEtMS03MDM2Mw_dde46dbe-56b4-4a0f-8640-d3f438b942d1"
      unitRef="usd">1000000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNS02LTEtMS03MDM2Mw_05e52443-38f0-43c4-9167-b513867fd241"
      unitRef="usd">3000000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNS04LTEtMS03MDM2Mw_562203dc-d425-4854-b24f-77e136eee453"
      unitRef="usd">3000000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNi0yLTEtMS03MDM2Mw_3a2658da-302d-4ea5-bccc-681d2696b616"
      unitRef="usd">45000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNi00LTEtMS03MDM2Mw_2b356442-31d6-4ae6-b34b-b9ee6f45941e"
      unitRef="usd">46000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNi02LTEtMS03MDM2Mw_694b5516-99fb-4a95-b9ca-9ef6a57d790c"
      unitRef="usd">132000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfNi04LTEtMS03MDM2Mw_7b1aa4bf-b217-4446-9921-b7206a4cabe3"
      unitRef="usd">131000000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfOS0yLTEtMS03MDM2Mw_1e8f8349-92c2-4948-9d2b-4ec4f754ee39"
      unitRef="usd">53000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfOS00LTEtMS03MDM2Mw_80cfdc4c-3fe3-4647-90bb-7abfd83a2918"
      unitRef="usd">53000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfOS02LTEtMS03MDM2Mw_d252c468-fb46-40ea-8d27-a91a8a765831"
      unitRef="usd">158000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfOS04LTEtMS03MDM2Mw_7652c9ae-8ceb-4fce-b944-5b4f48733d20"
      unitRef="usd">141000000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfMTAtMi0xLTEtNzAzNjM_17f34311-c61b-49c4-9736-28b273fd45ce"
      unitRef="usd">23000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i426f2bf1d0d14359b48305b709ceb1de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfMTAtNC0xLTEtNzAzNjM_ec9be220-d89c-4f5d-9d6e-121798612c5c"
      unitRef="usd">32000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfMTAtNi0xLTEtNzAzNjM_ec3221a6-4060-43a9-a621-af49c14abb63"
      unitRef="usd">62000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="if6d44bad46794a07a9ca2c7749235648_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOjQ4MzRkZWU2ZWZjMzQ0ZjA4NGEyNzlkN2U0NGRkNmMxL3RhYmxlcmFuZ2U6NDgzNGRlZTZlZmMzNDRmMDg0YTI3OWQ3ZTQ0ZGQ2YzFfMTAtOC0xLTEtNzAzNjM_a3f69101-0592-41cd-aacf-ea291cdaf9f3"
      unitRef="usd">192000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RleHRyZWdpb246YTkwZTIzZjIxYzliNDY1MGJkNjlmOGJlYTAzMjhkZmRfMzI3_46bd73f2-7bb4-423f-9282-299399e680d9">P7Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RleHRyZWdpb246YTkwZTIzZjIxYzliNDY1MGJkNjlmOGJlYTAzMjhkZmRfMzI3_74c64bbf-c16b-4918-9185-2cd6c00e72ea">P7Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RleHRyZWdpb246YTkwZTIzZjIxYzliNDY1MGJkNjlmOGJlYTAzMjhkZmRfNDEz_c39ea7a4-0240-4116-99f6-902effcc47a9"
      unitRef="number">0.0279</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RleHRyZWdpb246YTkwZTIzZjIxYzliNDY1MGJkNjlmOGJlYTAzMjhkZmRfNDI2_61304bf5-5ba4-4570-85fa-3e69c40a8fac"
      unitRef="number">0.0269</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RleHRyZWdpb246YTkwZTIzZjIxYzliNDY1MGJkNjlmOGJlYTAzMjhkZmRfNjU3_572a874c-20f1-42d8-bf59-870c292fdb53">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future lease payments for noncancellable operating leases with initial or remaining terms of one year or more are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 (excluding the nine months ended September 30, 2022)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum payments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmM0NmQ1NzJkMWU5YzQ0NDViOWFhMDExOGMzNGMzMGJjL3RhYmxlcmFuZ2U6YzQ2ZDU3MmQxZTljNDQ0NWI5YWEwMTE4YzM0YzMwYmNfMC0xLTEtMS03MDM2Mw_9c0e789a-059a-4855-8dcf-d782356c6832"
      unitRef="usd">54000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmM0NmQ1NzJkMWU5YzQ0NDViOWFhMDExOGMzNGMzMGJjL3RhYmxlcmFuZ2U6YzQ2ZDU3MmQxZTljNDQ0NWI5YWEwMTE4YzM0YzMwYmNfMS0xLTEtMS03MDM2Mw_5b074386-9e7f-4782-9256-dc9704b6c090"
      unitRef="usd">207000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmM0NmQ1NzJkMWU5YzQ0NDViOWFhMDExOGMzNGMzMGJjL3RhYmxlcmFuZ2U6YzQ2ZDU3MmQxZTljNDQ0NWI5YWEwMTE4YzM0YzMwYmNfMi0xLTEtMS03MDM2Mw_679b58de-73b5-4e3d-828d-ec7ab45a6aab"
      unitRef="usd">179000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmM0NmQ1NzJkMWU5YzQ0NDViOWFhMDExOGMzNGMzMGJjL3RhYmxlcmFuZ2U6YzQ2ZDU3MmQxZTljNDQ0NWI5YWEwMTE4YzM0YzMwYmNfMy0xLTEtMS03MDM2Mw_6000933a-dbcc-41d6-8b18-09ca99b41e2f"
      unitRef="usd">142000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmM0NmQ1NzJkMWU5YzQ0NDViOWFhMDExOGMzNGMzMGJjL3RhYmxlcmFuZ2U6YzQ2ZDU3MmQxZTljNDQ0NWI5YWEwMTE4YzM0YzMwYmNfNC0xLTEtMS03MDM2Mw_01a273ed-d179-4c00-931f-24309d66c713"
      unitRef="usd">105000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmM0NmQ1NzJkMWU5YzQ0NDViOWFhMDExOGMzNGMzMGJjL3RhYmxlcmFuZ2U6YzQ2ZDU3MmQxZTljNDQ0NWI5YWEwMTE4YzM0YzMwYmNfNS0xLTEtMS03MDM2Mw_e01bec86-8f95-4835-b6a5-d06acaf2648e"
      unitRef="usd">345000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmM0NmQ1NzJkMWU5YzQ0NDViOWFhMDExOGMzNGMzMGJjL3RhYmxlcmFuZ2U6YzQ2ZDU3MmQxZTljNDQ0NWI5YWEwMTE4YzM0YzMwYmNfNi0xLTEtMS03MDM2Mw_4f52a5f0-fe97-479a-a595-aae0cb62087b"
      unitRef="usd">1032000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmM0NmQ1NzJkMWU5YzQ0NDViOWFhMDExOGMzNGMzMGJjL3RhYmxlcmFuZ2U6YzQ2ZDU3MmQxZTljNDQ0NWI5YWEwMTE4YzM0YzMwYmNfNy0xLTEtMS03MDM2Mw_a55a7b23-7ab0-4ba0-9bfb-0cd665dacbad"
      unitRef="usd">111000000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85MS9mcmFnOmE5MGUyM2YyMWM5YjQ2NTBiZDY5ZjhiZWEwMzI4ZGZkL3RhYmxlOmM0NmQ1NzJkMWU5YzQ0NDViOWFhMDExOGMzNGMzMGJjL3RhYmxlcmFuZ2U6YzQ2ZDU3MmQxZTljNDQ0NWI5YWEwMTE4YzM0YzMwYmNfOC0xLTEtMS03MDM2Mw_768e024c-58b9-4689-b900-d9dfd00f646d"
      unitRef="usd">921000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RleHRyZWdpb246YTcwZTRiOGE5NmFmNDRiNjgwN2I2YTM2NDcyMGU2NGRfMTAyNg_cf68e8b2-9b0e-496d-9999-bc536461af17">Goodwill and Other Intangible Assets &lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the change in the carrying amount of goodwill for our segments (see Note 15, &#x201c;Segment Information&#x201d;) for 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Commercial &lt;br/&gt;&amp;amp; Specialty&lt;br/&gt;Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Government&lt;br/&gt;Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;IngenioRx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of other intangible assets as of September&#160;30, 2022 and December&#160;31, 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets with finite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,580)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider and hospital relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets with indefinite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blue Cross and Blue Shield and other trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State Medicaid licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2022, we recorded intangible assets related to Integra and also reclassified $308 of trademarks with indefinite lives to intangible assets with finite lives - Other, which relates to our new branding strategy. In addition, the amortization period of certain intangible assets was shortened to align with the anticipated dates the new branding will take place. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets, along with the related accumulated amortization, are removed from the table above at the end of the fiscal year in which they become fully amortized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, the estimated amortization expense for the year ending December 31, 2022 and each of the five succeeding years is as follows: 2022, $748; 2023, $735; 2024, $370; 2025, $311; 2026, $258; and 2027, $219.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RleHRyZWdpb246YTcwZTRiOGE5NmFmNDRiNjgwN2I2YTM2NDcyMGU2NGRfMTAyNw_a5995d36-1b8d-41a3-9730-ca2f24405935">&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the change in the carrying amount of goodwill for our segments (see Note 15, &#x201c;Segment Information&#x201d;) for 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Commercial &lt;br/&gt;&amp;amp; Specialty&lt;br/&gt;Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Government&lt;br/&gt;Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;IngenioRx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ie2c9a53d41b6411c8a7299de747052ee_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfMS0xLTEtMS03MDM2Mw_071898ba-d35a-4325-808d-5040a51d7c9b"
      unitRef="usd">11593000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iea0cd3e6f73d4c37a185721b7213f0fe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfMS0zLTEtMS03MDM2Mw_71092459-d238-4d94-a5ad-d606adc7d8e2"
      unitRef="usd">8331000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0372d0f0be2a4fa7ae88750cdaac34d5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfMS01LTEtMS03MDM2Mw_2a76e617-49a6-4b40-a4cc-3a0a90d4e3e3"
      unitRef="usd">48000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i1007523085804985812acc850dc8d6fe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfMS03LTEtMS03MDM2Mw_ee97e42b-a2a7-434a-8064-ba2791430793"
      unitRef="usd">1719000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9aceaf2b19bf4d5d916eb0f2039e41de_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfMS05LTEtMS03MDM2Mw_aff85def-644f-4f7f-8353-0e13c14f824e"
      unitRef="usd">21691000000</us-gaap:Goodwill>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="i35884d0201ae464ebc6e5b8946fa1612_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfMy0xLTEtMS03MDM2Mw_d17c3a1c-b5fe-4f1b-874d-d73ada873aa8"
      unitRef="usd">0</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="ie530874bee08404db56ee4857d5efd5d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfMy0zLTEtMS03MDM2Mw_c8698768-7cb3-45f3-a441-0f839a99670e"
      unitRef="usd">2018000000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="if6bbcf70f0bb4a6bbd6551b90da88d89_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfMy01LTEtMS03MDM2Mw_9472b322-9644-4048-8d01-1dc925383aa9"
      unitRef="usd">11000000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="i3c94be5ee16a47e7a9596ba6add05232_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfMy03LTEtMS03MDM2Mw_95401610-90ea-47d6-8130-75b4f1fe541b"
      unitRef="usd">508000000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="id593e5d6da124d95ab48675ffd8977c9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfMy05LTEtMS03MDM2Mw_c1e43568-edfd-4fa8-832c-505dfae59349"
      unitRef="usd">2537000000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:Goodwill
      contextRef="ib25ede8a88f9477dbd274859e7a2b1b1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNC0xLTEtMS03MDM2Mw_aa9569c2-0841-43ff-b804-59f8045574a7"
      unitRef="usd">11593000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i1bbc82c5b8774ddc80a06a94578b2a62_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNC0zLTEtMS03MDM2Mw_c9bd1709-f779-42e5-9622-4db3bbbf0e32"
      unitRef="usd">10349000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i14164de3b9fa4fbda3f76ea2a11abc8b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNC01LTEtMS03MDM2Mw_36208eb1-2067-43f8-b5a9-98fb014b79b6"
      unitRef="usd">59000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if7c1d9dfb7814c5da0eb0bcb78535511_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNC03LTEtMS03MDM2Mw_26c6c956-6561-4d75-94e5-6c744b8cc8ff"
      unitRef="usd">2227000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNC05LTEtMS03MDM2Mw_d9a2dd88-a4ec-472b-8d2b-5d99d06f0093"
      unitRef="usd">24228000000</us-gaap:Goodwill>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="i518bf560bf5b42db9717fa1237d56fc5_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNS0xLTEtMS03MDM2Mw_2b81091b-c92d-48a8-abf4-007254f90f6f"
      unitRef="usd">18000000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="i32803f4645204fb0b79a26f39fe31411_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNS0zLTEtMS03MDM2Mw_546dd3af-ea00-49ab-a2bc-1f386b22dab0"
      unitRef="usd">126000000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="i52e3da93e21e46f280c3dae71bf5cb8c_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNS01LTEtMS03MDM2Mw_6c67e236-6886-4840-ac81-06c2d2081228"
      unitRef="usd">0</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="i5866a8bbba704cf588b8904b077bac81_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNS03LTEtMS03MDM2Mw_5546c565-5a3c-44a1-903c-620895f0a451"
      unitRef="usd">9000000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNS05LTEtMS03MDM2Mw_a969910a-96a3-4a13-b2a2-e055bc717f71"
      unitRef="usd">153000000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:Goodwill
      contextRef="i2eef42da7d1c4cd495f66b68093f8dc3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNi0xLTEtMS03MDM2Mw_67e60806-b487-4678-9e57-8408bcdacebe"
      unitRef="usd">11611000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i17f3cb9f8c1d492197e639b5a0369fef_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNi0zLTEtMS03MDM2Mw_9d1f0824-f1a6-431e-a41f-ef61c2c67397"
      unitRef="usd">10475000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4de2ea0a2eff4ca086ad80177a4451f3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNi01LTEtMS03MDM2Mw_f2a1f3df-1d63-415b-9a53-8b03e4b716d0"
      unitRef="usd">59000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id8e9a443d6054bb489dd821a7385bab4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNi03LTEtMS03MDM2Mw_01c63c6d-5f74-43cc-9b48-ed0441d06636"
      unitRef="usd">2236000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNi05LTEtMS03MDM2Mw_5557fe27-565f-44f6-bf78-991b75c984b0"
      unitRef="usd">24381000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i2eef42da7d1c4cd495f66b68093f8dc3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNy0xLTEtMS03MDM2Mw_8cd46395-deed-4dd6-9fc9-2c53aceac60f"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i17f3cb9f8c1d492197e639b5a0369fef_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNy0zLTEtMS03MDM2Mw_c892eae4-9669-445a-aaae-c9d3fc1f9080"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i4de2ea0a2eff4ca086ad80177a4451f3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNy01LTEtMS03MDM2Mw_2c88302d-59a7-4d6b-87bb-cc5c82ffa03d"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="id8e9a443d6054bb489dd821a7385bab4_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNy03LTEtMS03MDM2Mw_6ccb3486-e092-4a2c-ac64-5533d7c0a2e8"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOmUxMjUzMjdjNmI5MzQxOGE5NGY0MWM5MzU2ODRkNjYyL3RhYmxlcmFuZ2U6ZTEyNTMyN2M2YjkzNDE4YTk0ZjQxYzkzNTY4NGQ2NjJfNy05LTEtMS03MDM2Mw_91549032-ac29-4e8c-9bf5-c60a1efc8c1a"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:PresentValueOfFutureInsuranceProfitsTableTextBlock
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RleHRyZWdpb246YTcwZTRiOGE5NmFmNDRiNjgwN2I2YTM2NDcyMGU2NGRfMTAyOA_570572e7-04f3-417a-ae38-98e93aa2f0f0">&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of other intangible assets as of September&#160;30, 2022 and December&#160;31, 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets with finite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,580)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider and hospital relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets with indefinite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blue Cross and Blue Shield and other trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State Medicaid licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PresentValueOfFutureInsuranceProfitsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i13859b3a61354d53ab9916db584893cd_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMy0xLTEtMS03MDM2Mw_b8838171-a3cf-4147-9168-11e33f61a416"
      unitRef="usd">5791000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i13859b3a61354d53ab9916db584893cd_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMy0zLTEtMS03MDM2Mw_006b434d-5b04-4fc2-99bc-4408e2f5cc9f"
      unitRef="usd">3580000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i13859b3a61354d53ab9916db584893cd_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMy01LTEtMS03MDM2Mw_b368faff-8625-485b-b043-f4b6299e8b8e"
      unitRef="usd">2211000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3bc3de5499444f1ba422babbbc5f65b9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMy03LTEtMS03MDM2Mw_ad971d73-88d6-4317-82b0-7fd94b5f2848"
      unitRef="usd">5598000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3bc3de5499444f1ba422babbbc5f65b9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMy05LTEtMS03MDM2Mw_fafbbc98-739d-4404-85a9-5cfff017e0e3"
      unitRef="usd">3236000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3bc3de5499444f1ba422babbbc5f65b9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMy0xMS0xLTEtNzAzNjM_4a67f0db-a04e-444b-b3ba-0b9a0b041a54"
      unitRef="usd">2362000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ibbcb7d1337e04045a0fcd99dc012728f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNC0xLTEtMS03MDM2Mw_bd8caef1-29a9-4bda-8315-9305a6747dad"
      unitRef="usd">326000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ibbcb7d1337e04045a0fcd99dc012728f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNC0zLTEtMS03MDM2Mw_fb57416e-1d7d-48b3-810c-9146f5ae77db"
      unitRef="usd">142000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ibbcb7d1337e04045a0fcd99dc012728f_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNC01LTEtMS03MDM2Mw_962885de-f53a-4682-9f11-c55455ff2e08"
      unitRef="usd">184000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3195b764ef2343888e4fdd71a0e4a7cc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNC03LTEtMS03MDM2Mw_9b4f642d-2182-497f-a0cf-90a3d2621c27"
      unitRef="usd">324000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3195b764ef2343888e4fdd71a0e4a7cc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNC05LTEtMS03MDM2Mw_a845898b-1c96-4842-83b7-2bb266e63947"
      unitRef="usd">129000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3195b764ef2343888e4fdd71a0e4a7cc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNC0xMS0xLTEtNzAzNjM_edb6a1ff-0e6f-4430-b867-5b0d1f4826b2"
      unitRef="usd">195000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4354544bc10d440fa1ec78849d381792_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNS0xLTEtMS03MDM2Mw_fc6c23f7-1141-4a45-8e39-7e87a5fb17b0"
      unitRef="usd">920000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4354544bc10d440fa1ec78849d381792_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNS0zLTEtMS03MDM2Mw_5061ee47-b378-4b40-8bb4-198f83f417e1"
      unitRef="usd">310000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4354544bc10d440fa1ec78849d381792_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNS01LTEtMS03MDM2Mw_9c527ff5-7037-4ba5-9dcf-b48d5d3ae868"
      unitRef="usd">610000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3e8f393fc0344308ba714b6a9bbd73cb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNS03LTEtMS03MDM2Mw_e887d3a3-7828-40c3-80b5-9276aa27e059"
      unitRef="usd">610000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3e8f393fc0344308ba714b6a9bbd73cb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNS05LTEtMS03MDM2Mw_88865904-7493-4dc9-ab03-25bc1b69189c"
      unitRef="usd">141000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3e8f393fc0344308ba714b6a9bbd73cb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNS0xMS0xLTEtNzAzNjM_e81453ea-d6d3-41d7-82c6-11244c6edb3a"
      unitRef="usd">469000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNi0xLTEtMS03MDM2Mw_a5be7e31-08ae-4b89-9727-8e756a96278a"
      unitRef="usd">7037000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNi0zLTEtMS03MDM2Mw_153fe327-50bf-4b57-9bd5-c64a0fae7135"
      unitRef="usd">4032000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNi01LTEtMS03MDM2Mw_00151a0f-a13d-4d03-99bc-db144b1decbf"
      unitRef="usd">3005000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNi03LTEtMS03MDM2Mw_a3c23dda-b9b3-41fa-b76f-73eabd5aa2e6"
      unitRef="usd">6532000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNi05LTEtMS03MDM2Mw_e9f45eed-fb44-4727-82d1-ebb8f701abc5"
      unitRef="usd">3506000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfNi0xMS0xLTEtNzAzNjM_23d0ab1e-2f2e-4874-8035-2c97ee2d2e0d"
      unitRef="usd">3026000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic90c1cc5ab9f4b6093ae613918639e5e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfOC0xLTEtMS03MDM2Mw_b5d95520-abc4-47ee-95dc-930ece771fe9"
      unitRef="usd">5991000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic90c1cc5ab9f4b6093ae613918639e5e_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfOC01LTEtMS03MDM2Mw_65073f21-a795-4066-ab12-e2e922be7e8c"
      unitRef="usd">5991000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="iab7acc5aba584173aa7d2d55cc110fc3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfOC03LTEtMS03MDM2Mw_983ce212-adbd-4906-9187-3dead9f1f7dd"
      unitRef="usd">6299000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="iab7acc5aba584173aa7d2d55cc110fc3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfOC0xMS0xLTEtNzAzNjM_14b4381d-b5e2-4e31-9153-212c650c7d38"
      unitRef="usd">6299000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic300e08f31844af79ab58566cb788e9a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfOS0xLTEtMS03MDM2Mw_b2083c8d-b18c-4b13-8a6a-e6fe88c5c1dd"
      unitRef="usd">1540000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic300e08f31844af79ab58566cb788e9a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfOS01LTEtMS03MDM2Mw_d10e2605-5f27-4d62-addc-d7847c9ead58"
      unitRef="usd">1540000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="icb088b3cd90a4e8a854fa32b4d4e5601_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfOS03LTEtMS03MDM2Mw_962adbc7-76a6-4d33-b4f2-c5d02c9718a2"
      unitRef="usd">1290000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="icb088b3cd90a4e8a854fa32b4d4e5601_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfOS0xMS0xLTEtNzAzNjM_d42a70f3-0e4d-4948-9d2a-7bec49732501"
      unitRef="usd">1290000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMTAtMS0xLTEtNzAzNjM_45fa34b7-441c-452d-a965-dc1ee1c9738f"
      unitRef="usd">7531000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMTAtNS0xLTEtNzAzNjM_5ef9be50-0db1-4500-b01c-6e894902f880"
      unitRef="usd">7531000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMTAtNy0xLTEtNzAzNjM_fdffadbf-793a-4a64-8a92-4882d99e433f"
      unitRef="usd">7589000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMTAtMTEtMS0xLTcwMzYz_9476884a-9538-49e5-b8d1-ea70c3829c5a"
      unitRef="usd">7589000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMTEtMS0xLTEtNzAzNjM_406a2c16-43f7-4767-bb96-bfa8fcb9dcc0"
      unitRef="usd">14568000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <elv:IntangibleAssetsAccumulatedAmortizationExcludingGoodwill
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMTEtMy0xLTEtNzAzNjM_6894edd6-06b9-42e2-ad42-54d199a42b4e"
      unitRef="usd">4032000000</elv:IntangibleAssetsAccumulatedAmortizationExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMTEtNS0xLTEtNzAzNjM_32d8439a-a096-4c43-afc3-fbad3ebe6bc7"
      unitRef="usd">10536000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMTEtNy0xLTEtNzAzNjM_cfaa518e-410f-4023-9840-55b778eb07cb"
      unitRef="usd">14121000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <elv:IntangibleAssetsAccumulatedAmortizationExcludingGoodwill
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMTEtOS0xLTEtNzAzNjM_f72ba793-bd9e-47d4-96d5-78a5d65b294c"
      unitRef="usd">3506000000</elv:IntangibleAssetsAccumulatedAmortizationExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if060cd6ed5574a068397b3bc9ec5ac0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RhYmxlOjU0ODE1NDExN2JiYTQ2YTZhMThiMjJjZGFkOTY4MTY5L3RhYmxlcmFuZ2U6NTQ4MTU0MTE3YmJhNDZhNmExOGIyMmNkYWQ5NjgxNjlfMTEtMTEtMS0xLTcwMzYz_e73ab55f-8a67-485d-8843-38c992d67ce2"
      unitRef="usd">10615000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RleHRyZWdpb246YTcwZTRiOGE5NmFmNDRiNjgwN2I2YTM2NDcyMGU2NGRfMzgy_5e4cf9a1-7df9-49b7-9724-675ada325de5"
      unitRef="usd">308000000</us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease>
    <us-gaap:IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease
      contextRef="i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RleHRyZWdpb246YTcwZTRiOGE5NmFmNDRiNjgwN2I2YTM2NDcyMGU2NGRfMzgy_87347d13-3d3e-4498-bb9d-c524c83b811c"
      unitRef="usd">308000000</us-gaap:IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RleHRyZWdpb246YTcwZTRiOGE5NmFmNDRiNjgwN2I2YTM2NDcyMGU2NGRfOTgw_3248c0fc-f191-42d1-928e-d9b0aa23cb37"
      unitRef="usd">748000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RleHRyZWdpb246YTcwZTRiOGE5NmFmNDRiNjgwN2I2YTM2NDcyMGU2NGRfOTg4_82ae9d2a-7211-434c-9c59-1e21b4424c8d"
      unitRef="usd">735000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RleHRyZWdpb246YTcwZTRiOGE5NmFmNDRiNjgwN2I2YTM2NDcyMGU2NGRfOTk2_400702a8-4701-4583-ba52-74a2066bbb6b"
      unitRef="usd">370000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RleHRyZWdpb246YTcwZTRiOGE5NmFmNDRiNjgwN2I2YTM2NDcyMGU2NGRfMTAwNA_012d2830-bfcb-44ee-83bd-d73c6c8a269b"
      unitRef="usd">311000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RleHRyZWdpb246YTcwZTRiOGE5NmFmNDRiNjgwN2I2YTM2NDcyMGU2NGRfMTAxMg_81a77a31-34e2-44b7-9da6-391fde19334d"
      unitRef="usd">258000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <elv:FiniteLivedIntangibleAssetExpectedAmortizationYearSix
      contextRef="i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4NmUwNTE4NzhmZTQyMTk5NzBlZmM3MmE5ZmNkYWQ0L3NlYzoxODZlMDUxODc4ZmU0MjE5OTcwZWZjNzJhOWZjZGFkNF85Ny9mcmFnOmE3MGU0YjhhOTZhZjQ0YjY4MDdiNmEzNjQ3MjBlNjRkL3RleHRyZWdpb246YTcwZTRiOGE5NmFmNDRiNjgwN2I2YTM2NDcyMGU2NGRfMTAyNA_2bdc7649-e9d0-40d4-a61d-faa87cc052c1"
      unitRef="usd">219000000</elv:FiniteLivedIntangibleAssetExpectedAmortizationYearSix>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>92
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" #'9%-57Q!N/<X%  #R'@  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;+69:W/B-AB%_XJ&=CKM3 B6S"U;P@SQ)@W3;#8;TG2VG7Y0; &>M2U7%I#\
M^[ZRP4XR\@OU+%_ MW.L1Q?KV!IMI/J6+870Y#F.DNR\M=0Z_=#I9/Y2Q#P[
ME:E(X,Q<JIAKV%6+3I8JP8-<%$<=YCC]3LS#I#4>Y<?NU'@D5SH*$W&G2+:*
M8ZY>+D0D-^<MVMH=N \72VT.=,:CE"_$3.@_TCL%>YW2)0ACD62A3(@2\_/6
MA'[P7&8$^16/H=ADK[:)07F2\IO9F0;G+<>42$3"U\:"P]]:>"**C!.4X]^M
M::N\IQ&^WMZY7^7P //$,^')Z,\PT,OSUK!% C'GJTC?R\VUV +UC)\OHRS_
M)9OBVI[3(OXJTS+>BJ$$<9@4__QY6Q&O!&Z=@&T%[)V =FL$[E;@YJ!%R7*L
MCUSS\4C)#5'F:G S&WG=Y&J@"1/3C#.MX&P(.CW^*/T5M(HFDR0@EXD.]0N9
M)D7W,-5<GF^3;,F5R$8=#;<UXHZ_O<5%<0M6<XLS\DDF>IF!?2""M_H.%+<L
M,]N5^8*AAC.1GA+7.2',8<Q2'@^7?_;U*:',)G]3'+>L0C?W<VO\++7V]PU<
M0Z9:Q-D_M@HK#+MV0S-R/V0I]\5Y"X9F)M1:M,8__4#[SJ\VVN]D]H:]6[)W
M,?>J^SR\I,)&BLNIT_YB0T)5#9%Z)5+O,*0O*ZZT4-$+N1>I5-J&AUMIM;)5
MBH>J&N+U2[S^87AW0H72C/F P)/#VGBX4SD,:\<AJF_(.2@Y!P?V3,5ATLF'
M97T[XEYS'F76AD1E#0&')> 0+=0$Z(*<\"KB"QL4KJ^%0F4-H<Y*J+/#6NTJ
MS'P>D:^"*W(%!ZWS#NY5URM154,^ZE3SK?._"+?#L)9QC]T7UX:(BYHROLH4
M%"V4MU+J?2-BSYD]=NTV96V76D%195-05H$RM&3;J=\#6 6@4P@XS^1W\6*%
MQ*T<QZ&TUW?<,RLG*F[*624<BH:('>=5& ERNXJ?A+(2XB8 V*;]0<_>D,=(
M,;2*,10/(EO >[$(,VA*Z+NW/+;WU3U&-Y>/DUOODEQ?3FX>KD_(]-8[M0(?
M(^/0*N10/)J4H=67"B;%/+:>D)F&$4JD(IY<09>&GBT#>RW@[M-;*_(Q<@^M
M@@_%\\H6^8$_DVD (S:<AWX1UY$NC5NZO3:CW=Z ]JR\Q\@_M I %$\M6]Y)
M$(![=K+;(/F[R>?$WJZX)6,.>0S5(DQ"3B9KD=CS+>[2%+P*1A1/-N_!/;,'
MG?I!;A(K-&X'3_60)SR546B;H3U<WI2V2DP4CSGO:<LQ?*?D.DQ\>SOCGC7C
M]QC)B57)B>%1YSWHG<PT3+I_A6GM8VJ/8[?/G*[U \(Q\A.K\A/;DY]R3B5X
M/1AN,'2ML1!7-<6JTA+#(\Z-S /O4B98BMACTC4IHC<86/F.D9)8E9(8'G >
M0@WY2,X)93\__4)FPE\I:$DK).[DR3B&>6FFI?_MA/SHG#J4I!"BUSRR/W%Q
MOZ;D57QB>.J!=^P@3!9D]A(_R<@*O"\V/5JQCA&26!62&!YC=BU(+I_])4\6
MHC85[C&Z_3J[M/(=(Q&Q*A&Q@Q+1[G6M^#R2MR/,(?;7T3V.7ZT?B#U<U92S
M2D+LH"0T3;10Q;J!>17E.W K)^Y8QWF,X,.JX,,."C[F-0TB/,2 A53VQP_N
M<\,5]/6)[PLP IN@L+02'R/\L"K\L(/"SRSF440N5AF<SNS]%O>I_1B&ZQKR
MN57F<0_*/)>Q,*%[07X#![V$6!"G/+$V[1[#6E!<UQ2TBCPNGEAV#;D4T) 8
M'FY3CW>,Z.-6T<<][$/1FWE]EB^HD<\K#4$V,1.HE?@[A9IM/11NO=S-K/&N
MQ\P=#MF@-V2CSOHU9.?5JJ+I?_EB:T9\\VF@6& LCY8+NI-\&;-375ZL!G_B
MIOMF)!)SD#JG [B_*A98BQTMTWR-\DEJ+>-\<REX()2Y ,[/I=2['7.#<IE[
M_!]02P,$%     @ QV135:3X>21Y!P  92$  !@   !X;"]W;W)K<VAE971S
M+W-H965T,BYX;6RM6FUOVS@2_BN$M]B[ YQ:)/7F-C'0IOMR0+L7--?=SXQ,
MQT0ET2O2>;E??T/)MFQQQ+A /B21[.'H&7(XSS-4+A]U\]VLI;3DJ2IK<S59
M6[MY-YN98BTK8=[JC:SAFY5N*F'AMKF?F4TCQ;(=5)4S%D7IK!*JGBPNV\]N
MFL6EWMI2U?*F(69;5:)Y_BA+_7@UH9/]!U_5_=JZ#V:+RXVXE[?2?MO<-' W
M.WA9JDK61NF:-')U-?E WUW'W UH+?Y4\M$<71,7RIW6W]W-OY=7D\@ADJ4L
MK',AX,^#O)9EZ3P!CK]W3B>'9[J!Q]=[[[^VP4,P=\+(:UW^I99V?37))V0I
M5V);VJ_Z\7>Y"RAQ_@I=FO8W>=S91A-2;(W5U6XP(*A4W?T53[N).!I XY$!
M;#> G3N [P:T,S?KD+5A?1)6+"X;_4@:9PW>W$4[-^UHB$;5;AEO;0/?*AAG
M%]>Z-KI42V'EDGP4I:@+26Z=.T,NR+?;3^2?;_Y%WA!5DR^J+&'FS>7,PH/=
M\%FQ>\C'[B%LY"&W<O.6\&A*6,08,OPZ//R3+& X;8?3T^$S"/<0,SO$S%I_
M?"SF;=/(VA)A#(3Y#HNG<Q#C#MS6>F<VHI!7$]@[1C8/<K+X^2>:1N^QZ%[)
MV4FL_! K#WE?7 NS)J)>DL)=R+^WZD&4$#RZBIVKM'7E]O_#(L\S6+"'XVA\
MHSC/HX/1"<KX@#(.HOQ5/4'ZP:;<-LHJ:::0^NT:82@[5\D1 )8D+!W 1*Q2
MEF8XSN2 ,PGB_ 7FSSX3(XL=4 Q?XCV9)A$?P$.,\ISBZ-(#NC2([J:1E=I6
M4%T+"<M\5^+X4N_1:9H/5]DW2M(Q?-D!7Q;$=RO+U<5J6R]AK5_ F'F/YWDV
MG$/?*([H2";F!XQY$.-_[%HV+Z'+?71I0@?H$*,LGN/HY@=T\S/0%2?U"P,X
M]U<OG@]WB&\4ITF, Z11SR=1$.)_M17E&1!W;DXP)JFW3S S2AD;@7E$>S3(
M 9]U?7]A95,!LSU(8RM7$U$JV#EZ)2YX+6^G8??,1X-D@Q3:<C\1:.S,KQ5L
M6"HP(SZV0#UOT3!Q=:G>+0Y #B021Q*)#I,=LV(L&4'9\Q8-$]=- X*Z 4IP
M%.O8=>,2:4IJB5(7]5DIIO-LB-6WXG,Z4CIHSUTT3%Z_:;U\! V' O/YB,4\
M']8TU(RQ? 1:3UPTS%S[Q;:BOE=0=4/+[3,3C1+NK3=FEM*Q!>\IC(8YK$-:
MZ_J,"N?S$Z.9-Z6^%1B-+79/8S3,8UT9#H#SZ8E&//)D%&(WS^)TA&5I3V1T
M?I8&_ZS$G2K;6H17WR A_G#U?25OIVU'SXTLS(U?Y%(5CAU+H2I#-N+920RT
M__!ICR:PU0:K@YGQA([L1]:S(PO2T"[+-] 8%L]K72[AINP7"@5,$<GAJ4K,
M*F$CLI(=]7-A5OM62]'4P!*J+G2%3ZA/4CR+/'R^%:4)'\'7<QD+<]F'HM!;
MT!?[%6_90A1%LP7,\FDC:S,RJSYK@8X;:B34*AO9HJSG-A;FMMNU;FRGD>YT
M \-5?8^CQ'JM9 @2,<I&RC'K.8V%.6U?1C8 U9T*Z54O:,A2WJ$LS! 68T?2
M? <8Z^/F(X69]53'SJ&Z/7N\M*M\%IOS/!XB]:VR?*S58#W5L3#5G2KYEY B
MS1AE^5#:(&8\SO.Q/.CICH7I[O/)HH.JE<8<H.^2 X7MTQNC+,F'L#$SFHR<
M)K">!5FXG_O:D8PA*]V0U194N=Q577(G:[E2%A1Z+S;0"/PV+F?>YD.,HA&)
MSGLZXV$Z^R17$G MB15/Q_DQ*G\Y0E<^6,2*Y=%(BO">T_@YG':DW%[(:.YS
M%<WR869@5FD^PAB\9S0>9K1N[[V$$&F\TGD^I ?,C/*Q#HT?G2R^<+2HJTIU
MC7-WPJAK"Q0AZP+PDI]_RF&+O"=_:"L)I2C^H']<C1%,UKV"H],YZ#F2QT$9
M>[L6C>P4DOE'VP#:9S34(-7^J(Q]+6^G0?>DR\.D>]/L-[ZQNO@^)8_*KO46
M"JUHR(,HMW)*C)L8R(LM?-.H_X'M/B%H%$VC[N?]WDP9XZ20RR+P8Z -7$(F
M'8; ID5%'?<I.AHF?\CD-/Z>PGF8PEWB@];8!7\(FKR)WD8T%/K\QT-G/)]"
MPS5-6=S:L)A.LRR:0@^&SH@O!;SS^Y#)Z8ST4H&'I<*'Y5(YBH6:M1%J>:%J
M4HB-@AJ&@O1%P)RF0_V%6L4CK0WOE0(/*X6OT@KE>@77,HPI6H[P_3R-AL(+
M,\NB? QC+PMX6!9 O["MMF7[3DYW>E%7L)77[O7I@P2):W#8/LU?L,S3BY@9
M4-O(*YQ>#L3GG/R:,RMB[+,\!WD]/![!S-)H[/PA[M5 '%8#?X . +YJ=%FZ
M[:9J$(_2X&<E,=*U#G<58I..S6BO N)S5$!@#I&F%K)T* !0,SIV:A?W B .
M"P!/I+05ZNP$\%\DHB=0B!UV C4[>@?N_@'ABVCN56V@$UC!N.AM!N$WW3O]
M[L;J3?M:_$Y;JZOV<BT%H'8&\/U*@W+9W;@W[8?_K%C\'U!+ P04    " #'
M9%-5%N=JRXP#  #@#   &    'AL+W=O<FMS:&5E=',O<VAE970S+GAM;*V7
M46^C.!#'OXK%K4Z[4K=@2"#I)4C;5-6==)6BC7;WX70/+CC!JK$YVTEZ]^EO
M#)1"(#25-@\!P\S?OQD&CUD<I7K2&:4&/>=<Z*63&5/<N*Y.,IH3?2T+*N#.
M5JJ<&!BJG:L+14E:.N7<]3TO='/"A!,ORFMK%2_DWG FZ%HAO<]SHOZ]I5P>
MEPYV7BY\9;O,V MNO"C(CFZH^5:L%8S<1B5E.16:28$4W2Z=+_AFA2?6H;3X
MSNA1M\Z1#>51RB<[^"-=.IXEHIPFQDH0.!SHBG)NE8#CGUK4:>:TCNWS%_7[
M,G@(YI%HNI+\!TM-MG1F#DKIENRY^2J/O],ZH*G52R37Y3\Z5K8A&"=[;61>
M.P-!SD1U),]U(EH.$.BP@U\[^)<Z!+5#4 9:D95AW1%#XH621Z2L-:C9DS(W
MI3=$PX1]C!NCX"X#/Q.OI-"2LY08FJ);PHE(*-I8.8T^KHFBPF34L(3P3^@S
M^K:Y0Q\_?$(?$!/H@7$.3T(O7 ,@5LY-ZDEOJTG],Y-N:'&- N\*^9[O#[BO
MQMWO: +NN'3'77<7PF]RX#<Y\$N]X!R.@>BA- V26W3/!.2 $8[64K.RU/[Z
M\JB-@H+[>RC42GLRK&W?PAM=D(0N'7C--%4'ZL2__H)#[[>AP'^26"<-09.&
M8$P]OF?/4 /P9NP5Q$WU%2*Y5(;]!U<3J<T5U*.R!3&4A4HZ+*7MTG&(_5G@
MA0OWT YOP&H:3G!CU>&>--R3]W)S6)W*2H9U#B6*ILP@+K4>#:&:9=J"P]X)
M?]\D'&:?-NS3"]@?6NQ<BMUG0U5^FOXAY&F?)\(GS ,V^ QUV%"'/R/C?Y89
M%U*,)#WL5<1ISL<L.O110Q^-TJ^A45  2A&LKLG3%2J(0@?"]W0(,'H3<,RB
M SAK &>C@"N9Y[#L7$)7"47MN:^]TPIXPZC#.&\8Y^]@U!ET"HW(WF12V8H=
M8IWW"G'NU;\3X$LL.]38>VUWWONYF=;[8>9:K8WB![-Y- G]R0GTD.D$1Y$'
MQF>H6TT:OY\:-F7:$)$RL1M$QY>C#YB^@?[:6_%HS^J_;1?52BW:78R'B^4B
MTR[\:T?$XRWQ'/Q(P00]FA[PF$D7]+4%XO$>> [TK1KI-[0>[9A)1>NVMI]V
M[_] U(X)C3C=@H]W'8&SJK;3U<#(HMR1/DH#^]OR-(-/$*JL =S?2FE>!G:3
MVWS4Q/\#4$L#!!0    ( ,=D4U6S\_#OGP8  / >   8    >&PO=V]R:W-H
M965T<R]S:&5E=#0N>&ULK5EM;]LV$/XKA%<4+=#:)/6>)@8:R\,"K%O0K-MG
MQ:)MH9+HB722[=>/E!3+)D],MCD?8KT\=^1S).\>BI>/O/DNMHQ)]%25M;B:
M;*7<7<QF8K5E52:F?,=J]6;-FRJ3ZK;9S,2N85G>&E7EC&(<SJJLJ"?SR_;9
M;3._Y'M9%C6[;9#85U76_'7-2OYX-2&3YP=?B\U6Z@>S^>4NV[ [)K_M;AMU
M-SMXR8N*U:+@-6K8^FKRF5PL::0-6L3O!7L41]=(4[GG_+N^N<FO)ECWB)5L
M);6+3/T\L 4K2^U)]>//WNGDT*8V/+Y^]OYC2UZ1N<\$6_#RCR*7VZM)/$$Y
M6V?[4G[ECS^QGE"@_:UX*=K_Z+'#!LD$K?9"\JHW5CVHBKK[S9[Z0!P9*#^P
M >T-J&G@CQAXO8'WVA;\WL!_;0M!;]!2GW7<V\"EF<SFEPU_1(U&*V_ZHHU^
M:ZWB5=1ZHMS)1KTME)V<+W@M>%GDF60YNI/J1\T"*="O:W13KWC%T$?T[2Y%
M[]Z\1V]04:,O15FJ$1:7,ZF:UTYFJ[ZIZZXI.M*4A[[P6FX%6M8YRP'[U&V?
M..QGBO:!.WWF?DV=#N_8;HH\_ %13"G0G\7KS0E$Y_^UOOS/K9\$PSM,!*_U
MYXWX^\H>6+UGX+AVECYLJ5/9A=AE*W8U4;E*L.:!3>9O?R A_@0%]9S.TG,Z
M6Y[)V4GX_4/X?9?W^6W#JF)?@>'O+,/64B?^A[GG17K./!S'%4!A+PE.4:F-
M2I(@]DY12QL5AR'V#Z@3BL&!8O "19[O5U*5EW:F04P[!\$QAR0RB0(@+S 8
MI#:(X-@G!D\;E1"/PC3# \W02?-SKM)T(623Z1*(UHP)E-4YXG++&A?YT.YR
MXAD]7@"@&&.#O T*@C QN ,@$B<P]^C /7)R_XW+K$1*Q6CR]<;%-@*&.J3&
M=%T J"#P8X.OC2(D2!)S5@,PC).C-D\XQP?.L9/S+TK-%?4#$U)73G6IJR;$
M.+:Y1.;P AC/7,(VAA!B+)(E ,(TA)DF!Z;)BTS?E5P()MZCC1*A BFIMR[J
MK%X5:MS5 ]GL6_T \4^L+GT,(H,_@ F-&*4 QO?,V6V#"(Y@^@0/6@F_8GHW
MCDK9.SB=UHG9NP4$"V(SI:< C)!0_1ED(1RF.(A'"!^)0^(4!<LGM2$1(U3)
M.57!6;VE9_6V/)>WTT&@PR!0YZR[9C5;%Q*Q;C# L:#6!*")?U2P^R #L##T
MS00#P.)096=SUMFP*!A?98,0)4ZAI;8D0B*^1KM.+PBD-BC0=N&Z]W.RBGS/
M3"D BL:)64( 5.+%9E8!4%$\5D#(H/V(6_S=J7VR*I<?T$8-=:-2C-8+V:F.
M<(V^;_7*#X@U^#;*2_S0C(.-(AZAOAD( $;"9$0ZD4$B$K=&O*DE4VO(/=EM
MU4:)9[(%0-BL)  H-)/P$@ %R5AF'40B>4$E5KR1Q=]9^[5$3?9.'1:US.I-
M<5\RE*DR"]=18BLW:@DG $0\:[ !#4BQR=\&>7A$29!!*!*W4OQ9R0BM'MB3
M%HK[0FQ;]:0BD;-["=*VY1LV2;\(25^&+ '(V H?-")QB\1..3!7.87D861J
MV 4$\V)JC2PD$C$.S T0@$N"P/-&^ Y*D;BE8O_MZ)ZM><-Z38QD]N1<U[9F
MH\1,4 L 11*S-J4 *@Q)8+('4,%8.J>#3*1NF7CS*KK4%FW'@>^_0-D@/S&2
M<0J 2&!*ZR6,&B,[2$3J5#_]]F=LS],;GS0:6LD:0@785,, *CC6N#U-&^4G
M$1ZA.8@PZA9AFJ;>^J!W'=GW*).R*>[W,M/96G)4<_6BE@UO:[E.Y6TE Q<[
MM:63F< !2&0&Q(80*QPVYN/(ZJ:#0J-NA7:WS1JV5:J,->+M#S$ET2=4N^>!
M9WU14O,@-CD#J  G)FT;%>#(5*< RD_"$7%*!ZE&?>>.R$T=[501%QH"!L&I
M O_MCNFLWM*S>EN>R]OI( TJDKI5Y'4FBM7KAZ5S%AU7@6EDK4<(9:4H&T3)
ME)A5%X+AZ5C5I8.HI&Y1F1;E7I_CO)IYYRX^X11:JQ)"F3D\!5"*4VPM2Q"&
M1[X[TD%/4K>>3(N'(F=U+EY@'%F1)U-J,890-F,;Y4UC<Z<$HCR3[^SH!*]B
MS:8].A5HQ?>U[,YP#D\/Q[.?VT-)X_DUN5@0X'E*+I;=X>O@OCL+_I(U&_TI
MKV1KU116,W^"FNYXM;N1?->>']YS*7G57FY9IA*@!JCW:\[E\XUNX'#(/?\'
M4$L#!!0    ( ,=D4U4&N-9-H00  +L2   8    >&PO=V]R:W-H965T<R]S
M:&5E=#4N>&ULK5A=D]HV%/TK&B>3V9W)KBUC8R# S"[0:1ZVW<DV[4.G#\(6
MV(TMN9* 37]])=EKL"R<;<(+_N#<*]USCZZN-3U0]H6G& OP7.2$SYQ4B'+B
MNCQ.<8'X+2TQD?]L*"N0D(]LZ_*2891HHR)W?<\;N@7*B#.?ZG>/;#ZE.Y%G
M!#\RP'=%@=C7>YS3P\R!SLN+3]DV%>J%.Y^6:(N?L/A</C+YY#9>DJS A&>4
M (8W,^<.3E8P4 8:\7N&#_SD'JA0UI1^40\?DYGCJ1GA',="N4#RLL<+G.?*
MDYS'/[53IQE3&9[>OWC_20<O@UDCCA<T_R-+1#IS1@Y(\ ;M<O&)'G[&=4"A
M\A?3G.M?<*BPD>^ >,<%+6IC.8,B(]45/==$G!A(/W8#OS;P38/@C,&@-AB\
M=H2@-@A>.T)8&^C0W2IV3=P2"32?,GH 3*&E-W6CV=?6DJ^,**$\"2;_S:2=
MF"\HX33/$B1P IZ$O$@5" [H!BQH(;67*E'L,?A(8EI@< ,^/RW!U=MK\!9D
M!#QD>2[SS:>ND)-1+MVX'OB^&M@_,_  /% B4@Y6),&)Q7[9;S_NL7<E"0T3
M_@L3]WZOPR=<WH*!]Q[XGN];YK-XO3FTA?-CHZ^^>_06&8-&%@/M;W#.WXL2
MS@KAS[LU%TRN\[]LN:^\!W;OJOA->(EB/'.D8X[9'COS=V_@T/M@(_Z2SI:7
M=+:ZD+-6BH(F14&?]_DO<A?)="YL":ALA]I6;1;[.1S"P=3=GQ)K 86>WP8M
MNZ#0"T=MT*H+"L:1UX!: 89-@&&O!G\5*68@;HGO*J><7]=QOP<$:X$*]#RQ
MD1!>4H67=+:\I+/5A9RUDC1LDC3L5>$B162+U5:@<K$CLEG)LW_E7J(2A;F[
ME;V*W$V(1.PQ%WISL:6J&B4\$=#-<# V]&H!C2-#KA:,/QQXAEYMJ%%@UVO4
M4!&]E@I*;F*&DTQH^5)2%]*L*%'&=%FMZ'D%,5%WIM"@Y=N0I05B%(-5%P+M
M?(P:/D;?)PVM"??(0(QX"C:R904I3K;82L.H,SNC3BVZB, @H8LPRU@7 <\4
ML7%#POA_D%!BEM$DB^5-U6HCDH"2RHT4BXQ5&VXL'ZT4C#N3,[2_Z"*, )==
MA&_JP (9VCF WK')]'I9D#V][-AEIG>,81)_!;)S(#Q'U;="\O>N9P'4KEO:
M-0.W8<PE8,6$1O#]@[6C/VFQ86_TMHU,J=\:+;05PI$9KP4U,BNA#>0/862&
M;(.%9VHA](]!^]]L3U20X*K:K*\!$H)EZYU ZQP#0565C&4+SZC\A"!;N40$
MEOO3&1'XG4F&)B==2(>1+@2:)<"".2F5;3*.W33L[03/*N#'.!ET9FHV>!9(
M9UE8(-#DI,]-FY)C]PK[V]??J$ YX"F2C- \P8R_>S/R8?3!H.E\BPN[3>=X
MU&' TN,&9LU;6E!^$)E-@P451-!<*>[)QWB!V5:?@G 9U8Z(Z@.L>=N<M-SI
M\P7C_3V<+*#E_5*=S.B/_Z/[ZECG ;&M:K=RO)%#>;>1S!BK3DJJ!T%+?12P
MID+00M^F&$GR%4#^OZ%4O#RH 9KSJOE_4$L#!!0    ( ,=D4U4623>H#0@
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M3T@ <_@.\BYYR4E\H<Y.1BL]C%9Z=A(;H117Z-7:I'[U&ID,NZI;9@:--6;
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M+;;=QPUG)LU: _/]2@C]?&%_X/ ZT^)_4$L#!!0    ( ,=D4U6[;E33J2
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M9WEH-@'5RH-F+W[U>H%5Z* "U22J*533J&8HS:ZJ)IU0Q-,)_1J/=!<9&D=
MM1FJE0<MMO*U\&>WI\G0.Z,+S($7DW'N?O. A@)030=>PD7B? =IJ"'M';V)
M!13Q6$"?]B3=NSG:2 '59JA6HEJ%:@+5)*HI5-.H9@H_X#(^$;@NFH1 <4X7
MA><<.@(3L\4P]ZYFT+P JI6H5J&:0#6):@K5-*H92K/*:M1$"T:/$ZQ?9\GK
M",T8H-H,U4I4JU!-H)I$-85J&M4,I=FEV&011O$L0I\EKR-_PCTIW%/_R_B
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M]=H_8/?O[U>K[?&'USO_M]7ZUX<QWOP_4$L#!!0    ( ,=D4U7-H4?&.0D
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MX_3%L[5:ZBO=?5R_<_37:=JE,HUNO;%MX?3B^='E[,G+<SS/#_S#Z!N?O2[
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M))JT"9FZY-L, B&U@#2XS<,6>Q>V*T=*::'F_7R3;N=2DG T"@3E3&=4!%<
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M8E*\RJRQ>-- 3SIEY$GP]V?38QR3)=E<Y9T]_;NE:AEY#H/.SSH43I)EO.*
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M@<<K>Q' ][F#4^U&#&R>P]._ 5!+ P04    " #'9%-5+;OVD9$4  !62P
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M<[1IT#%(:FLDH"ES=W&=5W;=BCH^M!C4'=76OA-M6"/_0&<M\'@L,Q%ES,+
M$=FP (QLV72PK$2=<O4@G;?>J)=X.AHM#]3VTX$U&:[W-$;[.5IY[P)0S<!]
MM"JQE^AU%"4<Y4!,<M\JVH^;H+2!,5?G;<XNV.S0Y[D $<O@??Q>&XKHP!:>
M*[#4X+2T77/$7_\@"'(GA2^BG]V)"GS3KIIGOJAKQ\"I/NOS&L81=%H.B:19
M_ L]4^C1*4V\ ]"PX7]KWOY<>?,K WU$@V()RH$I.>%486Z-$91F5]3:W.FJ
M@5M.L>T?.G+1LT;Q7:K 3M&$(#?Z/]<%0$# ".P:;EN,&[*E_M8M8QHXHM'
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M$/TK \7)::'OC1U[=P$[;E$?@AIQTAR*'KC22")"D2I)>=?Y]1V26F5=V$Z
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M^YGRMTJ55&[(4 +TI2R_4S2_J%OQ)\8#\5GEZ-K%-UMCL+D"D8$/^N++X&+
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M$/ZF7;5-9?%52;2O-<DI"43;T1=)B+%]#:^AVZ:FM;:**&%7@#/</:, !$1
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M='9R>D;D(J%MA:&75Y>W%RQ<&2Y>37*4*EL@>J"]/<5K?_W+J[.SD]?\!.E
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MUU>9 ]F#TFX0&Q*#(>T4A4 .0D3A33!C"M$W13P^1E\ L ]]#'Q.P?(<)/B
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M$G2UQMQAJQNR9-+!J3E;+XFX1<SB"#$>L F3HVQ-JRK$S%@A%'&=,!O<P2O
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M[[;E5D)(AH+>Q[?]/,].=^ATU'+UQ39?5!KEIX3.?S^*R'2 ,7K:C91VN)?
M9(F./J_5W^S@Z\R:Q&WTPM8__IO)A])\_N6KI;Z4ELB/WS9L1Z!&$4"*^?:G
M57GQU6;T"\6!6Y[.;GVD?+/4;H5D]=*W^ZYUK66<9!2813E_R<-Q0=@\_%@-
MV;],\ JC7Y.'0*Q'VEJB"IV<)_/JYO):M=YP3+((:1#QWQ_:X.1S9IEN*9K=
MF67ZU6S4_S3N;A"W#0&DJ2:T/0(IQ.UD!HO_^>KTQ>051?$H5_D)2@Y' @/(
M_A<Q+R?&+<GN!:\&!V"@ZIQ6DL5$W2&^D<JUJ2L_,]W&F,%<S& ?/]S^S(3=
MT^#WV)Z_RE$-\T#<N\0\AR^K./2>P1>-#B(*W&V<"RX-VC@[->6=I?/!8=[]
MB),R'>R7DBY(JE8#H]HL2+6A5(3Q K.[%&=V2_$RC5 %/R$.X$7PRB91'!,!
MKZ5$ \4=A%]^NOIQ#M"#?1HP8^DEF,%][VSXM9]%YJ,#85L'GI3BT?TSB$1$
M[!%BYDA3&- =Q:(UIGBB&A&5']V2-(1(SQ3'**ECCL9/!G)'[7A39-77O=1,
M'$=PSL\CAV(26E,M*PI@!D%I,HOLN3XL&G9VE85%XJ!M$=G@2YJ/BEHLQH5S
M'4L>"AI)E*GE](',D$*1#<B$S?M!Z$*AF\1V-I(L/.Z'I@<[=])T;Q@&I7:8
MST79=$>'=SFJPT 3)+]M4'1+R-IVJ &8;.+H;R#=0\68AG-/%)F1U>.QO<D.
M(SVO!IOBFE9?_TXA. :L:UIC*2T\+C#ZYA(:@R\F+[\^']CR#8]]<8.=VY)[
M-SL,J;X6)S^RVB'(@'"E=IR/),;;B#T3I.3&^4U!N)-1"0)ET:1%@9],8*UE
M(R-S@AD']"8K9G@4)B&))T@*M @3DF?2N- "E#'H0C)V#E1J[BR$GFX^BP$<
M$WY!EGC-7&&D(3XJW9_NLO,SHL.L(K2W.7;V*#M"$T 0K&WVU0&>/!J0?=Q=
MR;/8LWZ?U1 "2CBQAW;\JXR7:%OY\T4\3A<=';!?D=W$>X"RZ^UB^XW3:-H7
M3DC%T:%1O$U(VO83W$[GQ?*TCQ3[[ST1S^ ,RP>#,BNR!!SI5:<G1W_G8AUD
M^#$L_81_4Q]B@62=6BJW4DH*4RJ>&"S?GZ%4(WG%=GQWA$Q$<2=.J<U:-'MT
M_Y#,^G&RQQ(;F[J5)*9D8"F#K[F* _HDFA_DYZ[P"\QJNR_V]E$VI_+:D0;N
M02GP7J5 /XZ=2FDHB^#7O4..R0XS.4D?UX?@>F#$OKQ^NUN]C5E""O4_5="]
M-C@920M]L.V=NBAA^!Y)%T*B*.'WH#+P"[V)8E-(#MZ^_R56L@+G"WMOJ]TD
M@WPO#]-(<2$D&?/CNV,]R N>_6>C__CE_C1 BL4HKF=IRG X9=BI4-[,R<8Y
M?Y1]\@@WPK05AKI\U68IIS2#0Y[KJL4!H70.C86L*'KN/H8CJ%8OZJ;%<4[=
M:;R7)J*\$[YBMRQ.,7(7TB<?;)GJ-K&Z=WV;6(7C4R0+1SK)0BRR2EP3H=[
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M<J].)O IPZY<;#@\L;A_0O&(G34(W;J#FW7K,X^CI \Z@G-'B;QCA8<!03#
M4,16% N(;RK9:82'V+G1@#9'.S!OV$4G4A>4,%<B55#)/5^&L+F7=Z1%DYD,
MCF+7%/=0S1](B2X6[5/B5U[69%<R#0OO.2+/XE'OM?WZ(HZ20_8"]$?L#/F<
ML_BHX51#7$OGWI+)'K)?:Y1&2[53Z?%*,GY$/OL[5L4[JV9AH6=5W+<J)O[Q
M&/R3^3Q8E;2<.E:%MSUDA]ZJEFJG4OQX*7BE2S]C'TOV$<GF2 Z]V4.7:6>
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MQN'[TX"9X0$X=)QN_:-KI1T^X7RSQC<S&#+ ^4IKM^O0 N,K?/DW4$L#!!0
M   ( ,=D4U70$!M?6@L  #T?   9    >&PO=V]R:W-H965T<R]S:&5E=#(R
M+GAM;-59VW+<-A+]%=3$E9*K:(GW&5JVJBPGV;AJ[;CL;/*PM0\8$C.#F"0F
M *FQ\O5[&@ Y'(M2Y&Q>]H57H-&7TZ<;Y(N#TI_,3HB.?6[JUKQ<[+IN__SB
MPI0[T7!SKO:BQ9N-T@WO<*NW%V:O!:_LI*:^B,,POVBX;!=7+^RS]_KJA>J[
M6K;BO6:F;QJN;Z]%K0XO%]%B>/!!;G<=/;BX>K'G6_%1=/_:O]>XNQBE5+(1
MK9&J95IL7BY>1<^O4QIO!_PBQ<%,KAE9LE;J$]V\J5XN0E)(U*+L2 +'Z4:\
M%G5-@J#&[U[F8ER2)DZO!^D_6-MARYH;\5K5O\JJV[U<K!:L$AO>U]T'=?A1
M>'LRDE>JVM@C.[BQ<;%@96\ZU?C)T*"1K3OSS]X/DPFK\)X)L9\06[W=0E;+
M[WC'KUYH=6":1D,:75A3[6PH)UL*RL=.XZW$O.[JH]C"Q1U[T[H PU,O+CH(
MIM<7I1=R[83$]P@IV%O5=CO#OF\K49W.OX!"HU;QH-5U_*# CV)_SI(P8'$8
MQP_(2T8K$RLO^1,K/XB]TIULM^S?K]:FT\#$?^;,==+2>6F4)\_-GI?BY0*)
M8(2^$8NK;[^)\O#R 5W34=?T(>F/C<B#0N95G)',7AE620.@&5$QV;)WJA,L
M8M]^LXKC\/(GO>6M_,,.M8^BRX =!#!:UVPMF'+OR:&J1WIHWE:,7+Q1M520
MURG6[;00K%1:L*UZUJEG2/Y/8!L[V#!U(S3&"-:*SQTS K>\9K>":W/.?AJ$
MT@H4KTYL;XD+**F-G29N5-U;4]3&*=$;.,,8MM&J89QA5B5I ,3N!*^['?0R
M/:26I%:SY^TM@YZ<U7(C.C!.@#G(/#C$C]]SW;5"!XS,VX)%6BPMS61M^(3#
M0-E:G?9:E:0!--+B!D1"ZM/<1E5R<TMW.X!B<&3#6_#?B?+"#+(V?==K<<Y>
M]UHC>/5M0(^U6Z]5K-SQ=HOAL( $&!=CP[@QJI2<K#A(V& 5ON/+<_8SU@!"
M0&)F\" 87]N0&_BG1;KT@L0CWI4PI99KR$145;_=L0U-T#:M^+H6X_K/V6O5
M-$)#A9I]RYO])?NX%W37W;)K;V7 _D'A;RTJCP_?P*!6J@^?K<]^(G,=%!XA
M<E  MFR$-FQ?<YA!<B@)9'GTU!MXXD96/:^A!HS9,RW-IV=$\=7P9".$>V E
M7->]>,UUA>R(ENDE:T2S%@13\N%?T&U EU953W"F(H5XU_4STH2*C327]!IJ
M0F^.\"D.5;3FMQ0K7J$@2!M*8-+#J&(E(>-+:X^6N**"]2^M41/Q-UQ+T5G1
M9E2>QB@*P21K1HU/_&KZ<@?8 21M1TZ]D52Y YM6 ;$,7\M:>I&FW^]KT=BA
M=]-R+5JQD9UG@!F0C*Z4;5GWI#X9^594TEI/*[@;64UR*F#ON&>"B<R/WH#@
MU!SOF(I9#D,BBLI2T_8X$RF*!&E]@^'33+ ?OO_QFJ9O-6^<!4=$S^K]_OKM
MJ.7Y9+!C2N=FCQD:^F5L^68#Q_(I80'UQT '%)4#&A\Z8PZ(%A; E'$$Q'0&
MQE+HR8*)&)K)U*&=ZK7C!!?B3BUVU* !?2>*C24 U6(GR]W1W#MHH5+4U^@'
M/7[).P';[S@J5'F+JM#9!A6/M"6?O?5UI?LMJ]#P$*8#GXE'X99KN:Q1H! T
M9,3>84\*#RE+*O/!^ [6:",W$NX<X6;I( #?'M@G'%K2'%2 GK8=3733O>M&
M58[E2,'=D GMT0D+331,OBZ5Z:S"LK&0\X]_!S%)EXQ.I 7V^I:)%D0[%)02
MC;CM9UKTOW9$)6HRP&79GM]: U%W1 T?6HCR(;N9:.!G(RWS6(7MVLH(-Y "
M7 O'PB7XOI4EX=U54TM[\IB(O#;JZ,A2H!X@/: ,.,H7$RM':8 #6 4*L;&@
M0M<JFEVKTB+88]I1SDQA.6>_DI$;.'4H5- :95:@3%EX>R4(,(WL&[I75-0]
M:PUCK3I?4"A8TDP8;Y *S-Q=R3E;8UKE6@V_GA-@)6E1"GI/:TLDLZQOW5 *
ML.'U71U<&^,Q-+"@"^60$;/D.]5P2XY'9$I>E\@L<JK->V+:.QYC-6'3KS3$
M)'"@A";C8D;5E5^Q)O0%#&1@^7#&C5[,.7MU9*;1;X@I=:1M=WRDM%L07##/
MO[:SZ=>@*$DURE >G'8)8S(2GP@-1X]Y^F=)/2'' ;9K7GYZ!L:%(C,*87&2
MB>Z6:-07E&F5L2[1U%>51$"XZ;Q']83EJ*&.EI=H(PVZ3DH).'S#I?:\CWJ,
MAL-V%\A(/N-*6F/(,->^(ST1*5E9K<[9#WC3VE0GKB3%[V:4]3H!TC7JI'M+
MR=6X+9V@+1UJY+YS'#OLRNQ 7$0$-<OC2.'#:=\W*;+':#GJ_7Y*##];;/YL
MUY_N).>6O9.)[!GKVXEWGK H#-(BQ46<!MDRPD42%/:<K0H<K>/C2WI>!'F<
MS<J<2!S&#^<DB)<K%@?+9<[.\B#,TJ?CNR_2<+G*V"I?L2S*H58T#HLA(GR4
MQ=%C+"Z"59Z0P5&09RMK<)*3J>YN8G 69.GJZPV.5B%T#J.8G65!5,3W&IS'
M(2OR)4O3C,7+B;UA5K!WA*N_(<!)%"0Q!7@9!U&>NI"O$C(5#L#J4Y.C* N*
M(OE:FR$QRA&\ #G*SJ)5D*SNMSH.\F5"QRR!!@E62S!W&+P,PE7Z&.,?%>MX
M%10AV9Q'01@N;?2C)+*VKU;)J>UA&!1?#_ "^5.P#$:E,!T!7R8/FE[@F$1D
M>IPM61:/8_,@ >AI>]3PWT S7Y1@V_TQP=$]^<9SIN#_S_QD-P03@IK)NKNQ
ML2+L]./58[9X;Z>;L+%Z/@&.TN7*GL,PHR@B$<.0+I(@746G\\:2 S1'(8XI
M>"O%]0K'N(C8=W;?=/&+W6'=LQU+\I E:8S9X3*C(P+DN#?-*34),U%4>/)]
MC&V>5QW9^!ST:)S;HLV[ IR<9CDQ588460*S<<+R,%A&]SHARAAE5(I8%+G7
M=VY!3_>>!#TW^"PYUI_W#S922-8X+0#<#,>8Y@+6JR!/0N^\-ZCZ6SW=;!T]
M'D09L4 6YG!2B%Q<!A$EM9V(A&"DT H9D2:#'>X=T75F4RDD]X(MED&&5#JI
MDB<W0]T9Z'ADJ#%?G?P[&3<6O;$8'"GR2!B4LF7-#;5,I>M+U]B)"=&>?F8X
M\>'\!PC_'8NO$3'F4OO8#5=H&D$EO30[ZNK\$C2^AL*U^X1&'T.@2M^(ZOP>
M5!V;RIFO% ?[O>Q GQ6XHY+C(!(>N!'@B'D+CL(';]K-./2>R/;=(7E-TAZ@
M^JVO!M<==Q1?-,K3G;S="_H->8!VLCMY0CY#)[?'1NG6VF%F#$'#;7M.#"1F
M][N)&4[UK>?,=L KPAO5M^Z+H-LXC/CQNRO;;5(7?.PX\<QT.#G6QDRW\?J[
M^\N_3-\?OL8/CTN3=X( =X,&?OB.0 8G(*$D(<Z-(LN_<6Y'GM6*]@=/;>&T
MF^[-V)_C0:=[Y[JS;(D\SB,<TJ1XBM66/IM/L[A("J?>"B:2>CF:G]RJ1_W6
M:A8-7L>UV"C[P=K>=?SSL&DC!#P*,6Z;^7^+AC=_Y@>4YB!*K3L1=3K#O5%F
MS]F]L3]#\!$WA)^HF !@SX# 4SO#08"=60@\O1\#(/^<ZD2!V2'@0&4')#1N
MT5%.4&I02G(8E!6(=4-_MOX8XSQ\L^UXNY4423 H?4N,H7J$\I.A44]0J/ZI
MC(6B^#P0L?]$S2JQ[NZTAL,Y>UPZ69 \\=N=)WX;\,1WQ$]\?SCWT^QB\DL3
M]+>U/V[I?P1HR?W=')^._X9?N5^BQ^'NQ_);KK>4;[788&IXOLP68$O[L];=
M=&IO?Y"N50>NM9<H[970- #O-TIUPPTM,/XQO_HO4$L#!!0    ( ,=D4U4D
M:!,1CP0  .L*   9    >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;(U6VV[C
M-A#]E8&:%KN 8UN2KZEM(-D+MD"V"=;;[D/1!UH:6<1*HD)2<?+WG2'E2]:.
MNP^F*7(N9X9GAIQME/YN<D0+3V51F7F06UM?]7HFR;$4IJMJK&@G4[H4EC[U
MNF=JC2)U2F71B_K]4:\4L@H6,[=VKQ<SU=A"5GBOP31E*?3S#19J,P_"8+OP
M1:YSRPN]Q:P6:URB_:N^U_35VUE)98F5D:H"C=D\N ZO;@8L[P3^EK@Q!W/@
M2%9*?>>//])YT&= 6&!BV8*@OT=\AT7!A@C&0VLSV+EDQ</YUOI'%SO%LA(&
MWZGBFTQM/@\F :28B::P7]3F$[;Q#-E>H@KC1MAXV9"$D\985;;*A*"4E?\7
M3VT>#A0F_5<4HE8A<KB](X?RO;!B,=-J YJER1I/7*A.F\#)B@]E:37M2M*S
MBUNDD,RL9\D6K_225N_&ZT6OZ$WALZIL;N!#E6+Z4K]'&'9 HBV0F^BLP276
M78C['8CZ473&7KP++';VXK.!P3_7*V,UG?V_IV+T)@:G37 ]7)E:)#@/B/ &
M]2,&B]]^"4?]W\\ '.P #LY9/Y/YG]&#;P@%ST!EF4P0'% 050H):DO5"(DJ
MZ\:B=HL:"V$Q!7QH9$U%9:$QLEI#I:I$5 E5A5@59*Q&+2QO...F"W>-;N>0
MBT<D0USJ.PD@!Z4A$!#",PH-5D$8N2DI?\T19.5;AZ]BCX*$U-ZN-" ,9*J@
M#F&NX$84C B6KBG=JL3K$D$LEBN*9\L2>(])NQ*ZE1#N=OC;-+DN<ZFRRX:P
M"F/0&KBS.>EPY(W6G(IV_0)&_3Z/T<2K0R'%2A;22C0=V$I[]>W7@0B$DPC"
M.#ZE?.#MR/VAB7$\A<EH0)G3B"]J#/XD(KQ<<4EP<>]GWO>')^K:]'_W\CP!
MV_4+B(<\C&D(7= \+G.E[26?Z _B84C[K!(/8-FL_*:LB&$(;\*W_A?[WU=E
M17'D;L#N!B-V%$=N#-M$'/)C#S<1)H=:R)1X00PN55/1"9'+HN'(B=ZD#"5Y
M:8B1G$6B8'&<]Q\)3:Z'\78(AQ,>!^%)FJ@5EY%WAD])+JHU.C05W34_YRIB
M+R[>D0MZ&L&U*Y839.8J/2)TQX6Y<7<+(:$"U'15GBQ"-LM%=01C0\4U]A7I
MX*-(*+6HI4I]A1[%PK<M7YL@CEVGTB1\&$!.N/E U!U/?P5A7XLIZH[\_E%P
M7?C86#J^%D MGOD@/<C_Z4MT2]J<#H;@$ME(?I^174-25"ZN)=%VJ<B-X-]!
MHW$0W]#1$J><)N6BXB(K?9&A*[+CL-XR?P8\C6D8\V0 X7C*DR'1R57BB"IF
MR.FEIU+&73BF$O"UD?FHZ3:795/NXPX[?>+*+1HBNFO=3#U216.IPL+P96T=
MGM<%3*GT7Z-6AT[1-^]*[<E+.<PE,6$CBX+O"L) 33=M]#85&;&)DOS0",WX
M^:C)6/?4U=<[>("4J-?NF67 $<6_17:KNY?<M7_ [,7],_"ST&M9&<*8D6J_
M.QX&H/W3RG]85;OGS$I9>ARY:4ZO4=0L0/N94G;[P0YV[]O%?U!+ P04
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M!EGN;FR(F2NJS-41GD7Q^I[#?#C+HXQ=]9HZ)[71%ELS:_QH!1JM>Y(U8"O
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M#'B^4/B2&0@RL/F]=?8_4$L#!!0    ( ,=D4U4OI?4^6A8  ")(   9
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M(K@WB746.C<N-*>E-F(NM3^9\H?W=![%!]_%AM.ZA9+.MF<F^B.C;.Q\=?5
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M2F=C[B3339J1PT?ND.[P#:;D?%+8.KZ#\3=>B7W='TZ^.WO9\OWLIP$XC/:
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M<$N^%(:G?8(K/YZ2:ZZ71/Q92E#-VO6&!$XT\>'^\T\QH^R7C5+U[KU\!*.
M'DHES1/1:(JUV"'\GLL48^H$_'*B0>@I^9I+ ^WO##?@E%^+>Z%R=&*G8S,$
M=0(_WJIU>ZR*7!?HTIZ^(>T6 2U 3SE9#([' KI1KI1T2%;F,I$K7L\DSL.J
MP$H"_M3E=";O)9(T-#7\\40\BFQE&DF^X\9TJW9=J%6A0'JOV<QQHPG<\'*8
M&P.*M9R!TA+&RPIE%K!<G$QY\JW?=M]A?K15NRZR3*CD0 F1VRU^-$N 2T\S
MS_$B"E"$RPEC5B-L_A)$=!SN1&"J[[N$A0Z%J;X!)&[T/R4WC\F2YPM!@+6
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MP8BHZ@2\JIAB94^=IX4Q16:+2\%G0F$#>#\OP/JZ@@,T_PWAXC]02P,$%
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MD,"'>K"/T2!&? :VG'45XC-B5$!<@NH(119B%#4=PJ4O+/>*T0SZ9,!'A9Y
M!A)3\1EX,2HFG(1>$EM]8W07%+%)Y'$_83NH+!ZI+-Z3RJY7X%$*?7?GB1?J
M?8%QN>F)SW\)NQ/3/F1'&*;K4OK"4KGJJ*]W;)6/&)AC=P;\6Y&TW;[NZ%ZW
M O*1F&&^_8CA4<R152>2Y=Z-Z?.[@(/^)=GCUU._SZNRJZ:%@Y"6M'EM[^2V
M*&VM_Q2#_PQS!#Q]\_P;7[:!W,)T\V6;",5D'!QO?$."66_LES(J.KO&N,])
MX]WQ8]RY^P;U9;C[DH>,AU*_995<8JI_E*!6T^[KF+LP:FV_2,V5,:JVIRB-
M"ZEI )XOE3+#!2TP?J(\^Q]02P,$%     @ QV135=<*G\JI @  _@4  !D
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M)-?-!Z[FQNJ%^Z@TTM;JTEW"YF&B:AP _T^UMJL;7*#]RCC\%U!+ P04
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MBQ%R4[I>S E:-+;_60F-%6J'!;:O(,T&7%\+?%DZP3CH&^+9_U!+ P04
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MR?A7-533.$GUM"[#[H)PRB#TWN)A9EVI+\_#H0][ SW7AY P_SAZ<SIN1K^
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M;@"G($P#?7_%N=H73 ?5%Y/H!U!+ P04    " #'9%-5K+?+/L4#  "0$@
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M;3DY(3U9:R=$=2O8WZWT^"J(FNO+E.FKI 6%(M>CJIH-[#^AZ$1+V#QZP"Q
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M5.RO:ON.XNOBMC/C"N].17.%UUL0>@(^7W"NWCKZ E5>F./_ %!+ P04
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M,>7Z 75_Q9A\.M$$]=[P^7]02P,$%     @ QV135<$PL^1F P  CPX  !D
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MR3/)!<)J+L#@Y  RU05"RR[0#-T%NXWB*Z-S\Z07%BU]P*HOP."4F#&*Z9D
M V$5&&!P2@ 9^T2+,- ,%0:[C>(K(WKSA!B>6O6 U6* P2EA89S2,SD&PNHQ
MP."4 #+*B99D((/@ D5:S8/!*HZSL7G &-X\:09\R0-6G0$&IP2*T4O/!!H(
MJ]  @U,"R/@G6J2!9J@TF&S&VI8PG0::)]0 KW; :C7 X)0X,9KIF5P#8?4:
M8'!* !GG1$LVT S-!KN-XBNC=_-D&YY2[(!5;H#!*2%A+-(S\0;"JC? X)0
M,KZ)%G @@SP#UY(^WIAN-;H_S60<:)Z.PY-*';!2#C X)2:,07JFYD!8.0<8
MG!) QBP1B@YD$&LHM=U!@U$QFO:,NLU3=%BVU@$KZ@"#DX/&9!W(,UT'P@H[
MP."4 #)RB=!V((-L@\:'K#:*?XR[S5-V6+S8 2ON (-3XL9XI&?Z#H05>(#!
M*0%DK!.A\4 &!0=]8LS?F&8R#S1/YV'Y6@>LU ,,3@D<HY>>J3T05NX!!J<$
MD'%1A.(#&?0<="IE,!JE4DSV@>;I/BQ>[H"5?H#!*7%C%-0S]0?"RC_ X*0
M1DS_(4+I/T0&90?UQ6&W47PDYN,C=JWGUCM,@+N.& Q.B4;$HN'7?G2$57^
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M_P79?D?EV_(CK&6N5)Z6FQM&UTP4 ?KWNUP_9E4[Q7==]7=\L_\ 4$L#!!0
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MOIW+61B8"I#/IY2*S4()5--U^!=02P,$%     @ QV1359 !Z;Q[#0  9I,
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M*XKZZR^[ 9Z*\L]].%?_!U!+ P04    " #'9%-5%A>,390%   A)0  &0
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MGR3YRR]%!T])^KV\.]?_ E!+ P04    " #'9%-5=+C7,UT$  #9$@  &0
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M2K=Q=KC6G38(,T&_7W*N#C=F@:IWG_P'4$L#!!0    ( ,=D4U6OV/HR%0,
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M%5 J)DHB83ERKOVK263B;< #@XW:&1/C9"'$RDR^I2/',X* 0Z(- \7'&B;
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MD1?A.R\DWYBX/V(O_DG<T[UQ23Y'G,SS&RC?*R^M#B5/!&\8$PB]<N1%W54
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MM,V J))1++?#&D,W5!6:4,R2N44IPV8<L&;-0)C5"Z+VGH?X3-(3,&,?YN)
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MWT&^ M[I+[TTYTH\)%DX)%DT$%DK%],F%]-?MB*F;RW[96]?SLW!](1I/E#
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M&D']^X<\K_8;S0$._S7!_#]02P,$%     @ QV13599")]UT P  )PL  !D
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MS9.%43C*D&>F"UCCKAOR7C0Y9S?OZAER*7+&6=/^N"+/4$EEZ)(#:1F:?*Q
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M34;EV(.8C/A6I2R'!T'D-LNH^#:%E._'EFL=!Q[9)E%ZP)Z,"KJ!!:C/Q8/
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M:L7L?P57$>(PS=A7< ->7R)P]>4K^ )2#)[2+!,2;&!S$4MAT4XJOP^E7^^
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M!X19H.?GG*M-QSBHGU/Q;U!+ P04    " #'9%-5H7B>_E,#  "6%0  #0
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MK[Z3ZO%R;[D]_KK\.HDXKZXXU_<5P_-?4$L#!!0    ( ,=D4U7=)VL+& (
M (4M   3    6T-O;G1E;G1?5'EP97-=+GAM;,W:WT[;,!0&\%>I<HL:U_\W
M1+D!;C<N]@)><MI&36++-JR\_9P4D#:Q"E2D?3>-6MOG._&1?E>]^O$4*"T.
M0S^F=;7+.5PREIH=#2[5/M!85C8^#BZ7KW'+@FOV;DM,K%:&-7[,-.9EGFI4
MUU>WM'$/?5[<'<K/J?/CNHK4IVIQ<]PX9:TK%T+?-2Z7=?8XMG^E+)\3ZG)R
MWI-V74@794/%WDR85OX=\'SN^R/%V+6TN'<Q?W-#V<4./4OYJ:=4GR[Q1H]^
ML^D::GWS,)0C=0J17)MV1'GHZV/1B]/)N=PP'3_YV?ESF5.!9>=]]"&5B47Z
M>-S+2*;3RU *4<S=Z5=\32RESWX_FJ;=4OO.['*]OWS<S_-(;'Z<?\=_SOBU
M_@?[$"!]2) ^%$@?&J0/ ]*'!>GC"T@?7T'ZX"N41E!$Y2BD<A13.0JJ'$55
MCL(J1W&5H\#*4605*+(*%%D%BJP"15:!(JM D56@R"I09!4HL@H4626*K!)%
M5HDBJT215:+(*E%DE2BR2A19)8JL$D56A2*K0I%5H<BJ4&15*+(J%%D5BJP*
M15:%(JM"D56CR*I19-4HLFH4636*K!I%5HTBJT:15:/(JE%D-2BR&A19#8JL
M!D56@R*K09'5H,AJ4&0U*+(:%%DMBJP615:+(JM%D=6BR&I19+4HLEH462V*
MK/9_ROK3^_TGQ\_/>G#=^)+/YG]?7_\&4$L! A0#%     @ QV1350=!36*!
M    L0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"
M% ,4    " #'9%-54)-J%N\    K @  $0              @ &O    9&]C
M4')O<',O8V]R92YX;6Q02P$"% ,4    " #'9%-5F5R<(Q &  "<)P  $P
M            @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M ,=D4U5?$&X]S@4  /(>   8              " @0X(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    " #'9%-5I/AY)'D'  !E(0  &
M            @($2#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#
M%     @ QV1351;G:LN, P  X P  !@              ("!P14  'AL+W=O
M<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( ,=D4U6S\_#OGP8  / >
M   8              " @8,9  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q0
M2P$"% ,4    " #'9%-5!KC63:$$  "[$@  &               @(%8(
M>&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ QV13519)-Z@-
M"   VB0  !@              ("!+R4  'AL+W=O<FMS:&5E=',O<VAE970V
M+GAM;%!+ 0(4 Q0    ( ,=D4U6[;E33J2   !\/ @ 8              "
M@7(M  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " #'9%-5
MS:%'QCD)  !+%@  &               @(%13@  >&PO=V]R:W-H965T<R]S
M:&5E=#@N>&UL4$L! A0#%     @ QV135;4T@QY%%@  .T<  !@
M     ("!P%<  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    (
M ,=D4U4%FI5V,P0  $8)   9              " @3MN  !X;"]W;W)K<VAE
M971S+W-H965T,3 N>&UL4$L! A0#%     @ QV1354U/Y<$% P  0P<  !D
M             ("!I7(  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"
M% ,4    " #'9%-59XE:"S,/   *+   &0              @('A=0  >&PO
M=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( ,=D4U7F,L*'NP0
M !H+   9              " @4N%  !X;"]W;W)K<VAE971S+W-H965T,3,N
M>&UL4$L! A0#%     @ QV1352V[]I&1%   5DL  !D              ("!
M/8H  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " #'9%-5
MB8M\\CH#  #8!P  &0              @($%GP  >&PO=V]R:W-H965T<R]S
M:&5E=#$U+GAM;%!+ 0(4 Q0    ( ,=D4U6(!ZI#@ @  .0:   9
M      " @7:B  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%
M  @ QV135:?V#^Y/"@  &!P  !D              ("!+:L  'AL+W=O<FMS
M:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " #'9%-5#&+YPO@<   ]5@
M&0              @(&SM0  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+
M 0(4 Q0    ( ,=D4U5\S4)/:PD  +48   9              " @>+2  !X
M;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ QV1351S0Q5#-
M!   @@T  !D              ("!A-P  'AL+W=O<FMS:&5E=',O<VAE970R
M,"YX;6Q02P$"% ,4    " #'9%-5."4#)OH#  "1"P  &0
M@(&(X0  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( ,=D
M4U70$!M?6@L  #T?   9              " @;GE  !X;"]W;W)K<VAE971S
M+W-H965T,C(N>&UL4$L! A0#%     @ QV13521H$Q&/!   ZPH  !D
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M=#(W+GAM;%!+ 0(4 Q0    ( ,=D4U6]@L__IP@  )(@   9
M  " @?(> 0!X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @
MQV135025<E?8"   KAP  !D              ("!T"<! 'AL+W=O<FMS:&5E
M=',O<VAE970R.2YX;6Q02P$"% ,4    " #'9%-5UPJ?RJD"  #^!0  &0
M            @('?, $ >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4
M Q0    ( ,=D4U54ZP?XU 4  (X1   9              " @;\S 0!X;"]W
M;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ QV135=>:*U+?!
MA@T  !D              ("!RCD! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX
M;6Q02P$"% ,4    " #'9%-5'7X(/O,"  "_!@  &0              @('@
M/@$ >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( ,=D4U4/
M+>Z(QP8  '$4   9              " @0I" 0!X;"]W;W)K<VAE971S+W-H
M965T,S0N>&UL4$L! A0#%     @ QV135?M)ECL6!   ]@D  !D
M     ("!"$D! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,=D4U6LM\L^Q0,  ) 2   9              "
M@>]> 0!X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ QV13
M5146B#^6!P  5C,  !D              ("!ZV(! 'AL+W=O<FMS:&5E=',O
M<VAE970T,2YX;6Q02P$"% ,4    " #'9%-5\H/&*WP(  "8/0  &0
M        @(&X:@$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0
M   ( ,=D4U7_BBI:H0,  #P/   9              " @6MS 0!X;"]W;W)K
M<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ QV1357),O7WX @  T0P
M !D              ("!0W<! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q0
M2P$"% ,4    " #'9%-53S-%UTH%  " '   &0              @(%R>@$
M>&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( ,=D4U7KQ,:S
M]@4  "<N   9              " @?-_ 0!X;"]W;W)K<VAE971S+W-H965T
M-#8N>&UL4$L! A0#%     @ QV135<$PL^1F P  CPX  !D
M ("!((8! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    " #'
M9%-5SGGO->L0  "/QP  &0              @(&]B0$ >&PO=V]R:W-H965T
M<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( ,=D4U6Y>I-6C D  'A'   9
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M970U,RYX;6Q02P$"% ,4    " #'9%-5W'!3'4X%  !()0  &0
M    @(&'P0$ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    (
M ,=D4U56HY5N_P,  ,L8   9              " @0S' 0!X;"]W;W)K<VAE
M971S+W-H965T-34N>&UL4$L! A0#%     @ QV135;,:CH=* P  4PL  !D
M             ("!0LL! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"
M% ,4    " #'9%-5T48J\]D1   9\@  &0              @('#S@$ >&PO
M=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( ,=D4U5TN-<S700
M -D2   9              " @=/@ 0!X;"]W;W)K<VAE971S+W-H965T-3@N
M>&UL4$L! A0#%     @ QV1353XX>\08!   BA0  !D              ("!
M9^4! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q02P$"% ,4    " #'9%-5
M'- "Z.4#  "F$@  &0              @(&VZ0$ >&PO=V]R:W-H965T<R]S
M:&5E=#8P+GAM;%!+ 0(4 Q0    ( ,=D4U6$X\V."00  ",0   9
M      " @=+M 0!X;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%
M  @ QV135?8&DKRJ P  QP\  !D              ("!$O(! 'AL+W=O<FMS
M:&5E=',O<VAE970V,BYX;6Q02P$"% ,4    " #'9%-5K]CZ,A4#   Y"
M&0              @('S]0$ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+
M 0(4 Q0    ( ,=D4U7R#_T^O@(  ,,&   9              " @3_Y 0!X
M;"]W;W)K<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @ QV135?(:*%&6
M!0  J"P  !D              ("!-/P! 'AL+W=O<FMS:&5E=',O<VAE970V
M-2YX;6Q02P$"% ,4    " #'9%-5_\.@#14,  !880  &0
M@($! @( >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( ,=D
M4U4^);_G3@,  'D*   9              " @4T. @!X;"]W;W)K<VAE971S
M+W-H965T-C<N>&UL4$L! A0#%     @ QV1350:7T@/% P  ?!(  !D
M         ("!TA$" 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4
M    " #'9%-53)C19.@'   F20  &0              @('.%0( >&PO=V]R
M:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    ( ,=D4U7#G./R:P<  *9
M   9              " @>T= @!X;"]W;W)K<VAE971S+W-H965T-S N>&UL
M4$L! A0#%     @ QV13599")]UT P  )PL  !D              ("!CR4"
M 'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q02P$"% ,4    " #'9%-5#B#K
M !$$   &#@  &0              @($Z*0( >&PO=V]R:W-H965T<R]S:&5E
M=#<R+GAM;%!+ 0(4 Q0    ( ,=D4U7BNO$U.@(  .@$   9
M  " @8(M @!X;"]W;W)K<VAE971S+W-H965T-S,N>&UL4$L! A0#%     @
MQV135<O.U^)^!   >A<  !D              ("!\R\" 'AL+W=O<FMS:&5E
M=',O<VAE970W-"YX;6Q02P$"% ,4    " #'9%-5PW8UCN<"  #S"   &0
M            @(&H- ( >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4
M Q0    ( ,=D4U5B%F ]X0(  +T+   9              " @<8W @!X;"]W
M;W)K<VAE971S+W-H965T-S8N>&UL4$L! A0#%     @ QV135=4E?MVD!0
M+"4  !D              ("!WCH" 'AL+W=O<FMS:&5E=',O<VAE970W-RYX
M;6Q02P$"% ,4    " #'9%-5+Q7R\#(%  "V'@  &0              @(&Y
M0 ( >&PO=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+ 0(4 Q0    ( ,=D4U7I
ML^'XY (  %H)   9              " @2)& @!X;"]W;W)K<VAE971S+W-H
M965T-SDN>&UL4$L! A0#%     @ QV135:%XGOY3 P  EA4   T
M     ( !/4D" 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #'9%-5EXJ[',
M   3 @  "P              @ &[3 ( 7W)E;',O+G)E;'-02P$"% ,4
M" #'9%-5?8R 0@D&  #M,P  #P              @ &D30( >&PO=V]R:V)O
M;VLN>&UL4$L! A0#%     @ QV135;M)TM]B @  M"X  !H
M ( !VE," 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @
MQV135=TG:PL8 @  A2T  !,              ( !=%8" %M#;VYT96YT7U1Y
><&5S72YX;6Q02P4&     %< 5P#8%P  O5@"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>569</ContextCount>
  <ElementCount>418</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>92</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Document And Entity Information Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument</Role>
      <ShortName>Document And Entity Information Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Consolidated Statements Of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome</Role>
      <ShortName>Consolidated Statements Of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Consolidated Statements Of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements Of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Consolidated Statements Of Changes in Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity</Role>
      <ShortName>Consolidated Statements Of Changes in Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Organization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/Organization</Role>
      <ShortName>Organization</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Basis Of Presentation and Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/BasisOfPresentationandSignificantAccountingPolicies</Role>
      <ShortName>Basis Of Presentation and Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2106103 - Disclosure - Business Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/BusinessAcquisitions</Role>
      <ShortName>Business Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2108104 - Disclosure - Business Optimization Initiatives</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/BusinessOptimizationInitiatives</Role>
      <ShortName>Business Optimization Initiatives</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2111105 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2119106 - Disclosure - Derivative Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/DerivativeFinancialInstruments</Role>
      <ShortName>Derivative Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2121107 - Disclosure - Fair Value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/FairValue</Role>
      <ShortName>Fair Value</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2127108 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2129109 - Disclosure - Medical Claims Payable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/MedicalClaimsPayable</Role>
      <ShortName>Medical Claims Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2135110 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2139111 - Disclosure - Commitments And Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments And Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2141112 - Disclosure - Capital Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/CapitalStock</Role>
      <ShortName>Capital Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2150113 - Disclosure - Accumulated Other Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLoss</Role>
      <ShortName>Accumulated Other Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2153114 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2157115 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2164116 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2169117 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/GoodwillandOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/BasisofPresentationandSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/BasisOfPresentationandSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2309301 - Disclosure - Business Optimization Initiatives (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/BusinessOptimizationInitiativesTables</Role>
      <ShortName>Business Optimization Initiatives (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/BusinessOptimizationInitiatives</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2312302 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/Investments</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2322303 - Disclosure - Fair Value (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/FairValueTables</Role>
      <ShortName>Fair Value (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/FairValue</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2330304 - Disclosure - Medical Claims Payable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/MedicalClaimsPayableTables</Role>
      <ShortName>Medical Claims Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/MedicalClaimsPayable</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2336305 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/Debt</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2342306 - Disclosure - Capital Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/CapitalStockTables</Role>
      <ShortName>Capital Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/CapitalStock</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2351307 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLoss</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2354308 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/EarningsPerShare</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2358309 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/SegmentInformation</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2365310 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/Leases</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2370311 - Disclosure - Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/GoodwillandOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/GoodwillandOtherIntangibleAssets</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - Organization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/OrganizationDetails</Role>
      <ShortName>Organization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/Organization</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Basis of Presentation and Signficant Accounting Policies Basis of Presentation and Significant Acconting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails</Role>
      <ShortName>Basis of Presentation and Signficant Accounting Policies Basis of Presentation and Significant Acconting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Business Acquisitions Business Acquisition (Assets Liabilities Acquired) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/BusinessAcquisitionsBusinessAcquisitionAssetsLiabilitiesAcquiredDetails</Role>
      <ShortName>Business Acquisitions Business Acquisition (Assets Liabilities Acquired) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Business Optimization Initiatives (Employee Termination Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/BusinessOptimizationInitiativesEmployeeTerminationCostsDetails</Role>
      <ShortName>Business Optimization Initiatives (Employee Termination Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/BusinessOptimizationInitiativesTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2413405 - Disclosure - Investments (Current And Long-Term Fixed Maturity Securities, Available-For-Sale) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails</Role>
      <ShortName>Investments (Current And Long-Term Fixed Maturity Securities, Available-For-Sale) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/InvestmentsTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2414406 - Disclosure - Investments (Aggregate Fair Value And Gross Unrealized Loss Of Fixed Maturity Securities In An Unrealized Loss Position) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails</Role>
      <ShortName>Investments (Aggregate Fair Value And Gross Unrealized Loss Of Fixed Maturity Securities In An Unrealized Loss Position) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/InvestmentsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2415407 - Disclosure - Investments (Amortized Cost And Fair Value Of Fixed Maturity Securities, By Contractual Maturity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails</Role>
      <ShortName>Investments (Amortized Cost And Fair Value Of Fixed Maturity Securities, By Contractual Maturity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/InvestmentsTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2416408 - Disclosure - Investments (Current Equity Securities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/InvestmentsCurrentEquitySecuritiesDetails</Role>
      <ShortName>Investments (Current Equity Securities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/InvestmentsTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2417409 - Disclosure - Investments (Net Investment Gains/Losses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails</Role>
      <ShortName>Investments (Net Investment Gains/Losses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/InvestmentsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2418410 - Disclosure - Investments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/InvestmentsNarrativeDetails</Role>
      <ShortName>Investments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/InvestmentsTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2420411 - Disclosure - Derivative Financial Instruments (Financial Statement Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/DerivativeFinancialInstrumentsFinancialStatementNarrativeDetails</Role>
      <ShortName>Derivative Financial Instruments (Financial Statement Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/DerivativeFinancialInstruments</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2423412 - Disclosure - Fair Value (Fair Value Measurements By Level For Assets Measured At Fair Value On A Recurring Basis) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails</Role>
      <ShortName>Fair Value (Fair Value Measurements By Level For Assets Measured At Fair Value On A Recurring Basis) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/FairValueTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2424413 - Disclosure - Fair Value (Reconciliation Of The Beginning And Ending Balances Of Assets Measured At Fair Value On A Recurring Basis Using Level III Inputs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails</Role>
      <ShortName>Fair Value (Reconciliation Of The Beginning And Ending Balances Of Assets Measured At Fair Value On A Recurring Basis Using Level III Inputs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/FairValueTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2425414 - Disclosure - Fair Value (Carrying And Estimated Fair Values by Level Of Financial Instruments Not Recorded At Fair Value On Consolidated Balance Sheet) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails</Role>
      <ShortName>Fair Value (Carrying And Estimated Fair Values by Level Of Financial Instruments Not Recorded At Fair Value On Consolidated Balance Sheet) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/FairValueTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2428416 - Disclosure - Income Taxes (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/IncomeTaxes</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2431417 - Disclosure - Medical Claims Payable (Reconciliation Of The Beginning And Ending Balances For Medical Claims Payable By Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails</Role>
      <ShortName>Medical Claims Payable (Reconciliation Of The Beginning And Ending Balances For Medical Claims Payable By Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/MedicalClaimsPayableTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2432418 - Disclosure - Medical Claims Payable (Reconciliation Of Net Incurred Medical Claims To Benefit Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfNetIncurredMedicalClaimsToBenefitExpenseDetails</Role>
      <ShortName>Medical Claims Payable (Reconciliation Of Net Incurred Medical Claims To Benefit Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/MedicalClaimsPayableTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2433419 - Disclosure - Medical Claims Payable Medical Claims Payable (Reconciliation of the Claims Development to the Claims Liability) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/MedicalClaimsPayableMedicalClaimsPayableReconciliationoftheClaimsDevelopmenttotheClaimsLiabilityDetails</Role>
      <ShortName>Medical Claims Payable Medical Claims Payable (Reconciliation of the Claims Development to the Claims Liability) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2434420 - Disclosure - Medical Claims Payable (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/MedicalClaimsPayableNarrativeDetails</Role>
      <ShortName>Medical Claims Payable (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/MedicalClaimsPayableTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2437421 - Disclosure - Debt (Convertible Debenture Details) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/DebtConvertibleDebentureDetailsDetails</Role>
      <ShortName>Debt (Convertible Debenture Details) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/DebtTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2438422 - Disclosure - Debt (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/DebtNarrativeDetails</Role>
      <ShortName>Debt (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/DebtTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2440423 - Disclosure - Commitments And Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails</Role>
      <ShortName>Commitments And Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2443424 - Disclosure - Capital Stock (Summary of Cash Dividend Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/CapitalStockSummaryofCashDividendActivityDetails</Role>
      <ShortName>Capital Stock (Summary of Cash Dividend Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/CapitalStockTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2444425 - Disclosure - Capital Stock (Summary of Share Repurchases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/CapitalStockSummaryofShareRepurchasesDetails</Role>
      <ShortName>Capital Stock (Summary of Share Repurchases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/CapitalStockTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2445426 - Disclosure - Capital Stock (Summary of Stock Option Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/CapitalStockSummaryofStockOptionActivityDetails</Role>
      <ShortName>Capital Stock (Summary of Stock Option Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/CapitalStockTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2446427 - Disclosure - Capital Stock (Nonvested Restricted Stock Activity Including Restricted Stock Units) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/CapitalStockNonvestedRestrictedStockActivityIncludingRestrictedStockUnitsDetails</Role>
      <ShortName>Capital Stock (Nonvested Restricted Stock Activity Including Restricted Stock Units) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/CapitalStockTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2447428 - Disclosure - Capital Stock (Fair Values of Options Granted During The Period Estimated Using Weighted-Average Assumptions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/CapitalStockFairValuesofOptionsGrantedDuringThePeriodEstimatedUsingWeightedAverageAssumptionsDetails</Role>
      <ShortName>Capital Stock (Fair Values of Options Granted During The Period Estimated Using Weighted-Average Assumptions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/CapitalStockTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2448429 - Disclosure - Capital Stock (Schedule Of Weighted-Average Fair Values Determined For The Periods) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/CapitalStockScheduleOfWeightedAverageFairValuesDeterminedForThePeriodsDetails</Role>
      <ShortName>Capital Stock (Schedule Of Weighted-Average Fair Values Determined For The Periods) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/CapitalStockTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2449430 - Disclosure - Capital Stock (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/CapitalStockNarrativeDetails</Role>
      <ShortName>Capital Stock (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/CapitalStockTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2452431 - Disclosure - Accumulated Other Comprehensive Loss (Reconciliation Of The Components Of Accumulated Other Comprehensive Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails</Role>
      <ShortName>Accumulated Other Comprehensive Loss (Reconciliation Of The Components Of Accumulated Other Comprehensive Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2455432 - Disclosure - Earnings Per Share (Denominator For Basic And Diluted Earnings Per Share) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/EarningsPerShareDenominatorForBasicAndDilutedEarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share (Denominator For Basic And Diluted Earnings Per Share) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/EarningsPerShareTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2456433 - Disclosure - Earnings Per Share (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/EarningsPerShareNarrativeDetails</Role>
      <ShortName>Earnings Per Share (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/EarningsPerShareTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2459434 - Disclosure - Segment Information (Financial Data By Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails</Role>
      <ShortName>Segment Information (Financial Data By Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/SegmentInformationTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2460435 - Disclosure - Segment Information Segment Information (Major Product Revenues for Each Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails</Role>
      <ShortName>Segment Information Segment Information (Major Product Revenues for Each Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2461436 - Disclosure - Segment Information (Reconciliation Of Reportable Segments Operating Revenues To Total Revenues Reported In The Consolidated Statements Of Income) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/SegmentInformationReconciliationOfReportableSegmentsOperatingRevenuesToTotalRevenuesReportedInTheConsolidatedStatementsOfIncomeDetails</Role>
      <ShortName>Segment Information (Reconciliation Of Reportable Segments Operating Revenues To Total Revenues Reported In The Consolidated Statements Of Income) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/SegmentInformationTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2462437 - Disclosure - Segment Information (Reconciliation Of Income Before Income Tax Expense To Reportable Segments Operating Gain Included In The Consolidated Statements Of Income) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/SegmentInformationReconciliationOfIncomeBeforeIncomeTaxExpenseToReportableSegmentsOperatingGainIncludedInTheConsolidatedStatementsOfIncomeDetails</Role>
      <ShortName>Segment Information (Reconciliation Of Income Before Income Tax Expense To Reportable Segments Operating Gain Included In The Consolidated Statements Of Income) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/SegmentInformationTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2463438 - Disclosure - Segment Information Segment Information (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/SegmentInformationSegmentInformationNarrativeDetails</Role>
      <ShortName>Segment Information Segment Information (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2466439 - Disclosure - Leases (Lease and Other Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/LeasesLeaseandOtherInformationDetails</Role>
      <ShortName>Leases (Lease and Other Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/LeasesTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2467440 - Disclosure - Leases (Reconciliation of Future Lease Payments to Total Lease Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesDetails</Role>
      <ShortName>Leases (Reconciliation of Future Lease Payments to Total Lease Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/LeasesTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2468441 - Disclosure - Leases (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.elevancehealth.com/role/LeasesTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2471442 - Disclosure - Goodwill And Other Intangible Assets (Summary Of The Change In The Carrying Amount Of Goodwill By Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsSummaryOfTheChangeInTheCarryingAmountOfGoodwillByReportableSegmentDetails</Role>
      <ShortName>Goodwill And Other Intangible Assets (Summary Of The Change In The Carrying Amount Of Goodwill By Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2472443 - Disclosure - Goodwill And Other Intangible Assets (Components Of Other Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails</Role>
      <ShortName>Goodwill And Other Intangible Assets (Components Of Other Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="elv-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2473444 - Disclosure - Goodwill And Other Intangible Assets (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill And Other Intangible Assets (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 24 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:CommonStockParOrStatedValuePerShare, us-gaap:CommonStockSharesAuthorized, us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent, us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent, us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent, us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent, us-gaap:PreferredStockParOrStatedValuePerShare, us-gaap:PreferredStockSharesAuthorized, us-gaap:PreferredStockSharesIssued, us-gaap:PreferredStockSharesOutstanding -  elv-20220930.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="elv-20220930.htm">elv-20220930.htm</File>
    <File>elv-20220930.xsd</File>
    <File>elv-20220930_cal.xml</File>
    <File>elv-20220930_def.xml</File>
    <File>elv-20220930_lab.xml</File>
    <File>elv-20220930_pre.xml</File>
    <File>exhibit311-20220930q32022.htm</File>
    <File>exhibit312-20220930q32022.htm</File>
    <File>exhibit321-20220930q32022.htm</File>
    <File>exhibit322-20220930q32022.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>elv-20220930_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1871">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>98
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "elv-20220930.htm": {
   "axisCustom": 1,
   "axisStandard": 27,
   "contextCount": 569,
   "dts": {
    "calculationLink": {
     "local": [
      "elv-20220930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "elv-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "elv-20220930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "elv-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "elv-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "elv-20220930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 683,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 30,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 35
   },
   "keyCustom": 34,
   "keyStandard": 384,
   "memberCustom": 30,
   "memberStandard": 54,
   "nsprefix": "elv",
   "nsuri": "http://www.elevancehealth.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Document And Entity Information Document",
     "role": "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument",
     "shortName": "Document And Entity Information Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106103 - Disclosure - Business Acquisitions",
     "role": "http://www.elevancehealth.com/role/BusinessAcquisitions",
     "shortName": "Business Acquisitions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108104 - Disclosure - Business Optimization Initiatives",
     "role": "http://www.elevancehealth.com/role/BusinessOptimizationInitiatives",
     "shortName": "Business Optimization Initiatives",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111105 - Disclosure - Investments",
     "role": "http://www.elevancehealth.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119106 - Disclosure - Derivative Financial Instruments",
     "role": "http://www.elevancehealth.com/role/DerivativeFinancialInstruments",
     "shortName": "Derivative Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121107 - Disclosure - Fair Value",
     "role": "http://www.elevancehealth.com/role/FairValue",
     "shortName": "Fair Value",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127108 - Disclosure - Income Taxes",
     "role": "http://www.elevancehealth.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129109 - Disclosure - Medical Claims Payable",
     "role": "http://www.elevancehealth.com/role/MedicalClaimsPayable",
     "shortName": "Medical Claims Payable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135110 - Disclosure - Debt",
     "role": "http://www.elevancehealth.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139111 - Disclosure - Commitments And Contingencies",
     "role": "http://www.elevancehealth.com/role/CommitmentsAndContingencies",
     "shortName": "Commitments And Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141112 - Disclosure - Capital Stock",
     "role": "http://www.elevancehealth.com/role/CapitalStock",
     "shortName": "Capital Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Consolidated Balance Sheets",
     "role": "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2150113 - Disclosure - Accumulated Other Comprehensive Loss",
     "role": "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLoss",
     "shortName": "Accumulated Other Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2153114 - Disclosure - Earnings Per Share",
     "role": "http://www.elevancehealth.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2157115 - Disclosure - Segment Information",
     "role": "http://www.elevancehealth.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2164116 - Disclosure - Leases",
     "role": "http://www.elevancehealth.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2169117 - Disclosure - Goodwill and Other Intangible Assets",
     "role": "http://www.elevancehealth.com/role/GoodwillandOtherIntangibleAssets",
     "shortName": "Goodwill and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies)",
     "role": "http://www.elevancehealth.com/role/BasisofPresentationandSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309301 - Disclosure - Business Optimization Initiatives (Tables)",
     "role": "http://www.elevancehealth.com/role/BusinessOptimizationInitiativesTables",
     "shortName": "Business Optimization Initiatives (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312302 - Disclosure - Investments (Tables)",
     "role": "http://www.elevancehealth.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322303 - Disclosure - Fair Value (Tables)",
     "role": "http://www.elevancehealth.com/role/FairValueTables",
     "shortName": "Fair Value (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330304 - Disclosure - Medical Claims Payable (Tables)",
     "role": "http://www.elevancehealth.com/role/MedicalClaimsPayableTables",
     "shortName": "Medical Claims Payable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.elevancehealth.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336305 - Disclosure - Debt (Tables)",
     "role": "http://www.elevancehealth.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DividendsDeclaredTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2342306 - Disclosure - Capital Stock (Tables)",
     "role": "http://www.elevancehealth.com/role/CapitalStockTables",
     "shortName": "Capital Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DividendsDeclaredTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2351307 - Disclosure - Accumulated Other Comprehensive Loss (Tables)",
     "role": "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossTables",
     "shortName": "Accumulated Other Comprehensive Loss (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2354308 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://www.elevancehealth.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2358309 - Disclosure - Segment Information (Tables)",
     "role": "http://www.elevancehealth.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2365310 - Disclosure - Leases (Tables)",
     "role": "http://www.elevancehealth.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2370311 - Disclosure - Goodwill and Other Intangible Assets (Tables)",
     "role": "http://www.elevancehealth.com/role/GoodwillandOtherIntangibleAssetsTables",
     "shortName": "Goodwill and Other Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "elv:NumberOfMedicalMembersServed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "medical_member",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - Organization (Details)",
     "role": "http://www.elevancehealth.com/role/OrganizationDetails",
     "shortName": "Organization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "elv:NumberOfMedicalMembersServed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "medical_member",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndInvestmentsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Basis of Presentation and Signficant Accounting Policies Basis of Presentation and Significant Acconting Policies (Details)",
     "role": "http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails",
     "shortName": "Basis of Presentation and Signficant Accounting Policies Basis of Presentation and Significant Acconting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndInvestmentsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Business Acquisitions Business Acquisition (Assets Liabilities Acquired) (Details)",
     "role": "http://www.elevancehealth.com/role/BusinessAcquisitionsBusinessAcquisitionAssetsLiabilitiesAcquiredDetails",
     "shortName": "Business Acquisitions Business Acquisition (Assets Liabilities Acquired) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Consolidated Statements Of Income",
     "role": "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome",
     "shortName": "Consolidated Statements Of Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i3ce8730226514909b48e611420368522_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Business Optimization Initiatives (Employee Termination Costs) (Details)",
     "role": "http://www.elevancehealth.com/role/BusinessOptimizationInitiativesEmployeeTerminationCostsDetails",
     "shortName": "Business Optimization Initiatives (Employee Termination Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i3ce8730226514909b48e611420368522_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413405 - Disclosure - Investments (Current And Long-Term Fixed Maturity Securities, Available-For-Sale) (Details)",
     "role": "http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails",
     "shortName": "Investments (Current And Long-Term Fixed Maturity Securities, Available-For-Sale) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "ic06c4cd0bfbf4349bb38d37c2a08f1d5_I20220930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "securities",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414406 - Disclosure - Investments (Aggregate Fair Value And Gross Unrealized Loss Of Fixed Maturity Securities In An Unrealized Loss Position) (Details)",
     "role": "http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails",
     "shortName": "Investments (Aggregate Fair Value And Gross Unrealized Loss Of Fixed Maturity Securities In An Unrealized Loss Position) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "ic06c4cd0bfbf4349bb38d37c2a08f1d5_I20220930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "securities",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415407 - Disclosure - Investments (Amortized Cost And Fair Value Of Fixed Maturity Securities, By Contractual Maturity) (Details)",
     "role": "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails",
     "shortName": "Investments (Amortized Cost And Fair Value Of Fixed Maturity Securities, By Contractual Maturity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416408 - Disclosure - Investments (Current Equity Securities) (Details)",
     "role": "http://www.elevancehealth.com/role/InvestmentsCurrentEquitySecuritiesDetails",
     "shortName": "Investments (Current Equity Securities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "elv:InvestmentsinequitysecuritiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i4fddf0df137b450988ab2a4425925e2c_I20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:GainLossOnInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "elv:InvestmentGainsLosses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417409 - Disclosure - Investments (Net Investment Gains/Losses) (Details)",
     "role": "http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails",
     "shortName": "Investments (Net Investment Gains/Losses) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:GainLossOnInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "elv:InvestmentGainsLosses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedInvestmentIncomeReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418410 - Disclosure - Investments (Narrative) (Details)",
     "role": "http://www.elevancehealth.com/role/InvestmentsNarrativeDetails",
     "shortName": "Investments (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "if060cd6ed5574a068397b3bc9ec5ac0c_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AccruedInvestmentIncomeReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420411 - Disclosure - Derivative Financial Instruments (Financial Statement Narrative) (Details)",
     "role": "http://www.elevancehealth.com/role/DerivativeFinancialInstrumentsFinancialStatementNarrativeDetails",
     "shortName": "Derivative Financial Instruments (Financial Statement Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423412 - Disclosure - Fair Value (Fair Value Measurements By Level For Assets Measured At Fair Value On A Recurring Basis) (Details)",
     "role": "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails",
     "shortName": "Fair Value (Fair Value Measurements By Level For Assets Measured At Fair Value On A Recurring Basis) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "ia0a535c1ffe84e6da717792a25f25e09_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424413 - Disclosure - Fair Value (Reconciliation Of The Beginning And Ending Balances Of Assets Measured At Fair Value On A Recurring Basis Using Level III Inputs) (Details)",
     "role": "http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails",
     "shortName": "Fair Value (Reconciliation Of The Beginning And Ending Balances Of Assets Measured At Fair Value On A Recurring Basis Using Level III Inputs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "ia0a535c1ffe84e6da717792a25f25e09_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Consolidated Statements of Comprehensive Income",
     "role": "http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "elv:Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLongTermInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425414 - Disclosure - Fair Value (Carrying And Estimated Fair Values by Level Of Financial Instruments Not Recorded At Fair Value On Consolidated Balance Sheet) (Details)",
     "role": "http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails",
     "shortName": "Fair Value (Carrying And Estimated Fair Values by Level Of Financial Instruments Not Recorded At Fair Value On Consolidated Balance Sheet) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "elv:CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NotesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428416 - Disclosure - Income Taxes (Narrative) (Details)",
     "role": "http://www.elevancehealth.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "if060cd6ed5574a068397b3bc9ec5ac0c_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "elv:ShortDurationContractLiabilityForClaimsAdjustmentExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431417 - Disclosure - Medical Claims Payable (Reconciliation Of The Beginning And Ending Balances For Medical Claims Payable By Segment) (Details)",
     "role": "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails",
     "shortName": "Medical Claims Payable (Reconciliation Of The Beginning And Ending Balances For Medical Claims Payable By Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "elv:ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432418 - Disclosure - Medical Claims Payable (Reconciliation Of Net Incurred Medical Claims To Benefit Expense) (Details)",
     "role": "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfNetIncurredMedicalClaimsToBenefitExpenseDetails",
     "shortName": "Medical Claims Payable (Reconciliation Of Net Incurred Medical Claims To Benefit Expense) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "elv:ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SupplementaryInsuranceInformationOtherOperatingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433419 - Disclosure - Medical Claims Payable Medical Claims Payable (Reconciliation of the Claims Development to the Claims Liability) (Details)",
     "role": "http://www.elevancehealth.com/role/MedicalClaimsPayableMedicalClaimsPayableReconciliationoftheClaimsDevelopmenttotheClaimsLiabilityDetails",
     "shortName": "Medical Claims Payable Medical Claims Payable (Reconciliation of the Claims Development to the Claims Liability) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "ic61874748541445bb5346014604b1e2f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434420 - Disclosure - Medical Claims Payable (Narrative) (Details)",
     "role": "http://www.elevancehealth.com/role/MedicalClaimsPayableNarrativeDetails",
     "shortName": "Medical Claims Payable (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "ic61874748541445bb5346014604b1e2f_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "elv:CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437421 - Disclosure - Debt (Convertible Debenture Details) (Details)",
     "role": "http://www.elevancehealth.com/role/DebtConvertibleDebentureDetailsDetails",
     "shortName": "Debt (Convertible Debenture Details) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id074490de8a844b3947b679412d173b1_I20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438422 - Disclosure - Debt (Narrative) (Details)",
     "role": "http://www.elevancehealth.com/role/DebtNarrativeDetails",
     "shortName": "Debt (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i8956e0659bb44abdac0434240d851087_D20220101-20220930",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCovenantDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyEstimateOfPossibleLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440423 - Disclosure - Commitments And Contingencies (Details)",
     "role": "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails",
     "shortName": "Commitments And Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyEstimateOfPossibleLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DividendsDeclaredTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DividendsPayableDateDeclaredDayMonthAndYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443424 - Disclosure - Capital Stock (Summary of Cash Dividend Activity) (Details)",
     "role": "http://www.elevancehealth.com/role/CapitalStockSummaryofCashDividendActivityDetails",
     "shortName": "Capital Stock (Summary of Cash Dividend Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DividendsDeclaredTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DividendsPayableDateDeclaredDayMonthAndYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Consolidated Statements Of Cash Flows",
     "role": "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows",
     "shortName": "Consolidated Statements Of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodShares",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444425 - Disclosure - Capital Stock (Summary of Share Repurchases) (Details)",
     "role": "http://www.elevancehealth.com/role/CapitalStockSummaryofShareRepurchasesDetails",
     "shortName": "Capital Stock (Summary of Share Repurchases) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": "2",
      "lang": "en-US",
      "name": "elv:StockRepurchasedAndRetiredDuringPeriodAveragePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "if060cd6ed5574a068397b3bc9ec5ac0c_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445426 - Disclosure - Capital Stock (Summary of Stock Option Activity) (Details)",
     "role": "http://www.elevancehealth.com/role/CapitalStockSummaryofStockOptionActivityDetails",
     "shortName": "Capital Stock (Summary of Stock Option Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "if060cd6ed5574a068397b3bc9ec5ac0c_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "if060cd6ed5574a068397b3bc9ec5ac0c_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446427 - Disclosure - Capital Stock (Nonvested Restricted Stock Activity Including Restricted Stock Units) (Details)",
     "role": "http://www.elevancehealth.com/role/CapitalStockNonvestedRestrictedStockActivityIncludingRestrictedStockUnitsDetails",
     "shortName": "Capital Stock (Nonvested Restricted Stock Activity Including Restricted Stock Units) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "if060cd6ed5574a068397b3bc9ec5ac0c_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447428 - Disclosure - Capital Stock (Fair Values of Options Granted During The Period Estimated Using Weighted-Average Assumptions) (Details)",
     "role": "http://www.elevancehealth.com/role/CapitalStockFairValuesofOptionsGrantedDuringThePeriodEstimatedUsingWeightedAverageAssumptionsDetails",
     "shortName": "Capital Stock (Fair Values of Options Granted During The Period Estimated Using Weighted-Average Assumptions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448429 - Disclosure - Capital Stock (Schedule Of Weighted-Average Fair Values Determined For The Periods) (Details)",
     "role": "http://www.elevancehealth.com/role/CapitalStockScheduleOfWeightedAverageFairValuesDeterminedForThePeriodsDetails",
     "shortName": "Capital Stock (Schedule Of Weighted-Average Fair Values Determined For The Periods) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DividendsDeclaredTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DividendPayableDateToBePaidDayMonthAndYear",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449430 - Disclosure - Capital Stock (Narrative) (Details)",
     "role": "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails",
     "shortName": "Capital Stock (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i90083e53041c4397abce83d13efa37ae_I20210126",
      "decimals": "-6",
      "lang": "en-US",
      "name": "elv:IncreaseInStockRepurchaseProgramAuthorization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "ia0a535c1ffe84e6da717792a25f25e09_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452431 - Disclosure - Accumulated Other Comprehensive Loss (Reconciliation Of The Components Of Accumulated Other Comprehensive Loss) (Details)",
     "role": "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails",
     "shortName": "Accumulated Other Comprehensive Loss (Reconciliation Of The Components Of Accumulated Other Comprehensive Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455432 - Disclosure - Earnings Per Share (Denominator For Basic And Diluted Earnings Per Share) (Details)",
     "role": "http://www.elevancehealth.com/role/EarningsPerShareDenominatorForBasicAndDilutedEarningsPerShareDetails",
     "shortName": "Earnings Per Share (Denominator For Basic And Diluted Earnings Per Share) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456433 - Disclosure - Earnings Per Share (Narrative) (Details)",
     "role": "http://www.elevancehealth.com/role/EarningsPerShareNarrativeDetails",
     "shortName": "Earnings Per Share (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "elv:MajorProductRevenueBySegmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InsuranceServicesRevenue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459434 - Disclosure - Segment Information (Financial Data By Reportable Segment) (Details)",
     "role": "http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails",
     "shortName": "Segment Information (Financial Data By Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id8f86bdb8cf2469aa0b7d726398ab429_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9bcdceadaae34b568b184717c1feb64d_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Consolidated Statements Of Changes in Equity",
     "role": "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity",
     "shortName": "Consolidated Statements Of Changes in Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i3fe61236f9a84e4fb0548f191cf989dd_D20210101-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "elv:MajorProductRevenueBySegmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InsuranceServicesRevenue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460435 - Disclosure - Segment Information Segment Information (Major Product Revenues for Each Reportable Segment) (Details)",
     "role": "http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails",
     "shortName": "Segment Information Segment Information (Major Product Revenues for Each Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "elv:MajorProductRevenueBySegmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9adaeacf598a42c3b72b8540b126e10b_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:InsuranceServicesRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "elv:MajorProductRevenueBySegmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InsuranceServicesRevenue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461436 - Disclosure - Segment Information (Reconciliation Of Reportable Segments Operating Revenues To Total Revenues Reported In The Consolidated Statements Of Income) (Details)",
     "role": "http://www.elevancehealth.com/role/SegmentInformationReconciliationOfReportableSegmentsOperatingRevenuesToTotalRevenuesReportedInTheConsolidatedStatementsOfIncomeDetails",
     "shortName": "Segment Information (Reconciliation Of Reportable Segments Operating Revenues To Total Revenues Reported In The Consolidated Statements Of Income) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "id7416b92a0f24b5285865ba00fcbd376_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462437 - Disclosure - Segment Information (Reconciliation Of Income Before Income Tax Expense To Reportable Segments Operating Gain Included In The Consolidated Statements Of Income) (Details)",
     "role": "http://www.elevancehealth.com/role/SegmentInformationReconciliationOfIncomeBeforeIncomeTaxExpenseToReportableSegmentsOperatingGainIncludedInTheConsolidatedStatementsOfIncomeDetails",
     "shortName": "Segment Information (Reconciliation Of Income Before Income Tax Expense To Reportable Segments Operating Gain Included In The Consolidated Statements Of Income) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463438 - Disclosure - Segment Information Segment Information (Narrative) (Details)",
     "role": "http://www.elevancehealth.com/role/SegmentInformationSegmentInformationNarrativeDetails",
     "shortName": "Segment Information Segment Information (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466439 - Disclosure - Leases (Lease and Other Information) (Details)",
     "role": "http://www.elevancehealth.com/role/LeasesLeaseandOtherInformationDetails",
     "shortName": "Leases (Lease and Other Information) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "if060cd6ed5574a068397b3bc9ec5ac0c_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467440 - Disclosure - Leases (Reconciliation of Future Lease Payments to Total Lease Liabilities) (Details)",
     "role": "http://www.elevancehealth.com/role/LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesDetails",
     "shortName": "Leases (Reconciliation of Future Lease Payments to Total Lease Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468441 - Disclosure - Leases (Narrative) (Details)",
     "role": "http://www.elevancehealth.com/role/LeasesNarrativeDetails",
     "shortName": "Leases (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9aceaf2b19bf4d5d916eb0f2039e41de_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2471442 - Disclosure - Goodwill And Other Intangible Assets (Summary Of The Change In The Carrying Amount Of Goodwill By Reportable Segment) (Details)",
     "role": "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsSummaryOfTheChangeInTheCarryingAmountOfGoodwillByReportableSegmentDetails",
     "shortName": "Goodwill And Other Intangible Assets (Summary Of The Change In The Carrying Amount Of Goodwill By Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PresentValueOfFutureInsuranceProfitsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2472443 - Disclosure - Goodwill And Other Intangible Assets (Components Of Other Intangible Assets) (Details)",
     "role": "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails",
     "shortName": "Goodwill And Other Intangible Assets (Components Of Other Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PresentValueOfFutureInsuranceProfitsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i578c5a2ae22d4fcf8e5f4f5f45ccf5f7_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2473444 - Disclosure - Goodwill And Other Intangible Assets (Narrative) (Details)",
     "role": "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill And Other Intangible Assets (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Organization",
     "role": "http://www.elevancehealth.com/role/Organization",
     "shortName": "Organization",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Basis Of Presentation and Significant Accounting Policies",
     "role": "http://www.elevancehealth.com/role/BasisOfPresentationandSignificantAccountingPolicies",
     "shortName": "Basis Of Presentation and Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "elv-20220930.htm",
      "contextRef": "i9607c090bb1947fcbddd65a1fbc6aae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 92,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r803"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r812"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DocumentAndEntityInformationDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "elv_A2021364DayFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 364-Day Facility [Member]",
        "label": "2021 364-Day Facility [Member]",
        "terseLabel": "2021 364-Day Facility [Member]"
       }
      }
     },
     "localname": "A2021364DayFacilityMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_A2021To2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 to 2023",
        "label": "2021 to 2023 [Member]",
        "terseLabel": "2021 to 2023 [Member]"
       }
      }
     },
     "localname": "A2021To2023Member",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_A2022To2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 to 2024",
        "label": "2022 to 2024 [Member]",
        "terseLabel": "2022 to 2024",
        "verboseLabel": "2022 to 2024 [Member]"
       }
      }
     },
     "localname": "A2022To2024Member",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails",
      "http://www.elevancehealth.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_A5YearFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5-Year Facility [Member]",
        "label": "5-Year Facility [Member]",
        "terseLabel": "5-Year Facility [Member]"
       }
      }
     },
     "localname": "A5YearFacilityMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_AccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Policies [Line Items]",
        "label": "Accounting Policies [Line Items]",
        "terseLabel": "Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "AccountingPoliciesLineItems",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "elv_AccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Policies",
        "label": "Accounting Policies [Table]",
        "terseLabel": "Accounting Policies [Table]"
       }
      }
     },
     "localname": "AccountingPoliciesTable",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "elv_AffiliatedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Affiliated [Member]",
        "label": "Affiliated [Member]",
        "terseLabel": "Affiliated [Member]"
       }
      }
     },
     "localname": "AffiliatedMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_AnthemInc.v.ExpressScriptsInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anthem, Inc. v. Express Scripts, Inc. [Member]",
        "label": "Anthem, Inc. v. Express Scripts, Inc. [Member]",
        "terseLabel": "Anthem, Inc. v. Express Scripts, Inc. [Member]"
       }
      }
     },
     "localname": "AnthemInc.v.ExpressScriptsInc.Member",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_BCBSAntitrustLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BCBS Antitrust Litigation [Member]",
        "label": "BCBS Antitrust Litigation [Member]",
        "terseLabel": "BCBS Antitrust Litigation [Member]"
       }
      }
     },
     "localname": "BCBSAntitrustLitigationMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_BusinessOptimizationInitiativesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Optimization Initiatives",
        "label": "Business Optimization Initiatives [Abstract]"
       }
      }
     },
     "localname": "BusinessOptimizationInitiativesAbstract",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "xbrltype": "stringItemType"
    },
    "elv_CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Carrying And Fair Values By Level Of Financial Instruments Not Recorded At Fair Value On Consolidated Balance Sheet [Table Text Block]",
        "terseLabel": "Carrying And Fair Values By Level Of Financial Instruments Not Recorded At Fair Value On Consolidated Balance Sheet"
       }
      }
     },
     "localname": "CarryingAndFairValuesByLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetTableTextBlock",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "elv_Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax": {
     "auth_ref": [],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in non-credit component of impairment losses on investments, net of tax effect.",
        "label": "Change in non-credit component of impairment losses on investments net of tax",
        "terseLabel": "Change in non-credit component of impairment losses on investments"
       }
      }
     },
     "localname": "Changeinnoncreditcomponentofimpairmentlossesoninvestmentsnetoftax",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elv_CommercialPaperMaximumBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Paper, Maximum Borrowing Capacity",
        "label": "Commercial Paper Maximum Borrowing Capacity",
        "terseLabel": "Commercial paper authorized"
       }
      }
     },
     "localname": "CommercialPaperMaximumBorrowingCapacity",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elv_CommercialSpecialtyBusinessSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial and Specialty Business Segment",
        "label": "Commercial &amp; Specialty Business Segment [Member]",
        "terseLabel": "Commercial &amp; Specialty Business Segment [Member]"
       }
      }
     },
     "localname": "CommercialSpecialtyBusinessSegmentMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessOptimizationInitiativesEmployeeTerminationCostsDetails",
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsSummaryOfTheChangeInTheCarryingAmountOfGoodwillByReportableSegmentDetails",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableMedicalClaimsPayableReconciliationoftheClaimsDevelopmenttotheClaimsLiabilityDetails",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableNarrativeDetails",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfNetIncurredMedicalClaimsToBenefitExpenseDetails",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails",
      "http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_CommercialSpecialtyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial &amp; Specialty [Member]",
        "label": "Commercial Specialty [Member]",
        "verboseLabel": "Commercial &amp; Specialty [Member]"
       }
      }
     },
     "localname": "CommercialSpecialtyMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_CommitmentsAndContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments And Contingencies [Line Items]",
        "label": "Commitments And Contingencies [Line Items]",
        "terseLabel": "Commitments And Contingencies [Line Items]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesLineItems",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "elv_CommitmentsAndContingenciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments and contingencies [Table].",
        "label": "Commitments And Contingencies [Table]",
        "terseLabel": "Commitments And Contingencies [Table]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesTable",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "elv_CommonEquitySecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Equity Securities [Member]",
        "label": "Common Equity Securities [Member]",
        "terseLabel": "Common Equity Securities [Member]"
       }
      }
     },
     "localname": "CommonEquitySecuritiesMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.elevancehealth.com/role/InvestmentsCurrentEquitySecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_DebtConversionDebtPrincipalAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate principal amount of the original debt instrument that was surrendered for conversion.",
        "label": "Debt Conversion Debt Principal Amount",
        "terseLabel": "Debt Conversion Debt Principal Amount"
       }
      }
     },
     "localname": "DebtConversionDebtPrincipalAmount",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elv_DentalVisionProductsAndServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dental Vision Products And Services [Member]",
        "label": "Dental Vision Products And Services [Member]",
        "terseLabel": "Dental Vision Products And Services [Member]"
       }
      }
     },
     "localname": "DentalVisionProductsAndServicesMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_EquitySecurities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investments in equity securities.",
        "label": "Equity Securities",
        "terseLabel": "Equity Securities"
       }
      }
     },
     "localname": "EquitySecurities",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elv_FiniteLivedIntangibleAssetExpectedAmortizationYearSix": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Asset, Expected Amortization, Year Six",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Six",
        "terseLabel": "Finite-Lived Intangible Asset, Expected Amortization, 2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationYearSix",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elv_FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Point Five Five Zero Due Two Thousand Fifty Two",
        "label": "Four Point Five Five Zero Due Two Thousand Fifty Two [Member]",
        "terseLabel": "Four Point Five Five Zero Due Two Thousand Fifty Two [Member]"
       }
      }
     },
     "localname": "FourPointFiveFiveZeroDueTwoThousandFiftyTwoMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_FourPointOneZeroPercentDueTwoThousandThirtyTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Point One Zero Percent Due Two Thousand Thirty Two",
        "label": "Four Point One Zero Percent Due Two Thousand Thirty Two [Member]",
        "terseLabel": "Four Point One Zero Percent Due Two Thousand Thirty Two [Member]"
       }
      }
     },
     "localname": "FourPointOneZeroPercentDueTwoThousandThirtyTwoMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_GainsFromOtherInvestments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gains From Other Investments",
        "label": "Gains From Other Investments",
        "terseLabel": "Gross gains"
       }
      }
     },
     "localname": "GainsFromOtherInvestments",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elv_GovernmentBusinessSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Business Segment",
        "label": "Government Business Segment [Member]",
        "terseLabel": "Government Business Segment [Member]",
        "verboseLabel": "Government Business [Member]"
       }
      }
     },
     "localname": "GovernmentBusinessSegmentMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessOptimizationInitiativesEmployeeTerminationCostsDetails",
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsSummaryOfTheChangeInTheCarryingAmountOfGoodwillByReportableSegmentDetails",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableMedicalClaimsPayableReconciliationoftheClaimsDevelopmenttotheClaimsLiabilityDetails",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableNarrativeDetails",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfNetIncurredMedicalClaimsToBenefitExpenseDetails",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails",
      "http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails",
      "http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_GrossLossesFromOtherInvestments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross Losses From Other Investments",
        "label": "Gross Losses From Other Investments",
        "negatedTerseLabel": "Gross losses"
       }
      }
     },
     "localname": "GrossLossesFromOtherInvestments",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elv_GrossPremiumTaxRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross premium tax rate",
        "label": "Gross Premium Tax Rate",
        "terseLabel": "Gross premium tax rate, state of California"
       }
      }
     },
     "localname": "GrossPremiumTaxRate",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "elv_Impairmentlossesreversalsoninvestments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total impairment (losses) reversals on investments, before considering whether or not such amount is recognized in earnings or other comprehensive income.",
        "label": "Impairment (losses) reversals on investments",
        "negatedTerseLabel": "Impairment (losses) recoveries recognized in income"
       }
      }
     },
     "localname": "Impairmentlossesreversalsoninvestments",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elv_IncreaseInStockRepurchaseProgramAuthorization": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of an increase authorized by an entity's Board of Directors to a previously authorized stock repurchase program.",
        "label": "Increase In Stock Repurchase Program Authorization",
        "terseLabel": "Increase In Stock Repurchase Program Authorization"
       }
      }
     },
     "localname": "IncreaseInStockRepurchaseProgramAuthorization",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elv_IngenioRxSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IngenioRx Segment [Member]",
        "label": "IngenioRx Segment [Member]",
        "terseLabel": "IngenioRx Segment [Member]"
       }
      }
     },
     "localname": "IngenioRxSegmentMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessOptimizationInitiativesEmployeeTerminationCostsDetails",
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsSummaryOfTheChangeInTheCarryingAmountOfGoodwillByReportableSegmentDetails",
      "http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails",
      "http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_IntangibleAssetsAccumulatedAmortizationExcludingGoodwill": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets Accumulated Amortization Excluding Goodwill",
        "label": "Intangible Assets Accumulated Amortization Excluding Goodwill",
        "negatedTerseLabel": "Accumulated Amortization, Total Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsAccumulatedAmortizationExcludingGoodwill",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elv_IntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets",
        "label": "Intangible Assets [Line Items]",
        "terseLabel": "Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IntangibleAssetsLineItems",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "elv_IntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets",
        "label": "Intangible Assets [Table]",
        "terseLabel": "Intangible Assets [Table]"
       }
      }
     },
     "localname": "IntangibleAssetsTable",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "elv_IntegraManagedCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Integra Managed Care",
        "label": "Integra Managed Care [Member]",
        "terseLabel": "Integra Managed Care [Member]"
       }
      }
     },
     "localname": "IntegraManagedCareMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessAcquisitionsBusinessAcquisitionAssetsLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_IntegratedHealthServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Integrated health services",
        "label": "Integrated health services [Member]",
        "terseLabel": "Integrated health services"
       }
      }
     },
     "localname": "IntegratedHealthServicesMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_InvestmentGainsLosses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Gains (Losses)",
        "label": "Investment Gains (Losses)",
        "verboseLabel": "Net (losses) gains on investments"
       }
      }
     },
     "localname": "InvestmentGainsLosses",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elv_InvestmentsinequitysecuritiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in equity securities [Table Text Block]",
        "label": "Investments in equity securities [Table Text Block]",
        "terseLabel": "Investments In Equity Securities"
       }
      }
     },
     "localname": "InvestmentsinequitysecuritiesTableTextBlock",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "elv_LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation of future lease payments to total lease liabilities.",
        "label": "Leases (Reconciliation of Future Lease Payments to Total Lease Liabilities) [Abstract]",
        "terseLabel": "Leases (Reconciliation of Future Lease Payments to Total Lease Liabilities) [Abstract]"
       }
      }
     },
     "localname": "LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesAbstract",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "xbrltype": "stringItemType"
    },
    "elv_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Unpaid Claims And Claims Adjustment Expense Purchase Adjustments",
        "label": "Liability For Unpaid Claims And Claims Adjustment Expense Purchase Adjustments",
        "terseLabel": "Business combinations and purchase adjustments"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePurchaseAdjustments",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elv_MajorProductRevenueBySegmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Major Product Revenue By Segment [Table]",
        "label": "Major Product Revenue By Segment [Line Items]",
        "terseLabel": "Major Product Revenue By Segment [Line Items]"
       }
      }
     },
     "localname": "MajorProductRevenueBySegmentLineItems",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "elv_MajorProductRevenueBySegmentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major Product Revenue By Segment [Table]",
        "label": "Major Product Revenue By Segment [Table]",
        "terseLabel": "Major Product Revenue By Segment [Table]"
       }
      }
     },
     "localname": "MajorProductRevenueBySegmentTable",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "elv_MajorProductRevenueBySegmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Table Text Block] for Major Product Revenue By Segment [Table]",
        "label": "Major Product Revenue By Segment [Table Text Block]",
        "terseLabel": "Major Product Revenue by Segment"
       }
      }
     },
     "localname": "MajorProductRevenueBySegmentTableTextBlock",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "elv_ManagedCareProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Managed Care Products [Member]",
        "label": "Managed Care Products [Member]",
        "terseLabel": "Managed Care Products [Member]"
       }
      }
     },
     "localname": "ManagedCareProductsMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_ManagedCareServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Managed Care Services [Member]",
        "label": "Managed Care Services [Member]",
        "terseLabel": "Managed Care Services [Member]"
       }
      }
     },
     "localname": "ManagedCareServicesMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_MedicalClaimsPayableReconciliationofNetIncurredMedicalClaimstoBenefitExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Claims Payable (Reconciliation of Net Incurred Medical Claims to Benefit Expense) [Abstract]",
        "label": "Medical Claims Payable (Reconciliation of Net Incurred Medical Claims to Benefit Expense) [Abstract]",
        "terseLabel": "Medical Claims Payable (Reconciliation of Net Incurred Medical Claims to Benefit Expense) [Abstract]"
       }
      }
     },
     "localname": "MedicalClaimsPayableReconciliationofNetIncurredMedicalClaimstoBenefitExpenseAbstract",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "xbrltype": "stringItemType"
    },
    "elv_NetLossesGainsOnFinancialInstruments": {
     "auth_ref": [],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net (losses) gains on financial instruments",
        "label": "Net (losses) gains on financial instruments",
        "negatedLabel": "Net losses (gains) on financial instruments",
        "negatedTerseLabel": "Net losses (gains) on financial instruments",
        "terseLabel": "Net (losses) gains on financial instruments"
       }
      }
     },
     "localname": "NetLossesGainsOnFinancialInstruments",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome",
      "http://www.elevancehealth.com/role/SegmentInformationReconciliationOfIncomeBeforeIncomeTaxExpenseToReportableSegmentsOperatingGainIncludedInTheConsolidatedStatementsOfIncomeDetails",
      "http://www.elevancehealth.com/role/SegmentInformationReconciliationOfReportableSegmentsOperatingRevenuesToTotalRevenuesReportedInTheConsolidatedStatementsOfIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elv_NonCreditComponentsOfImpairmentsOnInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-credit components of impairments on investments",
        "label": "Non-credit components of impairments on investments [Member]",
        "terseLabel": "Non-credit components of impairments on investments [Member]"
       }
      }
     },
     "localname": "NonCreditComponentsOfImpairmentsOnInvestmentsMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_NoncontrollingInterestPeriodIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Period Increase (Decrease)",
        "label": "Noncontrolling Interest, Period Increase (Decrease)",
        "terseLabel": "Noncontrolling interests adjustment"
       }
      }
     },
     "localname": "NoncontrollingInterestPeriodIncreaseDecrease",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elv_NumberOfCountiesInStateOfKansasCompanyDoesNotServe": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Counties In The State Of Kansas Company Does Not Serve",
        "label": "Number Of Counties In State Of Kansas Company Does Not Serve",
        "terseLabel": "Number of counties in the Kansas City area the Company does not serve"
       }
      }
     },
     "localname": "NumberOfCountiesInStateOfKansasCompanyDoesNotServe",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/OrganizationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "elv_NumberOfMedicalMembersServed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of medical members served",
        "label": "Number Of Medical Members Served",
        "verboseLabel": "Number of Medical Members"
       }
      }
     },
     "localname": "NumberOfMedicalMembersServed",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/OrganizationDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "elv_OperatingRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from insurance services and products sold.",
        "label": "Operating Revenue",
        "totalLabel": "Total operating revenue"
       }
      }
     },
     "localname": "OperatingRevenue",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elv_OperationalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operational [Member]",
        "label": "Operational [Member]",
        "terseLabel": "Damages for Operational Breaches [Member]"
       }
      }
     },
     "localname": "OperationalMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Other Net Change In Unrecognized Periodic Benefit Costs For Defined Benefit Pension And Postretirement Benefit Plans Tax Benefit Expense",
        "terseLabel": "Net change in unrecognized periodic benefit costs for defined benefit pension and postretirement benefit plans, tax expense"
       }
      }
     },
     "localname": "OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elv_OtherProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Products [Member]",
        "label": "Other Products [Member]",
        "terseLabel": "Other Products [Member]"
       }
      }
     },
     "localname": "OtherProductsMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_OtherSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other segment",
        "label": "Other Segment [Member]",
        "terseLabel": "Other Segment [Member]",
        "verboseLabel": "Other [Member]"
       }
      }
     },
     "localname": "OtherSegmentMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessOptimizationInitiativesEmployeeTerminationCostsDetails",
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsSummaryOfTheChangeInTheCarryingAmountOfGoodwillByReportableSegmentDetails",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableMedicalClaimsPayableReconciliationoftheClaimsDevelopmenttotheClaimsLiabilityDetails",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableNarrativeDetails",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfNetIncurredMedicalClaimsToBenefitExpenseDetails",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails",
      "http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails",
      "http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_PerformanceMeasurementPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance measurement period [Domain]",
        "label": "Performance measurement period [Domain]",
        "terseLabel": "Performance measurement period [Domain]"
       }
      }
     },
     "localname": "PerformanceMeasurementPeriodDomain",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails",
      "http://www.elevancehealth.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_PerformancemeasurementperiodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance measurement period [Axis]",
        "label": "Performance measurement period [Axis]",
        "terseLabel": "Performance measurement period [Axis]"
       }
      }
     },
     "localname": "PerformancemeasurementperiodAxis",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails",
      "http://www.elevancehealth.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "elv_PharmacypricingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy pricing [Member]",
        "label": "Pharmacy pricing [Member]",
        "terseLabel": "Damages for Pharmacy Pricing [Member]"
       }
      }
     },
     "localname": "PharmacypricingMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_PharmacyproductsandservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy products and services [Member]",
        "label": "Pharmacy products and services [Member]",
        "terseLabel": "Pharmacy products and services [Member]"
       }
      }
     },
     "localname": "PharmacyproductsandservicesMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potentially Dilutive Restricted Stock Units Contingent On Operating Results",
        "label": "Potentially Dilutive Restricted Stock Units Contingent On Operating Results",
        "terseLabel": "Restricted stock units excluded from the denominator for diluted earnings per share"
       }
      }
     },
     "localname": "PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "elv_Proceedsfromsaleofequityandfixedmaturitysecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from sale of equity and fixed maturity securities.",
        "label": "Proceeds from sale of equity and fixed maturity securities",
        "terseLabel": "Proceeds from sale of investments"
       }
      }
     },
     "localname": "Proceedsfromsaleofequityandfixedmaturitysecurities",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elv_ProductRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "elv_OperatingRevenue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold.",
        "label": "Product Revenue",
        "terseLabel": "Product revenue"
       }
      }
     },
     "localname": "ProductRevenue",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elv_ReconciliationOfTheClaimsDevelopmentToTheClaimsLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation Of The Claims Development To The Claims Liability [Abstract]",
        "label": "Reconciliation Of The Claims Development To The Claims Liability [Abstract]",
        "terseLabel": "Reconciliation Of The Claims Development To The Claims Liability [Abstract]"
       }
      }
     },
     "localname": "ReconciliationOfTheClaimsDevelopmentToTheClaimsLiabilityAbstract",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "xbrltype": "stringItemType"
    },
    "elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation of net incurred medical claims to benefit expense [Table]",
        "label": "Reconciliation of Net Incurred Medical Claims to Benefit Expense [Table]",
        "terseLabel": "Reconciliation of Net Incurred Medical Claims to Benefit Expense [Table]"
       }
      }
     },
     "localname": "ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTable",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfNetIncurredMedicalClaimsToBenefitExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "elv_ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular Disclosure For Reconciliation of Net Incurred Medical Claims to Benefit Expense.",
        "label": "Reconciliation of Net Incurred Medical Claims to Benefit Expense [Table Text Block]",
        "terseLabel": "Reconciliation of Net Incurred Medical Claims to Benefit Expense"
       }
      }
     },
     "localname": "ReconciliationofNetIncurredMedicalClaimstoBenefitExpenseTableTextBlock",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "elv_ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Reconciliation of net incurred medical claims to benefit expense [Table]",
        "label": "reconciliation of net incurred medical claims to benefit expense [Line Items]",
        "terseLabel": "Reconciliation of net incurred medical claims to benefit expense [Line Items]"
       }
      }
     },
     "localname": "ReconciliationofnetincurredmedicalclaimstobenefitexpenseLineItems",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfNetIncurredMedicalClaimsToBenefitExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "elv_SecuritiesLendingTransactionsInitialCollateralPercentageValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial minimum percentage of cash and/or securities collateral accepted as compared to the value of securities on loan in a securities lending transaction.",
        "label": "Securities Lending Transactions Initial Collateral Percentage Value",
        "terseLabel": "Securities lending transactions, initial collateral percentage value"
       }
      }
     },
     "localname": "SecuritiesLendingTransactionsInitialCollateralPercentageValue",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "elv_SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio of fair value of collateral held to fair value of securities loaned in securities lending transactions.",
        "label": "Securities Lending Transactions Ratio of Fair Value of Collateral Held To Securities On Loan",
        "terseLabel": "Securities lending transactions ratio of fair value of collateral held to fair value of securities loaned"
       }
      }
     },
     "localname": "SecuritiesLendingTransactionsRatioofFairValueofCollateralHeldToSecuritiesOnLoan",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "elv_SegmentEliminationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Eliminations [Member]",
        "label": "Segment Eliminations [Member]",
        "terseLabel": "Segment Eliminations [Member]"
       }
      }
     },
     "localname": "SegmentEliminationsMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_SelfFundedReceivablesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount as of the balance sheet date due the entity from self-insured customers, net of the allowance for doubtful accounts.",
        "label": "Self-Funded Receivables, Net",
        "terseLabel": "Self-funded receivables"
       }
      }
     },
     "localname": "SelfFundedReceivablesNet",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elv_SelffundedReceivablesAllowanceForDoubtfulAccounts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the estimated valuation allowance to reduce gross self-funded receivable to net realizable value.",
        "label": "Self-funded Receivables, Allowance For Doubtful Accounts",
        "terseLabel": "Self-funded receivables, allowance for doubtful accounts"
       }
      }
     },
     "localname": "SelffundedReceivablesAllowanceForDoubtfulAccounts",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elv_SeniorUnsecuredNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes [Member]",
        "label": "Senior Unsecured Notes [Member]",
        "terseLabel": "Senior Unsecured Notes [Member]"
       }
      }
     },
     "localname": "SeniorUnsecuredNotesMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_ShortDurationContractLiabilityForClaimsAdjustmentExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling short duration contract claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date for short duration.",
        "label": "Short Duration Contract Liability For Claims Adjustment Expense",
        "periodEndLabel": "Gross medical claims payable, end of period",
        "periodStartLabel": "Gross medical claims payable, beginning of period"
       }
      }
     },
     "localname": "ShortDurationContractLiabilityForClaimsAdjustmentExpense",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elv_ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short duration contract liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for short duration contract claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid short duration contract claims.",
        "label": "Short duration contract liability for unpaid claims and adjustment expense, Net",
        "terseLabel": "Net medical claims payable, end of period"
       }
      }
     },
     "localname": "ShortdurationcontractliabilityforunpaidclaimsandadjustmentexpenseNet",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elv_StockRepurchasedAndRetiredDuringPeriodAveragePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Repurchased and Retired During Period Average Price",
        "label": "Stock Repurchased and Retired During Period Average Price",
        "terseLabel": "Average price per share"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodAveragePrice",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofShareRepurchasesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "elv_SurplusNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Surplus Notes [Member]",
        "label": "Surplus Notes [Member]",
        "terseLabel": "Surplus Notes [Member]"
       }
      }
     },
     "localname": "SurplusNotesMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax (expense) benefit of non-credit component of impairment loss on available-for-sale securities recognized in other comprehensive income",
        "label": "Tax (expense) benefit of non credit impairment on available-for-sale securities recognized in other comprehensive income (loss)",
        "terseLabel": "Tax (expense) benefit of non credit impairment on available-for-sale securities recognized in other comprehensive income (loss)"
       }
      }
     },
     "localname": "Taxexpensebenefitofnoncreditimpairmentonavailableforsalesecuritiesrecognizedinothercomprehensiveincomeloss",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "elv_ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Point One Two Five Percent Due Two Thousand Twenty Two",
        "label": "Three Point One Two Five Percent Due Two Thousand Twenty Two [Member]",
        "terseLabel": "Three Point One Two Five Percent Due Two Thousand Twenty Two [Member]"
       }
      }
     },
     "localname": "ThreePointOneTwoFivePercentDueTwoThousandTwentyTwoMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "elv_UnaffiliatedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unaffiliated [Member]",
        "label": "Unaffiliated [Member]",
        "terseLabel": "Unaffiliated"
       }
      }
     },
     "localname": "UnaffiliatedMember",
     "nsuri": "http://www.elevancehealth.com/20220930",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r132",
      "r337",
      "r341",
      "r346",
      "r510",
      "r511",
      "r518",
      "r519",
      "r621",
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r132",
      "r337",
      "r341",
      "r346",
      "r510",
      "r511",
      "r518",
      "r519",
      "r621",
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": {
     "auth_ref": [
      "r2",
      "r137",
      "r144",
      "r256",
      "r467",
      "r468",
      "r469",
      "r481",
      "r482",
      "r539",
      "r544",
      "r545",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjusted Balance"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r137",
      "r144",
      "r150",
      "r256",
      "r467",
      "r468",
      "r469",
      "r481",
      "r482",
      "r539",
      "r542",
      "r544",
      "r545",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r137",
      "r144",
      "r150",
      "r256",
      "r467",
      "r468",
      "r469",
      "r481",
      "r482",
      "r539",
      "r542",
      "r544",
      "r545",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r137",
      "r144",
      "r150",
      "r256",
      "r467",
      "r468",
      "r469",
      "r481",
      "r482",
      "r539",
      "r542",
      "r544",
      "r545",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r206",
      "r417",
      "r419",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r326",
      "r328",
      "r329",
      "r330",
      "r352",
      "r391",
      "r431",
      "r433",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r657",
      "r755",
      "r759",
      "r797",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails",
      "http://www.elevancehealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r326",
      "r328",
      "r329",
      "r330",
      "r352",
      "r391",
      "r431",
      "r433",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r657",
      "r755",
      "r759",
      "r797",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails",
      "http://www.elevancehealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r206",
      "r417",
      "r419",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r203",
      "r328",
      "r329",
      "r417",
      "r418",
      "r658",
      "r752",
      "r756"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails",
      "http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r203",
      "r328",
      "r329",
      "r417",
      "r418",
      "r658",
      "r752",
      "r756"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails",
      "http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r305",
      "r326",
      "r328",
      "r329",
      "r330",
      "r352",
      "r391",
      "r420",
      "r431",
      "r433",
      "r460",
      "r461",
      "r462",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r657",
      "r755",
      "r759",
      "r797",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails",
      "http://www.elevancehealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r305",
      "r326",
      "r328",
      "r329",
      "r330",
      "r352",
      "r391",
      "r420",
      "r431",
      "r433",
      "r460",
      "r461",
      "r462",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r657",
      "r755",
      "r759",
      "r797",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails",
      "http://www.elevancehealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate202006Member": {
     "auth_ref": [
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity.",
        "label": "Accounting Standards Update 2020-06 [Member]",
        "terseLabel": "Accounting Standards Update 2020-06 [Member]"
       }
      }
     },
     "localname": "AccountingStandardsUpdate202006Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "verboseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedInvestmentIncomeReceivable": {
     "auth_ref": [
      "r27",
      "r667",
      "r717"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest, dividends, rents, ancillary and other revenues earned but not yet received by the entity on its investments.",
        "label": "Accrued Investment Income Receivable",
        "terseLabel": "Accrued investment income receivable"
       }
      }
     },
     "localname": "AccruedInvestmentIncomeReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r60",
      "r66",
      "r75",
      "r76",
      "r77",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Pension and other postretirement benefits"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r54",
      "r66",
      "r75",
      "r76",
      "r77",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember": {
     "auth_ref": [
      "r66",
      "r75",
      "r76",
      "r77",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, including portion attributable to noncontrolling interest.",
        "label": "Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]",
        "terseLabel": "Net cash flow hedges"
       }
      }
     },
     "localname": "AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r56",
      "r57",
      "r59",
      "r66",
      "r75",
      "r76",
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest [Member]",
        "terseLabel": "Net unrealized investment (losses) gains"
       }
      }
     },
     "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r65"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "AOCI, Debt Securities, Available-for-Sale, Adjustment, after Tax",
        "periodEndLabel": "AOCI, Debt Securities, Ending Balance",
        "periodStartLabel": "AOCI, Debt Securities, Beginning Balance"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r61",
      "r66",
      "r428"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedPeriodEndLabel": "AOCI, Defined Benefit Plan, Ending Balance",
        "negatedPeriodStartLabel": "AOCI, Defined Benefit Plan, Beginning Balance"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r53",
      "r63",
      "r65",
      "r66",
      "r564"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "periodEndLabel": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax, Ending Balance",
        "periodStartLabel": "AOCI, Foreign Currency Translation Adjustment, Net of Tax, Beginning Balance"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r30",
      "r63",
      "r65",
      "r66",
      "r713",
      "r767",
      "r771"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Accumulated Other Comprehensive Loss, Ending Balance",
        "periodStartLabel": "Accumulated Other Comprehensive Loss, Beginning Balance",
        "verboseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails",
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities": {
     "auth_ref": [
      "r66",
      "r222"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of accumulated other comprehensive loss related to that portion of other than temporary impairment (OTTI) due to factors other than credit losses on debt securities categorized either as available-for-sale or held-to-maturity that an entity does not intend to sell and which it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis of the debt security. The amount represented by this item is net of tax, as applicable.",
        "label": "Accumulated Other Comprehensive Income (Loss), Other than Temporary Impairment, Not Credit Loss, Net of Tax, Debt Securities",
        "periodEndLabel": "AOCI, Other than Temporary Impairment, Not Credit Loss, Ending Balance",
        "periodStartLabel": "Accumulated Other Comprehensive Income (Loss), Other than Temporary Impairment, Not Credit Loss, Net of Tax, Debt Securities"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r62",
      "r66",
      "r75",
      "r76",
      "r77",
      "r134",
      "r135",
      "r136",
      "r517",
      "r620",
      "r762",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive (Loss) Income [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r28",
      "r624"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r467",
      "r468",
      "r469",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r138",
      "r139",
      "r140",
      "r141",
      "r150",
      "r216",
      "r217",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r467",
      "r468",
      "r469",
      "r479",
      "r480",
      "r481",
      "r482",
      "r501",
      "r502",
      "r503",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r586",
      "r587",
      "r594",
      "r595",
      "r596",
      "r597",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r660",
      "r661",
      "r662",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of subsequent adjustments to additional paid in capital for convertible financial instruments where a component of equity and a component of debt are recognized.",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments",
        "terseLabel": "Convertible debenture repurchases, conversions and tax adjustments"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent": {
     "auth_ref": [
      "r27"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on receivable, classified as other and current.",
        "label": "Allowance for Credit Loss, Receivable, Other, Current",
        "terseLabel": "Allowance for doubtful accounts, other receivables"
       }
      }
     },
     "localname": "AllowanceForDoubtfulOtherReceivablesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r112",
      "r290",
      "r298"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of other intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome",
      "http://www.elevancehealth.com/role/SegmentInformationReconciliationOfIncomeBeforeIncomeTaxExpenseToReportableSegmentsOperatingGainIncludedInTheConsolidatedStatementsOfIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Weighted average shares excluded from denominator for diluted earnings per share because the stock options were anti-dilutive"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax",
        "periodEndLabel": "AOCI, Cash Flow Hedge, Ending Balance",
        "periodStartLabel": "AOCI, Cash Flow Hedge, Beginning Balance",
        "terseLabel": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax"
       }
      }
     },
     "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails",
      "http://www.elevancehealth.com/role/DerivativeFinancialInstrumentsFinancialStatementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r17",
      "r126",
      "r185",
      "r192",
      "r199",
      "r252",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r510",
      "r518",
      "r565",
      "r622",
      "r624",
      "r668",
      "r709"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r10",
      "r35",
      "r126",
      "r252",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r510",
      "r518",
      "r565",
      "r622",
      "r624"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r549"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodDomain": {
     "auth_ref": [
      "r131",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maturity period remaining for repurchase agreements and similar transactions, for example, but not limited to, securities lending arrangements. Element name and standard label in Maturity [numeric lower end] to [numeric higher end] [date measure] [Member] or Maturity Greater Than [low end numeric value] [date measure] [Member] or Maturity Less Than [high end numeric value] [date measure] [Member] formats.",
        "label": "Repurchase Agreements and Similar Transactions, Maturity Periods [Domain]",
        "terseLabel": "Repurchase Agreements and Similar Transactions, Maturity Periods [Domain]"
       }
      }
     },
     "localname": "AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis": {
     "auth_ref": [
      "r131",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by maturity period remaining for repurchase agreements and similar transactions, for example, but not limited to, securities lending arrangements. Element name and standard label in Maturity [numeric lower end] to [numeric higher end] [date measure] [Member] or Maturity Greater Than [low end numeric value] [date measure] [Member] or Maturity Less Than [high end numeric value] [date measure] [Member] formats.",
        "label": "Repurchase Agreements and Similar Transactions, Maturity Periods [Axis]",
        "terseLabel": "Repurchase Agreements and Similar Transactions, Maturity Periods [Axis]"
       }
      }
     },
     "localname": "AssetsSoldUnderAgreementsToRepurchaseMaturityPeriodsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "verboseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r228"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r224",
      "r266"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "terseLabel": "Cost or Amortized Cost",
        "totalLabel": "Available-for-sale securities, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails",
      "http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost": {
     "auth_ref": [
      "r233"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "verboseLabel": "Due after five years through ten years, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r229",
      "r233",
      "r692"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "verboseLabel": "Due after five years through ten years, Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r232"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "verboseLabel": "Due after one year through five years, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r229",
      "r232",
      "r691"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "verboseLabel": "Due after one year through five years, Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost": {
     "auth_ref": [
      "r234"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10",
        "verboseLabel": "Due after ten years, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r229",
      "r234",
      "r693"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "verboseLabel": "Due after ten years, Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r231"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "verboseLabel": "Due in one year or less, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r229",
      "r231",
      "r690"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "verboseLabel": "Due in one year or less, Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": {
     "auth_ref": [
      "r235"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost",
        "verboseLabel": "Mortgage-backed securities, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": {
     "auth_ref": [
      "r235",
      "r694"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value",
        "verboseLabel": "Mortgage-backed securities, Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r219",
      "r225",
      "r266",
      "r674"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Available-for-sale Securities",
        "totalLabel": "Available-for-sale securities, Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails",
      "http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r221",
      "r266"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-Sale, Current",
        "terseLabel": "Fixed maturities, current"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "auth_ref": [
      "r13",
      "r221",
      "r266"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Debt Securities, Available-for-Sale, Noncurrent",
        "terseLabel": "Fixed maturities, long-term"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r434",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r453",
      "r454",
      "r456",
      "r457",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation and Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisOfPresentationandSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BenefitsLossesAndExpenses": {
     "auth_ref": [
      "r739"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs.",
        "label": "Benefits, Losses and Expenses",
        "totalLabel": "Total expenses"
       }
      }
     },
     "localname": "BenefitsLossesAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BenefitsLossesAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Benefits, Losses and Expenses [Abstract]",
        "terseLabel": "Expenses"
       }
      }
     },
     "localname": "BenefitsLossesAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r430",
      "r432",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessAcquisitionsBusinessAcquisitionAssetsLiabilitiesAcquiredDetails",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r430",
      "r432",
      "r494",
      "r495",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessAcquisitionsBusinessAcquisitionAssetsLiabilitiesAcquiredDetails",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessAcquisitionsBusinessAcquisitionAssetsLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Banking Regulation, Total Capital [Abstract]",
        "terseLabel": "Capital [Abstract]"
       }
      }
     },
     "localname": "CapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r8",
      "r12",
      "r114"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r108",
      "r114",
      "r119"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r108",
      "r575"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Change in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging [Member]"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DerivativeFinancialInstrumentsFinancialStatementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashMember": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.",
        "label": "Cash [Member]",
        "terseLabel": "Cash [Member]"
       }
      }
     },
     "localname": "CashMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClaimsDevelopmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Claims Development [Line Items]",
        "terseLabel": "Claims Development [Line Items]"
       }
      }
     },
     "localname": "ClaimsDevelopmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r24",
      "r25",
      "r26",
      "r123",
      "r126",
      "r153",
      "r154",
      "r155",
      "r157",
      "r159",
      "r167",
      "r168",
      "r169",
      "r252",
      "r337",
      "r341",
      "r342",
      "r343",
      "r346",
      "r347",
      "r389",
      "r390",
      "r393",
      "r397",
      "r404",
      "r565",
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r412",
      "r413",
      "r414",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r235",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by commercial real estate mortgage loans.",
        "label": "Commercial Mortgage-Backed Securities [Member]",
        "terseLabel": "Commercial Mortgage-Backed Securities [Member]"
       }
      }
     },
     "localname": "CommercialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails",
      "http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails",
      "http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaper": {
     "auth_ref": [
      "r18",
      "r669",
      "r712"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.",
        "label": "Commercial Paper",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails",
      "http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper",
        "verboseLabel": "Commercial Paper Program"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r47",
      "r677",
      "r719"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies \u2013 Note 11"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r321",
      "r322",
      "r323",
      "r332",
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments And Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "verboseLabel": "Cash dividends per share"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofCashDividendActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "verboseLabel": "Dividends per share"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r134",
      "r135",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r26",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r26",
      "r624"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $0.01, shares authorized \u2013 900,000,000; shares issued and outstanding \u2013 238,974,624 and 241,770,746"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r71",
      "r73",
      "r74",
      "r85",
      "r683",
      "r729"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Total shareholders\u2019 comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r84",
      "r91",
      "r682",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractualRightsMember": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights that arise from a contractual arrangement with a third party (not including franchise rights and license agreements).",
        "label": "Contractual Rights [Member]",
        "terseLabel": "Provider And Hospital Relationships [Member]"
       }
      }
     },
     "localname": "ContractualRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r348",
      "r349",
      "r350",
      "r352",
      "r362",
      "r363",
      "r364",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r380",
      "r381",
      "r382",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Debt [Member]"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtConvertibleDebentureDetailsDetails",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "Convertible debentures",
        "verboseLabel": "Net debt carrying amount"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtConvertibleDebentureDetailsDetails",
      "http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.",
        "label": "Convertible Debt [Table Text Block]",
        "terseLabel": "Convertible Debenture Terms"
       }
      }
     },
     "localname": "ConvertibleDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r421",
      "r429",
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate Securities [Member]"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails",
      "http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails",
      "http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r87",
      "r658"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r122",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r366",
      "r373",
      "r374",
      "r376",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r20",
      "r22",
      "r23",
      "r125",
      "r132",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r356",
      "r362",
      "r363",
      "r364",
      "r365",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r380",
      "r381",
      "r382",
      "r383",
      "r592",
      "r670",
      "r671",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails",
      "http://www.elevancehealth.com/role/DebtConvertibleDebentureDetailsDetails",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r23",
      "r377",
      "r671",
      "r706"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "verboseLabel": "Outstanding principal amount"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtConvertibleDebentureDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r351",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Effective conversion price (per $1,000 of principal amount) per share"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtConvertibleDebentureDetailsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r44",
      "r351",
      "r405",
      "r406",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Conversion rate (shares of common stock per $1,000 of principal)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtConvertibleDebentureDetailsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentCovenantCompliance": {
     "auth_ref": [
      "r23",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "States whether the entity was in compliance with the debt covenants throughout the reporting period, and describes facts and circumstances of any compliance failure.",
        "label": "Debt Instrument, Covenant Compliance",
        "terseLabel": "Covenant compliance"
       }
      }
     },
     "localname": "DebtInstrumentCovenantCompliance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCovenantDescription": {
     "auth_ref": [
      "r23",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of minimum financial levels (for example, tangible net worth and working capital) and achievement of certain financial ratios (for example, working capital ratio and debt service coverage ratio), and adherence to certain clauses which generally require or restrict certain actions (for example, entering into a debt arrangement with equal or greater seniority, and selling or discontinuing a certain business segment or material subsidiary) to be in compliance with the covenant clauses of the debt agreement. May also include a discussion of the adverse consequences that would result if the entity violates or fails to satisfy the covenants.",
        "label": "Debt Instrument, Covenant Description",
        "terseLabel": "Covenant description"
       }
      }
     },
     "localname": "DebtInstrumentCovenantDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r349",
      "r380",
      "r381",
      "r590",
      "r592",
      "r593"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt Instrument, Face Amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r43",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtConvertibleDebentureDetailsDetails",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r45",
      "r125",
      "r132",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r356",
      "r362",
      "r363",
      "r364",
      "r365",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r380",
      "r381",
      "r382",
      "r383",
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails",
      "http://www.elevancehealth.com/role/DebtConvertibleDebentureDetailsDetails",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtConvertibleDebentureDetailsDetails",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtConvertibleDebentureDetailsDetails",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRepurchasedFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of the original debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchased Face Amount",
        "terseLabel": "Debt instruments, repurchased face amount"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r45",
      "r125",
      "r132",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r356",
      "r362",
      "r363",
      "r364",
      "r365",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r375",
      "r380",
      "r381",
      "r382",
      "r383",
      "r405",
      "r407",
      "r408",
      "r409",
      "r589",
      "r590",
      "r592",
      "r593",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtConvertibleDebentureDetailsDetails",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instruments [Abstract]",
        "terseLabel": "Debt Instruments [Abstract]"
       }
      }
     },
     "localname": "DebtInstrumentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r226",
      "r266",
      "r272",
      "r273"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss",
        "terseLabel": "Fixed maturities, allowance for credit losses",
        "verboseLabel": "Fixed maturities, allowance for credit loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails",
      "http://www.elevancehealth.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent": {
     "auth_ref": [
      "r266"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss, Current",
        "terseLabel": "Fixed maturities, allowance for credit loss, current"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent": {
     "auth_ref": [
      "r266"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss, Noncurrent",
        "terseLabel": "Fixed maturities, allowance for credit Loss, noncurrent"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent": {
     "auth_ref": [
      "r224",
      "r266"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Current",
        "terseLabel": "Fixed maturities, amortized cost, current"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent": {
     "auth_ref": [
      "r224",
      "r266"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Noncurrent",
        "verboseLabel": "Fixed Maturities, long-term, amortized cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r240",
      "r270",
      "r275"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "verboseLabel": "Estimated fair value, 12 months or greater"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r240",
      "r270"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "negatedLabel": "Gross unrealized loss, 12 months or greater"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions",
        "terseLabel": "Number of securities, 12 months or greater"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r240",
      "r270",
      "r275"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "verboseLabel": "Estimated fair value, less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r240",
      "r270"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "negatedLabel": "Gross unrealized loss, less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions",
        "terseLabel": "Number of securities, less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGain": {
     "auth_ref": [
      "r242"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Realized Gain",
        "terseLabel": "Debt Securities, Available-for-sale, Realized Gain"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss": {
     "auth_ref": [
      "r242"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Realized Gain (Loss)",
        "terseLabel": "Debt Securities, Available-for-sale, Realized Gain (Loss)"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss": {
     "auth_ref": [
      "r242"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Realized Loss",
        "terseLabel": "Debt Securities, Available-for-sale, Realized Loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r112",
      "r127",
      "r478",
      "r485",
      "r486",
      "r487"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r471",
      "r472"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liabilities, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting, and liabilities classified as noncurrent and other.",
        "label": "Deferred Tax and Other Liabilities, Noncurrent",
        "terseLabel": "Deferred Tax and Other Liabilities, Noncurrent"
       }
      }
     },
     "localname": "DeferredTaxAndOtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositsReceivedForSecuritiesLoanedAtCarryingValue": {
     "auth_ref": [
      "r776"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash received as security in return for loaning securities to another party.",
        "label": "Deposits Received for Securities Loaned, at Carrying Value",
        "terseLabel": "Collateral received for securities loaned, at carrying value"
       }
      }
     },
     "localname": "DepositsReceivedForSecuritiesLoanedAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAmortizationAndAccretionNet": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Depreciation, Amortization and Accretion, Net",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAmortizationAndAccretionNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement": {
     "auth_ref": [
      "r50",
      "r52"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and elected not to be offset.",
        "label": "Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement",
        "terseLabel": "Derivative assets"
       }
      }
     },
     "localname": "DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r527"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Derivative, Gain (Loss) Recognized"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DerivativeFinancialInstrumentsFinancialStatementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r52",
      "r526",
      "r528",
      "r529",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r533",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DerivativeFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DerivativeFinancialInstrumentsFinancialStatementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivatives and hedging activities.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DerivativeFinancialInstrumentsFinancialStatementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r525",
      "r526",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DerivativeFinancialInstrumentsFinancialStatementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement": {
     "auth_ref": [
      "r50",
      "r52"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and elected not to be offset.",
        "label": "Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement",
        "negatedTerseLabel": "Derivative liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeMember": {
     "auth_ref": [
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents types of derivative financial instruments which are financial instruments or other contractual arrangements with all three of the following characteristics: (a) it has (1) one or more underlyings and (2) one or more notional amounts or payment provisions or both. Those terms determine the amount of the settlement or settlements, and, in some cases, whether or not a settlement is required; (b) it requires no initial net investment or an initial net investment that is smaller than would be required for other types of contracts that would be expected to have a similar response to changes in market factors; and (c) its terms require or permit net settlement, it can readily be settled net by a means outside the contract, or it provides for delivery of an asset that puts the recipient in a position not substantially different from net settlement. Notwithstanding the above characteristics, loan commitments that relate to the origination of mortgage loans that will be held for sale are accounted for as derivative instruments by the issuer of the loan commitment (that is, the potential lender).",
        "label": "Derivative [Member]",
        "terseLabel": "Derivatives [Member]"
       }
      }
     },
     "localname": "DerivativeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendPayableDateToBePaidDayMonthAndYear": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the declared dividend will be paid, in YYYY-MM-DD format.",
        "label": "Dividends Payable, Date to be Paid",
        "terseLabel": "Payment date",
        "verboseLabel": "Dividends Payable, Date to be Paid"
       }
      }
     },
     "localname": "DividendPayableDateToBePaidDayMonthAndYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails",
      "http://www.elevancehealth.com/role/CapitalStockSummaryofCashDividendActivityDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r410",
      "r697"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "negatedLabel": "Dividends and dividend equivalents"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsDeclaredTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to dividends declared, including paid and unpaid dividends.",
        "label": "Dividends Declared [Table Text Block]",
        "terseLabel": "Summary of Cash Dividend Activity"
       }
      }
     },
     "localname": "DividendsDeclaredTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsPayableAmountPerShare": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.",
        "label": "Dividends Payable, Amount Per Share",
        "terseLabel": "Dividends Payable, Amount Per Share"
       }
      }
     },
     "localname": "DividendsPayableAmountPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DividendsPayableDateDeclaredDayMonthAndYear": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the dividend to be paid was declared, in YYYY-MM-DD format.",
        "label": "Dividends Payable, Date Declared",
        "terseLabel": "Declaration date"
       }
      }
     },
     "localname": "DividendsPayableDateDeclaredDayMonthAndYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofCashDividendActivityDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DividendsPayableDateOfRecordDayMonthAndYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the holder must own the stock to be entitled to the dividend, in YYYY-MM-DD format.",
        "label": "Dividends Payable, Date of Record",
        "terseLabel": "Record date",
        "verboseLabel": "Dividends Payable, Date of Record"
       }
      }
     },
     "localname": "DividendsPayableDateOfRecordDayMonthAndYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails",
      "http://www.elevancehealth.com/role/CapitalStockSummaryofCashDividendActivityDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]",
        "verboseLabel": "Shareholders\u2019 net income per share"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r86",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r151",
      "r153",
      "r157",
      "r158",
      "r159",
      "r163",
      "r164",
      "r545",
      "r546",
      "r684",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic net income per share"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r86",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r153",
      "r157",
      "r158",
      "r159",
      "r163",
      "r164",
      "r545",
      "r546",
      "r684",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net income per share"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r160",
      "r161",
      "r162",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r575"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of foreign exchange rates on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "verboseLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Severance [Member]"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessOptimizationInitiativesEmployeeTerminationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r75",
      "r76",
      "r77",
      "r134",
      "r135",
      "r136",
      "r139",
      "r147",
      "r149",
      "r166",
      "r256",
      "r404",
      "r410",
      "r467",
      "r468",
      "r469",
      "r481",
      "r482",
      "r544",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r583",
      "r620",
      "r762",
      "r763",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails",
      "http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r9",
      "r21",
      "r563"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets",
      "http://www.elevancehealth.com/role/InvestmentsCurrentEquitySecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r249"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "terseLabel": "Net losses on equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedGain": {
     "auth_ref": [
      "r249"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Realized Gain",
        "terseLabel": "Unrealized (losses) gains recognized on equity securities still held at the end of the period"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedGainLoss": {
     "auth_ref": [
      "r249",
      "r732"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Realized Gain (Loss)",
        "terseLabel": "Net realized gains (losses) recognized on equity securities sold during the period"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedLoss": {
     "auth_ref": [
      "r249"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized loss from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Realized Loss",
        "negatedTerseLabel": "Net realized gains (losses) recognized on equity securities sold during the period"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r249",
      "r732"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized (losses) gains recognized on equity securities still held at the end of the period"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r245",
      "r708",
      "r789",
      "r790",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity Securities [Member]"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails",
      "http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails",
      "http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExchangeTradedFundsMember": {
     "auth_ref": [
      "r421",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment that follows an index, commodity or basket of assets that trades similar to a stock on an exchange.",
        "label": "Exchange Traded Funds [Member]",
        "terseLabel": "Exchange Traded Funds [Member]"
       }
      }
     },
     "localname": "ExchangeTradedFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.elevancehealth.com/role/InvestmentsCurrentEquitySecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAxis": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to the debt extinguished including the amount of gain (loss), the income tax effect on the gain (loss), and the amount of gain (loss), net or the related income tax, by debt instrument.",
        "label": "Extinguishment of Debt [Axis]",
        "terseLabel": "Extinguishment of Debt [Axis]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ExtinguishmentOfDebtTypeDomain": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of debt extinguished.",
        "label": "Extinguishment of Debt, Type [Domain]",
        "terseLabel": "Extinguishment of Debt, Type [Domain]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails",
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r549",
      "r550",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails",
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss": {
     "auth_ref": [
      "r558"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3) and still held.",
        "label": "Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss)",
        "terseLabel": "Change in unrealized gains (losses) included in net income related to assets still held"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r553",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r553",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation Of The Beginning And Ending Balances Of Assets Measured At Fair Value On A Recurring Basis Using Level III Inputs"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r364",
      "r380",
      "r381",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r429",
      "r550",
      "r629",
      "r630",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails",
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r549",
      "r550",
      "r551",
      "r552",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r364",
      "r421",
      "r422",
      "r427",
      "r429",
      "r550",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level I [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails",
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r364",
      "r380",
      "r381",
      "r421",
      "r422",
      "r427",
      "r429",
      "r550",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level II [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails",
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r364",
      "r380",
      "r381",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r429",
      "r550",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level III [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails",
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": {
     "auth_ref": [
      "r554"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings",
        "terseLabel": "Total gains (losses) recognized in net income"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss": {
     "auth_ref": [
      "r555"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "terseLabel": "Total gains (losses) recognized in accumulated other comprehensive loss"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": {
     "auth_ref": [
      "r556"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases",
        "terseLabel": "Purchases"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales": {
     "auth_ref": [
      "r556"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales",
        "negatedTerseLabel": "Sales"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements": {
     "auth_ref": [
      "r556"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3": {
     "auth_ref": [
      "r557"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3",
        "terseLabel": "Transfers into Level III"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": {
     "auth_ref": [
      "r557"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3",
        "negatedTerseLabel": "Transfers out of Level III"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "auth_ref": [
      "r553"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r364",
      "r380",
      "r381",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r429",
      "r629",
      "r630",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails",
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r549",
      "r550",
      "r551",
      "r552",
      "r559",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Fair Value, Nonrecurring [Member]"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r560",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring [Member]"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of advances from Federal Home Loan Bank (FHLBank) maturing in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Federal Home Loan Bank, Advances, Maturities Summary, Due in Next Rolling 12 Months",
        "verboseLabel": "Federal Home Loan Bank, advances, short-term"
       }
      }
     },
     "localname": "FederalHomeLoanBankAdvancesMaturitiesSummaryDueInNextRollingTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FederalHomeLoanBankAdvancesMember": {
     "auth_ref": [
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowings from the Federal Home Loan Bank, which are primarily used to cover shortages in the required reserve balance and also in times of liquidity shortages. The member institution executes a promissory note, which is generally collateralized by government securities to the Federal Reserve or loans.",
        "label": "Federal Home Loan Bank Advances [Member]",
        "terseLabel": "Federal Home Loan Bank Advances [Member]"
       }
      }
     },
     "localname": "FederalHomeLoanBankAdvancesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r236",
      "r237",
      "r246",
      "r247",
      "r248",
      "r259",
      "r262",
      "r263",
      "r264",
      "r265",
      "r269",
      "r271",
      "r274",
      "r275",
      "r375",
      "r402",
      "r533",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails",
      "http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails",
      "http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails",
      "http://www.elevancehealth.com/role/InvestmentsCurrentEquitySecuritiesDetails",
      "http://www.elevancehealth.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.",
        "label": "Financial Liabilities Fair Value Disclosure",
        "negatedTerseLabel": "Total liabilities"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r15",
      "r297"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated Amortization, Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Finite-Lived Intangible Asset, Expected Amortization, 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Finite-Lived Intangible Asset, Expected Amortization, 2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Finite-Lived Intangible Asset, Expected Amortization, 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Finite-Lived Intangible Asset, Expected Amortization, 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Finite-Lived Intangible Asset, Expected Amortization, 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r291",
      "r294",
      "r297",
      "r301",
      "r659",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r297",
      "r663"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount, Finite Lived Intangibles"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r291",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r297",
      "r659"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Net Carrying Amount, Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in carrying value of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Period Increase (Decrease)",
        "terseLabel": "Finite-Lived Intangible Assets, Period Increase"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r292"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
        "label": "Finite-Lived Intangible Assets Acquired",
        "terseLabel": "Finite-lived Intangible Assets Acquired"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessAcquisitionsBusinessAcquisitionAssetsLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FixedMaturitiesMember": {
     "auth_ref": [
      "r775"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element provides types of investments that may be contained within the fixed maturity category which are securities having a stated final repayment date. Examples of items within this category may include bonds, including convertibles and bonds with warrants, and redeemable preferred stocks.",
        "label": "Fixed Maturities [Member]",
        "terseLabel": "Fixed Maturities [Member]"
       }
      }
     },
     "localname": "FixedMaturitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails",
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails",
      "http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails",
      "http://www.elevancehealth.com/role/InvestmentsNarrativeDetails",
      "http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignGovernmentDebtMember": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities (such as bonds) issued by a national, local, or municipal government not within the country of domicile of the entity.",
        "label": "Foreign Government Debt [Member]",
        "terseLabel": "Foreign Government Securities [Member]"
       }
      }
     },
     "localname": "ForeignGovernmentDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails",
      "http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainContingenciesByNatureAxis": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nature of gain contingency.",
        "label": "Gain Contingencies, Nature [Axis]",
        "terseLabel": "Gain Contingency, Nature [Axis]"
       }
      }
     },
     "localname": "GainContingenciesByNatureAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainContingencyNatureDomain": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or before issuance of the financial statements) that might result in a gain, typically reflecting care to avoid misleading implications as to the likelihood of realization.",
        "label": "Gain Contingency, Nature [Domain]",
        "terseLabel": "Gain Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "GainContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnInvestmentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of realized and unrealized gain (loss) on investment in security.",
        "label": "Gain (Loss) on Securities [Table Text Block]",
        "terseLabel": "Net Investment Gains (Losses)"
       }
      }
     },
     "localname": "GainLossOnInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossOnSaleOfOtherInvestments": {
     "auth_ref": [
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) included in earnings for investments classified as other.",
        "label": "Gain (Loss) on Sale of Other Investments",
        "terseLabel": "Net losses (gains) on other investments"
       }
      }
     },
     "localname": "GainLossOnSaleOfOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r112",
      "r384",
      "r385"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Loss on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails",
      "http://www.elevancehealth.com/role/SegmentInformationReconciliationOfIncomeBeforeIncomeTaxExpenseToReportableSegmentsOperatingGainIncludedInTheConsolidatedStatementsOfIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r14",
      "r276",
      "r277",
      "r284",
      "r288",
      "r624",
      "r666"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, Ending Balance",
        "periodStartLabel": "Goodwill, Beginning Balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessAcquisitionsBusinessAcquisitionAssetsLiabilitiesAcquiredDetails",
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets",
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsSummaryOfTheChangeInTheCarryingAmountOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r278",
      "r288"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill, Acquired During Period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessAcquisitionsBusinessAcquisitionAssetsLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Text Block]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillandOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r277",
      "r284",
      "r288"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "terseLabel": "Goodwill, Impaired, Accumulated Impairment Loss as of September 30, 2022"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsSummaryOfTheChangeInTheCarryingAmountOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsSummaryOfTheChangeInTheCarryingAmountOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPeriodIncreaseDecrease": {
     "auth_ref": [
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Period Increase (Decrease)",
        "terseLabel": "Goodwill, Period Increase (Decrease)"
       }
      }
     },
     "localname": "GoodwillPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsSummaryOfTheChangeInTheCarryingAmountOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r283",
      "r493"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Goodwill, Purchase Accounting Adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessAcquisitionsBusinessAcquisitionAssetsLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsSummaryOfTheChangeInTheCarryingAmountOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DerivativeFinancialInstrumentsFinancialStatementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r81",
      "r185",
      "r191",
      "r195",
      "r198",
      "r201",
      "r664",
      "r680",
      "r686",
      "r733"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income before income tax expense",
        "totalLabel": "Income before income tax expense"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome",
      "http://www.elevancehealth.com/role/SegmentInformationReconciliationOfIncomeBeforeIncomeTaxExpenseToReportableSegmentsOperatingGainIncludedInTheConsolidatedStatementsOfIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r82",
      "r112",
      "r182",
      "r250",
      "r679",
      "r725"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "Equity in net earnings of other invested assets"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r128",
      "r475",
      "r476",
      "r477",
      "r483",
      "r488",
      "r490",
      "r491",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r129",
      "r148",
      "r149",
      "r183",
      "r473",
      "r484",
      "r489",
      "r734"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome",
      "http://www.elevancehealth.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r27",
      "r675",
      "r723"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income taxes receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other.",
        "label": "Increase (Decrease) in Accounts Payable and Other Operating Liabilities",
        "terseLabel": "Accounts payable and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInCollateralHeldUnderSecuritiesLending": {
     "auth_ref": [],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the carrying amount of assets, which may include but are not limited to cash and investments, received as collateral pertaining to securities loaned to a counterparty to the transaction. Includes the change during the period in any unrealized gain or loss on such investments.",
        "label": "Increase (Decrease) in Collateral Held under Securities Lending",
        "negatedTerseLabel": "Changes in securities lending collateral"
       }
      }
     },
     "localname": "IncreaseDecreaseInCollateralHeldUnderSecuritiesLending",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "verboseLabel": "Unearned income"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes.",
        "label": "Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInsuranceLiabilities": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in insurance liability balances during the period.",
        "label": "Increase (Decrease) in Insurance Liabilities",
        "terseLabel": "Policy liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInInsuranceLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOutstandingChecksFinancingActivities": {
     "auth_ref": [
      "r115",
      "r116"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The change in cash during the period due to the net increase or decrease in outstanding checks, the liability that represents checks that have been issued but that have not cleared. The entity may classify these cash flows as financing or operating activities.",
        "label": "Increase (Decrease) in Outstanding Checks, Financing Activities",
        "terseLabel": "Changes in bank overdrafts"
       }
      }
     },
     "localname": "IncreaseDecreaseInOutstandingChecksFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Receivables, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInSecuritiesLendingPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the carrying amount of the liability pertaining to obligations to return collateral that the entity received when it loaned securities to the counterparty to the transaction.",
        "label": "Increase (Decrease) in Securities Lending Payable",
        "terseLabel": "Changes in securities lending payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInSecuritiesLendingPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTradingSecurities": {
     "auth_ref": [
      "r106",
      "r111"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of investment in debt and equity securities, measured at fair value with changes in fair value recognized in net income.",
        "label": "Increase (Decrease) in Debt Securities, Trading, and Equity Securities, FV-NI",
        "negatedLabel": "Other invested assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInTradingSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r293",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r300"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Net Carrying Amount, Indefinite-Lived Intangible Assets",
        "verboseLabel": "Gross Carrying Amount, Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r293",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets, Period Increase (Decrease)",
        "terseLabel": "Indefinite-Lived Intangible Assets, Period Decrease"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefinitelivedIntangibleAssetsAcquired": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.",
        "label": "Indefinite-Lived Intangible Assets Acquired",
        "terseLabel": "Indefinite-lived Intangible Assets Acquired"
       }
      }
     },
     "localname": "IndefinitelivedIntangibleAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessAcquisitionsBusinessAcquisitionAssetsLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InsuranceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance [Abstract]",
        "terseLabel": "Insurance [Abstract]"
       }
      }
     },
     "localname": "InsuranceAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InsuranceServicesRevenue": {
     "auth_ref": [
      "r735"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from insurance services, including net premiums earned, gain on sale of insurance block, agency management fees and insurance contract fees and commissions.",
        "label": "Insurance Services Revenue",
        "terseLabel": "Insurance Services Revenue",
        "verboseLabel": "Reportable segments operating revenues"
       }
      }
     },
     "localname": "InsuranceServicesRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails",
      "http://www.elevancehealth.com/role/SegmentInformationReconciliationOfReportableSegmentsOperatingRevenuesToTotalRevenuesReportedInTheConsolidatedStatementsOfIncomeDetails",
      "http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r14"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Gross Carrying Amount, Total Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r289",
      "r295"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other intangible assets",
        "verboseLabel": "Net Carrying Amount, Total Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets",
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r79",
      "r179",
      "r588",
      "r591",
      "r685"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome",
      "http://www.elevancehealth.com/role/SegmentInformationReconciliationOfIncomeBeforeIncomeTaxExpenseToReportableSegmentsOperatingGainIncludedInTheConsolidatedStatementsOfIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r177",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r197",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Eliminations [Member]"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r251",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investment, Policy"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails",
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails",
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails",
      "http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails",
      "http://www.elevancehealth.com/role/InvestmentsNarrativeDetails",
      "http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails",
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails",
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails",
      "http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails",
      "http://www.elevancehealth.com/role/InvestmentsNarrativeDetails",
      "http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Amortized Cost and Fair Value of Fixed Maturity Securities, By Contractual Maturity"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r245",
      "r665",
      "r695",
      "r792",
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r611",
      "r613"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesLeaseandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Disclosure [Table Text Block]"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r612"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "verboseLabel": "Total future minimum payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r612"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Operating lease payments, Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r612"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "Operating lease payments, 2022; excluding the nine months ended September 30, 2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r612"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "Operating lease payments, 2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r612"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "Operating lease payments, 2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r612"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "Operating lease payments, 2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r612"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "Operating lease payments, 2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r612"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Imputed Interest, Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseNotYetCommencedDescriptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Not yet Commenced, Description [Abstract]",
        "terseLabel": "Lessee, Operating Lease, Not yet Commenced, Description [Abstract]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseNotYetCommencedDescriptionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lessee, Operating Lease, Term of Contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r40",
      "r126",
      "r193",
      "r252",
      "r337",
      "r338",
      "r339",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r511",
      "r518",
      "r519",
      "r565",
      "r622",
      "r623"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r33",
      "r126",
      "r252",
      "r565",
      "r624",
      "r673",
      "r716"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r11",
      "r42",
      "r126",
      "r252",
      "r337",
      "r338",
      "r339",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r511",
      "r518",
      "r519",
      "r565",
      "r622",
      "r623",
      "r624"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r743",
      "r746"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
        "label": "Liability for Claims and Claims Adjustment Expense",
        "terseLabel": "Gross medical claims payable, end of period",
        "verboseLabel": "Medical claims payable"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableMedicalClaimsPayableReconciliationoftheClaimsDevelopmenttotheClaimsLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Claims and Claims Adjustment Expense [Abstract]",
        "terseLabel": "Liability for Claims and Claims Adjustment Expense [Abstract]"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Liability for Claims and Claims Adjustment Expense [Line Items]",
        "terseLabel": "Medical Claims Payable [Line Items]"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the liability for claims and claims adjustment expense.",
        "label": "Liability for Claims and Claims Adjustment Expense [Table]",
        "terseLabel": "Medical Claims Payable"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefits": {
     "auth_ref": [
      "r704",
      "r753",
      "r754",
      "r758",
      "r765"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance, of present value of future benefit to be paid to or on behalf of policyholder and related expense less present value of future net premium receivable under insurance contract.",
        "label": "Liability for Future Policy Benefit, before Reinsurance",
        "terseLabel": "Reserves for future policy benefits, noncurrent"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock": {
     "auth_ref": [
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments.",
        "label": "Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]",
        "terseLabel": "Medical Claims payable"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": {
     "auth_ref": [
      "r745"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year",
        "terseLabel": "Net payments attributable to current period medical claims"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": {
     "auth_ref": [
      "r745"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years",
        "terseLabel": "Net payments attributable to prior periods medical claims"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": {
     "auth_ref": [
      "r744"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims",
        "terseLabel": "Total net incurred medical claims"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfNetIncurredMedicalClaimsToBenefitExpenseDetails",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet": {
     "auth_ref": [
      "r705",
      "r743",
      "r746"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Net",
        "periodStartLabel": "Net medical claims payable, beginning of period",
        "terseLabel": "Net medical claims payable, end of period"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableMedicalClaimsPayableReconciliationoftheClaimsDevelopmenttotheClaimsLiabilityDetails",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "State Medicaid Licenses [Member]"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityDescription": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the terms of a credit facility arrangement. Terms typically include interest rate, collateral required, guarantees required, repayment requirements, and restrictions on use of assets and activities of the entity.",
        "label": "Line of Credit Facility, Description",
        "terseLabel": "Line of Credit Facility, Description"
       }
      }
     },
     "localname": "LineOfCreditFacilityDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r37"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "verboseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Subsidiary Credit Facilities [Member]"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r23",
      "r363",
      "r378",
      "r380",
      "r381",
      "r671",
      "r712"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Long-term Debt",
        "verboseLabel": "Senior revolving credit facility"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails",
      "http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, less current portion"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Investments [Abstract]",
        "terseLabel": "Long-term investments:"
       }
      }
     },
     "localname": "LongTermInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment.",
        "label": "Long-Term Purchase Commitment, Amount",
        "terseLabel": "Long-term purchase commitment, amount"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtConvertibleDebentureDetailsDetails",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r45",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtConvertibleDebentureDetailsDetails",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r333",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualPayments": {
     "auth_ref": [
      "r324"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow reducing loss contingency liability.",
        "label": "Loss Contingency Accrual, Payments",
        "terseLabel": "Loss Contingency Accrual, Payments"
       }
      }
     },
     "localname": "LossContingencyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r324",
      "r325",
      "r327"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Approximate amount of damages sought for breaches"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "auth_ref": [
      "r326",
      "r328",
      "r333"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.",
        "label": "Loss Contingency, Estimate of Possible Loss",
        "terseLabel": "Aggregate settlement amount"
       }
      }
     },
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r333",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r325",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Loss Contingency, Pending Claims, Number"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MarketableSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Marketable Securities [Line Items]",
        "terseLabel": "Equity Securities [Line Items]"
       }
      }
     },
     "localname": "MarketableSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsCurrentEquitySecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in marketable security.",
        "label": "Marketable Securities [Table]",
        "terseLabel": "Equity Securities [Table]"
       }
      }
     },
     "localname": "MarketableSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsCurrentEquitySecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MaturityOvernightMember": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maturity period of the day after the reporting date for repurchase agreements and similar transactions, for example, but not limited to, securities lending arrangements.",
        "label": "Maturity Overnight [Member]",
        "terseLabel": "Overnight and Continuous [Member]"
       }
      }
     },
     "localname": "MaturityOvernightMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r7",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "Business Acquisitions"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessAcquisitions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r49",
      "r126",
      "r252",
      "r337",
      "r341",
      "r342",
      "r343",
      "r346",
      "r347",
      "r565",
      "r672",
      "r715"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "periodEndLabel": "Noncontrolling interests, Ending Balance",
        "periodStartLabel": "Noncontrolling interests, Beginning Balance",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r170",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Organization"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/Organization"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r108",
      "r110",
      "r113"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r6",
      "r69",
      "r72",
      "r77",
      "r83",
      "r113",
      "r126",
      "r138",
      "r142",
      "r143",
      "r144",
      "r145",
      "r148",
      "r149",
      "r156",
      "r185",
      "r191",
      "r195",
      "r198",
      "r201",
      "r252",
      "r337",
      "r338",
      "r339",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r546",
      "r565",
      "r681",
      "r726"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Shareholders' net income",
        "totalLabel": "Shareholders\u2019 net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r69",
      "r72",
      "r77",
      "r148",
      "r149",
      "r513",
      "r521"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Net loss (income) attributable to noncontrolling interests",
        "terseLabel": "Net Income (Loss) Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentIncome": {
     "auth_ref": [
      "r728"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.",
        "label": "Net Investment Income",
        "negatedTerseLabel": "Net investment income",
        "terseLabel": "Net investment income"
       }
      }
     },
     "localname": "NetInvestmentIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome",
      "http://www.elevancehealth.com/role/SegmentInformationReconciliationOfIncomeBeforeIncomeTaxExpenseToReportableSegmentsOperatingGainIncludedInTheConsolidatedStatementsOfIncomeDetails",
      "http://www.elevancehealth.com/role/SegmentInformationReconciliationOfReportableSegmentsOperatingRevenuesToTotalRevenuesReportedInTheConsolidatedStatementsOfIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": {
     "auth_ref": [
      "r411",
      "r509",
      "r515"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance",
        "terseLabel": "Noncontrolling interests adjustment"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r410",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest [Member]"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesPayable": {
     "auth_ref": [
      "r23",
      "r671",
      "r712"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.",
        "label": "Notes Payable",
        "terseLabel": "Notes"
       }
      }
     },
     "localname": "NotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of Reportable Segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationSegmentInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStatesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of states the entity operates in as of the balance sheet date.",
        "label": "Number of States in which Entity Operates",
        "terseLabel": "Number of states in which the Company is licensed to conduct insurance operations"
       }
      }
     },
     "localname": "NumberOfStatesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/OrganizationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r185",
      "r191",
      "r195",
      "r198",
      "r201"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Reportable segments operating gain",
        "verboseLabel": "Operating gain (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails",
      "http://www.elevancehealth.com/role/SegmentInformationReconciliationOfIncomeBeforeIncomeTaxExpenseToReportableSegmentsOperatingGainIncludedInTheConsolidatedStatementsOfIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r604",
      "r613"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating Lease, Cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesLeaseandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r599"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating Lease Liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesReconciliationofFutureLeasePaymentstoTotalLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r599"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating Lease, Liability, Current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesLeaseandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Balance sheet location of current operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesLeaseandOtherInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r599"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesLeaseandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Balance sheet location of noncurrent operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesLeaseandOtherInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r601",
      "r607"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating Lease, Payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesLeaseandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r598"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesLeaseandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Balance sheet location of operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesLeaseandOtherInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r610",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r609",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityEquityAxis": {
     "auth_ref": [
      "r388",
      "r531",
      "r532",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of options indexed to an issuer's equity.",
        "label": "Option Indexed to Issuer's Equity [Axis]",
        "terseLabel": "Option Indexed to Issuer's Equity [Axis]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityEquityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding.",
        "label": "Option Indexed to Issuer's Equity, Type [Domain]",
        "terseLabel": "Option Indexed to Issuer's Equity, Type [Domain]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAggregatedInvestmentsMember": {
     "auth_ref": [
      "r778",
      "r781",
      "r784"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other investments in debt and equity securities and other forms of securities that provide ownership interests.",
        "label": "Other Security Investments [Member]",
        "terseLabel": "Other Securities [Member]"
       }
      }
     },
     "localname": "OtherAggregatedInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails",
      "http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails",
      "http://www.elevancehealth.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r34",
      "r624"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other noncurrent assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r56",
      "r57",
      "r63"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "verboseLabel": "Change in net unrealized losses/gains on investments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, Tax",
        "terseLabel": "Net holding gain (loss) on investment securities arising during the period, tax (expense) benefit"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r55",
      "r63"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Cash flow hedges, holding gain (loss), net of tax",
        "verboseLabel": "Change in net unrealized gains/losses on cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax",
        "terseLabel": "Cash flow hedges, holding gain (loss), tax (expense) benefit"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment, net of tax",
        "verboseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "auth_ref": [
      "r53",
      "r64",
      "r574",
      "r582"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax (Expense) Benefit"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r70",
      "r73",
      "r75",
      "r76",
      "r78",
      "r84",
      "r404",
      "r576",
      "r581",
      "r583",
      "r682",
      "r727"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive (loss) income, net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r70",
      "r73",
      "r507",
      "r508",
      "r516"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Other comprehensive loss attributable to noncontrolling interests",
        "terseLabel": "Other Comprehensive (Loss) Income, Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r70",
      "r73",
      "r507",
      "r508",
      "r516"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "verboseLabel": "Shareholders' other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r61",
      "r63"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedLabel": "Change in net periodic pension and postretirement costs",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": {
     "auth_ref": [
      "r63",
      "r67",
      "r68",
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax": {
     "auth_ref": [
      "r64",
      "r244"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax",
        "negatedTerseLabel": "Reclassification adjustment for net realized loss (gain) on investment securities, tax (benefit) expense"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r507",
      "r508",
      "r516"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to noncontrolling interest.",
        "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": {
     "auth_ref": [
      "r507",
      "r508",
      "r516"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent",
        "terseLabel": "Other Comprehensive Income (Loss), Tax (Expense) Benefit, Portion Attributable to Parent"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r56",
      "r63"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDebtSecuritiesMember": {
     "auth_ref": [
      "r238",
      "r267",
      "r421",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt securities classified as other.",
        "label": "Other Debt Obligations [Member]",
        "terseLabel": "Other Securities [Member]"
       }
      }
     },
     "localname": "OtherDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIncome": {
     "auth_ref": [
      "r737"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "elv_OperatingRevenue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue and income classified as other.",
        "label": "Other Income",
        "terseLabel": "Administrative fees and other revenue"
       }
      }
     },
     "localname": "OtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other [Member]"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other investments.",
        "label": "Other Investments [Member]",
        "terseLabel": "Other Investments [Member]"
       }
      }
     },
     "localname": "OtherInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails",
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r41",
      "r624"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other noncurrent liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermInvestments": {
     "auth_ref": [
      "r13",
      "r721"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term investments classified as other.",
        "label": "Other Long-Term Investments",
        "terseLabel": "Other invested assets",
        "verboseLabel": "Other invested assets"
       }
      }
     },
     "localname": "OtherLongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets",
      "http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails",
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPolicyholderFunds": {
     "auth_ref": [
      "r722"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due to policyholders for funds held that are returnable under the terms of insurance contracts, classified as other.",
        "label": "Other Policyholder Funds",
        "terseLabel": "Other policyholder liabilities"
       }
      }
     },
     "localname": "OtherPolicyholderFunds",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivables": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from parties in nontrade transactions, classified as other.",
        "label": "Other Receivables",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities": {
     "auth_ref": [
      "r58",
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other than temporary impairment (OTTI) loss on investment in available-for-sale debt security, recognized in other comprehensive loss.",
        "label": "Other than Temporary Impairment Losses, Investments, Portion in Other Comprehensive Loss, Net of Tax, Including Portion Attributable to Noncontrolling Interest, Available-for-Sale Securities",
        "terseLabel": "Other than Temporary Impairment Losses, Investments, Portion in Other Comprehensive Loss, Net of Tax, Including Portion Attributable to Noncontrolling Interest, Available-for-sale Securities"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": {
     "auth_ref": [
      "r109",
      "r745"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid",
        "totalLabel": "Total net payments"
       }
      }
     },
     "localname": "PaymentsForLossesAndLossAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r95",
      "r98"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase and retirement of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r105",
      "r308"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedLabel": "Payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessOptimizationInitiativesEmployeeTerminationCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Cash dividends",
        "terseLabel": "Total payment"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofCashDividendActivityDetails",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedLabel": "Taxes paid through withholding of common stock under employee stock plans"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Purchases of subsidiaries, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedTerseLabel": "Purchases of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredNet": {
     "auth_ref": [
      "r701",
      "r738"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred.",
        "label": "Policyholder Benefits and Claims Incurred, Net",
        "terseLabel": "Benefit expense"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfNetIncurredMedicalClaimsToBenefitExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PositionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by position taken for a security.",
        "label": "Position [Axis]",
        "terseLabel": "Position [Axis]"
       }
      }
     },
     "localname": "PositionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PositionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates position taken for a security.",
        "label": "Position [Domain]",
        "terseLabel": "Position [Domain]"
       }
      }
     },
     "localname": "PositionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r25",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r25",
      "r624"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "verboseLabel": "Preferred stock, without par value, shares authorized \u2013 100,000,000; shares issued and outstanding \u2013 none"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsEarnedNet": {
     "auth_ref": [
      "r678",
      "r724",
      "r741",
      "r773"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "elv_OperatingRevenue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.",
        "label": "Premiums Earned, Net",
        "terseLabel": "Premiums"
       }
      }
     },
     "localname": "PremiumsEarnedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r208",
      "r210",
      "r260",
      "r261",
      "r707"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the estimated valuation allowance to reduce gross premiums receivable to net realizable value.",
        "label": "Premium Receivable, Allowance for Credit Loss",
        "terseLabel": "Premium receivable, allowance for doubtful accounts"
       }
      }
     },
     "localname": "PremiumsReceivableAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsReceivableAtCarryingValue": {
     "auth_ref": [
      "r720"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.",
        "label": "Premiums Receivable, Net",
        "terseLabel": "Premium receivables"
       }
      }
     },
     "localname": "PremiumsReceivableAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PresentValueOfFutureInsuranceProfitsTableTextBlock": {
     "auth_ref": [
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of present value of future profits of insurance contract acquired in business combination.",
        "label": "Present Value of Future Insurance Profits [Table Text Block]",
        "terseLabel": "Components Of Other Intangible Assets"
       }
      }
     },
     "localname": "PresentValueOfFutureInsuranceProfitsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PrivateEquityFundsMember": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments held in private equity funds.",
        "label": "Private Equity Funds [Member]",
        "terseLabel": "Private Equity Funds [Member]",
        "verboseLabel": "Private Equity Securities [Member]"
       }
      }
     },
     "localname": "PrivateEquityFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.elevancehealth.com/role/InvestmentsCurrentEquitySecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r94"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "verboseLabel": "Proceeds originally received at time of divestiture"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Proceeds from long-term borrowings"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r92",
      "r93",
      "r220"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale",
        "terseLabel": "Maturities, calls and redemptions from investments"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r101",
      "r104"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r100",
      "r103",
      "r116"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.",
        "label": "Proceeds from (Repayments of) Commercial Paper",
        "terseLabel": "Net proceeds from (repayments of) commercial paper borrowings"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r92",
      "r93",
      "r220"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-Sale",
        "terseLabel": "Proceeds from Sale of Available-for-sale Securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from Short-Term Debt",
        "terseLabel": "Proceeds from short-term borrowings"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r99",
      "r466"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from issuance of common stock under employee stock plans"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r6",
      "r69",
      "r72",
      "r77",
      "r107",
      "r126",
      "r138",
      "r148",
      "r149",
      "r185",
      "r191",
      "r195",
      "r198",
      "r201",
      "r252",
      "r337",
      "r338",
      "r339",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r507",
      "r512",
      "r514",
      "r521",
      "r522",
      "r546",
      "r565",
      "r686"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r303",
      "r624",
      "r696",
      "r718"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r209",
      "r213",
      "r214",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r191",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "verboseLabel": "Reconciliation Of Income Before Income Tax Expense To Reportable Segments Operating Gain Included In The Consolidated Statements Of Income"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r190",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table Text Block]",
        "verboseLabel": "Reconciliation Of Reportable Segments Operating Revenues To Total Revenues Reported In The Consolidated Statements Of Income"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments": {
     "auth_ref": [
      "r702",
      "r742",
      "r743",
      "r746"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.",
        "label": "Reinsurance Recoverable for Unpaid Claims and Claims Adjustments",
        "negatedPeriodStartLabel": "Ceded medical claims payable, beginning of period",
        "periodEndLabel": "Ceded medical claims payable, end of period",
        "terseLabel": "Ceded medical claims payable end of period"
       }
      }
     },
     "localname": "ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableMedicalClaimsPayableReconciliationoftheClaimsDevelopmenttotheClaimsLiabilityDetails",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedLabel": "Repayments of long-term borrowings",
        "terseLabel": "Repayments of Long-term Debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Repayments of Short-Term Debt",
        "negatedLabel": "Repayments of short-term borrowings"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResidentialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r223",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by residential real estate mortgage loans.",
        "label": "Residential Mortgage-Backed Securities [Member]",
        "terseLabel": "Residential Mortgage-Backed Securities [Member]"
       }
      }
     },
     "localname": "ResidentialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails",
      "http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails",
      "http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndInvestmentsCurrent": {
     "auth_ref": [
      "r35",
      "r793",
      "r794"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.",
        "label": "Restricted Cash and Investments, Current",
        "terseLabel": "Customer funds and cash and cash equivalents on deposit for regulatory requirements"
       }
      }
     },
     "localname": "RestrictedCashAndInvestmentsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs) [Member]"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r306",
      "r308",
      "r311",
      "r319",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Business Optimization Initiatives"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessOptimizationInitiatives"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r307",
      "r308",
      "r316",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Business Optimization Initiatives by Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessOptimizationInitiativesEmployeeTerminationCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Business Optimization Initiatives [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessOptimizationInitiativesEmployeeTerminationCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r308",
      "r314"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Liability for employee terminations costs, ending",
        "periodStartLabel": "Liability for employee terminations costs, beginning"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessOptimizationInitiativesEmployeeTerminationCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r29",
      "r410",
      "r624",
      "r714",
      "r766",
      "r771"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r134",
      "r135",
      "r136",
      "r139",
      "r147",
      "r149",
      "r256",
      "r467",
      "r468",
      "r469",
      "r481",
      "r482",
      "r544",
      "r762",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]",
        "verboseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r120",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r80",
      "r126",
      "r176",
      "r177",
      "r190",
      "r196",
      "r197",
      "r203",
      "r204",
      "r206",
      "r252",
      "r337",
      "r338",
      "r339",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r565",
      "r686"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome",
      "http://www.elevancehealth.com/role/SegmentInformationReconciliationOfReportableSegmentsOperatingRevenuesToTotalRevenuesReportedInTheConsolidatedStatementsOfIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Senior Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r608",
      "r613"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for new operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesLeaseandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Activity in Liability [Abstract]",
        "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense, Activity in Liability [Abstract]"
       }
      }
     },
     "localname": "RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r66",
      "r581",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Reconciliation Of Components Of Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]",
        "verboseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails",
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails",
      "http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Current and Long-Term Investments, Available-For-Sale"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r230",
      "r235",
      "r239",
      "r240",
      "r241",
      "r243",
      "r688",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-Sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails",
      "http://www.elevancehealth.com/role/InvestmentsAmortizedCostAndFairValueOfFixedMaturitySecuritiesByContractualMaturityDetails",
      "http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r494",
      "r495",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Business Acquisitions [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessAcquisitionsBusinessAcquisitionAssetsLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Denominator for Basic and Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r464",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r549",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value Measurements By Level For Assets Measured At Fair Value On A Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Gain (Loss) on Securities [Line Items]",
        "terseLabel": "Investment [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGainLossOnInvestmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about realized and unrealized gain (loss) on investment in security.",
        "label": "Schedule of Gain (Loss) on Securities [Table]",
        "terseLabel": "Investment [Table]"
       }
      }
     },
     "localname": "ScheduleOfGainLossOnInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNetInvestmentGainsLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsSummaryOfTheChangeInTheCarryingAmountOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Summary Of The Change In The Carrying Amount Of Goodwill By Reportable Segment"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable": {
     "auth_ref": [
      "r89",
      "r90",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.",
        "label": "Investment Income [Table]",
        "terseLabel": "Investment Income [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Investments [Line Items]",
        "terseLabel": "Schedule of Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
        "terseLabel": "Reconciliation Of The Beginning And Ending Balances For Medical Claims Payable"
       }
      }
     },
     "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r307",
      "r308",
      "r309",
      "r310",
      "r316",
      "r317",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Business Optimization Initiatives [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessOptimizationInitiativesEmployeeTerminationCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r312",
      "r313",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Business Optimization Initiatives"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessOptimizationInitiativesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r185",
      "r188",
      "r194",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r185",
      "r188",
      "r194",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Financial Data By Reportable Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r437",
      "r452",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Summary of Weighted-Average Assumptions Used to Estimate the Fair Value of Options Granted During the Periods"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "verboseLabel": "Summary of Nonvested Restricted Stock Activity Including Restricted Stock Units"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r412",
      "r413",
      "r414",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Summary of Share Repurchases"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value).",
        "label": "Schedule of Unrealized Loss on Investments [Table Text Block]",
        "terseLabel": "Aggregate Fair Value and Gross Unrealized Loss of Fixed Maturity Securities in an Unrealized Loss Position"
       }
      }
     },
     "localname": "ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuritiesHeldAsCollateralAtFairValue": {
     "auth_ref": [
      "r211"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount (fair value) as of the balance sheet date of securities held that had been pledged by counterparties under financing and lending arrangements, pursuant to which the entity has the right by agreement or custom to sell or re-pledge such securities.",
        "label": "Securities Held as Collateral, at Fair Value",
        "terseLabel": "Securities lending collateral"
       }
      }
     },
     "localname": "SecuritiesHeldAsCollateralAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SecuritiesLoanedFairValueOfCollateral": {
     "auth_ref": [
      "r51"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the securities pledged as collateral against securities loaned.",
        "label": "Securities Loaned, Fair Value of Collateral",
        "verboseLabel": "Fair value of collateral received at time of securities lending transactions"
       }
      }
     },
     "localname": "SecuritiesLoanedFairValueOfCollateral",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r172",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r201",
      "r206",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r288",
      "r310",
      "r318",
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessOptimizationInitiativesEmployeeTerminationCostsDetails",
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsSummaryOfTheChangeInTheCarryingAmountOfGoodwillByReportableSegmentDetails",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableMedicalClaimsPayableReconciliationoftheClaimsDevelopmenttotheClaimsLiabilityDetails",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableNarrativeDetails",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfNetIncurredMedicalClaimsToBenefitExpenseDetails",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails",
      "http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract]",
        "terseLabel": "Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r172",
      "r174",
      "r175",
      "r185",
      "r189",
      "r195",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r205",
      "r206",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/SegmentInformationFinancialDataByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expense"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited, Restricted Stock Shares And Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNonvestedRestrictedStockActivityIncludingRestrictedStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited, Weighted-Average Grant Date Fair Value per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNonvestedRestrictedStockActivityIncludingRestrictedStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted, Restricted Stock Shares and Units",
        "verboseLabel": "Restricted stock units issued under stock incentive plan"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNonvestedRestrictedStockActivityIncludingRestrictedStockUnitsDetails",
      "http://www.elevancehealth.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Restricted stock awards granted during the period",
        "verboseLabel": "Granted, Weighted-Average Grant Date Fair Value per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNonvestedRestrictedStockActivityIncludingRestrictedStockUnitsDetails",
      "http://www.elevancehealth.com/role/CapitalStockScheduleOfWeightedAverageFairValuesDeterminedForThePeriodsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r446",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Nonvested at Ending Balance, Restricted Stock Shares and Units",
        "periodStartLabel": "Nonvested at Beginning Balance, Restricted Stock Shares and Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNonvestedRestrictedStockActivityIncludingRestrictedStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Restricted Stock Shares and Units [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNonvestedRestrictedStockActivityIncludingRestrictedStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r446",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Nonvested at Ending Balance, Weighted-Average Grant Date Fair Value per Share",
        "periodStartLabel": "Nonvested at Beginning Balance, Weighted-Average Grant Date Fair Value per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNonvestedRestrictedStockActivityIncludingRestrictedStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value Per Share [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNonvestedRestrictedStockActivityIncludingRestrictedStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested, Restricted Stock Shares And Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNonvestedRestrictedStockActivityIncludingRestrictedStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Vested, Weighted-Average Grant Date Fair Value per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNonvestedRestrictedStockActivityIncludingRestrictedStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Quarterly dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockFairValuesofOptionsGrantedDuringThePeriodEstimatedUsingWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Volatility factor"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockFairValuesofOptionsGrantedDuringThePeriodEstimatedUsingWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockFairValuesofOptionsGrantedDuringThePeriodEstimatedUsingWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable at end of period, Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable at end of period, Weighted-Average Option Price per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Forfeited or expired, Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "verboseLabel": "Forfeited or expired, Weighted-Average Option Price per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "verboseLabel": "Granted, Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Options granted during the period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockScheduleOfWeightedAverageFairValuesDeterminedForThePeriodsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock": {
     "auth_ref": [
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Weighted-Average Fair Values Determined for the Periods"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r465"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Outstanding at end of period, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r438",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at end of period, Number of Shares",
        "periodStartLabel": "Outstanding at beginning of period, Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r438",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at end of period, Weighted-Average Option Price per Share",
        "periodStartLabel": "Outstanding at beginning of period, Weighted-Average Option Price per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Option Price Per Share [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r457"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "verboseLabel": "Exercisable at end of period, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r434",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r453",
      "r454",
      "r456",
      "r457",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Exercised, Weighted-Average Option Price per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted, Weighted-Average Option Price per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Weighted-average expected life (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockFairValuesofOptionsGrantedDuringThePeriodEstimatedUsingWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable at end of period, Weighted-Average Remaining Contractual Life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding at end of period, Weighted-Average Remaining Contractual Life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance (in shares), Ending",
        "periodStartLabel": "Balance (in shares), Beginning"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortDurationInsuranceContractAccidentYear2020Member": {
     "auth_ref": [
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year 2020 in which covered event occurs under terms of short-duration insurance contract.",
        "label": "Short-Duration Insurance Contract, Accident Year 2020 [Member]",
        "terseLabel": "Short-Duration Insurance Contract, Accident Year 2020 [Member]"
       }
      }
     },
     "localname": "ShortDurationInsuranceContractAccidentYear2020Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortDurationInsuranceContractAccidentYear2021Member": {
     "auth_ref": [
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year 2021 in which covered event occurs under terms of short-duration insurance contract.",
        "label": "Short-Duration Insurance Contract, Accident Year 2021 [Member]",
        "terseLabel": "Short-Duration Insurance Contract, Accident Year 2021 [Member]"
       }
      }
     },
     "localname": "ShortDurationInsuranceContractAccidentYear2021Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortDurationInsuranceContractAccidentYear2022Member": {
     "auth_ref": [
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year 2022 in which covered event occurs under terms of short-duration insurance contract.",
        "label": "Short-Duration Insurance Contract, Accident Year 2022 [Member]",
        "terseLabel": "Short-Duration Insurance Contract, Accident Year 2022 [Member]"
       }
      }
     },
     "localname": "ShortDurationInsuranceContractAccidentYear2022Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r19",
      "r624",
      "r670",
      "r711"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-Term Debt",
        "terseLabel": "Short-term borrowings",
        "verboseLabel": "Short-term borrowings"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails",
      "http://www.elevancehealth.com/role/FairValueCarryingAndEstimatedFairValuesbyLevelOfFinancialInstrumentsNotRecordedAtFairValueOnConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-Term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-Term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r605",
      "r613"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-Term Lease, Cost",
        "terseLabel": "Short-term Lease, Cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesLeaseandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsAccidentYearAxis": {
     "auth_ref": [
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by accident year in which a covered event occurs under the terms of the short-duration insurance contract.",
        "label": "Short-Duration Insurance Contracts, Accident Year [Axis]",
        "terseLabel": "Short-duration Insurance Contracts, Claim Year [Axis]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsAccidentYearAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsAccidentYearDomain": {
     "auth_ref": [
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year in which a covered event occurs under the terms of the short-duration insurance contract.",
        "label": "Short-Duration Insurance Contracts, Accident Year [Domain]",
        "terseLabel": "Short-duration Insurance Contracts, Claim Year [Domain]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsAccidentYearDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable": {
     "auth_ref": [
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about undiscounted information about claims development by accident year for short-duration insurance contracts.",
        "label": "Short-Duration Insurance Contracts, Claims Development [Table]",
        "terseLabel": "Short-duration Insurance Contracts, Claims Development [Table]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsClaimsDevelopmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet": {
     "auth_ref": [
      "r750",
      "r751"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net",
        "terseLabel": "Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem": {
     "auth_ref": [
      "r749"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reconciling item for the reconciliation of the liability in the disclosure of claims development (in excess of) less than the liability for unpaid claims and claims adjustment expense for short-duration insurance contracts, classified as other.",
        "label": "Short-Duration Insurance Contracts, Liability for Unpaid Claims and Claim Adjustment Expense, Other Reconciling Item",
        "terseLabel": "Insurance lines other than short duration"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableMedicalClaimsPayableReconciliationoftheClaimsDevelopmenttotheClaimsLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]",
        "terseLabel": "Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableMedicalClaimsPayableReconciliationoftheClaimsDevelopmenttotheClaimsLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable": {
     "auth_ref": [
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the reconciliation of claims development to the liability for unpaid claims and claim adjustment expense for short-duration insurance contracts.",
        "label": "Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table]",
        "terseLabel": "Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableMedicalClaimsPayableReconciliationoftheClaimsDevelopmenttotheClaimsLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock": {
     "auth_ref": [
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for the reconciliation of claims development to the liability for unpaid claims and claim adjustment expense for short-duration insurance contracts.",
        "label": "Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table Text Block]",
        "terseLabel": "Reconciliation of Short Duration Medical Claims Payable to the Consolidated Medical Claims Payable"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r5",
      "r172",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r201",
      "r206",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r288",
      "r304",
      "r310",
      "r318",
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessOptimizationInitiativesEmployeeTerminationCostsDetails",
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsSummaryOfTheChangeInTheCarryingAmountOfGoodwillByReportableSegmentDetails",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableMedicalClaimsPayableReconciliationoftheClaimsDevelopmenttotheClaimsLiabilityDetails",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableNarrativeDetails",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfNetIncurredMedicalClaimsToBenefitExpenseDetails",
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails",
      "http://www.elevancehealth.com/role/SegmentInformationSegmentInformationMajorProductRevenuesforEachReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r24",
      "r25",
      "r26",
      "r123",
      "r126",
      "r153",
      "r154",
      "r155",
      "r157",
      "r159",
      "r167",
      "r168",
      "r169",
      "r252",
      "r337",
      "r341",
      "r342",
      "r343",
      "r346",
      "r347",
      "r389",
      "r390",
      "r393",
      "r397",
      "r404",
      "r565",
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r48",
      "r75",
      "r76",
      "r77",
      "r134",
      "r135",
      "r136",
      "r139",
      "r147",
      "r149",
      "r166",
      "r256",
      "r404",
      "r410",
      "r467",
      "r468",
      "r469",
      "r481",
      "r482",
      "r544",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r583",
      "r620",
      "r762",
      "r763",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Statement, Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails",
      "http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity",
      "http://www.elevancehealth.com/role/EarningsPerShareNarrativeDetails",
      "http://www.elevancehealth.com/role/LeasesLeaseandOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r166",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/AccumulatedOtherComprehensiveLossReconciliationOfTheComponentsOfAccumulatedOtherComprehensiveLossDetails",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity",
      "http://www.elevancehealth.com/role/EarningsPerShareNarrativeDetails",
      "http://www.elevancehealth.com/role/LeasesLeaseandOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r25",
      "r26",
      "r404",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under employee stock plans, net of related tax benefits, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r25",
      "r26",
      "r404",
      "r410",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised, Number of Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r48",
      "r404",
      "r410"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock under employee stock plans, net of related tax benefits"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Authorization remaining at the end of the period"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r25",
      "r26",
      "r404",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedTerseLabel": "Repurchase and retirement of common stock, shares",
        "verboseLabel": "Shares repurchased"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofShareRepurchasesDetails",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r25",
      "r26",
      "r404",
      "r410"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedTerseLabel": "Repurchase and retirement of common stock",
        "terseLabel": "Aggregate cost"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockSummaryofShareRepurchasesDetails",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r26",
      "r31",
      "r32",
      "r126",
      "r212",
      "r252",
      "r565",
      "r624"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Total shareholders' equity, Ending Balance",
        "periodStartLabel": "Total shareholders' equity, Beginning Balance",
        "terseLabel": "Stockholders' equity attributable to parent",
        "totalLabel": "Total shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails",
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r2",
      "r3",
      "r76",
      "r126",
      "r134",
      "r135",
      "r136",
      "r139",
      "r147",
      "r252",
      "r256",
      "r410",
      "r467",
      "r468",
      "r469",
      "r481",
      "r482",
      "r505",
      "r506",
      "r520",
      "r544",
      "r565",
      "r576",
      "r577",
      "r583",
      "r620",
      "r763",
      "r764"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Total equity, Ending Balance",
        "periodStartLabel": "Total equity, Beginning Balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r124",
      "r390",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r403",
      "r410",
      "r416",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Capital Stock"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r606",
      "r613"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "negatedTerseLabel": "Sublease Income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/LeasesLeaseandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r584",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails",
      "http://www.elevancehealth.com/role/CapitalStockSummaryofShareRepurchasesDetails",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r584",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails",
      "http://www.elevancehealth.com/role/CapitalStockSummaryofShareRepurchasesDetails",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r584",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/CapitalStockNarrativeDetails",
      "http://www.elevancehealth.com/role/CapitalStockSummaryofShareRepurchasesDetails",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r744"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.",
        "label": "Current Year Claims and Claims Adjustment Expense",
        "terseLabel": "Current period net incurred medical claims"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r744"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.",
        "label": "Prior Year Claims and Claims Adjustment Expense",
        "negatedLabel": "Prior periods redundancies"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfTheBeginningAndEndingBalancesForMedicalClaimsPayableBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense": {
     "auth_ref": [
      "r740"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating expense classified as other, disclosed in supplementary insurance information.",
        "label": "SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Operating Expense",
        "terseLabel": "Quality improvement and other claims expense"
       }
      }
     },
     "localname": "SupplementaryInsuranceInformationOtherOperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/MedicalClaimsPayableReconciliationOfNetIncurredMedicalClaimsToBenefitExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Blue Cross And Blue Shield And Other Trademarks [Member]"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/GoodwillAndOtherIntangibleAssetsComponentsOfOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r236",
      "r237",
      "r246",
      "r247",
      "r248",
      "r375",
      "r402",
      "r533",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.elevancehealth.com/role/FairValueReconciliationOfTheBeginningAndEndingBalancesOfAssetsMeasuredAtFairValueOnARecurringBasisUsingLevelIIIInputsDetails",
      "http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails",
      "http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails",
      "http://www.elevancehealth.com/role/InvestmentsCurrentEquitySecuritiesDetails",
      "http://www.elevancehealth.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r138",
      "r139",
      "r140",
      "r141",
      "r150",
      "r216",
      "r217",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r467",
      "r468",
      "r469",
      "r479",
      "r480",
      "r481",
      "r482",
      "r501",
      "r502",
      "r503",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r586",
      "r587",
      "r594",
      "r595",
      "r596",
      "r597",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r660",
      "r661",
      "r662",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BasisofPresentationandSignficantAccountingPoliciesBasisofPresentationandSignificantAccontingPoliciesDetails",
      "http://www.elevancehealth.com/role/ConsolidatedStatementsOfChangesinEquity",
      "http://www.elevancehealth.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r307",
      "r308",
      "r316",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Business Optimization Initiatives by Type [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/BusinessOptimizationInitiativesEmployeeTerminationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r131",
      "r421",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "United States Government Securities [Member]"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails",
      "http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails",
      "http://www.elevancehealth.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember": {
     "auth_ref": [
      "r421",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, bonds and other debt securities issued by US government sponsored entities (GSEs), for example, but not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB). Excludes debt issued by the Government National Mortgage Association (GNMA or Ginnie Mae).",
        "label": "US Government-sponsored Enterprises Debt Securities [Member]",
        "terseLabel": "Government Sponsored Securities [Member]"
       }
      }
     },
     "localname": "USGovernmentSponsoredEnterprisesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails",
      "http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USStatesAndPoliticalSubdivisionsMember": {
     "auth_ref": [
      "r421",
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bonds or similar securities issued by state, city, or local US governments or the agencies operated by state, city, or local governments. Debt securities issued by state governments may include bond issuances of US state authorities including, for example, but not limited to, housing authorities, dormitory authorities, and general obligations while debt securities issued by political subdivisions of US states would include, for example, debt issuances by county, borough, city, or municipal governments.",
        "label": "US States and Political Subdivisions Debt Securities [Member]",
        "terseLabel": "States, Municipalities And Political Subdivisions [Member]"
       }
      }
     },
     "localname": "USStatesAndPoliticalSubdivisionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/FairValueFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.elevancehealth.com/role/InvestmentsAggregateFairValueAndGrossUnrealizedLossOfFixedMaturitySecuritiesInAnUnrealizedLossPositionDetails",
      "http://www.elevancehealth.com/role/InvestmentsCurrentAndLongTermFixedMaturitySecuritiesAvailableForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnearnedPremiums": {
     "auth_ref": [
      "r710"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date.",
        "label": "Unearned Premiums",
        "verboseLabel": "Unearned income"
       }
      }
     },
     "localname": "UnearnedPremiums",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtConvertibleDebentureDetailsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/DebtConvertibleDebentureDetailsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/EarningsPerShareDenominatorForBasicAndDilutedEarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "terseLabel": "Effect of dilutive securities \u2013 employee stock options, nonvested restricted stock awards and convertible debentures"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/EarningsPerShareDenominatorForBasicAndDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r152",
      "r159"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/EarningsPerShareDenominatorForBasicAndDilutedEarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Denominator for diluted earnings per share"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/EarningsPerShareDenominatorForBasicAndDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r151",
      "r159"
     ],
     "calculation": {
      "http://www.elevancehealth.com/role/EarningsPerShareDenominatorForBasicAndDilutedEarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Denominator for basic earnings per share - weighted-average shares"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.elevancehealth.com/role/EarningsPerShareDenominatorForBasicAndDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3444-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3095-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3098-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5086-111524"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260725&loc=d3e25362-111560"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=SL6284427-111562"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6283291-111563"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27340-111563"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=7516071&loc=d3e13374-112631"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "63",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=126970277&loc=d3e23176-110880"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569655-111683"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226013-175313"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "83",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126929950&loc=d3e34841-113949"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90193-114008"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90198-114008"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=SL116692626-108610"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/subtopic&trid=2176304"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13(3)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(c))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/subtopic&trid=2209399"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(g)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6811-158387"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6824-158387"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=122135039&loc=d3e569990-122904"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(13)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(13)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(13)(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),5)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(f))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.14)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.1,4)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.4)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.5)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.5,6,7)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120401096&loc=d3e574960-122915"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99404803&loc=d3e21412-158489"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(cc)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671315-158438"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671317-158438"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671321-158438"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819541-158441"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/subtopic&trid=2560295"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(c)(3)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(11))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "https://asc.fasb.org/subtopic&trid=2324412"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=127002003&loc=SL6242269-115581"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r799": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r800": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r801": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r802": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r803": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r804": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r805": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r806": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r807": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r808": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r809": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r810": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r811": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403"
  },
  "r812": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>99
<FILENAME>0001156039-22-000084-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001156039-22-000084-xbrl.zip
M4$L#!!0    ( ,=D4U5.J00>W<<# "SS,@ 0    96QV+3(P,C(P.3,P+FAT
M;>R]:Y=31[(M^GW_"E_.&/=3JYV/R)=OM\_ !KS=QX!M</O EQ[Q2A"N!UM5
MA8%??R,+"LRCVV +26N5>F]<)6EI295S9L2,R,R(O_WOIX<'GSW1U<GR^.CO
M5_Q?W97/_O>7?_M_%HO_^]6/WWUV[9C/#O7H]+.O5XJG*I_]NCQ]^-G/HB>_
M?-97QX>?_7R\^F7Y!!>+\_=\??SXV6KYX.'I9\&%\-:+JR]:21DRYD5WWBT
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MCT+N3ERX\N5_JF+QOVZ?/M35.5B_V9[V,6<6/\:V[*FS,]1II*VQQD6IH2S
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M=PT2N0.AN1D<3:Q*#"VI.ME]=NQ%Z:=A1E5LG'I''Q,4+Q5"<T8-YCRV5DY
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M<:Z. ^Y(C:24T5M1*4"?PT3:1BBU/H!\:[6E@"8>&+2W.A9E"Y11A"SFI#,
M:-NAU!J/I/342G$%@@BHX[&[O.<,D*'GGOP,P-IR*+4^K%H."!X\YA:!Q%%I
MU45,FFKI-K(SP&I+H=0:,:(8S0!2TNK ::T<2VF$Y&.LAM[NA[NOQ_SNL\=O
MK17>6#Y5N8FG'S9O9A.]_:E(^W5I@5=?]OWE!5Z]?'&C#RX*T+DW3=E\;JT0
M8\?H4F^E.9^I^CB'99JUQH1;F N[DNK)TA-)%^VA0\AIY'Q*]LTI97^AGG>:
M*KMHGZ:\B,B]!Q8IJ40$+$R9FU#KI. S0MPS8G+!]AK7+:NY%<B8O7- 3;!#
M9";&D2$FU#TYIA+?KW/79.A%U$)%C<"(;93X5%\2>R"7VYX34TPIK'%U5CP3
M@".O&3J;5P&?:C4H2[77)K U_].G%"ZQ FU%,E;5(&8^!"Q"00N:76?IR+[M
M(^0I)4[6*$-=9F!QU,DT!C2B6"46#NAJ]Y(N$RUV!1,7N\W.T'T)YNE[K0"9
M.UJ $$A3G$!R>!>GZFRV(D27QQH<<<K#C@O6U%$%DK9::0IE:?9IIPU1Q5FL
M&+2;5?<=M)?:8D@BE42DN%AVGRJ[:$FFO.$")#I3@-P*5FA^V(LV:B<%BRNK
M@PFL$N\B(V:RQR.DED=G=@H:P'-LZJ51MJ !1P_'NB?'5-).:]SXJ"7WKN0;
MF9400&\A) #'X)(RTIX34TP[K=&A%,VQ>U]-6)QOL#00-;663&7X$B=0LWF?
M=OJ$]*A)0ZC)^-$):O45?<P^>H>52VD3V#:XB^9C\OMU"F97?"HM8 .AA,Y%
M$36_PLY)N52TV!5,JJNQ>:[H<K"I*EBE,Y>L'KIWF5X6^2H3*/*U57#>KNKU
MH0WCUEBN#5&<1ZXY%$@^8X!0-,0 3(*3ZE:R4TANOCX;9^T^8%6IU:2WPR3:
M6O&=' :UB&PZ?1UW!\FM-'&,X"EE*ARC0.6,$I/K4CIA#T722R3]'LF/0_)#
MY^3ZD(0NTIUT'PM!<JU6I(  (;60YE'^X?I3?HA'#_3N"D7EQMF13&7M3,>!
MLE!23(9(JFK@V.^JT47?,TX@O[ESX*PQEU3$H4^I<^Z0@U <%00T#Y?&"?.$
M9\Y%G='CHQ?=!">W?2A&[>(QE3B:7818'8A/TK,%[NQ?;B^;YL39$C9KC):U
MHTF\5*1V:.);#.+:B)R[^A0FL/7O=XW:]ZOE$_/'+P":DL,I BR9?!2+FEU3
MS*-V(03I$B<^;[:$S?KFC8B7($7(APH9 :.R]]([(M94<"89C4]OU;:?TB!7
MQ45TC2&#4B*.0%XU=>Q%,<PD$-XPE%N)A%-(HH2E5$C0FE!MH9%J335WBZ=F
MDIW:_*S<?'JJUVC*I'&MS4-4(0$%0JB>DW=99Y+4V/RLW'Q6HV1QDDLN'/RY
MKS1YV8.CUGU2!#<37WF^<O9)U\NV[RN9M&'.H4CV0,KF.UW,D8&Y-!_GXBLW
M#.56?&73C"E%"B -HH.:NDNU9T&2IGU*_0UW",KM-)T/4;3[7J0U !^PM1:+
M6"!?T&#+,_&5FY^5F_>5U ,6[:$U1R,?4Z6CA2)!:K;HLLRA\,/7>/)P7=M9
MKIZ<Z.G)G>,#^>E(QKZ5E9XWSSBY>_RC/CY;\4,\T9=K1L^^/X?AY,UO<_'B
M[;'C>OG@X50.^6?)N<004^,$7 A=5Y-97#/7YEY6")EV<N@R$V6-?8P3C@:S
MX_!=@,;=7'PR?R\1J:AQ9?<MRN:Q6Q^'IUSGZ$U[DTK"[J1@C)"35(=:C4%F
M8912@=VW-WL:[8 UJ@%\[$HE6,C!79H+M83:2V@Q>Y[ #H<ITVCR9\I-"J=D
M]#'!XZ$VKN!)I29CDJCG"9PZW--GB]:GR]@EUZ'746I]G(27GIU&%7-FK4Z@
M,M8U/5\Q73[1UR"=?(/+H^^.3TZ^>O;?*@^61P]^U .[YOCHY.'R\;N:^L;!
M\:\O+YS(M$>G&M3WQ)4A@F_J0%/E3LV7WB;0SF!*N*VQ=FI5L\\94(2@!L52
M@X4?/B;)#MT$2H#<P.7JGWAPIE\]>_7K?]L=T0SUL^_TB1Z\M4GUXJ)OCQZ?
MG9Z<7^$G,LM\YZ 5:/0U !?*V L4DVN%6F\D4RCSM :TPD30JJ1$G(,)HFP6
M$3 ;5&%D?]GEGJ?0AF<-:,6IH*7B"P%1Z18^9V<!D,OB TO),=8I-+C:@"6<
M3<"\1N)@' 7(L3-XP-X:<F:?6I,>+'2>PH+ !HSRGCCO$*>,,M M-XXN@(9L
MQ&%I%CF[6%5A G6A/SU6>U?U/HL3.7<:&W."@RBI@N^N>1Y'7HQ&$PB2=[0(
MV&6*)5*-H3<,63%"3$22LN=0:XL]09A F>D9DV@J(4X"2C#6FX)FJ&CRQ[D4
M8_>IN.[2%-('\R719-R9Z]5)B-F!0%%LDB5)% K%^YPO259C<Y'7E#MGN!P=
M5TCB$@#73J4&GY6;">8 >1]L[;GRF^IUF'M'9Q)'H*'4ZD(-,4:+SM6E2V)7
M?L\+[+ER;E>:<JE8>V@14$9=AX051F5E[-JF(&0FY8-FTJNGM1Q]"L4U:,#%
M-]/!J5=IIEXRTA12.)-R1S.A#4:2T42T=E#(.5?,+:/&Y*-+7B:PQVI:GFDF
MM*FEM1H98DP-?#,KXU))B3AX\E[KY:#-YIS4M'N&>3*+PEAZ'(O.C2GFY KV
M"%UJT@DT_9F6;YHV6WH"#>A:AA @DL,>@CFI6JAEYCKE\DQ_#J"=<HF[PI9H
M]L2X$'I* 2#T9M['E8ZC9%1N%"; EDEYHFV7C%\?<Z08:<8NW^8$:HVUJ?/!
M55]\QIKW7FG/G'^[-3P%B=XQYP!-M$D&35$*E=ZRNR2Q]N:"IODPI[0$S56F
M3 RF<; 7@9A).R,4[A-@SNZTJ;A,>R0HB^_4/65 J-),\=2B@C&DJ*G-88_$
MM(@SE7T1F4OI3-R;\]!2H'"^Z7MTX.LM3+K8[32),Y7 JN9BX5,CTS;V?U4P
M.Z=2BZ IG;C?"[%ND7-^8'*2"9O4Q[ID$?OI@=#7TGL'[[-PKVT*/;VG%4A-
MERGLC"E58XVN@ODC\L0-*096"%&F$#BM'YR]]WD/4Z)#UTWA)J0&+;))7R%(
M([XN+83+R91= 4="2)0B)24/$#QZ]HH ."J2D9]"%+M+TF"--5_7Q\[I]EY)
M)3"3<&E01@G@:M]?$*L&EROC?F/FGIW;C,>+PJB(FW)74'-SH_^,D+$U\:O.
MYSO-SJT08E+YZNFR4WW1G% ;C ,0W5-U*301K\$T.DY@7\_>7*TW[QPH)G0-
M0D<@C:W6F+740N!B[!,P5SLE]=;?'&H;$V-7R.D;B*D[GWHE"SZT8;!0$4+5
M7G-)^\33GIQ;M)QB9"E21&J".':TF4-%8!=]R%6F$"3/@@\[I3%WA9QF):E2
M/B^/">;1&_0VMG(WWXR1<0HQ\BS(N3-\2*-S4B^0S5B9+VWLT;1_9;-4*8.;
M !]V2>;M9! RV=Z6/>9>HR.*G&$4)RH^MU:906*.?@IK ;LD\_;D7&L^S[F0
M70)-$L$CMU1XM-+)N=4<Z@3(.0\^[&7>>\C9BJ3J2 7]2.B9O)-N,3.)!TJ:
M)U">:Q[DW!4^( 9.33J6L=20\Z@#VYMSU"1$GL0NTIG*O%UAB$8L'2"2H(#/
ME5)IM15?7.;4+TL@L(M::V<8PMHB,L3L'73)Z%E:X\CB-.4P@=3!/KGT:1D"
M%<;!.@ F^XVX$3 D1(VML)_" =X93ML.V36)U8!1@T>K2G/J2^+><PR7Q+#/
M?2'OT[<]_23D#*U5(B^%HT)D:N9;"+T3#CU(NR15:.:^D#=1<K(CJ*Z33]2
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MDG1$$4[!]Z7!>D6)]\HIILN0*[NJ.S!SV<U-G!F9C%?1!JXUM>#F$.QR4Z5
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M.'5&!^#WR::@$S4VEK_=PLJJTWRZ=PB'DP>W4!/'!:QW*F?X \WRA%AP&TO
MKRIU6APV99-2@EK%C14<+)2./B:5!)')>^?*'\5:676:SVGWX#&1P,29\IP+
MHD5,+%A/#?:&>U=Z[O3PO=UI*M4<JR0]/7&R0<!_QC J-3>.&RUAZ9-&1NP\
M<V5I'%?IT@*P)AU,P"Q@D2SF&E8[$T2,#GB2B5B%6'K6M)JZ-)^Z4=1I$I65
MGE!N)'7@TW$7J*8,1RK+$("J=&E!^!).E JA4V[VQC6V6@DB*(U1:.F]+4->
M^B)O(J\47P*R3303+$DIN!+6.(<#CDPHK26E9>G)7.G2 O EYD7"F7<+S+@-
MRB5F'0&SY*+4EI>EZ'.E2PO EZ+%+KJ(!0Z:8YILD205(DZ>9AZU3'QIA71I
M/@7RB)=!1B)-TMP29K1D3G-IK#.!\C+D1_U8E]X<VW['^HO3,?&VW3!X>IUZ
M^OK-3T^7C NY-V_"*3B.B="4.$TU6"M/(]7E#R^MI"K-A2T9GL\IY!X++G'M
MDO'".8N%Q[G=0BC_GMQ*JM)\6L,FP:)53'G".<9*YT-Z241.A29T"<I%K*0J
MS>=\7F2&,J6-$)B'%"U76%LFL8\\!9-*SY5R8:Z/?9B=\'>T[>'Q',CWT_9(
M>'J2)+C&/&KJ@PF<*&+ .HFD+.:<*6'*?QQOM71H+NS(QD@3B;"@&<DUD;GT
ML9,N>IERHU)3>G:T6CHTGSVWE(\!)X:)8YS#2RY]M%(P'041L0P%#"H=FC,?
M\DD!A5:Y>UKDD0;#!8F4P.(F&,.V_'QH7JENRTZ"0G(4"Z.5#)HGERR7,3JB
MF.64"55E<)= <>;#?+C0S#GEHI1<<.(2+&,L>!9RE3 E2\]\5D!QYM-'6:K<
MKI4)$0+'$;O M$R$)P9^O%*\]'1G!11G/H5*,8DXEPD68'&, \J,(XW6F!"]
MY<Z4@.,\0)KCO]PHRKZ49_:UY8$*+(@4AF-#K<#<:Z"P/L*_M@R)/0LMU/ED
M)&OM@L"YC5?DDB=+1=1.:4:#4YZ6@1LLM%#GLFXKGC-:",.YN3H#7\%KH5+2
MD6 LG7 E6+<76JCSR=%EB@:<L(O4 DZ5C5HK@7VPUC,>Q(<=N!T&8D]*+,O9
M;XBUNB N^&R>+$0H8M=BO'KG%V03!<-:<1<CUASSX 2XYAQ %T1,04PV+"FY
MD$J1ZO6-:!]SE% ZYY/*P'/<PB]!"D&<P<%J'?3D,8N2BW:1-Z2G)5'F#2!5
MQ$BD!1=%62.,=%;:$+"@C"Z71!?5U9R6-(,P+(H@@R64!R.LXUHJD1)@4RD_
M#WR68MX()Y*'W+,WY:+<P;*D9+34$I)[A+N"3I1=^9^43I"IT0E!(PL6]!IH
M/)>):NSA=V#T+@GOM%\NIVP5\ND :31:;&E,B7N+-:PV&A.E;"Y/D%B!MDJ0
M#T#;A&P>@3;"M#".64F8 #^*66<,D<#A-=>&^;#XLGG9ZK:&\77K<PP[79B&
MCRW7CIN#01P._KH8=2%LV\%$/\FKQH1[L3URFH];IS-PG&<B,N; ($;!C>&<
M)^)RQ2%G'3!UD:1P9O$7KY*(;'IK&LC&J4 84Q&#BRQL+A]E3"[40A75:5E1
M!G/0MWYX9MM[K8_'LVC!,1N$$2.<DCPFRCC36N=DW:"(Q9%;Y?VR(NQ)Q34]
M='%8N@3GSA,<.,?)DNA5[E81F";*T"5%5^'<3GZ\+ B+.C'#DL>,<X:URTV1
MG,SGY8-BO@0.6$E$-CV4>8,]\3ZW5DA%4S1F([!&0[1D)HJX^"C;Z8:8?D5L
MS;X-L6/[G\H"+^N4+41E@<?G)#FK @U"Y *50#W8XL-KT64U15PQC",&<T@T
MYS8I8\'Y$E("8P3B8>P2X^IUR^=K=3]N?NS'PK\N"\"\PSKW5PL&6QZUU8(G
MRZCC@4>87[+$ 'MJH?TBTOYHG3_OQT'OK._C8/3K<033D,<36I\W_@/_7-7L
MD1$+HI5.D5-BC,*YB1"U!IPT&_B'+,.OWQD,+]H@K4ZKBXYCILG/N3@=_OFE
M%8;'SPG&_V>M^-S&?P:GMKOQ']?_ [X]>CVZR*U+Y0$CVVY][#Z'J1W&/EQA
M:$$45Q]PO3X,'/E>NVU/!_'YU8L_0VMPVK87,"GM5C>BXDM_@O'["(-SO2'X
MR\_SV#['_K#E;7M\D^)^H[?'PS;FF18LCWP(\S,,5S<>/]2SXJ'^&(;;[QG]
MS.#OOXV?D>OW_BBNW;_ZP'CR8'QKQ??@H?(L_?<:6YMX[O&3L--A+?3.\KS\
M"Q?__7EJ0P!-?(YKI+C,U_O\4<S%/2<[W_?J?1A&K__\Z@8)U DEVVFU+Y[_
MWR:@:%!KQ"^UO5['=O_O^L!V!V@ "IA&'QRT+N-SHF'&BU^_C)Y0P74*\8R?
MF- \7P>-G>;V5FV_N=G<WO]6019PM/O;+P[V=IH[V_NUS<96;?M_7OR]V7BU
M77NQ6Z_O[._O[#;F^ CT7H_PW@Z.05>&O>YZ;>O9BV<UB@4W"S_S+W?WZK7_
M@/7J]KJ-LPY<Q-?&1FXOIESX0&+EL<'.$<-5\BZ$((4ER7EI;>1W[9?4NC:O
M."&VGF_U_%DVR\V+T[@VWE5D[R[<5N_S:[KW^9#5S\+)]N>C5^9D]V2;-SH'
M7QI-^'EYW#EJOKVH-S^)QN5?[:-.G=4[V^*HT_AT^/XM?LT:[</+WOGNUE&[
MOG4 /ST_ZAS@^LFVV&WZ+T?OCTX:E_\<[\+/HU<O/S5>ZO/7].CB\+V71YV]
MUE'G[9>C5V\O#D\\:VQMXMWF1W)XTCX^;.Z<'[T_O&@T_^DT+C]]#J_>\?#W
M/^TCVO[L3DX[1Z_^Z1QM_?7I:.N?5N/2X_K66[&[]:ZU^_[E<?WD9?OH9(?4
M.X=L]YV&L7_\\H$:1G%@#*40,.*6:@1^:$).&"&-YPHKN[9!,'I;K"%?I;!1
MNZ4[4]:0207A=RK(;W4@N[7=;OS]N[K\[8H =O1JC1CV3O.O)5IO^#,EY+V6
MFP>M8NP9YOPAJ]CWEJRK%8F>GN<UZ<\;9J0=T^VIZ9W>WZYL]ENV73OHMGPO
MQ%I]_WN&!?],;T8+]NQMRMLSVP?+V;[8BZ>]_G"MEGK]CAW"#6!2@.,^=[U>
MV]EVNS=TO?-26I^7+??J0#8N-[_43_QY_=7!^5%GFS2VMB\;)^W.T?MW[7R]
M.CV ,7^Z@#&/O_,.[B6Z1\T>JV]M7C0NM[\<-5]V#ILPQF:=PKC:\%VP9CN7
M1\V/;+?Y3QO&^.5U<W-8W\?GK^$9ZI>'EQ\8<%4!]@LY'PCBTH#U(E0 7_92
M8 %.O]%K&__U+Z.X_'/2@%W;B['./[$Z3VMU+[3Y[<'F7G-[[_5A;6_[S>Y>
ML_;F8&__8+/1K#5W:\!>FD!1:H35=O=J1/P6?J_MOJPU_]ZNW2 VUZ1F\T4S
MOTT,X]],T8^)Y6TC.WL*,8GT[U"(7K\V/(ZU:SC6WA1.4VT;?,#P%.1B=+_M
M40K!-V;@>8"_H [<\SA_#05[@2ZB[:/8+:4]^&4V<EZ_? MPCDI3P5#@22".
M#4<N18^P<C#K4JI()9#Q>#H<^?4,K]?RO/^<FCP=K;V?3N[N_8RM5-RDXB:S
M]'?Z,+Y63B18=G)R>%G_<K1UW&YTMOG1UB?:V'I+#SM@I$X.Z5&S3NK-M^>-
MRX]T=^OC!#DY/:E?_O5I]]4!/6P>?]IM'N+&UE'KL/.NTSB!L5\>G /18;M;
MAWSW+G)"96"<*(HHI0RLF?+(.,.0MX+D"FN>:CDF)WRIR4ES;[.QOU-0D'FQ
MDT6Q^U=<9'@-O]HH@EM+_5ZG]E__(A+_^?3_#GMSN_4]U\&%89.YJ59KD#<3
M:JD%ZW+W+%.1Y[.DD=O%3L%+N%NCN%DIC?%CXE2>?/#2<:^-0BX2B3@)%%G/
M!8I!YAS.X!F/>:^(("*5(/=GA/=0LU;G8VW0]_^]%MN?KP7TX2-Y=G+Z<:UF
MV\/OO/-MI)_CT_-?(61@0T_/U_XH#T)FCH2]^+$UR!9TV(!W5@\-](,70G%-
M-4I&6\2-]DA;29!)'F8M,B:"6=O8?KW];K/Q8KOV]_;FZ^;?Z[6=QHMGWR4:
MB[ID_K9];OVP4():+]7ZU\*OV4%MD!L;IA:X\:UNK34<U/QQX>3_-!@\+_<*
MT/P,CTC^@_TK]4QC\4L.UH_>H\^$8E-WVV"P0'MG[+:-]/(IB.Y/5776?MO(
M\NUT?:\/[EJ1 5Z<RGC1.^L.^Q<OP.V\[<(-\B=.^[W/^3HEC2B-G+CZ>[C?
M^_I%X]5>N_Z^_J6Q]0\X9)\N=K=>PN__=."[K<.3.CN\/)R,,)\?TG?'AY<[
M^.C5P?GAY2:N=\"Z-G=X_3W\WCD"*_M/JWX93AKM.YPX\-("802#:0T)<:XL
M<L$!^= 2++!3@>FPMK'3#2W;M=-UXN[6[I$UF;:"_W2OK=#O"<8^Q:=:8LPV
M[?G..&')%[@M,8E_:C#N? M&);AC3%K$;"2(!Q$!C,PC<  $L5XIY^S:!A.(
M$BX4$3_$8PF6G9^F2!0:_%NQ$-1Z_5HOYU?73L[ZK4%H^2*ZT$M%"E;KYL)1
M?+3_T79;E\7OOU=V:O&%O/-L[]G^L]IVY[3=NXC]0JK?VI7:R+#\7L*PV,R-
M\&8(_3@8C'^\A@&04AK@1V7[G'](0BDNDD'.NXAX\A+I:!VB0B;"@LG5B-<V
M8!)K[UK9M6G9VN;GV#V+Y=MA>RJ5>@$O=_O-WI=RTNM'!2+8!PZ&-ED'&N0C
M1EP3A8Q."@5EK.*,>2G4-3T^[;5;@TE-6I]]Y'0LJ6*9W,TE/S_#<KBD[M*C
M#,3%AZ #-<%X1(C6V4 HY'CB*&H3-'$F>I6^Z^X\F23?]$!4[:/6Z<CM734Q
M78*8!,::1V258(A;:9#A^9P X$XJ+UG0?&V#2XKY EGN>R9TCH6<@WVG?4!J
MZ]2V:_$\^K-AZW.. :;<E>#WVF^@ +6L ?<-]BU,A/QK /N__J4I47\.:L/8
MCJ?'O>[5AM)Z#9Z\?9;9:<WVHZWEQ(+GM=]F"+&\DFW"K5835/@#Q8DI Y2(
M* +D2&"!G"4<!6D$X$D%(</:AF9L$E*_C_V-V8GF=0]<D#=9/4H</'B4>,@'
M@S&/1F!DH@;GWRB!-(X<F$?0+*I$!?=@\_(.(+#<J6X SL-&-'K#VN9I/DF6
M?;<'Y+8_N1G_SK;-2V!7L5\H\7I!M> 7.S;MMANN_I1: ]#M6DYZ!)N7\@9.
M]V,,M4'F:+6V'0QK_2)#Z?M6?E%$M@]+5+\U;,$51[M4L0\/<GK6'YSE[:IA
MKP:?*#QU0G]SO^<%+N>";/KA\P<]6UD2 AE[ALG]4O<>]IY@]]M9>LA@J7E&
ML2K)8(N9O=]6X+3#G+.)ZYG[)9*UANUB$SA:?USS^7#N X)\WYR27(;9Z-N"
M'@XN.J[7_FWPD##NLLU%8YP=4"A&/!\M(C6PM%^.6_"7K^;X(5L 8].:F0%,
M0&W0:[?"K;.W<YZ>^6<4CU>]"T)=@<]2<M/Q.::M37'T'J[3/#X^>O^6-U[5
M27WKDX Q7=1/ZFQW:^?+T=;'R\.3^N3&%O#7=AO&3'9? 7?=^H@/+P^^Y$TQ
MN-=%_=+S^LE?GW:W&JTZ@3'>.L<4D\T3CP2/.>PB)-(I!42P(<$1YK'4H]1#
M4.G]8<]_6J_]&\,:4#NU_=IGV[X=H9VN,:B@<!\HC"WR?F&0*QS< P<3&[S,
M)*<#$<@**Q#7/!\  A><*JNCE=''(')>V[M*V^>O[5>&?WN\W(Z2,2>#ZGDQ
M+G$\_:D!\?9;0'B;'%/4(,:,0IQ$C[3##@4LL%?:2ZTBL!_0E<->_]-H::A=
M">3GZ0_W/,TI[SHR_\3:7'C8>>/!YV0'=U'SQQ&>-9>Z I(7B\R'[$U_S0]]
M7ON-C$-SQW909.N'FFVWQ_&$[*3_[UDKN^C@F;LX_@!<>>REC[Y*6$Z7&!U+
M&3OL-_S\JZG.3GQ^.Q]+J05X%WAY_NAI/]NL_!NAM>*8YZ#V&UP/4%(;G $S
M'1SW<K[JU2F0X;$=3CQ&[8O]=JC%L8/BR^,'^7V]"*C\1F\\K0/ P8?<"3Q+
M_E+Q>?AF'LKX8D7MHF(DQ4CM8#CZNL&CG\%>#)Y]]]C&K+=Z7ISU^S# T>FT
MO*@.[?!L4$H;\JC )_W@DS?6 _RQ8QAQSH <:I80!U>($T:)Q; H'L9;6ZM7
M\BI.O]?@OT;O6T&.3Y[=*[183AM0RU@ &'1:PR&@)[8!#OU>-Z_.[8M:A)7Z
MHI;[7N>ZKWES:<L.;2V?M)DT#E^O<3.>MW<&G^189.COQ8]GH]+,M7W4K/V6
M)UG]21E]-O[ \+A5Y*>?YOST61N)T7BO81\'O\\/RC<F.,_O&-DK!V4O/N2Z
M\@XGA3Q5''&9]VV3<H@$X2,-FBDA?PCE&X#^GCA7$.2 *UMKP[ACS7H/("^Z
MV!=ZW\]KXYU_K<'THCO?&'3 .L!=^E=K#V"B Y-PL9ZI %P.ELX\1Q]K'_N]
M+\/CJ[>? 3.(Q=C&M05SF?:,_+S+2^$Q[QYA\2[Y<_WJ8S_]P'?'=_W!3 ?&
M'_[.6,<?S<=F"B-&J$/TBN#<9#7?WYKX85DE4:ZS-0S>)-,O7L"><?IK)W9^
MN%5!GVG^J]L1/SH(1-CT!POK'V9Z^G, 4S#K#9"[3M$OJS/_]8QQ_P58GH^]
M_L4=OGSQH<(F^?&'2NW6PWU.&LU/7V"=OFQL'7YI;-7)[OL=T7A?/S_LO#P^
M:NZU=E\=G=0O)TM#]."9X+/-OSK@_N/&R2:N7QZ(PY-/Y/#R9>OP_<MVX]4.
MC+U^>6=I"")!4 2(O#69TDMID5,I@)?/K59!Z(3!K7]]]WHQ^U(1<U7RZVI=
M3[29]703\)##"],XPK!PHMW\JLJCYQOK\U(]Y"3C7K(UJ'$7:UX!$58F:+&?
M[)ZBW1_Y3J-GNW:@1K^.7:,E>^*9D\9B2J\Z RYO';$G(HM $@^^)8M21"JB
M(PA+9A#7AB/K!$662&=Y% 93<K\Z8DNT#&W?'=:HL/LP[%Y-XZMB%E^,)K'"
M\",Q?/&ZN?TMAAW#S@HJ47(A(JYT0LY&A;#%P7!!0O)T&K4 '\!#GN"C#]QC
MGE>L.?T@IIO/X=P9BFZEN[::B@TF8,7=7K$_=#88Q8,!M+$H-GQ'W;]>O[A7
M^R+?_$L+;@VWK77AV7HYQ/NY-2A8=M=V?:XQ"MP[EWPI$C^'MAML/PQJ^=!B
M*WPOV9S]9G^_%=J%_S;]\%GMP1L$Y=D1&!S'=OM*D+7?0#Q%7'Y4+.K'4>_O
M[Y8=QL&3;I[MYX=88L/\J!TU_L$89[4G#$6=#VVI?&A+286\UBKR1*66XKN&
M]0%;:/+/^YX@FA,^-HN=IET_[.7*V(2.*F-?GZY^66S @C4XZ[9&ZCDXMOT(
M?/T;E14I14NQ,])3+JDW%.;-RLBY<U((,>K&!AI+UP!,O@74?_#?:W>E;Q2Y
MJD4^TGYQH]VS86&OP'!]6P&]>]9!H3=$X\O!B@+D*Q8773%UWJ8?K$X\&4E1
M%($C3J5#3G.!O />P!R/B86U#<KTNJ9J7>CKTN=7\MVHC>1Z9=3N.&IZ,XVX
M]B7V8ZWW53;/OJOE-[M]G?9&B]CS?M&-^G.\U?_KZZ9?L6[@KU^Q;M!KGPUO
M?^5G+<,>VK=,K5U]Y[C_E:9\C,CUH_V$;!K&_G/;_F(O!KF\YMW-S12=?G.S
M>9Q-VV['SS:?J/L[VO;P>+VVT_7?E_6W&[D+<R;R:P>'45I8/N"1CQG61OV)
M%OQXX%7MYV^Z3UPW,QBM-5<=#>ZUV"R2:)K%3C\8G=Q%.R<6SKH[U.2YH+M7
MQ?O7F"Y9PH)YAHF9^JZZS@D+,R@&^HR*^Z4 E"%"]70UR);QF>99+>[NLX-O
M[,?X\S"I7*2^"_<K;?EF<Z]9VWE6>[G3V&R\V-E\7=MIY'Z*F\V;#2M_):;S
MH#:F3QUPFD\'F*G&?7>:V_7Q\8-G,S0A/UJ54YK9\XW&!_[>N![E\S.@0OW\
M*1B379BQU([[V2?^USTZ)#-@=]<@*WK:UK<;S?W__&$G_8,51-L,]\9O4+GQ
M)5#^?$$.BVNTNKE$YG-D?A27J53] :HN\SGD;G$DLLC_^,NV"[]R_SC&X2#7
MY <GH%#\LCX>N&2E'O^X.5ZIG^':#_[MH&O/0@LT[?<BJWTK^ION,BD^1G[)
MT$[=V(P^W\^S45F?F:D&_8ZPJ]5H]?2!THG5J*CQ.CK8"LM0;I?1B=_8D*OC
MKDVX1RPL2FGM9'[X!GREU ]0[NFOCPYKCAL)E_E)KN/0I7Z*ZX[ !;(K9K!:
M*P&KF$&E#U?Z('[(#')"33\>Q^X@G_I?<IX@RLX3X %J2[+4BJ58:L757E"U
MWJZP?>75>EOIPY4^Z!^OMW9P7'O9[GT9W+G*EM<2ZK*OK7IYUE:]%&NKKM;6
MRI9NB&IMK?1AK ^,_'AM+4ZM#/*AENW_/6L-+Y9KB<U/7^HE-C_ DBRQ^5'V
MRRV)LO,#1BI^4*T'&[+B!Y4^7.D#+]J%P9B&O=HW1.'E];'A&Y3A!CNH+,;J
M:(C^L<4H=8IIB1*ZZ8P3NBO;^[09:9BM;=0W&YNOBI3O\2';_=K6SOZ+@_W]
MG=U&;;.Q!?_??'VXO[-?VWUYXSC&B]W&UD[SZC-[V_L'KYO%1W;?;.\5IS1^
M+86\LM +,I8'ZA%_9&YC&4H:?;6$K+*$2Z7!G*YMO#W8;#1WFF"[WFT71@W^
M\/KJ]VP37^_N'X"AJVW^M7O0K-4W]_[?=K.VM[/__RI#MT)J(O$J&3I>&;KE
MTN"<6[;;:.[MOMXOC-R;O=T7VUO9KE56;(5TX&%6[)</D#^1%?O1&?*=9[7=
MYM_;>U,\0+Y<)G[6Q[0K$_^T\!9D;>/U]BOPT0O;OKVUTWA5&?=5DOYJ452R
M61FPY5)AOK:1W>K:R\T7S=V]RG:MDN!7RW95.RI+IL%J;>.@L;?]:F>_N;VW
MO57;WWR]76R+;+\]V&D>UO:W7QSL[31WMD?>]\'^=GYS3-0J2[=*>B*_E_2T
ME):NVC%9+@V6>&UC:_OE9K'M>_!FMP&FK;&SNW?#PE76;$5T8?6L6;4MLEP:
M+',FS$YC&_C:RVV@:3>V>RLKMB(ZL'I63%16;*DT6,JUC3OVNBK[M1+27SW[
M)2O[M50:+,W:QO;__+WSU\XOUI^NS-:"C.6!0I</2AY^?#;*0F'[KN25>8GY
M@6-Y@)A5+M2X\ZJQV:R<JA5"=Q:[_&%QP^_V6+W9Q6PF3=NNOG)#%YZH#]7=
M#9\00=/H'4?PVM67'M$\CIMGN0_4+[2/FT\3K_LUC'GH5+*U.Q3SVVY9I-#/
MF_9%\,EE)/_EZ9,@Z15;KI'OMH2]N_7'+\Z6O&NV9HZNR6YJTV@BN""#_D&W
MBB7L"Z?X,\;EU#NX$?Q,8_Y+E_WQ>X+_VE5_.MC[S<&3E$M8O)9GUV72<L'L
M8AW*A41FTV>^%!-RU5:DQLCU?)"?-X5;L.#/];,6%WS>&L+-_#VB0;_M=&MP
MGS8PO<%Z+9Y[4(]1'^$:F$W[^ST48VP3L\4D^<O9XM:N'F5!5>$[DW&S/,8T
M ?&K4U2"+I _ 8>S_M/'?@^<'S0>H_<Q@M\U__H-]S,/FX/!3;KP QG_[$GO
MHR=/?HT'BR\5_RV@^.[6V!=G_3[8F9HMQ/C\E^0X\<B_)(-97V-*,*P5/\TB
M"S27$\YESWQ^$?_WK/79MK_I.OTM\;O7D^-:"8SOOQ_UA+=#=@OT:/]IG3_O
M]KHO^];GF%/MK-L:[N48V=D@K($^=_/@BS^TA-)>6&HCI8$GGW04B2?XO_ >
M?J@/.YG/8L/P6BU$W^K8]N"_UY!<JW5M)^8KHH_6GC[/>K39#?G']E<EVAR^
ML/W^!<S:.]L^BVNYAF;'#N&^Y\/GW;,."KTBJ)<O"^""V8M%0+WP\ -[=^&V
M>I]?T[W/AZQ^%DZV/Q^],B>[)]N\T3GXTFC"S\OCSE'S[46]^4DT+O]J'W7J
MK-[9%D>=QJ?#]V_Q:]9H'U[VSG>WCMKUK0/XZ?E1YP#73[;%;M-_.7I_=-*X
M_.=X%WX>O7KYJ?%2GS=:IN,[+[N[G4-^2-^UCIJ'HG[B+QHG;R_@N_RH^5?G
M\!+N<?+/)Q@#;IQ\(J_9WO%AY[R]VVG =0XOZQ0^=_*6'6V])8TM>*_Y3Z=Q
M68?O[US"&,71^VUQ]1VXU]D1/9"'M/'IZ*1^>=0\[C2VPJ?&U@%NO'IY7._
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M!2O@S^. =P7\&0%_LN2>8IPKA@'S+K,20Q!8 (48D=YZ94T*9&V#\76MI]4
MXJE*[BU![;"[8?GZFYV3]5H[#@;7%&:\PU*%09YP/Z4J-3\+8W6[5T1(QAM%
M"++<@K$*+!<^MA%A3I3#WBN5SP]18"EBD6I.5&&0!>4:%81G#^')8T01<R^2
M0=CBA+A)%&D>-)(D2H"QQE[Q L)$/-K1J,(@]T;?7H3O?8;+@>[7TMGPK!_'
MI5AJ+G9C:E7M+9^T!-_+0@2C8@Y_C050V9X'V9[;QX^])U0(IU$,7B+NK !?
M!X,!<MP*IPPQ)*YM:+I(G>ZJ?(P%Y0X56*<,UDFB8(A(3EG$"$"48P-</ZJ
MHF+,8^4X30[ ^OA* 8N7?;&P+&$KI@@<.=2&]OSF7LEZK1M_+8-S%=R5:?&#
MJ]G?*4K#-.WYC5AI(U9^RQ3-T>T#Q; ^V$080=(J#^:(!V0C_(,5EUPFEK!U
M.1UL"NRABCPL+)2GQ1XJ*#\EE">8!;;8&V,)PM9D-T Q< .81PE[B8,B$AA&
M3LS6>)&@O.P1B%LMKZOBK_/+Z:RBH;,P18=WL KC!&<*"(4 )T<RC;3R @DB
M,+Q' Y:TZ)VK'[V?4<4D%A;%LTKKK% \(Q1/$ KM@4A@RE D(5<E202Y'&'T
MFH!N2,.L"1G%(-@%0O$3!2OFWP%[2H=#5C>W:P9)G95!FIY!\K=H!:'*VIS/
MY4V(B!LFD29*(>$#.)Y<!QZ 5DBY;AYOD1Z*CA*%,E87\3/(YJP0/U7$3U 0
MQ9)ET3H4&7?@2/B(#%,&)<EQ\((:YC@@GJPS-JW2RO-.XUR"HEXE"]&\Z'4Z
MK:+#UJ@%<389,.[8];DI\7_]2X-)^+/6Z UCC9#'-$+]KFK=,NNS(3'G@];S
M;JO]WVO#_EF<M&DW9B'W'KLY!Y7QNH?QNEU9"P?N96YV*"-Q>:LW(!,E1MKR
M0*P(DC&9,39AMF83C)B3>CYDQ:W4<[;J.;&V<@P.?(H)5E2*$6<VN_>"(V-)
M"I@IK&/\KGHN_R*VL#D,=\<$]H]M/X[Z(PV*)4O]68O_>]8:7E1]V*?!2T+K
M\US(R9O^57+*8-CSG]9K7UK#X][9L'9J^[7/MGT6UVN#+'O@+F?P3A\N':Y)
MRW<M]>@K4PF([#1>3AKKZT'OYS$7JCG8O![=_5PF7)GUGYOUYLZP_N(;L_XY
MO'K'P]__M(]H^[,[Z9'&R0&IGQP?-]X?T,;)1]SHO#N!:YP<-@^_[,+<-."9
M#R_]Y>X[3>N;'T1P2D4GD#!8(AZP1M9$@X@,R5(N*3,Y(03C=3SZ_ZT%XL\K
M?6P-!KE+0Z;4H+"#(;P V"VB;NX4(_U6+U/K/ 9T&?N]2B7GIY*B\?$#5H9Q
MY1/"C@-1D<$@&XQ&03HLI?7.R["VD1?[.\C*>.TKS'>U0S>C"/BWF'J75Z6?
M@JD*B=T33!->903.+HW22%/O$7>!(B=ER@E\BDA*G:9J;:,PLO3/!=J7JW;7
M%S.676%WAMB=++XH+,:61D1TR&U5I4$ZUTZECG"B2$[&E8N(W2=UGN?E:>4(
M4Z][Y69=NU>U?_\(E&]BOZ"0LV*KHT$5T'QC^[O]_:$=QE"@].NM*WKZ %36
M?T)/3T_JS1T80X K-C[5Z5M\]/[@"SPSAG%= %7MU)MOV>%[&,]+?;&[^8$%
MRDD4 0E/3::GL"!'PX&MZA25X3)QO;:!G^';K9(7T'6_H7"5WUX2+23UCQ^B
M4@R(0$ F<0ZTD ODDL%(2RV) \KH!%O;,-/PV[_QJ>"?*SL]MO8HF_;GIF!M
MBT2AGA@W=\44*LPL#&;X[ML/VGG/N(F()Y40CT6"8U0H*"&Y8]$)G$],,+UN
M%%^7]'8-V@(D#].X7^/ME<:57N-R*(L:;24-! 4/W)]KK9&U3B.&/:>!,4=2
MUCA.UI7"ZXK+:4:T5N$DV[0B6C? -7:)*]?W8<"9"%LQ&6WTB2&';:[$Z>!5
M( $E28W+_2VCM*#Y"W0RK3IDNI@!JPJ:CX7F1%0JL,BYR!6\ P4N)!C0("(9
MDI$;0J-DV*K%@N:R9R1NPC#S%-MV[=2V FIU:]Z>MH:V71T9G76K^^NI?P,S
MO]-],9KW*LU[>A;H=@4KA2VE4@@DA..Y*9%%&M8!I UF(BC)@XBY#0B1B]24
MJ-K16DR"4$'X*2 \>5)#&,M-\LCQ%! 0!X&<YPQA$8UT@4OC:0%AODA'OI<G
M*_1[]2^'%OX8:M'VNU6+\B?@#U<SOCV>\$WOSSIG[;QKMQ53R[>J0^M3M$.W
M"UHY@64@02$0G4*<6(:<M, LM#7<<Q<E\>#,F'6)JY9BRPOG:7&)"LY/#.<)
M6I%HPL1@BI3F%O$H-7(Q<20D9114FWB9X:S6\>-+R50!BOL'*+["H-8;M2SM
M=4[[\3AV!ZW/L=;N#5:LNM5O3\(U!O"8\.J6Q_-5'$6QG!<WA3$JQO<:)-*(
MP]W4M.>5R9J>R;I=_(HIA:TS#@D&A@KDRI ).4%72A-B-%05#&1=W='3]/<J
MCK$$^/YU\C$M?%<0?AB$)_-T@P51"8NH=1%Q&S#20A@40*P46^)Q3@PAZC;E
MF N 5Z;DU>#AAUP?4P^GA&9J#A&/8B=V+)3M0A@5OYB><;I=!4O32+@C#D65
M-TM,X,@H+E$$<0HM0TC!KFTPL6[,[8SC*=?$*6OL8T4A/ZVH2 7Y&4-^@H]X
MS1./1"!)N$><.W IJ-2(::+!@@,;R6?^F%P'^98"\D\4'YDG8\E5:N%#_5Z[
MG;/G6P##?AQ4_<9FSD?JK6ZO#R9I9SSCE?5YD/7Y>(MP"*.%\22@R(A&7":#
MC,<&.7" B,,ZN'QJ42Q2QZ(JI+&8Q*'"YF.Q.;D_8C365'&$@X^(:^^1B]8B
M[T2R$7MM\N%#N8(Y%_./5E21B86+3.QT??LL3]R;43OYS>&PWW)G0^O:L=G[
MEK)]M5&5:S,M W:[2&94UBN=",+"YW,AT2(=J$(R>6^IQL$:-G)M^,QK>E?1
MC%*9B=E%,RHS,7<S<:L0>,11)84XQP+,A%#(R 2T!RMAI9?<YN-C8"8(G58>
M2!4!F7:;DN*T]-VLZ)ZUB4>/\YS!I(?>&:#QNC+[(VS@_.;M;A/X[WE-SK(L
M##-H[++9#570>X8F_V3S%C.$Y9U23BQ*F(#=-Q(C*XQ"#&,2F&,BX90KD;)U
M3&^?D_\U_W9*2)ISV*HRII4Q73B671G3)S6FDV>\3= ),XV284720$*6@5EU
M6KC@K24VXK4-H];YXW<0%\.6%@3[C\)ENU&K:H2VC?^X_A\;MPI9W>/-J>&4
MX"N@%E=\GD\HMOR/H4N+0O\QUJS/Z=:V>Y%W%KN]81P\^VY5KO&7N7DFX(ZG
MO4%Q-O)Y/[;ML/4Y_OFE%8;'5V;AQO?&<L-?OV(=B.AL^/VOW!"0C]DMGK9Q
M^SII/YPB1-%$F9P;_^;Q%B:$:!FQ(%KI%#DEQB@<DU?4FN2##?P#I6M77SKN
M?RUR]C$BUX_V$[()'O&Y;7^Q%X.U/[Z9B4ZK>S4D16',DS/V?4V[);^GG]1;
MWEPQJ=OM^-EV?:S]'6U[>+Q>V^GZ[VO=HHSZ1:];V)7BI$)1/'/4YZF7:J.\
MV>\^0<?V/X(4OYJO/Q=%O7\[Z-JST((GNLXVG>HPS+U&,;$H_'SZQG_)YEY\
M9S8+:_W5 !7+ SQ.VYX.XO.K%W]>M7=I=8M1%5_Z\]O[Y1M,GI7)]QN]/8:C
MT<\T-AF1XSC,^,9CL#XKP#JQVHW>X_H9Y_J[;^-GY+OO_>BR!#\SOWC9'[\G
M!*L&6Z[!FGM=]B=1Q(4,%M[MD=S-,:^?R=SGF49VY&F>:M)(?B<$>MP'NE:'
MSQT/:MO=$,/X.?/"/WJY'T]A47*Q7V/X'JV:?KI?5-*9:L!??G&B2@6"^[/]
MT;&CG6X-[M,&_CU8K\5S#Y-0.X4Y*(Y"U(#7V%M'3NX*(3V@J>EBZTF.W$[K
M@>_3D6R9)NX^S4M7=6XJI9J*4I4ZN>OG/N6XJ,[GV#V+W\_DOL?S3DV59MEU
ML1KD_ 99ZOR GP<RKGI;=EIGG5M >G2J]<(]Z8-WH19A*^F>S_: O:2@.)'.
M4(L3Y4Y0+;04SF*<O M,R0];Q<:\P@3=N_%<H4&Y/$\,C5B.+*R+^O4NTEY[
M]_TAV7UU\&5W*W1VFWLGAYUWK4:GT3EZM?>I_C[O$M4O=K?>TJ^[2-NL<?GQ
M$L;T9;>YP^O-O=;1^T.1*\W7FYN71^_K%T?-1KO>/"2W=I&:GNUN-=J-K4U1
M/_EXWGCU3_OHY--Y8\N?U[?R<_S3KM.#\\;)NW2U@U3?QZR^5:?U+Q_R+I%+
MCB!/*4,\^8!L/A:OC$Z6X6A!EFL;C*TKNH2'02JKM*16B5.9J$LDX$ X$\9Q
MS;!P"AL?'0FQL$KDRBJ1RBK-URI=3E@E'XD(TBK$!,_%.J1'SC&.?&)<1,J4
M\1JL$EYG1E16J;)*);%*1F+EL<'.$<-5)D@A2&%)<EY:&_F8*Y&**RV$52(3
M5DD['3$G'GD9@2MY(Y#A+B!'O".$,5ARS-J&,>M"/_I<2V65*JOT1%8IR<"Y
MLX%+9;C%RAIOJ5>*&\J$Y'K,E4C%E1;"*K$)J^1<=$8HC:P+"G$!_QCG%<(<
MC)7SFG,>UC:TG$9UY.K(\ .#8;UPYH>U_BBZO"R%VA<XB!3;GY^/9WT<TJ]L
MS[1L3^/%K>@1-8Y(+P-23@BP/8HBA[%!GA(2M:26* %^VKI1B]1J:L4+LR]P
MM*6"[TSA.QEF(=A33H5!)$B)N*0$64DCP@$G8;U3//H,7R:F=4Z_@N\"PG=J
M88D*OC.%[V0\PA(KL< !)6TC JX/\*78(DD N-Q[(37.IRG7-9]6U= *OPN(
MWZDY\!5^9XK?2<\=2QR<=PR)2 SBS'&D&>>(*$^DI"!.SXK^:FR1V/,J9+%L
MADZKVQH,^\5YNEJ*XT(7H[XHCW'G%["RX *[\U<1Q:)#PNAP5V61IF:1]F_Y
M\YA&+F.NRL!\CB5ZB@PS&CDF55 T@I-G@5&L&_9H0K%X&QP5?F>6/5'A=S;X
MG73H+5<TI5PK5$4"^ 4D&\_ 08@L8LJ!:Q"=\:OQM"H"5/A=0/Q./<^@PN]L
M\#OIT4NPM8H9 <X\N 4\!HHL. ,H466BH":J7!])K(NJ:?HRXW?J._(5?F>#
MWTF/7GI'< +\@O6U*(L+F80MHI[ RNO@=?;HQ3K1BX3?Y=J*_U'ARMYIS"Y]
M]^,TMN3O?>1O^0S45/?K=Z^$4L4<IVVA6K<\?,VI,3ES,1=)0IQ3C8P,&"FK
M0B16A&#XV@8SZY(^.K/ZH3@IT8;""F-_JIO]%?9GB/U;IRJ<$I1*X"3>!P2&
MP"$3L43*<VT%9ESX4'09%'SF!;<K[)<1^U/-%*BP/T/L3T86,'=!.!&0S!D"
M/%B*-,OMCVD2T0M'O<^5ETEN,3KSIAP5^,L(_JFF&53@GR'X;R4:*!>LI0$9
M)U+>UA/PRL*O1@4N9 1ANIPHA-=->5C_*N0A-.*PUNI^CH-A+G$*+[\I;UK%
M36>==P#SOW,]_5?QT\H6W=\6W2XXH67P"D@'2C(QQ)6*X([HA))0SA-M@%SF
MYF"J2C!88J!./<&@ NJC@3H9+1":<R, HT)HC;A5!#GJ&'))TIA"H,*F7!EF
M"0LP5$"=62;!G4"MJ/_44'S+[W<&*ZDP4H8!]8^& .LG%#D50T@V9A<@9P01
MLH3EG2H<SRRCH,+Q;'$\Z<)K&KQS7"'#M4.<"HHT<1+\^&0\#<8JF5WX*?9-
MJS(+[N^C_];N#09Q\'OMHVUU!S7 8FIU;=>W;!N<]L&P?U:T*%FQ @"_/:WK
M/H 'AE<WHXP@F]>%9%YEN>QV7UY)9>>K4"K+] #+M'N[!@ 33$K"*3+)"<23
MCL@2H!F<6.LY3BEJOK8AU"VS=*O(?77XL(S(G8(O7R'W29![*Q^ >T:CP<B#
M"!%G%C LE$52:6X2R(H1\/#E[4A<A=RE0.X4G/L*N4^"W$FOGB<O +D&N9@4
MXM8G9%WNJ(P3 X&"1Q< N9S=SC*NH+NPT)W75GP%V.D#=M)]CU[3A U'..2#
MM9P1I)6Q2&G/A9 LQ+SK!2RI.N@_AV,!_9]U?[E'_'"%$X.FONU^U8VGBBA.
MS23=<=9?N,BDB;F:,7CKR3JD@?@A$2TL&?^?O6_M;>/(MOTK!._!00;0=NK]
M< X$.+8SH\%(]L3.!,Z7H!Z[+#H4J2$IQ_:OOU4MR99)R1'%IMBD*D!D22Q2
MU;U[K=JU:C^2%4VN/[=[]AHW8J7VX9L/"&SQW. !X[[U4_R*^S7@?N%</VKI
M% :0@2*4(D/@: R@LQFYCI1)]$T6@&FMXTO%_4[AOO6@@(K[->!^(1+ *<NT
M9."%(I!WC1&LS"9*T4:30I(!2[5 JO:4:NL,L0)_IX#?>A1!!?X:@#^O/0CB
M*2>*0_)>@X@L@?>2 +=<1)5<RCNUHCVP/2)7SON[+^#O5F3!]>+$\P^G.)JN
MUI2V*]U2ZV?<XC-V2W&[?KGY$4>8!K,>GC_<-9GE_AJK9A(.'X_'P\S,%U:8
M/AG%IT,W.)D>C,+99%*[];3;K>=\(6Z4MZ-/3SX=O3O\/3M,+GIK@% :093J
M7M9; 13SZBNH"33I_CZS>Z)3[7IJ1&[7Q;,*[XW ^^/7\#916T6L!A/S%T&]
M!*^]@I)*DQ07R5&6X9TWV:(FSNPPO-MO]5GAO0%X'\VMWHDHPKE3H"T)((3V
M8(1();$^2BN-1L>:9GO<=BD.O\*[ZTI8A?=&X#VW>BNG$F9C@A6Q]!W7(L/;
M6@@^2,51*$I<?U_+O18B=6J:S5+@?#J>SGKCU#L][T\S+9IB?& )-9M4#\K]
M?Y'^/A['PDNO</)^$'#Z*ANA4E)[E'2PH!=PBD@U]V 3FM+>UX%WDH*/*'RR
M+C%-2H\^P;L4.U@C?KLN%U0\WQ.>YUR,8)+T& 4HFP1DLRIPWC&@.N:=(0U4
M(._OLSUCVZK!6?'<03RWK@]4/-\/GN<5@6"\R-L^ IR%4E#;$?#2(7!,2A"&
M4I<>NG:/KU[RO^*YNWAN71"H>+XG/,^MSU)8$QSGD#E9@4C>@)/Y1^5#(#%[
M82GH_K[>,ZU5RJRY.K=#XRL<YE^^W>N]Q1%.W+#IR.F^[M19HPKN6Q>XL,K?
MSVV2J>KKWJD7,4R5L]KCK,,%C8!J:JS3%I30 42T# P+%"(Q*ON6C'CK^_MB
M3](:4K##V&Y=(ZC8W@"VYX\DF)5:H81DC0#AD@%C.0-O!8N<1I=WCT7_LZ(>
M..XPMEO7"RJV[Q_;\]J!,D8@41&H5'G=MM:"\4R!*10>G0ZQ:=?+]RBK"_<.
M@[MU\:"">P/@GH\$#,0)&25X64*%4"FPBEJ(%#'OMD@VM"OY=GO*=JGT[D.(
M)3C(V)O@=+4DA <A:[8N%US>^L\45%EF"9;Y]\+67^5;[IWBP(T@4/KX@0^!
M@Y:(,CCJ>2#]?4;;ZNE5#Q\ZB-+6-_X5I2NB=,X7T(9[S' #U53O-LJ#<UR"
MDJB]2#%%5U!*5FYZ4U':792VOH6O*%T-I?/;<<JHE,QQ$)QECYUS#9YH#YIQ
MFQ(1+..TOZ]6+XM34=I=E+:^%Z\H71&E<VNI2T$E#!&DXQ$$#02\I13R"AN8
MYPHU"_U]V:GPN8=P//_D9)PG\\DU !NGWGAVC)/>8#1SH[<#/\2>FT[QCCTP
M'H0*V/I>^ZI%7J2#SY9XTABB$M%21/3+PM9;9Z>=IN(I9/\ 1+ <#",(,BAF
MM3*$-EOOU>.$JG3?7="VOO6NH&T7M'/>0_;G!6ID($0HU2^-!%/*YQ-I/ L&
M7:.745X/TW<8M*WOQ"MH6P7M_,;<1Y$=H*9*=<S()3J#-G #S)5@7<U-(B:[
M_(Q4T.XN:%O?F%?0M@O:N966$64<80FHH^2\NY1+-F3DNNA=DAJ5[>]STJ65
M]B$<?I=>+Z5#99YBGO+98'I<.KR4'7M$/ZM'X?>V/6_:[9QWWGDQ>OZ5-5ZD
M9]D67\?GI,$'C/ ))^-*34M1TYO%G'J5'0:5!#BM\LY=1P4&#0%D5)/\'0\Q
M^Q/_^_\,H^R'#LF(5>SO^NZ]8OK>,#WG;F1[.4\3!^)\B:55#"SG$8A07/N
MS#):,?T ,-WZYKYB^KXPO9!;[RE/B XH#7GS[U0"4YI7\,BEU)I9(T3%] /
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MF(Q1H,GPUZR_3]M*PMJZ^(K-ZQ2G^4/&<1#R-QDK&:IN%'NGX^EL@K/!I*F
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MAJ%-P>B8:"G%OI<M6E6*G85VZ][%K:%=T;L,>N?]"^.#\0X-)"0>!'<>K,8
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MR[@2IK!>NL(8B8,J-,NHN26HN:AGPE[&A99(!\Q!SZ0"@0E0(B:]Q(85I#2
MFE3MEIAEV,RPF6%SLR$'@5ICF<-.J))I6DKBN.5!8TR)#=)<CYO71!ID /V^
M 'JRH':*LBRM= X)$[O3*.J0M-@CA0M&L21>>0H NBOD,GZN7=4[0V>&SI\:
M.M= 3BL]I8HIJS%EGB@MC%<$!Q&,H,[?VDX_ZO8'0X#)0WCVT(_&&1'7=5T"
M&LY'5/%24!DD*ITK$//<(%,*CYPN2E4247 &.B7/SLL,BAD4-PN*7$C+-=4
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MI7B^IZED4?>C__53UXW/&X1IW57O!SR[11L@_61\_2TMJEL?M:H?#Y1I@9!
M"UEGK7_C>!,V$5EZS(D4,GA&B5("^V %U2I8IQU[5["=YJ;SX2PO[\PC,_3Z
M ](!IOA4]S[IJ]'.+W,K<='MH_:R+Z[8]?MLB7H_?E&7HMW2HC[O^8^I/M:_
MO.Z-SW<[AWU[_9[;EE$?1];HC >=9X-^ JY4I^OW;A^FTM6]SJLQ?'"Q7'!\
M"Z?RC]=]/7%=&/\_MWZLT]#(2B35\9&T<^W +_3P#'@FRA@^KZ!^[WFL";[_
M..QWCKJ]7DQMW>T\_VQAIIT7?MA)@86= SW6G<&PLS_JG(S/_?!3=^2K3>:
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MF[>AR6_/?GNUWU EJ4FZ=552AV?OJA>Q7NMJ%Z1]%Y>UTI ;Q-2CQ=%,!QI
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M^?W5I!]Q*PDQ *M*,XL/ ,PZ.H(]=#GN7DR:)U1?O *[J->,R*:/@$"_  G
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M<T>FL+88(%S[<RM#.ZY/)$,J\#8SC6*<GN\GKITDS:C;#T#"!HMG%1GA)3,
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MGXYZ<6O-(FD7%++%,>\V"='^<ZPY.[7J8D7.*6:>1RS0O5X]ZOU1*CP=7<N
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M(G-V%+(_&_&CW1]'I_LPEM>?P2CX O]_.CI[QPSGH#I[A$E$ Q 72%E'D2Z
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M%IM5P4+_J1CIK^:J70&Q\FK.5:LS67WT/T@LDUCQ.4.H?;Q"$5YIPXQ3A4Q
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M173S.RZ"Z*[?,7K:22\"E,@5"6F4,U/'9%ETE)FA9AM;?%Y&KW)ZZIJC^0'
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MB"Y$Z;.419;L4>CDE6(Z&9:8\R5%/V-M^DQ.SRIW8I*&<2.4-Q&)PKV6**S
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MO)$%T#-!_W(,:.>9\C8GP6K4@K>RBA5"^8HJ_"ULL62P=\,6A.CB T;@40I
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MIXSU(((6@$$D\)JT5"4C&:$^1^44F:";1BVK]V_CX,;!CXR#;^(.Z"<)-W?
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M8N*?KV02\9+"FD>S^5_N'>!X>K&PJ8T&Y1ML0P3;E^_W!W? ,%,T3_;H5FZ
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MK-+7]\12>W[<O\K3=RZKY[+!\'RCX]W=T0?:'1K@SWO>E^-V]*,#OIM)Z;5
M5\KY4E31Q9>D= "'@(:R4J561 S6X^T=?9>-<3G;Y2[H;R'HWRS7 4%TJ9)R
M@EI:$$"M(K9*Q1AC5D#*2AVW=J#G'S]3_"89BC0H8P8'E&S*!I(BLA6K)]2W
MKP/J^+T/_"XZZ@)@U-$ZP?IZPZ^1 C&A<(581^<=C&V&\0KL\P[?=82OU;90
M0N\#6(BQI,"G(1$%&URU,M[>T=;A>Q_P772P)8C&^V2$\\AVMJ309E"24#7G
M$#$&63/;V7%-:@<Z@%<]\S"8BC[F$*("0R45H)8&%E2V2CJZL9NLP_8^8+OH
M'I,V4Y&L)ML<E  G4;1)4\*AS,5#E,ZDRZ3NDQ],_A1= Q?2@.8^@0O5/Y]T
M#DQVRZCP=_OO[^H/V(C<QA6X S[/9]W9?P<V>_7V16.RP0_P^J\7?[W^]=4O
MSAEOT62A-7,:D"VLA;@@3"GDDV?1I,(*Z*PG):^Q)?&PCH .X;M"^.-%"#,0
MC2W6B@)@FQ\@BY!"9@@G(RF;K'*]+#&YEQ0\"_0^K!^@H_>.Z'V](( U9,K!
M*)%(5<'6GQ$A AL5,J+5U;@"I4TZZO!]GO!=@1N@P_<!X;L@?!M6DU9*F. B
M"U_&<-"6U6F'+M?$NUIQ:\?Z]8#OYHQV:I;_<6//RZS[7MSS%&+^G:5NQ5)?
M+UGYZ$.@*$E8#:WE9P:1= RB.&=-8*F23.LUMH*6GSV7]WD!_F%] QWPMP7\
M@EJ2*@494Q+.&2L@ZBJBIB0:U FE-$J:NW7[Z7A_EGA_6&]"Q_LM\;[H1?"M
MX-)[$-&9UDRT%I$BD8"J(DF*;*7 UHY6*T@FZ(A_7HA_6 =$1_QM$;\@X:U5
MP;7Q:RZ%EOUGJ\"6C&!-IAJ=K1&))?P*LG=[@<[*</GF\ --1^>:\O0"G4VY
MQJ:-UQFR;3:L>N8&4M>[(HOSSF>M!D<:1JA:IEB5)01YHPZZ3:C.OIE.]@9^
M>=E[?MU2RKY:<IPIX]%D947A/6I2MHA@C!>D"_'&1?2NS<I9-J0?+]VO)^JN
MNI]-HHC.:5^<@D0YR2"-,QER]E&9Z[C .E3O :H+"K%,1;K@0'ACL@!94*2D
M@_"@'&%Q)5!D$[@C]?DB-9)#:TW24"(8"<%6:4-U!5.)5.6-&N)VI*X*J8O.
MJMP\TS(&P<*U"D P G.PH@*9J)0SI<BM':676\MUK#X;K#IM"E55?8D10&F,
M,1K/.Q\],B[=M<M?.E97BM7%_):<LBHQM:2T($!7*Y!58J&*43IX BT=*\!K
MA-15>I.>@J$]SW+9L+J4FSBX5VMJMV?^K^&1=[ZY,]]\MUR/8F-%99R0J)K!
M7;3 P*2C4"66"QZMP<NT^)X-^RRPNEI;NV-UM5A=T U*ZQ0K8Q:8' DPU@E4
MV@BOG:\$.1(1ZP9W"4%UL*XQ6%=K;G>PKA2LBT:WU2E5(ZT(UD0!!%'$8K.0
MU82J%#G2:FL'^N299PK6U=K;':RK!>N"9,V4-+:&;'IHONQ!BJ!8%989),IJ
M<VY-)M8$JQO<>O*AILH^78_@HQGJ?2C6/3#5CTOV>DJDG6,;0.76/T+KT.K?
MK""47B-YWC9HOOS>Q.KI8/9A[?4^T.[!L+NH902L);@JLJ^,W1R2P%C:X!>+
M5F9/S+TKF&C7\;O&,G>E-GS'[;W@=LF4EYHM-]-26Q(Q;ET24>HJ0K%:JS9A
M5A?&[5UJSCMFUQBS*S7E.V;O![,+LE:7FJPJ19309&W5V JT4(2 .6.!7#*L
MI"!SW4+H3W!P[''?B/\[I+#_6^L?,5FLV[A+N/VY%9L]AH5_4F)V4D[V9K^-
M@GI3NR?R3KSU;LF^!\BJ1HD"50T"T)% 0TX &_T S&BJ38,,JQI[O3;%I2L,
M+#PWO#]P//^*XM*._%4C?U%CD6# @1.14L.[,@(MZ>;><TX%%WE+MW;B"AK3
M=="O/^@?PZ70H7Y/4%_J01DIZEJBP*QD$^U9Q";DT:1,SJ +SF[MN%5U@>YX
M7W^\/[ _H@OY!T+^@I#W)GF(N84 T+?&<"BBUEJXF*JK1E53S$IZ1Z]?$XG+
M_27KF^W?/!,+\RTG^Y_R25RSK\?\,7YI^+F7R5':I6%;KMZPS[/99<_M4<GL
M;X_R:)X/P9=60YNB1EDU)*M;,S";4,J:4S'>W;SKY^!Y/CVZ0_G6/)VL,_J-
M&#TO)V34K+#U*5 2*NMR.0FVU()0FJK3P6&U<FO'KF LX"I \LA!I4Z1G2)7
M0Y&@7=6IJB*+ F-C@F"D35[&3$D5NF4B3*?(55#D8MZ+B:H":59Z91#@C1?)
M)",HNEI099_!;^WXU;5.ZQ39*;)39'329QEE2BJ";ZIC*<ZBJBD[1(*;MY;M
M%+DJBEST"-:HO+=!"Q5U$J"C%2G[*-! -IB]1]1;.Q!6UT^V<V3GR.?)D3?I
MQ>L*0,("SD= Z3%FU(PVB-I8!^%FF5V=&5?!C(MA48U!9U,%-3X$$RHS(T21
M;61NQ&2 7&/&%65-/R8[?L:E6L:S@UW\V!9)GR;4_LZ+[^P/MC_8I_7._F#[
M@WU:[^P/MC_8I_7._F#[@WU:[^P/]CX?[+\?(AMZ_'<9_[YS8DZ^/MJCZ3CO
M_ >_>'*%/9R^'^^?V(AQ<$W=DZ-CN.*7XT,V%_,%UX=?='WHYOIXD?/TB,KH
MS!7!7U[H@C&L[<JU*'UPL5A(A?M<W55NG/E:#D<_T,$A[26:SFUY([='S5,]
MPOTR^HKR^1^IX4?\)QX_@K-$G>-&(*/#"3]&_LG?;C*>S8=L42-I7:#F&LA6
MJ/R_S9G_\K^\O%Y*[?'&G.W+?%N^YT6,?V_'[JG[B7;I/[__^/-/Y2!I<*_?
MOO_C];??C/ES?WW]ZW?J];?O[)MO7^J??WJI7[_]9N_U5__8??73=W^^_NEU
M??WK*_WZNU]B53K9DD4($@50"2(6!<(J7]':%%)+B=5ZV<\SG(:;[&F53N;B
MJ%CK :4+)OID4H[$6YUE'O94*6U4W]-;[ZEY]?X7U-(8\E78ZH* 0$D$@R02
MDY?,T@/_QWLJEZLPMT=3FAT0?_,[[7[\8O03G?7V^03"CYBTIJ/##S3*># <
M@____PL,S[_/YT!-3W=F-KRN_C[4&AY-V_D8?'EXR-=-N(O[F4:S#T2'LR]N
M0)UK(P?.9L"-_D7[S3$Y^N_IY/T4]V;77$Y<'T' FW^ S6TZ/N#]:9V=SN:*
MCW:/EW=PO+S1'[S3E#Z.>#F_T2#1S[]]/-_O<T?G8#(]K+SWDQ%.649,^48K
M3:=\#@XGH[;X QJ>P"A-)[_1=#::3)D5&-;3X6KT9_Z ^^]I5/GUC+,/ QV=
M^T1^2KM\VU/<_6+TED]FQ?%T]#ON'M%H4N=G]?0=QR>4/QL/AQ\=\G,\>=MP
M:W-\S$:X-SG:/YS?Y&/(L[,#]J\)[E/YAE?U/VU1;^H_3Y>SU1[*'A[RY_YY
M^.7^T9XHDT-Q?-D-)L?W?[[Y[A= %CZ8@DA6^S8^)8M(4HF<M3/.0L'4!-YV
M@.5L\$<3>7W;[[+M'U^__\63#[SU12C;^A)XHUCC:45 J'EG3 Y@FDS<5G99
M*C96N(U*?%&6-A*ZFG\.^,TT,,N5QXMWE#]D)<3R\O4WYR.HYX[7G-;?GN.\
M[Y'_FM33(S<Y=^3^DW;+V\G9K[_9;^?S]*P)O7F'S;[^XY=L?2("*S ;$*!]
M:Q970#CO0"I0D;S]1+S\THV^'97TC;[7C2X2BVW3:,$5W<91MXWF/U3P!1(8
MXO^V=I1<3A]:>N'_G-#"7(&Z2!7G]!H^*+O\Z!LG$>8/[1TWYZ8%S7Z!C9#U
M'/Z V8QOXS.J/=_6M"EIPYM/M?OQ9[7[[>'F_KA@7O#[IXTR)W/-<G>,:;P[
M/OPXJ'CM#B9I=_P>AYM@]6M*AT?3_<5[YQ^T5Q)?:O('W^ U[__DP_@)?W&R
MBK=7//AIN^NFOL[;G;9KX\$!&PB#TGM.Q<U\3^\GTX_7L79&F^,I:@]L2GLX
MWF_;W$BN8>"(-X^5E_:T/[9#W1[8)?8&OI\2#65@S?C</2K\*%L;VOUV7\/'
MM@N.]X\F1[.+JCM?<[ 3VFFZB0Z7JD9/5<<H$\2B0JE(9'4)3I7J\;JJ^U=\
M9F;CP]GWQ[;&-Y/IHEKWXO"?.)U^Y'4.!-P5NDNI]Z_O[*OO?BFFH K1BH V
MM%IN+V)521BP1(XE,+7A:GJ;E?J[Z_&N\/6--C9F"]DGE)4O7W)P.41I\+IZ
M?#\#JSL#;U[\DDCF'#0*EPR+7RD=6W52B@(@32A0:G0L?K>#7RX#NZB>;S=Z
M^)$/ -/)#X=,T+/1MP.M#$1^CH=NRA[6(EL8.O'MZ%: '"K;F$86@\D3'Y[[
M9(^-/1P_*C;T)9424RPBJ58@B*WD6RH^*\!Z,]9(I?665V&YL<O-Z<%ZBU46
MC\: LR5(I,#[RX1 B=7U^Z2'S=UDS68]U4I&NRRJ5BP%(DL!U F$B>"4\Z5:
MKUD*7-*W:Q'_;<^9 ^9JX1T 'S0H4REY;23D6J+4P>M0O8[&J9P[X._A++S[
M\]7[7ZPQB-F3T$5: =E:$;,F80A=DH'1B9[/PF7^G1OBG=4_:WF/61-0$&(.
MH!*58'F["ZGL.][O98^9U"N%"-([H2(Z <8DD9(/@HPJA!B4]65K9YG2%YQQ
M%XVM]N9CJP'GQGDSOX;'JX(C:=F<#Y5 JQB]I)J]QEASP0*_V.;(N49,YSA/
M7;1*EL%FN]@;]$&LN,MC5NZ+N8&V_.=_7$C%6$&1V^+IGXY_Q[8C+_=GA].C
MP:I[L5_^DPH_O/<OVF8-2/AJ/,N[D]G1E-[RY_]C=Y)_>]S3KUZ?G/Z];W9?
M[;V"G]^^DN_VWNEWOW[_VYN?OOGP^JL7?(UW?[W^Z:7B4_S;._WUQ\73_^ZG
M'S^^^^O#[JN_OA_SE<>OO_W.OOOI:_GJ*[[?7U^I=[_R/7S[_:_OWOY7FYWS
MUZL_?F'14BV@$M&Y)" A"-9P@*V?:J3AATU@MDX,X,8=31ZQ&F)L93V4Y:+-
M/IA44JQLR9*2D/36B)A2#GA?> MH:^=L5T;?C/=Q/X_9,#^W04L).A>@M("D
M^2Y]_A8NWG+B5Z/,I) <&%!!E6QS#(@IASH@[JG$3Z?,_5.^]+%;Z,1?5">[
MNY,_FC_C\.,!#;Z)<O;<Z^ES'Y\]]R_YFT.:MHM,6SAV]@<>S+9']>B0<=&^
MF$S_P&DY]:?P2P='QQX1W-T=30;O%[_:?O'XR^:>*<V#<O;AL[ECCF4.[C>W
M%"^B]<@>M=A$B]\>3D9[.&M?[]/AX46/S/;HCP_C_(&IMAQE&F7^>\QW.Y[]
M-DH?1P<TW1O/?X5_E56LP\/=X?<&)^<Y3\UU(__KM=4?D'=N>$J#6Y"?T^^\
M\\T+M;QO9YO4_)7\32M/&N$0$V^H.79_7?Q%^O-@X, 3;^+NA,4)OV&/=R\=
MCNITLL<GYT_^].E@O_*5Z^X$AP<^O'(<![_PVN@ /PYN2[[H<$KFGWPN6/Z!
MV;B="O[@1/OYP^">'N+?UQ&BQ_MP_+!\<UX.*@^_X<LI[0Y'[N]_C,OAAY,B
MPG._=;S/\NQ7,,TFNT>'5__*N<*O/&S&(QT(H9Q8>#[G_OPP/;F? WQ/(DT)
M?Q-8^7:_Q-T_\.-LZ]\OGGL^].<?X>+JYVO<^8\T_?>=RS[U4E:^(\L^TH/]
MU\M_O/E^=!P0&)1E/HQO3AW QR*+C_?W#3/_]]C9_\.;;[X_=NO_VQ>C%_L?
MCQ,Y+HPN&S))AJ22(<-D*6%D1A=Y<DIG+NAC7C^.,<P^%239/HDO7'@/2]3K
MO.V2>,5I2M7TRBM>\N[/AVBN'9)8(QYN!'>T?VY/6Q^Y86,;N3&#CMMQ:1*N
M$2>?E;;L>52 Y?$)UYW?5<SY:.]H=WCCO#M^GNP=3.D#[<^:K&X?L#T(M'9(
M\$^6@3B[68Y(23Z;"BUT#R8%U*4Z288*LK$3S-4.@RN:2;Z8Y'$K@OXGK^L;
M7E;3I^F?\U7P+9_TFGS1^.8M_KDN)N4C*-4OY.L_?DG&!6-("6>8M-F21X'>
M%F&4E4;[7&)HF2%F!>E *(DTL0Z?0VZ4&TD"V9!KBLK7^(ETH+[5=]UJ]?J[
M7Z!9'EXZ(9M?B.UYMI_ \J93I$HID3<M]\O$>TH!6AVA7EE'_P!,JRPS[5='
MT\%\8<(]6=4#$_YP&X<?V/@8=F"??S;:XU_X,!NUS-%RU7Y==KN/_CBW+^1"
ME$&@+#=!Y1,I/LR](Q=4$18]?WO</I?+/IVSEL9GK[VFPPVFH*];5,K7(%TH
M2@20A2DH!1&Q>)%E<<6!]1G4ULXE+=EN+&Q6T(:J[^VU][8%HW(TIF2)PD3/
M0B53%E&&+'@?P&K/($NMF=3RYB[*B2=+KNK)D.NU./5A^V)VM%T7;7R=][\4
M:R3:PLI<Z^L.V9*((;92IUP*\UE&,)=.9+YY%O^JNE7UO;W&WNI7?_S"0I!L
MS:RCA\I_L*XB4JI1*!\3.? $KC5W7M;3/QGG>Q))E=\T9T4I@[]SB #,\[_:
M$9T[3)M@F">Y7O10-7?.N2#"W(LTG/5S[I_MT8PI_?7DD$9^^\1?U#*^1T-X
M^=3I-'B\QK,1W\W>2$GQW2I#IN&RD.GZ!DC]8P5(3S/QSP*@LW6)@+[YYPDQ
M_/B1KZ5^_O:=;3D KW[][H]77^V.W_WT^K>?W[[3_#OC5V__\>&5_OJO16+X
M^>W+C^_>_L]O/_^Z.W[SU;N/3"9_O/GIOSZ\T]_OOO[U'=_?RS]???OU7^_>
MOIZKSV_?_U*5<R&Q_FQJCFRX&Q)#DI>J,E7OR!J/B_%$:U0HLB*54L$[':B5
M_$ ,-A8HOBR&0,_P<(M@Y^<_[.+- 07G4@[21PLM;ZP64R KC];E81[1);S5
M&N&Y]>&L%Y=RS:!R3<N\JO(<5WW>]3SXUH^SYP>-+>&,_SPZF,S=[+O$[-XX
MZM>C\G[OV&<^R>/A4G^,#S\,[QKO'QSQM8YF\W#5'N$0/N,?C<]'N+X8_6NX
MW/SMVZWZH5#E-986M?SFQ0__&+T_XMMLM]<\R>=6<GS)>3IZ6WTY ^KVL B<
M'<=Z9U]^3A:U/;7#%AY7SYX$P8;6AT.)P\&,OCSYXN\G_33&^\.&#+_T]XMR
MS5XR<;:=F/F/C\-(,7YAK6F1I.,.)\<??!QD^F((,BVT<9S_+'QAE+_RI_(+
M=<N?6;C=53]YK^$+;]RU+ON9;B\W'*1S/RU9P^<DEY3_9WYGI8%PX*<OAUJ8
M]JZMG>'(SX78RW;NKYSSN[SN*Z>'/;-'-#R7T5>-"@9E[,(C6NT9>;QA2W/J
M>_FHV_]XJW\YEQ"-J(_VL?QZ-&,!LCWZWZ-)$R0'+/&/$X#'3<*V6SY1J_FU
M\Y)N"!0.:O>\>F]VTDC@G(08-4GWQ7,^11M^C.;AX<,/? ,73]#Y>/+QHVIO
M.QP.WB3QIP[-44[K'.>5E^>.V$=^>3HY>O]A*)&<I&.VFJLZQ_6B?+IP,T_=
MIAZ['_?/G9UC97<X5E.JNY0/^63LX_OA%#2S7OF_ST:II9/Q_^.]EA[#&O0?
M[1>.C]!IMY>FSOXQ.=HM37ENI[8=Y!./]"6G\_K'[F*OMT]&0,^IQ; ^IL[;
M"]F;>W3X85(&HV%VM'><^],,@>/M^(.::#DV0 K-DT[H$N?-4,J==_DR)R7?
M9Q]RN2?G]M;59RV11\GKN;+3TN7[T#(>1O2_1V->]9 >^TB!DN%F1HMW<R[Q
MMVW$>#:D!WW@7^%7IL.>[$WVZ:1;TJBRWCD[H?/#TXKS=A):".8X\M(P1[/Y
M26BBX^!HFC\,EG'!]E$X0/CX' P7:Z[0<1WS.SZ.:;><Y(%^=40G/L1V3^UE
M/FCS"\\^3*:'\[S2_78KIST(AGL<0BF%6O2W$4C+JLJ+:\?9B91;STS>&YZT
M;X:<VM/2]+/2,$;][_S<&Z$)%MUBQNM_W&/XS2D-#(=G^?:.$X0O6<P\P7<X
M3)-3_>5$+@QJS/:\Q=?958=\XMEY)IL=:S2'.+A/SD P)"<??AA/BVA"YN.I
M0&GRZ^3B+77\/>VW-@[\*TWRG"A+?/!/A/T)LY[H2B>DBB>)T^>HL&5 8VY\
MV<[J-?TV7YQ]U+FG<SZ1?U#FFB9V,)EG=)\[$><+!]N:9T,M\?9H[VA_D*S'
MW-T^\V#2OFDVQ>PH,33&LWE2_A[C[_V0%HRY95J?O_S%"N7WEU4H#Y4 ?"KV
MK_KQ4!' .@PV23&HK(. 6?ZX+YKW__R*]B>'QV8./X?#*99F++5-6-Q-/CCS
M#;SL' V-&"9[? Z.%9?3$H>AQ1OOQ'&+M;.\3-9C=C_.VLVWAH/SY]X^[[S2
M,[@,Y_FN?'<7-*-S;57F!V<V9O3A],):3U+XA]1\U@H'M6<7,\U[C?P^9HQ>
MMM9CU8J7RIM;>3_/E("#Z213:8?J$AW@'&J^&+W</XWY# Q[P 0P*>UP-'GQ
M^0\_>7VNCS#=O!^V>K )9JP.Y),S=_R^DP?7ZCI.G*(7<'R*X7FW$YQ-]N>0
M?[GPR"?UD/;GRSM^T.T*<S1>N)L3X&R/TM'\5]MQVN6=F+?3VSYN]#<_,WSS
MI]4&<]G%KQP7E,P.^(;:]X4J'NT>'E<RS-='!_AQ?N0/B,JY I;YYAZ?^RMI
M</N"Y#Y!^%!@<?Y-<[)JBSB5A>64-UXN86B>/'[^ I]Z4 T\9^><+CZ7SV*$
M]^)8:3Q52 </QGS?9D?MOF<M%9HMA/,76-43/SL:;7^OQ.&S4 V^9JWGPO%9
M*_%/BW<W[,J9A#UW=,]4ME/E\I.ZP/Q8GZ!IZ8.V+R?^$YE]YDT[_I6/I^=E
M7OYRIF/,Q=6"O32>G9JP0XR&[5U63/;G5+W,[</GSA%[T2^#EVDS"X_K$GQ?
MP2F7/(4YY<W;I+:X/%WVIK.[^^0R3[9CL!1/GMNI77]2Z9%;\ZR!4]ISFQ<'
MGB,)EDB_TG&5W>B'H[,K?6*Y+Q?[I\[.ZF&N7-;"43N[^_&@<5R/TL[=[26L
MULO//E5^YM>]_.RS<>_%.F;G@(50*MX"Q!R2"\$7I6+5.LC6ZVD=R]4N$;T-
MY?/?H2*80*:\![S6N8L@XT&3/MOGJCM9_2-^"J/WT\D?AQ_.B5["Z?Y@MB=J
M*O]IN>AVJT,:U+_65;1%Q4_X )MM,?X+YWHFO_+OD^GI]?=8L(\/=FFC)/BY
MAMTG'>;.F@FNE32_I!?>^9:-S\YZW[ZE^?X<3N59+N@::907CEC;O$MUO/1Q
MKL9<:&$P/CR:=^ULQ#*>'??L;.)^.C]0Q\[(<^F+YQH"#/K6N8[P?+Q^;^OY
M>/*9K"?\/BYS77#ATN-3@^B<M34IM'O,<N?MK'-,=[RF<Z?U1*V\_!:;3W6A
M-/A2[?JB:7C^5\[Z/S?'[4F;B'-E^&-&UC1_X!4.=YAH,/J:%_CT-QO+-S$Q
MF[6-&L^Q,7!X^\%"VX;Y.]+'"QMQK2S/S56JPAHI55<RF[F<V2[OS/(YI6I!
M"9.A8)4A>JLC5*E#3=D[;0U85WWTITVM[RLE]H?\@<K1+KTY:U,]3SY\L5_^
M=18<>S67$.7-_O<-;ZV:YA_MO+]MV-G@%%K]ZNVK7PJ9FC,485AQ%& <BD1(
MPA2)P6+K::H64V(?)ZV4=>8]/MP?%_SZ%^0_,]@\'72H\K\\5'K\"XNATH$6
MIR<'Y(0S;U/HVX3:):F>#YO(R=SQA9SSQTTS.:W[PH?K94?>+$$T^*M_>I<$
M4>CW^H3N5:\R[_9N*3QS#>)A,E _7U_R*#F8Z_L(^C,X3LG>["?QM@V,O$G*
MXG*%<<Y$M?Y]+1+1K[GJ4ZUCM-BIXA,;>^7*C[6-ECW'"Q\-N6"CDT7<X.1\
M]M'>Y1K])A_O)F\,J>.B_:<$J;EI^.6M<+2PW%MM3K_&PU[C>8F)R[.^%U--
M%P_W3=8J1T]AQ7^[TQ+/+VW:KKI6:[M)/Y] JC4_X,4E")K0!UV=5<86)U':
MZPX6: ?HQ7YI?WU]=HPNJ35_$J-G;NM%^_!N[\]=_AV^[GO]YNVKO]Y\^_-O
M[_[Z?OSN[<_C=_KG#Z]^^NZ/US]]O_?ZKQ?JU=O\Y\GO\&<=_:Q_=#_S&MY\
M]<Z^^NL5W^/WO[[^]K\^O-[[KU]_WOOZSY^_>M'NP[0UO/[KF_KJH_SS7V^_
M/GSU@^377K4.%Q2JMZ"LR-"Z#CK^"HM3(E'*KI1<,+<.%]L^+H^N.6X^< =4
M-!WAANA8I6;3.>J9<I2J65. E+$8D-I'HXNQ,OH4:TPEW3-'#6F=XB^:3CH]
MW8R>_EJ@)^N]MFU*<G"HVUR=*!!R%JE$YAZEBT.UM3.DG^F_=X+J!/5$""JP
M?&4!JZVU#E0$=,Q.&I1F<>NJN_8<]DY0#TQ0:H&@?-:6HG6"]\T*T(@B!F5$
M25G+%"B[A)V@.D&MQ=IN,B_R5O/<NY6W'BQE%E@*"PN80"24S&T0?-0B*@N"
MF*-XFV/KD+=^5M[S<@U?#LG;5?6NE;>S7V-M/<ASB6O6' /7F'=\Y<'7-WLF
ME^H@3UI0!RK*)TC)5P/.R>2U=$7I7+PS)L!U!?6+$[9IPS^9:\XJ$KZB='CV
M73<D5B"B7_^PY(B511N Q-+9>A+@E1-!@A:HHLL8D[*^/F-#H@/Z%-!HDC$*
M:P8%6&/$[+*R,9:6#.WQ?@'=%>\[H7K1?UERLF1]$JY(%)"\%U%6$-6U@>PF
MEUI8\5;;%D+']//%M(_2N^AB-E(#:<>8SB6F[*5AJPQ*%]+K">=%;U]$F:JL
M3FA7+,,Y!9$4RVP*&!W9I#1V(;T)@*[@$AIT5*(&+P%3D E<@1!UIN,)>EU(
MKR>J%[UCN4BRQA8!3DL!12:! 4G(R#IY3&2"K>LGI%?D'7L:+H+S3H&#UE)R
M>J%%V*W< Y<\C^='5,%D5Q,A2"W!%!M 51E5MH$"ZR&?F.K:-8_'XZCQDGO
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MR!( ('L5I+NV.[ +]?7$_**;H75=@5!).-_<# @D6@&G*-%:H[V,6O=$H$T
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MO*^F,U1GJ+58VPT8JDK'9IZC8JT'E([)R2>3<J1L,<O<#;WUIJG%G"QEJ@(
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M@0G/$A=ZBW=E5#S;)#S[WT?-Z>P8T"IPW0RX6KX==4PZGSGX)"T(B;Z=8T9
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M9:NRD%IU?IY'1=:*K#N&K#>Q2+M*AJX6Z3U!:-LBS4HFU'Y@HPL@6/!@11#
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M-;XS)^\#!Q]4 N%2 ALH!VYH3L8J[G2MR%JQ9>MR/"NV=(\M;3+44G1@959
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M)50Q1F/&-:V=L,)SX;4QP?F<?<I,D5"A:E.@JA65+,%F$XV&()D 82@%QUT
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M(&0L!^$H"LKR%#R51*?B2=SY (<>"WHU(7:+2:W@<6LGI$V2JIR-%L0 -2X
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MK:T&E1OFC''P.BM(*3GF@A5.ZEW8B%!MBAUCXJM-T85;TJ;D!279L"Q!2RY
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M1DSY>#QIWM2L\B'.P<?A_'AY%V)/,_2#,M89%])DZ;:O]26-WZ&M$B_\UZL
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M-^2]UM=X9 %-E$DE<*HYI8))YZP*Z$IEZ[6(P5P[5%E/P[M'P6W3;S9K)4(
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MIZNKB$_"<,=HMJIL>,LND[=V\JOFKJ[F+HLZJ_;V+I1V;C<*/61TE E04W)
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MYT^PZM>GU(WROA#M;(XU &VYDTX3%"YZ*)0ZXDL=$,%*[19<^#&))MOGDF)
M*\I\UIZUZY0!4Z%A5:"AS4>4D^>2L5*;5:''$X(M1R(-"5$Y)[*PLL0MNJLN
MX10K-%1H6!JC<4-HJ-J_B/:W60M0,J?2!)++4BJ.I42,CP'!0%"I,G.0\U/,
M"ZFZ?Z]41W4+'AH8VAP(RV"C$X:XZ#T!CVZ!,UJ04,I4(%8(!JE)EJ!FOE;@
MBF+#4TB6^%8@, R.?.^X24 :32I3G [#@1NECOO.%-XF4^)*<3URS -FN+,<
MW1L5(9G@@2M4!JV-5BJQ22D7]N-"ZHOCW>]3Z=6=G.5"W^[+^12+'()GC!+)
ME22@ R?>246L$M2'($V*2^^.?3UE6J,]GJ>*#C@A7D9/4_8,D0(](E&"(2.\
M42(Z>8_H4%%@$128.QH4&7 .FD0H93I3<S1(:H((;T 8ZJS%R$CH6T=&%0$>
M%P($ES.7CB7!.$B.RT0[F;*@299Z?Z(BP(HB0)L;8188=4:2&!/Z 0$$L3P#
ML2AA*27-*NN-+:@ 4 '@8G57+0TUPEJN,B0.GI8^O8@&,2H+VE8 6%$ :',@
MEFJ3(V6D=,PBD'DF7D(B/*=L=:8N9HL P.E:(,!3R1/Y5NGY8L+(LVO40[HY
M35SOL3KW6!+--[%+?)/+%5_T+\MR/QX_S<-/B]AE9CDZY1*,]\ SMY'Y+")$
M[U6(CG_8;NPR*X#_0P/]K1CSZ<E)/Q53Z_KGBHNBR?Y].$!IC,]>NM%I*=7W
MK5+SG\>(\%^&O7$:CJ9RVT]N^#/C7K<ZEF;FYX]4*4J]2\(3EH,AX$0D/B1-
MK),8L4D>',-(G],NV%MO==3$[=7%!^5I<@(R0VB R*D3&/[QE#'R8X%FJ/CP
M-/"AS03*:"W&_):HG"T!"13# ,&)L.!YS%J8TE]5\B[P^0X1%1\>#3Y(X)!$
MX)1)"_B[21!8<M'H;!B#B@]/!!_F>,*4G9*@23)4$H@N$$<IX@.-48.3&7V(
MC2W69?K61<0J/*PN/&05 ;R+H+0%1[5#F\&#UF"YD I,A8>G 0]M%E$'(8(,
MB3B@NG2:2:5B RX"YG5I["9UZ32CH4OM?+.9A\.')=&%:\.B_%X:]TPYE%%G
MF"(^&JI4+]TL2>J2V5@3R%ODJ.NJ42J-$*^'>!74K@]J\P?*&-5>Y-)B/$6*
M/D\TQ'A9ZEGXH)042="TL07V-F=D?P H:Y 5_L@U?]7(D@4TO_HZ2X.%-E5"
M#:3(3"8,0R("C ,QQF!DE#0(RE76376JKJ#S3&H%AD<!#*O&DE27X(YTOTV#
MF.BR=(&3F',HA:T"<58$DC47QF;+E%2H^_,Q3E7\1Z'XJ\9_5(_@(5"AS7Z
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M^BG Z L[]!5@U@5@6-N#R2DYBK 2)4\$I,W$*AJ)1Z'G*#3%EQN 80O6'JT
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M1T:[1;FF3FQL<=UE8FT:I3X __^$ 2-RXYBV'" #Z)PL]PY<T$I)A\!!:RK
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M@UJ<R :FOZM/8QIP0OON9)2>S7YY/NM)V3MNIJ7YT/.+=Y>7I-,6N4TN?U^
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M<@8P, .86GQNK0"&MHO/<2FTUI18ZA6!J#3Q*B+>\,P40 A.-P"CV0.4W*T
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M]?IL!W5R=SO@=W^B^U]_/7NSC=^W_9KB==3U?M[%\>]^_& RI1%#?>)XE@1
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MU5(T?T*0M[SI\-T\;>RJ6L8:"YO#_(*A,UJCH=^AX95HV%]44-,P93P*L90
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M(P\:#_K-ZAYUGE*I?)W0@#.61"*COHPU]1D+63/H=\YANI#8-^<O_63-X;<
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M<HRV]XN1=PS@;.I;847O3C$_'@7(8\93-SPUTBY,:$=M7<!S1O@5I<F3L-'
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M]M>%T)*021C01),@$PEAW$^)R'-)LC1/N>1"**E:Y=AQA99=#M63XJTNNO0
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MJO=JF7Y+OGU.1M1*NU!:1-"Y4&X.=8OYZ;E*<1@D(['0&6%4<<)S'^PEX:O
M3W24!.'::WKWX9#WSVBKXEKOXFZKY61I843G9+D_Y%C(:(]$F,F$$LWBB#">
M181+I8C/::0U#Z((.\T%8;81W!=XK"+WWTW%6EF^7U4GR\7,?9&3A79.ECOQ
M_;R3)04#*!("*UFXQHJVF/ X3(D? <;G 8]C)M9>1QMA="].EJZS]HU>\4F
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M5SL6>?$D^FFIYH*0VO?#(%=1'NB0A;X22>J'69@%8:ZC0,9N/&(\-Q0M!E:
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MLC7G;SG'T(1%EIT^OL8UOC^"-[EZN\,UNL.6IOQB!.VE1G!G<,+B,*?^Z?@
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M?D>K 7QM +Z$V*X!O#, GSO&0?9:@;1,!1.K,&]B00O"N_8F::MION7FMFL
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MWUIHY:6B2C(^035EFD>7G172:JN=XB+HI1Z3:RNO^RMOYV"_+@(*4I'QNMX
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MX@R%/4&RPCDY09ESYD)!IFV@D)=<8B]KT'.35D3WV+_[5FN%'BPQ@)5%2J'
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M[]W+YT__?4G/O/-AGX*WS $UHZ5 4;RLQPYT#0.B*U('I1(/==M\WH%83)T
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M/#U=7-HS5#69E^]^Z?8M+YP_XV%.9T?Y99E=0K_@J!\?GZ0G_4I[:7>\R?R
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M\]Q/@[71>%9Z.?7C>3@W^:6?+ICSK8T=G#HA%Z[YYW3$M[X>_^E,CBO/QCY
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ME\=S.*S)J5@=$_KE=+H$AA>\G[%ZLOUYM%'WBFKQ2ETA!?O#J3](H1 %QN/
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M)&\;.761G&:W[H3,/'/#F?,.&<1H6!"VL!!35%;DE&2LAUN4:;(.C9M6A9M
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MWZ#\$* ,$E5M)!9<Y,!S\L$6E9W7(G,5@F\10R?Q/)OA)X<J%@F!!2,#F>:
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M3O?<JZ0H)]H*M-/!&N*ED01*BQ9-E4Z,EGUZ,;=6'C<#S!+M$CQ5!H 44?4
M+7,,X)0U@2O)<=W8["VNIKJWOY@,,*&<L,0#90$GR4943B*GQ'IF2+0Y*.DE
MXTUOKG6E9XS1K@RPZ@P@C5+.>.^=IA!R*==@+ 5/M<:Q,K4<SV(RP*0W(=D@
M$RB<)!3Y!!0D8@R7A$%$L\7R'&DL\0#&W'LUGLH 2\8 P"&)@!B7%O"U21!8
M<M'H;!B#6H=G01E@TOUOE=7  N'<9 +.:6*T"R1ISX3)SD?A2@R!E/=>AJ=&
M%]Q#7LW+;N>HTW-EOGY6DGC9DTKJ.6H7[A\)MQF@L)H1@O^8Q<2G+%$ G:12
M8+WQF2:>G+4H>!UX>P,GWQ ?&%]5.?_@<OYPNA2W+O':$@RQN=CZC&7B#"K^
MR3M.O3,9."UU2:B<UO3_68-^5P'2QD'DDDJF4&.GECN)IKN!Q$/"G^XF7;<J
MI!\3TI-[BU0EQ[DG.(F2@'&>&)E*IHZ,R-0I"L_7-N4ZL].A=A72JP'I4B95
M4AH\)%"0'9?)>&T$CUX'?I.XG0KI1X3T5'Y.S!DG+Y$0'24EGH/8XIG+EE('
MSAJI0E,V19B*Z17%M(;2IHL)FJ4# =D'(S4NBX2G4E[Z&SC6*J8?$].3+33!
M>VE1+O.8+0'/4$P'$PB 4\#1O)(*Q31#.:VGD^X>!=-/UX?VHWBA\\K!K<$8
M-->X$'XV1N?>S_& /Q,X0[%_XKOI:R'RNY7VOVJ<'Y7Y_GO6"+8Y#M!BRX19
MLBDT,.718J.9@Y?<2*.D=Y3FX*/0\VQO7B7!O"3!]G3$E>:!B9);H4,N$5<1
M#38GB(N4RF \"!?7-H5=5WQ>[<_GAZ9'#OZNO%IY=?YQ;%QE[C.+-#(0TGHP
M@DJOJ0W)LYAJ'-MB\NJ$AITUJM:&4B*I5P1L%L1DR0A*R\R$%=:4JA9"KDNX
M<W>YRJN55RNO_JR0NJ(Z4$N]9[9TH?<Q1B4=RSXHYQ+4Z,"%Y-5);Z2-E@*3
MD4C/&/)J"L1JP4E6CIM >9:T>"Z87+?VSO6"*K%68JW$^A-BS2H">!=!:0N.
M:F>#XT%KL%Q(!:8&72XFL4ZV0^; 79:&0 HE&$, L3P$XA+7V0L#(3(D5DK7
M[0IY AJW\B\CAQ?]ZC4=/UK[Y BA$RXY@X_<X&.G=W&_D]Y@9A[#&\P;;_!!
M:H6N&PX[&1^U0:Q/H\\I]5IX;O<QH?QP@W2YT]RE(Q>EH%N=7FN$9W.^_W=J
M-0.#WT*$#?"N6[$S'.&0GW2&!_C1BTN4SW<1H]UAJY];@\[P4PMO!<<O;K1V
MKKS\(!T/TA '#2]W#O9O!S\?)/SLYX3G=X/FY-\^5$Z^/OZ$&U[S!-].?N$>
M[^>,X]K[^-VY\=#?G=B,6N<(QR,>GL2+H2N#TV\J8+EXU.GA,P_PP-_?76+4
M;^XKG QQ(:3!>LN?C"Z]4\:L%SK'KHNC5IYC>,6#;$R@IEE^EU;?'%38R]SZ
M)N$90Z?;:9YT-Y]3Z^^#_M';]/$(!VVXU_^MWVN05DJ%[^'5?^WVPZ?EI-5N
M^M\W2)WQV'-0NZ]>?GG_[G>DPT^?=_8.#MJO_CC<.?LDVEL?S][OO8#W6VVD
M6J3;=^V\<_;QR\[K#S):IH/W)'B'ZJ;AE/@<@&1M/5,Q&:/]6BNA[#G&41X-
M3M+:#QC#+ YCO$"8?+\4&N2FX_Y@#/GA^6+XG_\RG.GGK?YQ*ACH?;S8:KJ
M@#M"7A\UP!\U6U(76U&XUD/W)"(ZD5'Z)X.RE+^N*GQ:_-5<H7P3/XJ@*>*]
M.>?H8)!2@\(>WG?K"!_F8-A*O7*RM^D8O^C38(P=0==;9:TWGR[J1:N#8![B
MJ;K=_N?AL\O8^B&5G[]39(ULIN5\),YEV%@2X?1TW?$P/;MX\?RB,T:GUPQR
M\Z7GE\^.IYO:9RRK8'SX^>=.'!T4O6N#CG6O\VW.\RN?']YH#DU(UO$QJ3:T
M4=<>IAOLVF,_.JW9,/KZHS\ZZX^/28!ZKTMTK_Q&9YUO5][[,7[,C6R?JW79
MK\]D;_), :DM#1[GJ:Y.NMEK2'5GS*4O"Y>>/Z<?_'+^R%^YM54:8/VT[<U/
MXZ:6=*3:1>C<;J"># B^<T+-8*(M]KP7/6)>#WR3Q*E5&C@V#[Y8T;&IBVHN
MB^J!(@ ?U>WZ9@8+[);.MJ?NNW]*KOD:HS<_U_S1?SIX;[Q]U.[N[OWGH+WU
M6K2WWG3:>[&S^VH;WF]]Y#M'.WSWU4LQZ9I__VZ;O]_;Y_O\+]E^]Y*VMP)M
MO]IF;;X-^X<'GW:W]D_WS_;Q/F+>Z8S=\CMOJ=C9VN$[GS](:U3*7I"<.2>0
MF2&^Q.E9XVPR6CJJ[RE$;U4V-"OG/1W.FUO\7.K^_6SW0NA6GIL_SYU-\%SP
M6G*N!+$A1 *\M(Y)5!$=P#A)!<@0[R=DKO+<8L&]\ER-9UM-SF,3G*>=\BQ$
M3C)8AYQ'@3B46<AY+@9A13#,W%,X6R6]Q<)^);T'C#6KRMT]$YV8(#JJ?72.
MH]7J92:HRDE\Y?!/JR-(E7 R_3V%E]US]-C]5S-[5'2V4PG2^CL-1T?C>*T2
MJG&7%@5+6"KA,5UN./[;7X=_NQG]RD6S<-'IE$/-J!@TSY)DE04!K1.:G":3
M++4/S%A4J@4:FGJ1.I36FB:+ZB>J0)T;4"<]0M( 6(D8E=(8 DXSXKD7Q&?%
M4XZ12Y<1J&)>S4 J4!<0J'-W=%P)U*KZSPW%DSX.ZBW52M/2U =5_V09:OV,
M$Z]3C-FE8@*@ZK_.[MY^M^)X<7$\]SRQBN/[Q?&D"6]X#-Z#)A:,)\ E)X9Y
MA79\MH%'Z[0J)OPZY7?N'+A\A<,>W4;_1[<_'*;A/UL?7:<W;"$6<Z?G>J'C
MNB7M:#0X:<*);F6Y+V\#TUF*',[!=)\H<EB\C#@W_VYFYE69E]W>[Q>SLOUM
M4BHSS<!,[=^F#'HAA5(,.+'92P+9).(8JAG G M <TX&UC:OZ!9R\U*&M?7P
M B-W#K9\1>Z#('<JY@."X,E2$G *"0B'&);:$:4-V(QS)1A:^&K:$U>1NQ+(
MG8-Q7Y'[(,B=M.HA!XG(M<2GK FXD(GS#%_1+'!"T:*+N701MQ6ZRP/=Q]J*
MKX"=/V GS?<4#,_4 J$Q($Q!,&*T=42; %(J$5/9]4(M:4Z[[W6#?99*WE,5
MO&?K7'B+$CHK'2(UY]%9&=:>>WC">>S4L'I>YT;=;Z?\&S@UEE())#GN4-<2
MB3BI!9$@ V<Q&ZYEDP%DKU"W[M01]:[(>>3=E\J>E3T7.6:DLN<]L.>DCTDY
MKQQG0(PHY0V]R\1G8(3ER+(0(''ZFKPBP^>U 5W9L[)G9<_[#N2I['D/[#GI
MYS-2&Q>4)L%(1H R1[SSD3B19=!(IMFIDJ&DUI6:U[Y_I<]*GY4^[SM^JM+G
M/=#GI-=5R0 !91[A20 !E1.Q0@G"(>!$LJB-SL7KRM>IO'-6^V+0YPUJ:I>_
MR^+N]$Z:ZK.72K.> T1S1-!Q?]@I'W@V2-VF!O.W:JG_[W*EW?.GI=^^XCP^
MV,GH^J],U;]ZI%J\1!@RT;GQNY\'@V\%U#XFX@?)?2(NX^T^<]W/[G2X]LOE
MRK:='OE^"">??OR,FTTYPZNN.C$U8]2SY(/18%A"1:UP3N1,>PLFA,!\"FL/
M7;CZ:_+FGX-^[C2[1[6(]55%K'=??& ZIQP4(QFGCD!)=?).!P+6",=8B)[%
MFQ>Q%HM=Q/J\EK1/*-32Q5\C]Z65OARGWK I7'VC0M<ECG*IBE@S7LM6+V%Y
MY7JOM6SU7&R)6K>ZUJU>X;K5\T'!BI;*K36&:^'JNJ@69>">7N'J[9]87;58
M=:WM]?#%JLLJO/ ,_3;V:>&XG;N.T)+_M5FNX\_MN2]I^/++:.!PZ#L]-SC=
M1EUIV.[WRET.T&[&KVX7LDG#T1-PF1^^_+*_MT/WW_VGN_\.[W'K]9?]LY=R
M_UV[B]>F.WOO#]X?!O'^U?NCJ5:4>[\?[)R]P>OA-?=>T/;6[X<[>]V#??X7
M/N?K+^VCWX_:9_'3^Z/W5]6[YDQ%*DTLTVP)2*Z)DSR3$#U T,&"$TBSZPSN
MO-]8*R)6UEQNUIQ[2%IES>5@S<DH-YZ9\2J5 BLE1C@81YQ(EBBJJ(64I FV
M5&>PMK)F9<TGSIKW4#R[LN8RL.9D=!MG6JB0)(G&HZZI#! OLB&9:L\YZ!2Y
M7]M4ZXHM35':RIJ5-9<D JVRYG*PYF106Y Z""L%B<*CKAF9($8%10*#DHJ&
MQH=AA35E+>6]2%"OI;P?O"#8$RD1_%!4-%W+&YPP8&,FU'*)5"0B\=%$ CHP
MEGBF*K.K:WG?O Q)K2JZP""M=;P7#Z23OBDODV0XM21Z$XJ5Q8ASP1$5HC-<
M,A&EOKJ.=P7I2H"TUO!>,@1/^DEDH)HI+8EPFA-(CA('#$APU&;'N0/IKJOA
M73&\$ABN];N7#,.35GM.S$4M40KGTH)+&$=,,&C$*TZS*+7!K+VN?O>C8/@I
M!$X5FWQ<N;OUCZ9R]S]KZ>['"!UZTE5$'XB3KJK<S0RJA%F1K$MJ&EH%Q%%1
M"K1P+BQJ':@<7EFY^_%J$M9*HHL7PE+1^R#HG;3K@7J6!'<D9QH)3EL@UEL@
MRC.O.(3L(UQ9O;NB=V706RMX+PMZ)VUZ*Y@&Z3W.BU*EJJ0BUAD@7'!@0C.N
MM+NZ@G>%[V+#]U',^@K;^X'MI!G/HE(B!$>\=!;->$N)$2:2J%VV.0 8ZZZN
MX_THA?>?PL;Z1=#)==E.*^Y%?-PDG_'0OQR/?"676<AENM*T<SI'-+J)]-(3
MP)?$<D#MP-"<C+:H%(2U3<[$ G7XJZ[^Q3/(*TCG"-))LUNG%'1&Q=V@G"8
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M#,8(RB.1MC3KBJHT'/">A""#X3FCN(R572N[5G9=XNVNRJX/Q*Z36V$J!"_
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MH0(.X(P$R[IPR :V)J/ G?#A&C,)!FDWP*(/ 575"^)^+0H2/)LRO=BXSOW
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M2&_;72XA(H-VO'TKQ\!*%V&:SL$E91 1,S2\.)XB?5R$R.*#  LM@6Q8CJ9
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MQD^[5;5._4RXM] URLC$<:.59S^\\@-LT]I%4/I)_>0QG]2$JI]LQ),74(.
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M$J7X#=DDM+F80^@F82H:6\8WM'+4%PDR4%"_^5[4L=$"?@18=WC- ) ,-]O
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M2Q;Y*XQ?FONWA9N/](0;01IMCNT?HBL!ED)3!;0('QP!/ ;BTY%N(A 'IJ&
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MK>U?MUO6UN]V+3MJC8;[K;K[NWZO=]%[';8&PW%#]FI9K5%OT*3-EH/L(X-
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MR=5WL!J>I0U(4N#(+OTU>:3\ND :R9I_C]% [RHOPA8%-%$0.PX#M-" $7X
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M"J4&.J-\H +%ZQT6VZX'2@:'H=ZYL+Y J9<3NI(20BETE>$_-3?B/O@Q%S=
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MMD$PV H+ =4L[1_N,EENV3*IM'ND1]\/8F$R.0;^S7Y@%&D7NE'SXI,3QFW
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M*N:8 (BP65D&4)+"A=OT!QH\PD[G'@R7BSS=(:P7F644YH98Z8:_*85E!A!
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M;.$),TQDSA9(QZ!LG9&-@5FDR\F;2MZ9@,?00EQ%6 FW3R2#H(J#8!LS</6
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M/@85F 0]+84+%73LJB4X)<P-9O>V"#/4=EW<$:[E;X*@F'#[TEM>RI&PNDF
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M*'57R[:Z8^%W\'C/A>N,4PMDXW5G**1OP;@T+\V.V5*'Y8/M2-@TH2=.R,B
M$V$FN4ML%;7KB1[:[+7E@2_'QA<#GTVDK;943H4@<6+)\"CWEY"V_NOQ!3!
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M*3#*W:2"T1@ZPF3YZ+$=VN^WT#96DDEX66 3E. ;<"5CR!EGBX9K*9;04)]
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M'L^=A8$>$H"*GR%V/'C(^&?NF!'P!2,T '"?W+&I[4PD:#A>.(@&D('&YB[
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M!XH>GD3/%@O*IEP_D(\ L$\Q:@]D&ANQC$7.&1KJGT]8V(*[)>/H<"'X@HB
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M%BY?$C(APJ-,O;WD?M#0']NN+J,1EL.TP4!%'^)*4:I6I*KMINF]8;); I7
MJP=NFM!H4N5_*GF_AE2*NIN=W<109LF-1G$@[6(F"DGQZ*+Y2S7_,A1"[Z^X
MY6P&YN":OA+G&PY"08/E(['A7W .GZ51@)ZZYN(1NZ21+=QEQ6;#.+*,PPU]
MB.I7>T! @AZ(@)0,*!8")5+\%:WDZ$E!>B!)YVWE>#839(8#<HVI^"=V0R)[
M\ZO@OO^#"0D]_9-(=.74-RW ]H:-V7K1>Z[C@VW5ZR>(9E9 RU(+?L4*N)(0
M@8A(R:BT44F)DKH15 XYV4+EE(PE988D%GBOIQX7 ?0+N#BRBU<Z48C^Q?*2
MLT!@.PBQ&[_>6B=W*X99_XXLM61IT+]8&N7X*<U+*:))W?Z*+I8H)=BJ3.<5
M+9I4]*IOTF$[FBN+V)H5X=CJGU::"37[%,Z=A_,["9+?OF+*?+"KV^-9QM<,
MZ(G5/S,"*MFG'B!5P:&N80\I%D)%P5MCN,G(#-JIC-7-H,7\N@G1%1'T6;7_
MFC+9]12[-\P/1-@@*"_A98[3SP99ORUAB%8<48KE'J>H(U;/5ANBMAMO6]=F
M')3#OC7(Y$O+L$8?DL?)?K".C]Z5)UL/WH3,.";EJ,SZLHFOVL5^;I(XVR0V
MILV&PU%V>2\5'W0P:[;JO]4/WPB&GE%VX6)Y2YZ)>\V%7MB,WCGC( GSV/@!
MG&M!V4QM9VAD$]].#+.Q'%F#3!XUK1"IG],"0:RH1$)2)A0M^L92H7&P%G0R
M-$8KV?26CXX;5-D;7$XV+E4"W4TG<W)!9I0QV4'J4)RC4%2';?R[:770?_CR
M)P7,C?R/+<*&RUOO*JE98RUK8#1AZQ)#RD/*C%9"1\<#':V*6FXH5%^'D6I"
M- QD&Y!N1<=5^U+Z3,M(.?R >K"3?O72?]*&#%)C6<_O.P\ /.%L:$[1T;;M
M-/L=!#4K]I$UR*SZIA4[%EAK<"QRJHB/GF*KK!)]>7ZN%!W%LF=UO/BP7\>U
M>KN IYB-62..K4%FN2NM$1V/3_3IMPE^K;_8G!":8Y2305Z:%:B1(N]F;V^;
M;BMF9!X/I]8@9_4M0:/S(^(;<> D]J6+J>??XR5$<_7 R>5@'B-G@VSF.F*#
M-!\4,>HX$DW">P,?8Z0OX_SL'K)\5+H8]>=U:ZU01X:]>3PNEH]D!IY6(\OX
MTZ0RFMG1P!ID$G-%JM,DVH*400&_"UBI5*+N#7B1!JAU1HA$B;-6?,(O")/"
M!%]>%X3YS2;GMQ# K&VPC-9<V_2JJ!9FDVS"4200BB3:*U6,:3G.?!K,B7Y_
M!3$E7\"P#/CJ:7S&H]D.FI\EE%GY1M:@HN]252?Y%$EAXE(I(5' TV]6@NYU
M,H9ZN["B$D>S-EC6,+.<7P1[QR.-*_)4]](WH#!&$J.C078[!9!UK%^;Q DI
M.G-<<#S*;J$&XBY& =#N2\Z>X1+&)]B#_B3;(KLD&L\--S=4XFDV1"?6,&<+
M X"48HU6O%%L@#IKBK;=D)+#P8S0J37,K)MJA#H^,5QRSZ/1SFCF7.IS^X35
MOR?#Q,@\C9P-LAN 4MQ43+K&;P]/XWLI*O S#B2K;PTSR[E&L+HYJO""!K E
MCMN_UP0H36D<-Y8<-AF;%I$C1=_1#F_BC^70&_TR.0JR.U37.K^+#EJZ%Q]#
MS\-BR=7EC%?TF3J$.6-;SK1-4Q"UN9LMF<0PDW'?0#"J15WD"9=!QA6AN*:.
M^@QY0#S.L2 /9!$*>XZ;'L^HQ=D,KV4-,X%3,;RJ#I2J9(]LTO_P&UQCP-GN
MQZ^!N1G?(VM89H#3^*HGNI[]Z%W!\)VKTR_$>9!_"VJK^UGE\[B';ICMAK :
MM/'^AY1F^Q&^D]K-6G)L#3-K8QM:LI(")=5$[V)!T$J2;!DES%Z3DJUX?*J'
MF?]58";[Z2J$/9B3.;DG@O)D\Y[:COD;@6^:$6?\3 2>D;'OAYZFWEJ[WDPB
ML\:=6,/,^MB&QJ6W $K;% F'(NF0%D\MS&H!4[L']1[66,9>)"1*2;E71?@8
MG1.ZY&ZZ@66B$;*'U)T[Q+GF8J4(._!9MJ[:K%RGUC"S_K4YZ44BP&IK1D_2
MFI<(HE;X$W7;J]#OV^4GC9S, )]9H\R2RN9\U>V$Y=BV0P^DD.3!G(BU+RS
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M7/IIH4I"V\X/G%!$FU;\4-9+@Q!^^RIXN#@_T,5I0+P#%.CB@>C!3SXP41N
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M,(^'",U5T8PD[Y<'V)^".I^-;(X949'MD8:@*.E9-%HP",:E')0*5C5FQ8U
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M8B+)9>3".X8E5<, CD6HLP'%ON0HY.3$(,F&:TC&Y*@W)D<#T3>CP1\S)%\
M\UE*FR)%+]$[&HE-EFD5 H/,Z[98<-&H8@RTMI)7,8S)06^L^JW$W=+=FJ]F
MR\4'.%DO7LPR?=*O,-\P6B"'H)28F0D4/^@HB)51>99H3A<"> ';?$'Z[O#&
MY*LWILI02FJ7M#R8]\M:J?IBWO?SKS6>F)20C#$Z,!XMT1F$8N""89"X! 5!
M>6R=X;D!QIB<[\:LV%;H@Y2&?Z>A5R[GE%@!56HLX5E 5W=50C!1241M6_N;
MUV&,:7FJM5NYI= 'J^\\ Q.S4Z90F*<0/1FB &2(=&$QI&@3"@4XB/OXL)EA
M5PM60_B/6PI_B$";IJ@;4@VRH->V-IL)IF:A'5FGX"RS E%RY[S-S3>+_ 13
MRTU=2IKLLY,L!8E,(Z^KQ/0BDA[JG\"7V-SFW;:I:S0A]/9,^,&.J'N)?,@E
M6NZ*-;8H9K*J1=KU?4NU&,QI QP2JO;.SD^X/)HXN3T#ME1 TU7-;K.EM.9T
MYK,E.6$X2Y69PO 89$Q,%%=#>%.8MTFR+*TI7DJ;7.OBG!_ &6D<W9X:K532
MC"._=[-Y3Z-Z.UMBCXO:QBB(F&-@ G1-\24B:7!$5] ENH#2^]:SQ%4,(PV5
MV[-A*^$/.%^\G9VVHOA (5R5^W+9=W&UK-']YWG=I4/$)3'2';]\QZXC2F4I
MF$M6<J9Y)L?> ,5V(6L9%&0I].!SS$.0#S#?JD01K4!!D8[53/N86;2Q%M[[
MD!3-^S:U[IGPL/EV?X5#@W/L#K/R?=0TG,6-/!HAE&$6,@58V2KF-5*\)916
MJ 37J74D^A"+N[]:HYU392L572'*WY]=E>D[^KU=S\Y/2_JZ=BC>E\V2]F4@
M]V[<><,-A^G>^3/DC5IX?NCGI5O6=?Z)<%)S;R)S!FLJ P,+ )KYP).0K@@N
M6YOE\Z=OW[WKK%[A#;TS&]=Q18Q_?X3]6A^+%UCF/7[?78V+U]^6/=#KV\V@
M/WE+PE[<\K* %F"X-BP786O556 @;"+_TPER;X22I74)[X##&=/$]T#V7>\7
M-@[E-^Q%=PKTM+3@M#_$Q(/P)D0@'*Z:;:S9QA29 :7HNTI9MMZ.? N4>\Z)
M[/'0:#NI-Z/ 64N0.JIU='4*:C%!FT&"*TP"S[7W*6>0E&3%T0B1AY";5^#>
M"F;KC047JB?.'O*]PN;MIM]!KINVP#D:<@WZ375&$SD:D$TMJE Y%7)44;7.
MT=T5VY@,:AO67-N),(26&B;R%LOWI?:%7"<AL#_N$BX^$=I)<"*EFB^"0+ZN
M]K578+#(.& L1F)2KG6ZYG8T8PHCAN%)(TVTR]W@>B[_=QIL#]-:>9$/NUFW
M6%:OX!C/ZO8D%\8$H9F3(,F^>YHS3):,.V,-=R(GVWR+UIV0C2GQ.PQC!M!0
MRX; :Q?P#(15P@*&PA"M9UJDN@/'.B:PQ)C(&<3<>E'@"H0QI7Z'X<,V,F]7
M5G=8,RG_LY9"#;XO-R.>0!#@@)"(&@QH+&3*:J5602ZU1OH06_/@QXC&5"8U
M#"T::J1= WCH9J?#?#^C<)+,V*I;'-24S?M2"WOJOKVD-0!3/-;VM(J\(1X=
MDP&X4-PXW[R,ZJ>@[EE4-6S<-@Q9VBJF&5_(/S[/4TR4#^ ]36;%0*T73IZ!
MH<!2<A5D4$I9V;KE[B4 #<[". NY/:K,N0 RRA%)5X6SZ&A06:4HE0@R8>O"
MH-ORAOL-OAZNX1N.NWB(=(?AZIT6%*Q0,EJ:F9.L"[VAUO+H9)G09(.C4\7I
MUC[TO4&.*F?5CBS#*JOA-N)CG*UJ/Q8A0G"9S+IVD='_M1./\+4GIL6 )?GF
M+?//GKU-9Z;39/+LR^G-)I ]."\2DZXVX02@.<I!9A%I&@DAQJ*OF/ ;.S)=
MO>^8+-J#=':Q"=-60FMKSLX.$-B\*Q.=@TE66X:VMIOQ'ED$3SX .H*HM!"V
M]:QU XPQY82V4G8K43=IHD8@-O[?VA5\/WO3S6"6.IB^G2V6_6ISC$2"[(*6
MG)'M=4P;FUG@OK"<DPR\9,"K,]:-K^]=GC6F/,[6KW1SX39>-1MF&5 &J4DJ
MR)3V)"V[=L,P,T>AA%&&IE#7VE_?V1KP%G-Y#(;,MT"695T?X_4X)E4TRVB,
M$B8E:UJ'N#?/Y?N=)\?"O.M]0AZ@IQTL80(840I*YE#G6A9*#D 6Y(6F:G6"
M(?NPIR7,/4<%8R52&U4VF=RON90Y:^?JJ;(E.4\(H+ HZZPC=1#6 WW/6_OA
M#\F0;+:&OUYO%*^KHU$HM$E:DDWAIR<X)"=9C!Q=M)J<HN9KV%=!C,%J;JW%
MV_KX/DS435CYH9_G55J>C<8C.4"*!QJ#EYN%<!^*9;&DHKF6*5T]#?9&3EZ^
MZQB"A6:ZVU)H;7? G@8JUF0E+2^,QXSU2$D"X$UBV=NDG=">F]8OZ(7'CR%*
M:/YJ/E2\>ZL3GI<;^F U*QJ^^>Y#5Q#?84R-RHEO>,[W_F$&@XSU"'@1ZEHN
MUC,[I?&L&'JN,L+$W+HCS0_@-%P 094T3URQ:'P]Y3(Y%JVHA8<J9>VU,WQ7
MA=/[#8-::?\'RR'WD77;.>)G[?'J,>,1BV2D*TNVT2<6M(TLIA"Y0EV4:EV;
MVZJ!X:XRC$/QH[E^]KB05BB:,C499P+48ZTQD!RT99ZG@#%;Z9JWQ!QD(4WM
M*F0>BE3#JFZGMND^.\- *T[ADF8HH5:\UTUA0/%\*<6YK'(4OG6BL_$0[EDE
M]SC9N4^U[W9>Q0+%1F=85#R1E+QB'N@GH8MTEDRW;)XUN?^\VG;LMQ]B=MYT
M]+PM+QD=B]$Q!4G4!%QAH" R8JN0')P1S7=3M\(^)M^U.1?O\\8.IO FN:V7
M!S#[@MUL1J:CQ]PM"?;1?$:8R"T_/(*NK_BFZ]3P?-9]7_Y=S)"N6%;?2ZC"
M94*F J^'L=1ROD@VKV ]14L4'J\>-'YC.FQK(&-RA@<CW.Y5MI,)H9X*^F8Z
M__H?F+]@77M>OSAEN3[L:0J+15>ZM%'F+*]E!]Z+DA*3)=/TZC,%C2H'YG3)
M/&I+@>0@/>P:X1]#.G 4QG%0Q>^$NA_J!VMXIRVC%\L>EUV_SLZ=+JU]F,+L
M)FL? !R@,HQC(6O/0=-@PGK53ME8C,ANEVF%+88R*K]\KXS>%1]V0FYR64AC
MLTWSRG3RN2?<D,Y>Q_K;J9:OC\4[[9)RR%RDR$-C22Q8$C>/'*(.5L:R2]?^
MX2,9TPZ<O3)[1V388Q>9L]EHT6Q-Z.(]A^\E<PO^5NL_=/<KQ[=_)->R[Q+!
M.#W>_?('%Z[\@'TWSV^KQPH+?(6;[]_[&[W^EM9>[4<:S.M2,"TGF9Q1*PNR
MK#(90YDB$5HK1A$2>"5S-,TGQ]V.L$'^N4+XT,^/.]+NBY,_%DC/_[[$^YS>
MS>---U;I73&IOG!%0SU*R#*HS?:4<#(F;;+4K=WENZ,;4Z9@Q!R_(8<]A/I;
M+H_<A&]307X97P#KA3%BTX)'&XDL1&Y8\-Y)ZRTOS1LHWAW=F/(*CY^>VZI_
M:'J>5KQ?PA>#4.0V.19RCDP7 2QB[7MJI-2&HW57,UQ#T?,&=&-*)3Q^>FZK
M_F;TW SQ?;DX[/>SK00\R=8I(6U=^ $:B*XU6H">"0'!ED(>>6S-XP&&,:9&
M&8^(\/LFU-"&^R:_AZ+@Q%$GDI=43->C+8'>5V9DX0X$)XQC<7L'V 1G<^!9
M9LU$#,BTC<AB;7(7C# 9O?%:^9\$M2TWP8D=[KX>@B#WWB=W'_D/M$]NTT7X
M=UP>5$/S?2%HPI-+L8C,. ^%#$D0+/)<F,R&3(Q3THC6AX[>"=BH]NL,S*/A
M--:,3*_PJ$>B]5H#%]KTG)YSA_7GNB,C^,(SV7QFL1YN)I-D@4P("YJ+'+E5
M7K;>*7A':&/RCG?$IR&4UI!1!6M#R=O:L18T600?&%_O8S.JYJ[)X0Y:E'67
M28H3FS/IAY#&Y&[NC$'ME-3P)$OH\04YR+DN3Q"<M< F2#.I%8X<86=,;79/
M+JA)A8D@HBL^"FC>!?1F)&-:)MH13QJHI*7?<R6,^H@)*5*)4QJE ^116<&L
MQMH4I^YA12.822$(F8$K'&"'_^V 1M6I;7=^3B,-#4B:SSW4V/N\1F^BLW16
M(;"UQ=/9%7+@0ZC'01KKLE$Y#'! P,]@W?/DS+\H@;;3UH T6B^CGX]_T\D2
M950T0Q;F><V6F*B9%THRPV,4.E)0V+RW^]V0W85,_B]/IJUU-B"?WLX6J[Y6
M EP\8I,+3,8[Q9*H;ICCD4'1%!>2S8QUKUS0K=.Y=T-V%SZ%OY8K-(#*!J33
M]6/K+Y/_(N0(FI.'+YE,)C&=4F9>.T?./@E+R!2X'=YUN@?@.Z4B^5^=?4-I
M>$!2GD6=9YT)*$[0N.Y<Z=5Z*G<$JPA6'&J9)1=1R,&)=P74G<BUPY:T^R'7
M-IH:=)+\WC?IE/;K^L,+'Y\''!,4SL2HZJX\[6KS><,\JGJX"6:NG<YA@(;_
MVR"^$_5V58>RQUEU(!WO+!AX"4?=$J;K1D9@#"+YE<:YFH$E;R!8#$Q:)0('
MRR,.;^%N0W<GONUL(_A(HH('*J\9N2XTRPB)XMPB(A,JUIV"RC+0,C$G L4E
MVH#DK9?P[MF8Y"^6%7^@[/=13QEY(#R$*DCPQ$W)F5?DUB6O@P8T5H4=U3W\
MM)[R >\ G*R71#_/GZ?_7G6U7^+Y,BF]A]*5Z%FV@+7[>6)1^<Q"YJ3A$% Z
MU?JM^ &>QU 7L2V!KKTGK?33JG=?0LR+*HX%3'%><+W"#K-<NF^827(U=WBR
M.,\A)D[A4)3D)[@$3'M3FR=+R:RUW.F N80K75INZ^]WSR>/J=)X8++L0#4M
M)]TUSEJ>\?L&$V'YT./1*=/K<8DPG2[>E]OW^D_((PC9&L6B%#1G*$P,$@\L
M1 J1P'&AFQ_OV@3X(ZB@:&[!=J[P=ER]:GQ?K!;=#&NIVCI06I=T;OZ2)T+S
M$)-+3)IB*#[BGMXK\FI*A>?KBEOS8HO[X!O5GN)]39ZM]#<<PT@DY&DO3^JF
MYF7M'DV?'M5+)B8[,$$&)D+=SAP@4/Q-)MM1W.2D+MDWWW5V=W3WK-?X:[*K
MC>Z:<XN,Z44;?-IG]KHL*,A.FOYC"BI(@XI,++T F)2V/(')T+SI]OT@/H9"
MCZ%8-H06!TS3O9Q/237UJ-K_P&G^8T:Z.9_-W^&L5AI,0@SH72"/$V2F25W7
MAM8V,I=,2)GPR]B:<0]#^A@*1%H3;P<ZW<?VP\"A9&4# ^4DTY$[!A YH]=#
M(B@-I7D%TD.W'VX77'W\[F"_KTVM#[&O6RH^ $U1-?+C,>?$ A3-=/U"6JNY
M_&BD0$6R:.ZKW@W:F+:O#\2J'P5(K936\"S"<T#OYK,OG[$_7)\,2\;$6"2K
M D$BTT@O>U! +HTINCBPWC0_R_0V+(]AGTMKTC31RR!)G4\'\W[Y'4Z(P@KI
M.3-<6QJCM\Q'K9@55N:(R1EH7?!R*YA'D'P9TK8\7#&#6)/+<)P6V<@L&5DR
M78_= AHD$3@;D"I' ^3)#FA.[LV3?:=*AK0G#]?,@ '%-4_SM&)A4G**44E@
MCN?:[R(7FA;K-F[MZ\;ID (/@P<1MZ%[!/M86C-I(-4-65*R6BZ6L$;V\@#3
MGXN;1*)M!BB<I"&\J$>S2A8<(A/%FR"M([S#UP??!>D]DR1_3<HU5^D063FR
MN:L^'1#@C;,_GWU:SM.?$R0OS99@F<- %E> 9L#)XJ8LZ$]9NQ2:%Z/\%-5C
M2($T]Y[:ZJHYA]Z75UT5P"PO)D*ZG)V*+"4%]<@P1WX_?4%TL6C%>9'-'>WK
M,![#YI>A6/)0;0P3A55VOC]:'X3Z^EM-(RSJ&I>UH QY<"@UIV'2K.NU11:-
M*C('ST/S&LF?@GH$^UL&C<JV5E1SL_(1:YHW?YY_AF__ZI8'!_-IG4CKHOS-
M>Y0-0G(J%&91$-LI*F 4708"GR'P)'S60ZT<W1?K?3>T_*4LU*"*'<2,O5TL
M5G7;UY4D%P6>3A:N6=*Z>FZ18E)K$Y.A\!+!>RY:QWP_1_48MK,,:<D:Z&H0
M#EWPXM:KIC?)P&;I=$'%A,=$($5D@5O.($0+G.)08P>H_[X/Q,>P8V5(=K76
MX@X:HU\HU3UM'53-ZZ*6AKR!KO]/F*[H97E3JS-/"^-.SE,E+T[JF?8]I.4*
MIF=_?H5+Z*8/::@^')9VC=AW)*]&#=RO%BM68W?A-*J+ Z")M5M,HE0 0B"3
M4"S3(686*4I@ 5T.3B0'J77'@OMBW-;LWE[ 69]\7OU9G8]N]GZ&_Q>AOP1C
M4J+G.J;$>%9(+D<L+"8N&8\&8U;:J>9G$6V/>DRKUH/R\JJ%WK'"F_D'=\6]
M/CR)8'\^Z.>K+P=ONN/U""Z+<0+>!FV+8LK'FDV4EGEG"\M%H$M.*&=;5Z,W
M'<"8MDJ,DK[M:; ?)E?@IV/XC+,;AI"LB134699R)F$:\J# N,R*32HD94).
MK3=R-QW F);XQ\ODIC38#Y-OQ@T%*:04I1[%R)GFQK.Z/X2YPEW&Z*TU^W(>
M;D<]IIZ8X^7L]@K?.5&KTS-?+3]1D#K%[R$)+/'*RX8RHJ>WBV09: S)LJAD
M8L'GHFA\P4#KIIMM1S"F(H=1$G@ (NR(S!=VX&&124LEF(\E$[I ,O+HF1.0
MZ1>A8QXZ?+T-VU["UN\IB8GP/'L(KA9':8I@UD>:N,AT-!:2]U;&UM74VR$>
M<[C:A']-PM2'*7@T(>HY? 4J5<^-D:4CR45I&&@LC"N3R9VSI33?+-T,_)A#
MT[U2M:W:1Q..GL-/SBOIM62F2'+MT-!$F(VNW0FR2P:*#JW7^)J!'W,8NG_6
M-E/[?D//<\P%L[5B?;XT =<IT/R0:_&&$MJ$$(6T>\V:/(B?^PHY]\_/[10\
MGC#S''_,H+W5@0E,]2CT>IR 3H7YY$,QFN8'5\868MZ+K/L*+_?NK394_ Y6
MQ'_'W-$-7TZA.SQK.?D1TWR6NNGFC)WWY?,!OL OW6Q6U_9G^?6ZB/L%3.O]
MZNK_3?=X<?()O]2%XX<OD.\,6KOU\OU(L]'R^85ZCLWA;X2N_G!^WOWI.3D3
M[4J"*#T#K,97>\4@9TUN0=$N@M6E#-B7XL?@MK7Q9YVC3^A)?\R.H,L;3=2>
M2)L?KC[Q3%-TY:KOZ?,Z58E)!&>$-YG1EU#;3@<6E)$,!3E3T4LG4NOM*:VP
MCRD;,0PKKQKXO6B]F5^R#?H/?3?OU\Z5F* J4GO4+/':*:+4&GE(=?]$#!2X
M0J+Y<D24O0!]3$F)\3/VH3K?@3_R&OHZ,=;#@]<5T*]P-C_L9O4%H('6!8)$
M(WS535=+S-<O?JBOT>2Q[?R(]E)HY"/\:_T"87Y^C#U\P7^N#B/V=9O-&LGZ
M\8L+._TFW"DE%08&14+-'106I 'R=J6V*FA>3.M^M?>$N*WMO>5QUYZS5MI$
M!1N$*H5EE^AMLQ9)'O13YBE:;HLRS<OD[P5P3#/_D%R[:DV'TV*S2?Y&B+<)
MX]SX3Z0T*G!?6#+U4/7:#MQ#,@R"%E::X*UOO1;V0*ACFL3W3K[&FKWCU'WZ
M>?T288'_^-O_!U!+ P04    " #'9%-5/-1W+9V-  !0/P8 %    &5L=BTR
M,#(R,#DS,%]D968N>&UL[+UI=YM'DB[XO7^%Q_-UHIS[4J>K[Y%DJUKGNFR-
M)=^^/5]P(C<*MR! #8"RU;]^(@'N!$DLF0"X^%1)E$CA?3+B>3,C,K9__1]_
M?AY]]S5/9\/)^&_?\[^P[[_+XSA)P_')W[[__>-;<-__CW_[EW_YU_\+X'^_
M_NWG[WZ<Q-//>3S_[LTTXSRG[_X8SC]]]Q\IS_[Y79E./G_W'Y/I/X=?$>#?
M%O_HS>3+M^GPY-/\.\&$N/G=Z5^]U489-% 89Z P,/ N1N!.1Y.$3S:*_^?D
MK]Z8I+0,H&.RH%)*@(5%\-%'AIDYEOWB0T?#\3__6G\).,O?T>+&L\4?__;]
MI_G\RU]_^.&//_[XRY]A.OK+9'KR@V!,_G#^T]^?_?B?MW[^#[GX:>Z]_V'Q
MW8L?G0U7_2!]+/_A?__CYP_Q4_Z,,!S/YCB.EP^@QZ?YQ3^\BD;_L/PF_>AL
M^-?9XM__/(DX7ZCGP25\=^=/U#_!^8]!_2O@ B3_RY^S]/V__<MWWRTEA],X
MG8SR;[E\=_;E[[^]NXUT.)[_D(:??SC[F1]P-"+$BT^8?_N2__;];/CYRRB?
M_]VG:2YWHC]?<@6E*YS_NW[:#SMC^D1 IO$T9*"_S>-*\(885WWZ[I@O/@M2
M+G@ZFC=$?/NSF^*=?,9A2P'?^N@&:!<?!)_SYY"G+:%>^]PK.,]!WD18/S*/
M\M>Z*7S*.)I_^DN<?/YA ?)\@WTU3C^-Y\/YMW?C,IE^7NP Y]][&'L>?86Z
MX3(OV0+C6A][!3IQ9#@>UN_^3'\\^^P*L-,B\I_S/$XY??_=,/WM^V$6EEN1
M8BQ:*^.+MUQ((XO,JN28TV"M)]3EG"]H-(G7'CBJN^KD@@8C#'FT^-M!RL/!
MK<\D*>1W\_QY-M!6,*DS!X%,@8K1@M=*@(E9!U$DC\K>)M+LG)BS'/]R,OGZ
M SWEAZJA^L5"54LJW?OLI8*V6]&Y4#[2SPZ$(,DZE)"%3J",-H!&*CJ$@Y4H
MD^1ZMS5<?=IUU)?$>C4]QW_V@F[Y!E>SH[GFYI,&HEOJA<!__]UDFO+T;]^S
M%BK\?T]Q.L_3T;??\I?)=#YPS-,Z(H(S)8)R:"$(F<"$%(WTSJ$23;1YX\%/
M1K&["/2VCGD+';_/T^&$MK;T(UG9 ^Z3B2J0Y9LU_:(T!R\2V<O6.>&=0.5C
M$PU?>^R3T>_VPKRM7=%D$YXBV39UD6>,*TI[\H(TY.0XJ&(8A%PR..&X32)X
M:U=8)]MLR#>>_&1TO)-(;ZM9[J+F5P0H55!O1W@RT/0?.80<"@9:61("@HP2
M3 K2*A&*"G(GW5Y[W*-7Z/;"NZU%U>)E?3N<11S]9\;I6_J;V<"1">I8T&"-
M%J \3X#1&G"T;R2AC;2NC?%TX\&/7K,M!'I;Q[J=CI?GQ!*4TB6CL@6RTF0#
MQ"(A1!^@&".9#MJ44AIJ^<JCGYB>MQ7J;4V;733]YG0ZO<:]<W,@R>P"SQ:2
M\0@*>0 DPD%02&B%,JSXG11]UY,?O9Z;B/2VFNTN:EXN\PW!FN+HW3CE/_]G
M_C9 D[E@44'"XD )1V9 ]@E\XBY8GC+S+7SV&X]]] K>79BWM>MVU^[;X2C_
M<EHE,2B>O/%(2\G*:5!,>G#1**@VGLY61L=U \5>/O&)Z'1+$=Y6I]]=G;_E
MD^&,&#:>_X*?:?,P23,D;]OJHJN/QL!99<!+-,(++I-E#51Z_:E/1*T[B'+%
M/<9.EU7G:XR3*;ECBU5^F-/A\&9R2MO)MS>3E ?&."E8"9"L\(3/R1K5,Q!9
M,$JC#XSO=O2N >*):+Z=H%<08:<;K26^C_CGNT0'R; ,E]',L]U'&A58R@*T
M5K9>IY)%R(P''X*03I$H<HL-_(['/Q'EMQ#N"K7O=-6U1/8JI6F>S<Y^J^OE
M TUFH$?G(9,S0 >.*^"\8J"E+(B<L^A< Y6O>/034?>N0EVAZIVNNZZA>D-?
M_CK]./EC/!"N8"Z2=IV,Y.UA8N M?15420F9(4^_Q;M]Z\%/2\U;"G2%DG>Z
M#;N&:7' _#I]/YU\'8YC'A3F6/+2@O&.@2J<@S?: 7>)R\ MAHCM-'WCZ4]+
MW;N(=H7.=[H=NP;L_60VQ]'_-_RRL"BB98(KQH +3TZ@Y19<H:\R!L<*UR:&
M%J;;JF<_+7UO+]85VM[MAJR"FF9< ,G(3=3$.!_(?E H)+B Y"0*XU%Q8QC?
MS0N[^K1'K]&M1;="ASM=?]5<P='[3Y/QN7?/%<_<&^)2=($(Y<DN"$5 *.3M
M9TDF0]PML'CSB8]>ESN)<(4^=[KP^I#CZ916R$7X.)R/Z#AP2GG+$#SZ#$IS
MA( L@8\$PVOOL.P63+SYQ$>OSYU$N$*?.]UX?9QB3:W^\.USF(P&S!OO2R12
MJ1JBSCH3LP09[3[R;+(Q-N_F"5U[W*/7Y/;"6Y'&L=/EUCFG?OHS?L+Q25[<
MMEG)11210UPLBY9(AKD)P$T@B\TK16MK\FI>?>JC5^K.HERAVP;W56>QK64N
M224=F>4U5.T,<N\3.,D6H>I,>X<1$)57Q=M"Z%2+0-+*IS]Z73<3[0J=-[BL
M>C>>YRG&^?!K_A'G>(9S(#U'8SP#*P5M-*C()@^>]AU.?I@+BJF\6WKE?4]_
M(CIO(-H5.F]P:U4#8=,WY'*?3*;?!MHD0P8!H;"!4 CA:9'!0.!,RI 3.M_B
M'N/:0Y^(AK<7Y K%-KBI^O 91Z/7IS-:WFPVD+RH9+6#:!UM+KDP@I(]!*94
M85;&%%L$%:\]](DH=GM!KE!L@^NHGS[GZ0D=&W^?3OZ8?WHS^?P%Q]\&/";&
MG$)@7!I09!J2>5_(@! Z2%N,#SOZN?<\_(DH>G?!KE#X3C=29P3\E$>C<S@.
M(T^Z%+!6%MI85 #'N02?F"CDP*$UJ<6+?.693T2]6XMQA59;I&A-/G^ND>I)
M_.>'3SC-LU]/Y[5,MGIX QZ23C)Z(!_ @G+DX#F;,S"7K4Y9E\Q:W"[?A^&)
M:+V9F%>P8/=4KF&>?<0PR@.> D9-!.11I(K$ SIA09)+;PM&VF0:&%[GCVNH
MVRN5S_O1Z%8B6U6D]-VRC/6O<329Y?2W[^?3TWSYEQ,RV/^<_S3*-9'W;]_/
M\LGG6][(AE?3^01'9Z&//X>S 7,ERD@.GLVN'BQ6UXBUK'$N<@I<23+O5M-T
MXX$-E7Y/:?D*$FRGL4D;R34N3UNB^'&QH:V%8W"CD'V'W?K'*W7@;?;ENZKM
MKRMQ)_'?VI!WD%U/77*,EC%.!H%+H=ZX(>')"HJ6I@@C?&$MDG)ZZO!:!X(]
MJ' 3D=VING_]X88,Z)CXYVX=!-Y,QK/):)AJ>Y9%-D'=N6>_EC>+^U7RXW[Z
MKU-:Q75H:S416/>3F_41V&HI-UH)2!M(*S(DD5--AT,55,A&TP',LI9EL.Y#
MMGO33F=P@OAE</')EW: M=PCG05@HZ\1C.( C3<@DW(U#E54"?>\<P5G8?%.
MG#UB^>+ET7QV_C>7;^#=*+;=02X^\995B<EHQI',FY0BJ* %!%WO=;WQ@OX+
MY=Y+M*V6=3CKO9%^SW>9-F)MV'C@<GWD0GR:C.C39LL78D!OE+>:5J6U(B=2
M!PZHD@9OHHM!)=3F/@MN._[>1/'X-;V;8!L:!>>(_C$<3Z;GE_9Y-A^0LZ)#
M6=SRT:)4]@H0LP0?; FJ*,<5;ZSHFQ@>O9IW$FK#-@1WT^[=.(Y.ZU;SOL;E
M2+3S^7083N?5=_DX^64RKDXA29 ^\>1B%4AK%J;0-B2TKRFILOHT$1A1.#G+
M9/"F^QZP#?)'3Z@#*+!AFX3S51#F:<99_C$O?W\WOKVNWPCRV\GT#YRF :.M
MKT1/GK<3#I0W9+E+@9 D0Q-]+$FT/G,VA/CHB=53)0U;-)S#_27/:_'3Y_SS
M9#8;*)>*\4K1T8ET=-(V"H[\.] F6:$EXSJVWH^N =B_]KNJ:])*UAW,E&M@
MUMKK4@Y"LR0 ?36AT=&1&QFO>6,U<%E*\O<E3^Y,CN,\EPY&H.8ZZV FO9].
MRG"^H+N/!DWM:N M+5DEZ<#SB&!9*4K1GLI4ZZWE\NE/FQ9;2KF#/?+K_%.>
MUBCI-'^J%XM?\R5?B;R_EH_XYTKSZCTN,IJ4UX9)D8"5($D*FA;B7"#V!F_)
MR,^LW-=I8AN2[ CY:3-KG_KL8-QL#?^.W51Q9:4(%HI#>KO0!/!H(W#%I.-%
M1*[N"ZSOE9[/\7P\I+X;MM;:9#D#KQ.3VG"0-;E(Y9@@.%E <R80!3,VW)>;
MUXN3+T3;2#,-VW5=&(LK.7TNI;<DOP^G839,0YQ^.[L!F<U.:QQID(KUSI+#
MRXU&4-Q:VK%YAES;%;G$ZFO1VM+?&NW39MJ>M-BPCU@>?;T#];*7W4WI#6)V
M0<=L@ F504G,@"@9(%,E."^*] ^%5C=]YM/D3%?)-^Q%=NT.]K?\Y70:/Q&<
M]&J<?LOSX32G'T^G]2)V@7H9RQLDB2(G+6M%=ZTC=1X"3[5JC44"JXT2K:,H
MF^![FHSJKJF&+=$VP_J_<'2:!UYJ&S3S$'G-QW=&0A#& P],1BY2L.*^XJ1^
MI%K >^'4-GIJV8KM'.N/PZ_#E,=I=B4AF';/$*-6!$HI.E\) BQZ"#&O:>%%
M>2];)Z"LPO&T6;*SY%LV9+M&W6IGK=K_%K^^KHRN#@)Y!XO\9=H5R0.PSM1<
M!/(&5(C@%5EC(N:<::<LF;6VJ;> ^;3)U%MO+;O /8!YL2\NOO?KEXIS]M.?
M>1J'A'[@56&:64TF/R?$-E4)*09DS"'S.4?A[ZND;\BTNT$^2YXUTEG+!G3G
MB%^E_W,ZFR]2-S].7J6T4 :.WN.0O(8W^&4XQ]%21O7EF(SI!W\M;R;CKWDZ
M'X81237,JR.:_^N4OG7ETP;*2)%%SF!UKAVXI() (@2MDBA>>XRV=<I!M\4\
M;=8>!P=:=MZ[.QTTL<@\<@G1Q+CL[>EB]%"RU<8)QA0V/XWOS[)MDE,:2DI%
MIP3&ZE*;9Q4(M21-9QV]$9E<K_OJ$'KDE+9(H/0ED =9P BL4TZ]H,,8.41O
MZ7>CE0RMO;3[$R@/EB^H!>,IL@C&1TYGA4BD7V\@:>[)]J4#A#V&?,$=\O_/
M:L$$B]E8.A\5O;1*2%.-,@$ZN:(BP\)L\R3Y:PAZUT!VRWK<6HR'+H*\M80;
M1]%L49IDB@FY!$4'7LQD1]$N@:5$X,ARG9(BK6V_ =X#:-]EDRT4?1=G=A9X
MARRV&YC.:LO6 ;5&:>4V;%@):+]5EQT4-^DE];U1(DHO'.I YD.IS=SIY/1:
M!;(A?)*Z<.O$?1U.CIP*=Q1O'HH)FPB[ P.N7!7^8^%?#5S0O$0R'@VO(TF5
M5^"%J?N?8LER7;L&-];^+1#[=QX;*&?24K(=ZNKN<%//P.E@D*&V$'.N#6B-
MA5"R A4,5RESI>^=-;C=W<,]@)X"!=I)O,.;_UN>T_IR^@FG8_(^9F>H4+%@
M-.? 8ZIC,#61-*0,F') 60MXY'VC%+;AP6HD3X$ #63<(=/\58RGGT]'M0K]
MKN2L,Z \QNB-UN#J4&KE>"2,+$"VOB16D''7VH=>&]Q3X$<?371(5E]]4W%^
MKF5)X&CQFC8Q4#HB&46Q -><%6ZXMZEU$.4^/$^!&,WDW3!3?#:=#]XLZ4KL
M_*F4',^2I7XMK])D$:99&,G.>I^S"2"%9N1!>PL.A0+NE8M<>L;E6A8D/? *
M%^A/ESQ8%\LCOE/H(NZ&I\DZ^,[>A'40;G+'L",Q#G'1T$>;&U!E!U4T-#XW
M0$J[6! R(,14&T<JIB'X5* D(S'6SDEX7P/TQT"6.ZXBCH4KFVA@SQRYC)B>
MG8G*1,'0)4 ,M,.&4,"G.H#4>V98XBZO%Z3<]<RY@6M_MD@OO6YR&NVBE(87
M'NMCS>DUCFH!P!G@Y+EF$JLC+I DHPFZ#!)BB*$$8@*3^V/1#7#/D$J[J*?#
MC<F5-(VWD^DO^0]RW^KHVQK>G4[&]&5<=G1;;,XV$\,+=T!2B*!\$."X]U!*
M0!&D="JTOU#; . C-HW[*Z2#"_V1?NZ2X&>,7@=3I^C;*CR'";YU5..DDPXZ
M["XKL94B:<M+'M &PN;H[0A(KKYP122NZ##5K2MY]L>+!R)Q!Z;%)J+O<=A<
M+/9#S8'#:9K]_J5V#JW''#-G(&-=E@P.DEFT:BP,?%89F.0$,2;:7-=RDC:[
MH'T8V/[OX';7X>V[V<8*N-/$[=":]S7.AK-)>3_-,WI%%NGYM(@/PY-QG=P^
MGE]YER:C81SFV=W_8GCY3Z[]BQ]K=&,TN[Z\M=K[[A-=LQ;!!Q/IC3;#VFH7
MR?!VS#CEM?:R#N[U*?"B, 0QV"?0[>N>;Z/X^2)OSS.OBQ$"9$FVMF**@,(H
M4#87PX55M\HR5I8YW_.(W:.GL_ET&,E%>8.S3Z_&Z=WX:SX[K<YGCB7-+#,Y
MUM%4=??Q'%QB="X9@YX[SOV]LT6V"Z4^"&M_6W-++=^.K+:5?\/KA[KLLUF3
M=;EYD<#^<8KC61U+-QG/WE6!X^C-9%0C?U,<D?<;ZWMWDI<EG)*K7)</1M56
M0*J.OB)O&H(NTJHD0F9Z#?KO!.)QTV2_.NA@_M%6_'EX^GGV6XYY^+5ZRJ]&
MH\D?]5PB8_C'R6F8E]/1F=AFY$4[KGVJE\"19%2,!1^UANP+-R$D5G3KK(W-
M$#YN.NU!*PTC<TORCTHYK5;#)=;9O6"QT(Y8QQIS:6H]C$F G!"3':N#%K*P
MFT6W=VPZ&S[X<3.COZP[7$6MPK;(/[F"__P098[YX@P';6O&*PNT#Q8; ).4
M2<3 =&J=#KH!O,=-GM[ZZ- F\.<)G:-Y^KD6, Z$])''$D'(E$!II<"A=9"5
M<T8;3PYVZRONJ\]_&LK?6J(=NNC]F$LFFJ6/^">9U L*_CS$,!PMS*B:E'1N
M6GNF@O8:D,F:RJP*.%\4Z<LXK:5CP;<N,UP7V]-@11=-=.B<MZ*PEK8DKF*H
M+75-357,B3B<'6AO?%)1*XY/:5A+3Q;L*-W&G>INKW(9PA,*H_0N@ZT7K,KK
M!-Y8"1:]E"&Y+#);PW*\X^-[EX_VL@I;2.O0A:1K9R+E8F/TL5JPTM5K< W!
MH(0HLO7.2!WU?<.2'W/*9S-=;YKWN8G,#Y/"MP["E[S/+;2Y>2[?-JHX$&E0
M:FM,!&GI3:DCR, 'I+>G1"]*X;JL-_S@B,FR:]YG;ZYLH(%#YWU*F6L+307&
MF0 JDB=<9\5 $HZ9S)649JV+S^>0][F17G?)^]Q$*5T*73=)'*&71D8F+824
M,QG4]67R7@)34JLZ)UVGUJTICSI/K[4]TU\K'4HD5V:3K(/I)5EO>S6NDY6U
MC0[VE:SGBL\NQ P\:/+/<Z@#A31"L5*R:+SDLO7%QR--UFM.BTU$?[!D/9,U
M$UIQX$G2^1L9K=^$ HK75GI,LM"\(]EC2M;;2(=;)>MMHH N@ZWO:RT3,X90
M7 &M3;W(%1(<*@E)&6%-M?>;9PL=53NN7G9'.ZEWB,3>43F^!JCGWI-K(\6M
MUXEI"ZGOK2<7<ZB5MZKV".$U,,BA3H>HKIP-VJ/)OK67\EAZ<K5GPB;"WE]G
MGF0YK:L$2 NG7<1P-L;=<&.L\YR^:)Y.>LR=>392TWJ=>3:1\5[3^4]GA'8V
M>Q5)$K/%A\Y6_-VKV2S/9U<"Q8OOU3$AVZ?J-WIRNS3\'J*XD6(?0LA!<INQ
M3LVPSLG @T"G=&9%%#]H!6*WC6+%$R_CEMDD+)HS<(8V0T5K 5>O_%22EKE<
MF"^M3XS[\.RZ*;ZME,FCX=><WHW)QC^I;=27\CT7*A_HD*0.AMY<5]-GO+/U
MS45@/#C&G,)06G<B6@?7_C?,9LRXN6\V5T,'/^O=^$S$]^,<1!V<]U$ O>FJ
M=FFBD\221!S77 G: X)J?5^S)K0G1)@>RNA@<_U],DE_#$>CBPWZRBR2@14Q
MF8@93 [5T' 2@E'$;,%*%$Z%W'STV7UXGA [FHF]0PS@'-O[LZEKEY<35^=U
M.%:4"M)"$N1X*,TJ2%L@L^BE#5E)WOJ870O8$R1).T5TN,DY!SF(1=*Q%R-X
MFVL*K\Z =9YL8$EZ\E8B3ZU/E?-G/T&=;R3.#OGN'^*GG$Y'^=>RTN3_=N5/
M9U>57I0L8[V-B%CGQ)('R8H#53 *X9G3MG5%_J88]S60HQLYNBKET#F7]TAO
M<=TE10I>N]HP1XHZMXA#P,(A6W)0LRS"Y=:E?G= .5@'H:[JG[170P=[=16L
MI0V5SV['U@'8*8CP(+C#!!2:J'(->NRNAX,0!H7E.9*;GAS26U*"H[V9";"B
M<*:$TIZWGO-V(*(\$&XX#$\V$7]#?M2P:^TO?3+%?^ 83VI#A>E%UW$GN7 B
M O.U@2.M$CS2%LJL5)S%R)*^X=RLK.RXZ_./PE[=10V3QC(\1$BASE?]//SO
M1=.795>$FNDY^^GSE]'D6\ZU-'$X7GSWS60VWZ7ISVX/;!Y :+'P&W$#9JSG
M0J FO:ILHXO!),>EYQ@P1CW8\=D->M:<QOGBCJ5^[F*,_"Q/O^9+NYRA-ARQ
M>EDAU>FZ"A"1]KR<,&J#J&Z^\FV:UCR JTF_GO-GG'WX0' I-;?UU2234"4R
M/S'+!#:ABTQ(ZV7K>[U5./:_#39GPLKV/+N(NT-8X#U^.\]/O 9OD+13*2D+
MA,W HKC2!1U!Y5RL) =!A=:!];NP/$$J-!%[ERR+5115Z!<@)!H+JA92>\$9
M)%:8\75/-UU:=MV[(^QR:W7MTQ>J74R;69PJ2^<X68>"&7*.#5?U;MV#0U*(
ME@6=<DF8YA?8&\#;UUU5]]>@ETJ.Y;KJ(D?KW,3YL/S<98X6L]%RQBR8Q2R<
ME J$D&E%PMNBC$O9M.X4<B^@PU]=-6;!74FO.VNCP\Y[AN4\BVL-,)WNJ:X!
M.7"2Z^Z*NDF!G:7<7?7D'&:4P8!0N9"O[6D_=9Z!,DP*F7E)L?G1TU_EZR:S
M=M;X)L)M?I]TDL?#R6]_GB$ZOPD),FJT"80W]?)=>#H^92:#SW'E-#>YK-/6
M<O6G[]]RWD'<DZ:R:MR[=-%LZ#H:PZ-BO'B(LG8S)%,'@J9E2@RV&&L=E[B&
MYFY_\F/5VHXR:OR^_7WR-4_'*_:4\ZQF;A4KDG81Q\G3(A\' OE>$$UBS,28
M75BGG?(#CWFLNFPIO<9=/.L,:3(NASCZ\"77W^;?[L)H@O4F0I!U[3KY&E<O
M4")G2J;"C7%K:'C=YSU657>19X=DHGN\T865D&AG44G3#H,U,TY(![Y@ .U)
M%!JYC#8W-IP>@/34':J6&NG6K^ :R+-791U@79L6K !U&%>KJ0I7%J6WDG^W
MA@6K #)N0_&:[);@ZJV\D^!LBI!**(6 NV);A_WW3(P''++#\&(3L?>H,CV+
M-'[(9/Q<&;$G,A;#ZO8H(RVVE%C;"VN"Y1WJE,GQ:)V^> >40W4EV%E9-TM,
M&TAZGWD!MP=IT/MPWJ3X[?#/G/Z!53CS;Y<#%EY]Q>&HGK%O)],/.,K;)PFT
M?'JSC(%N(KF1/F!"$,8'4;1$I;(.-F(B&AB45F1A!BV!M(HPW?S\*V,W+@(G
M%J.-UA@(-M?A;(XMN6XXDRH(>A'46NU!MXHQK0%PY_XOMV0<YE<T\'DRG0__
M>VF++D8M#6)(@200P0CO:BM?"T&)#%8R+J1!9+GY<- -,1[ Q^O&J5OM8GKJ
MJT='N_OQQKCLT)?3WZ>3V>SW\90VL+J OY/87^<RF>:/^.? )"NTIG,F>U7K
MJ5 #&O)L$SE%EEM&AU'KZM@FP)\Q$SMHMD?[JRT7\3/]Z7(1C"EI'.,@1+U
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M];G/D0<[R[=#5<HB4/WS9'SR,4\_7YV;H9A.P6&$9&P!I6C70Q-H@3:((,G
ML:;UM>]=6)XC5YKJIT-:\26#%Q,49I>=BJX8L .CM.=*"TAT/!*Y+1V8!3-D
MHX6QDH[1T+H]P5K GC.CVFNN2P>@\QNBA;PN<"VF\"W^ZF+&QR^3^8?3\']R
MG'^<_ -GM))?\GQ>13B=XOADX6T-,!<,(I9ZF)+ +#GYSBL&C >OI<BRB-;9
M48V7\)PI>T@V=.A M)3G*@<C)<Y4D@R*%JX6K05PEGX1@LQ!QKQ6KG7WV#O!
M/&?"M='0;>IL/7#X]IMP+IIOU]^&B[_>[(U(AF7#D@%T1=0.E@*<S('<#FZS
MSD*C*MWVQZ9+><ZT/09VW";]UI.2;]6C7)'KJG?3:<3(G !I';E2R=9!%<71
MJYJ1E208^=6]"A_OA_:<2=E#>[=)MO4 Y98"6Z9(&.ND\<'7>G->NT<K0!D4
M),LUUTJX))I78;<"OZ\$JB.BYT'T?BP)5A>K?WUY4OS[D)S!:?RT#% M(N]*
MZ<*0!&P6%Y)<9? LN3H%IB2/GO/8NG_->L@.E4!U(-;<Q=UVVNO1JV)5^/,V
MWK,H_SI@.R55;03T0#7D'31^%ZFZJ>O@'),JFYP8AWJ_7A.)(C@F"WB391WP
MD*/MMIT=CEL/57T?&[4VT5)/2KT;?SF=SQ82X&>)0ZZ0SU^XI_W:LCH$"R&@
M0! J%#(_?,+4VEV^!\X!O8OVBKR+,CMJH4?_G170Q!DT$;WSS&MPP=*2<_&T
M6LT@(R\IFN(*MH[ WP/GN1%D&RWL:0>1YY/Y>/$Z^@2E3A=27$2H??$!R<]5
MA,L)V;J9_#UPGAM!MM%"]Y:0B^,U$S\#EQY,9G2\,@S@8DJ@(^?2TJ^2M3Y9
MCJ=3Z'%X53MJY3"M0]=!^-(Z=",];MX4<ALE'*9UJ/"!>QDST+_.=#(&"ZXH
M#\%YGHQ.B3;:)T*3S5N'=F;))K+?6^M05-PX7FJ%.S,$2M<1=C7,R67QGC9-
MPUHWLGH\K4,WTMAZ,]4W$'<'U^6.$=_"*U$0/6@A!"@?%?AH:G%G+!Q19&5;
M9\D\HIGJN["@@<![-95:->);HE5,0+8IUMPO!"^< (RV"*:-1]>Z/O$1S53?
MA08-!-[!O+Q,&SC#$TVT":4&8[P"<H06G4X41.U$$C8IK_ME@SQ1U>\DY X)
MO'<U^;2&#B./ J(D"TC5J8].UE[9Z+U-6B2G6U<I'5GWZ./P0EOHY]C;2:^S
MEI=VTG?1M 5!>G;IW4:[Q]Y.VI=@$B<++66?:D](#<@-'=PINQR"53*U-HV.
MGZE;MI,^&J)NHM0.!%V[!:V3H9J))"%>)UAX5< QIL%BD45R'K1J3;YGTD%X
M(P9LVT%X$_5U;E3]X<MD/)N0&?/3>)ZG7Z;#V1V8/3-%V% @E"0)<^801-3
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MW\?3C*/A?^=T?K4RP%2D,(E#9%+1AND=.)0!9$[:.QF4S-W.VFU!O^P9!R+
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MOJ3"5!" HF10A1G .A3,^EP"SXP3R1^?RG<*T[;3^";"/5R8=C$= "%*6\?
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MN8JM3=)-.(YU77$P;]=+_ ^E<0?[8QW3S?R^ :@Z749L1G2<6XG#.?:,"!Q
M[O&$(9-RK&T F RU&78P@ODB!$O(%4_6!<#6]^)C"L$S]Q1CR< N5.[NB*P6
MF4HL-@C#8NW#J4NMST*,S-A<C\Q2VQYVM0Y.2?D?2-_N7L1O<'$CB4-P=5+^
MVS =1_T?RK,G1>! @G=7 ??P">ER(EN892NKYY(X"\9K$GXI+'"5C2FO6A">
M.0+&DH-=Z-R!_VM!LIO,*AO1.RF9R+7=0DR&>06"!4'4YZD(D*W#[QN!'#M<
ML"^?GHY$[D'D#J'H_X3Y9-6(&)97]HU.-EM R9)<Y5QER_QJ+'PHQJN0O76M
M,];6,9S*P7\0;3O$@>[CN9;G(8@Z'?B/T1SGJ#^,2T^P_  2=U#Q&Y 9DM\,
MF;-DN&7:RCK>P'#&43BGT$:O6E=UC,7T9X[UWCS?A;+=S;F/F/'B:Z7I!YQ/
M9GFUX""*-B77(7H\D!53KS""5$QY+DD6)>>Q->^?1W4JBK\Q_1]+B.XK(==2
M/ 3C*-[@9GPOP3,\G+<[B<X!C!E=S=Q8S* C%(A,\%H.5 IGX,G<385;RT$K
M!7 RPK.3-WD<V=F%'UMEIE-67H-62QL?TS3C;J=62L2PI(34LCBON>8^.5M\
MTMHKG@1/9QN?V">;3D%*B(8L&^>1/,V<&62;F"P&R<VLLYO[7OG^TBJ;KL;1
M/UW'T<^<IH5I(YA*=7H4^<LLH-",.V,29$GRWMJ2N?_^8P<G]N/OIIN)O2C:
M(23Q-R+"XI?98H&+]].?_JP3QB\GBR]UL>_+"F IPKM4&R(YI9BN_:IC%(()
M38:U+ZFH]:EV![/\65"G(0=M:3^"S?'U<IZ^P +SSY#P.KM3EBQBM*NA.B2_
MY-O5'OFVMG?@VB<IK.N;3[L1UFD(2&OZ=[_=>C==XAP7R^J=KPK/,IE#B7X
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M8H4'IQQ9#JYY:<%&(*?BAQ].Y0Y-.!Z!NI;Q(;!ZW1IOAG2D.^/#F?:<&!Q
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MF@IKO(ZIV-PZ8/A<_>ZAZ[J7F3=D=4>M4FVX5E7J[I*%09&T5AE3]2J 2:*
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M8]8[#VX4JB'O.GR[+Q9W3_[^@2A=RWC/87*Q^.WRZM(8"QF&"E@PW-8<-\U
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M^QUSYE,!5K(+RA@#GML!3'STX--@X&'TVKH+>Y1_P=?)$LY_7\[2/WZ_O+B
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M'[ZO)BF^/8?%];5J*(I['YB6M1FKP\""E)8)6] *E=VC\38]7;QU>,<8-=E
M#H9[? ?Q8]R P!W0W^ ";[(G!L#ME*.R(]3C9+%T8_UP$6O&MQ<@;M([XT(!
MEGCMP1CI! 4E$]E;%HO,*677.MCP(L3LF<R9ERIEN["K@W2]O5PL9Q<X_XCG
M5W.NODR^WLRZ J<#C\XP*WB-.2C)HB?S';,GBT$$46SK3CM/P!G_@K@K*V=]
M^-#A.N6F4]0EG*\ZP][ JO:X0(VL<%[GC.<Z6-9Q9KDA\]=K)X5J+1Z;H9RX
M:#2@?X\V2YNNHV^FQOJ0D_2>I1J6UZ6.IP2(+'B(0FL1R==K+!I/P#EM\6C%
MA_$O2AZ=NU8FG:-0+&32<5H*R[S R&P*4M0$"J-;)_7O"/$TG*V>?!E?C#;N
MJ"&0.SE=>\ ]CN/550QV$[EF/.QPT.T#/8I@O;"<B82D>('VJ><E,J>T*AAR
M";)UJ?:+$;MG'+&7+G6[L*Z#M'V:0\8+F/_CY@Q'K8D$*;-B)&=:2\*3DV=H
M2 *D])Q^O[$HK6,8WX#JSKA90ZIW\+E^F:2ZG::?WWR>XRKR?0/,<85")\<D
M&D_.(&@6:S<]KNCS:)-2T/J6:BN8TY>+-GQHW8[I$1-7)$3,%_]V-VS@I^GE
MQ:K-:GWJ8CD@:WL'0:DO7-Q)2GWU;JG9#99PFVM]V%:[OLF.BZOVWVVWSMK#
M6[C<US>H=R-L._C1C]XQ^D;?S)6-ON\V@FQ5RUMVW?7']4N$!?Z__^/_ E!+
M P04    " #'9%-51X76GT-*  #/4   $P   &5L=BTR,#(R,#DS,%]G,2YJ
M<&>TNW=8$UV[+CX(@H"(=*1% 05!1!0$%(B*@,@+$9%>HB(@($5Z"8F"@-0(
M"B@M M)+I$L-O8B*U A(":'7A!I(._$[9Y^SO_?;9U^_LW_7GBOKC[4RL^9Y
MUM/N>\T,_1=]!CAY5U=?%V!B'!>8+@  ?0+0!IB/'/GS8QPLC-_18T>/LK <
MY6!C8SUVG./X<4X.3DZN$[PGN4[PG.#D/"EXDH>/7T! X#BWD+ @OS OOP#_
MGTF8F!G7L!QE/WJ4G9^+DXO___F@MP \QX ?3 O,3)+ $1XF9AXF>@<  @"F
MHTS_.(#_=3 =8<C(RG:,G8.3<4+U2> ($S/S$1;F/U(S_@UA_ ^P\!SE/:-T
MDY7/^!&;Y'/^RR\3LHY)W2IO%;@_0)"^\M@KE)U#4$CXE,C9<S*RY^645:ZJ
MJJE?T[ZMHZMW1_^NR0-3,W,+2RO[)PZ.3D^=7;Q]?/W\ P*#PEZ%1T2^CHI.
M?/LN*3GE_8?4[)Q/N7GY!85%%955U36U7^KJV]H[.KNZ>WJ_#@X-CXQB?XV-
MXV;Q<_,+BTO+*\2M[9W=O7W2P>$?O9@ 9J9_._Y#O7@8>AUA86%F8?NC%],1
M_S\G\+ </:/$RGO3F.W1<S[)RR^/\=]*R"IO99>Z<I\@\-AK@$-06AEWEOA'
MM7]H]O]-L=#_DF;_6['_H]<X<)R9B6$\9AX #%!-LJ-E@7]KGR[P\QH!*T\=
M.=AE "]]='JS*LR#[(_Z& !_9NV5HOH:,1I4A-HXS*0#1LW)S$SFEXK7"A7-
M!Z1ZOFW?/67*9E6)S5Z9WFU8NH[WZ&;V&WJJ)?&E@WF^KC&6#I3L/@!/[FK2
M,ORTCE'<18K:/ZYN,_E=2L:Z,R:5 D&UI_/M,"J)^KUS@\7*STX9"7L=0P^?
M3<"=?758!-6JW:0# .6QF'Y\_/75,O/F]":%"=J)??#-)30'28I8YWLV[ 9V
M<>+/?(F@W<S7B]B?^TN!JQO5!XZJ1\V93 >+FD"Z#3E[C0U*61]^FBZ!34>T
MOLEF1\]H7OKW"_#?V3[]KU7->B^7: 3,O86J4=Q)T]2LQ241EE_5\Q<]3M*!
MTEU3\.3^YL[J\L-+ MX<S5^3)Z&WD2#E[[(.#\1=^NUBBA&CFQ]A[J3)/3H
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M98BI"P\;L.,AZ.&#5CA97\ZR$[W^X4*8I?B0$&YX9&;S)O0-WM/TLX"M7/'
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M!@78U#<K3H56;/RP^I7JX_-VF/HX&\.F@HQ'\&C<]'0<ACV?Y:R#$/4+#>E
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M]%G '(D;*9XR5<0\#$O+W#67_VG])K&(TJ;EXLS@;V=").$[ U DXCC#';)
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M>V"%CMN'_07HN-$)&$<,@9_O(XT./04LW2/>_K75* O W3'LT%N'ON^NE4P
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MAB IA+D;'E89Q.-Z[B]BM_SZH3N#?P%02P,$%     @ QV135:E2$PCB40$
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M01:5O&+5JJ1\-0]DP$.&4ABFC$$D0PDIY2GD&9$\4IRJV,EZZR/$U$RXK0Y
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MCMXX8FI E^#/$P,ZK^QG'_UEN11_Y(O%QVU9 D(%YY)QJ-U !%$:*LA2DL!
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M,F86T6_ZWCK#FI) QC)((#95MQ%7"&(<!E F(L$Q$X1DL=.*L__TJ2T.M7#
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M1YQPM;/!/* U,$WT <K9-CH#@R=;Y]0HH]HN9U1]:8N<N[QO2Z)EN1+KLDY
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M]M/_VME]W<\>Y4.W4F_SO=M=[&[?O;TS>U1Y46A9ZP+2?'G_L"PTHRQ5?O]
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MTN@ ^'NB7I^2C4K7 T#ZDN*'&**GC;BI:?N+EF1=UF/^-5_=_5HLF>G(8$X
MKXN']:KZ(@U^6L[Z%?YB3@5-_X8WM,JKNEG,YD"Q.4,T8<CO:6G*\%?A'%$4
MQ3%6D$?21-G%>L7(%((Q9W$8)SQ+J5./XG'$GMIB\FUIO+9;+7 %?FBR[G\$
MI5;PMJ@[DYLZ#7J5Z1._-])[8&DB3VYVA[:XMY789V!/9_"'5AKL:PT:M<%S
MO4US^E9S4*L^:QITS?9SR<$& O.:;$#P:,^/.F>^W(-QA![7VQAU(@Z<EW%'
M[[GH+4N9WQ9_63[*LC 2FH+/FWWL5&KOA60P84RO5(2ED-$0PS0@<1@R297C
MYLCIL::VO+2B@IVLST+=G'9;;:"V7 S\ #@T@Q]B5U=Q]U^,PP(/7^S8,=*X
ME'9>Y0,>LKBE[T:*X:OK0LCO4GQ;7E?56G^;37<)TV"N+3J9<,D)CC/(68)-
MX6%M\<H80Y[$@N H0:FP2I!S&W9JE-)(#5JQS<%T(_@_5VTOFUG;E*]7MU;+
MJ;#=R? -\.";%)ZP[;'IX *5M_T$JT%'WBIP >)P%\#I[IZY*6MM=_UM;4*O
M'N6VCG62A1D.:0(Y#0/CCU-(1$)AQI6(,$GC$%F5YND<96IDM!,2U%+V-&F.
M(VI',A?C-#"GN$/DGMS0!8&O?(.C8XR; M"EYD%4?N?%[L6XWK5A!#>;?HBF
M?=4\X"R+<$:AC%4$49+&$"=(0,J"(-._CT)FY=J<'&%J'_Q&2-!(:3HUUIWO
M[,MR'0>R^UOW L_ W[DS,DX%NCJU[U6CZ_@31RO3U:G0?J6N[@M[.ARF]<!>
MXLTF2DDA09BI ,YY!E$8Z9]4$L* Q%F82/W?R.T0]N@P4_NDFXX5SXI3]5K$
M3X!JZ2I<#-70KH$[2NY.0"<(OHS^XX.,:^1W*GI@U'=?W:-KP/+^/F]+@Q7B
M[;(PYX:RX+FL/FZ3>J.8!(P)9D[5M#V/50I9BD)(18"X#(A$L149V XX-5K8
MD[F.8GPF=8]\;6O@NPEC"#@'IHY70]*ATKYG1,<JIG\YLFX%\AU@ZJJ!;_.8
M\<K<.RCUK)*]RWV]B]6;A&?]W*\K6@A:BNK7!Z'M/PUI$*2MA8$(SE#**,QD
M(B&B-("$$PP#'&=93%*N#3G'8O3G1YT:7>^$!ENI02.V21H+8)#VM.OL)L'.
MS/,.[<#4[075/L7A[5'R5_S=8LRQB[O;PW"D>+O#S9<6*=HK%5];JZ:F="GO
M3%#9HVR*.9AS]V_FK'[77!NGF,8RDC!)0@61##DDIDMQ&+.,:E<48[>"L1?*
M,S5*>Q[. #ZKNN9YW2NE,O_:[_#0N&?/U 1&P[ZUA/I-J.6.]7C3-/3>=JN)
MB=4]-QMMB=LV<NJW6B<P2!=V3_AZ+]333YI7JK)S$72G2^1<]MB>5J0)?=(.
M?<HQ)8&$61HD$"4D@C1.F#$8N1)A%"5FK][$@UJ:B?5CG4AS^_#A/LDFH)76
MLCG:>0U,EH:<L_)#6VK=&KO;8,\4]&5D-0\=UXIZILB!F?3\K_T^L$V2_(=E
M^;$.H=;^H/GAH$;)7%*%8L)BR%,I]#<H"<0\BJ$,L>2!P%&D4I=OT'KD:7ZF
M)K1\4P_$[6.UA]SN>QX$R($_^0OJ+[5_,O4\_%&&,X:>6,5^W%&)QQF.E]SD
M_H!^]/4+79F(W*?/)K QO[W;-CGD3 @I&>2A.0&@&$-"]$\B0ZDV')(,Q\+%
M/3LQSM3<KJUXS4=4[^NME^N^QX*GT+7C)0^8#<Q"&PG!#C?_.T)G8/!$)*=&
M&94VSJCZDB3.7=ZWU0];O<LKOEB:C(MMI4.I6)0J4^$R9)H1DH1"@F@,DT!D
M:<A8%$=.$<C'AYD:(=11]SLQ>]>;/ &J'1%<#M7 /- #I1X-?+I \-:WY^@@
M([?KZ5+TL$M/Y]7]*&"3&74CRZ]W=.]]39)(J#!"ILT7A0@'(:0ACF"&J4A%
M(&@8<[?.%J>&<GF[QVEH48MWMUQH&*O_^4\X"K-_V<N/!0^R!)6YQ(T83D)-
M<"@#CC.((JD@"L,$XHQBS;=28,)2AD,G"\P'T*,T/FWE-+&$H):T-^F>Q-:.
M=GT@-C#Q]@/+F7O/(>&)?4\.,RK_GE/V)0.?O;YG5JG4U]+%?]2[PK1X0XO?
MK\2CJ?ZRB2Y$21QR)#D,(B4A(BB"--4NFTRP3*5,>9IAI]S2<R-.C2I:@8&1
M&!B1@9$9;(3NFV-Z%G@[^O *Y\ \<C&2[GFGMNCXRCX].]ZX.:BVZA]DHEK?
MZ*N[V=OEPIQ9F4'E0OQ:Z&?M\K@_RL+4;Y[''(>$9A%$,C(98$*;B PK&"*>
MHC@D0H;QO)"WYO#KFTO7YS[26'U8I/FP#F0:[B-[>Z?_I3^FO #5+A%^T<@,
M^%:Q2UNE64V8'8<-B/^K-E7;:0&,&F!M]-@O3]!J,F2S-1<D!^O 9B7$*[=E
M<P'J?*\VIZ?U=)_KG-O=4S\\?LKG*@T((IS E,8)1$)Q2#(A8: =.2X2)8E=
MNES7(%,ST!H9]]C.T7\[AJ.E[W8A.D/[;0TP._EFX,-_PD_7,_"VJ=CFT7?K
M0,*7WW9LB'%]M@XE#_RUKFLOR*D[&<[S_699FBB^J]6JS-FZ;H/U;7E#S3R'
M\RC!(@U# 4F21B8@AT*,B8 \#E-*HU0FL5MEC_ZR3(T^SH;2S>JN\3^T1Z$_
M@K8U^0RT6H)]-4U)BT;1'KE]/2?7CJQ&FK*!.<UNMGK/3;^,PLM0]9EVV%.2
M\7,3+X/L: +CA8^\-$+]BS25K[DY+"UNKPKQ1=9!F*;98!-M.2=A% N*)20B
M%A"%@D$6QQ2J,*;Z]R%3 >L7C7YV[*F1[GY<\YMUE1>RJH"I+7.?_YVV)8+T
MNJE_?#0;0[4.O=O6GI\9.P8=".^!&7,?ZF=RU]$GK>2@%OTLT!=$BEM#YCTJ
M_/S(KQ0!;@W)Z6AO^T?T;%:W+&Z_R?+>' "W3L.<R"",DBB& @D$$8HH))1J
MES/1_):Q#,=<.?6A.QQC:G35B@4>6JM"?TH++3748]\#H>5V[!AW!%4["KH0
MJX&IQD@'C7AU'<FMFPG:$*(NU]R]H]MI)'PU:SLRPKA]V$ZK>-!BK>-2]_(-
MU\5*3ZNIUMY$KW_<);SS+$Z%MEE09DP8H3 D2"&8(<J#6 4H2*R^_<Y1IO;U
M[P1M2E3W+2EP&M;NC]\;6(-O@P^-DWV]!2]XC51DX0 W/[44SD+044#A]+VC
M54TX*_Y^J83S%P_;K-=T+/V@?95Y%&8\"4BJ?;S M)2D%-)$A9"I**(ABW&0
M.&4<NPHP->[L;,Z;#M-H=SL9EC;5@! /;7#U::QK=!B_L^Y+]$;NJ+L=?I*=
M=%^"T[>#[L%S>FYJF0BS-WH,8?;49%'5"^!569K0@GJL-T^[:]KQKTQ?]:8\
M</7^NRQY7LGJNFBJ"OY5FLP!*:X>M0JW<O/WFS+G<LZ98"A,,&0RT98EXQR2
M "'M4*HLBV3*<(K<XGW'5<"%$,:)(MZ(IS_YC>"PE1RT);AKR>MXXJ_N\<0C
MOR"6VW.3G?2A=_B,4K#6"NRK#O9U!^P)[%_8Z@]J &;M6Z&7Y2T()H*E@6'W
M$H'-2[2YJGF-/.X7OLH<^MIR'%?X<7<M7V5B#C8^7T>*WJV,\Y5<Z.58O'1/
MKOC?UGDI13B7@F>,HQ@FB=+^ D899'&(3%G<2/\M89(Y^0LV@T[-1VADAK70
MX' 382.W<\/C\^C;+2R^,1UX.6CA_-@7SCYMD:WQ\=<C^?R08S=,M@;A2/=D
M^WO[D=$GN7I+J[N;<OF8"RG>//U:F<':1IW%[15?Y8_U%OT<HUB@E&>0LEB:
M/5X)J<8?RAAG42!1&,3$I82(_=!.Q#1"#1$M.>!:=/##NJI[$/X('EHMC#FE
M-AH NE7!C:0<9L6.JH;!>F#",C ;J<'-'K@__+J!?"L\N#H/LS-YN2/FB<(<
M!AZ5R-P!>4EG/9YP:?7:F^4B-W5QM\F72$6A1%C *$L41"3FD*:"PP0C$?(
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MSC$XAB2,$618)'$HE2*A4RWC4P--C>U;.3>1/[6D/7,M3F(;X22,0\JAY$I
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MK=5@8[9W:H?5 -@Q;6A8!U\97HRH1Y2./43!8G LNAPYPL8>A,/X&8=G?34
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M><8AC26'*-;+MR(3.8Q(QG.]LB,B<V(RQ_ZGQF@[\V%M_^'IJBDR5OL :B?
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M#.IL\.V"ZHLVOYTLBS1"&<HPI*2N(59$)IA)0L%8G&:1P"AQTHHYV^/4>.!
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M2:Y7C4C&L"B0@GDJS3U6*FGBM&"T['=JT\/.;#@_7ED4;$QW%7RT&P<[NA\
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M]:U</9A8_9D2-"'ZNPBCV%2%XFD*69KGL!")*FC.<)$Z;>].]C0U'ML8VH2
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M+:OU]J=:BJ*R,?Y2L1SKU- #$A#1*('$QO@C;39[!%."H\POQO_"B%/CBXW
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M%WIP!-O-KQP>PH%7L8W X+>-R+];\MKUR7CO@&N/=M\^, 7K_>TTZ,B-P'V
M..P*[G6WOT'_O!G%0I=J5319Z_*Q"7(7=;#M:L%5J72Q4OM!Z)1*AH@QZA'-
M,XB(S"!-$($$Y5&:T@AEU*G(6Q!IID9=AXUGC$I@HQ-HE0*-5M;L:/4"RB>2
M?8!9O6SECSI7 W/D\E>=)G>[?]3I&LGV[Z+>ECNX=A[K2M:!G.3!(#]CO%\_
MQF@&?# XND9\N(?VS!5Y7F]UKQJKC8TJRO5BW:F\:OMB?VI[$-BHJJ\/K(R3
M/\V5#U5S./I1;_Z]FA'",)4QA7E&.41"VU: G,!,4&/[IY&6D5,/Y9'DG=KZ
MNXM=J3HUEN>V\<K*Z 'B!#S6FGCFK P\ZVY;D0G-Y<#KLU.5[)W"W?+8[^N#
ME5:G&_"^._6-XMT(IZWR 9-PQIFE4%D\ TL[;AK0.- ?Y!&--&S?:MUF4[E8
M?E\T_0EMR5\CT[I<+9]>+Z2:I03+*$$(DEPD$&DM(6>Q+1!AZW7GFD?(J5^7
MXWA36S':8M3/9+ZI*U$K8-./&\F!%=VWCO=YW,]S_@!H#LS9(8#L4>';"9XK
M"GV??_[(];Z=E#TL^^UV6S^#^!6KBNJCOA7"/M+V'JR]M\V?NX9**<ES@1F%
M6EB[-D\,P:3*_*10*KF,TRB1/G:MV[!3(YM:ZMKN,$_=[)?]3%%'O-TLRO H
M#DPR6P!W(M^ ]KS@6_O?0=I2^2$5R#AS''14&\L/B'U3R?/NGE6PM%9B]5&_
M_2D>;,"RC8'Y6+YFU8/]_]O_71<_C%U6VL[,U6I9B)62]A]N2_G\%YTK9[&*
M8HWR&&:V_CK*B(848P01B2,F"1.,>=5.'$#&J9%=HZ+]6&W;F>*^!*I5M@[D
MJH_6-^?US0]JIXQG?:X!9MR-05]X'H>VZ;93N-&OCE.T,V>%OJG_!!W9;\!.
MK?82.[M[OWQ^1[M!LL$4;;YAT/WX@#,4JF39 !*.6^YL.(@/2J4-.%3/8MW+
MA7EK5T^?S)>S,N/8)W^WAR$?U&J&-<D8HA*F6FJ(F,20"F',WE3E5,41U](I
M_MMEL*GQ_T;6F@'41M ;>T3C6</[',)N-!T*MX'Y=B.FL6FMH#5R;W?(?3B#
MG']-;P=(0M7U/C?4N+6]'90^J._M<D_/]A[/\NLWA<1G*HTEBQ(.8RF488W(
M)HQ0 9F.4HZ2.$H3IQ"+\\-,C2\."D/TJ_A_ E,WGK@>J8$9PA\D_RX?9S$(
MU>;C^"#C]ODXJ^A!HX_S5_N'8GU8E*^72A8KFV.[*.W3/NJ[Q^^L6-:/_EC>
ME3]44_&P:C,6#1<D@B2&"AC-(:)9!!G!%"I*$RUBA"1VJLG3<_RI4891 8I:
MASJ6NU'";E>*G1IVLU+L%.F1.=IGHL[3S0CP#\Q#TT7>/41JX!D8*2BJQTR$
M"7>Z KXS 4Y]GCI:2-,5*G>#F*YYC/\Z\TDM]6+Y:&.('\W2M5[6%1R::B^W
M/XMJ)A#.(J1SB#&-;<Q1 CG+%:0T%2*/$>7".:+WTF!36T$Z\H*.P&TQ'/#-
MRNQ!6!>QOKPNA$1PZ.WJR."Y4WM($$?B\>O ]&)N5W3.T/3%1XS&R:[*= G8
M^9Z^0:+?ETHT(:JWC[;5]O]M?B[EK3!KM?W9^JYDQG62LACJ*$XA2N,,,LO#
M3%."&4YD++T.Q1W'G1H'=\6N75ZL([MOH*8;\F[>@ 'P')B1NQ+7E<:W,M?
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M,SX.@7.S-JZ"8V!&W<@&&N$">X%/:A[(6#A\_JC6P4GU]LV!TQ=>D<+PRG;
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M52OIC6'V]O3-SVW58S;<?%7#8CPPO]>'<3L9C[77N $[R</YH?JC%LCYU$.
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MO:>#@1 /-"^$EF[4"6(@: ]GBJ&&N3*MH I"_:"^J65:%\%6+)>ISCA(.<$
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M.6J$#I!HW@>C8(5M'88<N;ZM.PC'96X][O4O0&+WWV6P=,EQ[; 'Q#!2,>=
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MH.!QQ<I+-_1<'N_.$C\4;*7D+NGB3M\6RZ59ZZW9<@X)P3G4"3 +7$,22"+
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MV I,[U=F+?I@-X8WFXW:;FX>"[-/K%9 ==/+_U%L_<Y<.T\8357*&<!86'+
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MS?BWY>+W]:?7B]//8?YMPE-FS*D C,O: ^H)VZ&0?R5TE+88'X_,8SSR\-U
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M^BJ3Z@Z #"'4SN(8"_A:JN*]9X9E[C#LM/'F6&MUAZY^ 7<()O:Q9L<HZ$6
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ME^E\47=C75X$3*1&'0O6O;QUR31Z!2&@!!]MB:HHQU5K__@N#9U$5VV <I2
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M5=1+3;<]E'C:*5=UZU\<7J+RG-0]2SIO8*$.G_[#XBEJ+1RREW3,ZGV?8\J
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M=(VSZ1?,=&K"_*3NRSP/DBXC(S[1,4L=C0'EJI/IG:V%C'1L>'2,.15B:;T
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M^^[0L[7QA1F/"5, 90O]PK4%9XH#:8RQ*(,V9KBY)B^FUVPOO>_?:[:/$CJ
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M/7MHR0!#YH.N@]-SJ!6=T4/D3(-!PX)/1F/SLNQC=H<,!IQ&BMYQ5\@^4N\
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M>)I\GMXR6IFZ7JJEE5.YMONO!DF@H-@[%8KF0WV#\\8&UKQ!X'%R7M!RGV-
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ME1U =/46M?U$"&BS#PZLT_5%TWAPTCB0Q4HNK-4DM"'> @\^PMV+!V$;976
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M'GO ZI,%A$A2$XX,3Z]>RI-(X)'7 D+O+=/>,\=:@_+HDMZQ/.40&5(S[?0
MM1\JC<@2C.'. "\A 8G!@C-"0TY62J:-+[+UVMNSJ=O=2[%/UNWN(^5SJ=N-
M05NTQ8/+H58U!PN4TCF*7(M.7";/U;V>WA=3M[N7.@^IV]U'MIW7[<HZ8E^Z
M5"54914*("L)8F"BN"1*R&H'F)Q1W>ZAZ&@IR0[K=DNR= !K8+$.%\)BZG"A
M"$(KZSUG 0WN@(.^ZW8/5?V1\NH@JG@0==V^_,I$R6'2"KB+!E2I:2.KEQTL
MLA"5UI*WG@#X.#5=)TX#A*Z-]-(!PIZ1W?4(@-=7R]]FRP_Y&_WMG'X)T_F]
M%M355N#$M-1"0:VD!R4+!W*@'*STR9;@3 FM9^PT)'_<4*@5HO:[YA],O7V7
M@/R4P_* $H_5/VM8PO&0C$8E&O6#?YHLXN6,%'[[ZFZ\$ JS!V.8KPN0#011
M.Y90,:$+%MW\PF,[)<<ZK1\_]1-)[37]\=\OK)>N^FT(RFI"*%*@P!12DIF,
M]R)[%EKO(7N$E'&=20/]WW<D+43>OU-810:'5'_=^<>-'<0VDH9U$\6[(B.C
MH+C6^RG/=)UBBY"C1V/(UP>'9^$FZ)BCW&\Y(0'>2/(6N25;X40I0*=9!J4,
M@D^<@<R!THJ@A2RMZQ&>)*A+E[$/%AX$R<W$W[_C^)%7^FP2XJ8(\_"2TAT_
MN+'#V9>589T1(8$IG0SH6,OE'2L0#*JZB@*C9Y(YW[HB8[B8A0+PY?SJ-@45
MA/*$=%H*YQ*HZ#V@-P&*$CHQ#-RJUO7R6\CHTO'LH_=ML<HQHNX@+?]U-OU,
MG_9UY3CIWZQ>3HI,/F<I*.W2Y#*]E.",=!!MYLK*P$AHK=LKMM Q/EZ.4N[]
M+HAC)=TA6C;WILF;7+M Z/"NXZ6]IH2]< XQD_U$8SWFUE47VRD9%S'':_@9
MR!P@[@Y \Z,AK8022RC&<PVA3K]7I4ZUR#F -BGEP(I)98C\^4<JQGUT:NU>
MCI1R=SCY#;]>XYT+FZ+/"9(1=09*9'78H"+9"&Z0R:1U&10MM[3T="3MK^,G
M(7.@P#L SKW\[[J$S(3LK!"4]]6Q;2%J<!(Y>)YR8;%P%*U+8[82TA-D#M7Q
MTPGW 0+O #7_A?/):F(P+M<GM8HF&<P"HEB]TU%.X**I5=U%.^F3,[;UK?5]
M&L9]WFQ])!TEX<X0LK$:32PG3 RB9@:4$77'DF; ,K=69A.<;'U+\)"*<3W*
M<5I] B('B+@#D/QH-!]RRE^_556\7VUR7@G(\Z)T276&?7T.*852 "\D2,=$
M+DA4A2&NEIZF:MP9!<-&OT=KH7M<71_BJ (6#,!9;>DHA0$Z.H%C8<8P5%+B
M$"\HS]'54\AS/!;V@MH!BND.;+_>;OR@%,*;["%G72]''8+3U<DSBAQ9,DZX
MUC'T(Z3L!"E]GN[J,'EW!YLW.)]_GTP_O_HZNYHN+XH*M1_2@2PL@Q(I@Q<I
MUJ*>P*7AG$[U0;'S(ST]^:0#%?XDB(Z0_L%(HB0PS(9)XG^;K2O&B!6,G$?E
M&!C+Z_+"3"EEW3H1D@XI112<M=X^]B@Q/=T9MD%1&[EW :%[!G'+V/JW"]+2
MAZHK?E%0FR"=A,(8B4F8!*AJ$""R*T0^2\V7;.Q,7$]W (,XJD9ZZ>_\V\;8
M^_DD9GZ1*52(VB!HX5=CO -@K7:IJ[JYRF1JP9X><&OB>LH$3P:X _32?W%0
M@^ER6S^F<>'/2:;'/5+NX3D:6:(#JVIB%@E;#EU=AQQ8\D47[X<PQ*'+?!8W
M##)7*V&]AJ(%64O,$8*AHULSF1CGNLC4^BW^$5+&C[B/U/_3;N4PD7=W:FT6
MA!OIG#0>4DAU%C.=N8%L$ 1F)5UTWOAAGU@[*1 [6KT[5(CM(^L.X/*&OG*R
M_!GC>@/@ZM&9CL[BM +CN0$50H'@;88Z8,;$PIDSK<L)'U+1$U@.4.S]-.PX
M*7>'D^O!,2[*;),!9J4 I;*A@-Y$X)@MI9?*I]3Z374;'2.WW!VIVR>A<H"@
M1^XN?U5G4DFC?L+OUTQL*@BT+]D)K@&]KR/+.8)GY&Z9%3H%&R2:7692//H%
M/<'@$+W-6@MQ;"3H.O;I'OU64=*5T0&7=<MX#!X\.4]PQFK'DY66VUU L.6S
MQ[V]:ZO_8T77P8GQ\2HL\C^N2'1O_ZB'Z'7); Y<>VDRY)0D*%P5$DD'AA<O
MN4TEN-8YVB.D]'3=>WR,T4+>?<)F8TPJ2U6L<1 4<:-20 B18G8CF<U*:!]3
M\[D CQ$S\L"C%JI^'CX'R+T_ %TO6T4K&!V7@+I>!=*OE.;5Y>8ZE\091J^:
MC^3=1DAWP#E$R4]#YP")=P";7>I*HO#,)0LIE@3*4FSO S+02>N(Q:<@6CN@
M1I5>)RTJ/>80:ZR%[G%UO5(V&I55()\ME*,X,6CB*0:04J+/+%D;AKV@.]=*
MKWVP<$BEUSZ*Z0!L6WO45.:E3M4%6QBY7X,)'$H&PCK-N(@NN^;KM [M]SQI
M2>HQCNIH27>(EFO,2Q&#SIQ CA0*:.L K58@N6$F%:W;;]@XFW[/O32\6[_G
M/N+N 323:7Y7UK<=-UO,HS:E4*07A (5?*)(3Q>06D2NZX5';EW"]9"*OL!R
MB&X?[-4[2M C7_Y]O)I_N[Q:_#9;YL6&>E6O\&REWB&2[3@#Y'X9,"F4M8IA
MNM^!M?7J[^$GCWN/TU#U#037@8?XD/^87?XQF7[^\4ITPXR1AHY694$87\.J
M*,!IRC8=CYR%'"@-;1V-/$G0N/G3 'ZCG?C'=B%Y.JDK<A<Y7M$WW[4(9[F@
M\+L.B:MC70Q%Y#XYDA1%<S*74 <O[.)*'OV&<8/5UBZEC2 [<"VW,]K?X[<\
MWS"1HA"%!PY&1 TJ%0O!%T7_R4E<(96@VH]@VT+(N%TL [B2X\7= 696LVL_
MW0_DK3.,)8& =7.$XMH ZJ2A,&^EI<C*YN9;6[81TE_GTU%O4$?+ND? ;"PI
MH^9!%@?"UXTCM9 =2W*0(N?><>5,;MU6\ @I'2SN.T[)S\'F (EW )PM&9N.
M]$6<UV%.1H#*65/N9@V8G)150BH=6S\9])8:-U'N\[GQ/I+N "L_9Y(Z7O['
M[&O^=8;3USC]^ZNTJJF_#LV"",%IS<&79.O]LX J%CIKF<M9N+HKK3%TGB6J
M@]UBC9'45@\= .MZ/<VK^(^KR6*RTLUJ4EWDY(I5(M%P8B,X!\%:#0GK,'[G
M3!&M+^D>(64G$)ES"7E:R+M3V-3?SO.-E>G@M64<A*BU;-I1JA@T,<31VH I
ME>85%,\2->[)UD3U.\#I<#UT *RW?RTGT\_$RY=J;^]*M;_U4XKD+K$B0'!R
MW2J1^7DNR/R<Q6*\9EZT;F5ZC):=8&3/Q2,UD7BGR+ESZNM<4-?!5%G5@71:
M& @\:A E&99+T/G^BL-!\--+5M9&ZSM Z4 5= "H[8,-<PPN<%10Z^KK,)\"
M06*$$BP3S'/C1>MSK<-)DBTUO=,\R7W$WN]#1(F4: B2!DLVU=)&"XB\@)6L
MI!"=X_+>(3;$0\1@&=< J&@HT Y<RI:9O8%)6T(D#D0="<ZUI:,[6BA&6>-]
M+,:&06OY=HYHW+E$-$=*N3N<W!G4RX1DP>H"2F3Z13+*%9*H%QB9%6U-4,V'
MZY_-].N]=+SK].M]!-[ON>-0."VE!!GJ?&=51^DP+L ZYFR,5B)_;A9(@W/G
M]'.M]]+>CD_@>XBR T_R='D'9UKKS!58+0T%^[& CRZ"MQA+D=Z9TGJDX_'5
M-2=JL3L21NT5T &:MK_P&UL*SP%!H223\*XV Y$+9DIK"L2$<:5]2G1H0<6)
M>EL:H>=X@8\ZC.^1"D7.A(T\,/*A%?7:!L#L'&A,*C(;O,2=CJ/#2CM/U#30
MXA@Z3G1=.(QMR7PQ+$8N.41NZPL<03>$PH!;Q6U2/I?[HQU&O$,Y435-,X=Q
MK,!'CF)_GEW-W\\FT^6[:?[_\WSVGMP?B>>GJ_SIS]FG+[.K!4[3IR^3^?([
M_>"ZY#EA#I)9\,;5VR&7P">+( )/V0DRE51V<"B'?'=/SY,-7,[@XN\%7C]/
M_LCU_RJ3/W+W\Z3<94Z@(:,)I;K8NH ^:O"E7EUY75L&Z=RUNQQ6>W]Q3Z],
M+8$UB.!'1M4G4GR^-AOBH/*WW7+^I!_=X9&8BHD5#H$\,%E.%A3_J]J6&F46
MCOOH]0[@.O3[>[KW:X"QDZAA1*@MYLN+#SC]O&DNM!3XV5BK!3!0%A I"]"2
M@78N,<U9\7*GR3CTJ7<B*/JOV^CIAR_<"2S^-& Y_)+X<!GVH/CKUS!?!\:Y
M#-(["RI+!\A1@F8YVF*DC[M-TMM%]6->\!VAK/OJ/D!R(RO\/R?3R=>KKQO"
M/<,4/')PMDY%X<0"<DV )Y![3\0GM],ERS,J_^%+1U;Z(2J;M9#?V(K'O^X0
M+CUS!I6'DNE84C9Y\/0K.$.G(%,J:KY3!^1SBK_[I>/<PS93_,'R&UGQ;ZZ^
M7EVNAJ&_+27'Y7JVR+OR*LV^W90+,F5506^!V=I/I3 2*TE!H%2>1U]2:.((
M=J%E-__ SB$D:"[ZSJ%TO9HL,V\%A=8J957?3)%R+!: BR)4<%GIM-/.N"/!
M-.:+\C#:WP-:!ZBB<W"]2O]]M5A^O1WNIKG(0?MJAF20RHH,@8<(V9K$C!,F
MF)/XK'MT]0NX0S"QCS<[1D$=/"O<TK_X>3;_+?_Y*L:ZZ6PR_?Q^/IO2;V->
MS^U?%]@+EPH*8'6Y@U+20D!;0*B(UC-+:4/K5^Z]"-P-AF<SO7XXY72 O%K.
M>&M'U_??=<Y3LHS2445FFK#0H6 U9 Q.>60YA-9#2K;1,6X1SH!JGS7600<X
MNA7.QR5.$\[3XO=O"9>9-,V8V3"%3I&[]P*<KQ-ZF2'_[SP#KH,(4@5,KG53
MYTZ$C8NTX_5_WV,U5T8'""-6EBN#>_N/J\GR^YO9UV^SZ8W])9]3*((\N@N4
M%9?$(;@0:J#!N;0EZBP:(^M)@G9#U/E,5V\F_ Z0=(^'36QJ97&<@D1RWCJ1
M>*0'CS: EEE[#%P%UKKJ:RLA(X\K:*?H^\U41TN] ^A\J$O]ICF]Q?F4W.OM
MB+J<9&4@>TY<"(H#O!&>N-!&,AZD":UGHVRG9.0NJN-5_*#:]&AY=X":Q]:
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MQEK[A::N BP9<A$^1:.%O1]!'M^<]",)[8?DU<;V;:U[)FJ?K%20/"N@9*1
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ML2@*U=&!RS$9)90+V/%IL2.7?;7]=W)5.P1"_GELZ$)ZK\1Z+TTVH!ACI,6
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MGB%W/VA>RJ'CN?0V "MY#*L[^B1DS9TKV8%2F9'SK!E$[REL#*)$$:+CT@X
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M$O7GP]YYM-)].Z#U?]0O,<SQ__Z?_P]02P,$%     @ QV1350CS1X-F"
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M+B7/5/48/9\ NS]F@%F.!2HC.FI8$27!J1&^U0%KHD^8*HD%5@45Z+828^4
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M\S( $               @ $     96QV+3(P,C(P.3,P+FAT;5!+ 0(4 Q0
M   ( ,=D4U7UQO,[W18  +?N   0              "  0O( P!E;'8M,C R
M,C Y,S N>'-D4$L! A0#%     @ QV1355U=?5IF'@  7B@! !0
M     ( !%M\# &5L=BTR,#(R,#DS,%]C86PN>&UL4$L! A0#%     @ QV13
M53S4=RV=C0  4#\& !0              ( !KOT# &5L=BTR,#(R,#DS,%]D
M968N>&UL4$L! A0#%     @ QV1354>%UI]#2@  SU   !,
M ( !?8L$ &5L=BTR,#(R,#DS,%]G,2YJ<&=02P$"% ,4    " #'9%-5J5(3
M".)1 0!+Q@T %               @ 'QU00 96QV+3(P,C(P.3,P7VQA8BYX
M;6Q02P$"% ,4    " #'9%-5_<;B; [0  !AHPD %               @ $%
M* 8 96QV+3(P,C(P.3,P7W!R92YX;6Q02P$"% ,4    " #'9%-5"/-'@V8(
M  "N*0  '0              @ %%^ 8 97AH:6)I=#,Q,2TR,#(R,#DS,'$S
M,C R,BYH=&U02P$"% ,4    " #'9%-5-Y"305D(   9*0  '0
M    @ 'F  < 97AH:6)I=#,Q,BTR,#(R,#DS,'$S,C R,BYH=&U02P$"% ,4
M    " #'9%-56%,V.]4$   X$@  '0              @ %Z"0< 97AH:6)I
M=#,R,2TR,#(R,#DS,'$S,C R,BYH=&U02P$"% ,4    " #'9%-5Y'L=:^D$
M  !"$@  '0              @ &*#@< 97AH:6)I=#,R,BTR,#(R,#DS,'$S
>,C R,BYH=&U02P4&      L "P#Q @  KA,'

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
